PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Efron, L; Dagan, A; Gaidukov, L; Ginsburg, H; Mor, A				Efron, L; Dagan, A; Gaidukov, L; Ginsburg, H; Mor, A			Direct interaction of dermaseptin S4 aminoheptanoyl derivative with intraerythrocytic malaria parasite leading to increased specific antiparasitic activity in culture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMODIUM-FALCIPARUM; ANTIMICROBIAL PEPTIDES; PLASMA-MEMBRANE; TARGET; ANTIBIOTICS; MAGAININ; BLOOD	Antiplasmodial activity of the dermaseptin S4 derivative K(4)S4(1-13) (P) was shown to be mediated by lysis of the host cells. To identify antiplasmodial peptides with enhanced selectivity, we produced and screened new derivatives based on P and singled out the aminoheptanoylated peptide (NC7-P) for its improved antiplasmodial properties. Compared with P, NC7-P displayed both increased antiparasitic efficiency and reduced hemolysis, including against infected cells. Antiplasmodial activity of P and its derivative was time-dependent and irreversible, implying a cytotoxic effect. But, whereas the dose dependence of growth inhibition and hemolysis of infected cells overlapped when treated with P, NC7-P exerted more than 50% growth inhibition at peptide concentrations that did not cause hemolysis. Noticeably, NC7-P but not P, dissipated the parasite plasma membrane potential and caused depletion of intraparasite potassium at nonhemolytic conditions. Confocal microscopy analysis of infected cells localized the rhodaminated derivative in association with parasite membranes and intraerythrocytic tubulovesicular structures, whereas in normal cells, the peptide localized exclusively at the plasma membrane. Overall, the data demonstrate that antimicrobial peptides can be engineered to act specifically on the membrane of intracellular parasites and support a mechanism whereby NC7-P crosses the host cell plasma membrane and disrupts the parasite membrane(s).	Hebrew Univ Jerusalem, Dept Biol Chem, Inst Life Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Ginsburg, H (corresponding author), Hebrew Univ Jerusalem, Dept Biol Chem, Inst Life Sci, IL-91904 Jerusalem, Israel.	hagai@vms.huji.ac.il						Andreu D, 1998, BIOPOLYMERS, V47, P415, DOI 10.1002/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO;2-D; Blondelle SE, 2000, BIOPOLYMERS, V55, P74, DOI 10.1002/1097-0282(2000)55:1&lt;74::AID-BIP70&gt;3.0.CO;2-S; Chen J, 2000, BIOPOLYMERS, V55, P88, DOI 10.1002/1097-0282(2000)55:1<88::AID-BIP80>3.3.CO;2-B; CRUCIANI RA, 1991, P NATL ACAD SCI USA, V88, P3792, DOI 10.1073/pnas.88.9.3792; Dagan A, 2002, ANTIMICROB AGENTS CH, V46, P1059, DOI 10.1128/AAC.46.4.1059-1066.2002; Diaz-Achirica P, 1998, BIOCHEM J, V330, P453, DOI 10.1042/bj3300453; ELFORD BC, 1993, PARASITOL TODAY, V9, P80, DOI 10.1016/0169-4758(93)90205-T; ELMENDORF HG, 1994, J CELL BIOL, V124, P449, DOI 10.1083/jcb.124.4.449; Feder R, 2000, J BIOL CHEM, V275, P4230, DOI 10.1074/jbc.275.6.4230; Feder R, 2001, PEPTIDES, V22, P1683, DOI 10.1016/S0196-9781(01)00504-6; Ganz T, 1998, CURR OPIN IMMUNOL, V10, P41, DOI 10.1016/S0952-7915(98)80029-0; Ghosh JK, 1997, J BIOL CHEM, V272, P31609, DOI 10.1074/jbc.272.50.31609; GRELLIER P, 1991, J CELL BIOL, V112, P267, DOI 10.1083/jcb.112.2.267; Gura T, 2001, SCIENCE, V291, P2068, DOI 10.1126/science.291.5511.2068; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317; Huang HW, 2000, BIOCHEMISTRY-US, V39, P8347, DOI 10.1021/bi000946l; JAYNES JM, 1988, FASEB J, V2, P2878, DOI 10.1096/fasebj.2.13.3049204; Krugliak M, 2000, ANTIMICROB AGENTS CH, V44, P2442, DOI 10.1128/AAC.44.9.2442-2451.2000; KUTNER S, 1985, J CELL PHYSIOL, V125, P521, DOI 10.1002/jcp.1041250323; Lamb HM, 1998, DRUGS, V56, P1047, DOI 10.2165/00003495-199856060-00011; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Levy O, 2000, BLOOD, V96, P2664; MALOY WL, 1995, BIOPOLYMERS, V37, P105, DOI 10.1002/bip.360370206; MARTIN E, 1995, J LEUKOCYTE BIOL, V58, P128, DOI 10.1002/jlb.58.2.128; MATSUZAKI K, 1995, BIOCHEMISTRY-US, V34, P3423, DOI 10.1021/bi00010a034; MIKKELSEN RB, 1982, J CELL BIOL, V93, P685, DOI 10.1083/jcb.93.3.685; MILIK M, 1993, PROTEINS, V15, P10, DOI 10.1002/prot.340150104; Mor A, 2000, DRUG DEVELOP RES, V50, P440, DOI 10.1002/1098-2299(200007/08)50:3/4<440::AID-DDR27>3.3.CO;2-W; MOR A, 1994, J BIOL CHEM, V269, P1934; MOR A, 1994, J BIOL CHEM, V269, P31635; MOR A, 1994, EUR J BIOCHEM, V219, P145, DOI 10.1111/j.1432-1033.1994.tb19924.x; MOR A, 2001, KIRK OTHMER ENCY CHE; Navon-Venezia S, 2002, ANTIMICROB AGENTS CH, V46, P689, DOI 10.1128/AAC.46.3.689-694.2002; NICOLAS P, 1995, ANNU REV MICROBIOL, V49, P277, DOI 10.1146/annurev.mi.49.100195.001425; Oren Z, 1998, BIOPOLYMERS, V47, P451; Saliba KJ, 1999, J BIOL CHEM, V274, P33213, DOI 10.1074/jbc.274.47.33213; SHAI Y, 1995, TRENDS BIOCHEM SCI, V20, P460, DOI 10.1016/S0968-0004(00)89101-X; SOBALLE PW, 1995, INT J CANCER, V60, P280; Sokolov Y, 1999, BBA-BIOMEMBRANES, V1420, P23, DOI 10.1016/S0005-2736(99)00086-3; STRAHILEVITZ J, 1994, BIOCHEMISTRY-US, V33, P10951, DOI 10.1021/bi00202a014; TANABE K, 1989, J PROTOZOOL, V36, P139, DOI 10.1111/j.1550-7408.1989.tb01060.x; Tossi A, 2000, BIOPOLYMERS, V55, P4; Uematsu N, 2000, BIOPHYS J, V79, P2075, DOI 10.1016/S0006-3495(00)76455-1; Vial H., 1998, MALARIA PARASITE BIO, P159; WADE D, 1990, P NATL ACAD SCI USA, V87, P4761, DOI 10.1073/pnas.87.12.4761; White SH, 1998, BBA-REV BIOMEMBRANES, V1376, P339, DOI 10.1016/S0304-4157(98)00021-5; *WHO, 1999, DIS STAT WORLD HLTH; Yang L, 2000, BIOPHYS J, V79, P2002, DOI 10.1016/S0006-3495(00)76448-4; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	49	66	75	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2002	277	27					24067	24072		10.1074/jbc.M202089200	http://dx.doi.org/10.1074/jbc.M202089200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	569PV	11937508	hybrid			2022-12-27	WOS:000176611800014
J	Ahamed, J; Ali, H				Ahamed, J; Ali, H			Distinct roles of receptor phosphorylation, G protein usage, and mitogen-activated protein kinase activation on platelet activating factor-induced leukotriene C-4 generation and chemokine production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); KAPPA-B ACTIVATION; PERIPHERAL-BLOOD MONOCYTES; SIGNAL-REGULATED KINASES; MAP KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; PROINFLAMMATORY CYTOKINE; CROSS-DESENSITIZATION; ARACHIDONIC-ACID; GENE-EXPRESSION	Platelet activating factor (PAF) interacts with cell surface G protein-coupled receptors on leukocytes to induce degranulation, leukotriene C-4 (LTC4) generation, and chemokine CCL2 production. Using a basophilic leukemia RBL-2H3 cell line expressing wild-type PAF receptor (PAFR) and a phosphorylation-deficient mutant (mPAFR), we have previously demonstrated that receptor phosphorylation mediates desensitization of PAF-induced degranulation. Here, we sought to determine the role of receptor phosphorylation on PAF-induced LTC4 generation and CCL2 production. We found that PAF caused a significantly enhanced LTC4 generation in cells expressing mPAFR when compared with PAFR cells. In contrast, PAF-induced CCL2 production was greatly reduced in mPAFR cells. Pertussis toxin and U0126, which inhibit G(i) and p44/42 mitogen-activated protein kinase (ERK) activation, respectively, caused very little inhibition of PAF-induced CCL2 production (similar to20% inhibition). In contrast, these inhibitors almost completely blocked both PAF-induced ERK phosphorylation and LTC4 generation in PAFR cells. However, in mPAFR cells pertussis toxin only partially inhibited PAF-induced ERK phosphorylation. A Ca2+/calmodulin inhibitor had no effect on PAF-induced ERK phosphorylation in PAFR cells but completely blocked the response in mPAFR cells. These data demonstrate that receptor phosphorylation, which serves to desensitize PAF-induced LTC4, generation, is required for chemokine CCL2 production. They also indicate a previously unrecognized selectivity in G protein usage and ERK activation for PAF-induced responses. Whereas PAF-induced CCL2 production is, in large part, mediated independently of Gi activation or ERK phosphorylation, LTC4 generation requires ERK phosphorylation, which is mediated by different G proteins depending on the phosphorylation status of the receptor.	Univ Penn, Sch Dent Med, Dept Pathol, Philadelphia, PA 19104 USA	University of Pennsylvania	Ali, H (corresponding author), Univ Penn, Sch Dent Med, Dept Pathol, 4010 Locust St,346 Levy Bldg, Philadelphia, PA 19104 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL054166, R01HL063372] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-54166, HL-63372] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahamed J, 2001, J IMMUNOL, V167, P3559, DOI 10.4049/jimmunol.167.7.3559; Ali H, 2000, J IMMUNOL, V165, P7215, DOI 10.4049/jimmunol.165.12.7215; Ali H, 1999, J BIOL CHEM, V274, P6027, DOI 10.1074/jbc.274.10.6027; ALI H, 1994, J BIOL CHEM, V269, P24557; ALI H, 1993, J BIOL CHEM, V268, P24247; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; BRAQUET P, 1987, PHARMACOL REV, V39, P97; Briscoe C, 2001, DEV BIOL, V233, P225, DOI 10.1006/dbio.2001.0217; Cao WH, 2000, J BIOL CHEM, V275, P38131, DOI 10.1074/jbc.C000592200; Carlson SA, 1996, J BIOL CHEM, V271, P23146, DOI 10.1074/jbc.271.38.23146; Chen ZG, 2002, J BIOL CHEM, V277, P7356, DOI 10.1074/jbc.M110058200; Claing A, 2001, J BIOL CHEM, V276, P42509, DOI 10.1074/jbc.M108399200; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; Ferby IM, 1996, J BIOL CHEM, V271, P11684, DOI 10.1074/jbc.271.20.11684; FERBY IM, 1994, J BIOL CHEM, V269, P30485; Gilbert TL, 2001, BIOCHEMISTRY-US, V40, P3467, DOI 10.1021/bi001320y; Haribabu B, 1999, J BIOL CHEM, V274, P37087, DOI 10.1074/jbc.274.52.37087; HARIBABU B, 1993, P NATL ACAD SCI USA, V90, P9398, DOI 10.1073/pnas.90.20.9398; Hirabayashi T, 1999, J BIOL CHEM, V274, P5163, DOI 10.1074/jbc.274.8.5163; HONDA Z, 1994, J BIOL CHEM, V269, P2307; Huang S, 2001, J BIOL CHEM, V276, P40977, DOI 10.1074/jbc.M105242200; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; Izumi T, 1995, BBA-LIPID LIPID MET, V1259, P317, DOI 10.1016/0005-2760(95)00171-9; Jocks T, 1998, NEPHROL DIAL TRANSPL, V13, P37, DOI 10.1093/ndt/13.1.37; KRAVCHENKO VV, 1995, J BIOL CHEM, V270, P14928, DOI 10.1074/jbc.270.25.14928; LEFKOWITZ RJ, 1992, COLD SPRING HARB SYM, V57, P127, DOI 10.1101/SQB.1992.057.01.016; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Maruoka S, 2000, AM J RESP CRIT CARE, V161, P922, DOI 10.1164/ajrccm.161.3.9906059; Miller WE, 2001, CURR OPIN CELL BIOL, V13, P139, DOI 10.1016/S0955-0674(00)00190-3; Miura K, 1999, J IMMUNOL, V162, P4198; Montrucchio G, 2000, PHYSIOL REV, V80, P1669, DOI 10.1152/physrev.2000.80.4.1669; Myou S, 2001, NAT IMMUNOL, V2, P145, DOI 10.1038/84244; Nasu K, 1999, MOL HUM REPROD, V5, P548, DOI 10.1093/molehr/5.6.548; Pan ZXK, 2000, J IMMUNOL, V164, P404, DOI 10.4049/jimmunol.164.1.404; Pan ZXK, 1998, BBA-GENE STRUCT EXPR, V1443, P90, DOI 10.1016/S0167-4781(98)00198-5; Qiu ZH, 1998, J BIOL CHEM, V273, P8203, DOI 10.1074/jbc.273.14.8203; Richardson RM, 1996, J BIOL CHEM, V271, P28717, DOI 10.1074/jbc.271.45.28717; RICHARDSON RM, 1995, BIOCHEMISTRY-US, V34, P14193, DOI 10.1021/bi00043a025; Roth M, 1996, J EXP MED, V184, P191, DOI 10.1084/jem.184.1.191; Schwarz M, 2001, J IMMUNOL, V167, P505, DOI 10.4049/jimmunol.167.1.505; Syrbu SI, 1999, J IMMUNOL, V162, P2334; vanBiesen T, 1996, J BIOL CHEM, V271, P1266, DOI 10.1074/jbc.271.3.1266; VENABLE ME, 1993, J LIPID RES, V34, P691; VERGHESE MW, 1987, J IMMUNOL, V138, P4374	46	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22685	22691		10.1074/jbc.M110210200	http://dx.doi.org/10.1074/jbc.M110210200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11934880	hybrid			2022-12-27	WOS:000176313600076
J	Lu, ML; Huang, YW; Lin, SX				Lu, ML; Huang, YW; Lin, SX			Purification, reconstitution, and steady-state kinetics of the trans-membrane 17 beta-hydroxysteroid dehydrogenase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 MESSENGER-RNA; EXPRESSION; PROTEINS; CELLS; IDENTIFICATION; TRANSPORTER; ENZYME	Human membrane 17beta-hydroxysteroid dehydrogenase 2 is an enzyme essential in the conversion of the highly active 17beta-hydroxysteroids into their inactive keto forms in a variety of tissues. 17beta-hydroxysteroid dehydrogenase 2 with 6 consecutive histidines at its N terminus was expressed in Sf9 insect cells. This recombinant protein retained its biological activity and facilitated the enzyme purification and provided the most suitable form in our studies. Dodecyl-p-D-maltoside was found to be the best detergent for the solubilization, purification, and reconstitution of this enzyme. The overexpressed integral membrane protein was purified with a high catalytic activity and a purity of more than 90% by nickel-chelated chromatography. For reconstitution, the purified protein was incorporated into dodecyl-beta-D-maltoside-destabilized liposomes prepared from L-alpha-phosphatidylcholine. The detergent was removed by adsorption onto polystyrene beads. The reconstituted enzyme had much higher stability and catalytic activity (2.6 mumol/min/mg of enzyme protein with estradiol) than the detergent-solubilized and purified protein (0.9 mumol/ min/mg of enzyme protein with estradiol). The purified and reconstituted protein (with a 2-kDa His tag) was proved to be a homodimer, and its functional molecular mass was calculated to be 90.4 +/- 1.2 kDa based on glycerol gradient analytical ultracentrifugation and chemical cross-linking study. The kinetic studies demonstrated that 17beta-hydroxysteroid dehydrogenase 2 was an NAD-preferring dehydrogenase with the K-m of NAD being 110 +/- 10 muM and that of NADP 9600 +/- 100 muM using estradiol as substrate. The kinetic constants using estradiol, testosterone, dihydrotestosterone, and 20alpha-dihydroprogesterone as substrates were also determined.	Univ Laval, Med Ctr, Oncol & Mol Endocrinol Res Ctr, CHUQ, Quebec City, PQ G1V 4G2, Canada	Laval University	Lin, SX (corresponding author), Univ Laval, Med Ctr, Oncol & Mol Endocrinol Res Ctr, CHUQ, Quebec City, PQ G1V 4G2, Canada.	sxlin@crchul.ulaval.ca		Lin, Sheng-Xiang/0000-0001-9149-375X				Blomquist CH, 1997, J ENDOCRINOL, V153, P453, DOI 10.1677/joe.0.1530453; CASSEY ML, 1994, J CLIN INVEST, V94, P2135; English MA, 2001, MOL CELL ENDOCRINOL, V171, P53, DOI 10.1016/S0303-7207(00)00418-4; KAPLAN RS, 1985, ANAL BIOCHEM, V150, P97, DOI 10.1016/0003-2697(85)90445-2; KNOLLER S, 1991, J BIOL CHEM, V266, P2795; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LuuThe V, 1995, J STEROID BIOCHEM, V55, P581, DOI 10.1016/0960-0760(95)00209-X; Michel H., 1991, CRYSTALLIZATION MEMB, P73; Miettinen MM, 1996, BIOCHEM J, V314, P839, DOI 10.1042/bj3140839; Mustonen M, 1997, MOL CELL ENDOCRINOL, V134, P33, DOI 10.1016/S0303-7207(97)00157-3; Mustonen MVJ, 1998, J MOL ENDOCRINOL, V20, P67, DOI 10.1677/jme.0.0200067; Puglielli L, 1999, J BIOL CHEM, V274, P35596, DOI 10.1074/jbc.274.50.35596; Puglielli L, 1999, J BIOL CHEM, V274, P12665, DOI 10.1074/jbc.274.18.12665; Puranen TJ, 1999, ENDOCRINOLOGY, V140, P3334, DOI 10.1210/en.140.7.3334; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; ROMER LCR, 1980, BIOCHIM BIOPHYS ACTA, V601, P123; Schagger H., 1994, PRACTICAL GUIDE MEMB, P59; *SIGM, 1986, TECHN B SIGM; SMITH MH, 1970, HDB BIOCH, pC3; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; VOET D, 1990, BIOCHEMISTRY-US, P577; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; WU L, 1993, J BIOL CHEM, V268, P12964	24	27	28	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22123	22130		10.1074/jbc.M111726200	http://dx.doi.org/10.1074/jbc.M111726200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11940569	hybrid			2022-12-27	WOS:000176313600005
J	Diemel, RV; Snel, MME; Waring, AJ; Walther, FJ; van Golde, LMG; Putz, G; Haagsman, HP; Batenburg, JJ				Diemel, RV; Snel, MME; Waring, AJ; Walther, FJ; van Golde, LMG; Putz, G; Haagsman, HP; Batenburg, JJ			Multilayer formation upon compression of surfactant monolayers depends on protein concentration as well as lipid composition - An atomic force microscopy study	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL SEGMENT; B SP-B; RESPIRATORY-DISTRESS-SYNDROME; PULMONARY SURFACTANT; LUNG SURFACTANT; SP-C; FILMS; DIPALMITOYLPHOSPHATIDYLCHOLINE; PHOSPHOLIPIDS; SPECTROSCOPY	The determinants for the formation of multilayers upon compression of surfactant monolayers were investigated by compressing films, beyond the squeeze-out plateau, to a surface tension of 22 millinewtons/m. Atomic force microscopy was used to visualize the topography of lipid films containing varying amounts of native surfactant protein B (SP-B). These films were compared with films containing synthetic peptides based on the N terminus of human SP-B: monomeric mSP-B-(1-25) or dimeric dSP-B-(1-25). The formation of typical hexagonal network structures as well as the height of protrusions were shown to depend on the concentration of SP-B. Protrusions of bilayer height were formed from physiologically relevant concentrations of 0.2-0.4 mol % (4.5-8.5 wt %) SP-B upwards. Much higher concentrations of SP-B-(1-25) peptides were needed to obtain network structures, and protrusion heights were not equal to those found for films with native SP-B. A striking observation was that while protrusions formed in films of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC)/1,2-dipalmitoyl-sn-glycero-3-(phospho-rac-(1 -glycerol)) (DPPG) (80/20) had single bilayer thickness, those formed in DPPC/1-palmitoyl-2-oleoyl-snglycero-3-(phospho-rac-(l-glycerol)) (80/20) had various heights of multilayers, whereas those seen in DPPC/1palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine/DPPG (60/20/20) were mainly of bilayer height. For the first time direct observations by atomic force microscopy show M that a certain minimal concentration of SP-B is required for the formation of layered protrusions upon film compression, (ii) that protrusion height depends on whether the phospholipids contain an unsaturated fatty acyl chain, and (iii) that protrusion height also depends on whether the unsaturated acyl chain is present in phosphatidylcholine or in phosphatidylglycerol.	Univ Utrecht, Fac Vet Med, Grad Sch Anim Hlth, Dept Biochem & Cell Biol, NL-3508 TD Utrecht, Netherlands; Univ Utrecht, Fac Vet Med, Grad Sch Anim Hlth, Dept Sci Food Anim Origin, NL-3508 TD Utrecht, Netherlands; Univ Innsbruck, Dept Anaesthesiol & Crit Care Med, A-6020 Innsbruck, Austria; Univ Utrecht, Fac Chem, NL-3584 CH Utrecht, Netherlands; Univ Calif Los Angeles, Dept Med, Div Infect Dis, Los Angeles, CA 90502 USA; Univ Calif Los Angeles, Los Angeles Cty Harbor Med Ctr, Dept Pediat, Div Med Genet, Torrance, CA 90502 USA	Utrecht University; Utrecht University; University of Innsbruck; Utrecht University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Batenburg, JJ (corresponding author), Univ Utrecht, Fac Vet Med, Grad Sch Anim Hlth, Dept Biochem & Cell Biol, POB 80176, NL-3508 TD Utrecht, Netherlands.	J.J.Batenburg@vet.uu.nl	Haagsman, Henk P/F-8919-2010	Walther, Frans/0000-0003-1931-159X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055534] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL055534] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Amrein M, 1997, EUR BIOPHYS J BIOPHY, V26, P349, DOI 10.1007/s002490050089; BAATZ JE, 1990, BIOCHEMISTRY-US, V29, P6714, DOI 10.1021/bi00480a022; BANGHAM AD, 1979, BIOCHIM BIOPHYS ACTA, V573, P552, DOI 10.1016/0005-2760(79)90229-7; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; BOHLEN P, 1973, ARCH BIOCHEM BIOPHYS, V155, P213, DOI 10.1016/S0003-9861(73)80023-2; CLEMENTS JA, 1977, AM REV RESPIR DIS, V115, P67; Crane JM, 2001, BIOPHYS J, V80, P1863, DOI 10.1016/S0006-3495(01)76156-5; Creuwels LAJM, 1996, BBA-BIOMEMBRANES, V1285, P1, DOI 10.1016/S0005-2736(96)00131-9; Diemel RV, 2001, ARCH BIOCHEM BIOPHYS, V385, P338, DOI 10.1006/abbi.2000.2157; Gordon LM, 2000, J PEPT RES, V55, P330, DOI 10.1034/j.1399-3011.2000.00693.x; Gordon LM, 1996, PROTEIN SCI, V5, P1662, DOI 10.1002/pro.5560050820; Gregory TJ, 1997, AM J RESP CRIT CARE, V155, P1309, DOI 10.1164/ajrccm.155.4.9105072; Gupta M, 2000, EUR RESPIR J, V16, P1129, DOI 10.1034/j.1399-3003.2000.16f19.x; GUPTA M, 2000, AM J RESP CRIT CARE, V161, pA656; Haagsman HP, 2001, COMP BIOCHEM PHYS A, V129, P91, DOI 10.1016/S1095-6433(01)00308-7; HAWGOOD S, 1987, P NATL ACAD SCI USA, V84, P66, DOI 10.1073/pnas.84.1.66; Johansson J, 1997, EUR J BIOCHEM, V244, P675, DOI 10.1111/j.1432-1033.1997.00675.x; Krol S, 2000, BIOPHYS J, V79, P904, DOI 10.1016/S0006-3495(00)76346-6; LEWIS BA, 1983, J MOL BIOL, V166, P211, DOI 10.1016/S0022-2836(83)80007-2; Lipp MM, 1998, PHYS REV LETT, V81, P1650, DOI 10.1103/PhysRevLett.81.1650; Marsh D., 2013, HDB LIPID BILAYERS; NOGEE LM, 1994, J CLIN INVEST, V93, P1860, DOI 10.1172/JCI117173; OOSTERLAKENDIJKSTERHUIS MA, 1992, BIOCHIM BIOPHYS ACTA, V1110, P45, DOI 10.1016/0005-2736(92)90292-T; OOSTERLAKENDIJKSTERHUIS MA, 1991, BIOCHEMISTRY-US, V30, P10965, DOI 10.1021/bi00109a022; PEREZGIL J, 1995, BIOCHEMISTRY-US, V34, P3964, DOI 10.1021/bi00012a014; Robertson B, 1998, BBA-MOL BASIS DIS, V1408, P346, DOI 10.1016/S0925-4439(98)00080-5; Rodriguez-Capote K, 2001, AM J PHYSIOL-LUNG C, V281, pL231, DOI 10.1152/ajplung.2001.281.1.L231; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Schurch S, 1998, BBA-MOL BASIS DIS, V1408, P180, DOI 10.1016/S0925-4439(98)00067-2; SCHURCH S, 1995, BIOL NEONATE, V67, P61; SEEGER W, 2000, ACP-APPL CARDIOPUL P, V9, P295; Takamoto DY, 2001, BIOPHYS J, V81, P153, DOI 10.1016/S0006-3495(01)75688-3; Tredano M, 1999, HUM MUTAT, V14, P502, DOI 10.1002/(SICI)1098-1004(199912)14:6<502::AID-HUMU9>3.0.CO;2-C; Veldhuizen EJA, 2000, BIOPHYS J, V79, P377, DOI 10.1016/S0006-3495(00)76299-0; Veldhuizen EJA, 2001, CHEM PHYS LIPIDS, V110, P47, DOI 10.1016/S0009-3084(00)00228-0; Veldhuizen R, 1998, BBA-MOL BASIS DIS, V1408, P90, DOI 10.1016/S0925-4439(98)00061-1; Walmrath D, 1996, AM J RESP CRIT CARE, V154, P57, DOI 10.1164/ajrccm.154.1.8680699; WALTHER FJ, 2000, AM J RESP CRIT CARE, V161, pA656; WARING A, 1989, Peptide Research, V2, P308; Weaver TE, 1999, BIOL NEONATE, V76, P15, DOI 10.1159/000047041; YU SH, 1992, BIOCHIM BIOPHYS ACTA, V1126, P26, DOI 10.1016/0005-2760(92)90212-E	41	62	62	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21179	21188		10.1074/jbc.M111758200	http://dx.doi.org/10.1074/jbc.M111758200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11923286	hybrid			2022-12-27	WOS:000176286000010
J	Hong, DP; Gozu, M; Hasegawa, K; Naiki, H; Goto, Y				Hong, DP; Gozu, M; Hasegawa, K; Naiki, H; Goto, Y			Conformation of beta(2)-microglobulin amyloid fibrils analyzed by reduction of the disulfide bond	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-E; CONSTANT FRAGMENT; KINETIC-MODEL; PROTEIN; BETA-2-MICROGLOBULIN; EXTENSION; DEPOSITS; POLYMERIZATION; HEMODIALYSIS; FORM	beta(2)-Microglobulin (beta2-m), a major component of dialysis-related amyloid fibrils, has an intrachain disulfide bond buried inside the native structure. We examined the conformation of beta2-m amyloid fibrils by analyzing the reactivity of the disulfide bond to a reducing reagent, dithiothreitol. Although the disulfide bond in the native structure was highly protected from reduction, the disulfide bonds in the amyloid fibrils prepared at pH 2.5 were progressively reduced at pH 8.5 by 50 mm dithiothreitol. Because beta2-m amyloid fibrils prepared under acidic conditions have been known to depolymerize at a neutral pH, we examined the relation between depolymerization and reduction of the disulfide bond. The results indicate that the disulfide bonds in the amyloid fibrils were protected from reduction, and the reduction occurred during depolymerization. On the other hand, the disulfide bonds of immature filaments, the thin and flexible filaments prepared under conditions of high salt at pH 2.5, were reduced at pH 8.5 more readily than those of amyloid fibrils, suggesting that the disulfide bonds are exposed to the solvent. Taken together, the disulfide bond once exposed to the solvent upon acid denaturation may be progressively buried in the interior of the amyloid fibrils during its formation.	Osaka Univ, Inst Prot Res, Osaka 5650871, Japan; Fukui Med Univ, Dept Pathol, Fukui 9101193, Japan	Osaka University; University of Fukui	Goto, Y (corresponding author), Osaka Univ, Inst Prot Res, Yamadaoka 3-2, Osaka 5650871, Japan.	ygoto@protein.osaka-u.ac.jp	Naiki, Hironobu/G-5599-2014					Bellotti V, 1998, EUR J BIOCHEM, V258, P61, DOI 10.1046/j.1432-1327.1998.2580061.x; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Campistol JM, 1996, KIDNEY INT, V50, P1262, DOI 10.1038/ki.1996.436; CAPEILLEREBLANDIN C, 1991, BIOCHEM J, V277, P175, DOI 10.1042/bj2770175; Chiti F, 2001, J MOL BIOL, V307, P379, DOI 10.1006/jmbi.2000.4478; Davison AM, 1995, NEPHROL DIAL TRANSPL, V10, P48; Esposito G, 2000, PROTEIN SCI, V9, P831, DOI 10.1110/ps.9.5.831; GarciaGarcia M, 1997, NEPHROL DIAL TRANSPL, V12, P1192, DOI 10.1093/ndt/12.6.1192; Gejyo F, 1990, Contrib Nephrol, V78, P47; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; GOTO Y, 1981, J MOL BIOL, V146, P321, DOI 10.1016/0022-2836(81)90391-0; GOTO Y, 1979, J BIOCHEM-TOKYO, V86, P1433, DOI 10.1093/oxfordjournals.jbchem.a132661; Hashimoto N, 1999, AMYLOID, V6, P256, DOI 10.3109/13506129909007337; Heegaard NHH, 2001, J BIOL CHEM, V276, P32657, DOI 10.1074/jbc.M104452200; ISENMAN DE, 1975, P NATL ACAD SCI USA, V72, P548, DOI 10.1073/pnas.72.2.548; Kad NM, 2001, J MOL BIOL, V313, P559, DOI 10.1006/jmbi.2001.5071; KINDY MS, 1995, LAB INVEST, V73, P469; Kozhukh GV, 2002, J BIOL CHEM, V277, P1310, DOI 10.1074/jbc.M108753200; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KROLL J, 1976, BIOCHIM BIOPHYS ACTA, V434, P490, DOI 10.1016/0005-2795(76)90239-7; LINKE RP, 1989, KIDNEY INT, V36, P675, DOI 10.1038/ki.1989.245; LINKE RP, 1986, BIOCHEM BIOPH RES CO, V136, P665, DOI 10.1016/0006-291X(86)90492-4; MARLEY RW, 1988, SCIENCE, V240, P622; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; MIYATA T, 1993, J CLIN INVEST, V92, P1243, DOI 10.1172/JCI116696; Naiki H, 1997, AMYLOID, V4, P223, DOI 10.3109/13506129709003833; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Naiki H, 1996, LAB INVEST, V74, P374; NAIKI H, 1991, LAB INVEST, V65, P104; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; Ohhashi Y, 2002, J BIOCHEM, V131, P45, DOI 10.1093/oxfordjournals.jbchem.a003076; Verdone G, 2002, PROTEIN SCI, V11, P487, DOI 10.1110/ps.29002; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; YAMADA T, 1994, ANN CLIN LAB SCI, V24, P243; Yamaguchi I, 2001, BIOCHEMISTRY-US, V40, P8499, DOI 10.1021/bi0027128; Yamaguchi I, 2001, AMYLOID, V8, P30, DOI 10.3109/13506120108993812	39	68	70	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21554	21560		10.1074/jbc.M200188200	http://dx.doi.org/10.1074/jbc.M200188200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11943769	hybrid, Green Published			2022-12-27	WOS:000176286000058
J	Jardine, H; MacNee, W; Donaldson, K; Rahman, I				Jardine, H; MacNee, W; Donaldson, K; Rahman, I			Molecular mechanism of transforming growth factor (TGF)-beta(1)-induced glutathione depletion in alveolar epithelial cells - Involvement of AP-1/ARE and Fra-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; ANTIOXIDANT RESPONSE ELEMENT; IDIOPATHIC PULMONARY FIBROSIS; NAPHTHOFLAVONE-INDUCED EXPRESSION; HEAVY SUBUNIT GENE; FACTOR-KAPPA-B; FACTOR-BETA; OXIDATIVE STRESS; ENDOTHELIAL-CELLS; C-JUN	Glutathione (GSH) is a ubiquitous antioxidant in lung epithelial cells and lung lining fluid. Transforming growth factor beta(1) (TGF-beta(1)) is a pleiotropic cytokine involved in cellular proliferation and differentiation. The level of TGF-beta(1), is elevated in many chronic inflammatory lung disorders associated with oxidant/antioxidant imbalance. In this study, we show that TGF-beta(1), depletes GSH by down-regulating expression of the enzyme responsible for its formation, gamma-glutamylcysteine synthetase (gamma-GCS) and induces reactive oxygen species production in type II alveolar epithelial cells (A549). To investigate the molecular mechanisms of inhibition of glutathione synthesis, we employed reporters containing fragments from the promoter region of the gamma-GCS heavy subunit (h), the gene that encodes the catalytic subunit of gamma-GCS. We found that TGF-beta(1), reduced the expression of the long gamma-GCSh construct (-3802/GCSh5'-Luc), suggesting that an antioxidant response element (ARE) may be responsible for mediating the TGF-beta(1) effect. Interestingly, the electrophoretic mobility shift assay revealed that the DNA binding activity of both activator protein-1 (A-P-1) and ARE was increased in TGF-beta(1)-treated epithelial cells. The gamma-GCSh ARE contains a perfect AP-1 site embedded within it, and mutation of this internal AP-1 sequence, but not the surrounding ARE, prevented DNA binding. Further studies revealed that c-Jun and Fra-1 dimers, members of the AP-1 family previously shown to exert a negative effect on phase II gene expression, bound to the ARE sequence. We propose a novel mechanism of gamma-GCSh down-regulation by TGF-beta(1), that involves the binding of c-Jun and Fra-1 dimers to the distal promoter. The findings of this study provide important information, which may e used for the modulation of glutathione biosynthesis in inflammation.	Univ Edinburgh, Sch Med, Ctr Inflammat Res, Resp Med Unit,MRC,ELEGI,Colt Res Labs, Edinburgh EH8 9AG, Midlothian, Scotland; Napier Univ, Biomed Res Grp, Edinburgh EH10 5DT, Midlothian, Scotland	University of Edinburgh; Edinburgh Napier University	Rahman, I (corresponding author), Univ Edinburgh, Sch Med, Ctr Inflammat Res, Resp Med Unit,MRC,ELEGI,Colt Res Labs, Wilkie Bldg,Teviot Pl, Edinburgh EH8 9AG, Midlothian, Scotland.			MacNee, William/0000-0002-3692-1448				Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; Arsalane K, 1997, AM J RESP CELL MOL, V17, P599, DOI 10.1165/ajrcmb.17.5.2833; BUNNELL E, 1993, AM REV RESPIR DIS, V148, P1174, DOI 10.1164/ajrccm/148.5.1174; CANTIN AM, 1987, J APPL PHYSIOL, V63, P152, DOI 10.1152/jappl.1987.63.1.152; CANTIN AM, 1989, AM REV RESPIR DIS, V139, P370, DOI 10.1164/ajrccm/139.2.370; Chen YH, 1999, BIOCHEM BIOPH RES CO, V265, P18, DOI 10.1006/bbrc.1999.1609; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Dahl EL, 2001, TOXICOL SCI, V61, P265, DOI 10.1093/toxsci/61.2.265; de Boer WI, 1998, AM J RESP CRIT CARE, V158, P1951, DOI 10.1164/ajrccm.158.6.9803053; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; FAVREAU LV, 1995, J BIOL CHEM, V270, P24468, DOI 10.1074/jbc.270.41.24468; FRILING RS, 1992, P NATL ACAD SCI USA, V89, P668, DOI 10.1073/pnas.89.2.668; GIPP JJ, 1992, BIOCHEM BIOPH RES CO, V185, P29, DOI 10.1016/S0006-291X(05)80950-7; GIRI SN, 1993, THORAX, V48, P959, DOI 10.1136/thx.48.10.959; Hagiwara S, 2000, AM J RESP CRIT CARE, V162, P225, DOI 10.1164/ajrccm.162.1.9903129; Hong YH, 1997, J IMMUNOL, V159, P2418; Huang Y, 2000, J BIOL CHEM, V275, P18234, DOI 10.1074/jbc.M909431199; Jeyapaul J, 2000, BIOCHEM PHARMACOL, V59, P1433, DOI 10.1016/S0006-2952(00)00256-2; Junn E, 2000, J IMMUNOL, V165, P2190, DOI 10.4049/jimmunol.165.4.2190; Kardassis D, 1999, J BIOL CHEM, V274, P29572, DOI 10.1074/jbc.274.41.29572; KAYANOKI Y, 1994, J BIOL CHEM, V269, P15488; KHALIL N, 1991, AM J RESP CELL MOL, V5, P155, DOI 10.1165/ajrcmb/5.2.155; MACNEE W, 1995, THORAX, V50, pS53, DOI 10.1136/thx.50.Suppl_1.S53; MAIER JAM, 1990, SCIENCE, V249, P1570, DOI 10.1126/science.2218499; Manna SK, 1999, ONCOGENE, V18, P4371, DOI 10.1038/sj.onc.1202811; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Mulcahy RT, 1997, J BIOL CHEM, V272, P7445, DOI 10.1074/jbc.272.11.7445; MULCAHY RT, 1995, CANCER RES, V55, P4771; Pittet JF, 2001, J CLIN INVEST, V107, P1537, DOI 10.1172/JCI11963; Rahman I, 1999, FREE RADICAL BIO MED, V27, P60, DOI 10.1016/S0891-5849(99)00035-0; Rahman I, 2000, EUR RESPIR J, V16, P534, DOI 10.1034/j.1399-3003.2000.016003534.x; Rahman I, 1998, FEBS LETT, V427, P129, DOI 10.1016/S0014-5793(98)00410-4; Rahman I, 1999, AM J PHYSIOL-LUNG C, V277, pL1067, DOI 10.1152/ajplung.1999.277.6.L1067; Rahman I, 1996, BIOCHEM BIOPH RES CO, V229, P832, DOI 10.1006/bbrc.1996.1888; Rahman I, 1999, J BIOL CHEM, V274, P5088, DOI 10.1074/jbc.274.8.5088; ROUM JH, 1993, J APPL PHYSIOL, V75, P2419, DOI 10.1152/jappl.1993.75.6.2419; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Sano Y, 1999, J BIOL CHEM, V274, P8949, DOI 10.1074/jbc.274.13.8949; SCHMIDT KN, 1995, J BIOL CHEM, V270, P27136, DOI 10.1074/jbc.270.45.27136; SEELIG GF, 1984, J BIOL CHEM, V259, P9345; Sekhar KR, 1997, BIOCHEM BIOPH RES CO, V234, P588, DOI 10.1006/bbrc.1997.6697; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Takizawa H, 2001, AM J RESP CRIT CARE, V163, P1476, DOI 10.1164/ajrccm.163.6.9908135; THANNICKAL VJ, 1993, AM J PHYSIOL, V265, pL622, DOI 10.1152/ajplung.1993.265.6.L622; Thannickal VJ, 1998, J BIOL CHEM, V273, P23611, DOI 10.1074/jbc.273.36.23611; Thannickal VJ, 1995, J BIOL CHEM, V270, P30334, DOI 10.1074/jbc.270.51.30334; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; VANDEPUTTE C, 1994, CELL BIOL TOXICOL, V10, P415, DOI 10.1007/BF00755791; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wang QJ, 1999, THORAX, V54, P805, DOI 10.1136/thx.54.9.805; WHITE AC, 1992, AM J RESP CELL MOL, V6, P364, DOI 10.1165/ajrcmb/6.4.364; Wild AC, 1999, J BIOL CHEM, V274, P33627, DOI 10.1074/jbc.274.47.33627; Wild AC, 1998, BIOCHEM J, V332, P373, DOI 10.1042/bj3320373; Wotton D, 1999, J BIOL CHEM, V274, P37105, DOI 10.1074/jbc.274.52.37105; XIE T, 1995, J BIOL CHEM, V270, P6894, DOI 10.1074/jbc.270.12.6894; YOSHIOKA K, 1995, P NATL ACAD SCI USA, V92, P4972, DOI 10.1073/pnas.92.11.4972; Yu R, 2000, J BIOL CHEM, V275, P39907, DOI 10.1074/jbc.M004037200	58	87	95	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21158	21166		10.1074/jbc.M112145200	http://dx.doi.org/10.1074/jbc.M112145200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11912197	hybrid			2022-12-27	WOS:000176286000008
J	Kishi, H; Krishnamurthy, H; Galet, C; Bhaskaran, RS; Ascoli, M				Kishi, H; Krishnamurthy, H; Galet, C; Bhaskaran, RS; Ascoli, M			Identification of a short linear sequence present in the C-terminal tail of the rat follitropin receptor that modulates arrestin-3 binding in a phosphorylation-independent fashion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; LEYDIG TUMOR-CELLS; FOLLICLE-STIMULATING-HORMONE; HUMAN CHORIO-GONADOTROPIN; BETA-ARRESTIN; LUTROPIN/CHORIOGONADOTROPIN RECEPTOR; CHORIOGONADOTROPIN RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; INTRACELLULAR DOMAINS; MEDIATED ENDOCYTOSIS	The rat follitropin receptor (rFSHR) is an unusual G protein-coupled receptor in that agonist-induced activation leads to the phosphorylation of the first and third intracellular loops instead of the C-terminal tail. To determine regions of G protein-coupled receptors that affect internalization independently of phosphorylation we examined the effects of truncations of the C-terminal tail of the rFSHR on agonist-induced internalization. Our studies show that progressive truncations of a region flanked by residues 642 and 651 enhance the internalization of human follicle-stimulating hormone (hFSH). Further characterization of a mutant truncated at residue 649 (designated rFSHR-t649) and another mutant in which the 642-651 region was deleted in the context of the full-length rFSHR, designated rFSHR(Delta642-651), showed that both of them internalized hFSH at rates that were 2-3 times faster than rF-SHR-wild type (wt). Like rFSHR-wt, however, the internalization of hFSH mediated by rFSHR-t649 and rFSHR(Delta642-651) can be inhibited with dominant-negative mutants of the non-visual arrestins or dynamin. Alanine-scanning mutagenesis of the 642-651 region suggests that the effects on internalization are not mediated by a single residue, however. In an attempt to understand the molecular basis of the enhanced internalization of hFSH mediated by these mutants we used an assay that can be readily used to assess the association of the rFSHR with the arrestin-3 in co-transfected cells. Using this assay we were able to show that, when compared with rFSHR-wt, rFSHR(Delta642-651) displays an similar to4-fold enhancement in binding affinity for arrestin-3 and an similar to1.7-fold reduction in maximal arrestin-3 binding capacity. We conclude that a short linear sequence present in the C-terminal tail of the rFSHR ((642)SATHN-FHARK(651)) that is not phosphorylated limits internalization by lowering the affinity of the rFSHR for the endogenous non-visual arrestins.	Univ Iowa, Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA	University of Iowa	Ascoli, M (corresponding author), Univ Iowa, Coll Med, Dept Pharmacol, 2-319A BSB,51 Newton Rd, Iowa City, IA 52242 USA.	mario-ascoli@uiowa.edu	Bhaskaran, Ravi Sankar/Q-2823-2016; galet, colette/C-4620-2011	Bhaskaran, Ravi Sankar/0000-0002-2003-6276; galet, colette/0000-0002-5931-2143	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-28962] Funding Source: Medline; NIDDK NIH HHS [DK-25295] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASCOLI M, 1978, P NATL ACAD SCI USA, V75, P99, DOI 10.1073/pnas.75.1.99; ASCOLI M, 1989, J BIOL CHEM, V264, P6674; Bhatnagar A, 2001, J BIOL CHEM, V276, P8269, DOI 10.1074/jbc.M006968200; BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; Bunemann M, 1999, J PHYSIOL-LONDON, V517, P5, DOI 10.1111/j.1469-7793.1999.0005z.x; Cen B, 2001, MOL PHARMACOL, V59, P758, DOI 10.1124/mol.59.4.758; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen W, 2001, J BIOL CHEM, V276, P43564, DOI 10.1074/jbc.M107938200; Cheng ZJ, 2000, J BIOL CHEM, V275, P2479, DOI 10.1074/jbc.275.4.2479; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Fabritz J, 1998, BIOCHEMISTRY-US, V37, P664, DOI 10.1021/bi972355+; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; HIPKIN RW, 1995, J BIOL CHEM, V270, P26683, DOI 10.1074/jbc.270.44.26683; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Kishi H, 2000, J BIOL CHEM, V275, P31030, DOI 10.1074/jbc.M005528200; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; KRUPNICK JG, 1994, J BIOL CHEM, V269, P3226; Krupnick JG, 1997, J BIOL CHEM, V272, P32507, DOI 10.1074/jbc.272.51.32507; Lazari MDM, 1999, MOL ENDOCRINOL, V13, P866, DOI 10.1210/me.13.6.866; Maestri-El Kouhen O, 2000, J BIOL CHEM, V275, P36659, DOI 10.1074/jbc.M006788200; MARGOLSKEE RF, 1993, BIOTECHNIQUES, V15, P906; Min L, 2000, MOL ENDOCRINOL, V14, P1797, DOI 10.1210/me.14.11.1797; Min L, 2002, J BIOL CHEM, V277, P702, DOI 10.1074/jbc.M106082200; Mukherjee S, 1999, J BIOL CHEM, V274, P12984, DOI 10.1074/jbc.274.19.12984; Nakamura K, 1998, MOL ENDOCRINOL, V12, P580, DOI 10.1210/me.12.4.580; Nakamura K, 1999, J BIOL CHEM, V274, P25426, DOI 10.1074/jbc.274.36.25426; Nakamura K, 1998, J BIOL CHEM, V273, P24346, DOI 10.1074/jbc.273.38.24346; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Orsini MJ, 1998, J BIOL CHEM, V273, P34616, DOI 10.1074/jbc.273.51.34616; Penn RB, 2001, J BIOL CHEM, V276, P32648, DOI 10.1074/jbc.M104143200; PEREIRA ME, 1987, J BIOL CHEM, V262, P6093; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Qian HW, 2001, MOL ENDOCRINOL, V15, P1706, DOI 10.1210/me.15.10.1706; QUINTANA J, 1993, ENDOCRINOLOGY, V133, P2098, DOI 10.1210/en.133.5.2098; QUINTANA J, 1994, J BIOL CHEM, V269, P8772; ROZELL TG, 1995, MOL ENDOCRINOL, V9, P1727; SEGALOFF DL, 1981, J BIOL CHEM, V256, P1420; SEGALOFF DL, 1993, ENDOCR REV, V14, P324, DOI 10.1210/er.14.3.324; Simoni M, 1997, ENDOCR REV, V18, P739, DOI 10.1210/er.18.6.739; SPRENGEL R, 1990, MOL ENDOCRINOL, V4, P525, DOI 10.1210/mend-4-4-525; Vishnivetskiy SK, 1999, J BIOL CHEM, V274, P11451, DOI 10.1074/jbc.274.17.11451; WANG Z, 1993, MOL ENDOCRINOL, V7, P85, DOI 10.1210/me.7.1.85; Whistler JL, 2001, J BIOL CHEM, V276, P34331, DOI 10.1074/jbc.M104627200; WILEY HS, 1982, J BIOL CHEM, V257, P4222; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; Zhang J, 1997, J BIOL CHEM, V272, P27005, DOI 10.1074/jbc.272.43.27005	49	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21939	21946		10.1074/jbc.M110894200	http://dx.doi.org/10.1074/jbc.M110894200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11934883	hybrid			2022-12-27	WOS:000176286000106
J	Oudgenoeg, G; Dirksen, E; Ingemann, S; Hilhorst, R; Gruppen, H; Boeriu, CG; Piersma, SR; van Berkel, WJH; Laane, C; Voragen, AGJ				Oudgenoeg, G; Dirksen, E; Ingemann, S; Hilhorst, R; Gruppen, H; Boeriu, CG; Piersma, SR; van Berkel, WJH; Laane, C; Voragen, AGJ			Horseradish peroxidase-catalyzed oligomerization of ferulic acid on a template of a tyrosine-containing tripeptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE CROSS-LINKING; SUGAR-BEET PULP; LIGNIN; BIOSYNTHESIS; DEHYDRODIMERS; POLYMERS; GRASSES; COMPLEX; PROTEIN; SUBERIN	Ferulic acid (FA) is an abundantly present phenolic constituent of plant cell walls. Kinetically controlled incubation of FA and the tripeptide Gly-Tyr-Gly (GYG) with horseradish peroxidase and H2O2 yielded a range of new cross-linked products. Two predominant series of hetero-oligomers of FA linked by dehydrogenation to the peptidyl tyrosine were characterized by electrospray ionization (tandem) mass spectrometry. One series comprises GYG coupled with 4-7 FA moieties linked by dehydrogenation, of which one is decarboxylated. In the second series 4-9 FA moieties linked by dehydrogenation, of which two are decarboxylated, are coupled to the tripeptide. A third series comprises three hetero-oligomers in which the peptidyl tyrosine is linked to 1-3 FA moieties of which none is decarboxylated. Two mechanisms for the formation of the FA-Tyr oligomers that result from the dualistic, concentration-dependent chemistry of FA and their possible role in the regulation of plant cell wall tissue growth are presented.	Ctr Prot Technol TNO WU, NL-6700 EV Wageningen, Netherlands; Univ Wageningen & Res Ctr, Dept Agrotechnol & Food Sci, Biochem Lab, NL-6703 HA Wageningen, Netherlands; Univ Wageningen & Res Ctr, Dept Agrotechnol & Food Sci, Food Chem Lab, NL-6700 EV Wageningen, Netherlands; Univ Amsterdam, Fac Sci, Swammerdam Inst Life Sci, NL-1018 WV Amsterdam, Netherlands; ATO, NL-6708 PD Wageningen, Netherlands; TNO Food & Nutr Res, NL-3700 AJ Zeist, Netherlands	Netherlands Organization Applied Science Research; Wageningen University & Research; Wageningen University & Research; University of Amsterdam; Netherlands Organization Applied Science Research	Voragen, AGJ (corresponding author), Ctr Prot Technol TNO WU, Bomenweg 2, NL-6700 EV Wageningen, Netherlands.	Fons.voragen@chem.fdsci.wag-ur.nl	Oudgenoeg, Gideon/I-6532-2013; van Berkel, Willem J.H./O-2431-2014; Boeriu, Carmen/L-1173-2016	van Berkel, Willem J.H./0000-0002-6551-2782; Boeriu, Carmen/0000-0003-4903-6621; Hilhorst, Riet/0000-0002-8261-1299				ANDERSEN SO, 1964, BIOCHIM BIOPHYS ACTA, V93, P213, DOI 10.1016/0304-4165(64)90289-2; BERNARDS MA, 1995, J BIOL CHEM, V270, P7382, DOI 10.1074/jbc.270.13.7382; Bernards MA, 2001, PHYTOCHEMISTRY, V57, P1115, DOI 10.1016/S0031-9422(01)00046-2; BRADLEY DJ, 1992, CELL, V70, P21, DOI 10.1016/0092-8674(92)90530-P; Bunzel M, 2001, J SCI FOOD AGR, V81, P653, DOI 10.1002/jsfa.861; Davin LB, 2000, PLANT PHYSIOL, V123, P453, DOI 10.1104/pp.123.2.453; Davin LB, 1997, SCIENCE, V275, P362, DOI 10.1126/science.275.5298.362; Gang DR, 1999, CHEM BIOL, V6, P143, DOI 10.1016/S1074-5521(99)89006-1; Grabber JH, 2000, J AGR FOOD CHEM, V48, P6106, DOI 10.1021/jf0006978; GROSS AJ, 1959, J BIOL CHEM, V234, P1611; Henriksen A, 1999, J BIOL CHEM, V274, P35005, DOI 10.1074/jbc.274.49.35005; LEWIS NG, 1987, SCIENCE, V237, P1344, DOI 10.1126/science.237.4820.1344; Michener Charles D., 1997, Scientific Papers Natural History Museum University of Kansas, V1, P1; Michon T, 1999, BIOTECHNOL BIOENG, V63, P449, DOI 10.1002/(SICI)1097-0290(19990520)63:4<449::AID-BIT8>3.0.CO;2-M; NOSE M, 1995, PHYTOCHEMISTRY, V39, P71, DOI 10.1016/0031-9422(95)95268-Y; Oosterveld A, 2001, CARBOHYD POLYM, V44, P9, DOI 10.1016/S0144-8617(00)00193-4; Oosterveld A, 1997, CARBOHYD RES, V300, P179, DOI 10.1016/S0008-6215(97)00041-4; Oosterveld A, 2000, CARBOHYD RES, V328, P199, DOI 10.1016/S0008-6215(00)00096-3; Ostergaard L, 2000, PLANT MOL BIOL, V44, P231, DOI 10.1023/A:1006442618860; Oudgenoeg G, 2001, J AGR FOOD CHEM, V49, P2503, DOI 10.1021/jf000906o; RALPH J, 1992, J CHEM SOC PERK T 1, P2971, DOI 10.1039/p19920002971; RALPH J, 1992, J CHEM SOC PERK T 1, P2961, DOI 10.1039/p19920002961; RALPH J, 1994, J CHEM SOC PERK T 1, P3485, DOI 10.1039/p19940003485; Wang WC, 1999, BIOCHEM J, V340, P329, DOI 10.1042/0264-6021:3400329; Ward G, 2001, J BIOL CHEM, V276, P18734, DOI 10.1074/jbc.M009785200	25	33	35	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21332	21340		10.1074/jbc.M201679200	http://dx.doi.org/10.1074/jbc.M201679200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11925445	Green Published, hybrid			2022-12-27	WOS:000176286000029
J	Abreu, MT; Arnold, ET; Thomas, LS; Gonsky, R; Zhou, YH; Hu, B; Arditi, M				Abreu, MT; Arnold, ET; Thomas, LS; Gonsky, R; Zhou, YH; Hu, B; Arditi, M			TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-4; NF-KAPPA-B; DERMAL ENDOTHELIAL-CELLS; BACTERIAL LIPOPOLYSACCHARIDE; INFLAMMATORY CYTOKINES; ESCHERICHIA-COLI; STAT3 ACTIVATION; CUTTING EDGE; TNF-ALPHA; INDUCTION	The normal intestinal epithelium is not inflamed despite contact with a high density of commensal bacteria. Intestinal epithelial cells (IEC) express low levels of TLR4 and MD-2 and are lipopolysaccharide (LPS)-unresponsive. We hypothesized that immune-mediated signals regulate the expression of TLR4 and MD-2 in IEC. Expression of TLR4 and MD-2 was examined in normal colonic epithelial cells or intestinal epithelial cell lines. The effect of the cytokines interferon (IFN)-gamma, IFN-alpha, and tumor necrosis factor-alpha (TNF-alpha) on TLR4 and MD-2 expression was examined by reverse transcription-PCR and Western blot. NF-kappaB transcriptional activation and interleukin-8 secretion were used as measures of LPS responsiveness. Native colonic epithelial cells and IEC lines express a low level of TLR4 and MD-2 mRNA. IFN-gamma regulates MD-2 expression in both IEC lines, whereas IFN-gamma and TNF-a regulate TLR4 mRNA expression in IEC lines. Pre-incubation with IFN-gamma and/or TNF-alpha sensitizes IEC to LPS-dependent interleukin-8 secretion. To examine MD-2 transcriptional regulation, we cloned a 1-kb sequence proximal to the MD-2 gene translational start site. This promoter directed expression of a reporter gene in endothelial cells and IEC. IFN-gamma positively regulated MD-2 promoter activity in IEC. Co-expression of a STAT inhibitor, SOCS3, blocked IFN-gamma-mediated MD-2 promoter activation. T cell-derived cytokines lead to increased expression of TLR4 and MD-2 and LPS-dependent pro-inflammatory cytokine secretion in IEC. IFN-gamma regulates expression of the critical TLR4 co-receptor MD-2 through the Janus tyrosine kinase-STAT pathway. Th1 cytokines may initiate or perpetuate intestinal inflammation by altering toll-like receptor expression and bacterial reactivity.	Cedars Sinai Med Ctr, Ctr Inflammatory Bowel Dis, Div Gastroenterol, Dept Med, Los Angeles, CA 90048 USA; Cedars Sinai Med Ctr, Div Pediat Infect Dis, Dept Pediat,Burns & Allen Res Inst, Steven Spielberg Pediat Res Ctr, Los Angeles, CA 90048 USA; Cedars Sinai Med Ctr, Dept Pathol, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Abreu, MT (corresponding author), Cedars Sinai Med Ctr, Ctr Inflammatory Bowel Dis, Div Gastroenterol, Dept Med, 8631 W 3rd St,Suite 245E, Los Angeles, CA 90048 USA.	maria.abreu@cshs.org	Eckhardt, Erik/G-1567-2010	Abreu, Maria T./0000-0002-7294-0574	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI040275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002635] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL66436] Funding Source: Medline; NIAID NIH HHS [AI40275] Funding Source: Medline; NIDDK NIH HHS [DK02635] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Abreu MT, 2000, GASTROENTEROLOGY, V119, P1524, DOI 10.1053/gast.2000.20232; Abreu-Martin MT, 1999, MOL CELL BIOL, V19, P5143; ABREUMARTIN MT, 1995, J IMMUNOL, V155, P4147; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Backhed F, 2001, CELL MICROBIOL, V3, P153, DOI 10.1046/j.1462-5822.2001.00101.x; Blumberg RS, 2000, CURR OPIN IMMUNOL, V12, P226, DOI 10.1016/S0952-7915(99)00079-5; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Bowie A, 2000, J LEUKOCYTE BIOL, V67, P508, DOI 10.1002/jlb.67.4.508; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Casola A, 1998, GASTROENTEROLOGY, V114, P947, DOI 10.1016/S0016-5085(98)70314-2; Chackerian AA, 2001, INFECT IMMUN, V69, P2666, DOI 10.1128/IAI.69.4.2666-2674.2001; Cong YZ, 2000, J IMMUNOL, V165, P2173, DOI 10.4049/jimmunol.165.4.2173; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DHARMSATHAPHORN K, 1984, AM J PHYSIOL, V246, pG204, DOI 10.1152/ajpgi.1984.246.2.G204; Dohi T, 2000, GASTROENTEROLOGY, V119, P724, DOI 10.1053/gast.2000.16500; Doughty LA, 2001, J IMMUNOL, V166, P2658, DOI 10.4049/jimmunol.166.4.2658; Dunne C, 2001, INFLAMM BOWEL DIS, V7, P136, DOI 10.1097/00054725-200105000-00010; ECKMANN L, 1993, INFECT IMMUN, V61, P4569, DOI 10.1128/IAI.61.11.4569-4574.1993; Elewaut D, 1999, J IMMUNOL, V163, P1457; Faure E, 2000, J BIOL CHEM, V275, P11058, DOI 10.1074/jbc.275.15.11058; Faure E, 2001, J IMMUNOL, V166, P2018, DOI 10.4049/jimmunol.166.3.2018; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; French N, 2000, GUT, V47, P162, DOI 10.1136/gut.47.2.162; Hecht G, 1999, AM J PHYSIOL-CELL PH, V277, pC351, DOI 10.1152/ajpcell.1999.277.3.C351; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; HOGAN MM, 1988, J IMMUNOL, V140, P513; HOGAN MM, 1987, J IMMUNOL, V139, P3697; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jiang QQ, 2000, J IMMUNOL, V165, P3541, DOI 10.4049/jimmunol.165.7.3541; JUNG HC, 1995, J CLIN INVEST, V95, P55, DOI 10.1172/JCI117676; Kim JM, 1998, J CLIN INVEST, V102, P1815, DOI 10.1172/JCI2466; MacDonald TT, 2000, INFLAMM BOWEL DIS, V6, P116, DOI 10.1097/00054725-200005000-00008; MADARA JL, 1985, J CELL BIOL, V101, P2124, DOI 10.1083/jcb.101.6.2124; Matsuguchi T, 2000, J IMMUNOL, V165, P5767, DOI 10.4049/jimmunol.165.10.5767; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; MCINTIRE FC, 1967, BIOCHEMISTRY-US, V6, P2363, DOI 10.1021/bi00860a011; Means TK, 1999, J IMMUNOL, V163, P3920; Mita Y, 2001, BRIT J HAEMATOL, V112, P1041, DOI 10.1046/j.1365-2141.2001.02658.x; Naidu AS, 1999, CRIT REV FOOD SCI, V39, P13, DOI 10.1080/10408699991279187; Naik S, 2001, J PEDIATR GASTR NUTR, V32, P449, DOI 10.1097/00005176-200104000-00011; Novak U, 1999, GROWTH FACTORS, V16, P305, DOI 10.3109/08977199909069148; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Papadakis KA, 2000, GASTROENTEROLOGY, V119, P1148, DOI 10.1053/gast.2000.18160; Plevy SE, 1997, J IMMUNOL, V159, P6276; Qureshi N, 1995, Prog Clin Biol Res, V392, P151; Rath HC, 1999, INFECT IMMUN, V67, P2969, DOI 10.1128/IAI.67.6.2969-2974.1999; Rath HC, 1999, GASTROENTEROLOGY, V116, P310, DOI 10.1016/S0016-5085(99)70127-7; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Riffault S, 2001, VET RES, V32, P71, DOI 10.1051/vetres:2001111; Rollo EE, 1999, J IMMUNOL, V163, P4442; Sansonetti PJ, 1999, SEMIN IMMUNOL, V11, P193, DOI 10.1006/smim.1999.0175; Savkovic SD, 1997, AM J PHYSIOL-CELL PH, V273, pC1160, DOI 10.1152/ajpcell.1997.273.4.C1160; Schultz M, 2000, AM J GASTROENTEROL, V95, pS19, DOI 10.1016/S0002-9270(99)00812-6; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Svanborg C, 2001, J INFECT DIS, V183, pS61, DOI 10.1086/318858; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Veltkamp C, 2001, GASTROENTEROLOGY, V120, P900, DOI 10.1053/gast.2001.22547; Wang TY, 2000, J IMMUNOL, V165, P6308, DOI 10.4049/jimmunol.165.11.6308; Zhang FX, 1999, J BIOL CHEM, V274, P7611, DOI 10.1074/jbc.274.12.7611	65	300	330	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20431	20437		10.1074/jbc.M110333200	http://dx.doi.org/10.1074/jbc.M110333200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11923281	hybrid			2022-12-27	WOS:000176204500043
J	Herter, S; Fuchs, G; Bacher, A; Eisenreich, W				Herter, S; Fuchs, G; Bacher, A; Eisenreich, W			A bicyclic autotrophic CO2 fixation pathway in Chloroflexus aurantiacus.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-HYDROXYPROPIONATE CYCLE; CARBON FIXATION; ASSIMILATION; METABOLISM; ACETATE; C-13-NMR	Phototrophic CO2 assimilation by the primitive, green eubacterium. Chloroflexus aurantiacus has been shown earlier to proceed in a cyclic mode via 3-hydroxypropionate, propionyl-CoA, succinyl-CoA, and malyl-CoA. The metabolic cycle could be closed by cleavage of malyl-CoA affording glyoxylate (the primary CO2 fixation product) with regeneration of acetyl-CoA serving as the starter unit of the cycle. The pathway of glyoxylate assimilation to form gluconeogenic precursors has not been elucidated to date. We could now show that the incubation of cell extract with a mixture of glyoxylate and [1,2,3-C-13(3)]propionyl-CoA afforded erythro-beta-[1,2,2'-C-13(3)]methylmalate and [1,2,2'-C-13(3)]citramalate. Similar experiments using a partially purified protein fraction afforded erythro-beta-[1,2,2'-C-13(3)]methylmalyl-CoA and [1,2,2'-C-13(3)]mesaconyl-CoA. Cell extracts of C. aurantiacus were also shown to catalyze the conversion of citramalate into pyruvate and acetyl-CoA in a succinyl-CoA-dependent reaction. The data suggest that glyoxylate obtained by the cleavage of malyl-CoA can be utilized by condensation with propionyl-CoA affording erythro-beta-methylmalyl-CoA, which is converted to acetyl-CoA and pyruvate. This reaction sequence regenerates acetyl-CoA which serves as the precursor of propionyl-CoA in the 3-hydroxypropionate cycle. Autotrophic CO2 fixation proceeds by combination of the 3-hydroxypropionate cycle with the methylmalyl-CoA cycle. The net product of that bicyclic autotrophic CO2 fixation pathway is pyruvate serving as an universal building block for anabolic reactions.	Univ Freiburg, Inst Biol 2, Lehrstuhl Mikrobiol, D-79104 Freiburg, Germany; Tech Univ Munich, Lehrstuhl Organ Chem & Biochem, D-85747 Garching, Germany	University of Freiburg; Technical University of Munich	Fuchs, G (corresponding author), Univ Freiburg, Inst Biol 2, Lehrstuhl Mikrobiol, Schanzlestr 1, D-79104 Freiburg, Germany.		Eisenreich, Wolfgang/A-1258-2013	Eisenreich, Wolfgang/0000-0002-9832-8279				Alber BE, 2002, J BIOL CHEM, V277, P12137, DOI 10.1074/jbc.M110802200; BHAT KS, 1985, INDIAN J CHEM B, V24, P509; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUCKEL W, 1976, EUR J BIOCHEM, V64, P255, DOI 10.1111/j.1432-1033.1976.tb10295.x; CASTENHOLZ RW, 1969, BACTERIOL REV, V33, P476, DOI 10.1128/MMBR.33.4.476-504.1969; COX RB, 1976, J GEN MICROBIOL, V95, P121, DOI 10.1099/00221287-95-1-121; DIMROTH P, 1977, EUR J BIOCHEM, V80, P469, DOI 10.1111/j.1432-1033.1977.tb11902.x; EGGERER H, 1964, BIOCHEM Z, V339, P436; EISENREICH W, 1993, EUR J BIOCHEM, V215, P619, DOI 10.1111/j.1432-1033.1993.tb18073.x; Han L, 1997, J BACTERIOL, V179, P5157, DOI 10.1128/jb.179.16.5157-5164.1997; Herter S, 2001, J BACTERIOL, V183, P4305, DOI 10.1128/JB.183.14.4305-4316.2001; HOLO H, 1986, ARCH MICROBIOL, V145, P173, DOI 10.1007/BF00446776; HOLO H, 1989, ARCH MICROBIOL, V151, P252, DOI 10.1007/BF00413138; HOLO H, 1987, ARCH MICROBIOL, V148, P292, DOI 10.1007/BF00456707; Hugler M, 2002, J BACTERIOL, V184, P2404, DOI 10.1128/JB.184.9.2404-2410.2002; IVANOVSKII RN, 1995, MICROBIOLOGY+, V64, P257; IVANOVSKY RN, 1993, ARCH MICROBIOL, V159, P257, DOI 10.1007/BF00248481; Ivanovsky RN, 1997, FEMS MICROBIOL LETT, V153, P399, DOI 10.1016/S0378-1097(97)00280-2; KAKINUMA K, 1993, BIOSCI BIOTECH BIOCH, V57, P1916, DOI 10.1271/bbb.57.1916; KONDRATIEVA EN, 1992, FEMS MICROBIOL LETT, V100, P269, DOI 10.1111/j.1574-6968.1992.tb05714.x; KORKES S, 1956, ANNU REV BIOCHEM, V25, P723; KORNBERG HL, 1957, NATURE, V179, P988, DOI 10.1038/179988a0; Korotkova N, 2002, J BACTERIOL, V184, P1750, DOI 10.1128/JB.184.6.1750-1758.2002; LOKEN O, 1982, ARCH MICROBIOL, V132, P276, DOI 10.1007/BF00407965; Menendez C, 1999, J BACTERIOL, V181, P1088, DOI 10.1128/JB.181.4.1088-1098.1999; NANAKO H, 1970, BIOCHEM BIOPH RES CO, V41, P1605; OSUMI T, 1975, J BIOCHEM-TOKYO, V78, P763, DOI 10.1093/oxfordjournals.jbchem.a130965; RENAUD P, 1987, HELV CHIM ACTA, V70, P292, DOI 10.1002/hlca.19870700204; SIMON E, 1957, BIOCHEM PREP, V5, P30; STADTMAN ER, 1957, METHOD ENZYMOL, V3, P931, DOI 10.1016/S0076-6879(57)03481-3; STRAUSS G, 1992, EUR J BIOCHEM, V205, P853, DOI 10.1111/j.1432-1033.1992.tb16850.x; STRAUSS G, 1993, EUR J BIOCHEM, V215, P633, DOI 10.1111/j.1432-1033.1993.tb18074.x; SUBHASH CG, 1984, J BIOL CHEM, V259, P10012; Ugol'kova N. V., 2000, Mikrobiologiya, V69, P175	34	95	104	3	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20277	20283		10.1074/jbc.M201030200	http://dx.doi.org/10.1074/jbc.M201030200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11929869	hybrid			2022-12-27	WOS:000176204500025
J	Lin, TH; Chia, CM; Hsiao, JC; Chang, W; Ku, CC; Hung, SC; Tzou, DLM				Lin, TH; Chia, CM; Hsiao, JC; Chang, W; Ku, CC; Hung, SC; Tzou, DLM			Structural analysis of the extracellular domain of vaccinia virus envelope protein, A27L, by NAM and CD spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							14-KILODALTON FUSION PROTEIN; CHEMICAL-SHIFTS; GUANIDINE-HYDROCHLORIDE; HEPARAN-SULFATE; BINDING-SITES; AMINO-ACIDS; NMR; IDENTIFICATION; FORMS; C-13	This study presents the molecular structure of the extracellular domain of vaccinia virus envelope protein, A27L, determined by NMR and CD spectroscopy. A recombinant protein, eA27L-aa, containing this domain in which cysteines 71 and 72 were replaced with alanine, was constructed to prevent self-assembly due to intermolecular disulfide bonds between these two cysteines. The soluble eA27L-aa protein forms an oligomer resembling that of A27L on vaccinia virions. Heteronuclear correlation NMR spectroscopy was carried out on eA27L-aa in the presence or absence of urea to determine backbone resonance assignments. Chemical shift index (CSI) propensity analysis showed that eA27L-aa has two distinct structural domains, a relatively flexible 22-amino acid random coil in the N-terminal region and a fairly rigid a-helix structure in the remainder of the structure. Binding interaction studies using isothermal titration calorimetry suggest that a 12-amino acid lysine/arginine-rich segment in the N-terminal region is responsible for glycosaminoglycan binding. The rigid a-helix portion of eA27L-aa is probably involved in the intrinsic self-assembly, and CSI propensity analysis suggests that region N37-E49, with a residual a-helix tendency, is probably the self-assembly core. Self-assembly was ascribed to three hydrophobic leucine residues (Leu(41), Leu(45), and LeU(48)) in this segment. The folding mechanism of eA27L-aa was analyzed by CD spectroscopy, which revealed a two-step transition with a Gibbs free energy of 2.5 kcal/mol in the absence of urea. Based on these NMR and CD studies, a residue-specific molecular model of the extracellular domain of A27L is proposed. These studies on the molecular structure of eA27L-aa will help in understanding how vaccinia virus enters cells.	Acad Sinica, Inst Chem, Taipei 11529, Taiwan; Natl Yang Ming Univ, Inst Biochem, Taipei 11221, Taiwan; Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei 11217, Taiwan; Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Academia Sinica - Taiwan	Tzou, DLM (corresponding author), Acad Sinica, Inst Chem, 128 Yen Chiu Yuan Rd,Sec 2, Taipei 11529, Taiwan.	tzou@ccvax.sinica.edu.tw	Chang, Wen/AAA-5076-2021; Tzou, Der-Lii M/E-9499-2015	Chang, Wen/0000-0003-3369-083X; Tzou, Der-Lii M/0000-0002-3755-8230				Alexandrescu AT, 1998, J BIOMOL NMR, V11, P461, DOI 10.1023/A:1008283925446; Alexandrescu AT, 2000, J MOL BIOL, V295, P239, DOI 10.1006/jmbi.1999.3354; BAX A, 1994, METHOD ENZYMOL, V239, P79; BENTZ J, 1993, VIRAL FUSION MECH; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chung CS, 1998, J VIROL, V72, P1577, DOI 10.1128/JVI.72.2.1577-1585.1998; Eliezer D, 1997, FEBS LETT, V417, P92, DOI 10.1016/S0014-5793(97)01256-8; FINN BE, 1992, PROTEIN ENG PRACTICA, P167; Fromm JR, 1997, ARCH BIOCHEM BIOPHYS, V346, P252, DOI 10.1006/abbi.1997.0299; Fromm JR, 1997, ARCH BIOCHEM BIOPHYS, V343, P92, DOI 10.1006/abbi.1997.0147; Fry EE, 1999, EMBO J, V18, P543, DOI 10.1093/emboj/18.3.543; HAYWOOD AM, 1994, J VIROL, V68, P1; Hileman RE, 1998, BIOCHEMISTRY-US, V37, P15231, DOI 10.1021/bi980212x; Hsiao JC, 1998, J VIROL, V72, P8374, DOI 10.1128/JVI.72.10.8374-8379.1998; Kay LE, 1997, BIOCHEM CELL BIOL, V75, P1, DOI 10.1139/o97-023; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; LOGAN TM, 1994, J MOL BIOL, V236, P637, DOI 10.1006/jmbi.1994.1173; MEYER H, 1994, VIROLOGY, V200, P778, DOI 10.1006/viro.1994.1241; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Radhakrishnan I, 1998, FEBS LETT, V430, P317, DOI 10.1016/S0014-5793(98)00680-2; RODRIGUEZ D, 1993, J VIROL, V67, P3435, DOI 10.1128/JVI.67.6.3435-3440.1993; RODRIGUEZ D, 1995, J VIROL, V69, P4640; RODRIGUEZ JF, 1987, J VIROL, V61, P3550, DOI 10.1128/JVI.61.11.3550-3554.1987; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; SCHLEUCHER J, 1993, ANGEW CHEM INT EDIT, V32, P1489, DOI 10.1002/anie.199314891; SCHULMAN BA, 1997, NAT STRUCT, V6, P24; Shirley B A, 1995, Methods Mol Biol, V40, P177; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; TAKAHASHI T, 1994, VIROLOGY, V202, P844, DOI 10.1006/viro.1994.1406; Vazquez MI, 1998, J VIROL, V72, P10126; Wang Y, 1996, PROTEIN SCI, V5, P1898, DOI 10.1002/pro.5560050916; WIMMR E, 1994, CELLULAR RECEPTORS A; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; [No title captured]	37	13	13	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20949	20959		10.1074/jbc.M110403200	http://dx.doi.org/10.1074/jbc.M110403200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11901147	hybrid			2022-12-27	WOS:000176204500109
J	Milutinovic, S; Zhuang, QL; Szyf, M				Milutinovic, S; Zhuang, QL; Szyf, M			Proliferating cell nuclear antigen associates with histone deacetylase activity, integrating DNA replication and chromatin modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIGENETIC INHERITANCE; FISSION YEAST; COMPLEX; PCNA; TRANSCRIPTION; METHYLATION; INHIBITION; H3	Faithful inheritance of the chromatin structure is essential for maintaining the gene expression integrity of a cell. Histone modification by acetylation and deacetylation is a critical control of chromatin structure. In this study, we test the hypothesis that histone deacetylase 1 (HDAC1) is physically associated with a basic component of the DNA replication machinery as a mechanism of coordinating histone deacetylation and DNA synthesis. Proliferating cell nuclear antigen (PCNA) is a sliding clamp that serves as a loading platform for many proteins involved in DNA replication and DNA repair. We show that PCNA interacts with HDAC1 in human cells and in vitro and that a considerable fraction of PCNA and HDAC1 colocalize in the cell nucleus. PCNA associates with histone deacetylase activity that is completely abolished in the presence of the HDAC inhibitor trichostatin A. Trichostatin A treatment arrests cells at the G(2)-M phase of the cell cycle, which is consistent with the hypothesis that the proper formation of the chromatin after DNA replication may be important in signaling the progression through the cell cycle. Our results strengthen the role of PCNA as a factor coordinating DNA replication and epigenetic inheritance.	McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada	McGill University	Szyf, M (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.							Araujo FD, 1998, MOL CELL BIOL, V18, P3475, DOI 10.1128/MCB.18.6.3475; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Cai RL, 2000, J BIOL CHEM, V275, P27909; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Fischer DD, 2002, J BIOL CHEM, V277, P6656, DOI 10.1074/jbc.M108055200; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Grewal SIS, 1998, GENETICS, V150, P563; Hasan S, 2001, NATURE, V410, P387, DOI 10.1038/35066610; HENDERSON DS, 1994, EMBO J, V13, P1450, DOI 10.1002/j.1460-2075.1994.tb06399.x; HUFF JP, 1990, J EXP MED, V172, P419, DOI 10.1084/jem.172.2.419; Knox JD, 2000, J BIOL CHEM, V275, P17986, DOI 10.1074/jbc.C900894199; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Szyf M, 2001, PROG NUCLEIC ACID RE, V69, P47, DOI 10.1016/S0079-6603(01)69044-5; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601	23	81	85	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20974	20978		10.1074/jbc.M202504200	http://dx.doi.org/10.1074/jbc.M202504200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11929879	hybrid			2022-12-27	WOS:000176204500112
J	Muto, A; Tashiro, S; Tsuchiya, H; Kume, A; Kanno, M; Ito, E; Yamamoto, M; Igarashi, K				Muto, A; Tashiro, S; Tsuchiya, H; Kume, A; Kanno, M; Ito, E; Yamamoto, M; Igarashi, K			Activation of Maf/AP-1 repressor Bach2 by oxidative stress promotes apoptosis and its interaction with promyelocytic leukemia nuclear bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL MAF PROTEINS; ANTIOXIDANT RESPONSIVE ELEMENTS; TRANSCRIPTION FACTOR BACH2; LEUCINE-ZIPPER PROTEIN; LOCUS-CONTROL REGION; ABL TYROSINE KINASE; YA SUBUNIT GENE; INTERACTION MOTIF; DNA-BINDING; BTB/POZ DOMAIN	The oxidative stress response operates by inducing the expression of genes that counteract the stress. We show here that the oxidative stress-responsive transcription factor Bach2 is a generic inhibitor of gene expression directed by the 12-O-tetradecanoylphorbol-13-acetate response element, the Maf recognition element, and the antioxidant-responsive element. The Bach2-enhanced green fluorescent protein bicistronic retrovirus was used to monitor the fate of Bach2-expressing cells at the single cell level. Bach2 exerted an inhibitory effect on NIH3T3 cell proliferation and caused massive apoptosis upon mild oxidative stress in both NIH3T3 and Raji B-lymphoid cells. Interestingly, Bach1, a highly homologous protein, could not induce cell death, demonstrating the specificity for the apoptosis induction. Although both oxidative stress and leptomycin B, an inhibitor of nuclear export, induce nuclear accumulation of Bach2, the leptomycin B-induced nuclear accumulation of Bach2 was not sufficient to elicit apoptosis. Upon oxidative stress, Bach2 formed nuclear foci that associated with promyelocytic leukemia nuclear bodies. Our results suggest that Bach2 constitutes a cell lineage-specific system that couples oxidative stress and cell death and that inhibition of 12-O-tetradecanoylphorbol-13-acetate response element, the Maf recognition element, and the antioxidant-responsive element upon oxidative stress may be critical determinants for apoptosis.	Hiroshima Univ, Sch Med, Dept Biochem, Hiroshima 7348551, Japan; Jichi Med Sch, Ctr Mol Med, Div Genet Therapeut, Tochigi 3290498, Japan; Hiroshima Univ, Sch Med, Dept Immunol, Hiroshima 7348551, Japan; Hirosaki Univ, Sch Med, Dept Pediat, Hirosaki, Aomori 0368563, Japan; Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058575, Japan; Univ Tsukuba, Inst Basic Med, Tsukuba, Ibaraki 3058575, Japan	Hiroshima University; Jichi Medical University; Hiroshima University; Hirosaki University; University of Tsukuba; University of Tsukuba	Igarashi, K (corresponding author), Hiroshima Univ, Sch Med, Dept Biochem, Kasumi 1-2-3, Hiroshima 7348551, Japan.	igarak@hiroshima-u.ac.jp	Yamamoto, Masayuki/A-4873-2010	Yamamoto, Masayuki/0000-0002-9073-9436; Kanno, masamoto/0000-0001-9169-3444; Ito, Etsuro/0000-0002-0168-2475; Igarashi, Kazuhiko/0000-0002-2470-2475				Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Albagli O, 1996, BIOCHEM BIOPH RES CO, V220, P911, DOI 10.1006/bbrc.1996.0505; ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; BIGUET C, 1994, J BIOL CHEM, V269, P28865; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; Chan JY, 2000, BBA-GENE STRUCT EXPR, V1517, P19, DOI 10.1016/S0167-4781(00)00238-4; Deininger MWN, 1997, BLOOD, V90, P3691, DOI 10.1182/blood.V90.9.3691; Dhordain P, 1995, ONCOGENE, V11, P2689; Dong S, 1996, P NATL ACAD SCI USA, V93, P3624, DOI 10.1073/pnas.93.8.3624; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; FRILING RS, 1992, P NATL ACAD SCI USA, V89, P668, DOI 10.1073/pnas.89.2.668; FUJIWARA KT, 1993, ONCOGENE, V8, P2371; Hoshino H, 2000, J BIOL CHEM, V275, P15370, DOI 10.1074/jbc.275.20.15370; IGARASHI K, 1995, J BIOL CHEM, V270, P7615, DOI 10.1074/jbc.270.13.7615; Igarashi K, 1998, J BIOL CHEM, V273, P11783, DOI 10.1074/jbc.273.19.11783; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; KATAOKA K, 1993, J VIROL, V67, P2133, DOI 10.1128/JVI.67.4.2133-2141.1993; KATAOKA K, 1995, MOL CELL BIOL, V15, P2180; Kataoka K, 2001, J BIOL CHEM, V276, P36849, DOI 10.1074/jbc.M102234200; Kataoka K, 2001, J BIOL CHEM, V276, P34074, DOI 10.1074/jbc.M105383200; Khan MM, 2001, MOL CELL, V7, P1233, DOI 10.1016/S1097-2765(01)00257-X; Kobayashi A, 1999, J BIOL CHEM, V274, P6443, DOI 10.1074/jbc.274.10.6443; Kume A, 2000, GENE THER, V7, P1193, DOI 10.1038/sj.gt.3301225; Kwong M, 1999, J BIOL CHEM, V274, P37491, DOI 10.1074/jbc.274.52.37491; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Motohashi H, 2000, CELL, V103, P865, DOI 10.1016/S0092-8674(00)00190-2; Muto A, 1998, EMBO J, V17, P5734, DOI 10.1093/emboj/17.19.5734; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; NISHIZAWA M, 1989, P NATL ACAD SCI USA, V86, P7711, DOI 10.1073/pnas.86.20.7711; OHBA M, 1994, J CELL BIOL, V126, P1079, DOI 10.1083/jcb.126.4.1079; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Quignon F, 1998, NAT GENET, V20, P259, DOI 10.1038/3068; RUSHMORE TH, 1990, P NATL ACAD SCI USA, V87, P3826, DOI 10.1073/pnas.87.10.3826; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sasaki S, 2000, ONCOGENE, V19, P3739, DOI 10.1038/sj.onc.1203716; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Sun JY, 2001, J BIOCHEM, V130, P385, DOI 10.1093/oxfordjournals.jbchem.a002997; Toki T, 1997, ONCOGENE, V14, P1901, DOI 10.1038/sj.onc.1201024; Vallian S, 1997, EXP CELL RES, V237, P371, DOI 10.1006/excr.1997.3801; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; Vieira SAD, 2001, GENE CHROMOSOME CANC, V32, P353, DOI 10.1002/gcc.1200; Vigneri P, 2001, NAT MED, V7, P228, DOI 10.1038/84683; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Yoshida C, 1999, GENES CELLS, V4, P643, DOI 10.1046/j.1365-2443.1999.00291.x; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583; Zhong S, 2000, J EXP MED, V191, P631, DOI 10.1084/jem.191.4.631	59	76	79	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20724	20733		10.1074/jbc.M112003200	http://dx.doi.org/10.1074/jbc.M112003200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11923289	hybrid			2022-12-27	WOS:000176204500081
J	Nordin, BE; Schimmel, P				Nordin, BE; Schimmel, P			Plasticity of recognition of the 3 '-end of mischarged tRNA by class I aminoacyl-tRNA synthetases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; BAKERS-YEAST; 3-HYDROXYL GROUP; MIS-ACYLATION; ISOLEUCINE; SIEVE; SITE; DETERMINANTS; THREONINE; MECHANISM	Certain aminoacyl-tRNA synthetases prevent potential errors in protein synthesis through deacylation of mischarged tRNAs. For example, the close homologs isoleucyl-tRNA synthetase (IleRS) and valyl-tRNA synthetase (ValRS) deacylate Val-tRNA(Ile) and Thr-tRNA(Val), respectively. Here we examined the chemical requirements at the 3'-end of the tRNA for these hydrolysis reactions. Single atom substitutions at the 2'- and 3'-hydroxyls of a variety of mischarged RNAs revealed that, while acylation is at the 2'-OH for both enzymes, IleRS catalyzes deacylation specifically from the 3'-OH and not from the 2'-OH. In contrast, ValRS can deacylate non-cognate amino acids from the 2'-OH. Moreover, for IleRS the specificity for a 3'-O location of the scissile ester bond could be forced to the 2'-position by introduction of a 3'-O-methyl moiety. Cumulatively, these and other results suggest that the editing sites of these class I aminoacyl-tRNA synthetases have a degree of inherent plasticity for substrate recognition. The ability to adapt to subtle differences in mischarged RNAs may be important for the high accuracy of aminoacylation.	Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Schimmel, P (corresponding author), Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	schimmel@scripps.edu			NIGMS NIH HHS [GM15539] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM015539, R37GM015539] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexander RW, 1998, P NATL ACAD SCI USA, V95, P12214, DOI 10.1073/pnas.95.21.12214; BALDWIN AN, 1966, J BIOL CHEM, V241, P839; BRUICE TC, 1962, J AM CHEM SOC, V84, P1973, DOI 10.1021/ja00869a040; Burke TR, 1996, BIOCHEMISTRY-US, V35, P15989, DOI 10.1021/bi961256d; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; CRAMER F, 1975, FEBS LETT, V56, P212, DOI 10.1016/0014-5793(75)81093-3; Doring V, 2001, SCIENCE, V292, P501, DOI 10.1126/science.1057718; ELDRED EW, 1972, J BIOL CHEM, V247, P2961; ENGLISCH S, 1986, NUCLEIC ACIDS RES, V14, P7529, DOI 10.1093/nar/14.19.7529; Farrow MA, 1999, BIOCHEMISTRY-US, V38, P16898, DOI 10.1021/bi9920782; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; FERSHT AR, 1976, BIOCHEMISTRY-US, V15, P3342, DOI 10.1021/bi00660a026; FERSHT AR, 1979, BIOCHEMISTRY-US, V18, P2627, DOI 10.1021/bi00579a030; FRANCIS TA, 1983, J BIOL CHEM, V258, P4279; FRASER TH, 1975, P NATL ACAD SCI USA, V72, P3044, DOI 10.1073/pnas.72.8.3044; FREIST W, 1983, EUR J BIOCHEM, V131, P65, DOI 10.1111/j.1432-1033.1983.tb07232.x; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; GIEGE R, 1993, PROG NUCLEIC ACID RE, V45, P129, DOI 10.1016/S0079-6603(08)60869-7; Glasfeld E, 1996, BIOCHEMISTRY-US, V35, P4139, DOI 10.1021/bi9527810; Hale SP, 1997, SCIENCE, V276, P1250, DOI 10.1126/science.276.5316.1250; Hendrickson TL, 2000, BIOCHEMISTRY-US, V39, P8180, DOI 10.1021/bi0004798; Hendrickson TL, 2002, MOL CELL, V9, P353, DOI 10.1016/S1097-2765(02)00449-5; IGLOI GL, 1977, BIOCHEMISTRY-US, V16, P1696, DOI 10.1021/bi00627a027; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; LOFTFIELD RB, 1963, BIOCHEM J, V89, P82, DOI 10.1042/bj0890082; MILLIGAN JF, 1989, METHOD ENZYMOL, V180, P51; Mursinna RS, 2001, BIOCHEMISTRY-US, V40, P5376, DOI 10.1021/bi002915w; Nomanbhoy TK, 2000, P NATL ACAD SCI USA, V97, P5119, DOI 10.1073/pnas.090102197; Nordin BE, 1999, J BIOL CHEM, V274, P6835, DOI 10.1074/jbc.274.11.6835; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; NUREKI O, 1993, TRANSLATIONAL APPARATUS, P59; PAULING L, 1958, FESTSCHRIFT PROF DR; PYLE AM, 1992, NATURE, V358, P123, DOI 10.1038/358123a0; SCHIMMEL P, 2002, IN PRESS COLD SPRING; SCHMIDT E, 1995, BIOCHEMISTRY-US, V34, P11204, DOI 10.1021/bi00035a028; SCHMIDT E, 1994, SCIENCE, V264, P265, DOI 10.1126/science.8146659; SCHMIDT E, 1996, THESIS MIT CAMBRIDGE, P160; SHEPARD A, 1992, P NATL ACAD SCI USA, V89, P9964, DOI 10.1073/pnas.89.20.9964; Shi PY, 1998, RNA, V4, P276; SHIBA K, 1992, P NATL ACAD SCI USA, V89, P1880, DOI 10.1073/pnas.89.5.1880; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; SPRINZL M, 1975, P NATL ACAD SCI USA, V72, P3049, DOI 10.1073/pnas.72.8.3049; TAIJI M, 1983, BIOCHEMISTRY-US, V22, P3220, DOI 10.1021/bi00282a028; von der Haar F, 1976, Biochemistry, V15, P4131, DOI 10.1021/bi00663a034; VONDERHAAR F, 1975, FEBS LETT, V56, P215, DOI 10.1016/0014-5793(75)81094-5; WINCOTT F, 1995, NUCLEIC ACIDS RES, V23, P2677, DOI 10.1093/nar/23.14.2677; Yoshizawa S, 1999, SCIENCE, V285, P1722, DOI 10.1126/science.285.5434.1722	48	53	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20510	20517		10.1074/jbc.M202023200	http://dx.doi.org/10.1074/jbc.M202023200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11923317	hybrid			2022-12-27	WOS:000176204500054
J	Zhang, DW; Cole, SPC; Deeley, RG				Zhang, DW; Cole, SPC; Deeley, RG			Determinants of the substrate specificity of multidrug resistance protein 1 - Role of amino acid residues with hydrogen bonding potential in predicted transmembrane helix 17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC ANION TRANSPORTER; BINDING CASSETTE TRANSPORTER; DRUG-RESISTANCE; LEUKOTRIENE C-4; PHARMACOLOGICAL CHARACTERIZATION; ANTICANCER AGENTS; EXPORT PUMP; MRP; GENE; CELLS	Human multidrug resistance protein 1 (MRP1) confers resistance to many natural product chemotherapeutic agents and actively transports structurally diverse organic anion conjugates. We previously demonstrated that two hydrogen-bonding amino acid residues in the predicted transmembrane 17 (TM17) of MRP1, Thr(1242) and Trp(1246), were important for drug resistance and 17beta-estradiol 17-(beta-D-glueuronide) (E(2)17betaG) transport. To determine whether other residues with hydrogen bonding potential within TM17 influence substrate specificity, we replaced Ser(I233), Ser(1235), Ser(1237), Gln(1239), Thr(1241), and Asn(1245) with Ala and Tyr(1236) and Tyr(1243) with Phe. Mutations S1233A, S1235A, S1237A, and Q1239A had no effect on any substrate tested. In contrast, mutations Y1236F and T1241A decreased resistance to vincristine but not to VP-16, doxorubicin, and epirubicin. Mutation Y1243F reduced resistance to all drugs tested by 2-3-fold. Replacement of Asn(1245) with Ala also decreased resistance to VP-16, doxorubicin, and epirubicin but increased resistance to vincristine. This mutation also decreased E(2)17betaG transport similar to5-fold. Only mutation Y1243F altered the ability of MRP1 to transport both leukotriene 4 and E(2)17betaG. Together with our previous results, these findings suggest that residues with side chain hydrogen bonding potential, clustered in the cytoplasmic half of TM17, participate in the formation of a substrate binding site.	Queens Univ, Canc Res Labs, Kingston, ON K7L 3N6, Canada; Queens Univ, Dept Pathol, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada	Deeley, RG (corresponding author), Queens Univ, Canc Res Labs, Botterell Hall, Kingston, ON K7L 3N6, Canada.		Deeley, Roger/J-4828-2012; Cole, Susan P.C./I-6389-2017; Zhang, Dawei/ABD-8990-2022	Cole, Susan P.C./0000-0001-6571-6884; Zhang, Dawei/0000-0001-8279-8041				Arkin IT, 1998, BBA-PROTEIN STRUCT M, V1429, P113, DOI 10.1016/S0167-4838(98)00225-8; Bera TK, 2001, MOL MED, V7, P509, DOI 10.1007/BF03401856; Borst P, 2000, JNCI-J NATL CANCER I, V92, P1295, DOI 10.1093/jnci/92.16.1295; Borst P, 1999, BBA-BIOMEMBRANES, V1461, P347, DOI 10.1016/S0005-2736(99)00167-4; Chang G, 2001, SCIENCE, V293, P1793, DOI 10.1126/science.293.5536.1793; COLE SPC, 1994, CANCER RES, V54, P5902; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cui YH, 1999, MOL PHARMACOL, V55, P929; Daoud R, 2001, J BIOL CHEM, V276, P12324, DOI 10.1074/jbc.M009782200; Deeley RG, 1997, SEMIN CANCER BIOL, V8, P193, DOI 10.1006/scbi.1997.0070; GRANT CE, 1994, CANCER RES, V54, P357; Hipfner DR, 1997, J BIOL CHEM, V272, P23623, DOI 10.1074/jbc.272.38.23623; Hipfner DR, 1998, BRIT J CANCER, V78, P1134, DOI 10.1038/bjc.1998.642; Hipfner DR, 1996, CANCER RES, V56, P3307; Hipfner DR, 1999, BBA-BIOMEMBRANES, V1461, P359, DOI 10.1016/S0005-2736(99)00168-6; Hooijberg JH, 1999, CANCER RES, V59, P2532; Ito K, 2001, J BIOL CHEM, V276, P15616, DOI 10.1074/jbc.M011246200; Ito K, 2001, J BIOL CHEM, V276, P38108; Jedlitschky G, 2000, J BIOL CHEM, V275, P30069, DOI 10.1074/jbc.M005463200; Jedlitschky G, 1996, CANCER RES, V56, P988; Kawabe T, 1999, FEBS LETT, V456, P327, DOI 10.1016/S0014-5793(99)00979-5; KEPPLER D, 2001, J BIOL CHEM, V276, P38636; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kiuchi Y, 1998, FEBS LETT, V433, P149, DOI 10.1016/S0014-5793(98)00899-0; Konig J, 1999, BBA-BIOMEMBRANES, V1461, P377, DOI 10.1016/S0005-2736(99)00169-8; Leslie EM, 2001, TOXICOLOGY, V167, P3, DOI 10.1016/S0300-483X(01)00454-1; Litman T, 2001, CELL MOL LIFE SCI, V58, P931, DOI 10.1007/PL00000912; Loe DW, 1996, J BIOL CHEM, V271, P9683, DOI 10.1074/jbc.271.16.9683; Loe DW, 1996, J BIOL CHEM, V271, P9675, DOI 10.1074/jbc.271.16.9675; Paulusma CC, 1996, SCIENCE, V271, P1126, DOI 10.1126/science.271.5252.1126; Ren XQ, 2001, J BIOL CHEM, V276, P23197, DOI 10.1074/jbc.M101554200; Robbiani DF, 2000, CELL, V103, P757, DOI 10.1016/S0092-8674(00)00179-3; Ryu S, 2000, J BIOL CHEM, V275, P39617, DOI 10.1074/jbc.M005149200; Schuetz JD, 1999, NAT MED, V5, P1048, DOI 10.1038/12487; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Seelig A, 2000, INT J CLIN PHARM TH, V38, P111; Stride BD, 1999, J BIOL CHEM, V274, P22877, DOI 10.1074/jbc.274.32.22877; Stride BD, 1997, MOL PHARMACOL, V52, P344, DOI 10.1124/mol.52.3.344; Stride BD, 1996, MOL PHARMACOL, V49, P962; Taguchi Y, 1997, BIOCHEMISTRY-US, V36, P8883, DOI 10.1021/bi970553v; Tammur J, 2001, GENE, V273, P89, DOI 10.1016/S0378-1119(01)00572-8; Taniguchi K, 1996, CANCER RES, V56, P4124; Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762; Wijnholds J, 2000, P NATL ACAD SCI USA, V97, P7476, DOI 10.1073/pnas.120159197; Wijnholds J, 1997, NAT MED, V3, P1275, DOI 10.1038/nm1197-1275; Yabuuchi H, 2001, BIOCHEM BIOPH RES CO, V288, P933, DOI 10.1006/bbrc.2001.5865; Zelcer N, 2001, J BIOL CHEM, V276, P46400, DOI 10.1074/jbc.M107041200; Zeng H, 1999, CANCER RES, V59, P5964; Zeng H, 2000, CANCER RES, V60, P4779; Zhang DW, 2001, J BIOL CHEM, V276, P34966, DOI 10.1074/jbc.M105063200; Zhang DW, 2001, J BIOL CHEM, V276, P13231, DOI 10.1074/jbc.M010008200	51	46	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20934	20941		10.1074/jbc.M201311200	http://dx.doi.org/10.1074/jbc.M201311200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11925441	hybrid			2022-12-27	WOS:000176204500107
J	Pullar, JM; Hampton, MB				Pullar, JM; Hampton, MB			Diphenyleneiodonium triggers the efflux of glutathione from cultured cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAS-MEDIATED APOPTOSIS; NEUTROPHIL NADPH OXIDASE; ISOLATED RAT HEPATOCYTES; REDUCED GLUTATHIONE; HYDROGEN-PEROXIDE; GSH EXTRUSION; REDOX STATE; ANTI-FAS; INHIBITION; BCL-2	Diphenyleneiodonium (DPI) is a broad-spectrum flavoprotein inhibitor commonly used to inhibit oxidant production by the NADPH oxidase of phagocytic and nonphagocytic cells. A previous study has shown that DPI can sensitize T24 bladder carcinoma cells to Fas-mediated apoptosis. We observed DPI to deplete intracellular reduced glutathione (GSH) in T24 cells and a range of other primary and transformed cell types. The effect was immediate, with 50% loss of intracellular GSH within 2 h of treatment with DPI. The glutathione was quantitatively recovered in the extracellular medium, indicating that efflux was occurring. The loss of GSH was blocked with bromosulfophthalein, an inhibitor of the canalicular GSH transporters. We conclude that DPI induces a dramatic efflux of cellular GSH from T24 cells via a specific transport channel. This provides a potential mechanism for its proapoptotic effect, and it also has important implications for the regulation of glutathione homeostasis in cells.	Christchurch Sch Med & Hlth Sci, Free Rad Res Grp, Dept Pathol, Christchurch, New Zealand	University of Otago	Pullar, JM (corresponding author), Christchurch Sch Med & Hlth Sci, Free Rad Res Grp, Dept Pathol, POB 4345, Christchurch, New Zealand.	juliet.pullar@chmeds.ac.nz	Hampton, Mark B/A-8490-2008	Hampton, Mark B/0000-0002-7349-3729				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; AW TY, 1986, AM J PHYSIOL, V251, pG354, DOI 10.1152/ajpgi.1986.251.3.G354; AW TY, 1984, J BIOL CHEM, V259, P9355; BALLATORI N, 1994, J BIOL CHEM, V269, P19731; BALLATORI N, 1985, AM J PHYSIOL, V248, pG238, DOI 10.1152/ajpgi.1985.248.2.G238; CERUTTI PA, 1985, SCIENCE, V227, P375, DOI 10.1126/science.2981433; Clement MV, 1996, EMBO J, V15, P216, DOI 10.1002/j.1460-2075.1996.tb00352.x; CROSS AR, 1986, BIOCHEM J, V237, P111, DOI 10.1042/bj2370111; DOUSSIERE J, 1992, EUR J BIOCHEM, V208, P61, DOI 10.1111/j.1432-1033.1992.tb17159.x; Doussiere J, 1999, BIOCHEMISTRY-US, V38, P3694, DOI 10.1021/bi9823481; Ellerby LM, 1996, J NEUROCHEM, V67, P1259; FERNANDEZ A, 1995, J IMMUNOL, V155, P5133; FERNANDEZCHECA JC, 1992, J BIOL CHEM, V267, P1667; Finkel T, 2000, FEBS LETT, V476, P52, DOI 10.1016/S0014-5793(00)01669-0; GHIBELLI L, 1995, BIOCHEM BIOPH RES CO, V216, P313, DOI 10.1006/bbrc.1995.2626; Ghibelli L, 1998, FASEB J, V12, P479, DOI 10.1096/fasebj.12.6.479; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hampton MB, 1997, FEBS LETT, V414, P552, DOI 10.1016/S0014-5793(97)01068-5; HAMPTON MB, 1995, FREE RADICAL BIO MED, V18, P633, DOI 10.1016/0891-5849(94)00181-I; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jenkins M, 1999, J IMMUNOL, V163, P1195; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Krammer PH, 1997, CELL DEATH DIFFER, V4, P362, DOI 10.1038/sj.cdd.4400252; Li YB, 1998, BIOCHEM BIOPH RES CO, V253, P295, DOI 10.1006/bbrc.1998.9729; Lu SC, 1999, FASEB J, V13, P1169, DOI 10.1096/fasebj.13.10.1169; Lu SC, 1996, J CLIN INVEST, V97, P1488, DOI 10.1172/JCI118571; LU SC, 1995, INVEST OPHTH VIS SCI, V36, P2523; Macho A, 1997, J IMMUNOL, V158, P4612; MARTIN J, 1991, J CHROMATOGR-BIOMED, V568, P219, DOI 10.1016/0378-4347(91)80356-H; MEISTER A, 1994, CANCER RES, V54, pS1969; Meredith MJ, 1998, BIOCHEM BIOPH RES CO, V248, P458, DOI 10.1006/bbrc.1998.8998; Micheau O, 1999, J BIOL CHEM, V274, P7987, DOI 10.1074/jbc.274.12.7987; Midis GP, 1996, CANCER RES, V56, P3870; Mirkovic N, 1997, ONCOGENE, V15, P1461, DOI 10.1038/sj.onc.1201310; Mittur AV, 1998, AM J PHYSIOL-GASTR L, V274, pG923, DOI 10.1152/ajpgi.1998.274.5.G923; Mittur AV, 2000, BBA-BIOMEMBRANES, V1464, P207, DOI 10.1016/S0005-2736(00)00152-8; Mori S, 1996, CANCER RES, V56, P1874; NATOLI G, 1995, ONCOGENE, V11, P1157; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; O'Flaherty E, 2000, IMMUNOLOGY, V100, P289, DOI 10.1046/j.1365-2567.2000.00048.x; ODONNELL VB, 1993, BIOCHEM J, V290, P41, DOI 10.1042/bj2900041; OWENSCHAUB LB, 1994, CANCER RES, V54, P1580; Pitti RM, 1998, NATURE, V396, P699, DOI 10.1038/25387; Poulaki V, 2001, CANCER RES, V61, P4864; Pullar JM, 1999, AM J PHYSIOL-HEART C, V277, pH1505, DOI 10.1152/ajpheart.1999.277.4.H1505; RAGAN CI, 1977, BIOCHEM J, V163, P605, DOI 10.1042/bj1630605; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; SHIMA Y, 1995, BLOOD, V85, P757, DOI 10.1182/blood.V85.3.757.bloodjournal853757; Siegel RM, 2000, NAT IMMUNOL, V1, P469, DOI 10.1038/82712; STUEHR DJ, 1991, FASEB J, V5, P98, DOI 10.1096/fasebj.5.1.1703974; SZATROWSKI TP, 1991, CANCER RES, V51, P794; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; vandenDobbelsteen DJ, 1996, J BIOL CHEM, V271, P15420, DOI 10.1074/jbc.271.26.15420; Vile GF, 2000, ARCH BIOCHEM BIOPHYS, V377, P122, DOI 10.1006/abbi.2000.1706; Voehringer DW, 1999, FREE RADICAL BIO MED, V27, P945, DOI 10.1016/S0891-5849(99)00174-4; Voehringer DW, 1998, P NATL ACAD SCI USA, V95, P2956, DOI 10.1073/pnas.95.6.2956; Willems F, 2000, BLOOD, V95, P3478, DOI 10.1182/blood.V95.11.3478.011k10_3478_3482	60	46	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19402	19407		10.1074/jbc.M111053200	http://dx.doi.org/10.1074/jbc.M111053200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11904296	hybrid			2022-12-27	WOS:000175894800023
J	Lin, DY; Shih, HM				Lin, DY; Shih, HM			Essential role of the 58-kDa microspherule protein in the modulation of Daxx-dependent transcriptional repression as revealed by nucleolar sequestration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAS-BINDING-PROTEIN; INTERACTING PROTEIN; INDUCED APOPTOSIS; CELL-DEATH; PML; ACTIVATION; INHIBITION; DOMAINS; TARGET; HELIX	Daxx has been reported to mediate the Fas/JNK-dependent signals in the cytoplasm. However, several lines of evidence have suggested that Daxx is located mainly in the nucleus and functions as a transcriptional regulator. Recent studies have further indicated that Daxx-elicited transcriptional repression can be inhibited by the nuclear body-associated promyelocytic leukemia protein and apoptosis signal-regulating kinase 1 by sequestering Daxx to the nuclear bodies and the cytoplasm, respectively. Here, we further investigated the coordinated molecular mechanism by which Daxx function is regulated through protein-protein interaction. Using yeast two-hybrid screens to identify Daxx-interacting protein(s), three independent clones encoding the 58-kDa microspherule protein (MSP58) fragments were identified. Furthermore, we have demonstrated that Daxx interacts in vitro and in vivo with MSP58 via its NH2-terminal segment, which is distinct from the binding region of Fas, apoptosis signal-regulating kinase 1, and promyelocytic leukemia protein, suggesting a unique modulatory role of MSP58 on Daxx function. Transient transfection experiments revealed that MSP58 relieves the repressor activity of Daxx in a dose-dependent manner in COS-1 and 293 cells but not in HeLa cells, implicating cell type-specific modulation of Daxx function by MSP58. Moreover, immunofluorescence analysis unequivocally demonstrated that MSP58 overexpression results in a translocation of Daxx to the enlarged nucleoli in COS-1 or 293 cells, whereas Daxx exhibited a diffuse nuclear pattern in HeLa cells. Taken together, these findings delineate a network of regulatory signaling pathways that converges on MSP58/Daxx interaction, causally associating Daxx nucleolus targeting with its transcriptional activation function.	Natl Def Med Ctr, Grad Inst Life Sci, Taipei 11456, Taiwan; Natl Hlth Res Inst, Div Mol & Genom Med, Taipei 11529, Taiwan	National Defense Medical Center; National Health Research Institutes - Taiwan	Shih, HM (corresponding author), 128,Sec 2,Yen Chiu Yuan Rd, Taipei 11529, Taiwan.							AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; Bader AG, 2001, ONCOGENE, V20, P7524, DOI 10.1038/sj.onc.1204938; Chang HY, 1999, P NATL ACAD SCI USA, V96, P1252, DOI 10.1073/pnas.96.4.1252; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Charette SJ, 2000, MOL CELL BIOL, V20, P7602, DOI 10.1128/MCB.20.20.7602-7612.2000; Charette SJ, 2001, J BIOL CHEM, V276, P36071, DOI 10.1074/jbc.C100340200; Eilers AL, 1999, J BIOL CHEM, V274, P32750, DOI 10.1074/jbc.274.46.32750; Everett RD, 1999, J CELL SCI, V112, P3443; Gongora R, 2001, IMMUNITY, V14, P727, DOI 10.1016/S1074-7613(01)00152-2; Hollenbach AD, 1999, EMBO J, V18, P3702, DOI 10.1093/emboj/18.13.3702; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Ko YG, 2001, J BIOL CHEM, V276, P39103, DOI 10.1074/jbc.M105928200; Kwok RPS, 1996, NATURE, V380, P642, DOI 10.1038/380642a0; Lehembre F, 2001, ONCOGENE, V20, P1, DOI 10.1038/sj.onc.1204063; Li H, 2000, MOL CELL BIOL, V20, P1784, DOI 10.1128/MCB.20.5.1784-1796.2000; Li RZ, 2000, ONCOGENE, V19, P745, DOI 10.1038/sj.onc.1203385; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; Pluta AF, 1998, J CELL SCI, V111, P2029; Ren Y, 1998, EUR J BIOCHEM, V253, P734, DOI 10.1046/j.1432-1327.1998.2530734.x; Ryu SW, 2000, BIOCHEM BIOPH RES CO, V279, P6, DOI 10.1006/bbrc.2000.3882; Schul W, 1998, J CELL BIOCHEM, V70, P159, DOI 10.1002/(SICI)1097-4644(19980801)70:2<159::AID-JCB2>3.0.CO;2-N; Torii S, 1999, EMBO J, V18, P6037, DOI 10.1093/emboj/18.21.6037; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; WANG HM, 1990, MOL CELL BIOL, V10, P5927, DOI 10.1128/MCB.10.11.5927; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583; Zhong S, 2000, J EXP MED, V191, P631, DOI 10.1084/jem.191.4.631	29	86	90	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 12	2002	277	28					25446	25456		10.1074/jbc.M200633200	http://dx.doi.org/10.1074/jbc.M200633200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	571YP	11948183	hybrid			2022-12-27	WOS:000176747000079
J	Burk, O; Tegude, H; Koch, I; Hustert, E; Wolbold, R; Glaeser, H; Klein, K; Fromm, MF; Nuessler, AK; Neuhaus, P; Zanger, UM; Eichelbaum, M; Wojnowski, L				Burk, O; Tegude, H; Koch, I; Hustert, E; Wolbold, R; Glaeser, H; Klein, K; Fromm, MF; Nuessler, AK; Neuhaus, P; Zanger, UM; Eichelbaum, M; Wojnowski, L			Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREGNANE-X-RECEPTOR; XENOBIOTIC RESPONSE; SMALL-BOWEL; CYTOCHROME-P450; GENE; ACTIVATION; IDENTIFICATION; METABOLISM; PREDICTION; MODULATORS	Human CYP3A enzymes play a pivotal role in the metabolism of many drugs, and the variability of their expression among individuals may have a strong impact on the efficacy of drug treatment. However, the individual contributions of the four CYP3A genes to total CYP3A activity remain unclear. To elucidate the role of CYP3A7, we have studied its expression in human liver and intestine. In both organs, expression of CYP3A7 mRNA was polymorphic. The recently identified CYP3A7*1C allele was a consistent marker of increased CYP3A7 expression both in liver and intestine, whereas the CYP3A7*1B allele was associated with increased CYP3A7 expression only in liver. Because of the replacement of part of the CYP3A7 promoter by the corresponding region of CYP3A4, the CYP3A7*1C allele contains the proximal ER6 motif of CYP3A4. The pregnane X and constitutively activated receptors were shown to bind with higher affinity to CYP3A4-ER6 than to CYP3A7-ER6 motifs and transactivated only promoter constructs containing CYP3A4-ER6. Furthermore, we identified mutations in CYP3A7*1C in addition to the ER6 motif that were necessary only for activation by the constitutively activated receptor. We conclude that the presence of the ER6 motif of CYP3A4 mediates the high expression of CYP3A7 in subjects carrying CYP3A7*1C.	Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany; Univ Tubingen, Div Pharmacol, D-72076 Tubingen, Germany; Humboldt Univ, Charite, Dept Surg, D-13353 Berlin, Germany; Epidauros Biotechnol AG, D-82347 Bernried, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Burk, O (corresponding author), Dr Margarete Fischer Bosch Inst Clin Pharmacol, Auerbachstr 112, D-70376 Stuttgart, Germany.	oliver.burk@ikp-stuttgart.de	Zanger, Ulrich M./A-9364-2012	Zanger, Ulrich M./0000-0002-5276-2002				Bertilsson G, 2001, BIOCHEM BIOPH RES CO, V280, P139, DOI 10.1006/bbrc.2000.4066; Drocourt L, 2001, DRUG METAB DISPOS, V29, P1325; Geick A, 2001, J BIOL CHEM, V276, P14581, DOI 10.1074/jbc.M010173200; Gellner K, 2001, PHARMACOGENETICS, V11, P111, DOI 10.1097/00008571-200103000-00002; Gillam EMJ, 1997, ARCH BIOCHEM BIOPHYS, V346, P81, DOI 10.1006/abbi.1997.0286; Goodwin B, 1999, MOL PHARMACOL, V56, P1329, DOI 10.1124/mol.56.6.1329; Greuet J, 1996, BIOCHEM BIOPH RES CO, V225, P689, DOI 10.1006/bbrc.1996.1231; Guengrich FP, 1999, ANNU REV PHARMACOL, V39, P1, DOI 10.1146/annurev.pharmtox.39.1.1; HASHIMOTO H, 1993, EUR J BIOCHEM, V218, P585, DOI 10.1111/j.1432-1033.1993.tb18412.x; Hustert E, 2001, PHARMACOGENETICS, V11, P773, DOI 10.1097/00008571-200112000-00005; Hustert E, 2001, DRUG METAB DISPOS, V29, P1454; JAIN VK, 1991, ANAL BIOCHEM, V199, P119, DOI 10.1016/0003-2697(91)90278-2; Kast HR, 2002, J BIOL CHEM, V277, P2908, DOI 10.1074/jbc.M109326200; Kivisto KT, 1996, BRIT J CLIN PHARMACO, V42, P387, DOI 10.1046/j.1365-2125.1996.42615.x; KOLARS JC, 1992, J CLIN INVEST, V90, P1871, DOI 10.1172/JCI116064; KOMORI M, 1990, BIOCHEMISTRY-US, V29, P4430, DOI 10.1021/bi00470a024; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Lacroix D, 1997, EUR J BIOCHEM, V247, P625, DOI 10.1111/j.1432-1033.1997.00625.x; Lang T, 2001, PHARMACOGENETICS, V11, P399, DOI 10.1097/00008571-200107000-00004; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; LOWN KS, 1994, DRUG METAB DISPOS, V22, P947; Marill J, 2000, MOL PHARMACOL, V58, P1341, DOI 10.1124/mol.58.6.1341; Moore JT, 2000, TOXICOLOGY, V153, P1, DOI 10.1016/S0300-483X(00)00300-0; Ohmori S, 1998, BBA-GEN SUBJECTS, V1380, P297, DOI 10.1016/S0304-4165(97)00156-6; Ozdemir V, 2000, PHARMACOGENETICS, V10, P373, DOI 10.1097/00008571-200007000-00001; Pascussi JM, 1999, BIOCHEM BIOPH RES CO, V260, P377, DOI 10.1006/bbrc.1999.0745; Saito T, 2001, J BIOL CHEM, V276, P38010; Schuetz EG, 1996, MOL PHARMACOL, V49, P311; SCHUETZ JD, 1994, PHARMACOGENETICS, V4, P11, DOI 10.1097/00008571-199402000-00002; Shimada T, 1996, DRUG METAB DISPOS, V24, P515; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; Thummel KE, 2001, MOL PHARMACOL, V60, P1399, DOI 10.1124/mol.60.6.1399; TOM BH, 1976, IN VITRO CELL DEV B, V12, P180; Westlind A, 2001, BIOCHEM BIOPH RES CO, V281, P1349, DOI 10.1006/bbrc.2001.4505; Wilkinson GR, 1996, J PHARMACOKINET BIOP, V24, P475, DOI 10.1007/BF02353475; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116; Xie W, 2000, GENE DEV, V14, P3014, DOI 10.1101/gad.846800; YANG HYL, 1994, MOL PHARMACOL, V46, P922; Zelko I, 2000, BIOCHEM BIOPH RES CO, V277, P1, DOI 10.1006/bbrc.2000.3557	39	153	156	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2002	277	27					24280	24288		10.1074/jbc.M202345200	http://dx.doi.org/10.1074/jbc.M202345200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	569PV	11940601	hybrid			2022-12-27	WOS:000176611800041
J	Petrescu, AD; Hertz, R; Bar-Tana, J; Schroeder, F; Kier, AB				Petrescu, AD; Hertz, R; Bar-Tana, J; Schroeder, F; Kier, AB			Ligand specificity and conformational dependence of the hepatic nuclear factor-4 alpha (HNF-4 alpha).	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROL CARRIER PROTEIN-2; ACID-BINDING PROTEIN; ACYL-COENZYME-A; FATTY-ACID; ENERGY-TRANSFER; CIRCULAR-DICHROISM; COA THIOESTERS; LIVER-CELLS; RAT; TRANSCRIPTION	Hepatic nuclear factor-4alpha (HNF-4alpha) controls the expression of genes encoding proteins involved in lipid and carbohydrate metabolism. Fatty acyl-CoA thioesters have recently been proposed to be naturally occurring ligands of HNF-4alpha and to regulate its transcriptional activity as function of their chain length and degree of unsaturation (Hertz, R., Magenheim, J., Berman, I., and Bar-Tana, J. (1998) Nature 392, 512-516). However, the apparent low affinities (p m K-d values) obtained with a radiolabeled fatty acyl-CoA ligand binding assay raised questions regarding the physiological significance of this finding. Furthermore, it is not known whether interaction with fatty acyl-CoA alters the structure of HNF-4alpha. These issues were examined using rat recombinant HNF-4alpha ligand-binding domain (HNF-4alphaLBD) in conjunction with photon counting fluorescence and circular dichroism. First, fluorescence resonance energy transfer between FWF-4alphaLBD tryptophan (Trp) and cis-parinaroyl-CoA yielded an intermolecular distance of less than or equal to42 Angstrom, thus pointing to direct molecular interaction rather than nonspecific coaggregation. Second, quenching of HNF-4alphaLBD intrinsic Trp fluorescence by fatty acyl-CoAs (e.g. pamitoyl-, stearoyl-, linoleoyl-, and arachidonoyl-CoAs) yielded a single binding site with K-d values of 1.6-4.0 nm. These affinities were 2-3 orders of magnitude higher than those previously derived by radiolabeled fatty acyl-CoA ligand binding assay. Third, binding of fatty acyl-CoAs was specific as the binding affinities of the respective free fatty acids or free CoA (K-d values of 421-742 nm) were significantly lower. Fourth, circular dichroism demonstrated that the HNF-4alphaLBD secondary structure was significantly and differentially altered by fatty acyl-CoA binding. The opposite effects of saturated versus polyunsaturated fatty acyl-CoAs on HNF-4alphaLBD secondary structure correlated with their opposite regulatory effects on HNF-4alpha function. Fifth, the CoA thioesters of some hypolipidemic peroxisome proliferators bind with high affinity (K-d values as low as 2.6 nm) to HNF-4alphaLBD, thus indicating that HNF-4alpha may serve as target for these drugs. In summary, these data demonstrate for the first time high affinity binding to HNF-4alpha of fatty and xenobiotic acyl-CoAs in the physiological range, resulting in significantly altered HNF-4alpha conformation.	Texas A&M Univ, Dept Pathobiol, Texas Vet Med Ctr, College Stn, TX 77843 USA; Texas A&M Univ, Dept Physiol & Pharmacol, Texas Vet Med Ctr, College Stn, TX 77843 USA; Hebrew Univ Jerusalem, Dept Human Nutr & Metab, Sch Med, IL-91120 Jerusalem, Israel	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Hebrew University of Jerusalem	Kier, AB (corresponding author), Texas A&M Univ, Dept Pathobiol, Texas Vet Med Ctr, College Stn, TX 77843 USA.	akier@cvm.tamu.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009106] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK41402] Funding Source: Medline; NIEHS NIH HHS [ES09106] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BARTANA J, 1985, J BIOL CHEM, V260, P8404; Bogan AA, 2000, J MOL BIOL, V302, P831, DOI 10.1006/jmbi.2000.4099; BORDEWICK U, 1989, BIOL CHEM H-S, V370, P229, DOI 10.1515/bchm3.1989.370.1.229; CARTER ME, 1993, J BIOL CHEM, V268, P13805; Cattley RC, 1998, REGUL TOXICOL PHARM, V27, P47, DOI 10.1006/rtph.1997.1163; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Elholm M, 2000, J LIPID RES, V41, P538; FORSTER TH., 1967, COMPREHENSIVE BIOCH, P61; Frolov A, 1998, J BIOL CHEM, V273, P11049, DOI 10.1074/jbc.273.18.11049; Frolov A, 1997, BIOCHEMISTRY-US, V36, P6545, DOI 10.1021/bi970205t; Frolov A, 2000, J BIOL CHEM, V275, P12769, DOI 10.1074/jbc.275.17.12769; Frolov A, 1997, LIPIDS, V32, P1201, DOI 10.1007/s11745-997-0154-5; Frolov A, 1996, J BIOL CHEM, V271, P31878, DOI 10.1074/jbc.271.50.31878; Gallegos AM, 2001, PROG LIPID RES, V40, P498, DOI 10.1016/S0163-7827(01)00015-7; Gossett RE, 1996, LIPIDS, V31, P895, DOI 10.1007/BF02522684; HadzopoulouCladaras M, 1997, J BIOL CHEM, V272, P539; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; HENNESSEY JP, 1981, BIOCHEMISTRY-US, V20, P1085, DOI 10.1021/bi00508a007; Hertz R, 1998, NATURE, V392, P512, DOI 10.1038/33185; HERTZ R, 1995, J BIOL CHEM, V270, P13470, DOI 10.1074/jbc.270.22.13470; Hertz R, 1998, TOXICOL LETT, V103, P85, DOI 10.1016/S0378-4274(98)00290-2; HERTZ R, 2001, BIOCHEM PHARMACOL, V61, P1507; HUBBELL T, 1994, BIOCHEMISTRY-US, V33, P3327, DOI 10.1021/bi00177a025; JIANG GQ, 1995, MOL CELL BIOL, V15, P5131; Jover R, 2001, HEPATOLOGY, V33, P668, DOI 10.1053/jhep.2001.22176; JUGUELIN H, 1984, ANAL BIOCHEM, V142, P329, DOI 10.1016/0003-2697(84)90472-X; KAWAGUCHI A, 1981, J BIOCHEM-TOKYO, V89, P337, DOI 10.1093/oxfordjournals.jbchem.a133207; Knudsen J, 1999, MOL CELL BIOCHEM, V192, P95, DOI 10.1023/A:1006830606060; KTISTAKI E, 1995, P NATL ACAD SCI USA, V92, P9876, DOI 10.1073/pnas.92.21.9876; Lakowicz J.R, 1999, PRINCIPLES FLUORESCE, P368; Li JX, 2000, GENE DEV, V14, P464; Lin QO, 1999, BIOCHEMISTRY-US, V38, P185, DOI 10.1021/bi9816094; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; McArthur MJ, 1999, J LIPID RES, V40, P1371; NAKSHATRI H, 1994, J BIOL CHEM, V269, P890; NEMECZ G, 1991, ARCH BIOCHEM BIOPHYS, V286, P300, DOI 10.1016/0003-9861(91)90044-J; Parker C.A, 1968, PHOTOLUMINESCENCE SO; Petrescu AD, 2001, J BIOL CHEM, V276, P36970, DOI 10.1074/jbc.M101939200; SCHROEDER F, 1995, BIOCHEMISTRY-US, V34, P11919, DOI 10.1021/bi00037a033; Schroeder F, 2000, J BIOL CHEM, V275, P25547, DOI 10.1074/jbc.M000431200; Serrero G, 2000, BBA-MOL CELL BIOL L, V1488, P245, DOI 10.1016/S1388-1981(00)00128-1; Shih DQ, 2000, DIABETES, V49, P832, DOI 10.2337/diabetes.49.5.832; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; SLADEK FM, 1994, LIVER GENE EXPRESSIO, P207; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Wang HY, 2000, J BIOL CHEM, V275, P35953, DOI 10.1074/jbc.M006612200; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134; Zannis VI, 2001, FRONT BIOSCI-LANDMRK, V6, pD456, DOI 10.2741/Zannis	50	70	73	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2002	277	27					23988	23999		10.1074/jbc.M201241200	http://dx.doi.org/10.1074/jbc.M201241200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	569PV	11940586				2022-12-27	WOS:000176611800005
J	Fisher, TS; Prasad, VR				Fisher, TS; Prasad, VR			Substitutions of Phe(61) located in the vicinity of template 5 '-overhang influence polymerase fidelity and nucleoside analog sensitivity of HIV-1 reverse transcriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DNA-SYNTHESIS; ANGSTROM RESOLUTION; ERROR SPECIFICITY; CRYSTAL-STRUCTURE; MISPAIR EXTENSION; THUMB SUBDOMAIN; DRUG-RESISTANT; TYPE-1; PROCESSIVITY	Human immunodeficiency virus type I reverse transcriptase (RT) is an error-prone DNA polymerase. Structural determinants of its fidelity are incompletely understood. RT/template primer contacts have been shown to influence its fidelity and sensitivity to nucleoside analog inhibitors. The Phe(61) residue, located within the beta3 sheet of the finger subdomain, is highly conserved among retroviral RTs. The crystal structure of a ternary complex revealed that Phe(61) contacts the first and second bases of the 5'-template overhang. To determine whether such contacts influence the dNTP-binding pocket, we performed a limited vertical scanning mutagenesis (Phe --> Ala, Leu, Trp, or Tyr) at Phe(61). The F61A mutant displayed the highest increase in fidelity, followed by the F61L and F61W variants, which had intermediate phenotypes. F61Y RT had a minimal effect. The increase in fidelity of the F61A mutant was corroborated by a 12-fold decrease in its forward mutation rate. The Phe(61) mutant RTs also displayed large reductions in sensitivity to 2',3'-dideoxythymidine triphosphate and 2',3'-dideohydrothymidine triphosphate. Mutants displaying the largest increase in fidelity (F61A and F61L) were also the most resistant. These results suggest that contacts between the finger subdomain of human immunodeficiency virus type 1 RT and the template 5'-overhang are important determinants of the geometry of the dNTP-binding pocket.	Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Prasad, VR (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, 1300 Morris Pk Ave,Rm GB 401, Bronx, NY 10461 USA.		Prasad, Vinayaka R./A-1029-2011	Prasad, Vinayaka/0000-0002-9461-0189	NIAID NIH HHS [R01 AI30861] Funding Source: Medline; NIGMS NIH HHS [T32-GM07491] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Back NKT, 1996, EMBO J, V15, P4040, DOI 10.1002/j.1460-2075.1996.tb00777.x; BEARD WA, 1994, J BIOL CHEM, V269, P28091; BEBENEK K, 1995, J BIOL CHEM, V270, P19516, DOI 10.1074/jbc.270.33.19516; Bebenek K, 1995, METHOD ENZYMOL, V262, P217; Bebenek K, 1997, NAT STRUCT BIOL, V4, P194, DOI 10.1038/nsb0397-194; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Drosopoulos WC, 1998, J VIROL, V72, P4224, DOI 10.1128/JVI.72.5.4224-4230.1998; Drosopoulos WC, 1996, J VIROL, V70, P4834, DOI 10.1128/JVI.70.7.4834-4838.1996; Essink BBO, 1997, NUCLEIC ACIDS RES, V25, P3212, DOI 10.1093/nar/25.16.3212; GU ZX, 1994, ANTIMICROB AGENTS CH, V38, P275, DOI 10.1128/AAC.38.2.275; HAHN BH, 1986, SCIENCE, V232, P1548, DOI 10.1126/science.3012778; Hsu ML, 1997, NUCLEIC ACIDS RES, V25, P4532, DOI 10.1093/nar/25.22.4532; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; Jonckheere H, 2000, EUR J BIOCHEM, V267, P2658, DOI 10.1046/j.1432-1327.2000.01272.x; KEW Y, 1994, J BIOL CHEM, V269, P15331; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Kim B, 1998, BIOCHEMISTRY-US, V37, P5831, DOI 10.1021/bi972672g; Kim B, 1999, J BIOL CHEM, V274, P27666, DOI 10.1074/jbc.274.39.27666; Klarmann GJ, 2000, J BIOL CHEM, V275, P359, DOI 10.1074/jbc.275.1.359; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Matray TJ, 1999, NATURE, V399, P704, DOI 10.1038/21453; METZGER W, 1993, P NATL ACAD SCI USA, V90, P5909, DOI 10.1073/pnas.90.13.5909; Morales JC, 1998, NAT STRUCT BIOL, V5, P950, DOI 10.1038/2925; Omrani AS, 2000, J INFECTION, V41, P5, DOI 10.1053/jinf.2000.0702; Pandey VN, 1996, BIOCHEMISTRY-US, V35, P2168, DOI 10.1021/bi9516642; PATEL PH, 1995, BIOCHEMISTRY-US, V34, P5351, DOI 10.1021/bi00016a006; Peletskaya EN, 2001, J VIROL, V75, P9435, DOI 10.1128/JVI.75.19.9435-9445.2001; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; PRASAD VR, 1991, P NATL ACAD SCI USA, V88, P11363, DOI 10.1073/pnas.88.24.11363; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Rezende LF, 1998, NUCLEIC ACIDS RES, V26, P3066, DOI 10.1093/nar/26.12.3066; Rezende LF, 1998, J VIROL, V72, P2890, DOI 10.1128/JVI.72.4.2890-2895.1998; ROBERTS JD, 1989, MOL CELL BIOL, V9, P469, DOI 10.1128/MCB.9.2.469; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Rubinek T, 1997, EUR J BIOCHEM, V247, P238, DOI 10.1111/j.1432-1033.1997.00238.x; SAAG MS, 1988, NATURE, V334, P440, DOI 10.1038/334440a0; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; Shahs FS, 2000, J BIOL CHEM, V275, P27037; Sharma PL, 1999, J VIROL, V73, P8448, DOI 10.1128/JVI.73.10.8448-8456.1999; TELESNITSKY A, 1998, RETROVIRUSES, P121; Tong WJ, 1997, BIOCHEMISTRY-US, V36, P5749, DOI 10.1021/bi962410z; Wainberg MA, 1996, SCIENCE, V271, P1282, DOI 10.1126/science.271.5253.1282; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; WOHRL BM, 1995, BIOCHEMISTRY-US, V34, P5343; XIONG Y, 1990, EMBO J, V9, P3353, DOI 10.1002/j.1460-2075.1990.tb07536.x	46	33	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22345	22352		10.1074/jbc.M200282200	http://dx.doi.org/10.1074/jbc.M200282200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11948182	hybrid			2022-12-27	WOS:000176313600031
J	Iijima, Y; Laser, M; Shiraishi, H; Willey, CD; Sundaravadivel, B; Xu, L; McDermott, PJ; Kuppuswamy, D				Iijima, Y; Laser, M; Shiraishi, H; Willey, CD; Sundaravadivel, B; Xu, L; McDermott, PJ; Kuppuswamy, D			c-Raf/MEK/ERK pathway controls protein kinase C-mediated p70S6K activation in adult cardiac muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; CAP-DEPENDENT INITIATION; VIVO PRESSURE-OVERLOAD; S6 KINASE; ANGIOTENSIN-II; IN-VIVO; CYCLIC-AMP; RAT-HEART; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION SITE	p70S6 kinase (S6K1) plays a pivotal role in hypertrophic cardiac growth via ribosomal biogenesis. In pressure-overloaded myocardium, we show S6K1 activation accompanied by activation of protein kinase C (PKC), c-Raf, and mitogen-activated protein kinases (MAPKs). To explore the importance of the c-Raf/MAPK kinase (MEK)/MAPK pathway, we stimulated adult feline cardiomyocytes with 12-O-tetradecanoylphorbol-13-acetate (TPA), insulin, or forskolin to activate PKC, phosphatidylinositol-3-OH kinase, or protein kinase A (PKA), respectively. These treatments resulted in S6K1 activation with Thr-389 phosphorylation as well as mammalian target of rapamycin (mTOR) and S6 protein phosphorylation. Thr-421/Ser-424 phosphorylation of S6K1 was observed predominantly in TPA-treated cells. Dominant negative c-Raf expression or a MEK1/2 inhibitor (U0126) treatment showed a profound blocking effect only on the TPA-stimulated phosphorylation of S6K1 and mTOR. Whereas p38 MAPK inhibitors exhibited only partial effect, MAPK-phosphatase-3 expression significantly blocked the TPA-stimulated S6K1 and mTOR phosphorylation. Inhibition of mTOR with rapamycin blocked the Thr-389 but not the Thr-421/Ser-424 phosphorylation of S6K1. Therefore, during PKC activation, the c-Raf/MEK/extracellular signal-regulated kinase-1/2 (ERK1/2) pathway mediates both the Thr-421/Ser-424 and the Thr-389 phosphorylation in an mTOR-independent and -dependent manner, respectively. Together, our in vivo and in vitro studies indicate that the PKC/c-Raf/MEK/ERK pathway plays a major role in the S6K1 activation in hypertrophic cardiac growth.	Med Univ S Carolina, Gazes Cardiac Res Inst, Dept Med, Div Cardiol, Charleston, SC 29425 USA; Ralph H Johnson Dept Vet Affairs Med Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Kuppuswamy, D (corresponding author), Med Univ S Carolina, Gazes Cardiac Res Inst, Dept Med, Div Cardiol, 114 Doughty St, Charleston, SC 29425 USA.	kuppusd@musc.edu		Willey, Christopher/0000-0001-9953-0279	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048788] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-48788] Funding Source: Medline; NIGMS NIH HHS [GM08716] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Avruch J, 1998, MOL CELL BIOCHEM, V182, P31, DOI 10.1023/A:1006823109415; BALLOU LM, 1991, NATURE, V349, P348, DOI 10.1038/349348a0; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; BOGOYEVITCH MA, 1993, CIRC RES, V72, P757, DOI 10.1161/01.RES.72.4.757; Boknik P, 2001, CARDIOVASC RES, V51, P717, DOI 10.1016/S0008-6363(01)00346-7; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; Cass LA, 1999, MOL CELL BIOL, V19, P5882; CHOU MM, 1995, CURR OPIN CELL BIOL, V7, P806, DOI 10.1016/0955-0674(95)80064-6; CHUA BHL, 1987, AM J PHYSIOL, V252, pC323, DOI 10.1152/ajpcell.1987.252.3.C323; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; COOPER G, 1974, J APPL PHYSIOL, V37, P762, DOI 10.1152/jappl.1974.37.5.762; COOPER G, 1986, CIRC RES, V58, P692, DOI 10.1161/01.RES.58.5.692; COOPER G, 1987, ANNU REV PHYSIOL, V49, P501, DOI 10.1146/annurev.ph.49.030187.002441; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Eguchi S, 1999, J BIOL CHEM, V274, P36843, DOI 10.1074/jbc.274.52.36843; ERIKSON RL, 1991, J BIOL CHEM, V266, P6007; FERRARI S, 1992, P NATL ACAD SCI USA, V89, P7282, DOI 10.1073/pnas.89.15.7282; Filippa N, 1999, MOL CELL BIOL, V19, P4989; GERARD RD, 1995, DNA CLONING PRACTICA, P285; Gout I, 1998, J BIOL CHEM, V273, P30061, DOI 10.1074/jbc.273.46.30061; GROVE JR, 1991, MOL CELL BIOL, V11, P5541, DOI 10.1128/MCB.11.11.5541; Gu MF, 2000, J BIOL CHEM, V275, P11389, DOI 10.1074/jbc.275.15.11389; Hamilton M, 2001, J BIOL CHEM, V276, P29079, DOI 10.1074/jbc.M102001200; HAN JW, 1995, J BIOL CHEM, V270, P21396, DOI 10.1074/jbc.270.36.21396; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Herbert TP, 2000, J BIOL CHEM, V275, P11249, DOI 10.1074/jbc.275.15.11249; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; JENO P, 1988, P NATL ACAD SCI USA, V85, P406, DOI 10.1073/pnas.85.2.406; Koh H, 1999, ONCOGENE, V18, P5115, DOI 10.1038/sj.onc.1202895; KRISHENBAUM LA, 1993, J CLIN INVEST, V92, P381, DOI 10.1172/JCI116577; Kumar V, 2000, EMBO J, V19, P1087, DOI 10.1093/emboj/19.5.1087; Kuppuswamy D, 1997, J BIOL CHEM, V272, P4500, DOI 10.1074/jbc.272.7.4500; LANE HA, 1993, NATURE, V363, P170, DOI 10.1038/363170a0; Laser M, 1998, J BIOL CHEM, V273, P24610, DOI 10.1074/jbc.273.38.24610; Lee-Fruman KK, 1999, ONCOGENE, V18, P5108, DOI 10.1038/sj.onc.1202894; Lenormand P, 1996, J BIOL CHEM, V271, P15762, DOI 10.1074/jbc.271.26.15762; Mahalingam M, 1996, MOL CELL BIOL, V16, P405; Martin KA, 2001, J BIOL CHEM, V276, P7892, DOI 10.1074/jbc.M009972200; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; MING XF, 1994, NATURE, V371, P426, DOI 10.1038/371426a0; MONFAR M, 1995, MOL CELL BIOL, V15, P326, DOI 10.1128/MCB.15.1.326; Morgan HE, 1997, MOL CELL BIOCHEM, V176, P145, DOI 10.1023/A:1006855818855; MORGAN HE, 1991, CIRCULATION, V83, P13, DOI 10.1161/01.CIR.83.1.13; Moser BA, 1997, MOL CELL BIOL, V17, P5648, DOI 10.1128/MCB.17.9.5648; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Muda M, 1996, J BIOL CHEM, V271, P4319; MUKHOPADHYAY NK, 1992, J BIOL CHEM, V267, P3325; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Papst PJ, 1998, J BIOL CHEM, V273, P15077, DOI 10.1074/jbc.273.24.15077; PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x; Prasad SVN, 2000, J BIOL CHEM, V275, P4693, DOI 10.1074/jbc.275.7.4693; PRICE DJ, 1989, J BIOL CHEM, V264, P13825; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; Puceat M, 1996, MOL CELL BIOCHEM, V157, P65; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; REINHARD C, 1992, P NATL ACAD SCI USA, V89, P4052, DOI 10.1073/pnas.89.9.4052; REINHARD C, 1994, EMBO J, V13, P1557, DOI 10.1002/j.1460-2075.1994.tb06418.x; ROZICH JD, 1995, J MOL CELL CARDIOL, V27, P485, DOI 10.1016/S0022-2828(08)80044-2; SADOSHIMA J, 1995, CIRC RES, V76, P1; Scott PH, 1997, FEBS LETT, V409, P171, DOI 10.1016/S0014-5793(97)00500-0; Senbonmatsu T, 2000, J CLIN INVEST, V106, pR25, DOI 10.1172/JCI10037; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; STEWART MJ, 1994, BIOESSAYS, V16, P809, DOI 10.1002/bies.950161107; Stokoe D, 1997, EMBO J, V16, P2384, DOI 10.1093/emboj/16.9.2384; Takano H, 1996, FEBS LETT, V379, P255, DOI 10.1016/0014-5793(95)01523-X; TERADA N, 1994, P NATL ACAD SCI USA, V91, P11477, DOI 10.1073/pnas.91.24.11477; Volarevic S, 2001, PROG NUCLEIC ACID RE, V65, P101; vonManteuffel SR, 1997, MOL CELL BIOL, V17, P5426, DOI 10.1128/MCB.17.9.5426; Wang LJ, 2001, J BIOL CHEM, V276, P32670, DOI 10.1074/jbc.M102776200; WATSON PA, 1989, AM J PHYSIOL, V256, pC1257, DOI 10.1152/ajpcell.1989.256.6.C1257; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; WENG QP, 1995, P NATL ACAD SCI USA, V92, P5744, DOI 10.1073/pnas.92.12.5744; WENG QP, 1995, MOL CELL BIOL, V15, P2333; Wu GY, 2000, J BIOL CHEM, V275, P29927, DOI 10.1074/jbc.C000380200; YAMAZAKI T, 1993, J BIOL CHEM, V268, P12069	76	124	130	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					23065	23075		10.1074/jbc.M200328200	http://dx.doi.org/10.1074/jbc.M200328200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11940578	hybrid			2022-12-27	WOS:000176313600122
J	Cheng, H; Cenciarelli, C; Tao, MY; Parks, WP; Cheng-Mayer, C				Cheng, H; Cenciarelli, C; Tao, MY; Parks, WP; Cheng-Mayer, C			HTLV-1 tax-associated hTid-1, a human DnaJ protein, is a repressor of I kappa B kinase beta subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL LEUKEMIA; VIRUS TYPE-I; HUMAN-IMMUNODEFICIENCY-VIRUS; IKK-BETA; TRANSFORMING PROTEIN; REL PROTEINS; ACTIVATION; ALPHA; GENE; DROSOPHILA	hTid-1, a human DnaJ protein, is a novel cellular target for HTLV-1 Tax. Here, we show that hTid-1 represses NF-kappaB activity induced by Tax as well as other activators such as tumor necrosis factor alpha (TNFalpha) and Bcl10. hTid-1 specifically suppresses serine phosphorylation of IkappaBalpha by activated IkappaB kinase beta (IKKbeta), but the activities of other serine kinases including p38, ERK2, and JNK1 are not affected. The suppressive activity of hTid-1 on IKKbeta requires a functional J domain that mediates association with heat shock proteins and results in prolonging the half-life of the NF-kappaB inhibitors IkappaBalpha and IkappaBbeta. Collectively, our data suggest that hTid-1, in association with heat shock proteins, exerts a negative regulatory effect on the NF-kappaB activity induced by various extracellular and intracellular activators including HTLV-1 Tax.	Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; CNR, Ist Neurobiol & Med Mol, I-00137 Rome, Italy; NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; NYU, Sch Med, Dept Pediat, New York, NY 10016 USA	Rockefeller University; Consiglio Nazionale delle Ricerche (CNR); New York University; New York University	Cheng, H (corresponding author), Rockefeller Univ, Aaron Diamond AIDS Res Ctr, 455 1st Ave,7th Floor, New York, NY 10016 USA.		CENCIARELLI, CARLO/AAC-1603-2019	CENCIARELLI, CARLO/0000-0001-7480-4608				Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Beauparlant P, 1996, J VIROL, V70, P5777, DOI 10.1128/JVI.70.9.5777-5785.1996; BOHNLEIN E, 1989, J VIROL, V63, P1578; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Cheng H, 2001, CURR BIOL, V11, P1771, DOI 10.1016/S0960-9822(01)00540-1; Chu ZL, 1999, J BIOL CHEM, V274, P15297, DOI 10.1074/jbc.274.22.15297; Chu ZL, 1998, J BIOL CHEM, V273, P15891, DOI 10.1074/jbc.273.26.15891; Curry HA, 1999, J BIOL CHEM, V274, P23061, DOI 10.1074/jbc.274.33.23061; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Feinstein DL, 1996, J BIOL CHEM, V271, P17724, DOI 10.1074/jbc.271.30.17724; Geleziunas R, 1998, MOL CELL BIOL, V18, P5157, DOI 10.1128/MCB.18.9.5157; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GONZALEZCRESPO S, 1994, SCIENCE, V264, P255, DOI 10.1126/science.8146656; GROSSMAN WJ, 1995, P NATL ACAD SCI USA, V92, P1057, DOI 10.1073/pnas.92.4.1057; Harhaj EW, 2000, ONCOGENE, V19, P1448, DOI 10.1038/sj.onc.1203445; Jin DY, 1999, J BIOL CHEM, V274, P17402, DOI 10.1074/jbc.274.25.17402; KOPP EB, 1995, ADV IMMUNOL, V58, P1, DOI 10.1016/S0065-2776(08)60618-5; KURZIKDUMKE U, 1995, DEV GENET, V16, P64, DOI 10.1002/dvg.1020160110; Li XH, 1999, J BIOL CHEM, V274, P34417, DOI 10.1074/jbc.274.48.34417; MAHE Y, 1991, J BIOL CHEM, V266, P13759; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Patel A, 1998, VIROLOGY, V247, P212, DOI 10.1006/viro.1998.9243; Quinto I, 1999, J BIOL CHEM, V274, P17567, DOI 10.1074/jbc.274.25.17567; Rossi A, 1997, P NATL ACAD SCI USA, V94, P746, DOI 10.1073/pnas.94.2.746; Sarkar S, 2001, J BIOL CHEM, V276, P49034, DOI 10.1074/jbc.M103683200; Schilling B, 1998, VIROLOGY, V247, P74, DOI 10.1006/viro.1998.9220; Sun SC, 1999, ONCOGENE, V18, P6948, DOI 10.1038/sj.onc.1203220; Syken J, 1999, P NATL ACAD SCI USA, V96, P8499, DOI 10.1073/pnas.96.15.8499; Trentin GA, 2001, J BIOL CHEM, V276, P13087, DOI 10.1074/jbc.M009267200; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Wu BY, 1997, J VIROL, V71, P3161, DOI 10.1128/JVI.71.4.3161-3167.1997; Yamamoto Y, 2001, J BIOL CHEM, V276, P36327, DOI 10.1074/jbc.M104090200; Yamaoka S, 1996, EMBO J, V15, P873, DOI 10.1002/j.1460-2075.1996.tb00422.x; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yin MJ, 1998, CELL, V93, P875, DOI 10.1016/S0092-8674(00)81447-6; Yoneda T, 2000, J BIOL CHEM, V275, P11114, DOI 10.1074/jbc.275.15.11114; Yoo CG, 2000, J IMMUNOL, V164, P5416, DOI 10.4049/jimmunol.164.10.5416; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; Yoshida M, 2001, ANNU REV IMMUNOL, V19, P475, DOI 10.1146/annurev.immunol.19.1.475; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	43	38	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20605	20610		10.1074/jbc.M201204200	http://dx.doi.org/10.1074/jbc.M201204200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11927590	hybrid			2022-12-27	WOS:000176204500066
J	Fukiage, C; Nakajima, E; Ma, H; Azuma, M; Shearer, TR				Fukiage, C; Nakajima, E; Ma, H; Azuma, M; Shearer, TR			Characterization and regulation of lens-specific calpain Lp82	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-SPECIFIC CALPAIN; RAT LENS; MOLECULAR-CLONING; MESSENGER-RNA; IN-VIVO; CALPASTATIN; EXPRESSION; CALCIUM; P94; IDENTIFICATION	Eye tissues contain splice variants of muscle-preferred p94 (calpain 3), such as lens-specific Lp82 and Lp85, retina-specific Rt88, and cornea-specific Cn94. The purpose of the present experiment was to analyze the activation and regulation of the best characterized p94 splice variant, Lp82. Recombinant rat Lp82 (rLp82) was expressed using the baculovirus system, purified with Ni-NTA affinity and DEAE-ion exchange chromatographies, and characterized by SDS-PAGE, casein zymography, and immunoblotting. After incubation with calcium, rLp82 autolyzed into two major fragments at similar to60 and 22 kDa. Sequencing of the autolytic fragments showed loss of three amino acids from the N terminus and cleavage near the IS2 region. Also, Lp82 and calpain 2 were found to hydrolyze each other. Calpastatin inhibited calpain 2 activity, but not Lp82. Homology modeling suggested that the lack of inhibition of Lp82 by calpastatin was due to molecular clashes at the unique AX1 region of Lp82. Lp82 also hydrolyzed calpastatin. These results suggested that Lp82 might regulate other calpain activities and cause hydrolysis of substrates such as crystallins during lens cataract formation.	Senju Pharmaceut Corp Ltd, Senju Lab Ocular Sci, Beaverton, OR 97006 USA; Oregon Hlth & Sci Univ, Dept Oral Mol Biol & Ophthalmol, Portland, OR 97201 USA	Senju Pharmaceutical Co. Ltd.; Oregon Health & Science University	Fukiage, C (corresponding author), Oregon Hlth & Sci Univ, Senju Lab Ocular Sci, W Campus 505 NW 185th Ave, Beaverton, OR 97006 USA.	fukiagec@ohsu.edu			NEI NIH HHS [EY05786] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Azuma M, 2000, CURR EYE RES, V21, P710, DOI 10.1076/0271-3683(200009)21:3;1-R;FT710; EMORI Y, 1988, J BIOL CHEM, V263, P2364; GRAHAMSIEGENTHALER K, 1994, J BIOL CHEM, V269, P30457; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Kinbara K, 1998, BIOCHEM J, V335, P589, DOI 10.1042/bj3350589; Lee HJ, 1998, BIOL CHEM, V379, P175, DOI 10.1515/bchm.1998.379.2.175; Ma H, 2000, CURR EYE RES, V20, P183, DOI 10.1076/0271-3683(200003)20:3;1-9;FT183; Ma H, 1998, EXP EYE RES, V67, P221, DOI 10.1006/exer.1998.0515; Ma H, 1998, INVEST OPHTH VIS SCI, V39, P454; Ma H, 2000, INVEST OPHTH VIS SCI, V41, P4232; MAKI M, 1989, J BIOL CHEM, V264, P18866; Murachi T, 1980, Adv Enzyme Regul, V19, P407; MURACHI T, 1989, BIOCHEM INT, V18, P263; Nakajima T, 2001, BBA-GENE STRUCT EXPR, V1519, P55, DOI 10.1016/S0167-4781(01)00212-3; Nakamura Y, 1999, EXP EYE RES, V69, P155, DOI 10.1006/exer.1998.0686; Nakamura Y, 2000, INVEST OPHTH VIS SCI, V41, P1460; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Shearer TR, 1998, CURR EYE RES, V17, P1037, DOI 10.1076/ceyr.17.11.1037.5232; SORIMACHI H, 1989, J BIOL CHEM, V264, P20106; Sorimachi H, 1995, J BIOL CHEM, V270, P31158, DOI 10.1074/jbc.270.52.31158; Sorimachi H, 1997, BIOCHEM J, V328, P721, DOI 10.1042/bj3280721; SORIMACHI H, 1993, J BIOL CHEM, V268, P19476; Strobl S, 2000, P NATL ACAD SCI USA, V97, P588, DOI 10.1073/pnas.97.2.588; TAKANO E, 1995, FEBS LETT, V362, P93, DOI 10.1016/0014-5793(95)00219-Y; TAKEMOTO LJ, 1995, CURR EYE RES, V14, P837, DOI 10.3109/02713689508995806; Ueda Y, 2001, EXP EYE RES, V73, P625, DOI 10.1006/exer.2001.1071	26	33	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20678	20685		10.1074/jbc.M200697200	http://dx.doi.org/10.1074/jbc.M200697200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11904300	hybrid			2022-12-27	WOS:000176204500075
J	Shen, GZ; Antonkine, ML; van der Est, A; Vassiliev, IR; Brettel, K; Bittl, R; Zech, SG; Zhao, JD; Stehlik, D; Bryant, DA; Golbeck, JH				Shen, GZ; Antonkine, ML; van der Est, A; Vassiliev, IR; Brettel, K; Bittl, R; Zech, SG; Zhao, JD; Stehlik, D; Bryant, DA; Golbeck, JH			Assembly of photosystem III. Rubredoxin is required for the in vivo assembly of F-x in Synechococcus sp PCC 7002 as shown by optical and EPR spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; IRON-SULFUR CENTERS; RADICAL PAIRS; P-700(CENTER DOT+); A(1)(CENTER DOT-); TRANSFER KINETICS; TRANSIENT EPR; ACCEPTOR A(1); PULSED EPR; PCC 7002	The rubA gene was insertionally inactivated in Synechococcus sp. PCC 7002, and the properties of photosystem I complexes were characterized spectroscopically. X-band EPR spectroscopy at low temperature shows that the three terminal iron-sulfur clusters, F-X, F-A, and F-B, are missing in whole cells, thylakoids, and photosystein (PS) I complexes of the rubA mutant. The flashinduced decay kinetics of both P700(+) in the visible and A(1)(-) in the near-UV show that charge recombination occurs between P700degrees and A(1)(-) in both thylakoids and PS I complexes. The spin-polarized EPR signal at room temperature from PS I complexes also indicates that forward electron transfer does not occur beyond A, In agreement, the spin-polarized X-band EPR spectrum of P700(+) A(1)(-) at low temperature shows that an electron cycle between A(1)(-) and P700degrees occurs in a much larger fraction of PS I complexes than in the wild-type, wherein a relatively large fraction of the electrons promoted are irreversibly transferred to [F-A/F-B]. The electron spin polarization pattern shows that the orientation of phylloquinone in the PS I complexes is identical to that of the wild type, and out-of-phase, spin-echo modulation spectroscopy shows the same P700degrees to A(1)(-) center-to-center distance in photosystem I complexes of wild type and the rubA mutant. In contrast to the loss of F-X, F-B, and F-A, the Rieske iron-sulfur protein and the non-heme iron in photosystem 11 are intact. It is proposed that rubredoxin is specifically required for the assembly of the Fx iron-sulfur cluster but that Fx is not required for the biosynthesis of trimeric P700-A(1) cores. Since the PsaC protein requires the presence of Fx for binding, the absence of F-A and F-B, may be an indirect result of the absence of F-X.	Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; Brock Univ, Dept Chem, St Catharines, ON L2S 3A1, Canada; CEA, Serv Bioenerget, F-91191 Gif Sur Yvette, France; CEA Saclay, CNRS, URA 2096, F-91191 Gif Sur Yvette, France; Free Univ Berlin, Inst Phys Expt, D-14195 Berlin, Germany; Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Brock University; CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Free University of Berlin; Peking University	Golbeck, JH (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, S-310 Frear Bldg, University Pk, PA 16802 USA.	jhg5@psu.edu	Bittl, Robert/I-8149-2013	Bittl, Robert/0000-0003-4103-3768				Bittl R, 1997, J PHYS CHEM B, V101, P1429, DOI 10.1021/jp962256q; BOCK CH, 1989, FEBS LETT, V247, P91, DOI 10.1016/0014-5793(89)81247-5; Boudreaux B, 2001, J BIOL CHEM, V276, P37299, DOI 10.1074/jbc.M102327200; BRETTEL K, 1988, FEBS LETT, V239, P93, DOI 10.1016/0014-5793(88)80552-0; Brettel K, 1997, BBA-BIOENERGETICS, V1318, P322, DOI 10.1016/S0005-2728(96)00112-0; Brettel K, 1995, PHOTOSYNTH RES, V45, P183, DOI 10.1007/BF00015559; CHITNIS VP, 1993, FEBS LETT, V336, P330, DOI 10.1016/0014-5793(93)80831-E; da Costa PN, 2001, MOL MICROBIOL, V41, P217, DOI 10.1046/j.1365-2958.2001.02509.x; DEAN DR, 1993, J BACTERIOL, V175, P6737, DOI 10.1128/jb.175.21.6737-6744.1993; Dzuba SA, 1997, CHEM PHYS LETT, V264, P238, DOI 10.1016/S0009-2614(96)01302-4; Golbeck J. H., 1995, CRC HDB ORGANIC PHOT, P1407; Golbeck JH, 1999, PHOTOSYNTH RES, V61, P107, DOI 10.1023/A:1006281802710; GOLBECK JH, 1991, CURR TOP BIOENERG, V16, P83; GOLBECK JH, 1994, MOL BIOL CYANOBACTER, P179; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Krebs C, 2001, BIOCHEMISTRY-US, V40, P14069, DOI 10.1021/bi015656z; MILLER AF, 1991, BIOCHIM BIOPHYS ACTA, V1056, P1, DOI 10.1016/S0005-2728(05)80067-2; Muhiuddin IP, 2001, FEBS LETT, V503, P56, DOI 10.1016/S0014-5793(01)02696-5; Ollagnier-de-Choudens S, 2001, J BIOL CHEM, V276, P22604, DOI 10.1074/jbc.M102902200; PARRETT KG, 1989, BIOCHIM BIOPHYS ACTA, V973, P324, DOI 10.1016/S0005-2728(89)80439-6; SALIKHOV JM, 1992, APPL MAGN RESON, V15, P199; Schluchter WM, 1996, PHOTOCHEM PHOTOBIOL, V64, P53, DOI 10.1111/j.1751-1097.1996.tb02421.x; Shen GZ, 2002, J BIOL CHEM, V277, P20343, DOI 10.1074/jbc.M201103200; Shen GZ, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P3147; SIECKMAN I, 1991, FEBS LETT, V284, P98, DOI 10.1016/0014-5793(91)80771-T; VANDEREST A, 1994, BIOCHEMISTRY-US, V33, P11789, DOI 10.1021/bi00205a015; Vassiliev IR, 1997, BIOPHYS J, V72, P301, DOI 10.1016/S0006-3495(97)78669-7; Vassiliev IR, 2001, BBA-BIOENERGETICS, V1507, P139, DOI 10.1016/S0005-2728(01)00197-9; WARREN PV, 1990, BIOCHEMISTRY-US, V29, P6545, DOI 10.1021/bi00480a001; WARREN PV, 1993, BIOCHEMISTRY-US, V32, P849, DOI 10.1021/bi00054a016; Wastl J, 2000, J BIOL CHEM, V275, P30058, DOI 10.1074/jbc.M004629200; Wastl J, 2000, FEBS LETT, V471, P191, DOI 10.1016/S0014-5793(00)01399-5; XU Q, 1994, J BIOL CHEM, V269, P21512; Yang F, 1998, J PHYS CHEM B, V102, P8288, DOI 10.1021/jp981952i; YU JP, 1995, PLANT MOL BIOL, V29, P331, DOI 10.1007/BF00043656; Zech SG, 1996, BER BUNSEN PHYS CHEM, V100, P2041, DOI 10.1002/bbpc.19961001220; Zech SG, 1997, BIOCHEMISTRY-US, V36, P9774, DOI 10.1021/bi970754z; ZHAO J, 1993, MOL MICROBIOL, V9, P183, DOI 10.1111/j.1365-2958.1993.tb01680.x; Zybailov B, 2000, J BIOL CHEM, V275, P8531, DOI 10.1074/jbc.275.12.8531	39	71	86	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20355	20366		10.1074/jbc.M201104200	http://dx.doi.org/10.1074/jbc.M201104200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11914374	hybrid			2022-12-27	WOS:000176204500034
J	Galasinski, SC; Resing, KA; Goodrich, JA; Ahn, NG				Galasinski, SC; Resing, KA; Goodrich, JA; Ahn, NG			Phosphatase inhibition leads to histone deacetylases 1 and 2 phosphorylation and disruption of corepressor interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REPRESSION; COMPLEX; GENE; PROTEIN; BINDING; IDENTIFICATION; CHROMATIN; COMPONENT; FAMILY; YEAST	The regulation of histone deacetylases (HDACs) by phosphorylation was examined by elevating intracellular phosphorylation in cultured cells with the protein phosphatase inhibitor okadaic acid. After fractionation of extracts from treated versus untreated cells, HDAC 1 and 2 eluted in several peaks of deacetylase activity, assayed using mixed acetylated histones or acetylated histone H4 peptide. Stimulation of cells with okadaic acid led to hyperphosphorylation of HDAC I and 2 as well as changes in column elution of both enzymes. Hyperphosphorylated HDAC2 was also observed in cells synchronized with nocodazole or taxol, demonstrating regulation of HDAC phosphorylation during mitosis. Phosphorylated HDAC1 and 2 showed a gel mobility retardation that correlated with a small but significant increase in activity, both of which were reversed upon phosphatase treatment in vitro. However, the most pronounced effect of HDAC phosphorylation was to disrupt protein complex formation between HDAC1 and 2 as well as complex formation between HDAC1 and corepressors mSin3A and YY1 In contrast, interactions between HDAC1/2 and RbAp46/48 were unaffected by okadaic acid. These results establish a novel link between HDAC phosphorylation and the control of protein-protein interactions and suggest a mechanism for relief of deacetylase-catalyzed transcriptional repression by phosphorylation-dependent signaling.	Univ Colorado, Dept Chem & Biochem, Howard Hughes Med Inst, Boulder, CO 80309 USA; Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Ahn, NG (corresponding author), Univ Colorado, Dept Chem & Biochem, Howard Hughes Med Inst, Campus Box 215, Boulder, CO 80309 USA.	Natalie.Ahn@colorado.edu						Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; Ayer DE, 1999, TRENDS CELL BIOL, V9, P193, DOI 10.1016/S0962-8924(99)01536-6; Bartl S, 1997, MOL CELL BIOL, V17, P5033, DOI 10.1128/MCB.17.9.5033; Brehm A, 1999, TRENDS BIOCHEM SCI, V24, P142, DOI 10.1016/S0968-0004(99)01368-7; Cai R, 2001, BIOCHEM BIOPH RES CO, V283, P445, DOI 10.1006/bbrc.2001.4786; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; Emiliani S, 1998, P NATL ACAD SCI USA, V95, P2795, DOI 10.1073/pnas.95.6.2795; Fischle W, 1999, J BIOL CHEM, V274, P11713, DOI 10.1074/jbc.274.17.11713; Galasinski SC, 2002, J BIOL CHEM, V277, P2579, DOI 10.1074/jbc.M107894200; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; HENDZEL MJ, 1992, BIOCHIM BIOPHYS ACTA, V1130, P307, DOI 10.1016/0167-4781(92)90443-4; Huang EY, 2000, GENE DEV, V14, P45; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; JOHNS EW, 1967, BIOCHEM J, V105, P611, DOI 10.1042/bj1050611; Johnson CA, 1999, SEMIN CELL DEV BIOL, V10, P179, DOI 10.1006/scdb.1999.0299; Koipally J, 1999, EMBO J, V18, P3090, DOI 10.1093/emboj/18.11.3090; Laherty CD, 1998, MOL CELL, V2, P33, DOI 10.1016/S1097-2765(00)80111-2; Laj A, 1999, MOL CELL BIOL, V19, P6632; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Nicol R, 1998, J BIOL CHEM, V273, P3588, DOI 10.1074/jbc.273.6.3588; Pazin MJ, 1997, CELL, V89, P325, DOI 10.1016/S0092-8674(00)80211-1; Pflum MKH, 2001, J BIOL CHEM, V276, P47733, DOI 10.1074/jbc.M105590200; Shinagawa T, 2000, EMBO J, V19, P2280, DOI 10.1093/emboj/19.10.2280; Spencer VA, 1999, GENE, V240, P1, DOI 10.1016/S0378-1119(99)00405-9; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Verdel A, 1999, J BIOL CHEM, V274, P2440, DOI 10.1074/jbc.274.4.2440; Wang AH, 2000, MOL CELL BIOL, V20, P6904, DOI 10.1128/MCB.20.18.6904-6912.2000; Wotton D, 1999, J BIOL CHEM, V274, P37105, DOI 10.1074/jbc.274.52.37105; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; Yarden RI, 1999, P NATL ACAD SCI USA, V96, P4983, DOI 10.1073/pnas.96.9.4983; Zeng YY, 1998, J BIOL CHEM, V273, P28921, DOI 10.1074/jbc.273.44.28921; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhang Y, 1998, MOL CELL, V1, P1021, DOI 10.1016/S1097-2765(00)80102-1	45	126	131	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19618	19626		10.1074/jbc.M201174200	http://dx.doi.org/10.1074/jbc.M201174200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11919195	hybrid			2022-12-27	WOS:000175894800051
J	Gao, L; Cueto, MA; Asselbergs, F; Atadja, P				Gao, L; Cueto, MA; Asselbergs, F; Atadja, P			Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; REVERSIBLE ACETYLATION; TRICHOSTATIN-A; PROTEIN SIR2; CLASS-I; YEAST; REPRESSION; RPD3; COMPLEX; SMRT	We have cloned and characterized a human cDNA that belongs to the histone deacetylase family, which we designate as HDAC11. The predicted HDAC11 amino acid sequence reveals an open reading frame of 347 residues with a corresponding molecular mass of 39 kDa. Sequence analyses of the putative HDAC11 protein indicate that it contains conserved residues in the catalytic core regions shared by both class I and 11 mammalian HDAC enzymes. Putative orthologues of HDAC11 exist in primate, mouse, Drosophila, and plant. Epitope-tagged HDAC11 protein expressed in mammalian cells displays histone deacetylase activity in vitro. Furthermore, HDAC11's enzymatic activity is inhibited by trapoxin, a known histone deacetylase inhibitor. Multiple tissue Northern blot and real-time PCR experiments show that the high expression level of HDAC11 transcripts is limited to kidney, heart, brain,, skeletal muscle, and testis. Epitope-tagged HDAC11 protein localizes predominantly to the cell nucleus. Co-immunoprecipitation experiments indicate that HDAC11 may be present in protein complexes that also contain HDAC6. These results indicate that HDAC11 is a novel and unique member of the histone deacetylase family and it may have distinct physiological roles from those of the known HDACs.	Novartis Pharmaceut Corp, Oncol Biol Unit, Dept Oncol, Summit, NJ 07901 USA; Novartis Pharmaceut Corp, Funct Genom, Summit, NJ 07901 USA	Novartis; Novartis	Atadja, P (corresponding author), Novartis Pharmaceut Corp, Oncol Biol Unit, Dept Oncol, Summit, NJ 07901 USA.							Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Buggy JJ, 2000, BIOCHEM J, V350, P199, DOI 10.1042/0264-6021:3500199; Carmen AA, 1999, P NATL ACAD SCI USA, V96, P12356, DOI 10.1073/pnas.96.22.12356; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; Emiliani S, 1998, P NATL ACAD SCI USA, V95, P2795, DOI 10.1073/pnas.95.6.2795; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Fischle W, 2001, BIOCHEM CELL BIOL, V79, P337, DOI 10.1139/bcb-79-3-337; Furukawa Y, 1996, CYTOGENET CELL GENET, V73, P130, DOI 10.1159/000134323; Furumai R, 2001, P NATL ACAD SCI USA, V98, P87, DOI 10.1073/pnas.011405598; Gray SG, 2001, EXP CELL RES, V262, P75, DOI 10.1006/excr.2000.5080; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Guenther MG, 2000, GENE DEV, V14, P1048; Hu E, 2000, J BIOL CHEM, V275, P15254, DOI 10.1074/jbc.M908988199; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Imhof A, 1997, CURR BIOL, V7, P689, DOI 10.1016/S0960-9822(06)00296-X; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Kao HY, 2002, J BIOL CHEM, V277, P187, DOI 10.1074/jbc.M108931200; Kao HY, 2000, GENE DEV, V14, P55; Leipe DD, 1997, NUCLEIC ACIDS RES, V25, P3693, DOI 10.1093/nar/25.18.3693; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; LOIDL P, 1988, FEBS LETT, V227, P91, DOI 10.1016/0014-5793(88)80874-3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Marzio G, 2000, J BIOL CHEM, V275, P10887, DOI 10.1074/jbc.275.15.10887; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Mizzen CA, 1998, CELL MOL LIFE SCI, V54, P6, DOI 10.1007/s000180050121; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Shore D, 2000, P NATL ACAD SCI USA, V97, P14030, DOI 10.1073/pnas.011506198; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Van den Wyngaert I, 2000, FEBS LETT, V478, P77, DOI 10.1016/S0014-5793(00)01813-5; VanLint C, 1996, GENE EXPRESSION, V5, P245; Verdel A, 2000, CURR BIOL, V10, P747, DOI 10.1016/S0960-9822(00)00542-X; VIDAL M, 1991, MOL CELL BIOL, V11, P6317, DOI 10.1128/MCB.11.12.6317; VIDAL M, 1991, MOL CELL BIOL, V11, P6306, DOI 10.1128/MCB.11.12.6306; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; Zhou XB, 2001, P NATL ACAD SCI USA, V98, P10572, DOI 10.1073/pnas.191375098	43	525	568	1	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 12	2002	277	28					25748	25755		10.1074/jbc.M111871200	http://dx.doi.org/10.1074/jbc.M111871200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	571YP	11948178	hybrid			2022-12-27	WOS:000176747000118
J	Chi, YI; Sadler, I; Jablonski, LM; Callantine, SD; Deobald, CF; Stauffacher, CV; Bohach, GA				Chi, YI; Sadler, I; Jablonski, LM; Callantine, SD; Deobald, CF; Stauffacher, CV; Bohach, GA			Zinc-mediated dimerization and its effect on activity and conformation of staphylococcal enterotoxin type C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXIC-SHOCK SYNDROME; MHC CLASS-II; CRYSTAL-STRUCTURE; CYSTEINYL LEUKOTRIENES; NUCLEOTIDE-SEQUENCE; SUPERANTIGEN; PROTEINS; BINDING; RESOLUTION; MOLECULES	Staphylococcal enterotoxins are superantigen exotoxins that mediate food poisoning and toxic shock syndrome in humans. Despite their structural and functional similarities, superantigens display subtle differences in biological properties and modes of receptor binding as a result of zinc atoms bound differently in their crystal structures. For example, the crystal structures of the staphylococcal enterotoxins in the type C serogroup (SECs) contain a zinc atom coordinated by one aspartate and two histidine residues from one molecule and another aspartate residue from the next molecule, thus forming a dimer. This type of zinc ligation and zinc-mediated dimerization occurs in several SECs, but not in most other staphylococcal enterotoxin serogroups. This prompted us to investigate the potential importance of zinc in SEC-mediated pathogenesis. Site-directed mutagenesis was used to replace SEC zinc binding ligands with alanine. SEC mutants unable to bind zinc did not have major conformational alterations although they failed to form dimers. Zinc binding was not essential for T cell stimulation, emesis, or lethality although in general the mutants were less pyrogenic. Thus the zinc atom in SECs might represent a non-functional heavy atom in an exotoxin group that has diverged from related bacterial toxins containing crucial zinc atoms.	Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; Univ Idaho, Dept Microbiol Mol Biol & Biochem, Moscow, ID 83843 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Idaho; University of Idaho	Chi, YI (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA.	young-in.chi@joslin.harvard.edu						ALBER G, 1990, J IMMUNOL, V144, P4501; BERGDOLL MS, 1988, METHOD ENZYMOL, V165, P324; BINZ T, 1990, NUCLEIC ACIDS RES, V18, P5556, DOI 10.1093/nar/18.18.5556; BOHACH GA, 1989, INFECT IMMUN, V57, P23, DOI 10.1128/IAI.57.1.23-28.1989; BOHACH GA, 1992, PROTEINS, V13, P152, DOI 10.1002/prot.340130208; BOHACH GA, 1987, INFECT IMMUN, V55, P428, DOI 10.1128/IAI.55.2.428-432.1987; BOHACH GA, 1990, CRIT REV MICROBIOL, V17, P251, DOI 10.3109/10408419009105728; Bohach GA, 1995, MOL APPROACHES FOOD, P339; BRUNGER AT, 1992, X PLOR MANUAL VERSIO; COLEMAN JE, 1992, ANNU REV BIOCHEM, V61, P897, DOI 10.1146/annurev.bi.61.070192.004341; CUNNINGHAM BC, 1991, SCIENCE, V253, P545, DOI 10.1126/science.1907025; Edwards VM, 1997, INFECT IMMUN, V65, P2346, DOI 10.1128/IAI.65.6.2346-2352.1997; FRASER JD, 1992, P NATL ACAD SCI USA, V89, P5507, DOI 10.1073/pnas.89.12.5507; Hakansson M, 2000, J MOL BIOL, V302, P527, DOI 10.1006/jmbi.2000.4093; HARRIS TO, 1993, INFECT IMMUN, V61, P3175, DOI 10.1128/IAI.61.8.3175-3183.1993; HOVDE CJ, 1990, MOL GEN GENET, V220, P329; HOVDE CJ, 1994, MOL MICROBIOL, V13, P897, DOI 10.1111/j.1365-2958.1994.tb00481.x; Jablonski L. M., 1997, FOOD MICROBIOLOGY FU, P353; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; Jarvis K.E., 1991, HDB INDUCTIVELY COUP; JETT M, 1990, INFECT IMMUN, V58, P3494, DOI 10.1128/IAI.58.11.3494-3499.1990; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KIM Y B, 1970, Journal of Experimental Medicine, V131, P611, DOI 10.1084/jem.131.3.611; KUSHNARYOV VM, 1989, REV INFECT DIS, V11, pS282; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE PK, 1991, J INFECT DIS, V164, P711, DOI 10.1093/infdis/164.4.711; Li YL, 2001, IMMUNITY, V14, P93, DOI 10.1016/S1074-7613(01)00092-9; MARR JC, 1993, INFECT IMMUN, V61, P4254, DOI 10.1128/IAI.61.10.4254-4262.1993; Monday S. R., 1999, COMPREHENSIVE SOURCE, P589; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; PAPAGEORGIOU AC, 1995, STRUCTURE, V3, P769, DOI 10.1016/S0969-2126(01)00212-X; Papageorgiou AC, 2000, TRENDS MICROBIOL, V8, P369, DOI 10.1016/S0966-842X(00)01793-5; Papageorgiou AC, 1998, J MOL BIOL, V277, P61, DOI 10.1006/jmbi.1997.1577; Petersson K, 2001, EMBO J, V20, P3306, DOI 10.1093/emboj/20.13.3306; POINDEXTER NJ, 1985, J INFECT DIS, V151, P65, DOI 10.1093/infdis/151.1.65; SCHAD EM, 1995, EMBO J, V14, P3292, DOI 10.1002/j.1460-2075.1995.tb07336.x; SCHEUBER PH, 1987, INT ARCH ALLER A IMM, V82, P289, DOI 10.1159/000234209; SCHEUBER PH, 1987, EUR J CLIN INVEST, V17, P455, DOI 10.1111/j.1365-2362.1987.tb01142.x; SCHLIEVERT PM, 1982, INFECT IMMUN, V36, P123, DOI 10.1128/IAI.36.1.123-128.1982; Sundberg EJ, 2002, CURR OPIN IMMUNOL, V14, P36, DOI 10.1016/S0952-7915(01)00296-5; Sundstrom M, 1996, EMBO J, V15, P6832, DOI 10.1002/j.1460-2075.1996.tb01074.x; Sundstrom M, 1996, J BIOL CHEM, V271, P32212, DOI 10.1074/jbc.271.50.32212; SWAMINATHAN S, 1992, NATURE, V359, P801, DOI 10.1038/359801a0; SWAMINATHAN S, 1995, NAT STRUCT BIOL, V2, P680, DOI 10.1038/nsb0895-680; TONELLO F, 1996, ADV EXP MED BIOL, V89, P251; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X	51	28	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22839	22846		10.1074/jbc.M201932200	http://dx.doi.org/10.1074/jbc.M201932200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11934896	hybrid			2022-12-27	WOS:000176313600094
J	Hsu, HY; Wen, MH				Hsu, HY; Wen, MH			Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; NEUTROPHIL NADPH-OXIDASE; GTP-BINDING PROTEINS; SCAVENGER RECEPTOR; FACTOR-ALPHA; TRANSCRIPTIONAL ACTIVATION; TNF-ALPHA; CONVERTING-ENZYME	Lipopolysaccharide (LPS) stimulates macrophages to release inflammatory cytokines, interleukin-1beta (IL-1), and tumor necrosis factor (TNF). LPS-induced TNF suppresses scavenger receptor functions in macrophages (van Lenten, B. J., and Fogelman, A. M. (1992) J. Immunol. 148, 112-116), which is regulated by TNF-mediated protein kinases (Hsu, H. Y., and Twu, Y. C. (2000) J. Biol. Chem. 275, 41035-41048). To examine the molecular mechanism for LPS induction of IL-1 in macrophages, we demonstrated that LPS quickly stimulated reactive oxygen species (ROS), and 3 h later induced prointerleukin-1beta (pro-IL-1, precursor of IL-1) production and IL-1 secretion. LPS stimulated pro-IL-1 message/protein between 3 and 10 h; however, there was a 40% reduction of pro-IL-1 in preincubation of the antioxidant, N-acetyl-cysteine (NAC). Moreover, NAC moderated LPS-induced IL-1 secretion partially via interleukin 1-converting enzyme. The maximal activity of LPS-induced ERK, JNK, and p38 was 12- (30 min), 5- (30 min), and 16-fold (15 min), respectively. In contrast, NAC reduced ERK activity to 60% and decreased p38 activity to the basal level, but JNK activity was induced 2-fold. Furthermore, the pharmacological antagonists LY294002, S13203580, curcumin, calphostin C, and PD98059 revealed the diverse roles of LPS-mediated protein kinases in pro-IL-1. On the other hand, NAC and diphenyleneiodonium chloride partially inhibited LPS-induced Rac activity and protein-tyrosine kinase (PTK), indicating that LPS-mediated ROS and NADPH oxidase correspond to Rac activation and IL-1 expression. Our findings establish for the first time that LPS-mediated PTK/phosphatidylinositol 3-kinase/ Rac/p38 pathways play a more important role than pathways of PTK/PKC/MEK/ERK and of PTK/phosphatidylinositol 3-kinase/Rac/JNK in the regulation of pro-IL-1/ IL-1. The findings also further elucidate the critical role of LPS-mediated ROS in signal transduction pathways. Our results suggest that understanding LPS-transduced signals in IL-1 induction upon the antibacterial action of macrophages should provide a therapeutic strategy for aberrant inflammatory responses leading to severe cellular injury or concurrent multiorgan septic damage.	Natl Yang Ming Univ, Inst Biotechnol Med, Fac Med Technol, Taipei 112, Taiwan	National Yang Ming Chiao Tung University	Hsu, HY (corresponding author), Natl Yang Ming Univ, Inst Biotechnol Med, Fac Med Technol, 155 Li Nong St, Taipei 112, Taiwan.	hyhsu@ym.edu.tw						BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Beutler B, 2002, CURR OPIN HEMATOL, V9, P2, DOI 10.1097/00062752-200201000-00002; BINETRUY B, 1991, NATURE, V351, P122, DOI 10.1038/351122a0; Boggs SE, 1998, BIOCHEM BIOPH RES CO, V247, P229, DOI 10.1006/bbrc.1998.8765; BOKOCH GM, 1995, TRENDS CELL BIOL, V5, P109, DOI 10.1016/S0962-8924(00)88960-6; Carter AB, 1999, AM J RESP CELL MOL, V20, P751, DOI 10.1165/ajrcmb.20.4.3420; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Chan ED, 1999, J IMMUNOL, V162, P415; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; CRAWFORD D, 1988, CANCER RES, V48, P2132; DeLeo FR, 1998, J CLIN INVEST, V101, P455, DOI 10.1172/JCI949; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; DINARELLO CA, 1984, REV INFECT DIS, V6, P51, DOI 10.1016/S1359-6101(97)00023-3; Fenton MJ, 1998, J LEUKOCYTE BIOL, V64, P25, DOI 10.1002/jlb.64.1.25; FIALKOW L, 1994, J BIOL CHEM, V269, P31234; Finkel T, 1999, J LEUKOCYTE BIOL, V65, P337, DOI 10.1002/jlb.65.3.337; Geng Y, 1996, J CLIN INVEST, V98, P2425, DOI 10.1172/JCI119056; GEPPERT TD, 1994, MOL MED, V1, P93; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; GRAY JG, 1993, MOL CELL BIOL, V13, P6678, DOI 10.1128/MCB.13.11.6678; Hambleton J, 1996, P NATL ACAD SCI USA, V93, P2774, DOI 10.1073/pnas.93.7.2774; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; HANUKOGLU I, 1993, ARCH BIOCHEM BIOPHYS, V305, P489, DOI 10.1006/abbi.1993.1452; Henderson B, 1996, MICROBIOL REV, V60, P316, DOI 10.1128/MMBR.60.2.316-341.1996; Hong YH, 1997, J IMMUNOL, V159, P2418; Hsu HY, 1998, J BIOL CHEM, V273, P1240, DOI 10.1074/jbc.273.2.1240; Hsu HY, 2001, J BIOL CHEM, V276, P28719, DOI 10.1074/jbc.M011117200; Hsu HY, 2000, J BIOL CHEM, V275, P41035, DOI 10.1074/jbc.M003464200; Hwang D, 1997, BIOCHEM PHARMACOL, V54, P87, DOI 10.1016/S0006-2952(97)00154-8; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; KARLSSON A, 1995, INFECT IMMUN, V63, P4606, DOI 10.1128/IAI.63.12.4606-4612.1995; Kaul N, 1998, ARCH BIOCHEM BIOPHYS, V350, P79, DOI 10.1006/abbi.1997.0487; Koay MA, 2001, INFECT IMMUN, V69, P5991, DOI 10.1128/IAI.69.10.5991-5996.2001; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Li YS, 1996, MOL CELL BIOL, V16, P5947; Lin Y, 2000, J BIOL CHEM, V275, P24255, DOI 10.1074/jbc.M002137200; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; LO YYC, 1995, J BIOL CHEM, V270, P11727, DOI 10.1074/jbc.270.20.11727; Loppnow H, 1998, EUR CYTOKINE NETW, V9, P675; LOPPNOW H, 1990, J CLIN INVEST, V85, P731, DOI 10.1172/JCI114498; Manna SK, 1999, J IMMUNOL, V162, P1510; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Matsuno R, 1997, BIOCHEM BIOPH RES CO, V237, P601, DOI 10.1006/bbrc.1997.7195; MIKUNI Y, 2000, J IMMUNOL, V165, P931; MINDEN A, 1994, MOL CELL BIOL, V14, P6683, DOI 10.1128/MCB.14.10.6683; MURRELL GAC, 1990, BIOCHEM J, V265, P659, DOI 10.1042/bj2650659; ODONNELL VB, 1993, BIOCHEM J, V290, P41, DOI 10.1042/bj2900041; Park LCH, 1999, J NEUROCHEM, V72, P1948, DOI 10.1046/j.1471-4159.1999.0721948.x; POMBO CM, 1994, J BIOL CHEM, V269, P26546; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; REIMANN T, 1994, J IMMUNOL, V153, P5740; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; Scherle PA, 1998, J IMMUNOL, V161, P5681; Schletter J, 1995, ARCH MICROBIOL, V164, P383, DOI 10.1007/BF02529735; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Schumann RR, 1998, BLOOD, V91, P577, DOI 10.1182/blood.V91.2.577.577_577_584; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; Sweet MJ, 1996, J LEUKOCYTE BIOL, V60, P8, DOI 10.1002/jlb.60.1.8; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; VANLENTEN BJ, 1992, J IMMUNOL, V148, P112; WAN CP, 1993, J IMMUNOL METHODS, V159, P131, DOI 10.1016/0022-1759(93)90150-6; WEINSTEIN SL, 1991, P NATL ACAD SCI USA, V88, P4148, DOI 10.1073/pnas.88.10.4148; Wong G H, 1996, EXS, V77, P321; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703; Xaus J, 2000, BLOOD, V95, P3823; Yang H, 2000, J BIOL CHEM, V275, P20861, DOI 10.1074/jbc.M002896200; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934; Zhu W, 2000, J IMMUNOL, V164, P6349, DOI 10.4049/jimmunol.164.12.6349	71	409	426	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22131	22139		10.1074/jbc.M111883200	http://dx.doi.org/10.1074/jbc.M111883200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11940570	hybrid			2022-12-27	WOS:000176313600006
J	Qiao, YM; Prabhakar, S; Coccia, EM; Weiden, M; Canova, A; Giacomini, E; Pine, R				Qiao, YM; Prabhakar, S; Coccia, EM; Weiden, M; Canova, A; Giacomini, E; Pine, R			Host Defense responses to infection by Mycobacterium tuberculosis - Induction of IRF-1 and a serine protease inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR; LEUKEMIA-CELL LINE; TRANSCRIPTION FACTOR; REGULATORY FACTOR-1; BACTERIAL LIPOPOLYSACCHARIDE; HUMAN MACROPHAGES; INTERFERON-GAMMA; GENE-EXPRESSION; NUCLEAR FACTOR; I INTERFERON	Alveolar macrophages and newly recruited monocytes are targets of infection by Mycobacterium tuberculosis. Therefore, we examined the expression of interferon regulatory factor 1 (IRF-1), which plays an important role in host defense against M. tuberculosis, in undifferentiated and differentiated cells. Infection induced IRF-1 in both. IRF-1 from undifferentiated, uninfected monocytic cell lines was modified during extraction to produce specific species that were apparently smaller than intact IRF-1. After infection by M. tuberculosis or differentiation, intact IRF-1 was recovered. Subcellular fractions were assayed for the ability to modify IRF-1 or inhibit its modification. A serine protease on the cytoplasmic surface of an organelle or vesicle in the "lysosomal/mitochondrial" fraction from undifferentiated cells was responsible for the modification of IRF-1. Thus, the simplest explanation of the modification is cleavage of IRF-1 by the serine protease. Recovery of intact IRF-1 correlated with induction of a serine protease inhibitor that was able to significantly reduce the modification of IRF-1. The inhibitor was present in the cytoplasm of M. tuberculosis-infected or -differentiated cells. It is likely that induction of both IRF-1 and the serine protease inhibitor in response to infection by M. tuberculosis represent host defense mechanisms.	Publ Hlth Res Inst, Newark, NJ 07103 USA; Ist Super Sanita, I-00161 Rome, Italy; NYU, Sch Med, New York, NY 10016 USA; Bellevue Hosp, New York, NY 10016 USA	Istituto Superiore di Sanita (ISS); New York University; Bellevue Hospital Center	Pine, R (corresponding author), Publ Hlth Res Inst, 225 Warren St, Newark, NJ 07103 USA.		GIACOMINI, ELENA/M-4359-2015; Coccia, Eliana M/B-4752-2013	Coccia, Eliana M/0000-0002-1606-2949	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037877] Funding Source: NIH RePORTER; NIAID NIH HHS [AI37877] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Antalis TM, 1998, J EXP MED, V187, P1799, DOI 10.1084/jem.187.11.1799; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Balcewicz-Sablinska MK, 1998, J IMMUNOL, V161, P2636; Bird PI, 1999, IMMUNOL CELL BIOL, V77, P47, DOI 10.1046/j.1440-1711.1999.00787.x; CHANG KJ, 1975, J BIOL CHEM, V250, P488; CHAPMAN HA, 1982, CELL, V28, P653, DOI 10.1016/0092-8674(82)90220-3; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cooper AM, 2000, INFECT IMMUN, V68, P6879, DOI 10.1128/IAI.68.12.6879-6882.2000; de Duve C, 1971, J Cell Biol, V50, P20; DICKINSON JL, 1995, J BIOL CHEM, V270, P27894, DOI 10.1074/jbc.270.46.27894; DUNN WA, 1980, J BIOL CHEM, V255, P5971; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; FRANZOSO G, 1994, J EXP MED, V180, P1445, DOI 10.1084/jem.180.4.1445; GAN HX, 1995, J IMMUNOL, V155, P1304; GENTON C, 1987, J CELL BIOL, V104, P705, DOI 10.1083/jcb.104.3.705; Improta T, 1997, CYTOKINE, V9, P383, DOI 10.1006/cyto.1996.0180; Jin FY, 1998, INFECT IMMUN, V66, P2447, DOI 10.1128/IAI.66.6.2447-2452.1998; Jin FY, 1997, CELL, V88, P417, DOI 10.1016/S0092-8674(00)81880-2; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; KIMURA T, 1994, SCIENCE, V264, P1921, DOI 10.1126/science.8009222; KUMAR S, 1991, J BIOL CHEM, V266, P20960; LIN RT, 1994, J BIOL CHEM, V269, P17542; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Matikainen S, 1996, BLOOD, V88, P114; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; NEISH AS, 1995, MOL CELL BIOL, V15, P2558; PARRINGTON J, 1993, EUR J BIOCHEM, V214, P617, DOI 10.1111/j.1432-1033.1993.tb17961.x; PINE R, 1989, MOL CELL BIOL, V9, P3533, DOI 10.1128/MCB.9.8.3533; PINE R, 1990, MOL CELL BIOL, V10, P2448, DOI 10.1128/MCB.10.6.2448; Pine R, 2002, J INTERF CYTOK RES, V22, P15, DOI 10.1089/107999002753452629; Pine R, 1997, NUCLEIC ACIDS RES, V25, P4346, DOI 10.1093/nar/25.21.4346; Rao J, 1998, J CELL PHYSIOL, V175, P121, DOI 10.1002/(SICI)1097-4652(199805)175:2<121::AID-JCP1>3.0.CO;2-Q; Raupach B, 2001, CURR OPIN IMMUNOL, V13, P417, DOI 10.1016/S0952-7915(00)00236-3; REICH N, 1987, P NATL ACAD SCI USA, V84, P6394, DOI 10.1073/pnas.84.18.6394; REIS LFL, 1994, EMBO J, V13, P4798, DOI 10.1002/j.1460-2075.1994.tb06805.x; SCHMITT E, 1977, BRIT J HAEMATOL, V35, P11, DOI 10.1111/j.1365-2141.1977.tb00557.x; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Weiden M, 2000, J IMMUNOL, V165, P2028, DOI 10.4049/jimmunol.165.4.2028; Zhao BY, 1999, ANTIMICROB AGENTS CH, V43, P661, DOI 10.1128/AAC.43.3.661; Zhu J, 1999, BBA-MOL CELL RES, V1451, P219, DOI 10.1016/S0167-4889(99)00111-1	43	15	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22377	22385		10.1074/jbc.M202965200	http://dx.doi.org/10.1074/jbc.M202965200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11948194	hybrid			2022-12-27	WOS:000176313600035
J	Ruvolo, PP; Clark, W; Mumby, M; Gao, FQ; May, WS				Ruvolo, PP; Clark, W; Mumby, M; Gao, FQ; May, WS			A functional role for the B56 alpha-subunit of protein phosphatase 2A in ceramide-mediated regulation of Bcl2 phosphorylation status and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; MOLECULAR-CLONING; CANCER-CELLS; APOPTOSIS; KINASE; STRESS; FAMILY; INTERLEUKIN-3; BRYOSTATIN-1; SUPPRESSION	Recently it has been shown that the potent apoptotic agent ceramide activates a mitochondrial protein phosphatase 2A (PP2A) and promotes dephosphorylation of the anti-apoptotic molecule Bcl2 (Ruvolo, P. P., Deng, X., Ito, T., Carr, B. K., and May, W. S. (1999) J. Biol. Chem. 274, 20296-20300). In cells expressing Bcl2, dephosphorylation of Bcl2 appears to be required for ceramide-induced cell death because treatment of cells with low doses of the PP2A inhibitor okadaic acid blocks Bcl2 dephosphorylation and promotes cell survival. Furthermore, the non-phosphorylatable (i.e. PP2A-resistant) gain-of-function S70E mutant Bcl2 can protect cells from ceramide-induced apoptosis. These findings support a model whereby Bcl2 function is regulated by PP2A. PP2A is a heterotrimer that contains a catalytic C-subunit, a structural A-subunit, and a regulatory B-subunit. The A- and C-subunits are fairly conserved and ubiquitously expressed, and they form the catalytic complex of the phosphatase. In contrast, there are at least three families of diverse B-subunit molecules that vary in expression temporally and by tissue type. It is hypothesized that ceramide regulates PP2A via the B-subunit. Thus, understanding the mechanism of how PP2A regulates Bcl2 phosphorylation status and how ceramide might regulate this process requires identification of the regulatory B-subunit of PP2A that comprises the Bcl2 phosphatase. Results indicate that the B56 alpha-subunit is a candidate regulatory subunit of the physiologic Bcl2 phosphatase since (a) B56 a associates with Bcl2 as evidenced by pull-down experiments, (b) B56 alpha co-localizes with Bcl2 in mitochondrial membranes, (c) ceramide promotes translocation of B56 alpha to mitochondrial membranes, and (d) overexpression of B56 a promotes mitochondrial PP2A activity and Bcl2 dephosphorylation and potentiates cell killing with ceramide. These findings suggest a role for B56 alpha in regulating the Bcl2 phosphatase.	Univ Florida, Shands Canc Ctr, Gainesville, FL 32610 USA; Univ Florida, Dept Med, Gainesville, FL 32610 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75235 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Ruvolo, PP (corresponding author), Univ Texas, Hlth Sci Ctr, Inst Mol Med, IBT 900,2121 Holcombe Blvd, Houston, TX 77030 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054083] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL54083] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CEGIELSKA A, 1994, MOL CELL BIOL, V14, P4616, DOI 10.1128/MCB.14.7.4616; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Csortos C, 1996, J BIOL CHEM, V271, P2578, DOI 10.1074/jbc.271.5.2578; Deng XM, 2000, P NATL ACAD SCI USA, V97, P1578, DOI 10.1073/pnas.97.4.1578; Deng XM, 1998, J BIOL CHEM, V273, P34157, DOI 10.1074/jbc.273.51.34157; Deng XM, 2001, J BIOL CHEM, V276, P23681, DOI 10.1074/jbc.M100279200; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; HALDAR S, 1995, P NATL ACAD SCI USA, V92, P4507, DOI 10.1073/pnas.92.10.4507; Haldar S, 1996, CANCER RES, V56, P1253; Haldar S, 1998, CANCER RES, V58, P1609; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; HEMMINGS BA, 1990, BIOCHEMISTRY-US, V29, P3166, DOI 10.1021/bi00465a002; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Ito T, 1997, J BIOL CHEM, V272, P11671, DOI 10.1074/jbc.272.18.11671; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Luberto C, 1998, J BIOL CHEM, V273, P14550, DOI 10.1074/jbc.273.23.14550; Maundrell K, 1997, J BIOL CHEM, V272, P25238, DOI 10.1074/jbc.272.40.25238; MAY WS, 1994, J BIOL CHEM, V269, P26865; MAYER RE, 1991, BIOCHEMISTRY-US, V30, P3589, DOI 10.1021/bi00229a001; MAYERJAEKEL RE, 1992, MOL BIOL CELL, V3, P287, DOI 10.1091/mbc.3.3.287; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; MCCRIGHT B, 1995, J BIOL CHEM, V270, P26123, DOI 10.1074/jbc.270.44.26123; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; NGUYEN M, 1993, J BIOL CHEM, V268, P25265; Nickels JT, 1996, GENE DEV, V10, P382, DOI 10.1101/gad.10.4.382; ORGAD S, 1990, FEBS LETT, V275, P44, DOI 10.1016/0014-5793(90)81435-Q; Petit PX, 1996, FEBS LETT, V396, P7, DOI 10.1016/0014-5793(96)00988-X; RUEDIGER R, 1991, MOL CELL BIOL, V11, P4282, DOI 10.1128/MCB.11.8.4282; Ruvolo PP, 1999, J BIOL CHEM, V274, P20296, DOI 10.1074/jbc.274.29.20296; Ruvolo PP, 2001, LEUKEMIA, V15, P1153, DOI 10.1038/sj.leu.2402197; Ruvolo PP, 2001, J BIOL CHEM, V276, P11754, DOI 10.1074/jbc.M011400200; Ruvolo PP, 1998, J BIOL CHEM, V273, P25436, DOI 10.1074/jbc.273.39.25436; Smyth M J, 1997, Adv Pharmacol, V41, P133, DOI 10.1016/S1054-3589(08)61057-1; SONTAG E, 1995, J CELL BIOL, V128, P1131, DOI 10.1083/jcb.128.6.1131; STONE SR, 1987, BIOCHEMISTRY-US, V26, P7215, DOI 10.1021/bi00397a003; Xu Z, 2000, MOL CELL BIOL, V20, P5285, DOI 10.1128/MCB.20.14.5285-5299.2000; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Zhu WJ, 1996, EMBO J, V15, P4130, DOI 10.1002/j.1460-2075.1996.tb00788.x	39	126	139	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22847	22852		10.1074/jbc.M201830200	http://dx.doi.org/10.1074/jbc.M201830200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11929874	hybrid			2022-12-27	WOS:000176313600095
J	Bouche, N; Scharlat, A; Snedden, W; Bouchez, D; Fromm, H				Bouche, N; Scharlat, A; Snedden, W; Bouchez, D; Fromm, H			A novel family of calmodulin-binding transcription activators in multicellular organisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT GLUTAMATE-DECARBOXYLASE; REGULATED GENE-EXPRESSION; ARABIDOPSIS-THALIANA; PROTEIN SEQUENCES; PLASMA-MEMBRANE; HUMAN GENOME; DOMAINS; CALCIUM; SITE; LOOP	Screening of cDNA expression libraries derived from plants exposed to stress, with (35)S-labeled recombinant calmodulin as a probe, revealed a new family of proteins containing a transcription activation domain and two types of DNA-binding domains designated the CG-1 domain and the transcription factor immunoglobulin domain, ankyrin repeats, and a varying number of IQ calmodulin-binding motifs. Based on domain organization and amino acid sequence comparisons, similar proteins, with the same domain organization, were identified in the genomes of other multicellular organisms including human, Drosophila, and Caenorhabditis, whereas none were found in the complete genomes of single cell eukaryotes and prokaryotes. This family of proteins was designated calmodulin-binding transcription activators (CAMTAs). Arabidopsis thaliana contains six CAMTA genes (AtCAMTA1-AtCAMTA6). The transcription activation domain of AtCAMTA1 was mapped by testing a series of protein fusions with the DNA-binding domain of the bacterial Lex-A transcription factor and two reporter genes fused to LexA recognition sequences in yeast cells. Two human proteins designated HsCAMTA1 and HsCAMTA2 were also shown to activate transcription in yeast using the same reporter system. Subcellular fractionation of Arabidopsis tissues revealed the presence of CAMTAs predominantly in the nucleus. Calmodulin binding assays identified a region of 25 amino acids capable of binding calmodulin with high affinity (K(d) = 1.2 nM) in the presence of calcium. We suggest that CAMTAs comprise a conserved family of transcription factors in a wide range of multicellular eukaryotes, which possibly respond to calcium signaling by direct binding of calmodulin.	Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England; Tel Aviv Univ, Dept Plant Sci, IL-69978 Tel Aviv, Israel; Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel; Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; INRA, Stn Genet, F-78026 Versailles, France	University of Leeds; Tel Aviv University; Weizmann Institute of Science; Queens University - Canada; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Fromm, H (corresponding author), Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England.	h.fromm@leeds.ac.uk	FROMM, HILLEL/AAF-6783-2019; Bouchez, David/B-7463-2019	FROMM, HILLEL/0000-0003-1977-1211; Bouchez, David/0000-0003-3545-4339; Bouche, Nicolas/0000-0002-3800-2613				Ach RA, 1997, PLANT CELL, V9, P1595, DOI 10.1105/tpc.9.9.1595; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; ARAZI T, 1995, PLANT PHYSIOL, V108, P551, DOI 10.1104/pp.108.2.551; Arazi T, 2000, PLANT MOL BIOL, V42, P591, DOI 10.1023/A:1006345302589; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; BAUM G, 1993, J BIOL CHEM, V268, P19610; Bork P, 1999, TRENDS BIOCHEM SCI, V24, P261, DOI 10.1016/S0968-0004(99)01416-4; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; CORNELIUSSEN B, 1994, NATURE, V368, P760, DOI 10.1038/368760a0; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; DOWNING WL, 1992, PLANT J, V2, P685, DOI 10.1046/j.1365-313X.1992.t01-11-00999.x; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5820; Faiman GA, 1996, J BIOL CHEM, V271, P13829, DOI 10.1074/jbc.271.23.13829; Foster R., 1992, Methods in Arabidopsis research., P378; Gadgil H, 1999, J CHROMATOGR A, V848, P131, DOI 10.1016/S0021-9673(99)00338-6; GEISER JR, 1991, CELL, V65, P949, DOI 10.1016/0092-8674(91)90547-C; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; HAGMAN J, 1995, EMBO J, V14, P2907, DOI 10.1002/j.1460-2075.1995.tb07290.x; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Heist EK, 1998, CELL CALCIUM, V23, P103; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; KINCAID RL, 1982, J BIOL CHEM, V257, P638; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liu LS, 1999, EUR J BIOCHEM, V262, P247, DOI 10.1046/j.1432-1327.1999.00349.x; LIU MY, 1994, SCIENCE, V266, P1348, DOI 10.1126/science.266.5189.1348; LUCKOW VA, 1993, J VIROL, V67, P4566, DOI 10.1128/JVI.67.8.4566-4579.1993; LUTHE DS, 1980, PLANT PHYSIOL, V65, P305, DOI 10.1104/pp.65.2.305; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; Nagase T, 1998, DNA Res, V5, P355, DOI 10.1093/dnares/5.6.355; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Onions J, 1997, J BIOL CHEM, V272, P23930, DOI 10.1074/jbc.272.38.23930; Onions J, 2000, BIOCHEMISTRY-US, V39, P4366, DOI 10.1021/bi992533u; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; Reddy ASN, 2000, BIOCHEM BIOPH RES CO, V279, P762, DOI 10.1006/bbrc.2000.4032; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Rodriguez-Concepcion M, 1999, EMBO J, V18, P1996, DOI 10.1093/emboj/18.7.1996; Rubtsov AM, 2000, FEBS LETT, V482, P1, DOI 10.1016/S0014-5793(00)01924-4; RUDEN DM, 1991, NATURE, V350, P250, DOI 10.1038/350250a0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Shannon KB, 2000, CURR BIOL, V10, P727, DOI 10.1016/S0960-9822(00)00539-X; SILVA ODE, 1994, PLANT MOL BIOL, V25, P921, DOI 10.1007/BF00028887; Snedden WA, 1997, PLANT MOL BIOL, V33, P753, DOI 10.1023/A:1005737026289; Snedden WA, 2001, NEW PHYTOL, V151, P35, DOI 10.1046/j.1469-8137.2001.00154.x; Szymanski DB, 1996, PLANT CELL, V8, P1069, DOI 10.1105/tpc.8.6.1069; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; VOGEL HJ, 1994, BIOCHEM CELL BIOL, V72, P357, DOI 10.1139/o94-049; Yanagisawa S, 1998, PLANT CELL, V10, P75, DOI 10.1105/tpc.10.1.75; Yanagisawa S, 2000, PLANT J, V21, P281, DOI 10.1046/j.1365-313x.2000.00685.x; Yang TB, 2000, J BIOL CHEM, V275, P38467, DOI 10.1074/jbc.M003566200; Zegzouti H, 1999, PLANT J, V18, P589, DOI 10.1046/j.1365-313x.1999.00483.x; ZHUANG SB, 1995, BIOCHEM BIOPH RES CO, V209, P12, DOI 10.1006/bbrc.1995.1463; Zik M, 1998, PLANT MOL BIOL, V37, P967, DOI 10.1023/A:1006047623263	60	202	235	4	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21851	21861		10.1074/jbc.M200268200	http://dx.doi.org/10.1074/jbc.M200268200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11925432	Green Published, hybrid			2022-12-27	WOS:000176286000095
J	Funahashi, J; Takano, K; Yamagata, Y; Yutani, K				Funahashi, J; Takano, K; Yamagata, Y; Yutani, K			Positive contribution of hydration structure on the surface of human lysozyme to the conformational stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAVITY-CREATING MUTATIONS; LOW-HUMIDITY VARIANT; X-RAY-ANALYSIS; STAPHYLOCOCCAL NUCLEASE; WATER-MOLECULES; LOW-TEMPERATURE; HYDROGEN-BONDS; AMINO-ACIDS; BIOLOGICAL MACROMOLECULES; HYDROPHOBIC RESIDUES	Water molecules make a hydration structure with the network of hydrogen bonds, covering on the surface of proteins. To quantitatively estimate the contribution of the hydration structure to protein stability, a series of hydrophilic mutant human lysozymes (Val to Ser, Tyr, Asp, Asn, and Arg) modified at three different positions on the surface, which are located in the a-helix (VaI-110), the beta-sheet (Val-2), and the loop (Val-74), were constructed. Their thermodynamic parameters of denaturation and crystal structures were examined by calorimetry and by x-ray crystallography at 100 K, respectively. The introduced polar residues made hydrogen bonds with protein atoms and/or water molecules, sometimes changing the hydration structure around the mutation site. Changes in the stability of the mutant proteins can be evaluated by a unique equation that considers the conformational changes resulting from the substitutions. Using this analysis, the relationship between the changes in the stabilities and the hydration structures for mutant human lysozymes substituted on the surface could be quantitatively estimated. The analysis indicated that the hydration structure on protein surface plays an important role in determining the conformational stability of the protein.	Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; Kumamoto Univ, Grad Sch Pharmaceut Sci, Kumamoto 8620973, Japan	Osaka University; Kumamoto University	Yutani, K (corresponding author), Osaka Univ, Inst Prot Res, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	yutani@protein.osaka-u.ac.jp	Yamagata, Yoshiki/T-6489-2019					Biswal BK, 2000, ACTA CRYSTALLOGR D, V56, P1110, DOI 10.1107/S0907444900008866; BRUNGER AT, 1992, XPLOR VERSION 3 1; BUCKLE AM, 1993, J MOL BIOL, V234, P847, DOI 10.1006/jmbi.1993.1630; BYRNE MP, 1995, BIOCHEMISTRY-US, V34, P13949, DOI 10.1021/bi00042a029; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Cordes MHJ, 1999, PROTEIN SCI, V8, P318; DOIG AJ, 1995, PROTEIN SCI, V4, P2247, DOI 10.1002/pro.5560041101; DOSTER W, 1986, BIOPHYS J, V50, P213, DOI 10.1016/S0006-3495(86)83455-5; DUNITZ JD, 1994, SCIENCE, V264, P670, DOI 10.1126/science.264.5159.670; EARNEST T, 1991, PROTEINS, V10, P171, DOI 10.1002/prot.340100303; EISENSTEIN M, 1988, ACTA CRYSTALLOGR B, V44, P625, DOI 10.1107/S0108768188004732; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; FERRAND M, 1993, P NATL ACAD SCI USA, V90, P9668, DOI 10.1073/pnas.90.20.9668; FINERMOORE JS, 1992, PROTEINS, V12, P203, DOI 10.1002/prot.340120302; Funahashi J, 1996, J BIOCHEM, V120, P1216; Funahashi J, 1999, PROTEIN ENG, V12, P841, DOI 10.1093/protein/12.10.841; Funahashi J, 2000, BIOCHEMISTRY-US, V39, P14448, DOI 10.1021/bi0015717; Garman EF, 1997, J APPL CRYSTALLOGR, V30, P211, DOI 10.1107/S0021889897002677; HAYWARD S, 1993, J MOL BIOL, V234, P100; HONIG BH, 1984, P NATL ACAD SCI-BIOL, V81, P5412, DOI 10.1073/pnas.81.17.5412; HOPE H, 1988, ACTA CRYSTALLOGR B, V44, P22, DOI 10.1107/S0108768187008632; HOPE H, 1990, ANNU REV BIOPHYS BIO, V19, P107; JACKSON SE, 1993, BIOCHEMISTRY-US, V32, P11259, DOI 10.1021/bi00093a001; JOHNSON CK, 1976, ORTEP2; KELLIS JT, 1989, BIOCHEMISTRY-US, V28, P4914, DOI 10.1021/bi00437a058; Koehl P, 1999, P NATL ACAD SCI USA, V96, P12524, DOI 10.1073/pnas.96.22.12524; LEVITT M, 1993, STRUCTURE, V1, P223, DOI 10.1016/0969-2126(93)90011-5; LONCHARICH RJ, 1990, J MOL BIOL, V215, P439, DOI 10.1016/S0022-2836(05)80363-8; Myers JK, 1996, BIOPHYS J, V71, P2033, DOI 10.1016/S0006-3495(96)79401-8; Nagata C, 1996, ACTA CRYSTALLOGR D, V52, P623, DOI 10.1107/S0907444995016623; Nakasako M, 1999, J MOL BIOL, V289, P547, DOI 10.1006/jmbi.1999.2795; Otwinowski Z., 1990, DENZO DATA PROCESSIN; Pace CN, 1996, FASEB J, V10, P75, DOI 10.1096/fasebj.10.1.8566551; PACE CN, 1992, J MOL BIOL, V226, P29, DOI 10.1016/0022-2836(92)90121-Y; PARRY RM, 1969, ARCH BIOCHEM BIOPHYS, V130, P59, DOI 10.1016/0003-9861(69)90009-5; Perl D, 2000, NAT STRUCT BIOL, V7, P380; PRIVALOV PL, 1974, J MOL BIOL, V86, P665, DOI 10.1016/0022-2836(74)90188-0; RUPLEY JA, 1991, ADV PROTEIN CHEM, V41, P37; SAENGER W, 1987, ANNU REV BIOPHYS BIO, V16, P93; Schwehm JM, 1998, BIOCHEMISTRY-US, V37, P6939, DOI 10.1021/bi9725069; SERRANO L, 1992, J MOL BIOL, V224, P783, DOI 10.1016/0022-2836(92)90562-X; SHIRLEY BA, 1992, BIOCHEMISTRY-US, V31, P725, DOI 10.1021/bi00118a013; SHORTLE D, 1990, BIOCHEMISTRY-US, V29, P8033, DOI 10.1021/bi00487a007; Sukumar N, 1999, ACTA CRYSTALLOGR D, V55, P934, DOI 10.1107/S0907444998015522; TAKANO K, 1995, J MOL BIOL, V254, P62, DOI 10.1006/jmbi.1995.0599; Takano K, 1997, J MOL BIOL, V274, P132, DOI 10.1006/jmbi.1997.1365; Takano K, 1998, J MOL BIOL, V280, P749, DOI 10.1006/jmbi.1998.1906; Takano K, 1999, BIOCHEMISTRY-US, V38, P12698, DOI 10.1021/bi9910169; Takano K, 1997, BIOCHEMISTRY-US, V36, P688, DOI 10.1021/bi9621829; Takano K, 1999, BIOCHEMISTRY-US, V38, P6623, DOI 10.1021/bi9901228; Takano K, 1999, PROTEIN ENG, V12, P663, DOI 10.1093/protein/12.8.663; TEETER MM, 1991, ANNU REV BIOPHYS BIO, V20, P577, DOI 10.1146/annurev.bb.20.060191.003045; WETLAUFER DB, 1962, ADV PROTEIN CHEM, V17, P303; Xu JA, 1998, PROTEIN SCI, V7, P158, DOI 10.1002/pro.5560070117; Yamagata Y, 1998, BIOCHEMISTRY-US, V37, P9355, DOI 10.1021/bi980431i; YU MH, 1995, J MOL BIOL, V249, P388, DOI 10.1006/jmbi.1995.0304; Yutani K, 1999, INT CONGR SER, V1194, P175	58	18	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21792	21800		10.1074/jbc.M110728200	http://dx.doi.org/10.1074/jbc.M110728200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11927576	hybrid			2022-12-27	WOS:000176286000088
J	Ghosh, SK; Gadiparthi, L; Zeng, ZZ; Bhanoori, M; Tellez, C; Bar-Eli, M; Rao, GN				Ghosh, SK; Gadiparthi, L; Zeng, ZZ; Bhanoori, M; Tellez, C; Bar-Eli, M; Rao, GN			ATF-1 mediates protease-activated receptor-1 but not receptor tyrosine kinase-induced DNA synthesis in vascular smooth muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; GENE-EXPRESSION; GROWTH-FACTOR; MAP KINASE; C-JUN; HUMAN KERATINOCYTES; RESPONSE ELEMENT; HUMAN-MELANOMA; MITOGEN; PROLIFERATION	Previously we have demonstrated that activation of p38 mitogen-activated protein kinase (MAPK) and induction of DNA synthesis in response to receptor tyrosine kinase (RTK) and G protein-coupled receptor (GPCR) agonists require NADH/NADPH-like oxidase activity in vascular smooth muscle cells (VSMC). Here we tested the role of p38 MAPK in RTK and GPCR agonist-induced DNA synthesis in VSMC. Platelet-derived growth factor (PDGF)-BB and thrombin (RTK and GPCR agonists, respectively) activated p38 MAPK in a time-dependent manner in VSMC. Inhibition of p38 MAPK led to a 50% decrease in the DNA synthesis induced by thrombin but not PDGF-BB. ATF-1 was found to be the predominant member of the cyclic AMP response element (CRE)-DNA complex formed in VSMC in response to PDGF-BB and thrombin, and both agonists induced its phosphorylation. Regardless of this, inhibition of p38 MAPK reduced only thrombin- but not PDGF-BB-induced ATF-1 phosphorylation. Similarly, inhibition of p38 MAPK caused a 50% decrease in thrombin-but not PDGF-BB-induced CRE promoter-dependent transcription. Ectopic expression of an inhibitory anti-ATF-1 single-chain antibody fragment, ScFv, significantly interfered with DNA synthesis induced by thrombin but not PDGF-BB. Together, these results suggest the following conclusions. 1) Both RTK and GPCR agonists activate p38 MAPK and induce CRE promoter-dependent transcription; 2) both RTK and GPCR agonists induce ATF-1 phosphorylation, and ATF-1 is a predominant member in the CRE-DNA complexes formed in response to these agents; and 3) p38 MAPK-dependent ATF-1 phosphorylation and CRE promoter-mediated transcription are associated with GPCR agonist-induced VSMC growth.	Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA; Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Texas System; UTMD Anderson Cancer Center	Rao, GN (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.		Bhanoori, Manjula/ACH-9333-2022					Balmanno K, 1999, ONCOGENE, V18, P3085, DOI 10.1038/sj.onc.1202647; Bar-Eli M, 2001, PIGM CELL RES, V14, P78, DOI 10.1034/j.1600-0749.2001.140202.x; BOHM M, 1995, CELL GROWTH DIFFER, V6, P291; Bosilevac JM, 1999, J BIOL CHEM, V274, P34811, DOI 10.1074/jbc.274.49.34811; Burns CJ, 2000, BIOCHEM BIOPH RES CO, V268, P541, DOI 10.1006/bbrc.2000.2179; Chai YC, 1996, J BIOL CHEM, V271, P17791, DOI 10.1074/jbc.271.30.17791; CHAIKOF EL, 1995, J BIOL CHEM, V270, P7431, DOI 10.1074/jbc.270.13.7431; Chen WX, 1999, ONCOGENE, V18, P7469, DOI 10.1038/sj.onc.1203210; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; De Graeve F, 1999, ONCOGENE, V18, P3491, DOI 10.1038/sj.onc.1202723; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; EDELMAN ER, 1995, CIRC RES, V76, P176, DOI 10.1161/01.RES.76.2.176; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Janknecht R, 1997, EMBO J, V16, P1620, DOI 10.1093/emboj/16.7.1620; Jean D, 1998, J BIOL CHEM, V273, P24884, DOI 10.1074/jbc.273.38.24884; Jean D, 2000, ONCOGENE, V19, P2721, DOI 10.1038/sj.onc.1203569; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kawata Y, 1998, J BIOL CHEM, V273, P16905, DOI 10.1074/jbc.273.27.16905; Klemm DJ, 2001, J BIOL CHEM, V276, P46132, DOI 10.1074/jbc.M104769200; KUMAR S, 1995, J BIOL CHEM, V270, P29043, DOI 10.1074/jbc.270.49.29043; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; LANSCHULZ WH, 1988, SCIENCE, V240, P1759; LaVallee TM, 1998, J CELL BIOL, V141, P1647, DOI 10.1083/jcb.141.7.1647; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; LIBBY P, 1988, NEW ENGL J MED, V318, P1493, DOI 10.1056/NEJM198806093182303; LINDNER V, 1991, P NATL ACAD SCI USA, V88, P3739, DOI 10.1073/pnas.88.9.3739; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MCNAMARA CA, 1993, J CLIN INVEST, V91, P94, DOI 10.1172/JCI116206; Miao RQ, 2000, CIRC RES, V86, P418, DOI 10.1161/01.RES.86.4.418; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; Nierodzik ML, 1998, BLOOD, V92, P3694, DOI 10.1182/blood.V92.10.3694.422k40_3694_3700; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; RAO GN, 1992, CIRC RES, V70, P593, DOI 10.1161/01.RES.70.3.593; RAO GN, 1995, J CLIN INVEST, V96, P842, DOI 10.1172/JCI118130; Rao GN, 1999, J BIOL CHEM, V274, P6003, DOI 10.1074/jbc.274.9.6003; Reddy MA, 2002, J BIOL CHEM, V277, P9920, DOI 10.1074/jbc.M111305200; Rolli M, 1999, J BIOL CHEM, V274, P19559, DOI 10.1074/jbc.274.28.19559; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Tang QB, 2001, ONCOGENE, V20, P5164, DOI 10.1038/sj.onc.1204667; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; WILCOX JN, 1988, J CLIN INVEST, V82, P1134, DOI 10.1172/JCI113671; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Zechner D, 1997, J CELL BIOL, V139, P115, DOI 10.1083/jcb.139.1.115	47	17	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21325	21331		10.1074/jbc.M201608200	http://dx.doi.org/10.1074/jbc.M201608200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11925444	hybrid			2022-12-27	WOS:000176286000028
J	Hall, DR; Bond, CS; Leonard, GA; Watt, I; Berry, A; Hunter, WN				Hall, DR; Bond, CS; Leonard, GA; Watt, I; Berry, A; Hunter, WN			Structure of tagatose-1,6-bisphosphate aldolase - Insight into chiral discrimination, mechanism, and specificity of class II aldolases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE; CRYSTAL-STRUCTURE; ACTIVE-SITE; BINDING; PROGRAM; PHOSPHOGLYCOLOHYDROXAMATE; DIHYDROXYACETONE; COMPLEX	Tagatose-1,6-bisphosphate aldolase (TBPA) is a tetrameric class II aldolase that catalyzes the reversible condensation of dihydroxyacetone phosphate with glyceraldehyde 3-phosphate to produce tagatose 1,6-bisphosphate. The high resolution (1.45 Angstrom) crystal structure of the Escherichia coli enzyme, encoded by the agaY gene, complexed with phosphoglycolohydroxamate (PGH) has been determined. Two subunits comprise the asymmetric unit, and a crystallographic 2-fold axis generates the functional tetramer. A complex network of hydrogen bonds position side chains in the active site that is occupied by two cations. An unusual Na+ binding site is created using a pi interaction with Tyr(183) in addition to five oxygen ligands. The catalytic Zn2+ is five-coordinate using three histidine nitrogens and two PGH oxygens. Comparisons of TBPA with the related fructose-1,6-bisphosphate aldolase (FBPA) identifies common features with implications for the mechanism. Because the major product of the condensation catalyzed by the enzymes differs in the chirality at a single position, models of FBPA and TBPA with their cognate bisphosphate products provide insight into chiral discrimination by these aldolases. The TBPA active site is more open on one side than FBPA, and this contributes to a less specific enzyme. The availability of more space and a wider range of aldehyde partners used by TBPA together with the highly specific nature of FBPA suggest that TBPA might be a preferred enzyme to modify for use in biotransformation chemistry.	Univ Dundee, Sch Life Sci, Div Biol Chem & Mol Microbiol, Dundee DD1 5EH, Scotland; European Synchrotron Radiat Facil, Joint Struct Biol Grp, F-38043 Grenoble, France; Univ Manchester, Dept Chem, Manchester M13 9PL, Lancs, England; Univ Leeds, Sch Biochem & Mol Biol, Leeds LS2 9JT, W Yorkshire, England	University of Dundee; European Synchrotron Radiation Facility (ESRF); University of Manchester; University of Leeds	Hunter, WN (corresponding author), Univ Dundee, Sch Life Sci, Div Biol Chem & Mol Microbiol, Dundee DD1 5EH, Scotland.	w.n.hunter@dundee.ac.uk	Bond, Charles S/B-4094-2011; Bond, Charles/AAF-9608-2020; Leonard, Gordon/D-2160-2019; Hunter, William/AAE-3947-2019	Bond, Charles S/0000-0002-9584-6783; Bond, Charles/0000-0002-9584-6783; Leonard, Gordon/0000-0001-5030-0122; Berry, Alan/0000-0003-3502-0426; Hall, David/0000-0002-5333-6136				ANASTASSIS P, 1999, NAT STRUCT BIOL, V7, P458; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Blom N, 1997, NAT STRUCT BIOL, V4, P36, DOI 10.1038/nsb0197-36; Blom NS, 1996, NAT STRUCT BIOL, V3, P856, DOI 10.1038/nsb1096-856; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chevrier B, 1996, EUR J BIOCHEM, V237, P393, DOI 10.1111/j.1432-1033.1996.0393k.x; COLLINS KD, 1974, J BIOL CHEM, V249, P136; Cooper SJ, 1996, STRUCTURE, V4, P1303, DOI 10.1016/S0969-2126(96)00138-4; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Erion MD, 1998, J AM CHEM SOC, V120, P3295, DOI 10.1021/ja972906j; Gefflaut T, 1995, PROG BIOPHYS MOL BIO, V63, P301, DOI 10.1016/0079-6107(95)00008-9; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Hall DR, 1999, J MOL BIOL, V287, P383, DOI 10.1006/jmbi.1999.2609; Heine A, 2001, SCIENCE, V294, P369, DOI 10.1126/science.1063601; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Marrs B, 1999, CURR OPIN MICROBIOL, V2, P241, DOI 10.1016/S1369-5274(99)80042-3; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Plater AR, 1999, J MOL BIOL, V285, P843, DOI 10.1006/jmbi.1998.2376; Qamar S, 1996, PROTEIN SCI, V5, P154; Reizer J, 1996, MICROBIOL-SGM, V142, P231, DOI 10.1099/13500872-142-2-231; Schoevaart R, 2001, J ORG CHEM, V66, P4559, DOI 10.1021/jo001766k; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Takayama S, 1997, ANNU REV MICROBIOL, V51, P285, DOI 10.1146/annurev.micro.51.1.285; vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047; VONDEROSTEN CH, 1989, J AM CHEM SOC, V111, P3924, DOI 10.1021/ja00193a025; WONG CH, 1995, TETRAHEDRON ORGANIC, V12; Wouters J, 1998, PROTEIN SCI, V7, P2472, DOI 10.1002/pro.5560071127; Zgiby S, 2002, J MOL BIOL, V315, P131, DOI 10.1006/jmbi.2001.5237; Zgiby SM, 2000, EUR J BIOCHEM, V267, P1858, DOI 10.1046/j.1432-1327.2000.01191.x	35	50	52	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					22018	22024		10.1074/jbc.M202464200	http://dx.doi.org/10.1074/jbc.M202464200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11940603	hybrid, Green Published			2022-12-27	WOS:000176286000114
J	Saez-Cirion, A; Nir, S; Lorizate, M; Agirre, A; Cruz, A; Perez-Gil, J; Nieva, JL				Saez-Cirion, A; Nir, S; Lorizate, M; Agirre, A; Cruz, A; Perez-Gil, J; Nieva, JL			Sphingomyelin and cholesterol promote HIV-1 gp41 pretransmembrane sequence surface aggregation and membrane restructuring	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 ENVELOPE GLYCOPROTEIN; SPIN-LABEL ESR; MEDIATED FUSION; PORE FORMATION; INFLUENZA HEMAGGLUTININ; LIPID-COMPOSITION; MIXED MEMBRANES; PEPTIDE; VESICLES	The interfacial sequence DKWASLWNWFNITNWLWYIK, preceding the transmembrane anchor of gp41 glycoprotein subunit, has been shown to be essential for fusion activity and incorporation into virions. HIVc, a peptide representing this region, formed lytic pores in liposomes composed of the main lipids occurring in the human immunodeficiency virus, type 1 (HIV-1), envelope, i.e. 1-palmitoyl-2-oleoylphosphatidylcholine (POPC):sphingomyelin (SPM):cholesterol (Chol) (1:1:1 mole ratio), at low (>1:10,000) peptide-to-lipid mole ratio, and promoted the mixing of vesicular lipids at >1: 1000 peptide-to-lipid mole ratios. Inclusion of SPM or Chol in POPC membranes had different effects. Whereas SPM sustained pore formation, Chol promoted fusion activity. Even if partitioning into membranes was not affected in the absence of both SPM and Chol, HIVc had virtually no effect on POPC vesicles. Condition; described to disturb occurrence of lateral separation of phases in these systems reproduced the high peptide-dose requirements for leakage as found in pure POPC vesicles and inhibited fusion. Surface aggregation assays using rhodamine-labeled peptides demonstrated that SPM and Chol promoted HIVc self-aggregation in membranes. Employing head-group fluorescent phospholipid analogs in planar supported lipid layers, we were able to discern HIVc clusters associated to ordered domains. Our results support the notion that the pre-transmembrane sequence may participate in the clustering of gp41 monomers within the HIV-1 envelope, and in bilayer architecture destabilization at the loci of fusion.	Univ Basque Country, CSIC, Unidad Biofis, E-48080 Bilbao, Spain; Univ Basque Country, Dept Bioquim, E-48080 Bilbao, Spain; Hebrew Univ Jerusalem, Fac Agr Food & Environm Qual Sci, Seagram Ctr Soil & Water Sci, IL-76100 Rehovot, Israel; Univ Complutense Madrid, Fac Biol, Dept Bioquim & Biol Mol 1, E-28040 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; Hebrew University of Jerusalem; Complutense University of Madrid	Nieva, JL (corresponding author), Univ Basque Country, CSIC, Unidad Biofis, Apartado 644, E-48080 Bilbao, Spain.	gbpniesj@lg.ehu.es	Cruz, Antonio/H-2881-2015; Perez-Gil, Jesus/H-3102-2019; Nieva, Jose L/Q-2063-2019; Saez-Cirion, Asier/A-8640-2008; Lorizate, Maier/S-1151-2018	Cruz, Antonio/0000-0002-0465-4111; Perez-Gil, Jesus/0000-0003-3587-7147; Nieva, Jose L/0000-0001-6446-5649; Saez-Cirion, Asier/0000-0003-2406-7536; Lorizate, Maier/0000-0001-8173-2788				Ahmed SN, 1997, BIOCHEMISTRY-US, V36, P10944, DOI 10.1021/bi971167g; ALOIA RC, 1988, P NATL ACAD SCI USA, V85, P900, DOI 10.1073/pnas.85.3.900; ALOIA RC, 1993, P NATL ACAD SCI USA, V90, P5181, DOI 10.1073/pnas.90.11.5181; ARRONDO JLR, 1989, FEBS LETT, V252, P118, DOI 10.1016/0014-5793(89)80901-9; Ben-Efraim I, 1999, J MOL BIOL, V285, P609, DOI 10.1006/jmbi.1998.2370; Bentz J, 2000, BIOPHYS J, V78, P886, DOI 10.1016/S0006-3495(00)76646-X; BOETTCHER C, 1961, ANAL CHIM ACTA, V24, P203, DOI 10.1016/0003-2670(61)80041-X; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; Caaveiro JMM, 2001, BIOPHYS J, V80, P1343, DOI 10.1016/S0006-3495(01)76107-3; Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369; CHERNOMORDIK LV, 1995, CURR OPIN STRUC BIOL, V5, P541, DOI 10.1016/0959-440X(95)80041-7; Cruz A, 2000, EUR BIOPHYS J BIOPHY, V29, P204, DOI 10.1007/PL00006647; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Dimitrov AS, 2001, J BIOL CHEM, V276, P30335, DOI 10.1074/jbc.M103788200; Doms RW, 2000, J CELL BIOL, V151, pF9, DOI 10.1083/jcb.151.2.F9; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; ELLENS H, 1985, BIOCHEMISTRY-US, V24, P3099, DOI 10.1021/bi00334a005; Gorny MK, 2000, J VIROL, V74, P6186, DOI 10.1128/JVI.74.13.6186-6192.2000; HOEKSTRA D, 1984, BIOCHEMISTRY-US, V23, P5675, DOI 10.1021/bi00319a002; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; Kliger Y, 2001, J BIOL CHEM, V276, P1391, DOI 10.1074/jbc.M004113200; Kozlov MM, 1998, BIOPHYS J, V75, P1384, DOI 10.1016/S0006-3495(98)74056-1; Kuzmin PI, 2001, P NATL ACAD SCI USA, V98, P7235, DOI 10.1073/pnas.121191898; Liao ZH, 2001, AIDS RES HUM RETROV, V17, P1009, DOI 10.1089/088922201300343690; Maget-Dana R, 1999, BBA-BIOMEMBRANES, V1462, P109, DOI 10.1016/S0005-2736(99)00203-5; Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3; MATEO CR, 1995, BIOPHYS J, V68, P978, DOI 10.1016/S0006-3495(95)80273-0; Milhiet PE, 2001, BIOPHYS J, V81, P547, DOI 10.1016/S0006-3495(01)75721-9; Munoz-Barroso I, 1998, J CELL BIOL, V140, P315, DOI 10.1083/jcb.140.2.315; Munoz-Barroso I, 1999, J VIROL, V73, P6089; Nguyen DH, 2000, J VIROL, V74, P3264, DOI 10.1128/JVI.74.7.3264-3272.2000; Nicol F, 1996, BIOPHYS J, V71, P3288, DOI 10.1016/S0006-3495(96)79521-8; Nicol F, 1999, BIOPHYS J, V76, P2121, DOI 10.1016/S0006-3495(99)77368-6; Nicol F, 2000, BIOPHYS J, V78, P818, DOI 10.1016/S0006-3495(00)76639-2; NIEVA JL, 1994, BIOCHEMISTRY-US, V33, P3201, DOI 10.1021/bi00177a009; NIEVA JL, 1994, EMBO J, V13, P2797, DOI 10.1002/j.1460-2075.1994.tb06573.x; Nir S, 2000, PROG LIPID RES, V39, P181, DOI 10.1016/S0163-7827(00)00004-7; PARENTE RA, 1990, BIOCHEMISTRY-US, V29, P8720, DOI 10.1021/bi00489a031; Parker CE, 2001, J VIROL, V75, P10906, DOI 10.1128/JVI.75.22.10906-10911.2001; Patra SK, 1999, J LIPOSOME RES, V9, P247, DOI 10.3109/08982109909024788; RAPAPORT D, 1991, J BIOL CHEM, V266, P23769; Rapaport D, 1996, BIOPHYS J, V70, P2502, DOI 10.1016/S0006-3495(96)79822-3; Raulin J, 2002, PROG LIPID RES, V41, P27, DOI 10.1016/S0163-7827(01)00019-4; Razinkov VI, 1998, J GEN PHYSIOL, V112, P409, DOI 10.1085/jgp.112.4.409; Rietveld A, 1998, BBA-REV BIOMEMBRANES, V1376, P467, DOI 10.1016/S0304-4157(98)00019-7; Ruano MLF, 1998, BIOPHYS J, V74, P1101, DOI 10.1016/S0006-3495(98)77828-2; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; SARIN PS, 1985, NEW ENGL J MED, V313, P1289, DOI 10.1056/NEJM198511143132011; SCHAFFNER CP, 1986, BIOCHEM PHARMACOL, V35, P4110, DOI 10.1016/0006-2952(86)90037-7; Schibli DJ, 2001, BIOCHEMISTRY-US, V40, P9570, DOI 10.1021/bi010640u; Schroeder RJ, 1998, J BIOL CHEM, V273, P1150, DOI 10.1074/jbc.273.2.1150; SHAI Y, 1995, TRENDS BIOCHEM SCI, V20, P460, DOI 10.1016/S0968-0004(00)89101-X; Siegel DP, 1997, BIOPHYS J, V73, P3089, DOI 10.1016/S0006-3495(97)78336-X; Silvius JR, 1996, BIOCHEMISTRY-US, V35, P15198, DOI 10.1021/bi9615506; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Suarez T, 2000, FEBS LETT, V477, P145, DOI 10.1016/S0014-5793(00)01785-3; Suarez T, 2000, J VIROL, V74, P8038, DOI 10.1128/JVI.74.17.8038-8047.2000; TILCOCK CPS, 1982, BIOCHEMISTRY-US, V21, P4596, DOI 10.1021/bi00262a013; Veiga MP, 2000, BIOCHEMISTRY-US, V39, P9876, DOI 10.1021/bi000678r; Veiga MP, 2001, BIOCHEMISTRY-US, V40, P2614, DOI 10.1021/bi0019803; White SH, 1998, METHOD ENZYMOL, V295, P62; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wimley WC, 2000, BIOCHEMISTRY-US, V39, P4432, DOI 10.1021/bi992746j; Xu XL, 2000, BIOCHEMISTRY-US, V39, P843, DOI 10.1021/bi992543v; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	67	106	109	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21776	21785		10.1074/jbc.M202255200	http://dx.doi.org/10.1074/jbc.M202255200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11929877	hybrid			2022-12-27	WOS:000176286000086
J	Das Sarma, J; Wang, FS; Koval, M				Das Sarma, J; Wang, FS; Koval, M			Targeted gap junction protein constructs reveal connexin-specific differences in oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-FREE SYNTHESIS; ENDOPLASMIC-RETICULUM; INTRACELLULAR-TRANSPORT; KIN RECOGNITION; PLASMA-MEMBRANE; QUALITY-CONTROL; INTERCELLULAR COMMUNICATION; SECRETORY PATHWAY; GOLGI-APPARATUS; BREFELDIN-A	To define further the mechanisms of gap junction protein (connexin (Cx)) oligomerization without pharmacologic disruption, we have examined the transport and assembly of connexin constructs containing C-terminal di-lysine-based endoplasmic reticulum (ER) (HKKSL) or ER-Golgi intermediate compartment (AKKFF) targeting sequences. By immunofluorescence microscopy, Cx43-HKKSL transiently transfected into HeLa cells showed a predominantly ER localization, although Cx43-AKYFF was localized to the perinuclear region of the cell. Sucrose gradient analysis of Triton X-100-solubilized connexins showed that either Cx43-HKKSL or Cx43-AKKFF expressed alone by HeLa cells was maintained as an apparent monomer. In contrast to Cx43-HKKSL, Cx32-HKKSL was maintained in the ER as stable hexamers, consistent with the notion that Cx32 and Cx43 oligomerization occur in distinct intracellular compartments. Furthermore, Cx43-HKKSL and Cx43-AKKFF inhibited trafficking of Cx43 and Cx46 to the plasma membrane. The inhibitory effect was because of the formation of mixed oligomers between Cx43-HKKSL or Cx43-AKKF and wild type Cx43 or Cx46. Taken together, these results suggest that Cx43-HKKSL and Cx43-AKKFF recirculate through compartments where oligomerization occurs and may be maintained as apparent monomers by a putative Cx43-specific quality control mechanism.	Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; Inst Environm Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Koval, M (corresponding author), Univ Penn, Sch Med, Dept Physiol, B-400 Richards Bldg,6085,3700 Hamilton Walk, Philadelphia, PA 19104 USA.	mkoval@mail.med.upenn.edu	Koval, Michael/C-6366-2015; Sarma, Jayasri Das/AAS-3837-2020	Koval, Michael/0000-0002-5422-5614; 	NIGMS NIH HHS [GM61012, R01 GM061012, R01 GM061012-03] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061012] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham V, 1999, AM J PHYSIOL-LUNG C, V276, pL825, DOI 10.1152/ajplung.1999.276.5.L825; Ahmad S, 1999, BIOCHEM J, V339, P247, DOI 10.1042/0264-6021:3390247; Ahmad S, 1998, BIOCHEM SOC T, V26, pS304, DOI 10.1042/bst026s304; Andersson H, 1999, J BIOL CHEM, V274, P15080, DOI 10.1074/jbc.274.21.15080; Berthoud VM, 2001, EUR J CELL BIOL, V80, P11, DOI 10.1078/0171-9335-00132; Caldwell SR, 2001, J BIOL CHEM, V276, P23296, DOI 10.1074/jbc.M102962200; CIVITELLI R, 1993, J CLIN INVEST, V91, P1888, DOI 10.1172/JCI116406; Cosson P, 1995, COLD SPRING HARB SYM, V60, P113, DOI 10.1101/SQB.1995.060.01.014; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; CROW DS, 1990, MOL CELL BIOL, V10, P1754, DOI 10.1128/MCB.10.4.1754; Cruciani V, 1999, EXP CELL RES, V251, P285, DOI 10.1006/excr.1999.4574; Das Sarma J, 2001, J CELL SCI, V114, P4013; Diez JA, 1999, EUR J BIOCHEM, V262, P142, DOI 10.1046/j.1432-1327.1999.00343.x; Dogic D, 2001, EUR J CELL BIOL, V80, P151, DOI 10.1078/0171-9335-00145; Falk MM, 1997, EMBO J, V16, P2703, DOI 10.1093/emboj/16.10.2703; FALK MM, 1994, J CELL BIOL, V127, P343, DOI 10.1083/jcb.127.2.343; George CH, 1999, J BIOL CHEM, V274, P8678, DOI 10.1074/jbc.274.13.8678; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41; Hauri HP, 2000, J CELL SCI, V113, P587; Jordan K, 1999, MOL BIOL CELL, V10, P2033, DOI 10.1091/mbc.10.6.2033; Jordan K, 2001, J CELL SCI, V114, P763; Kamhi-Nesher S, 2001, MOL BIOL CELL, V12, P1711, DOI 10.1091/mbc.12.6.1711; Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801; Kelsell DP, 2001, TRENDS CELL BIOL, V11, P2, DOI 10.1016/S0962-8924(00)01866-3; KOVAL M, 1995, J CELL BIOL, V130, P987, DOI 10.1083/jcb.130.4.987; Koval M, 1997, J CELL BIOL, V137, P847, DOI 10.1083/jcb.137.4.847; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; KUMAR NM, 1995, J CELL SCI, V108, P3725; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; LAIRD DW, 1995, J CELL BIOL, V131, P1193, DOI 10.1083/jcb.131.5.1193; Lauf U, 2001, FEBS LETT, V498, P11, DOI 10.1016/S0014-5793(01)02462-0; LETOURNEUR F, 1995, J CELL BIOL, V129, P971, DOI 10.1083/jcb.129.4.971; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Marsh BJ, 2001, P NATL ACAD SCI USA, V98, P2399, DOI 10.1073/pnas.051631998; Martin PEM, 1998, J BIOL CHEM, V273, P1719, DOI 10.1074/jbc.273.3.1719; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; Musil LS, 1990, CURR OPIN CELL BIOL, V2, P875, DOI 10.1016/0955-0674(90)90086-T; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; MUSIL LS, 1993, CELL, V74, P1065, DOI 10.1016/0092-8674(93)90728-9; NILSSON T, 1994, EMBO J, V13, P562, DOI 10.1002/j.1460-2075.1994.tb06294.x; Nilsson T, 1996, J CELL SCI, V109, P1975; NILSSON T, 1993, FEBS LETT, V330, P1, DOI 10.1016/0014-5793(93)80906-B; Paulson AF, 2000, J CELL SCI, V113, P3037; PELHAM HRB, 1995, CURR OPIN CELL BIOL, V7, P530, DOI 10.1016/0955-0674(95)80010-7; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; PURANAM KL, 1993, EXP CELL RES, V206, P85, DOI 10.1006/excr.1993.1123; Simon AM, 1998, TRENDS CELL BIOL, V8, P477, DOI 10.1016/S0962-8924(98)01372-5; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; VanSlyke JK, 2002, J CELL BIOL, V157, P381, DOI 10.1083/jcb.200111045; Vanslyke JK, 2000, MOL BIOL CELL, V11, P1933, DOI 10.1091/mbc.11.6.1933; VanSlyke JK, 2000, METHODS, V20, P156, DOI 10.1006/meth.1999.0933; WEISZ OA, 1993, J CELL BIOL, V122, P1185, DOI 10.1083/jcb.122.6.1185; Yeager M, 1998, CURR OPIN STRUC BIOL, V8, P517, DOI 10.1016/S0959-440X(98)80131-0; Zhang JT, 1996, MOL BIOL CELL, V7, P471, DOI 10.1091/mbc.7.3.471	55	68	70	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20911	20918		10.1074/jbc.M111498200	http://dx.doi.org/10.1074/jbc.M111498200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11929864	hybrid			2022-12-27	WOS:000176204500104
J	Huang, KJ; Zemelman, BV; Lehman, IR				Huang, KJ; Zemelman, BV; Lehman, IR			Endonuclease G, a candidate human enzyme for the initiation of genomic inversion in herpes simplex type 1 virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRAL-DNA REPLICATION; A-SEQUENCES; STRUCTURAL FEATURES; RECOMBINATION; MITOCHONDRIA; SEGMENT; SITE; AMPLIFICATION; SPECIFICITY; COMPONENTS	The herpes simplex virus type 1 (HSV-1) a sequence is present as a direct repeat at the two termini of the 152-kilobase viral genome and as an inverted repeat at the junction of the two unique components L and S. During replication, the HSV-1 genome undergoes inversion of L and S, producing an equimolar mixture of the four possible isomers. Isomerization is believed to result from recombination triggered by breakage at the a sequence, a recombinational hot spot. We have identified an enzyme in HeLa cell extracts that preferentially cleaves the a sequence and have purified it to near homogeneity. Microsequencing showed it to be human endonuclease G, an enzyme with a strong preference for G+C-rich sequences. Endonuclease G appears to be the only cellular enzyme that can specifically cleave the a sequence. Endonuclease G also showed the predicted recombination properties in an in vitro recombination assay. Based on these findings, we propose that endonuclease G initiates the a sequence-mediated inversion of the L and S components during HSV-1 DNA replication.	Stanford Univ, Dept Biochem, Beckman Ctr, Stanford, CA 94305 USA	Stanford University	Lehman, IR (corresponding author), Stanford Univ, Dept Biochem, Beckman Ctr, Stanford, CA 94305 USA.			Zemelman, Boris/0000-0003-2463-4887	NIAID NIH HHS [AI20538] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bataille D, 1997, J VIROL, V71, P7736, DOI 10.1128/JVI.71.10.7736-7743.1997; BRUCKNER RC, 1992, P NATL ACAD SCI USA, V89, P10950, DOI 10.1073/pnas.89.22.10950; COTE J, 1993, SCIENCE, V261, P765, DOI 10.1126/science.7688144; COTE J, 1989, J BIOL CHEM, V264, P3301; DAVISON AJ, 1981, J GEN VIROL, V55, P315, DOI 10.1099/0022-1317-55-2-315; DEISS LP, 1986, J VIROL, V59, P605, DOI 10.1128/JVI.59.3.605-618.1986; DELIUS H, 1976, Journal of General Virology, V33, P125, DOI 10.1099/0022-1317-33-1-125; DUTCH RE, 1992, J VIROL, V66, P277, DOI 10.1128/JVI.66.1.277-285.1992; DUTCH RE, 1994, J VIROL, V68, P3733, DOI 10.1128/JVI.68.6.3733-3741.1994; DUTCH RE, 1995, J VIROL, V69, P3084, DOI 10.1128/JVI.69.5.3084-3089.1995; GERSCHENSON M, 1995, NUCLEIC ACIDS RES, V23, P88, DOI 10.1093/nar/23.1.88; GOTTLIEB J, 1990, J BIOL CHEM, V265, P10842; HARLOW E, 1999, USING ANTIBODIES LAB, P311; HAYWARD GS, 1975, P NATL ACAD SCI USA, V72, P4243, DOI 10.1073/pnas.72.11.4243; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Ikeda S, 1997, ACTA MED OKAYAMA, V51, P55; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Martin DW, 1996, J VIROL, V70, P8801, DOI 10.1128/JVI.70.12.8801-8812.1996; Martinez R, 1996, J VIROL, V70, P2075, DOI 10.1128/JVI.70.4.2075-2085.1996; MOCARSKI ES, 1982, P NATL ACAD SCI-BIOL, V79, P5626, DOI 10.1073/pnas.79.18.5626; MOCARSKI ES, 1981, P NATL ACAD SCI-BIOL, V78, P7047, DOI 10.1073/pnas.78.11.7047; MOCARSKI ES, 1985, J VIROL, V55, P140, DOI 10.1128/JVI.55.1.140-146.1985; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; PATTON JG, 1991, GENE DEV, V5, P1237, DOI 10.1101/gad.5.7.1237; ROIZMAN B, 2001, FIELDS VIROLOGY, V2, P2399; RUIZCARRILLO A, 1987, EMBO J, V6, P401, DOI 10.1002/j.1460-2075.1987.tb04769.x; Sambrook J., 2002, MOL CLONING LAB MANU; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Umene K, 1999, REV MED VIROL, V9, P171, DOI 10.1002/(SICI)1099-1654(199907/09)9:3&lt;171::AID-RMV243&gt;3.0.CO;2-A; UMENE K, 1991, J VIROL, V65, P5410, DOI 10.1128/JVI.65.10.5410-5416.1991; WEBER PC, 1988, CELL, V54, P369, DOI 10.1016/0092-8674(88)90200-0; Widlak P, 2001, J BIOL CHEM, V276, P48404, DOI 10.1074/jbc.M108461200; WOHLRAB F, 1991, P NATL ACAD SCI USA, V88, P6432, DOI 10.1073/pnas.88.15.6432; WOHLRAB F, 1987, J BIOL CHEM, V262, P6407; ZEMELMAN BV, 1997, THESIS STANFORD U; ZHANG X, 1994, VIROLOGY, V202, P530, DOI 10.1006/viro.1994.1375	36	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					21071	21079		10.1074/jbc.M201785200	http://dx.doi.org/10.1074/jbc.M201785200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11912214	hybrid			2022-12-27	WOS:000176204500122
J	Kim, JH; Rah, JC; Fraser, SP; Chang, KA; Djamgoz, MBA; Suh, YH				Kim, JH; Rah, JC; Fraser, SP; Chang, KA; Djamgoz, MBA; Suh, YH			Carboxyl-terminal peptide of beta-amyloid precursor protein blocks inositol 1,4,5-trisphosphate-sensitive Ca2+ release in Xenopus laevis oocytes.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPACITATIVE CALCIUM-ENTRY; ALZHEIMERS-DISEASE; SECRETORY CLEAVAGE; CORTICAL-NEURONS; LUMINAL CA2+; FRAGMENT; TRISPHOSPHATE; RECEPTOR; CELLS; NEUROTOXICITY	The effects of Alzheimer's disease-related amyloidogenic peptides on inositol 1,4,5-trisphosphate receptor-mediated Ca2+ mobilization were examined in Xenopus laevis oocytes. Intracellular Ca2+ was monitored by electrophysiological measurement of the endogenous Ca2+-activated Cl- current. Application of a hyperpolarizing pulse released intracellular Ca2+ in oocytes primed by pre-injection of a non-metabolizable inositol 1,4,5-trisphosphate analogue. The carboxyl terminus of the amyloid precursor protein inhibited inositol 1,4,5-trisphosphate receptor-mediated intracellular Ca2+ release in a dose-dependent manner. Equimolar beta-amyloid peptides Abeta(1-40) or Abeta(1-42) had no effect, and whereas a truncated carboxyl terminus lacking the Abeta domain was equipotent to the full-length one, a carboxyl terminus fragment lacking the NPTY sequence was less effective than the full-length fragment. The inhibition induced by the carboxyl terminus was not associated with the block of the Ca2+-dependent Cl- channel itself or compromised Ca2+ influx. We conclude that the carboxyl terminus of the amyloid precursor protein inhibits inositol 1,4,5-trisphosphate-sensitive Ca2+ release and could thus disrupt Ca2+ homeostasis and that the carboxyl terminus is much more effective than the P-amyloid fragments used. By perturbing the coupling of inositol 1,4,5-trisphosphate and Ca2+ release, the carboxyl terminus of the amyloid precursor protein can potentially be involved in inducing the neural toxicity characteristic of Alzheimer's disease.	Seoul Natl Univ, Coll Med, Natl Creat Res Initiat Ctr Alzheimers Dementia, Dept Pharmacol, Seoul 110799, South Korea; Seoul Natl Univ, MRC, Neurosci Res Inst, Seoul 110799, South Korea; Univ London Imperial Coll Sci Technol & Med, Dept Biol, Neurobiol Grp, London SW7 2AZ, England	Seoul National University (SNU); Seoul National University (SNU); Imperial College London	Suh, YH (corresponding author), Seoul Natl Univ, Coll Med, Natl Creat Res Initiat Ctr Alzheimers Dementia, Dept Pharmacol, Seoul 110799, South Korea.		Suh, Yoo-Hun/J-2761-2012	Rah, Jong-Cheol/0000-0003-3780-0522				Bach JH, 2001, J NEUROCHEM, V78, P109, DOI 10.1046/j.1471-4159.2001.00370.x; BARISH ME, 1983, J PHYSIOL-LONDON, V342, P309, DOI 10.1113/jphysiol.1983.sp014852; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Buxbaum JD, 1998, J NEUROSCI, V18, P9629; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; CAPUTO CB, 1992, BIOCHEM BIOPH RES CO, V185, P1034, DOI 10.1016/0006-291X(92)91730-E; CHONG YH, 1994, LIFE SCI, V54, P1259; Chong YH, 2001, J BIOL CHEM, V276, P23511, DOI 10.1074/jbc.M009466200; DeGiorgio LA, 2000, BRAIN RES, V874, P137, DOI 10.1016/S0006-8993(00)02545-2; DYRKS T, 1992, J BIOL CHEM, V267, P18210; EINSTEIN G, 1994, J NEUROSCI, V14, P5077; Fraser SP, 1996, J NEUROCHEM, V66, P2034; Fraser SP, 1997, TRENDS NEUROSCI, V20, P67, DOI 10.1016/S0166-2236(96)10079-5; FRASER SP, 1993, ELECTROPHYSIOLOGY PR, P65; FUKUCHI K, 1993, NATURE, V361, P122, DOI 10.1038/361122a0; GEARING M, 1993, J NEUROPATH EXP NEUR, V52, P22, DOI 10.1097/00005072-199301000-00004; GomezHernandez JM, 1997, J PHYSIOL-LONDON, V502, P569, DOI 10.1111/j.1469-7793.1997.569bj.x; Hartell NA, 2000, J NEUROCHEM, V74, P1112; JOACHIM CL, 1989, AM J PATHOL, V135, P309; KAMETANI F, 1994, FEBS LETT, V351, P165, DOI 10.1016/0014-5793(94)00851-5; Kim HS, 1998, NEUROREPORT, V9, P3875, DOI 10.1097/00001756-199812010-00020; Kim SH, 1996, J NEUROCHEM, V67, P1172; KOZIKOWSKI AP, 1990, J AM CHEM SOC, V112, P7403, DOI 10.1021/ja00176a055; KOZLOWSKI MR, 1992, J NEUROSCI, V12, P1679; Lee JP, 2000, J NEUROSCI RES, V60, P565, DOI 10.1002/(SICI)1097-4547(20000515)60:4<565::AID-JNR16>3.0.CO;2-I; LEVY S, 1993, J GEN PHYSIOL, V101, P67, DOI 10.1085/jgp.101.1.67; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Mak DOD, 1997, J GEN PHYSIOL, V109, P571, DOI 10.1085/jgp.109.5.571; MARUYAMA K, 1990, NATURE, V347, P566, DOI 10.1038/347566a0; MATSUMOTO A, 1994, BIOCHEM BIOPH RES CO, V175, P361; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; MILEDI R, 1989, J PHYSIOL-LONDON, V415, P189, DOI 10.1113/jphysiol.1989.sp017718; MISSIAEN L, 1992, J PHYSIOL-LONDON, V455, P623, DOI 10.1113/jphysiol.1992.sp019319; MISSIAEN L, 1992, NATURE, V357, P599, DOI 10.1038/357599a0; Nalbantoglu J, 1997, NATURE, V387, P500, DOI 10.1038/387500a0; OsterGranite ML, 1996, J NEUROSCI, V16, P6732; PAREKH AB, 1993, J PHYSIOL-LONDON, V469, P653, DOI 10.1113/jphysiol.1993.sp019836; PAREKH AB, 1995, PFLUG ARCH EUR J PHY, V430, P954, DOI 10.1007/BF01837409; PARKER I, 1990, P NATL ACAD SCI USA, V87, P260, DOI 10.1073/pnas.87.1.260; PARKER I, 1987, PROC R SOC SER B-BIO, V231, P27, DOI 10.1098/rspb.1987.0033; PARYS JB, 1992, J BIOL CHEM, V267, P18776; PETERSEN CCH, 1994, J BIOL CHEM, V269, P32246; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; Rah JC, 2001, FASEB J, V15, P1463, DOI 10.1096/fj.00-0724fje; SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.neuro.17.1.489; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7319; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; Suh YH, 1997, J NEUROCHEM, V68, P1781; TAMAOKA A, 1992, P NATL ACAD SCI USA, V89, P1345, DOI 10.1073/pnas.89.4.1345; Thrower EC, 1998, BIOCHEM J, V330, P559; TOKUDA T, 1995, NEUROSCI LETT, V186, P149, DOI 10.1016/0304-3940(95)11307-I; Wilcox RA, 1998, TRENDS PHARMACOL SCI, V19, P467, DOI 10.1016/S0165-6147(98)01260-7; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4; YAO Y, 1992, J PHYSIOL-LONDON, V458, P319, DOI 10.1113/jphysiol.1992.sp019420; YAO Y, 1993, J PHYSIOL-LONDON, V468, P275, DOI 10.1113/jphysiol.1993.sp019771; Yoo AS, 2000, NEURON, V27, P561, DOI 10.1016/S0896-6273(00)00066-0	57	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20256	20263		10.1074/jbc.M108326200	http://dx.doi.org/10.1074/jbc.M108326200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11927572	hybrid			2022-12-27	WOS:000176204500022
J	Kimura, Y; Sakai, F; Nakano, O; Kisaki, O; Sugimoto, H; Sawamura, T; Sadano, H; Osumi, T				Kimura, Y; Sakai, F; Nakano, O; Kisaki, O; Sugimoto, H; Sawamura, T; Sadano, H; Osumi, T			The newly identified human nuclear protein NXP-2 possesses three distinct domains, the nuclear matrix-binding, RNA-binding, and coiled-coil domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; REPLICATIONAL SITES; HNRNP PROTEINS; DNA; ORGANIZATION; CHROMATIN; NUCLEOSKELETON; VISUALIZATION; SPECIFICITIES; PURIFICATION	Using a monoclonal antibody that recognizes a nuclear matrix protein, we selected a cDNA clone from a lambdagt11 human placenta cDNA library. This cDNA encoded a 939-amino acid protein designated nuclear matrix protein NXP-2. Northern blot analysis indicated that NXP-2 was expressed in various tissues at different levels. Forcibly expressed green fluorescent protein-tagged NXP-2 as well as endogenous NXP-2 was localized in the nucleus and distributed to the nuclear matrix. NXP-2 was released from the nuclear matrix when RNase A was included in the buffer for nuclear matrix preparation. Mapping of functional domains was carried out using green fluorescent protein-tagged truncated mutants of NXP-2. The region of amino acids 326-353 was responsible for nuclear matrix binding and contained a cluster of hydrophobic amino acids that was similar to the nuclear matrix targeting signal of acute myeloleukemia protein. The central region (amino acids 500-591) was demonstrated to be required for RNA binding by Northwestern analysis, although NXP-2 lacked a known RNA binding motif. The region of amino acid residues 682-876 was predicted to have a coiled-coil structure. The RNA-binding, nuclear matrix-binding, and coiled-coil domains are structurally separated, suggesting that NXP-2 plays important roles in diverse nuclear functions, including RNA metabolism and maintenance of nuclear architecture.	Himeji Inst Technol, Dept Life Sci, Grad Sch, Kamigori, Hyogo 6781201, Japan; Himeji Inst Technol, Fac Sci, Kamigori, Hyogo 6781201, Japan	University of Hyogo; University of Hyogo	Sadano, H (corresponding author), Himeji Inst Technol, Dept Life Sci, Grad Sch, 3-2-1 Koto, Kamigori, Hyogo 6781201, Japan.							BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; CACERES JF, 1993, EMBO J, V12, P4715, DOI 10.1002/j.1460-2075.1993.tb06160.x; CAPCO DG, 1982, CELL, V29, P847, DOI 10.1016/0092-8674(82)90446-9; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; COOK PR, 1984, EMBO J, V3, P1837, DOI 10.1002/j.1460-2075.1984.tb02056.x; DeFranco DB, 2000, CRIT REV EUKAR GENE, V10, P39; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; DICKINSON P, 1990, EMBO J, V9, P2207, DOI 10.1002/j.1460-2075.1990.tb07390.x; GIBSON TJ, 1993, TRENDS BIOCHEM SCI, V18, P331, DOI 10.1016/0968-0004(93)90068-X; HE DC, 1990, J CELL BIOL, V110, P569, DOI 10.1083/jcb.110.3.569; HOZAK P, 1993, CELL, V73, P361, DOI 10.1016/0092-8674(93)90235-I; JACKSON DA, 1985, EMBO J, V4, P919, DOI 10.1002/j.1460-2075.1985.tb03719.x; JACKSON DA, 1993, EMBO J, V12, P1059, DOI 10.1002/j.1460-2075.1993.tb05747.x; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Ma H, 1999, J CELL BIOL, V146, P531, DOI 10.1083/jcb.146.3.531; MCCREADY SJ, 1980, J CELL SCI, V46, P365; McNeil S, 1998, J CELL BIOCHEM, V68, P500, DOI 10.1002/(SICI)1097-4644(19980315)68:4<500::AID-JCB9>3.3.CO;2-T; Mintz PJ, 1999, EMBO J, V18, P4308, DOI 10.1093/emboj/18.15.4308; MIRKOVITCH J, 1984, CELL, V39, P223, DOI 10.1016/0092-8674(84)90208-3; NAKAYASU H, 1989, J CELL BIOL, V108, P1, DOI 10.1083/jcb.108.1.1; Nickerson JA, 2001, J CELL SCI, V114, P463; PAULSON JR, 1977, CELL, V12, P817, DOI 10.1016/0092-8674(77)90280-X; Reyes JC, 1997, J CELL BIOL, V137, P263, DOI 10.1083/jcb.137.2.263; Sadano H, 2000, BIOCHEM BIOPH RES CO, V267, P418, DOI 10.1006/bbrc.1999.1969; SCHENKEL J, 1988, EUR J BIOCHEM, V171, P565, DOI 10.1111/j.1432-1033.1988.tb13825.x; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; SMITH HC, 1984, J CELL BIOL, V99, P1794, DOI 10.1083/jcb.99.5.1794; Spector DL, 1996, EXP CELL RES, V229, P189, DOI 10.1006/excr.1996.0358; Stein GS, 2000, J CELL SCI, V113, P2527; SWANSON MS, 1988, EMBO J, V7, P3519, DOI 10.1002/j.1460-2075.1988.tb03228.x; SWANSON MS, 1988, MOL CELL BIOL, V8, P2237, DOI 10.1128/MCB.8.5.2237; TACKE R, 1995, EMBO J, V14, P3540, DOI 10.1002/j.1460-2075.1995.tb07360.x; Tan JH, 2000, MOL BIOL CELL, V11, P1547, DOI 10.1091/mbc.11.5.1547; Tang L, 1999, J BIOL CHEM, V274, P33580, DOI 10.1074/jbc.274.47.33580; TUBO RA, 1987, J BIOL CHEM, V262, P5857; WANSINK DG, 1993, J CELL BIOL, V122, P283, DOI 10.1083/jcb.122.2.283; Wei XY, 1999, J CELL BIOL, V146, P543, DOI 10.1083/jcb.146.3.543; Wei XY, 1998, SCIENCE, V281, P1502, DOI 10.1126/science.281.5382.1502; XING YG, 1991, J CELL BIOL, V112, P1055, DOI 10.1083/jcb.112.6.1055; YAMASAKI M, 1997, BIOIMAGES, V6, P1; ZANG CM, 1997, P NATL ACAD SCI USA, V94, P6746; ZEITLIN S, 1987, MOL CELL BIOL, V7, P111, DOI 10.1128/MCB.7.1.111; ZUO P, 1993, EMBO J, V12, P4727, DOI 10.1002/j.1460-2075.1993.tb06161.x	44	45	47	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20611	20617		10.1074/jbc.M201440200	http://dx.doi.org/10.1074/jbc.M201440200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11927593	hybrid			2022-12-27	WOS:000176204500067
J	Liu, SC; Kiosses, WB; Rose, DM; Slepak, M; Salgia, R; Griffin, JD; Turner, CE; Schwartz, MA; Ginsberg, MH				Liu, SC; Kiosses, WB; Rose, DM; Slepak, M; Salgia, R; Griffin, JD; Turner, CE; Schwartz, MA; Ginsberg, MH			A fragment of paxillin binds the alpha(4) integrin cytoplasmic domain (tail) and selectively inhibits alpha(4)-mediated cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION PROTEIN; CYTOSKELETAL LINKAGES; LD MOTIFS; ASSOCIATION; KINASE; LOCALIZATION; MODULATION; PEST; SRC	The alpha(4) integrins play important roles in embryogenesis, hematopoiesis, cardiac development, and the immune responses. The alpha(4) integrin subunit is indispensable for these biological processes, possibly because the alpha(4) subunit regulates cellular functions differently from other integrin a subunits. We have previously reported that the alpha(4) cytoplasmic domain directly and tightly binds paxillin, an intracellular signaling adaptor molecule, and this interaction accounts for some of the unusual functional responses to alpha(4) integrin-mediated cell adhesion. We also have identified a conserved 9-amino acid region (Glu(983)-Tyr(991)) in the alpha(4) cytoplasmic domain that is sufficient for paxillin binding, and an alanine substitution at either Glu(983) or Tyr(991) within this regrion disrupted the alpha(4)-paxillin interaction and reversed the effects of the alpha(4) cytoplasmic domain on cell spreading and migration. In the current study, we have mapped the alpha(4)-binding site within paxillin using mutational analysis, and examined its effects on the alpha(4) tail-mediated functional responses. Here we report that sequences between residues Ala(176) and Asp(275) of paxillin are sufficient for binding to the alpha(4) tail. We found that the alpha(4) tail, paxillin, and FAT, the focal adhesion targeting domain of pp125(FAK), could form a ternary complex and that the alpha(4)-binding paxillin fragment, P(Ala(176)-Asp(275)), specifically blocked paxillin binding to the alpha(4) tail more efficiently than it blocked binding to FAT. Furthermore, when expressed in cells, this alpha(4)-binding paxillin fragment specifically inhibited the alpha(4) tail-stimulated cell migration. Thus, paxillin binding to the alpha(4) tail leads to enhanced cell migration and inhibition of the alpha(4)-paxillin interaction selectively blocks the alpha(4)-dependent cellular responses.	Scripps Res Inst, Dept Vasc Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA	Scripps Research Institute; Scripps Research Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Liu, SC (corresponding author), Millennium Pharmaceut Inc, Cardiovasc Res, 256 E Grand Ave, San Francisco, CA 94080 USA.	shouchun.liu@mpi.com		schwartz, martin/0000-0002-2071-1243	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048728, P01HL031950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027214, R37AR027214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047607, R29GM047607] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL48728, HL31950] Funding Source: Medline; NIAMS NIH HHS [AR27214] Funding Source: Medline; NIGMS NIH HHS [GM47607, R01 GM047607] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; BARSAGI D, 1993, CELL, V74, P83, DOI 10.1016/0092-8674(93)90296-3; Brown MC, 1998, NAT STRUCT BIOL, V5, P677, DOI 10.1038/1370; Cary LA, 1996, J CELL SCI, V109, P1787; Cote JF, 1999, J BIOL CHEM, V274, P20550, DOI 10.1074/jbc.274.29.20550; Han JW, 2001, J BIOL CHEM, V276, P40903, DOI 10.1074/jbc.M102665200; Hanks SK, 1997, BIOESSAYS, V19, P137, DOI 10.1002/bies.950190208; Hemler M E, 1995, Curr Opin Hematol, V2, P61; HEMLER ME, 1992, COLD SPRING HARB SYM, V57, P213, DOI 10.1101/SQB.1992.057.01.026; Huttenlocher A, 1996, J CELL BIOL, V134, P1551, DOI 10.1083/jcb.134.6.1551; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; ILLC D, 1995, NATURE, V377, P539; KASSNER PD, 1995, MOL BIOL CELL, V6, P661, DOI 10.1091/mbc.6.6.661; Kiosses WB, 1999, J CELL BIOL, V147, P831, DOI 10.1083/jcb.147.4.831; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Liu S, 1999, NATURE, V402, P676, DOI 10.1038/45264; Liu S, 2000, TRENDS CARDIOVAS MED, V10, P253, DOI 10.1016/S1050-1738(00)00073-6; Liu SC, 2001, J BIOL CHEM, V276, P37086, DOI 10.1074/jbc.M105114200; Liu SC, 2000, J BIOL CHEM, V275, P22736, DOI 10.1074/jbc.M000388200; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Nikolopoulos SN, 2001, J BIOL CHEM, V276, P23499, DOI 10.1074/jbc.M102163200; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; SALGIA R, 1995, J BIOL CHEM, V270, P5039, DOI 10.1074/jbc.270.10.5039; Sastry SK, 1993, CURR OPIN CELL BIOL, V5, P819, DOI 10.1016/0955-0674(93)90031-K; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Shen Y, 1998, J BIOL CHEM, V273, P6474, DOI 10.1074/jbc.273.11.6474; Shimizu Y, 1999, ADV IMMUNOL, V72, P325, DOI 10.1016/S0065-2776(08)60024-3; Stewart M, 1996, J CELL BIOCHEM, V61, P554, DOI 10.1002/(SICI)1097-4644(19960616)61:4<554::AID-JCB8>3.0.CO;2-N; Tong X, 1997, J BIOL CHEM, V272, P33373, DOI 10.1074/jbc.272.52.33373; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Turner CE, 1998, INT J BIOCHEM CELL B, V30, P955, DOI 10.1016/S1357-2725(98)00062-4; WENG ZG, 1993, J BIOL CHEM, V268, P14956	33	45	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20887	20894		10.1074/jbc.M110928200	http://dx.doi.org/10.1074/jbc.M110928200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11919182	hybrid			2022-12-27	WOS:000176204500101
J	Pu, HX; Scanzano, R; Blostein, R				Pu, HX; Scanzano, R; Blostein, R			Distinct regulatory effects of the Na,K-ATPase gamma subunit.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; NA+-K+-ATPASE; SODIUM-PUMP; IMMUNOCYTOCHEMICAL LOCALIZATION; FUNCTIONAL-ROLE; TRANSPORT; SEQUENCE; FAMILY; KIDNEY; CELLS	The two variants of the gamma subunit of the rat renal sodium pump, gamma(a) and gamma(b), have similar effects on the Na,K-ATPase. Both increase the affinity for ATP due to a shift in the enzyme's E-1 <----> E-2 conformational equilibrium toward E-1. In addition, both increase K+ antagonism of cytoplasmic Na+ activation. To gain insight into the structural basis for these distinct effects, extramembranous N-terminal and C-terminal mutants of gamma were expressed in rat alpha1-transfected HeLa cells. At the N terminus, the variant-distinct region was deleted (gammaNDelta7) or replaced by alanine residues (gammaN7A). At the C terminus, four (gamma(a)CDelta4) or ten (gamma(a)CDelta10) residues were deleted. None of these mutations abrogates the K+/Na+ antagonism as evidenced in a similar increase in K'(Na) seen at high (100 mm) K+ concentration. In contrast, the C-terminal as well as N-terminal deletions (gammaNDelta7, gamma(a)CDelta4, and gamma(a)CDelta10) abolished the decrease in K'(ATP) seen with wildtype gamma(a) or gamma(b). It is concluded that different regions of the gamma chain mediate the distinct functional effects of gamma, and the effects can be long-range. In the transmembrane region, the impact of G41R replacement was analyzed since this mutation is associated with autosomal dominant renal Me2+-wasting in man (Meij, I.C., Koenderink, J. B., van Bokhoven, H., Assink, K. F. H., Groenestege, W. T., de Pont, J. J. H. H. M., Bindels, R. J. M., Monnens, L. A. H., Van den Heuvel, L. P. W. J., and Knoers, N. V. A. M. (2000) Nat. Genet. 26, 265-266). The results show that Gly-41 --> Arg prevents trafficking of gamma but not alphabeta pumps to the cell surface and abrogates functional effects of gamma on alphabeta pumps. These findings underscore a potentially important role of gamma in affecting solute transport, in this instance Me2+ reabsorption, consequent to its primary effect on the sodium pump.	McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University	Blostein, R (corresponding author), Montreal Gen Hosp, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	Rhoda.Blostein@mcgill.ca						Arystarkhova E, 1999, J BIOL CHEM, V274, P33183, DOI 10.1074/jbc.274.47.33183; ATTALI B, 1995, P NATL ACAD SCI USA, V92, P6092, DOI 10.1073/pnas.92.13.6092; BARLETBAS C, 1990, AM J PHYSIOL, V259, pF246, DOI 10.1152/ajprenal.1990.259.2.F246; Beguin P, 1997, EMBO J, V16, P4250, DOI 10.1093/emboj/16.14.4250; Beguin P, 2001, EMBO J, V20, P3993, DOI 10.1093/emboj/20.15.3993; Capurro C, 1996, AM J PHYSIOL-CELL PH, V271, pC753, DOI 10.1152/ajpcell.1996.271.3.C753; COLLINS JH, 1987, BIOCHEMISTRY-US, V26, P8665, DOI 10.1021/bi00400a026; Feraille E, 2001, PHYSIOL REV, V81, P345, DOI 10.1152/physrev.2001.81.1.345; FORBUSH B, 1978, BIOCHEMISTRY-US, V17, P3667, DOI 10.1021/bi00610a037; GARAY RP, 1973, J PHYSIOL-LONDON, V231, P297, DOI 10.1113/jphysiol.1973.sp010234; Garty H, 2001, BIOPHYS J, V80, p501A; GARTY H, 2002, IN PRESS AM J PHYSL; Jones DH, 2001, PHYSIOL GENOMICS, V6, P129, DOI 10.1152/physiolgenomics.2001.6.3.129; Kuster B, 2000, J BIOL CHEM, V275, P18441, DOI 10.1074/jbc.M001411200; Mahmmoud YA, 2000, J BIOL CHEM, V275, P35969, DOI 10.1074/jbc.M005168200; Meij IC, 2000, NAT GENET, V26, P265, DOI 10.1038/81543; MERCER RW, 1993, J CELL BIOL, V121, P579, DOI 10.1083/jcb.121.3.579; PALMER CJ, 1991, J BIOL CHEM, V266, P11126; Pu HX, 2001, J BIOL CHEM, V276, P20370, DOI 10.1074/jbc.M010836200; SACHS JR, 1988, J PHYSIOL-LONDON, V400, P575, DOI 10.1113/jphysiol.1988.sp017137; Shi HK, 2001, AM J PHYSIOL-RENAL, V280, pF505, DOI 10.1152/ajprenal.2001.280.3.F505; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; Stephan MM, 1997, BIOCHEMISTRY-US, V36, P1322, DOI 10.1021/bi962150l; Sweadner KJ, 2000, BIOCHEM BIOPH RES CO, V279, P196, DOI 10.1006/bbrc.2000.3907; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Therien AG, 1997, J BIOL CHEM, V272, P32628, DOI 10.1074/jbc.272.51.32628; Therien AG, 1999, J BIOL CHEM, V274, P12252, DOI 10.1074/jbc.274.18.12252; Therien AG, 2001, J BIOENERG BIOMEMBR, V33, P407, DOI 10.1023/A:1010619623841; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Wetzel RK, 2001, AM J PHYSIOL-RENAL, V281, pF531, DOI 10.1152/ajprenal.2001.281.3.F531	30	52	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20270	20276		10.1074/jbc.M201009200	http://dx.doi.org/10.1074/jbc.M201009200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11929868	hybrid			2022-12-27	WOS:000176204500024
J	Kageyama, K; Ihara, Y; Goto, S; Urata, Y; Toda, G; Yano, K; Kondo, T				Kageyama, K; Ihara, Y; Goto, S; Urata, Y; Toda, G; Yano, K; Kondo, T			Overexpression of calreticulin modulates protein kinase B/Akt signaling to promote apoptosis during cardiac differentiation of cardiomyoblast H9c2 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; RETINOIC ACID; PHOSPHATIDYLINOSITOL 3-KINASE; CATALYTIC SUBUNIT; GENE-EXPRESSION; PHOSPHATASE 2A; IN-VITRO; MOLECULAR CHAPERONE; CANCER-CELLS; CA2+ INFLUX	Calreticulin is a Ca2+-binding molecular chaperone of the lumen of the endoplasmic reticulum. Calreticulin has been shown to be essential for cardiac and neural development in mice, but the mechanism by which it functions in cell differentiation is not fully understood. To examine the role of calreticulin in cardiac differentiation, the calreticulin gene was introduced into rat cardiomyoblast H9c2 cells, and the effect of calreticulin overexpression on cardiac differentiation was examined. Upon culture in a differentiation medium containing fetal calf serum (1%) and retinoic acid (10 nM), cells transfected with the calreticulin gene were highly susceptible to apoptosis compared with controls. In the gene-transfected cells, protein kinase B/Akt signaling was significantly suppressed during differentiation. Furthermore, protein phosphatase 2A, a Ser/Thr protein phosphatase, was significantly up-regulated, implying suppression of Akt signaling due to dephosphorylation of Akt by the up-regulated protein phosphatase 2A via regulation of Ca2+ homeostasis. Thus, overexpression of calreticulin promotes differentiation-dependent apoptosis in H9c2 cells by suppressing the Akt signaling pathway. These findings indicate a novel mechanism by which cytoplasmic Akt signaling is modulated to cause apoptosis by a resident protein of the endoplasmic reticulum, calreticulin.	Atom Bomb Dis Inst, Dept Biochem & Mol Biol Dis, Nagasaki 8528523, Japan; Nagasaki Univ, Sch Med, Dept Internal Med 3, Nagasaki 8528523, Japan	Nagasaki University	Ihara, Y (corresponding author), Atom Bomb Dis Inst, Dept Biochem & Mol Biol Dis, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.							Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Ballif BA, 2001, CELL GROWTH DIFFER, V12, P397; BASTIANUTTO C, 1995, J CELL BIOL, V130, P847, DOI 10.1083/jcb.130.4.847; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Chen D, 1999, MOL CELL BIOL, V19, P4684; CHEN Q, 1994, J CELL PHYSIOL, V161, P293, DOI 10.1002/jcp.1041610214; Coffer PJ, 1998, BIOCHEM J, V335, P1; Danilczyk UG, 2001, J BIOL CHEM, V276, P25532, DOI 10.1074/jbc.M100270200; DE LUCA LM, 1991, FASEB J, V5, P2924; DEDHAR S, 1994, NATURE, V367, P480, DOI 10.1038/367480a0; Desai D, 1996, J BIOL CHEM, V271, P15153, DOI 10.1074/jbc.271.25.15153; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Ellgaard L, 2001, CURR OPIN CELL BIOL, V13, P431, DOI 10.1016/S0955-0674(00)00233-7; Fadel MP, 2001, J BIOL CHEM, V276, P27083, DOI 10.1074/jbc.M101676200; Fasolato C, 1998, MOL BIOL CELL, V9, P1513, DOI 10.1091/mbc.9.6.1513; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guo L, 2001, J BIOL CHEM, V276, P2797, DOI 10.1074/jbc.C000822200; Helenius A, 1997, TRENDS CELL BIOL, V7, P193; HESCHELER J, 1991, CIRC RES, V69, P1476, DOI 10.1161/01.RES.69.6.1476; Holaska JM, 2001, J CELL BIOL, V152, P127, DOI 10.1083/jcb.152.1.127; Ihara Y, 1999, MOL CELL, V4, P331, DOI 10.1016/S1097-2765(00)80335-4; Ihara Y, 1997, J BIOL CHEM, V272, P9629; ImanakaYoshida K, 1996, J MOL CELL CARDIOL, V28, P553, DOI 10.1006/jmcc.1996.0051; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; John LM, 1998, J CELL BIOL, V142, P963, DOI 10.1083/jcb.142.4.963; Johnson S, 2001, TRENDS CELL BIOL, V11, P122, DOI 10.1016/S0962-8924(01)01926-2; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; KHEWGOODALL Y, 1991, BIOCHEMISTRY-US, V30, P89, DOI 10.1021/bi00215a014; Kim JM, 1999, ARCH BIOCHEM BIOPHYS, V367, P67, DOI 10.1006/abbi.1999.1232; KIMES BW, 1976, EXP CELL RES, V98, P367, DOI 10.1016/0014-4827(76)90447-X; KITAGAWA Y, 1991, BIOCHIM BIOPHYS ACTA, V1089, P339, DOI 10.1016/0167-4781(91)90174-K; KITAGAWA Y, 1988, BIOCHIM BIOPHYS ACTA, V951, P123, DOI 10.1016/0167-4781(88)90032-2; KITAMURA K, 1991, J BIOCHEM-TOKYO, V109, P307; Konishi H, 1996, P NATL ACAD SCI USA, V93, P7639, DOI 10.1073/pnas.93.15.7639; Krause KH, 1997, CELL, V88, P439, DOI 10.1016/S0092-8674(00)81884-X; Mayer-Jaekel Regina E., 1994, Trends in Cell Biology, V4, P287, DOI 10.1016/0962-8924(94)90219-4; Meier R, 1998, EMBO J, V17, P7294, DOI 10.1093/emboj/17.24.7294; Menard C, 1999, J BIOL CHEM, V274, P29063, DOI 10.1074/jbc.274.41.29063; Mery L, 1996, J BIOL CHEM, V271, P9332, DOI 10.1074/jbc.271.16.9332; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; MICHALAK M, 1992, BIOCHEM J, V285, P681, DOI 10.1042/bj2850681; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakamura K, 2000, J CELL BIOL, V150, P731, DOI 10.1083/jcb.150.4.731; Nakamura K, 2001, J CLIN INVEST, V107, P1245, DOI 10.1172/JCI12412; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; NISHIKAWA M, 1994, CANCER RES, V54, P4879; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; RAMACHANDRAN C, 1987, J BIOL CHEM, V262, P3210; Rauch F, 2000, EXP CELL RES, V256, P105, DOI 10.1006/excr.2000.4818; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; SAMBROOK J, 1989, MOL CLONING LAB MANU, P7; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Shago M, 1997, EXP CELL RES, V230, P50, DOI 10.1006/excr.1996.3408; SMITH MJ, 1989, EMBO J, V8, P3581, DOI 10.1002/j.1460-2075.1989.tb08530.x; Songyang Zhou, 1995, Trends in Biochemical Sciences, V20, P470, DOI 10.1016/S0968-0004(00)89103-3; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; WINROW CJ, 1995, MOL CELL ENDOCRINOL, V111, P175, DOI 10.1016/0303-7207(95)03563-M; Xu W, 2000, J BIOL CHEM, V275, P36676, DOI 10.1074/jbc.M002041200; Zhu N, 1999, CANCER RES, V59, P1896	68	74	81	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19255	19264		10.1074/jbc.M112377200	http://dx.doi.org/10.1074/jbc.M112377200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11907032	hybrid			2022-12-27	WOS:000175894800004
J	Wierzbicka-Patynowski, I; Schwarzbauer, JE				Wierzbicka-Patynowski, I; Schwarzbauer, JE			Regulatory role for Src and phosphatidylinositol 3-kinase in initiation of fibronectin matrix assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; CELL-CYCLE PROGRESSION; PHOSPHOINOSITIDE 3-OH KINASE; EXTRACELLULAR-MATRIX; FAMILY KINASES; PROTEIN-KINASE; GROWTH-FACTOR; INTEGRIN; ACTIVATION; BINDING	Fibronectin (FN) matrix assembly is a tightly regulated stepwise process that is initiated by interactions between FN and cell surface integrin receptors. These interactions activate many intracellular signaling pathways that regulate processes such as cell adhesion, migration, and survival. Here we demonstrate that cells lacking Src family kinases showed reduced ability to assemble FN fibrils as detected by immunofluorescence and by analysis of detergent extracts. The amount of FN matrix was further reduced by treatment with the phosphatidylinositol 3 (PI 3-kinase) inhibitor, wortmannin. CHOalpha5 cells, which are dependent on exogenous FN to initiate fibril formation, also showed significant reductions in matrix when treated with inhibitors of Src and PI 3-kinase. Combination of both inhibitors showed an additive inhibitory effect on assembly, which was concomitant with a loss of focal adhesion kinase phosphorylation. Decreased binding of the 70-kDa amino-terminal FN fragment at matrix assembly sites further supports a role for these kinases early during the process. We propose that these two signaling molecules, which lie downstream of integrins and focal adhesion kinase, are essential for efficient initiation of FN matrix assembly.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Schwarzbauer, JE (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.			Schwarzbauer, Jean/0000-0003-1012-7593	NATIONAL CANCER INSTITUTE [T32CA009528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059383] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA09528-16] Funding Source: Medline; NIGMS NIH HHS [R01 GM59383] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGUIRRE KM, 1994, J BIOL CHEM, V269, P27863; Bourdoulous S, 1998, J CELL BIOL, V143, P267, DOI 10.1083/jcb.143.1.267; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; CALALB MB, 1995, MOL CELL BIOL, V15, P954; CHEN HC, 1994, P NATL ACAD SCI USA, V91, P10148, DOI 10.1073/pnas.91.21.10148; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; DZAMBA BJ, 1994, J BIOL CHEM, V269, P19646; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; Frisch SM, 1996, J CELL BIOL, V135, P1377, DOI 10.1083/jcb.135.5.1377; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Guan JL, 1997, INT J BIOCHEM CELL B, V29, P1085, DOI 10.1016/S1357-2725(97)00051-4; GUINEBAULT C, 1995, J CELL BIOL, V129, P831, DOI 10.1083/jcb.129.3.831; Han DC, 2000, J BIOL CHEM, V275, P28911, DOI 10.1074/jbc.M001997200; Han DC, 1999, J BIOL CHEM, V274, P24425, DOI 10.1074/jbc.274.34.24425; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hocking DC, 1996, J CELL BIOL, V133, P431, DOI 10.1083/jcb.133.2.431; Hynes RO, 1990, FIBRONECTINS; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; King WG, 1997, MOL CELL BIOL, V17, P4406, DOI 10.1128/MCB.17.8.4406; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; KUNDRA V, 1994, NATURE, V367, P474, DOI 10.1038/367474a0; KWON HJ, 1992, CANCER RES, V52, P6926; Lowell CA, 1996, GENE DEV, V10, P1845, DOI 10.1101/gad.10.15.1845; Mercurius KO, 1998, CIRC RES, V82, P548, DOI 10.1161/01.RES.82.5.548; Mercurius KO, 2001, BMC CELL BIOL, V2, part. no., DOI 10.1186/1471-2121-2-18; Mosher DF, 1989, FIBRONECTIN; Parsons JT, 1997, CURR OPIN CELL BIOL, V9, P187, DOI 10.1016/S0955-0674(97)80062-2; Reiske HR, 1999, J BIOL CHEM, V274, P12361, DOI 10.1074/jbc.274.18.12361; SCHALLER MD, 1994, CURR OPIN CELL BIOL, V6, P705, DOI 10.1016/0955-0674(94)90097-3; Schwartz MA, 2001, TRENDS CELL BIOL, V11, P466, DOI 10.1016/S0962-8924(01)02152-3; Schwarzbauer JE, 1999, CURR OPIN CELL BIOL, V11, P622, DOI 10.1016/S0955-0674(99)00017-4; SCHWARZBAUER JE, 1991, J CELL BIOL, V113, P1463, DOI 10.1083/jcb.113.6.1463; Sechler JL, 1996, J CELL BIOL, V134, P573, DOI 10.1083/jcb.134.2.573; Sechler JL, 1998, J BIOL CHEM, V273, P25533, DOI 10.1074/jbc.273.40.25533; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Shen TL, 2001, FEBS LETT, V499, P176, DOI 10.1016/S0014-5793(01)02545-5; SOLOWSKA J, 1989, J CELL BIOL, V109, P853, DOI 10.1083/jcb.109.2.853; SOMERS CE, 1993, J BIOL CHEM, V268, P22277; SOTTILE J, 1994, J BIOL CHEM, V269, P17192; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; WENNSTROM S, 1994, ONCOGENE, V9, P651; WU CY, 1995, CELL, V83, P715, DOI 10.1016/0092-8674(95)90184-1; Wymann MP, 1996, MOL CELL BIOL, V16, P1722; XING Z, 1994, MOL BIOL CELL, V5, P413, DOI 10.1091/mbc.5.4.413; Zhang X, 1999, P NATL ACAD SCI USA, V96, P9021, DOI 10.1073/pnas.96.16.9021; Zhao J H, 2000, Prog Mol Subcell Biol, V25, P37	51	48	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19703	19708		10.1074/jbc.M200270200	http://dx.doi.org/10.1074/jbc.M200270200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11912200	hybrid			2022-12-27	WOS:000175894800062
J	Sundararajan, S; MacKenzie, RE				Sundararajan, S; MacKenzie, RE			Residues involved in the mechanism of the bifunctional methylenetetrahydrofolate dehydrogenase-cyclohydrolase - The roles of glutamine 100 and aspartate 125	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE; SITE-DIRECTED MUTAGENESIS; METHENYLTETRAHYDROFOLATE-CYCLOHYDROLASE; ESCHERICHIA-COLI; FORMYLTETRAHYDROFOLATE SYNTHETASE; ANGSTROM RESOLUTION; PORCINE LIVER; ACTIVE-SITE; DEHYDROGENASE/CYCLOHYDROLASE; BINDING	The human bifunctional dehydrogenase-cyclohydrolase domain catalyzes the interconversion of 5,10-methylene-H(4)folate and 10-formyl-H(4)folate. Although previous structure and mutagenesis studies indicated the importance of lysine 56 in cyclohydrolase catalysis, the role of several surrounding residues had not been explored. In addition to further defining the role of lysine 56, the work presented in this study explores the functions of glutamine 100 and aspartate 125 through the use of site-directed mutagenesis and chemical modification. Mutants at position 100 are inactive with respect to cyclohydrolase activity while preserving significant dehydrogenase levels. We succeeded in producing a K56Q/ Q100K double mutant, which has no cyclohydrolase yet retains more than two-thirds of wild type dehydrogenase activity. Neither activity is detectable in aspartate 125 mutants with the exception of D125E. The results indicate that the function of glutamine 100 is to activate lysine 56 for cyclohydrolase catalysis and that aspartate 125 is involved in the binding of the H(4)folate substrates. In highlighting the importance of these residues, catalytic mechanisms are proposed for both activities as well as an explanation for the differences in channeling efficiency in the forward and reverse directions.	McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	McGill University	MacKenzie, RE (corresponding author), McGill Univ, Dept Biochem, McIntyre Med Sci Bldg, Montreal, PQ H3G 1Y6, Canada.	remack@med.mcgill.ca						a'Bhaird NN, 1998, BIOCHEM J, V330, P1029, DOI 10.1042/bj3301029; Allaire M, 1998, STRUCTURE, V6, P173, DOI 10.1016/S0969-2126(98)00019-7; ALMASSY RJ, 1992, P NATL ACAD SCI USA, V89, P6114, DOI 10.1073/pnas.89.13.6114; Anderson B M, 1980, Methods Enzymol, V66, P81; BOND MD, 1981, BIOCHEM BIOPH RES CO, V102, P243, DOI 10.1016/0006-291X(81)91513-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chiericatti G, 1998, BIOCHEMISTRY-US, V37, P9038, DOI 10.1021/bi9802770; CORMACK B, 1997, CURRENT PROTOCOLS MO, V1; DAWSON RMC, 1989, DATA BIOCH RES, P1; DRURY EJ, 1975, ARCH BIOCHEM BIOPHYS, V169, P662, DOI 10.1016/0003-9861(75)90210-6; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HUM DW, 1991, PROTEIN ENG, V4, P493, DOI 10.1093/protein/4.4.493; INGLESE J, 1990, BIOCHEMISTRY-US, V29, P6678, DOI 10.1021/bi00480a018; JACOB F, 1990, BIOCHEM J, V271, P399, DOI 10.1042/bj2710399; KAN CC, 1992, J PROTEIN CHEM, V11, P467, DOI 10.1007/BF01025023; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MacKenzie R E, 1984, FOLATES PTERINS CHEM, V1, P255; Pawelek PD, 2000, BBA-PROTEIN STRUCT M, V1479, P59, DOI 10.1016/S0167-4838(00)00058-3; Pawelek PD, 1998, BIOCHEMISTRY-US, V37, P1109, DOI 10.1021/bi971906t; PELLETIER JN, 1995, BIOCHEMISTRY-US, V34, P12673, DOI 10.1021/bi00039a025; PELLETIER JN, 1994, BIOCHEMISTRY-US, V33, P1900, DOI 10.1021/bi00173a037; Schmidt A, 2000, BIOCHEMISTRY-US, V39, P6325, DOI 10.1021/bi992734y; SMITH DDS, 1985, BIOCHEM BIOPH RES CO, V128, P148, DOI 10.1016/0006-291X(85)91657-2; SMITH DDS, 1983, CAN J BIOCHEM CELL B, V61, P1166, DOI 10.1139/o83-150; STRYNADKA NCJ, 1992, NATURE, V359, P700, DOI 10.1038/359700a0; TAN LUL, 1977, BIOCHIM BIOPHYS ACTA, V485, P52, DOI 10.1016/0005-2744(77)90192-9; Trimmer EE, 2001, BIOCHEMISTRY-US, V40, P6216, DOI 10.1021/bi002790v; VILLAR E, 1985, J BIOL CHEM, V260, P2245; WINDHOLZ M, 1976, MERCK INDEX ENCY CHE; YANG XM, 1992, PROTEIN EXPRES PURIF, V3, P256, DOI 10.1016/1046-5928(92)90022-O	30	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					18703	18709		10.1074/jbc.M200127200	http://dx.doi.org/10.1074/jbc.M200127200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11904299	hybrid			2022-12-27	WOS:000175975800062
J	Lamb, DC; Skaug, T; Song, HL; Jackson, CJ; Podust, LM; Waterman, MR; Kell, DB; Kelly, DE; Kelly, SL				Lamb, DC; Skaug, T; Song, HL; Jackson, CJ; Podust, LM; Waterman, MR; Kell, DB; Kelly, DE; Kelly, SL			The cytochrome p450 complement (CYPome) of Streptomyces coelicolor A3(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACCESSION NUMBERS; GRISEUS; SUPERFAMILY; EXPRESSION; NOMENCLATURE; ACTIVATION; SEQUENCES; ENZYMES; SYSTEM; GENOME	In the present study we describe the complete cytochrome P450 complement, the "CYPome," of Streptomyces coelicolor A3(2). Eighteen cytochromes P450 (CYP) are described, in contrast to the absence of CYPs in Escherichia coli, and the twenty observed in Mycobacterium tuberculosis. Here we confirm protein identity as cytochromes P450 by heterologous expression in E. coli and measurement of reduced carbon monoxide difference spectra. We also report on their arrangement in the linear chromosome and relatedness to other CYPs in the superfamily. The future development of manipulation of antibiotic pathways and the use of streptomycetes in bioremediation and biotransformations will involve many of the new CYP forms identified here.	Univ Wales, Wolfson Lab P450 Biodivers, Inst Biol Sci, Aberystwyth SY23 3DA, Dyfed, Wales; Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA	Aberystwyth University; Vanderbilt University	Kelly, SL (corresponding author), Univ Wales, Wolfson Lab P450 Biodivers, Inst Biol Sci, Aberystwyth SY23 3DA, Dyfed, Wales.		Podust, Larissa/ABB-7940-2020; Kell, Douglas/E-8318-2011	Podust, Larissa/0000-0002-8537-8760; Kell, Douglas/0000-0001-5838-7963				Bellamine A, 1999, P NATL ACAD SCI USA, V96, P8937, DOI 10.1073/pnas.96.16.8937; Berrie JR, 1999, J STEROID BIOCHEM, V71, P153, DOI 10.1016/S0960-0760(99)00132-6; CANNELL RJP, 1995, DRUG METAB DISPOS, V23, P724; CUPPVICKERY JR, 1995, NAT STRUCT BIOL, V2, P144, DOI 10.1038/nsb0295-144; EMBLEY TM, 1994, ANNU REV MICROBIOL, V48, P257, DOI 10.1146/annurev.mi.48.100194.001353; GUENGERICH FP, 1991, J BIOL CHEM, V266, P10019; Hopwood DA, 1999, MICROBIOL-UK, V145, P2183, DOI 10.1099/00221287-145-9-2183; Kelly SL, 2001, BIOCHEM SOC T, V29, P122, DOI 10.1042/0300-5127:0290122; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; MERSONDAVIES LA, 1994, MOL MICROBIOL, V13, P349, DOI 10.1111/j.1365-2958.1994.tb00428.x; NELSON DR, 1993, DNA CELL BIOL, V12, P1, DOI 10.1089/dna.1993.12.1; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Nelson DR, 1999, ARCH BIOCHEM BIOPHYS, V369, P1, DOI 10.1006/abbi.1999.1352; OKEEFE DP, 1994, PLANT PHYSIOL, V105, P473, DOI 10.1104/pp.105.2.473; Omura S, 2001, P NATL ACAD SCI USA, V98, P12215, DOI 10.1073/pnas.211433198; OMURA T, 1964, J BIOL CHEM, V239, P2370; Oritiz de Montellano P. R., 1995, CYTOCHROME P450; PORTER TD, 1991, J BIOL CHEM, V266, P13469; SARIASLANI FS, 1983, APPL ENVIRON MICROB, V46, P468, DOI 10.1128/AEM.46.2.468-474.1983; SARIASLANI FS, 1984, J MED CHEM, V27, P749, DOI 10.1021/jm00372a008; SARIASLANI FS, 1983, APPL ENVIRON MICROB, V49, P451; SCHENKEMKAN JB, 1982, HEPATIC CYTOCHROME; Schmid E, 1999, MICROBIOL-SGM, V145, P3331, DOI 10.1099/00221287-145-12-3331; SERIZAWA N, 1991, BIOCHIM BIOPHYS ACTA, V1084, P35, DOI 10.1016/0005-2760(91)90052-J; TAKEMORI S, 1993, CYTOCHROME P450; Taylor M, 1999, BIOCHEM BIOPH RES CO, V263, P838, DOI 10.1006/bbrc.1999.1427; TROWER MK, 1992, MOL MICROBIOL, V6, P2125, DOI 10.1111/j.1365-2958.1992.tb01386.x; TROWER MK, 1988, BIOCHEM BIOPH RES CO, V157, P1417, DOI 10.1016/S0006-291X(88)81033-7; WATERMAN MR, 1991, METHODS ENZYMOLOGY, V206	29	113	120	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 5	2002	277	27					24000	24005		10.1074/jbc.M111109200	http://dx.doi.org/10.1074/jbc.M111109200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	569PV	11943767	hybrid			2022-12-27	WOS:000176611800006
J	Casaus, JL; Navarro, JA; Hervas, M; Lostao, A; De la Rosa, MA; Gomez-Moreno, C; Sancho, J; Medina, A				Casaus, JL; Navarro, JA; Hervas, M; Lostao, A; De la Rosa, MA; Gomez-Moreno, C; Sancho, J; Medina, A			Anabaena sp PCC 7119 flavodoxin as electron carrier from photosystem I to Ferredoxin-NADP(+) reductase - Role of TRP57 and TYR94	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESULFOVIBRIO-VULGARIS HILDENBOROUGH; FLASH ABSORPTION-SPECTROSCOPY; MONONUCLEOTIDE BINDING-SITE; SYNECHOCYSTIS PCC-6803; OXIDIZED FLAVODOXIN; TERTIARY STRUCTURE; KINETIC-ANALYSIS; CYTOCHROME C(6); PCC 7119; RESOLUTION	The influence of the amino acid residues sandwiching the flavin ring in flavodoxin (Fld) from the cyanobacterium Anabaena sp. PCC 7119 in complex formation and electron transfer (ET) with its natural partners, photosystem I (PSI) and ferredoxin-NADP(+) reductase (FNR), was examined in mutants of the key residues Trp(57) and Tyr(94). The mutants' ability to form complexes with either FNR or PSI is similar to that of wild-type Fld. However, some of the mutants exhibit altered kinetic properties in their ET processes that can be explained in terms of altered flavin accessibility and/or thermodynamic parameters. The most noticeable alteration is produced upon replacement of Tyr(94) by alanine. In this mutant, the processes that involve the transfer of one electron from either PSI or FNR are clearly accelerated, which might be attributable to a larger accessibility of the flavin to the reductant. However, when the opposite ET flow is analyzed with FNR, the reduced Y94A mutant transfers electrons to FNR slightly more slowly than wild type. This can be explained thermodynamically from a decrease in driving force due to the significant shift of 137 mV in the reduction potential value for the semiquinone/hydroquinone couple (E-1) of Y94A, relative to wild type (Lostao, A., Gomez-Moreno, C., Mayhew, S. G., and Sancho, J. (1997) Biochemistry 36,14334-14344). The behavior of the rest of the mutants can be explained in the same way. Overall, our data indicate that Trp(57) and Tyr(94) do not play any active role in flavodoxin redox reactions providing a path for the electrons but are rather involved in setting an appropriate structural and electronic environment that modulates in vivo ET from PSI to FNR while providing a tight FMN binding.	Univ Zaragoza, Fac Ciencias, Dept Bioquim & Biol Mol & Celular, E-50009 Zaragoza, Spain; Univ Seville, CSIC, Inst Bioquim Vegetal & Fotosintesis, CIC Isla de la Cartuja, Seville 41092, Spain	University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-JA-USE - Centro de Investigaciones Cientificas Isla de La Cartuja (CICIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF)	Medina, A (corresponding author), Univ Zaragoza, Fac Ciencias, Dept Bioquim & Biol Mol & Celular, E-50009 Zaragoza, Spain.	mmedina@posta.unizar.es	Medina, Milagros/F-8310-2012; Sancho, javier/AAA-1225-2019; navarro, jose a/B-6354-2015; Hervas, Manuel/K-9279-2014; De la Rosa, Miguel/B-2545-2014; Lostao, Anabel/P-8693-2015	Medina, Milagros/0000-0001-8743-0182; Sancho, javier/0000-0002-2879-9200; navarro, jose a/0000-0002-0536-6074; Hervas, Manuel/0000-0003-4523-8891; De la Rosa, Miguel/0000-0003-1187-5737; Lostao, Anabel/0000-0001-7460-5916				ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BURNETT RM, 1974, J BIOL CHEM, V249, P4383; FUKUYAMA K, 1990, J BIOL CHEM, V265, P15804; Genzor CG, 1996, NAT STRUCT BIOL, V3, P329, DOI 10.1038/nsb0496-329; HERVAS M, 1994, BBA-BIOENERGETICS, V1184, P235, DOI 10.1016/0005-2728(94)90228-3; HERVAS M, 1995, BIOCHEMISTRY-US, V34, P11321, DOI 10.1021/bi00036a004; Hurley JK, 1997, BIOCHEMISTRY-US, V36, P11100, DOI 10.1021/bi9709001; Jenkins CM, 1997, J BIOL CHEM, V272, P22509, DOI 10.1074/jbc.272.36.22509; Lostao A, 1997, BIOCHEMISTRY-US, V36, P14334, DOI 10.1021/bi971384h; LUDWIG ML, 1992, CHEM BIOCH FLAVOENZY, V3, P427; MATHIS P, 1981, ISRAEL J CHEM, V21, P316; Mayhew S. G., 1992, CHEM BIOCH FLAVOENZY, V3, P389; Medina M, 1998, BIOCHEMISTRY-US, V37, P2715, DOI 10.1021/bi971795y; Medina M, 1999, BIOPHYS J, V77, P1712, DOI 10.1016/S0006-3495(99)77017-7; MEDINA M, 1992, FEBS LETT, V313, P239, DOI 10.1016/0014-5793(92)81200-6; MEYER TE, 1993, BIOCHEMISTRY-US, V32, P4552, DOI 10.1021/bi00068a010; Muhlenhoff U, 1996, BIOCHEMISTRY-US, V35, P1367, DOI 10.1021/bi952381c; NAVARRO JA, 1995, ARCH BIOCHEM BIOPHYS, V321, P229, DOI 10.1006/abbi.1995.1390; NAVARRO JA, 1994, PHOTOCHEM PHOTOBIOL, V60, P231, DOI 10.1111/j.1751-1097.1994.tb05096.x; RAO ST, 1992, PROTEIN SCI, V1, P1413, DOI 10.1002/pro.5560011103; Reynolds RA, 2001, ACTA CRYSTALLOGR D, V57, P527, DOI 10.1107/S0907444901002554; Rogers L.J, 1987, CYANOBACTERIA, P35; ROGNER M, 1990, J BIOL CHEM, V265, P6189; Shin M, 1971, METHOD ENZYMOL, V23, P440; SMITH WW, 1983, J MOL BIOL, V165, P737, DOI 10.1016/S0022-2836(83)80277-0; SWENSON RP, 1994, BIOCHEMISTRY-US, V33, P8505, DOI 10.1021/bi00194a015; VANMIERLO CPM, 1990, EUR J BIOCHEM, V194, P185; WALKER MC, 1990, ARCH BIOCHEM BIOPHYS, V281, P76, DOI 10.1016/0003-9861(90)90415-U; WATENPAUGH KD, 1973, P NATL ACAD SCI USA, V70, P3857, DOI 10.1073/pnas.70.12.3857; Zhou ZM, 1996, BIOCHEMISTRY-US, V35, P15980, DOI 10.1021/bi962124n	30	31	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22338	22344		10.1074/jbc.M112258200	http://dx.doi.org/10.1074/jbc.M112258200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11950835	hybrid, Green Published			2022-12-27	WOS:000176313600030
J	Matsui, T; Li, L; Wu, JC; Cook, SA; Nagoshi, T; Picard, MH; Liao, RL; Rosenzweig, A				Matsui, T; Li, L; Wu, JC; Cook, SA; Nagoshi, T; Picard, MH; Liao, RL; Rosenzweig, A			Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; GROWTH-FACTOR-I; NF-KAPPA-B; GLYCOGEN-SYNTHASE KINASE-3-BETA; SERINE-THREONINE KINASE; P70 S6 KINASE; CELL-SURVIVAL; PHOSPHATIDYLINOSITOL 3-KINASE; CARDIOMYOCYTE HYPERTROPHY; DEPENDENT PHOSPHORYLATION	The serine-threonine kinase, Akt, inhibits cardiomyocyte apoptosis acutely both in vitro and in vivo. However, the effects of chronic Akt activation in the heart are unknown. To address this issue, we generated transgenic mice (TG+) with cardiac-specific expression of a constitutively active mutant of Akt (myr-Akt) driven by the myosin heavy chain-alpha promoter. Three TG+ founders (9-19 weeks) died suddenly with massive cardiac dilatation. Two viable TG+ lines (TG564 and TG20) derived from independent founders demonstrated cardiac-specific transgene expression as well as activation of Akt and p70S6 kinase. TG564 (n = 19) showed cardiac hypertrophy with a heart/body weight ratio 2.3-fold greater than littermates (n = 17, p < 0.005). TG20 (n = 18) had less marked cardiac hypertrophy with a heart/body weight ratio 1.6-fold greater than littermates (a = 17, p < 0.005). Isolated TG564 myocytes were also hypertrophic with surface areas 1.7-fold greater than littermates (p < 0.000001). Echocardiograms in both lines demonstrated concentric hypertrophy and preserved systolic function. After ischemia-reperfusion, TG+ had a 50% reduction in infarct size versus TG- (17 +/- 3% versus 34 +/- 4%, p < 0.001). Thus, chronic Akt activation is sufficient to cause a spectrum of phenotypes from moderate cardiac hypertrophy with preserved systolic function and cardioprotection to massive cardiac dilatation and sudden death.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Program Cardiovasc Gene Therapy,CVRC, Boston, MA 02129 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA 02129 USA; Boston Univ, Sch Med, Cardiac Muscle Res Lab, Boston, MA 02118 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University	Rosenzweig, A (corresponding author), Massachusetts Gen Hosp East, Cardiovasc Res Ctr, Program Cardiovasc Gene Therapy, 114 16th St,2nd Floor,Rm 2600, Charlestown, MA 02129 USA.		Cook, Stuart/G-9567-2011; Picard, Michael/F-1567-2013	Picard, Michael/0000-0002-9264-3243; Cook, Stuart/0000-0001-6628-194X	NHLBI NIH HHS [HL59521, HL61557, HL04250] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059521, K08HL004250, R01HL061557] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baines CP, 1999, BASIC RES CARDIOL, V94, P188, DOI 10.1007/s003950050142; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; BUERKE M, 1995, P NATL ACAD SCI USA, V92, P8031, DOI 10.1073/pnas.92.17.8031; Camper-Kirby D, 2001, CIRC RES, V88, P1020, DOI 10.1161/hh1001.090858; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Choukroun G, 1999, J CLIN INVEST, V104, P391, DOI 10.1172/JCI6350; Choukroun G, 1998, J CLIN INVEST, V102, P1311, DOI 10.1172/JCI3512; Coffer PJ, 1998, BIOCHEM J, V335, P1; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Damen JE, 1996, P NATL ACAD SCI USA, V93, P1689, DOI 10.1073/pnas.93.4.1689; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Haq S, 2000, J CELL BIOL, V151, P117, DOI 10.1083/jcb.151.1.117; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Huang WY, 2000, NAT MED, V6, P482, DOI 10.1038/74914; Kitamura T, 1998, MOL CELL BIOL, V18, P3708, DOI 10.1128/MCB.18.7.3708; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Li BS, 1999, CIRC RES, V84, P1007, DOI 10.1161/01.RES.84.9.1007; Matsui T, 2001, CIRCULATION, V104, P330; Matsui T, 1999, CIRCULATION, V100, P2373, DOI 10.1161/01.CIR.100.23.2373; Morisco C, 2000, J BIOL CHEM, V275, P14466, DOI 10.1074/jbc.275.19.14466; Nagata K, 2000, CIRC RES, V87, P903, DOI 10.1161/01.RES.87.10.903; Oh H, 1998, J BIOL CHEM, V273, P9703, DOI 10.1074/jbc.273.16.9703; Ozes ON, 1999, NATURE, V401, P82; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Rossig L, 2001, MOL CELL BIOL, V21, P5644, DOI 10.1128/MCB.21.16.5644-5657.2001; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Thorell A, 1999, AM J PHYSIOL-ENDOC M, V277, pE733, DOI 10.1152/ajpendo.1999.277.4.E733; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; von Harsdorf R, 1999, CIRC RES, V85, P128, DOI 10.1161/01.RES.85.2.128; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	49	343	353	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22896	22901		10.1074/jbc.M200347200	http://dx.doi.org/10.1074/jbc.M200347200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11943770	hybrid, Green Published			2022-12-27	WOS:000176313600101
J	Schwientek, T; Bennett, EP; Flores, C; Thacker, J; Hollmann, M; Reis, CA; Behrens, J; Mandel, U; Keck, B; Schafer, MA; Haselmann, K; Zubarev, R; Roepstorff, P; Burchell, JM; Taylor-Papadimitriou, J; Hollingsworth, MA; Clausen, H				Schwientek, T; Bennett, EP; Flores, C; Thacker, J; Hollmann, M; Reis, CA; Behrens, J; Mandel, U; Keck, B; Schafer, MA; Haselmann, K; Zubarev, R; Roepstorff, P; Burchell, JM; Taylor-Papadimitriou, J; Hollingsworth, MA; Clausen, H			Functional conservation of subfamilies of putative UDP-N-acetylgalactosamine : polypeptide N-acetylgalactosaminyltransferases in Drosophila, Caenorhabditis elegans, and mammals - One subfamily composed of l(2)35Aa is essential in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-D-GALACTOSAMINE; ALPHA-D-GALACTOSAMINE; O-LINKED GLYCOSYLATION; CDNA CLONING; GALNAC-TRANSFERASES; 3 MEMBERS; EXPRESSION; FAMILY; GENE; SEQUENCE	The completed fruit fly genome was found to contain up to 15 putative UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetvlgalactosaminyltransferase (GalNAc-transferase) genes. Phylogenetic analysis of the putative catalytic domains of the large GalNAc-transferase enzyme families of Drosophila melanogaster (13 available), Caenorhabditis elegans (9 genes), and mammals (12 genes) indicated that distinct subfamilies of orthologous genes are conserved in each species. In support of this hypothesis, we provide evidence that distinctive functional properties of Drosophila and human GalNAc-tranferase isoforms were exhibited by evolutionarily conserved members of two subfamilies (dGalNAc-T1 (l(2)35Aa) and GalNAc-T11; dGalNAc-T2 (CG6394) and GalNAc-T7). dGalNAc-T1 and novel human GalNAc-T11 were shown to encode functional GalNAc-transferases,with the same polypeptide acceptor substrate specificity, and dGalNAc-T2 was shown to encode a GalNAc-transferase with similar GalNAc glycopeptide substrate specificity as GalNAc-T7. Previous data suggested that the putative GalNAc-transferase encoded by l(2)35Aa had a lethal phenotype (Flores, C., and Engels, W. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 2964-2969), and this was substantiated by sequencing of three lethal alleles l(2)35Aa(HG8), l(2)35Aa(SF12), and l(2)35Aa(SF32). The finding that subfamilies of GalNAc-transferases with distinct catalytic functions are evolutionarily conserved stresses that GalNAc-transferase isoforms may serve unique biological functions rather than providing functional redundancy, and this is further supported by the lethal phenotype of l(2)35Aa.	Univ Copenhagen, Sch Dent, DK-2200 Copenhagen N, Denmark; Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; MRC, Radiat & Genome Stabil Unit, Didcot OX11 0RD, Oxon, England; Univ Gottingen, Zool Inst entwicklungsbiol, Abt Mol Entwicklungsgenet, D-37073 Gottingen, Germany; Univ Porto, IPATIMUP, Inst Mol Pathol & Immunol, P-4200 Oporto, Portugal; Univ So Denmark, Odense Univ, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; Guys Hosp, Breast Canc Biol Grp, Imperial Canc Res Fund, London SE1 9RT, England; Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Copenhagen; University of Wisconsin System; University of Wisconsin Madison; MRC Harwell; University of Gottingen; Universidade do Porto; University of Southern Denmark; Cancer Research UK; Guy's & St Thomas' NHS Foundation Trust; University of Nebraska System; University of Nebraska Medical Center	Schwientek, T (corresponding author), Univ Cologne, Fak Med, Inst Biochem 2, Joseph Stelzmann Str 52, D-50931 Cologne, Germany.		Zubarev, Roman A/W-7891-2018; REIS, Celso A/B-9969-2008; Burchell, Joy/G-4560-2012; Bennett, Eric/AAG-6120-2020; clausen, henrik/AAD-8016-2021	Zubarev, Roman A/0000-0001-9839-2089; REIS, Celso A/0000-0002-0286-6639; Bennett, Eric/0000-0002-4976-0647; Behrens, Jane Windfeldt/0000-0002-0136-9681; Burchell, Joy/0000-0003-0413-3823	NCI NIH HHS [1 R01 CA66234] Funding Source: Medline; NIGMS NIH HHS [GM30948] Funding Source: Medline; CIT NIH HHS [FCT-POCTI/36376/99] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA066234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030948, R56GM030948] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CIT NIH HHS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ashburner M, 1999, GENETICS, V153, P179; Bennett EP, 1996, J BIOL CHEM, V271, P17006, DOI 10.1074/jbc.271.29.17006; Bennett EP, 1998, J BIOL CHEM, V273, P30472, DOI 10.1074/jbc.273.46.30472; Bennett EP, 1999, J BIOL CHEM, V274, P25362, DOI 10.1074/jbc.274.36.25362; Bennett EP, 1998, GLYCOBIOLOGY, V8, P547, DOI 10.1093/glycob/8.6.547; Bennett EP, 1999, FEBS LETT, V460, P226, DOI 10.1016/S0014-5793(99)01268-5; BENNETT EP, 2001, GLYCOCONJ J, V18, P113; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Clausen H, 1996, GLYCOBIOLOGY, V6, P635, DOI 10.1093/glycob/6.6.635; de Haan CAM, 1998, J BIOL CHEM, V273, P29905, DOI 10.1074/jbc.273.45.29905; Elhammer AP, 1999, GLYCOCONJUGATE J, V16, P171, DOI 10.1023/A:1026465232149; Felsenstein J, 1986, PHYLIP PHYLOGENY INF; Flores C, 1999, P NATL ACAD SCI USA, V96, P2964, DOI 10.1073/pnas.96.6.2964; Gentzsch M, 1997, GLYCOBIOLOGY, V7, P481, DOI 10.1093/glycob/7.4.481; Hagen FK, 1999, J BIOL CHEM, V274, P6797, DOI 10.1074/jbc.274.10.6797; Hagen FK, 1998, J BIOL CHEM, V273, P8268, DOI 10.1074/jbc.273.14.8268; Hagen FK, 1997, J BIOL CHEM, V272, P13843, DOI 10.1074/jbc.272.21.13843; HAGEN FK, 1995, GLYCOCONJUGATE J, V12, P901, DOI 10.1007/BF00731252; Hassan H, 2000, J BIOL CHEM, V275, P38197, DOI 10.1074/jbc.M005783200; Hassan H., 2000, CARBOHYDRATES CHEM B, P271; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; HOMA FL, 1993, J BIOL CHEM, V268, P12609; IRVINE KD, 1994, CELL, V79, P595, DOI 10.1016/0092-8674(94)90545-2; Jurado LAP, 1999, GENOMICS, V58, P171, DOI 10.1006/geno.1999.5819; Mandel U, 1999, GLYCOBIOLOGY, V9, P43, DOI 10.1093/glycob/9.1.43; Manzi AE, 2000, GLYCOBIOLOGY, V10, P669, DOI 10.1093/glycob/10.7.669; Marth JD, 1996, GLYCOBIOLOGY, V6, P701, DOI 10.1093/glycob/6.7.701; MartinBlanco E, 1996, P NATL ACAD SCI USA, V93, P6048, DOI 10.1073/pnas.93.12.6048; Mirgorodskaya E, 2001, ANAL CHEM, V73, P1263, DOI 10.1021/ac001288d; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Nehrke K, 1998, GLYCOBIOLOGY, V8, P367, DOI 10.1093/glycob/8.4.367; Rottger S, 1998, J CELL SCI, V111, P45; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Schmidt A, 1996, MOL GEN GENET, V251, P381, DOI 10.1007/BF02172530; SCHWIENTEK T, 2001, GLYCOCONJ J, V18, P44; Tambini CE, 1997, GENOMICS, V41, P84, DOI 10.1006/geno.1997.4636; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Ten Hagen BG, 1998, J BIOL CHEM, V273, P27749; Ten Hagen KG, 1999, J BIOL CHEM, V274, P27867; Ten Hagen KG, 2001, J BIOL CHEM, V276, P17395, DOI 10.1074/jbc.M009638200; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toba S, 2000, BBA-GENE STRUCT EXPR, V1493, P264, DOI 10.1016/S0167-4781(00)00180-9; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; WANG Y, 1993, J BIOL CHEM, V268, P22979; Westerman EL, 1999, GLYCOBIOLOGY, V9, P1121; White KE, 2000, GENE, V246, P347, DOI 10.1016/S0378-1119(00)00050-0; WHITE T, 1995, J BIOL CHEM, V270, P24156, DOI 10.1074/jbc.270.41.24156; WOJCZYK BS, 2002, GLYCOBIOLOGY, V18, P60; WOODRUFF RC, 1979, GENETICS, V92, P117; Zara J, 1996, BIOCHEM BIOPH RES CO, V228, P38, DOI 10.1006/bbrc.1996.1613	51	153	180	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22623	22638		10.1074/jbc.M202684200	http://dx.doi.org/10.1074/jbc.M202684200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11925450	hybrid			2022-12-27	WOS:000176313600069
J	Takata, Y; Yamada, T; Huang, YF; Komoto, J; Gomi, T; Ogawa, H; Fujioka, M; Takusagawa, F				Takata, Y; Yamada, T; Huang, YF; Komoto, J; Gomi, T; Ogawa, H; Fujioka, M; Takusagawa, F			Catalytic mechanism of S-adenosylhomocysteine hydrolase - Site-directed mutagenesis of Asp-130, Lys-185, Asp-189, and Asn-190	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER; CRYSTAL-STRUCTURE; BINDING; ENZYME	S-Adenosylhomocysteine hydrolase (AdoHeyase) catalyzes the hydrolysis of S-adenosylhomocysteine to form adenosine and homocysteine. On the bases of crystal structures of the wild type enzyme and the D244E mutated enzyme complexed with 3'-keto-adenosine (D244E.Ado*), we have identified the important amino acid residues, Asp-130, Lys-185, Asp-189, and Asn-190, for the catalytic reaction and have proposed a catalytic mechanism (Komoto, J., Huang, Y., Gomi, T., Ogawa, H., Takata, Y., Fujioka, M., and Takusagawa, F. (2000) J. Biol. Chem. 275, 32147-32156). To confirm the proposed catalytic mechanism, we have made the D130N, K185N, D189N, and N190S mutated enzymes and measured the catalytic activities. The catalytic rates (k(cat)) of D130N, K185N, D189N, and N190S mutated enzymes are reduced to 0.7%, 0.5%, 0.1%, and 0.5%, respectively, in comparison with the wild type enzyme, indicating that Asp-130, Lys-185, Asp-189, and Asn-190 are involved in the catalytic reaction. K-m values of the mutated enzymes are increased significantly, except for the N190S mutation, suggesting that Asp-130, Lys-185, and Asp-189 participate in the substrate binding. To interpret the kinetic data, the oxidation states of the bound NAD molecules of the wild type and mutated enzymes were measured during the catalytic reaction by monitoring the absorbance at 340 nm. The crystal structures of the WT and D244E.Ado*, containing four subunits in the crystallographic asymmetric unit, were re-refined to have the same subunit structures. A detailed catalytic mechanism of AdoHcyase has been revealed based on the oxidation states of the bound NAD and the re-refined crystal structures of WT and D244E.Ado*. Lys-185 and Asp-130 abstract hydrogen atoms from 3'-OH and 4'-CH, respectively. Asp-189 removes a proton from Lys-185 and produces the neutral Nzeta (-NH2), and Asn-190 facilitates formation of the neutral Lys-185. His-54 and His-300 hold and polarize a water molecule, which nucleophilically attacks the C5'- of 3'-keto-4',5'-dehydroadenosine to produce 3'-keto-Ado.	Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; Toyama Med & Pharmaceut Univ, Fac Med, Dept Biochem, Toyama 9300194, Japan	University of Kansas; University of Toyama	Takusagawa, F (corresponding author), Univ Kansas, Dept Mol Biosci, 3004 Haworth Hall,1200 Sunnyside Ave, Lawrence, KS 66045 USA.				NIGMS NIH HHS [GM37233] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRUNNETT B, 1993, SURVEYS MATH IND, V3, P1; CANTONI GL, 1954, J AM CHEM SOC, V76, P4744, DOI 10.1021/ja01647a081; FUJIOKA M, 1981, J BIOL CHEM, V256, P1631; GOMI T, 1989, BIOCHIM BIOPHYS ACTA, V994, P172, DOI 10.1016/0167-4838(89)90157-X; GOMI T, 1989, J BIOL CHEM, V264, P16138; Hu YB, 1999, BIOCHEMISTRY-US, V38, P8323, DOI 10.1021/bi990332k; Huang YF, 2002, J BIOL CHEM, V277, P7477, DOI 10.1074/jbc.M109187200; Komoto J, 2000, J BIOL CHEM, V275, P32147, DOI 10.1074/jbc.M003725200; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403; PALMER JL, 1979, J BIOL CHEM, V254, P1217; PALMER JL, 1976, J BIOL CHEM, V251, P5817; RICHARDS HH, 1978, J BIOL CHEM, V253, P4476; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; VOET D, 1995, BIOCHEMISTRY-US, P353	16	45	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22670	22676		10.1074/jbc.M201116200	http://dx.doi.org/10.1074/jbc.M201116200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11927587	hybrid			2022-12-27	WOS:000176313600074
J	Eaton, P; Fuller, W; Shattock, MJ				Eaton, P; Fuller, W; Shattock, MJ			S-thiolation of HSP27 regulates its multimeric aggregate size independently of phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; ALPHA-B-CRYSTALLIN; OXIDATIVE STRESS; CREATINE-KINASE; TROPONIN-I; MOLECULAR CHAPERONE; ENDOTHELIAL-CELLS; CARDIAC MYOCYTES; OXIDANT STRESS; RAT-HEART	HSP27 exists as large aggregates that breakdown after phosphorylation. We show rat cardiac HSP27 is S-thiolated during oxidant stress, and this modification, without phosphorylation, disaggregates multimeric HSP27. Biotinylated cysteine acts as a probe for thiolated proteins, which are detected using non-reducing Western blots probed with streptavidin-horseradish peroxidase. Controls show a low level of S-thiolation, which is increased 3.6-fold during post-ischemic reperfusion. S-Thiolated proteins were purified using streptavidin-agarose, and Western immunoblotting showed HSP27 was present. We increased protein S-thiolation 10-fold with 10 mum H2O2 with or without a kinase inhibitor mixture (staurosporine, genistein, bisindolylmaleimide, SB203580, and PD98059). H2O2 alone induced the phosphorylation of HSP27 Ser-86 and Ser-45/Ser-59 of its homologue alphaB crystallin. However, kinase inhibition reduced phosphorylation of these sites below basal. Despite effective kinase inhibition, H2O2 still disaggregated HSP27, but not aB crystallin. This is consistent with the lack of an S-thiolation site on aB crystallin. Thus, we have demonstrated a novel mechanism of HSP27 multimeric size regulation. S-Thiolation must occur at Cys-141, the only cysteine in rat HSP27.	St Thomas Hosp, Rayne Inst, Ctr Cardiovasc Biol & Med, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Eaton, P (corresponding author), St Thomas Hosp, Rayne Inst, Ctr Cardiovasc Biol & Med, London SE1 7EH, England.	philip.eaton@kcl.ac.uk	Eaton, Philip/I-5444-2015	Eaton, Philip/0000-0003-0748-2367; Shattock, Michael/0000-0001-6242-7585; Fuller, William/0000-0002-5883-4433				Armstrong SC, 1999, J MOL CELL CARDIOL, V31, P555, DOI 10.1006/jmcc.1998.0891; AUFRICHT C, 1998, AM J PHYSIOL, V43, pF215; Barbato R, 1996, CIRC RES, V78, P821, DOI 10.1161/01.RES.78.5.821; Benjamin IJ, 1998, CIRC RES, V83, P117, DOI 10.1161/01.RES.83.2.117; BENNARDINI F, 1992, CIRC RES, V71, P288, DOI 10.1161/01.RES.71.2.288; Bluhm WF, 1998, AM J PHYSIOL-HEART C, V275, pH2243, DOI 10.1152/ajpheart.1998.275.6.H2243; Bonini MG, 2001, J BIOL CHEM, V276, P9749, DOI 10.1074/jbc.M008456200; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Butt E, 2001, J BIOL CHEM, V276, P7108, DOI 10.1074/jbc.M009234200; CHAI YC, 1994, ARCH BIOCHEM BIOPHYS, V310, P273, DOI 10.1006/abbi.1994.1167; Cheung PY, 1998, ARCH BIOCHEM BIOPHYS, V350, P104, DOI 10.1006/abbi.1997.0496; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Cobb BA, 2002, BIOCHEMISTRY-US, V41, P483, DOI 10.1021/bi0112457; COLLISON MW, 1987, BIOCHIM BIOPHYS ACTA, V928, P121, DOI 10.1016/0167-4889(87)90112-1; Demasi M, 2001, ARCH BIOCHEM BIOPHYS, V389, P254, DOI 10.1006/abbi.2001.2332; Derham BK, 1999, PROG RETIN EYE RES, V18, P463, DOI 10.1016/S1350-9462(98)00030-5; DILISA F, 1995, BIOCHEM J, V308, P57, DOI 10.1042/bj3080057; DUDICH IV, 1995, BBA-PROTEIN STRUCT M, V1253, P163, DOI 10.1016/0167-4838(95)00135-X; Eaton P, 2002, J BIOL CHEM, V277, P9806, DOI 10.1074/jbc.M111454200; Eaton P, 1999, AM J PHYSIOL-HEART C, V276, pH935, DOI 10.1152/ajpheart.1999.276.3.H935; Eaton P, 2001, J MOL CELL CARDIOL, V33, P1659, DOI 10.1006/jmcc.2001.1418; Fiebig R, 1996, AGE, V19, P83, DOI 10.1007/BF02434087; GANOTE C, 1993, CARDIOVASC RES, V27, P1387, DOI 10.1093/cvr/27.8.1387; GANOTE CE, 1988, AM J PATHOL, V132, P212; Gao WD, 1997, CIRC RES, V80, P393, DOI 10.1161/01.res.0000435855.49359.47; Gopalakrishna R, 2000, FREE RADICAL BIO MED, V28, P1349, DOI 10.1016/S0891-5849(00)00221-5; Grant CM, 2001, MOL MICROBIOL, V39, P533, DOI 10.1046/j.1365-2958.2001.02283.x; GROENEN PJTA, 1994, EUR J BIOCHEM, V225, P1, DOI 10.1111/j.1432-1033.1994.00001.x; Hallk HM, 1998, CIRCULATION, V98, P220; HEARSE DJ, 1991, CARDIOVASC DRUG THER, V5, P853, DOI 10.1007/BF00053547; Hook DWA, 1998, INT J BIOL MACROMOL, V22, P295, DOI 10.1016/S0141-8130(98)00027-0; Huot J, 1996, CANCER RES, V56, P273; Ito H, 1997, J BIOL CHEM, V272, P29934, DOI 10.1074/jbc.272.47.29934; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Ji YB, 1999, ARCH BIOCHEM BIOPHYS, V362, P67, DOI 10.1006/abbi.1998.1013; Jiang MT, 2002, BIOPHYS J, V82, p347A; Kato K, 1998, J BIOL CHEM, V273, P28346, DOI 10.1074/jbc.273.43.28346; Lambert H, 1999, J BIOL CHEM, V274, P9378, DOI 10.1074/jbc.274.14.9378; Landry J, 1999, BIOCHEM SOC SYMP, P79; Li JF, 2001, J BIOL CHEM, V276, P3098, DOI 10.1074/jbc.M008260200; Liu W, 1999, J CELL SCI, V112, P2409; Loktionova SA, 1998, FEBS LETT, V433, P294, DOI 10.1016/S0014-5793(98)00920-X; Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200; Mallis RJ, 2001, BIOCHEM J, V355, P145, DOI 10.1042/bj3550145; Martin JL, 1997, CIRCULATION, V96, P4343; McDonough JL, 1999, CIRC RES, V84, P9; Mehlen P, 1997, BIOCHEM BIOPH RES CO, V241, P187, DOI 10.1006/bbrc.1997.7635; MILLER RM, 1990, ARCH BIOCHEM BIOPHYS, V276, P355, DOI 10.1016/0003-9861(90)90732-E; Mohr S, 1996, J BIOL CHEM, V271, P4209; Mohr S, 1999, J BIOL CHEM, V274, P9427, DOI 10.1074/jbc.274.14.9427; Pullar JM, 1999, AM J PHYSIOL-HEART C, V277, pH1505, DOI 10.1152/ajpheart.1999.277.4.H1505; Pullar JM, 2001, J BIOL CHEM, V276, P22120, DOI 10.1074/jbc.M102088200; Qin CA, 1996, CURR EYE RES, V15, P719, DOI 10.3109/02713689609003454; Reddy S, 1998, FREE RADICAL BIO MED, V25, pS78; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; SEKI N, 1986, B JPN SOC SCI FISH, V52, P1673; SHATTOCK MJ, 1993, CIRC RES, V72, P91, DOI 10.1161/01.RES.72.1.91; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; Vanden Hoek TL, 1998, J BIOL CHEM, V273, P18092, DOI 10.1074/jbc.273.29.18092; Wang HM, 2001, BIOCHEMISTRY-US, V40, P3316, DOI 10.1021/bi002786j; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Wang KY, 1996, EUR J BIOCHEM, V242, P56, DOI 10.1111/j.1432-1033.1996.0056r.x; Ward NE, 1998, J BIOL CHEM, V273, P12558, DOI 10.1074/jbc.273.20.12558; Zavialov A, 1998, INT J BIOL MACROMOL, V22, P163, DOI 10.1016/S0141-8130(98)00014-2; Zucchi R, 1998, CIRC RES, V83, P908	66	60	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21189	21196		10.1074/jbc.M200591200	http://dx.doi.org/10.1074/jbc.M200591200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11925435	hybrid			2022-12-27	WOS:000176286000011
J	Ogawara, Y; Kishishita, S; Obata, T; Isazawa, Y; Suzuki, T; Tanaka, K; Masuyama, N; Gotoh, Y				Ogawara, Y; Kishishita, S; Obata, T; Isazawa, Y; Suzuki, T; Tanaka, K; Masuyama, N; Gotoh, Y			Akt enhances Mdm2-mediated ubiquitination and degradation of p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; SERINE-THREONINE KINASE; NUCLEAR RECEPTOR NUR77; TUMOR-SUPPRESSOR P53; RING-FINGER DOMAIN; NF-KAPPA-B; PROTEIN-KINASE; CELL-SURVIVAL; MOLECULAR-CLONING; GENE-EXPRESSION	p53 plays a key role in DNA damage-induced apoptosis. Recent studies have reported that the phosphatidylinositol 3-OH-kinase-A-kt pathway inhibits p53-mediated transcription and apoptosis, although the underlying mechanisms have yet to be determined. Mdm2, a ubiquitin ligase for p53, plays a central role in regulation of the stability of p53 and serves as a good substrate for Akt. In this study, we find that expression of Akt reduces the protein levels of p53, at least in part by enhancing the degradation of p53. Both Akt expression and serum treatment induced phosphorylation of Mdm2 at Ser(186). Akt-mediated phosphorylation of Mdm2 at Ser(186) had little effect on the subcellular localization of Mdm2. However, both Akt expression and serum treatment increased Mdm2 ubiquitination of p53. The serum-induced increase in p53 ubiquitination was blocked by LY294002, a phosphatidylinositol 3-OH-kinase inhibitor. Moreover, when Ser(186) was replaced by Ala, Mdm2 became resistant to Akt enhancement of p53 ubiquitination and degradation. Collectively, these results suggest that Akt enhances the ubiquitination-promoting function of Mdm2 by phosphorylation of Ser(186), which results in reduction of p53 protein. This study may shed light on the mechanisms by which Akt promotes survival, proliferation, and tumorigenesis.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Univ Tokushima, Inst Enzyme Res, Tokushima 7708503, Japan; Tokyo Metropolitan Inst Med Sci, Dept Mol Oncol, Bunkyo Ku, Tokyo 1138613, Japan; Japan Sci & Technol Corp, PRESTO Res Project, Osaka 5600082, Japan	University of Tokyo; Tokushima University; Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST)	Gotoh, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.			Suzuki, Toshiaki/0000-0002-0650-6251				BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; COFFER PJ, 1991, EUR J BIOCHEM, V201, P475, DOI 10.1111/j.1432-1033.1991.tb16305.x; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DEL PL, 1997, SCIENCE, V278, P687; Fuchs SY, 1998, ONCOGENE, V17, P2543, DOI 10.1038/sj.onc.1202200; Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hay TJ, 2000, FEBS LETT, V478, P183, DOI 10.1016/S0014-5793(00)01850-0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hyun T, 2000, BLOOD, V96, P3560, DOI 10.1182/blood.V96.10.3560.h8003560_3560_3568; JONES PF, 1991, P NATL ACAD SCI USA, V88, P4171, DOI 10.1073/pnas.88.10.4171; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Kennedy SG, 1999, MOL CELL BIOL, V19, P5800; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; Kobet E, 2000, P NATL ACAD SCI USA, V97, P12547, DOI 10.1073/pnas.97.23.12547; Kohn AD, 1998, J BIOL CHEM, V273, P11937, DOI 10.1074/jbc.273.19.11937; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Laine J, 2000, MOL CELL, V6, P395, DOI 10.1016/S1097-2765(00)00039-3; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Masuyama N, 2001, J BIOL CHEM, V276, P32799, DOI 10.1074/jbc.M105431200; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Mayo LD, 1997, CANCER RES, V57, P5013; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; McFall A, 2001, MOL CELL BIOL, V21, P5488, DOI 10.1128/MCB.21.16.5488-5499.2001; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Ozes ON, 1999, NATURE, V401, P82; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Pekarsky Y, 2001, P NATL ACAD SCI USA, V98, P3690, DOI 10.1073/pnas.051003198; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Sabbatini P, 1999, J BIOL CHEM, V274, P24263, DOI 10.1074/jbc.274.34.24263; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; SKLAR MD, 1988, SCIENCE, V239, P645, DOI 10.1126/science.3277276; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Tao WK, 1999, P NATL ACAD SCI USA, V96, P3077, DOI 10.1073/pnas.96.6.3077; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Wadgaonkar R, 1999, J BIOL CHEM, V274, P13760, DOI 10.1074/jbc.274.20.13760; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Woods DB, 2001, EXP CELL RES, V264, P56, DOI 10.1006/excr.2000.5141; Yamaguchi A, 2001, J BIOL CHEM, V276, P5256, DOI 10.1074/jbc.M008552200; Zhang TT, 2001, J BIOL CHEM, V276, P29702, DOI 10.1074/jbc.M011326200; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zhou HL, 2000, J CELL BIOL, V151, P483, DOI 10.1083/jcb.151.3.483; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	60	450	476	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21843	21850		10.1074/jbc.M109745200	http://dx.doi.org/10.1074/jbc.M109745200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11923280	hybrid			2022-12-27	WOS:000176286000094
J	Tudzynski, B; Rojas, MC; Gaskin, P; Hedden, P				Tudzynski, B; Rojas, MC; Gaskin, P; Hedden, P			The gibberellin 20-oxidase of Gibberella fujikuroi is a multifunctional monooxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENT-KAURENE OXIDASE; CELL-FREE SYSTEM; BIOSYNTHESIS PATHWAY; MOLECULAR-CLONING; CUCURBITA-MAXIMA; GENE-CLUSTER; EXPRESSION; ENZYME; ENCODES; TRANSFORMATION	The genes for gibberellin (GA) biosynthesis are clustered in the fungus Gibberella fujikuroi. In addition to genes encoding a GA-specific geranylgeranyl diphosphate synthase and a bifunctional ent-copalyl diphosphate/ent-kaurene synthase, the cluster contains four cytochrome P450 monooxygenase genes (P450-1, -2, -3, -4). Recently it was shown that P450-4 and P450-1 encode multifunctional enzymes catalyzing the three oxidation steps from ent-kaurene to ent-kaurenoic acid and the four oxidation steps from ent-kaurenoic acid to GA(14), respectively. Here we describe the functional analysis of the P450-2 gene by gene disruption and by expressing the gene in a mutant that lacks the entire GA biosynthesis gene cluster. Mutants in which P450-2 is inactivated by the insertion of a large piece of DNA accumulated GA(14) and lacked biosynthetically more advanced metabolites, indicating that the gene encodes a 20-oxidase. This was confirmed by incubating lines containing P450-2 in the absence of the other GA biosynthesis genes with isotopically labeled substrates. The P450-2 gene product oxidized the 3beta-hydroxylated intermediate, GA(14), and its non-hydroxylated analogue GA(12) to GA(4) and GA(9), respectively. Expression of P450-2 is repressed by high amounts of nitrogen in the culture medium but is not affected by the presence of biosynthetically advanced GAs, i.e. there is no evidence for feedback regulation. The fact that the GA 20-oxidase is a cytochrome P450 monooxygenase in G. fujikuroi and not a 2-oxoglutarate-dependent dioxygenase as in plants, together with the significant differences in regulation of gene expression, are further evidence for independent evolution of the GA biosynthetic pathways in plants and fungi.	Univ Bristol, Dept Agr Sci, IACR Long Ashton Res Stn, Bristol BS41 9AF, Avon, England; Univ Munster, Inst Bot, D-48149 Munster, Germany; Univ Chile, Fac Ciencias, Dept Quim, Lab Bioorgan, Santiago, Chile	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Bristol; University of Munster; Universidad de Chile	Hedden, P (corresponding author), Univ Bristol, Dept Agr Sci, IACR Long Ashton Res Stn, Bristol BS41 9AF, Avon, England.		ROJAS, MARIA CECILIA/D-8730-2014	ROJAS, MARIA CECILIA/0000-0002-6034-9779	Biotechnology and Biological Sciences Research Council [BBS/E/C/00004161] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ASHMAN PJ, 1990, BIOCHIM BIOPHYS ACTA, V1036, P151, DOI 10.1016/0304-4165(90)90027-T; BARENDSE GWM, 1980, J CHROMATOGR, V198, P449, DOI 10.1016/S0021-9673(00)80514-2; Barrero AF, 1999, PHYTOCHEMISTRY, V50, P1133, DOI 10.1016/S0031-9422(98)00699-2; BEARDER JR, 1975, J CHEM SOC PERK T 1, P721, DOI 10.1039/p19750000721; CHAPMAN DJ, 1980, ANNU REV PLANT PHYS, V31, P639, DOI 10.1146/annurev.pp.31.060180.003231; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DESJARDINS AE, 1992, J IND MICROBIOL, V9, P201, DOI 10.1007/BF01569624; Doyle JJ., 1987, FOCUS, V19, P11, DOI DOI 10.2307/2419362; GASKIN P, 1992, GC MS GIBBERLLINS RE; GEISSMAN TA, 1966, PHYTOCHEMISTRY, V5, P933, DOI 10.1016/S0031-9422(00)82790-9; GRAEBE JE, 1974, PHYTOCHEMISTRY, V13, P1433, DOI 10.1016/0031-9422(74)80304-3; Hedden P, 2000, TRENDS PLANT SCI, V5, P523, DOI 10.1016/S1360-1385(00)01790-8; Hedden P, 1997, ANNU REV PLANT PHYS, V48, P431, DOI 10.1146/annurev.arplant.48.1.431; Helliwell CA, 2001, P NATL ACAD SCI USA, V98, P2065, DOI 10.1073/pnas.041588998; HENDRICK CA, 1964, AUST J CHEM, V17, P915; JENNINGS JC, 1993, PLANT PHYSIOL, V101, P925, DOI 10.1104/pp.101.3.925; KAMIYA Y, 1986, PLANTA, V169, P524, DOI 10.1007/BF00392102; Kawaide H, 1997, J BIOL CHEM, V272, P21706, DOI 10.1074/jbc.272.35.21706; Lange T, 1997, P NATL ACAD SCI USA, V94, P6553, DOI 10.1073/pnas.94.12.6553; LANGE T, 1994, PLANTA, V195, P108; LANGE T, 1994, P NATL ACAD SCI USA, V91, P8552, DOI 10.1073/pnas.91.18.8552; Lange T, 1997, PHYSIOL PLANTARUM, V100, P543, DOI 10.1034/j.1399-3054.1997.1000316.x; Linnemannstons P, 1999, APPL ENVIRON MICROB, V65, P2558; Maniatis T., 1989, MOL CLONING LAB MANU; MUNOZ GA, 1993, APPL ENVIRON MICROB, V59, P4317; PHILLIPS AL, 1995, PLANT PHYSIOL, V108, P1049, DOI 10.1104/pp.108.3.1049; PONTECORVO GV, 1952, ADV GENET, V5, P141; Rojas MC, 2001, P NATL ACAD SCI USA, V98, P5838, DOI 10.1073/pnas.091096298; Sakamoto T, 2001, GENE DEV, V15, P581, DOI 10.1101/gad.867901; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Tudzynski B, 1996, MICROBIOL-SGM, V142, P533, DOI 10.1099/13500872-142-3-533; Tudzynski B, 1998, CURR GENET, V34, P234, DOI 10.1007/s002940050392; Tudzynski B, 2001, APPL ENVIRON MICROB, V67, P3514, DOI 10.1128/AEM.67.8.3514-3522.2001; Tudzynski B, 1998, FUNGAL GENET BIOL, V25, P157, DOI 10.1006/fgbi.1998.1095; Urrutia O, 2001, PHYTOCHEMISTRY, V56, P505, DOI 10.1016/S0031-9422(00)00381-2; Ward JL, 1997, CHEM COMMUN, P13, DOI 10.1039/a606158c; West C. A., 1973, Phytochemical Society Symposia Series, P143; Wu KQ, 1996, PLANT PHYSIOL, V110, P547, DOI 10.1104/pp.110.2.547; XU YL, 1995, P NATL ACAD SCI USA, V92, P6640, DOI 10.1073/pnas.92.14.6640	39	71	81	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21246	21253		10.1074/jbc.M201651200	http://dx.doi.org/10.1074/jbc.M201651200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11943776	hybrid			2022-12-27	WOS:000176286000018
J	Bubb, MR; Govindasamy, L; Yarmola, EG; Vorobiev, SM; Almo, SC; Somasundaram, T; Chapman, MS; Agbandje-McKenna, M; McKenna, R				Bubb, MR; Govindasamy, L; Yarmola, EG; Vorobiev, SM; Almo, SC; Somasundaram, T; Chapman, MS; Agbandje-McKenna, M; McKenna, R			Polylysine induces an antiparallel actin dimer that nucleates filament assembly - Crystal structure at 3.5-angstrom resolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-ACTIN; BETA-ACTIN; DIFFRACTION DATA; ARP2/3 COMPLEX; POLYMERIZATION; KINETICS; GELSOLIN; DYNAMICS; MODEL; ASSOCIATION	An antiparallel actin dimer has been proposed to be an intermediate species during actin filament nucleation. We now show that latrunculin A, a marine natural product that inhibits actin polymerization, arrests polylysine-induced nucleation at the level of an antiparallel dimer, resulting in its accumulation. These dimers, when composed of pyrene-labeled actin subunits, give rise to a fluorescent excimer, permitting detection during polymerization in vitro. We report the crystallographic structure of the polylysine-actin-latrunculin A complex at 3.5-Angstrom resolution. The non-crystallographic contact is consistent with a dimeric structure and confirms the antiparallel orientation of its subunits. The crystallographic contacts reveal that the mobile DNase I binding loop of one subunit of a symmetry-related antiparallel actin dimer is partially stabilized in the interface between the two subunits of a second antiparallel dimer. These results provide a potential explanation for the paradoxical nucleation of actin filaments that have exclusively parallel subunits by a dimer containing antiparallel subunits.	Vet Affairs Med Ctr, Malcom Randall Dept, Res Serv, Gainesville, FL 32608 USA; Univ Florida, Coll Med, Gainesville, FL 32608 USA; Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); State University System of Florida; University of Florida; State University System of Florida; University of Florida; Yeshiva University; Albert Einstein College of Medicine; State University System of Florida; Florida State University	Bubb, MR (corresponding author), Univ Florida, Dept Med, Box 100277, Gainesville, FL 32610 USA.			Chapman, Michael/0000-0001-8525-8585; Somasundaram, Thayumanasamy/0000-0002-3629-5117	NIGMS NIH HHS [GM53807] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASPENSTROM P, 1993, FEBS LETT, V329, P163, DOI 10.1016/0014-5793(93)80215-G; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; BROWN SS, 1979, J CELL BIOL, V80, P499, DOI 10.1083/jcb.80.2.499; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; BUBB MR, 1994, J BIOL CHEM, V269, P25592; BUBB MR, 1994, J BIOL CHEM, V269, P25587; Burtnick LD, 1997, CELL, V90, P661, DOI 10.1016/S0092-8674(00)80527-9; CHATELIER RC, 1987, BIOPHYS CHEM, V28, P121, DOI 10.1016/0301-4622(87)80081-9; Chik JK, 1996, J MOL BIOL, V263, P607, DOI 10.1006/jmbi.1996.0602; COOPER JA, 1983, BIOCHEMISTRY-US, V22, P2193, DOI 10.1021/bi00278a021; delaTorre JG, 1997, EUR BIOPHYS J BIOPHY, V25, P361, DOI 10.1007/s002490050049; ELZINGA M, 1984, P NATL ACAD SCI-BIOL, V81, P6599, DOI 10.1073/pnas.81.21.6599; HESTERKAMP T, 1993, EUR J BIOCHEM, V218, P507, DOI 10.1111/j.1432-1033.1993.tb18403.x; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; JOHANNES FJ, 1991, EMBO J, V10, P3951, DOI 10.1002/j.1460-2075.1991.tb04965.x; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kim E, 2000, BIOPHYS CHEM, V86, P191, DOI 10.1016/S0301-4622(00)00143-5; Kuo SC, 2000, NATURE, V407, P1026, DOI 10.1038/35039544; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; MCLAUGHLIN PJ, 1993, NATURE, V364, P685, DOI 10.1038/364685a0; MILLONIG R, 1988, J CELL BIOL, V106, P785, DOI 10.1083/jcb.106.3.785; MOCKRIN SC, 1981, J BIOL CHEM, V256, P8228; MOCKRIN SC, 1983, J BIOL CHEM, V258, P3215; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; OOSAWA F, 1962, J MOL BIOL, V4, P10, DOI 10.1016/S0022-2836(62)80112-0; OOSAWA F, 1975, THERMODYNAMICS POLYM, P28; ORLOVA A, 1995, J MOL BIOL, V245, P598, DOI 10.1006/jmbi.1994.0049; ORLOVA A, 1993, J MOL BIOL, V232, P334, DOI 10.1006/jmbi.1993.1393; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; SCHACHMAN HK, 1959, ULTRACENTRIFUGATION, P75; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Sept D, 2001, BIOPHYS J, V81, P667, DOI 10.1016/S0006-3495(01)75731-1; Steinmetz MO, 1997, J CELL BIOL, V138, P559, DOI 10.1083/jcb.138.3.559; Terry DR, 1997, J BIOL CHEM, V272, P7841, DOI 10.1074/jbc.272.12.7841; TIRION MM, 1995, BIOPHYS J, V68, P5, DOI 10.1016/S0006-3495(95)80156-6; TOBACMAN LS, 1983, J BIOL CHEM, V258, P3207; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; WEGNER A, 1982, BIOCHEMISTRY-US, V21, P1909, DOI 10.1021/bi00537a032; WEGNER A, 1975, BIOPHYS CHEM, V3, P215, DOI 10.1016/0301-4622(75)80013-5; Yarmola EG, 2000, J BIOL CHEM, V275, P28120	43	63	63	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20999	21006		10.1074/jbc.M201371200	http://dx.doi.org/10.1074/jbc.M201371200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11932258	hybrid			2022-12-27	WOS:000176204500115
J	Czuwara-Ladykowska, J; Sementchenko, VI; Watson, DK; Trojanowska, M				Czuwara-Ladykowska, J; Sementchenko, VI; Watson, DK; Trojanowska, M			Ets1 is an effector of the transforming growth factor beta (TGF-beta) signaling pathway and an antagonist of the profibrotic effects of TGF-beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P300/CBP TRANSCRIPTIONAL COACTIVATORS; COLLAGEN GENE-EXPRESSION; HUMAN DERMAL FIBROBLASTS; HUMAN SKIN FIBROBLASTS; NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; EXTRACELLULAR-MATRIX; BREAST-CANCER; DIFFERENTIAL REGULATION; STROMELYSIN PROMOTER	Extracellular matrix (ECM) production and turnover are tightly controlled under normal physiological conditions. Ets factors regulate matrix turnover by activating transcription of several metalloproteinases (MMPs) and are frequently overexpressed in aggressive tumors and arthritis. Because of the prominent role of transforming growth factor beta (TGF-beta) in ECM synthesis, this study was undertaken to determine the possible interactions between Ets1 and the TGF-beta pathway. Experiments using adenoviral delivery of Ets1 in human fibroblasts have established that Ets1 strongly suppresses TGF-beta induction of collagen type I and other matrix-related genes and reverses TGF-beta-dependent inhibition of MMP-1. Subsequent experiments utilizing COLIA2 promoter demonstrated that Ets1 in the presence of TGF-beta signaling interferes with the stimulatory role of p300. To gain further insight into the mechanism of Ets1 inhibition of the TGF-beta signaling, the protein levels and post-translational modifications of Ets1 after TGF-beta treatment were analyzed. The level of total Ets1 protein was not affected after 24 h of TGF-beta stimulation. Moreover, TGF-beta did not affect either serine or threonine phosphorylation levels of Ets1. However, TGF-beta induced rapid and prolonged lysine acetylation of Ets1. In addition, analyses of endogenous p300-Ets1 complexes revealed that acetylated Ets1 is preferentially associated with the p3oo/CBP complexes. TGF-beta treatment leads to dissociation of Ets1 from the CBP/p300 complexes. Together, these findings suggest that elevated expression of Ets1 in fibroblasts fundamentally alters their responses to TGF-beta in favor of matrix degradation and away from matrix deposition as exemplified by arthritis and cancer.	Med Univ S Carolina, Div Rheumatol & Immunol, Dept Med, Charleston, SC 29425 USA; Med Univ S Carolina, Lab Canc Genom, Hollings Canc Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Trojanowska, M (corresponding author), Med Univ S Carolina, Div Rheumatol & Immunol, Dept Med, 96 Jonathan Lucas St,Suite 912, Charleston, SC 29425 USA.	trojanme@musc.edu	Czuwara, Joanna/AAK-4504-2020	Trojanowska, Maria/0000-0001-9550-7178	NCI NIH HHS [P01-CA78582] Funding Source: Medline; NIAMS NIH HHS [AR 44883, AR 42334] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA078582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044883, R01AR042334] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abraham DJ, 2000, J BIOL CHEM, V275, P15220, DOI 10.1074/jbc.275.20.15220; Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Akhurst RJ, 1999, J PATHOL, V187, P82, DOI 10.1002/(SICI)1096-9896(199901)187:1<82::AID-PATH248>3.0.CO;2-8; Basuyaux JP, 1997, J BIOL CHEM, V272, P26188, DOI 10.1074/jbc.272.42.26188; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; BOLON I, 1995, AM J PATHOL, V147, P1298; BONIFACINO JS, 2000, CURRENT PROTOCOLS CE; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Buttice G, 1996, ONCOGENE, V13, P2297; Chan HM, 2001, NAT CELL BIOL, V3, P667, DOI 10.1038/35083062; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen SJ, 1999, J INVEST DERMATOL, V112, P49, DOI 10.1046/j.1523-1747.1999.00477.x; Chen SJ, 2000, J CELL PHYSIOL, V183, P381, DOI 10.1002/(SICI)1097-4652(200006)183:3<381::AID-JCP11>3.0.CO;2-O; COFFER P, 1994, ONCOGENE, V9, P911; Cowley DO, 2000, GENE DEV, V14, P366; Czuwara-Ladykowska J, 2001, J BIOL CHEM, V276, P20839, DOI 10.1074/jbc.M010133200; DALAL BI, 1993, AM J PATHOL, V143, P381; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Ghosh AK, 2001, J BIOL CHEM, V276, P11041, DOI 10.1074/jbc.M004709200; Ghosh AK, 2000, ONCOGENE, V19, P3546, DOI 10.1038/sj.onc.1203693; Gilles F, 1996, EXP CELL RES, V222, P370, DOI 10.1006/excr.1996.0046; GOLAY J, 1988, CELL, V55, P1147, DOI 10.1016/0092-8674(88)90259-0; GORSCH SM, 1992, CANCER RES, V52, P6949; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hen BG, 2001, J BIOL CHEM, V276, P7937, DOI 10.1074/jbc.M007470200; Ichiki Y, 1997, J RHEUMATOL, V24, P90; ISHIKAWA O, 1990, BIOCHEM BIOPH RES CO, V169, P232, DOI 10.1016/0006-291X(90)91458-5; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Jayaraman G, 1999, J BIOL CHEM, V274, P17342, DOI 10.1074/jbc.274.24.17342; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; KOIZUMI S, 1990, ONCOGENE, V5, P675; LAFYATIS R, 1989, J IMMUNOL, V143, P1142; Le Gallic L, 1999, MOL CELL BIOL, V19, P4121; Li RZ, 2000, ONCOGENE, V19, P745, DOI 10.1038/sj.onc.1203385; Lindemann RK, 2001, J BIOL CHEM, V276, P46661, DOI 10.1074/jbc.M105816200; LUBINUS M, 1994, J BIOL CHEM, V269, P9822; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Mauviel A, 1996, J BIOL CHEM, V271, P10917, DOI 10.1074/jbc.271.18.10917; McEarchern JA, 2001, INT J CANCER, V91, P76, DOI 10.1002/1097-0215(20010101)91:1<76::AID-IJC1012>3.0.CO;2-8; MullerLadner U, 1996, AM J PATHOL, V149, P1607; Naito S, 2000, PATHOL RES PRACT, V196, P103, DOI 10.1016/S0344-0338(00)80041-2; NUNN MF, 1989, J VIROL, V63, P398, DOI 10.1128/JVI.63.1.398-402.1989; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; OVERALL CM, 1989, J BIOL CHEM, V264, P1860; Poncelet AC, 1999, KIDNEY INT, V56, P1354, DOI 10.1046/j.1523-1755.1999.00680.x; Poncelet AC, 2001, J BIOL CHEM, V276, P6983, DOI 10.1074/jbc.M006442200; Redlich K, 2001, ARTHRITIS RHEUM, V44, P266, DOI 10.1002/1529-0131(200102)44:2<266::AID-ANR43>3.3.CO;2-7; Reiss M, 1997, BREAST CANCER RES TR, V45, P81, DOI 10.1023/A:1005865812918; Rutter JL, 1998, CANCER RES, V58, P5321; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Santala M, 1998, BRIT J CANCER, V77, P1825, DOI 10.1038/bjc.1998.303; SETH A, 1989, P NATL ACAD SCI USA, V86, P7833, DOI 10.1073/pnas.86.20.7833; Shirasaki F, 1999, ONCOGENE, V18, P7755, DOI 10.1038/sj.onc.1203360; Taipale J, 1998, ADV CANCER RES, V75, P87, DOI 10.1016/S0065-230X(08)60740-X; Trojanowska M, 2000, ONCOGENE, V19, P6464, DOI 10.1038/sj.onc.1204043; Verrecchia F, 2001, ONCOGENE, V20, P3332, DOI 10.1038/sj.onc.1204448; Verrecchia F, 2001, ONCOGENE, V20, P2205, DOI 10.1038/sj.onc.1204347; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; WASYLYK C, 1991, EMBO J, V10, P1127, DOI 10.1002/j.1460-2075.1991.tb08053.x; Watabe T, 1998, INT J CANCER, V77, P128, DOI 10.1002/(SICI)1097-0215(19980703)77:1<128::AID-IJC20>3.0.CO;2-9; WATSON DK, 1990, ADV AP BIOT, V6, P221; Wernert N, 1997, VIRCHOWS ARCH, V430, P433, DOI 10.1007/s004280050053; Westermarck J, 1997, ONCOGENE, V14, P2651, DOI 10.1038/sj.onc.1201111; Yang BS, 1996, MOL CELL BIOL, V16, P538; Yang C, 1998, MOL CELL BIOL, V18, P2218, DOI 10.1128/MCB.18.4.2218; Yuan WH, 2001, J BIOL CHEM, V276, P38502, DOI 10.1074/jbc.M107081200; Zhang W, 2000, J BIOL CHEM, V275, P39237, DOI 10.1074/jbc.M003339200	67	101	102	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20399	20408		10.1074/jbc.M200206200	http://dx.doi.org/10.1074/jbc.M200206200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11919190	hybrid			2022-12-27	WOS:000176204500039
J	Pizzi, M; Goffi, F; Boroni, F; Benarese, M; Perkins, SE; Liou, HC; Spano, P				Pizzi, M; Goffi, F; Boroni, F; Benarese, M; Perkins, SE; Liou, HC; Spano, P			Opposing roles for NF-kappa B/Rel factors p65 and c-Rel in the modulation of neuron survival elicited by glutamate and interleukin-1 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; B ACTIVATION; NUCLEAR TRANSLOCATION; HIPPOCAMPAL-NEURONS; GENE-EXPRESSION; CELLS; ALPHA; INDUCTION	The nuclear transcription factors NF-kappaB/Rel have been shown to function as key regulators of either cell death or survival in neuronal cells. Here, we investigated whether selective activation of diverse NF-kappaB/Rel family members might lead to distinct effects on neuron viability. In both cultured rat cerebellar granule cells and mouse hippocampal slices, we examined NF-kappaB/Rel activation induced by two opposing modulators of cell viability: 1) interleukin-1beta (IL-1beta), which promotes neuron survival and 2) glutamate, which can elicit toxicity. IL-1beta produced a prolonged stimulation of NF-kappaB/Rel factors by inducing both IkappaBbeta and IkappaBbeta degradation. Glutamate produced a delayed and transient activation of NF-kappaB/Rel, which was associated with a brief loss of IkappaBalpha. Moreover, IL-1beta activated the p50, p65, and c-Rel subunits of NF-kappaB/Rel, whereas glutamate activated only the p50 and p65 proteins. The inhibition of NF-kappaB/Rel protein expression by antisense oligonucleotides in cerebellar granule cells showed that p65 was involved in glutamate-mediated cell death, whereas c-Rel was essential for IL-1beta-preserved cell survival. Furthermore, the depletion of c-Rel in cultured neurons as well as in the hippocampus from the c-Rel(-/-) mouse converted the IL-1beta effect into toxicity. These findings suggest that, within a single neuron, the balance between cell death and survival in response to external stimuli may rely on the activation of distinct NF-kappaB/Rel proteins.	Univ Brescia, Sch Med, Dept Biomed Sci & Biotechnol, Div Pharmacol & Expt Therapeut, I-25123 Brescia, Italy; Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Lab Anim Facil, New York, NY 10021 USA	University of Brescia; Cornell University; Cornell University	Pizzi, M (corresponding author), Univ Brescia, Sch Med, Dept Biomed Sci & Biotechnol, Div Pharmacol & Expt Therapeut, Via Valsabbina 19, I-25123 Brescia, Italy.	pizzi@med.unibs.it	Pizzi, Marina/C-1452-2011; Spano, Pier Franco F/J-9944-2016; Spano, Pier Franco A/E-7621-2010; Pizzi, Marina/K-2064-2016	Spano, Pier Franco F/0000-0002-9906-0964; Pizzi, Marina/0000-0002-4857-5204				ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Bernard D, 2001, CANCER RES, V61, P2656; Bethea JR, 1998, J NEUROSCI, V18, P3251; Brooks PJ, 1996, J NEUROSCI, V16, P939; Chapman NR, 2000, J BIOL CHEM, V275, P4719, DOI 10.1074/jbc.275.7.4719; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; CHENG B, 1994, NEURON, V12, P139, DOI 10.1016/0896-6273(94)90159-7; Clemens JA, 1997, STROKE, V28, P1073, DOI 10.1161/01.STR.28.5.1073; Darville MI, 2000, ENDOCRINOLOGY, V141, P153, DOI 10.1210/en.141.1.153; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Grilli M, 1996, J BIOL CHEM, V271, P15002, DOI 10.1074/jbc.271.25.15002; Grilli M, 1999, CELL DEATH DIFFER, V6, P22, DOI 10.1038/sj.cdd.4400463; Grilli M, 1996, SCIENCE, V274, P1383, DOI 10.1126/science.274.5291.1383; Grumont RJ, 1999, GENE DEV, V13, P400, DOI 10.1101/gad.13.4.400; Heck S, 1999, J BIOL CHEM, V274, P9828, DOI 10.1074/jbc.274.14.9828; Hunot S, 1997, P NATL ACAD SCI USA, V94, P7531, DOI 10.1073/pnas.94.14.7531; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; KALTSCHMIDT B, 1993, MOL ASPECTS MED, V14, P171, DOI 10.1016/0098-2997(93)90004-W; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Kaltschmidt B, 1999, P NATL ACAD SCI USA, V96, P9409, DOI 10.1073/pnas.96.16.9409; Koulich E, 2001, J NEUROCHEM, V76, P1188, DOI 10.1046/j.1471-4159.2001.00134.x; Lezoualc'h F, 1998, J NEUROSCI, V18, P3224; Lin SC, 1998, MOL CELL BIOL, V18, P5523, DOI 10.1128/MCB.18.9.5523; Liou HC, 1999, INT IMMUNOL, V11, P361, DOI 10.1093/intimm/11.3.361; Liou HC, 1993, CURR OPIN CELL BIOL, V5, P477, DOI 10.1016/0955-0674(93)90014-H; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Maggirwar SB, 1998, J NEUROSCI, V18, P10356; Mattson MP, 1997, J NEUROSCI RES, V49, P681, DOI 10.1002/(SICI)1097-4547(19970915)49:6<681::AID-JNR3>3.0.CO;2-3; Middleton G, 2000, J CELL BIOL, V148, P325, DOI 10.1083/jcb.148.2.325; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Owyang AM, 2001, J IMMUNOL, V167, P4948, DOI 10.4049/jimmunol.167.9.4948; Perkins ND, 1997, INT J BIOCHEM CELL B, V29, P1433, DOI 10.1016/S1357-2725(97)00088-5; Phelps CB, 2000, J BIOL CHEM, V275, P29840, DOI 10.1074/jbc.M004899200; Pizzi M, 1996, EUR J NEUROSCI, V8, P1516, DOI 10.1111/j.1460-9568.1996.tb01614.x; Pizzi M, 1996, MOL PHARMACOL, V49, P586; Qin ZH, 1999, J NEUROSCI, V19, P4023; Qin ZH, 2000, MOL BRAIN RES, V80, P111, DOI 10.1016/S0169-328X(00)00147-9; Qiu JX, 2001, J NEUROSCI RES, V64, P223, DOI 10.1002/jnr.1070; Roshak AK, 1996, J BIOL CHEM, V271, P31496, DOI 10.1074/jbc.271.49.31496; Schmitz ML, 2001, TRENDS BIOCHEM SCI, V26, P186, DOI 10.1016/S0968-0004(00)01753-9; Schneider A, 1999, NAT MED, V5, P554, DOI 10.1038/8432; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; STRIJBOS PJLM, 1995, J NEUROSCI, V15, P3468; Tam WF, 2001, J BIOL CHEM, V276, P7701, DOI 10.1074/jbc.C000916200; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; Terai K, 1996, BRAIN RES, V739, P343, DOI 10.1016/S0006-8993(96)01073-6; Terai K, 1996, BRAIN RES, V735, P159; Yu ZF, 1999, J NEUROSCI, V19, P8856, DOI 10.1523/JNEUROSCI.19-20-08856.1999; Zong WX, 1999, GENE DEV, V13, P382, DOI 10.1101/gad.13.4.382	50	133	138	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20717	20723		10.1074/jbc.M201014200	http://dx.doi.org/10.1074/jbc.M201014200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11912207	hybrid			2022-12-27	WOS:000176204500080
J	Ahn, JY; Li, XH; Davis, HL; Canman, CE				Ahn, JY; Li, XH; Davis, HL; Canman, CE			Phosphorylation of threonine 68 promotes oligomerization and autophosphorylation of the Chk2 protein kinase via the forkhead-associated domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE CHECKPOINT; LI-FRAUMENI-SYNDROME; FHA DOMAIN; IONIZING-RADIATION; IN-VIVO; MUTATION; P53; ACTIVATION; CANCER; CDS1	Phosphorylation of Thr-68 by the ataxia telangiectasia-mutated is necessary for efficient activation of Chk2 when cells are exposed to ionizing radiation. By an unknown mechanism, this initial event promotes additional autophosphorylation events including modifications of Thr-383 and Thr-387, two amino acid residues located within the activation loop segment within the Chk2 catalytic domain. Chk2 and related kinases possess one or more Forkhead-associated (FHA) domains that are phosphopeptide-binding modules believed to be crucial for their checkpoint control activities. We show that the Chk2 FHA domain is dispensable for Thr-68 phosphorylation but necessary for efficient autophosphorylation in response to ionizing radiation. Phosphorylation of Thr-68 promotes oligomerization of Chk2 by serving as a specific ligand for the FHA domain of another Chk2 molecule. In addition, Chk2 phosphorylates its own FHA domain, and this modification reduces its affinity for Thr-68-phosphorylated Chk2. Thus, activation of Chk2 in irradiated cells may occur through oligomerization of Chk2 via binding of the Thr-68-phosphorylated region of one Chk2 to the FHA domain of another. Oligomerization of Chk2 may therefore increase the efficiency of trans-autophosphorylation resulting in the release of active Chk2 monomers that proceed to enforce checkpoint control in irradiated cells.	St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Canman, CE (corresponding author), Pfizer Global Res & Dev, 2800 Plymouth Rd, Ann Arbor, MI 48105 USA.	Christine.Canman@Pfizer.com		, Christine/0000-0001-8892-7430	NATIONAL CANCER INSTITUTE [R01CA086861] Funding Source: NIH RePORTER; NCI NIH HHS [CA86861, R01 CA086861] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahn JY, 2000, CANCER RES, V60, P5934; Bartek J, 2001, NAT REV MOL CELL BIO, V2, P877, DOI 10.1038/35103059; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Blasina A, 1999, CURR BIOL, V9, P1, DOI 10.1016/S0960-9822(99)80041-4; Brown AL, 1999, P NATL ACAD SCI USA, V96, P3745, DOI 10.1073/pnas.96.7.3745; Chaturvedi P, 1999, ONCOGENE, V18, P4047, DOI 10.1038/sj.onc.1202925; Chehab NH, 2000, GENE DEV, V14, P278; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Haruki N, 2000, CANCER RES, V60, P4689; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hofmann WK, 2001, LEUKEMIA RES, V25, P333, DOI 10.1016/S0145-2126(00)00130-2; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Lee CH, 2001, J BIOL CHEM, V276, P30537, DOI 10.1074/jbc.M104414200; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Lee SB, 2001, CANCER RES, V61, P8062; Li J, 1999, P NATL ACAD SCI USA, V96, P7821, DOI 10.1073/pnas.96.14.7821; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Melchionna R, 2000, NAT CELL BIOL, V2, P762, DOI 10.1038/35036406; Miller CW, 2002, GENE CHROMOSOME CANC, V33, P17, DOI 10.1002/gcc.1207; Shieh SY, 2000, GENE DEV, V14, P289; Sun ZX, 1998, SCIENCE, V281, P272, DOI 10.1126/science.281.5374.272; Tomlinson GE, 1998, CANCER RES, V58, P3237; Vahteristo P, 2001, CANCER RES, V61, P5718; Ward IM, 2001, J BIOL CHEM, V276, P47755, DOI 10.1074/jbc.C100587200; Wu XL, 2001, J BIOL CHEM, V276, P2971, DOI 10.1074/jbc.M009727200; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	31	154	159	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19389	19395		10.1074/jbc.M200822200	http://dx.doi.org/10.1074/jbc.M200822200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11901158	hybrid			2022-12-27	WOS:000175894800021
J	Fong, AM; Alam, SM; Imai, T; Haribabu, B; Patel, DD				Fong, AM; Alam, SM; Imai, T; Haribabu, B; Patel, DD			CX(3)CR1 tyrosine sulfation enhances fractalkine-induced cell adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CX3C CHEMOKINE DOMAIN; P-SELECTIN; GLYCOPROTEIN LIGAND-1; RECEPTOR CX(3)CR1; IDENTIFICATION; BINDING; RECOGNITION; ACTIVATION; CONTRIBUTE; CONSENSUS	Fractalkine is a unique CX3C chemokine/mucin hybrid molecule that functions like selectins in inducing the capture of receptor-expressing cells. Because of the importance of tyrosine sulfation for ligand binding of the selectin ligand PSGLl, we tested the role of tyrosine sulfation for CX(3)CR1 function in cell adhesion. Tyrosine residues 14 and 22 in the N terminus of CX(3)CR1 were mutated to phenylalanine and stably expressed on K562 cells. Cells expressing CX(3)CR1-Y14F were competent in signal transduction but defective in capture by and firm adhesion to immobilized fractalkine under physiologic flow conditions. In static binding assays, CX(3)CR1-Y14F mutants had a 2-4-fold decreased affinity to fractalkine compared with wild type CX(3)CR1. By surface plasmon resonance measurements of fractalkine binding to biosensor chip-immobilized cell membranes, CX(3)CR1-Y14F mutants had a 100-fold decreased affinity to fractalkine. CX(3)CR1-expressing cell membranes treated with arylsulfatase to desulfate tyrosine residues also showed a 100-fold decreased affinity for fractalkine. Finally, synthesized, sulfated N-terminal CX(3)CR1 peptides immobilized on biosensor chips showed a higher affinity for fractalkine than non-sulfated peptides. Thus, we conclude that sulfation of tyrosine 14 enhances the function of CX(3)CR1 in cell capture and firm adhesion. Further, tyrosine sulfation may represent a general mechanism utilized by molecules that function in the rapid capture of circulating leukocytes.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Kinki Univ, Sch Med, Dept Microbiol, Osaka 5898511, Japan	Duke University; Kindai University (Kinki University)	Patel, DD (corresponding author), Duke Univ, Med Ctr, Dept Med, 223 Med Sci Res Bldg,Box 2632, Durham, NC 27710 USA.	patel003@mc.duke.edu	Alam, S. Munir/AAC-6711-2019; Bodduluri, Haribabu/A-2584-2010	Bodduluri, Haribabu/0000-0002-8261-3294	NIAMS NIH HHS [AR39162] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR039162] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALI H, 1994, J BIOL CHEM, V269, P24557; ASA D, 1995, J BIOL CHEM, V270, P11662, DOI 10.1074/jbc.270.19.11662; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Bundgaard JR, 1997, J BIOL CHEM, V272, P21700, DOI 10.1074/jbc.272.35.21700; Combadiere C, 1998, J BIOL CHEM, V273, P23799, DOI 10.1074/jbc.273.37.23799; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Farzan M, 2001, J EXP MED, V193, P1059, DOI 10.1084/jem.193.9.1059; Faure S, 2000, SCIENCE, V287, P2274, DOI 10.1126/science.287.5461.2274; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Fong AM, 2000, J BIOL CHEM, V275, P3781, DOI 10.1074/jbc.275.6.3781; Goda S, 2000, J IMMUNOL, V164, P4313, DOI 10.4049/jimmunol.164.8.4313; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Harrison JK, 2001, J BIOL CHEM, V276, P21632, DOI 10.1074/jbc.M010261200; Haskell CA, 2001, J CLIN INVEST, V108, P679, DOI 10.1172/JCI12976; Haskell CA, 1999, J BIOL CHEM, V274, P10053, DOI 10.1074/jbc.274.15.10053; HOFSTEENGE J, 1990, EUR J BIOCHEM, V188, P55, DOI 10.1111/j.1432-1033.1990.tb15370.x; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; LEYTE A, 1991, J BIOL CHEM, V266, P740; Liu W, 1998, J BIOL CHEM, V273, P7078, DOI 10.1074/jbc.273.12.7078; Mizoue LS, 1999, BIOCHEMISTRY-US, V38, P1402, DOI 10.1021/bi9820614; MOORE KL, 1992, J CELL BIOL, V118, P445, DOI 10.1083/jcb.118.2.445; Pan Y, 1997, NATURE, V387, P611, DOI 10.1038/42491; POUYANI T, 1995, CELL, V83, P333, DOI 10.1016/0092-8674(95)90174-4; Preobrazhensky AA, 2000, J IMMUNOL, V165, P5295, DOI 10.4049/jimmunol.165.9.5295; Ramachandran V, 1999, P NATL ACAD SCI USA, V96, P13771, DOI 10.1073/pnas.96.24.13771; Robinson LA, 2000, J IMMUNOL, V165, P6067, DOI 10.4049/jimmunol.165.11.6067; Snapp KR, 1998, BLOOD, V91, P154, DOI 10.1182/blood.V91.1.154.154_154_164; Sykulev Y, 1998, IMMUNITY, V9, P475, DOI 10.1016/S1074-7613(00)80631-7; WILKINS PP, 1995, J BIOL CHEM, V270, P22677, DOI 10.1074/jbc.270.39.22677; Yoneda O, 2000, J IMMUNOL, V164, P4055, DOI 10.4049/jimmunol.164.8.4055	31	80	87	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19418	19423		10.1074/jbc.M201396200	http://dx.doi.org/10.1074/jbc.M201396200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11909868	hybrid			2022-12-27	WOS:000175894800025
J	Hama, J; Suri, C; Haremaki, T; Weinstein, DC				Hama, J; Suri, C; Haremaki, T; Weinstein, DC			The molecular basis of Src kinase specificity during vertebrate mesoderm formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE; XENOPUS; INDUCTION; PROTEIN; INHIBITION; ACTIVATION; EXPRESSION; XWNT-8; LALOO	Members of the Src family of non-receptor tyrosine kinases play a critical role in mesoderm formation in the frog, Xenopus laevis, acting as required mediators downstream of the fibroblast growth factor receptor. At least four members of this gene family, Sre, Fyn, Yes, and Laloo, are expressed during early embryonic development. Ectopic expression of Laloo and Fyn, but not Src, induce mesoderm in ectodermal explants, indicating that these factors are non-redundant during early vertebrate development. Here we investigate the basis for the differential activity of the Src and Laloo kinases during mesoderm formation. We demonstrate that although both Src and Laloo physically interact with the substrate protein SNT-1/FRS2alpha only Laloo phosphorylates SNT-1, an event previously shown to be required for the activity of the latter and for mesoderm induction in vivo. We show that Src is enzymatically capable of stimulating mesoderm formation, as an activated Sre construct both phosphorylates SNT-1 and induces mesoderm in explant cultures. However, a chimeric Laloo construct containing a Src C-terminal tail is inactive, suggesting that the early embryo contains a specific Laloo-activating, or Src-inactivating, factor. Finally, through further chimeric analysis, we provide evidence to suggest that differences in Laloo and Sre activity are also mediated by the SH2, SH3, and kinase domains of these molecules.	CUNY Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Weinstein, DC (corresponding author), CUNY Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, 1 Gustave L Levy Pl,Box 1215, New York, NY 10029 USA.	weinsd01@doc.mssm.edu		Weinstein, Daniel/0000-0001-7832-9285	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061671] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM61671] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; BASSEZ T, 1990, DEVELOPMENT, V110, P955; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; CHRISTIAN JL, 1991, DEVELOPMENT, V111, P1045; Hadari YR, 1998, MOL CELL BIOL, V18, P3966, DOI 10.1128/MCB.18.7.3966; Hama J, 2001, MECH DEVELOP, V109, P195, DOI 10.1016/S0925-4773(01)00524-X; HEMMATIBRIVANLOU A, 1994, CELL, V77, P273, DOI 10.1016/0092-8674(94)90319-0; KLEIN PS, 1994, ENDOCR REV, V15, P326, DOI 10.1210/er.15.3.326; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; KRIEG PA, 1989, DEV BIOL, V133, P93, DOI 10.1016/0012-1606(89)90300-X; Kusakabe M, 2001, EMBO REP, V2, P727, DOI 10.1093/embo-reports/kve152; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; SMITH WC, 1991, CELL, V67, P753, DOI 10.1016/0092-8674(91)90070-F; Song Y, 2001, ONCOGENE, V20, P5210, DOI 10.1038/sj.onc.1204672; STEELE RE, 1985, NUCLEIC ACIDS RES, V13, P1747, DOI 10.1093/nar/13.5.1747; STEELE RE, 1989, ONCOGENE RES, V4, P223; SUPERTIFURGA G, 1995, FEBS LETT, V369, P62, DOI 10.1016/0014-5793(95)00636-N; TANG TL, 1995, CELL, V80, P473, DOI 10.1016/0092-8674(95)90498-0; Weinstein DC, 1997, DEVELOPMENT, V124, P4235; Weinstein DC, 1998, NATURE, V394, P904, DOI 10.1038/29808; Weinstein DC, 2001, DEV DYNAM, V220, P163, DOI 10.1002/1097-0177(2000)9999:9999<1::AID-DVDY1098>3.0.CO;2-5; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Xu H, 2001, J BIOL CHEM, V276, P13049, DOI 10.1074/jbc.M009925200	24	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19806	19810		10.1074/jbc.M110637200	http://dx.doi.org/10.1074/jbc.M110637200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11912191	hybrid			2022-12-27	WOS:000175894800074
J	Soeth, E; Thurber, DB; Smith, CL				Soeth, E; Thurber, DB; Smith, CL			The viral transactivator E1A regulates the mouse mammary tumor virus promoter in an isoform- and chromatin-specific manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG TERMINAL REPEAT; ADENOVIRUS E1A; GLUCOCORTICOID RECEPTOR; TRANSCRIPTION FACTOR; SACCHAROMYCES-CEREVISIAE; CELLULAR PROTEINS; BINDING PROTEIN; MMTV PROMOTER; ZINC-FINGER; ACTIVATION	Proteins encoded by the adenovirus E1A gene regulate both cellular and viral genes to mediate effects on cell cycle, differentiation, and cell growth control. We have identified the mouse mammary tumor virus (MMTV) promoter as a target of E1A action and investigated the role nucleoprotein structure plays in its response to E1A. Both 12 and 13 S forms target the MMTV promoter when it has a disorganized and accessible chromatin configuration. However, whereas the 13 S form is stimulatory, the 12 S form is repressive. When the MMTV promoter adopts an organized and repressed chromatin structure, it is targeted only by the 13 S form, which stimulates it. Although evidence indicates that E1A interacts with the SWI/SNF remodeling complex, E1A had no effect on chromatin remodeling at the MMTV promoter in organized chromatin. Analysis of E1A mutants showed that stimulation of the MMTV promoter is mediated solely through conserved region 3 and does not require interaction with Rb, p300/CBP-associated factor, or CBP/p300. Imaging analysis showed that E1A colocalizes with MMTV sequences in vivo, suggesting that it functions directly at the promoter. These results indicate that E1A stimulates the MMTV promoter in a fashion independent of chromatin conformation and through a direct mechanism involving interaction with the basal transcription machinery.	NCI, Signal Transduct Grp, Lab Receptor Biol & Gene Express, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Smith, CL (corresponding author), NCI, Signal Transduct Grp, Lab Receptor Biol & Gene Express, Ctr Canc Res,NIH, Bldg 41,Rm B608,41 Lib Dr MSC 5055, Bethesda, MD 20892 USA.							ARCHER TK, 1991, MOL CELL BIOL, V11, P688, DOI 10.1128/MCB.11.2.688; ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; Blanco JCG, 1998, GENE DEV, V12, P1638, DOI 10.1101/gad.12.11.1638; Boyer TG, 1999, NATURE, V399, P276, DOI 10.1038/20466; BROCKMANN D, 1995, CURR TOP MICROBIOL, V199, P81; Chakravarti D, 1999, CELL, V96, P393, DOI 10.1016/S0092-8674(00)80552-8; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; CORDINGLEY MG, 1987, CELL, V48, P261, DOI 10.1016/0092-8674(87)90429-6; DORSMAN JC, 1995, J VIROL, V69, P2962, DOI 10.1128/JVI.69.5.2962-2967.1995; Fletcher TM, 2000, MOL CELL BIOL, V20, P6466, DOI 10.1128/MCB.20.17.6466-6475.2000; FLINT J, 1989, ANNU REV GENET, V23, P141, DOI 10.1146/annurev.genet.23.1.141; Flint J, 1997, ANNU REV GENET, V31, P177, DOI 10.1146/annurev.genet.31.1.177; FOLKERS GE, 1995, MOL CELL BIOL, V15, P5868; Fragoso G, 1998, MOL CELL BIOL, V18, P3633, DOI 10.1128/MCB.18.6.3633; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; GEISBERG JV, 1995, MOL CELL BIOL, V15, P6283; GEISBERG JV, 1994, P NATL ACAD SCI USA, V91, P2488, DOI 10.1073/pnas.91.7.2488; Hamamori Y, 1999, CELL, V96, P405, DOI 10.1016/S0092-8674(00)80553-X; HORIKOSHI N, 1991, P NATL ACAD SCI USA, V88, P5124, DOI 10.1073/pnas.88.12.5124; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Klemm DJ, 1996, J BIOL CHEM, V271, P8082, DOI 10.1074/jbc.271.14.8082; Lee BH, 1997, P NATL ACAD SCI USA, V94, P4481, DOI 10.1073/pnas.94.9.4481; LEE WS, 1991, CELL, V67, P365, DOI 10.1016/0092-8674(91)90188-5; LEFEBVRE P, 1991, MOL CELL BIOL, V11, P2529, DOI 10.1128/MCB.11.5.2529; LIU F, 1994, NATURE, V368, P520, DOI 10.1038/368520a0; Mazzarelli JM, 1997, J VIROL, V71, P7978, DOI 10.1128/JVI.71.10.7978-7983.1997; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; MILLER ME, 1995, ONCOGENE, V11, P1623; Miller ME, 1996, MOL CELL BIOL, V16, P5737; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Muller WG, 2001, J CELL BIOL, V154, P33, DOI 10.1083/jcb.200011069; Mymryk JS, 1997, BIOCHEM CELL BIOL, V75, P95, DOI 10.1139/bcb-75-2-95; O'Connor MJ, 1999, J VIROL, V73, P3574; PENNIE WD, 1995, MOL CELL BIOL, V15, P2125; Perissi V, 1999, P NATL ACAD SCI USA, V96, P3652, DOI 10.1073/pnas.96.7.3652; Reid JL, 1998, EMBO J, V17, P4469, DOI 10.1093/emboj/17.15.4469; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; Sanchez TA, 2000, AM J RESP CELL MOL, V23, P670, DOI 10.1165/ajrcmb.23.5.3675; Sang NL, 1997, J CELL PHYSIOL, V170, P182, DOI 10.1002/(SICI)1097-4652(199702)170:2<182::AID-JCP10>3.0.CO;2-K; SINGH P, 1995, NATURE, V374, P562, DOI 10.1038/374562a0; Smith CL, 1997, J BIOL CHEM, V272, P27493, DOI 10.1074/jbc.272.44.27493; Smith CL, 1997, J BIOL CHEM, V272, P14227, DOI 10.1074/jbc.272.22.14227; SMITH CL, 1993, P NATL ACAD SCI USA, V90, P11202, DOI 10.1073/pnas.90.23.11202; Sudarsanam P, 2000, TRENDS GENET, V16, P345, DOI 10.1016/S0168-9525(00)02060-6; Torchia J, 1998, CURR OPIN CELL BIOL, V10, P373, DOI 10.1016/S0955-0674(98)80014-8; Wahlstrom GM, 1999, MOL ENDOCRINOL, V13, P1119, DOI 10.1210/me.13.7.1119; WANG HGH, 1995, J VIROL, V69, P7917, DOI 10.1128/JVI.69.12.7917-7924.1995; WANG HGH, 1993, J VIROL, V67, P476, DOI 10.1128/JVI.67.1.476-488.1993; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; Xu Y, 2000, MOL CELL BIOL, V20, P2138, DOI 10.1128/MCB.20.6.2138-2146.2000; YACIUK P, 1991, MOL CELL BIOL, V11, P5389, DOI 10.1128/MCB.11.11.5389; YOSHINAGA SK, 1992, SCIENCE, V258, P1598, DOI 10.1126/science.1360703	52	3	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19847	19854		10.1074/jbc.M200629200	http://dx.doi.org/10.1074/jbc.M200629200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11909860	hybrid			2022-12-27	WOS:000175894800080
J	Kozlenkov, A; Manes, T; Hoylaerts, MF; Millan, JL				Kozlenkov, A; Manes, T; Hoylaerts, MF; Millan, JL			Function assignment to conserved residues in mammalian alkaline phosphatases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-BINDING; UNCOMPETITIVE INHIBITION; REACTION-MECHANISM; MUTAGENESIS; CATALYSIS; MUTATIONS	We have probed the structural/functional relationship of key residues in human placental alkaline phosphatase (PLAP) and compared their properties with those of the corresponding residues in Escherichia coli alkaline phosphatase (ECAP). Mutations were introduced in wild-type PLAP, i.e. [E429]PLAP, and in some instances also in [G429]PLAP, which displays properties characteristic of the human germ cell alkaline phosphatase isozyme. All active site metal ligands, as well as residues in their vicinity, were substituted to alanines or to the homologous residues present in ECAP. We found that mutations at Zn2 or Mg sites had similar effects in PLAP and ECAP but that the environment of the Zn1 ion in PLAP is less affected by substitutions than that in ECAP. Substitutions of the Mg and Zn1 neighboring residues His-317 and His-153 increased k(cat) and increased K-m when compared with wild-type PLAP, contrary to what was predicted by the reciprocal substitutions in ECAP. All mammalian alkaline phosphatases (APs) have five cysteine residues (Cys-101, Cys-121, Cys-183, Cys-467, and Cys-474) per subunit, not homologous to any of the four cysteines in ECAP. By substituting each PLAP Cys by Ser, we found that disrupting the disulfide bond between Cys-121 and Cys-183 completely prevents the formation of the active enzyme, whereas the carboxyl-terminally located Cys-467-Cys-474 bond plays a lesser structural role. The substitution of the free Cys-101 did not significantly affect the properties of the enzyme. A distinguishing feature found in all mammalian APs, but not in ECAP, is the Tyr-367 residue involved in subunit contact and located close to the active site of the opposite subunit. We studied the A367 and F367 mutants of PLAP, as well as the corresponding double mutants containing G429. The mutations led to a 2-fold decrease in k(cat), a significant decrease in heat stability, and a significant disruption of inhibition by the uncompetitive inhibitors L-Phe and L-Leu. Our mutagenesis data, computer modeling, and docking predictions indicate that this residue contributes to the formation of the hydrophobic pocket that accommodates and stabilizes the side chain of the inhibitor during uncompetitive inhibition of mammalian APs.	Burnham Inst, La Jolla Canc Res Ctr, La Jolla, CA 92037 USA; Umea Univ, Dept Med Biosci, S-90185 Umea, Sweden; Univ Leuven, Ctr Mol & Vasc Biol, B-3000 Louvain, Belgium	Sanford Burnham Prebys Medical Discovery Institute; Umea University; KU Leuven	Millan, JL (corresponding author), Burnham Inst, La Jolla Canc Res Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	millan@burnham.org	Millan, Jose Luis/B-6580-2008	Hoylaerts, Marc/0000-0002-6474-3933				BOSSI M, 1993, J BIOL CHEM, V268, P25409; DIMAURO S, 2002, IN PRESS J BONE MINE; FISHMAN WH, 1971, ENZYMOLOGIA, V41, P141; HOYLAERTS MF, 1992, BIOCHEM J, V286, P23, DOI 10.1042/bj2860023; Hoylaerts MF, 1997, J BIOL CHEM, V272, P22781, DOI 10.1074/jbc.272.36.22781; HOYLAERTS MF, 1991, EUR J BIOCHEM, V202, P605, DOI 10.1111/j.1432-1033.1991.tb16414.x; HUMMER C, 1991, BIOCHEM J, V274, P91, DOI 10.1042/bj2740091; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KIM EE, 1990, CLIN CHIM ACTA, V186, P175, DOI 10.1016/0009-8981(90)90035-Q; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; Le Du MH, 2001, J BIOL CHEM, V276, P9158, DOI 10.1074/jbc.M009250200; MA L, 1994, J BIOL CHEM, V269, P31614; McComb Jr RB, 1979, ALKALINE PHOSPHATASE, DOI 10.1007/978-1-4613-2970-1_4; MICANOVIC R, 1988, P NATL ACAD SCI USA, V85, P1398, DOI 10.1073/pnas.85.5.1398; Mornet E, 2001, J BIOL CHEM, V276, P31171, DOI 10.1074/jbc.M102788200; MURPHY JE, 1995, J MOL BIOL, V253, P604, DOI 10.1006/jmbi.1995.0576; OGATA S, 1988, J BIOL CHEM, V263, P10489; RAMASAMY I, 1975, BIOCHIM BIOPHYS ACTA, V384, P146, DOI 10.1016/0005-2744(75)90104-7; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Sone M, 1997, J BIOL CHEM, V272, P6174, DOI 10.1074/jbc.272.10.6174; Tibbitts TT, 1996, J MOL BIOL, V257, P700, DOI 10.1006/jmbi.1996.0195; WATANABE T, 1991, J BIOL CHEM, V266, P21174; XU X, 1994, BIOCHEMISTRY-US, V33, P2279, DOI 10.1021/bi00174a039; XU X, 1993, BIOCHEMISTRY-US, V32, P10683, DOI 10.1021/bi00091a019; XU X, 1992, J BIOL CHEM, V267, P16244	25	63	76	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22992	22999		10.1074/jbc.M202298200	http://dx.doi.org/10.1074/jbc.M202298200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11937510	hybrid			2022-12-27	WOS:000176313600114
J	Toompuu, M; Yasukawa, T; Suzuki, T; Hakkinen, T; Spelbrink, JN; Watanabe, K; Jacobs, HT				Toompuu, M; Yasukawa, T; Suzuki, T; Hakkinen, T; Spelbrink, JN; Watanabe, K; Jacobs, HT			The 7472insC mitochondrial DNA mutation impairs the synthesis and extent of aminoacylation of tRNA(Ser(UCN)) but not its structure or rate of turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTICODON WOBBLE NUCLEOTIDE; OSTEOSARCOMA CELL CYBRIDS; TRANSFER-RNA SYNTHETASE; INHERITED HEARING-LOSS; POINT MUTATION; PALMOPLANTAR KERATODERMA; MOLECULAR PHENOTYPE; MODIFICATION DEFECT; MYOCLONUS EPILEPSY; RIBONUCLEIC-ACID	The 7472insC mitochondrial DNA mutation in the tRNA(Scr(UCN)) gene is associated with sensorineural deafness combined, in some patients,,with a wider neurological syndrome. In cultured cybrid cells it causes a 70% decrease in tRNA(Src(UCN)) abundance and mild respiratory impairment, previously suggested to be due to decreased tRNA stability. When mitochondrial transcription was blocked by ethidium bromide treatment, the half-life of the mutant tRNA was not significantly different from that of wild-type tRNA(Ser(UCN)). Over-expression of mitochondrial translational elongation factor EF-Tu also had no effect on the mutant phenotype. However, during recovery from prolonged ethidium bromide treatment, the synthesis of the mutant tRNA(Ser(UCN)) was specifically impaired, without polarity effects on downstream tRNAs of the light strand transcription unit. We infer that the mutation acts posttranscriptionally to decrease tRNA(Ser(UCN)) abundance by affecting its synthesis rather than its stability. The extent of aminoacylation of the mutant tRNA was also decreased by similar to25%. In contrast, the mutation had no detectable effect on tRNA(Ser(UCN)) base modification or structure other than the insertion of an extra guanosine templated by the mutation, which was structurally protected from nuclease digestion like the surrounding nucleotides. These findings indicate a common molecular process underlying sensorineural deafness caused by mitochondrial tRNA(Ser(UCN)) mutations.	Univ Tampere, Inst Med Technol, FIN-33014 Tampere, Finland; Tampere Univ Hosp, FIN-33014 Tampere, Finland; NICPB, EE-12618 Tallinn, Estonia; Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Tokyo 1138656, Japan; Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo 1138656, Japan; Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland	Tampere University; Tampere University; Tampere University Hospital; National Institute of Chemical Physics & Biophysics (NICPB); University of Tokyo; University of Tokyo; University of Glasgow	Jacobs, HT (corresponding author), Univ Tampere, Inst Med Technol, FIN-33014 Tampere, Finland.	howy.jacobs@uta.fi	Suzuki, Tsutomu/J-1776-2015; Yasukawa, Takehiro/AAP-1335-2020; Jacobs, Howard T/G-2434-2011; Spelbrink, Johannes N/L-4661-2015	Suzuki, Tsutomu/0000-0002-9731-1731; Spelbrink, Johannes N/0000-0002-9756-2602; Jacobs, Howard/0000-0003-1895-6003; Yasukawa, Takehiro/0000-0001-9531-8780				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Asahara H, 1993, NUCL ACIDS S SER, V29, P207; BINDOFF LA, 1993, J BIOL CHEM, V268, P19559; Borner GV, 2000, HUM MOL GENET, V9, P467, DOI 10.1093/hmg/9.4.467; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai YC, 2000, J BIOL CHEM, V275, P20308, DOI 10.1074/jbc.M001899200; CARRARA G, 1989, CELL, V58, P37, DOI 10.1016/0092-8674(89)90400-5; Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199; DiMauro S, 2000, BRAIN PATHOL, V10, P431; DONISKELLER H, 1980, NUCLEIC ACIDS RES, V8, P3133, DOI 10.1093/nar/8.14.3133; Dunbar DR, 1996, HUM MOL GENET, V5, P123, DOI 10.1093/hmg/5.1.123; El Meziane A, 1998, NAT GENET, V18, P350; El Meziane A, 1998, HUM MOL GENET, V7, P2141, DOI 10.1093/hmg/7.13.2141; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; Enriquez JA, 1996, P NATL ACAD SCI USA, V93, P8300, DOI 10.1073/pnas.93.16.8300; Francisci S, 1998, CURR GENET, V33, P110, DOI 10.1007/s002940050315; GELFAND R, 1981, MOL CELL BIOL, V1, P497, DOI 10.1128/MCB.1.6.497; Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868; Helm M, 1999, NUCLEIC ACIDS RES, V27, P756, DOI 10.1093/nar/27.3.756; Hutchin TP, 2000, J MED GENET, V37, P692, DOI 10.1136/jmg.37.9.692; Jaksch M, 1998, ANN NEUROL, V44, P635, DOI 10.1002/ana.410440409; Kaufmann P, 1996, ANN NEUROL, V40, P172, DOI 10.1002/ana.410400208; Kelley SO, 2000, NAT STRUCT BIOL, V7, P862, DOI 10.1038/79612; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; KNIGHT E, 1969, BIOCHEMISTRY-US, V8, P5089, DOI 10.1021/bi00840a062; KRUPP JL, 1988, NUCLEIC ACIDS RES, V16, P770, DOI 10.1093/nar/16.2.770; KUCHINO Y, 1987, METHOD ENZYMOL, V155, P379; Levinger L, 2001, NUCLEIC ACIDS RES, V29, P4334, DOI 10.1093/nar/29.21.4334; Lynn S, 1998, DIABETES, V47, P1800, DOI 10.2337/diabetes.47.11.1800; Mansergh FC, 1999, AM J HUM GENET, V64, P971, DOI 10.1086/302344; Martin L, 2000, BRIT J DERMATOL, V143, P876, DOI 10.1046/j.1365-2133.2000.03797.x; MASUCCI JP, 1995, MOL CELL BIOL, V15, P2872; Mohan A, 2000, J MOL BIOL, V303, P605, DOI 10.1006/jmbi.2000.4162; NAKAMURA M, 1995, BIOCHEM BIOPH RES CO, V214, P86, DOI 10.1006/bbrc.1995.2260; Nashimoto M, 1999, J MOL BIOL, V287, P727, DOI 10.1006/jmbi.1999.2639; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Puranam RS, 2001, MOL CELL BIOL, V21, P548, DOI 10.1128/MCB.21.2.548-561.2001; Reid FM, 1997, HUM MOL GENET, V6, P443, DOI 10.1093/hmg/6.3.443; Rinaldi T, 1997, CURR GENET, V31, P494, DOI 10.1007/s002940050235; ROSSMANITH W, 1995, J BIOL CHEM, V270, P12885, DOI 10.1074/jbc.270.21.12885; Rossmanith W, 1998, FEBS LETT, V433, P269, DOI 10.1016/S0014-5793(98)00928-4; Sevior KB, 1998, AM J MED GENET, V75, P179, DOI 10.1002/(SICI)1096-8628(19980113)75:2<179::AID-AJMG11>3.3.CO;2-1; Shah Z H, 2001, Hum Mutat, V17, P433, DOI 10.1002/humu.1123; Shimada N, 2001, J BIOL CHEM, V276, P46770, DOI 10.1074/jbc.M105150200; Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; Sue CM, 1999, NEUROLOGY, V52, P1905, DOI 10.1212/WNL.52.9.1905; TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421; Toompuu M, 1999, HUM MOL GENET, V8, P2275, DOI 10.1093/hmg/8.12.2275; Verhoeven K, 1999, EUR J HUM GENET, V7, P45, DOI 10.1038/sj.ejhg.5200247; WAKITA K, 1994, NUCLEIC ACIDS RES, V22, P347, DOI 10.1093/nar/22.3.347; WELLS J, 1995, FEBS LETT, V358, P119, DOI 10.1016/0014-5793(94)01403-N; WU XQ, 1993, NUCLEIC ACIDS RES, V21, P5589, DOI 10.1093/nar/21.24.5589; Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251; Yasukawa T, 2000, FEBS LETT, V467, P175, DOI 10.1016/S0014-5793(00)01145-5; Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794; YOKAGAWA T, 1991, NUCLEIC ACIDS RES, V19, P6101; ZYLBER E, 1969, J MOL BIOL, V46, P201, DOI 10.1016/0022-2836(69)90067-9	58	42	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22240	22250		10.1074/jbc.M200338200	http://dx.doi.org/10.1074/jbc.M200338200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11919191	hybrid			2022-12-27	WOS:000176313600019
J	Werner, AB; de Vries, E; Tait, SWG; Bontjer, I; Borst, J				Werner, AB; de Vries, E; Tait, SWG; Bontjer, I; Borst, J			Bcl-2 family member Bfl-1/A1 sequesters truncated bid to inhibit its collaboration with pro-apoptotic Bak or Bax	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; CYTOCHROME-C RELEASE; ALPHA-INDUCED APOPTOSIS; CELL-DEATH; BH3 DOMAIN; MITOCHONDRIAL APOPTOSIS; P53-INDUCED APOPTOSIS; CASPASE ACTIVATION; SIGNALING PATHWAYS	Following caspase-8 mediated cleavage, a carboxyl-terminal fragment of the BH3 domain-only Bcl-2 family member Bid transmits the apoptotic signal from death receptors to mitochondria. In a screen for possible regulators of Bid, we defined Bfl-1/A1 as a potent Bid interacting protein. Bfl-1 is an anti-apoptotic Bcl-2 family member, whose preferential expression in hematopoietic cells and endothelium is controlled by inflammatory stimuli. Its mechanism of action is unknown. We find that Bfl-1 associates with both full-length Bid and truncated (t)Bid, via the Bid BH3 domain. Cellular expression of Bfl-1 confers protection against CD95- and Trail receptor-induced cytochrome c release. In vitro assays, using purified mitochondria and recombinant proteins, demonstrate that Bfl-1 binds full-length Bid, but does not interfere with its processing by caspase-8, or with its mitochondrial association. Confocal microscopy supports that Bfl-1, which at least in part constitutively localizes to mitochondria, does not impede tBid translocation. However, Bfl-1 remains tightly and selectively bound to tBid and blocks collaboration between tBid and Bax or Bak in the plane of the mitochondrial membrane, thereby preventing mitochondrial apoptotic activation. Lack of demonstrable interaction between Bfl-1 and Bak or Bax in the mitochondrial membrane suggests that Bfl-1 generally prevents the formation of a pro-apoptotic complex by sequestering BH3 domain-only proteins.	Netherlands Canc Inst, Div Cellular Biochem, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Borst, J (corresponding author), Netherlands Canc Inst, Div Cellular Biochem, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.			Tait, Stephen/0000-0001-7697-132X; Borst, Jannie/0000-0002-8043-5009				Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; CHOI SS, 1995, ONCOGENE, V11, P1693; D'Sa-Eipper C, 1998, ONCOGENE, V16, P3105, DOI 10.1038/sj.onc.1201851; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; DSaEipper C, 1996, CANCER RES, V56, P3879; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Duriez PJ, 2000, J BIOL CHEM, V275, P18099, DOI 10.1074/jbc.M908925199; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Grumont RJ, 1999, GENE DEV, V13, P400, DOI 10.1101/gad.13.4.400; Hamasaki A, 1998, J EXP MED, V188, P1985, DOI 10.1084/jem.188.11.1985; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Karsan A, 1996, J BIOL CHEM, V271, P27201, DOI 10.1074/jbc.271.44.27201; Karsan A, 1996, BLOOD, V87, P3089, DOI 10.1182/blood.V87.8.3089.bloodjournal8783089; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Kenny JJ, 1997, ONCOGENE, V14, P997, DOI 10.1038/sj.onc.1200898; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Kuss AW, 1999, EUR J IMMUNOL, V29, P3077, DOI 10.1002/(SICI)1521-4141(199910)29:10<3077::AID-IMMU3077>3.0.CO;2-R; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; LIN EY, 1993, J IMMUNOL, V151, P1979; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Mikhailov V, 2001, J BIOL CHEM, V276, P18361, DOI 10.1074/jbc.M100655200; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Orlofsky A, 1999, J IMMUNOL, V163, P412; PETIT PX, 1990, EUR J BIOCHEM, V194, P389, DOI 10.1111/j.1432-1033.1990.tb15632.x; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Smit L, 1996, J BIOL CHEM, V271, P8564, DOI 10.1074/jbc.271.15.8564; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tepper AD, 1999, J CLIN INVEST, V103, P971, DOI 10.1172/JCI5457; Tepper AD, 2000, J CELL BIOL, V150, P155, DOI 10.1083/jcb.150.1.155; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wang CY, 1999, MOL CELL BIOL, V19, P5923; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; YSSEL H, 1984, J IMMUNOL METHODS, V72, P219, DOI 10.1016/0022-1759(84)90450-2; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zhang H, 2000, J BIOL CHEM, V275, P11092, DOI 10.1074/jbc.275.15.11092; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601; Zong WX, 1999, GENE DEV, V13, P382, DOI 10.1101/gad.13.4.382	56	140	168	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22781	22788		10.1074/jbc.M201469200	http://dx.doi.org/10.1074/jbc.M201469200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11929871	hybrid			2022-12-27	WOS:000176313600087
J	Yang, HJ; Chiang, JH; Fitz-Gibbon, S; Lebel, M; Sartori, AA; Jiricny, J; Slupska, MM; Miller, JH				Yang, HJ; Chiang, JH; Fitz-Gibbon, S; Lebel, M; Sartori, AA; Jiricny, J; Slupska, MM; Miller, JH			Direct interaction between uracil-DNA glycosylase and a proliferating cell nuclear antigen homolog in the crenarchaeon Pyrobaculum aerophilum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE PROCESSIVITY FACTOR; CLAMP-LOADER COMPLEX; REPLICATION FACTOR-C; CRYSTAL-STRUCTURE; BIOCHEMICAL-CHARACTERIZATION; FUNCTIONAL INTERACTIONS; FLAP ENDONUCLEASE; SLIDING CLAMPS; ARCHAEON; PCNA	Proliferating cell nuclear antigen (PCNA) acts as a sliding clamp on duplex DNA. Its homologs, present in Eukarya and Archaea, are part of protein complexes that are indispensable for DNA replication and DNA repair. In Eukarya, PCNA is known to interact with more than a dozen different proteins, including a human major nuclear uracil-DNA glycosylase (hUNG2) involved in immediate postreplicative repair. In Archaea, only three classes of PCNA-binding proteins have been reported previously: replication factor C (the PCNA clamp loader), family B DNA polymerase, and flap endonuclease. In this study, we report a direct interaction between a uracil-DNA glycosylase (Pa-UDGa) and a PCNA homolog (Pa-PCNA1), both from the hyperthermophilic crenarchaeon Pyrobaculum aerophilum (T-opt = 100 degreesC). We demonstrate that the Pa-UDGa-Pa-PCNA1 complex is thermostable, and two hydrophobic amino acid residues on Pa-UDGa (Phe(191) and Len(192)) are shown to be crucial for this interaction. It is interesting to note that although Pa-UDGa has homologs throughout the Archaea and bacteria, it does not share significant sequence similarity with hUNG2. Nevertheless, our results raise the possibility that Pa-UDGa may be a functional analog of hUNG2 for PCNA-dependent postreplicative removal of misincorporated uracil.	Univ Calif Los Angeles, Dept Microbiol & Mol Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; CHUQ, Ctr Rech Cancerol, Quebec City, PQ GIR 2J6, Canada; Univ Zurich, Inst Med Radiobiol, CH-8008 Zurich, Switzerland; Paul Scherrer Inst, CH-8008 Zurich, Switzerland	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Laval University; University of Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Miller, JH (corresponding author), Univ Calif Los Angeles, Dept Microbiol & Mol Genet, 1602 Mol Sci Bldg,405 Hilgard Ave, Los Angeles, CA 90095 USA.	jhmiller@mbi.ucla.edu	Sartori, Alessandro/AAK-7840-2021	Sartori, Alessandro/0000-0003-2770-0333	NATIONAL CANCER INSTITUTE [T32CA009056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057917] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA09056] Funding Source: Medline; NIGMS NIH HHS [GM 57917] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bruck I, 2001, GENOME BIOL, V2; Cann IKO, 2001, J BACTERIOL, V183, P2614, DOI 10.1128/JB.183.8.2614-2623.2001; Cann IKO, 1999, J BACTERIOL, V181, P6591, DOI 10.1128/JB.181.21.6591-6599.1999; De Felice M, 1999, J MOL BIOL, V291, P47, DOI 10.1006/jmbi.1999.2939; Fitz-Gibbon ST, 2002, P NATL ACAD SCI USA, V99, P984, DOI 10.1073/pnas.241636498; FitzGibbon S, 1997, EXTREMOPHILES, V1, P36, DOI 10.1007/s007920050013; FUCHS R, 1994, COMPUT APPL BIOSCI, V10, P171; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Haracska L, 2001, MOL CELL BIOL, V21, P7199, DOI 10.1128/MCB.21.21.7199-7206.2001; Hingorani MM, 2000, CURR BIOL, V10, pR25, DOI 10.1016/S0960-9822(99)00252-3; Hinks JA, 2002, J BIOL CHEM, V277, P16936, DOI 10.1074/jbc.M200668200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hosfield DJ, 1998, J BIOL CHEM, V273, P27154, DOI 10.1074/jbc.273.42.27154; Hosfield DJ, 1998, CELL, V95, P135, DOI 10.1016/S0092-8674(00)81789-4; Hwang KY, 1998, NAT STRUCT BIOL, V5, P707, DOI 10.1038/1406; Iwai T, 2000, EXTREMOPHILES, V4, P357, DOI 10.1007/s007920070005; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Jeruzalmi D, 2001, CELL, V106, P417, DOI 10.1016/S0092-8674(01)00462-7; Kelman Z, 1998, TRENDS BIOCHEM SCI, V23, P236, DOI 10.1016/S0968-0004(98)01223-7; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Krokan HE, 2001, PROG NUCLEIC ACID RE, V68, P365; Krude T, 1999, CURR BIOL, V9, pR394, DOI 10.1016/S0960-9822(99)80251-6; Lebel M, 1999, J BIOL CHEM, V274, P37795, DOI 10.1074/jbc.274.53.37795; Matsui E, 1999, J BIOL CHEM, V274, P18297, DOI 10.1074/jbc.274.26.18297; Matsumiya S, 2001, PROTEIN SCI, V10, P17, DOI 10.1110/ps.36401; Moarefi I, 2000, J MOL BIOL, V296, P1215, DOI 10.1006/jmbi.1999.3511; Otterlei M, 1999, EMBO J, V18, P3834, DOI 10.1093/emboj/18.13.3834; Oyama T, 2001, MOL CELL, V8, P455, DOI 10.1016/S1097-2765(01)00328-8; Pisani FM, 2000, J MOL BIOL, V301, P61, DOI 10.1006/jmbi.2000.3964; Rao HGV, 1998, J BACTERIOL, V180, P5406, DOI 10.1128/JB.180.20.5406-5412.1998; Sandigursky M, 1999, CURR BIOL, V9, P531, DOI 10.1016/S0960-9822(99)80237-1; Sandigursky M, 2000, J BIOL CHEM, V275, P19146, DOI 10.1074/jbc.M001995200; Sartori AA, 2001, J BIOL CHEM, V276, P29979, DOI 10.1074/jbc.M102985200; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsurimoto Toshiki, 1999, Frontiers in Bioscience, V4, pd849, DOI 10.2741/Tsurimoto; VOLKL P, 1993, APPL ENVIRON MICROB, V59, P2918; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; ZHANG P, 1995, BIOCHEMISTRY-US, V34, P10703, DOI 10.1021/bi00034a002	41	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22271	22278		10.1074/jbc.M201820200	http://dx.doi.org/10.1074/jbc.M201820200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11927597	hybrid, Green Accepted			2022-12-27	WOS:000176313600022
J	Rao, RV; Castro-Obregon, S; Frankowski, H; Schuler, M; Stoka, V; del Rio, G; Bredesen, DE; Ellerby, HM				Rao, RV; Castro-Obregon, S; Frankowski, H; Schuler, M; Stoka, V; del Rio, G; Bredesen, DE; Ellerby, HM			Coupling endoplasmic reticulum stress to the cell death program - An Apaf-1-independent intrinsic pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-DEPENDENT ACTIVATION; CYTOCHROME-C; CASPASE ACTIVATION; POLY(ADP-RIBOSE) POLYMERASE; EPITHELIAL-CELLS; APOPTOSIS; PROTEIN; MITOCHONDRIAL; MECHANISM; INDUCTION	Accumulation of misfolded proteins and alterations in Ca2+ homeostasis in the endoplasmic reticulum (ER) causes ER stress and leads to cell death. However, the signal-transducing events that connect ER stress to cell death pathways are incompletely understood. To discern the pathway by which ER stress-induced cell death proceeds, we performed studies on Apaf-1(-/-) (null) fibroblasts that are known to be relatively resistant to apoptotic insults that induce the intrinsic apoptotic pathway. While these cells were resistant to cell death initiated by proapoptotic stimuli such as tamoxifen, they were susceptible to apoptosis induced by thapsigargin and brefeldin-A, both of which induce ER stress. This pathway was inhibited by catalytic mutants of caspase-12 and caspase-9 and by a peptide inhibitor of caspase-9 but not by caspase-8 inhibitors. Cleavage of caspases and poly(ADP-ribose) polymerase was observed in cell-free extracts lacking cytochrome c that were isolated from thapsigargin or brefeldin-treated cells. To define the molecular requirements for this Apaf-1 and cytochrome c-independent apoptosis pathway further, we developed a cell-free system of ER stress-induced apoptosis; the addition of microsomes prepared from ER stress-induced cells to a normal cell extract lacking mitochondria or cytochrome c resulted in processing of caspases. Immunodepletion experiments suggested that caspase-12 was one of the microsomal components required to activate downstream caspases. Thus, ER stress-induced programmed cell death defines a novel, mitochondrial and Apaf-1-independent, intrinsic apoptotic pathway.	Buck Inst Age Res, Novato, CA 94945 USA; Johannes Gutenberg Univ Mainz, Dept Med 3, D-55101 Mainz, Germany	Buck Institute for Research on Aging; Johannes Gutenberg University of Mainz	Bredesen, DE (corresponding author), Buck Inst Age Res, 8001 Redwood Blvd, Novato, CA 94945 USA.	dbredesen@buckinstitute.org; mellerby@buckinstitute.org	Stoka, Veronika/AAM-2283-2021; Castro-Obregon, Susana/AAE-5105-2020	Castro-Obregon, Susana/0000-0003-0549-5690	NCI NIH HHS [R01 CA84262] Funding Source: Medline; NIA NIH HHS [AG12282] Funding Source: Medline; NINDS NIH HHS [NS35155, NS33376] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA084262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035155, R01NS033376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG012282] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bitko V, 2001, J CELL BIOCHEM, V80, P441, DOI 10.1002/1097-4644(20010301)80:3<441::AID-JCB170>3.0.CO;2-C; Brewster JL, 2000, GENESIS, V26, P271, DOI 10.1002/(SICI)1526-968X(200004)26:4<271::AID-GENE90>3.0.CO;2-E; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Burgess DH, 1999, CELL DEATH DIFFER, V6, P256, DOI 10.1038/sj.cdd.4400489; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Chauhan D, 2001, J BIOL CHEM, V276, P24453, DOI 10.1074/jbc.C100074200; Chua BT, 2000, J BIOL CHEM, V275, P5131, DOI 10.1074/jbc.275.7.5131; Duan HJ, 1996, J BIOL CHEM, V271, P1621, DOI 10.1074/jbc.271.3.1621; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Ellerby HM, 1997, J NEUROSCI, V17, P6165; Finkel E, 2001, SCIENCE, V292, P624, DOI 10.1126/science.292.5517.624; Forcet C, 2001, P NATL ACAD SCI USA, V98, P3416, DOI 10.1073/pnas.051378298; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Hong NA, 2000, DEV BIOL, V220, P76, DOI 10.1006/dbio.2000.9615; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Koya RC, 2000, J BIOL CHEM, V275, P15343, DOI 10.1074/jbc.275.20.15343; Lankiewicz S, 2000, J BIOL CHEM, V275, P17064, DOI 10.1074/jbc.275.22.17064; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; LI LJ, 1992, J CELL PHYSIOL, V153, P575, DOI 10.1002/jcp.1041530319; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu H, 1997, J BIOL CHEM, V272, P21751, DOI 10.1074/jbc.272.35.21751; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Mattson MP, 2000, TRENDS NEUROSCI, V23, P222, DOI 10.1016/S0166-2236(00)01548-4; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Nakamura K, 2000, J CELL BIOL, V150, P731, DOI 10.1083/jcb.150.4.731; Ng FWH, 1997, J CELL BIOL, V139, P327, DOI 10.1083/jcb.139.2.327; Ozawa K, 1999, J BIOL CHEM, V274, P6397, DOI 10.1074/jbc.274.10.6397; Paschen W, 2001, CELL CALCIUM, V29, P1, DOI 10.1054/ceca.2000.0162; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Rao RV, 2001, J BIOL CHEM, V276, P33869, DOI 10.1074/jbc.M102225200; Saleh A, 1999, J BIOL CHEM, V274, P17941, DOI 10.1074/jbc.274.25.17941; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Song ZW, 1999, TRENDS CELL BIOL, V9, pM49, DOI 10.1016/S0968-0004(99)01485-1; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Tanaka S, 2000, J BIOL CHEM, V275, P10388, DOI 10.1074/jbc.275.14.10388; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wolf BB, 1999, J BIOL CHEM, V274, P20049, DOI 10.1074/jbc.274.29.20049; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	49	404	423	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21836	21842		10.1074/jbc.M202726200	http://dx.doi.org/10.1074/jbc.M202726200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11919205	hybrid			2022-12-27	WOS:000176286000093
J	Wilson, IBH				Wilson, IBH			Functional characterization of Drosophila melanogaster peptide O-xylosyltransferase, the key enzyme for proteoglycan chain initiation and member of the core 2/I N-acetylglucosaminyltransferase family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-D-XYLOSE; BETA-D-XYLOSYLTRANSFERASE; PROTEIN LINKAGE REGION; HEPARAN-SULFATE; CAENORHABDITIS-ELEGANS; MOLECULAR-CLONING; CHONDROITIN SULFATE; STRUCTURAL-ANALYSIS; TOUT-VELU; GENE	Chondroitin and heparan sulfates are essential players in animal development and are synthesized by a series of glycosyltransferases, the first of which is UDP-alpha-D-xylose:proteoglyean core protein beta-D-xylosyltransferase (EC 2.4.2.26). In the present study, a Drosophila melanogaster gene (CG17771), previously designated as a homologue of core 2 and I beta1,6-N-acetylglucosaminyltransferases, was shown to encode an active peptide O-xylosyltransferase. A novel coupled assay using matrix-assisted laser desorption ionization time-of-flight mass spectrometry demonstrated transfer of xylose to the peptide DDDSIEGSGGR. Analysis of sequences of various peptide O-xylosyltransferase and beta1,6-N-acetyl-glucosaminyltransferase sequences indicates that they are members of a large multifunctional protein family with a range of roles in U-glycosylation of either peptide or glycan substrates. Because in contrast to mammals, there is only one fly peptide O-xylosyltransferase gene, it is anticipated that, given the key roles of proteoglycans, the hereby designated oxt gene is essential for viability.	Univ Bodenkultur Wien, Inst Chem, Glycobiol Div, A-1190 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna	Wilson, IBH (corresponding author), Univ Bodenkultur Wien, Inst Chem, Glycobiol Div, Muthgasse 18, A-1190 Vienna, Austria.	iwilson@edv2.boku.ac.at	Wilson, Iain/B-3326-2009	Wilson, Iain/0000-0001-8996-1518				Almeida R, 1999, J BIOL CHEM, V274, P26165, DOI 10.1074/jbc.274.37.26165; Bai XM, 2001, J BIOL CHEM, V276, P48189, DOI 10.1074/jbc.M107339200; Bar-Peled M, 2001, P NATL ACAD SCI USA, V98, P12003, DOI 10.1073/pnas.211229198; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Benevolenskaya EV, 1998, MOL GEN GENET, V260, P131, DOI 10.1007/s004380050879; BIERHUIZEN MFA, 1995, GLYCOBIOLOGY, V5, P417, DOI 10.1093/glycob/5.4.417; Brinkmann T, 1997, J BIOL CHEM, V272, P11171; Bulik DA, 2000, P NATL ACAD SCI USA, V97, P10838, DOI 10.1073/pnas.97.20.10838; CAMBIAZO V, 1990, COMP BIOCHEM PHYS B, V97, P307, DOI 10.1016/0305-0491(90)90286-3; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; Duncan G, 2001, J CLIN INVEST, V108, P511, DOI 10.1172/JCI200113737; Ebner A, 2002, GENE, V287, P55, DOI 10.1016/S0378-1119(01)00895-2; Esko JD, 1996, CURR OPIN STRUC BIOL, V6, P663, DOI 10.1016/S0959-440X(96)80034-0; Fabini G, 2001, J BIOL CHEM, V276, P28058, DOI 10.1074/jbc.M100573200; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; Hacker U, 1997, DEVELOPMENT, V124, P3565; Haerry TE, 1997, DEVELOPMENT, V124, P3055; Herman T, 1999, P NATL ACAD SCI USA, V96, P974, DOI 10.1073/pnas.96.3.974; Kamimura K, 2001, J BIOL CHEM, V276, P17014, DOI 10.1074/jbc.M011354200; KEARNS AE, 1991, BIOCHEMISTRY-US, V30, P7477, DOI 10.1021/bi00244a016; Kim BT, 2002, J BIOL CHEM, V277, P13659, DOI 10.1074/jbc.M111630200; Kitagawa H, 1998, J BIOL CHEM, V273, P6615, DOI 10.1074/jbc.273.12.6615; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Krause E, 1999, ANAL CHEM, V71, P4160, DOI 10.1021/ac990298f; Kuhn J, 2001, J BIOL CHEM, V276, P4940, DOI 10.1074/jbc.M005111200; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Lin XH, 1999, DEVELOPMENT, V126, P3715; Majewska-Sawka A, 2000, PLANT PHYSIOL, V122, P3, DOI 10.1104/pp.122.1.3; Mirgorodskaya E, 2001, ANAL CHEM, V73, P1263, DOI 10.1021/ac001288d; Okajima T, 1999, J BIOL CHEM, V274, P22915, DOI 10.1074/jbc.274.33.22915; Pfeil U, 2000, GLYCOBIOLOGY, V10, P803, DOI 10.1093/glycob/10.8.803; POWERS PA, 1991, GENETICS, V129, P133; SCHWARTZ NB, 1974, CARBOHYD RES, V37, P167, DOI 10.1016/S0008-6215(00)87072-X; Schwientek T, 2000, J BIOL CHEM, V275, P11106, DOI 10.1074/jbc.275.15.11106; SEGEEV P, 2001, DEV DYNAM, V220, P122; Selleck SB, 2000, TRENDS GENET, V16, P206, DOI 10.1016/S0168-9525(00)01997-1; Selleck SB, 2001, SEMIN CELL DEV BIOL, V12, P127, DOI 10.1006/scdb.2000.0242; Sen J, 1998, CELL, V95, P471, DOI 10.1016/S0092-8674(00)81615-3; SPRING J, 1994, P NATL ACAD SCI USA, V91, P3334, DOI 10.1073/pnas.91.8.3334; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Toyoda H, 2000, J BIOL CHEM, V275, P21856, DOI 10.1074/jbc.M003540200; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; Warren CE, 2001, GLYCOBIOLOGY, V11, P979, DOI 10.1093/glycob/11.11.979	43	37	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21207	21212		10.1074/jbc.M201634200	http://dx.doi.org/10.1074/jbc.M201634200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11929872	hybrid			2022-12-27	WOS:000176286000013
J	Englert, RP; Shacter, E				Englert, RP; Shacter, E			Distinct modes of cell death induced by different reactive oxygen species - Amino acyl chloramines mediate hypochlorous acid-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEROXIDE-CHLORIDE SYSTEM; HUMAN NEUTROPHILS EMPLOY; HYDROGEN-PEROXIDE; N-CHLOROTAURINE; GROWTH ARREST; MYELOPEROXIDASE; TAURINE; CHLORINATION; OXIDATION; CHOLESTEROL	Oxidants derived from inflammatory phagocytes compose a key element of the host immune defense system and can kill mammalian cells by one of several different mechanisms. In this report, we compare mechanisms of cell death induced in human B lymphoma cells by the inflammatory oxidants superoxide, H2O2, and HOCl. The results indicate that the mode of cell death induced depends on the nature of the oxidant involved and the medium in which the cells are treated. When human Burkitt's lymphoma cells are exposed to superoxide anion, generated as a flux from xanthine and xanthine oxidase, the cells die by a non-apoptotic mechanism (pyknosis/necrosis) identical to that seen when cells are treated with a bolus of reagent H2O2. Addition of superoxide dismutase has no effect, whereas catalase is completely protective, indicating that exogenously generated superoxide kills cells entirely through its dismutation into H2O2. In contrast, cells treated in culture media with reagent 1100 die largely by apoptosis. HOCl-induced apoptosis is mediated by aminoacyl chloramines generated in the culture media and can be mimicked by treatment of cells with taurine chloramine or with long lived chloramines generated from modified Lys or Arg. The results suggest that in a physiological milieu in which O-2(-) and H2O2 are the main oxidants being formed, the principal form of cell death may be necrotic, and under inflammatory conditions in which HOCl is generated, apoptotic cell death may predominate.	US FDA, Ctr Biol Evaluat & Res, Div Therapeut Prot, Immunol Lab, Bethesda, MD 20892 USA; Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20815 USA	US Food & Drug Administration (FDA); Uniformed Services University of the Health Sciences - USA	Shacter, E (corresponding author), US FDA, Ctr Biol Evaluat & Res, Div Therapeut Prot, Immunol Lab, Bldg 29A,Rm 2A-11,29 Lincoln Dr, Bethesda, MD 20892 USA.	shacter@cber.fda.gov						Anderson MM, 1997, J CLIN INVEST, V99, P424, DOI 10.1172/JCI119176; BABIOR BM, 1978, NEW ENGL J MED, V298, P659, DOI 10.1056/NEJM197803232981205; Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; CANTIN AM, 1994, J CLIN INVEST, V93, P606, DOI 10.1172/JCI117013; Carr AC, 1996, ARCH BIOCHEM BIOPHYS, V332, P63, DOI 10.1006/abbi.1996.0317; Carr AC, 2001, FREE RADICAL BIO MED, V30, P526, DOI 10.1016/S0891-5849(00)00495-0; DALLEGRI F, 1986, J CLIN LAB IMMUNOL, V20, P37; DAVIES JMS, 1994, ARTHRITIS RHEUM, V37, P424, DOI 10.1002/art.1780370317; Eguchi Y, 1997, CANCER RES, V57, P1835; FOOTE CS, 1983, NATURE, V301, P715, DOI 10.1038/301715a0; Gardner AM, 1997, FREE RADICAL BIO MED, V22, P73, DOI 10.1016/S0891-5849(96)00235-3; GRISHAM MB, 1984, J BIOL CHEM, V259, P404; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; Hampton MB, 1997, FEBS LETT, V414, P552, DOI 10.1016/S0014-5793(97)01068-5; Hazen SL, 1998, BIOCHEMISTRY-US, V37, P6864, DOI 10.1021/bi972449j; Hazen SL, 1998, J BIOL CHEM, V273, P4997, DOI 10.1074/jbc.273.9.4997; HEINECKE JW, 1994, BIOCHEMISTRY-US, V33, P10127, DOI 10.1021/bi00199a041; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Klebanoff S.J., 1999, INFLAMMATION BASIC P, P721; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMPERT MB, 1983, BLOOD, V62, P645; LEARN DB, 1990, J LEUKOCYTE BIOL, V48, P174, DOI 10.1002/jlb.48.2.174; Lee Y, 1999, J BIOL CHEM, V274, P19792, DOI 10.1074/jbc.274.28.19792; Lee YJ, 2000, FREE RADICAL BIO MED, V29, P684, DOI 10.1016/S0891-5849(00)00366-X; Lee YJ, 1997, BLOOD, V89, P4480, DOI 10.1182/blood.V89.12.4480; Lelli JL, 1998, FREE RADICAL BIO MED, V25, P694, DOI 10.1016/S0891-5849(98)00107-5; LENNON SV, 1991, CELL PROLIFERAT, V24, P203, DOI 10.1111/j.1365-2184.1991.tb01150.x; LINDER M, 1992, NUTR BIOCH METABOLIS, P87; MAIER KL, 1989, FEBS LETT, V250, P221, DOI 10.1016/0014-5793(89)80725-2; MONNIER VM, 1991, GERONTOLOGY, V37, P152; Nagl M, 2000, ANTIMICROB AGENTS CH, V44, P2507, DOI 10.1128/AAC.44.9.2507-2513.2000; Palomba L, 1996, EUR J PHARMACOL, V318, P167, DOI 10.1016/S0014-2999(96)00763-7; Peskin AV, 2001, FREE RADICAL BIO MED, V30, P572, DOI 10.1016/S0891-5849(00)00506-2; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; SCHRAUFSTATTER IU, 1986, P NATL ACAD SCI USA, V83, P4908, DOI 10.1073/pnas.83.13.4908; SCHRAUFSTATTER IU, 1990, J CLIN INVEST, V85, P554, DOI 10.1172/JCI114472; Shacter E, 2000, BLOOD, V96, P307, DOI 10.1182/blood.V96.1.307.013k47_307_313; SPRAGG RG, 1985, J CLIN INVEST, V76, P1471, DOI 10.1172/JCI112126; STADTMAN ER, 1991, J BIOL CHEM, V266, P17201; TEST ST, 1984, J CLIN INVEST, V74, P1341, DOI 10.1172/JCI111544; TEST ST, 1986, ADV FREE RADICAL BIO, V2, P91, DOI 10.1016/S8755-9668(86)80025-4; Thomas E L, 1986, Methods Enzymol, V132, P585; THOMAS EL, 1983, J CLIN INVEST, V72, P441, DOI 10.1172/JCI110992; THOMAS EL, 1985, J BIOL CHEM, V260, P3321; THURMAN RG, 1972, EUR J BIOCHEM, V25, P420, DOI 10.1111/j.1432-1033.1972.tb01711.x; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; VANDENBERG JJM, 1993, J LIPID RES, V34, P2005; Vile GF, 2000, ARCH BIOCHEM BIOPHYS, V377, P122, DOI 10.1006/abbi.2000.1706; Vissers MCM, 1999, BIOCHEM J, V344, P443, DOI 10.1042/0264-6021:3440443; Wagner BA, 2000, J BIOL CHEM, V275, P22461, DOI 10.1074/jbc.M001434200; WEISS SJ, 1982, J CLIN INVEST, V70, P598, DOI 10.1172/JCI110652; WEISS SJ, 1983, SCIENCE, V222, P625, DOI 10.1126/science.6635660; WRIGHT CE, 1986, ANNU REV BIOCHEM, V55, P427, DOI 10.1146/annurev.bi.55.070186.002235; WYLLIE AH, 1992, OXFORD TXB PATHOLOGY, P141; ZGLICZYNSKI JM, 1968, EUR J BIOCHEM, V4, P540, DOI 10.1111/j.1432-1033.1968.tb00246.x; ZGLICZYNSKI JM, 1971, BIOCHIM BIOPHYS ACTA, V235, P419, DOI 10.1016/0005-2744(71)90281-6; Zimmermann KC, 2001, J ALLERGY CLIN IMMUN, V108, pS99, DOI 10.1067/mai.2001.117819	58	70	72	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20518	20526		10.1074/jbc.M200212200	http://dx.doi.org/10.1074/jbc.M200212200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11925431	hybrid			2022-12-27	WOS:000176204500055
J	Boucher, N; Wu, Y; Dumas, C; Dube, M; Sereno, D; Breton, M; Papadopoulou, B				Boucher, N; Wu, Y; Dumas, C; Dube, M; Sereno, D; Breton, M; Papadopoulou, B			A common mechanism of stage-regulated gene expression in Leishmania mediated by a conserved 3 '-untranslated region element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEINASE GENES; PROCYCLIN MESSENGER-RNAS; 3' UNTRANSLATED REGION; TRYPANOSOMA-BRUCEI; TRANSLATIONAL REGULATION; DEVELOPMENTAL REGULATION; DIFFERENTIAL EXPRESSION; CAENORHABDITIS-ELEGANS; DONOVANI AMASTIGOTES; AXENIC AMASTIGOTES	Developmental regulation of mRNA levels in trypanosomatid protozoa is determined post-transcriptionally and often involves sequences located in the 3'-untranslated regions (3'-UTR) of the mRNAs. We have previously identified a developmentally regulated gene family in Leishmania encoding the amastin surface proteins and showed that stage-specific accumulation of the amastin mRNA is mediated by sequences within the 3'-UTR. Here we identified a 450-nt region within the amastin 3'-UTR that can confer amastigote-specific gene expression by a novel mechanism that increases mRNA translation without an increase in mRNA stability. Remarkably, this 450-nt 3'-UTR element is highly conserved among a large number of Leishmania mRNAs in several Leishmania species. Here we show that several of these mRNAs are differentially expressed in the intracellular amastigote stage of the parasite and that the 450-nt conserved element in their 3'-UTRs is responsible for stage-specific gene regulation. We propose that the 450-nt conserved element, which is unlike any other regulatory element identified thus far, is part of a common mechanism of stage-regulated gene expression in Leishmania that regulates mRNA translation in response to intracellular stresses.	CHU Laval, Ctr Rech Infectiol, Ctr Rech, Laval, PQ G1V 4G2, Canada; Univ Laval, Fac Med, Dept Biol Med, Laval, PQ G1V 4G2, Canada	Laval University; Laval University	Papadopoulou, B (corresponding author), CHU Laval, Ctr Rech Infectiol, Ctr Rech, Laval, PQ G1V 4G2, Canada.		denis, Sereno/I-7242-2019	denis, Sereno/0000-0002-0034-9291				AGABIAN N, 1990, CELL, V61, P1157, DOI 10.1016/0092-8674(90)90674-4; ALY R, 1994, NUCLEIC ACIDS RES, V22, P2922, DOI 10.1093/nar/22.15.2922; ARGAMAN M, 1994, MOL BIOCHEM PARASIT, V64, P95, DOI 10.1016/0166-6851(94)90138-4; ASHFORD RW, 1992, PARASITOL TODAY, V8, P104, DOI 10.1016/0169-4758(92)90249-2; Beetham JK, 1997, J BIOL CHEM, V272, P17360, DOI 10.1074/jbc.272.28.17360; BERBEROF M, 1995, EMBO J, V14, P2925, DOI 10.1002/j.1460-2075.1995.tb07292.x; Bergsten SE, 1999, DEVELOPMENT, V126, P659; BORST P, 1986, ANNU REV BIOCHEM, V55, P701, DOI 10.1146/annurev.bi.55.070186.003413; BRODIN TN, 1992, MOL BIOCHEM PARASIT, V52, P241, DOI 10.1016/0166-6851(92)90056-P; Brooks DR, 2001, J BIOL CHEM, V276, P47061, DOI 10.1074/jbc.M108498200; Burchmore RJS, 1998, J BIOL CHEM, V273, P29118, DOI 10.1074/jbc.273.44.29118; Charest H, 1996, J BIOL CHEM, V271, P17081, DOI 10.1074/jbc.271.29.17081; CHAREST H, 1994, MOL CELL BIOL, V14, P2975, DOI 10.1128/MCB.14.5.2975; Coughlin BC, 2000, J BIOL CHEM, V275, P12051, DOI 10.1074/jbc.275.16.12051; Coulson RMR, 1996, MOL BIOCHEM PARASIT, V82, P227, DOI 10.1016/0166-6851(96)02739-9; CURTIS D, 1995, CELL, V81, P171, DOI 10.1016/0092-8674(95)90325-9; de Moor CH, 2001, INT REV CYTOL, V203, P567; Denison SH, 2000, FUNGAL GENET BIOL, V29, P61, DOI 10.1006/fgbi.2000.1188; Di Noia JM, 2000, J BIOL CHEM, V275, P10218, DOI 10.1074/jbc.275.14.10218; Dumas C, 1997, EMBO J, V16, P2590, DOI 10.1093/emboj/16.10.2590; Dyall SD, 2000, MOL BIOCHEM PARASIT, V109, P73, DOI 10.1016/S0166-6851(00)00235-8; ELFAKHRY Y, 2002, IN PRESS PROTEOMICS, V9; FLINN HM, 1992, NUCLEIC ACIDS RES, V20, P755, DOI 10.1093/nar/20.4.755; Foster JW, 1999, CURR OPIN MICROBIOL, V2, P170, DOI 10.1016/S1369-5274(99)80030-7; Furger A, 1997, MOL CELL BIOL, V17, P4372, DOI 10.1128/MCB.17.8.4372; Garlapati S, 1999, MOL BIOCHEM PARASIT, V100, P95, DOI 10.1016/S0166-6851(99)00037-7; Ghosh M, 2000, MOL BIOCHEM PARASIT, V108, P93, DOI 10.1016/S0166-6851(00)00208-5; GLASER TA, 1991, MOL BIOCHEM PARASIT, V45, P337, DOI 10.1016/0166-6851(91)90102-C; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; Gunkel N, 1998, GENE DEV, V12, P1652, DOI 10.1101/gad.12.11.1652; HEHL A, 1994, P NATL ACAD SCI USA, V91, P370, DOI 10.1073/pnas.91.1.370; Hotz HR, 1997, NUCLEIC ACIDS RES, V25, P3017, DOI 10.1093/nar/25.15.3017; Hubel A, 1997, MOL CELL BIOL, V17, P5987; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; Krobitsch S, 1998, J BIOL CHEM, V273, P6488, DOI 10.1074/jbc.273.11.6488; Lamontagne J, 1999, J BIOL CHEM, V274, P6602, DOI 10.1074/jbc.274.10.6602; LEBOWITZ JH, 1993, GENE DEV, V7, P996, DOI 10.1101/gad.7.6.996; Lipshitz HD, 2000, CURR OPIN GENET DEV, V10, P476, DOI 10.1016/S0959-437X(00)00116-7; Liu KY, 2000, PARASITOL RES, V86, P140, DOI 10.1007/s004360050023; Macdonald P, 2001, CURR OPIN CELL BIOL, V13, P326, DOI 10.1016/S0955-0674(00)00215-5; MACFARLANE J, 1990, EUR J BIOCHEM, V190, P377, DOI 10.1111/j.1432-1033.1990.tb15586.x; MATTHEWS KR, 1994, GENE DEV, V8, P491, DOI 10.1101/gad.8.4.491; McKean PG, 1997, MOL BIOCHEM PARASIT, V85, P221, DOI 10.1016/S0166-6851(97)02829-6; MEADE JC, 1989, MOL BIOCHEM PARASIT, V33, P81, DOI 10.1016/0166-6851(89)90045-5; Mottram JC, 1997, J BIOL CHEM, V272, P14285, DOI 10.1074/jbc.272.22.14285; Muyombwe A, 1998, J INFECT DIS, V177, P188, DOI 10.1086/513821; Myler PJ, 1999, P NATL ACAD SCI USA, V96, P2902, DOI 10.1073/pnas.96.6.2902; Noll TM, 1997, MOL BIOCHEM PARASIT, V84, P215, DOI 10.1016/S0166-6851(96)02801-0; Nourbakhsh F, 1996, MOL BIOCHEM PARASIT, V76, P201, DOI 10.1016/0166-6851(95)02559-6; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; PAPADOPOULOU B, 1992, EMBO J, V11, P3601, DOI 10.1002/j.1460-2075.1992.tb05444.x; PAPADOPOULOU B, 1994, MOL BIOCHEM PARASIT, V65, P39, DOI 10.1016/0166-6851(94)90113-9; Papadopoulou B, 1996, BIOCHEM BIOPH RES CO, V224, P772, DOI 10.1006/bbrc.1996.1098; Quijada L, 1997, J BIOL CHEM, V272, P4493, DOI 10.1074/jbc.272.7.4493; Quijada L, 2000, MOL BIOCHEM PARASIT, V110, P79, DOI 10.1016/S0166-6851(00)00258-9; RAMAMOORTHY R, 1995, J BIOL CHEM, V270, P12133, DOI 10.1074/jbc.270.20.12133; Richter JD, 2001, SCIENCE, V293, P60, DOI 10.1126/science.1062237; Richter JD, 1999, MICROBIOL MOL BIOL R, V63, P446, DOI 10.1128/MMBR.63.2.446-456.1999; Roy G, 2000, MOL BIOCHEM PARASIT, V110, P195, DOI 10.1016/S0166-6851(00)00270-X; Sambrook J., 2002, MOL CLONING LAB MANU; SCHURCH N, 1994, MOL CELL BIOL, V14, P3668, DOI 10.1128/MCB.14.6.3668; Sereno D, 1997, ANTIMICROB AGENTS CH, V41, P972, DOI 10.1128/AAC.41.5.972; Sereno D, 2001, ANTIMICROB AGENTS CH, V45, P1168, DOI 10.1128/AAC.45.4.1168-1173.2001; SOUZA AE, 1992, FEBS LETT, V311, P124, DOI 10.1016/0014-5793(92)81382-V; Tamar S, 2000, MOL BIOCHEM PARASIT, V111, P401, DOI 10.1016/S0166-6851(00)00337-6; TEIXEIRA SMR, 1994, J BIOL CHEM, V269, P20509; Thompson JF, 1997, J BIOL CHEM, V272, P18766, DOI 10.1074/jbc.272.30.18766; Thompson SR, 2000, MOL CELL BIOL, V20, P2129, DOI 10.1128/MCB.20.6.2129-2137.2000; TRAUBCSEKO YM, 1993, MOL BIOCHEM PARASIT, V57, P101, DOI 10.1016/0166-6851(93)90248-V; TURCO SJ, 1992, ANNU REV MICROBIOL, V46, P65, DOI 10.1146/annurev.mi.46.100192.000433; Uliana SRB, 1999, EXP PARASITOL, V92, P183, DOI 10.1006/expr.1999.4410; VASSELLA E, 1994, NUCLEIC ACIDS RES, V22, P1359, DOI 10.1093/nar/22.8.1359; Viviani V, 2001, BIOCHEM BIOPH RES CO, V280, P1286, DOI 10.1006/bbrc.2001.4254; Wreden C, 1997, DEVELOPMENT, V124, P3015; Wu Y, 2000, MOL BIOCHEM PARASIT, V110, P345, DOI 10.1016/S0166-6851(00)00290-5; Zhang WW, 2001, MOL MICROBIOL, V39, P935, DOI 10.1046/j.1365-2958.2001.02286.x; ZILBERSTEIN D, 1994, ANNU REV MICROBIOL, V48, P449, DOI 10.1146/annurev.mi.48.100194.002313; Zilka A, 2001, J BIOL CHEM, V276, P47922, DOI 10.1074/jbc.M108271200	78	112	119	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19511	19520		10.1074/jbc.M200500200	http://dx.doi.org/10.1074/jbc.M200500200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11912202	hybrid			2022-12-27	WOS:000175894800038
J	Brown, KD; Hostager, BS; Bishop, GA				Brown, KD; Hostager, BS; Bishop, GA			Regulation of TRAF2 signaling by self-induced degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-RECEPTOR; KAPPA-B ACTIVATION; LATENT MEMBRANE-PROTEIN-1; EFFECTOR FUNCTIONS; CD40; UBIQUITIN; LYMPHOCYTES; FAMILY; LIGAND; DOMAIN	Receptors belonging to the tumor necrosis factor receptor (TNF-R) family utilize cytoplasmic adapter proteins called TNF-R-associated factors (TRAFs) as key elements in their signaling pathways. However, it is not yet clear how individual TRAFs regulate signaling by this large and growing receptor family. Signaling via the TNF-R family member CD40 has recently been shown to result in recruitment of TRAF2 to plasma membrane detergent-resistant microdomains (lipid rafts) as well as to subsequently initiate TRAF2 degradation. As TRAF2 associates with most members of the TNF-R family, we wished to determine how this degradation occurs. We show here that CD40-mediated TRAF2 degradation requires the zinc-binding RING domain of TRAF2 and is preceded by TRAF2 ubiquitination, suggesting that the TRAF2 RING may promote ubiquitination although the RING itself is not a target of ubiquitination. Several approaches show that ubiquitination and proteasomal activity are integral to TRAF2 degradation, and inhibition of this process potentiates CD40 signaling.	Univ Iowa, Dept Microbiol, Coll Med, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Med Scientist Training Program, Grad Program Immunol, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Bishop, GA (corresponding author), Univ Iowa, Dept Microbiol, Coll Med, 3-570 Bowen Sci Bldg, Iowa City, IA 52242 USA.			Bishop, Gail/0000-0002-1291-5078	NATIONAL CANCER INSTITUTE [P01CA066570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028847, R56AI028847, R29AI028847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER; NCI NIH HHS [CA66570] Funding Source: Medline; NIAID NIH HHS [AI28847] Funding Source: Medline; NIDDK NIH HHS [DK25295] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Baccam M, 1999, EUR J IMMUNOL, V29, P3855, DOI 10.1002/(SICI)1521-4141(199912)29:12<3855::AID-IMMU3855>3.0.CO;2-S; Baker SJ, 1996, ONCOGENE, V12, P1; BISHOP GA, 1995, EUR J IMMUNOL, V25, P1230, DOI 10.1002/eji.1830250515; Bishop GA, 2001, IMMUNOL RES, V24, P97, DOI 10.1385/IR:24:2:097; Bishop GA, 2001, ARCH IMMUNOL THER EX, V49, P129; Brown KD, 2001, J EXP MED, V193, P943, DOI 10.1084/jem.193.8.943; Busch LK, 1999, J IMMUNOL, V162, P2555; Busch LK, 2001, J IMMUNOL, V167, P5805, DOI 10.4049/jimmunol.167.10.5805; Chan FKM, 2000, EUR J IMMUNOL, V30, P652; Devergne O, 1996, MOL CELL BIOL, V16, P7098; Duckett CS, 1997, GENE DEV, V11, P2810, DOI 10.1101/gad.11.21.2810; Dunn IF, 1999, MOL IMMUNOL, V36, P611, DOI 10.1016/S0161-5890(99)00075-9; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; HAMANO T, 1982, J IMMUNOL, V129, P1403; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Hostager BS, 1999, J IMMUNOL, V162, P6307; Hostager BS, 1996, J IMMUNOL, V157, P1047; Hostager BS, 2000, J BIOL CHEM, V275, P15392, DOI 10.1074/jbc.M909520199; Hsing Y, 1999, J IMMUNOL, V162, P2804; Hsing Y, 1997, J IMMUNOL, V159, P4898; Jalukar SV, 2000, J IMMUNOL, V164, P623, DOI 10.4049/jimmunol.164.2.623; KULKA RG, 1988, J BIOL CHEM, V263, P15726; Lafont F, 2001, P NATL ACAD SCI USA, V98, P3180, DOI 10.1073/pnas.051003498; LEE SY, 1997, IMMUNITY, V7, P701; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; LONG EO, 1991, HUM IMMUNOL, V31, P229, DOI 10.1016/0198-8859(91)90092-N; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Lotz M, 1996, J LEUKOCYTE BIOL, V60, P1; Oda H, 1999, P NATL ACAD SCI USA, V96, P9557, DOI 10.1073/pnas.96.17.9557; Pullen SS, 1998, BIOCHEMISTRY-US, V37, P11836, DOI 10.1021/bi981067q; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Schwenzer R, 1999, J BIOL CHEM, V274, P19368, DOI 10.1074/jbc.274.27.19368; Strous GJ, 1996, EMBO J, V15, P3806, DOI 10.1002/j.1460-2075.1996.tb00754.x; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X	38	84	89	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19433	19438		10.1074/jbc.M111522200	http://dx.doi.org/10.1074/jbc.M111522200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11909853	hybrid			2022-12-27	WOS:000175894800027
J	Nunn, CM; Djordjevic, S; Hillas, PJ; Nishida, CR; de Montellano, PRO				Nunn, CM; Djordjevic, S; Hillas, PJ; Nishida, CR; de Montellano, PRO			The crystal structure of Mycobacterium tuberculosis alkylhydroperoxidase AhpD, a potential target for antibubercular drug design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISONIAZID RESISTANCE; OXIDATIVE-STRESS; SELENOMETHIONYL PROTEINS; ANTIOXIDANT DEFENSE; CATALASE PEROXIDASE; GENE; PEROXIREDOXIN; SENSITIVITY; EXPRESSION; MUTANT	The resistance of Mycobacterium tuberculosis to isoniazid is commonly linked to inactivation of a catalase-peroxidase, KatG, that converts isoniazid to its biologically active form. Loss of KatG is associated with elevated expression of the alkylhydroperoxidases AhpC and AhpD. AhpD has no sequence identity with AhpC or other proteins but has alkylhydroperoxidase activity and possibly additional physiological activities. The alkylhydroperoxidase activity, in the absence of KatG, provides an important antioxidant defense. We have determined the M. tuberculosis AhpD structure to a resolution of 1.9 Angstrom. The protein is a trimer in a symmetrical cloverleaf arrangement. Each subunit exhibits a new all-helical protein fold in which the two catalytic sulfhydryl groups, Cys-130 and Cys-133, are located near a central cavity in the trimer. The structure supports a mechanism for the alkylhydroperoxidase activity in which Cys-133 is deprotonated by a distant glutamic acid via the relay action of His-137 and a water molecule. The cysteine then reacts with the peroxide to give a sulfenic acid that subsequently forms a disulfide bond with Cys-130. The crystal structure of AhpD identifies a new protein fold relevant to members of this protein family in other organisms. The structural details constitute a potential platform for the design of inhibitors of potential utility as antitubercular agents and suggest that AhpD may have disulfide exchange properties of importance in other areas of M. tuberculosis biology.	Univ Calif San Francisco, Sch Pharm, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of London; University College London	Djordjevic, S (corresponding author), Univ Calif San Francisco, Sch Pharm, S-926, San Francisco, CA 94143 USA.	snezana@biochemistry.ucl.ac.uk; ortiz@cgl.ucsf.edu			NIGMS NIH HHS [GM56531] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM056531] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryk R, 2002, SCIENCE, V295, P1073, DOI 10.1126/science.1067798; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7022, DOI 10.1073/pnas.91.15.7022; Chen JW, 2000, J BIOL CHEM, V275, P28421, DOI 10.1074/jbc.M005073200; Cole ST, 1998, NATURE, V396, P190, DOI 10.1038/24206; Declercq JP, 2001, J MOL BIOL, V311, P751, DOI 10.1006/jmbi.2001.4853; DelVecchio VG, 2002, P NATL ACAD SCI USA, V99, P443, DOI 10.1073/pnas.221575398; DERETIC V, 1995, MOL MICROBIOL, V17, P889, DOI 10.1111/j.1365-2958.1995.mmi_17050889.x; Dhandayuthapani S, 1996, J BACTERIOL, V178, P3641, DOI 10.1128/jb.178.12.3641-3649.1996; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hillas PJ, 2000, J BIOL CHEM, V275, P18801, DOI 10.1074/jbc.M001001200; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; JOHNSSON K, 1994, J AM CHEM SOC, V116, P7425, DOI 10.1021/ja00095a063; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keshavjee S, 2000, JAMA-J AM MED ASSOC, V283, P1201, DOI 10.1001/jama.283.9.1201; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li ZM, 1998, J INFECT DIS, V177, P1030, DOI 10.1086/515254; Manca C, 1999, INFECT IMMUN, V67, P74, DOI 10.1128/IAI.67.1.74-79.1999; Menchise V, 2001, BIOCHEM J, V359, P65, DOI 10.1042/0264-6021:3590065; MITCHISON DA, 1963, J PATHOL BACTERIOL, V86, P377, DOI 10.1002/path.1700860213; MORSE WC, 1954, AM REV TUBERC PULM, V69, P464; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pablos-Mendez A, 1998, NEW ENGL J MED, V338, P1641, DOI 10.1056/NEJM199806043382301; Pearl FMG, 2001, NUCLEIC ACIDS RES, V29, P223, DOI 10.1093/nar/29.1.223; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Redenbach M, 1996, MOL MICROBIOL, V21, P77, DOI 10.1046/j.1365-2958.1996.6191336.x; ROUSEL A, 2000, TURBO MANUAL AFMB IF; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; Schroder E, 1998, PROTEIN SCI, V7, P2465, DOI 10.1002/pro.5560071125; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; SHERMAN DR, 1995, P NATL ACAD SCI USA, V92, P6625, DOI 10.1073/pnas.92.14.6625; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Slayden RA, 2000, MICROBES INFECT, V2, P659, DOI 10.1016/S1286-4579(00)00359-2; Tame JRH, 2002, BIOCHEMISTRY-US, V41, P2982, DOI 10.1021/bi015717t; Wengenack NL, 2001, BIOCHEMISTRY-US, V40, P8990, DOI 10.1021/bi002614m; Wilson TM, 1996, MOL MICROBIOL, V19, P1025, DOI 10.1046/j.1365-2958.1996.449980.x; WILSON TM, 1995, MOL MICROBIOL, V15, P1009, DOI 10.1111/j.1365-2958.1995.tb02276.x; Wilson W, 1999, P NATL ACAD SCI USA, V96, P12833, DOI 10.1073/pnas.96.22.12833; Zhang Y, 1996, P NATL ACAD SCI USA, V93, P13212, DOI 10.1073/pnas.93.23.13212; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0	48	36	41	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					20033	20040		10.1074/jbc.M200864200	http://dx.doi.org/10.1074/jbc.M200864200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11914371	hybrid			2022-12-27	WOS:000175894800104
J	Smirnova, JB; McFarlane, RJ				Smirnova, JB; McFarlane, RJ			The unique centromeric chromatin structure of Schizosaccharomyces pombe is maintained during meiosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDUCTIONAL CHROMOSOME SEGREGATION; FISSION YEAST; FUNCTIONAL-ANALYSIS; DNA; PROTEIN; RECOMBINATION; MIS6; COMPLEXES; DOMAINS; NUMBER	In meiosis I sister centromeres are unified in their polarity on the spindle, and this unique behavior is known to require the function of meiosis-specific factors that set some intrinsic property of the centromeres. The fission yeast, Schizosaccharomyces pombe, possesses complex centromeres consisting of repetitive DNA elements, making it an excellent model in which to study the behavior of complex centromeres. In mitosis, during which sister centromeres mediate chromosome segregation by establishing bipolar chromosome attachments to the spindle, the central core of the S. pombe centromere chromatin has a unique irregular nucleosome pattern. Deletion of repeats flanking this core structure have no effect on mitotic chromosome segregation, but have profound effects during meiosis. While this demonstrates that the outer repeats are critical for normal meiotic sister centromere behavior, exactly how they function and how monopolarity is established remains unclear. In this study we provide the first analysis of the chromatin structure of a complex centromere during meiosis. We show that the nature and extent of the unique central core chromatin structure is maintained with no measurable expansion. This demonstrates that monopolarity of sister centromeres, and subsequent reversion to bipolarity, does not involve a global change to the centromeric chromatin structure.	Univ Wales, Sch Biol Sci, Mol & Cell Biol Grp, Bangor LL57 2UW, Gwynedd, Wales	Bangor University	McFarlane, RJ (corresponding author), Univ Wales, Sch Biol Sci, Mol & Cell Biol Grp, Mem Bldg,Deiniol Rd, Bangor LL57 2UW, Gwynedd, Wales.	ramsay@sbs.bangor.ac.uk		McFarlane, Ramsay/0000-0002-3139-3092				ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; Bernard P, 2001, NAT CELL BIOL, V3, P522, DOI 10.1038/35074598; Cervantes MD, 2000, MOL CELL, V5, P883, DOI 10.1016/S1097-2765(00)80328-7; Choo KHA, 2000, TRENDS CELL BIOL, V10, P182, DOI 10.1016/S0962-8924(00)01739-6; Choo KHA, 2001, DEV CELL, V1, P165, DOI 10.1016/S1534-5807(01)00028-4; Clarke L, 1998, CURR OPIN GENET DEV, V8, P212, DOI 10.1016/S0959-437X(98)80143-3; CLARKE L, 1990, MOL CELL BIOL, V10, P1863, DOI 10.1128/MCB.10.5.1863; CLARKE L, 1993, COLD SPRING HARB SYM, V58, P687, DOI 10.1101/SQB.1993.058.01.076; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; FISHEL B, 1988, MOL CELL BIOL, V8, P754, DOI 10.1128/MCB.8.2.754; Gilbert N, 2001, P NATL ACAD SCI USA, V98, P11949, DOI 10.1073/pnas.211322798; Goshima G, 1999, GENE DEV, V13, P1664, DOI 10.1101/gad.13.13.1664; HAHNENBERGER KM, 1991, MOL CELL BIOL, V11, P2206, DOI 10.1128/MCB.11.4.2206; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; KISHIDA M, 1994, CURR GENET, V25, P497, DOI 10.1007/BF00351668; Kitagawa K, 2001, NAT REV MOL CELL BIO, V2, P678, DOI 10.1038/35089568; Kniola B, 2001, MOL BIOL CELL, V12, P2767, DOI 10.1091/mbc.12.9.2767; Lee B, 2001, CURR OPIN CELL BIOL, V13, P770, DOI 10.1016/S0955-0674(00)00282-9; MARSCHALL LG, 1995, J CELL BIOL, V128, P445, DOI 10.1083/jcb.128.4.445; Mizuno K, 1997, GENE DEV, V11, P876, DOI 10.1101/gad.11.7.876; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Ngan VK, 1997, MOL CELL BIOL, V17, P3305, DOI 10.1128/MCB.17.6.3305; Paliulis LV, 2000, J CELL BIOL, V150, P1223, DOI 10.1083/jcb.150.6.1223; Partridge JF, 2000, GENE DEV, V14, P783; Pidoux AL, 2000, CURR OPIN CELL BIOL, V12, P308, DOI 10.1016/S0955-0674(00)00094-6; POLIZZI C, 1991, J CELL BIOL, V112, P191, DOI 10.1083/jcb.112.2.191; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; Watanabe Y, 2001, NATURE, V409, P359, DOI 10.1038/35053103; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yamamoto M, 1996, TRENDS BIOCHEM SCI, V21, P18, DOI 10.1016/0968-0004(96)80880-2	34	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19817	19822		10.1074/jbc.M200765200	http://dx.doi.org/10.1074/jbc.M200765200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11909862	hybrid			2022-12-27	WOS:000175894800076
J	Sun, YP; Nonobe, E; Kobayashi, Y; Kuraishi, T; Aoki, F; Yamamoto, K; Sakai, S				Sun, YP; Nonobe, E; Kobayashi, Y; Kuraishi, T; Aoki, F; Yamamoto, K; Sakai, S			Characterization and expression of L-amino acid oxidase of mouse milk	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIPER CALLOSELASMA-RHODOSTOMA; HYDROGEN-PEROXIDE; BOVINE MASTITIS; MAMMARY-GLAND; RECEPTOR GENE; PEPTIDES; PURIFICATION; PREVALENCE; MODULATION; MELPHALAN	L-Amino acid oxidase (LAO) was purified from mouse milk. LAO reacted with L-amino acids in an apparent order of Phe > Met, Tyr > Cys, Leu > His >> other 11 amino acids tested and produced H2O2 in a dose- and time-dependent manner. LAO in milk had a molecular mass of about 113 kDa and was converted to a 60-kDa protein by SDS-PAGE. LAO consisted of two subunits. The N- and C-terminal amino acid sequence determination followed by cDNA cloning showed that the 60-kDa protein consisted of 497 amino acids. LAO mRNA spanned about 2.0 kb, and its expression was found only in the mammary epithelial cells. Glucocorticoid was essential for LAO gene expression. Thus, the LAO gene is expressed acutely upon the onset of milk synthesis. LAO mRNA increased I day before parturition, peaked during early to mid-lactation, and decreased at the end of lactation. This is the first demonstration showing that LAO is present in milk. Mastitis is caused by an intra-mammary bacterial infection. As mouse milk produced H2O2 using endogenous free amino acids, we suggest that LAO, together with free amino acids, is responsible for killing bacteria in the mammary gland.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Breeding, Bunkyo Ku, Tokyo 1138657, Japan; Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan	University of Tokyo; University of Tokyo	Sakai, S (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Breeding, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	asenkiti@mail.ecc.u-tokyo.ac.jp	Sun, Youping/AAX-7058-2021					ARMSTRONG MD, 1963, P SOC EXP BIOL MED, V113, P680, DOI 10.3181/00379727-113-28460; ATKINSON SA, 1980, AM J CLIN NUTR, V33, P811, DOI 10.1093/ajcn/33.4.811; BHUYAN KC, 1977, BIOCHIM BIOPHYS ACTA, V497, P641, DOI 10.1016/0304-4165(77)90284-7; Blanchard M, 1944, J BIOL CHEM, V155, P421; Bramley A. J., 1996, CURRENT CONCEPTS BOV, P1; BRIGHT HJ, 1975, ENZYMES, V12, P456; Chu CC, 1997, P NATL ACAD SCI USA, V94, P2507, DOI 10.1073/pnas.94.6.2507; Clare DA, 2000, J DAIRY SCI, V83, P1187, DOI 10.3168/jds.S0022-0302(00)74983-6; CURTI B, 1968, J BIOL CHEM, V243, P2306; CURTI B, 1992, CHEM BIOCH FLAVOENZY, V3, P84; DAVIS TA, 1994, BRIT J NUTR, V72, P845, DOI 10.1079/BJN19940089; De Oliveira AP, 2000, J DAIRY SCI, V83, P855, DOI 10.3168/jds.S0022-0302(00)74949-6; EKSTRAND B, 1989, FOOD BIOTECHNOL, V3, P105, DOI 10.1080/08905438909549703; Fujimura S, 1998, J VET MED SCI, V60, P937, DOI 10.1292/jvms.60.937; GROSVENOR CE, 1993, ENDOCR REV, V14, P710, DOI 10.1210/edrv-14-6-710; GROVES ML, 1971, MILK PROTEINS CHEMIS, V2, P367; JARAALMONTE M, 1972, J DAIRY SCI, V55, P1502, DOI 10.3168/jds.S0022-0302(72)85703-5; Kim Jae-Young, 1998, Animal Science and Technology, V69, P728; KLEBANOFF SJ, 1966, BIOCHIM BIOPHYS ACTA, V117, P63, DOI 10.1016/0304-4165(66)90152-8; KOLDOVSKY O, 1989, J NUTR, V119, P1543, DOI 10.1093/jn/119.11.1543; Macheroux P, 2001, EUR J BIOCHEM, V268, P1679, DOI 10.1046/j.1432-1327.2001.02042.x; MCRIPLEY RJ, 1967, J BACTERIOL, V94, P1425, DOI 10.1128/JB.94.5.1425-1430.1967; Mizoguchi Y, 1996, ENDOCR J, V43, P537, DOI 10.1507/endocrj.43.537; Mizoguchi Y, 1997, MOL CELL ENDOCRINOL, V132, P177, DOI 10.1016/S0303-7207(97)00134-2; Moynihan K, 1997, CANCER CHEMOTH PHARM, V39, P179; NIEDERMANN DM, 1990, J BIOL CHEM, V265, P17246; PONNUDURAI G, 1994, ARCH BIOCHEM BIOPHYS, V313, P373, DOI 10.1006/abbi.1994.1401; Raibekas AA, 1998, BIOCHEM BIOPH RES CO, V248, P476, DOI 10.1006/bbrc.1998.9024; RASSIN DK, 1978, EARLY HUM DEV, V2, P1, DOI 10.1016/0378-3782(78)90048-8; REITER B, 1978, J DAIRY RES, V45, P131, DOI 10.1017/S0022029900016290; RICH JN, 1995, CANCER CHEMOTH PHARM, V36, P379, DOI 10.1007/BF00686186; RICH JN, 1996, J IMMUNOL, V156, P42; SAKAI S, 1979, BIOCHIM BIOPHYS ACTA, V582, P79, DOI 10.1016/0304-4165(79)90290-3; SIKORA L, 1982, MOL GEN GENET, V186, P33, DOI 10.1007/BF00422908; SMITH KL, 1985, J DAIRY SCI, V68, P1531, DOI 10.3168/jds.S0022-0302(85)80993-0; SPINCER J, 1969, BIOCHEM J, V111, P727, DOI 10.1042/bj1110727; Stevenson EM, 1994, INT DAIRY J, V4, P205, DOI 10.1016/0958-6946(94)90013-2; STILES BG, 1991, TOXICON, V29, P1129, DOI 10.1016/0041-0101(91)90210-I; Sun Y, 2001, MOL CELL ENDOCRINOL, V172, P177, DOI 10.1016/S0303-7207(00)00370-1; TAN NH, 1991, INT J BIOCHEM, V23, P323; TAN NH, 1989, BIOCHEM INT, V19, P937; Torii S, 1997, J BIOL CHEM, V272, P9539, DOI 10.1074/jbc.272.14.9539; UEDA N, 1992, J CLIN INVEST, V90, P2593, DOI 10.1172/JCI116154; Varadi M, 1999, BIOSENS BIOELECTRON, V14, P335, DOI 10.1016/S0956-5663(98)00130-4; VINA JR, 1987, J NUTR, V117, P533, DOI 10.1093/jn/117.3.533; Wilson DJ, 1997, J DAIRY SCI, V80, P2592, DOI 10.3168/jds.S0022-0302(97)76215-5; WU GY, 1994, J NUTR, V124, P415, DOI 10.1093/jn/124.3.415; Xu RJ, 1998, FOOD REV INT, V14, P1, DOI 10.1080/87559129809541147	48	59	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					19080	19086		10.1074/jbc.M200936200	http://dx.doi.org/10.1074/jbc.M200936200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11907037	hybrid			2022-12-27	WOS:000175975800109
J	Boner, W; Taylor, ER; Tsirimonaki, E; Yamane, K; Campo, MS; Morgan, IM				Boner, W; Taylor, ER; Tsirimonaki, E; Yamane, K; Campo, MS; Morgan, IM			A functional interaction between the human papillomavirus 16 transcription/replication factor E2 and the DNA damage response protein TopBP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSACTIVATION DOMAIN; TRANSCRIPTIONAL ACTIVATOR; BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; MUTATIONAL ANALYSIS; CAPSID PROTEIN; TYPE-16 E1; COACTIVATOR; REPLICATION; TFIIB	The human papillomavirus (HPV) transcription/replication factor E2 is essential for the life cycle of HPVs. E2 protein binds to DNA target sequences in the viral long control regions to regulate transcription of the viral genome. It also enhances viral DNA replication by interacting with the viral replication factor E1 and recruiting it to the origin of replication and may also play a more direct role in replication. The cellular proteins with which E2 interacts to carry out these functions are largely unknown. To identify these proteins a yeast two-hybrid screen was carried out with the transcription/ replication domain of HPV16 E2. This screen identified several candidate interacting partners for E2 including TopBP1 (topoisomerase IIbeta-binding protein 1). TopBP1 has eight BRCA1 carboxyl-terminal domains that are found in proteins regulating the DNA damage response, transcription, and replication. Here we demonstrate that HPV16 E2 and TopBP1 interact in vitro and in vivo and that TopBP1 can enhance the ability of E2 to activate transcription and replication. This is the first time that TopBP1 has been shown to function as a transcriptional coactivator and that E2 interacts with TopBP1. Removal of the amino-terminal domain of TopBP1 abolishes coactivation of transcription and replication. This interaction may have functional consequences upon the viral life cycle.	Univ Glasgow, Dept Vet Pathol, Inst Comparat Med, Glasgow G61 1QH, Lanark, Scotland; Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; Univ Tokyo, Inst Mol & Cellular Biosci, Biomed Res Lab, Bunkyo Ku, Tokyo 1130032, Japan	University of Glasgow; Beatson Institute; University of Tokyo	Morgan, IM (corresponding author), Univ Glasgow, Dept Vet Pathol, Inst Comparat Med, Garscube Estate,Bearsden Rd, Glasgow G61 1QH, Lanark, Scotland.	i.morgan@vet.gla.ac.uk						Anderson SE, 1998, NAT GENET, V19, P254, DOI 10.1038/930; Antson AA, 2000, NATURE, V403, P805, DOI 10.1038/35001638; Bakshi RP, 2001, CRIT REV BIOCHEM MOL, V36, P1, DOI 10.1080/20014091074165; Benson JD, 1997, J VIROL, V71, P8041, DOI 10.1128/JVI.71.10.8041-8047.1997; Berg M, 1997, J VIROL, V71, P3853, DOI 10.1128/JVI.71.5.3853-3863.1997; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; BOUVARD V, 1994, EMBO J, V13, P5451, DOI 10.1002/j.1460-2075.1994.tb06880.x; Breiding DE, 1997, MOL CELL BIOL, V17, P7208, DOI 10.1128/MCB.17.12.7208; Day PM, 1998, J VIROL, V72, P142, DOI 10.1128/JVI.72.1.142-150.1998; Desaintes C, 1999, ONCOGENE, V18, P4538, DOI 10.1038/sj.onc.1202818; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; Gillitzer E, 2000, EMBO J, V19, P3069, DOI 10.1093/emboj/19.12.3069; GIRI I, 1988, EMBO J, V7, P2823, DOI 10.1002/j.1460-2075.1988.tb03138.x; Goodwin EC, 2001, CELL GROWTH DIFFER, V12, P525; HAM J, 1991, TRENDS BIOCHEM SCI, V16, P440, DOI 10.1016/0968-0004(91)90172-R; HAUSEN HZ, 1991, VIROLOGY, V184, P9, DOI 10.1016/0042-6822(91)90816-T; Heino P, 2000, VIROLOGY, V276, P304, DOI 10.1006/viro.2000.0342; HIBMA MH, 1995, EUR J BIOCHEM, V229, P517, DOI 10.1111/j.1432-1033.1995.tb20493.x; Ilves I, 1999, J VIROL, V73, P4404, DOI 10.1128/JVI.73.5.4404-4412.1999; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; LAMBERT PF, 1989, GENE DEV, V3, P38, DOI 10.1101/gad.3.1.38; Lee CW, 1998, ONCOGENE, V16, P2695, DOI 10.1038/sj.onc.1201818; Lee D, 2000, J BIOL CHEM, V275, P7045, DOI 10.1074/jbc.275.10.7045; Lehman CW, 1998, P NATL ACAD SCI USA, V95, P4338, DOI 10.1073/pnas.95.8.4338; Makiniemi M, 2001, J BIOL CHEM, V276, P30399, DOI 10.1074/jbc.M102245200; Massimi P, 1999, ONCOGENE, V18, P7748, DOI 10.1038/sj.onc.1203208; Masterson PJ, 1998, J VIROL, V72, P7407, DOI 10.1128/JVI.72.9.7407-7419.1998; MORRISSEY LC, 1989, J VIROL, V63, P4422, DOI 10.1128/JVI.63.10.4422-4425.1989; Ouchi T, 1998, P NATL ACAD SCI USA, V95, P2302, DOI 10.1073/pnas.95.5.2302; RANK NM, 1995, J VIROL, V69, P6323, DOI 10.1128/JVI.69.10.6323-6334.1995; ROMANCZUK H, 1990, J VIROL, V64, P2849, DOI 10.1128/JVI.64.6.2849-2859.1990; Sakai H, 1996, J VIROL, V70, P1602, DOI 10.1128/JVI.70.3.1602-1611.1996; Shimizu K, 2001, MOL CELL BIOL, V21, P3901, DOI 10.1128/MCB.21.12.3901-3912.2001; Skiadopoulos MH, 1998, J VIROL, V72, P2079, DOI 10.1128/JVI.72.3.2079-2088.1998; Steger G, 1997, J VIROL, V71, P50, DOI 10.1128/JVI.71.1.50-58.1997; STEGER G, 1995, EMBO J, V14, P329, DOI 10.1002/j.1460-2075.1995.tb07007.x; Strasswimmer J, 1999, HUM MOL GENET, V8, P1219, DOI 10.1093/hmg/8.7.1219; Vance KW, 1999, J BIOL CHEM, V274, P27839, DOI 10.1074/jbc.274.39.27839; Webster K, 2000, J BIOL CHEM, V275, P87, DOI 10.1074/jbc.275.1.87; Witt E, 2000, J MOL BIOL, V301, P1, DOI 10.1006/jmbi.2000.3959; Yamamoto RR, 2000, GENETICS, V156, P711; Yamane K, 1997, EUR J BIOCHEM, V250, P794, DOI 10.1111/j.1432-1033.1997.00794.x; Yamane K, 1999, ONCOGENE, V18, P5194, DOI 10.1038/sj.onc.1202922; Yamane K, 2002, MOL CELL BIOL, V22, P555, DOI 10.1128/MCB.22.2.555-566.2002; Yao JM, 1998, J VIROL, V72, P1013, DOI 10.1128/JVI.72.2.1013-1019.1998; Yasugi T, 1997, J VIROL, V71, P891, DOI 10.1128/JVI.71.2.891-899.1997	46	72	73	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22297	22303		10.1074/jbc.M202163200	http://dx.doi.org/10.1074/jbc.M202163200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11934899	hybrid			2022-12-27	WOS:000176313600025
J	Zhu, YH; Mao, XO; Sun, YJ; Xia, ZG; Greenberg, DA				Zhu, YH; Mao, XO; Sun, YJ; Xia, ZG; Greenberg, DA			p38 mitogen-activated protein kinase mediates hypoxic regulation of Mdm2 and p53 in neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOREGULATORY FEEDBACK LOOP; GROWTH-FACTOR; INDUCED APOPTOSIS; DOWN-REGULATION; UV-RADIATION; PC12 CELLS; DEGRADATION; UBIQUITINATION; PATHWAY; EXPRESSION	The multifunctional tumor suppressor protein, p53, inhibits cell growth and promotes differentiation and programmed cell death. p53 activity is controlled by transcriptional, translational, and post-translational regulation. A major pathway for post-translational regulation of p53 comprises its nucleocytoplasmic transport and subsequent proteasomal degradation, which involves binding to the oncoprotein, murine double minute-2 (Mdm2). Hypoxia and other stress signals cause cellular injury partly through the action of p53. In this study, we show that hypoxia induces down-regulation of Mdm2 as well as serine 15 phosphorylation and nuclear accumulation of p53 in cultured cortical neurons from E16 mice. These effects are diminished by the p38 mitogen-activated protein kinase inhibitors SB203580 and SB202190, but not by the inactive analog SB202474, and by a dominant-interfering mutant of the p38-activating kinase mitogen-activated protein kinase kinase 3 (MKK3). Hypoxic neuronal death was also reduced by p38 inhibitors, by dominant-interfering MKK3, and by a p53-antisense oligodeoxynucleotide and was increased by a constitutively active form of p38 and by an Mdm2-antisense oligodeoxynucleotide. These results demonstrate that p38 and Mdm2 have roles in coupling hypoxic-ischemic neuronal insults to activation of p53 and hypoxic cell death.	Buck Inst Age Res, Novato, CA 94945 USA; Univ Washington, Dept Environm Hlth, Seattle, WA 98195 USA	Buck Institute for Research on Aging; University of Washington; University of Washington Seattle	Greenberg, DA (corresponding author), 8001 Redwood Blvd, Novato, CA 94945 USA.				NINDS NIH HHS [NS35965] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS035965] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alarcon R, 1999, CANCER RES, V59, P6046; Almog Nava, 1998, Biochimica et Biophysica Acta, V1378, pR43; Alvarez-Tejado M, 2001, J BIOL CHEM, V276, P22368, DOI 10.1074/jbc.M011688200; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Conrad PW, 1999, J BIOL CHEM, V274, P23570, DOI 10.1074/jbc.274.33.23570; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; DERYCKERE F, 1994, BIOTECHNIQUES, V16, P405; FAKHARZADEH SS, 1991, EMBO J, V10, P1565, DOI 10.1002/j.1460-2075.1991.tb07676.x; Fuchs SY, 1998, GENE DEV, V12, P2658, DOI 10.1101/gad.12.17.2658; Fuchs SY, 1998, ONCOGENE, V17, P2543, DOI 10.1038/sj.onc.1202200; Ghatan S, 2000, J CELL BIOL, V150, P335, DOI 10.1083/jcb.150.2.335; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; GOULD GW, 1995, BIOCHEM J, V311, P735, DOI 10.1042/bj3110735; Haas M, 2000, J BIOL CHEM, V275, P27832; Halterman MW, 1999, EXP NEUROL, V159, P65, DOI 10.1006/exnr.1999.7160; Halterman MW, 1999, J NEUROSCI, V19, P6818, DOI 10.1523/JNEUROSCI.19-16-06818.1999; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Kawasaki H, 1997, J BIOL CHEM, V272, P18518, DOI 10.1074/jbc.272.30.18518; Lohrum MAE, 1999, CELL DEATH DIFFER, V6, P1162, DOI 10.1038/sj.cdd.4400625; Maki CG, 1996, CANCER RES, V56, P2649; Maki CG, 1997, MOL CELL BIOL, V17, P355, DOI 10.1128/MCB.17.1.355; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Muller JN, 1997, J BIOL CHEM, V272, P23435, DOI 10.1074/jbc.272.37.23435; Namgung U, 2000, J NEUROSCI, V20, P6442, DOI 10.1523/JNEUROSCI.20-17-06442.2000; PICKSLEY SM, 1993, BIOESSAYS, V15, P689, DOI 10.1002/bies.950151008; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; Prives C, 1999, J PATHOL, V187, P112; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; She QB, 2000, J BIOL CHEM, V275, P20444, DOI 10.1074/jbc.M001020200; Tan Z, 2000, CELL DEATH DIFFER, V7, P675, DOI 10.1038/sj.cdd.4400697; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; Tao WK, 1999, P NATL ACAD SCI USA, V96, P3077, DOI 10.1073/pnas.96.6.3077; Trinh E, 2001, MOL CELL NEUROSCI, V17, P342, DOI 10.1006/mcne.2000.0928; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xiang H, 1996, J NEUROSCI, V16, P6753; Zhu YH, 1999, BIOCHEM BIOPH RES CO, V258, P87, DOI 10.1006/bbrc.1999.0586	41	81	82	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22909	22914		10.1074/jbc.M200042200	http://dx.doi.org/10.1074/jbc.M200042200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11948180	hybrid			2022-12-27	WOS:000176313600103
J	Kukor, Z; Mayerle, J; Kruger, B; Toth, M; Steed, PM; Halangk, W; Lerch, MM; Sahin-Toth, M				Kukor, Z; Mayerle, J; Kruger, B; Toth, M; Steed, PM; Halangk, W; Lerch, MM; Sahin-Toth, M			Presence of cathepsin B in the human pancreatic secretory pathway and its role in trypsinogen activation during hereditary pancreatitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CATIONIC TRYPSINOGEN; HEPATOCYTE LYSOSOMES; PROTON PUMP; IN-VITRO; MUTATIONS; PREMATURE; PRSS1; GENE; SITE; CELL	The lysosomal cysteine protease cathepsin B is thought to play a central role in intrapancreatic trypsinogen activation and the onset of experimental pancreatitis. Recent in vitro studies have suggested that this mechanism might be of pathophysiological relevance in hereditary pancreatitis, a human inborn disorder associated with mutations in the cationic trypsinogen gene. In the present study evidence is presented that cathepsin B is abundantly present in the secretory compartment of the human exocrine pancreas, as judged by immunogold electron microscopy. Moreover, pro-cathepsin B and mature cathepsin B are both secreted together with trypsinogen and active trypsin into the pancreatic juice of patients with sporadic pancreatitis or hereditary pancreatitis. Finally, cathepsin B-catalyzed activation of recombinant human cationic trypsinogen with hereditary pancreatitis-associated mutations N291, N29T, or R122H were characterized. In contrast to a previous report, cathepsin B-mediated activation of wild type and all three mutant trypsinogen forms was essentially identical under a wide range of experimental conditions. These observations confirm the presence of active cathepsin B in the human pancreatic secretory pathway and are consistent with the notion that cathepsin B-mediated trypsinogen activation might play a pathogenic role in human pancreatitis. On the other hand, the results clearly demonstrate that hereditary pancreatitis-associated mutations do not lead to increased or decreased trypsinogen activation by cathepsin B. Therefore, mutation-dependent alterations in cathepsin B-induced trypsinogen activation are not the cause of hereditary pancreatitis.	Univ Calif Los Angeles, HHMI, Dept Physiol, MacDonald Res Labs 5 748, Los Angeles, CA 90095 USA; Univ Munster, Dept Med B, D-48129 Munster, Germany; Univ Rostock, Dept Pathol, Div Med Biol, D-18057 Rostock, Germany; Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, H-1088 Budapest, Hungary; Novartis Pharmaceut, Res Dept, Summit, NJ 07901 USA; Otto von Guericke Univ, Dept Surg, D-39120 Magdeburg, Germany	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of Munster; University of Rostock; Semmelweis University; Novartis; Otto von Guericke University	Sahin-Toth, M (corresponding author), Univ Calif Los Angeles, HHMI, Dept Physiol, MacDonald Res Labs 5 748, Box 951662, Los Angeles, CA 90095 USA.	miklos@hhmi.ucla.edu	Mayerle, Julia/W-7907-2019; Lerch, Markus M./E-2206-2016	Lerch, Markus M./0000-0002-9643-8263; Sahin-Toth, Miklos/0000-0003-4513-9922	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058088] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK58088] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; Chen JM, 2000, GASTROENTEROLOGY, V119, P277, DOI 10.1016/S0016-5085(00)70073-4; Chen JM, 2001, HUM GENET, V109, P245, DOI 10.1007/s004390100580; Ferec C, 1999, J MED GENET, V36, P228; FIGARELLA C, 1988, BIOL CHEM H-S, V369, P293; Gorry MC, 1997, GASTROENTEROLOGY, V113, P1063, DOI 10.1053/gast.1997.v113.pm9322498; Grady T, 1998, AM J PHYSIOL-GASTR L, V275, pG1010, DOI 10.1152/ajpgi.1998.275.5.G1010; GREENBAUM LM, 1959, J BIOL CHEM, V234, P2885; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Halangk W, 2002, AM J PHYSIOL-GASTR L, V282, pG367, DOI 10.1152/ajpgi.00315.2001; HIRANO T, 1991, J CLIN INVEST, V87, P865, DOI 10.1172/JCI115091; Hofbauer B, 1998, AM J PHYSIOL-GASTR L, V275, pG352, DOI 10.1152/ajpgi.1998.275.2.G352; Kruger B, 2000, AM J PATHOL, V157, P43, DOI 10.1016/S0002-9440(10)64515-4; Kruger B, 2001, BIOCHEM BIOPH RES CO, V282, P159, DOI 10.1006/bbrc.2001.4561; KRUGER B, 1990, FRESEN J ANAL CHEM, V337, P101; Kukor Z, 2002, J BIOL CHEM, V277, P6111, DOI 10.1074/jbc.M110959200; Le Marechal C, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-19; Lerch MM, 1997, GASTROENTEROLOGY, V113, P1355, DOI 10.1053/gast.1997.v113.pm9322531; Lerch MM, 2000, MED CLIN N AM, V84, P549, DOI 10.1016/S0025-7125(05)70239-X; LERCH MM, 1993, GASTROENTEROLOGY, V104, P1768, DOI 10.1016/0016-5085(93)90658-Y; Lerch MM, 2000, ADV EXP MED BIOL, V477, P403; Mooren FC, 2001, FASEB J, V15, P659, DOI 10.1096/fj.00-0172com; MORIYAMA Y, 1992, FEBS LETT, V302, P18, DOI 10.1016/0014-5793(92)80274-K; MYERS BM, 1991, J CLIN INVEST, V88, P1207, DOI 10.1172/JCI115423; MYERS BM, 1993, GASTROENTEROLOGY, V105, P1814, DOI 10.1016/0016-5085(93)91080-2; NIEDERAU C, 1988, J CLIN INVEST, V81, P229, DOI 10.1172/JCI113300; NIEDERAU C, 1986, GASTROENTEROLOGY, V91, P1433, DOI 10.1016/0016-5085(86)90197-6; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; OHKUMA S, 1982, P NATL ACAD SCI-BIOL, V79, P2758, DOI 10.1073/pnas.79.9.2758; Pfutzer R, 2002, GUT, V50, P271, DOI 10.1136/gut.50.2.271; Ren WP, 1996, BIOCHEM J, V319, P793, DOI 10.1042/bj3190793; Sahin-Toth M, 2000, BIOCHEM BIOPH RES CO, V278, P286, DOI 10.1006/bbrc.2000.3797; Sahin-Toth M, 2000, J BIOL CHEM, V275, P22750, DOI 10.1074/jbc.M002943200; Sahin-Toth M, 2001, PANCREATOLOGY, V1, P461, DOI 10.1159/000055848; SALUJA A, 1987, AM J PHYSIOL, V253, pG508, DOI 10.1152/ajpgi.1987.253.4.G508; Saluja AK, 1997, GASTROENTEROLOGY, V113, P304, DOI 10.1016/S0016-5085(97)70108-2; SCHNEIDER DL, 1981, J BIOL CHEM, V256, P3858; Simon P, 2002, J BIOL CHEM, V277, P5404, DOI 10.1074/jbc.M108073200; Steed PM, 1998, PROTEIN SCI, V7, P2033, DOI 10.1002/pro.5560070920; STEER ML, 1987, NEW ENGL J MED, V316, P144; Szilagyi L, 2001, J BIOL CHEM, V276, P24574, DOI 10.1074/jbc.M011374200; Teich N, 2000, GASTROENTEROLOGY, V119, P461, DOI 10.1053/gast.2000.9312; Teich N, 1998, HUM MUTAT, V12, P39, DOI 10.1002/(SICI)1098-1004(1998)12:1<39::AID-HUMU6>3.0.CO;2-P; TOOZE J, 1991, EUR J CELL BIOL, V56, P187; VANDYKE RW, 1992, BIOCHEM BIOPH RES CO, V184, P300, DOI 10.1016/0006-291X(92)91192-S; WATANABE O, 1984, AM J PHYSIOL, V246, pG457, DOI 10.1152/ajpgi.1984.246.4.G457; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 1999, GASTROENTEROLOGY, V117, P7, DOI 10.1016/S0016-5085(99)70543-3; ZIMMERLE CT, 1989, BIOCHEM J, V258, P381, DOI 10.1042/bj2580381	49	94	96	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21389	21396		10.1074/jbc.M200878200	http://dx.doi.org/10.1074/jbc.M200878200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11932257	hybrid			2022-12-27	WOS:000176286000036
J	Mansy, SS; Wu, G; Surerus, KK; Cowan, JA				Mansy, SS; Wu, G; Surerus, KK; Cowan, JA			Iron-sulfur cluster biosynthesis - Thermatoga maritima IscU is a structured iron-sulfur cluster assembly protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TO-SERINE MUTANTS; NIFS-LIKE PROTEIN; ESCHERICHIA-COLI; AZOTOBACTER-VINELANDII; THERMOTOGA-MARITIMA; 2FE-2S FERREDOXIN; SECONDARY STRUCTURE; MEMBRANE PROTEINS; IDENTIFICATION; SPECTROSCOPY	Genetic evidence has indicated that Isc proteins play an important role in iron-sulfur cluster biogenesis. In particular, IscU is believed to serve as a scaffold for the assembly of a nascent iron-sulfur cluster that is subsequently delivered to target iron-sulfur apoproteins. We report the characterization of an IscU from Thermatoga maritima, an evolutionarily ancient hyperthermophilic bacterium. The stabilizing influence of a D40A substitution allowed characterization of the holoprotein. Mossbauer (delta = 0.29 +/- 0.03 mm/s, DeltaE(Q) = 0.58 +/- 0.03 mm/s), UV-visible absorption, and circular dichroism studies of the D40A protein show that T. maritima IscU coordinates a [2Fe-2S](2+) cluster. Thermal denaturation experiments demonstrate that T. maritima IscU is a thermally stable protein with a thermally unstable cluster. This is also the first IscU type domain that is demonstrated to possess a high degree of secondary and tertiary structure. CD spectra indicate 36.7% alpha-helix, 13.1% antiparallel beta-sheet, 11.3% parallel beta-sheet, 20.2% beta-turn, and 19.1% other at 20 degreesC, with negligible spectral change observed at 70 degreesC. Cluster coordination also has no effect on the secondary structure of the protein. The dispersion of signals in H-1-N-15 heteronuclear single quantum correlation NMR spectra of wild type and D40A IscU supports the presence of significant tertiary structure for the apoprotein, consistent with a scaffolding role, and is in marked contrast to other low molecular weight Fe-S proteins where cofactor coordination is found to be necessary for proper protein folding. Consistent with the observed sequence homology and proposed conservation of function for IscU-type proteins, we demonstrate T. maritima IscU-mediated reconstitution of human apoferredoxin.	Ohio State Univ, Evans Lab Chem, Columbus, OH 43210 USA; Univ Wisconsin, Dept Chem, Milwaukee, WI 53201 USA	University System of Ohio; Ohio State University; University of Wisconsin System; University of Wisconsin Milwaukee	Cowan, JA (corresponding author), Ohio State Univ, Evans Lab Chem, 100 W 18th Ave, Columbus, OH 43210 USA.		Mansy, Sheref/E-6266-2010	Mansy, Sheref/0000-0003-2382-198X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008512] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM08512-03] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agar JN, 2000, J BIOL INORG CHEM, V5, P167, DOI 10.1007/s007750050361; Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Agar JN, 2000, J AM CHEM SOC, V122, P2136, DOI 10.1021/ja9944195; AGARWAL A, 1993, BIOCHEM BIOPH RES CO, V197, P1357, DOI 10.1006/bbrc.1993.2626; Bates DM, 2000, J BIOL CHEM, V275, P6234, DOI 10.1074/jbc.275.9.6234; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Bocchetta M, 2000, J MOL EVOL, V50, P366, DOI 10.1007/s002399910040; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; DELEAGE G, 1993, COMPUT APPL BIOSCI, V9, P197; Foster MW, 2000, J AM CHEM SOC, V122, P6805, DOI 10.1021/ja000800+; FU WG, 1994, BIOCHEMISTRY-US, V33, P13455, DOI 10.1021/bi00249a034; Hagen WR, 2000, J BIOL INORG CHEM, V5, P527, DOI 10.1007/s007750050013; HALL DO, 1971, NATURE, V233, P136, DOI 10.1038/233136a0; HINDENNACH I, 1975, EUR J BIOCHEM, V59, P207, DOI 10.1111/j.1432-1033.1975.tb02443.x; Hoff KG, 2000, P NATL ACAD SCI USA, V97, P7790, DOI 10.1073/pnas.130201997; Hurley JK, 1997, BIOCHEMISTRY-US, V36, P15109, DOI 10.1021/bi972001i; Hwang DM, 1996, J MOL EVOL, V43, P536, DOI 10.1007/PL00006114; Iametti S, 2001, EUR J BIOCHEM, V268, P2421, DOI 10.1046/j.1432-1327.2001.02130.x; JACOBSON MR, 1989, MOL GEN GENET, V219, P45; JOHNSON WC, 1990, PROTEINS, V7, P205, DOI 10.1002/prot.340070302; Jung YS, 1999, J BIOL CHEM, V274, P2978, DOI 10.1074/jbc.274.5.2978; Jung YS, 1999, J BIOL CHEM, V274, P32402, DOI 10.1074/jbc.274.45.32402; Kaiser JT, 2000, J MOL BIOL, V297, P451, DOI 10.1006/jmbi.2000.3581; Lill R, 2000, TRENDS BIOCHEM SCI, V25, P352, DOI 10.1016/S0968-0004(00)01589-9; Michelini ET, 1999, J BACTERIOL, V181, P4237, DOI 10.1128/JB.181.14.4237-4244.1999; Muller K, 1998, EUR J BIOCHEM, V258, P1001, DOI 10.1046/j.1432-1327.1998.2581001.x; Natarajan K, 1997, J AM CHEM SOC, V119, P4082, DOI 10.1021/ja9639729; Nishio K, 2000, J BIOL CHEM, V275, P22615, DOI 10.1074/jbc.C000279200; Ollagnier-de-Choudens S, 2001, J BIOL CHEM, V276, P22604, DOI 10.1074/jbc.M102902200; Patzer SI, 1999, J BACTERIOL, V181, P3307, DOI 10.1128/JB.181.10.3307-3309.1999; Pfeil W, 1997, J MOL BIOL, V272, P591, DOI 10.1006/jmbi.1997.1278; Pozdnyakova I, 2001, J AM CHEM SOC, V123, P10135, DOI 10.1021/ja016252x; Sambrook J., 2002, MOL CLONING LAB MANU; SCHNAITMAN CA, 1974, J BACTERIOL, V118, P442, DOI 10.1128/JB.118.2.442-453.1974; SREERAMA N, 1994, J MOL BIOL, V242, P497, DOI 10.1006/jmbi.1994.1597; Stetter KO, 1996, FEMS MICROBIOL REV, V18, P149, DOI 10.1111/j.1574-6976.1996.tb00233.x; Urbina HD, 2001, J BIOL CHEM, V276, P44521, DOI 10.1074/jbc.M106907200; Verhagen MFJM, 2001, BBA-BIOENERGETICS, V1505, P209, DOI 10.1016/S0005-2728(01)00166-9; Vidakovic MS, 1996, J BIOL CHEM, V271, P14734, DOI 10.1074/jbc.271.25.14734; WACHTERSHAUSER G, 1992, PROG BIOPHYS MOL BIO, V58, P85, DOI 10.1016/0079-6107(92)90022-X; Xia B, 1996, BIOCHEMISTRY-US, V35, P9488, DOI 10.1021/bi960467f; Yuvaniyama P, 2000, P NATL ACAD SCI USA, V97, P599, DOI 10.1073/pnas.97.2.599; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	45	79	79	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21397	21404		10.1074/jbc.M201439200	http://dx.doi.org/10.1074/jbc.M201439200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11934893	hybrid			2022-12-27	WOS:000176286000037
J	Nair, AK; Kash, JC; Peegel, H; Menon, KMJ				Nair, AK; Kash, JC; Peegel, H; Menon, KMJ			Post-transcriptional regulation of luteinizing hormone receptor mRNA in the ovary by a novel mRNA-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CHORIONIC-GONADOTROPIN; INDUCED DOWN-REGULATION; CODING REGION; RIBONUCLEIC-ACID; HALF-LIFE; DEGRADATION; STABILITY; CELLS; SEQUENCE; STEP	Luteinizing hormone (LH) receptor mRNA is post-transcriptionally regulated. An ovarian cytosolic LH receptor mRNA-binding protein (LRBP) identified in our laboratory binds to a polypyrimidine-rich bipartite sequence in the coding region of LH receptor mRNA. The present studies show a role for LRBP in the regulation of LH receptor mRNA. We demonstrated that increased LH receptor mRNA degradation occurs during hormone-induced LH receptor down-regulation. Furthermore, increased degradation of LH receptor mRNA was seen when partially purified LRBP was included in an in vitro mRNA decay reaction. The LH receptor mRNA binding activity of LRBP measured by RNA electrophoretic mobility shift analysis showed an inverse relationship to LH receptor mRNA levels during different physiological states. These results suggest that LRBP is a physiological regulator of LHR mRNA expression in the ovary and provides a novel mechanism for the regulation of LH receptor expression in the ovary.	Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Obstet Gynecol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Menon, KMJ (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 6428 Med Sci Bldg I,1301 Catherine, Ann Arbor, MI 48109 USA.		Kash, John/ABE-8280-2021		NICHD NIH HHS [HD-06656, 5-T32-HD-07048] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD006656] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007048, R37HD006656] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BERNSTEIN PL, 1992, GENE DEV, V6, P642, DOI 10.1101/gad.6.4.642; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; CAMP TA, 1991, MOL ENDOCRINOL, V5, P1405, DOI 10.1210/mend-5-10-1405; CHEN CYA, 1992, MOL CELL BIOL, V12, P5748, DOI 10.1128/MCB.12.12.5748; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DECKER CJ, 1994, TRENDS BIOCHEM SCI, V19, P336, DOI 10.1016/0968-0004(94)90073-6; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; GOLOS TG, 1987, J CLIN INVEST, V80, P896, DOI 10.1172/JCI113149; HERRICK DJ, 1994, MOL CELL BIOL, V14, P2119, DOI 10.1128/MCB.14.3.2119; HOFFMAN YM, 1991, ENDOCRINOLOGY, V128, P388, DOI 10.1210/endo-128-1-388; Kash JC, 1998, J BIOL CHEM, V273, P10658, DOI 10.1074/jbc.273.17.10658; Kash JC, 1999, BIOCHEMISTRY-US, V38, P16889, DOI 10.1021/bi9915770; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; LAPOLT PS, 1990, ENDOCRINOLOGY, V126, P3277, DOI 10.1210/endo-126-6-3277; LU DL, 1993, ENDOCRINOLOGY, V132, P235, DOI 10.1210/en.132.1.235; NAKAMURA K, 1990, BIOCHEM BIOPH RES CO, V172, P786, DOI 10.1016/0006-291X(90)90743-7; PEEGEL H, 1994, ENDOCRINOLOGY, V135, P1044, DOI 10.1210/en.135.3.1044; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; PROKIPCAK RD, 1994, J BIOL CHEM, V269, P9261; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; ROSS J, 1993, RNA PROTEIN INTERACT, P459; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SEGALOFF DL, 1990, MOL ENDOCRINOL, V4, P1856, DOI 10.1210/mend-4-12-1856; SHYU AB, 1991, GENE DEV, V5, P221, DOI 10.1101/gad.5.2.221; SHYU AB, 1989, GENE DEV, V3, P60, DOI 10.1101/gad.3.1.60; VEYRUNE JL, 1995, ONCOGENE, V11, P2127; Zhang MC, 1999, MOL CELL BIOL, V19, P7314	28	51	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21468	21473		10.1074/jbc.M111653200	http://dx.doi.org/10.1074/jbc.M111653200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11940568	hybrid			2022-12-27	WOS:000176286000046
J	Ninomiya, T; Sugiura, N; Tawada, A; Sugimoto, K; Watanabe, H; Kimata, K				Ninomiya, T; Sugiura, N; Tawada, A; Sugimoto, K; Watanabe, H; Kimata, K			Molecular cloning and characterization of chondroitin polymerase from Escherichia coli strain K4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CUCUMBER STICHOPUS-JAPONICUS; CAPSULE GENE-CLUSTER; PASTEURELLA-MULTOCIDA; SEA-CUCUMBER; SULFATE PROTEOGLYCANS; HYALURONAN SYNTHASE; NUCLEOTIDE-SEQUENCE; SQUID CARTILAGE; GLUCURONIC-ACID; ELEMENT IS2	Escherichia coli strain K4 produces the K4 antigen, a capsule polysaccharide consisting of a chondroitin backbone (GlcUA beta(1-3)-GalNAc beta(1-4))(n) to which beta-fructose is linked at position C-3 of the GlcUA residue. We molecularly cloned region 2 of the K4 capsular gene cluster essential for biosynthesis of the polysaccharide, and we further identified a gene encoding a bifunctional glycosyltransferase that polymerizes the chondroitin backbone. The enzyme, containing two conserved glycosyltransferase sites, showed 59 and 61% identity at the amino acid level to class 2 hyaluronan synthase and chondroitin synthase from Pasteurella multocida, respectively. The soluble enzyme expressed in a bacterial expression system transferred GalNAc and GlcUA residues alternately, and polymerized the chondroitin chain up to a molecular mass of 20 kDa when chondroitin sulfate hexasaccharide was used as an acceptor. The enzyme exhibited apparent K-m values for UDP-GlcUA and UDP-GalNAc of 3.44 and 31.6 muM, respectively, and absolutely required acceptors of chondroitin sulfate polymers and oligosaccharides at least longer than a tetrasaccharide. In addition, chondroitin polymers and oligosaccharides and hyaluronan polymers and oligosaccharides served as acceptors for chondroitin polymerization, but dermatan sulfate and heparin did not. These results may lead to elucidation of the mechanism for chondroitin chain synthesis in both microorganisms and mammals.	Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan; Seikagaku Corp, Cent Res Labs, Tokyo 2070021, Japan; Hokkaido Univ, Grad Sch Sci, Dept Chem, Sapporo, Hokkaido 0600810, Japan	Aichi Medical University; Seikagaku Corporation; Hokkaido University	Kimata, K (corresponding author), Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan.	kimata@aichi-med-u.ac.jp		Watanabe, Hideto/0000-0001-5291-0696				BOULNOIS GJ, 1989, MOL MICROBIOL, V3, P1819, DOI 10.1111/j.1365-2958.1989.tb00168.x; Boyce JD, 2000, VET MICROBIOL, V72, P121, DOI 10.1016/S0378-1135(99)00193-5; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DAUDE N, 1995, BIOCHEM MOL MED, V56, P1, DOI 10.1006/bmme.1995.1048; David CL, 1998, J BIOL CHEM, V273, P32063, DOI 10.1074/jbc.273.48.32063; DAVID G, 1989, J CELL BIOL, V108, P1165, DOI 10.1083/jcb.108.3.1165; DeAngelis PL, 1999, CELL MOL LIFE SCI, V56, P670, DOI 10.1007/s000180050461; DeAngelis PL, 2000, J BIOL CHEM, V275, P24124, DOI 10.1074/jbc.M003385200; DeAngelis PL, 1998, J BIOL CHEM, V273, P8454, DOI 10.1074/jbc.273.14.8454; GHOSAL D, 1979, NUCLEIC ACIDS RES, V6, P1111, DOI 10.1093/nar/6.3.1111; Griffiths G, 1998, J BIOL CHEM, V273, P11752, DOI 10.1074/jbc.273.19.11752; HABUCHI O, 1977, J BIOL CHEM, V252, P4570; Habuchi O, 2000, BBA-GEN SUBJECTS, V1474, P115, DOI 10.1016/S0304-4165(00)00016-7; Hodson N, 2000, J BIOL CHEM, V275, P27311; HU ST, 1988, MOL GEN GENET, V214, P490, DOI 10.1007/BF00330485; HU ST, 1987, GENE, V55, P157, DOI 10.1016/0378-1119(87)90276-9; INOUE Y, 1981, CARBOHYD RES, V97, P263, DOI 10.1016/S0008-6215(00)80672-2; Ito Y, 2000, J BIOL CHEM, V275, P34728, DOI 10.1074/jbc.M909633199; JANN B, 1990, CURR TOP MICROBIOL, V150, P19; Jing W, 2000, GLYCOBIOLOGY, V10, P883, DOI 10.1093/glycob/10.9.883; Kariya Y, 1997, CARBOHYD RES, V297, P273, DOI 10.1016/S0008-6215(96)00258-3; KARIYA Y, 1990, J BIOL CHEM, V265, P5081; KIMATA K, 1974, J BIOL CHEM, V249, P1646; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lidholt K, 1997, J BIOL CHEM, V272, P2682, DOI 10.1074/jbc.272.5.2682; May BJ, 2001, P NATL ACAD SCI USA, V98, P3460, DOI 10.1073/pnas.051634598; OOHIRA A, 1994, NEUROSCI RES, V20, P195, DOI 10.1016/0168-0102(94)90088-4; Pedersen LC, 2000, J BIOL CHEM, V275, P34580, DOI 10.1074/jbc.M007399200; PETIT C, 1995, MOL MICROBIOL, V17, P611, DOI 10.1111/j.1365-2958.1995.mmi_17040611.x; Prydz K, 2000, J CELL SCI, V113, P193; ROBERTS I, 1986, J BACTERIOL, V168, P1228, DOI 10.1128/jb.168.3.1228-1233.1986; ROBERTS IS, 1988, J BACTERIOL, V170, P1305, DOI 10.1128/jb.170.3.1305-1310.1988; RODRIGUEZ ML, 1988, EUR J BIOCHEM, V177, P117, DOI 10.1111/j.1432-1033.1988.tb14351.x; RONECKER HJ, 1987, GENE, V59, P291, DOI 10.1016/0378-1119(87)90337-4; SKURNIK M, 1995, MOL MICROBIOL, V17, P575, DOI 10.1111/j.1365-2958.1995.mmi_17030575.x; STAUFFER GV, 1981, GENE, V14, P63, DOI 10.1016/0378-1119(81)90148-7; Sugahara K, 1996, J BIOL CHEM, V271, P26745, DOI 10.1074/jbc.271.43.26745; Townsend KM, 2001, J CLIN MICROBIOL, V39, P924, DOI 10.1128/JCM.39.3.924-929.2001; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; VANN WF, 1981, EUR J BIOCHEM, V116, P359, DOI 10.1111/j.1432-1033.1981.tb05343.x; VIEIRA RP, 1991, J BIOL CHEM, V266, P13530; VYNIOS DH, 1990, BIOCHIM BIOPHYS ACTA, V1033, P139, DOI 10.1016/0304-4165(90)90004-G; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; YAMAGATA M, 1987, J BIOL CHEM, V262, P4146; YOSHIDA K, 1989, ANAL BIOCHEM, V177, P327, DOI 10.1016/0003-2697(89)90061-4; Yoshida M, 2000, J BIOL CHEM, V275, P497, DOI 10.1074/jbc.275.1.497; Zako M, 1997, J NEUROCHEM, V69, P2155	48	82	98	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21567	21575		10.1074/jbc.M201719200	http://dx.doi.org/10.1074/jbc.M201719200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11943778	hybrid			2022-12-27	WOS:000176286000060
J	Bontems, S; Di Valentin, E; Baudoux, L; Rentier, B; Sadzot-Delvaux, C; Piette, J				Bontems, S; Di Valentin, E; Baudoux, L; Rentier, B; Sadzot-Delvaux, C; Piette, J			Phosphorylation of varicella-zoster virus IE63 protein by casein kinases influences its cellular localization and gene regulation activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMEDIATE-EARLY PROTEIN; TERMINAL PEST DOMAIN; KAPPA-B-ALPHA; VZV TRANSCRIPTION; HUMAN GANGLIA; NUCLEAR-LOCALIZATION; CDNA LIBRARY; EXPRESSION; LATENCY; ORF47	During the early phase of varicella-zoster virus (VZV) infection, Immediate Early protein 63 (IE63) is expressed rapidly and abundantly in the nucleus, while during latency, this protein is confined mostly to the cytoplasm. Because phosphorylation is known to regulate many cellular events, we investigated the importance of this modification on the cellular localization of IE63 and on its regulatory properties. We demonstrate here that cellular casein kinases I and II are implicated in the in vitro and in vivo phosphorylation of IE63. A mutational approach also indicated that phosphorylation of the protein is important for its correct cellular localization in a cell type-dependent fashion. Using an activity test, we demonstrated that IE63 was able to repress the gene expression driven by two VZV promoters and that phosphorylation of the protein was required for its full repressive properties. Finally, we showed that IE63 was capable of exerting its repressive activity in the cytoplasm, as well as in the nucleus, suggesting a regulation at the transcriptional and/or posttranscriptional level.	Univ Liege, Inst Pathol B23, Lab Virol & Immunol, B-4000 Liege, Belgium	University of Liege	Piette, J (corresponding author), Univ Liege, Inst Pathol B23, Lab Virol & Immunol, B-4000 Liege, Belgium.	jpiette@ulg.ac.be						Advani SJ, 2000, P NATL ACAD SCI USA, V97, P10996, DOI 10.1073/pnas.200375297; BAUDOUX L, 1995, NUCLEIC ACIDS RES, V23, P1341, DOI 10.1093/nar/23.8.1341; Blanquet PR, 2000, PROG NEUROBIOL, V60, P211, DOI 10.1016/S0301-0082(99)00026-X; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 1998, NUCLEIC ACIDS RES, V26, P382, DOI 10.1093/nar/26.1.382; Briggs LJ, 2001, BIOCHEM J, V353, P69, DOI 10.1042/bj3530069; CAELLES C, 1995, MOL CELL BIOL, V15, P6694; Calkhoven CF, 1996, BIOCHEM J, V317, P329, DOI 10.1042/bj3170329; Cohrs RJ, 1996, J VIROL, V70, P2789, DOI 10.1128/JVI.70.5.2789-2796.1996; COHRS RJ, 1995, J VIROL, V69, P2674, DOI 10.1128/JVI.69.4.2674-2678.1995; COHRS RJ, 1994, J VIROL, V68, P7900, DOI 10.1128/JVI.68.12.7900-7908.1994; CROEN KD, 1988, P NATL ACAD SCI USA, V85, P9773, DOI 10.1073/pnas.85.24.9773; DEBRUS S, 1995, J VIROL, V69, P3240, DOI 10.1128/JVI.69.5.3240-3245.1995; DEFECHEREUX P, 1993, J VIROL, V67, P4379, DOI 10.1128/JVI.67.7.4379-4385.1993; DEWIND N, 1992, J VIROL, V66, P5200, DOI 10.1128/JVI.66.9.5200-5209.1992; ElHodiri HM, 1997, J BIOL CHEM, V272, P20463, DOI 10.1074/jbc.272.33.20463; Flisser A, 1999, Contrib Microbiol, V3, P76; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Guerra B, 1999, ELECTROPHORESIS, V20, P391, DOI 10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N; HASHIMOTO N, 1994, FEBS LETT, V352, P236, DOI 10.1016/0014-5793(94)00964-3; HEINEMAN TC, 1995, J VIROL, V69, P7367, DOI 10.1128/JVI.69.11.7367-7370.1995; Hicks GR, 1995, ANNU REV CELL DEV BI, V11, P155, DOI 10.1146/annurev.cb.11.110195.001103; HONESS RW, 1974, J VIROL, V14, P8, DOI 10.1128/JVI.14.1.8-19.1974; INCHAUSPE G, 1989, VIROLOGY, V173, P700, DOI 10.1016/0042-6822(89)90583-7; JACKERS P, 1992, J VIROL, V66, P3899, DOI 10.1128/JVI.66.6.3899-3903.1992; JANS DA, 1991, J CELL BIOL, V115, P1203, DOI 10.1083/jcb.115.5.1203; Jans DA, 1996, PHYSIOL REV, V76, P651, DOI 10.1152/physrev.1996.76.3.651; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; Kennedy PGE, 1999, VIROLOGY, V258, P451, DOI 10.1006/viro.1999.9745; Kennedy PGE, 2001, VIROLOGY, V289, P218, DOI 10.1006/viro.2001.1173; Kenyon TK, 2001, J VIROL, V75, P8854, DOI 10.1128/JVI.75.18.8854-8858.2001; KINCHINGTON PR, 1992, J VIROL, V66, P359, DOI 10.1128/JVI.66.1.359-366.1992; Kinchington PR, 2001, J VIROL, V75, P9106, DOI 10.1128/JVI.75.19.9106-9113.2001; KING RW, 1994, CELL, V79, P563, DOI 10.1016/0092-8674(94)90542-8; KOST RG, 1995, VIROLOGY, V209, P218, DOI 10.1006/viro.1995.1246; Lin RT, 1996, MOL CELL BIOL, V16, P1401; Lungu O, 1999, Contrib Microbiol, V3, P61; Lungu O, 1998, P NATL ACAD SCI USA, V95, P7080, DOI 10.1073/pnas.95.12.7080; Mahalingam R, 1996, P NATL ACAD SCI USA, V93, P2122, DOI 10.1073/pnas.93.5.2122; MEGGIO F, 1990, EUR J BIOCHEM, V187, P89, DOI 10.1111/j.1432-1033.1990.tb15280.x; MEIER JL, 1994, MOL CELL BIOL, V14, P6896, DOI 10.1128/MCB.14.10.6896; MEIER JL, 1993, VIROLOGY, V193, P193, DOI 10.1006/viro.1993.1115; Moffat JF, 1998, P NATL ACAD SCI USA, V95, P11969, DOI 10.1073/pnas.95.20.11969; MORIUCHI H, 1993, J VIROL, V67, P2739, DOI 10.1128/JVI.67.5.2739-2746.1993; NG TI, 1992, VIROLOGY, V191, P9, DOI 10.1016/0042-6822(92)90161-H; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; OVERTON H, 1994, VIROLOGY, V202, P97, DOI 10.1006/viro.1994.1326; PERERA LP, 1992, J VIROL, V66, P5298, DOI 10.1128/JVI.66.9.5298-5304.1992; PERERA LP, 1992, VIROLOGY, V191, P346, DOI 10.1016/0042-6822(92)90197-W; PURVES FC, 1993, P NATL ACAD SCI USA, V90, P6701, DOI 10.1073/pnas.90.14.6701; Rahaus M, 1999, Contrib Microbiol, V3, P1; Sakanaka C, 2000, RECENT PROG HORM RES, V55, P225; Sanford JR, 2001, P NATL ACAD SCI USA, V98, P10184, DOI 10.1073/pnas.181340498; Schoonbroodt S, 1996, J MED VIROL, V49, P264, DOI 10.1002/(SICI)1096-9071(199608)49:4<264::AID-JMV2>3.0.CO;2-1; Schoonbroodt S, 2000, J IMMUNOL, V164, P4292, DOI 10.4049/jimmunol.164.8.4292; Sommer MH, 2001, J VIROL, V75, P8224, DOI 10.1128/JVI.75.17.8224-8239.2001; Spengler M, 2001, ARCH VIR S, V17, P71; Stevenson D, 1996, J VIROL, V70, P658, DOI 10.1128/JVI.70.1.658-662.1996; VAFAI A, 1988, P NATL ACAD SCI USA, V85, P2767, DOI 10.1073/pnas.85.8.2767; WOOD JN, 1990, P ROY SOC B-BIOL SCI, V241, P187, DOI 10.1098/rspb.1990.0084; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737	61	45	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					21050	21060		10.1074/jbc.M111872200	http://dx.doi.org/10.1074/jbc.M111872200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11912195	hybrid, Green Submitted			2022-12-27	WOS:000176204500120
J	Gong, QG; Guo, Q; Tong, KL; Zhu, GA; Wong, JTF; Xue, H				Gong, QG; Guo, Q; Tong, KL; Zhu, GA; Wong, JTF; Xue, H			NMR analysis of bovine tRNA(Trp) - Conformation dependence of Mg2+ binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHENYLALANINE TRANSFER-RNA; NUCLEAR-MAGNETIC-RESONANCE; MAGNESIUM-ION BINDING; IMINO PROTON SIGNALS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; TRANSFER RNA(TRP); METAL-BINDING; SYNTHETASE; ASSIGNMENT	NMR was used to study the solution structure of bovine tRNA(TrP) hyperexpressed in Escherichia coli. With the use of N-15 labeling and site-directed mutagenesis to assign overlapping resonances through the base pair replacement of U(71)A(2) by G(2)C(71), U(27)A(43) by G(27)C(43), and G(12)C(23) by U(12)A(23), the resonances of all 26 observable imino protons in the helical regions and in the tertiary interactions were assigned unambiguously by means of two-dimensional nuclear Overhauser effect spectroscopy and heteronuclear single quantum coherence methods. When the discriminator base A(73) and the G(12)C(23) base pair on the D stem, two identity elements on bovine tRNA(Trp) that are important for effective recognition by tryptophanyl-tRNA synthetase, were mutated to the ineffective forms of G(73) and U(12)A(23), respectively, NMR analysis revealed an important conformational change in the U(12)A(23) mutant but not in the G(73) mutant molecule. Thus A(73) appears to be directly recognized by tryptophanyl-tRNA synthetase, and G(12)C(23) represents an important structural determinant. Mg2+ effects on the assigned resonances of imino protons allowed the identification of strong, medium, and weak Mg2+ binding sites in tRNA(Trp). Strong Mg2+ binding modes were associated with the residues G(7), s(4)U(8) (where s(4)U(8) is 4-thiouridine), G(12), and U-12. The observations that G(42) was associated with strong Mg2+ binding in only the U(12)A(23) mutant tRNA(Trp) but not the wild type or G(73) mutant tRNA(Trp) and that the G(7), s(4)U(8), G(24), and G(12) imino protons are associated with a two-site Mg2+ binding mode in wild type and G(73) mutant but only a one-site mode in the U(12)A(21) mutant established the occurrence of conformational change in the U(12)A(21) mutant tRNA(Trp). These observations also established the dependence of Mg2+ binding on tRNA conformation and the usefulness of Mg2+ binding sites as conformational probes. The thermal titration of tRNATrP in the presence and absence of 10 mM Mg2+ indicated that overall tRNA(Trp) structure stability was increased by more than 15 degreesC by the presence of Mg2+.	Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Xue, H (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Clear Water Bay, Kowloon, Hong Kong, Peoples R China.	hxue@ust.hk		Wong, J. Tze-Fei/0000-0001-8539-8537; Xue, Hong/0000-0002-8133-9828				BIOU V, 1994, SCIENCE, V263, P1404, DOI 10.1126/science.8128220; BRADBURY EM, 1986, NMR LIFE SCI, P93; Colmenarejo G, 1999, J MOL BIOL, V290, P119, DOI 10.1006/jmbi.1999.2867; Gonzalez RL, 1999, J MOL BIOL, V289, P1267, DOI 10.1006/jmbi.1999.2841; Guo Q, 2002, J BIOL CHEM, V277, P14343, DOI 10.1074/jbc.M111745200; HALL KB, 1989, BIOCHEMISTRY-US, V28, P5794, DOI 10.1021/bi00440a014; HARE DR, 1985, BIOCHEMISTRY-US, V24, P4300, DOI 10.1021/bi00337a008; HARE DR, 1982, BIOCHEMISTRY-US, V21, P1835, DOI 10.1021/bi00537a020; Hayashi I, 1997, J BIOCHEM-TOKYO, V121, P1115, DOI 10.1093/oxfordjournals.jbchem.a021703; Hayashi I, 1998, J MOL BIOL, V284, P57, DOI 10.1006/jmbi.1998.2151; HYDE EI, 1986, EUR J BIOCHEM, V155, P57, DOI 10.1111/j.1432-1033.1986.tb09458.x; HYDE EI, 1985, BIOCHEMISTRY-US, V24, P4307, DOI 10.1021/bi00337a009; JACK A, 1977, J MOL BIOL, V111, P315, DOI 10.1016/S0022-2836(77)80054-5; Jovine L, 2000, J MOL BIOL, V301, P401, DOI 10.1006/jmbi.2000.3950; KEARNS DR, 1971, J MOL BIOL, V61, P265, DOI 10.1016/0022-2836(71)90224-5; KIM SH, 1974, SCIENCE, V185, P435, DOI 10.1126/science.185.4149.435; Maderia M, 2000, BIOCHEMISTRY-US, V39, P12113, DOI 10.1021/bi001249w; Misra VK, 2000, J MOL BIOL, V299, P813, DOI 10.1006/jmbi.2000.3769; MOORE PB, 1995, ACCOUNTS CHEM RES, V28, P251, DOI 10.1021/ar00054a002; MORAS D, 1980, NATURE, V288, P669, DOI 10.1038/288669a0; NIIMI T, 1993, BIOCHIMIE, V75, P1109, DOI 10.1016/0300-9084(93)90010-P; QUIGLEY GJ, 1978, P NATL ACAD SCI USA, V75, P64, DOI 10.1073/pnas.75.1.64; QUIGLEY GJ, 1976, SCIENCE, V194, P796, DOI 10.1126/science.790568; Roberts G. C. K., 1993, NMR MACROMOLECULES P, P217; ROBERTUS JD, 1974, NATURE, V250, P546, DOI 10.1038/250546a0; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; ROY S, 1982, BIOCHEMISTRY-US, V21, P6081, DOI 10.1021/bi00267a009; Rudisser S, 2000, J MOL BIOL, V295, P1211, DOI 10.1006/jmbi.1999.3421; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; SCHIMMEL PR, 1980, ANNU REV BIOPHYS BIO, V9, P181, DOI 10.1146/annurev.bb.09.060180.001145; WALLIS NG, 1995, BIOCHEMISTRY-US, V34, P7668, DOI 10.1021/bi00023a013; WESTHOF E, 1986, BIOCHEMISTRY-US, V25, P4868, DOI 10.1021/bi00365a022; XUE H, 1993, J CHROMATOGR-BIOMED, V613, P247, DOI 10.1016/0378-4347(93)80139-U; XUE H, 1993, J BIOL CHEM, V268, P9316; Yan XZ, 2000, J BIOL CHEM, V275, P6712, DOI 10.1074/jbc.275.10.6712; YUE DX, 1994, BIOCHEMISTRY-US, V33, P8905, DOI 10.1021/bi00196a007	36	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20694	20701		10.1074/jbc.M202299200	http://dx.doi.org/10.1074/jbc.M202299200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11919203	hybrid			2022-12-27	WOS:000176204500077
J	Akgoz, M; Azpiazu, I; Kalyanaraman, V; Gautam, N				Akgoz, M; Azpiazu, I; Kalyanaraman, V; Gautam, N			Role of the G protein gamma subunit in beta gamma complex modulation of phospholipase C beta function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEIN; CRYSTAL-STRUCTURE; ACTIVATION; INTERACTS; ADENYLYL-CYCLASE-2; STIMULATION; RESOLUTION; EFFECTORS; REGULATOR; PHOSDUCIN	The G protein betagamma complex regulates a wide range of effectors, including the phospholipase C isozymes (PLCbetas). Different domains on the beta subunit are known to contact phospholipase Cbeta and affect its regulation. In contrast, the role of the gamma subunit in Gbetagamma modulation of PLCbeta function is not known. Results here show that the gamma subunit C-terminal domain is involved in mediating Gbetagamma interactions with phospholipase Cbeta. Mutations were introduced to alter the position of the post-translational prenyl modification at the C terminus of the gamma subunit with reference to the beta subunit. These mutants were appropriately post-translationally modified with the geranylgeranyl moiety. A deletion that shortened the C-terminal domain, insertions that extended this domain, and a point mutation, F59A, that disrupted the interaction of this domain with the beta subunit were all affected in their ability to activate PLCbeta to varying degrees. All mutants, however, interacted equally effectively with the G(o)alpha subunit. The results indicate that the G protein gamma subunit plays a direct role in the modulation of effector function by the betagamma complex.	Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Gautam, N (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, Box 8054, St Louis, MO 63110 USA.	gautam@morpheus.wustl.edu	Akgoz, Muslum/A-6234-2015; Akgoz, Muslum/AAG-4598-2019	Akgoz, Muslum/0000-0001-5065-8087; Akgoz, Muslum/0000-0001-5065-8087	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046963] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM046963, GM46963] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Azpiazu I, 2001, J BIOL CHEM, V276, P41742, DOI 10.1074/jbc.M104034200; Buck E, 2001, J BIOL CHEM, V276, P36014, DOI 10.1074/jbc.M103228200; CASEY PJ, 1991, METHOD ENZYMOL, V195, P315; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Dietrich A, 1996, BIOCHEMISTRY-US, V35, P15174, DOI 10.1021/bi960305j; Fogg VC, 2001, J BIOL CHEM, V276, P41797, DOI 10.1074/jbc.M107661200; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Gautam N, 1998, CELL SIGNAL, V10, P447, DOI 10.1016/S0898-6568(98)00006-0; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; KATZ A, 1992, NATURE, V360, P686, DOI 10.1038/360686a0; KISSELEV O, 1995, J BIOL CHEM, V270, P25356, DOI 10.1074/jbc.270.43.25356; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LINDER ME, 1995, METHOD ENZYMOL, V250, P314; Loew A, 1998, STRUCT FOLD DES, V6, P1007, DOI 10.1016/S0969-2126(98)00102-6; Myung CS, 2000, P NATL ACAD SCI USA, V97, P9311, DOI 10.1073/pnas.97.16.9311; Myung CS, 1999, J BIOL CHEM, V274, P16595, DOI 10.1074/jbc.274.23.16595; Panchenko MP, 1998, J BIOL CHEM, V273, P28298, DOI 10.1074/jbc.273.43.28298; PRONIN AN, 1994, METHOD ENZYMOL, V237, P482; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Romoser V, 1996, J BIOL CHEM, V271, P25071, DOI 10.1074/jbc.271.41.25071; Sankaran B, 1998, J BIOL CHEM, V273, P7148, DOI 10.1074/jbc.273.12.7148; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Weng GZ, 1996, J BIOL CHEM, V271, P26445, DOI 10.1074/jbc.271.43.26445; Yan K, 1997, J BIOL CHEM, V272, P2056; Yan K, 1996, J BIOL CHEM, V271, P17597, DOI 10.1074/jbc.271.30.17597; YI F, 1991, J BIOL CHEM, V266, P3900; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zhang SY, 1996, J BIOL CHEM, V271, P20208, DOI 10.1074/jbc.271.33.20208	31	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19573	19578		10.1074/jbc.M201546200	http://dx.doi.org/10.1074/jbc.M201546200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11914377	hybrid			2022-12-27	WOS:000175894800045
J	Dyckman, D; Fried, AG				Dyckman, D; Fried, AG			The Escherichia coli cyclic AMP receptor protein forms a 2 : 2 complex with RNA polymerase holoenzyme, in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATABOLITE ACTIVATOR PROTEIN; LARGE-SCALE PURIFICATION; CAP-DNA COMPLEX; TRANSCRIPTION ACTIVATION; DEPENDENT PROMOTERS; SIGMA(70) SUBUNIT; BINDING; CAMP; CORE; CRP	Sedimentation equilibrium studies show that the Escherichia coli cyclic AMP receptor protein (CAP) and RNA polymerase holoenzyme associate to form a 2:2 complex in vitro. No complexes of lower stoichiometry (1:1, 2:1,1:2) were detected over a wide range of CAP and RNA polymerase concentrations, suggesting that the interaction is highly cooperative. The absence of higher stoichiometry complexes, even in the limit of high [protein], suggests that the 2:2 species represents binding saturation for this system. The 2:2 pattern of complex formation is robust. A lower-limit estimate of the formation constant in our standard buffer (40 mM Tris (pH 7.9), 10 mM MgCl2, 0.1 mM dithiothreitol, 5% glycerol, 100 mM KCl) is 2 x 10(20) M-3. The qualitative pattern of association is unchanged over the temperature range 4 degreesC less than or equal to T less than or equal to 20 degreesC, by substitution of glutamate for chloride as the dominant anion, or on addition of 20 muM cAMP to the reaction mix. These results limit the possible mechanisms of CAP-polymerase association. In addition, they support the idea that CAP binding may influence the availability of the monomeric form of RNA polymerase that mediates transcription at many promoters.	Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Fried, AG (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, POB 850, Hershey, PA 17033 USA.	mfried@psu.edu						ADHYA S, 1990, J BIOL CHEM, V265, P10797; AIBA H, 1982, NUCLEIC ACIDS RES, V10, P1345, DOI 10.1093/nar/10.4.1345; ANDERSON WB, 1971, J BIOL CHEM, V246, P5929; Bailey, 1981, STAT METHODS BIOL; BELL A, 1990, NUCLEIC ACIDS RES, V18, P7243, DOI 10.1093/nar/18.24.7243; BERG D, 1970, BIOCHEMISTRY-US, V9, P5055; Bevington PR., 2002, DATA REDUCTION ERROR; BLAZY B, 1980, MOL BIOL REP, V6, P39, DOI 10.1007/BF00775753; BURGESS RR, 1969, J BIOL CHEM, V244, P6160; BURGESS RR, 1975, BIOCHEMISTRY-US, V14, P4634, DOI 10.1021/bi00692a011; Burgess RR, 1976, RNA POLYMERASE, P69; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Callaci S, 1998, BIOCHEMISTRY-US, V37, P3312, DOI 10.1021/bi972041m; Chamberlin M., 1976, RNA POLYMERASE BOOK, P17; Chamberlin M.J., 1976, RNA POLYMERASE, P159; DECROMBRUGGHE B, 1984, SCIENCE, V224, P831, DOI 10.1126/science.6372090; EBRIGHT RH, 1993, MOL MICROBIOL, V8, P797, DOI 10.1111/j.1365-2958.1993.tb01626.x; FRIED M, 1982, THESIS YALE U NEW HA; FRIED MG, 1984, J MOL BIOL, V172, P241, DOI 10.1016/S0022-2836(84)80025-X; HAGER DA, 1990, BIOCHEMISTRY-US, V29, P7890, DOI 10.1021/bi00486a016; HARRIS SJ, 1995, BIOCHEMISTRY-US, V34, P8752, DOI 10.1021/bi00027a026; HEYDUK T, 1993, NATURE, V364, P548, DOI 10.1038/364548a0; HUANG CY, 1982, METHOD ENZYMOL, V87, P509; HUDSON JM, 1993, EUR J BIOCHEM, V212, P539, DOI 10.1111/j.1432-1033.1993.tb17691.x; JIN RZ, 1995, J BIOL CHEM, V270, P19213, DOI 10.1074/jbc.270.33.19213; Johnson CM, 2000, J BACTERIOL, V182, P1995, DOI 10.1128/JB.182.7.1995-2000.2000; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533; MCKAY DB, 1982, J BIOL CHEM, V257, P9518; Nasser W, 2001, J BIOL CHEM, V276, P17878, DOI 10.1074/jbc.M100632200; Niu W, 1996, CELL, V87, P1123, DOI 10.1016/S0092-8674(00)81806-1; Parkinson G, 1996, J MOL BIOL, V260, P395, DOI 10.1006/jmbi.1996.0409; Passner JM, 1997, P NATL ACAD SCI USA, V94, P2843, DOI 10.1073/pnas.94.7.2843; PILZ I, 1972, EUR J BIOCHEM, V28, P205, DOI 10.1111/j.1432-1033.1972.tb01904.x; PINKNEY M, 1988, BIOCHEM J, V250, P897, DOI 10.1042/bj2500897; RAMSEIER TM, 1995, MICROBIOL-SGM, V141, P1901, DOI 10.1099/13500872-141-8-1901; RICHARDS.JP, 1966, P NATL ACAD SCI USA, V55, P1616, DOI 10.1073/pnas.55.6.1616; Richet E, 2000, EMBO J, V19, P5222, DOI 10.1093/emboj/19.19.5222; ROE JH, 1985, BIOCHEMISTRY-US, V24, P4271; Savery N, 1996, PHILOS T ROY SOC B, V351, P543, DOI 10.1098/rstb.1996.0053; Savery NJ, 1998, EMBO J, V17, P3439, DOI 10.1093/emboj/17.12.3439; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; SHANER SL, 1982, BIOCHEMISTRY-US, V21, P5539, DOI 10.1021/bi00265a025; SHANER SL, 1982, COLD SPRING HARB SYM, V47, P463; SPASSKY A, 1985, BIOCHEMISTRY-US, V24, P2723, DOI 10.1021/bi00332a019; STRANEY DC, 1985, CELL, V43, P449, DOI 10.1016/0092-8674(85)90175-8; TANG H, 1994, GENE DEV, V8, P3058, DOI 10.1101/gad.8.24.3058; TRAVERS AA, 1982, NUCLEIC ACIDS RES, V10, P5043, DOI 10.1093/nar/10.16.5043; VONHIPPEL PH, 1992, TRANSCRIPTIONAL REGU, P179; ZOU C, 1992, MOL MICROBIOL, V6, P2599, DOI 10.1111/j.1365-2958.1992.tb01437.x	50	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					19064	19070		10.1074/jbc.M110554200	http://dx.doi.org/10.1074/jbc.M110554200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11904295	hybrid			2022-12-27	WOS:000175975800107
J	Weeber, EJ; Levy, M; Sampson, MJ; Anflous, K; Armstrong, DL; Brown, SE; Sweatt, JD; Craigen, WJ				Weeber, EJ; Levy, M; Sampson, MJ; Anflous, K; Armstrong, DL; Brown, SE; Sweatt, JD; Craigen, WJ			The role of mitochondrial porins and the permeability transition pore in learning and synaptic plasticity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; DEPENDENT ANION CHANNEL; PROTEIN-KINASE; MEMORY FORMATION; CYCLOSPORINE-A; CYCLOPHILIN-D; CELL-DEATH; CALCINEURIN; PHOSPHATASE; INHIBITOR	Mitochondrial outer membrane permeability is conferred by a family of porin proteins. Mitochondrial porins conduct small molecules and constitute one component of the permeability transition pore that opens in response to apoptotic signals. Because mitochondrial porins have significant roles in diverge cellular processes including regulation of mitochondrial ATP and calcium flux, we sought to determine their importance in learning and synaptic plasticity in mice. We show that fear conditioning and spatial learning are disrupted in porin-deficient mice. Electrophysiological recordings of porin-deficient hippocampal slices reveal deficits in long and short term synaptic plasticity. Inhibition of the mitochondrial permeability transition pore by cyclosporin A in wild-type hippocampal slices reproduces the electrophysiological. phenotype of porin-deficient mice. These results demonstrate a dynamic functional role for mitochondrial porins and the permeability transition pore in learning and synaptic plasticity.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Craigen, WJ (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.		Levy, Michael/A-3268-2011; Weeber, Edwin J/A-5396-2012	Levy, Michael/0000-0002-7969-8346; Sweatt, J. David/0000-0003-3567-485X	PHS HHS [R01 55713] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Beal MF, 1998, BBA-BIOENERGETICS, V1366, P211, DOI 10.1124/jpet.112.192138; Bennett PC, 1998, FEBS LETT, V431, P386, DOI 10.1016/S0014-5793(98)00795-9; Bennett PC, 1996, BRAIN RES, V730, P107; Bradley A, 1987, TERATOCARCINOMAS EMB, P113; Brustovetsky N, 2000, J NEUROSCI, V20, P8229, DOI 10.1523/JNEUROSCI.20-22-08229.2000; CHAPMAN PF, 1995, NEURON, V14, P591, DOI 10.1016/0896-6273(95)90315-1; CONNERN CP, 1992, BIOCHEM J, V284, P381, DOI 10.1042/bj2840381; Crompton M, 2000, J PHYSIOL-LONDON, V529, P11, DOI 10.1111/j.1469-7793.2000.00011.x; Crompton M, 1998, EUR J BIOCHEM, V258, P729, DOI 10.1046/j.1432-1327.1998.2580729.x; David G, 1998, J PHYSIOL-LONDON, V509, P59, DOI 10.1111/j.1469-7793.1998.059bo.x; Decker WK, 2000, MOL GENET METAB, V70, P69, DOI 10.1006/mgme.2000.2987; Doolette DJ, 1997, NEUROCHEM INT, V30, P211, DOI 10.1016/S0197-0186(96)00055-1; FUNAUCHI M, 1994, NEUROSCI RES, V19, P269, DOI 10.1016/0168-0102(94)90039-6; Goosens KA, 2001, LEARN MEMORY, V8, P148, DOI 10.1101/lm.37601; Hodge T, 1997, J MEMBRANE BIOL, V157, P271, DOI 10.1007/s002329900235; Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; Lemasters JJ, 1999, J BIOENERG BIOMEMBR, V31, P305, DOI 10.1023/A:1005419617371; LINDEN M, 1984, BIOCHIM BIOPHYS ACTA, V770, P93, DOI 10.1016/0005-2736(84)90077-4; Lu YF, 1996, NEUROSCI LETT, V205, P103, DOI 10.1016/0304-3940(96)12384-3; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nguyen PV, 1997, J NEUROPHYSIOL, V78, P281, DOI 10.1152/jn.1997.78.1.281; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Onuma H, 1998, NEUROSCI RES, V30, P313, DOI 10.1016/S0168-0102(98)00012-1; Roberson ED, 1996, J BIOL CHEM, V271, P30436, DOI 10.1074/jbc.271.48.30436; Sampson MJ, 2001, J BIOL CHEM, V276, P39206, DOI 10.1074/jbc.M104724200; Sampson MJ, 1997, J BIOL CHEM, V272, P18966, DOI 10.1074/jbc.272.30.18966; Sampson MJ, 1998, J BIOL CHEM, V273, P30482, DOI 10.1074/jbc.273.46.30482; SANDOVAL ME, 1980, BRAIN RES, V181, P357, DOI 10.1016/0006-8993(80)90618-6; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Silva AJ, 1996, CURR BIOL, V6, P1509, DOI 10.1016/S0960-9822(96)00756-7; Tang YG, 1997, NEURON, V18, P483, DOI 10.1016/S0896-6273(00)81248-9; Vyssokikh MY, 2001, BIOCHEM J, V358, P349, DOI 10.1042/0264-6021:3580349; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wang JH, 1996, LEARN MEMORY, V3, P170, DOI 10.1101/lm.3.2-3.170; Weeber EJ, 2000, J NEUROSCI, V20, P5906, DOI 10.1523/JNEUROSCI.20-16-05906.2000; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; WU LG, 1994, J NEUROSCI, V14, P645; Wu SL, 1999, BBA-MOL CELL RES, V1452, P68, DOI 10.1016/S0167-4889(99)00120-2; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	45	142	149	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					18891	18897		10.1074/jbc.M201649200	http://dx.doi.org/10.1074/jbc.M201649200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11907043	hybrid			2022-12-27	WOS:000175975800084
J	Kim, JH; Lee-Kwon, W; Park, JB; Ryu, SH; Yun, CHC; Donowitz, M				Kim, JH; Lee-Kwon, W; Park, JB; Ryu, SH; Yun, CHC; Donowitz, M			Ca2+-dependent inhibition of Na+/H+ exchanger 3 (NHE3) requires an NHE3-E3KARP-alpha-actinin-4 complex for oligomerization and endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-MEDIATED INHIBITION; C-TERMINAL DOMAINS; PROTEIN-KINASE-C; BRUSH-BORDER; ISOFORM 3; PDZ; TRAFFICKING; PHOSPHORYLATION; IDENTIFICATION; STIMULATION	Two PDZ domain-containing proteins, NHERF and E3KARP are necessary for cAMP-dependent inhibition of Na+/H+' exchanger 3 (NHE3). In this study, we demonstrate a specific role of E3KARP, which is not duplicated by NHERF, in Ca2+-dependent inhibition of NHE3 activity. NHE3 activity is inhibited by elevation of intracellular Ca2+ ([Ca2+](i)) in PS120 fibroblasts stably expressing E3KARP but not those expressing NHERF. In addition, this Ca2+-dependent inhibition requires Ca2+-dependent association between alpha-actinin-4 and E3KARP. NHE3 is indirectly connected to alpha-actinin-4 in a protein complex through Ca2+-dependent interaction between alpha-actinin-4 and E3KARP, which occurs through the actin-binding domain plus spectrin repeat domain of alpha-actinin-4. Elevation of [Ca2+](i) results in oligomerization and endocytosis of NHE3 as well as in inhibition of NHE3 activity. Overexpression of alpha-actinin-4 potentiates the inhibitory effect of ionomycin on NHE3 activity by accelerating the oligomerization and endocytosis of NHE3. In contrast, overexpression of the actin-binding domain plus spectrin repeat domain acts as a dominant-negative mutant and prevents the inhibitory effect of ionomycin on NHE3 activity as well as the oligomerization and internalization of NHE3. From these results, we propose that elevated Ca2+ inhibits NHE3 activity through oligomerization and endocytosis of NHE3, which occurs via formation of an NRE3-E3KARP-alpha-actinin-4 complex.	Johns Hopkins Univ, Sch Med, Dept Med, GI Div, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Physiol, GI Div, Baltimore, MD 21205 USA; Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea	Johns Hopkins University; Johns Hopkins University; Pohang University of Science & Technology (POSTECH)	Donowitz, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, GI Div, 925 Ross Res Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.	mdonowit@jhmi.edu		Ryu, Sung Ho/0000-0003-0913-3048	NIDDK NIH HHS [P01 DK44484, R01 DK26523] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026523, P01DK044484] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akhter S, 2000, BIOCHEMISTRY-US, V39, P1990, DOI 10.1021/bi991739s; Araki N, 2000, J CELL SCI, V113, P3329; Aronson PS, 1997, WIEN KLIN WOCHENSCHR, V109, P435; BLANCHARD A, 1989, J MUSCLE RES CELL M, V10, P280, DOI 10.1007/BF01758424; Cavet ME, 2001, AM J PHYSIOL-CELL PH, V281, pC2039, DOI 10.1152/ajpcell.2001.281.6.C2039; Chow CW, 1999, J BIOL CHEM, V274, P37551, DOI 10.1074/jbc.274.53.37551; COHEN ME, 1991, J CLIN INVEST, V88, P855, DOI 10.1172/JCI115387; D'Souza S, 1998, J BIOL CHEM, V273, P2035, DOI 10.1074/jbc.273.4.2035; DeMarco SJ, 2002, J BIOL CHEM, V277, P10506, DOI 10.1074/jbc.M111616200; DONOWITZ M, 1983, AM J PHYSIOL, V245, pG165, DOI 10.1152/ajpgi.1983.245.2.G165; Donowitz M, 1998, AM J PHYSIOL-GASTR L, V274, pG971, DOI 10.1152/ajpgi.1998.274.6.G971; DONOWITZ M, 1986, REV INFECT DIS, V8, pS188; FLOOD G, 1995, J MOL BIOL, V252, P227, DOI 10.1006/jmbi.1995.0490; GOYAL J, 1987, BIOCHIM BIOPHYS ACTA, V925, P341, DOI 10.1016/0304-4165(87)90200-5; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Hu MC, 2001, J BIOL CHEM, V276, P26906, DOI 10.1074/jbc.M011338200; Hwang JI, 2000, J BIOL CHEM, V275, P16632, DOI 10.1074/jbc.M001410200; Janecki AJ, 2000, J BIOL CHEM, V275, P8133, DOI 10.1074/jbc.275.11.8133; Janecki AJ, 1998, J BIOL CHEM, V273, P8790, DOI 10.1074/jbc.273.15.8790; Jensen ON, 1996, ELECTROPHORESIS, V17, P938, DOI 10.1002/elps.1150170516; Jensen ON, 1997, ANAL CHEM, V69, P4741, DOI 10.1021/ac970896z; Kurashima K, 1999, J BIOL CHEM, V274, P29843, DOI 10.1074/jbc.274.42.29843; Kurashima K, 1998, J BIOL CHEM, V273, P20828, DOI 10.1074/jbc.273.33.20828; Lamprecht G, 1998, J BIOL CHEM, V273, P29972, DOI 10.1074/jbc.273.45.29972; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; LEVINE SA, 1995, J BIOL CHEM, V270, P13716, DOI 10.1074/jbc.270.23.13716; Li XH, 2001, J PHYSIOL-LONDON, V537, P537, DOI 10.1111/j.1469-7793.2001.00537.x; McSwine RL, 1998, AM J PHYSIOL-CELL PH, V275, pC693, DOI 10.1152/ajpcell.1998.275.3.C693; Morris AP, 1999, AM J PHYSIOL-GASTR L, V277, pG431, DOI 10.1152/ajpgi.1999.277.2.G431; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Shenolikar S, 2001, AM J PHYSIOL-RENAL, V280, pF389, DOI 10.1152/ajprenal.2001.280.3.F389; Tang JH, 2001, J MOL BIOL, V310, P845, DOI 10.1006/jmbi.2001.4789; Vallenius T, 2000, J BIOL CHEM, V275, P11100, DOI 10.1074/jbc.275.15.11100; WAKABAYASHI S, 1995, J BIOL CHEM, V270, P26460, DOI 10.1074/jbc.270.44.26460; Weinman EJ, 2000, BIOCHEMISTRY-US, V39, P6123, DOI 10.1021/bi000064m; Weinman EJ, 2001, KIDNEY INT, V60, P450, DOI 10.1046/j.1523-1755.2001.060002450.x; Xia HH, 1997, J CELL BIOL, V139, P507, DOI 10.1083/jcb.139.2.507; Yun CC, 2002, J BIOL CHEM, V277, P7676, DOI 10.1074/jbc.M107768200; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856; Zhou Q, 1999, J BIOL CHEM, V274, P19807, DOI 10.1074/jbc.274.28.19807; Zizak M, 1999, J BIOL CHEM, V274, P24753, DOI 10.1074/jbc.274.35.24753	43	106	106	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2002	277	26					23714	23724		10.1074/jbc.M200835200	http://dx.doi.org/10.1074/jbc.M200835200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567FX	11948184	hybrid			2022-12-27	WOS:000176475700081
J	Karisola, P; Alenius, H; Mikkola, J; Kalkkinen, N; Helin, J; Pentikainen, OT; Repo, S; Reunala, T; Turjanmaa, K; Johnson, MS; Palosuo, T; Kulomaa, MS				Karisola, P; Alenius, H; Mikkola, J; Kalkkinen, N; Helin, J; Pentikainen, OT; Repo, S; Reunala, T; Turjanmaa, K; Johnson, MS; Palosuo, T; Kulomaa, MS			The major conformational IgE-binding epitopes of hevein (Hev b6.02) are identified by a novel chimera-based allergen epitope mapping strategy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-RUBBER LATEX; AMARANTHUS-CAUDATUS; PROHEVEIN; PROTEINS; DER-P-2; AVIDIN; GLOVES; TOOLS	A novel approach to localize and reconstruct conformational IgE-binding epitope regions of hevein (Hev b6.02), a major natural rubber latex allergen, is described. An antimicrobial protein (AMP) from the amaranth Amaranthus caudatus was used as an immunologically non-IgE-binding adaptor molecule to which terminal or central parts of hevein were fused. Hevein and AMP share a structurally identical core region but have different N-terminal and C-terminal regions. Only 1 of 16 hevein-allergic patients showed weak IgE binding to purified native or recombinant AMP. Chimeric AMP with the hevein N terminus was recognized by IgE from 14 (88%) patients, and chimeric AMP with the hevein C terminus was recognized by IgE from 6 (38%) patients. In contrast, chimeric AMP containing the hevein core region was recognized by IgE from only two patients. When both the N-terminal and C-terminal regions of hevein were fused with the AMP core, IgE from all 16 patients bound to the chimera. This chimera was also able to significantly inhibit (>70%) IgE binding to the native hevein. On the contrary, linear synthetic peptides corresponding to hevein regions in the AMP chimeras showed no significant IgE binding capacity in either enzyme-linked immunosorbent assay or inhibition enzyme-linked immunosorbent assay. These results suggest that the IgE binding ability of hevein is essentially determined by its N-terminal and C-terminal regions and that major IgE-binding epitopes of hevein are conformational. The chimera-based epitope mapping strategy described here provides a valuable tool for defining structural epitopes and creating specific reagents for allergen immunotherapy.	Univ Jyvaskyla, Dept Biol & Environm Sci, FIN-40014 Jyvaskyla, Finland; Finnish Inst Occupat Hlth, FIN-00250 Helsinki, Finland; Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; Abo Akad Univ, Dept Biochem & Pharm, FIN-20521 Turku, Finland; Tampere Univ Hosp, Dept Clin Chem, FIN-33521 Tampere, Finland; Natl Publ Hlth Inst, FIN-00300 Helsinki, Finland	University of Jyvaskyla; Finnish Institute of Occupational Health; University of Helsinki; Abo Akademi University; Tampere University; Tampere University Hospital; Finland National Institute for Health & Welfare	Kulomaa, MS (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, POB 35 YAB, FIN-40014 Jyvaskyla, Finland.		Kalkkinen, Nisse EJ/B-3923-2010; Kulomaa, Markku S/C-9063-2014; Pentikäinen, Olli T/E-1980-2012	Pentikäinen, Olli T/0000-0001-7188-4016; Susanna, Repo/0000-0003-3488-4767; Alenius, Harri/0000-0003-0106-8923				Aalberse RC, 2000, J ALLERGY CLIN IMMUN, V106, P228, DOI 10.1067/mai.2000.108434; Airenne KJ, 1999, PROTEIN EXPRES PURIF, V17, P139, DOI 10.1006/prep.1999.1123; ALENIUS H, 1995, CLIN EXP ALLERGY, V25, P659, DOI 10.1111/j.1365-2222.1995.tb01114.x; ALENIUS H, 1994, ANN ALLERGY, V73, P315; Alenius H, 1996, J IMMUNOL, V156, P1618; ANDERSEN NH, 1993, BIOCHEMISTRY-US, V32, P1407, DOI 10.1021/bi00057a004; Banerjee B, 1997, J IMMUNOL, V159, P5724; Beezhold DH, 1997, CLIN EXP IMMUNOL, V108, P114, DOI 10.1046/j.1365-2249.1997.d01-983.x; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berman HM, 2000, NAT STRUCT BIOL, V7, P957, DOI 10.1038/80734; BROEKAERT WF, 1992, BIOCHEMISTRY-US, V31, P4308, DOI 10.1021/bi00132a023; Chen ZP, 2000, INT ARCH ALLERGY IMM, V123, P291, DOI 10.1159/000053641; Colombo P, 1998, J IMMUNOL, V160, P2780; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; Hakkaart GAJ, 1998, CLIN EXP ALLERGY, V28, P169, DOI 10.1046/j.1365-2222.1998.00205.x; Hanninen AR, 1999, J ALLERGY CLIN IMMUN, V104, P194, DOI 10.1016/S0091-6749(99)70135-1; Johnson M. S., 2000, BIOINFORMATICS SEQUE, P15; King TP, 2001, J IMMUNOL, V166, P6057, DOI 10.4049/jimmunol.166.10.6057; Martins JC, 1996, J MOL BIOL, V258, P322, DOI 10.1006/jmbi.1996.0253; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; ORR GA, 1986, METHOD ENZYMOL, V122, P83; Palosuo T, 1998, ALLERGY, V53, P59, DOI 10.1111/j.1398-9995.1998.tb03774.x; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Simon-Nobbe B, 2000, J ALLERGY CLIN IMMUN, V106, P887, DOI 10.1067/mai.2000.110799; Smith AM, 1997, CLIN EXP ALLERGY, V27, P593, DOI 10.1111/j.1365-2222.1997.tb00750.x; Tamborini E, 1997, EUR J BIOCHEM, V249, P886, DOI 10.1111/j.1432-1033.1997.00886.x; Tang B, 2000, BIOCHEM BIOPH RES CO, V270, P1128, DOI 10.1006/bbrc.2000.2546; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Regenmortal Marc H. V., 1996, Methods (Orlando), V9, P465, DOI 10.1006/meth.1996.0054; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Vrtala S, 2000, J IMMUNOL, V165, P6653, DOI 10.4049/jimmunol.165.11.6653; Wilson KS, 1998, J MOL BIOL, V276, P417; Ylitalo L, 2000, CLIN EXP ALLERGY, V30, P1611	33	34	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22656	22661		10.1074/jbc.M201076200	http://dx.doi.org/10.1074/jbc.M201076200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11909866	hybrid			2022-12-27	WOS:000176313600072
J	Lequin, O; Bolbach, G; Frank, F; Convert, O; Girault-Lagrange, S; Chassaing, G; Lavielle, S; Sagan, S				Lequin, O; Bolbach, G; Frank, F; Convert, O; Girault-Lagrange, S; Chassaing, G; Lavielle, S; Sagan, S			Involvement of the second extracellular loop (E2) of the neurokinin-1 receptor in the binding of substance P - Photoaffinity labeling and modeling studies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TACHYKININ NK1 RECEPTOR; COMMON AMINO-ACIDS; NK-1 RECEPTOR; TRANSMEMBRANE HELICES; IDENTIFICATION; PEPTIDE; SITE; CELLS; NMR; SEPTIDE	Substance P (SP) interacts with the neurokinin-1 (NR-1) G-protein-coupled receptor, which has been cloned in several species. In the present study, the domains of the NK-1 receptor involved in the binding of SP and SP-(7-11) C-terminal fragment have been analyzed using two peptide analogs containing the photoreactive amino acid para-benzoylphenylalanine ((p-Bz)Phe) in position 8 of their sequence. This study was carried out with [BAPA-Lys(6),(p-Bz)Phe(8),Pro(9),Met(O-2)(11)]SP-(7-11) and [BAPA(0),(p-Bz)Phe(8)]SP on both rat and human NK-1 receptors expressed in CHO cells. Combined trypsin and endo-GluC enzymatic complete digestions and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis led to the identification of the same domain of covalent interaction, (TMPSR177)-T-173, for the two photoactivatable peptides. Further digestion of this fragment with carboxypeptidase Y led to the identification of (TMP175)-T-173 in the second extracellular loop (E2) of the NK-1 receptor as the site of covalent attachment. Models of the conformation of this E2 loop in the human NLK-1 receptor were generated using two different strategies, one based on homology with bovine rhodopsin and the other based on the solution conformation preferences of a synthetic peptide corresponding to the E2 loop.	Univ Paris 06, CNRS, Unite Mixte Rech 7613, F-75252 Paris 05, France; Sanofi Synthelabo, F-31676 Labege, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Sanofi-Aventis; Sanofi France	Sagan, S (corresponding author), Univ Paris 06, CNRS, Unite Mixte Rech 7613, Boite Courrier 182,4 Pl Jussieu, F-75252 Paris 05, France.	sagan@ccr.jussieu.fr	s, s/HIK-1178-2022; s, s/GVS-3323-2022; s, s/HHD-0404-2022; S, SAGAN/I-8132-2013; QI, DANDAN/GVR-9324-2022; s, s/GYR-2278-2022; SAGAN, Sandrine/AAA-8537-2022	S, SAGAN/0000-0003-0083-4411; LEQUIN, Olivier/0000-0001-5307-3068				AYOUB M, 1995, TETRAHEDRON LETT, V36, P4069, DOI 10.1016/0040-4039(95)00683-4; Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; Beaujouan JC, 2000, J NEUROCHEM, V75, P1015, DOI 10.1046/j.1471-4159.2000.0751015.x; Beujouan JC, 1999, PEPTIDES, V20, P1347, DOI 10.1016/S0196-9781(99)00140-0; Boucard AA, 2000, BIOCHEMISTRY-US, V39, P9662, DOI 10.1021/bi000597v; Bremer AA, 2000, FEBS LETT, V486, P43, DOI 10.1016/S0014-5793(00)02228-6; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; CHASSAING G, 1985, TETRAHEDRON LETT, V26, P623, DOI 10.1016/S0040-4039(00)89163-7; Ciucci A, 1997, FEBS LETT, V416, P335, DOI 10.1016/S0014-5793(97)01236-2; Dong MQ, 1999, J BIOL CHEM, V274, P19161, DOI 10.1074/jbc.274.27.19161; Dong MQ, 1999, J BIOL CHEM, V274, P903, DOI 10.1074/jbc.274.2.903; Elling CE, 2000, BIOCHEMISTRY-US, V39, P667, DOI 10.1021/bi991777b; Elling CE, 1996, EMBO J, V15, P6213, DOI 10.1002/j.1460-2075.1996.tb01011.x; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Girault S, 1996, EUR J BIOCHEM, V240, P215, DOI 10.1111/j.1432-1033.1996.0215h.x; Girault S, 1996, ANAL CHEM, V68, P2122, DOI 10.1021/ac960043r; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hastrup H, 1996, FEBS LETT, V399, P264, DOI 10.1016/S0014-5793(96)01337-3; Kage R, 1996, J BIOL CHEM, V271, P25797, DOI 10.1074/jbc.271.42.25797; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LAVIELLE S, 1988, BIOCHEM PHARMACOL, V37, P41, DOI 10.1016/0006-2952(88)90753-8; LI YM, 1995, J BIOL CHEM, V270, P1213, DOI 10.1074/jbc.270.3.1213; Liu HT, 1999, P NATL ACAD SCI USA, V96, P5286, DOI 10.1073/pnas.96.9.5286; Macdonald D, 2001, BIOCHEMISTRY-US, V40, P2530, DOI 10.1021/bi001880x; Mannstadt M, 1999, AM J PHYSIOL-RENAL, V277, pF665, DOI 10.1152/ajprenal.1999.277.5.F665; McNicoll N, 1996, BIOCHEMISTRY-US, V35, P12950, DOI 10.1021/bi960818q; Mills JS, 1998, J BIOL CHEM, V273, P10428, DOI 10.1074/jbc.273.17.10428; NAKANISHI S, 1991, ANNU REV NEUROSCI, V14, P123, DOI 10.1146/annurev.ne.14.030191.001011; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pellegrini M, 2001, J BIOL CHEM, V276, P22862, DOI 10.1074/jbc.M101057200; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; Rupniak NMJ, 1999, TRENDS PHARMACOL SCI, V20, P485, DOI 10.1016/S0165-6147(99)01396-6; Sagan S, 1996, J PHARMACOL EXP THER, V276, P1039; Sagan S, 1997, MOL PHARMACOL, V52, P120, DOI 10.1124/mol.52.1.120; Sagan S, 2001, BIOCHEM BIOPH RES CO, V282, P958, DOI 10.1006/bbrc.2001.4687; Sagan S, 2001, EUR J BIOCHEM, V268, P2997, DOI 10.1046/j.1432-1327.2001.02192.x; Sagan S, 1999, J BIOL CHEM, V274, P23770, DOI 10.1074/jbc.274.34.23770; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Singh D, 2000, P NATL ACAD SCI USA, V97, P388, DOI 10.1073/pnas.97.1.388; Wijkhuisen A, 1999, FEBS LETT, V447, P155, DOI 10.1016/S0014-5793(99)00298-7; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WUTHRICH K, 1983, J MOL BIOL, V169, P949, DOI 10.1016/S0022-2836(83)80144-2	47	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22386	22394		10.1074/jbc.M110614200	http://dx.doi.org/10.1074/jbc.M110614200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11950831	hybrid			2022-12-27	WOS:000176313600036
J	Dallas, SL; Rosser, JL; Mundy, GR; Bonewald, LF				Dallas, SL; Rosser, JL; Mundy, GR; Bonewald, LF			Proteolysis of latent transforming growth factor-beta (TGF-beta)-binding protein-1 by osteoclasts - A cellular mechanism for release of TGF-beta from bone matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; EXTRACELLULAR-MATRIX; RABBIT OSTEOCLASTS; ACTIVATION; CELLS; IDENTIFICATION; TGF-BETA-1; COMPLEX; CULTURES; GROWTH-FACTOR-BETA-1	The binding of growth factors to the extracellular matrix (ECM) may be a key pathway for regulation of their activity. We have shown that a major mechanism for storage of transforming growth factor-beta (TGF-beta) in bone ECM is via its association with latent TGF-beta-binding protein-1 (LTBP1). Although proteolytic cleavage of LTBP1 has been reported, it remains unclear whether this represents a physiological mechanism for release of matrix-bound TGF-beta. Here we examined the role of LTBP1 in cell-mediated release of TGF-beta from bone ECM. We first characterized the soluble and ECM-bound forms of latent TGF-beta produced by primary osteoblasts. Next, we examined release of ECM-bound TGF-beta by bone resorbing cells. Isolated avian osteoclasts and rabbit bone marrow-derived osteoclasts released bone matrix-bound TGF-beta via LTBP1 cleavage. 1,25-Dihydroxyvitamin D. enhanced LTBP1 cleavage, resulting in release of 90%, of the ECM-bound LTBP1. In contrast, osteoblasts failed to cleave LTBP1 or release TGF-beta from bone ECM. Cleavage of LTBP1 by avian osteoclasts was inhibited by serine protease and metalloproteinase (MMP) inhibitors. Studies using purified proteases showed that plasmin, elastase, MMP2, and MMP9 were able to cleave LTBP1 to produce 125-165-kDa fragments. These studies identify LTBP1 as a novel substrate for MMPs and provide the first demonstration that LTBP1 proteolysis may be a physiological mechanism for release of TGF-beta from ECM-bound stores, potentially the first step in the pathway by which matrix-bound TGF-beta is rendered active.	Univ Texas, Hlth Sci Ctr, Dept Med, Div Endocrinol & Metab, San Antonio, TX 78284 USA; Univ Manchester, Sch Biol Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78284 USA; Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78284 USA	University of Texas System; University of Texas Health San Antonio; University of Manchester; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Dallas, SL (corresponding author), Univ Missouri, Sch Dent, Dept Oral Biol, 650 E 25th St, Kansas City, MO 64108 USA.		Bonewald, Lynda/Q-3638-2019	Bonewald, Lynda/0000-0002-5536-9943	NCI NIH HHS [K01CA75387, R29CA74262] Funding Source: Medline; NIAMS NIH HHS [R01 AR43775] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA074262, K01CA075387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043775] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; ALVAREZ JI, 1991, ENDOCRINOLOGY, V128, P2324, DOI 10.1210/endo-128-5-2324; Ashworth JL, 1999, BIOCHEM J, V340, P171, DOI 10.1042/0264-6021:3400171; Bonewald LF, 1999, CRIT REV EUKAR GENE, V9, P33, DOI 10.1615/CritRevEukaryotGeneExpr.v9.i1.30; BONEWALD LF, 1991, MOL ENDOCRINOL, V5, P741, DOI 10.1210/mend-5-6-741; Bonewald LF, 1997, ENDOCRINOLOGY, V138, P657, DOI 10.1210/en.138.2.657; Dallas SL, 2000, METH MOL B, V139, P231; DALLAS SL, 1994, J BIOL CHEM, V269, P6815; Dallas SL, 2000, J BONE MINER RES, V15, P68, DOI 10.1359/jbmr.2000.15.1.68; DALLAS SL, 1995, J CELL BIOL, V131, P539, DOI 10.1083/jcb.131.2.539; DENNIS PA, 1991, P NATL ACAD SCI USA, V88, P580, DOI 10.1073/pnas.88.2.580; FLAUMENHAFT R, 1993, J CELL BIOL, V120, P995, DOI 10.1083/jcb.120.4.995; HAUSCHKA PV, 1986, J BIOL CHEM, V261, P2665; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; JONES JI, 1993, J CELL BIOL, V121, P679, DOI 10.1083/jcb.121.3.679; KANZAKI T, 1990, CELL, V61, P1051, DOI 10.1016/0092-8674(90)90069-Q; KOKUBO T, 1998, ADV ORG BIO A-C, V5, P359; LittlewoodEvans A, 1997, BONE, V20, P81, DOI 10.1016/S8756-3282(96)00351-1; LYONS RM, 1990, J CELL BIOL, V110, P1361, DOI 10.1083/jcb.110.4.1361; MCCAFFREY TA, 1992, J CELL PHYSIOL, V152, P430, DOI 10.1002/jcp.1041520226; MIYAZONO K, 1991, EMBO J, V10, P1091, DOI 10.1002/j.1460-2075.1991.tb08049.x; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Nunes I, 1997, J CELL BIOL, V136, P1151, DOI 10.1083/jcb.136.5.1151; OKADA Y, 1995, LAB INVEST, V72, P311; OREFFO ROC, 1989, BIOCHEM BIOPH RES CO, V158, P817, DOI 10.1016/0006-291X(89)92795-2; OURSLER MJ, 1994, J BONE MINER RES, V9, P443; PFEILSCHIFTER J, 1987, P NATL ACAD SCI USA, V84, P2024, DOI 10.1073/pnas.84.7.2024; Reinhardt DP, 2000, J BIOL CHEM, V275, P12339, DOI 10.1074/jbc.275.16.12339; Rifkin DB, 1999, APMIS, V107, P80, DOI 10.1111/j.1699-0463.1999.tb01529.x; Roberts AB, 1998, MINER ELECTROL METAB, V24, P111, DOI 10.1159/000057358; Saharinen J, 2000, MOL BIOL CELL, V11, P2691, DOI 10.1091/mbc.11.8.2691; Saharinen J, 1999, CYTOKINE GROWTH F R, V10, P99, DOI 10.1016/S1359-6101(99)00010-6; SCHULTZCHERRY S, 1994, J BIOL CHEM, V269, P26775; SEYEDIN SM, 1985, P NATL ACAD SCI USA, V82, P2267, DOI 10.1073/pnas.82.8.2267; Sinha S, 1998, MATRIX BIOL, V17, P529, DOI 10.1016/S0945-053X(98)90106-8; Strehlow David, 1998, Current Opinion in Rheumatology, V10, P572, DOI 10.1097/00002281-199811000-00011; TAIPALE J, 1995, J BIOL CHEM, V270, P4689, DOI 10.1074/jbc.270.9.4689; Taipale J, 1996, J HISTOCHEM CYTOCHEM, V44, P875, DOI 10.1177/44.8.8756760; TAIPALE J, 1994, J CELL BIOL, V124, P171, DOI 10.1083/jcb.124.1.171; Taipale J, 1997, FASEB J, V11, P51, DOI 10.1096/fasebj.11.1.9034166; TEZUKA K, 1994, J BIOL CHEM, V269, P15006; TEZUKA K, 1992, BIOCHEM BIOPH RES CO, V186, P911, DOI 10.1016/0006-291X(92)90832-6; Tiedemann K, 2001, J BIOL CHEM, V276, P36035, DOI 10.1074/jbc.M104985200; TSUJI T, 1990, P NATL ACAD SCI USA, V87, P8835, DOI 10.1073/pnas.87.22.8835; YEE JA, 1993, J CELL PHYSIOL, V157, P528, DOI 10.1002/jcp.1041570312; Yu Q, 2000, GENE DEV, V14, P163	46	295	306	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21352	21360		10.1074/jbc.M111663200	http://dx.doi.org/10.1074/jbc.M111663200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11929865	hybrid			2022-12-27	WOS:000176286000032
J	Loh, E; Hong, WJ				Loh, E; Hong, WJ			Sec34 is implicated in traffic from the endoplasmic reticulum to the Golgi and exists in a complex with GTC-90 and ldlBp	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; OVARY CELL MUTANTS; MEMBRANE-PROTEIN; VESICLE DOCKING; CIS-GOLGI; SACCHAROMYCES-CEREVISIAE; DEFICIENT MUTANT; REQUIRES USO1P; SNARE COMPLEX; EXIT SITES	Sec34p/Grd20p has been implicated in endoplasmic reticulum. (ER)-to-Golgi transport and/or post-Golgi trafficking events and exists in a protein complex consisting of at least eight subunits in yeast. Although the mammalian counterpart (Sec34) of Sec34p has been molecularly identified, its role and interacting partners remain undefined. In this study, we have prepared antibodies specifically against the recombinant N-terminal fragment of Sec34 that recognize a polypeptide of about 93 kDa and label the Golgi apparatus. In a well-characterized semi-intact cell assay that reconstitutes transport of the envelope glycoprotein (VSVG) of vesicular stomatitis virus from the ER to the Golgi apparatus, anti-Sec34 antibodies inhibited the transport in a dose-dependent manner. The inhibition by anti-Sec34 antibodies could be neutralized by a noninhibitory amount of the antigen. Large-scale immunoprecipitation of rat liver cytosol with immobilized anti-Sec34 antibodies has co-immunoprecipitated GTC-90 and ldlBp, two peripheral Golgi proteins previously shown to exist in separate protein complexes. Two mammalian homologues (Dor1 and Cod1) of the yeast Sec34 complex were similarly recovered in the Sec34 immunoprecipitates. When expressed in transfected cells, epitope-tagged ldlCp and Cod2 were co-immunoprecipitated with anti-Sec34 antibodies with efficiencies comparable to that observed for tagged ldlBp, Dor1, and Cod1. Direct interactions of Sec34 with ldlBp and ldlCp were further demonstrated in vitro. These results suggest that Sec34, GTC-90, and ldlBp/ldlCp are part of the same protein complex(es) that regulates diverse aspects of Golgi function, including transport from the ER to the Golgi apparatus.	Inst Mol & Cell Biol, Membrane Biol Lab, Singapore 117609, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Hong, WJ (corresponding author), Inst Mol & Cell Biol, Membrane Biol Lab, 30 Med Dr, Singapore 117609, Singapore.	mcbhwj@imcb.nus.edu.sg	HONG, Wanjin/E-9927-2010					Allan RB, 1999, SCIENCE, V285, P63, DOI 10.1126/science.285.5424.63; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BALCH WE, 1994, CELL, V76, P841, DOI 10.1016/0092-8674(94)90359-X; Cao XC, 1998, EMBO J, V17, P2156, DOI 10.1093/emboj/17.8.2156; Chatterton JE, 1999, P NATL ACAD SCI USA, V96, P915, DOI 10.1073/pnas.96.3.915; GUO Q, 1994, J CELL BIOL, V125, P1213, DOI 10.1083/jcb.125.6.1213; Guo W, 2000, TRENDS CELL BIOL, V10, P251, DOI 10.1016/S0962-8924(00)01754-2; Hauri HP, 2000, J CELL SCI, V113, P587; HOBBIE L, 1994, J BIOL CHEM, V269, P20958; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; Hong WJ, 1998, J CELL SCI, V111, P2831; Kim DW, 1999, MOL BIOL CELL, V10, P3317, DOI 10.1091/mbc.10.10.3317; Kim DW, 2001, TRAFFIC, V2, P820, DOI 10.1034/j.1600-0854.2001.21111.x; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; KINGSLEY DM, 1986, J CELL BIOL, V102, P1576, DOI 10.1083/jcb.102.5.1576; KOZARSKY KF, 1986, J CELL BIOL, V102, P1567, DOI 10.1083/jcb.102.5.1567; Lowe SL, 1996, J CELL SCI, V109, P209; MALMSTROM K, 1991, J BIOL CHEM, V266, P24025; Nagahama M, 1996, J CELL BIOL, V133, P507, DOI 10.1083/jcb.133.3.507; NAKAJIMA H, 1991, J CELL BIOL, V113, P245, DOI 10.1083/jcb.113.2.245; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; PODOS SD, 1994, J CELL BIOL, V127, P679, DOI 10.1083/jcb.127.3.679; Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sapperstein SK, 1996, J CELL BIOL, V132, P755, DOI 10.1083/jcb.132.5.755; Seet LF, 2001, J BIOL CHEM, V276, P42445, DOI 10.1074/jbc.M105917200; Spelbrink RG, 1999, MOL BIOL CELL, V10, P4263, DOI 10.1091/mbc.10.12.4263; Subramaniam VN, 1996, SCIENCE, V272, P1161, DOI 10.1126/science.272.5265.1161; SUBRAMANIAM VN, 1995, J CELL SCI, V108, P2405; Suvorova ES, 2001, J BIOL CHEM, V276, P22810, DOI 10.1074/jbc.M011624200; Tang BL, 2001, J BIOL CHEM, V276, P40008, DOI 10.1074/jbc.M106189200; Tang BL, 2000, J BIOL CHEM, V275, P13597, DOI 10.1074/jbc.275.18.13597; Ungar D, 2002, J CELL BIOL, V157, P405, DOI 10.1083/jcb.200202016; VanRheenen SM, 1999, J CELL BIOL, V147, P729, DOI 10.1083/jcb.147.4.729; VanRheenen SM, 1998, J CELL BIOL, V141, P1107, DOI 10.1083/jcb.141.5.1107; Walter DM, 1998, J BIOL CHEM, V273, P29565, DOI 10.1074/jbc.273.45.29565; Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9; Whyte JRC, 2001, DEV CELL, V1, P527, DOI 10.1016/S1534-5807(01)00063-6; Wuestehube LJ, 1996, GENETICS, V142, P393; Xu DL, 2000, J BIOL CHEM, V275, P39631, DOI 10.1074/jbc.M007684200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang T, 2001, J BIOL CHEM, V276, P27480, DOI 10.1074/jbc.M102786200	42	22	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21955	21961		10.1074/jbc.M202326200	http://dx.doi.org/10.1074/jbc.M202326200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11929878	hybrid			2022-12-27	WOS:000176286000108
J	Trebak, M; Bird, GSJ; McKay, RR; Putney, JW				Trebak, M; Bird, GSJ; McKay, RR; Putney, JW			Comparison of human TRPC3 channels in receptor-activated and store-operated modes - Differential sensitivity to channel blockers suggests fundamental differences in channel composition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; INOSITOL TRISPHOSPHATE RECEPTOR; CAPACITATIVE CALCIUM-ENTRY; STIMULATES CA2+ INFLUX; 2-AMINOETHOXYDIPHENYL BORATE; ENDOTHELIAL-CELLS; CATION CHANNELS; HTRP3 CHANNELS; DEPLETION; RELEASE	Capacitative calcium entry or store-operated calcium entry in nonexcitable cells is a process whereby the activation of calcium influx across the plasma membrane is signaled by depletion of intracellular calcium stores. Transient receptor potential (TRP) proteins have been proposed as candidates for store-operated calcium channels. Human TRPC3 (hTRPC3), an extensively studied member of the TRP family, is activated through a phospholipase C-dependent mechanism, not by store depletion, when expressed in HEK293 cells. However, store depletion by thapsigargin is sufficient to activate hTRPC3 channels when expressed in DT40 avian B-lymphocytes. To gain further insights into the differences between hTRPC3 channels generated in these two expression systems and further understand the role of hTRPC3 in capacitative calcium entry, we examined the effect of two well characterized inhibitors of capacitative calcium entry, Gd3+ and 2-aminoethoxydiphenyl borane (2APB). We confirmed that in both DT40 cells and HEK293 cells, 1 muM Gd3+ or 30 mum 2APB completely blocked calcium entry due to receptor activation or store depletion. In HEK293 cells, 1 mum Gd3+ did not block receptor-activated hTRPC3-mediated cation entry, whereas 2APB had a partial (similar to60%) inhibitory effect. Interestingly, store-operated hTRPC3-mediated cation entry in DT40 cells was also partially inhibited by 2APB, whereas 1 mum Gd3+ completely blocked store-operated hTRPC3 activity in these cells. Furthermore, the sensitivity of store-operated hTRPC3 channels to Gd3+ in DT40 cells was similar to the endogenous store-operated channels, with essentially 100% block of activity at concentrations as low as 0.1 mum. Finally, Gd3+ has a rapid inhibitory effect when added to fully developed hTRPC3-mediated calcium entry, suggesting a direct action of Gd3+ on hTRPC3 channels. The distinct action of these inhibitors on hTRPC3-mediated cation entry in these two cell types may result from their different modes of activation and may also reflect differences in basic channel structure.	NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Trebak, M (corresponding author), NIEHS, Lab Signal Transduct, NIH, POB 12233,MD F2-02, Res Triangle Pk, NC 27709 USA.		Putney, James W/F-7247-2019; Trebak, Mohamed/E-7405-2014; Bird, Gary/AAI-8186-2021	Putney, James W/0000-0002-3379-4789; Bird, Gary/0000-0003-1389-8748	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090087, Z01ES090087] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; Braun FJ, 2001, J BIOL CHEM, V276, P1063, DOI 10.1074/jbc.M008348200; Broad LM, 1999, J PHYSIOL-LONDON, V517, P121, DOI 10.1111/j.1469-7793.1999.0121z.x; Broad LM, 2001, J BIOL CHEM, V276, P15945, DOI 10.1074/jbc.M011571200; BYRON KL, 1995, J PHYSIOL-LONDON, V485, P455, DOI 10.1113/jphysiol.1995.sp020742; Csutora P, 1999, P NATL ACAD SCI USA, V96, P121, DOI 10.1073/pnas.96.1.121; Dobryndeva Y, 2001, MOL PHARMACOL, V60, P541; Elliott AC, 2001, CELL CALCIUM, V30, P73, DOI 10.1054/ceca.2001.0215; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; Iwasaki H, 2001, RECEPTOR CHANNEL, V7, P429; Kamouchi M, 1999, J PHYSIOL-LONDON, V518, P345, DOI 10.1111/j.1469-7793.1999.0345p.x; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; KREYE VAW, 1986, PFLUG ARCH EUR J PHY, V406, P308, DOI 10.1007/BF00640919; Kukkonen JP, 2001, CELL CALCIUM, V30, P117, DOI 10.1054/ceca.2001.0219; LANSMAN JB, 1990, J GEN PHYSIOL, V95, P679, DOI 10.1085/jgp.95.4.679; LUCKHOFF A, 1994, BIOPHYS J, V67, P177, DOI 10.1016/S0006-3495(94)80467-9; Luo D, 2001, J BIOL CHEM, V276, P5613, DOI 10.1074/jbc.M007524200; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Ma HT, 2001, J BIOL CHEM, V276, P18888, DOI 10.1074/jbc.M100944200; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; McKay RR, 2000, BIOCHEM J, V351, P735, DOI 10.1042/0264-6021:3510735; MLINAR B, 1993, J PHYSIOL-LONDON, V469, P639, DOI 10.1113/jphysiol.1993.sp019835; Ohki G, 2000, J BIOL CHEM, V275, P39055, DOI 10.1074/jbc.M003606200; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Putney J W Jr, 2001, Mol Interv, V1, P84; Putney Jr JW, 1997, CAPACITATIVE CALCIUM; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; Trepakova ES, 2001, J BIOL CHEM, V276, P7782, DOI 10.1074/jbc.M010104200; VACA L, 1993, AM J PHYSIOL, V264, pH1319, DOI 10.1152/ajpheart.1993.264.4.H1319; VANDERKOOI JM, 1971, ARCH BIOCHEM BIOPHYS, V144, P99, DOI 10.1016/0003-9861(71)90458-9; Vazquez G, 2001, P NATL ACAD SCI USA, V98, P11777, DOI 10.1073/pnas.201238198; YAMAGUCHI DT, 1989, J BIOL CHEM, V264, P197; ZHANG H, 1994, EUR J PHARMACOL, V251, P119, DOI 10.1016/0014-2999(94)90391-3; Zhang ZM, 2001, P NATL ACAD SCI USA, V98, P3168, DOI 10.1073/pnas.051632698; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133	41	203	212	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21617	21623		10.1074/jbc.M202549200	http://dx.doi.org/10.1074/jbc.M202549200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11943785	hybrid			2022-12-27	WOS:000176286000067
J	Beer, HD; Munding, C; Dubois, N; Mamie, C; Hohl, D; Werner, S				Beer, HD; Munding, C; Dubois, N; Mamie, C; Hohl, D; Werner, S			The estrogen-responsive B box protein - A novel regulator of keratinocyte differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; NUCLEAR RECEPTOR; FACTOR FGF-7; FACTOR-ALPHA; BINDING; FAMILY; GENE; EXPRESSION; CELLS; COACTIVATORS	Keratinocyte growth factor (KGF) regulates proliferation, differentiation, migration, and survival of different types of epithelial cells, including keratinocytes of the skin. To gain insight into the mechanisms underlying these multiple functions, we searched for KGF-regulated genes in keratinocytes. Using the differential display reverse transcriptase-PCR technology, we identified the gene encoding the estrogen-responsive B box protein (EBBP) which has as yet not been functionally characterized. The full-length murine and human EBBP cDNAs were cloned and fully sequenced. They were shown to encode 75-kDa proteins, which are mainly localized in the cytoplasm of keratinocytes in vitro and in vivo. In vivo, EBBP was found at high levels in the KGF and epidermal growth factor-responsive basal keratinocytes of human skin, but the expression was downregulated in the hyperthickened epithelium of skin wounds. Stable overexpression of EBBP in HaCaT keratinocytes did not affect the proliferation rate of the transfected cells, but enhanced the early differentiation process. These results suggest that the presence of EBBP in basal keratinocytes is important for the differentiation capacity of these cells, and that downregulation of EBBP expression in a hyperproliferative epithelium is required to maintain the cells in a non-differentiated stage.	ETH Zurich, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland; CHU Vaudois, Hop Beaumont, Serv Dermatol, CH-1011 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Beer, HD (corresponding author), ETH Zurich, Inst Cell Biol, Dept Biol, HPM D44, CH-8093 Zurich, Switzerland.			Werner, Sabine/0000-0001-7397-8710; Beer, Hans-Dietmar/0000-0002-8085-713X				ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Borden KLB, 1998, BIOCHEM CELL BIOL, V76, P351, DOI 10.1139/bcb-76-2-3-351; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; CARTER DM, 1987, DERMATOLOGY GENERAL, P759; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTOPHERS E, 1987, DERMATOLOGY GENERAL, P461; Frank S, 1996, J BIOL CHEM, V271, P24337, DOI 10.1074/jbc.271.40.24337; FUCHS E, 1990, J CELL BIOL, V111, P2807, DOI 10.1083/jcb.111.6.2807; Harvat BL, 1998, J CELL SCI, V111, P1185; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Henry J, 1998, MOL BIOL EVOL, V15, P1696, DOI 10.1093/oxfordjournals.molbev.a025896; Hines MD, 1996, J BIOL CHEM, V271, P6245, DOI 10.1074/jbc.271.11.6245; Huang NW, 1998, EMBO J, V17, P3398, DOI 10.1093/emboj/17.12.3398; Igarashi M, 1998, J BIOL CHEM, V273, P13230, DOI 10.1074/jbc.273.21.13230; KING LE, 1990, J INVEST DERMATOL, V95, pS10, DOI 10.1111/1523-1747.ep12505661; Liu HLC, 1998, MOL ENDOCRINOL, V12, P1733, DOI 10.1210/me.12.11.1733; Madlener H, 1997, GENE, V202, P75, DOI 10.1016/S0378-1119(97)00456-3; Marchese C, 1997, CELL GROWTH DIFFER, V8, P989; MARCHESE C, 1995, J EXP MED, V182, P1369, DOI 10.1084/jem.182.5.1369; MARCHESE C, 1990, J CELL PHYSIOL, V144, P326, DOI 10.1002/jcp.1041440219; MARIKOVSKY M, 1993, P NATL ACAD SCI USA, V90, P3889, DOI 10.1073/pnas.90.9.3889; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; RHEINWALD JG, 1977, NATURE, V265, P421, DOI 10.1038/265421a0; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; RUBIN JS, 1995, CELL BIOL INT, V19, P399, DOI 10.1006/cbir.1995.1085; TODD R, 1991, AM J PATHOL, V138, P1307; Torok M, 2001, DIFFERENTIATION, V67, P63, DOI 10.1046/j.1432-0436.2001.067003063.x; TSUBOI R, 1993, J INVEST DERMATOL, V101, P49, DOI 10.1111/1523-1747.ep12358892; Wakita N, 1999, J BIOL CHEM, V274, P37285, DOI 10.1074/jbc.274.52.37285; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Werner S, 1998, CYTOKINE GROWTH F R, V9, P153, DOI 10.1016/S1359-6101(98)00010-0; WERNER S, 1994, SCIENCE, V266, P819, DOI 10.1126/science.7973639; WERNER S, 1992, P NATL ACAD SCI USA, V89, P6896, DOI 10.1073/pnas.89.15.6896	35	31	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20740	20749		10.1074/jbc.M111233200	http://dx.doi.org/10.1074/jbc.M111233200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11919186	hybrid, Green Published			2022-12-27	WOS:000176204500083
J	Honda, A; Yamada, M; Saisu, H; Takahashi, H; Mori, KJ; Abe, T				Honda, A; Yamada, M; Saisu, H; Takahashi, H; Mori, KJ; Abe, T			Direct, Ca2+-dependent interaction between tubulin and synaptotagmin I. A possible mechanism for attaching synaptic vesicles to microtubules.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTRANSMITTER RELEASE; BINDING-SITES; SNARE COMPLEX; BETA-TUBULIN; C-TERMINUS; C2B DOMAIN; TRANSMITTER RELEASE; MEMBRANE-FUSION; DISTINCT POOLS; EXOCYTOSIS	The synaptic vesicle protein synaptotagmin I probably plays important roles in the synaptic vesicle cycle. However, the mechanisms of its action remain unclear. In this study, we have searched for cytoplasmic proteins that interact with synaptotagmin I. We found that the cytoskeletal protein tubulin directly and stoichiometrically bound to recombinant synaptotagmin L The binding depended on mm Ca2+, and 1 mol of tubulin dimer bound 2 mol of synaptotagmin I with half-maximal binding at 6.6 mum tubulin. The Ca2+ dependence mainly resulted from Ca2+ binding to the Ca2+ ligands of synaptotagmin I. The C-terminal region of beta-tubulin and both C2 domains of synaptotagmin I were involved in the binding. The YVK motif in the C2 domains of synaptotagmin I was essential for tubulin binding. Tubulin and synaptotagmin I were co-precipitated from the synaptosome extract with monoclonal antibodies to tubulin and SNAP-25 (synaptosome-associated protein of 25 kDa), indicating the presence of tubulin/synaptotagmin I complex and tubulin binding to synaptotagmin I in SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) complexes. Synaptotagmin I promoted tubulin polymerization and bundled microtubules in the presence of Ca2+. These results suggest that direct interaction between synaptotagmin I and tubulin provides a mechanism for attaching synaptic vesicles to microtubules in high Ca2+ concentrations.	Niigata Univ, Brain Res Inst, Dept Cellular Neurobiol, Niigata 9518585, Japan; Niigata Univ, Brain Res Inst, Dept Pathol, Niigata 9518585, Japan; Niigata Univ, Fac Sci, Dept Biol, Niigata 9518585, Japan	Niigata University; Niigata University; Niigata University	Abe, T (corresponding author), Niigata Univ, Brain Res Inst, Dept Cellular Neurobiol, Niigata 9518585, Japan.							Augustine GJ, 1999, J PHYSIOL-LONDON, V520, P33, DOI 10.1111/j.1469-7793.1999.00033.x; Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; BENFENATI F, 1991, P NATL ACAD SCI USA, V88, P575, DOI 10.1073/pnas.88.2.575; BHATTACHARYYA B, 1985, J BIOL CHEM, V260, P208; BOMMERT K, 1993, NATURE, V363, P163, DOI 10.1038/363163a0; Chae YK, 1998, J BIOL CHEM, V273, P25659, DOI 10.1074/jbc.273.40.25659; CHAPMAN ER, 1994, J BIOL CHEM, V269, P5735; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Charvin N, 1997, EMBO J, V16, P4591, DOI 10.1093/emboj/16.15.4591; COHEN MW, 1991, J NEUROSCI, V11, P1032; CROSS D, 1991, BIOCHEMISTRY-US, V30, P4362, DOI 10.1021/bi00231a036; CUMMING R, 1983, NEUROSCI LETT, V37, P215, DOI 10.1016/0304-3940(83)90433-0; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Desai RC, 2000, J CELL BIOL, V150, P1125, DOI 10.1083/jcb.150.5.1125; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; Earles CA, 2001, J CELL BIOL, V154, P1117, DOI 10.1083/jcb.200105020; Fergestad T, 2001, J NEUROSCI, V21, P1218; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fujiwara T, 1997, BIOCHEM BIOPH RES CO, V231, P352, DOI 10.1006/bbrc.1997.6092; FUKUDA M, 1995, P NATL ACAD SCI USA, V92, P10708, DOI 10.1073/pnas.92.23.10708; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; GRAY EG, 1982, CELL TISSUE RES, V226, P579; GRAY EG, 1978, PROC R SOC SER B-BIO, V203, P219, DOI 10.1098/rspb.1978.0102; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Harlow ML, 2001, NATURE, V409, P479, DOI 10.1038/35054000; Haucke V, 2000, EMBO J, V19, P6011, DOI 10.1093/emboj/19.22.6011; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; HONDA A, 2000, SOC NEUR ABSTR, V26, P347; HONDA A, 2000, SOC NEUR ABSTR, V29, P714; Honda Atsuko, 1999, Society for Neuroscience Abstracts, V25, P1742; Ishizuka T, 1999, NEUROSCIENCE, V88, P295, DOI 10.1016/S0306-4522(98)00223-1; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Jarousse N, 2001, CURR OPIN CELL BIOL, V13, P461, DOI 10.1016/S0955-0674(00)00237-4; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Katz B., 1969, RELEASE NEURAL TRANS; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; LIN RC, 1997, NEURON, V19, P1095; Littleton JT, 2001, J NEUROSCI, V21, P1421, DOI 10.1523/JNEUROSCI.21-05-01421.2001; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; MELKI R, 1991, BIOCHEMISTRY-US, V30, P11536, DOI 10.1021/bi00113a008; Morimoto T, 1998, NEUROSCIENCE, V82, P969; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; Rai SS, 1998, P NATL ACAD SCI USA, V95, P4253, DOI 10.1073/pnas.95.8.4253; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; RODIONOV VI, 1990, J BIOL CHEM, V265, P5702; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Schiavo G, 1998, BIOCHEM BIOPH RES CO, V248, P1, DOI 10.1006/bbrc.1998.8527; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; SERRANO L, 1986, J BIOL CHEM, V261, P7076; Shao XG, 1997, NEURON, V18, P133, DOI 10.1016/S0896-6273(01)80052-0; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; SOLOMON F, 1977, BIOCHEMISTRY-US, V16, P358, DOI 10.1021/bi00622a003; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takei Y, 1995, J CELL BIOL, V131, P1789, DOI 10.1083/jcb.131.6.1789; Thomas DM, 1998, J NEUROSCI, V18, P3511; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; WEISENBERG RC, 1972, SCIENCE, V177, P1104, DOI 10.1126/science.177.4054.1104; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1	74	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20234	20242		10.1074/jbc.M112080200	http://dx.doi.org/10.1074/jbc.M112080200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11925429	hybrid			2022-12-27	WOS:000176204500019
J	Justman, QA; Clinton, GM				Justman, QA; Clinton, GM			Herstatin, an autoinhibitor of the human epidermal growth factor receptor 2 tyrosine kinase, modulates epidermal growth factor signaling pathways resulting in growth arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; EXTRACELLULAR DOMAIN; ERBB RECEPTORS; EGF RECEPTOR; INHIBITION; PHOSPHORYLATION; NETWORK; FAMILY; HETERODIMERIZATION; P185(NEU)	Herstatin is an autoinhibitor of the ErbB family consisting of subdomains I and II of the human epidermal growth factor receptor 2 (ErbB-2) extracellular domain and a novel C-terminal domain encoded by an intron. Herstatin binds to human epidermal growth factor receptor 2 and to the epidermal growth factor receptor (EGFR), blocking receptor oligomerization and tyrosine phosphorylation. In this study, we characterized several early steps in EGFR activation and investigated downstream signaling events induced by epidermal growth factor (EGF) and by transforming growth factor a (TGF-alpha) in NIH3T3 cell lines expressing EGFR with and without herstatin. Herstatin expression decreased EGF-induced EGFR tyrosine phosphorylation and delayed receptor down-regulation despite receptor occupancy by ligand with normal binding affinity. Akt stimulation by EGF and TGF-alpha, but not by fibroblast growth factor 2, was almost completely blocked in the presence of herstatin. Surprisingly, EGF and TGF-alpha induced full activation of MAPK in duration and intensity and stimulated association of the EGFR with She and Grb2. Although MAPK was fully stimulated, herstatin expression prevented TGF-alpha-induced DNA synthesis and EGF-induced proliferation. The herstatin-mediated uncoupling of MAPK from Akt activation was also observed in Chinese hamster ovary cells co-transfected with EGFR and herstatin. These findings show that herstatin expression alters EGF and TGF-alpha signaling profiles, culminating in inhibition of proliferation.	Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA	Oregon Health & Science University	Clinton, GM (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	clinton@ohsu.edu						Alroy I, 1997, FEBS LETT, V410, P83, DOI 10.1016/S0014-5793(97)00412-2; Azios NG, 2001, ONCOGENE, V20, P5199, DOI 10.1038/sj.onc.1204555; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; Busse D, 2000, J BIOL CHEM, V275, P6987, DOI 10.1074/jbc.275.10.6987; CADENA DL, 1994, J BIOL CHEM, V269, P260; CAMPOSGONZALEZ R, 1992, J BIOL CHEM, V267, P14535; CARRAWAY KL, 1994, CELL, V78, P5, DOI 10.1016/0092-8674(94)90564-9; Christianson TA, 1998, CANCER RES, V58, P5123; Deb TB, 2001, J BIOL CHEM, V276, P15554, DOI 10.1074/jbc.M100928200; Doherty JK, 1999, P NATL ACAD SCI USA, V96, P10869, DOI 10.1073/pnas.96.19.10869; DOUGALL WC, 1994, ONCOGENE, V9, P2109; Gibson S, 1999, J BIOL CHEM, V274, P17612, DOI 10.1074/jbc.274.25.17612; GOTOH N, 1994, P NATL ACAD SCI USA, V91, P167, DOI 10.1073/pnas.91.1.167; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; HACK N, 1993, J BIOL CHEM, V268, P26441; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Heldin Carl-Henrik, 1996, Cytokine and Growth Factor Reviews, V7, P3, DOI 10.1016/1359-6101(96)00002-0; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; HYNES NE, 1994, BBA-REV CANCER, V1198, P165, DOI 10.1016/0304-419X(94)90012-4; Jones SM, 2001, NAT CELL BIOL, V3, P165, DOI 10.1038/35055073; Klapper LN, 2000, ADV CANCER RES, V77, P25; Kumagai T, 2001, P NATL ACAD SCI USA, V98, P5526, DOI 10.1073/pnas.071060598; Lee H, 2001, CANCER RES, V61, P4467; Lemmon MA, 1997, EMBO J, V16, P281, DOI 10.1093/emboj/16.2.281; Lenferink AEG, 1998, EMBO J, V17, P3385, DOI 10.1093/emboj/17.12.3385; Liu BL, 2001, ONCOGENE, V20, P1913, DOI 10.1038/sj.onc.1204277; Maihle N J, 2002, Cancer Treat Res, V107, P247; Malumbres M, 1998, FRONT BIOSCI-LANDMRK, V3, P887; Mendelsohn J, 1997, CLIN CANCER RES, V3, P2703; O'Rourke DM, 1998, ONCOGENE, V16, P1197, DOI 10.1038/sj.onc.1201635; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Olayioye MA, 2001, EXP CELL RES, V267, P81, DOI 10.1006/excr.2001.5242; ORourke DM, 1997, P NATL ACAD SCI USA, V94, P3250, DOI 10.1073/pnas.94.7.3250; Qian XL, 1999, J BIOL CHEM, V274, P574, DOI 10.1074/jbc.274.2.574; Qian XL, 1996, ONCOGENE, V13, P2149; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; SCHLESSINGER J, 1988, COLD SPRING HARB SYM, V53, P515, DOI 10.1101/SQB.1988.053.01.059; SELVA E, 1993, J BIOL CHEM, V268, P2250; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; Sweeney C, 2000, ONCOGENE, V19, P5568, DOI 10.1038/sj.onc.1203913; Tanner KG, 1999, J BIOL CHEM, V274, P35985, DOI 10.1074/jbc.274.50.35985; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Tzahar E, 1997, EMBO J, V16, P4938, DOI 10.1093/emboj/16.16.4938; TZAHAR E, 1998, BIOCHIM BIOPHYS ACTA, V1377, P25; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Vinos J, 2000, ONCOGENE, V19, P3560, DOI 10.1038/sj.onc.1203702; Walker F, 1998, GROWTH FACTORS, V16, P53, DOI 10.3109/08977199809017491; Walker F, 1998, MOL CELL BIOL, V18, P7192, DOI 10.1128/MCB.18.12.7192; Wennstrom S, 1999, MOL CELL BIOL, V19, P4279; WINKLER ME, 1989, BIOCHEMISTRY-US, V28, P6373, DOI 10.1021/bi00441a033; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhao DB, 1999, DEV GENET, V25, P375, DOI 10.1002/(SICI)1520-6408(1999)25:4<375::AID-DVG11>3.0.CO;2-X; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	59	30	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20618	20624		10.1074/jbc.M111359200	http://dx.doi.org/10.1074/jbc.M111359200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11934884	hybrid			2022-12-27	WOS:000176204500068
J	Lee, SR; Yang, KS; Kwon, J; Lee, C; Jeong, W; Rhee, SG				Lee, SR; Yang, KS; Kwon, J; Lee, C; Jeong, W; Rhee, SG			Reversible inactivation of the tumor suppressor PTEN by H2O2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; MAMMALIAN THIOREDOXIN REDUCTASE; TYROSINE-PHOSPHATASE 1B; AIRWAY SMOOTH-MUSCLE; HYDROGEN-PEROXIDE; PHOSPHATIDYLINOSITOL 3-KINASE; TRANSCRIPTIONAL ACTIVATION; PHOSPHOINOSITIDE 3-KINASE; AKT PHOSPHORYLATION; CATALYTIC DOMAIN	The tumor suppressor PTEN regulates cell migration, growth, and survival by removing the T-phosphate of phosphoinositides. Exposure of purified PTEN or of cells to H2O2 resulted in inactivation of PTEN in a time-and H2O2 concentration-dependent manner. Analysis of various cysteine mutants, including mass spectrometry of tryptic peptides, indicated that the essential Cys(124) residue in the active site of PTEN specifically forms a disulfide with Cys(71) during oxidation by H2O2. The reduction of H2O2-oxidized PTEN in cells appears to be mediated predominantly by thioredoxin. Thus, thioredoxin was more efficient than glutaredoxin, glutathione, or a 14-kDa thioredoxin-like protein with regard to the reduction of oxidized PTEN in vitro. Thioredoxin co-immunoprecipitated with PTEN from cell lysates; and incubation of cells with 2,4-dinitro-1-chlorobenzene (an inhibitor of thioredoxin reductase) delayed the reduction of oxidized PTEN, whereas incubation with buthioninesulfoximine (an inhibitor of glutathione biosynthesis) did not. These results suggest that the reversible inactivation of PTEN by H2O2 might be important for the accumulation of 3'-phosphorylated phosphoinositides and that the uncontrolled generation of H2O2 associated with certain pathological conditions might contribute to cell proliferation by inhibiting PTEN function.	NHLBI, Lab Cell Signaling, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Rhee, SG (corresponding author), NHLBI, Lab Cell Signaling, NIH, Bldg 50,Rm 3523, Bethesda, MD 20892 USA.			Kwon, Jaeyul/0000-0002-2452-4111				Adey NB, 2000, CANCER RES, V60, P35; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Besse D, 1997, ANGEW CHEM INT EDIT, V36, P883, DOI 10.1002/anie.199708831; Brar SS, 1999, J BIOL CHEM, V274, P20017, DOI 10.1074/jbc.274.28.20017; BURDON RH, 1995, FREE RADICAL BIO MED, V18, P775, DOI 10.1016/0891-5849(94)00198-S; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; DATTA R, 1992, BIOCHEMISTRY-US, V31, P8300, DOI 10.1021/bi00150a025; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Denu JM, 1998, CURR OPIN CHEM BIOL, V2, P633, DOI 10.1016/S1367-5931(98)80095-1; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Furnari FB, 1997, P NATL ACAD SCI USA, V94, P12479, DOI 10.1073/pnas.94.23.12479; Georgescu MM, 1999, P NATL ACAD SCI USA, V96, P10182, DOI 10.1073/pnas.96.18.10182; Goldkorn T, 1998, AM J RESP CELL MOL, V19, P786, DOI 10.1165/ajrcmb.19.5.3249; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Holmgren A, 2000, ANTIOXID REDOX SIGN, V2, P811, DOI 10.1089/ars.2000.2.4-811; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Ishikawa A, 1999, NEUROSCI LETT, V277, P99, DOI 10.1016/S0304-3940(99)00850-2; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Kim JR, 2000, ANAL BIOCHEM, V283, P214, DOI 10.1006/abio.2000.4623; Kisseleva MV, 2000, J BIOL CHEM, V275, P20110, DOI 10.1074/jbc.M910119199; Kisseleva MV, 2002, J BIOL CHEM, V277, P6266, DOI 10.1074/jbc.M105969200; Knebel A, 1996, EMBO J, V15, P5314, DOI 10.1002/j.1460-2075.1996.tb00916.x; Konishi H, 1997, FEBS LETT, V410, P493, DOI 10.1016/S0014-5793(97)00541-3; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Lee SR, 2000, P NATL ACAD SCI USA, V97, P2521, DOI 10.1073/pnas.050579797; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Leslie NR, 2000, BIOCHEM J, V346, P827, DOI 10.1042/0264-6021:3460827; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; Majerus PW, 1999, J BIOL CHEM, V274, P10669, DOI 10.1074/jbc.274.16.10669; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Nordberg J, 1998, J BIOL CHEM, V273, P10835, DOI 10.1074/jbc.273.18.10835; NOSE K, 1991, EUR J BIOCHEM, V201, P99, DOI 10.1111/j.1432-1033.1991.tb16261.x; Page K, 2000, AM J RESP CELL MOL, V23, P436, DOI 10.1165/ajrcmb.23.4.3953; Pani G, 2000, J BIOL CHEM, V275, P38891, DOI 10.1074/jbc.M007319200; Rhee S.G., 2000, SCI STKE; Salsman S, 2001, ARCH BIOCHEM BIOPHYS, V386, P275, DOI 10.1006/abbi.2000.2202; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; SZATROWSKI TP, 1991, CANCER RES, V51, P794; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; Tolkacheva T, 2000, ONCOGENE, V19, P680, DOI 10.1038/sj.onc.1203331; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Ushio-Fukai M, 1999, J BIOL CHEM, V274, P22699, DOI 10.1074/jbc.274.32.22699; Van der Kaay J, 1999, J BIOL CHEM, V274, P35963, DOI 10.1074/jbc.274.50.35963; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Wang XT, 2000, J BIOL CHEM, V275, P14624, DOI 10.1074/jbc.275.19.14624; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587; Wu Y, 2000, J BIOL CHEM, V275, P21477, DOI 10.1074/jbc.M909741199	54	792	815	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20336	20342		10.1074/jbc.M111899200	http://dx.doi.org/10.1074/jbc.M111899200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11916965	hybrid			2022-12-27	WOS:000176204500032
J	Wiest, A; Grzegorski, D; Xu, BW; Goulard, C; Rebuffat, S; Ebbole, DJ; Bodo, B; Kenerley, C				Wiest, A; Grzegorski, D; Xu, BW; Goulard, C; Rebuffat, S; Ebbole, DJ; Bodo, B; Kenerley, C			Identification of peptaibols from Trichoderma virens and cloning of a peptaibol synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIBIOTIC PEPTIDES; 11-RESIDUE PEPTAIBOL; FORMING PEPTAIBOLS; TRICHORZINS HA; HARZIANUM; SEQUENCE; GENE; BIOSYNTHESIS; MODEL; MA	The fungus Trichoderma virens is a ubiquitous soil saprophyte that has been applied as a biological control agent to protect plants from fungal pathogens. One mechanism of biocontrol is mycoparasitism, and T. virens produces antifungal compounds to assist in killing its fungal targets. Peptide synthetases produce a wide variety of peptide secondary metabolites in bacteria and fungi. Many of these are known to possess antibiotic activities. Peptaibols form a class of antibiotics known for their high a-aminoisobutyric acid content and their synthesis as a mixture of isoforms ranging from 7 to 20 amino acids in length. Here we report preliminary characterization of a 62.8-kb continuous open reading frame encoding a peptaibol synthetase from T. virens. The predicted protein structure consists of 18 peptide synthetase modules with additional modifying domains at the N- and C-termini. T. virens was shown to produce a mixture of peptaibols, with the largest peptides being 18 residues. Mutation of the gene eliminated production of all peptaibol isoforms. Identification of the gene responsible for peptaibol production will facilitate studies of the structure and function of peptaibol antibiotics and their contribution to biocontrol activity.	Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; Museum Natl Hist Nat, Lab Chim Subst Nat, F-75005 Paris, France	Texas A&M University System; Texas A&M University College Station; Museum National d'Histoire Naturelle (MNHN)	Kenerley, C (corresponding author), Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA.	kenerley@ppserver.tamu.edu	Rebuffat, Sylvie/AAE-4194-2021; Rebuffat, Sylvie/AAO-2072-2020	Rebuffat, Sylvie/0000-0002-5257-5039				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AugevenBour I, 1997, J CHEM SOC PERK T 1, P1587, DOI 10.1039/a605629f; AUVINGUETTE C, 1992, J AM CHEM SOC, V114, P2170, DOI 10.1021/ja00032a035; Baek JM, 1998, FUNGAL GENET BIOL, V23, P34, DOI 10.1006/fgbi.1997.1025; BODO B, 1985, J AM CHEM SOC, V107, P6011, DOI 10.1021/ja00307a028; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; DUVAL D, 1998, BIOCHIM BIOPHYS ACTA, V17, P370; ELHAJJI M, 1987, INT J PEPT PROT RES, V29, P207; Engelberth J, 2000, ANGEW CHEM INT EDIT, V39, P1860, DOI 10.1002/(SICI)1521-3773(20000515)39:10<1860::AID-ANIE1860>3.0.CO;2-F; GOULARD C, 1995, J ANTIBIOT, V48, P1248, DOI 10.7164/antibiotics.48.1248; GRZEGORSKI D, 2001, THESIS TEXAS A M U; HLIMI S, 1995, J ANTIBIOT, V48, P1254, DOI 10.7164/antibiotics.48.1254; HOWELL CR, 1993, BIOCONTROL SCI TECHN, V3, P435, DOI 10.1080/09583159309355298; JEN WC, 1987, J APPL BACTERIOL, V63, P293, DOI 10.1111/j.1365-2672.1987.tb02705.x; KARLE IL, 1991, P NATL ACAD SCI USA, V88, P5307, DOI 10.1073/pnas.88.12.5307; Keller NP, 1997, FUNGAL GENET BIOL, V21, P17, DOI 10.1006/fgbi.1997.0970; Konz D, 1999, CHEM BIOL, V6, pR39, DOI 10.1016/S1074-5521(99)80002-7; Lorito M, 1996, MOL PLANT MICROBE IN, V9, P206, DOI 10.1094/MPMI-9-0206; Lorito M, 1996, J BACTERIOL, V178, P6382, DOI 10.1128/jb.178.21.6382-6385.1996; Marahiel MA, 1997, CHEM BIOL, V4, P561, DOI 10.1016/S1074-5521(97)90242-8; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; PANDEY RC, 1977, J AM CHEM SOC, V99, P8469, DOI 10.1021/ja00468a016; REBUFFAT S, 1995, J CHEM SOC PERK T 1, P1849, DOI 10.1039/p19950001849; REBUFFAT S, 1992, FEMS MICROBIOL IMMUN, V105, P151, DOI 10.1016/0378-1097(92)90086-4; REBUFFAT S, 1989, INT J PEPT PROT RES, V34, P200; Rebuffat S, 1996, J CHEM SOC PERK T 1, P2021, DOI 10.1039/p19960002021; RINEHART KL, 1981, J AM CHEM SOC, V103, P6517, DOI 10.1021/ja00411a052; SANSOM MSP, 1991, PROG BIOPHYS MOL BIO, V55, P139, DOI 10.1016/0079-6107(91)90004-C; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Stein T, 1996, J BIOL CHEM, V271, P15428, DOI 10.1074/jbc.271.26.15428; THOMAS MD, 1989, CURR GENET, V15, P415, DOI 10.1007/BF00376798; Weber T, 2001, STRUCTURE, V9, pR3, DOI 10.1016/S0969-2126(00)00560-8; Wilhite SE, 2001, APPL ENVIRON MICROB, V67, P5055, DOI 10.1128/AEM.67.11.5055-5062.2001; Xu BW, 1996, J FERMENT BIOENG, V81, P473, DOI 10.1016/0922-338X(96)81465-6; Yun BS, 2000, TETRAHEDRON LETT, V41, P1429, DOI 10.1016/S0040-4039(99)02308-4; Zocher R, 1997, ADV MICROB PHYSIOL, V38, P85	37	157	171	4	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20862	20868		10.1074/jbc.M201654200	http://dx.doi.org/10.1074/jbc.M201654200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11909873	hybrid			2022-12-27	WOS:000176204500098
J	Liang, YX; Li, XY; Rebar, EJ; Li, PX; Zhou, YY; Chen, BL; Wolffe, AP; Case, CC				Liang, YX; Li, XY; Rebar, EJ; Li, PX; Zhou, YY; Chen, BL; Wolffe, AP; Case, CC			Activation of vascular endothelial growth factor A transcription in tumorigenic glioblastoma cell lines by an enhancer with cell type-specific DNase I accessibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAS DOMAIN PROTEIN-1; HYPOXIA-INDUCIBLE FACTOR-1; FACTOR GENE-TRANSCRIPTION; C6 GLIOMA-CELLS; FACTOR EXPRESSION; FACTOR VEGF; TUMOR-GROWTH; NITRIC-OXIDE; INDUCTION; ANGIOGENESIS	Unregulated expression of vascular endothelial growth factor-A (VEGF-A) plays an important role in tumor growth. We have identified a cell type-specific enhancer, HS-1100, that contributes to VEGF-A transcriptional activation in tumorigenic glioblastoma cell lines. This enhancer exhibits increased accessibility to DNase I in glioblastoma cell lines that express high levels of VEGF-A but not in several other cell lines that express much lower levels of VEGF-A. HS-1100 contains a number of sequence elements that are highly conserved among human, mouse, and rat, including the hypoxia-response element (HRE). We show that the HRE contributes significantly to the cell type-specific enhancer activity of HS-1100 in U87MG glioblastoma cells. We use chromatin immunoprecipitation assays to show that endothelial PAS domain protein 1 (EPAS1) can efficiently bind to the endogenous HRE in U87MG cells but not in HEK293 cells in which the chromosomal HS-1100 is not accessible to DNase I. A dominant negative EPAS1 significantly reduces HS-1100 enhancer activity and VEGF-A levels in U87MG cells. Our results provide insight into the molecular mechanisms of VEGF-A up-regulation during cancer development.	Sangamo Biosci Inc, Point Richmond Tech Ctr, Richmond, CA 94804 USA	Sangamo Therapeutics, Inc.	Case, CC (corresponding author), Sangamo Biosci Inc, Point Richmond Tech Ctr, 501 Canal Blvd Suite A100, Richmond, CA 94804 USA.	ccase@sangamo.com						Akeno N, 2001, ENDOCRINOLOGY, V142, P959, DOI 10.1210/en.142.2.959; Benjamin LE, 1997, P NATL ACAD SCI USA, V94, P8761, DOI 10.1073/pnas.94.16.8761; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chaudhry IH, 2001, HISTOPATHOLOGY, V39, P409, DOI 10.1046/j.1365-2559.2001.01230.x; Cheng SY, 1996, P NATL ACAD SCI USA, V93, P8502, DOI 10.1073/pnas.93.16.8502; Damert A, 1997, BIOCHEM J, V327, P419, DOI 10.1042/bj3270419; Farrara N, 2000, CURR OPIN BIOTECH, V11, P617, DOI 10.1016/S0958-1669(00)00153-1; Feldkamp MM, 1999, INT J CANCER, V81, P118, DOI 10.1002/(SICI)1097-0215(19990331)81:1<118::AID-IJC20>3.3.CO;2-X; Flamme I, 1998, AM J PATHOL, V153, P25, DOI 10.1016/S0002-9440(10)65541-1; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Hossain MA, 2000, J BIOL CHEM, V275, P27874; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Kimura H, 2000, BLOOD, V95, P189, DOI 10.1182/blood.V95.1.189.001k05_189_197; Kimura H, 2001, J BIOL CHEM, V276, P2292, DOI 10.1074/jbc.M008398200; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; Liu PQ, 2001, J BIOL CHEM, V276, P11323, DOI 10.1074/jbc.M011172200; Machein MR, 1999, HUM GENE THER, V10, P1117, DOI 10.1089/10430349950018111; Maemura K, 1999, J BIOL CHEM, V274, P31565, DOI 10.1074/jbc.274.44.31565; Maity A, 2000, CANCER RES, V60, P5879; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; Milanini J, 1998, J BIOL CHEM, V273, P18165, DOI 10.1074/jbc.273.29.18165; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; Mori K, 2000, FREE RADICAL RES, V33, P157, DOI 10.1080/10715760000300711; Mueller MD, 2000, P NATL ACAD SCI USA, V97, P10972, DOI 10.1073/pnas.200377097; Pal S, 2001, J BIOL CHEM, V276, P2395, DOI 10.1074/jbc.M007818200; PLATE KH, 1995, GLIA, V15, P339, DOI 10.1002/glia.440150313; Saleh M, 1996, CANCER RES, V56, P393; Sanchez-Elsner T, 2001, J BIOL CHEM, V276, P38527, DOI 10.1074/jbc.M104536200; Shi Q, 2001, CANCER RES, V61, P4143; Smith CL, 1997, J BIOL CHEM, V272, P27493, DOI 10.1074/jbc.272.44.27493; STEIN GH, 1979, J CELL PHYSIOL, V99, P43, DOI 10.1002/jcp.1040990107; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Valter MM, 1999, INT J DEV NEUROSCI, V17, P565, DOI 10.1016/S0736-5748(99)00048-9; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Xia GB, 2001, CANCER-AM CANCER SOC, V91, P1429, DOI 10.1002/1097-0142(20010415)91:8<1429::AID-CNCR1149>3.0.CO;2-V; Yuan F, 1996, P NATL ACAD SCI USA, V93, P14765, DOI 10.1073/pnas.93.25.14765	38	26	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					20087	20094		10.1074/jbc.M201766200	http://dx.doi.org/10.1074/jbc.M201766200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11912213	hybrid			2022-12-27	WOS:000175894800110
J	Christensen, MO; Barthelmes, HU; Feineis, S; Knudsen, BR; Andersen, AH; Boege, F; Mielke, C				Christensen, MO; Barthelmes, HU; Feineis, S; Knudsen, BR; Andersen, AH; Boege, F; Mielke, C			Changes in mobility account for camptothecin-induced subnuclear relocation of topoisomerase I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR ARCHITECTURE; PROTEIN DYNAMICS; DNA; CELLS; EXPRESSION; RNA; MECHANISM; BINDING	DNA topoisomerase I is a nucleolar protein, which relocates to the nucleoplasm in response to drugs stabilizing topoisomerase I-DNA intermediates (e.g. camptothecin). Here we demonstrate that this phenomenon is solely caused by the drug's impact on the interplay between mobility and localization of topoisomerase I in a living cell nucleus. We show by photobleaching of cells expressing biofluorescent topoisomerase I-chimera that the enzyme moves continuously between nucleoli and nucleoplasm. Complex kinetics of fluorescence recovery after photobleaching indicates that two enzyme fractions with different mobility coexist in nucleoli and nucleoplasm. However, the whole complement of topoisomerase I is in continuous flux between these compartments and nucleolar accumulation can plausibly explained by the enzyme's 2-fold lesser overall mobility in nucleoli versus nucleoplasm. Upon addition of camptothecin, topoisomerase I relocates within 30 s from the nucleoli to radial nucleoplasmic structures. At these sites, the enzyme becomes retarded in a dose-dependent manner. Inside nucleoli the mobility of topoisomerase I is much less affected by camptothecin. Thus, the enzyme's distribution equilibrium is shifted toward the nucleoplasm, which causes nucleolar delocalization. In general, topoisomerase I is an entirely mobile nuclear component, unlikely to require specific signaling for movements between nuclear compartments.	Univ Wurzburg, Med Poliklin, Dept Clin Chem, D-97070 Wurzburg, Germany; Univ Aarhus, Dept Mol & Struct Biol, DK-8200 Aarhus C, Denmark	University of Wurzburg; Aarhus University	Mielke, C (corresponding author), Univ Wurzburg, Med Poliklin, Dept Clin Chem, Klin Str 6-8, D-97070 Wurzburg, Germany.		Andersen, Anni/O-1162-2017; Boege, Fritz/H-3261-2019	Knudsen, Birgitta Ruth/0000-0002-3484-3802; Andersen, Anni/0000-0001-7194-3258				Buckwalter CA, 1996, CANCER RES, V56, P1674; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Danks MK, 1996, CANCER RES, V56, P1664; Hendzel MJ, 1999, MOL BIOL CELL, V10, P2051, DOI 10.1091/mbc.10.6.2051; HERTZBERG RP, 1989, BIOCHEMISTRY-US, V28, P4629, DOI 10.1021/bi00437a018; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; Mao Y, 2000, P NATL ACAD SCI USA, V97, P4046, DOI 10.1073/pnas.080536597; Meyer KN, 1997, J CELL BIOL, V136, P775, DOI 10.1083/jcb.136.4.775; Mielke C, 2000, GENE, V254, P1, DOI 10.1016/S0378-1119(00)00294-8; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Mo YY, 2002, J BIOL CHEM, V277, P2958, DOI 10.1074/jbc.M108263200; Mo YY, 2000, EXP CELL RES, V256, P480, DOI 10.1006/excr.2000.4864; MULLER MT, 1985, EMBO J, V4, P1237, DOI 10.1002/j.1460-2075.1985.tb03766.x; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Shopland LS, 2000, J CELL BIOL, V150, pF1, DOI 10.1083/jcb.150.1.F1; Straub T, 1997, BIOCHEMISTRY-US, V36, P10777, DOI 10.1021/bi970417q; White J, 1999, TRENDS CELL BIOL, V9, P61, DOI 10.1016/S0962-8924(98)01433-0; ZHANG H, 1988, P NATL ACAD SCI USA, V85, P1060, DOI 10.1073/pnas.85.4.1060	20	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 3	2002	277	18					15661	15665		10.1074/jbc.C200066200	http://dx.doi.org/10.1074/jbc.C200066200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	550PA	11907023	hybrid			2022-12-27	WOS:000175510400060
J	Lee, MCS; Hamamoto, S; Schekman, R				Lee, MCS; Hamamoto, S; Schekman, R			Ceramide biosynthesis is required for the formation of the oligomeric H+-ATPase Pma1p in the yeast endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE ATPASE; GPI-ANCHORED PROTEINS; INOSITOL PHOSPHORYLCERAMIDE SYNTHASE; DOMINANT LETHAL MUTATIONS; SACCHAROMYCES-CEREVISIAE; INTRACELLULAR-TRANSPORT; GOLGI-APPARATUS; COAT PROTEINS; COPII; GENE	The yeast plasma membrane H+-ATPase Pma1p is one of the most abundant proteins to traverse the secretory pathway. Newly synthesized Pma1p exits the endoplasmic reticulum (ER) via COPII-coated vesicles bound for the Golgi. Unlike most secreted proteins, efficient incorporation of Pma1p into COPII vesicles requires the Sec24p homolog Lst1p, suggesting a unique role for Lst1p in ER export. Vesicles formed with mixed Sec24pLst1p coats are larger than those with Sec24p alone. Here, we examined the relationship between Pma1p biosynthesis and the requirement for this novel coat sub. unit. We show that Pma1p forms a large oligomeric complex of >1 MDa in the ER, which is packaged into COPII vesicles. Furthermore, oligomerization of Pma1p is linked to membrane lipid composition; Pma1p is rendered monomeric in cells depleted of ceramide, suggesting that association with lipid rafts may influence oligomerization. Surprisingly, monomeric Pma1p present in ceramide-deficient membranes can be exported from the ER in COPII vesicles in a reaction that is stimulated by Lst1p. We suggest that Lst1p directly conveys Pma1p into a COPII vesicle and that the larger size of mixed Sec24pLst1p COPII vesicles is not essential to the packaging of large oligomeric complexes.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Schekman, R (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.			Lee, Marcus/0000-0002-4973-0915				Antonny B, 2001, CURR OPIN CELL BIOL, V13, P438, DOI 10.1016/S0955-0674(00)00234-9; Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; Auer M, 1998, NATURE, V392, P840, DOI 10.1038/33967; Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; Bagnat M, 2001, MOL BIOL CELL, V12, P4129, DOI 10.1091/mbc.12.12.4129; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; BUEDE R, 1991, J BACTERIOL, V173, P4325, DOI 10.1128/JB.173.14.4325-4332.1991; CHADWICK CC, 1987, ARCH BIOCHEM BIOPHYS, V252, P348, DOI 10.1016/0003-9861(87)90041-5; CHANG A, 1991, J CELL BIOL, V115, P289, DOI 10.1083/jcb.115.2.289; DUFOUR JP, 1980, EUR J BIOCHEM, V105, P145, DOI 10.1111/j.1432-1033.1980.tb04484.x; Ferreira T, 2001, J BIOL CHEM, V276, P29613, DOI 10.1074/jbc.R100022200; GOORMAGHTIGH E, 1986, J BIOL CHEM, V261, P7466; HARRIS SL, 1994, P NATL ACAD SCI USA, V91, P10531, DOI 10.1073/pnas.91.22.10531; HOLCOMB CL, 1988, J CELL BIOL, V106, P641, DOI 10.1083/jcb.106.3.641; HORVATH A, 1994, EMBO J, V13, P3687, DOI 10.1002/j.1460-2075.1994.tb06678.x; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Levine TP, 2000, MOL BIOL CELL, V11, P2267, DOI 10.1091/mbc.11.7.2267; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Morsomme P, 2000, BBA-REV BIOMEMBRANES, V1469, P133, DOI 10.1016/S0304-4157(00)00015-0; Muniz M, 2000, EMBO J, V19, P10, DOI 10.1093/emboj/19.1.10; Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809; Pagano A, 1999, J BIOL CHEM, V274, P7833, DOI 10.1074/jbc.274.12.7833; Portillo F, 1997, FEBS LETT, V402, P136, DOI 10.1016/S0014-5793(96)01515-3; Roberg KJ, 1999, J CELL BIOL, V145, P659, DOI 10.1083/jcb.145.4.659; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Serrano R, 1991, MOL CELLULAR BIOL YE, P523; Shimoni Y, 2000, J CELL BIOL, V151, P973, DOI 10.1083/jcb.151.5.973; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sutterlin C, 1997, J CELL SCI, V110, P2703; WUESTEHUBE LJ, 1992, METHOD ENZYMOL, V219, P124; Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824	33	114	114	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22395	22401		10.1074/jbc.M200450200	http://dx.doi.org/10.1074/jbc.M200450200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11950838	hybrid			2022-12-27	WOS:000176313600037
J	Schreiber, V; Ame, JC; Dolle, P; Schultz, I; Rinaldi, B; Fraulob, V; Menissier-de Murcia, J; de Murcia, G				Schreiber, V; Ame, JC; Dolle, P; Schultz, I; Rinaldi, B; Fraulob, V; Menissier-de Murcia, J; de Murcia, G			Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; LIGASE-III; PROTEIN; DAMAGE; CELLS; GENE; BETA; EXPRESSION; TANKYRASE; INTERACTS	The DNA damage dependence of poly(ADP-ribose) polymerase-2 (PARP-2) activity is suggestive of its implication in genome surveillance and protection. Here we show that the PARP-2 gene, mainly expressed in actively dividing tissues follows, but to a smaller extent, that of PARP-1 during mouse development. We found that PARP-2 and PARP-1 homo- and heterodimerize; the interacting interfaces, sites of reciprocal modification, have been mapped. PARP-2 was also found to interact with three other proteins involved in the base excision repair pathway: x-ray cross complementing factor 1 (XRCC1), DNA polymerase beta, and DNA ligase M, already known as partners of PARP-1. XRCC1 negatively regulates PARP-2 activity, as it does for PARP-1, while being a polymer acceptor for both PARP-1 and PARP-2. To gain insight into the physiological role of PARP-2 in response to genotoxic stress, we developed by gene disruption mice deficient in PARP-2. Following treatment by the alkylating agent N-nitroso-N-methylurea (MNU), PARP-2-deficient cells displayed an important delay in DNA strand breaks resealing, similar to that observed in PARP-1 deficient cells, thus confirming that PARP-2 is also an active player in base excision repair despite its low capacity to synthesize ADP-ribose polymers.	Univ Strasbourg 1, Ecole Super Biotechnol Strasbourg, CEA, Lab Convent,CNRS,UPR 9003, F-67400 Illkirch Graffenstaden, France; Coll France, ULP, CNRS, INSERM,Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	de Murcia, G (corresponding author), Univ Strasbourg 1, Ecole Super Biotechnol Strasbourg, CEA, Lab Convent,CNRS,UPR 9003, Blvd Sebastian Brant, F-67400 Illkirch Graffenstaden, France.		Schreiber, Valérie/M-5007-2016; Dolle, Pascal/A-8037-2010	Schreiber, Valérie/0000-0003-0507-639X; Dolle, Pascal/0000-0002-9294-9090				Ame JC, 1999, J BIOL CHEM, V274, P17860, DOI 10.1074/jbc.274.25.17860; Barlow C, 2000, P NATL ACAD SCI USA, V97, P871, DOI 10.1073/pnas.97.2.871; BAUER PI, 1990, BIOCHEM J, V270, P17, DOI 10.1042/bj2700017; Beneke R, 2000, MOL CELL BIOL, V20, P6695, DOI 10.1128/MCB.20.18.6695-6703.2000; Berghammer H, 1999, FEBS LETT, V449, P259, DOI 10.1016/S0014-5793(99)00448-2; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; Caldecott KW, 2001, BIOESSAYS, V23, P447, DOI 10.1002/bies.1063; Cappelli E, 1997, J BIOL CHEM, V272, P23970, DOI 10.1074/jbc.272.38.23970; CHATTON B, 1995, BIOTECHNIQUES, V18, P142; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; CONCHA II, 1989, EXP CELL RES, V180, P353, DOI 10.1016/0014-4827(89)90063-3; Dantzer F, 2000, BIOCHEMISTRY-US, V39, P7559, DOI 10.1021/bi0003442; DeMurcia G., 2000, DNA DAMAGE STRESS SI; Desnoyers S, 1996, EXP CELL RES, V227, P146, DOI 10.1006/excr.1996.0259; Dianov GL, 1999, J BIOL CHEM, V274, P13741, DOI 10.1074/jbc.274.20.13741; Doucet-Chabeaud G, 2001, MOL GENET GENOMICS, V265, P954, DOI 10.1007/s004380100506; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Horton JK, 2000, J BIOL CHEM, V275, P2211, DOI 10.1074/jbc.275.3.2211; Johansson M, 1999, GENOMICS, V57, P442, DOI 10.1006/geno.1999.5799; Kaminker PG, 2001, J BIOL CHEM, V276, P35891, DOI 10.1074/jbc.M105968200; Kickhoefer VA, 1999, J CELL BIOL, V146, P917, DOI 10.1083/jcb.146.5.917; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; LAMARRE D, 1988, BIOCHIM BIOPHYS ACTA, V950, P147, DOI 10.1016/0167-4781(88)90007-3; Lavrik OI, 2001, J BIOL CHEM, V276, P25541, DOI 10.1074/jbc.M102125200; LECAM E, 1994, J MOL BIOL, V235, P1062, DOI 10.1006/jmbi.1994.1057; Lyons RJ, 2001, J BIOL CHEM, V276, P17172, DOI 10.1074/jbc.M009756200; Ma Q, 2001, BIOCHEM BIOPH RES CO, V289, P499, DOI 10.1006/bbrc.2001.5987; Marintchev A, 1999, NAT STRUCT BIOL, V6, P884; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Masutani M, 1999, MOL CELL BIOCHEM, V193, P149; MENDOZAALVAREZ H, 1993, J BIOL CHEM, V268, P22575; Menissier De Murcia Josiane, 1997, Proceedings of the National Academy of Sciences of the United States of America, V94, P7303; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Niederreither K, 1998, ONCOGENE, V17, P1577, DOI 10.1038/sj.onc.1202072; Niederreither K, 1998, METH MOL B, V89, P247; OLIVE PL, 1990, RADIAT RES, V122, P86, DOI 10.2307/3577587; Pieper AA, 2000, P NATL ACAD SCI USA, V97, P1845, DOI 10.1073/pnas.97.4.1845; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Prasad R, 2001, J BIOL CHEM, V276, P32411, DOI 10.1074/jbc.C100292200; Prasad R, 2000, J BIOL CHEM, V275, P4460, DOI 10.1074/jbc.275.6.4460; SCHMID P, 1991, DEVELOPMENT, V113, P857; Shieh WM, 1998, J BIOL CHEM, V273, P30069, DOI 10.1074/jbc.273.46.30069; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Szabo C, 2000, DNA DAMAGE STRESS SI, P151; Trucco C, 1998, NUCLEIC ACIDS RES, V26, P2644, DOI 10.1093/nar/26.11.2644; Vidal AE, 2001, EMBO J, V20, P6530, DOI 10.1093/emboj/20.22.6530; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wilson TM, 1996, MUTAT RES-DNA REPAIR, V362, P237, DOI 10.1016/0921-8777(95)00053-4	49	548	582	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					23028	23036		10.1074/jbc.M202390200	http://dx.doi.org/10.1074/jbc.M202390200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11948190	hybrid			2022-12-27	WOS:000176313600118
J	Ayoub, MA; Couturier, C; Lucas-Meunier, E; Angers, S; Fossier, P; Bouvier, M; Jockers, R				Ayoub, MA; Couturier, C; Lucas-Meunier, E; Angers, S; Fossier, P; Bouvier, M; Jockers, R			Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROPOIETIN RECEPTOR; HORMONE RECEPTOR; HUMAN MEL1A; DOPAMINE; OLIGOMERIZATION; SURFACE; SOMATOSTATIN; ANTAGONISTS; INHIBITION; ACTIVATION	Several G protein-coupled receptors have been shown to exist as homo-and hetero-oligomeric complexes in living cells. However, the link between ligand-induced receptor activation and its oligomerization state as well as the proportion of the total receptor population that can engage in oligomeric complexes remain open questions. Here, the closely related human MT1 and MT2 melatonin receptors (MT1R, MT2R) were used to address these issues. Bioluminescence resonance energy transfer (BRET) experiments in living HEK 293 cells revealed that these receptors form homo- and hetero-oligomers. Constitutive energy transfer was observed for all receptor combinations at physiological expression levels and could be detected in single cell BRET experiments. Inhibition of the energy transfer by dilution of the BRET partners identified MT1R and MT2R dimers as the predominant receptor species, and this oligomerization state did not change upon agonist and antagonist binding. Agonists, neutral antagonists, and inverse agonists all promoted increases in BRET values for MT2R but not for MT1R homodimers in living cells and isolated plasma membranes. This indicates that no correlation could be inferred between the receptor activation state and the dimerization state of the receptor. This also suggests that ligand-promoted BRET increases represent specific ligand-induced conformational changes of pre-existing dimers rather then increased dimerization. The observation that ligands favored the energy transfer within the hetero-oligomer from MT1R to MT2R but not in the reverse orientation, from MT2R to MT1R, supports this view.	Inst Cochin Genet Mol, Dept Cell Biol, CNRS, UMR 8104,INSERM,U567, F-75014 Paris, France; CNRS, UPR 9040, Neurobiol Cellulaire & Mol Lab, F-91198 Gif Sur Yvette, France; Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Universite de Montreal	Jockers, R (corresponding author), Inst Cochin Genet Mol, Dept Cell Biol, CNRS, UMR 8104,INSERM,U567, 22 Rue Mechain, F-75014 Paris, France.	jockers@cochin.inserm.fr	Jockers, Ralf/Q-2100-2019; Bouvier, Michel/H-2758-2014; Couturier, Cyril CC/I-3020-2016; Angers, Stephane/E-1432-2014; Couturier, Cyril/ABG-9063-2020; Jockers, Ralf/P-2272-2017	Jockers, Ralf/0000-0002-4354-1750; Bouvier, Michel/0000-0003-1128-0100; Angers, Stephane/0000-0001-7241-9044; Jockers, Ralf/0000-0002-4354-1750; AYOUB, Mohammed Akli/0000-0003-0022-578X				Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Armstrong D, 2001, J BIOL CHEM, V276, P22621, DOI 10.1074/jbc.M006936200; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Boute N, 2001, MOL PHARMACOL, V60, P640; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; Brydon L, 1999, MOL ENDOCRINOL, V13, P2025, DOI 10.1210/me.13.12.2025; Cheng ZJ, 2001, J BIOL CHEM, V276, P48040, DOI 10.1074/jbc.M105668200; Cornea A, 2001, J BIOL CHEM, V276, P2153, DOI 10.1074/jbc.M007850200; DUBOCOVICH ML, 1983, NATURE, V306, P782, DOI 10.1038/306782a0; Dubocovich ML, 1997, N-S ARCH PHARMACOL, V355, P365, DOI 10.1007/PL00004956; Dubocovich ML, 1998, FASEB J, V12, P1211, DOI 10.1096/fasebj.12.12.1211; DUBOCOVICH ML, 1987, P NATL ACAD SCI USA, V84, P3916, DOI 10.1073/pnas.84.11.3916; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Jockers R, 1999, J BIOL CHEM, V274, P28900, DOI 10.1074/jbc.274.41.28900; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Karpa KD, 2000, MOL PHARMACOL, V58, P677, DOI 10.1124/mol.58.4.677; Kenakin T, 1997, TRENDS PHARMACOL SCI, V18, P416, DOI 10.1016/S0165-6147(97)01127-9; Kroeger KM, 2001, J BIOL CHEM, V276, P12736, DOI 10.1074/jbc.M011311200; Lee SP, 2000, MOL PHARMACOL, V58, P120, DOI 10.1124/mol.58.1.120; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; McVey M, 2001, J BIOL CHEM, V276, P14092, DOI 10.1074/jbc.M008902200; MORGAN PJ, 1989, J NEUROENDOCRINOL, V1, P1, DOI 10.1111/j.1365-2826.1989.tb00068.x; MORIN JG, 1971, J CELL PHYSIOL, V77, P313, DOI 10.1002/jcp.1040770305; Overton MC, 2000, CURR BIOL, V10, P341, DOI 10.1016/S0960-9822(00)00386-9; Petit L, 1999, BIOCHEM PHARMACOL, V58, P633, DOI 10.1016/S0006-2952(99)00134-3; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; REPPERT SM, 1988, SCIENCE, V242, P78, DOI 10.1126/science.2845576; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; Rocheville M, 2000, J BIOL CHEM, V275, P7862, DOI 10.1074/jbc.275.11.7862; Roka F, 1999, MOL PHARMACOL, V56, P1014, DOI 10.1124/mol.56.5.1014; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Tucek S, 1997, TRENDS PHARMACOL SCI, V18, P414; VEATCH W, 1977, J MOL BIOL, V113, P89, DOI 10.1016/0022-2836(77)90042-0; WUCH T, 2001, FEBS LETT, V507, P109; Xu Y, 1999, P NATL ACAD SCI USA, V96, P151, DOI 10.1073/pnas.96.1.151	36	250	260	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21522	21528		10.1074/jbc.M200729200	http://dx.doi.org/10.1074/jbc.M200729200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11940583	hybrid			2022-12-27	WOS:000176286000053
J	Carmona, MC; Iglesias, R; Obregon, MJ; Darlington, GJ; Villarroya, F; Giralt, M				Carmona, MC; Iglesias, R; Obregon, MJ; Darlington, GJ; Villarroya, F; Giralt, M			Mitochondrial biogenesis and thyroid status maturation in brown fat require CCAAT/enhancer-binding protein alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; ADIPOSE-TISSUE; C/EBP-ALPHA; TRANSCRIPTIONAL REGULATION; ADIPOCYTE DIFFERENTIATION; ACTIVATES TRANSCRIPTION; ADRENERGIC REGULATION; RETINOIC ACID; PPAR-ALPHA; BETA	Brown fat differentiation in mice is fully achieved in fetuses at term and entails the acquisition of not only adipogenic but also thermogenic and oxidative mitochondrial capacities. The present study of the mice homozygous for a deletion in the gene for CCAAT/enhancer-binding protein a (C/EBPalpha-null mice) demonstrates that C/EBPalpha is essential for all of these processes. Developing brown fat from C/EBPalpha-null mice showed a lack of uncoupling protein-1 expression, impaired adipogenesis, and reduced size and number of mitochondria per cell when compared with wild-type mice. Furthermore, immature mitochondrial morphology was found in brown fat, but not in liver or heart, from C/EBPalpha-null mice. Concordantly, expression of both nuclear and mitochondrial genome-encoded genes for mitochondrial proteins was reduced in C/EBPalpha-null brown fat, although expression of mitochondrial rRNA and mitochondrial DNA content were unaltered. Expression of nuclear respiratory factor-2, thyroid hormone nuclear receptors, and peroxisome proliferator-activated receptor gamma coactivator-1, was delayed in C/EBPalpha-null brown fat. Iodothyronine 5'-deiodinase activity and thyroid hormone content were also reduced in brown fat from C/EBPalpha-null mice, indicating for the first time a crucial role for C/EBPalpha in controlling thyroid status in developing brown fat, which may contribute to impaired mitochondrial biogenesis and cell differentiation. When survival of C/EBPalpha-null mice was achieved by transgenically expressing C/EBPalpha only in the liver, a substantial recovery in brown fat differentiation was found by day 7 of postnatal age, which is associated with a compensatory overexpression of C/EBPdelta and C/EBPbeta.	Univ Barcelona, Dept Bioquim & Biol Mol, E-08028 Barcelona, Spain; Univ Autonoma Madrid, CSIC, Ctr Mixto, Inst Invest Biomed Alberto Sols, E-28029 Madrid, Spain; Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA	University of Barcelona; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Baylor College of Medicine	Giralt, M (corresponding author), Univ Barcelona, Dept Bioquim & Biol Mol, Avda Diagonal 645, E-08028 Barcelona, Spain.	giralt@bio.ub.es	Giralt, Marta/A-4756-2013; OBREGON, Maria Jesus/E-2946-2010; Villarroya, Francesc/K-4357-2014; Iglesias, Roser/C-5561-2017	Giralt, Marta/0000-0001-7968-4190; Iglesias, Roser/0000-0002-7107-8097; Carmona Orozco, Mamen/0000-0001-5911-6938; Villarroya, Francesc/0000-0003-1266-9142				ALVAREZ R, 1995, J BIOL CHEM, V270, P5666, DOI 10.1074/jbc.270.10.5666; BADDELEY AJ, 1986, J MICROSC-OXFORD, V142, P259, DOI 10.1111/j.1365-2818.1986.tb04282.x; Barbera MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200; BIANCO AC, 1987, J CLIN INVEST, V79, P295, DOI 10.1172/JCI112798; BIRKENMEIER EH, 1989, GENE DEV, V3, P1146, DOI 10.1101/gad.3.8.1146; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Carmona MC, 1998, BIOCHEM BIOPH RES CO, V243, P224, DOI 10.1006/bbrc.1998.8088; Casas F, 1999, MOL CELL BIOL, V19, P7913; CASSARDDOULCIER AM, 1993, MOL ENDOCRINOL, V7, P497, DOI 10.1210/me.7.4.497; Chen SS, 2000, MOL CELL BIOL, V20, P7292, DOI 10.1128/MCB.20.19.7292-7299.2000; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; DEONA CR, 1991, ENDOCRINOLOGY, V128, P422, DOI 10.1210/endo-128-1-422; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Elberg G, 2000, J BIOL CHEM, V275, P27815; Enriquez JA, 1999, MOL CELL BIOL, V19, P657; Flodby P, 1996, J BIOL CHEM, V271, P24753, DOI 10.1074/jbc.271.40.24753; FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654; GIRALT M, 1990, EUR J BIOCHEM, V193, P297, DOI 10.1111/j.1432-1033.1990.tb19336.x; GIRALT M, 1988, BIOCHEM BIOPH RES CO, V156, P493, DOI 10.1016/S0006-291X(88)80868-4; GIRALT M, 1991, J BIOL CHEM, V266, P21991; IZQUIERDO JM, 1995, J BIOL CHEM, V270, P10342, DOI 10.1074/jbc.270.17.10342; KAESTNER KH, 1990, P NATL ACAD SCI USA, V87, P251, DOI 10.1073/pnas.87.1.251; Lane MD, 1999, BIOCHEM BIOPH RES CO, V266, P677, DOI 10.1006/bbrc.1999.1885; Li R, 1997, MOL CELL ENDOCRINOL, V128, P69, DOI 10.1016/S0303-7207(97)04023-9; LIN FT, 1994, P NATL ACAD SCI USA, V91, P8757, DOI 10.1073/pnas.91.19.8757; LIN FT, 1992, GENE DEV, V6, P533, DOI 10.1101/gad.6.4.533; Linhart HG, 2001, P NATL ACAD SCI USA, V98, P12532, DOI 10.1073/pnas.211416898; MANCHADO C, 1994, BIOCHEM J, V302, P695, DOI 10.1042/bj3020695; MARTIN I, 1995, BIOCHEM J, V308, P749, DOI 10.1042/bj3080749; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Nedergaard J., 1986, BROWN ADIPOSE TISSUE, P152; NICHOLLS DG, 1986, BROWN ADIPOSE TISSUE, P52; OBREGON MJ, 1989, AM J PHYSIOL, V257, pE625, DOI 10.1152/ajpendo.1989.257.5.E625; PARK EA, 1990, MOL CELL BIOL, V10, P6264, DOI 10.1128/MCB.10.12.6264; Pillar TM, 1997, EUR J ENDOCRINOL, V136, P231, DOI 10.1530/eje.0.1360231; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; RABELO R, 1995, ENDOCRINOLOGY, V136, P1003, DOI 10.1210/en.136.3.1003; REHNMARK S, 1993, FEBS LETT, V318, P235, DOI 10.1016/0014-5793(93)80519-Z; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Scarpulla RC, 1997, J BIOENERG BIOMEMBR, V29, P109, DOI 10.1023/A:1022681828846; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Song S, 2000, MOL CELL ENDOCRINOL, V165, P189, DOI 10.1016/S0303-7207(00)00246-X; Tai TAC, 1996, J BIOL CHEM, V271, P29909, DOI 10.1074/jbc.271.47.29909; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; TERUEL T, 1995, BIOCHEM J, V310, P771, DOI 10.1042/bj3100771; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TUCA A, 1993, ENDOCRINOLOGY, V132, P1913, DOI 10.1210/en.132.5.1913; Valmaseda A, 1999, MOL CELL ENDOCRINOL, V154, P101, DOI 10.1016/S0303-7207(99)00081-7; Villena JA, 1998, BIOCHEM J, V331, P121, DOI 10.1042/bj3310121; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; WEIBEL ER, 1979, STEREOLOGICAL METHOD, V1, P23; Welm AL, 1999, MOL CELL BIOL, V19, P1695; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yubero P, 1998, MOL ENDOCRINOL, V12, P1023, DOI 10.1210/me.12.7.1023; YUBERO P, 1994, BIOCHEM BIOPH RES CO, V198, P653, DOI 10.1006/bbrc.1994.1095	58	40	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21489	21498		10.1074/jbc.M201710200	http://dx.doi.org/10.1074/jbc.M201710200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11940593	hybrid			2022-12-27	WOS:000176286000049
J	El Kirat, K; Besson, F; Prigent, AF; Chauvet, JP; Roux, B				El Kirat, K; Besson, F; Prigent, AF; Chauvet, JP; Roux, B			Role of calcium and membrane organization on phospholipase D localization and activity - Competition between a soluble and an insoluble substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-CHROMOFUSCUS; PHOSPHATIDIC-ACID; PHOSPHATIDYLCHOLINE; CHOLESTEROL; MONOLAYERS; ACTIVATION; HYDROLYSIS; BINDING; DETERGENT; BILAYERS	The phospholipase D (PLD) from Streptomyces chromofuscus is a soluble enzyme known to be activated by the phosphatidic acid-calcium complexes. PLD-catalyzed hydrolysis of phospholipids in aqueous medium leads to the formation of phosphatidic acid (PA). Previous studies concluded on an allosteric activation of PLD by the PA-calcium complexes. In this work, the role of PA and calcium was investigated in terms of membrane structure and dynamics. The role of calcium in PLD partitioning between the soluble phase and the water-lipid interface was tested. The monomolecular film technique was used to measure both membrane dynamics and PLD activity. These experiments provided information on PLD activity at a water-lipid interface. Moreover, the ability of PA to enhance PLD activity toward phosphatidylcholine was correlated to the physical proper-ties of PA itself, affecting the rheology of the membrane. The effect of calcium was investigated on PLD binding to lipids and on the catalytic process by competition experiments between a soluble and a vesicular substrate. These experiments confirmed the absolute PLD requirement for calcium and pointed out the importance of calcium for PLD catalytic process and for the enzyme location at the water-lipid interface.	Univ Lyon 1, CNRS, UMR 5013, Lab Physicochim Biol, F-69622 Villeurbanne, France; Inst Natl Sci Appl, INSERM, U352, Lab Biochim & Pharmacol, F-69621 Villeurbanne, France; Ecole Cent Lyon, CNRS, UMR 5621, Lab Ingn & Fonct Surfaces, F-69131 Ecully, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Centrale de Lyon	El Kirat, K (corresponding author), Univ Lyon 1, CNRS, UMR 5013, Lab Physicochim Biol, 43 Blvd 11-11-1918, F-69622 Villeurbanne, France.	elkirat@univ-lyon1.fr	KIRAT, Karim EL/C-5136-2009; EL KIRAT, Karim/A-4590-2017	KIRAT, Karim EL/0000-0003-4884-7270; EL KIRAT, Karim/0000-0003-4884-7270				ALBRECHT O, 1981, J COLLOID INTERF SCI, V79, P319, DOI 10.1016/0021-9797(81)90084-9; Bechoua S, 1998, J LIPID RES, V39, P873; Beisson F, 2000, EUR J LIPID SCI TECH, V102, P133, DOI 10.1002/(SICI)1438-9312(200002)102:2<133::AID-EJLT133>3.3.CO;2-O; Davis LL, 1998, LIPIDS, V33, P223, DOI 10.1007/s11745-998-0199-5; Dong GA, 1999, BBA-PROTEIN STRUCT M, V1430, P234, DOI 10.1016/S0167-4838(99)00005-9; Dumaual AC, 2000, BBA-BIOMEMBRANES, V1463, P395, DOI 10.1016/S0005-2736(99)00235-7; Estrela-Lopis I, 2001, BIOPHYS J, V80, P749, DOI 10.1016/S0006-3495(01)76054-7; Geng D, 1998, J BIOL CHEM, V273, P12195, DOI 10.1074/jbc.273.20.12195; HOLBROOK PG, 1991, BIOCHIM BIOPHYS ACTA, V1084, P155, DOI 10.1016/0005-2760(91)90214-3; IMAMURA S, 1979, J BIOCHEM, V85, P79, DOI 10.1093/oxfordjournals.jbchem.a132334; Iwasaki Y, 1999, EUR J BIOCHEM, V264, P577, DOI 10.1046/j.1432-1327.1999.00669.x; KONDO T, 1994, THIN SOLID FILMS, V244, P887, DOI 10.1016/0040-6090(94)90593-2; Leiros I, 2000, STRUCTURE, V8, P655, DOI 10.1016/S0969-2126(00)00150-7; Li XM, 2001, BIOCHEMISTRY-US, V40, P5954, DOI 10.1021/bi002791n; Morris AJ, 1997, ANAL BIOCHEM, V252, P1, DOI 10.1006/abio.1997.2299; Ponting CP, 1996, PROTEIN SCI, V5, P914; Stieglitz K, 1999, J BIOL CHEM, V274, P35367, DOI 10.1074/jbc.274.50.35367; Stieglitz KA, 2001, BIOCHEMISTRY-US, V40, P13954, DOI 10.1021/bi011338o; Vinggaard AM, 1996, BIOCHEM J, V319, P861, DOI 10.1042/bj3190861; YAMAMOTO I, 1993, BIOCHIM BIOPHYS ACTA, V1145, P293, DOI 10.1016/0005-2736(93)90302-G; YAMAMOTO I, 1995, BBA-BIOMEMBRANES, V1233, P21, DOI 10.1016/0005-2736(94)00220-J; Yu CH, 1996, MOL CELL BIOCHEM, V157, P101	22	32	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21231	21236		10.1074/jbc.M106449200	http://dx.doi.org/10.1074/jbc.M106449200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11940565	hybrid			2022-12-27	WOS:000176286000016
J	Maxwell, RA; Welch, WH; Schooley, DA				Maxwell, RA; Welch, WH; Schooley, DA			Juvenile hormone diol kinase - I. Purification, characterization, and substrate specificity of juvenile hormone-selective diol kinase from Manduca sexta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPOXIDE HYDROLASE; CYTOSOLIC SULFOTRANSFERASES; TOBACCO HORNWORM; TRICHOPLUSIA-NI; ESTERASE; ACID; STADIUM; CHROMATOGRAPHY; IDENTIFICATION; METAMORPHOSIS	Manduca sexta juvenile hormone diol kinase (JHDK) catalyzes the conversion of juvenile hormone (JH) diol to JH diol phosphate. JHDK may be the first example of a phosphotransferase directly involved in the catabolism and inactivation of a lipid-soluble hormone. JHDK is an enzyme crucial for secondary metabolism of JH and possesses high specificity and catalytic efficiency for JH diol. In this study, the purification and characterization of native JHDK are described; its enzymatic properties are examined; and its role in cellular JH metabolism is explored. Using a variety of potential substrates, we show that JHDK has a preference for ATP, but will catalyze the formation of JH diol phosphate with GTP as the phosphate donor. JHDK has a nanomolar K-m for JH I diol and a low micromolar value for MgATP. JH II and III diols also serve as phosphate acceptors with low micromolar K-m, whereas other diol derivatives of terpenoid esters structurally similar to JH metabolites are not phosphorylated. The reaction proceeds via a sequential Bi Bi mechanism. JHDK is active as a homodimer with a subunit molecular mass of 20 kDa. JHDK binds 5'-p-fluorosulfonylbenzoyladenosine and is inhibited by micromolar levels of Ca2+.	Univ Nevada, Dept Biochem, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Schooley, DA (corresponding author), Univ Nevada, Dept Biochem, 1664 N Virginia St, Reno, NV 89557 USA.							ABDELAAL YAI, 1985, INSECT BIOCHEM, V15, P111, DOI 10.1016/0020-1790(85)90051-4; BAKER FC, 1987, INSECT BIOCHEM, V17, P989, DOI 10.1016/0020-1790(87)90108-9; BERGOT BJ, 1981, J CHROMATOGR, V204, P231, DOI 10.1016/S0021-9673(00)81664-7; COHEN SA, 1993, ANAL BIOCHEM, V211, P279, DOI 10.1006/abio.1993.1270; DANN LG, 1978, BIOCHEM J, V169, P39, DOI 10.1042/bj1690039; DEBERNARD S, 1994, J INSECT PHYSIOL, V40, P975, DOI 10.1016/0022-1910(94)90136-8; deKort CAD, 1996, ARCH INSECT BIOCHEM, V33, P1, DOI 10.1002/(SICI)1520-6327(1996)33:1&lt;1::AID-ARCH1&gt;3.0.CO;2-2; Falany CN, 1997, FASEB J, V11, P1; Falany CN, 1997, FASEB J, V11, P206, DOI 10.1096/fasebj.11.4.9068609; Feyereisen R., 1985, P391; GRANGER NA, 1995, INSECT BIOCHEM MOLEC, V25, P427, DOI 10.1016/0965-1748(94)00076-B; GRIENEISEN ML, 1995, ARCH INSECT BIOCHEM, V30, P255, DOI 10.1002/arch.940300213; Grieneisen ML, 1997, INSECT BIOCHEM MOLEC, V27, P365, DOI 10.1016/S0965-1748(97)00008-8; HALARNKAR PP, 1993, EXPERIENTIA, V49, P988, DOI 10.1007/BF02125646; HAMMOCK B, 1975, MOL CELL ENDOCRINOL, V3, P167, DOI 10.1016/0303-7207(75)90043-X; HAMMOCK BD, 1980, LIFE SCI, V27, P1635, DOI 10.1016/0024-3205(80)90636-0; Hinton AC, 2001, INSECT BIOCHEM MOLEC, V32, P57, DOI 10.1016/S0965-1748(01)00079-0; Ismail SM, 1998, ARCH INSECT BIOCHEM, V37, P305, DOI 10.1002/(SICI)1520-6327(1998)37:4&lt;305::AID-ARCH6&gt;3.0.CO;2-P; Ismail SM, 2000, J INSECT PHYSIOL, V46, P59, DOI 10.1016/S0022-1910(99)00102-X; Kallapur VL, 1996, J INSECT PHYSIOL, V42, P181, DOI 10.1016/0022-1910(95)00057-7; KNOWLES JR, 1980, ANNU REV BIOCHEM, V49, P877, DOI 10.1146/annurev.bi.49.070180.004305; LASSITER MT, 1994, J MED ENTOMOL, V31, P586, DOI 10.1093/jmedent/31.4.586; Maxwell RA, 2002, ANAL BIOCHEM, V305, P40, DOI 10.1006/abio.2002.5660; NAKANISHI K, 1971, J CHEM SOC CHEM COMM, P1235, DOI 10.1039/c29710001235; Rees H.H., 1989, P28; RHOADS DG, 1968, J BIOL CHEM, V243, P3963; RICARD J, 1972, EUR J BIOCHEM, V31, P14, DOI 10.1111/j.1432-1033.1972.tb02494.x; SANBURG LL, 1975, NATURE, V253, P266, DOI 10.1038/253266a0; Schooley D.A., 1984, P373; Schooley DA, 1985, COMPREHENSIVE INSECT, P363; SHARE MR, 1988, ANAL BIOCHEM, V169, P81, DOI 10.1016/0003-2697(88)90257-6; SLADE M, 1974, COMP BIOCHEM PHYSIOL, V49, P99, DOI 10.1016/0305-0491(74)90228-4; Slade M., 1972, P155; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Strydom D. J., 1993, TECHNIQUES PROTEIN C, VIV, P299; SU S, 1967, BIOCHIM BIOPHYS ACTA, V132, P370, DOI 10.1016/0005-2744(67)90156-8; Sutherland TD, 1998, P NATL ACAD SCI USA, V95, P12884, DOI 10.1073/pnas.95.22.12884; TOUHARA K, 1993, J BIOL CHEM, V268, P19604; Truman JW, 1999, NATURE, V401, P447, DOI 10.1038/46737; Vakiani E, 1998, J BIOL CHEM, V273, P35381, DOI 10.1074/jbc.273.52.35381; YAMAMOTO RT, 1969, J ECON ENTOMOL, V62, P1427, DOI 10.1093/jee/62.6.1427; ZIMOWSKA G, 1989, ARCH INSECT BIOCHEM, V12, P1, DOI 10.1002/arch.940120102	42	42	48	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21874	21881		10.1074/jbc.M201510200	http://dx.doi.org/10.1074/jbc.M201510200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11909871	hybrid			2022-12-27	WOS:000176286000098
J	Nakayama, T; Matsushita, T; Dong, ZY; Sadler, JE; Jorieux, S; Mazurier, C; Meyer, D; Kojima, T; Saito, H				Nakayama, T; Matsushita, T; Dong, ZY; Sadler, JE; Jorieux, S; Mazurier, C; Meyer, D; Kojima, T; Saito, H			Identification of the regulatory elements of the human von Willebrand factor for binding to platelet GPIb - Importance of structural integrity of the regions flanked by the Cys(1272)-Cys(1458) disulfide bond	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE GLYCOPROTEIN-IB; VONWILLEBRAND-FACTOR-BINDING; FACTOR A1 DOMAIN; ALANINE-SCANNING MUTAGENESIS; MONOCLONAL-ANTIBODIES; CRYSTAL-STRUCTURE; HEMOPHILIA-A; ALPHA-CHAIN; RISTOCETIN; BOTROCETIN	In vitro platelet glycoprotein Ib (GPIb) binding of the human von Willebrand factor (VWF) increases markedly by exogenous modulators such as ristocetin or botrocetin, and the binding does not occur in normal circulation. GPIb binding sites have been assigned in the VWF A1 domain, which consists of a disulfide loop Cys(1272(509))-cys(1458(695)) where amino acid residues are numbered from the starting methionine as + 1. The previous numbering from the N-terminal Ser of the mature processed VWF is indicated in parentheses. In contrast, several gain-of-function mutations have been found in two regions comprised of the disulfide loop and its Nand C-terminal flanking regions. In this study, cys(1222(459))-Tyr(1271(508)), Gln(1238(475))-Tyr(1271(508)), Glu(1260(497))-Tyr(1271(508)), and Asp(1459(696))Asp(1472(709)) were sequentially deleted of full-length multimeric recombinant VWF. Deletions at either side resulted in normal GPIb binding, indicating that the flanking regions are not GPIb binding sites. However, the addition of a mutation at Arg(1308(545)) on each deletion mutant resulted in spontaneous GPIb binding without requiring modulators, suggesting that both regions are important for the inhibition of GPIb binding. Spontaneous binding was completely inhibited by monoclonal antibodies that recognize the GPIb binding sites. Interestingly, mutant proteins with N-terminal but not C-terminal deletions lost binding to monoclonal antibodies 13328, 13710, and 23C7, which selectively inhibit ristocetin-induced GPI binding. Their epitopes were found at His(1268(505)) or Asp(1269(506)). The crystallographic structure of the A1 domain suggests that GPIb binding is influenced by the molecular interface between the two regions and that the antibody binding to the interface inhibits binding.	Nagoya Univ, Sch Med, Dept Internal Med 1, Showa Ku, Nagoya, Aichi 4668550, Japan; Washington Univ, Sch Med, Dept Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; Ctr Reg Transfus Sanguine, F-59012 Lille, France; LRB, Diveloppement Pri Clin, F-59011 Lille, France; Hop Bicetre, INSERM, U143, F-94275 Le Kremlin Bicetre, France; Nagoya Univ, Sch Hlth Sci, Dept Med Technol, Higashi Ku, Nagoya, Aichi 4618673, Japan; Aichi Blood Dis Res Fdn, Moriyama Ku, Nagoya, Aichi 4630074, Japan; Nagoya Natl Hosp, Naka Ku, Nagoya, Aichi 4610001, Japan	Nagoya University; Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Nagoya University	Matsushita, T (corresponding author), Nagoya Univ, Sch Med, Dept Internal Med 1, Showa Ku, 65 Tsurumacho, Nagoya, Aichi 4668550, Japan.	tmatsu@med.nagoya-u.ac.jp	Matsushita, Tadadshi/I-7349-2014; Sadler, Evan/D-8556-2011; Kojima, Tetsuhito/I-6271-2014	Kojima, Tetsuhito/0000-0002-1905-1065; Nakayama, Takayuki/0000-0003-2389-2542				ANDREWS RK, 1989, BIOCHEMISTRY-US, V28, P8326, DOI 10.1021/bi00447a010; ANDREWS RK, 1989, BIOCHEMISTRY-US, V28, P8317, DOI 10.1021/bi00447a009; AZUMA H, 1993, THROMB HAEMOSTASIS, V69, P192; Celikel R, 2000, NAT STRUCT BIOL, V7, P881; Celikel R, 1998, NAT STRUCT BIOL, V5, P189, DOI 10.1038/nsb0398-189; CHRISTOPHE O, 1995, BRIT J HAEMATOL, V90, P195, DOI 10.1111/j.1365-2141.1995.tb03400.x; COLLER BS, 1983, BLOOD, V61, P99; De Luca M, 2000, BLOOD, V95, P164; Emsley J, 1998, J BIOL CHEM, V273, P10396, DOI 10.1074/jbc.273.17.10396; FUJIMURA Y, 1992, THROMB HAEMOSTASIS, V68, P464; FUJIMURA Y, 1991, BLOOD, V77, P113; FUJIMURA Y, 1986, J BIOL CHEM, V261, P381; GIRMA JP, 1990, THROMB HAEMOSTASIS, V64, P326; HANDA M, 1986, J BIOL CHEM, V261, P2579; JORIEUX S, 1987, THROMB HAEMOSTASIS, V57, P278; KAWAI Y, 1987, ANN NY ACAD SCI, V509, P60, DOI 10.1111/j.1749-6632.1987.tb30984.x; Kroner PA, 1996, BIOCHEMISTRY-US, V35, P13460, DOI 10.1021/bi9610313; MARTI T, 1987, BIOCHEMISTRY-US, V26, P8099, DOI 10.1021/bi00399a013; MASCELLI MA, 1986, BIOCHEMISTRY-US, V25, P6325, DOI 10.1021/bi00368a074; Matsushita T, 2000, J BIOL CHEM, V275, P11044, DOI 10.1074/jbc.275.15.11044; MATSUSHITA T, 1995, J BIOL CHEM, V270, P13406, DOI 10.1074/jbc.270.22.13406; MAZURIER C, 1990, BRIT J HAEMATOL, V76, P372, DOI 10.1111/j.1365-2141.1990.tb06371.x; MOHRI H, 1988, J BIOL CHEM, V263, P17901; MURATA M, 1991, J BIOL CHEM, V266, P15474; PIETU G, 1994, THROMB HAEMOSTASIS, V71, P788; RABINOWITZ I, 1992, P NATL ACAD SCI USA, V89, P9846, DOI 10.1073/pnas.89.20.9846; RAINES G, 1990, THROMB RES, V60, P201, DOI 10.1016/0049-3848(90)90181-B; SCHULLEK J, 1984, J CLIN INVEST, V73, P421, DOI 10.1172/JCI111228; SCOTT JP, 1991, J BIOL CHEM, V266, P8149; STEL HV, 1984, BLOOD, V63, P1408; Tessier D C, 1996, Methods Mol Biol, V57, P229; TULEY EA, 1991, P NATL ACAD SCI USA, V88, P6377, DOI 10.1073/pnas.88.14.6377; VICENTE V, 1990, J BIOL CHEM, V265, P274	33	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					22063	22072		10.1074/jbc.M201327200	http://dx.doi.org/10.1074/jbc.M201327200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11943773	hybrid			2022-12-27	WOS:000176286000119
J	Renshaw, PS; Panagiotidou, P; Whelan, A; Gordon, SV; Hewinson, RG; Williamson, RA; Carr, MD				Renshaw, PS; Panagiotidou, P; Whelan, A; Gordon, SV; Hewinson, RG; Williamson, RA; Carr, MD			Conclusive evidence that the major T-cell antigens of the Mycobacterium tuberculosis complex ESAT-6 and CFP-10 form a tight, 1 : 1 complex and characterization of the structural properties of ESAT-6, CFP-10, and the ESAT-6-CFP-10 complex - Implications for pathogenesis and virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; SEQUENCE; TRANSCRIPTION; DIAGNOSIS; VACCINES; SPECTRA; DOMAIN; FOS; BCG	The proteins ESAT-6 and CFP-10 have been shown to be secreted by Mycobacterium tuberculosis and Mycobacterium bovis cells, to be potent T-cell antigens, and to have a clear but as yet undefined role in tuberculosis pathogenesis. We have successfully overexpressed both ESAT-6 and CFP-10 in Escherichia coli and developed efficient purification schemes. Under in vivo-like conditions, a combination of fluorescence, circular dichroism, and nuclear magnetic resonance spectroscopy have shown that ESAT-6 contains up to 75% helical secondary structure, but little if any stable tertiary structure, and exists in a molten globule-like state. In contrast, CFP-10 was found to form an unstructured, random coil polypeptide. An exciting discovery was that ESAT-6 and CFP-10 form a tight, 1:1 complex, in which both proteins adopt a fully folded structure, with about two-thirds of the backbone in a regular helical conformation. This clearly suggests that ESAT-6 and CFP-10 are active as the complex and raises the interesting question of whether other ESAT-6/CFP-10 family proteins (22 paired genes in M. tuberculosis) also form tight, 1:1 complexes, and if so, is this limited to their genome partner, or is there scope for wider interactions within the protein family, which could provide greater functional flexibility?	Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England; Vet Labs Agcy Weybridge, Dept Bacterial Dis, TB Res Grp, Addlestone KT15 3NB, Surrey, England	University of Leicester; University of Kent; Veterinary Laboratories Agency	Carr, MD (corresponding author), Univ Leicester, Dept Biochem, Adrian Bldg,Univ Rd, Leicester LE1 7RH, Leics, England.	mdc12@le.ac.uk	Hewinson, Glyn/J-1902-2014; Whelan, Adam O/C-9497-2011; Hewinson, Glyn/F-7077-2010; Hewinson, Glyn/AAA-2364-2019	Carr, Mark/0000-0002-3939-0996; Gordon, Stephen/0000-0002-4833-5542; Hewinson, Glyn/0000-0002-5517-4281				Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Brosch R, 1998, INFECT IMMUN, V66, P2221, DOI 10.1128/IAI.66.5.2221-2229.1998; Carr MD, 1996, EUR J BIOCHEM, V235, P721, DOI 10.1111/j.1432-1033.1996.00721.x; Cole ST, 1999, FEBS LETT, V452, P7, DOI 10.1016/S0014-5793(99)00536-0; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Ehlers S, 1999, FEMS IMMUNOL MED MIC, V23, P149, DOI 10.1111/j.1574-695X.1999.tb01234.x; FEENEY J, 1991, J MAGN RESON, V91, P607, DOI 10.1016/0022-2364(91)90388-A; Gey van Pittius NC, 2001, GENOME BIOL, V2; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; KERPPOLA T, 1995, NATURE, V373, P199, DOI 10.1038/373199a0; MACURA S, 1980, MOL PHYS, V41, P95, DOI 10.1080/00268978000102601; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Murray CJL, 1998, P NATL ACAD SCI USA, V95, P13881, DOI 10.1073/pnas.95.23.13881; Skjot RLV, 2000, INFECT IMMUN, V68, P214, DOI 10.1128/IAI.68.1.214-220.2000; SORENSEN AL, 1995, INFECT IMMUN, V63, P1710; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Stenger S, 1999, CURR OPIN MICROBIOL, V2, P89, DOI 10.1016/S1369-5274(99)80015-0; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Pinxteren LAH, 2000, CLIN DIAGN LAB IMMUN, V7, P155, DOI 10.1128/CDLI.7.2.155-160.2000; Vordermeier HM, 2001, CLIN DIAGN LAB IMMUN, V8, P571, DOI 10.1128/CDLI.8.3.571-578.2001; Wards BJ, 2000, TUBERCLE LUNG DIS, V80, P185, DOI 10.1054/tuld.2000.0244; Williamson RA, 1996, EUR J BIOCHEM, V241, P476, DOI 10.1111/j.1432-1033.1996.00476.x; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Young DB, 1999, SCIENCE, V284, P1479, DOI 10.1126/science.284.5419.1479; Young DB, 1998, NATURE, V393, P515, DOI 10.1038/31095; Zumla A, 1998, BRIT MED J, V316, P1962, DOI 10.1136/bmj.316.7149.1962	34	257	289	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21598	21603		10.1074/jbc.M201625200	http://dx.doi.org/10.1074/jbc.M201625200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11940590	hybrid			2022-12-27	WOS:000176286000064
J	Sano, T; Baker, D; Virag, T; Wada, A; Yatomi, Y; Kobayashi, T; Igarashi, Y; Tigyi, G				Sano, T; Baker, D; Virag, T; Wada, A; Yatomi, Y; Kobayashi, T; Igarashi, Y; Tigyi, G			Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDIC-ACID; LYSOPHOSPHOLIPASE-D; PHOSPHOLIPASE A(1); ARACHIDONIC-ACID; XENOPUS OOCYTES; HUMAN-PLASMA; THROMBIN; PHOSPHATIDYLINOSITOL; IDENTIFICATION; MICROVESICLES	Lysophosphatidic acid (LPA) and sphingosine 1-phosphate (Sph1P) production was examined in vitro under conditions that simulated blood clotting. Several approaches were utilized to elucidate the metabolic pathways. 1) Platelet phospholipids were labeled using [P-32]orthophosphate, and the production of [P-32]Sph1P and LPA was examined. Thrombin stimulation of platelets resulted in rapid secretion of Sph1P stored within the platelet. In contrast, LPA was neither stored within nor secreted from platelets. Nonetheless, extracellular levels of LPA gradually increased following stimulation. 2) Stable-isotope dilution mass spectrometry was used to quantify the molecular species of LPA generated from platelets in vitro. Only 10% of the LPA generated following thrombin stimulation was associated with platelets, the remaining 90% was contained within the extracellular medium. The acyl composition of LPA produced by platelets differed depending on the presence or absence of plasma in the incubation. 3) The fate of exogenously added fluorescent phospholipid analogs was determined. Incubation of [(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl-(NDD) -labeled phosphatidylcholine, phosphatidylethanolamine, and phosphatidylserine with the supernatant fractions from thrombin-stimulated platelets yielded no LPA production. However, these lipids were converted to the corresponding lysolipids by released PLA(1) and PLA(2) activities. When incubated with plasma or serum the NBD-labeled lysophospholipids were readily converted to LPA. Inhibitors of lysophospholipase D and the biological activity of LPA were detected in plasma. These results suggest that the bulk of LPA produced through platelet activation results from the sequential cleavage of phospholipids to lysophospholipids by released phospholipases A(1) and A(2) and then to LPA by plasma lysophospholipase D.	Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biomembrane & Biofunct Chem, Sapporo, Hokkaido 060812, Japan; Yamanashi Med Univ, Dept Lab Med, Yamanashi 4093898, Japan; Ochanomizu Univ, Dept Biol, Tokyo 112, Japan	University of Tennessee System; University of Tennessee Health Science Center; Hokkaido University; University of Yamanashi; Ochanomizu University	Tigyi, G (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	gtigyi@physio1.utmem.edu	Sano, Takamitsu/F-9410-2012	Yatomi, Yutaka/0000-0003-1719-4297; Baker, Daniel/0000-0003-1482-0416	NHLBI NIH HHS [HL61469, HL027641] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061469] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBERGHINA M, 1994, FEBS LETT, V351, P181, DOI 10.1016/0014-5793(94)00811-6; Baker DL, 2001, ANAL BIOCHEM, V292, P287, DOI 10.1006/abio.2001.5063; Bandoh K, 2000, FEBS LETT, V478, P159, DOI 10.1016/S0014-5793(00)01827-5; BILLAH MM, 1981, J BIOL CHEM, V256, P5399; BILLAH MM, 1980, J BIOL CHEM, V255, P227; Croset M, 2000, BIOCHEM J, V345, P61, DOI 10.1042/0264-6021:3450061; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; ELLA KM, 1994, ANAL BIOCHEM, V218, P136, DOI 10.1006/abio.1994.1152; FOURCADE O, 1995, CELL, V80, P919, DOI 10.1016/0092-8674(95)90295-3; Friedman P, 1996, J BIOL CHEM, V271, P953, DOI 10.1074/jbc.271.2.953; GERRARD JM, 1984, BIOCHIM BIOPHYS ACTA, V795, P487, DOI 10.1016/0005-2760(84)90177-2; GERRARD JM, 1989, BIOCHIM BIOPHYS ACTA, V1001, P282, DOI 10.1016/0005-2760(89)90112-4; GOETZL E, 2000, CYTOKINE REFERENCE, P1407; Goetzl EJ, 2000, J BIOL CHEM, V275, P14573, DOI 10.1074/jbc.275.19.14573; Guo Z, 1996, P NATL ACAD SCI USA, V93, P14367, DOI 10.1073/pnas.93.25.14367; Hayashi K, 2001, CIRC RES, V89, P251, DOI 10.1161/hh1501.094265; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; HIGGS HN, 1994, P NATL ACAD SCI USA, V91, P9574, DOI 10.1073/pnas.91.20.9574; HIRAMATSU T, 2001, 7 INT C PLAT ACT FAC, P146; KATES M, 1986, TECHNIQUES LIPIDOLOG, P404; Kimura Y, 2001, J BIOL CHEM, V276, P15208, DOI 10.1074/jbc.M011588200; LAPETINA EG, 1981, J BIOL CHEM, V256, P5037; LAPETINA EG, 1981, NATURE, V292, P367, DOI 10.1038/292367a0; LAPETINA EG, 1981, J BIOL CHEM, V256, P1984; LAPETINA EG, 1979, BIOCHIM BIOPHYS ACTA, V573, P394, DOI 10.1016/0005-2760(79)90072-9; Le Balle F, 1999, ADV ENZYME REGUL, V39, P275, DOI 10.1016/S0065-2571(98)00024-7; LLOYD JV, 1974, BRIT J HAEMATOL, V26, P243, DOI 10.1111/j.1365-2141.1974.tb00469.x; LLOYD JV, 1972, BRIT J HAEMATOL, V23, P571, DOI 10.1111/j.1365-2141.1972.tb07092.x; MAHADEVAPPA VG, 1982, BIOCHIM BIOPHYS ACTA, V713, P73, DOI 10.1016/0005-2760(82)90168-0; MARCUS AJ, 1972, BLOOD LIPIDS LIPOPRO, P429; MAUCO G, 1978, BIOCHIMIE, V60, P653, DOI 10.1016/S0300-9084(78)80784-6; Murata N, 2000, BIOCHEM J, V352, P809, DOI 10.1042/0264-6021:3520809; MYHER JJ, 1989, LIPIDS, V24, P408, DOI 10.1007/BF02535148; NACELLIN N, 2002, J BIOL CHEM, V277, P6667; Nakajima K, 2002, J BIOL CHEM, V277, P11329, DOI 10.1074/jbc.M111092200; Okita M, 1997, INT J CANCER, V71, P31, DOI 10.1002/(SICI)1097-0215(19970328)71:1<31::AID-IJC7>3.0.CO;2-4; SKIPSKI VP, 1967, BIOCHEM J, V104, P340, DOI 10.1042/bj1040340; SWITZER S, 1965, J LIPID RES, V6, P506; THUMSER AEA, 1994, BIOCHEM J, V301, P801, DOI 10.1042/bj3010801; TIGYI G, 1992, J BIOL CHEM, V267, P21360; Tigyi G, 2001, PROSTAG OTH LIPID M, V64, P47, DOI 10.1016/S0090-6980(01)00107-1; TIGYI GJ, 1999, PHOSPHOLIPID GROWTH, P51; Tokumura A, 1998, LIPIDS, V33, P1009, DOI 10.1007/s11745-998-0299-2; TOKUMURA A, 1986, BIOCHIM BIOPHYS ACTA, V875, P31; Yatomi Y, 2000, BLOOD, V96, P3431; Yatomi Y, 1997, J BIOCHEM, V121, P969; YATOMI Y, 1995, BLOOD, V86, P193, DOI 10.1182/blood.V86.1.193.bloodjournal861193; YATOMI Y, 1995, ANAL BIOCHEM, V230, P315, DOI 10.1006/abio.1995.1480	48	212	233	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21197	21206		10.1074/jbc.M201289200	http://dx.doi.org/10.1074/jbc.M201289200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11929870	hybrid			2022-12-27	WOS:000176286000012
J	Wang, WL; Prince, CZ; Mou, YS; Pollman, MJ				Wang, WL; Prince, CZ; Mou, YS; Pollman, MJ			Notch3 signaling in vascular smooth muscle cells induces c-FLIP expression via ERK/MAPK activation - Resistance to Fas ligand-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONDITION CAUSING STROKE; FATE; INHIBITION; CADASIL; INJURY; MUTATIONS; GRIDLOCK; DOWNSTREAM; REPRESSES; KINASE	Mutations in the Notch3 receptor result in the cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephelopathy (CADASIL) syndrome, a heritable arteriopathy predisposing to early onset stroke. Based upon clinical evidence that CADASIL arteriopathy results in degeneration and loss of vascular smooth muscle cells (VSMC) from the arterial wall, we postulated that Notch3 signaling is a critical determinant of VSMC survival. We initially established that both transient and constitutive Notch3 signaling promoted VSMC survival in response to the proapoptotic Fas ligand (FasL). Resistance to FasL-induced apoptosis was associated with the induction of e-FLIP, a primary inhibitor of the FasL signaling pathway. We determined that Notch3's regulation of c-FLIP was independent of the activity of the classical DNA-binding protein, RBPJk, but dependent upon cross-talk activation of the ERK/MAPK pathway. We extended our observations to the in vivo context by deter-mining a coordinate regulation of Notch3 and c-FLIP within the arterial wall in response to injury. Furthermore, we defined that expression levels of Notch3 and c-FLIP are coordinately up-regulated within the neointima of remodeled arteries. Taken together, these findings provide initial evidence that Notch3 signaling may be a critical determinant of VSMC survival and vascular structure by modulating the expression of downstream mediators of apoptosis via signaling cross-talk with the ERK/MAPK pathway.	Morehouse Sch Med, Cardiovasc Res Inst, Atlanta, GA 30310 USA	Morehouse School of Medicine	Pollman, MJ (corresponding author), Morehouse Sch Med, Cardiovasc Res Inst, Atlanta, GA 30310 USA.	mpollman@msm.edu						Aoudjit F, 2001, J CELL BIOL, V152, P633, DOI 10.1083/jcb.152.3.633; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Beatus P, 1999, DEVELOPMENT, V126, P3925; Berset T, 2001, SCIENCE, V291, P1055, DOI 10.1126/science.1055642; Boyle JJ, 2001, ARTERIOSCL THROM VAS, V21, P1402, DOI 10.1161/hq0901.094279; Cai WJ, 1997, ATHEROSCLEROSIS, V131, P177, DOI 10.1016/S0021-9150(97)06099-1; Chan SW, 2000, CIRC RES, V86, P1038, DOI 10.1161/01.RES.86.10.1038; CHITNIS AB, 1995, MOL CELL NEUROSCI, V6, P311, DOI 10.1006/mcne.1995.1024; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Fitzgerald K, 2000, ONCOGENE, V19, P4191, DOI 10.1038/sj.onc.1203766; GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431; Gibbons GH, 2000, CIRC RES, V86, P1009, DOI 10.1161/01.RES.86.10.1009; Hamada Y, 1999, DEVELOPMENT, V126, P3415; HAN DKM, 1995, AM J PATHOL, V147, P267; Holmstrom TH, 2000, CRIT REV IMMUNOL, V20, P121; Holmstrom TH, 2000, EMBO J, V19, P5418, DOI 10.1093/emboj/19.20.5418; Imanishi T, 2000, AM J PATHOL, V156, P125, DOI 10.1016/S0002-9440(10)64712-8; Imanishi T, 2000, J VASC RES, V37, P523, DOI 10.1159/000054085; Iso T, 2001, MOL CELL BIOL, V21, P6071, DOI 10.1128/MCB.21.17.6071-6079.2001; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; Joutel A, 2000, ANN NEUROL, V47, P388, DOI 10.1002/1531-8249(200003)47:3<388::AID-ANA19>3.3.CO;2-H; Joutel A, 1997, ANN NY ACAD SCI, V826, P213, DOI 10.1111/j.1749-6632.1997.tb48472.x; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Joutel A, 1997, LANCET, V350, P1511, DOI 10.1016/S0140-6736(97)08083-5; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Lewis J, 1998, SEMIN CELL DEV BIOL, V9, P583, DOI 10.1006/scdb.1998.0266; McLaughlin KA, 2000, DEV BIOL, V227, P567, DOI 10.1006/dbio.2000.9913; Miele L, 1999, J CELL PHYSIOL, V181, P393, DOI 10.1002/(SICI)1097-4652(199912)181:3<393::AID-JCP3>3.0.CO;2-6; Milner LA, 1999, BLOOD, V93, P2431, DOI 10.1182/blood.V93.8.2431.408k33_2431_2448; MORISHITA R, 1993, P NATL ACAD SCI USA, V90, P8474, DOI 10.1073/pnas.90.18.8474; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; Pollman MJ, 1999, J CELL PHYSIOL, V178, P359, DOI 10.1002/(SICI)1097-4652(199903)178:3<359::AID-JCP10>3.3.CO;2-F; Pollman MJ, 1998, NAT MED, V4, P222, DOI 10.1038/nm0298-222; Pollman MJ, 1996, CIRC RES, V79, P748, DOI 10.1161/01.RES.79.4.748; Pollman MJ, 1999, CIRC RES, V84, P113; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Schaub FJ, 2000, NAT MED, V6, P790, DOI 10.1038/77521; Small D, 2001, J BIOL CHEM, V276, P32022, DOI 10.1074/jbc.M100933200; Wang WL, 2001, CIRCULATION, V104, P89; WEINSTEIN BM, 1995, NAT MED, V1, P1143, DOI 10.1038/nm1195-1143; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820; Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599	44	105	109	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21723	21729		10.1074/jbc.M202224200	http://dx.doi.org/10.1074/jbc.M202224200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11925448	hybrid			2022-12-27	WOS:000176286000080
J	Liu, J; Tian, ZG; Gao, B; Kunos, G				Liu, J; Tian, ZG; Gao, B; Kunos, G			Dose-dependent activation of antiapoptotic and proapoptotic pathways by ethanol treatment in human vascular endothelial cells - Differential involvement of adenosine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; GLYCOGEN-SYNTHASE KINASE-3; NF-KAPPA-B; MODERATE ALCOHOL-CONSUMPTION; CORONARY HEART-DISEASE; NITRIC-OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; MOLECULAR-CLONING; INDUCED APOPTOSIS	Moderate but not heavy drinking has been found to have a protective effect against cardiovascular morbidity. We investigated the effects of ethanol (EtOH) treatment on the cell survival-promoting phosphatidylinositol 3-kinase (PI3K)/Akt pathway in cultured human umbilical vein endothelial cells (HUVEC). Exposure of cells to 2-20 mm EtOH resulted in rapid (< 10 min) induction of Akt phosphorylation that could be prevented by pertussis toxin or the PI3K inhibitors wortmannin and LY294002. Among the downstream effectors of PI3K/Akt, p70S6 kinase, glycogen synthase kinase 3alpha/p, and IKB-alpha were phosphorylated, the latter resulting in 3-fold activation of NF-kappaB. EtOH also activated p44/42 mitogenactivated protein kinase in a PI3K-dependent manner. Low concentrations of EtOH increased endothelial nitric-oxide synthase activity, which could be blocked transfection of HUVEC with dominant-negative Akt, implicating the PI3K/Akt pathway in this effect. The adenosine Al receptor antagonist 1,3-dipopyleyclopentylxanthine prevented the phosphorylation of Akt observed in the presence of EtOH, adenosine, or the Al agonist N-6-cyclopentyladenosine. Incubation of HUVEC with 50100 mm EtOH resulted in mitochondrial permeability transition and caspase-3 activation followed by apoptosis, as documented by DNA fragmentation and TUNEL assays. EtOH-induced apoptosis was unaffected by DPCPX and was potentiated by wortmannin or LY294002. We conclude that treatment with low concentrations of EtOH activates the cell survival promoting PI3K/Akt pathway in endothelial cells by an adenosine receptor-dependent mechanism and activation of the proapoptotic caspase pathway by higher concentrations of EtOH via an adenosine-independent mechanism can mask or counteract such effects.	NIAAA, Lab Physiol Studies, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Kunos, G (corresponding author), NIAAA, Lab Physiol Studies, NIH, 12420 Parklawn Dr,Rm 120,MSC 8115, Bethesda, MD 20892 USA.	gkunos@mail.nih.gov	Tian, Zhigang/J-3512-2013		NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000351, Z01AA000351, Z01AA000366] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Abraham RT, 1998, CURR OPIN IMMUNOL, V10, P330, DOI 10.1016/S0952-7915(98)80172-6; Acevedo CG, 1997, PLACENTA, V18, P387, DOI 10.1016/S0143-4004(97)80038-0; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bottomley MJ, 1998, BBA-MOL CELL BIOL L, V1436, P165, DOI 10.1016/S0005-2760(98)00141-6; Bouma MG, 1996, AM J PHYSIOL-CELL PH, V270, pC522, DOI 10.1152/ajpcell.1996.270.2.C522; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Chen CH, 1999, P NATL ACAD SCI USA, V96, P12784, DOI 10.1073/pnas.96.22.12784; Constant J, 1997, CORONARY ARTERY DIS, V8, P645, DOI 10.1097/00019501-199710000-00007; Corder R, 2001, NATURE, V414, P863, DOI 10.1038/414863a; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DAVDA RK, 1993, HYPERTENSION, V21, P939, DOI 10.1161/01.HYP.21.6.939; de la Monte SM, 2001, ALCOHOL CLIN EXP RES, V25, P898, DOI 10.1097/00000374-200106000-00016; DEL PL, 1997, SCIENCE, V278, P687; Diao LH, 1996, J PHARMACOL EXP THER, V278, P542; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Foo SY, 1999, TRENDS GENET, V15, P229; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Fredholm BB, 1996, PHARMACOL TOXICOL, V79, P120, DOI 10.1111/j.1600-0773.1996.tb00254.x; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Germack R, 2000, BRIT J PHARMACOL, V130, P867, DOI 10.1038/sj.bjp.0703396; Gold MR, 1999, J IMMUNOL, V163, P1894; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Griffin G, 2000, J PHARMACOL EXP THER, V292, P886; Guo TL, 1998, TOXICOL APPL PHARM, V152, P397, DOI 10.1006/taap.1998.8526; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Higuchi H, 2001, HEPATOLOGY, V34, P320, DOI 10.1053/jhep.2001.26380; JARVIS MF, 1988, PHARMACOL BIOCHEM BE, V30, P707, DOI 10.1016/0091-3057(88)90088-3; JONES PF, 1991, P NATL ACAD SCI USA, V88, P4171, DOI 10.1073/pnas.88.10.4171; KOHN AD, 1995, EMBO J, V14, P4288, DOI 10.1002/j.1460-2075.1995.tb00103.x; KRAUSS SW, 1993, MOL PHARMACOL, V44, P1021; KROEMER G, 1995, FASEB J, V9, P1277, DOI 10.1096/fasebj.9.13.7557017; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; KUNOS G, 1996, NIAAA RES MONOGR, V31, P243; LANGER RD, 1992, CIRCULATION, V85, P910, DOI 10.1161/01.CIR.85.3.910; Linden J, 2001, ANNU REV PHARMACOL, V41, P775, DOI 10.1146/annurev.pharmtox.41.1.775; Liu J, 2000, BIOCHEM J, V346, P835, DOI 10.1042/0264-6021:3460835; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Madge LA, 2000, J BIOL CHEM, V275, P15458, DOI 10.1074/jbc.M001237200; Marchetti P, 1996, J IMMUNOL, V157, P4830; NAGY LE, 1991, MOL PHARMACOL, V40, P812; NAGY LE, 1990, J BIOL CHEM, V265, P1946; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Reif K, 1997, J BIOL CHEM, V272, P14426, DOI 10.1074/jbc.272.22.14426; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; SAPRU MK, 1994, J PHARMACOL EXP THER, V271, P542; Scheid MP, 1998, P NATL ACAD SCI USA, V95, P7439, DOI 10.1073/pnas.95.13.7439; Shaw M, 1997, FEBS LETT, V416, P307, DOI 10.1016/S0014-5793(97)01235-0; STAAL SP, 1987, P NATL ACAD SCI USA, V84, P5034, DOI 10.1073/pnas.84.14.5034; Takasuga S, 1999, J BIOL CHEM, V274, P19545, DOI 10.1074/jbc.274.28.19545; Tanasescu M, 2001, J AM COLL CARDIOL, V38, P1836, DOI 10.1016/S0735-1097(01)01655-2; Toker A, 2000, MOL PHARMACOL, V57, P652, DOI 10.1124/mol.57.4.652; Ueki K, 1998, J BIOL CHEM, V273, P5315, DOI 10.1074/jbc.273.9.5315; van Tol A, 2001, CURR OPIN LIPIDOL, V12, P19, DOI 10.1097/00041433-200102000-00004; van Weeren PC, 1998, J BIOL CHEM, V273, P13150, DOI 10.1074/jbc.273.21.13150; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	57	62	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20927	20933		10.1074/jbc.M110712200	http://dx.doi.org/10.1074/jbc.M110712200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11919181	hybrid			2022-12-27	WOS:000176204500106
J	Walter, L; Franklin, A; Witting, A; Moller, T; Stella, N				Walter, L; Franklin, A; Witting, A; Moller, T; Stella, N			Astrocytes in culture produce anandamide and other acylethanolamides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOGENOUS CANNABINOID ANANDAMIDE; FATTY-ACID ETHANOLAMIDES; RAT-BRAIN; N-ACYLETHANOLAMINES; STRIATAL ASTROCYTES; RECEPTOR; CELLS; STIMULATION; NEURONS; DELTA(9)-TETRAHYDROCANNABINOL	Anandamide (arachidonylethanolamide) is an endocannabinoid that belongs to the acylethanolamide lipid family. It is produced by neurons in a calcium-dependent manner and acts through cannabinoid CB1 receptors. Other members of the acylethanolamide lipid family are also produced by neurons and act through G-protein-coupled receptors: homo-gamma-linolenylethanolamide (HEA) and docosatetraenylethanolamide (DEA) act through CB1 receptors, palmitylethanolamide (PEA) acts through CB2-like receptors, and oleylethanolamide (OEA) acts through receptors that have not yet been cloned. Although it is clear that anandamide and other acylethanolamides play a major role in neuronal signaling, whether astrocytes also produce these lipids is unknown. We developed a chemical ionization gas chromatography/mass spectrometry method that allows femtomole detection and quantification of anandamide and other acylethanolamides. Using this method, we unambiguously detected and quantified anandamide, HEA, DEA, PEA, and OEA in mouse astrocytes in culture. Stimulation of mouse astrocytes with ionomycin, a calcium ionophore, enhanced the production of anandamide, REA, and DEA, whereas PEA and OEA levels were unchanged. Endothelin-1, a peptide known to act on astrocytes, enhanced the production of anandamide, without affecting the levels of other acylethanolamides. These results show that astrocytes produce anandamide, REA, and DEA in a calcium-dependent manner and that anandamide biosynthesis can be selectively stimulated under physiologically relevant conditions. The relative levels of acylethanolamides in astrocytes from rat and human were different from the relative levels of acylethanolamides in mouse astrocytes, indicating that the production of these lipids differs between species. Because astrocytes are known to express CB1 receptors and inactivate endocannabinoids, our finding strongly suggests the existence of a functional endocannabinoid signaling system in these cells.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Dept Neurol, Seattle, WA 98195 USA; Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Stella, N (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.			Walter, Lisa/0000-0003-3421-2362	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD000836] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD000836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014486] Funding Source: NIH RePORTER; NICHD NIH HHS [HD000836] Funding Source: Medline; NIDA NIH HHS [DA14486] Funding Source: Medline; NIGMS NIH HHS [GM07270] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANTEL J, 1997, CLIN NEUROIMMUNOLOGY; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Berdyshev EV, 2000, BIOCHEM J, V346, P369, DOI 10.1042/0264-6021:3460369; Blazquez C, 1999, J NEUROCHEM, V72, P1759, DOI 10.1046/j.1471-4159.1999.721759.x; BOUABOULA M, 1995, J BIOL CHEM, V270, P13973, DOI 10.1074/jbc.270.23.13973; Cadas H, 1997, J NEUROSCI, V17, P1226; Calignano A, 2000, NATURE, V408, P96, DOI 10.1038/35040576; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Costa B, 2000, EUR J PHARMACOL, V395, P1, DOI 10.1016/S0014-2999(00)00170-9; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; Desagher S, 1997, J NEUROCHEM, V68, P78; Deutsch DG, 2001, J BIOL CHEM, V276, P6967, DOI 10.1074/jbc.M003161200; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; DiMarzo V, 1996, BIOCHEM BIOPH RES CO, V227, P281, DOI 10.1006/bbrc.1996.1501; DiTomaso E, 1997, ADV EXP MED BIOL, V407, P335; Fedoroff Sergey, 1997, P131; Felder CC, 1996, FEBS LETT, V393, P231, DOI 10.1016/0014-5793(96)00891-5; FELDER CC, 1993, P NATL ACAD SCI USA, V90, P7656, DOI 10.1073/pnas.90.16.7656; Galve-Roperh I, 2000, NAT MED, V6, P313, DOI 10.1038/73171; GEBICKEHAERTER PJ, 1989, J NEUROSCI, V9, P183; Gerhards P., 1999, GC MS CLIN CHEM; Giuffrida A, 1998, FEBS LETT, V422, P373, DOI 10.1016/S0014-5793(98)00046-5; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; GIUFFRIDA A, 1999, LIPID 2 MESSENGERS; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Griffin G, 2000, J PHARMACOL EXP THER, V292, P886; HANUS L, 1993, J MED CHEM, V36, P3032, DOI 10.1021/jm00072a026; Magistretti PJ, 2000, BRAIN RES, V886, P108, DOI 10.1016/S0006-8993(00)02945-0; PERTWEE R, 1994, EUR J PHARMACOL, V259, P115, DOI 10.1016/0014-2999(94)90499-5; Piomelli D, 1999, P NATL ACAD SCI USA, V96, P5802, DOI 10.1073/pnas.96.10.5802; Piomelli D, 1998, NEUROBIOL DIS, V5, P462, DOI 10.1006/nbdi.1998.0221; Rezaie P, 1999, MICROSC RES TECHNIQ, V45, P359, DOI 10.1002/(SICI)1097-0029(19990615)45:6<359::AID-JEMT4>3.3.CO;2-4; Rodriguez JJ, 2001, J NEUROSCI, V21, P823, DOI 10.1523/JNEUROSCI.21-03-00823.2001; Sagan S, 1999, EUR J NEUROSCI, V11, P691, DOI 10.1046/j.1460-9568.1999.00480.x; Sanchez C, 1998, FEBS LETT, V436, P6, DOI 10.1016/S0014-5793(98)01085-0; Sanchez C, 1998, MOL PHARMACOL, V54, P834, DOI 10.1124/mol.54.5.834; SATOH JI, 1995, J NEUROSCI RES, V41, P805, DOI 10.1002/jnr.490410611; Schmid HHO, 2000, CHEM PHYS LIPIDS, V108, P71, DOI 10.1016/S0009-3084(00)00188-2; Schmid PC, 1997, P NATL ACAD SCI USA, V94, P4188, DOI 10.1073/pnas.94.8.4188; Schmid PC, 1997, CHEM PHYS LIPIDS, V87, P103, DOI 10.1016/S0009-3084(97)00032-7; Spinedi A, 1999, BIOCHEM BIOPH RES CO, V255, P456, DOI 10.1006/bbrc.1999.0230; Stella N, 2001, EUR J PHARMACOL, V425, P189, DOI 10.1016/S0014-2999(01)01182-7; SUGITA M, 1975, BIOCHIM BIOPHYS ACTA, V398, P125, DOI 10.1016/0005-2760(75)90176-9; Sugiura T, 1996, EUR J BIOCHEM, V240, P53, DOI 10.1111/j.1432-1033.1996.0053h.x; VENANCE L, 1995, NATURE, V376, P590, DOI 10.1038/376590a0; VOGEL Z, 1993, J NEUROCHEM, V61, P352, DOI 10.1111/j.1471-4159.1993.tb03576.x; Walker JM, 1999, P NATL ACAD SCI USA, V96, P12198, DOI 10.1073/pnas.96.21.12198; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076	49	147	149	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20869	20876		10.1074/jbc.M110813200	http://dx.doi.org/10.1074/jbc.M110813200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11916961	hybrid			2022-12-27	WOS:000176204500099
J	Yamauchi, S; Tokita, Y; Aono, S; Matsui, F; Shuo, T; Ito, H; Kato, K; Kasahara, K; Oohira, A				Yamauchi, S; Tokita, Y; Aono, S; Matsui, F; Shuo, T; Ito, H; Kato, K; Kasahara, K; Oohira, A			Phosphorylation of neuroglycan C, a brain-specific transmembrane chondroitin sulfate proteoglycan, and its localization in the lipid rafts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN KINASE-ACTIVITY; CAVEOLAE-LIKE DOMAINS; MOLECULE HB-GAM; CELL-SURFACE; SIGNAL-TRANSDUCTION; ECTOPROTEIN KINASE; NEURONAL SURVIVAL; NERVOUS-SYSTEM; ZETA/RPTP-BETA; AXON GROWTH	Neuroglycan C (NGC) is a brain-specific transmembrane chondroitin sulfate proteoglycan. In the present study, we examined whether NGC could be phosphorylated in neural cells. On metabolic labeling of cultured cerebral cortical cells from the rat fetus with P-32(i), serine residues in NGC were radiolabeled. Some NGC became detectable in the raft fraction from the rat cerebrum, a signaling microdomain of the plasma membrane, with cerebral development. NGC from the non-raft fraction, not the raft fraction, could be phosphorylated by an in vitro kinase reaction. The phosphorylation of NGC was inhibited by adding to the reaction mixture a recombinant peptide representing the ectodomain of NGC, but not by adding a peptide representing its cytoplasmic domain. NGC could be labeled by an in vitro kinase reaction using [gamma-P-32]GTP as well as [gamma-P-32]ATP, and this kinase activity was partially inhibited by 5,6-dichloro-1-beta-D-ribofaranosylbenzimidazole, a selective inhibitor of casein kinase II. In addition to the intracellular phosphorylation, NGC was also phosphorylated at the cell surface by an ectoprotein kinase. This is the first report to demonstrate that NGC can be phosphorylated both intracellularly and pericellularly, and our findings suggest that a kinase with a specificity similar to that of casein kinase II is responsible for the NGC ectodomain phosphorylation.	Aichi Human Serv Ctr, Dept Perinatol, Inst Dev Res, Kasugai, Aichi 4800392, Japan; Nagoya Univ, Grad Sch Med, Dept Neurochem, Showa Ku, Nagoya, Aichi 4668550, Japan; Nagoya City Univ, Grad Sch Nat Sci, Showa Ku, Nagoya, Aichi 4678501, Japan; Tokyo Metropolitan Inst Med Sci, Tokyo Metropolitan Org Med Res, Bunkyo Ku, Tokyo 1138613, Japan	Nagoya University; Nagoya City University; Tokyo Metropolitan Institute of Medical Science	Oohira, A (corresponding author), Aichi Human Serv Ctr, Dept Perinatol, Inst Dev Res, 713-8 Kagiua Cho, Kasugai, Aichi 4800392, Japan.	oohira@inst-hsc.pref.aichi.jp		Kasahara, Kohji/0000-0001-7010-8365; Ito, Hidenori/0000-0002-6527-477X				Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Aono S, 2000, J BIOL CHEM, V275, P337, DOI 10.1074/jbc.275.1.337; Apasov SG, 1996, J BIOL CHEM, V271, P25677, DOI 10.1074/jbc.271.41.25677; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Carey DJ, 1996, PERSPECT DEV NEUROBI, V3, P331; Chen W, 1996, P NATL ACAD SCI USA, V93, P8688, DOI 10.1073/pnas.93.16.8688; CHIJIWA T, 1989, J BIOL CHEM, V264, P4924; CORBIN JD, 1983, METHOD ENZYMOL, V99, P317; EHRLICH YH, 1988, J NEUROCHEM, V50, P295, DOI 10.1111/j.1471-4159.1988.tb13263.x; EHRLICH YH, 1986, NATURE, V320, P67, DOI 10.1038/320067a0; Fitch MT, 1997, CELL TISSUE RES, V290, P379, DOI 10.1007/s004410050944; Gary SC, 1998, CURR OPIN NEUROBIOL, V8, P576, DOI 10.1016/S0959-4388(98)80083-4; Grumet M, 1996, PERSPECT DEV NEUROBI, V3, P319; HARDWICK JC, 1989, J NEUROCHEM, V53, P1512, DOI 10.1111/j.1471-4159.1989.tb08546.x; HENDLEY ED, 1988, J NEUROCHEM, V50, P263, DOI 10.1111/j.1471-4159.1988.tb13259.x; HOGAN MV, 1995, J NEUROCHEM, V65, P2022; Ito H, 1997, J BIOL CHEM, V272, P29934, DOI 10.1074/jbc.272.47.29934; Kasahara K, 1997, J BIOL CHEM, V272, P29947, DOI 10.1074/jbc.272.47.29947; Kasahara K, 2000, J BIOL CHEM, V275, P34701, DOI 10.1074/jbc.M003163200; Kramer EM, 1999, J BIOL CHEM, V274, P29042, DOI 10.1074/jbc.274.41.29042; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; KUBLER D, 1983, P NATL ACAD SCI-BIOL, V80, P4021, DOI 10.1073/pnas.80.13.4021; KUBLER D, 1989, J BIOL CHEM, V264, P14549; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Lander AD, 1996, PERSPECT DEV NEUROBI, V3, P347; Levine JM, 1996, PERSPECT DEV NEUROBI, V3, P245; MAEDA N, 1992, DEV BIOL, V151, P564, DOI 10.1016/0012-1606(92)90194-L; Maeda N, 1999, J BIOL CHEM, V274, P12474, DOI 10.1074/jbc.274.18.12474; Maeda N, 1998, J CELL BIOL, V142, P203, DOI 10.1083/jcb.142.1.203; MARGOLIS RK, 1993, EXPERIENTIA, V49, P429, DOI 10.1007/BF01923587; Margolis RU, 1997, CELL TISSUE RES, V290, P343, DOI 10.1007/s004410050939; Masserini M, 1999, J NEUROCHEM, V73, P1, DOI 10.1046/j.1471-4159.1999.0730001.x; Mineo C, 1999, J BIOL CHEM, V274, P30636, DOI 10.1074/jbc.274.43.30636; MURATA H, 1994, RAPID COMMUN MASS SP, V8, P205, DOI 10.1002/rcm.1290080216; NAGASHIMA K, 1991, FEBS LETT, V293, P119, DOI 10.1016/0014-5793(91)81165-5; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Oohira A, 2000, ARCH BIOCHEM BIOPHYS, V374, P24, DOI 10.1006/abbi.1999.1598; OOHIRA A, 1994, NEUROSCI RES, V20, P195, DOI 10.1016/0168-0102(94)90088-4; OOHIRA A, 1998, CONNECT TISSUE, V30, P49; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; RAULO E, 1994, J BIOL CHEM, V269, P12999; Schumacher S, 2001, J BIOL CHEM, V276, P7337, DOI 10.1074/jbc.M007234200; Schumacher S, 1997, J CELL BIOL, V136, P895, DOI 10.1083/jcb.136.4.895; SCOTT MG, 1988, BIOCHEM BIOPH RES CO, V155, P1353, DOI 10.1016/S0006-291X(88)81290-7; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Small DH, 1996, J NEUROCHEM, V67, P889; SNOW AD, 1989, NEUROBIOL AGING, V10, P481, DOI 10.1016/0197-4580(89)90108-5; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Tansey MG, 2000, NEURON, V25, P611, DOI 10.1016/S0896-6273(00)81064-8; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; TUAZON PT, 1991, ADV SEC MESS PHOSPH, V23, P123; WALTER J, 1994, CELL MOL BIOL RES, V40, P473; Walter J, 1996, J BIOL CHEM, V271, P111, DOI 10.1074/jbc.271.1.111; Walter J, 1997, J BIOL CHEM, V272, P1896, DOI 10.1074/jbc.272.3.1896; WATANABE E, 1995, J BIOL CHEM, V270, P26876, DOI 10.1074/jbc.270.45.26876; Watanabe E, 1996, J NEUROSCI RES, V44, P84, DOI 10.1002/(SICI)1097-4547(19960401)44:1<84::AID-JNR11>3.3.CO;2-V; Yasuda Y, 1998, NEUROSCI RES, V32, P313, DOI 10.1016/S0168-0102(98)00098-4; ZANDOMENI R, 1984, J BIOL CHEM, V259, P4804; ZANDOMENI R, 1986, J BIOL CHEM, V261, P3414; Zhou WL, 2000, J BIOL CHEM, V275, P34737, DOI 10.1074/jbc.M003756200	65	15	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20583	20590		10.1074/jbc.M200909200	http://dx.doi.org/10.1074/jbc.M200909200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11929867	hybrid			2022-12-27	WOS:000176204500063
J	Plohl, M; Prats, E; Martinez-Lage, A; Gonzalez-Tizon, A; Mendez, J; Cornudella, L				Plohl, M; Prats, E; Martinez-Lage, A; Gonzalez-Tizon, A; Mendez, J; Cornudella, L			Telomeric localization of the vertebrate-type hexamer repeat, (TTAGGG)(n), in the wedgeshell clam Donax trunculus and other marine invertebrate genomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-SITU HYBRIDIZATION; CHROMOSOMAL LOCATION; SATELLITE DNA; SEQUENCE; MOLLUSCA; INSECTS; NUMBER; FAMILY; GENES; ENDS	The hexamer repeat sequence (TTAGGG)(n), found at the ends of all vertebrate chromosomes, was previously identified as the main building element of one member of a HindIII satellite DNA family characterized in the genome of the bivalve mollusc Donax trunculus. It was also found in 22 perfect tandem repeats in a cloned junction region juxtaposed to the proper satellite sequence, from which the DNA tract encompassing the clustered tandem copies was excised and subeloned. Here, the chromosomal distribution of (TTAGGG)(n) sequences in the Donax was studied by the sensitivity to Bal31 exonuclease digestion, fluorescence in situ hybridization (FISH) on metaphase chromosomes and rotating-field gel electrophoresis. To verify the occurrence of the hexamer repeat in the genomes of taxonomically related molluscs and other marine invertebrates, genomic DNA from the mussel Mytilus galloprovincialis and the echinoderm. Holothuria tubulosa was also analyzed. The kinetics of Bal31 hydrolysis of high molecular mass DNA from the three marine invertebrates revealed a marked decrease over time of the hybridization with the cloned (TTAGGG)(22) sequence, concomitantly with a progressive shortening of the positively reacting DNA fragments. This revealed a marked susceptibility to exonuclease consistent with terminal positioning on the respective chromosomal DNAs. In full agreement, FISH results with the (TTAGGG)(22) probe showed that the repeat appears located in telomeric regions in all chromosomes of both bivalve molluscs. The presence of (TTAGGG)(n) repeat tracts in marine invertebrate telomeres points to its wider distribution among eukaryotic organisms and suggests an ancestry older than originally presumed from its vertebrate distinctiveness.	CSIC, Dept Mol & Cell Biol, Inst Biol Mol Barcelona, E-08034 Barcelona, Spain; Univ A Coruna, Dept Mol & Cellular Biol, E-15071 La Coruna, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Universidade da Coruna	Cornudella, L (corresponding author), CSIC, Dept Mol & Cell Biol, Inst Biol Mol Barcelona, Jordi Girona 18-26, E-08034 Barcelona, Spain.	lcmbmc@cid.csic.es	González-Tizón, Ana M./A-4409-2015; Plohl, Miroslav/AAQ-6428-2021; Prats, Eva/K-6434-2014; Martinez-Lage, Andres/A-4356-2015; Mendez, Josefina/H-7318-2016	Prats, Eva/0000-0001-7838-2027; Martinez-Lage, Andres/0000-0002-8218-7002; Mendez, Josefina/0000-0002-7567-980X				Biessmann H, 2000, CHROMOSOMA, V109, P372, DOI 10.1007/s004120000094; BIESSMANN H, 1994, CHROMOSOMA, V103, P154, DOI 10.1007/BF00368007; BLACKBURN EH, 1994, CELL, V77, P621, DOI 10.1016/0092-8674(94)90046-9; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Chiurillo MA, 1999, MOL BIOCHEM PARASIT, V100, P173, DOI 10.1016/S0166-6851(99)00047-X; Collins K, 2000, CURR OPIN CELL BIOL, V12, P378, DOI 10.1016/S0955-0674(00)00103-4; CORNET M, 1990, GENETICA, V82, P93, DOI 10.1007/BF00124637; Drabent B, 1995, DNA SEQUENCE, V6, P41, DOI 10.3109/10425179509074698; Drabent B, 1999, J MOL EVOL, V49, P645, DOI 10.1007/PL00006585; Estabrooks SL, 1999, J SHELLFISH RES, V18, P401; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Garrido-Ramos MA, 1998, CYTOGENET CELL GENET, V83, P3, DOI 10.1159/000015151; GONZALEZTIZON A, 2000, GENOME, V43, P1; Guo XM, 1997, J SHELLFISH RES, V16, P87; HINEGARDNER R, 1974, COMP BIOCHEM PHYSIOL, V47, P447, DOI 10.1016/0300-9629(74)90008-5; JHA AN, 1995, CHROMOSOME RES, V3, P507, DOI 10.1007/BF00713966; Joffe BI, 1998, CHROMOSOMA, V107, P173, DOI 10.1007/s004120050294; Kazazian HH, 2000, SCIENCE, V289, P1152, DOI 10.1126/science.289.5482.1152; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; LEJNINE S, 1995, P NATL ACAD SCI USA, V92, P2393, DOI 10.1073/pnas.92.6.2393; Malik HS, 1999, MOL BIOL EVOL, V16, P793, DOI 10.1093/oxfordjournals.molbev.a026164; Martens UM, 2000, BIOCHEM SOC T, V28, P245, DOI 10.1042/bst0280245; MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049; MEYNE J, 1990, CHROMOSOMA, V99, P3, DOI 10.1007/BF01737283; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; MULLER F, 1991, CELL, V67, P815, DOI 10.1016/0092-8674(91)90076-B; Nomoto Y, 2001, ZOOL SCI, V18, P417, DOI 10.2108/zsj.18.417; OKAZAKI S, 1993, MOL CELL BIOL, V13, P1424, DOI 10.1128/MCB.13.3.1424; Plohl M, 1997, J MOL EVOL, V44, P189, DOI 10.1007/PL00006135; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; Sahara K, 1999, CHROMOSOME RES, V7, P449, DOI 10.1023/A:1009297729547; SAIGA H, 1985, EMBO J, V4, P799, DOI 10.1002/j.1460-2075.1985.tb03700.x; SAINZ J, 1990, NUCLEIC ACIDS RES, V18, P885, DOI 10.1093/nar/18.4.885; TESCHKE C, 1991, NUCLEIC ACIDS RES, V19, P2677, DOI 10.1093/nar/19.10.2677; Vermeesch JR, 1996, CYTOGENET CELL GENET, V72, P310, DOI 10.1159/000134211; Vitturi R, 2000, GENETICA, V108, P253, DOI 10.1023/A:1004151513129; ZAKIAN VA, 1995, SCIENCE, V270, P1601, DOI 10.1126/science.270.5242.1601; ZHANG YJ, 1994, MOL CELL BIOL, V14, P8028, DOI 10.1128/MCB.14.12.8028; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	39	44	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19839	19846		10.1074/jbc.M201032200	http://dx.doi.org/10.1074/jbc.M201032200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11907038	hybrid, Green Accepted			2022-12-27	WOS:000175894800079
J	Ricort, JM; Binoux, M				Ricort, JM; Binoux, M			Insulin-like growth factor-binding protein-3 activates a phosphotyrosine phosphatase - Effects on the insulin-like growth factor signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; TYPE-1 IGF RECEPTOR; FACTOR-I; PHOSPHATIDYLINOSITOL 3-KINASE; INHIBITION; AFFINITY; GENE	The proliferative action of insulin-like growth factors (IGF-I and -II) is mediated via the type I IGF receptor (IGF-IR) and is modulated by their association with high affinity binding proteins, IGFBP-1 to -6. We recently found that, in addition to its ability to bind IGFs, IGFBP-3 also inhibits IGF-IR activation independently of IGF binding and without interacting directly with IGF-IR. Here, we show that IGFBP-3 is capable of blocking the signal triggered by IGFs. Breast carcinoma-derived cells (MCF-7) were stimulated by des(1-3)IGF-I or [Gln(3),Ala(4),Tyr(15),Leu(16)]IGF-I, two IGF analogues with intact affinity for IGF-IR, but with weak or virtually no affinity for IGFBPs, then incubated with IGFBP-3. The activated IGF-IR was desensitized through reversal of its autophosphorylation, following which both phosphatidylinositol 3-kinase and p42(MAPK) activities were depressed. Direct measurement of phosphotyrosine phosphatase activity and reconstitution experiments using tyrosine-phosphorylated insulin receptor substrate-1 (IRS-1) indicated that IGFBP-3 activated a phosphotyrosine phosphatase (PTPase). This action appeared to be peculiar to IGFBP-3 among the IGFBPs, since neither IGFBP-1 nor IGFBP-5 (structurally the closest to IGFBP-3), had any such effect. Several cell lines derived from normal or tumor cells responsive to IGF-I were used to show that IGFBP-3-stimulated PTPase is cell type-specific. Although the precise nature of the phosphatase remains to be determined, the results of this study demonstrate that IGFBP-3 stimulates a phosphotyrosine phosphatase activity that down-regulates the IGF-I signaling pathway, suggesting a major role for IGFBP-3 in regulating cell proliferation.	Univ Paris 06, INSERM U515, Hop St Antoine, Assistance Publ Hop Paris, F-75571 Paris 12, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite	Ricort, JM (corresponding author), Univ Paris 06, INSERM U515, Hop St Antoine, Assistance Publ Hop Paris, 184 Rue Faubourg St Antoine, F-75571 Paris 12, France.	ricort@st-antoine.inserm.fr						Baserga R, 1999, CONT ENDOCRINOL, V17, P329; Baxter RC, 1997, ADV MOL CELL ENDOCRI, V1, P123, DOI [10.1016/S1569-2566(97)80036-1, DOI 10.1016/S1569-2566(97)80036-1]; Cool D E, 1993, Semin Cell Biol, V4, P443, DOI 10.1006/scel.1993.1052; Desbois-Mouthon C, 2000, ENDOCRINOLOGY, V141, P922, DOI 10.1210/en.141.3.922; Dufourny B, 1997, J BIOL CHEM, V272, P31163, DOI 10.1074/jbc.272.49.31163; GIORGETTI S, 1992, EUR J BIOCHEM, V207, P599; Gucev ZS, 1996, CANCER RES, V56, P1545; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; HEYDRICK SJ, 1993, J CLIN INVEST, V91, P1358, DOI 10.1172/JCI116337; Holly JMP, 1999, J ENDOCRINOL, V162, P321, DOI 10.1677/joe.0.1620321; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Kenner KA, 1996, J BIOL CHEM, V271, P19810, DOI 10.1074/jbc.271.33.19810; KLARLUND JK, 1985, CELL, V41, P707, DOI 10.1016/S0092-8674(85)80051-9; Leal SM, 1997, J BIOL CHEM, V272, P20572, DOI 10.1074/jbc.272.33.20572; Leal SM, 1999, J BIOL CHEM, V274, P6711, DOI 10.1074/jbc.274.10.6711; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; MohseniZadeh S, 1997, ENDOCRINOLOGY, V138, P5645, DOI 10.1210/en.138.12.5645; OH Y, 1993, ENDOCRINOLOGY, V132, P1337, DOI 10.1210/en.132.3.1337; OH Y, 1993, J BIOL CHEM, V268, P26045; Oh Y, 1999, CONT ENDOCRINOL, V17, P257; OH Y, 1995, J BIOL CHEM, V270, P13589, DOI 10.1074/jbc.270.23.13589; OH YM, 1993, J BIOL CHEM, V268, P14964; Rajah R, 1997, J BIOL CHEM, V272, P12181, DOI 10.1074/jbc.272.18.12181; RECHLER MM, 1993, VITAM HORM, V47, P1, DOI 10.1016/S0083-6729(08)60444-6; Ricort JM, 1997, J BIOL CHEM, V272, P19814, DOI 10.1074/jbc.272.32.19814; Ricort JM, 2001, ENDOCRINOLOGY, V142, P108, DOI 10.1210/en.142.1.108; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Tamura M, 1999, JNCI-J NATL CANCER I, V91, P1820, DOI 10.1093/jnci/91.21.1820; TANTI JF, 1994, J BIOL CHEM, V269, P6051; VALENTINIS B, 1995, MOL ENDOCRINOL, V9, P361, DOI 10.1210/me.9.3.361; WHITE MF, 1994, J BIOL CHEM, V269, P1	31	50	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19448	19454		10.1074/jbc.M200439200	http://dx.doi.org/10.1074/jbc.M200439200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11940579	hybrid			2022-12-27	WOS:000175894800029
J	Wu, JF; Li, JF; Huang, KP; Huang, FL				Wu, JF; Li, JF; Huang, KP; Huang, FL			Attenuation of protein kinase C and cAMP-dependent protein kinase signal transduction in the neurogranin knockout mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE MODIFICATION; RAT-BRAIN NEUROGRANIN; MAP KINASE; SYNAPTIC PLASTICITY; SUBSTRATE RC3; LATE-PHASE; AREA CA1; PHOSPHORYLATION; ACTIVATION; CASCADE	Neurogranin (Ng) is a brain-specific, postsynaptically located protein kinase C (PKC) substrate, highly expressed in the cortex, hippocampus, striatum, and amygdala. This protein is a Ca2+-sensitive calmodulin (CaM)-binding protein whose CaM-binding affinity is modulated by phosphorylation and oxidation. To investigate the role of Ng in neural function, a strain of Ng knockout mouse (KO) was generated. Previously we reported (Pak, J. H., Huang, F. L., Li, J., Balschun, D., Reymann, K. G., Chiang, C., Westphal, H., and Huang, K.-P. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 1123211237) that these KO mice displayed no obvious neuro-anatomical abnormality, but exhibited deficits in learning and memory and activation of Ca2+/CaM-dependent protein kinase II. In this report, we analyzed several downstream phosphorylation targets in phorbol 12-myristate 13-acetate- and forskolin-treated hippocampal slices from wild type (WT) and KO mice. Phorbol 12-myristate 13-acetate caused phosphorylation of Ng in WT mice and promoted the translocation of PKC from the cytosolic to the particulate fractions of both the WT and KO mice, albeit to a lesser extent in the latter. Phosphorylation of downstream targets, including mitogen-activated protein kinases, 90-kDa ribosomal S6 kinase, and the cAMP response element binding protein (CREB) was significantly attenuated in KO mice. Stimulation of hippocampal slices with forskolin also caused greater stimulation of protein kinase A (PKA) in the WT as compared with those of the KO mice. Again, phosphorylation of the downstream targets of PKA was attenuated in the KO mice. These results suggest that Ng plays a pivotal role in regulating both PKC- and PKA-mediated signaling pathways, and that the deficits in learning and memory of spatial tasks detected in the KO mice may be the result of defects in the signaling pathways leading to the phosphorylation of CREB.	NICHHD, Metab Regulat Sect, Endocrinol & Reprod Res Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Huang, FL (corresponding author), NICHHD, Metab Regulat Sect, Endocrinol & Reprod Res Branch, NIH, Bethesda, MD 20892 USA.	fhuang@helix.nih.gov	Li, Junfa/H-8707-2013	Li, Junfa/0000-0002-1930-9724	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000187] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000187] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Bapat S, 2001, FEBS LETT, V499, P21, DOI 10.1016/S0014-5793(01)02511-X; Blum S, 1999, J NEUROSCI, V19, P3535; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHETKOVICH DM, 1993, J NEUROCHEM, V61, P1933, DOI 10.1111/j.1471-4159.1993.tb09836.x; Crow T, 2001, J NEUROCHEM, V78, P358, DOI 10.1046/j.1471-4159.2001.00404.x; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; FEDOROV NB, 1995, EUR J NEUROSCI, V7, P819, DOI 10.1111/j.1460-9568.1995.tb00685.x; FIORE RS, 1993, J NEUROCHEM, V61, P1626, DOI 10.1111/j.1471-4159.1993.tb09796.x; Gerendasy DD, 1997, MOL NEUROBIOL, V15, P131, DOI 10.1007/BF02740632; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Giovannini MG, 2001, J NEUROSCI, V21, P7053, DOI 10.1523/JNEUROSCI.21-18-07053.2001; HUANG KP, 1993, ARCH BIOCHEM BIOPHYS, V305, P570, DOI 10.1006/abbi.1993.1463; HUANG KP, 1986, P NATL ACAD SCI USA, V83, P8535, DOI 10.1073/pnas.83.22.8535; HUANG KP, 1988, J BIOL CHEM, V263, P14839; Huang YY, 2000, J NEUROSCI, V20, P6317, DOI 10.1523/JNEUROSCI.20-17-06317.2000; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; KLANN E, 1992, J NEUROCHEM, V58, P1576, DOI 10.1111/j.1471-4159.1992.tb11382.x; Li JF, 1999, J BIOL CHEM, V274, P1294, DOI 10.1074/jbc.274.3.1294; Lo LW, 2001, J CELL PHYSIOL, V188, P304, DOI 10.1002/jcp.1124; Mahoney CW, 1996, J BIOL CHEM, V271, P28798, DOI 10.1074/jbc.271.46.28798; MARTZEN MR, 1995, J NEUROCHEM, V64, P92; Miao HH, 2000, BIOELECTROCHEMISTRY, V51, P163, DOI 10.1016/S0302-4598(00)00062-3; MIYASAKA T, 1990, BIOCHEM BIOPH RES CO, V168, P1237, DOI 10.1016/0006-291X(90)91161-K; NeunerJehle M, 1996, BRAIN RES, V733, P149, DOI 10.1016/0006-8993(96)00786-X; Pak JH, 2000, P NATL ACAD SCI USA, V97, P11232, DOI 10.1073/pnas.210184697; POSADA J, 1992, SCIENCE, V255, P212, DOI 10.1126/science.1313186; Prichard L, 1999, J BIOL CHEM, V274, P7689, DOI 10.1074/jbc.274.12.7689; RAMAKERS GMJ, 1995, J BIOL CHEM, V270, P13892, DOI 10.1074/jbc.270.23.13892; REPRESA A, 1990, J NEUROSCI, V10, P3782, DOI 10.1523/JNEUROSCI.10-12-03782.1990; Roberson ED, 1999, J NEUROSCI, V19, P4337; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sheu FS, 1996, J BIOL CHEM, V271, P22407, DOI 10.1074/jbc.271.37.22407; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Tang WJ, 1998, MOL PHARMACOL, V54, P231, DOI 10.1124/mol.54.2.231; Villacres EC, 1998, J NEUROSCI, V18, P3186; Viola HE, 2000, J NEUROSCI, V20; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; WATSON JB, 1992, P NATL ACAD SCI USA, V89, P8581, DOI 10.1073/pnas.89.18.8581; WATSON JB, 1994, MOL BRAIN RES, V27, P323, DOI 10.1016/0169-328X(94)90017-5; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Zanassi P, 2001, J BIOL CHEM, V276, P11487, DOI 10.1074/jbc.M007631200; Zhang YG, 2001, J BIOL CHEM, V276, P14572, DOI 10.1074/jbc.M004615200	48	51	70	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19498	19505		10.1074/jbc.M109082200	http://dx.doi.org/10.1074/jbc.M109082200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11912190	hybrid			2022-12-27	WOS:000175894800036
J	Haas, A; Wang, HJ; Tian, J; Xie, ZJ				Haas, A; Wang, HJ; Tian, J; Xie, ZJ			Src-mediated inter-receptor cross-talk between the Na+/K+-ATPase and the epidermal growth factor receptor relays the signal from ouabain to mitogen-activated protein kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC MYOCYTES; TYROSINE KINASE; TRANSDUCING FUNCTION; RESPONSE GENES; TRANSACTIVATION; FAMILY; CELLS; NA+,K+-ATPASE; HYPERTROPHY; CASCADES	Binding of ouabain to Na+/K+-ATPase activates tyrosine phosphorylation of the epidermal growth factor receptor (EGFR), Src, and p42/44 mitogen-activated protein kinases (MAPKs) in both cardiac myocytes and A7r5 cells. Here, we explored the roles of Src and the EGFR in the ouabain-invoked pathways that lead to the activation of MAPKs. Exposure of A7r5 and LLC-PK1 cells to ouabain caused a dose-dependent inhibition of Na+/K+-ATPase activity, which correlated well with ouabain-induced activation of Src and MAPKs in these cells. Immunoprecipitation experiments showed that ouabain stimulated Src binding to Na+/K+-ATPase in a dose- and time-dependent manner and increased phosphorylation of Sre at Tyr(418) but had no effect on Tyr(529) phosphorylation. Ouabain failed to activate MAPKs in A7r5 cells that were pretreated with the Src inhibitor PP2 and in SYF cells in which Src family kinases are knocked out. Preincubation with AG1478, but not AG1295, also blocked the effects of ouabain on p42/44 MAPKs in A7r5 cells. Significantly, both herbimycin A and PP2 abrogated ouabain-induced but not epidermal growth factor-induced Sre binding to the EGFR and the subsequent EGFR tyrosine phosphorylation. Ouabain also failed to affect tyrosine phosphorylation of the EGFR in SYF cells. In addition, unlike epidermal growth factor, ouabain did not increase EGFR autophosphorylation at Tyr(1173). These findings clearly indicate that ouabain transactivates the EGFR by activation of Src and stimulation of Sre binding to the EGFR. Furthermore, we found that the transactivated EGFR was capable of recruiting and phosphorylating the adaptor protein She. This resulted in increased binding of another adaptor protein Grb2 to the Src-EGFR complex and the subsequent activation of Ras and MAPKs. Taken together, these new findings suggest that Sre mediates the inter-receptor cross-talk between Na+/K+-ATPase and the EGFR to transduce the signals from ouabain to the Ras/ MAPK cascade.	Med Coll Ohio, Dept Pharmacol, Toledo, OH 43614 USA; Med Coll Ohio, Dept Med, Toledo, OH 43614 USA		Xie, ZJ (corresponding author), Med Coll Ohio, Dept Pharmacol, 3035 Arlington Ave, Toledo, OH 43614 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036573, R01HL063238] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-63238, HL-36573] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; Andreev J, 2001, J BIOL CHEM, V276, P20130, DOI 10.1074/jbc.M102307200; Aydemir-Koksoy A, 2001, J BIOL CHEM, V276, P46605, DOI 10.1074/jbc.M106178200; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Chen K, 2001, J BIOL CHEM, V276, P16045, DOI 10.1074/jbc.M011766200; Eguchi S, 1998, J BIOL CHEM, V273, P8890, DOI 10.1074/jbc.273.15.8890; Haas M, 2000, J BIOL CHEM, V275, P27832; Heeneman S, 2000, J BIOL CHEM, V275, P15926, DOI 10.1074/jbc.M909616199; Huang LY, 1997, J MOL CELL CARDIOL, V29, P429, DOI 10.1006/jmcc.1996.0320; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; KELLY RA, 1993, J AM COLL CARDIOL, V22, pA107, DOI 10.1016/0735-1097(93)90472-D; Kometiani P, 1998, J BIOL CHEM, V273, P15249, DOI 10.1074/jbc.273.24.15249; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Liu J, 2000, J BIOL CHEM, V275, P27838; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Peng M, 1996, J BIOL CHEM, V271, P10372, DOI 10.1074/jbc.271.17.10372; Prenzel N, 2001, ENDOCR-RELAT CANCER, V8, P11, DOI 10.1677/erc.0.0080011; SKOU JC, 1988, METHOD ENZYMOL, V156, P1; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tian J, 2001, AM J PHYSIOL-HEART C, V281, pH1899, DOI 10.1152/ajpheart.2001.281.5.H1899; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Xie ZJ, 2001, CELL MOL BIOL, V47, P383; Xie ZJ, 1999, J BIOL CHEM, V274, P19323, DOI 10.1074/jbc.274.27.19323; XIE ZJ, 1989, ANAL BIOCHEM, V183, P215, DOI 10.1016/0003-2697(89)90470-3; Yudowski GA, 2000, P NATL ACAD SCI USA, V97, P6556, DOI 10.1073/pnas.100128297	26	235	248	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					18694	18702		10.1074/jbc.M111357200	http://dx.doi.org/10.1074/jbc.M111357200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11907028	hybrid			2022-12-27	WOS:000175975800061
J	Tang, T; Arbiser, JL; Brandt, SJ				Tang, T; Arbiser, JL; Brandt, SJ			Phosphorylation by mitogen-activated protein kinase mediates the hypoxia-induced turnover of the TAL1/SCL transcription factor in endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX PROTEIN; ACUTE LYMPHOBLASTIC-LEUKEMIA; DNA-BINDING MOTIF; SCL GENE-PRODUCT; IN-VIVO; CHROMOSOMAL TRANSLOCATION; HEMATOPOIETIC LINEAGES; BLOOD-VESSELS; GROWTH-FACTOR; MAP KINASES	The basic helix-loop-helix transcription factor TAL1 (or SCL), originally identified from its involvement by a chromosomal rearrangement in T-cell acute lymphoblastic leukemia, is required for hematopoietic development. TAL1 also has a critical role in embryonic vascular remodeling and is expressed in endothelial cells postnatally, although little is known about its function or regulation in this cell type. We report here that the important proangiogenic stimulus hypoxia stimulates phosphorylation, ubiquitination, and proteasomal breakdown of TAL1 in endothelial cells. Tryptic phosphopeptide mapping and chemical inhibitor studies showed that hypoxia induced the mitogen-activated protein kinase-mediated phosphorylation of a single serine residue, Ser(122), in the protein, and site-directed mutagenesis demonstrated that Ser(122) phosphorylation was necessary for hypoxic acceleration of TAL1 turnover in an immortalized murine endothelial cell line. Finally, whereas TAL1 expression was detected in endothelial cells from both large and small vessels, hypoxia-induced TAL1 turnover was observed only in microvascular endothelial cells. Besides their implications for TAL1 function in angiogenic processes, these results demonstrate that a protein kinase(s) important for mitogenic signaling is also utilized in hypoxic endothelial cells to target a transcription factor for destruction.	Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Dept Cell Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; Vet Affairs Tennessee Valley Hlth Care Syst, Nashville, TN 37232 USA; Emory Univ, Sch Med, Dept Dermatol, Atlanta, GA 30322 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Emory University	Brandt, SJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Rm 777,Preston Res Bldg, Nashville, TN 37232 USA.	stephen.brandt@mcmail.vanderbilt.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049118] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL49118] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; APLAN PD, 1992, EMBO J, V11, P4073, DOI 10.1002/j.1460-2075.1992.tb05500.x; APLAN PD, 1990, SCIENCE, V250, P1426, DOI 10.1126/science.2255914; APLAN PD, 1990, MOL CELL BIOL, V10, P6426, DOI 10.1128/MCB.10.12.6426; Arbiser JL, 1997, P NATL ACAD SCI USA, V94, P861, DOI 10.1073/pnas.94.3.861; BASH RO, 1995, BLOOD, V86, P666, DOI 10.1182/blood.V86.2.666.bloodjournal862666; BEGLEY CG, 1989, P NATL ACAD SCI USA, V86, P10128, DOI 10.1073/pnas.86.24.10128; BERNARD O, 1991, ONCOGENE, V6, P1477; Bies J, 2000, ONCOGENE, V19, P2846, DOI 10.1038/sj.onc.1203613; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRANDT SJ, 2000, TRANSCRIPTION FACTOR, P51; BROWN L, 1990, EMBO J, V9, P3343, DOI 10.1002/j.1460-2075.1990.tb07535.x; Candal FJ, 1996, MICROVASC RES, V52, P221, DOI 10.1006/mvre.1996.0060; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; CHEN Q, 1990, EMBO J, V9, P415, DOI 10.1002/j.1460-2075.1990.tb08126.x; CHEN RH, 1990, MOL CELL BIOL, V10, P3204, DOI 10.1128/MCB.10.6.3204; CHENG JT, 1993, MOL CELL BIOL, V13, P801, DOI 10.1128/MCB.13.2.801; CHENG JT, 1993, ONCOGENE, V8, P677; Cohen-Kaminsky S, 1998, EMBO J, V17, P5151, DOI 10.1093/emboj/17.17.5151; Conrad PW, 1999, J BIOL CHEM, V274, P23570, DOI 10.1074/jbc.274.33.23570; DAMORE PA, 1993, GROWTH FACTORS, V8, P61, DOI 10.3109/08977199309029135; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DOYLE K, 1994, J BIOL CHEM, V269, P12099; Drake CJ, 1997, DEV BIOL, V192, P17, DOI 10.1006/dbio.1997.8751; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; ELLEDGE SJ, 1998, BIOCHIM BIOPHYS ACTA, V1377, P61; Elwood NJ, 1998, BLOOD, V91, P3756; Gavine PR, 1999, ONCOGENE, V18, P7552, DOI 10.1038/sj.onc.1203102; Gering M, 1998, EMBO J, V17, P4029, DOI 10.1093/emboj/17.14.4029; GOLDFARB AN, 1992, BLOOD, V80, P2858; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Hofmann TJ, 1996, ONCOGENE, V13, P617; HSU HL, 1994, P NATL ACAD SCI USA, V91, P5947, DOI 10.1073/pnas.91.13.5947; HSU HL, 1991, MOL CELL BIOL, V11, P3037, DOI 10.1128/MCB.11.6.3037; Huang S, 2000, MOL CELL BIOL, V20, P2248, DOI 10.1128/MCB.20.6.2248-2259.2000; Huang SM, 2000, EMBO J, V19, P6792, DOI 10.1093/emboj/19.24.6792; Huang SM, 1999, ONCOGENE, V18, P4958, DOI 10.1038/sj.onc.1202889; HWANG LY, 1993, ONCOGENE, V8, P3043; KALLIANPUR AR, 1994, BLOOD, V83, P1200; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kroon ME, 2001, J CELL SCI, V114, P825; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lange CA, 2000, P NATL ACAD SCI USA, V97, P1032, DOI 10.1073/pnas.97.3.1032; Matsuda N, 1998, BIOCHEM BIOPH RES CO, V249, P350, DOI 10.1006/bbrc.1998.9151; MELLENTIN JD, 1989, CELL, V58, P77, DOI 10.1016/0092-8674(89)90404-2; Minet E, 2000, FEBS LETT, V468, P53, DOI 10.1016/S0014-5793(00)01181-9; Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5; Molinari E, 1999, EMBO J, V18, P6439, DOI 10.1093/emboj/18.22.6439; Muller JN, 1997, J BIOL CHEM, V272, P23435, DOI 10.1074/jbc.272.37.23435; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Niu HF, 1998, GENE DEV, V12, P1953, DOI 10.1101/gad.12.13.1953; OKAZAKI K, 1995, EMBO J, V14, P5048, DOI 10.1002/j.1460-2075.1995.tb00187.x; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; PRASAD KSS, 1995, J BIOL CHEM, V270, P11603, DOI 10.1074/jbc.270.19.11603; Ray-Gallet D, 1999, FEBS LETT, V464, P164, DOI 10.1016/S0014-5793(99)01687-7; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; Robb L, 1996, EMBO J, V15, P4123, DOI 10.1002/j.1460-2075.1996.tb00787.x; ROBBINS DJ, 1992, P NATL ACAD SCI USA, V89, P6924, DOI 10.1073/pnas.89.15.6924; Roland I, 2000, EUR J BIOCHEM, V267, P3567, DOI 10.1046/j.1432-1327.2000.01385.x; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; Seimiya H, 1999, BIOCHEM BIOPH RES CO, V260, P365, DOI 10.1006/bbrc.1999.0910; Seko Y, 1996, CIRC RES, V78, P82, DOI 10.1161/01.RES.78.1.82; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Song A, 1998, MOL CELL BIOL, V18, P4994, DOI 10.1128/MCB.18.9.4994; Song XD, 1999, J BIOL CHEM, V274, P1677, DOI 10.1074/jbc.274.3.1677; Tang T, 1999, BIOCHEM J, V343, P615, DOI 10.1042/0264-6021:3430615; Taylor CT, 2000, P NATL ACAD SCI USA, V97, P12091, DOI 10.1073/pnas.220211797; Thomas D, 2000, CURR BIOL, V10, pR341, DOI 10.1016/S0960-9822(00)00462-0; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; VALGEARCHER VE, 1994, P NATL ACAD SCI USA, V91, P8617, DOI 10.1073/pnas.91.18.8617; Valtieri M, 1998, CANCER RES, V58, P562; Visvader JE, 1998, GENE DEV, V12, P473, DOI 10.1101/gad.12.4.473; WADMAN I, 1994, EMBO J, V13, P4831, DOI 10.1002/j.1460-2075.1994.tb06809.x; Wang JJ, 2000, P NATL ACAD SCI USA, V97, P3497, DOI 10.1073/pnas.97.7.3497; Wu M, 2000, GENE DEV, V14, P301; XIA Y, 1991, P NATL ACAD SCI USA, V88, P11416, DOI 10.1073/pnas.88.24.11416; Yan SF, 1999, J BIOL CHEM, V274, P15030, DOI 10.1074/jbc.274.21.15030; ZETTER BR, 1981, DIABETES, V30, P24, DOI 10.2337/diab.30.2.S24	86	22	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					18365	18372		10.1074/jbc.M109812200	http://dx.doi.org/10.1074/jbc.M109812200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11904294	hybrid			2022-12-27	WOS:000175975800016
J	Fairley, K; Westman, BJ; Pham, LH; Haymet, ADJ; Harding, MM; Mackay, JP				Fairley, K; Westman, BJ; Pham, LH; Haymet, ADJ; Harding, MM; Mackay, JP			Type I shorthorn sculpin antifreeze protein - Recombinant synthesis, solution conformation, and ice growth inhibition studies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WINTER FLOUNDER ANTIFREEZE; BIOLOGICAL MACROMOLECULES; MOLECULAR-DYNAMICS; PSEUDOPLEURONECTES-AMERICANUS; DIPOLAR COUPLINGS; BINDING MECHANISM; H-1-NMR SPECTRA; POLYPEPTIDE; SPECTROSCOPY; PRESERVATION	A number of structurally diverse classes of "antifreeze" proteins that allow fish to survive in sub-zero ice-laden waters have been isolated from the blood plasma of cold water teleosts. However, despite receiving a great deal of attention, the one or more mechanisms through which these proteins act are not fully understood. In this report we have synthesized a type I antifreeze polypeptide (AFP) from the shorthorn sculpin Myoxocephalus scorpius using recombinant methods. Construction of a synthetic gene with optimized codon usage and expression as a glutathione S-transferase fusion protein followed by purification yielded milligram amounts of polypeptide with two extra residues appended to the N terminus. Circular dichroism and NMR experiments, including residual dipolar coupling measurements on a N-15-labeled recombinant polypeptide, show that the polypeptides are a-helical with the first four residues being more flexible than the remainder of the sequence. Both the recombinant and synthetic polypeptides modify ice growth, forming facetted crystals just below the freezing point, but display negligible thermal hysteresis. Acetylation of Lys-10, Lys-20, and Lys-21 as well as the N terminus of the recombinant polypeptide gave a derivative that displays both thermal hysteresis (0.4 degreesC at 15 mg/ml) and ice crystal faceting. These results confirm that the N terminus of wild-type polypeptide is functionally important and support our previously proposed mechanism for all type I proteins, in which the hydrophobic face is oriented toward the ice at the ice/water interface.	Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia; Univ Sydney, Dept Biochem, Sydney, NSW 2006, Australia; Univ Houston, Dept Chem, Houston, TX 77204 USA	University of Sydney; University of Sydney; University of Houston System; University of Houston	Harding, MM (corresponding author), Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia.		FTSE, Tony Haymet PhD/A-9881-2009; Mackay, Joel/D-6834-2011	FTSE, Tony Haymet PhD/0000-0002-5617-2106; Mackay, Joel/0000-0001-7508-8033; Harding, Margaret/0000-0003-1072-3870				Baardsnes J, 1999, FEBS LETT, V463, P87, DOI 10.1016/S0014-5793(99)01588-4; Baardsnes J, 2001, PROTEIN SCI, V10, P2566, DOI 10.1110/ps.ps.26501; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Bax A, 2001, METHOD ENZYMOL, V339, P127, DOI 10.1016/S0076-6879(01)39313-8; Brown CJ, 1997, CAN MED ASSOC J, V156, P629; BRYK T, 2002, IN PRESS J CHEM PHYS; Bystrov V. F., 1976, PROGR NMR SPECTROSCO, V10, P41; Cai ML, 1998, J BIOMOL NMR, V11, P97, DOI 10.1023/A:1008222131470; CHAKRABARTTY A, 1988, CAN J ZOOL, V66, P403, DOI 10.1139/z88-057; Chao HM, 1996, J EXP BIOL, V199, P2071; Chao HM, 1997, BIOCHEMISTRY-US, V36, P14652, DOI 10.1021/bi970817d; Cheng AL, 1997, BIOPHYS J, V73, P2851, DOI 10.1016/S0006-3495(97)78315-2; Cheng C.C., 1991, P1; CHOU KC, 1992, J MOL BIOL, V223, P509, DOI 10.1016/0022-2836(92)90666-8; Dalal P., 2001, PHYSCHEMCOMM, V7, P1; Davies PL, 1997, CURR OPIN STRUC BIOL, V7, P828, DOI 10.1016/S0959-440X(97)80154-6; DUMAN JG, 1974, NATURE, V247, P237, DOI 10.1038/247237a0; DUMAN JG, 1976, COMP BIOCHEM PHYS B, V54, P375, DOI 10.1016/0305-0491(76)90260-1; Ewart KV, 1999, CELL MOL LIFE SCI, V55, P271, DOI 10.1007/s000180050289; Feeney RE, 1998, TRENDS FOOD SCI TECH, V9, P102, DOI 10.1016/S0924-2244(98)00025-9; FLETCHER GL, 1982, ARCTIC, V35, P302; Fletcher GL, 1999, CHEMTECH, V29, P17; FOURNEY RM, 1984, CAN J ZOOL, V62, P28, DOI 10.1139/z84-006; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Gronwald W, 1996, BIOCHEMISTRY-US, V35, P16698, DOI 10.1021/bi961934w; Harding MM, 1999, EUR J BIOCHEM, V264, P653, DOI 10.1046/j.1432-1327.1999.00617.x; Haymet ADJ, 1998, FEBS LETT, V430, P301, DOI 10.1016/S0014-5793(98)00652-8; Haymet ADJ, 1999, J AM CHEM SOC, V121, P941, DOI 10.1021/ja9801341; Haymet ADJ, 2001, FEBS LETT, V491, P285, DOI 10.1016/S0014-5793(01)02213-X; Hayward JA, 2001, J CHEM PHYS, V114, P3713, DOI 10.1063/1.1333680; HEW CL, 1985, EUR J BIOCHEM, V151, P167, DOI 10.1111/j.1432-1033.1985.tb09081.x; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; JORGENSEN H, 1993, PROTEIN ENG, V6, P19, DOI 10.1093/protein/6.1.19; KNIGHT CA, 1991, BIOPHYS J, V59, P409, DOI 10.1016/S0006-3495(91)82234-2; Kowalski K, 1999, J BIOMOL NMR, V13, P249, DOI 10.1023/A:1008309602929; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; LAL M, 1993, FARADAY DISCUSS, V95, P299; Loewen MC, 1999, BIOCHEMISTRY-US, V38, P4743, DOI 10.1021/bi982602p; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; MCDONALD SM, 1995, AICHE J, V41, P959, DOI 10.1002/aic.690410426; Prestegard JH, 2000, Q REV BIOPHYS, V33, P371, DOI 10.1017/S0033583500003656; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; Rubinsky B, 2000, ANNU REV BIOMED ENG, V2, P157, DOI 10.1146/annurev.bioeng.2.1.157; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; SICHERI F, 1995, NATURE, V375, P427, DOI 10.1038/375427a0; Sonnichsen FD, 1998, BIOCHEM CELL BIOL, V76, P284, DOI 10.1139/bcb-76-2-3-284; Tolman JR, 2001, CURR OPIN STRUC BIOL, V11, P532, DOI 10.1016/S0959-440X(00)00245-1; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Wang JH, 2000, CRYOBIOLOGY, V41, P1, DOI 10.1006/cryo.2000.2265; WEN DY, 1992, BIOPHYS J, V63, P1659, DOI 10.1016/S0006-3495(92)81750-2; WEN DY, 1993, FEBS LETT, V317, P31, DOI 10.1016/0014-5793(93)81485-I; Wierzbicki A, 1996, BIOPHYS J, V71, P8, DOI 10.1016/S0006-3495(96)79204-4; YANG DSC, 1988, NATURE, V333, P232, DOI 10.1038/333232a0; Yeh Y, 1996, CHEM REV, V96, P601, DOI 10.1021/cr950260c; Zhang W, 1998, J BIOL CHEM, V273, P34806, DOI 10.1074/jbc.273.52.34806	56	24	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 5	2002	277	27					24073	24080		10.1074/jbc.M200307200	http://dx.doi.org/10.1074/jbc.M200307200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	569PV	11940576	hybrid			2022-12-27	WOS:000176611800015
J	Bagai, S; Rubio, E; Cheng, JF; Sweet, R; Thomas, R; Fuchs, E; Grady, R; Mitchell, M; Bassuk, JA				Bagai, S; Rubio, E; Cheng, JF; Sweet, R; Thomas, R; Fuchs, E; Grady, R; Mitchell, M; Bassuk, JA			Fibroblast growth factor-10 is a mitogen for urothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATIC DEVELOPMENT; HUMAN BLADDER; IN-VITRO; PROLIFERATION; EXPRESSION; INDUCTION; MOUSE; STRATIFICATION; OBSTRUCTION; CYSTITIS	Fibroblast growth factor (FGF)-10 plays an important role in regulating growth, differentiation, and repair of the urothelium. This process occurs through a paracrine cascade originating in the mesenchyme (lamina propria) and targeting the epithelium (urothelium). In situ hybridization analysis demonstrated that (i) fibroblasts of the human lamina propria were the cell type that synthesized FGF-10 RNA and (ii) the FGF-10 gene is located at the 5p12-p13 locus of chromosome 5. Recombinant (r) preparations of human FGF-10 were found to induce proliferation of human urothelial cells in vitro and of transitional epithelium of wild-type and FGF7-null mice in vivo. Mechanistic studies with human cells indicated two modes of FGF-10 action: M translocation of rFGF-10 into urothelial cell nuclei and (ii) a signaling cascade that begins with the heparin-dependent phosphorylation of tyrosine residues of surface transmembrane receptors. The normal urothelial phenotype, that of quiescence, is proposed to be typified by negligible levels of FGF-10. During proliferative phases, levels of FGF-10 rise at the urothelial cell surface and/or within urothelial cell nuclei. An understanding of how FGF-10 works in conjunction with these other processes will lead to better management of many diseases of the bladder and urinary tract.	Univ Washington, Dept Urol, Sch Med, Seattle, WA 98195 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome Sci, Berkeley, CA 94720 USA; Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Univ Washington, Childrens Hosp & Med Ctr, Div Pediat Urol, Seattle, WA 98105 USA; Univ Washington, Sch Med, Dept Urol, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of Chicago; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bassuk, JA (corresponding author), Univ Washington, Dept Urol, Sch Med, Box 356510, Seattle, WA 98195 USA.	bassuk@u.washington.edu						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baker LA, 1998, SEMIN NEPHROL, V18, P569; Baskin LS, 1996, LAB INVEST, V75, P157; Bassuk JA, 2000, J UROLOGY, V164, P170, DOI 10.1016/S0022-5347(05)67490-3; BASSUK JA, 2002, BLADDER DIS RES CONC; BIRREN B, 2000, GENOME ANAL LAB MANU; Chai TC, 2000, J UROLOGY, V163, P1440, DOI 10.1016/S0022-5347(05)67638-0; CUNHA GR, 1983, DIFFERENTIATION, V24, P174, DOI 10.1111/j.1432-0436.1983.tb01317.x; Danilenko DM, 1999, TOXICOL PATHOL, V27, P64, DOI 10.1177/019262339902700113; DONJACOUR AA, 1988, DEV BIOL, V128, P1, DOI 10.1016/0012-1606(88)90260-6; Emoto H, 1997, J BIOL CHEM, V272, P23191, DOI 10.1074/jbc.272.37.23191; Freeman MR, 1997, J CLIN INVEST, V99, P1028, DOI 10.1172/JCI119230; Guo LF, 1996, GENE DEV, V10, P165, DOI 10.1101/gad.10.2.165; HAINAU B, 1974, CANCER-AM CANCER SOC, V33, P115, DOI 10.1002/1097-0142(197401)33:1<115::AID-CNCR2820330118>3.0.CO;2-V; Igarashi M, 1998, J BIOL CHEM, V273, P13230, DOI 10.1074/jbc.273.21.13230; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; LEVIN RM, 1994, WORLD J UROL, V12, P226; Lu WQ, 1999, J BIOL CHEM, V274, P12827, DOI 10.1074/jbc.274.18.12827; McKeehan WL, 1998, PROG NUCLEIC ACID RE, V59, P135; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Miyakawa K, 1999, GROWTH FACTORS, V16, P191, DOI 10.3109/08977199909002129; NEUBAUER BL, 1983, J CELL BIOL, V96, P1671, DOI 10.1083/jcb.96.6.1671; Ohuchi H, 2000, BIOCHEM BIOPH RES CO, V277, P643, DOI 10.1006/bbrc.2000.3721; Qiao JZ, 1999, DEVELOPMENT, V126, P547; REBEL JM, 1994, J PATHOL, V173, P283, DOI 10.1002/path.1711730312; RUBIN JS, 1995, CELL BIOL INT, V19, P399, DOI 10.1006/cbir.1995.1085; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SOUTHGATE J, 1994, LAB INVEST, V71, P583; Tash JA, 2001, J UROLOGY, V166, P2536, DOI 10.1016/S0022-5347(05)65630-3; Thomas R, 2000, CLIN CANCER RES, V6, P1140; Ulich TR, 1997, CANCER RES, V57, P472; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; YI ES, 1995, J UROLOGY, V154, P1566, DOI 10.1016/S0022-5347(01)66930-1; YOUNG NS, 1972, J CLIN INVEST, V51, P1790, DOI 10.1172/JCI106980; [No title captured]	35	45	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2002	277	26					23828	23837		10.1074/jbc.M201658200	http://dx.doi.org/10.1074/jbc.M201658200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567FX	11923311	hybrid			2022-12-27	WOS:000176475700096
J	Gannon-Murakami, L; Murakami, K				Gannon-Murakami, L; Murakami, K			Selective association of protein kinase C with 14-3-3 zeta in neuronally differentiated PC12 cells - Stimulatory and inhibitory effect of 14-3-3 zeta in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; ADRENAL CHROMAFFIN CELLS; CALCIUM-DEPENDENT EXOCYTOSIS; HUMAN NEUROBLASTOMA-CELLS; ARACHIDONIC-ACID RELEASE; CIS-FATTY ACID; NEURITE OUTGROWTH; PHOSPHORYLATED FORMS; SHEEP BRAIN; RAT-BRAIN	The 14-3-3 protein is a family of highly conserved acidic proteins found in a wide range of eukaryotes from yeast to mammals. 14-3-3 acts as an adapter protein and interacts with signaling molecules including protein kinase C (PKC). Although 14-3-3 was originally characterized as an endogenous PKC inhibitor, it was reported to activate PKC in vitro, but the in vivo regulation of PKC by 14-3-3 is still not well understood. To examine the regulation of PKC by 14-3-3 in the cell, we have generated a sub-cell line, PC 12-B3, that stably expresses FLAG epitope-tagged 14-3-3 isoform in PC 12 cells. Here we show that PKC-alpha and PKC-epsilon become associated with 14-3-3 when the cells are neuronally differentiated by nerve growth factor. We found that the immunoprecipitate by anti-FLAG antibody contains constitutive and autonomous Ca2+-independent non-classical PKC activity. In contrast, the FLAG immunoprecipitate has no Ca2+-dependent classical PKC activity despite the fact that PKC-a is present in the FLAG immunoprecipitate from differentiated PC12-B3 cells. Our results show that the association with 14-3-3 has distinct effects on classical PKC and non-classical PKC activity.	Univ Vermont, Dept Biol, Burlington, VT 05405 USA	University of Vermont	Murakami, K (corresponding author), Univ Vermont, Dept Biol, 307 Marsh Life Sci Bldg, Burlington, VT 05405 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH048973] Funding Source: NIH RePORTER; NIMH NIH HHS [MH48973] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ACS P, 1995, BIOCHEM BIOPH RES CO, V216, P103, DOI 10.1006/bbrc.1995.2597; AITKEN A, 1995, J BIOL CHEM, V270, P5706, DOI 10.1074/jbc.270.11.5706; AITKEN A, 1992, BIOCHEM SOC T, V20, P607, DOI 10.1042/bst0200607; AITKEN A, 1992, TRENDS BIOCHEM SCI, V17, P498, DOI 10.1016/0968-0004(92)90339-B; Broadie K, 1997, NEURON, V19, P391, DOI 10.1016/S0896-6273(00)80948-4; Brodie C, 1999, CELL GROWTH DIFFER, V10, P183; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BURGOYNE RD, 1993, J ANAT, V183, P309; CHEN SG, 1992, BIOCHEM J, V282, P33, DOI 10.1042/bj2820033; COLEMAN ES, 1994, J MOL NEUROSCI, V5, P39, DOI 10.1007/BF02736693; Corbit KC, 1999, MOL CELL BIOL, V19, P4209; DEHAUT F, 1993, NEUROSCI LETT, V161, P133, DOI 10.1016/0304-3940(93)90277-R; Fagerstrom S, 1996, CELL GROWTH DIFFER, V7, P775; FINK DW, 1990, J NEUROCHEM, V55, P1716, DOI 10.1111/j.1471-4159.1990.tb04961.x; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; GREENE LA, 1991, CULTURING NERVE CELL, P207; Gu MY, 1999, J CELL BIOL, V147, P1085, DOI 10.1083/jcb.147.5.1085; HARLOW E, 1988, ANTIBODIES LAB MANUA, P41; Hausser A, 1999, J BIOL CHEM, V274, P9258, DOI 10.1074/jbc.274.14.9258; Huang XP, 1997, J CELL SCI, V110, P1625; Hundle B, 1997, J BIOL CHEM, V272, P15028, DOI 10.1074/jbc.272.23.15028; HUNDLE B, 1995, J BIOL CHEM, V270, P30134; ISOBE T, 1992, FEBS LETT, V308, P121, DOI 10.1016/0014-5793(92)81257-M; KOIDE H, 1992, P NATL ACAD SCI USA, V89, P1149, DOI 10.1073/pnas.89.4.1149; Kolkova K, 2000, J NEUROSCI, V20, P2238; Liu YC, 1997, J BIOL CHEM, V272, P9979, DOI 10.1074/jbc.272.15.9979; MARTIN H, 1994, J NEUROCHEM, V63, P2259; MattoYelin M, 1997, MOL BIOL CELL, V8, P1889, DOI 10.1091/mbc.8.10.1889; MCPHAIL LC, 1984, SCIENCE, V224, P622, DOI 10.1126/science.6231726; Meller N, 1996, MOL CELL BIOL, V16, P5782; MORGAN A, 1992, BIOCHEM J, V286, P807, DOI 10.1042/bj2860807; MORGAN A, 1992, NATURE, V355, P833, DOI 10.1038/355833a0; MURAKAMI K, 1986, J BIOL CHEM, V261, P5424; Murakami K, 1996, GENE, V179, P245, DOI 10.1016/S0378-1119(96)00368-X; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; NIELSEN PJ, 1991, BIOCHIM BIOPHYS ACTA, V1088, P425, DOI 10.1016/0167-4781(91)90136-A; ODRISCOLL KR, 1995, MOL BIOL CELL, V6, P449, DOI 10.1091/mbc.6.4.449; OLIVIER AR, 1992, BIOCHEM SOC T, V20, P603, DOI 10.1042/bst0200603; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; PARROW V, 1995, J NEUROSCI RES, V41, P782, DOI 10.1002/jnr.490410609; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; RAVID S, 1992, P NATL ACAD SCI USA, V89, P5877, DOI 10.1073/pnas.89.13.5877; ROIVAINEN R, 1995, P NATL ACAD SCI USA, V92, P1891, DOI 10.1073/pnas.92.6.1891; ROTH D, 1994, BIOCHEM J, V301, P305, DOI 10.1042/bj3010305; Russell P, 1998, TRENDS BIOCHEM SCI, V23, P399, DOI 10.1016/S0968-0004(98)01291-2; Shirai Y, 1998, J CELL BIOL, V143, P511, DOI 10.1083/jcb.143.2.511; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; Skoulakis EMC, 1998, MOL NEUROBIOL, V16, P269, DOI 10.1007/BF02741386; TANJI M, 1994, J NEUROCHEM, V63, P1908; TOKER A, 1992, EUR J BIOCHEM, V206, P453, DOI 10.1111/j.1432-1033.1992.tb16946.x; TOKER A, 1990, EUR J BIOCHEM, V191, P421, DOI 10.1111/j.1432-1033.1990.tb19138.x; Van der Hoeven PCJ, 2000, BIOCHEM J, V345, P297, DOI 10.1042/0264-6021:3450297; WATANABE M, 1994, MOL BRAIN RES, V25, P113, DOI 10.1016/0169-328X(94)90285-2; WILLIAMS EJ, 1994, J NEUROCHEM, V62, P1231; Wooten MW, 1998, CELL SIGNAL, V10, P265, DOI 10.1016/S0898-6568(97)00127-7; WOOTEN MW, 1994, CELL GROWTH DIFFER, V5, P395; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; YAMAUCHI T, 1981, J BIOL CHEM, V256, P5404; Zheng WH, 1996, J NEUROCHEM, V66, P1868; Zhou Y, 1999, NEURON, V22, P809, DOI 10.1016/S0896-6273(00)80739-4	61	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 28	2002	277	26					23116	23122		10.1074/jbc.M201478200	http://dx.doi.org/10.1074/jbc.M201478200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567FX	11950841	hybrid			2022-12-27	WOS:000176475700004
J	Petrucco, S; Volpi, G; Bolchi, A; Rivetti, C; Ottonello, S				Petrucco, S; Volpi, G; Bolchi, A; Rivetti, C; Ottonello, S			A nick-sensing DNA 3 '-repair enzyme from Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(ADP-RIBOSE) POLYMERASE; STRAND BREAKS; CONFORMATIONAL-ANALYSIS; LIGASE III; REPAIR; DOMAIN; XRCC1; GENE; 3'-PHOSPHATASE; SEQUENCE	DNA single-strand breaks, a major cause of genome instability, often produce unconventional end groups that must be processed to restore terminal moieties suitable for reparative DNA gap filling or ligation. Here, we describe a bifunctional repair enzyme from Arabidopsis (named AtZDP) that recognizes DNA strand breaks and catalyzes the removal of 3'-end-blocking lesions. The isolated C-terminal domain of AtZDP is by itself competent for T-end processing, but not for strand break recognition. The N-terminal domain instead contains three Cys(3)-His zinc fingers and recognizes various kinds of damaged double-stranded DNA. Gapped DNA molecules are preferential targets of AtZDP, which bends them by similar to73degrees upon binding, as measured by atomic force microscopy. Potential partners of AtZDP were identified in the Arabidopsis genome using the human single-strand break repairosome as a reference. These data identify a novel pathway for single-strand break repair in which a DNA-binding 3'-phosphoesterase acts as a "nick sensor" for damage recognition, as the catalyst of one repair step, and possibly as a nucleation center for the assembly of a fully competent repair complex.	Univ Parma, Dept Biochem & Mol Biol, I-43100 Parma, Italy	University of Parma	Petrucco, S (corresponding author), Univ Parma, Dept Biochem & Mol Biol, I-43100 Parma, Italy.	petrucco@unipr.it	Bolchi, Angelo/GOJ-9730-2022	Rivetti, Claudio/0000-0003-3775-6779				BABIYCHUK E, 1994, P NATL ACAD SCI USA, V91, P3299, DOI 10.1073/pnas.91.8.3299; Babiychuk E, 1998, PLANT J, V15, P635, DOI 10.1046/j.1365-313x.1998.00240.x; Betti M, 2001, J BIOL CHEM, V276, P18038, DOI 10.1074/jbc.M010648200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Britt AB, 1999, TRENDS PLANT SCI, V4, P20, DOI 10.1016/S1360-1385(98)01355-7; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; Craggs G, 2001, J BIOL CHEM, V276, P23719, DOI 10.1074/jbc.M102846200; Dantzer F, 1999, BIOCHIMIE, V81, P69, DOI 10.1016/S0300-9084(99)80040-6; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Dronkert MLG, 2000, MOL CELL BIOL, V20, P4553, DOI 10.1128/MCB.20.13.4553-4561.2000; FRIEDBERG EC, 1995, TRENDS BIOCHEM SCI, V20, P381, DOI 10.1016/S0968-0004(00)89082-9; GRADWOHL G, 1990, P NATL ACAD SCI USA, V87, P2990, DOI 10.1073/pnas.87.8.2990; IKEJIMA M, 1990, J BIOL CHEM, V265, P21907; Jilani A, 1999, J BIOL CHEM, V274, P24176, DOI 10.1074/jbc.274.34.24176; Karimi-Busheri F, 1999, J BIOL CHEM, V274, P24187, DOI 10.1074/jbc.274.34.24187; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LECAM E, 1994, J MOL BIOL, V235, P1062, DOI 10.1006/jmbi.1994.1057; LUTCKE HA, 1987, EMBO J, V6, P43, DOI 10.1002/j.1460-2075.1987.tb04716.x; Mackey ZB, 1999, J BIOL CHEM, V274, P21679, DOI 10.1074/jbc.274.31.21679; Mahajan PB, 1998, PLANT PHYSIOL, V118, P895, DOI 10.1104/pp.118.3.895; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; MAZEN A, 1989, NUCLEIC ACIDS RES, V17, P4689, DOI 10.1093/nar/17.12.4689; Meijer M, 2002, J BIOL CHEM, V277, P4050, DOI 10.1074/jbc.M109383200; MINET M, 1992, PLANT J, V2, P417; MOLINETE M, 1993, EMBO J, V12, P2109, DOI 10.1002/j.1460-2075.1993.tb05859.x; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Petrucco S, 1996, PLANT CELL, V8, P69, DOI 10.1105/tpc.8.1.69; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Rivetti C, 1996, J MOL BIOL, V264, P919, DOI 10.1006/jmbi.1996.0687; Rivetti C, 1998, J MOL BIOL, V280, P41, DOI 10.1006/jmbi.1998.1830; Sambrook J., 2001, MOL CLONING LAB MANU; SANDER M, 1995, BIOCHEMISTRY-US, V34, P1267, DOI 10.1021/bi00004a021; Thaller MC, 1998, PROTEIN SCI, V7, P1647, DOI 10.1002/pro.5560070722; Vance JR, 2001, MOL CELL BIOL, V21, P7191, DOI 10.1128/MCB.21.21.7191-7198.2001; Vance JR, 2001, J BIOL CHEM, V276, P15073, DOI 10.1074/jbc.M011075200; Ward JF, 1998, CONT CANC RES, P65; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wilson DM, 1998, CONT CANC RES, P29	38	27	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2002	277	26					23675	23683		10.1074/jbc.M201411200	http://dx.doi.org/10.1074/jbc.M201411200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567FX	11948185	hybrid			2022-12-27	WOS:000176475700076
J	Zrachia, A; Dobroslav, M; Blass, M; Kazimirsky, G; Kronfeld, I; Blumberg, PM; Kobiler, D; Lustig, S; Brodie, C				Zrachia, A; Dobroslav, M; Blass, M; Kazimirsky, G; Kronfeld, I; Blumberg, PM; Kobiler, D; Lustig, S; Brodie, C			Infection of glioma cells with sindbis virus induces selective activation and tyrosine phosphorylation of protein kinase C delta - Implications for sindbis virus-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERSISTENT ALPHAVIRUS INFECTION; PROTEOLYTIC ACTIVATION; SIGNAL-TRANSDUCTION; GROWTH-FACTOR; PKC-DELTA; TRANSLOCATION; EXPRESSION; PATHWAY; FAMILY; BCL-2	Sindbis virus (SV) is an alpha virus used as a model for studying the role of apoptosis in virus infection. In this study, we examined the role of protein kinase C (PKC) in the apoptosis induced by SVNI, a virulent strain of SV. Infection of C6 cells with SVNI induced a selective translocation of PKCdelta to the endoplasmic reticulum and its tyrosine phosphorylation. The specific PKCdelta inhibitor rottlerin and a PKCdelta kinase-dead mutant increased the apoptosis induced by SVNI. To examine the role of the tyrosine phosphorylation of PKCS in the apoptosis induced by SVNI we used a PKCdelta mutant in which five tyrosine residues were mutated to phenylalanine (PKCdelta5). PKCdelta5-overexpressing cells exhibited increased apoptosis in response to SVNI as compared with control cells and to cells overexpressing PKCdelta. SVNI also increased the cleavage of caspase 3 in cells overexpressing PKCdelta5 but did not induce cleavage of PKCdelta or PKCdelta5. Using single tyrosine mutants, we identified tyrosines 52, 64, and 155 as the phosphorylation sites associated with the apoptosis induced by SVNI. We conclude that PKCdelta exerts an inhibitory effect on the apoptosis induced by SV and that phosphorylation of PKCdelta on specific tyrosines is required for this function.	Bar Ilan Univ, Fac Life Sci, Med Diag Res Ctr, IL-52900 Ramat Gan, Israel; NCI, Cellular Carcinogenesis & Tumor Promot Lab, NIH, Bethesda, MD 20892 USA; Israel Inst Biol Res, Dept Infect Dis, IL-74100 Ness Ziona, Israel	Bar Ilan University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Brodie, C (corresponding author), Bar Ilan Univ, Fac Life Sci, Med Diag Res Ctr, IL-52900 Ramat Gan, Israel.							Appel E, 2000, VIROLOGY, V276, P238, DOI 10.1006/viro.2000.0458; Blass M, 2002, MOL CELL BIOL, V22, P182, DOI 10.1128/MCB.22.1.182-195.2002; Brodie C, 1998, J BIOL CHEM, V273, P30713, DOI 10.1074/jbc.273.46.30713; Cross TG, 2000, EXP CELL RES, V256, P34, DOI 10.1006/excr.2000.4836; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Denning MF, 1996, J BIOL CHEM, V271, P5325, DOI 10.1074/jbc.271.10.5325; Endo K, 2000, J BIOL CHEM, V275, P18476, DOI 10.1074/jbc.M002266200; Faleiro L, 2000, J CELL BIOL, V151, P951, DOI 10.1083/jcb.151.5.951; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; Griffin DE, 1999, TRENDS MICROBIOL, V7, P155, DOI 10.1016/S0966-842X(99)01470-5; Griffin DE, 1997, ANNU REV MICROBIOL, V51, P565, DOI 10.1146/annurev.micro.51.1.565; Griffin DE, 1998, NEUROSCI BIOBEHAV R, V22, P721, DOI 10.1016/S0149-7634(98)00010-4; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Gubina E, 1998, BLOOD, V91, P823, DOI 10.1182/blood.V91.3.823.823_823_829; HALEEMSMITH H, 1995, P NATL ACAD SCI USA, V92, P9112, DOI 10.1073/pnas.92.20.9112; Hayashi A, 1999, BBA-MOL CELL RES, V1450, P99, DOI 10.1016/S0167-4889(99)00040-3; Jaken S, 1996, CURR OPIN CELL BIOL, V8, P168, DOI 10.1016/S0955-0674(96)80062-7; Jan JT, 1999, J VIROL, V73, P10296, DOI 10.1128/JVI.73.12.10296-10302.1999; Jan JT, 2000, J VIROL, V74, P6425, DOI 10.1128/JVI.74.14.6425-6432.2000; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; Kajimoto T, 2001, MOL CELL BIOL, V21, P1769, DOI 10.1128/MCB.21.5.1769-1783.2001; Keenan C, 1997, FEBS LETT, V415, P101, DOI 10.1016/S0014-5793(97)01104-6; Konishi H, 2001, P NATL ACAD SCI USA, V98, P6587, DOI 10.1073/pnas.111158798; Koriyama H, 1999, CELL SIGNAL, V11, P831, DOI 10.1016/S0898-6568(99)00055-8; Kronfeld I, 2000, J BIOL CHEM, V275, P35491, DOI 10.1074/jbc.M005991200; LEVINE B, 1993, NATURE, V361, P739, DOI 10.1038/361739a0; Lewis J, 1999, NAT MED, V5, P832, DOI 10.1038/10556; Li LW, 1999, MOL CELL BIOL, V19, P8547; Li WQ, 1996, J BIOL CHEM, V271, P26404, DOI 10.1074/jbc.271.42.26404; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Lin KI, 1998, J CELL BIOL, V141, P1479, DOI 10.1083/jcb.141.7.1479; LUSTIG S, 1992, ARCH VIROL, V122, P237, DOI 10.1007/BF01317186; Majumder PK, 2000, J BIOL CHEM, V275, P21793, DOI 10.1074/jbc.C000048200; Nakatsue T, 1998, BIOCHEM BIOPH RES CO, V253, P59, DOI 10.1006/bbrc.1998.9724; Nava VE, 1998, J VIROL, V72, P452, DOI 10.1128/JVI.72.1.452-459.1998; NEWTON AC, 1995, CURR BIOL, V5, P973, DOI 10.1016/S0960-9822(95)00191-6; Newton AC, 2002, METHOD ENZYMOL, V345, P499; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Ruvolo PP, 1998, J BIOL CHEM, V273, P25436, DOI 10.1074/jbc.273.39.25436; SAITO S, 1990, MICROBIOL IMMUNOL, V34, P859, DOI 10.1111/j.1348-0421.1990.tb01064.x; Sarid R, 2001, CELL DEATH DIFFER, V8, P1224, DOI 10.1038/sj.cdd.4400926; Song JS, 1998, ONCOGENE, V16, P3357, DOI 10.1038/sj.onc.1201886; STRAUSS EG, 1976, VIROLOGY, V74, P154, DOI 10.1016/0042-6822(76)90137-9; Teodoro JG, 1997, J VIROL, V71, P1739, DOI 10.1128/JVI.71.3.1739-1746.1997; Toker Alex, 1998, Frontiers in Bioscience, V3, pD1134; Wang QMJ, 1999, J BIOL CHEM, V274, P37233, DOI 10.1074/jbc.274.52.37233; Wert MM, 2000, BIOCHEM J, V352, P175, DOI 10.1042/0264-6021:3520175; Yuan ZM, 1998, ONCOGENE, V16, P1643, DOI 10.1038/sj.onc.1201698	53	53	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 28	2002	277	26					23693	23701		10.1074/jbc.M111658200	http://dx.doi.org/10.1074/jbc.M111658200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567FX	11927579	hybrid			2022-12-27	WOS:000176475700078
J	Fisher, AA; Ye, DJ; Sergueev, DS; Fisher, MH; Shaw, BR; Juliano, RL				Fisher, AA; Ye, DJ; Sergueev, DS; Fisher, MH; Shaw, BR; Juliano, RL			Evaluating the specificity of antisense oligonucleotide conjugates - A DNA array analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; P-GLYCOPROTEIN; PHOSPHOROTHIOATE; INHIBITION; OLIGODEOXYNUCLEOTIDES; RESISTANCE; SEQUENCE; CLEAVAGE; DELIVERY; PROTEIN	Antisense oligonucleotides are potentially powerful tools for selective control of cellular and viral gene expression. Crucial to successful application of this approach is the specificity of the oligonucleotide for the chosen RNA target. Here we apply DNA array technology to examine the specificity of antisense oligonucleotide treatments. The molecules used in these studies consisted of phosphorothioate oligomers linked to the Antennapedia (Ant) delivery peptide. The antisense oligonucleotide component was complementary to a site Ranking the AUG of the MDR1 message, which codes for P-glycoprotein, a membrane ATPase associated with multidrug resistance in tumor cells. Using a DNA array of 2059 genes, we analyzed cellular responses to molecules comprised of Ant peptide-oligonucleotide conjugates, as well as to the Ant peptide alone. Besides the expected reduction in MDR1 message level, 37 other genes (similar to2% of those tested) showed changes of comparable magnitude. The validity of the array results was confirmed for selected genes using Northern blots to assess messenger RNA levels. These results suggest that studies using antisense oligonucleotide technology to modulate gene expression need to be interpreted with caution.	Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; Duke Univ, Dept Chem, Durham, NC 27708 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University	Juliano, RL (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, CB 7365,1106 Jones Bldg, Chapel Hill, NC 27599 USA.				NIGMS NIH HHS [P01 GM59299] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM059299] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal S, 1999, BBA-GENE STRUCT EXPR, V1489, P53, DOI 10.1016/S0167-4781(99)00141-4; Alahari SK, 1996, MOL PHARMACOL, V50, P808; ALWINE JC, 1977, P NATL ACAD SCI USA, V74, P5350, DOI 10.1073/pnas.74.12.5350; Astriab-Fisher A, 2000, BIOCHEM PHARMACOL, V60, P83, DOI 10.1016/S0006-2952(00)00310-5; Astriab-Fisher A, 2002, PHARMACEUT RES, V19, P744, DOI 10.1023/A:1016136328329; Baker BF, 1997, J BIOL CHEM, V272, P11994, DOI 10.1074/jbc.272.18.11994; BENNETT CF, 1992, MOL PHARMACOL, V41, P1023; BERGAN R, 1994, NUCLEIC ACIDS RES, V22, P2150, DOI 10.1093/nar/22.11.2150; BROWN DA, 1994, J BIOL CHEM, V269, P26801; Celis JE, 2000, FEBS LETT, V480, P2, DOI 10.1016/S0014-5793(00)01771-3; Cho YS, 2001, P NATL ACAD SCI USA, V98, P9819, DOI 10.1073/pnas.171314398; Crooke ST, 1999, BBA-GENE STRUCT EXPR, V1489, P31, DOI 10.1016/S0167-4781(99)00148-7; Gewirtz AM, 1998, BLOOD, V92, P712, DOI 10.1182/blood.V92.3.712.415a32_712_736; GILES RV, 1992, NUCLEIC ACIDS RES, V20, P763, DOI 10.1093/nar/20.4.763; HARKER WG, 1986, CANCER RES, V46, P2369; Juliano RL, 1999, PHARM RES-DORDR, V16, P494, DOI 10.1023/A:1011958726518; Kaminski N, 2000, P NATL ACAD SCI USA, V97, P1778, DOI 10.1073/pnas.97.4.1778; KRIEG AM, 1995, ANTISENSE RES DEV, V5, P241, DOI 10.1089/ard.1995.5.241; Lindgren M, 2000, TRENDS PHARMACOL SCI, V21, P99, DOI 10.1016/S0165-6147(00)01447-4; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; MONIA BP, 1992, J BIOL CHEM, V267, P19954; Notterman DA, 2001, CANCER RES, V61, P3124; Stein CA, 2000, PHARMACOL THERAPEUT, V85, P231, DOI 10.1016/S0163-7258(99)00053-4; Stein CA, 1998, ANTISENSE NUCLEIC A, V8, P129, DOI 10.1089/oli.1.1998.8.129; SZANI P, 2001, NUCLEIC ACIDS RES, V29, P3965; Yoo H, 2000, NUCLEIC ACIDS RES, V28, P4225, DOI 10.1093/nar/28.21.4225	26	56	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22980	22984		10.1074/jbc.M203347200	http://dx.doi.org/10.1074/jbc.M203347200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11948195	hybrid			2022-12-27	WOS:000176313600112
J	Baumann, F; Neupert, W; Herrmann, JM				Baumann, F; Neupert, W; Herrmann, JM			Insertion of bitopic membrane proteins into the inner membrane of mitochondria involves an export step from the matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; INTERMEMBRANE SPACE; CHARGED RESIDUES; TARGETING SIGNAL; AAA PROTEASE; NUCLEAR GENE; N-TERMINI; C-TERMINI; YEAST; TRANSLOCATION	The mitochondrial inner membrane contains a large number of polytopic proteins that are derived from prokaryotic ancestors of mitochondria. Little is known about the intramitochondrial sorting of these proteins. We chose two proteins of known topology as examples to study the pathway of insertion into the inner membrane; Mrs2 and Yta10 are bitopic proteins that expose negatively charged loops of different complexity into the intermembrane space. Here we show that both Mrs2 and Yta10 transiently accumulate as sorting intermediates in the matrix before they integrate into the inner membrane. The sorting pathway of both proteins can be separated into two sequential reactions: (i) import into the matrix and (ii) insertion from the matrix into the inner membrane. The latter process was found to depend on the membrane potential and, in this respect, is similar to the insertion of membrane proteins in bacteria. A comparison of the charge distribution of intermembrane space loops in a variety of mitochondrial inner membrane proteins suggests that this mode of "conservative sorting" might be the typical insertion route for polytopic inner membrane proteins that originated from bacterial ancestors.	Inst Physiol Chem, D-81377 Munich, Germany		Herrmann, JM (corresponding author), Inst Physiol Chem, Butenandtstr 5, D-81377 Munich, Germany.		Baumann, Frank/F-7737-2016					Altamura N, 1996, FEBS LETT, V382, P111, DOI 10.1016/0014-5793(96)00165-2; ANDERSSON H, 1994, EMBO J, V13, P2267, DOI 10.1002/j.1460-2075.1994.tb06508.x; Arlt H, 1998, EMBO J, V17, P4837, DOI 10.1093/emboj/17.16.4837; Arlt H, 1996, CELL, V85, P875, DOI 10.1016/S0092-8674(00)81271-4; Arnold I, 1998, J BIOL CHEM, V273, P1469, DOI 10.1074/jbc.273.3.1469; BAUER M, 1994, MOL GEN GENET, V245, P272, DOI 10.1007/BF00290106; Bui DM, 1999, J BIOL CHEM, V274, P20438, DOI 10.1074/jbc.274.29.20438; Folsch H, 1996, EMBO J, V15, P479, DOI 10.1002/j.1460-2075.1996.tb00380.x; GAVEL Y, 1992, EUR J BIOCHEM, V205, P1207, DOI 10.1111/j.1432-1033.1992.tb16892.x; GUELIN E, 1994, YEAST, V10, P1389, DOI 10.1002/yea.320101016; HARTL FU, 1986, CELL, V47, P939, DOI 10.1016/0092-8674(86)90809-3; He SC, 1997, MOL BIOL CELL, V8, P1449, DOI 10.1091/mbc.8.8.1449; Hell K, 1998, P NATL ACAD SCI USA, V95, P2250, DOI 10.1073/pnas.95.5.2250; Hell K, 1997, FEBS LETT, V418, P367, DOI 10.1016/S0014-5793(97)01412-9; Hell K, 2001, EMBO J, V20, P1281, DOI 10.1093/emboj/20.6.1281; Herrmann J. M., 1994, CELL BIOL LAB HDB, VI, P538; Herrmann JM, 1997, EMBO J, V16, P2217, DOI 10.1093/emboj/16.9.2217; Herrmann JM, 2000, CURR OPIN MICROBIOL, V3, P210, DOI 10.1016/S1369-5274(00)00077-1; HERRMANN JM, 1995, J BIOL CHEM, V270, P27079, DOI 10.1074/jbc.270.45.27079; Ii M, 2001, J BIOL CHEM, V276, P24704, DOI 10.1074/jbc.M102584200; KAPUT J, 1982, J BIOL CHEM, V257, P5054; Karlberg O, 2000, YEAST, V17, P170, DOI 10.1002/1097-0061(20000930)17:3<170::AID-YEA25>3.0.CO;2-V; Kerscher O, 1997, J CELL BIOL, V139, P1663, DOI 10.1083/jcb.139.7.1663; Lee CM, 1999, J BIOL CHEM, V274, P20937, DOI 10.1074/jbc.274.30.20937; Leonhard K, 2000, MOL CELL, V5, P629, DOI 10.1016/S1097-2765(00)80242-7; Luirink J, 2001, FEBS LETT, V501, P1, DOI 10.1016/S0014-5793(01)02616-3; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; PAJIC A, 1994, FEBS LETT, V353, P201, DOI 10.1016/0014-5793(94)01046-3; Preuss M, 2001, J CELL BIOL, V153, P1085, DOI 10.1083/jcb.153.5.1085; Rojo EE, 1999, J BIOL CHEM, V274, P19617, DOI 10.1074/jbc.274.28.19617; ROJO EE, 1995, EMBO J, V14, P3445, DOI 10.1002/j.1460-2075.1995.tb07350.x; Rojo EE, 1998, J BIOL CHEM, V273, P8040, DOI 10.1074/jbc.273.14.8040; Samuelson JC, 2001, J BIOL CHEM, V276, P34847, DOI 10.1074/jbc.M105793200; Schuenemann TA, 1999, J BIOL CHEM, V274, P6855, DOI 10.1074/jbc.274.11.6855; SDAINTGEORGES Y, 2001, P NATL ACAD SCI USA, V98, P13814; Sherman F., 1986, METHODS YEAST GENETI; SIKORSKI RS, 1989, GENETICS, V122, P19; Sirrenberg C, 1996, NATURE, V384, P582, DOI 10.1038/384582a0; UNGERMANN C, 1994, SCIENCE, V266, P1250, DOI 10.1126/science.7973708; VANLOON APGM, 1987, EMBO J, V6, P2441, DOI 10.1002/j.1460-2075.1987.tb02523.x; Woolhead CA, 2001, J BIOL CHEM, V276, P40841, DOI 10.1074/jbc.M106523200	41	19	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21405	21413		10.1074/jbc.M201670200	http://dx.doi.org/10.1074/jbc.M201670200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11932259	hybrid			2022-12-27	WOS:000176286000038
J	Eicken, C; Sharma, V; Klabunde, T; Lawrenz, MB; Hardham, JM; Norris, SJ; Sacchettini, JC				Eicken, C; Sharma, V; Klabunde, T; Lawrenz, MB; Hardham, JM; Norris, SJ; Sacchettini, JC			Crystal structure of Lyme disease variable surface antigen VlsE of Borrelia burgdorferi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODOMINANT CONSERVED REGION; TERMINAL INVARIABLE DOMAIN; GENETIC-VARIATION; PROTEIN-C; INFECTIVITY; ANTIBODY; RECOMBINATION; POPULATIONS; EXPRESSION; SPIROCHETE	VlsE is an outer surface lipoprotein of Borrelia burgdorferi that undergoes antigenic variation through an elaborate gene conversion mechanism and is thought to play a major role in the immune response to the Lyme disease borellia. The crystal structure of recombinant variant protein VlsE1 at 2.3-Angstrom resolution reveals that the six variable regions form loop structures that constitute most of the membrane distal surface of VlsE, covering the predominantly a-helical, invariant regions of the protein. The surface localization of the variable amino acid segments appears to protect the conserved regions from interaction with antibodies and hence may contribute to immune evasion.	Texas A&M Univ, Ctr Struct Biol, College Stn, TX 77843 USA; Albert B Alkeck Inst Biosci & Technol, Houston, TX 77030 USA; Univ Texas, Sch Med, Dept Pathol & Lab Med, Houston, TX 77225 USA; Univ Texas, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77225 USA	Texas A&M University System; Texas A&M University College Station; University of Texas System; University of Texas System	Sacchettini, JC (corresponding author), Texas A&M Univ, Ctr Struct Biol, College Stn, TX 77843 USA.	sacchett@tamu.edu	Norris, Steven James/K-6586-2019	Norris, Steven James/0000-0002-2501-8034	NIAID NIH HHS [R01 AI037277] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037277] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barbour AG, 2000, EMERG INFECT DIS, V6, P449, DOI 10.3201/eid0605.000502; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bunikis J, 1999, INFECT IMMUN, V67, P2874, DOI 10.1128/IAI.67.6.2874-2883.1999; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Davies C, 2000, STRUCTURE, V8, P185, DOI 10.1016/S0969-2126(00)00094-0; Eicken C, 2001, J BIOL CHEM, V276, P10010, DOI 10.1074/jbc.M010062200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hudson CR, 2001, MOL MICROBIOL, V41, P229, DOI 10.1046/j.1365-2958.2001.02511.x; Indest KJ, 2001, INFECT IMMUN, V69, P7083, DOI 10.1128/IAI.69.11.7083-7090.2001; Jones K, 2001, BIOCHEM BIOPH RES CO, V289, P389, DOI 10.1006/bbrc.2001.5983; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kumaran D, 2001, EMBO J, V20, P971, DOI 10.1093/emboj/20.5.971; Labandeira-Rey M, 2001, INFECT IMMUN, V69, P446, DOI 10.1128/IAI.69.1.446-455.2001; Lawrenz MB, 1999, J CLIN MICROBIOL, V37, P3997, DOI 10.1128/JCM.37.12.3997-4004.1999; Liang FT, 1999, J IMMUNOL, V163, P5566; Liang FT, 2000, J BACTERIOL, V182, P3597, DOI 10.1128/JB.182.12.3597-3601.2000; Liang FT, 1999, J CLIN MICROBIOL, V37, P3990, DOI 10.1128/JCM.37.12.3990-3996.1999; Liang FT, 2001, INFECT IMMUN, V69, P1337, DOI 10.1128/IAI.69.3.1337-1343.2001; Liang FT, 2001, INFECT IMMUN, V69, P3224, DOI 10.1128/IAI.69.5.3224-3231.2001; Liang FT, 1999, INFECT IMMUN, V67, P6702; Liang FT, 2000, INFECT IMMUN, V68, P2349, DOI 10.1128/IAI.68.4.2349-2352.2000; NORRIS SJ, 1995, INFECT IMMUN, V63, P2206, DOI 10.1128/IAI.63.6.2206-2212.1995; Ohnishi J, 2001, P NATL ACAD SCI USA, V98, P670, DOI 10.1073/pnas.98.2.670; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Sung SY, 2001, J BACTERIOL, V183, P5855, DOI 10.1128/JB.183.20.5855-5861.2001; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Zhang JR, 1997, CELL, V89, P275, DOI 10.1016/S0092-8674(00)80206-8; Zhang JR, 1998, INFECT IMMUN, V66, P3689, DOI 10.1128/IAI.66.8.3689-3697.1998; Zhang JR, 1998, INFECT IMMUN, V66, P3698, DOI 10.1128/IAI.66.8.3698-3704.1998; Zucker WR, 2001, J BIOL CHEM, V276, P457, DOI 10.1074/jbc.M008449200; [No title captured]	35	100	107	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21691	21696		10.1074/jbc.M201547200	http://dx.doi.org/10.1074/jbc.M201547200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11923306	hybrid			2022-12-27	WOS:000176286000077
J	Newell, JG; Dunn, SMJ				Newell, JG; Dunn, SMJ			Functional consequences of the loss of high affinity agonist binding to gamma-aminobutyric acid type A receptors - Implications for receptor desensitization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; MOLECULAR-MECHANISMS; SUBUNIT STRUCTURE; BRAIN; STOICHIOMETRY; PHARMACOLOGY; SITES	We reported previously that tyrosine 62 of the 132 subunit of the gamma-aminobutyric acid, type A (GABA(A)) receptor is an important determinant of high affinity agonist binding and that recombinant alpha1beta2gamma2(L) receptors carrying the Y62S mutation lack measurable high affinity sites for [H-3]muscimol. We have now examined the effects of disrupting these sites on the macroscopic desensitization properties of receptors expressed in Xenopus oocytes. Desensitization was measured by the ability of low concentrations of bath-perfused agonist to reduce the current responses elicited by subsequent challenges with saturating concentrations of GABA. Wild-type receptors were desensitized by pre-perfused muscimol with an IC50 similar to0.7 muM, which correlates well with the lower affinity sites for this agonist that are measured in direct binding studies. Receptors carrying the beta2 Y62S and Y62F mutations desensitized at slightly higher (2-7-fold) agonist concentrations. However, at low perfusate concentrations, the Y62S-containing receptor recovered from the desensitized state even in the continued presence of agonist. The characteristics of desensitization in the wild-type and mutant receptors lead us to suggest that the major role of the high affinity agonist-binding site(s) of the GABAA receptor is not to induce desensitization but rather to stabilize the desensitized state once it has been formed.	Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2H7, Canada; Univ Alberta, Ctr Neurosci, Edmonton, AB T6G 2H7, Canada	University of Alberta; University of Alberta	Dunn, SMJ (corresponding author), Univ Bristol, Sch Med Sci, Dept Pharmacol, Bristol BS8 1TD, Avon, England.	susan.dunn@bristol.ac.uk						AGEY MW, 1989, BIOCHEMISTRY-US, V28, P4200, DOI 10.1021/bi00436a012; Barnard EA, 1998, PHARMACOL REV, V50, P291; Bartrup JT, 1996, J PHYSIOL-LONDON, V490, P679, DOI 10.1113/jphysiol.1996.sp021177; Belelli D, 1996, BRIT J PHARMACOL, V118, P563, DOI 10.1111/j.1476-5381.1996.tb15439.x; Bianchi MT, 2001, J NEUROSCI, V21, P1127; Chang YC, 1996, J NEUROSCI, V16, P5415; Changeux JP, 1998, NEURON, V21, P959, DOI 10.1016/S0896-6273(00)80616-9; Corringer PJ, 1998, J NEUROSCI, V18, P648; DAVIES M, 1994, CAN J PHYSL PHARM, V72, P337; Dunn SMJ, 1997, BIOCHEMISTRY-US, V36, P3854, DOI 10.1021/bi9615046; Dunn SMJ, 1997, BIOCHEMISTRY-US, V36, P3846, DOI 10.1021/bi961503d; Dunn SMJ, 2000, BIOCHEM BIOPH RES CO, V279, P358, DOI 10.1006/bbrc.2000.3960; Edelstein SJ, 1996, BIOL CYBERN, V75, P361, DOI 10.1007/s004220050302; EDMONDS B, 1995, ANNU REV PHYSIOL, V57, P495; Farrar SJ, 1999, J BIOL CHEM, V274, P10100, DOI 10.1074/jbc.274.15.10100; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; Jones MV, 1998, J NEUROSCI, V18, P8590; LOHSE MJ, 1993, BIOCHIM BIOPHYS ACTA, V1179, P171, DOI 10.1016/0167-4889(93)90139-G; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Newell JG, 2000, MOL BIOTECHNOL, V14, P25, DOI 10.1385/MB:14:1:25; Newell JG, 2000, J BIOL CHEM, V275, P14198, DOI 10.1074/jbc.275.19.14198; OCHOA ELM, 1989, CELL MOL NEUROBIOL, V9, P141, DOI 10.1007/BF00713026; OLSEN RW, 1981, MOL PHARMACOL, V19, P217; Overstreet LS, 2000, J NEUROSCI, V20, P7914; RAFTERY MA, 1983, COLD SPRING HARB SYM, V48, P21, DOI 10.1101/SQB.1983.048.01.005; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; Scholze P, 1996, EUR J PHARMACOL, V304, P155, DOI 10.1016/0014-2999(96)00088-X; SIEGHART W, 1995, PHARMACOL REV, V47, P181; Sigel E, 1997, TRENDS PHARMACOL SCI, V18, P425, DOI 10.1016/S0165-6147(97)90675-1; Tretter V, 1997, J NEUROSCI, V17, P2728; YANG JSJ, 1987, MOL PHARMACOL, V32, P266	31	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21423	21430		10.1074/jbc.M110312200	http://dx.doi.org/10.1074/jbc.M110312200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11932253	hybrid			2022-12-27	WOS:000176286000040
J	Dziegielewski, J; Beerman, TA				Dziegielewski, J; Beerman, TA			Cellular responses to the DNA strand-scission enediyne C-1027 can be independent of ATM, ATR, and DNA-PK kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; ATAXIA-TELANGIECTASIA CELLS; IONIZING-RADIATION; ANTITUMOR ANTIBIOTICS; DAMAGE; P53; NEOCARZINOSTATIN; BLEOMYCIN; PHOSPHORYLATION; REPLICATION	The current paradigm based upon ionizing radiation (IR) studies states that cells deficient in either ataxiatelangiectasia-mutated kinase (ATM) or related phosphatidylinositol 3 (PI 3) -kinases (ATR and DNA-PK) are hypersensitive to DNA strand breaks because they are unable to rapidly activate downstream effectors such as p53. Here we have contrasted cell responses to IR and C-1027, a radiomimetic antibiotic that induces DNA strand breaks. At equal levels of DNA double strand breaks, cell lines with inactive ATM or other phosphatidylinositol 3-kinases displayed classical hypersensitivity to IR but not to C-1027. Moreover, phosphorylation of p53 Ser-15 induced by C-1027 was independent of ATM, ATR, or DNA-PK function. We have concluded that the model based on IR studies cannot always be directly applied to DNA damage induced by other strand-scission agents.	Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Beerman, TA (corresponding author), Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Elm & Charlton Sts, Buffalo, NY 14263 USA.				NCI NIH HHS [CA77491] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA077491] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abramova NA, 1997, P NATL ACAD SCI USA, V94, P7186, DOI 10.1073/pnas.94.14.7186; Anderson Carl W., 1994, Seminars in Cell Biology, V5, P427, DOI 10.1006/scel.1994.1050; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; BECKMANN RP, 1987, BIOCHEMISTRY-US, V26, P5409, DOI 10.1021/bi00391a029; Canman CE, 1998, ONCOGENE, V17, P3301, DOI 10.1038/sj.onc.1202577; CANMAN CE, 1994, CANCER RES, V54, P5054; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chan DW, 2000, J BIOL CHEM, V275, P7803, DOI 10.1074/jbc.275.11.7803; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; DEDON PC, 1992, CHEM RES TOXICOL, V5, P311, DOI 10.1021/tx00027a001; DiBiase SJ, 1999, INT J RADIAT ONCOL, V45, P743, DOI 10.1016/S0360-3016(99)00229-1; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Dziegielewski J, 2001, BIOCHEMISTRY-US, V40, P704, DOI 10.1021/bi002181n; GRIMWADE JE, 1986, MOL PHARMACOL, V30, P358; HENNER WD, 1982, J BIOL CHEM, V257, P1750; Jackson SP, 1997, INT J BIOCHEM CELL B, V29, P935, DOI 10.1016/S1357-2725(97)00006-X; JASPERS NGJ, 1982, CANCER RES, V42, P335; KHANNA KK, 1995, ONCOGENE, V11, P609; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kirk CA, 1997, BIOPHYS CHEM, V63, P201, DOI 10.1016/S0301-4622(96)02217-X; Lakin ND, 1999, ONCOGENE, V18, P3989, DOI 10.1038/sj.onc.1202973; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; Leuther KK, 1999, EMBO J, V18, P1114, DOI 10.1093/emboj/18.5.1114; Li L, 2001, INT J RADIAT ONCOL, V49, P1157, DOI 10.1016/S0360-3016(00)01524-8; LU X, 1993, CELL, V75, P765, DOI 10.1016/0092-8674(93)90496-D; MCHUGH MM, 1995, BIOCHEMISTRY-US, V34, P1805, DOI 10.1021/bi00005a038; McHugh MM, 2001, BIOCHEMISTRY-US, V40, P4792, DOI 10.1021/bi001668t; Miller SD, 1997, MOL CELL BIOL, V17, P2194, DOI 10.1128/MCB.17.4.2194; Povirk LF, 1996, MUTAT RES-FUND MOL M, V355, P71, DOI 10.1016/0027-5107(96)00023-1; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; SHILOH Y, 1983, CARCINOGENESIS, V4, P917, DOI 10.1093/carcin/4.7.917; Smith GCM, 1999, P NATL ACAD SCI USA, V96, P11134, DOI 10.1073/pnas.96.20.11134; SUGIMOTO Y, 1990, J ANTIBIOT, V43, P417, DOI 10.7164/antibiotics.43.417; SUGIURA Y, 1993, BIOCHEMISTRY-US, V32, P5548, DOI 10.1021/bi00072a008; Sutherland BM, 2000, BIOCHEMISTRY-US, V39, P8026, DOI 10.1021/bi9927989; SUWA A, 1994, P NATL ACAD SCI USA, V91, P6904, DOI 10.1073/pnas.91.15.6904; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Wang JYJ, 1998, CURR OPIN CELL BIOL, V10, P240, DOI 10.1016/S0955-0674(98)80146-4; Wright JA, 1998, P NATL ACAD SCI USA, V95, P7445, DOI 10.1073/pnas.95.13.7445; XU YJ, 1990, CANCER CHEMOTH PHARM, V27, P41, DOI 10.1007/BF00689274; XU YJ, 1994, BIOCHEMISTRY-US, V33, P5947, DOI 10.1021/bi00185a036; Xu YJ, 1997, BIOCHEMISTRY-US, V36, P14975, DOI 10.1021/bi972101o; ZAMPETTIBOSSELER F, 1985, MUTAT RES, V151, P89, DOI 10.1016/0027-5107(85)90187-3; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	45	28	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20549	20554		10.1074/jbc.M109897200	http://dx.doi.org/10.1074/jbc.M109897200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11927575	hybrid			2022-12-27	WOS:000176204500059
J	Glick, M; Price, DA; Vuidepot, AL; Andersen, TB; Hutchinson, SL; Laugel, B; Sewell, AK; Boulter, JM; Dunbar, PR; Cerundolo, V; Oxenius, A; Bell, JI; Richards, WG; Jakobsen, BK				Glick, M; Price, DA; Vuidepot, AL; Andersen, TB; Hutchinson, SL; Laugel, B; Sewell, AK; Boulter, JM; Dunbar, PR; Cerundolo, V; Oxenius, A; Bell, JI; Richards, WG; Jakobsen, BK			Novel CD8(+) T cell antagonists based on beta(2)-microglobulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION; DYNAMICS; COMPLEX; CTL; PEPTIDES; BINDING; ENERGY; DOMAIN	The CD8 coreceptor of cytotoxic T lymphocytes binds to a conserved region of major histocompatibility complex class I molecules during recognition of peptidemajor histocompatibility complex (AMC) class I antigens on the surface of target cells. This event is central to the activation of cytotoxic T lymphocyte (CTL) effector functions. The contribution of the AMC complex class I light chain, beta(2)-microglobulin, to CD8alphaalpha binding is relatively small and is mediated mainly through the lysine residue at position 58. Despite this, using molecular modeling, we predict that its mutation should have a dramatic effect on CD8aa binding. The predictions are confirmed using surface plasmon resonance binding studies and human CTL activation assays. Surprisingly, the charge-reversing mutation, Lys58 --> Glu, enhances beta(2)M-MHC class I heavy chain interactions. This mutation also significantly reduces CD8aa binding and is a potent antagonist of CTL activation. These results suggest a novel approach to CTL-specific therapeutic immunosuppression.	Avidex Ltd, Abingdon OX14 4RX, Oxon, England; Univ Oxford, Dept Chem, Cent Chem Lab, Oxford OX1 3QH, England; John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Jakobsen, BK (corresponding author), Avidex Ltd, 57 Milton Pk, Abingdon OX14 4RX, Oxon, England.		Sewell, Andrew/GPT-4220-2022; Oxenius, Annette/G-7794-2015; Dunbar, Rod/C-2570-2012; Price, David A/C-7876-2013	Sewell, Andrew/0000-0003-3194-3135; Dunbar, Rod/0000-0001-9626-2600; Price, David A/0000-0001-9416-2737; Cerundolo, Vincenzo/0000-0003-0040-3793				Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Broder CC, 1999, MOL BIOTECHNOL, V13, P223, DOI 10.1385/MB:13:3:223; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BROOKS CL, 1989, J MOL BIOL, V208, P159, DOI 10.1016/0022-2836(89)90093-4; BRUNGER AT, 1987, BIOCHEMISTRY-US, V26, P5153; Dunbar PR, 1999, J IMMUNOL, V162, P6959; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004; LEHNER PJ, 1995, J EXP MED, V181, P79, DOI 10.1084/jem.181.1.79; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MOSS PA, 1991, P NATL ACAD SCI USA, V20, P8987; O'Callaghan CA, 1999, ANAL BIOCHEM, V266, P9, DOI 10.1006/abio.1998.2930; Price DA, 1998, CURR BIOL, V8, P355, DOI 10.1016/S0960-9822(98)70138-1; Purbhoo MA, 2001, J BIOL CHEM, V276, P32786, DOI 10.1074/jbc.M102498200; ROCK KL, 1990, P NATL ACAD SCI USA, V87, P7517, DOI 10.1073/pnas.87.19.7517; Sewell AK, 1999, NAT MED, V5, P399, DOI 10.1038/7398; Shields MJ, 1998, J BIOL CHEM, V273, P28010, DOI 10.1074/jbc.273.43.28010; Tolfvenstam T, 2001, J VIROL, V75, P540, DOI 10.1128/JVI.75.1.540-543.2001; Whelan JA, 1999, J IMMUNOL, V163, P4342; Willcox BE, 1999, PROTEIN SCI, V8, P2418; Xu XN, 2001, IMMUNITY, V14, P591, DOI 10.1016/S1074-7613(01)00133-9	22	14	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20840	20846		10.1074/jbc.M201819200	http://dx.doi.org/10.1074/jbc.M201819200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11914379	hybrid			2022-12-27	WOS:000176204500095
J	Newby, LJ; Streets, AJ; Zhao, Y; Harris, PC; Ward, CJ; Ong, ACM				Newby, LJ; Streets, AJ; Zhao, Y; Harris, PC; Ward, CJ; Ong, ACM			Identification, characterization, and localization of a novel kidney polycystin-1-polycystin-2 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE PROTEIN; PLASMA-MEMBRANE; GENE-PRODUCT; CELL-LINES; PKD1; POLYCYSTIN-1; EXPRESSION; DISTRIBUTIONS; ANTIBODIES; INTERACTS	The functions of the two proteins defective in autosomal dominant polycystic kidney disease, polycystin-1 and polycystin-2, have not been fully clarified, but it has been hypothesized that they may heterodimerize to form a "polycystin complex" involved in cell adhesion. In this paper, we demonstrate for the first time the existence of a native polycystin complex in mouse kidney tubular cells transgenic for PKD1, non-transgenic kidney cells, and normal adult human kidney. Polycystin-1 is heavily N-glycosylated, and several glycosylated forms of polycystin-1 differing in their sensitivity to endoglycosidase H (Endo H) were found; in contrast, native polycystin-2 was fully Endo H-sensitive. Using highly specific antibodies to both proteins, we show that polycystin-2 associates selectively with two species of full-length polycystin-1, one Endo H-sensitive and the other Endo H-resistant; importantly, the latter could be further enriched in plasma membrane fractions and coimmunoprecipitated with poolycystin-2. Finally, a subpopulation of this complex co-localized to the lateral cell borders of PKD1 transgenic kidney cells. These results demonstrate that polycystin-1 and polycystin-2 interact in vivo to form a stable heterodimeric complex and suggest that disruption of this complex is likely to be of primary relevance to the pathogenesis of cyst formation in autosomal dominant polycystic kidney disease.	Univ Sheffield, Sect Med, Div Clin Sci, Sheffield Kidney Inst, Sheffield S5 7AU, S Yorkshire, England; Mayo Clin & Mayo Fdn, Div Nephrol, Dept Internal Med, Rochester, MN 55905 USA	University of Sheffield; Mayo Clinic	Ong, ACM (corresponding author), Univ Sheffield, No Gen Hosp, Med Sect, Sheffield Kidney Inst Clin Sci Ctr, Herries Rd, Sheffield S5 7AU, S Yorkshire, England.	a.ong@sheffield.ac.uk	Ong, Albert/AAN-9430-2021	Ong, Albert/0000-0002-7211-5400				ACKERMANN U, 1990, FEBS LETT, V269, P105, DOI 10.1016/0014-5793(90)81130-G; BERGSMA DJ, 1991, J BIOL CHEM, V266, P23204; BESKROVNAYA OI, 2000, HUM MOL GENET, V9, P1641, DOI DOI 10.1093/HMG/9.11.1641; Boletta A, 2000, MOL CELL, V6, P1267, DOI 10.1016/S1097-2765(00)00123-4; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Charron AJ, 2000, J CELL BIOL, V149, P111, DOI 10.1083/jcb.149.1.111; Chen XZ, 1999, NATURE, V401, P383, DOI 10.1038/43907; Foggensteiner L, 2000, J AM SOC NEPHROL, V11, P814, DOI 10.1681/ASN.V115814; Gallagher AR, 2000, P NATL ACAD SCI USA, V97, P4017, DOI 10.1073/pnas.97.8.4017; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; GREEN M, 1982, CELL, V257, P9039; Grupp C, 1998, EXP NEPHROL, V6, P542; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Huan YH, 1999, J CLIN INVEST, V104, P1459, DOI 10.1172/JCI5111; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; IbraghimovBeskrovnaya O, 1997, P NATL ACAD SCI USA, V94, P6397, DOI 10.1073/pnas.94.12.6397; JAT PS, 1989, MOL CELL BIOL, V9, P1672, DOI 10.1128/MCB.9.4.1672; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Lehtonen S, 2000, J BIOL CHEM, V275, P32888, DOI 10.1074/jbc.M006624200; Lohning C, 1997, MAMM GENOME, V8, P307, DOI 10.1007/s003359900429; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; MAN NT, 1991, J CELL BIOL, V115, P1695; Markowitz GS, 1999, AM J PHYSIOL-RENAL, V277, pF17, DOI 10.1152/ajprenal.1999.277.1.F17; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Moy GW, 1996, J CELL BIOL, V133, P809, DOI 10.1083/jcb.133.4.809; NATHKE IS, 1994, J CELL BIOL, V125, P1341, DOI 10.1083/jcb.125.6.1341; Obermuller N, 1999, AM J PHYSIOL-RENAL, V277, pF914, DOI 10.1152/ajprenal.1999.277.6.F914; OLMSTED JB, 1981, J BIOL CHEM, V256, P1955; Ong ACM, 1999, AM J PATHOL, V154, P1721, DOI 10.1016/S0002-9440(10)65428-4; Ong ACM, 1997, LANCET, V349, P1039, DOI 10.1016/S0140-6736(05)62286-6; Ong ACM, 2000, EXP NEPHROL, V8, P208; Ong ACM, 1999, KIDNEY INT, V56, P1324, DOI 10.1046/j.1523-1755.1999.00659.x; POLLACK L, 1983, J CELL BIOL, V97, P293, DOI 10.1083/jcb.97.2.293; Pritchard L, 2000, HUM MOL GENET, V9, P2617, DOI 10.1093/hmg/9.18.2617; Putney JW, 1999, CELL, V99, P5, DOI 10.1016/S0092-8674(00)80056-2; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; ROTHMAN JE, 1980, P NATL ACAD SCI-BIOL, V77, P780, DOI 10.1073/pnas.77.2.780; Scheffers MS, 2000, HUM MOL GENET, V9, P2743, DOI 10.1093/hmg/9.18.2743; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Vassilev PM, 2001, BIOCHEM BIOPH RES CO, V282, P341, DOI 10.1006/bbrc.2001.4554; Ward CJ, 1996, P NATL ACAD SCI USA, V93, P1524, DOI 10.1073/pnas.93.4.1524; WARD CJ, 1994, CELL, V77, P881; Watnick T, 2000, NAT GENET, V25, P143, DOI 10.1038/75981; Xu XZS, 1997, CELL, V89, P1155, DOI 10.1016/S0092-8674(00)80302-5	44	158	164	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20763	20773		10.1074/jbc.M107788200	http://dx.doi.org/10.1074/jbc.M107788200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11901144	hybrid, Green Accepted			2022-12-27	WOS:000176204500086
J	Saydam, N; Adams, TK; Steiner, F; Schaffner, W; Freedman, JH				Saydam, N; Adams, TK; Steiner, F; Schaffner, W; Freedman, JH			Regulation of metallothionein transcription by the metal-responsive transcription factor MTF-1 - Identification of signal transduction cascades that control metal-inducible transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; I GENE; OXIDATIVE STRESS; MESSENGER-RNA; C-JUN; BINDING-ACTIVITY; HEAVY-METALS; ZINC; INDUCTION; ELEMENT	Every living organism must detoxify nonessential metals and carefully control the intracellular concentration of essential metals. Metallothioneins, which are small, eysteine-rich, metal-binding proteins, play an important role in these processes. In addition, the transcription of their cognate genes is activated in response to metal exposure. The zinc finger transcription factor MTF-1 plays a central role in the metal-inducible transcriptional activation of metallothionein and other genes involved in metal homeostasis and cellular stress response. Here we report that the phosphorylation of MTF-1 plays a critical role in its activation by zinc and cadmium. Inhibitor studies indicate that multiple kinases and signal transduction cascades, including those mediated by protein kinase C, tyrosine kinase, and casein kinase 11, are essential for zinc- and cadmium-inducible transcriptional activation. In addition, calcium signaling is also involved in regulating metal-activated transcription. In contrast, cAMP-dependent protein kinase may not be directly involved in the metal response. Contrary to what has been reported for other transcription factors, inhibition of transcriptional activation does not impair the binding of MTF-1 to DNA, suggesting that phosphorylation is not regulating DNA binding. Elevated phosphorylation of MTF-1 is observed tinder condition of protein kinase C inhibition, suggesting that specific dephosphorylation of this transcription factor contributes to its activation.	Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA; Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland	Duke University; University of Zurich	Freedman, JH (corresponding author), Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA.	jonf@duke.edu			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009949] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01 ES09949] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ADAMS TK, 2000, METAL IONS BIOL MED, V6, P694; Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9; ARIZONO K, 1993, LIFE SCI, V53, P1031, DOI 10.1016/0024-3205(93)90126-N; Athie-M V, 2000, EUR J IMMUNOL, V30, P1425, DOI 10.1002/(SICI)1521-4141(200005)30:5<1425::AID-IMMU1425>3.0.CO;2-Q; Ausubel FM, 1998, CURRENT PROTOCOLS MO; Beyersmann D, 1997, TOXICOL APPL PHARM, V144, P247, DOI 10.1006/taap.1997.8125; Bittel D, 1998, J BIOL CHEM, V273, P7127, DOI 10.1074/jbc.273.12.7127; Bittel DC, 2000, J BIOL CHEM, V275, P37194, DOI 10.1074/jbc.M003863200; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; BRUGNERA E, 1994, NUCLEIC ACIDS RES, V22, P3167, DOI 10.1093/nar/22.15.3167; Chen JP, 1998, ZOOL STUD, V37, P111; Chen XH, 1999, BIOCHEMISTRY-US, V38, P12915, DOI 10.1021/bi9913000; CULOTTA VC, 1989, MOL CELL BIOL, V9, P1376, DOI 10.1128/MCB.9.3.1376; DALTON T, 1994, NUCLEIC ACIDS RES, V22, P5016, DOI 10.1093/nar/22.23.5016; Dalton TP, 1996, J BIOL CHEM, V271, P26233, DOI 10.1074/jbc.271.42.26233; Dalton TP, 2000, COMP BIOCHEM PHYS B, V126, P325, DOI 10.1016/S0305-0491(00)00182-6; Datta PK, 1997, BIOCHEM BIOPH RES CO, V230, P159, DOI 10.1006/bbrc.1996.5655; Ding W, 2000, BIOCHEM BIOPH RES CO, V273, P718, DOI 10.1006/bbrc.2000.3009; DURNAM DM, 1984, MOL CELL BIOL, V4, P484, DOI 10.1128/MCB.4.3.484; FREEDMAN JH, 1989, BIOCHEM BIOPH RES CO, V164, P134, DOI 10.1016/0006-291X(89)91693-8; GARRETT SH, 1992, INT J BIOCHEM, V24, P1669, DOI 10.1016/0020-711X(92)90186-5; Gerber DA, 2000, J BIOL CHEM, V275, P23919, DOI 10.1074/jbc.M002697200; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Gunes C, 1998, EMBO J, V17, P2846, DOI 10.1093/emboj/17.10.2846; HAMER DH, 1986, ANNU REV BIOCHEM, V55, P913, DOI 10.1146/annurev.biochem.55.1.913; Hermesz E, 2001, COMP BIOCHEM PHYS C, V128, P457, DOI 10.1016/S1532-0456(01)00165-X; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; Hofmann K, 1999, NUCLEIC ACIDS RES, V27, P215, DOI 10.1093/nar/27.1.215; IMBRA RJ, 1987, MOL CELL BIOL, V7, P1358, DOI 10.1128/MCB.7.4.1358; KAGI JHR, 1988, BIOCHEMISTRY-US, V27, P8509, DOI 10.1021/bi00423a001; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; KARIN M, 1980, NATURE, V286, P295, DOI 10.1038/286295a0; Karin M, 1998, ANN NY ACAD SCI, V851, P139, DOI 10.1111/j.1749-6632.1998.tb08987.x; Kelly EJ, 1997, P NATL ACAD SCI USA, V94, P10045, DOI 10.1073/pnas.94.19.10045; LaRochelle O, 2001, J BIOL CHEM, V276, P41879, DOI 10.1074/jbc.M108313200; Laychock SG, 2000, MOL CELL ENDOCRINOL, V165, P179, DOI 10.1016/S0303-7207(00)00247-1; Lichtlen P, 2001, NUCLEIC ACIDS RES, V29, P1514, DOI 10.1093/nar/29.7.1514; Masuya Y, 1998, J BIOCHEM-TOKYO, V124, P628; Maur AAD, 1999, BIOL CHEM, V380, P175, DOI 10.1515/BC.1999.026; Murphy BJ, 1999, CANCER RES, V59, P1315; NEBES VL, 1988, BIOCHEM J, V255, P741; PALMITER RD, 1994, P NATL ACAD SCI USA, V91, P1219, DOI 10.1073/pnas.91.4.1219; Pfundt R, 2001, J PATHOL, V193, P248; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; RADTKE F, 1993, EMBO J, V12, P1355, DOI 10.1002/j.1460-2075.1993.tb05780.x; RADTKE F, 1995, NUCLEIC ACIDS RES, V23, P2277, DOI 10.1093/nar/23.12.2277; RIMOLDI D, 1992, RADIAT RES, V131, P325, DOI 10.2307/3578423; Samson SLA, 1998, PROG NUCLEIC ACID RE, V59, P257, DOI 10.1016/S0079-6603(08)61034-X; SATO M, 1993, FREE RADICAL BIO MED, V14, P325, DOI 10.1016/0891-5849(93)90029-T; Saydam N, 2001, J BIOL CHEM, V276, P25487, DOI 10.1074/jbc.M009154200; Sayed M, 2000, J BIOL CHEM, V275, P16569, DOI 10.1074/jbc.M000312200; SEARLE PF, 1990, NUCLEIC ACIDS RES, V18, P4683, DOI 10.1093/nar/18.16.4683; SEARLE PF, 1985, MOL CELL BIOL, V5, P1480, DOI 10.1128/MCB.5.6.1480; Smirnova IV, 2000, J BIOL CHEM, V275, P9377, DOI 10.1074/jbc.275.13.9377; Stohs Sidney J., 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P201; TAMAI KT, 1994, MOL CELL BIOL, V14, P8155, DOI 10.1128/MCB.14.12.8155; THORNALLEY PJ, 1985, BIOCHIM BIOPHYS ACTA, V827, P36, DOI 10.1016/0167-4838(85)90098-6; Viarengo A, 2000, CELL MOL BIOL, V46, P407; WHISLER RL, 1995, ARCH BIOCHEM BIOPHYS, V319, P23, DOI 10.1006/abbi.1995.1263; Winge DR, 1998, PROG NUCLEIC ACID RE, V58, P165; Yu CW, 1997, FEBS LETT, V420, P69, DOI 10.1016/S0014-5793(97)01489-0; YU CW, 1995, BBA-GENE STRUCT EXPR, V1262, P150, DOI 10.1016/0167-4781(95)00070-W; Zhang B, 2001, MOL CELL BIOL, V21, P4505, DOI 10.1128/MCB.21.14.4505-4514.2001	63	146	152	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20438	20445		10.1074/jbc.M110631200	http://dx.doi.org/10.1074/jbc.M110631200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11923282	hybrid			2022-12-27	WOS:000176204500044
J	Yang, YL; Dong, B; Mittelstadt, PR; Xiao, H; Ashwell, JD				Yang, YL; Dong, B; Mittelstadt, PR; Xiao, H; Ashwell, JD			HIV tat binds Egr proteins and enhances Egr-dependent transactivation of the Fas ligand promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; UP-REGULATION; TRANSCRIPTION FACTOR; CYCLOSPORINE-A; DOWN-REGULATION; RETINOIC ACID; EXPRESSION; ACTIVATION; APOPTOSIS	HIV Tat can enhance activation-induced up-regulation of Fas ligand (Fast,), which may contribute to T cell apoptosis in human immune deficiency virus (HIV)-infected individuals. We have assessed functional and physical interactions between Tat and the Egr family of transcription factors (Egr-1, -2, and -3), the latter two of which are major participants in activation-induced Fast, up-regulation. Here we report that whereas Tat itself has no effect on the Fast, promoter, it binds to Egr-2 and -3 and synergizes with them to superinduce expression of a Fast, promoter-driven reporter. A Tat molecule containing a single amino acid substitution that results in the loss of transactivation activity for the HIV long terminal repeat still binds Egr-3 but can no longer enhance Egr-mediated transactivation of the Fast, promoter. Furthermore, the mutated Tat acts as a dominant negative inhibitor, blocking the superinduction of Fast, caused by wild type Tat. Because Tat is present in virus-infected cells and in the serum of HIV-infected individuals, these results suggest that increased expression of Fast, in these circumstances may result from the cooperative activities of activation-induced Egrs and Tat.	NCI, Lab Immune Cell Biol, NIH, Bethesda, MD 20892 USA; Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rockefeller University	Ashwell, JD (corresponding author), NCI, Lab Immune Cell Biol, NIH, Bldg 10,Rm 1B-40, Bethesda, MD 20892 USA.	jda@pop.nci.nih.gov						Albini A, 1998, P NATL ACAD SCI USA, V95, P13153, DOI 10.1073/pnas.95.22.13153; Alexander L, 1997, J VIROL, V71, P6094, DOI 10.1128/JVI.71.8.6094-6099.1997; Algeciras A, 1998, J EXP MED, V187, P711, DOI 10.1084/jem.187.5.711; Badley AD, 1996, J VIROL, V70, P199, DOI 10.1128/JVI.70.1.199-206.1996; Bartz SR, 1999, J VIROL, V73, P1956, DOI 10.1128/JVI.73.3.1956-1963.1999; Baumler CB, 1996, BLOOD, V88, P1741; BAUR AS, 1994, IMMUNITY, V1, P373, DOI 10.1016/1074-7613(94)90068-X; Bieniasz PD, 1999, P NATL ACAD SCI USA, V96, P7791, DOI 10.1073/pnas.96.14.7791; Bohler T, 1997, BLOOD, V90, P886, DOI 10.1182/blood.V90.2.886.886_886_887; Boykins RA, 1999, J IMMUNOL, V163, P15; Brunner T, 2000, J BIOL CHEM, V275, P9767, DOI 10.1074/jbc.275.13.9767; Brunner T, 1996, INT IMMUNOL, V8, P1017, DOI 10.1093/intimm/8.7.1017; Carroll IR, 1998, MOL IMMUNOL, V35, P1171, DOI 10.1016/S0161-5890(98)00107-2; Chow WA, 2000, J IMMUNOL, V164, P3512, DOI 10.4049/jimmunol.164.7.3512; Conant K, 1998, P NATL ACAD SCI USA, V95, P3117, DOI 10.1073/pnas.95.6.3117; CULLEN BR, 1990, CELL, V63, P655, DOI 10.1016/0092-8674(90)90129-3; DEBATIN KM, 1994, BLOOD, V83, P3101, DOI 10.1182/blood.V83.10.3101a.3101a; Dockrell DH, 1998, J CLIN INVEST, V101, P2394, DOI 10.1172/JCI1171; DU ZJ, 1995, CELL, V82, P665, DOI 10.1016/0092-8674(95)90038-1; Gandhi RT, 1998, J EXP MED, V187, P1113, DOI 10.1084/jem.187.7.1113; Genestier L, 1999, J EXP MED, V189, P231, DOI 10.1084/jem.189.2.231; Glynn JM, 1996, J IMMUNOL, V157, P2754; Gougeon ML, 1999, ANN NY ACAD SCI, V887, P199, DOI 10.1111/j.1749-6632.1999.tb07934.x; Herbein G, 1998, J VIROL, V72, P660, DOI 10.1128/JVI.72.1.660-670.1998; Holtz-Heppelmann CJ, 1998, J BIOL CHEM, V273, P4416, DOI 10.1074/jbc.273.8.4416; Hosaka N, 1998, J INFECT DIS, V178, P1030, DOI 10.1086/515700; HOWCROFT TK, 1993, SCIENCE, V260, P1320, DOI 10.1126/science.8493575; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; JONES KA, 1994, ANNU REV BIOCHEM, V63, P717, DOI 10.1146/annurev.bi.63.070194.003441; Jones KA, 1997, GENE DEV, V11, P2593, DOI 10.1101/gad.11.20.2593; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Ju S T, 1999, Int Rev Immunol, V18, P485, DOI 10.3109/08830189909088495; Karn J, 1999, J MOL BIOL, V293, P235, DOI 10.1006/jmbi.1999.3060; Kasibhatla S, 1999, J BIOL CHEM, V274, P987, DOI 10.1074/jbc.274.2.987; KATSIKIS PD, 1995, J EXP MED, V181, P2029, DOI 10.1084/jem.181.6.2029; KUPPUSWAMY M, 1989, NUCLEIC ACIDS RES, V17, P3551, DOI 10.1093/nar/17.9.3551; Lafrenie RM, 1996, J IMMUNOL, V157, P974; Lafrenie RM, 1997, J IMMUNOL, V159, P4077; Latinis KM, 1997, J BIOL CHEM, V272, P31427, DOI 10.1074/jbc.272.50.31427; LI CJ, 1995, SCIENCE, V268, P429, DOI 10.1126/science.7716549; Li-Weber M, 2000, EUR J IMMUNOL, V30, P661, DOI 10.1002/1521-4141(200002)30:2<661::AID-IMMU661>3.3.CO;2-C; MAGES HW, 1993, INT IMMUNOL, V5, P63, DOI 10.1093/intimm/5.1.63; Matsui K, 2000, J IMMUNOL, V164, P3002, DOI 10.4049/jimmunol.164.6.3002; Matsui K, 1998, J IMMUNOL, V161, P3469; Mitra D, 1996, IMMUNOLOGY, V87, P581, DOI 10.1046/j.1365-2567.1996.510589.x; Mittelstadt PR, 1998, MOL CELL BIOL, V18, P3744, DOI 10.1128/MCB.18.7.3744; Mittelstadt PR, 1999, J BIOL CHEM, V274, P3222, DOI 10.1074/jbc.274.5.3222; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Noraz N, 1997, AIDS, V11, P1671, DOI 10.1097/00002030-199714000-00003; Oyaizu N, 1997, J IMMUNOL, V158, P2456; Rengarajan J, 2000, IMMUNITY, V12, P293, DOI 10.1016/S1074-7613(00)80182-X; RUSSELL JH, 1995, CURR OPIN IMMUNOL, V7, P382, DOI 10.1016/0952-7915(95)80114-6; RUSSO MW, 1993, MOL CELL BIOL, V13, P6858, DOI 10.1128/MCB.13.11.6858; Silvestris F, 1998, AIDS, V12, P1103; Sloand EM, 1997, BLOOD, V89, P1357, DOI 10.1182/blood.V89.4.1357; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; Tschopp J, 1998, CURR OPIN IMMUNOL, V10, P552, DOI 10.1016/S0952-7915(98)80223-9; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; WESTENDORP MO, 1995, EMBO J, V14, P546, DOI 10.1002/j.1460-2075.1995.tb07030.x; Xiao H, 2000, EMBO J, V19, P956, DOI 10.1093/emboj/19.5.956; Xiao H, 1998, P NATL ACAD SCI USA, V95, P2146, DOI 10.1073/pnas.95.5.2146; Xu XN, 1999, J EXP MED, V189, P1489, DOI 10.1084/jem.189.9.1489; Xu XN, 1997, J EXP MED, V186, P7, DOI 10.1084/jem.186.1.7; Yagi T, 1998, J ACQ IMMUN DEF SYND, V18, P307, DOI 10.1097/00042560-199808010-00001; YANG Y, 1995, J BIOL CHEM, V270, P18672, DOI 10.1074/jbc.270.31.18672; Yang Y, 2001, APOPTOSIS, V6, P139, DOI 10.1023/A:1009600901706; Yang YL, 1998, IMMUNOPHARMACOLOGY, V40, P139, DOI 10.1016/S0162-3109(98)00036-8; YANG YL, 1995, J EXP MED, V181, P1673, DOI 10.1084/jem.181.5.1673	68	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19482	19487		10.1074/jbc.M201687200	http://dx.doi.org/10.1074/jbc.M201687200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11909874	hybrid			2022-12-27	WOS:000175894800034
J	Kranz, JK; Lee, EK; Nairn, AC; Wand, AJ				Kranz, JK; Lee, EK; Nairn, AC; Wand, AJ			A direct test of the reductionist approach to structural studies of calmodulin activity - Relevance of peptide models of target proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; BINDING DOMAIN PEPTIDE; RESONANCE ASSIGNMENTS; MULTIDIMENSIONAL NMR; SECONDARY STRUCTURE; COMPLEX; RECOGNITION; SENSITIVITY; N-15; C-13	Ca2+-saturated calmodulin (CaM) directly associates with and activates CaM-dependent protein kinase I (CaMKI) through interactions with a short sequence in its regulatory domain. Using heteronuclear NMR C-13-N-15-H-1 correlation experiments, the backbone assignments were determined for CaM bound to a peptide (CaMKIp) corresponding to the CaM-binding sequence of CaMKI. A comparison of chemical shifts for free CaM with those of the CaM-CaMKIp complex indicate large differences throughout the CaM sequence. Using NMR techniques optimized for large proteins, backbone resonance assignments were also determined for CaM bound to the intact CaMKI enzyme. NMR spectra of CaM bound to either the CaMKI enzyme or peptide are virtually identical, indicating that calmodulin is structurally indistinguishable when complexed to the intact kinase or the peptide CaM-binding domain. Chemical shifts of CaM bound to a peptide (smMLCKp) corresponding to the calmodulin-binding domain of smooth muscle myosin light chain kinase are also compared with the CaM.CaMKI complexes. Chemical shifts can differentiate one complex from another, as well as bound versus free states of CaM. In this context, the observed similarity between CaM.CaMKI enzyme and peptide complexes is striking, indicating that the peptide is an excellent mimetic for interaction of calmodulin with the CaMKI enzyme.	Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; Johnson Res Fdn, Philadelphia, PA 19104 USA; Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA	University of Pennsylvania; Rockefeller University	Wand, AJ (corresponding author), Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.			Nairn, Angus/0000-0002-7075-0195	NIDDK NIH HHS [R01 DK039806, DK39806] Funding Source: Medline; NIGMS NIH HHS [GM50402, GM20206] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM020206, R01GM050402] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; BODANSZKY M, 1993, PEPTIDE CHEM PRACTIC; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chin D, 1997, J BIOL CHEM, V272, P31235, DOI 10.1074/jbc.272.50.31235; Chou JJ, 2001, NAT STRUCT BIOL, V8, P990, DOI 10.1038/nsb1101-990; CLUBB RT, 1992, J MAGN RESON, V97, P213, DOI 10.1016/0022-2364(92)90252-3; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; FISHER PJ, 1994, NATURE, V368, P651, DOI 10.1038/368651a0; Goldberg J, 1996, CELL, V84, P875, DOI 10.1016/S0092-8674(00)81066-1; Gomes AV, 2000, ARCH BIOCHEM BIOPHYS, V379, P28, DOI 10.1006/abbi.2000.1827; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; IKURA M, 1991, BIOCHEMISTRY-US, V30, P9216, DOI 10.1021/bi00102a013; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; JAMES P, 1995, TRENDS BIOCHEM SCI, V20, P38, DOI 10.1016/S0968-0004(00)88949-5; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; KNIGHTON DR, 1992, SCIENCE, V258, P130, DOI 10.1126/science.1439761; Kranz JK, 2002, BIOCHEMISTRY-US, V41, P2599, DOI 10.1021/bi011818f; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Larsson G, 2001, PROTEIN SCI, V10, P169, DOI 10.1110/ps.28401; Lee AL, 2000, NAT STRUCT BIOL, V7, P72; Liddington RC, 2002, NATURE, V415, P373, DOI 10.1038/415373a; Matsushita M, 1998, J BIOL CHEM, V273, P21473, DOI 10.1074/jbc.273.34.21473; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Persechini A, 2000, J BIOL CHEM, V275, P4199, DOI 10.1074/jbc.275.6.4199; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; ROTH SM, 1992, BIOCHEMISTRY-US, V31, P1443, DOI 10.1021/bi00120a022; ROTH SM, 1991, BIOCHEMISTRY-US, V30, P10078, DOI 10.1021/bi00106a003; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; VANBERKUM MFA, 1991, J BIOL CHEM, V266, P21488; VANELDIK LJ, 1998, CALMODULIN SIGNAL TR; VUISTER GW, 1992, J MAGN RESON, V98, P428, DOI 10.1016/0022-2364(92)90144-V; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; YOKOKURA H, 1995, J BIOL CHEM, V270, P23851, DOI 10.1074/jbc.270.40.23851; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413	44	43	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 10	2002	277	19					16351	16354		10.1074/jbc.C200139200	http://dx.doi.org/10.1074/jbc.C200139200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	551MB	11904288	hybrid			2022-12-27	WOS:000175564500002
J	Fessler, MB; Malcolm, KC; Duncan, MW; Worthen, GS				Fessler, MB; Malcolm, KC; Duncan, MW; Worthen, GS			A genomic and proteomic analysis of activation of the human neutrophil by lipopolysaccharide and its mediation by p38 mitogen-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; GDP DISSOCIATION INHIBITOR; CALCIUM-BINDING PROTEIN; MESSENGER-RNA; RECEPTOR 2; FUNCTIONAL PROTEOMICS; ACTIN CYTOSKELETON; CYTOSOLIC TARGET; EXPRESSION; PHOSPHORYLATION	Bacterial lipopolysaccharide (LPS) evokes several functional responses in the neutrophil that contribute to innate immunity. Although certain responses, such as adhesion and synthesis of tumor necrosis factor-alpha, are inhibited by pretreatment with an inhibitor of p38 mitogen-activated protein kinase, others, such as actin assembly, are unaffected. The aim of the present study was to investigate the changes in neutrophil gene transcription and protein expression following lipopolysaccharide exposure and to establish their dependence on p38 signaling. Microarray analysis indicated expression of 13% of the 7070 Affymetrix gene set in nonstimulated neutrophils, and LPS up-regulation of 100 distinct genes, including cytokines and chemokines, signaling molecules, and regulators of transcription. Proteomic analysis yielded a separate list of up-regulated modulators of inflammation, signaling molecules, and cytoskeletal proteins. Poor concordance between mRNA transcript and protein expression changes was noted. Pretreatment with the p38 inhibitor SB203580 attenuated 23% of LPS-regulated genes and 18% of LPS-regulated proteins by greater than or equal to40%. This study indicates that p38 plays a selective role in regulation of neutrophil transcripts and proteins following lipopolysaccharide exposure, clarifies that several of the effects of lipopolysaccharide are post-transcriptional and post-translational, and identifies several proteins not previously reported to be involved in the innate immune response.	Natl Jewish Med & Res Ctr, Dept Med, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Sch Pharm, Biochem Mass Spectrometry Facil, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Div Pulm Sci & Crit Care Med, Denver, CO 80262 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Worthen, GS (corresponding author), Natl Jewish Med & Res Ctr, Dept Med, Neustadt Bldg,D403,1400 Jackson St, Denver, CO 80206 USA.	worthens@njc.org	Fessler, Michael B/C-6323-2019	Fessler, Michael B/0000-0002-8262-8613; Duncan, Mark/0000-0001-9256-8274				Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Arnott D, 1998, ANAL BIOCHEM, V258, P1, DOI 10.1006/abio.1998.2566; Barraclough R, 1998, BBA-MOL CELL RES, V1448, P190, DOI 10.1016/S0167-4889(98)00143-8; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bowie A, 2000, J LEUKOCYTE BIOL, V67, P508, DOI 10.1002/jlb.67.4.508; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Brown SB, 1997, BIOCHEM J, V323, P233, DOI 10.1042/bj3230233; CASSATELLA MA, 1995, IMMUNOL TODAY, V16, P21, DOI 10.1016/0167-5699(95)80066-2; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Cohen P, 2000, J BIOL CHEM, V275, P11181, DOI 10.1074/jbc.275.15.11181; Corthals GL, 2000, ELECTROPHORESIS, V21, P1104, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1104::AID-ELPS1104>3.3.CO;2-3; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; de Wit H, 1998, LEUKEMIA, V12, P363, DOI 10.1038/sj.leu.2400950; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; DORSEUIL O, 1995, J LEUKOCYTE BIOL, V58, P108, DOI 10.1002/jlb.58.1.108; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Geiszt M, 2001, BIOCHEM J, V355, P851, DOI 10.1042/bj3550851; Gilbert PM, 2001, J BIOL CHEM, V276, P8014, DOI 10.1074/jbc.M008845200; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Johnston CJ, 1998, TOXICOL SCI, V46, P300, DOI 10.1006/toxs.1998.2557; Karlsson A, 2000, J LEUKOCYTE BIOL, V67, P396, DOI 10.1002/jlb.67.3.396; Karpf AR, 1999, P NATL ACAD SCI USA, V96, P14007, DOI 10.1073/pnas.96.24.14007; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Kriajevska M, 1998, J BIOL CHEM, V273, P9852, DOI 10.1074/jbc.273.16.9852; le Gouvello S, 1998, J IMMUNOL, V161, P1113; LECABEC V, 1994, BIOCHEM J, V303, P481, DOI 10.1042/bj3030481; LEE A, 1993, J LEUKOCYTE BIOL, V54, P283, DOI 10.1002/jlb.54.4.283; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lewis TS, 2000, MOL CELL, V6, P1343, DOI 10.1016/S1097-2765(00)00132-5; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; MARDIAN JKW, 1978, ANAL BIOCHEM, V91, P1, DOI 10.1016/0003-2697(78)90811-4; MARKLUND U, 1993, J BIOL CHEM, V268, P15039; Masuda H, 1996, J BIOCHEM-TOKYO, V120, P415; McDonald PP, 1997, BLOOD, V89, P3421, DOI 10.1182/blood.V89.9.3421; Muzio M, 2000, J LEUKOCYTE BIOL, V67, P450, DOI 10.1002/jlb.67.4.450; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Nick JA, 1997, J CLIN INVEST, V99, P975, DOI 10.1172/JCI119263; Nick JA, 1999, CHEST, V116, p54S, DOI 10.1378/chest.116.suppl_1.54S; Nick JA, 2000, J IMMUNOL, V164, P2151, DOI 10.4049/jimmunol.164.4.2151; Nick JA, 1999, J CLIN INVEST, V103, P851, DOI 10.1172/JCI5257; Pahan K, 1998, J BIOL CHEM, V273, P12219, DOI 10.1074/jbc.273.20.12219; Parker CG, 1998, BIOCHEM BIOPH RES CO, V249, P791, DOI 10.1006/bbrc.1998.9250; PARSONS PE, 1989, AM REV RESPIR DIS, V140, P294, DOI 10.1164/ajrccm/140.2.294; RABILLOUD T, 1994, ELECTROPHORESIS, V15, P1552, DOI 10.1002/elps.11501501223; Regenhard P, 2001, J LEUKOCYTE BIOL, V69, P651; Rosales JL, 1997, J IMMUNOL, V159, P6195; Soskic V, 1999, BIOCHEMISTRY-US, V38, P1757, DOI 10.1021/bi982093r; Steinmetz MO, 2001, EMBO REP, V2, P505, DOI 10.1093/embo-reports/kve105; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; TEAHAN CG, 1992, BIOCHEM J, V286, P549, DOI 10.1042/bj2860549; Teh C, 2000, IMMUNOLOGY, V101, P225, DOI 10.1046/j.1365-2567.2000.00099.x; Triantafilou K, 2001, NAT IMMUNOL, V2, P338, DOI 10.1038/86342; ULICH TR, 1991, AM J PATHOL, V138, P1485; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Valentijn K, 1999, BIOCHEM BIOPH RES CO, V266, P652, DOI 10.1006/bbrc.1999.1883; VALERIUS NH, 1982, ADV EXP MED BIOL, V141, P19; Vartiainen M, 2000, MOL CELL BIOL, V20, P1772, DOI 10.1128/MCB.20.5.1772-1783.2000; Wagner JG, 1999, J LEUKOCYTE BIOL, V66, P10, DOI 10.1002/jlb.66.1.10; Yan JX, 1999, ELECTROPHORESIS, V20, P723, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<723::AID-ELPS723>3.3.CO;2-H; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Yoshimura A, 1999, J IMMUNOL, V163, P1	67	142	178	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2002	277	35					31291	31302		10.1074/jbc.M200755200	http://dx.doi.org/10.1074/jbc.M200755200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	588UB	11943771	hybrid			2022-12-27	WOS:000177718700004
J	Cox, CJ; Espinoza, HM; McWilliams, B; Chappell, K; Morton, L; Hjalt, TA; Semina, EV; Amendt, BA				Cox, CJ; Espinoza, HM; McWilliams, B; Chappell, K; Morton, L; Hjalt, TA; Semina, EV; Amendt, BA			Differential regulation of gene expression by PITX2 isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEFT-RIGHT ASYMMETRY; RIEGER-SYNDROME; HOMEOBOX GENE; HOMEODOMAIN PROTEIN; SIGNALING PATHWAY; DLX2 EXPRESSION; PITUITARY-GLAND; BRANCHIAL ARCH; HEART; TRANSCRIPTION	Three major PITX2 isoforms are differentially expressed in human, mice, zebrafish, chick, and frog tissues. To demonstrate differential regulation of gene expression by these isoforms we used three different promoters and three cell lines. Transient transfection of Chinese hamster ovary, HeLa, and LS-8 cell lines revealed differences in PITX2A and PITX2C activation of the PLOD1 and Dlx2 promoters, however, PITX2B is inactive. In contrast, PITX2B actives the pituitary-specific Prolactin promoter at higher levels than either PITX2A or PITX2C. Interestingly, co-transfection of either PITX2A or PITX2C with PITX2B results in a synergistic activation of the PLOD1 and Dlx2 promoters. Furthermore, PITX2 isoforms have different transcriptional activity dependent upon the cells used for transfection analysis. We have isolated a fourth PITX2 isoform (PITX2D) expressed only in humans, which acts to suppress the transcriptional activity of the other PITX2 isoforms. Electrophoretic mobility shift assays and glutathione S-transferase pull-down experiments demonstrated that all isoforms interact with PITX2D and that PITX2B forms heterodimeric complexes with PITX2A and PITX2C. Our research provides a molecular basis for differential gene regulation through the expression of PITX2 isoforms. PITX2 isoform activities are both promoter- and cell-specific, and our data reveal new mechanisms for PITX2-regulated gene expression.	Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA; Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA	University of Tulsa; University of Iowa	Amendt, BA (corresponding author), Univ Tulsa, Dept Biol Sci, 600 S Coll Ave, Tulsa, OK 74104 USA.			Amendt, Brad A./0000-0001-6524-1006; Cox, Carol/0000-0002-1394-3978	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013941] Funding Source: NIH RePORTER; NIDCR NIH HHS [1-R01-DE13941] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Amendt BA, 1999, MOL CELL BIOL, V19, P7001; Amendt BA, 1998, J BIOL CHEM, V273, P20066, DOI 10.1074/jbc.273.32.20066; Amendt BA, 2000, CELL MOL LIFE SCI, V57, P1652, DOI 10.1007/PL00000647; Arakawa H, 1998, P NATL ACAD SCI USA, V95, P4573, DOI 10.1073/pnas.95.8.4573; Campione M, 1999, DEVELOPMENT, V126, P1225; DAY RN, 1994, MOL ENDOCRINOL, V8, P374, DOI 10.1210/me.8.3.374; Dubnau J, 1996, NATURE, V379, P694, DOI 10.1038/379694a0; Essner JJ, 2000, DEVELOPMENT, V127, P1081; Flomen RH, 1997, J MED GENET, V34, P191, DOI 10.1136/jmg.34.3.191; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Gage PJ, 1999, DEV BIOL, V210, P234; Gage PJ, 1997, HUM MOL GENET, V6, P457, DOI 10.1093/hmg/6.3.457; Green PD, 2001, GENE EXPRESSION, V9, P265, DOI 10.3727/000000001783992515; Hjalt TA, 2000, DEV DYNAM, V218, P195, DOI 10.1002/(SICI)1097-0177(200005)218:1<195::AID-DVDY17>3.0.CO;2-C; Hjalt TA, 2001, J CELL BIOL, V152, P545, DOI 10.1083/jcb.152.3.545; Kitamura K, 1999, DEVELOPMENT, V126, P5749; Kitamura K, 1997, MECH DEVELOP, V67, P83, DOI 10.1016/S0925-4773(97)00110-X; Lamonerie T, 1996, GENE DEV, V10, P1284, DOI 10.1101/gad.10.10.1284; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Liu CY, 2001, DEVELOPMENT, V128, P2039; Liu JK, 1997, DEV DYNAM, V210, P498, DOI 10.1002/(SICI)1097-0177(199712)210:4<498::AID-AJA12>3.0.CO;2-3; Logan M, 1998, CELL, V94, P307, DOI 10.1016/S0092-8674(00)81474-9; Lowen M, 2001, J BIOL CHEM, V276, P42565, DOI 10.1074/jbc.M106536200; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; Mucchielli ML, 1996, MOL CELL NEUROSCI, V8, P258, DOI 10.1006/mcne.1996.0062; Mucchielli ML, 1997, DEV BIOL, V189, P275, DOI 10.1006/dbio.1997.8672; Padanilam B. J., 1992, Human Molecular Genetics, V1, P407, DOI 10.1093/hmg/1.6.407; Piedra ME, 1998, CELL, V94, P319, DOI 10.1016/S0092-8674(00)81475-0; QIU MS, 1995, GENE DEV, V9, P2523, DOI 10.1101/gad.9.20.2523; Ryan AK, 1998, NATURE, V394, P545, DOI 10.1038/29004; Schweickert A, 2000, MECH DEVELOP, V90, P41, DOI 10.1016/S0925-4773(99)00227-0; Semina EV, 1997, HUM MOL GENET, V6, P2109, DOI 10.1093/hmg/6.12.2109; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Smidt MP, 2000, J NEUROCHEM, V75, P1818, DOI 10.1046/j.1471-4159.2000.0751818.x; St Amand TR, 1998, BIOCHEM BIOPH RES CO, V247, P100; Szeto DP, 1996, P NATL ACAD SCI USA, V93, P7706, DOI 10.1073/pnas.93.15.7706; Thomas BL, 2000, DEVELOPMENT, V127, P217; Tremblay JJ, 2000, NEUROENDOCRINOLOGY, V71, P277, DOI 10.1159/000054547; Yoshioka H, 1998, CELL, V94, P299, DOI 10.1016/S0092-8674(00)81473-7; Yu XY, 2001, DEVELOPMENT, V128, P1005	40	130	137	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 12	2002	277	28					25001	25010		10.1074/jbc.M201737200	http://dx.doi.org/10.1074/jbc.M201737200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	571YP	11948188	hybrid			2022-12-27	WOS:000176747000023
J	Eiraku, M; Hirata, Y; Takeshima, H; Hirano, T; Kengaku, M				Eiraku, M; Hirata, Y; Takeshima, H; Hirano, T; Kengaku, M			Delta/Notch-like epidermal growth factor (EGF)-related receptor, a novel EGF-like ReDeat-cont ining protein T ryeted to dendrites of developing and adult central nervous system neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERIC IMMUNOGLOBULIN RECEPTOR; POLARIZED EPITHELIAL-CELLS; SORTING SIGNALS; HIPPOCAMPAL-NEURONS; CYTOPLASMIC DOMAIN; ADAPTER COMPLEXES; MICE LACKING; MDCK CELLS; NOTCH; AP-1	We have identified a novel epidermal growth factor (EGF)-like repeat-containing single-pass transmembrane protein that is specifically expressed in the developing and mature central nervous system. Sequence analysis revealed that the 10 EGF-like repeats in the extracellular domain are closely related to those of the developmentally important receptor Notch and its ligand Delta. We thus named the molecule Delta/Notch-like EGF-related receptor (DNER). DNER protein is strongly expressed in several types of post-mitotic neurons, including cortical and hippocampal pyramidal neurons, cerebellar granule cells, and Purkinje cells. DNER protein is localized to the dendritic plasma membrane and endosomes and is excluded from the axons, even when overexpressed. The tyrosine-based sorting motif in the cytoplasmic domain is required for dendritic targeting of DNER. Direct in vivo binding of DNER to the coat-associated protein complex AP-1 strongly suggests that DNER undergoes AP-1-dependent sorting to the somatodendritic compartments from the transGolgi network and subsequent passage through the endosomal system.	Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi 3320012, Japan; Kurume Univ, Inst Life Sci, Kurume, Fukuoka 8390861, Japan	Kyoto University; Japan Science & Technology Agency (JST); Kurume University	Kengaku, M (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.			Eiraku, Mototsugu/0000-0002-9433-9085; Takeshima, Hiroshi/0000-0003-4525-3725				Baker NE, 2000, BIOESSAYS, V22, P264, DOI 10.1002/(SICI)1521-1878(200003)22:3<264::AID-BIES8>3.0.CO;2-M; Berezovska O, 1999, NEUROSCIENCE, V93, P433, DOI 10.1016/S0306-4522(99)00157-8; Bradke F, 1998, BBA-MOL CELL RES, V1404, P245, DOI 10.1016/S0167-4889(98)00060-3; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; CASANOVA JE, 1991, CELL, V66, P65, DOI 10.1016/0092-8674(91)90139-P; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; Dwyer ND, 2001, NEURON, V31, P277, DOI 10.1016/S0896-6273(01)00361-0; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Folsch H, 2001, J CELL BIOL, V152, P595, DOI 10.1083/jcb.152.3.595; Futter CE, 1998, J CELL BIOL, V141, P611, DOI 10.1083/jcb.141.3.611; Goslin K., 1998, CULTURING NERVE CELL, P339; HANDFORD PA, 1991, NATURE, V351, P164, DOI 10.1038/351164a0; Heilker R, 1999, BIOESSAYS, V21, P558, DOI 10.1002/(SICI)1521-1878(199907)21:7<558::AID-BIES4>3.0.CO;2-R; Honing S, 1998, EMBO J, V17, P1304, DOI 10.1093/emboj/17.5.1304; Jareb M, 1998, NEURON, V20, P855, DOI 10.1016/S0896-6273(00)80468-7; Kawaguchi S, 2000, NEURON, V27, P339, DOI 10.1016/S0896-6273(00)00041-6; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Lehman NL, 2001, AM J MED GENET, V100, P179, DOI 10.1002/ajmg.1245; Lewis J, 1996, CURR OPIN NEUROBIOL, V6, P3, DOI 10.1016/S0959-4388(96)80002-X; MATTER K, 1992, CELL, V71, P741, DOI 10.1016/0092-8674(92)90551-M; Ohno H, 1998, J BIOL CHEM, V273, P25915, DOI 10.1074/jbc.273.40.25915; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Orzech E, 1999, J BIOL CHEM, V274, P2201, DOI 10.1074/jbc.274.4.2201; Poyatos I, 2000, MOL CELL NEUROSCI, V15, P99, DOI 10.1006/mcne.1999.0807; RAO Z, 1995, CELL, V82, P131, DOI 10.1016/0092-8674(95)90059-4; Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148; Rapoport I, 1997, EMBO J, V16, P2240, DOI 10.1093/emboj/16.9.2240; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Smith M, 2001, CYTOGENET CELL GENET, V94, P15, DOI 10.1159/000048775; Stowell JN, 1999, NEURON, V22, P525, DOI 10.1016/S0896-6273(00)80707-2; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Werner JM, 2000, J MOL BIOL, V296, P1065, DOI 10.1006/jmbi.1999.3513; West AE, 1997, J NEUROSCI, V17, P6038; Willnow TE, 1996, P NATL ACAD SCI USA, V93, P8460, DOI 10.1073/pnas.93.16.8460; Wilson JM, 2000, MOL BIOL CELL, V11, P2657, DOI 10.1091/mbc.11.8.2657; Wolpowitz D, 2000, NEURON, V25, P79, DOI 10.1016/S0896-6273(00)80873-9; Yamasaki T, 2001, DEVELOPMENT, V128, P3133; Yang X, 1998, NEURON, V20, P255, DOI 10.1016/S0896-6273(00)80454-7	42	79	84	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 12	2002	277	28					25400	25407		10.1074/jbc.M110793200	http://dx.doi.org/10.1074/jbc.M110793200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	571YP	11950833	hybrid			2022-12-27	WOS:000176747000073
J	Adachi, M; Lewis, EJ				Adachi, M; Lewis, EJ			The paired-like homeodomain protein, arix, mediates protein kinase A-stimulated dopamine beta-hydroxylase gene transcription through its phosphorylation status	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYMPATHETIC NEURON DEVELOPMENT; PHOSPHATASE 2A; DNA-BINDING; CYCLIC-AMP; CAMP-RESPONSE; ACTIVATION; PHOX2A; EXPRESSION; GROWTH; DIFFERENTIATION	The homeodomain transcription factor Arix/Phox2a plays a critical role in the specification of noradrenergic neurons by inducing the expression of dopamine beta-hydroxylase (DBH), the terminal enzyme for noradrenaline biosynthesis. In reporter assays, Arix together with activation of cAMP-dependent protein kinase (PKA) potentiates DBH gene transcription. We have evaluated whether post-translational modification of Arix regulates PKA-mediated DBH gene transcription. We found that Arix is constitutively phosphorylated in vivo at the basal level and that the phosphorylation level is substantially decreased upon stimulation of the PKA pathway. The change in the Arix phosphorylation state coincides with DNA binding activity of Arix. Treatment of cells with forskolin results in a robust enhancement of the DNA binding of Arix, which is reversed by treatment with serine/threonine and tyrosine phosphatase inhibitors. Consistent with the DNA binding activity of Arix, treatment of cultured cells with phosphatase inhibitors diminishes transcriptional activation with Arix plus forskolin. Amino acid analysis demonstrates the presence of phosphoserine within Arix. The results collectively suggest that dephosphorylation of Arix is a necessary event to fully activate PKA-mediated DBH transcription. Thus, the present study demonstrates that Arix can integrate extrinsic signals through post-translational modification, regulating DBH gene transcription in response to activation of the PKA pathway.	Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA	Oregon Health & Science University	Lewis, EJ (corresponding author), Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, L224, Portland, OR 97201 USA.		Adachi, Megumi/M-7746-2017	Adachi, Megumi/0000-0003-3404-6640	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM038696, R01GM038696] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM38696] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adachi M, 2000, DNA CELL BIOL, V19, P539, DOI 10.1089/104454900439773; Berry M, 2000, EMBO J, V19, P2946, DOI 10.1093/emboj/19.12.2946; Bilodeau ML, 2000, MOL CELL BIOL, V20, P3004, DOI 10.1128/MCB.20.9.3004-3014.2000; Coqueret O, 1996, J BIOL CHEM, V271, P24862, DOI 10.1074/jbc.271.40.24862; Coqueret O, 1998, J BIOL CHEM, V273, P2561, DOI 10.1074/jbc.273.5.2561; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DZIENNIS S, 2001, P 31 ANN M SOC NEUR; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Francis NJ, 1999, ANNU REV NEUROSCI, V22, P541, DOI 10.1146/annurev.neuro.22.1.541; Goridis C, 1999, CURR OPIN NEUROBIOL, V9, P47, DOI 10.1016/S0959-4388(99)80006-3; Guo S, 1999, DEV BIOL, V208, P473, DOI 10.1006/dbio.1999.9204; Guo S, 1999, NEURON, V24, P555, DOI 10.1016/S0896-6273(00)81112-5; Gupta IR, 1999, J BIOL CHEM, V274, P26305, DOI 10.1074/jbc.274.37.26305; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; Jaffe L, 1997, GENE DEV, V11, P1327, DOI 10.1101/gad.11.10.1327; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kasahara H, 1999, MOL CELL BIOL, V19, P526; Kim HS, 1998, J NEUROSCI, V18, P8247; Lee YS, 1997, J CELL PHYSIOL, V170, P153, DOI 10.1002/(SICI)1097-4652(199702)170:2<153::AID-JCP7>3.0.CO;2-N; Lo LC, 1999, NEURON, V22, P693, DOI 10.1016/S0896-6273(00)80729-1; Marquardt T, 2001, CELL, V106, P651, DOI 10.1016/S0092-8674(01)00499-8; MAURER RA, 1989, J BIOL CHEM, V264, P6870; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; Morin X, 1997, NEURON, V18, P411, DOI 10.1016/S0896-6273(00)81242-8; Nakano M, 2001, NAT GENET, V29, P315, DOI 10.1038/ng744; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Patzke H, 2001, MECH DEVELOP, V108, P149, DOI 10.1016/S0925-4773(01)00503-2; Reissmann E, 1996, DEVELOPMENT, V122, P2079; Sabban EL, 2001, TRENDS NEUROSCI, V24, P91, DOI 10.1016/S0166-2236(00)01687-8; SEGIL N, 1991, SCIENCE, V254, P1814, DOI 10.1126/science.1684878; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; SHASKUS J, 1992, J BIOL CHEM, V267, P18821; Stanke M, 1999, DEVELOPMENT, V126, P4087; Stoker AW, 2001, CURR OPIN NEUROBIOL, V11, P95, DOI 10.1016/S0959-4388(00)00179-3; Swanson DJ, 1997, J BIOL CHEM, V272, P27382, DOI 10.1074/jbc.272.43.27382; Swanson DJ, 1998, J BIOL CHEM, V273, P24065, DOI 10.1074/jbc.273.37.24065; Swanson DJ, 2000, J BIOL CHEM, V275, P2911, DOI 10.1074/jbc.275.4.2911; Usui H, 1998, FEBS LETT, V430, P312, DOI 10.1016/S0014-5793(98)00684-X; Whitmarsh AJ, 2000, CELL MOL LIFE SCI, V57, P1172, DOI 10.1007/PL00000757; Yang CY, 1998, J NEUROCHEM, V71, P1813	42	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22915	22924		10.1074/jbc.M201695200	http://dx.doi.org/10.1074/jbc.M201695200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11943777	hybrid			2022-12-27	WOS:000176313600104
J	Dahle, MK; Gronning, LM; Cederberg, A; Blomhoff, HK; Miura, N; Enerback, S; Tasken, KA; Tasken, K				Dahle, MK; Gronning, LM; Cederberg, A; Blomhoff, HK; Miura, N; Enerback, S; Tasken, KA; Tasken, K			Mechanisms of FOXC2- and FOXD1-mediated regulation of the RI alpha subunit of cAMP-dependent protein kinase include release of transcriptional repression and activation by protein kinase B alpha and cAMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLLICLE-STIMULATING-HORMONE; HUMAN FORKHEAD GENE; WINGED HELIX PROTEINS; CYCLIC-AMP; BETA SUBUNIT; DNA-BINDING; TRANSLATION INITIATION; INSULIN-RESISTANCE; NUCLEAR EXCLUSION; MESSENGER-RNA	We have reported recently that mice overexpressing the forkhead/winged helix transcription factor FOXC2 are lean and show increased responsiveness to insulin due to sensitization of the beta-adrenergic cAMP-PKA(+) pathway and increased levels of the RIalpha subunit of cAMP-dependent protein kinase (PKA) (Cederberg, A., Gronning, L.M., Ahren, B., Tasken, K., Carlsson, P., and Enerback, S. (2001) Cell 106, 563-573). In this present study, we reveal that FOXC2 and a related factor, FOXD1, specifically activate the 1b promoter of the RIa gene in adipocytes and testicular Sertoli cells, respectively. By deletional mapping, we discovered two different mechanisms by which the Fox proteins activated expression from the RIalpha1b promoter. In 3T3-L1 adipocytes, an upstream region represses promoter activity under basal conditions. Bandshift experiments indicate that overexpression of FOXC2 promotes the release of a potential repressor from this region. In Sertoli cells, sequences downstream of the transcription start sites mediate the activating effect of FOXD1, and protein kinase Balpha/Akt1 strongly induces this effect. Furthermore, we show that an inactive FOXD1 mutant lowers the cAMP-mediated induction of the RIalpha1b reporter construct. In summary, winged helix transcription factors of the FOXC/FOXD families function as regulators of the RIalpha subunit of PKA and may integrate hormonal signals acting through protein kinase B and cAMP in a cell-specific manner.	Univ Oslo, Inst Basic Med Sci, Dept Med Biochem, N-0317 Oslo, Norway; Gothenburg Univ, Dept Med Biochem, SE-40530 Gothenburg, Sweden; Hamamatsu Univ Sch Med, Dept Biochem, Hamamatsu, Shizuoka 4313192, Japan	University of Oslo; University of Gothenburg; Hamamatsu University School of Medicine	Tasken, K (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Med Biochem, POB 1112 Blindern, N-0317 Oslo, Norway.	kjetil.tasken@basalmed.uio.no	Dahle, Maria K/AAK-5130-2021	Dahle, Maria K/0000-0003-0380-084X; Tasken, Kjetil/0000-0003-2841-4697				Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Amieux PS, 1997, J BIOL CHEM, V272, P3993, DOI 10.1074/jbc.272.7.3993; Astoul E, 1999, J CELL BIOL, V145, P1511, DOI 10.1083/jcb.145.7.1511; Barradeau S, 2000, FEBS LETT, V476, P272, DOI 10.1016/S0014-5793(00)01653-7; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brodbeck D, 1999, J BIOL CHEM, V274, P9133, DOI 10.1074/jbc.274.14.9133; Calera MR, 1998, J BIOL CHEM, V273, P7201, DOI 10.1074/jbc.273.13.7201; Cass LA, 1999, MOL CELL BIOL, V19, P5882; Cederberg A, 1997, GENOMICS, V44, P344, DOI 10.1006/geno.1997.4864; Cederberg A, 1999, J BIOL CHEM, V274, P165, DOI 10.1074/jbc.274.1.165; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Chaudhary J, 2000, ENDOCRINOLOGY, V141, P2758, DOI 10.1210/en.141.8.2758; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; CHENG JQ, 1992, P NATL ACAD SCI USA, V89, P9267, DOI 10.1073/pnas.89.19.9267; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; COFFER PJ, 1991, EUR J BIOCHEM, V201, P475, DOI 10.1111/j.1432-1033.1991.tb16305.x; Collas P, 1999, J CELL SCI, V112, P1045; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; Dahle MK, 2001, EUR J BIOCHEM, V268, P5920, DOI 10.1046/j.0014-2956.2001.02542.x; Dahle MK, 2001, MOL REPROD DEV, V59, P11, DOI 10.1002/mrd.1001; DAHLE MK, 2001, MOL REPROD DEV, V268, P5920; DIRKSEN ML, 1995, DEV GENET, V17, P107, DOI 10.1002/dvg.1020170203; DORRINGTON JH, 1975, MOL CELL ENDOCRINOL, V3, P57, DOI 10.1016/0303-7207(75)90031-3; Ernstsson S, 1997, GENOMICS, V46, P78, DOI 10.1006/geno.1997.4986; Ernstsson S, 1996, J BIOL CHEM, V271, P21094, DOI 10.1074/jbc.271.35.21094; Filippa N, 1999, MOL CELL BIOL, V19, P4989; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gonzalez-Robayna IJ, 2000, MOL ENDOCRINOL, V14, P1283, DOI 10.1210/me.14.8.1283; Gronning LM, 2002, MOL ENDOCRINOL, V16, P873, DOI 10.1210/me.16.4.873; Gronning LM, 1999, EUR J ENDOCRINOL, V141, P75, DOI 10.1530/eje.0.1410075; HANSSON V, 1976, VITAM HORM, V34, P187, DOI 10.1016/S0083-6729(08)60076-X; Iida K, 1997, DEVELOPMENT, V124, P4627; Jackson JG, 2000, ONCOGENE, V19, P4574, DOI 10.1038/sj.onc.1203825; KAESTNER KH, 1993, P NATL ACAD SCI USA, V90, P7628, DOI 10.1073/pnas.90.16.7628; Kaestner KH, 2000, GENE DEV, V14, P142; Knutsen HK, 1997, MOL CELL ENDOCRINOL, V129, P101, DOI 10.1016/S0303-7207(97)04045-8; Koipally J, 2000, J BIOL CHEM, V275, P19594, DOI 10.1074/jbc.M000254200; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kops GJPL, 2000, J ANAT, V197, P571, DOI 10.1046/j.1469-7580.2000.19740571.x; LAI E, 1993, P NATL ACAD SCI USA, V90, P10421, DOI 10.1073/pnas.90.22.10421; LAI E, 1991, GENE DEV, V5, P416, DOI 10.1101/gad.5.3.416; Larsson C, 1995, GENOMICS, V30, P464, DOI 10.1006/geno.1995.1266; Malik TH, 2001, EMBO J, V20, P1715, DOI 10.1093/emboj/20.7.1715; McKnight GS, 1998, RECENT PROG HORM RES, V53, P139; Miura N, 1997, GENOMICS, V41, P489, DOI 10.1006/geno.1997.4695; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Molnar A, 1996, J IMMUNOL, V156, P585; Nakayama Y, 1999, INT J DEV BIOL, V43, P343; OYEN O, 1987, BIOL REPROD, V37, P947, DOI 10.1095/biolreprod37.4.947; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; Planas JV, 1999, J BIOL CHEM, V274, P36281, DOI 10.1074/jbc.274.51.36281; POTHIER F, 1992, DNA CELL BIOL, V11, P83, DOI 10.1089/dna.1992.11.83; Shantz LM, 1996, CANCER RES, V56, P3265; Solberg R, 1997, ENDOCRINOLOGY, V138, P169, DOI 10.1210/en.138.1.169; Takaishi H, 1999, P NATL ACAD SCI USA, V96, P11836, DOI 10.1073/pnas.96.21.11836; Tasken K, 1997, ADV SEC MESS PHOSPH, V31, P191; van Dongen MJP, 2000, J MOL BIOL, V296, P351, DOI 10.1006/jmbi.1999.3476; Yanga XL, 2000, FEBS LETT, V470, P29, DOI 10.1016/S0014-5793(00)01285-0	61	37	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22902	22908		10.1074/jbc.M200131200	http://dx.doi.org/10.1074/jbc.M200131200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11943768	hybrid			2022-12-27	WOS:000176313600102
J	Kim, Y; Suh, N; Sporn, M; Reed, JC				Kim, Y; Suh, N; Sporn, M; Reed, JC			An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; NF-KAPPA-B; UBIQUITIN-PROTEASOME PATHWAY; PPAR-GAMMA; 2-CYANO-3,12-DIOXOOLEAN-1,9-DIEN-28-OIC ACID; SYNTHETIC OLEANANE; DIRECT INHIBITORS; CANCER-CELLS; DEATH; LIGAND	TRAIL (Apo2 ligand) is a member of the tumor necrosis factor (TNF) family of cytokines that induces apoptosis. Because TRAIL preferentially kills tumor cells, sparing normal tissues, interest has emerged in applying this biological factor for cancer therapy in humans. However, not all tumors respond to TRAIL, raising questions about resistance mechanisms. We demonstrate here that a variety of natural and synthetic ligands of peroxisome proliferator-activated receptor-gamma (PPARgamma) sensitize tumor but not normal cells to apoptosis induction by TRAIL. PPARgamma ligands selectively reduce levels of FLIP, an apoptosis-suppressing protein that blocks early events in TRAIL/TNF family death receptor signaling. Both PPARgamma agonists and antagonists displayed these effects, regardless of the levels of PPARgamma expression and even in the presence of a PPARgamma dominant-negative mutant, indicating a PPARgamma-independent mechanism. Reductions in FLIP and sensitization to TRAIL-induced apoptosis were also not correlated with TNF-kappaB, further suggesting a novel mechanism. PPARgamma modulators induced ubiquitination and proteasome-dependent degradation of FLIP, without concomitant reductions in FLIP mRNA. The findings suggest the existence of a pharmacologically regulated novel target of this class of drugs that controls FLIP protein turnover, and raise the possibility of combining PPARgamma modulators with TRAIL for more efficacious elimination of tumor cells through apoptosis.	Burnham Inst, La Jolla, CA 92037 USA; Dartmouth Coll, Sch Med, Dept Pharmacol, Hanover, NH 03755 USA	Sanford Burnham Prebys Medical Discovery Institute; Dartmouth College	Reed, JC (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jreed@burnham.org	高, 雨莉/HGU-8187-2022		NCI NIH HHS [CA 69381, CA55164, CA78040] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA055164, P01CA078040, P01CA069381] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Algeciras-Schimnich A, 1999, J IMMUNOL, V162, P5205; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BENNETT CF, 1992, MOL PHARMACOL, V41, P1023; Bonavida B, 1999, INT J ONCOL, V15, P793; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Elstner E, 1998, P NATL ACAD SCI USA, V95, P8806, DOI 10.1073/pnas.95.15.8806; Fukazawa T, 2001, ONCOGENE, V20, P5225, DOI 10.1038/sj.onc.1204673; Fulda S, 2000, CANCER RES, V60, P3947; Goke R, 2000, CELL IMMUNOL, V201, P77, DOI 10.1006/cimm.2000.1650; Golstein P, 1997, CURR BIOL, V7, pR750, DOI 10.1016/S0960-9822(06)90000-1; Griffith TS, 1998, J IMMUNOL, V161, P2833; Griffith TS, 1998, CURR OPIN IMMUNOL, V10, P559, DOI 10.1016/S0952-7915(98)80224-0; Gurnell M, 2000, J BIOL CHEM, V275, P5754, DOI 10.1074/jbc.275.8.5754; Honda T, 2000, J MED CHEM, V43, P4233, DOI 10.1021/jm0002230; Hu WH, 1999, J BIOL CHEM, V274, P30603, DOI 10.1074/jbc.274.43.30603; Hu WH, 2000, J BIOL CHEM, V275, P10838, DOI 10.1074/jbc.275.15.10838; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Ito Y, 2001, MOL PHARMACOL, V59, P1094, DOI 10.1124/mol.59.5.1094; Ito Y, 2000, CELL GROWTH DIFFER, V11, P261; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Kataoka T, 2001, J BIOL CHEM, V276, P19548, DOI 10.1074/jbc.M010520200; Kim YS, 1998, J BIOL CHEM, V273, P27686, DOI 10.1074/jbc.273.42.27686; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Lawrence D, 2001, NAT MED, V7, P383, DOI 10.1038/86397; Lefebvre AM, 1998, NAT MED, V4, P1053, DOI 10.1038/2036; LOS M, 1995, NATURE, V375, P81, DOI 10.1038/375081a0; McKay RA, 1999, J BIOL CHEM, V274, P1715, DOI 10.1074/jbc.274.3.1715; Nagata S, 2000, NAT MED, V6, P502, DOI 10.1038/74972; Palakurthi SS, 2001, CANCER RES, V61, P6213; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Polakis P, 2001, CELL, V105, P563, DOI 10.1016/S0092-8674(01)00379-8; Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Saez E, 1998, NAT MED, V4, P1058, DOI 10.1038/2042; Sarraf P, 1998, NAT MED, V4, P1046, DOI 10.1038/2030; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Scaffidi C, 1997, J BIOL CHEM, V272, P26953, DOI 10.1074/jbc.272.43.26953; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Suh N, 1999, CANCER RES, V59, P5671; Suh NJ, 1999, CANCER RES, V59, P336; TEWARI M, 1995, J BIOL CHEM, V270, P18738, DOI 10.1074/jbc.270.32.18738; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Torii S, 1999, EMBO J, V18, P6037, DOI 10.1093/emboj/18.21.6037; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang YP, 2000, MOL ENDOCRINOL, V14, P1550, DOI 10.1210/me.14.10.1550; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g	54	279	317	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22320	22329		10.1074/jbc.M202458200	http://dx.doi.org/10.1074/jbc.M202458200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11940602	hybrid			2022-12-27	WOS:000176313600028
J	Kisselev, AF; Kaganovich, D; Goldberg, AL				Kisselev, AF; Kaganovich, D; Goldberg, AL			Binding of hydrophobic peptides to several non-catalytic sites promotes peptide hydrolysis by all active sites of 20 S proteasomes - Evidence for peptide-induced channel opening in the alpha-rings	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SUBUNITS; MULTICATALYTIC PROTEASE; CORE PARTICLE; INHIBITORS; YEAST; 20-S-PROTEASOME; DEGRADATION; RESOLUTION; ACTIVATION; MECHANISM	The eukaryotic 20 S proteasome contains the following 6 active sites: 2 chymotrypsin-like, 2 trypsin-like, and 2 caspase-like. We previously showed that hydrophobic peptide substrates of the chymotrypsin-like sites allosterically stimulate peptide hydrolysis by the caspase-like sites and their own cleavage. More thorough analysis revealed that these peptides also stimulate peptide hydrolysis by the trypsin-like site. This general activation by hydrophobic peptides occurred even if the chymotrypsin-like sites were occupied by a covalent inhibitor and was highly cooperative, with an average Hill coefficient of 7. Therefore, this stimulation of peptide hydrolysis at all active sites occurs upon binding of hydrophobic peptides to several non-catalytic sites. The stimulation by hydrophobic peptides was not observed in the yeast DeltaNalpha3 mutant 20 S proteasomes, in 20 S-PA26 complexes, or SDS-activated proteasomes and was significantly lower in 26 S proteasomes, all of which appear to have the gated channel in the a-rings in an open conformation and hydrolyze peptides at much faster rates than 20 S proteasomes. Also the hydrophobic peptides altered K-m, V-max. of active sites in a similar fashion as PA26 and the DeltaNalpha3 mutation. The activation by hydrophobic peptides was decreased in K+-containing buffer, which favors the closed state of the channels. Therefore, hydrophobic peptides stimulate peptide hydrolysis most likely by promoting the opening of the channels in the a-rings. During protein breakdown, this peptide-induced channel opening may function to facilitate the release of products from the proteasome.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Goldberg, AL (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	alfred_goldberg@hms.harvard.edu		Kaganovich, Daniel/0000-0003-2398-1596				Arendt CS, 1997, P NATL ACAD SCI USA, V94, P7156, DOI 10.1073/pnas.94.14.7156; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Benaroudj N, 2000, NAT CELL BIOL, V2, P833, DOI 10.1038/35041081; Bogyo M, 1997, P NATL ACAD SCI USA, V94, P6629, DOI 10.1073/pnas.94.13.6629; Bogyo M, 1998, CHEM BIOL, V5, P307, DOI 10.1016/S1074-5521(98)90169-7; CASCIO P, 2002, IN PRESS EMBO J; Chen P, 1996, CELL, V86, P961, DOI 10.1016/S0092-8674(00)80171-3; CHU-PING M, 1992, Journal of Biological Chemistry, V267, P10515; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Dick TP, 1998, J BIOL CHEM, V273, P25637, DOI 10.1074/jbc.273.40.25637; DUBIEL W, 1992, J BIOL CHEM, V267, P22369; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Harris JL, 2001, CHEM BIOL, V8, P1131, DOI 10.1016/S1074-5521(01)00080-1; Heinemeyer W, 1997, J BIOL CHEM, V272, P25200, DOI 10.1074/jbc.272.40.25200; Kessler BM, 2001, CHEM BIOL, V8, P913, DOI 10.1016/S1074-5521(01)00069-2; Kisselev AF, 1999, MOL CELL, V4, P395, DOI 10.1016/S1097-2765(00)80341-X; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Kopp F, 2001, J MOL BIOL, V313, P465, DOI 10.1006/jmbi.2001.5063; Li J, 2001, EMBO J, V20, P3359, DOI 10.1093/emboj/20.13.3359; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; MA CP, 1994, J BIOL CHEM, V269, P3539; Myung J, 2001, MOL CELL, V7, P411, DOI 10.1016/S1097-2765(01)00188-5; Osmulski PK, 2000, J BIOL CHEM, V275, P13171, DOI 10.1074/jbc.C901035199; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Saric T, 2001, J BIOL CHEM, V276, P36474, DOI 10.1074/jbc.M105517200; Schmidtke G, 2000, J BIOL CHEM, V275, P22056, DOI 10.1074/jbc.M002513200; Tarcsa E, 2000, J BIOL CHEM, V275, P20295, DOI 10.1074/jbc.M001555200; Verma R, 2000, CELL, V101, P341, DOI 10.1016/S0092-8674(00)80843-0; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; WENZEL T, 1995, NAT STRUCT BIOL, V2, P199, DOI 10.1038/nsb0395-199; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Wilk S, 1999, ARCH BIOCHEM BIOPHYS, V362, P283, DOI 10.1006/abbi.1998.1034; WILK S, 1983, J NEUROCHEM, V40, P842, DOI 10.1111/j.1471-4159.1983.tb08056.x; [No title captured]	37	144	151	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22260	22270		10.1074/jbc.M112360200	http://dx.doi.org/10.1074/jbc.M112360200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11927581	hybrid			2022-12-27	WOS:000176313600021
J	Fujioka, Y; Kimata, Y; Nomaguchi, K; Watanabe, K; Kohno, K				Fujioka, Y; Kimata, Y; Nomaguchi, K; Watanabe, K; Kohno, K			Identification of a novel non-structural maintenance of chromosomes (SMC) component of the SMC5-SMC6 complex involved in DNA repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SISTER CHROMATIDS; PROTEIN; YEAST; SEPARATION; MUTATION; COHESION; RAD18; CONDENSATION; TRIGGERS	Structural maintenance of chromosomes (SMC) proteins play central roles in chromosome organization and dynamics. They have been classified into six subtypes, termed SMC1 to SMC6, and function as heterodimer components of large protein complexes that also include several non-SMC proteins. The SMC2-SMC4 and SMC1-SMC3 complexes are also known as condensin and cohesin, respectively, but the recently identified SMC5 and SMC6 complex is less well characterized. Here, we report that NSE1 from Saccharomyces cerevisiae encodes a novel non-SMC component of the SMC5(Yo1034wp)SMC6(Rhc18p) complex corresponding to the 2-3-MDa molecular mass. Nse1p is essential for cell proliferation and localizes primarily in the nucleus. nse1 mutants are highly sensitive to DNA-damaging treatments and exhibit abnormal cellular morphologies, suggesting aberrant mitosis as a terminal morphological phenotype. These results are consistent with the reported features of the Schizosaccharomyces pombe SMC6 gene, rad18, which is thought to be involved in recombinational DNA repair. We conclude that Nse1p and the SMC5-SMC6 heterodimer together form a high molecular mass complex that is conserved in eukaryotes and required for both DNA repair and proliferation.	Nara Inst Sci & Technol, Res & Educ Ctr Genet Informat, Nara 6300101, Japan	Nara Institute of Science & Technology	Kohno, K (corresponding author), Nara Inst Sci & Technol, Res & Educ Ctr Genet Informat, 8916-5 Takayama, Nara 6300101, Japan.		Kohno, Kenji/AAZ-6573-2020	Kohno, Kenji/0000-0002-3503-6551				Cobbe N, 2000, J STRUCT BIOL, V129, P123, DOI 10.1006/jsbi.2000.4255; Ewaskow SP, 1998, BIOCHEMISTRY-US, V37, P4437, DOI 10.1021/bi972652e; Fousteri MI, 2000, EMBO J, V19, P1691, DOI 10.1093/emboj/19.7.1691; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Higashio H, 2000, J BIOL CHEM, V275, P17900, DOI 10.1074/jbc.M000751200; Hirano T, 2000, ANNU REV BIOCHEM, V69, P115, DOI 10.1146/annurev.biochem.69.1.115; Hirano T, 1998, CURR OPIN CELL BIOL, V10, P317, DOI 10.1016/S0955-0674(98)80006-9; Hirano T, 1999, GENE DEV, V13, P11, DOI 10.1101/gad.13.1.11; Iha H, 1998, BIOTECHNIQUES, V25, P936, DOI 10.2144/98256bm01; Jensen ON, 1999, METH MOL B, V112, P513; Jessberger R, 1998, CURR OPIN GENET DEV, V8, P254, DOI 10.1016/S0959-437X(98)80149-4; JONES S, 2001, GENOME BIOL, V2; Kaiser C., 1994, METHODS YEAST GENETI; Kimata Y, 1997, BIOCHEM BIOPH RES CO, V232, P69, DOI 10.1006/bbrc.1997.6235; Kimata Y, 1999, CELL STRUCT FUNCT, V24, P197, DOI 10.1247/csf.24.197; Kimura K, 1998, SCIENCE, V282, P487, DOI 10.1126/science.282.5388.487; LEHMANN AR, 1995, MOL CELL BIOL, V15, P7067; Mengiste T, 1999, EMBO J, V18, P4505, DOI 10.1093/emboj/18.16.4505; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Okamura K, 2000, BIOCHEM BIOPH RES CO, V279, P445, DOI 10.1006/bbrc.2000.3987; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Strunnikov AV, 1999, EUR J BIOCHEM, V263, P6, DOI 10.1046/j.1432-1327.1999.00509.x; Taylor EM, 2001, MOL BIOL CELL, V12, P1583, DOI 10.1091/mbc.12.6.1583; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Verkade HM, 1999, MOL BIOL CELL, V10, P2905, DOI 10.1091/mbc.10.9.2905; WATANABE K, 1997, THESIS NARA I SCI TE	29	81	82	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21585	21591		10.1074/jbc.M201523200	http://dx.doi.org/10.1074/jbc.M201523200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11927594	hybrid			2022-12-27	WOS:000176286000062
J	Mito, M; Chong, KT; Miyazaki, G; Adachi, S; Park, SY; Tame, JRH; Morimoto, H				Mito, M; Chong, KT; Miyazaki, G; Adachi, S; Park, SY; Tame, JRH; Morimoto, H			Crystal structures of deoxy- and carbonmonoxyhemoglobin F1 from the hagfish Eptatretus burgeri	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; MYXINE-GLUTINOSA; OXYGEN EQUILIBRIUM; LAMPREY HEMOGLOBIN; AGGREGATION; SUPEROXIDE; SEQUENCES; BINDING; STATE; DEOXY	Hagfish are extremely primitive jawless fish of disputed ancestry. Although generally classed with lampreys as cyclostomes ("round mouths"), it is clear that they diverged from them several hundred million years ago. The crystal structures of the deoxy and CO forms of hemoglobin from a hagfish (Eptatretus burgeri) have been solved at 1.6 and 2.1 Angstrom, respectively. The deoxy crystal contains one dimer and two monomers in a unit cell, with the dimer being similar to that found in lamprey deoxy-Hb, but with a larger interface and different relative orientation of the partner chains. Ile(E11) and Gln(E7) obstruct ligand binding in the deoxy form and make room for ligands in the CO form, but no interaction path between the two hemes could be identified. The BGH core structure, which forms the a, 13, interface of all vertebrate alpha(2)beta(2) tetrameric Hbs, is conserved in hagfish and lamprey Hbs. It was shown previously that human and cartilaginous fish Hbs have independently evolved stereochemical mechanisms other than the movement of the proximal histidine to regulate ligand binding at the hemes. Our results therefore suggest that the formation of the alpha(2)beta(2) tetramer using the BGH core and the mechanism of quaternary structure change evolved between the branching points of hagfish and lampreys from other vertebrates.	Yokohama City Univ, Prot Design Lab, Kanagawa 2300045, Japan; Osaka Univ, Grad Sch Engn Sci, Div Biophys Engn, Osaka 5608531, Japan; Osaka Univ, Inst Prot Res, Osaka 5600871, Japan; RIKEN Harima Inst SPring8, Sayo, Hyogo 6795148, Japan	Yokohama City University; Osaka University; Osaka University; RIKEN	Tame, JRH (corresponding author), Yokohama City Univ, Prot Design Lab, Suehiro 1-7-29, Kanagawa 2300045, Japan.	jtame@tsurumi.yokohama-cu.ac.jp		Adachi, Shin-ichi/0000-0002-3676-1165				Adachi S, 2001, NUCL INSTRUM METH A, V467, P711, DOI 10.1016/S0168-9002(01)00472-7; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BALDWIN J, 1979, J MOL BIOL, V129, P175, DOI 10.1016/0022-2836(79)90277-8; BANNAI S, 1972, J BIOL CHEM, V247, P505; BORGSTAHL GEO, 1994, J MOL BIOL, V236, P831, DOI 10.1006/jmbi.1994.1192; BORGSTAHL GEO, 1994, J MOL BIOL, V236, P817, DOI 10.1006/jmbi.1994.1191; BRIEHL RW, 1963, J BIOL CHEM, V238, P2361; BRITTAIN T, 1991, COMP BIOCHEM PHYS B, V99, P731, DOI 10.1016/0305-0491(91)90136-2; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P585, DOI 10.1107/S0108767390002355; BRUNGER AT, 1996, XPLOR VERSION 3 85; CAMARDELLA L, 1992, J MOL BIOL, V224, P449, DOI 10.1016/0022-2836(92)91007-C; Chong KT, 1999, ACTA CRYSTALLOGR D, V55, P1291, DOI 10.1107/S0907444999005934; DOHI Y, 1973, J BIOL CHEM, V248, P2354; Fago A, 1999, RESP PHYSIOL, V115, P309, DOI 10.1016/S0034-5687(98)00102-9; Fago A, 1998, BIOLOGY OF HAGFISHES, P321; Fago A, 2001, J BIOL CHEM, V276, P27415, DOI 10.1074/jbc.M100759200; FAGO A, 1995, BBA-PROTEIN STRUCT M, V1249, P109, DOI 10.1016/0167-4838(95)00031-O; FOREY P, 1993, NATURE, V361, P129, DOI 10.1038/361129a0; GOODMAN M, 1987, COLD SPRING HARB SYM, V52, P875, DOI 10.1101/SQB.1987.052.01.096; Heaslet HA, 1999, STRUCT FOLD DES, V7, P517, DOI 10.1016/S0969-2126(99)80068-9; Heaslet HA, 2001, J BIOL CHEM, V276, P26230, DOI 10.1074/jbc.M101391200; HENDRICKSON WA, 1971, NATURE-NEW BIOL, V232, P197, DOI 10.1038/newbio232197a0; HONZATKO RB, 1986, P NATL ACAD SCI USA, V83, P8487, DOI 10.1073/pnas.83.22.8487; IMAI K, 1970, Biochimica et Biophysica Acta, V200, P189, DOI 10.1016/0005-2795(70)90163-7; Janin J, 1995, PROTEINS, V23, P580, DOI 10.1002/prot.340230413; JIANG JS, 1994, J MOL BIOL, V243, P100, DOI 10.1006/jmbi.1994.1633; KOMIYAMA NH, 1995, NATURE, V373, P244, DOI 10.1038/373244a0; Kuraku S, 1999, J MOL EVOL, V49, P729, DOI 10.1007/PL00006595; LESK AM, 1980, J MOL BIOL, V136, P225, DOI 10.1016/0022-2836(80)90373-3; LESLIE AGW, 1998, CCP4 NEWSLETTER PROT, V35, P18; LIDDINGTON R, 1992, J MOL BIOL, V228, P551, DOI 10.1016/0022-2836(92)90842-8; Liem KF., 2001, FUNCTIONAL ANATOMY V; LILJEQVIST G, 1982, J MOL EVOL, V18, P102, DOI 10.1007/BF01810828; LYNCH RE, 1976, J BIOL CHEM, V251, P1015; MITCHELL DT, 1995, ACTA CRYSTALLOGR D, V51, P760, DOI 10.1107/S0907444995001491; Naoi Y, 2001, J MOL BIOL, V307, P259, DOI 10.1006/jmbi.2000.4446; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; Qiu Y, 2000, J BIOL CHEM, V275, P13517, DOI 10.1074/jbc.275.18.13517; Rasmussen AS, 1998, J MOL EVOL, V46, P382, DOI 10.1007/PL00006317; ROYER WE, 1994, J MOL BIOL, V235, P657, DOI 10.1006/jmbi.1994.1019; ROYER WE, 1995, J MOL BIOL, V253, P168, DOI 10.1006/jmbi.1995.0543; Royer WE, 2001, TRENDS BIOCHEM SCI, V26, P297, DOI 10.1016/S0968-0004(01)01811-4; STOCK DW, 1992, SCIENCE, V257, P787, DOI 10.1126/science.1496398; Tame JRH, 1996, J MOL BIOL, V259, P749, DOI 10.1006/jmbi.1996.0355; WALD G, 1951, J GEN PHYSIOL, V35, P45, DOI 10.1085/jgp.35.1.45; WINTERBOURN CC, 1976, BIOCHEM J, V155, P493, DOI 10.1042/bj1550493	47	8	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21898	21905		10.1074/jbc.M111492200	http://dx.doi.org/10.1074/jbc.M111492200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11923284	hybrid			2022-12-27	WOS:000176286000101
J	Pedersen, LC; Darden, TA; Negishi, M				Pedersen, LC; Darden, TA; Negishi, M			Crystal structure of beta 1,3-glucuronyltransferase I in complex with active donor substrate UDP-GlcUA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN LINKAGE REGION; SULFATE BIOSYNTHESIS; N-ACETYLGLUCOSAMINE; MOLECULAR-CLONING; MECHANISM; EXPRESSION; HEPARIN	beta1,3-Glucuronyltransferase (GlcAT-I) is an essential enzyme involved in heparan sulfate and chondroitin sulfate biosynthesis. GlcAT-I is an inverting glycosyltransferase that catalyzes the transfer of glucuronic acid (GlcUA) to the common growing linker region Galbeta1-3Galbeta1-4Xyl that is attached to a serine side chain of a core protein. Previously the structure of GlcAT-I has been solved in the presence of the donor product UDP and an acceptor analog Galbeta1-3GalX1-4Xyl (Pedersen, L. C., Tsuchida, K., Kitagawa, H., Sugahara, K., Darden, T. A. & Negishi, M. (2000) J. Biol. Chem. 275, 34580-34585). Here we report the x-ray crystal structure of GIcAT-I in complex with the complete donor UDP-Glc-UA, thereby providing structures of an inverting glycosyltransferase in which both the complete donor and acceptor substrates are present in the active site. This structure supports the in-line displacement reaction mechanism previously proposed. It also provides information on the essential amino acid residues that determine donor substrate specificity.	NIEHS, Reprod & Dev Toxicol Lab, Pharmacogenet Sect, NIH, Res Triangle Pk, NC 27709 USA; NIEHS, Struct Biol Lab, Pharmacogenet Sect, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Negishi, M (corresponding author), NIEHS, Reprod & Dev Toxicol Lab, Pharmacogenet Sect, NIH, Res Triangle Pk, NC 27709 USA.	negishi@niehs.nih.gov	Pedersen, Lars/C-6173-2019; Negishi, Masahiko/F-7805-2019	Pedersen, Lars/0000-0002-4488-4077; Negishi, Masahiko/0000-0002-2076-8928	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES071005, Z01ES043010, ZIAES043010] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Aikawa J, 1999, J BIOL CHEM, V274, P2690, DOI 10.1074/jbc.274.5.2690; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Gastinel LN, 2001, EMBO J, V20, P638, DOI 10.1093/emboj/20.4.638; Gastinel LN, 1999, EMBO J, V18, P3546, DOI 10.1093/emboj/18.13.3546; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kitagawa H, 1998, J BIOL CHEM, V273, P6615, DOI 10.1074/jbc.273.12.6615; Kitagawa H, 1999, J BIOL CHEM, V274, P13933, DOI 10.1074/jbc.274.20.13933; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lind T, 1998, J BIOL CHEM, V273, P26265, DOI 10.1074/jbc.273.41.26265; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Morera S, 1999, J MOL BIOL, V292, P717, DOI 10.1006/jmbi.1999.3094; Murray BW, 1996, BIOCHEMISTRY-US, V35, P11183, DOI 10.1021/bi961065a; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pedersen LC, 2000, J BIOL CHEM, V275, P34580, DOI 10.1074/jbc.M007399200; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Ramakrishnan B, 2001, J BIOL CHEM, V276, P37665, DOI 10.1074/jbc.M102458200; Ramakrishnan B, 2001, J MOL BIOL, V310, P205, DOI 10.1006/jmbi.2001.4757; Ringvall M, 2000, J BIOL CHEM, V275, P25926, DOI 10.1074/jbc.C000359200; Roden L., 1980, BIOCH GLYCOPROTEINS, P267; Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Unligil UM, 2000, EMBO J, V19, P5269, DOI 10.1093/emboj/19.20.5269	28	60	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21869	21873		10.1074/jbc.M112343200	http://dx.doi.org/10.1074/jbc.M112343200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11950836	hybrid			2022-12-27	WOS:000176286000097
J	Tanaka, Y; Nakayamada, S; Fujimoto, H; Okada, Y; Umehara, H; Kataoka, T; Minami, Y				Tanaka, Y; Nakayamada, S; Fujimoto, H; Okada, Y; Umehara, H; Kataoka, T; Minami, Y			H-Ras/mitogen-activated protein kinase pathway inhibits integrin-mediated adhesion and induces apoptosis in osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; GROWTH-FACTORS; T-CELLS; RAS; BONE; INVOLVEMENT; VCAM-1	We have studied the relevance of H-Ras and its downstream effectors to osteoblast functions. 1) Purified human osteoblasts highly expressed integrins beta(1), alpha(4), alpha(5), alpha(6) and the activation epitope of beta(1), However, these molecules were markedly down-regulated on osteoblasts transfected with expression vector encoding fully activated H-Ras(V12), H-Ras(V12)T35S, activating Raf-1/mitogen-activated protein kinase (MAPK), or an active Raf-1 but not on cells having H-Ras(V12)Y40C, a phosphoinositide 3-kinase (PI3K)-binding mutant. 2) Although osteoblasts spontaneously adhered to fibronectin and laminin in beta(1)-dependent manner, the expression of H-Ras(V12) or H-RaS(V12)T35S, but not H-Ras(V12)Y40C, in osteoblasts reduced their adhesion. 3) Osteoblasts bearing H-Ras(V12), H-Ras(V12)T35S, or Raf-1 failed to proliferate, whereas those with H-Ras(V12)Y40C proliferated well. (4) The up-regulation of Fas and down-regulation of Bcl-2 were observed in osteoblasts expressing H-Ras(V12), H-Ras(V12)T35S, or Raf-1. (5) Most of the cells having H-Ras(V12), H-Ras(V12)T35S, or Raf-1 became annexin-V-(high)/propidium iodide (PI)(high) (or) (low) and terminal deoxynucleotidyl-transferase-mediated dUTP nick-end labeling (TUNEL)(high)/PIlow after 24 and 72 h incubation, respectively. Thus, we propose that H-Ras signals followed by Raf-1/MAPK pathway but not PI3K not only reduces beta(1)-mediated adhesion of osteoblasts to matrix proteins but induces apoptosis presumably via the Fas up-regulation and Bcl-2 down-regulation.	Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 1, Kitakyushu, Fukuoka 8078555, Japan; Kobe Univ, Sch Med, Dept Biomed Regulat, Kobe, Hyogo 6500017, Japan; Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto 6058507, Japan; Kobe Univ, Sch Med, Dept Physiol 2, Kobe, Hyogo 6500017, Japan	University of Occupational & Environmental Health - Japan; Kobe University; Kyoto University; Kobe University	Tanaka, Y (corresponding author), Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 1, Kitakyushu, Fukuoka 8078555, Japan.	tanaka@med.uoeh-u.ac.jp						Bennett JH, 2001, HISTOL HISTOPATHOL, V16, P603, DOI 10.14670/HH-16.603; BERESFORD JN, 1984, METAB BONE DIS RELAT, V5, P229, DOI 10.1016/0221-8747(84)90064-X; Bos JL, 1998, EMBO J, V17, P6776, DOI 10.1093/emboj/17.23.6776; Caverzasio J, 2000, J BONE MINER RES, V15, P1697, DOI 10.1359/jbmr.2000.15.9.1697; Clohisy DR, 1999, J LAB CLIN MED, V134, P190, DOI 10.1016/S0022-2143(99)90197-X; Damsky CH, 1999, BONE, V25, P95, DOI 10.1016/S8756-3282(99)00106-4; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Epler J A, 2000, Dev Immunol, V7, P155; Fujii K, 1999, J IMMUNOL, V162, P2391; Fujimoto H, 2001, GENES CELLS, V6, P337, DOI 10.1046/j.1365-2443.2001.00428.x; Globus RK, 1998, J CELL SCI, V111, P1385; Gomez M, 1997, EUR J IMMUNOL, V27, P8, DOI 10.1002/eji.1830270103; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; ITOH H, 1993, J CLIN INVEST, V91, P2268, DOI 10.1172/JCI116454; Jilka RL, 1998, J BONE MINER RES, V13, P793, DOI 10.1359/jbmr.1998.13.5.793; Karaplis AC, 2001, CURR PHARM DESIGN, V7, P655, DOI 10.2174/1381612013397753; Kido M, 2002, J BIOL CHEM, V277, P3117, DOI 10.1074/jbc.M109526200; Knall C, 1998, J CELL BIOCHEM, P137; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; Mercer JA, 2000, SEMIN CELL DEV BIOL, V11, P309, DOI 10.1006/scdb.2000.0181; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; Papaioannou S, 1999, BBA-MOL CELL RES, V1449, P284, DOI 10.1016/S0167-4889(99)00025-7; Quarles LD, 1996, J BONE MINER RES, V11, P1375; Raisz LG, 1999, CLIN CHEM, V45, P1353; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; Rodan GA, 1998, J CELL BIOCHEM, P55; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Schwindinger WF, 1998, ENDOCRINE, V8, P201, DOI 10.1385/ENDO:8:2:201; Shimizu Y, 2000, Immunol Today, V21, P597, DOI 10.1016/S0167-5699(00)01783-7; Tamada M, 1997, ONCOGENE, V15, P2959, DOI 10.1038/sj.onc.1201582; Tanaka Y, 1997, J IMMUNOL, V158, P3822; Tanaka Y, 1999, J IMMUNOL, V163, P6209; Tanaka Y, 1998, BLOOD, V91, P3909; TANAKA Y, 1995, J BONE MINER RES, V10, P1462; TANAKA Y, 1993, NATURE, V361, P79, DOI 10.1038/361079a0; Tanaka Y, 2000, J BONE MINER RES, V15, P1912, DOI 10.1359/jbmr.2000.15.10.1912; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799	38	42	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21446	21452		10.1074/jbc.M202238200	http://dx.doi.org/10.1074/jbc.M202238200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11934900	hybrid			2022-12-27	WOS:000176286000043
J	Yart, A; Roche, S; Wetzker, R; Laffargue, M; Tonks, N; Mayeux, P; Chap, H; Raynal, P				Yart, A; Roche, S; Wetzker, R; Laffargue, M; Tonks, N; Mayeux, P; Chap, H; Raynal, P			A function for phosphoinositide 3-kinase beta lipid products in coupling beta gamma to Ras activation in response to lysophosphatidic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; PROTEIN-KINASE ACTIVATION; PHOSPHATIDYLINOSITOL 3-KINASE; PI 3-KINASE; MAP KINASE; INDEPENDENT ACTIVATION; SIGNALING PATHWAY; TYROSINE KINASE; DOCKING PROTEIN; C-ZETA	Although Gbetagamma is thought to mediate mitogen-activated protein kinase (MAPK) activation in response to G protein-coupled receptor stimulation, the mechanisms involved in this pathway have not been clearly defined. Phosphoinositide 3-kinase (PI3K) has been proposed as an early intermediate in this process, but its role has remained elusive. We have observed that dominant negative mutants of p110beta, but not of p110gamma, inhibited MAPK stimulation in response to lysophosphatidic acid (LPA). The role of p110beta was located upstream from Ras. To determine which of the lipid or protein kinase activities of p110beta were important for Ras activation, we produced a mutant p110beta lacking the lipid but not the protein kinase activity. This protein displayed a dominant negative activity similar to a kinase-dead mutant, indicating that p110beta lipid kinase activity was essentially involved in Ras activation. In agreement, overexpression of the lipid phosphatase PTEN was found to specifically inhibit Ras stimulation induced by LPA. In addition, we have observed that the PH domain-containing adapter protein Gab 1, which is involved in p 11013 activation during LPA stimulation, is also implicated in this pathway downstream of p110beta. Indeed, both membrane redistribution and phosphorylation of Gab1 were reduced in the presence of PI3K inhibitors or dominant negative p110beta. Downstream of Gab1, the tyrosine phosphatase SHP2 was found to mediate Ras activation in response to LPA and to be recruited through PI3K and Gab1, because transfection of Gab1 mutant deficient for SHP2 binding inhibited Ras activation without interfering with PI3K activation. We conclude that LPA-induced Ras activation is mediated by a p110beta/Gab1/SHP2 pathway. Moreover, we present data indicating that p110beta is effectively the target of betagamma in this pathway, suggesting that the p110beta/Gab1/SHP2 pathway provides a novel link between betagamma and Ras by integrating two early events of LPA signaling, i.e. Gbetagamma release and tyrosine kinase receptor transactivation.	Hop Purpan, INSERM, U326, IFR 30, F-31059 Toulouse, France; CRBM, CNRS, UPR 1086, F-34293 Montpellier, France; Hop Cochin, INSERM, U363, F-75014 Paris, France; Univ Jena, Max Planck Res Unit Mol Cell Biol, D-07747 Jena, Germany; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Friedrich Schiller University of Jena; Max Planck Society; Cold Spring Harbor Laboratory	Raynal, P (corresponding author), Hop Purpan, INSERM, U326, IFR 30, F-31059 Toulouse, France.	raynal@toulouse.inserm.fr	Wetzker, Reinhard/AAD-8713-2019; Laffargue, Muriel/AAE-7849-2021; YART, Armelle/A-5656-2016; Raynal, Patrick/O-1926-2018	YART, Armelle/0000-0002-2412-9840; roche, serge/0000-0003-3413-3859; Raynal, Patrick/0000-0002-6731-3007; Laffargue, Muriel/0000-0003-1833-639X				August A, 1997, P NATL ACAD SCI USA, V94, P11227, DOI 10.1073/pnas.94.21.11227; Barbier M, 2001, NATURE, V413, P796, DOI 10.1038/35101660; Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Chun Jerold, 1999, Cell Biochemistry and Biophysics, V30, P213, DOI 10.1007/BF02738068; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Cunnick JM, 2000, J BIOL CHEM, V275, P13842, DOI 10.1074/jbc.275.18.13842; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Domin J, 1997, FEBS LETT, V410, P91, DOI 10.1016/S0014-5793(97)00617-0; Eguchi S, 1998, J BIOL CHEM, V273, P8890, DOI 10.1074/jbc.273.15.8890; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Gaits F, 1996, J BIOL CHEM, V271, P20151; Goetzl EJ, 1999, ADV EXP MED BIOL, V469, P259; Hawes BE, 1996, J BIOL CHEM, V271, P12133, DOI 10.1074/jbc.271.21.12133; Herrlich A, 1998, P NATL ACAD SCI USA, V95, P8985, DOI 10.1073/pnas.95.15.8985; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Hirsch E, 2001, FASEB J, V15, P2019, DOI 10.1096/fj.00-0810fje; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; HU P, 1993, MOL CELL BIOL, V13, P7677, DOI 10.1128/MCB.13.12.7677; HUNTER T, 1995, CELL, V83, P1, DOI 10.1016/0092-8674(95)90225-2; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; Kranenburg O, 2001, ONCOGENE, V20, P1540, DOI 10.1038/sj.onc.1204187; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; Laffargue M, 1999, J BIOL CHEM, V274, P32835, DOI 10.1074/jbc.274.46.32835; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Lee H, 2000, AM J PHYSIOL-CELL PH, V278, pC612, DOI 10.1152/ajpcell.2000.278.3.C612; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; LI W, 1994, MOL CELL BIOL, V14, P509, DOI 10.1128/MCB.14.1.509; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Luttrell LM, 1997, J BIOL CHEM, V272, P4637, DOI 10.1074/jbc.272.7.4637; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Lynch KR, 1999, TRENDS PHARMACOL SCI, V20, P473, DOI 10.1016/S0165-6147(99)01401-7; Maier U, 1999, J BIOL CHEM, V274, P29311, DOI 10.1074/jbc.274.41.29311; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Moolenaar WH, 1999, EXP CELL RES, V253, P230, DOI 10.1006/excr.1999.4702; Motohashi K, 2000, FEBS LETT, V468, P189, DOI 10.1016/S0014-5793(00)01222-9; Murga C, 2000, J BIOL CHEM, V275, P12069, DOI 10.1074/jbc.275.16.12069; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Roche S, 1998, MOL CELL BIOL, V18, P7119, DOI 10.1128/MCB.18.12.7119; Rodrigues GA, 2000, MOL CELL BIOL, V20, P1448, DOI 10.1128/MCB.20.4.1448-1459.2000; Rubio I, 2000, CURR BIOL, V10, P1225, DOI 10.1016/S0960-9822(00)00731-4; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Shi ZQ, 2000, MOL CELL BIOL, V20, P1526, DOI 10.1128/MCB.20.5.1526-1536.2000; Siess W, 1999, P NATL ACAD SCI USA, V96, P6931, DOI 10.1073/pnas.96.12.6931; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Takeda H, 1999, EMBO J, V18, P386, DOI 10.1093/emboj/18.2.386; TOKER A, 1994, J BIOL CHEM, V269, P32358; VANBIESEN T, 1995, NATURE, V376, P781, DOI 10.1038/376781a0; Vanhaesebroeck B, 1999, EMBO J, V18, P1292, DOI 10.1093/emboj/18.5.1292; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Xu Y, 1998, JAMA-J AM MED ASSOC, V280, P719, DOI 10.1001/jama.280.8.719; Yart A, 2001, J BIOL CHEM, V276, P8856, DOI 10.1074/jbc.M006966200; Zwick E, 1997, J BIOL CHEM, V272, P24767, DOI 10.1074/jbc.272.40.24767	63	71	74	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21167	21178		10.1074/jbc.M110411200	http://dx.doi.org/10.1074/jbc.M110411200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11916960	hybrid			2022-12-27	WOS:000176286000009
J	Baljinnyam, B; Schroth-Diez, B; Korte, T; Herrmann, A				Baljinnyam, B; Schroth-Diez, B; Korte, T; Herrmann, A			Lysolipids do not inhibit influenza virus fusion by interaction with hemagglutinin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-FUSION; LOW-PH; CONFORMATIONAL-CHANGE; KINETICS; GLYCOPROTEIN; PEPTIDE; VESICLE; BINDING; LIPIDS; STALK	The interaction of a spin-labeled lysophosphatidylcholine analog with intact and bromelain-treated influenza viruses as well as with the bromelain-solubilized hemagglutinin ectodomain has been studied. The inhibition of fusion of influenza viruses with erythrocytes by the lysophosphatidylcholine analog was similar to that observed for non-labeled lysophosphatidylcholine. Only a weak interaction of the lysophosphatidylcholine analog with the hemagglutinin ectodomain was observed even upon triggering the conformational change of the ectodomain at a low pH. A significant interaction of spin-labeled lysophosphatidylcholine with the hemagglutinin ectodomain of intact viruses was observed neither at neutral nor at low pH, whereas a strong interaction of the lipid analog with the viral lipid bilayer was evident. We suggest that the high number of lipid binding sites of the virus bilayer and their affinity compete efficiently with binding sites of the hemagglutinin ectodomain. We conclude that the inhibition of influenza virus fusion by lysolipids is not mediated by binding to the hemagglutinin ectodomain, preventing its interaction with the target membrane. The results unambiguously argue for an inhibition mechanism based on the action of lysolipid inserted into the lipid bilayer.	Humboldt Univ, Math Naturwissensch Fak 1, Inst Biol, D-10115 Berlin, Germany	Humboldt University of Berlin	Herrmann, A (corresponding author), Humboldt Univ, Math Naturwissensch Fak 1, Inst Biol, Invalidenstr 42, D-10115 Berlin, Germany.	andreas.herrmann@rz.hu-berlin.de		Schroth-Diez, Britta/0000-0002-4908-5952				BETHELL RC, 1995, BIOCHEM BIOPH RES CO, V206, P355, DOI 10.1006/bbrc.1995.1049; BLUMENTHAL R, 1991, ANN NY ACAD SCI, V635, P285, DOI 10.1111/j.1749-6632.1991.tb36499.x; Bottcher C, 1999, FEBS LETT, V463, P255, DOI 10.1016/S0014-5793(99)01475-1; BRAND CM, 1972, NATURE-NEW BIOL, V238, P145, DOI 10.1038/newbio238145a0; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Chen J, 1999, P NATL ACAD SCI USA, V96, P8967, DOI 10.1073/pnas.96.16.8967; Chernomordik L, 1996, CHEM PHYS LIPIDS, V81, P203, DOI 10.1016/0009-3084(96)02583-2; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; CHERNOMORDIK LV, 1987, BIOCHIM BIOPHYS ACTA, V906, P309, DOI 10.1016/0304-4157(87)90016-5; Chernomordik LV, 1999, MOL MEMBR BIOL, V16, P33; CHERNOMORDIK LV, 1993, FEBS LETT, V318, P71, DOI 10.1016/0014-5793(93)81330-3; Chernomordik LV, 1997, J CELL BIOL, V136, P81, DOI 10.1083/jcb.136.1.81; DODGE JT, 1963, ARCH BIOCHEM BIOPHYS, V100, P119, DOI 10.1016/0003-9861(63)90042-0; DOMS RW, 1985, J BIOL CHEM, V260, P2973; GETHING MJ, 1988, CURR TOP MEMBR TRANS, V32, P337; GuntherAusborn S, 1997, VIROLOGY, V235, P201, DOI 10.1006/viro.1997.8699; GUNTHERAUSBORN S, 1995, J BIOL CHEM, V270, P29279; GUTMAN O, 1993, BIOCHEMISTRY-US, V32, P101, DOI 10.1021/bi00052a014; HARTER C, 1989, J BIOL CHEM, V264, P6459; HOEKSTRA D, 1984, BIOCHEMISTRY-US, V23, P5675, DOI 10.1021/bi00319a002; KLENK HD, 1991, CLASSIFICATION NOMEN, P263; Korte T, 1999, J VIROL, V73, P4567, DOI 10.1128/JVI.73.6.4567-4574.1999; Korte T, 1997, J BIOL CHEM, V272, P9764; KORTE T, 1994, EUR BIOPHYS J BIOPHY, V23, P105; KOZLOV MM, 1989, EUR BIOPHYS J BIOPHY, V17, P121; KRUMBIEGEL M, 1994, BIOPHYS J, V67, P2355, DOI 10.1016/S0006-3495(94)80721-0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUNEBERG J, 1995, J BIOL CHEM, V270, P27606; Marx U, 2000, BIOPHYS J, V78, P2628, DOI 10.1016/S0006-3495(00)76807-X; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; MORROT G, 1989, BIOCHEMISTRY-US, V28, P3456, DOI 10.1021/bi00434a046; Qiao H, 1998, J CELL BIOL, V141, P1335, DOI 10.1083/jcb.141.6.1335; SIEGEL DP, 1993, BIOPHYS J, V65, P2124, DOI 10.1016/S0006-3495(93)81256-6; Skehel JJ, 1998, CELL, V95, P871, DOI 10.1016/S0092-8674(00)81710-9; STEGMANN T, 1986, J BIOL CHEM, V261, P966; TSURUDOME M, 1992, J BIOL CHEM, V267, P20225; VOGEL SS, 1993, J BIOL CHEM, V268, P25764; WHITE JM, 1987, J CELL BIOL, V105, P2887, DOI 10.1083/jcb.105.6.2887; WHITE JM, 1990, ANNU REV PHYSIOL, V52, P675, DOI 10.1146/annurev.ph.52.030190.003331; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; YEAGLE PL, 1994, BIOCHEMISTRY-US, V33, P1820, DOI 10.1021/bi00173a027; ZIMMERBERG J, 1993, ANNU REV BIOPH BIOM, V22, P433, DOI 10.1146/annurev.bb.22.060193.002245	42	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20461	20467		10.1074/jbc.M112217200	http://dx.doi.org/10.1074/jbc.M112217200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11923295	hybrid			2022-12-27	WOS:000176204500047
J	Bianchini, EP; Louvain, VB; Marque, PE; Juliano, MA; Juliano, L; Le Bonniec, BF				Bianchini, EP; Louvain, VB; Marque, PE; Juliano, MA; Juliano, L; Le Bonniec, BF			Mapping of the catalytic groove preferences of factor Xa reveals an inadequate selectivity for its macromolecule substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR PATHWAY INHIBITOR; RAY CRYSTAL-STRUCTURE; COAGULATION-FACTOR XA; ACTIVE-SITE; BLOOD-COAGULATION; SERINE PROTEASES; TISSUE FACTOR; FACTOR-IXA; PROTEIN-C; PROTHROMBINASE COMPLEX	Factor Xa (FXa) hydrolyzes two peptide bonds in prothrombin having (Glu/Asp)-Gly-Arg-(Thr/Ile) for P-3-P-2- P-1-P-1' residues, but the exact preferences of its catalytic groove remain largely unknown. To investigate the specificity of FXa, we synthesized full sets of fluorescence-quenched substrates carrying all natural amino acids (except Cys) in P-3, P-2, P-1', P-2', and P-3' and determined the k(cat)/K-m values of cleavage. Contrary to expectation, glycine was not the "best" P-2 residue; peptide with phenylalanine was cleaved slightly faster. In fact, FXa had surprisingly limited preferences, barely more pronounced than trypsin; in P-2, the ratio of the k(cat)/K-m values for the most favorable side chain over the least was 289 (12 with trypsin), but in P-1', this ratio was only 30 (versus 80 with trypsin). This unexpected selectivity undoubtedly distinguished FXa from thrombin, which exhibited ratios higher than 19,000 in P-2 and P-1'. Thus, with respect to the catalytic groove, FXa resembles a low efficiency trypsin rather than the highly selective thrombin. The rates of cleavage of the peptidyl substrates were virtually identical whether or not FXa was in complex with factor Va, suggesting that the cofactor did not exert a direct allosteric control on the catalytic groove. We conclude that the remarkable efficacy of FXa within prothrombinase originates from exosite interaction(s) with factor Va and/or prothrombin rather than from the selectivity of its catalytic groove.	Univ Paris 05, Fac Pharm, INSERM, U428, F-75270 Paris 06, France; Escola Paulista Med, Dept Biophys, BR-04044020 Sao Paulo, Brazil	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universidade Federal de Sao Paulo (UNIFESP)	Le Bonniec, BF (corresponding author), Univ Paris 05, Fac Pharm, INSERM, U428, 4 Av Observ, F-75270 Paris 06, France.		Le Bonniec, Bernard/S-5756-2016; Le Bonniec, Bernard/ABA-1366-2020; Juliano, Luiz/D-7204-2012	Le Bonniec, Bernard/0000-0002-8432-7363; Le Bonniec, Bernard/0000-0002-8432-7363; Juliano, Luiz/0000-0002-5589-2822; BIANCHINI, Elsa/0000-0002-1370-5312				Alves LC, 1996, PEPTIDE RES, V9, P92; Backes BJ, 2000, NAT BIOTECHNOL, V18, P187, DOI 10.1038/72642; BAJAJ SP, 1981, J BIOL CHEM, V256, P253; Banner DW, 1996, NATURE, V380, P41, DOI 10.1038/380041a0; Baugh RJ, 1998, J BIOL CHEM, V273, P4378, DOI 10.1074/jbc.273.8.4378; Betz A, 1998, J BIOL CHEM, V273, P10709, DOI 10.1074/jbc.273.17.10709; Bode W, 1997, THROMB HAEMOSTASIS, V78, P501; BODE W, 1983, J MOL BIOL, V164, P237, DOI 10.1016/0022-2836(83)90077-3; BODE W, 1992, PROTEIN SCI, V1, P426; Boskovic DS, 2000, J BIOL CHEM, V275, P38561, DOI 10.1074/jbc.M006637200; BRANDSTETTER H, 1996, J BIOL CHEM, V271, P29968; Burgering MJM, 1997, J MOL BIOL, V269, P395, DOI 10.1006/jmbi.1997.1029; Butenas S, 1997, THROMB HAEMOSTASIS, V78, P1193; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; CASTILLO MJ, 1983, BIOCHEMISTRY-US, V22, P1021, DOI 10.1021/bi00274a004; CHO K, 1984, BIOCHEMISTRY-US, V23, P644, DOI 10.1021/bi00299a009; Chuang YJ, 2001, J BIOL CHEM, V276, P14961, DOI 10.1074/jbc.M011550200; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Dang QD, 1996, P NATL ACAD SCI USA, V93, P10653, DOI 10.1073/pnas.93.20.10653; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; ESMON CT, 1989, J BIOL CHEM, V264, P4743; FOSTER WB, 1983, J BIOL CHEM, V258, P3970; Fraternali F, 1998, PROTEINS, V30, P264, DOI 10.1002/(SICI)1097-0134(19980215)30:3<264::AID-PROT6>3.0.CO;2-K; Fuentes-Prior P, 2000, NATURE, V404, P518, DOI 10.1038/35006683; GAILANI D, 1993, BLOOD, V82, P813; Gettins P.G.W., 1996, SERPINS STRUCTURE FU; Grahn S, 1999, BBA-PROTEIN STRUCT M, V1431, P329, DOI 10.1016/S0167-4838(99)00059-X; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Hirata IY, 1995, LETT PEPT SCI, V1, P299, DOI DOI 10.1007/BF00119771; Hopfner KP, 1997, EMBO J, V16, P6626, DOI 10.1093/emboj/16.22.6626; Jesty J, 1976, Methods Enzymol, V45, P95; KAWABATA SI, 1988, EUR J BIOCHEM, V172, P17, DOI 10.1111/j.1432-1033.1988.tb13849.x; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P12080, DOI 10.1021/bi970979+; Kurth T, 1998, BIOCHEMISTRY-US, V37, P11434, DOI 10.1021/bi980842z; LEBONNIEC BF, 1992, J BIOL CHEM, V267, P6970; LEBONNIEC BF, 1993, J BIOL CHEM, V268, P19055; LEBONNIEC BF, 1991, J BIOL CHEM, V266, P13796; LeBonniec BF, 1996, BIOCHEMISTRY-US, V35, P7114, DOI 10.1021/bi952701s; Long GL, 1998, J BIOL CHEM, V273, P11521, DOI 10.1074/jbc.273.19.11521; LOTTENBERG R, 1986, BIOCHIM BIOPHYS ACTA, V874, P326, DOI 10.1016/0167-4838(86)90032-4; LOTTENBERG R, 1981, METHOD ENZYMOL, V80, P341; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; Marque PE, 2000, J BIOL CHEM, V275, P809, DOI 10.1074/jbc.275.2.809; MATHEWS II, 1994, BIOCHEMISTRY-US, V33, P3266, DOI 10.1021/bi00177a018; MATTHEWS DJ, 1993, SCIENCE, V260, P1113, DOI 10.1126/science.8493554; MCRAE BJ, 1981, BIOCHEMISTRY-US, V20, P7196, DOI 10.1021/bi00528a022; MESSIER TL, 1991, GENE, V99, P291, DOI 10.1016/0378-1119(91)90141-W; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; PADMANABHAN K, 1993, J MOL BIOL, V232, P947, DOI 10.1006/jmbi.1993.1441; Parker ET, 1997, BIOCHEMISTRY-US, V36, P9365, DOI 10.1021/bi970599o; RAWLINGS ND, 1998, HDB PROTEOLYTIC ENZY, P3; REZAIE AR, 2001, BIOCHIM BIOPHYS ACTA, V1548, P167; SCHELLENBERGER V, 1993, BIOCHEMISTRY-US, V32, P4349, DOI 10.1021/bi00067a026; SCHELLENBERGER V, 1994, BIOCHEMISTRY-US, V33, P4251, DOI 10.1021/bi00180a020; STUBBS MT, 1992, EUR J BIOCHEM, V206, P187, DOI 10.1111/j.1432-1033.1992.tb16916.x; Underwood MC, 2000, J BIOL CHEM, V275, P36876, DOI 10.1074/jbc.M001386200; WALKER RK, 1993, J BIOL CHEM, V268, P13920	57	55	65	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20527	20534		10.1074/jbc.M201139200	http://dx.doi.org/10.1074/jbc.M201139200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11925440	hybrid			2022-12-27	WOS:000176204500056
J	Groth, G; Hisabori, T; Lill, H; Bald, D				Groth, G; Hisabori, T; Lill, H; Bald, D			Substitution of a single amino acid switches the tentoxin-resistant thermophilic F-1-ATPase into a tentoxinsensitive enzyme.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPLAST F-1-ATPASE; INHIBITION; F1-ATPASE; BINDING; SENSITIVITY; SUBCOMPLEX; SUBUNIT; SITE	In contrast to the homologous bacterial and mitochondrial enzymes the chloroplast F-1-ATPase (CF1) is strongly affected by the phytopathogenic inhibitor tentoxin. Based on structural information obtained from crystals of a CF1-tentoxin co-complex (Groth, G. (2002) Proc. Natt. Acad. Sci. U. S. A. 99, 3464-3468) we have replaced residues betaSer(66) and alphaArg(132) in the alpha(3)beta(3)gamma subcomplex of the thermophilic F-1-ATPase from Bacillus PS3 by the corresponding residues of the chloroplast ATPase to confer tentoxin sensitivity to the thermophilic enzyme. The mutation alphaArg(132)-->Pro, proposed to relieve steric constraints on tentoxin binding, did not have any significant effect. However, mutation betaSer(66)-->Ala, predicted to provide a crucial hydrogen bond with the inhibitor, resulted in tentoxin inhibition of ATP hydrolysis comparable with the situation found with the chloroplast enzyme.	Free Univ Amsterdam, Fac Earth & Life Sci, Dept Biol Struct, NL-1081 HV Amsterdam, Netherlands; Univ Dusseldorf, Dept Plant Biochem, D-40225 Dusseldorf, Germany; Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 2268503, Japan; Japan Sci & Technol Corp, ERATO, JST, Yoshida ATP Syst Project,Midori Ku, Yokohama, Kanagawa 2260026, Japan	Vrije Universiteit Amsterdam; Heinrich Heine University Dusseldorf; Tokyo Institute of Technology; Japan Science & Technology Agency (JST)	Bald, D (corresponding author), Free Univ Amsterdam, Fac Earth & Life Sci, Dept Biol Struct, De Boelelaan 1087, NL-1081 HV Amsterdam, Netherlands.		; Hisabori, Toru/E-5205-2014	Lill, H./0000-0001-9336-5428; Hisabori, Toru/0000-0003-2046-0277				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ARNTZEN CJ, 1972, BIOCHIM BIOPHYS ACTA, V283, P539, DOI 10.1016/0005-2728(72)90273-3; AVNI A, 1992, SCIENCE, V257, P1245, DOI 10.1126/science.1387730; Bald D, 2000, J BIOL CHEM, V275, P12757, DOI 10.1074/jbc.275.17.12757; Groth G, 2002, P NATL ACAD SCI USA, V99, P3464, DOI 10.1073/pnas.052546099; Groth G, 2001, J BIOL CHEM, V276, P1345, DOI 10.1074/jbc.M008015200; Hu DL, 1997, J BIOL CHEM, V272, P5457, DOI 10.1074/jbc.272.9.5457; HU NM, 1993, J BIOL CHEM, V268, P8536; LIEBERMANN B, 1983, Z ALLG MIKROBIOL, V23, P503, DOI 10.1002/jobm.3630230810; MATSUI T, 1995, BBA-BIOENERGETICS, V1231, P139, DOI 10.1016/0005-2728(95)00070-Y; Mochimaru M, 1997, FEBS LETT, V419, P23, DOI 10.1016/S0014-5793(97)01421-X; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Santolini J, 1999, J BIOL CHEM, V274, P849, DOI 10.1074/jbc.274.2.849; Shirakihara Y, 1997, STRUCTURE, V5, P825, DOI 10.1016/S0969-2126(97)00236-0; STEELE JA, 1976, P NATL ACAD SCI USA, V73, P2245, DOI 10.1073/pnas.73.7.2245; STEELE JA, 1978, BIOCHIM BIOPHYS ACTA, V501, P72, DOI 10.1016/0005-2728(78)90096-8; Stiggall D L, 1979, Methods Enzymol, V55, P308; Tucker WC, 2001, BIOCHEMISTRY-US, V40, P7542, DOI 10.1021/bi0105227; Tucker WC, 2001, EUR J BIOCHEM, V268, P2179, DOI 10.1046/j.1432-1327.2001.02110.x; YOSHIDA M, 1975, J BIOL CHEM, V250, P7910	20	6	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20117	20119		10.1074/jbc.C200168200	http://dx.doi.org/10.1074/jbc.C200168200			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11943766	Green Published, hybrid			2022-12-27	WOS:000176204500002
J	Matsuo, H; Kanai, Y; Kim, JY; Chairoungdua, A; Kim, DK; Inatomi, J; Shigeta, Y; Ishimine, H; Chaekuntode, S; Tachampa, K; Choi, HW; Babu, E; Fukuda, J; Endou, H				Matsuo, H; Kanai, Y; Kim, JY; Chairoungdua, A; Kim, DK; Inatomi, J; Shigeta, Y; Ishimine, H; Chaekuntode, S; Tachampa, K; Choi, HW; Babu, E; Fukuda, J; Endou, H			Identification of a novel Na+-independent acidic amino acid transporter with structural similarity to the member of a heterodimeric amino acid transporter family associated with unknown heavy chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODY 4F2; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-BIOLOGY; MEMBRANE-PROTEIN; CO-EXPRESSES; CLONING; SYSTEM; LOCALIZATION; SPECIFICITY; 4F2HC/CD98	We identified a novel Na+-independent acidic amino acid transporter designated AGT1 (aspartate/glutamate transporter 1). AGT1 exhibits the highest sequence similarity (48% identity) to the Na+-independent small neutral amino acid transporter Asc (asc-type amino acid transporter)-2 a member of the heterodimeric amino acid transporter family presumed to be associated with unknown heavy chains (Chairoungdua, A., Kanai, Y., Matsuo, H., Inatomi, J., Kim, D. K., and Endou, H. (2001) J. Biol Chem. 276, 49390-49399). The cysteine residue responsible for the disulfide bond formation between transporters (light chains) and heavy chain subunits of the heterodimeric amino acid transporter family is conserved for AGT1 Because AGT1 solely expressed or coexpressed with already known heavy chain 4F2hc ((4F2) under bar heavy chain) or rBAT related to (b) under bar (0,+)-amino acid transporter) did not induce functional activity, we generated fusion proteins in which AGT1 was connected with 4F2hc or rBAT. The fusion proteins were sorted to the plasma membrane and expressed the Na+-independent transport activity for acidic amino acids. Distinct from the Na+-independent cystine/glutamate transporter xCT structurally related to AGT1, AGT1 did not accept cystine, homocysteate, and L-alpha-aminoadipate and exhibited high affinity to aspartate as well as glutamate, suggesting that the negative charge recognition site in the side chain-binding site of AGT1 would be closer to the alpha-carbon binding site compared with that of xCT. The AGT1 message was predominantly expressed in kidney. In mouse kidney, AGT1 protein was present in the basolateral membrane of the proximal straight tubules and distal convoluted tubules. In the Western blot analysis, AGT1 was detected as a high molecular mass band in the nonreducing condition, whereas the band shifted to a 40-kDa band corresponding to the AGT1 monomer in the reducing condition, suggesting the association of AGT1 with other protein via a disulfide bond. The finding of AGT1 and Asc-2 has established a new subgroup of the heterodimeric amino acid transporter family whose members associate not with 4F2hc or rBAT but with other unknown heavy chains.	Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Tokyo 1818611, Japan; Natl Def Med Coll, Dept Physiol 1, Tokorozawa, Saitama 3598513, Japan; Chiba Univ, Sch Med, Dept Urol, Chuo Ku, Chiba 2608670, Japan; Japan Sci & Technol Corp, PRESTO, Tokyo 1818611, Japan	Kyorin University; National Defense Medical College - Japan; Chiba University; Japan Science & Technology Agency (JST)	Kanai, Y (corresponding author), Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, 6-20-2 Shinkawa,Mitaka, Tokyo 1818611, Japan.	ykanai@kyorin-u.ac.jp	Tachampa, Kittipong/AAK-3634-2020	Matsuo, Hirotaka/0000-0003-4302-8719; Tachampa, Kittipong/0000-0002-2011-3542				ALTMAN A, 1984, P NATL ACAD SCI-BIOL, V81, P2176, DOI 10.1073/pnas.81.7.2176; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Bassi MT, 2001, PFLUG ARCH EUR J PHY, V442, P286, DOI 10.1007/s004240100537; Chairoungdua A, 1999, J BIOL CHEM, V274, P28845, DOI 10.1074/jbc.274.41.28845; Chairoungdua A, 2001, J BIOL CHEM, V276, P49390, DOI 10.1074/jbc.M107517200; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43, DOI 10.1152/physrev.1990.70.1.43; DANTZLER WH, 1988, AM J PHYSIOL, V255, pF397, DOI 10.1152/ajprenal.1988.255.3.F397; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Feliubadalo L, 1999, NAT GENET, V23, P52, DOI 10.1038/12652; Fukasawa Y, 2000, J BIOL CHEM, V275, P9690, DOI 10.1074/jbc.275.13.9690; HAYNES BF, 1981, J IMMUNOL, V126, P1409; HEMLER ME, 1982, J IMMUNOL, V129, P623; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Isnard AD, 1996, J MOL BIOL, V262, P473, DOI 10.1006/jmbi.1996.0529; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Kanai Y, 2000, J BIOL CHEM, V275, P20787, DOI 10.1074/jbc.M000634200; KANAI Y, 1995, J BIOL CHEM, V270, P16561, DOI 10.1074/jbc.270.28.16561; KANAI Y, 1992, AM J PHYSIOL, V263, pF1087, DOI 10.1152/ajprenal.1992.263.6.F1087; Kanai Y, 2001, CURR DRUG METAB, V2, P339, DOI 10.2174/1389200013338324; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; Kanai Y, 1997, CURR OPIN CELL BIOL, V9, P565, DOI 10.1016/S0955-0674(97)80035-X; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; MACLEOD CL, 1994, J EXP BIOL, V196, P109; Mannion BA, 1998, J BIOL CHEM, V273, P33127, DOI 10.1074/jbc.273.50.33127; Mastroberardino L, 1998, NATURE, V395, P288, DOI 10.1038/26246; Matsuo H, 2000, NEUROREPORT, V11, P3507, DOI 10.1097/00001756-200011090-00021; Mizoguchi K, 2001, KIDNEY INT, V59, P1821, DOI 10.1046/j.1523-1755.2001.0590051821.x; Nakamura E, 1999, J BIOL CHEM, V274, P3009, DOI 10.1074/jbc.274.5.3009; Palacin M, 1998, PHYSIOL REV, V78, P969, DOI 10.1152/physrev.1998.78.4.969; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; Pfeiffer R, 1999, MOL BIOL CELL, V10, P4135, DOI 10.1091/mbc.10.12.4135; Pfeiffer R, 1998, FEBS LETT, V439, P157, DOI 10.1016/S0014-5793(98)01359-3; Pfeiffer R, 1999, EMBO J, V18, P49, DOI 10.1093/emboj/18.1.49; Pineda M, 1999, J BIOL CHEM, V274, P19738, DOI 10.1074/jbc.274.28.19738; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; Rossier G, 1999, J BIOL CHEM, V274, P34948, DOI 10.1074/jbc.274.49.34948; SACKTOR B, 1981, J MEMBRANE BIOL, V60, P63, DOI 10.1007/BF01870833; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Segawa H, 1997, BIOCHEM J, V328, P657, DOI 10.1042/bj3280657; Segawa H, 1999, J BIOL CHEM, V274, P19745, DOI 10.1074/jbc.274.28.19745; Shayakul C, 1997, AM J PHYSIOL-RENAL, V273, pF1023, DOI 10.1152/ajprenal.1997.273.6.F1023; SILBERNAGL S, 1983, PFLUG ARCH EUR J PHY, V396, P218, DOI 10.1007/BF00587858; Torrents D, 1998, J BIOL CHEM, V273, P32437, DOI 10.1074/jbc.273.49.32437; Torrents D, 1999, NAT GENET, V21, P293, DOI 10.1038/6809; UtsunomiyaTate N, 1997, FEBS LETT, V416, P312, DOI 10.1016/S0014-5793(97)01232-5; UtsunomiyaTate N, 1996, J BIOL CHEM, V271, P14883, DOI 10.1074/jbc.271.25.14883; Verrey F, 2000, PFLUG ARCH EUR J PHY, V440, P503, DOI 10.1007/s004240050001	48	41	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					21017	21026		10.1074/jbc.M200019200	http://dx.doi.org/10.1074/jbc.M200019200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11907033	hybrid			2022-12-27	WOS:000176204500117
J	Savitsky, PA; Finkel, T				Savitsky, PA; Finkel, T			Redox regulation of Cdc25C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; CELL-CYCLE; SUPEROXIDE-DISMUTASE; CHECKPOINT PATHWAY; CRYSTAL-STRUCTURE; PROTEIN-KINASE; ARREST; G(2); PHOSPHATASE; INHIBITION	The Cdc25 family of dual specific phosphatases are critical components of cell cycle progression and checkpoint control. Certain stresses such as ultraviolet light stimulate the rapid and selective destruction of Cdc25A protein through a Chk1 protein kinase-dependent pathway. We demonstrate that in contrast to cellular stresses previously examined, hydrogen peroxide exposure affects Cdc25C but not Cdc25A levels. Pharmacological inhibition of Chk1 activity or a mutant of Cdc25C that lacks the Chk1 phosphorylation site still undergoes degradation in response to oxidants. We also demonstrate that in vitro hydrogen peroxide stimulates an intramolecular disulfide bond between the active site cysteine at position 377 and another invariant cysteine at position 330. The in vivo stability of Cdc25C is substantially reduced by the mutation of either of these two cysteine residues. In contrast, a double (C2) mutant of both cysteine 330 and cysteine 377 results in a protein that is more stable than wild type Cdc25C and is resistant to oxidative stress-induced degradation. In addition, the C2 mutant, which is unable to form an intramolecular disulfide bond, has reduced binding to 14-3-3 in vitro and in vivo. These results suggest that oxidative stress may induce cell cycle arrest in part through the degradation of Cdc25C.	NHLBI, Cardiovasc Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Finkel, T (corresponding author), NHLBI, Cardiovasc Branch, NIH, Bldg 10 6N-240,10 Ctr Dr, Bethesda, MD 20892 USA.	finkelt@nih.gov		Savitsky, Pavel/0000-0001-8584-7750				Arrington ED, 2000, FREE RADICAL BIO MED, V29, P1166, DOI 10.1016/S0891-5849(00)00439-1; Chiarugi P, 2001, J BIOL CHEM, V276, P33478, DOI 10.1074/jbc.M102302200; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; D'Agnillo F, 2001, BLOOD, V98, P3315, DOI 10.1182/blood.V98.12.3315; Dalal SN, 1999, MOL CELL BIOL, V19, P4465; den Boer BGW, 2000, TRENDS CELL BIOL, V10, P245, DOI 10.1016/S0962-8924(00)01765-7; DUNPHY WG, 1991, CELL, V67, P189, DOI 10.1016/0092-8674(91)90582-J; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Fauman EB, 1998, CELL, V93, P617, DOI 10.1016/S0092-8674(00)81190-3; Flattery-O'Brien JA, 1998, J BIOL CHEM, V273, P8564, DOI 10.1074/jbc.273.15.8564; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Graves PR, 2001, ONCOGENE, V20, P1839, DOI 10.1038/sj.onc.1204259; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; KUGAMAI A, 1999, GENE DEV, V13, P1067; Li N, 1998, J CELL PHYSIOL, V177, P148, DOI 10.1002/(SICI)1097-4652(199810)177:1<148::AID-JCP16>3.0.CO;2-9; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Molinari M, 2000, EMBO REP, V1, P71, DOI 10.1093/embo-reports/kvd018; NATSUYAMA S, 1993, BIOCHIM BIOPHYS ACTA, V1176, P90, DOI 10.1016/0167-4889(93)90182-O; Obaya AJ, 2002, CELL MOL LIFE SCI, V59, P126, DOI 10.1007/s00018-002-8410-1; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Reynolds RA, 1999, J MOL BIOL, V293, P559, DOI 10.1006/jmbi.1999.3168; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Saydam N, 2001, J BIOL CHEM, V276, P25487, DOI 10.1074/jbc.M009154200; WALWORTH N, 1993, NATURE, V363, P368, DOI 10.1038/363368a0; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; Yang J, 1999, EMBO J, V18, P2174, DOI 10.1093/emboj/18.8.2174	27	179	181	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20535	20540		10.1074/jbc.M201589200	http://dx.doi.org/10.1074/jbc.M201589200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11925443	hybrid			2022-12-27	WOS:000176204500057
J	Weidenfeld, J; Shu, WG; Zhang, LL; Millar, SE; Morrisey, EE				Weidenfeld, J; Shu, WG; Zhang, LL; Millar, SE; Morrisey, EE			The WNT7b promoter is regulated by TTF-1, GATA6, and Foxa2 in lung epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID TRANSCRIPTION FACTOR-1; SURFACTANT PROTEIN-B; HEPATOCYTE NUCLEAR FACTOR-3; GENE-EXPRESSION; ACTIVATES TRANSCRIPTION; FACTOR-I; BRANCHING MORPHOGENESIS; SONIC HEDGEHOG; C GENE; ENHANCER	In this study, we find that WNT7b is the only member of the WNT family of autocrine/paracrine signaling molecules whose expression in the lung is restricted to the airway epithelium during embryonic development. To study the transcriptional mechanisms that underlie this restricted pattern of WNT7b expression, we isolated the proximal 1.0-kb mouse WNT7b promoter and mapped the transcriptional start sites. Transfection of the lung epithelial cell line MLE-15, which expresses WNT7b, shows that the 1.0-kb mouse WNT7b promoter is highly active in lung epithelial cells. This region of the WNT7b promoter contains several DNA binding sites for the important lung-restricted transcription factors TTF-1, GATA6, and Foxa2. Electrophoretic mobility shift assays showed that TTF-1, GATA6, and Foxa2 can bind to a specific subset of their consensus DNA binding sites within the WNT7b promoter. Using cotransfection assays, we demonstrate that TTF-1, GATA6, and Foxa2 can trans-activate the WNT7b promoter in NIH-3T3 cells. Truncation of GATA6 or Foxa2 binding sites reduced the ability of these transcriptional regulators to trans-activate the WNT7b promoter. Finally, the minimal 118-bp region of the mouse WNT7b promoter containing only TTF-1 binding sites was synergistically activated by TTF-1 and GATA6, and we show that TTF-1 and GATA6 physically interact in vivo. Together, these results suggest that WNT7b gene expression in the lung epithelium is regulated in a combinatorial fashion by TTF-1, GATA6, and Foxa2.	Univ Penn, Mol Cardiol Res Ctr, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Morrisey, EE (corresponding author), Univ Penn, Mol Cardiol Res Ctr, Dept Med, 953 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.			Millar, Sarah/0000-0001-8792-6890				BOHINSKI RJ, 1994, MOL CELL BIOL, V14, P5671, DOI 10.1128/MCB.14.9.5671; Braun H, 1998, J BIOL CHEM, V273, P9821, DOI 10.1074/jbc.273.16.9821; Bruno MD, 2000, J BIOL CHEM, V275, P1043, DOI 10.1074/jbc.275.2.1043; BRUNO MD, 1995, J BIOL CHEM, V270, P6531, DOI 10.1074/jbc.270.12.6531; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; GAVIN BJ, 1990, GENE DEV, V4, P2319, DOI 10.1101/gad.4.12b.2319; Glasser SW, 2000, AM J PHYSIOL-LUNG C, V278, pL933, DOI 10.1152/ajplung.2000.278.5.L933; Ikeda K, 1996, MOL CELL BIOL, V16, P3626; IP HS, 1994, MOL CELL BIOL, V14, P7517, DOI 10.1128/MCB.14.11.7517; KAESTNER KH, 1994, GENOMICS, V20, P377, DOI 10.1006/geno.1994.1191; Keijzer R, 2001, DEVELOPMENT, V128, P503; Kelly SE, 1996, J BIOL CHEM, V271, P6881, DOI 10.1074/jbc.271.12.6881; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Lako M, 1998, GENE, V219, P101, DOI 10.1016/S0378-1119(98)00393-X; Margana RK, 1997, J BIOL CHEM, V272, P3083, DOI 10.1074/jbc.272.5.3083; Mendelson CR, 2000, ANNU REV PHYSIOL, V62, P875, DOI 10.1146/annurev.physiol.62.1.875; Minoo P, 1999, DEV BIOL, V209, P60, DOI 10.1006/dbio.1999.9234; Monkley SJ, 1996, DEVELOPMENT, V122, P3343; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Morrisey EE, 1997, DEV BIOL, V183, P21, DOI 10.1006/dbio.1996.8485; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; SAWAYA PL, 1993, MOL CELL BIOL, V13, P3860, DOI 10.1128/MCB.13.7.3860; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Shaw-White JR, 1999, J BIOL CHEM, V274, P2658, DOI 10.1074/jbc.274.5.2658; Shu WG, 2001, J BIOL CHEM, V276, P27488, DOI 10.1074/jbc.M100636200; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; YAN C, 1995, J BIOL CHEM, V270, P24852, DOI 10.1074/jbc.270.42.24852; Zhou L, 1996, J HISTOCHEM CYTOCHEM, V44, P1183, DOI 10.1177/44.10.8813084	31	89	99	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					21061	21070		10.1074/jbc.M111702200	http://dx.doi.org/10.1074/jbc.M111702200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11914369	hybrid			2022-12-27	WOS:000176204500121
J	Taru, H; Iijima, K; Hase, M; Kirino, Y; Yagi, Y; Suzuki, T				Taru, H; Iijima, K; Hase, M; Kirino, Y; Yagi, Y; Suzuki, T			Interaction of Alzheimer's beta-amyloid precursor family proteins with scaffold proteins of the JNK signaling cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC DOMAIN; DEPENDENT REGULATION; CYTOSOLIC ADAPTER; AXONAL-TRANSPORT; PHOSPHORYLATION; GENE; APPL; RECEPTOR; EXPRESSION; VIABILITY	We have isolated a novel protein based on its association with Drosophila APP-like protein (APPL), a homolog of the beta-amyloid precursor protein (APP) that is implicated in Alzheimer's disease. This novel APPL-interacting protein 1 (APLIP1) contains a Src homology 3 domain and a phosphotyrosine interaction domain and is expressed abundantly in neural tissues. The phosphotyrosine interaction domain of APLIP1 interacts with a sequence containing GYENPTY in the cytoplasmic domain of APPL. APLIP1 is highly homologous to the carboxyl-terminal halves of mammalian c-Jun NH2-terminal kinase (JNK)-interacting protein 1b (JIP1b) and 2 (JIP2), which also contain Src homology 3 and phosphotyrosine interaction domains. The similarity of APLIP1 to JIP1b and JIP2 includes interaction with component(s) of the JNK signaling pathway and with the motor protein kinesin and the formation of homo-oligomers. JIP1b interacts strongly with the cytoplasmic domain of APP (APPcyt), as APLIP1 does with APPL, but the interaction of JIP2 with APPcyt is weak. Overexpression of JIP1b slightly enhances the JNK-dependent threonine phosphorylation of APP in cultured cells, but that of JIP2 suppresses it. These observations suggest that the interactions of APP family proteins with APLIP1, JIP1b, and JIP2 are conserved and play important roles in the metabolism and/or the function of APPs including the regulation of APP phosphorylation by JNK. Analysis of APP family proteins and their associated proteins is expected to contribute to understanding the molecular process of neural degeneration in Alzheimer's disease.	Hokkaido Univ, Grad Sch Pharmaceut Sci, Lab Neurosci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; Univ Tokyo, Sch Pharmaceut Sci, Lab Neurobiophys, Bunkyo Ku, Tokyo 1130033, Japan	Hokkaido University; University of Tokyo	Suzuki, T (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Lab Neurosci, Kita Ku, Kita 12 Nishi 6, Sapporo, Hokkaido 0600812, Japan.	tsuzuki@pharm.hokudai.ac.jp	Taru, Hidenori/B-7059-2009; Suzuki, Toshiharu/B-5342-2013					Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; ALLINQUANT B, 1995, J CELL BIOL, V128, P919, DOI 10.1083/jcb.128.5.919; Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Ando K, 1999, J NEUROSCI, V19, P4421; Bonny C, 1998, J BIOL CHEM, V273, P1843, DOI 10.1074/jbc.273.4.1843; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Coulson EJ, 2000, NEUROCHEM INT, V36, P175, DOI 10.1016/S0197-0186(99)00125-4; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Fan G, 1996, J BIOL CHEM, V271, P24788, DOI 10.1074/jbc.271.40.24788; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Guenette SY, 1996, P NATL ACAD SCI USA, V93, P10832, DOI 10.1073/pnas.93.20.10832; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Heber S, 2000, J NEUROSCI, V20, P7951; Iijima K, 2000, J NEUROCHEM, V75, P1085, DOI 10.1046/j.1471-4159.2000.0751085.x; Ito M, 1999, MOL CELL BIOL, V19, P7539; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; LUO LQ, 1992, NEURON, V9, P595, DOI 10.1016/0896-6273(92)90024-8; LUO LQ, 1990, J NEUROSCI, V10, P3849, DOI 10.1523/JNEUROSCI.10-12-03849.1990; Margolis B, 1999, KIDNEY INT, V56, P1230, DOI 10.1046/j.1523-1755.1999.00700.x; MARTINMORRIS LE, 1990, DEVELOPMENT, V110, P185; Matsuda S, 2001, J NEUROSCI, V21, P6597; Meyer D, 1999, J BIOL CHEM, V274, P35113, DOI 10.1074/jbc.274.49.35113; Noselli S, 1999, CURR OPIN GENET DEV, V9, P466, DOI 10.1016/S0959-437X(99)80071-9; Oishi M, 1997, MOL MED, V3, P111, DOI 10.1007/BF03401803; Perez RG, 1997, J NEUROSCI, V17, P9407; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; ROSEN DR, 1989, P NATL ACAD SCI USA, V86, P2478, DOI 10.1073/pnas.86.7.2478; SAMBROOK J, 1989, MOL CLONING LABORATO, pCH12; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Sluss HK, 1996, GENE DEV, V10, P2745, DOI 10.1101/gad.10.21.2745; Standen CL, 2001, J NEUROCHEM, V76, P316, DOI 10.1046/j.1471-4159.2001.00102.x; Stockinger W, 2000, J BIOL CHEM, V275, P25625, DOI 10.1074/jbc.M004119200; SUZUKI T, 1994, EMBO J, V13, P1114, DOI 10.1002/j.1460-2075.1994.tb06360.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomita S, 1999, J BIOL CHEM, V274, P2243, DOI 10.1074/jbc.274.4.2243; Tomita S, 1998, J BIOL CHEM, V273, P19304, DOI 10.1074/jbc.273.30.19304; Torroja L, 1996, J NEUROSCI, V16, P4638; Torroja L, 1999, CURR BIOL, V9, P489, DOI 10.1016/S0960-9822(99)80215-2; Torroja L, 1999, J NEUROSCI, V19, P7793; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Watanabe T, 1999, J NEUROCHEM, V72, P549, DOI 10.1046/j.1471-4159.1999.0720549.x; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Xu X, 1999, P NATL ACAD SCI USA, V96, P7547, DOI 10.1073/pnas.96.13.7547; Yagi Y, 1997, GENES CELLS, V2, P41, DOI 10.1046/j.1365-2443.1997.d01-282.x; Yagi Yoshimasa, 2000, Molecular Cell Biology Research Communications, V4, P43, DOI 10.1006/mcbr.2000.0248; Yasuda J, 1999, MOL CELL BIOL, V19, P7245; Zheng PZ, 1998, P NATL ACAD SCI USA, V95, P14745, DOI 10.1073/pnas.95.25.14745	49	107	116	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					20070	20078		10.1074/jbc.M108372200	http://dx.doi.org/10.1074/jbc.M108372200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11912189	hybrid			2022-12-27	WOS:000175894800108
J	Goel, R; Phillips-Mason, PJ; Raben, DM; Baldassare, JJ				Goel, R; Phillips-Mason, PJ; Raben, DM; Baldassare, JJ			alpha-Thrombin induces rapid and sustained Akt phosphorylation by beta-arrestin1-dependent and -independent mechanisms, and only the sustained Akt phosphorylation is essential for G(1) phase progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; COUPLED RECEPTOR ENDOCYTOSIS; BETA-ARRESTIN; PHOSPHOINOSITIDE 3-KINASE; CYCLIN D1; DNA-SYNTHESIS; PROTEOLYTIC MECHANISM; PERTUSSIS-TOXIN; GROWTH-FACTORS; CELL-GROWTH	In Chinese hamster embryonic fibroblasts (IIC9 cells) alpha-thrombin activates the MAPK(ERK) and phosphatidylinositol 3-OH-kinase (PI 3-kinase)/Akt pathways, and both are essential for progression through the G(1) phase of the cell cycle. We investigated in IIC9 cells, the role of beta-arrestin1 in alpha-thrombin signaling to these pathways. alpha-Thrombin stimulates rapid and sustained PI 3-kinase and Akt activities. Expression of a dominant negative alpha-arrestin1 (beta-arrestin1(V53D)) inhibits rapid but not sustained PI 3-kinase and Akt activities. Surprisingly, expression of beta-arrestin1(V53D) does not block activation of the MAPK(ERK pathway. PI 3-kinase and Akt activities are also inhibited by expression of beta-arrestin1 mutant, which impairs binding to c-Src (beta-arrestin1(P91G-P12E)), indicating the involvement of c-Src in the rapid stimulation of the PI 3-kinase/Akt pathway. Consistent with these results, PP1, a selective inhibitor of c-Src family kinases, prevents alpha-thrombin-stimulated Akt phosphorylation. Expression of Parrestin1(V53D) does not prevent G(1) progression, as its expression has no effect on [H-3]thymidine incorporation into DNA. In agreement with the ineffectiveness of beta-arrestin1(V53D) to block G(1) progression, cyclin D1 protein amounts and CDK4-cyclin D1 activity is unaffected by expression of beta-arrestin1(V53D). Thus in IIC9 cells, alpha-thrombin activates rapid beta-arrestin1-dependent and sustained beta-arrestin1-independent Akt activity, suggesting that two mechanisms are involved. Furthermore, although blocking the beta-arrestin1-independent PI 3-kinase/Akt pathway prevents G(1) progression, inhibition of the beta-arrestin1-dependent pathway does not, indicating different roles for the rapid and sustained activities.	St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Saint Louis University; Johns Hopkins University	Baldassare, JJ (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA.				NIDDK NIH HHS [R01 DK46814] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046814] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARAGAY AM, 1995, J BIOL CHEM, V270, P20073, DOI 10.1074/jbc.270.34.20073; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; BAFFY G, 1994, J BIOL CHEM, V269, P8483; Barlic J, 2000, NAT IMMUNOL, V1, P227, DOI 10.1038/79767; BELLONI PN, 1992, MICROVASC RES, V43, P20, DOI 10.1016/0026-2862(92)90004-9; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Carpenter CL, 1996, BBA-REV CANCER, V1288, pM11, DOI 10.1016/0304-419X(96)00018-2; CHAMBARD JC, 1987, NATURE, V326, P800, DOI 10.1038/326800a0; COUGHLIN SR, 1993, THROMB HAEMOSTASIS, V70, P184; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Gaidarov I, 1999, EMBO J, V18, P871, DOI 10.1093/emboj/18.4.871; Galetic I, 1999, PHARMACOL THERAPEUT, V82, P409, DOI 10.1016/S0163-7258(98)00071-0; HUNG DT, 1992, J CELL BIOL, V116, P827, DOI 10.1083/jcb.116.3.827; Kanthou C, 1996, CELL SIGNAL, V8, P59, DOI 10.1016/0898-6568(95)02018-7; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; Krasilnikov MA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P59; Krupnick JG, 1997, J BIOL CHEM, V272, P32507, DOI 10.1074/jbc.272.51.32507; LAMORTE VJ, 1993, J CELL BIOL, V121, P91, DOI 10.1083/jcb.121.1.91; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Liu Y, 1999, CHEM BIOL, V6, P671, DOI 10.1016/S1074-5521(99)80118-5; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; MCNAMARA C, 1992, J CLIN INVEST, V91, P94; Miller WE, 2000, J BIOL CHEM, V275, P11312, DOI 10.1074/jbc.275.15.11312; Miller WE, 2001, CURR OPIN CELL BIOL, V13, P139, DOI 10.1016/S0955-0674(00)00190-3; Ogino Y, 1996, EUR J PHARMACOL, V316, P105, DOI 10.1016/S0014-2999(96)00653-X; Phillips-Mason PJ, 2000, J BIOL CHEM, V275, P18046, DOI 10.1074/jbc.M909194199; PHILLIPSMASON PJ, 2000, THESIS SAINT LOUIS U; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Rakhit S, 2001, MOL PHARMACOL, V60, P63, DOI 10.1124/mol.60.1.63; RASMUSSEN UB, 1991, FEBS LETT, V288, P123, DOI 10.1016/0014-5793(91)81017-3; ROCHE S, 1994, P NATL ACAD SCI USA, V91, P9185, DOI 10.1073/pnas.91.19.9185; Toker A, 2000, MOL PHARMACOL, V57, P652, DOI 10.1124/mol.57.4.652; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Walker TR, 1998, MOL PHARMACOL, V54, P1007, DOI 10.1124/mol.54.6.1007; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061	43	81	82	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					18640	18648		10.1074/jbc.M108995200	http://dx.doi.org/10.1074/jbc.M108995200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11901145	hybrid			2022-12-27	WOS:000175975800054
J	Pokutta, S; Drees, F; Takai, Y; Nelson, WJ; Weis, WI				Pokutta, S; Drees, F; Takai, Y; Nelson, WJ; Weis, WI			Biochemical and structural definition of the 1-afadin- and actin-binding sites of alpha-catenin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL ADHESION; ADHERENS JUNCTIONS; CRYSTAL-STRUCTURE; BETA-CATENIN; CADHERIN; PROTEIN; COMPLEX; VINCULIN; AFADIN; DOMAIN	alpha-Catenin is an integral component of adherens junctions, where it links cadherins to the actin cytoskeleton. alpha-Catenin is also required for the colocalization of the nectin/afadin/ponsin adhesion system to adherens junctions, and it specifically associates with the nectin-binding protein afadin. A proteolytic fragment of alpha-catenin, residues 385-651, contains the afadin-binding site. The three-dimensional structure of this fragment comprises two side-by-side four-helix bundles, both of which are required for afadin binding. The alpha-catenin fragment 385-651 binds afadin more strongly than the full-length protein, suggesting that the full-length protein harbors a cryptic binding site for afadin. Comparison of the alpha-catenin 385-651 structure with the recently solved structure of the alpha-catenin M-fragment (Yang, J., Dokurno, P., Tonks, N. K, and Barford, D. (2001) EMBO J. 20, 3645-3656) reveals a surprising flexibility in the orientation of the two four-helix bundles. alpha-Catenin and the actin-binding protein vinculin share sequence and most likely structural similarity within their actin-binding domains. Despite this homology, actin binding requires additional sequences adjacent to this region.	Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Osaka Univ, Grad Sch Med, Dept Mol Biol & Biochem, Suita, Osaka 5650871, Japan	Stanford University; Stanford University; Osaka University	Weis, WI (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Fairchild Bldg,299 Campus Dr W, Stanford, CA 94305 USA.		Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035527, R01GM056169] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM35227, GM56169, R01 GM056169, R01 GM035527] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABERLE H, 1994, J CELL SCI, V107, P3655; Adams CL, 1996, J CELL BIOL, V135, P1899, DOI 10.1083/jcb.135.6.1899; Angres B, 1996, J CELL BIOL, V134, P549, DOI 10.1083/jcb.134.2.549; Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; HERRENKNECHT K, 1991, P NATL ACAD SCI USA, V88, P9156, DOI 10.1073/pnas.88.20.9156; Ikeda W, 1999, J CELL BIOL, V146, P1117, DOI 10.1083/jcb.146.5.1117; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Itoh M, 1999, J BIOL CHEM, V274, P5981, DOI 10.1074/jbc.274.9.5981; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JOU TS, 1995, P NATL ACAD SCI USA, V92, P5067, DOI 10.1073/pnas.92.11.5067; KNUDSEN KA, 1995, J CELL BIOL, V130, P67, DOI 10.1083/jcb.130.1.67; Koslov ER, 1997, J BIOL CHEM, V272, P27301, DOI 10.1074/jbc.272.43.27301; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Mandai K, 1999, J CELL BIOL, V144, P1001, DOI 10.1083/jcb.144.5.1001; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Miyahara M, 2000, J BIOL CHEM, V275, P613, DOI 10.1074/jbc.275.1.613; NAGAFUCHI A, 1991, CELL, V65, P849, DOI 10.1016/0092-8674(91)90392-C; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OZAWA M, 1992, J CELL BIOL, V116, P989, DOI 10.1083/jcb.116.4.989; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pradhan D, 2001, J BIOL CHEM, V276, P4175, DOI 10.1074/jbc.M009259200; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Sakisaka T, 1999, ONCOGENE, V18, P1609, DOI 10.1038/sj.onc.1202451; Steinberg MS, 1999, CURR OPIN CELL BIOL, V11, P554, DOI 10.1016/S0955-0674(99)00027-7; Tachibana K, 2000, J CELL BIOL, V150, P1161, DOI 10.1083/jcb.150.5.1161; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Tomschy A, 1996, EMBO J, V15, P3507, DOI 10.1002/j.1460-2075.1996.tb00719.x; Tsukita S, 1997, TRENDS BIOCHEM SCI, V22, P53, DOI 10.1016/S0968-0004(96)10071-2; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Weiss EE, 1998, J CELL BIOL, V141, P755, DOI 10.1083/jcb.141.3.755; Yang J, 2001, EMBO J, V20, P3645, DOI 10.1093/emboj/20.14.3645	40	177	180	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					18868	18874		10.1074/jbc.M201463200	http://dx.doi.org/10.1074/jbc.M201463200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11907041	hybrid, Green Accepted			2022-12-27	WOS:000175975800081
J	Torihashi, S; Fujimoto, T; Trost, C; Nakayama, S				Torihashi, S; Fujimoto, T; Trost, C; Nakayama, S			Calcium oscillation linked to pacemaking of interstitial cells of Cajal - Requirement of calcium influx and localization of TRP4 in caveolae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE SMALL-INTESTINE; SLOW-WAVE FREQUENCY; GASTROINTESTINAL-TRACT; ELECTRICAL RHYTHMICITY; SMOOTH MUSCLES; TRISPHOSPHATE RECEPTOR; MOLECULAR-BASIS; EXPRESSION; CHANNELS; PROTEIN	Interstitial cells of Cajal (ICC) are considered to be pacemaker cells in gastrointestinal tracts. ICC generate electrical rhythmicity (dihydropyridine-insensitive) as slow waves and drive spontaneous contraction of smooth muscles. Although cytosolic Ca2+ has been assumed to play a key role in pacemaking, Ca2+ movements in ICC have not yet been examined in detail. In the present study, using cultured cell clusters isolated from mouse small intestine, we demonstrated Ca2+ oscillations in ICC. Fluo-4 was loaded to the cell cluster, the relative amount of cytosolic Ca2+ was recorded, and ICC were identified by e-Kit immunoreactivity. We specifically detected Ca2+ oscillation in ICC in the presence of dihydropyridine, which abolishes Ca2+ oscillation in smooth muscles. The oscillation was coupled to the electrical activity corresponding to slow waves, and it depended on Ca2+ influx through a non-selective cation channel, which was SK&F 96365-sensitive and store-operated. We further demonstrated the presence of transient receptor potential-like channel 4 (TRP4) in caveolae of ICC. Taken together, the results infer that the Ca2+ oscillation in ICC is intimately linked to the pacemaker function and depends on Ca2+ influx mediated by TRP4.	Nagoya Univ, Grad Sch Med, Dept Anat & Cell Biol, Showa Ku, Nagoya, Aichi 4668550, Japan; Nagoya Univ, Grad Sch Med, Dept Cell Physiol, Nagoya, Aichi 4668550, Japan; Univ Saarland, Inst Pharmakol & Toxikol, D-66421 Homburg, Germany	Nagoya University; Nagoya University; Saarland University	Torihashi, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Anat & Cell Biol, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.							Birnbaumer L, 1996, P NATL ACAD SCI USA, V93, P15195, DOI 10.1073/pnas.93.26.15195; Boulay G, 1997, J BIOL CHEM, V272, P29672, DOI 10.1074/jbc.272.47.29672; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Epperson A, 2000, AM J PHYSIOL-CELL PH, V279, pC529, DOI 10.1152/ajpcell.2000.279.2.C529; Farrugia G, 1999, ANNU REV PHYSIOL, V61, P45, DOI 10.1146/annurev.physiol.61.1.45; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Fujita A, 2001, AM J PHYSIOL-CELL PH, V281, pC1727, DOI 10.1152/ajpcell.2001.281.5.C1727; GRIFFITHS G, 1983, METHOD ENZYMOL, V96, P466; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Horowitz B, 1999, ANNU REV PHYSIOL, V61, P19, DOI 10.1146/annurev.physiol.61.1.19; Huang SM, 1999, AM J PHYSIOL-GASTR L, V276, pG518, DOI 10.1152/ajpgi.1999.276.2.G518; HUIZINGA JD, 1995, NATURE, V373, P347, DOI 10.1038/373347a0; Kinoshita M, 2000, CELL CALCIUM, V28, P151, DOI 10.1054/ceca.2000.0143; Koh SD, 1998, J PHYSIOL-LONDON, V513, P203, DOI 10.1111/j.1469-7793.1998.203by.x; Lee JCF, 1999, AM J PHYSIOL-GASTR L, V277, pG409, DOI 10.1152/ajpgi.1999.277.2.G409; Lockwich T, 2001, J BIOL CHEM, V276, P42401, DOI 10.1074/jbc.M106956200; Malysz J, 2001, AM J PHYSIOL-GASTR L, V280, pG439, DOI 10.1152/ajpgi.2001.280.3.G439; McKay RR, 2000, BIOCHEM J, V351, P735, DOI 10.1042/0264-6021:3510735; Nakayama S, 1997, J PHYSIOL-LONDON, V505, P229, DOI 10.1111/j.1469-7793.1997.229bc.x; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Philipp S, 2000, J BIOL CHEM, V275, P23965, DOI 10.1074/jbc.M003408200; RUMESSEN JJ, 1994, DAN MED BULL, V41, P275; RUMESSEN JJ, 1992, GASTROENTEROLOGY, V102, P56, DOI 10.1016/0016-5085(92)91784-2; Sanders KM, 1996, GASTROENTEROLOGY, V111, P492, DOI 10.1053/gast.1996.v111.pm8690216; Stevens RJ, 2000, GASTROENTEROLOGY, V118, P892, DOI 10.1016/S0016-5085(00)70175-2; Suzuki H, 2000, J PHYSIOL-LONDON, V525, P105, DOI 10.1111/j.1469-7793.2000.00105.x; Suzuki H, 2000, JPN J PHYSIOL, V50, P289, DOI 10.2170/jjphysiol.50.289; SZURSZEWSKY JH, 1987, HDB GASTROINTESTINAL, P383; Tang Y, 2000, J BIOL CHEM, V275, P37559, DOI 10.1074/jbc.M006635200; Thomsen L, 1998, NAT MED, V4, P848, DOI 10.1038/nm0798-848; THUNEBERG L, 1982, ADV ANAT EMBRYOL CEL, V71, P1; Tokutomi N, 1995, PFLUG ARCH EUR J PHY, V431, P169, DOI 10.1007/BF00410188; TOKUYASU KT, 1989, J CELL BIOL, V108, P43, DOI 10.1083/jcb.108.1.43; TORIHASHI S, 1995, CELL TISSUE RES, V280, P97, DOI 10.1007/s004410050334; Walker RL, 2001, AM J PHYSIOL-CELL PH, V280, pC1184, DOI 10.1152/ajpcell.2001.280.5.C1184; WARD SM, 1994, J PHYSIOL-LONDON, V480, P91, DOI 10.1113/jphysiol.1994.sp020343; Ward SM, 2000, J PHYSIOL-LONDON, V525, P355, DOI 10.1111/j.1469-7793.2000.t01-1-00355.x; Yamazawa T, 2002, J PHYSIOL-LONDON, V538, P823, DOI 10.1113/jphysiol.2001.013045	38	157	173	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					19191	19197		10.1074/jbc.M201728200	http://dx.doi.org/10.1074/jbc.M201728200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11897792	hybrid			2022-12-27	WOS:000175975800122
J	Dhe-Paganon, S; Werner, ED; Chi, YI; Shoelson, SE				Dhe-Paganon, S; Werner, ED; Chi, YI; Shoelson, SE			Structure of the globular tail of nuclear lamin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; CAUSE AUTOSOMAL-DOMINANT; DILATED CARDIOMYOPATHY; IMMUNOGLOBULIN FOLD; MISSENSE MUTATIONS; A/C GENE; PROTEIN; DOMAIN; LMNA; IDENTIFICATION	The nuclear lamins form a two-dimensional matrix that provides integrity to the cell nucleus and participates in nuclear activities. Mutations in the region of human LMNA encoding the carboxyl-terminal tail Lamin A/C are associated with forms of muscular dystrophy and familial partial lipodystrophy (FPLD). To help discriminate tissue-specific phenotypes, we have solved at 1.4-Angstrom resolution the three-dimensional crystal structure of the lamin A/C globular tail. The domain adopts a novel, all beta-mmunoglobulin-like fold. FPLD-associated mutations cluster within a small surface, whereas muscular dystrophy-associated mutations are distributed throughout the protein core and on its surface. These findings distinguish myopathy- and lipodystrophy-associated mutations and provide a structural framework for further testing hypotheses concerning lamin function.	Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Shoelson, SE (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, 1 Joslin Pl, Boston, MA 02215 USA.	Steven.Shoelson@joslin.harvard.edu			NIDDK NIH HHS [R01 DK43123, DK09393] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043123, F32DK009393] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMZEL LM, 1979, ANNU REV BIOCHEM, V48, P961, DOI 10.1146/annurev.bi.48.070179.004525; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Bonne G, 2000, ANN NEUROL, V48, P170, DOI 10.1002/1531-8249(200008)48:2<170::AID-ANA6>3.0.CO;2-J; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Brodsky GL, 2000, CIRCULATION, V101, P473, DOI 10.1161/01.CIR.101.5.473; Brown CA, 2001, AM J MED GENET, V102, P359, DOI 10.1002/ajmg.1463; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burke B, 2001, TRAFFIC, V2, P675, DOI 10.1034/j.1600-0854.2001.21001.x; Cao H, 2000, HUM MOL GENET, V9, P109, DOI 10.1093/hmg/9.1.109; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Clements L, 2000, BIOCHEM BIOPH RES CO, V267, P709, DOI 10.1006/bbrc.1999.2023; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Cutler DA, 2002, BIOCHEM BIOPH RES CO, V291, P522, DOI 10.1006/bbrc.2002.6466; di Barletta MR, 2000, AM J HUM GENET, V66, P1407, DOI 10.1086/302869; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Goldberg M, 1999, P NATL ACAD SCI USA, V96, P2852, DOI 10.1073/pnas.96.6.2852; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LIN F, 1993, J BIOL CHEM, V268, P16321; Manilal S, 1996, HUM MOL GENET, V5, P801, DOI 10.1093/hmg/5.6.801; Muchir A, 2000, HUM MOL GENET, V9, P1453, DOI 10.1093/hmg/9.9.1453; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Shackleton S, 2000, NAT GENET, V24, P153, DOI 10.1038/72807; Speckman RA, 2000, AM J HUM GENET, V66, P1192, DOI 10.1086/302836; Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Wilson KL, 2001, CELL, V104, P647, DOI 10.1016/S0092-8674(02)01452-6; Worman HJ, 2000, J MEMBRANE BIOL, V177, P1, DOI 10.1007/s002320001096	33	211	219	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2002	277	20					17381	17384		10.1074/jbc.C200038200	http://dx.doi.org/10.1074/jbc.C200038200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	553PR	11901143	hybrid			2022-12-27	WOS:000175685100002
J	Zaganas, I; Plaitakis, A				Zaganas, I; Plaitakis, A			Single amino acid substitution (G456A) in the vicinity of the GTP binding domain of human housekeeping glutamate dehydrogenase markedly attenuates GTP inhibition and abolishes the cooperative behavior of the enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERINSULINISM/HYPERAMMONEMIA SYNDROME; HYPERAMMONEMIA SYNDROME; NEUROLOGICAL DISORDERS; CASSETTE MUTAGENESIS; REGULATORY MUTATIONS; MISSENSE MUTATIONS; HUMAN-LIVER; GENE; IDENTIFICATION; MECHANISM	Human glutamate dehydrogenase (GDH) exists in two isoforms encoded by the GLUD1 and GLUD2 genes, respectively. Although the two enzymes share in their mature form all but 15 of their 505 amino acids, they differ markedly in their allosteric regulation. To identify the structural basis for these allosteric characteristics, we performed site-directed mutagenesis on the human GLUD1 gene at sites that differ from the GLUD2 gene using a cloned GLUD1 cDNA. Results showed that substitution of Ala for Gly-456, but not substitution of His for Arg-470 or Ser for Asn-498, renders the enzyme markedly resistant to GTP inhibition (IC50 = 2.80 muM) as compared with the wild type GLUD1-derived GDH (IC50 = 0.19 muM). The G456A mutation abolished the cooperative behavior of the enzyme, as revealed by the GTP inhibitory curves. The catalytic and kinetic properties of the G456A mutant and its activation by ADP were comparable with those of the wild type GDH. Gly-456 lies in a very tightly packed region of the GDH molecule, and its replacement by Ala may lead to steric clashes with neighboring amino acids. These, in turn, may affect the conformational state of the protein that is essential for the allosteric regulation of the enzyme by GTP.	Univ Crete, Sch Hlth Sci, Med Sect, Dept Neurol, Iraklion 71500, Crete, Greece	University of Crete	Plaitakis, A (corresponding author), Univ Crete, Sch Hlth Sci, Med Sect, Dept Neurol, Iraklion 71500, Crete, Greece.	plaitak@med.uoc.gr	Zaganas, Ioannis/AAE-5441-2020	Zaganas, Ioannis/0000-0002-0774-5772				Cho SW, 1996, BIOCHEMISTRY-US, V35, P13907, DOI 10.1021/bi9618575; Cho SW, 2001, EUR J BIOCHEM, V268, P3205, DOI 10.1046/j.1432-1327.2001.02209.x; COLON AD, 1986, J NEUROCHEM, V46, P1811; Cornish-Bowden A, 2012, FUNDAMENTALS ENZYME, V3rd, DOI [10.1016/B978-0-408-10617-7.50013-4/, DOI 10.1016/B978-0-408-10617-7.50013-4]; CORNISHBOWDEN A, 1995, ANAL ENZYME KINETIC, P133; De Lonlay P, 2001, PEDIATR RES, V50, P353, DOI 10.1203/00006450-200109000-00010; HUDSON RC, 1993, COMP BIOCHEM PHYS B, V106, P767, DOI 10.1016/0305-0491(93)90031-Y; HUSSAIN MM, 1989, J BIOL CHEM, V264, P20730; JULLIARD JH, 1979, J BIOL CHEM, V254, P3427; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee EY, 2001, J BIOL CHEM, V276, P47930, DOI 10.1074/jbc.M108918200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacMullen C, 2001, J CLIN ENDOCR METAB, V86, P1782, DOI 10.1210/jc.86.4.1782; MAVROTHALASSITIS G, 1988, P NATL ACAD SCI USA, V85, P3494, DOI 10.1073/pnas.85.10.3494; MICHAELIDIS TM, 1993, GENOMICS, V16, P150, DOI 10.1006/geno.1993.1152; Miki Y, 2000, J PEDIATR-US, V136, P69, DOI 10.1016/S0022-3476(00)90052-0; MOON K, 1973, J BIOL CHEM, V248, P3082; Peterson PE, 1999, STRUCTURE, V7, P769, DOI 10.1016/S0969-2126(99)80101-4; Peterson PE, 1997, J STRUCT BIOL, V120, P73, DOI 10.1006/jsbi.1997.3899; Plaitakis A, 2000, J NEUROCHEM, V75, P1862, DOI 10.1046/j.1471-4159.2000.0751862.x; Plaitakis A, 2001, J NEUROSCI RES, V66, P899, DOI 10.1002/jnr.10054; PLAITAKIS A, 1984, ANN NEUROL, V15, P144, DOI 10.1002/ana.410150206; Santer R, 2001, HUM GENET, V108, P66, DOI 10.1007/s004390000432; Shashidharan P, 1997, J NEUROCHEM, V68, P1804; SHASHIDHARAN P, 1994, J BIOL CHEM, V269, P16971; SMITH EL, 1975, ENZYMES, P293; Smith TJ, 2001, J MOL BIOL, V307, P707, DOI 10.1006/jmbi.2001.4499; Stanley CA, 2000, DIABETES, V49, P667, DOI 10.2337/diabetes.49.4.667; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; Yorifuji T, 1999, HUM GENET, V104, P476, DOI 10.1007/s004390050990	30	39	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2002	277	29					26422	26428		10.1074/jbc.M200022200	http://dx.doi.org/10.1074/jbc.M200022200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	574UV	11950837	hybrid			2022-12-27	WOS:000176908700079
J	Simm, AM; Higgins, CS; Carenbauer, AL; Crowder, MW; Bateson, JH; Bennett, PM; Clarke, AR; Halford, SE; Walsh, TR				Simm, AM; Higgins, CS; Carenbauer, AL; Crowder, MW; Bateson, JH; Bennett, PM; Clarke, AR; Halford, SE; Walsh, TR			Characterization of monomeric L1 metallo-beta-lactamase and the role of the N-terminal extension in negative cooperativity and antibiotic hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STENOTROPHOMONAS-MALTOPHILIA; BACTEROIDES-FRAGILIS; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; BACILLUS-CEREUS; CLINICAL ISOLATE; MOLECULAR CHARACTERIZATION; ANGSTROM RESOLUTION; GENE; PURIFICATION	The L1 metallo-beta-lactamase from Stenotrophomonas maltophilia is unique among this class of enzymes because it is tetrameric. Previous work predicted that the two regions of important intersubunit interaction were the residue Met-140 and the N-terminal extensions of each subunit. The N-terminal extension was also implicated in beta-lactam binding. Mutation of methionine 140 to aspartic acid results in a monomeric L1 beta-lactamase with a greatly altered substrate specificity profile. A 20-amino acid N-terminal deletion mutant enzyme (N-Del) could be isolated in a tetrameric form but demonstrated greatly reduced rates of beta-lactam hydrolysis and different substrate profiles compared with that of the parent enzyme. Specific site-directed mutations of individual N terminus residues were made (Y11S, W17S, and a double mutant L5A/L8A). All N-terminal mutant enzymes were tetramers and all showed higher K-m values for ampicillin and nitrocefin, hydrolyzed ceftazidime poorly, and hydrolyzed imipenem more efficiently than ampicillin in contrast to wild-type L1. Nitrocefin turnover was significantly increased, probably because of an increased rate of breakdown of the intermediate species due to a lack of stabilizing forces. K-m values for monomeric L1 were greatly increased for all antibiotics tested. A model of a highly mobile N-terminal extension in the monomeric enzyme is proposed to explain these findings. Tetrameric L1 shows negative cooperativity, which is not present in either the monomer or N-terminal deletion enzymes, suggesting that the cooperative effect is mediated via N-terminal intersubunit interactions. These data indicate that while the N terminus of L1 is not essential for beta-lactam hydrolysis, it is clearly important to its activity and substrate specificity.	Univ Bristol, Sch Med Sci, Dept Pathol & Microbiol, Bristol BS8 1TD, Avon, England; Miami Univ, Dept Chem & Biochem, Oxford, OH 45056 USA; GlaxoSmithKline, Dept Med Chem, Harlow CM19 5AW, Essex, England; Univ Bristol, Dept Biochem, Bristol BS8 1TD, Avon, England	University of Bristol; University System of Ohio; Miami University; GlaxoSmithKline; University of Bristol	Simm, AM (corresponding author), Univ Bristol, Sch Med Sci, Dept Pathol & Microbiol, Univ Walk, Bristol BS8 1TD, Avon, England.	A.M.Simm@bristol.ac.uk	Walsh, Timothy R/F-6519-2010	Walsh, Timothy/0000-0003-4315-4096				Alonso A, 1997, ANTIMICROB AGENTS CH, V41, P1140, DOI 10.1128/AAC.41.5.1140; Avison MB, 2000, J ANTIMICROB CHEMOTH, V46, P879, DOI 10.1093/jac/46.6.879; Avison MB, 2001, ANTIMICROB AGENTS CH, V45, P413, DOI 10.1128/AAC.45.2.413-419.2001; Bellais S, 1999, FEMS MICROBIOL LETT, V171, P127, DOI 10.1111/j.1574-6968.1999.tb13422.x; BICKNELL R, 1985, BIOCHEM J, V229, P791, DOI 10.1042/bj2290791; Boschi L, 2000, ANTIMICROB AGENTS CH, V44, P1538, DOI 10.1128/AAC.44.6.1538-1543.2000; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Carfi A, 1998, ACTA CRYSTALLOGR D, V54, P47, DOI 10.1107/S090744499700927X; Carfi A, 1998, ACTA CRYSTALLOGR D, V54, P313, DOI 10.1107/S0907444997010627; CARFI A, 1995, EMBO J, V14, P4914, DOI 10.1002/j.1460-2075.1995.tb00174.x; Concha NO, 1996, STRUCTURE, V4, P823, DOI 10.1016/S0969-2126(96)00089-5; Concha NO, 2000, BIOCHEMISTRY-US, V39, P4288, DOI 10.1021/bi992569m; Cornaglia G, 2000, CLIN INFECT DIS, V31, P1119, DOI 10.1086/317448; Crowder MW, 1996, BIOCHEMISTRY-US, V35, P12126, DOI 10.1021/bi960976h; Crowder MW, 1998, ANTIMICROB AGENTS CH, V42, P921, DOI 10.1128/AAC.42.4.921; Crowder MW, 1999, RRD ANTIMICROB AG  1, V3, P105; Denton M, 1998, CLIN MICROBIOL REV, V11, P57, DOI 10.1128/CMR.11.1.57; Fabiane SM, 1998, BIOCHEMISTRY-US, V37, P12404, DOI 10.1021/bi980506i; GHUYSEN JM, 1991, ANNU REV MICROBIOL, V45, P37, DOI 10.1146/annurev.mi.45.100191.000345; Gibbs N, 2001, PROTEINS, V43, P186, DOI 10.1002/1097-0134(20010501)43:2<186::AID-PROT1030>3.0.CO;2-L; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hudson L, 1989, PRACTICAL IMMUNOLOGY, P348; HUSSAIN M, 1985, J BACTERIOL, V164, P223, DOI 10.1128/JB.164.1.223-229.1985; Laue T.M., 1991, ANAL ULTRACENTRIFUGA; MASSIDDA O, 1991, J BACTERIOL, V173, P4611, DOI 10.1128/jb.173.15.4611-4617.1991; McManus-Munoz S, 1999, BIOCHEMISTRY-US, V38, P1547, DOI 10.1021/bi9826512; McRorie D. K., 1993, SELF ASSOCIATING SYS; Mokaddas EM, 1999, J CHEMOTHERAPY, V11, P93, DOI 10.1179/joc.1999.11.2.93; OSANO E, 1994, ANTIMICROB AGENTS CH, V38, P71, DOI 10.1128/AAC.38.1.71; Paul-Soto R, 1999, J BIOL CHEM, V274, P13242, DOI 10.1074/jbc.274.19.13242; Payne DJ, 2000, EXPERT OPIN INV DRUG, V9, P247, DOI 10.1517/13543784.9.2.247; Poirel L, 2000, ANTIMICROB AGENTS CH, V44, P891, DOI 10.1128/AAC.44.4.891-897.2000; RASMUSSEN BA, 1990, ANTIMICROB AGENTS CH, V34, P1590, DOI 10.1128/AAC.34.8.1590; Rasmussen BA, 1997, ANTIMICROB AGENTS CH, V41, P223, DOI 10.1128/AAC.41.2.223; Riccio ML, 2000, ANTIMICROB AGENTS CH, V44, P1229, DOI 10.1128/AAC.44.5.1229-1235.2000; Rossolini GM, 1998, BIOCHEM J, V332, P145, DOI 10.1042/bj3320145; SAINO Y, 1982, ANTIMICROB AGENTS CH, V22, P564, DOI 10.1128/AAC.22.4.564; SAINO Y, 1984, ANTIMICROB AGENTS CH, V25, P362, DOI 10.1128/AAC.25.3.362; Segel I., 1975, ENZYME KINETICS, P371; Simm AM, 2001, FEBS LETT, V509, P350, DOI 10.1016/S0014-5793(01)03152-0; Spencer J, 2001, J BIOL CHEM, V276, P33638, DOI 10.1074/jbc.M105550200; Suzuki Yumiko, 1995, Japanese Journal of Antibiotics, V48, P1906; Ullah JH, 1998, J MOL BIOL, V284, P125, DOI 10.1006/jmbi.1998.2148; Walsh TR, 1998, ANTIMICROB AGENTS CH, V42, P436; WALSH TR, 1994, BBA-GENE STRUCT EXPR, V1218, P199, DOI 10.1016/0167-4781(94)90011-6; Wang ZG, 1998, J AM CHEM SOC, V120, P10788, DOI 10.1021/ja982621m; Wang ZG, 1999, BIOCHEMISTRY-US, V38, P10013, DOI 10.1021/bi990356r; Wang ZG, 1998, J BIOL CHEM, V273, P22402, DOI 10.1074/jbc.273.35.22402; Winston RL, 1998, ANAL BIOCHEM, V262, P83, DOI 10.1006/abio.1998.2754; Yanchak MP, 2000, BIOCHEMISTRY-US, V39, P11330, DOI 10.1021/bi0010524; Yang YJ, 1999, J BIOL CHEM, V274, P15706, DOI 10.1074/jbc.274.22.15706	52	32	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2002	277	27					24744	24752		10.1074/jbc.M201524200	http://dx.doi.org/10.1074/jbc.M201524200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	569PV	11940588	hybrid			2022-12-27	WOS:000176611800101
J	Cheriyath, V; Desgranges, ZP; Roy, AL				Cheriyath, V; Desgranges, ZP; Roy, AL			c-Src-dependent transcriptional activation of TFII-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY TYROSINE KINASES; GROWTH-FACTOR; BINDING PROTEIN; SH3 DOMAIN; SIGNAL; EXPRESSION; INTEGRIN; EGF; TRANSFORMATION; REQUIREMENT	TFII-I is a multifunctional transcription factor that is also involved in signal transduction. Here we show that TFII-I undergoes a c-Src-dependent tyrosine phosphorylation on tyrosine residues 248 and 611 and translocates to the nucleus in response to growth factor signaling. Tyrosine-phosphorylated nuclear TFII-l activates a stably integrated c-fos reporter gene. Withdrawal of signal leads to diminution of nuclear TFII-I, suggesting that the signal-dependent translocation is reversible. Antibodies against either TFH-I or c-Src abrogate growth factor-stimulated activation of c-fos. Consistent with the notion that tyrosine phosphorylation of TFII-I is required for its transcriptional activity, phosphorylation-deficient mutants of TFII-I fail to activate the c-fos promoter. These data demonstrate that TFH-I, through a Src-dependent mechanism, reversibly translocates from the cytoplasm to the nucleus, leading to the transcriptional activation of growth-regulated genes.	Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA; Tufts Univ, Sch Med, Program Immunol, Boston, MA 02111 USA; Tufts Univ, Sch Med, Genet Program, Boston, MA 02111 USA	Tufts University; Tufts University; Tufts University	Roy, AL (corresponding author), Tufts Univ, Sch Med, Dept Pathol, 136 Harrison Ave, Boston, MA 02111 USA.	ananda.roy@tufts.edu			NIAID NIH HHS [AI45150] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045150, R56AI045150] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Broome MA, 1996, J BIOL CHEM, V271, P16798, DOI 10.1074/jbc.271.28.16798; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; BRUGGE JS, 1977, NATURE, V269, P346, DOI 10.1038/269346a0; Cheriyath V, 2000, J BIOL CHEM, V275, P26300, DOI 10.1074/jbc.M002980200; Cheriyath V, 1998, MOL CELL BIOL, V18, P4444, DOI 10.1128/MCB.18.8.4444; Cheriyath V, 2001, J BIOL CHEM, V276, P8377, DOI 10.1074/jbc.M008411200; Cohen BD, 1996, J BIOL CHEM, V271, P30897, DOI 10.1074/jbc.271.48.30897; Erpel T, 1996, J BIOL CHEM, V271, P16807, DOI 10.1074/jbc.271.28.16807; Francke U, 1999, HUM MOL GENET, V8, P1947, DOI 10.1093/hmg/8.10.1947; Gao J, 1997, EMBO J, V16, P6414, DOI 10.1093/emboj/16.21.6414; Grueneberg DA, 1997, GENE DEV, V11, P2482, DOI 10.1101/gad.11.19.2482; Hakak Y, 1999, MOL CELL BIOL, V19, P6953; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Jurado LAP, 1998, HUM MOL GENET, V7, P325, DOI 10.1093/hmg/7.3.325; Karni R, 1999, ONCOGENE, V18, P4654, DOI 10.1038/sj.onc.1202835; Kim DW, 1998, MOL CELL BIOL, V18, P3310, DOI 10.1128/MCB.18.6.3310; Kim DW, 2001, MOL CELL BIOL, V21, P3387, DOI 10.1128/MCB.21.10.3387-3397.2000; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Morris MC, 1999, J BIOL CHEM, V274, P24941, DOI 10.1074/jbc.274.35.24941; Novina CD, 1998, J BIOL CHEM, V273, P33443, DOI 10.1074/jbc.273.50.33443; Novina CD, 1999, MOL CELL BIOL, V19, P5014; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; ROCHE S, 1995, MOL CELL BIOL, V15, P1102; ROY AL, 1991, NATURE, V354, P245, DOI 10.1038/354245a0; ROY AL, 1993, NATURE, V365, P355, DOI 10.1038/365355a0; Roy AL, 1997, EMBO J, V16, P7091, DOI 10.1093/emboj/16.23.7091; Roy AL, 2001, GENE, V274, P1, DOI 10.1016/S0378-1119(01)00625-4; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; TWAMLEYSTEIN GM, 1993, P NATL ACAD SCI USA, V90, P7696, DOI 10.1073/pnas.90.16.7696; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6; Wilde A, 1999, CELL, V96, P677, DOI 10.1016/S0092-8674(00)80578-4; Yang WY, 1997, P NATL ACAD SCI USA, V94, P604, DOI 10.1073/pnas.94.2.604; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555	41	46	46	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22798	22805		10.1074/jbc.M202956200	http://dx.doi.org/10.1074/jbc.M202956200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11934902	hybrid			2022-12-27	WOS:000176313600089
J	Dineley, KT; Xia, XF; Bui, D; Sweatt, JD; Zheng, H				Dineley, KT; Xia, XF; Bui, D; Sweatt, JD; Zheng, H			Accelerated plaque accumulation, associative learning deficits, and up-regulation of alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; CONTEXTUAL FEAR; NEUROPSYCHOLOGICAL MEASURES; HIPPOCAMPAL ATROPHY; DORSAL HIPPOCAMPUS; LONGITUDINAL MRI; KINASE CASCADE; BETA-PROTEIN; MAP KINASE	Familial Alzheimer's disease-associated mutations in presenilin 1 or 2 or amyloid precursor protein result in elevated beta-amyloid, beta-amyloid accumulation, and plaque formation in the brains of affected individuals. By crossing presenilin 1 transgenic mice carrying the A246E mutation with plaque-producing amyloid precursor protein K670N/M671L transgenic mice (Tg2576), we show that co-expression of both mutant transgenes results in acceleration of amyloid accumulation and associative learning deficits. At 5 months of age with no detectable plaque pathology, amyloid precursor protein transgenic animals are impaired in contextual fear learning following two pairings of conditioned and unconditioned stimuli but appear normal following a more robust five-pairing training. At 9 months of age when beta-amyloid deposition is evident, these mice are impaired following both two-pairing and five-pairing protocols. Mice carrying both transgenes are impaired in contextual fear conditioning at either age. All transgenic animal groups performed as well as controls in cued fear conditioning, indicating that the contextual fear learning deficits are hippocampus-specific. The associative learning impairments are coincident with elevated alpha7 nicotinic acetylcholine receptor protein in the dentate gyrus. These findings provide two robust and rapid assays for beta-amyloid-associated effects that can be performed on young animals: impaired contextual fear learning and up-regulation of alpha7 nicotinic receptors.	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Dineley, KT (corresponding author), Baylor Coll Med, Div Neurosci, Rm S603,1 Baylor Plaza, Houston, TX 77030 USA.	kdineley@cns.bcm.tmc.edu; jsweatt@cns.bcm.tmc.edu		Sweatt, J. David/0000-0003-3567-485X				Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Blum S, 1999, J NEUROSCI, V19, P3535; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Buisson B, 2001, J NEUROSCI, V21, P1819, DOI 10.1523/JNEUROSCI.21-06-01819.2001; BUTTERS N, 1987, J CLIN EXP NEUROPSYC, V9, P479, DOI 10.1080/01688638708410764; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; DEWEER B, 1995, J NEUROL NEUROSUR PS, V58, P590, DOI 10.1136/jnnp.58.5.590; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; Dodart JC, 2000, REV NEUROSCIENCE, V11, P75; Fenster CP, 1999, ANN NY ACAD SCI, V868, P620, DOI 10.1111/j.1749-6632.1999.tb11335.x; Fox NC, 1996, BRAIN, V119, P2001, DOI 10.1093/brain/119.6.2001; Fox NC, 1996, ANN NY ACAD SCI, V777, P226, DOI 10.1111/j.1749-6632.1996.tb34423.x; Frautschy SA, 1998, AM J PATHOL, V152, P307; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Ke L, 1998, J PHARMACOL EXP THER, V286, P825; KIM JJ, 1993, BEHAV NEUROSCI, V107, P1093, DOI 10.1037/0735-7044.107.6.1093; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Koistinaho M, 2001, P NATL ACAD SCI USA, V98, P14675, DOI 10.1073/pnas.261562998; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; MARKS MJ, 1983, J PHARMACOL EXP THER, V226, P817; McNish KA, 1997, J NEUROSCI, V17, P9353; Paylor R, 1998, LEARN MEMORY, V5, P302; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Qian S, 1998, NEURON, V20, P611, DOI 10.1016/S0896-6273(00)80999-X; Schafe GE, 1999, LEARN MEMORY, V6, P97; Selcher JC, 1999, LEARN MEMORY, V6, P478, DOI 10.1101/lm.6.5.478; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; WELSH K, 1991, ARCH NEUROL-CHICAGO, V48, P278, DOI 10.1001/archneur.1991.00530150046016; WELSH KA, 1992, ARCH NEUROL-CHICAGO, V49, P448, DOI 10.1001/archneur.1992.00530290030008; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002	36	188	206	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22768	22780		10.1074/jbc.M200164200	http://dx.doi.org/10.1074/jbc.M200164200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11912199	hybrid			2022-12-27	WOS:000176313600086
J	Lee, D; Kim, JW; Seo, T; Hwang, SG; Choi, EJ; Choe, J				Lee, D; Kim, JW; Seo, T; Hwang, SG; Choi, EJ; Choe, J			SWI/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEXES; SWI-SNF COMPLEX; GLUCOCORTICOID RECEPTOR; HUMAN HOMOLOG; BINDING; PROTEIN; BRG1; GROWTH; DOMAIN; GENE	The SWI/SNF complex is required for the transcription of several genes and has been shown to alter nucleosome structure in an ATP-dependent manner. The tumor suppressor protein p53 displays growth and transformation suppression functions that are frequently lost in mutant p53 proteins detected in various cancers. Using genetic and biochemical approaches, we show that several subunits of the human SWI/SNF complex bind to the tumor suppressor protein p53 in vivo and in vitro. The transactivation function of p53 is stimulated by overexpression of hSNF5 and BRG-1 and dominant forms of hSNF5 and BRG-1 repress p53-dependent transcription. Chromatin immunoprecipitation assay shows that hSNF5 and BRG-1 are recruited to a p53-dependent promoter in vivo. Overexpression of dominant negative forms of either hSNF5 or BRG-1 inhibited p53-mediated cell growth suppression and apoptosis. Molecular connection between p53 and the SWI/SNF complex implicates that (i) the SWI/SNF complex is necessary for p53-driven transcriptional activation, and (ii) the SWI/SNF complex plays an important role in p53-mediated cell cycle control.	Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; Korea Univ, Grad Sch Biotechnol, Natl Creat Res Initiat Ctr Cell Death, Seoul 136701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea University	Choe, J (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.		KIM, JIN WOO/C-1655-2011; Lee, Daeyoup/C-1653-2011; Choe, Joonho/F-3066-2011	KIM, JIN WOO/0000-0003-0767-1918; Lee, Daeyoup/0000-0003-2006-1823; 				BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Boyer LA, 2000, J BIOL CHEM, V275, P18864, DOI 10.1074/jbc.M002810200; BUCKBINDER L, 1995, NATURE, V377, P646, DOI 10.1038/377646a0; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; CHIBA H, 1994, NUCLEIC ACIDS RES, V22, P1815, DOI 10.1093/nar/22.10.1815; DeCristofaro MF, 1999, ONCOGENE, V18, P7559, DOI 10.1038/sj.onc.1203168; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FARMER G, 1992, NATURE, V358, P83, DOI 10.1038/358083a0; FUNK WD, 1992, MOL CELL BIOL, V12, P2866, DOI 10.1128/MCB.12.6.2866; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; Kadam S, 2000, GENE DEV, V14, P2441, DOI 10.1101/gad.828000; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Lee D, 1999, NATURE, V399, P487, DOI 10.1038/20966; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; MIYASHITA T, 1995, CELL, V80, P293; Muchardt C, 1998, EMBO J, V17, P223, DOI 10.1093/emboj/17.1.223; Muchardt C, 1999, J MOL BIOL, V293, P187, DOI 10.1006/jmbi.1999.2999; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Nagai M, 2001, P NATL ACAD SCI USA, V98, P3843, DOI 10.1073/pnas.061036798; Natarajan K, 1999, MOL CELL, V4, P657, DOI 10.1016/S1097-2765(00)80217-8; Neely KE, 1999, MOL CELL, V4, P649, DOI 10.1016/S1097-2765(00)80216-6; OKAMOTO K, 1994, EMBO J, V13, P4816, DOI 10.1002/j.1460-2075.1994.tb06807.x; Pugh B F, 1995, Methods Mol Biol, V37, P349; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Seo T, 2001, J VIROL, V75, P6193, DOI 10.1128/JVI.75.13.6193-6198.2001; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Sullivan EK, 2001, MOL CELL BIOL, V21, P5826, DOI 10.1128/MCB.21.17.5826-5837.2001; Tanese N, 1997, METHODS, V12, P224, DOI 10.1006/meth.1997.0475; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Wallberg AE, 2000, MOL CELL BIOL, V20, P2004, DOI 10.1128/MCB.20.6.2004-2013.2000; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yudkovsky N, 1999, GENE DEV, V13, P2369, DOI 10.1101/gad.13.18.2369	44	176	182	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22330	22337		10.1074/jbc.M111987200	http://dx.doi.org/10.1074/jbc.M111987200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11950834	hybrid			2022-12-27	WOS:000176313600029
J	Bagorda, A; Guerra, L; Di Sole, F; Hemle-Kolb, C; Cardone, RA; Fanelli, T; Reshkin, SJ; Gisler, SM; Murer, H; Casavola, V				Bagorda, A; Guerra, L; Di Sole, F; Hemle-Kolb, C; Cardone, RA; Fanelli, T; Reshkin, SJ; Gisler, SM; Murer, H; Casavola, V			Reciprocal protein kinase A regulatory interactions between cystic fibrosis transmembrane conductance regulator and Na+/H+ exchanger isoform 3 in a renal polarized epithelial cell model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE CHLORIDE PERMEABILITY; APICAL MEMBRANE; A6 CELLS; ARGININE-VASOPRESSIN; MOLECULAR MECHANISM; ANCHORING PROTEIN; CL-/HCO3 EXCHANGE; INTRACELLULAR PH; PROXIMAL TUBULE; PDZ PROTEINS	Although Cystic fibrosis transmembrane conductance regulator (CFTR) has been shown to regulate the activity of NHE3, the potential reciprocal interaction of NHE3 to modulate the protein kinase A (PKA)-dependent regulation of CFTR in epithelial cells is still unknown. In the present work, we describe experiments to define the interactions between CFTR and NHE3 with the regulatory, scaffolding protein, NHERF that organize their PKA-dependent regulation in a renal epithelial cell line that expresses endogenous CFTR. The expression of rat NHE3 significantly decreased PKA-dependent activation of CFTR without altering CFTR expression, and this decrease was prevented by mutation of either of the two rat NHE3 PKA target serines to alanine (S552A or S605A). Inhibition of CFTR expression by antisense treatment resulted in an acute decrease in PKA-dependent regulation of NHE3 activity. CFTR, NHE3, and ezrin were recognized by NHERF-2 but not NHERF-1 in glutathione S-transferase pull-down experiments. Ezrin may function as a protein kinase A anchoring protein (AKAP) in this signaling complex, because blocking the binding of PKA to an AKAP by incubation with the S-Ht31 peptide inhibited the PKA-dependent regulation of CFTR in the absence of NHE3. In the A6-NHE3 cells S-Ht31 blocked the PKA regulation of NHE3 whereas it now failed to affect the regulation of CFTR. We conclude that CFTR and NHE3 reciprocally interact via a shared regulatory complex comprised of NHERF-2, ezrin, and PKA.	Univ Bari, Dept Gen & Environm Physiol, I-70126 Bari, Italy; Univ Gottingen, Dept Physiol & Pathophysiol, Div Vegetat Physiol & Pathophysiol, D-37073 Gottingen, Germany; Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland	Universita degli Studi di Bari Aldo Moro; University of Gottingen; University of Zurich	Casavola, V (corresponding author), Univ Bari, Dept Gen & Environm Physiol, Via Amendola 165-A, I-70126 Bari, Italy.		Reshkin, Stephan/AAI-6680-2020	Reshkin, Stephan/0000-0001-9757-5908; GUERRA, Lorenzo/0000-0003-3950-9405; CASAVOLA, Valeria/0000-0003-4471-4948	Telethon [E.1125] Funding Source: Medline	Telethon(Fondazione Telethon)		Ahn W, 2001, J BIOL CHEM, V276, P17236, DOI 10.1074/jbc.M011763200; AMEMIYA M, 1995, KIDNEY INT, V48, P1206, DOI 10.1038/ki.1995.404; ANDERSON MP, 1992, AM J PHYSIOL, V263, pL1, DOI 10.1152/ajplung.1992.263.1.L1; Banderali U, 1999, J PHYSIOL-LONDON, V519, P737, DOI 10.1111/j.1469-7793.1999.0737n.x; BORON WF, 1976, J GEN PHYSIOL, V67, P91, DOI 10.1085/jgp.67.1.91; BROCHIERO E, 1995, PFLUG ARCH EUR J PHY, V431, P32, DOI 10.1007/BF00374375; CARR DW, 1992, J BIOL CHEM, V267, P13376; Casavola V, 1997, MOL PHARMACOL, V51, P516; Casavola V, 1996, J MEMBRANE BIOL, V151, P237, DOI 10.1007/s002329900074; CASAVOLA V, 1995, AM J PHYSIOL-CELL PH, V269, pC226, DOI 10.1152/ajpcell.1995.269.1.C226; CASAVOLA V, 1992, PFLUG ARCH EUR J PHY, V420, P282, DOI 10.1007/BF00374460; CHALFANT ML, 1993, AM J PHYSIOL, V264, pC1480, DOI 10.1152/ajpcell.1993.264.6.C1480; Clarke LL, 1996, AM J PHYSIOL-GASTR L, V270, pG259, DOI 10.1152/ajpgi.1996.270.2.G259; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Di Sole F, 2001, FASEB J, V15, pA144; Di Sole F, 1999, J PHYSIOL-LONDON, V515, P829, DOI 10.1111/j.1469-7793.1999.829ab.x; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; ERNST SA, 1994, AM J PHYSIOL-CELL PH, V267, pC990, DOI 10.1152/ajpcell.1994.267.4.C990; FAN PY, 1992, BIOCHIM BIOPHYS ACTA, V1111, P75, DOI 10.1016/0005-2736(92)90276-R; Gisler SM, 2001, J BIOL CHEM, V276, P9206, DOI 10.1074/jbc.M008745200; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Jiang QS, 2000, J BIOL CHEM, V275, P13266, DOI 10.1074/jbc.275.18.13266; KLEYMAN TR, 1994, AM J PHYSIOL, V266, pF506, DOI 10.1152/ajprenal.1994.266.3.F506; Klussmann E, 1999, J BIOL CHEM, V274, P4934, DOI 10.1074/jbc.274.8.4934; Kopito Ron R., 1999, Physiological Reviews, V79, pS167; KRAYERPAWLOWSKA D, 1991, J MEMBRANE BIOL, V120, P173, DOI 10.1007/BF01872400; Kunzelmann K, 2000, PFLUG ARCH EUR J PHY, V440, P193, DOI 10.1007/s004240000255; Kurashima K, 1998, J BIOL CHEM, V273, P20828, DOI 10.1074/jbc.273.33.20828; Lee MG, 1999, J BIOL CHEM, V274, P3414, DOI 10.1074/jbc.274.6.3414; Ling BN, 1997, J BIOL CHEM, V272, P594; MARUNAKA Y, 1991, AM J PHYSIOL, V260, pC1071, DOI 10.1152/ajpcell.1991.260.5.C1071; Moe OW, 1999, J AM SOC NEPHROL, V10, P2412; Moyer BD, 2000, J BIOL CHEM, V275, P27069; Quinton Paul M., 1999, Physiological Reviews, V79, pS3; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; Reddy MM, 1999, NATURE, V402, P301, DOI 10.1038/46297; Schultz B. D., 1999, Physiological Reviews, V79, pS109; SCHWIEBERT EM, 1994, AM J PHYSIOL, V266, pC1464, DOI 10.1152/ajpcell.1994.266.5.C1464; SCHWIEBERT EM, 1995, CELL, V81, P1063, DOI 10.1016/S0092-8674(05)80011-X; Schwiebert Erik M., 1999, Physiological Reviews, V79, pS145; Sheppard DN, 1999, PHYSIOL REV, V79, P23; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Singh AE, 1998, AM J PHYSIOL-CELL PH, V275, pC562, DOI 10.1152/ajpcell.1998.275.2.C562; Sun F, 2000, J BIOL CHEM, V275, P14360, DOI 10.1074/jbc.275.19.14360; Sun F, 2000, J BIOL CHEM, V275, P29539, DOI 10.1074/jbc.M004961200; VERREY F, 1994, J MEMBRANE BIOL, V138, P65; Wade JB, 2001, AM J PHYSIOL-CELL PH, V280, pC192, DOI 10.1152/ajpcell.2001.280.1.C192; Walsh DE, 2000, J MEMBRANE BIOL, V177, P209, DOI 10.1007/s002320010004; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Weinman EJ, 2000, BIOCHEMISTRY-US, V39, P6123, DOI 10.1021/bi000064m; Weinman EJ, 1998, J CLIN INVEST, V101, P2199, DOI 10.1172/JCI204; Wheat VJ, 2000, AM J PHYSIOL-CELL PH, V279, pC62, DOI 10.1152/ajpcell.2000.279.1.C62; Widdicombe JH, 2000, AM J RESP CELL MOL, V22, P11, DOI 10.1165/ajrcmb.22.1.f177; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Zhao H, 1999, J BIOL CHEM, V274, P3978, DOI 10.1074/jbc.274.7.3978	55	41	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21480	21488		10.1074/jbc.M112245200	http://dx.doi.org/10.1074/jbc.M112245200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11937500	Green Accepted, hybrid			2022-12-27	WOS:000176286000048
J	Ditzel, HJ; Strik, MCM; Larsen, MK; Willis, AC; Waseem, A; Kejling, K; Jensenius, JC				Ditzel, HJ; Strik, MCM; Larsen, MK; Willis, AC; Waseem, A; Kejling, K; Jensenius, JC			Cancer-associated cleavage of cytokeratin 8/18 heterotypic complexes exposes a neoepitope in human adenocarcinomas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MONOCLONAL-ANTIBODY; INTERMEDIATE FILAMENTS; CARCINOMA-CELLS; HUMAN KERATIN-18; TUMOR-MARKER; LUNG-CANCER; PLASMINOGEN-ACTIVATOR; MALLORY BODIES; COILED-COIL; EXPRESSION	The intermediate filament network in simple glandular epithelial cells predominantly consists of heterotypic complexes of cytokeratin 8 (K8) and cytokeratin 18 (K18). In contrast to other cytokeratins, K8 and K18 are persistently expressed during malignant transformation, but changes in cell morphology are accompanied by alterations in the intermediate filament network. To study molecular changes, K8 and K18 were purified from surgically removed colon cancer and normal epithelia tissues. Western blotting and amino acid sequencing revealed the presence of abundant K8 and K18 fragments, truncated at the N terminus, from cancerous, but not normal, epithelial cells. The fragmentation pattern indicates proteolysis mediated by several enzymes, including trypsin-like enzymes. The cancer-associated forms of K8 and K18 are specifically recognized by the human antibody, COU-1, cloned from the B cells of a cancer patient. We demonstrate that COU-1 recognizes a unique conformational epitope presented only by a complex between K8 and K18. The epitope is revealed after proteolytic removal of the head domain of either K8 or K18. A large panel of recombinant K8 and K18 fragments, deleted N- or C-terminally, allowed for the localization of the COU-1 epitope to the N-terminal part of the rod domains. Using surface plasmon resonance, the affinity of COU-1 for this epitope was determined to be 10(9) m(-1), i.e. more than 2 orders of magnitude higher than for intact heterotypic K8/K18 complexes. The cellular distribution of truncated K8/K18 heterotypic complexes in viable adenocarcinomas cells was probed using COU-1 showing small fibrillar structures distinct from those of intact K8/K18 complexes. Previously we demonstrated the binding and subsequent internalization of recombinant Fab COU-1 to live cancer cells. We have thus characterized a cancer neoepitope recognized by the humoral immune system. The results have biological as well as clinical implications.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Univ So Denmark, Biomed Lab, DK-5000 Odense, Denmark; Univ Oxford, Dept Biochem, MRC, Immunochem Unit, Oxford OX1 3QU, England; Kings Coll London, Guys Kings & St Thomas Dent Inst, Head & Neck Canc Res Program, London SE1 9RT, England; Aarhus Univ, Dept Med Microbiol & Immunol, DK-8000 Aarhus, Denmark	Scripps Research Institute; University of Southern Denmark; University of Oxford; University of London; King's College London; Aarhus University	Ditzel, HJ (corresponding author), Scripps Res Inst, Dept Immunol, IMM2,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hditzel@scripps.edu		Kobaek-Larsen, Morten/0000-0002-5097-9283; Ditzel, Henrik J./0000-0003-3927-5135				BADER BL, 1991, J CELL BIOL, V115, P1293, DOI 10.1083/jcb.115.5.1293; Bodenmueller Heinz, 1994, International Journal of Biological Markers, V9, P75; BORUPCHRISTENSEN P, 1990, APMIS, V98, P674, DOI 10.1111/j.1699-0463.1990.tb04988.x; BROERS JLV, 1988, CANCER RES, V48, P3221; Caulin C, 1997, J CELL BIOL, V138, P1379, DOI 10.1083/jcb.138.6.1379; CHAN R, 1986, CANCER RES, V46, P6353; CHEN PH, 1993, J VIROL, V67, P3507, DOI 10.1128/JVI.67.6.3507-3514.1993; CHU YW, 1993, P NATL ACAD SCI USA, V90, P4261, DOI 10.1073/pnas.90.9.4261; CRAWFORD C, 1990, BIOCHEM J, V265, P575, DOI 10.1042/bj2650575; Denk H, 1979, Int Rev Exp Pathol, V20, P77; DITZEL H, 1993, CANCER RES, V53, P5920; Ditzel HJ, 1997, P NATL ACAD SCI USA, V94, P8110, DOI 10.1073/pnas.94.15.8110; ERB K, 1992, HYBRIDOMA, V11, P121, DOI 10.1089/hyb.1992.11.121; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; GODFROID E, 1991, J CELL SCI, V99, P595; HATZFELD M, 1990, J CELL SCI, V97, P317; HATZFELD M, 1994, J CELL SCI, V107, P1959; HATZFELD M, 1985, J CELL BIOL, V101, P1826, DOI 10.1083/jcb.101.5.1826; HATZFELD M, 1990, J CELL BIOL, V110, P1199, DOI 10.1083/jcb.110.4.1199; HATZFELD M, 1987, J MOL BIOL, V197, P237, DOI 10.1016/0022-2836(87)90122-7; HAZAN R, 1986, LAB INVEST, V54, P543; HEMBROUGH TA, 1995, J CELL SCI, V108, P1071; Hembrough TA, 1996, BIOCHEM J, V317, P763, DOI 10.1042/bj3170763; HENDRIX MJC, 1992, JNCI-J NATL CANCER I, V84, P165, DOI 10.1093/jnci/84.3.165; JENSEN K, 1994, HEPATOLOGY, V20, P1330, DOI 10.1016/0270-9139(94)90776-5; JENSEN K, 1994, HEPATOLOGY, V20, P1061, DOI 10.1002/hep.1840200440; KARLSSON R, 1991, J IMMUNOL METHODS, V145, P229, DOI 10.1016/0022-1759(91)90331-9; Kralovich KR, 1998, J PROTEIN CHEM, V17, P845, DOI 10.1023/A:1020738620817; Ku NO, 1998, EMBO J, V17, P1892, DOI 10.1093/emboj/17.7.1892; KU NO, 1994, J CELL BIOL, V127, P161, DOI 10.1083/jcb.127.1.161; LANE EB, 1982, EMBO J, V1, P1365, DOI 10.1002/j.1460-2075.1982.tb01324.x; Leers MPG, 1999, J PATHOL, V187, P567, DOI 10.1002/(SICI)1096-9896(199904)187:5<567::AID-PATH288>3.0.CO;2-J; Marilley D, 2000, EXP CELL RES, V259, P12, DOI 10.1006/excr.2000.4942; MILLER RK, 1993, J CELL BIOL, V122, P123, DOI 10.1083/jcb.122.1.123; Moll R., 1994, International Journal of Biological Markers, V9, P63; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Moll R, 1998, Subcell Biochem, V31, P205; Nishibori H, 1996, CANCER RES, V56, P2752; OSHIMA RG, 1990, GENE DEV, V4, P835, DOI 10.1101/gad.4.5.835; Oshima RG, 1996, CANCER METAST REV, V15, P445, DOI 10.1007/BF00054012; PANKOV R, 1994, P NATL ACAD SCI USA, V91, P873, DOI 10.1073/pnas.91.3.873; Pankov R, 1997, J CELL SCI, V110, P965; Rydlander L, 1996, EUR J BIOCHEM, V241, P309, DOI 10.1111/j.1432-1033.1996.00309.x; SCHAAFSMA HE, 1990, AM J PATHOL, V136, P329; SCHILLER DL, 1983, CELL BIOL INT REP, V7, P3, DOI 10.1016/0309-1651(83)90098-X; SCHMIDT A, 1994, EUR J CELL BIOL, V65, P229; SHITARA K, 1992, ANTICANCER RES, V12, P1121; SHOEMAN RL, 1990, CELL BIOL INT REP, V14, P583, DOI 10.1016/0309-1651(90)90038-Z; SILEN A, 1994, PROSTATE, V24, P326, DOI 10.1002/pros.2990240609; STEINERT PM, 1990, J BIOL CHEM, V265, P8766; STEINERT PM, 1993, J MOL BIOL, V230, P436, DOI 10.1006/jmbi.1993.1161; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; Stewart M, 1993, CURR OPIN CELL BIOL, V5, P3, DOI 10.1016/S0955-0674(05)80002-X; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANDERGAAST A, 1994, BRIT J CANCER, V69, P525, DOI 10.1038/bjc.1994.95; Waseem A, 1996, EXP CELL RES, V223, P203, DOI 10.1006/excr.1996.0074; WEBER K, 1984, EMBO J, V3, P2707, DOI 10.1002/j.1460-2075.1984.tb02198.x; Wells MJ, 1997, J BIOL CHEM, V272, P28574, DOI 10.1074/jbc.272.45.28574; ZHANG Y, 1994, J VIROL, V68, P2544, DOI 10.1128/JVI.68.4.2544-2555.1994	60	32	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21712	21722		10.1074/jbc.M202140200	http://dx.doi.org/10.1074/jbc.M202140200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11923318	hybrid			2022-12-27	WOS:000176286000079
J	El Mezgueldi, M; Tang, NY; Rosenfeld, SS; Ostap, EM				El Mezgueldi, M; Tang, NY; Rosenfeld, SS; Ostap, EM			The kinetic mechanism of myole (human myosin-IC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTOMYOSIN SUBFRAGMENT-1; ATPASE ACTIVITY; ACANTHAMOEBA-CASTELLANII; MUSCLE-CONTRACTION; MOTOR DOMAIN; SH3 DOMAIN; F-ACTIN; EXPRESSION; NUCLEOTIDE; BINDING	Myole is the widely expressed subclass-1 member of the myosin-I family. We performed a kinetic analysis of a truncated myole that consists of the motor and the single IQ motif with a bound calmodulin. We determined the rates and equilibrium constants for the key steps in the ATPase cycle. The maximum actin activated ATPase rate (V-max) and the actin concentration at half-maximum of V-max (K-ATPase) of myole are similar to those of the native protein. The K-ATPase is low (similar to1 muM), however the affinity of myole for actin in the presence of ATP is very weak. A weak actin affinity and a rapid rate of phosphate release result in a pathway under in vitro assay conditions in which phosphate is released while myole is dissociated from actin. Actin activation of the ATPase activity and the low K-ATPase are the result of actin activation of ADP release. We propose that myole is tuned to function in regions of high concentrations of cross-linked actin filaments. Additionally, we found that ADP release from actomyole is > 10-fold faster than other vertebrate myosin-I isoforms. We propose that subclass-1 myosin-Is are tuned for rapid sliding, whereas subclass-2 isoforms are tuned for tension maintenance or stress sensing.	Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA; Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA	University of Pennsylvania; University of Pennsylvania; University of Alabama System; University of Alabama Birmingham	Ostap, EM (corresponding author), Univ Penn, Sch Med, Dept Physiol, B400 Richards,3700 Hamilton Walk, Philadelphia, PA 19104 USA.	ostap@mail.med.upenn.edu			NIGMS NIH HHS [GM57247] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057247] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBANESI JP, 1983, J BIOL CHEM, V258, P176; BEMENT WM, 1994, J MOL BIOL, V243, P356, DOI 10.1006/jmbi.1994.1662; BEMENT WM, 1995, CELL MOTIL CYTOSKEL, V31, P87, DOI 10.1002/cm.970310202; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; CHALOVICH JM, 1982, J BIOL CHEM, V257, P2432; Coluccio LR, 1999, J BIOL CHEM, V274, P21575, DOI 10.1074/jbc.274.31.21575; Dai JW, 1999, BIOPHYS J, V77, P1168, DOI 10.1016/S0006-3495(99)76968-7; De la Cruz EM, 2000, BIOCHEMISTRY-US, V39, P14196, DOI 10.1021/bi001701b; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; Geeves MA, 2000, J BIOL CHEM, V275, P21624, DOI 10.1074/jbc.M000342200; GEEVES MA, 1988, BIOCHEM J, V256, P41, DOI 10.1042/bj2560041; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Geli MI, 1996, SCIENCE, V272, P533, DOI 10.1126/science.272.5261.533; GILLESPIE PG, 1993, NEURON, V11, P581, DOI 10.1016/0896-6273(93)90071-X; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; HOUK TW, 1974, ANAL BIOCHEM, V62, P66, DOI 10.1016/0003-2697(74)90367-4; Joel PB, 2001, J BIOL CHEM, V276, P2998, DOI 10.1074/jbc.M006930200; JOHNSON KA, 1978, BIOCHEMISTRY-US, V17, P3432, DOI 10.1021/bi00610a002; Jontes JD, 1997, P NATL ACAD SCI USA, V94, P14332, DOI 10.1073/pnas.94.26.14332; Jung G, 1996, J CELL BIOL, V133, P305, DOI 10.1083/jcb.133.2.305; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; NOVAK KD, 1995, J CELL BIOL, V131, P1205, DOI 10.1083/jcb.131.5.1205; Ostap EM, 1996, J CELL BIOL, V132, P1053, DOI 10.1083/jcb.132.6.1053; Perreault-Micale C, 2000, J BIOL CHEM, V275, P21618, DOI 10.1074/jbc.M000363200; POLLARD TD, 1973, J BIOL CHEM, V248, P4682; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; PUTKEY JA, 1985, J BIOL CHEM, V260, P4704; Raposo G, 1999, MOL BIOL CELL, V10, P1477, DOI 10.1091/mbc.10.5.1477; Rosenfeld SS, 2000, J BIOL CHEM, V275, P25418, DOI 10.1074/jbc.M002685200; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; Skowron JF, 1998, CELL MOTIL CYTOSKEL, V41, P308, DOI 10.1002/(SICI)1097-0169(1998)41:4<308::AID-CM4>3.3.CO;2-A; Sokac AM, 2000, INT REV CYTOL, V200, P197, DOI 10.1016/S0074-7696(00)00005-X; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; STOFFLER HE, 1995, J CELL BIOL, V129, P819, DOI 10.1083/jcb.129.3.819; Stoffler HE, 1998, J BIOL CHEM, V273, P14605, DOI 10.1074/jbc.273.23.14605; Stoffler HE, 1998, J CELL SCI, V111, P2779; Tang NY, 2001, CURR BIOL, V11, P1131, DOI 10.1016/S0960-9822(01)00320-7; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h; WOODWARD SKA, 1991, BIOCHEMISTRY-US, V30, P422, DOI 10.1021/bi00216a017; Xing J, 2000, J BIOL CHEM, V275, P35413, DOI 10.1074/jbc.M004232200	43	47	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21514	21521		10.1074/jbc.M200713200	http://dx.doi.org/10.1074/jbc.M200713200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11940582	hybrid			2022-12-27	WOS:000176286000052
J	Grishanin, RN; Klenchin, VA; Loyet, KM; Kowalchyk, JA; Ann, K; Martin, TFJ				Grishanin, RN; Klenchin, VA; Loyet, KM; Kowalchyk, JA; Ann, K; Martin, TFJ			Membrane association domains in Ca2+-dependent activator protein for secretion mediate plasma membrane and dense-core vesicle binding required for Ca2+-dependent exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; INOSITOL PHOSPHATES; PH DOMAINS; CA2+-ACTIVATED EXOCYTOSIS; PHOSPHOINOSITIDE BINDING; NEUROENDOCRINE CELLS; SIGNALING MOLECULES; CYTOPLASMIC DOMAIN; CAPS; PHOSPHORYLATION	Ca2+-dependent activator protein for secretion (CAPS) is a cytosolic protein essential for the Ca2+-dependent fusion of dense-core vesicles (DCVs) with the plasma membrane and the regulated secretion of a subset of neurotransmitters. The mechanism by which CAPS functions in exocytosis and the means by which it associates with target membranes are unknown. We identified two domains in CAPS with distinct membrane-binding properties that were each essential for CAPS activity in regulated exocytosis. The first of these, a centrally located pleckstrin homology domain, exhibited three properties: charge-based binding to acidic phospholipids, binding to plasma membrane but not DCV membrane, and stereoselective binding to phosphatidylinositol 4,5-bisphosphate. Mutagenesis studies revealed that the former two properties but not the latter were essential for CAPS function. The central pleckstrin homology domain may mediate transient CAPS interactions with the plasma membrane during Ca2+-triggered exocytosis. The second membrane association domain comprising distal C-terminal sequences mediated CAPS targeting to and association with neuroendocrine DCVs. The CAPS C-terminal domain was also essential for optimal activity in regulated exocytosis. The presence of two membrane association domains with distinct binding specificities may enable CAPS to bind both target membranes to facilitate DCV-plasma membrane fusion.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Martin, TFJ (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.							Alconada A, 1999, J VIROL, V73, P377, DOI 10.1128/JVI.73.1.377-387.1999; Ann K, 1997, J BIOL CHEM, V272, P19637, DOI 10.1074/jbc.272.32.19637; Avery Leon, 1993, Genetics, V134, P455; Berwin B, 1998, NEURON, V21, P137, DOI 10.1016/S0896-6273(00)80521-8; Blomberg N, 1999, TRENDS BIOCHEM SCI, V24, P441, DOI 10.1016/S0968-0004(99)01472-3; Blomberg N, 1997, FOLD DES, V2, P343, DOI 10.1016/S1359-0278(97)00048-5; Bottomley MJ, 1998, BBA-MOL CELL BIOL L, V1436, P165, DOI 10.1016/S0005-2760(98)00141-6; Chen HJ, 1997, J BIOL CHEM, V272, P7003, DOI 10.1074/jbc.272.11.7003; Chen RH, 1997, EMBO J, V16, P1351, DOI 10.1093/emboj/16.6.1351; Dittie AS, 1997, EMBO J, V16, P4859, DOI 10.1093/emboj/16.16.4859; Elhamdani A, 1999, J NEUROSCI, V19, P7375, DOI 10.1523/JNEUROSCI.19-17-07375.1999; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Fukuda M, 1997, BIOESSAYS, V19, P593, DOI 10.1002/bies.950190710; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; HAY JC, 1993, NATURE, V366, P572, DOI 10.1038/366572a0; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; Holm L, 1998, PROTEINS, V33, P88, DOI 10.1002/(SICI)1097-0134(19981001)33:1<88::AID-PROT8>3.0.CO;2-H; HYVONEN M, 1995, EMBO J, V14, P4676, DOI 10.1002/j.1460-2075.1995.tb00149.x; Hyvonen M, 1997, EMBO J, V16, P3396, DOI 10.1093/emboj/16.12.3396; Irvine R, 1996, CURR BIOL, V6, P537, DOI 10.1016/S0960-9822(02)00536-5; JONES BG, 1995, EMBO J, V14, P5869, DOI 10.1002/j.1460-2075.1995.tb00275.x; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Klenchin VA, 1998, METHODS, V16, P204, DOI 10.1006/meth.1998.0668; Koch H, 2000, BIOCHEM J, V349, P247, DOI 10.1042/0264-6021:3490247; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Lemmon MA, 1996, CELL, V85, P621, DOI 10.1016/S0092-8674(00)81022-3; Loyet KM, 1998, J BIOL CHEM, V273, P8337, DOI 10.1074/jbc.273.14.8337; Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231; Martin TFJ, 1997, J BIOL CHEM, V272, P14447, DOI 10.1074/jbc.272.22.14447; Molloy SS, 1999, TRENDS CELL BIOL, V9, P28, DOI 10.1016/S0962-8924(98)01382-8; Piguet V, 2000, NAT CELL BIOL, V2, P163, DOI 10.1038/35004038; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Renden R, 2001, NEURON, V31, P421, DOI 10.1016/S0896-6273(01)00382-8; ROOF DM, 1992, J CELL BIOL, V118, P95, DOI 10.1083/jcb.118.1.95; Rupnik M, 2000, P NATL ACAD SCI USA, V97, P5627, DOI 10.1073/pnas.090359097; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Steveson TC, 2001, J BIOL CHEM, V276, P40326, DOI 10.1074/jbc.M011460200; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; Tandon A, 1998, NEURON, V21, P147, DOI 10.1016/S0896-6273(00)80522-X; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Waites CL, 2001, J CELL BIOL, V152, P1159, DOI 10.1083/jcb.152.6.1159; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xiang Y, 2000, MOL BIOL CELL, V11, P1257, DOI 10.1091/mbc.11.4.1257; Yagisawa H, 1998, J BIOL CHEM, V273, P417, DOI 10.1074/jbc.273.1.417	49	68	72	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					22025	22034		10.1074/jbc.M201614200	http://dx.doi.org/10.1074/jbc.M201614200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11927595	hybrid			2022-12-27	WOS:000176286000115
J	Hao, CM; Redha, R; Morrow, J; Breyer, MD				Hao, CM; Redha, R; Morrow, J; Breyer, MD			Peroxisome proliferator-activated receptor delta activation promotes cell survival following hypertonic stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL PAPILLARY NECROSIS; PPAR-DELTA; INTERSTITIAL-CELLS; EPITHELIAL-CELLS; IN-VIVO; EXPRESSION; DIFFERENTIATION; BRAIN; ALPHA; IMPLANTATION	COX2-selective non-steroidal anti-inflammatory drugs (NSAIDs) cause selective apoptosis of renal medullary interstitial cells (RMIC) in vivo and reduce their ability to tolerate hypertonic stress in vitro. To determine the mechanism by which COX2 activity promotes RMIC viability, we examined the capacity of COX2-derived prostanoids to promote RMIC survival. Although RMICs synthesize prostaglandin E2 (PGE2) >> PGI2 > PGF2a > TxA2, only PGI2 enhanced RMIC viability following hypertonic stress. RMICs do not express the prostacyclin receptor, but they do express the prostacyclin responsive nuclear transcription factor peroxisome proliferator-activated receptor delta (PPARdelta). Hypertonic stress increased PGI2 synthesis 330% above base line and also activated a PPARdelta specific reporter (delta response element (DRE)) by 90% above base line. Conversely DRE activity was only inhibited by the COX2-selective inhibitor SC236 but not by a COX1-selective NSAID (SC560). Overexpression of PPARdelta using an adenovirus not only drove DRE activity but also prevented RMIC death due to COX2 inhibition. These studies are consistent with a model whereby hypertonicity activates COX2-derived prostaglandin production, which promotes RMIC viability through PPARdelta. Inhibition of PPARdelta activity may contribute to the renal papillary necrosis associated with analgesic and/or NSAID use.	Vanderbilt Univ, Div Nephrol, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; Dept Vet Affairs Hosp, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Hao, CM (corresponding author), Vet Affairs Med Ctr, F-427 ACRE Bldg, Nashville, TN 37212 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037097, P01DK038226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM015431, P50GM015431] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-37097, P01 DK 38226] Funding Source: Medline; NIGMS NIH HHS [GM 15431] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bach PH, 1998, TOXICOL PATHOL, V26, P73, DOI 10.1177/019262339802600110; Bastie C, 1999, J BIOL CHEM, V274, P21920, DOI 10.1074/jbc.274.31.21920; Bastie C, 2000, J BIOL CHEM, V275, P38768, DOI 10.1074/jbc.M006450200; Bentzer P, 2001, J NEUROTRAUM, V18, P275, DOI 10.1089/08977150151070919; Breyer MD, 2000, AM J PHYSIOL-RENAL, V279, pF12, DOI 10.1152/ajprenal.2000.279.1.F12; Dowd NP, 2001, J CLIN INVEST, V108, P585, DOI 10.1172/JCI11334; DUBOIS RN, 1994, J CLIN INVEST, V93, P493, DOI 10.1172/JCI116998; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Guan YF, 1997, AM J PHYSIOL-RENAL, V273, pF18, DOI 10.1152/ajprenal.1997.273.1.F18; Gupta RA, 2000, P NATL ACAD SCI USA, V97, P13275, DOI 10.1073/pnas.97.24.13275; Hao CM, 1999, AM J PHYSIOL-RENAL, V277, pF352, DOI 10.1152/ajprenal.1999.277.3.F352; Hao CM, 2000, J CLIN INVEST, V106, P973, DOI 10.1172/JCI9956; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hertz R, 1996, EUR J BIOCHEM, V235, P242, DOI 10.1111/j.1432-1033.1996.00242.x; Lim H, 1999, GENE DEV, V13, P1561, DOI 10.1101/gad.13.12.1561; Lim H, 2000, TRENDS ENDOCRIN MET, V11, P137, DOI 10.1016/S1043-2760(00)00243-5; Matsuura H, 1999, MOL CELL ENDOCRINOL, V147, P85, DOI 10.1016/S0303-7207(98)00214-7; Mehlen P, 1996, EMBO J, V15, P2695, DOI 10.1002/j.1460-2075.1996.tb00630.x; MOLLAND EA, 1978, KIDNEY INT, V13, P5, DOI 10.1038/ki.1978.2; Narumiya S, 2001, J CLIN INVEST, V108, P25, DOI 10.1172/JCI200113455; NISSEN HM, 1969, Z ZELLFORSCH MIK ANA, V97, P274, DOI 10.1007/BF00344762; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Satoh T, 1999, EUR J NEUROSCI, V11, P3115, DOI 10.1046/j.1460-9568.1999.00791.x; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Yang TX, 1999, AM J PHYSIOL-RENAL, V277, pF1, DOI 10.1152/ajprenal.1999.277.1.F1; Zhang JF, 2002, J BIOL CHEM, V277, P11505, DOI 10.1074/jbc.M110580200; ZUSMAN RM, 1977, J CLIN INVEST, V60, P215, DOI 10.1172/JCI108758	28	85	90	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21341	21345		10.1074/jbc.M200695200	http://dx.doi.org/10.1074/jbc.M200695200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11927585	hybrid			2022-12-27	WOS:000176286000030
J	Rashid, KA; Hevi, S; Chen, Y; Le Caherec, F; Chuck, SL				Rashid, KA; Hevi, S; Chen, Y; Le Caherec, F; Chuck, SL			A proteomic approach identifies proteins in hepatocytes that bind nascent apolipoprotein B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; UBIQUITIN-PROTEASOME PATHWAY; LOW-DENSITY LIPOPROTEINS; HEP G2 CELLS; APO-B; MCA-RH7777 CELLS; LIPID-SYNTHESIS; APOPROTEIN-B; RAT-LIVER; SECRETION	The biogenesis of apolipoprotein B is quite complex in view of its huge size, hydrophobicity, obligate association with lipids such as cholesterol and triglycerides prior to secretion, and intracellular degradation of a substantial proportion of newly synthesized molecules. Multiple proteins likely serve roles as molecular chaperones to assist in folding, assembly with lipids, and regulation of the secretion of apolipoprotein B. In these studies, we developed a strategy to isolate proteins associated with apolipoprotein B in rat livers. The purification consisted of two stages: first, microsomes were prepared from rat liver and treated with chemical crosslinkers, and second, the solubilized proteins were coimmunoprecipitated with antibody against apolipoprotein B. We found that several proteins were cross-linked to apolipoprotein B. The proteins were digested with trypsin, and the released peptides were sequenced by tandem mass spectrometry. The sequences precisely matched 377 peptides in 99 unique proteins. We show that at least two of the identified proteins, ferritin heavy and light chains, can directly bind apolipoprotein B. These and possibly other proteins identified by this proteomic approach are novel candidates for proteins that affect apolipoprotein B during its biogenesis.	Beth Israel Deaconess Med Ctr, Mol Med Unit, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Chuck, SL (corresponding author), Beth Israel Deaconess Med Ctr, Mol Med Unit, Dept Med, RW663,330 Brookline Ave, Boston, MA 02215 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062545] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL62545] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGARWAL AK, 1989, J BIOL CHEM, V264, P18939; Asp L, 2000, J BIOL CHEM, V275, P26285, DOI 10.1074/jbc.M003520200; Benoist F, 1996, ARTERIOSCL THROM VAS, V16, P1229, DOI 10.1161/01.ATV.16.10.1229; BOREN J, 1993, ARTERIOSCLER THROMB, V13, P1743, DOI 10.1161/01.ATV.13.12.1743; BOREN J, 1992, J BIOL CHEM, V267, P9858; Chan L, 2000, RECENT PROG HORM RES, V55, P93; Chen Y, 1998, J BIOL CHEM, V273, P11887, DOI 10.1074/jbc.273.19.11887; Chittum HS, 1998, BIOCHEMISTRY-US, V37, P10866, DOI 10.1021/bi981042r; Davidson NO, 2000, ANNU REV NUTR, V20, P169, DOI 10.1146/annurev.nutr.20.1.169; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fisher EA, 2001, J BIOL CHEM, V276, P27855, DOI 10.1074/jbc.M008885200; Fisher EA, 1997, J BIOL CHEM, V272, P20427, DOI 10.1074/jbc.272.33.20427; Fleming JF, 1999, J BIOL CHEM, V274, P9509, DOI 10.1074/jbc.274.14.9509; Ghosh S, 1995, BBA-LIPID LIPID MET, V1259, P305, DOI 10.1016/0005-2760(95)00184-0; Ginsberg HN, 1997, CLIN EXP PHARMACOL P, V24, pA29, DOI 10.1111/j.1440-1681.1997.tb03051.x; Gordon DA, 2000, BBA-MOL CELL BIOL L, V1486, P72, DOI 10.1016/S1388-1981(00)00049-4; GORDON DA, 1994, P NATL ACAD SCI USA, V91, P7628, DOI 10.1073/pnas.91.16.7628; Kang S, 2000, BBA-MOL CELL BIOL L, V1529, P223, DOI 10.1016/S1388-1981(00)00151-7; KNOTT TJ, 1986, NATURE, V323, P734, DOI 10.1038/323734a0; KOSHIZAKA T, 1988, J BIOL CHEM, V263, P1619; Linnik KM, 1998, J BIOL CHEM, V273, P21368, DOI 10.1074/jbc.273.33.21368; Mitchell DM, 1998, P NATL ACAD SCI USA, V95, P14733, DOI 10.1073/pnas.95.25.14733; Olofsson SO, 1999, CURR OPIN LIPIDOL, V10, P341, DOI 10.1097/00041433-199908000-00008; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; Pariyarath R, 2001, J BIOL CHEM, V276, P541, DOI 10.1074/jbc.M007944200; PULLINGER CR, 1989, J LIPID RES, V30, P1065; RUSINOL AE, 1994, J BIOL CHEM, V269, P27494; RUSTAEUS S, 1995, J BIOL CHEM, V270, P28879, DOI 10.1074/jbc.270.48.28879; Stillemark P, 2000, J BIOL CHEM, V275, P10506, DOI 10.1074/jbc.275.14.10506; SUZUKI H, 1990, J BIOL CHEM, V265, P8681; WETTERAU JR, 1992, SCIENCE, V258, P999; WU XJ, 1994, J BIOL CHEM, V269, P12375; Wu XJ, 1997, J BIOL CHEM, V272, P11575; WU XW, 1994, P NATL ACAD SCI USA, V91, P742, DOI 10.1073/pnas.91.2.742; YANG CY, 1986, NATURE, V323, P738, DOI 10.1038/323738a0; Yeung SJ, 1996, BIOCHEMISTRY-US, V35, P13843, DOI 10.1021/bi9618777	36	40	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					22010	22017		10.1074/jbc.M112448200	http://dx.doi.org/10.1074/jbc.M112448200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11934886	hybrid			2022-12-27	WOS:000176286000113
J	Bodi, I; Koch, SE; Yamaguchi, H; Szigeti, GP; Schwartz, A; Varadi, G				Bodi, I; Koch, SE; Yamaguchi, H; Szigeti, GP; Schwartz, A; Varadi, G			The role of region IVS5 of the human cardiac calcium channel in establishing inactivated channel conformation - Use-dependent block by benzothiazepines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY PHENYLALKYLAMINE BLOCK; CA2+ CHANNEL; SODIUM-CHANNEL; MOLECULAR DETERMINANTS; RECEPTOR-SITE; HUMAN HEART; DIHYDROPYRIDINE ACTION; FUNCTIONAL EXPRESSION; POTASSIUM CHANNEL; ALPHA(1) SUBUNIT	The role of inactivated channel conformation and use dependence for diltiazem, a specific benzothiazepine calcium channel inhibitor, was studied in chimeric constructs and point mutants created in the IVS5 transmembrane segment of the L-type cardiac calcium channel. All mutations, chimeric or point mutations, were restricted to IVS5, while the YAI-containing segment in IVS6, i.e. the primary interaction site with benzothiazepines, remained intact. Slowed inactivation rate and incomplete steady state inactivation, a behavior of some mutants, were accompanied by a reduced or by a complete loss of use-dependent block by diltiazem. Single channel properties of mutants that lost use dependence toward diltiazem were characterized by drastically elongated mean open times and distinctly slower time constants of open time distribution. Mutation of individual residues of the IVMLF segment in IVS5 did not mimic the complete loss of use dependence as observed for the replacement of the whole stretch. These results establish evidence that amino acids that govern inactivation and the drug-binding site and other amino acids that are located distal from the putative drug-binding site contribute significantly to the function of the benzothiazepine receptor region. The data are consistent with a complex "pocket" conformation that is responsive to a specific class of L-type calcium channel inhibitors. The data allow for a concept that multiple sites within regions of the a, subunit contribute to auto-regulation of the L-type Ca2+ channel.	Univ Cincinnati, Coll Med, Inst Mol Pharmacol & Biophys, Cardiovasc Res Ctr,Dept Surg, Cincinnati, OH 45267 USA; SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, Buffalo, NY 14214 USA	University System of Ohio; University of Cincinnati; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Bodi, I (corresponding author), Univ Cincinnati, Coll Med, Inst Mol Pharmacol & Biophys, Cardiovasc Res Ctr,Dept Surg, G-933,POB 670828,231 Albert Sabin Way, Cincinnati, OH 45267 USA.		Szigeti, Gyula/A-1248-2008; Tuluc, Petronel/C-2527-2011	Szigeti, Gyula/0000-0003-0411-9992; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL022619, T32HL007382] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL07382, P01 HL22619] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Berjukow S, 1999, J BIOL CHEM, V274, P6154, DOI 10.1074/jbc.274.10.6154; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; Bodi I, 1997, J BIOL CHEM, V272, P24952, DOI 10.1074/jbc.272.40.24952; CHAHINE M, 1994, NEURON, V12, P281, DOI 10.1016/0896-6273(94)90271-2; COLLIN T, 1994, EUR J BIOCHEM, V220, P257, DOI 10.1111/j.1432-1033.1994.tb18621.x; Degtiar VE, 1997, BIOPHYS J, V73, P157, DOI 10.1016/S0006-3495(97)78056-1; Deschenes I, 1999, CARDIOVASC RES, V42, P521, DOI 10.1016/S0008-6363(99)00064-4; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; Ferrari R, 1997, EUR HEART J, V18, pA56; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Hering S, 1997, P NATL ACAD SCI USA, V94, P13323, DOI 10.1073/pnas.94.24.13323; Hering S, 1996, J BIOL CHEM, V271, P24471, DOI 10.1074/jbc.271.40.24471; Hering S, 1998, TRENDS PHARMACOL SCI, V19, P439, DOI 10.1016/S0165-6147(98)01258-9; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; HOCKERMAN GH, 1995, J BIOL CHEM, V270, P22119, DOI 10.1074/jbc.270.38.22119; Hockerman GH, 1997, J BIOL CHEM, V272, P18759, DOI 10.1074/jbc.272.30.18759; Hockerman GH, 1997, P NATL ACAD SCI USA, V94, P14906, DOI 10.1073/pnas.94.26.14906; Johnson BD, 1996, MOL PHARMACOL, V50, P1388; KLAUS D, 1992, J CARDIOVASC PHARM, V20, pS5; KLOCKNER U, 1995, J BIOL CHEM, V270, P17306, DOI 10.1074/jbc.270.29.17306; Kraus RL, 1998, J BIOL CHEM, V273, P27205, DOI 10.1074/jbc.273.42.27205; Kraus RL, 1998, J BIOL CHEM, V273, P5586, DOI 10.1074/jbc.273.10.5586; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; McPhee JC, 1998, J BIOL CHEM, V273, P1121, DOI 10.1074/jbc.273.2.1121; Motoike HK, 1999, J BIOL CHEM, V274, P9409, DOI 10.1074/jbc.274.14.9409; Opie LH, 1997, EUR HEART J, V18, pA71; Peterson BZ, 1997, J BIOL CHEM, V272, P18752, DOI 10.1074/jbc.272.30.18752; SCHULTZ D, 1993, P NATL ACAD SCI USA, V90, P6228, DOI 10.1073/pnas.90.13.6228; Sinnegger MJ, 1997, J BIOL CHEM, V272, P27686, DOI 10.1074/jbc.272.44.27686; Sokolov S, 1999, J PHYSIOL-LONDON, V519, P315, DOI 10.1111/j.1469-7793.1999.0315m.x; Sokolov S, 2001, CIRC RES, V89, P700, DOI 10.1161/hh2001.098983; TANG SQ, 1993, NEURON, V11, P1013, DOI 10.1016/0896-6273(93)90215-D; WAKAMORI M, 1993, BIOCHEM BIOPH RES CO, V196, P1170, DOI 10.1006/bbrc.1993.2374; WEIR MR, 1995, J CLIN PHARMACOL, V35, P220, DOI 10.1002/j.1552-4604.1995.tb04051.x; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Yamaguchi H, 1999, P NATL ACAD SCI USA, V96, P1357, DOI 10.1073/pnas.96.4.1357	36	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20651	20659		10.1074/jbc.M200752200	http://dx.doi.org/10.1074/jbc.M200752200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11912204	hybrid			2022-12-27	WOS:000176204500072
J	Diwa, AA; Belasco, JG				Diwa, AA; Belasco, JG			Critical features of a conserved RNA stem-loop important for feedback regulation of RNase E synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; ESCHERICHIA-COLI; NUCLEOTIDE-SEQUENCE; RIBONUCLEASE-E; STABILITY AMS; DEGRADATION; GENE; CLEAVAGE; PROTEIN; ENDORIBONUCLEASE	P,Nase E is an important regulatory enzyme that governs the principal pathway for mRNA degradation in Escherichia coli. This endonuclease controls its own synthesis via a feedback mechanism in which the longevity of rne (RNase E) mRNA is modulated by a cis-acting sensory element that responds to changes in cellular RNase E activity. Previous research has shown that this element is an RNA stem-loop (hp2) within the 5'-untranslated region of the rne transcript. Here we report studies involving mutational analysis and phylogenetic comparison that have identified the features of rne hp2 important for its function. These comprise an internal loop flanked on one side by a 2-bp stem and a hairpin loop and on the other side by a longer stem whose sequence is inconsequential. A search of bacterial genome sequences suggests that regulation by an hp2-like element may be a unique evolutionary adaptation of the rne transcript that is not shared by other mRNAs.	NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	New York University; New York University	Belasco, JG (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, 540 1St Ave, New York, NY 10016 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035769] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM35769] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		APIRION D, 1978, GENETICS, V90, P659; Arnold TE, 1998, RNA, V4, P319; BABITZKE P, 1991, P NATL ACAD SCI USA, V88, P1, DOI 10.1073/pnas.88.1.1; Belasco J, 1993, CONTROL MESSENGER RN, P3; BOUVET P, 1992, NATURE, V360, P488, DOI 10.1038/360488a0; CLAVERIEMARTIN F, 1991, J BIOL CHEM, V266, P2843; Diwa A, 2000, GENE DEV, V14, P1249; DIWA A, 2001, THESIS NEW YORK U; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Jain C, 2000, METHOD ENZYMOL, V318, P309; Jain C, 2002, MOL MICROBIOL, V43, P1053, DOI 10.1046/j.1365-2958.2002.02808.x; JAIN C, 1995, GENE DEV, V9, P84, DOI 10.1101/gad.9.1.84; KLUG G, 1991, P NATL ACAD SCI USA, V88, P1765, DOI 10.1073/pnas.88.5.1765; LINCHAO S, 1994, J BIOL CHEM, V269, P10797; Mackie GA, 1998, NATURE, V395, P720, DOI 10.1038/27246; MCDOWALL KJ, 1994, J BIOL CHEM, V269, P10790; MELEFORS O, 1991, MOL MICROBIOL, V5, P857, DOI 10.1111/j.1365-2958.1991.tb00759.x; MUDD EA, 1990, MOL MICROBIOL, V4, P2127, DOI 10.1111/j.1365-2958.1990.tb00574.x; MUDD EA, 1993, MOL MICROBIOL, V9, P557, DOI 10.1111/j.1365-2958.1993.tb01716.x; NILSSON G, 1984, NATURE, V312, P75, DOI 10.1038/312075a0; ONO M, 1979, J MOL BIOL, V129, P343, DOI 10.1016/0022-2836(79)90500-X; Rauhut R, 1999, FEMS MICROBIOL REV, V23, P353, DOI 10.1016/S0168-6445(99)00012-1; RESNEKOV O, 1990, P NATL ACAD SCI USA, V87, P8355, DOI 10.1073/pnas.87.21.8355; TARASEVICIENE L, 1991, MOL MICROBIOL, V5, P851, DOI 10.1111/j.1365-2958.1991.tb00758.x	24	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20415	20422		10.1074/jbc.M202313200	http://dx.doi.org/10.1074/jbc.M202313200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11919204	hybrid			2022-12-27	WOS:000176204500041
J	Higashi, N; Fujioka, K; Denda-Nagai, K; Hashimoto, S; Nagai, S; Sato, T; Fujita, Y; Morikawa, A; Tsuiji, M; Miyata-Takeuchi, M; Sano, Y; Suzuki, N; Yamamoto, K; Matsushima, K; Irimura, T				Higashi, N; Fujioka, K; Denda-Nagai, K; Hashimoto, S; Nagai, S; Sato, T; Fujita, Y; Morikawa, A; Tsuiji, M; Miyata-Takeuchi, M; Sano, Y; Suzuki, N; Yamamoto, K; Matsushima, K; Irimura, T			The macrophage C-type lectin specific for galactose/N-acetylgalactosamine is an endocytic receptor expressed on monocyte-derived immature dendritic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; IMMORTALIZED B-CELLS; ASIALOGLYCOPROTEIN RECEPTOR; GENE-EXPRESSION; SERIAL ANALYSIS; MOLECULAR-CLONING; SENSITIZATION PHASE; DC-SIGN; TRAFFICKING; CDNA	Lectins on antigen presenting cells are potentially involved in the antigen uptake and the cellular recognition and trafficking. Serial analysis of gene expression in monocyte-derived dendritic cells (DCs), monocytes, and macrophages revealed that 7 of the 19 C-type lectin mRNA were present in immature DCs. Two of these, the macrophage mannose receptor and the macrophage lectin specific for galactose/N-acetylgalactosamine (MGL), were found only in immature DCs, as confirmed by reverse transcriptase-PCR and flow cytometric analysis. By subcloning and sequencing the amplified mRNA, we obtained nucleotide sequences encoding seven different human MGL (hMGL) subtypes, which were apparently derived from alternatively spliced mRNA. In addition, the hMGL gene locus on human chromosome 17p13 contains one gene. A single nucleotide polymorphism was identified at a position in exon 3 that corresponds to the cytoplasmic region proximal to the transmembrane domain. Of all the splicing variants, the hMGL variant 6C was expressed at the highest levels on immature DCs from all donors tested. Immature DCs could incorporate alpha-GaINAc-modified soluble acrylamide polymers, and this was significantly inhibited by pretreatment of the cells with an anti-hMGL monoclonal antibody that blocks the lectin-carbohydrate interaction. We propose that hMGL is a marker of imDCs and that it functions as an endocytic receptor for glycosylated antigens.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Sch Med, Dept Mol Prevent Med, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo	Irimura, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	irimura@mol.f.u-tokyo.ac.jp	Fujioka, Kouki/AAL-7517-2021; Tsuiji, Makoto/G-1411-2010	Fujioka, Kouki/0000-0002-9472-2922; Tsuiji, Makoto/0000-0002-5607-4880; Nagai, Shigenori/0000-0002-5018-5942; Denda-Nagai, Kaori/0000-0001-8325-3289				Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; Ariizumi K, 2000, J BIOL CHEM, V275, P11957, DOI 10.1074/jbc.275.16.11957; Avrameas A, 1996, EUR J IMMUNOL, V26, P394, DOI 10.1002/eji.1830260219; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BARND DL, 1989, P NATL ACAD SCI USA, V86, P7159, DOI 10.1073/pnas.86.18.7159; Bates EEM, 1999, J IMMUNOL, V163, P1973; Bider MD, 1996, J BIOL CHEM, V271, P31996, DOI 10.1074/jbc.271.50.31996; Chun KH, 2000, INT IMMUNOL, V12, P1695, DOI 10.1093/intimm/12.12.1695; Chun KH, 2000, J LEUKOCYTE BIOL, V68, P471; Colonna M, 2000, EUR J IMMUNOL, V30, P697; Feinberg H, 2000, J BIOL CHEM, V275, P21539, DOI 10.1074/jbc.M002366200; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Guo M, 2000, HUM IMMUNOL, V61, P729, DOI 10.1016/S0198-8859(00)00144-0; Hashimoto S, 2000, BLOOD, V96, P2206, DOI 10.1182/blood.V96.6.2206.h8002206_2206_2214; Hashimoto S, 1999, BLOOD, V94, P837, DOI 10.1182/blood.V94.3.837.413k02_837_844; Hashimoto S, 1999, BLOOD, V94, P845, DOI 10.1182/blood.V94.3.845.415k09_845_852; HIGASHI N, 2002, IN PRESS INT IMMUNOL; Ichii S, 1997, J LEUKOCYTE BIOL, V62, P761, DOI 10.1002/jlb.62.6.761; Ichii S, 2000, CANCER IMMUNOL IMMUN, V49, P1, DOI 10.1007/s002620050021; II M, 1990, J BIOL CHEM, V265, P11295; Iida SI, 1999, J BIOL CHEM, V274, P10697, DOI 10.1074/jbc.274.16.10697; Imai Y, 1995, IMMUNOLOGY, V86, P591; JEROME KR, 1993, J IMMUNOL, V151, P1654; JEROME KR, 1992, CANCER RES, V52, P5985; Kato M, 2000, INT IMMUNOL, V12, P1511, DOI 10.1093/intimm/12.11.1511; KAWAKAMI K, 1994, JPN J CANCER RES, V85, P744, DOI 10.1111/j.1349-7006.1994.tb02423.x; LEUNG JO, 1985, J BIOL CHEM, V260, P2523; LUNDAHL J, 1994, INFLAMMATION, V18, P67, DOI 10.1007/BF01534599; MACEY MG, 1994, EXP HEMATOL, V22, P967; Mizuochi S, 1997, GLYCOBIOLOGY, V7, P137, DOI 10.1093/glycob/7.1.137; OZAKI K, 1992, J BIOL CHEM, V267, P9229; PAIETTA E, 1992, J BIOL CHEM, V267, P11078; SAKAMAKI T, 1995, J LEUKOCYTE BIOL, V57, P407, DOI 10.1002/jlb.57.3.407; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sato K, 1998, J IMMUNOL, V161, P6835; SATO M, 1992, J BIOCHEM-TOKYO, V111, P331, DOI 10.1093/oxfordjournals.jbchem.a123758; Soilleux EJ, 2000, J IMMUNOL, V165, P2937, DOI 10.4049/jimmunol.165.6.2937; Suzuki N, 1996, J IMMUNOL, V156, P128; Suzuki T, 2000, BLOOD, V96, P2584; TAKAHASHI T, 1994, J IMMUNOL, V153, P2102; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241; WEIS WI, 1994, STRUCTURE, V2, P1227, DOI 10.1016/S0969-2126(94)00124-3; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; YAMAMOTO K, 1994, BIOCHEMISTRY-US, V33, P8159, DOI 10.1021/bi00192a021; Zeng FY, 1996, BIOCHEM BIOPH RES CO, V218, P325, DOI 10.1006/bbrc.1996.0057; Zeng FY, 1996, J BIOL CHEM, V271, P32454, DOI 10.1074/jbc.271.50.32454; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268	51	127	132	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20686	20693		10.1074/jbc.M202104200	http://dx.doi.org/10.1074/jbc.M202104200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11919201	hybrid			2022-12-27	WOS:000176204500076
J	Holmes, WB; Appling, DR				Holmes, WB; Appling, DR			Cloning and characterization of methenyltetrahydrofolate synthetase from Saccharomyces cerevisiae.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOTIDE TRANSFORMYLASE; HUMAN 5,10-METHENYLTETRAHYDROFOLATE SYNTHETASE; GENES ENCODING ISOZYMES; SERINE HYDROXYMETHYLTRANSFERASE; PROTEIN-KINASE; RABBIT LIVER; 5-FORMYLTETRAHYDROFOLATE POLYGLUTAMATES; ESCHERICHIA-COLI; YEAST-CELLS; PURIFICATION	The folate derivative 5-formyltetrahydrofolate (folinic acid; 5-CHO-THF) was discovered over 40 years ago, but its role in metabolism remains poorly understood. Only one enzyme is known that utilizes 5-CHO-THF as a substrate: 5,10-methenyltetrahydrofolate synthetase (MTHFS). A BLAST search of the yeast genome using the human MTHFS sequence revealed a 211-amino acid open reading frame (YER183c) with significant homology. The yeast enzyme was expressed in Escherichia coli, and the purified recombinant enzyme exhibited kinetics similar to previously purified MTHFS. No new phenotype was observed in strains disrupted at MTHFS or in strains additionally disrupted at the genes encoding one or both serine hydroxymethyltransferases (SHMT) or at the genes encoding one or both methylenetetrahydrofolate reductases. However, when the MTHFS gene was disrupted in a strain lacking the de novo folate biosynthesis pathway, folinic acid (5-CHO-THF) could no longer support the folate requirement. We have thus named the yeast gene encoding methenyltetrahydrofolate synthetase FAU1 (folinic acid utilization). Disruption of the FAU1 gene in a strain lacking both 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) transformylase isozymes (ADE16 and ADE17) resulted in a growth deficiency that was alleviated by methionine. Genetic analysis suggested that intracellular accumulation of the purine intermediate AICAR interferes with a step in methionine biosynthesis. Intracellular levels of 5-CHO-THF were determined in yeast disrupted at FAU1 and other genes encoding folate-dependent enzymes. In fau1 disruptants, 5-CHO-THF was elevated 4-fold over wild-type yeast. In yeast lacking MTHFS along with both AICAR transformylases, 5-CHO-THF was elevated 12-fold over wild type. 5-CHO-THF was undetectable in strains lacking SHMT activity, confirming SMIT as the in vivo source of 5-CHO-THF. Taken together, these results indicate that S. cerevisiae harbors a single, nonessential, MTHFS activity. Growth phenotypes of multiply disrupted strains are consistent with a regulatory role for 5-CHO-THF in one-carbon metabolism and additionally suggest a metabolic interaction between the purine and methionine pathways.	Univ Texas, Inst Cellular & Mol Biol, Dept Chem & Biochem, Austin, TX 78712 USA; Univ Texas, Inst Biochem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Appling, DR (corresponding author), Univ Texas, Inst Cellular & Mol Biol, Dept Chem & Biochem, Austin, TX 78712 USA.	dappling@mail.utexas.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR009276] Funding Source: NIH RePORTER; NCRR NIH HHS [RR09276] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Baggott JE, 2000, BIOCHEMISTRY-US, V39, P14647, DOI 10.1021/bi001362m; BARLOWE CK, 1990, MOL CELL BIOL, V10, P5679, DOI 10.1128/MCB.10.11.5679; BENKOVIC SJ, 1972, J AM CHEM SOC, V94, P7542, DOI 10.1021/ja00776a043; BERTRAND R, 1987, BIOCHIM BIOPHYS ACTA, V911, P154, DOI 10.1016/0167-4838(87)90004-5; BERTRAND R, 1989, J BIOL CHEM, V264, P8843; BOCHNER BR, 1982, CELL, V29, P929, DOI 10.1016/0092-8674(82)90455-X; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Cherest H, 2000, J BIOL CHEM, V275, P14056, DOI 10.1074/jbc.275.19.14056; DALE GE, 1994, PROTEIN ENG, V7, P925, DOI 10.1093/protein/7.7.925; DAUM G, 1982, J BIOL CHEM, V257, P3028; DAYAN A, 1995, GENE, V165, P307, DOI 10.1016/0378-1119(95)00321-V; FELICIELLO I, 1993, ANAL BIOCHEM, V212, P394, DOI 10.1006/abio.1993.1346; Girgis S, 1997, J BIOL CHEM, V272, P4729, DOI 10.1074/jbc.272.8.4729; GRIMSHAW CE, 1984, J BIOL CHEM, V259, P2728; HA TS, 1994, J NUTR BIOCHEM, V5, P522, DOI 10.1016/0955-2863(94)90049-3; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; HOPKINS S, 1984, J BIOL CHEM, V259, P5618; HUANG T, 1995, J BIOL CHEM, V270, P22296, DOI 10.1074/jbc.270.38.22296; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jolivet J, 1997, METHOD ENZYMOL, V281, P162; Jones E. W., 1982, MOL BIOL YEAST SACCH, P181; Kastanos EK, 1997, BIOCHEMISTRY-US, V36, P14956, DOI 10.1021/bi971610n; Kim DW, 1997, ANAL BIOCHEM, V253, P201, DOI 10.1006/abio.1997.2388; KRUSCHWITZ HL, 1994, J BIOL CHEM, V269, P28757; MARAS B, 1994, J BIOL CHEM, V269, P18429; MAY M, 1951, J AM CHEM SOC, V73, P3067, DOI 10.1021/ja01151a028; MCKENZIE KQ, 1977, GENETICS, V86, P85; MCNEIL JB, 1994, J BIOL CHEM, V269, P9155; Nardese V, 1996, BIOCHEM BIOPH RES CO, V218, P273, DOI 10.1006/bbrc.1996.0048; OGUR M, 1977, J BACTERIOL, V129, P926, DOI 10.1128/JB.129.2.926-933.1977; PASTERNACK LB, 1992, BIOCHEMISTRY-US, V31, P8713, DOI 10.1021/bi00152a005; Piper MD, 2000, J BIOL CHEM, V275, P30987, DOI 10.1074/jbc.M004248200; Raymond RK, 1999, ARCH BIOCHEM BIOPHYS, V372, P300, DOI 10.1006/abbi.1999.1498; ROCA J, 1992, NUCLEIC ACIDS RES, V20, P4671, DOI 10.1093/nar/20.17.4671; ROMAN H, 1956, CR TRAV LAB CARLS P, V26, P299; SABINA RL, 1985, J BIOL CHEM, V260, P6107; SATHE GM, 1991, NUCLEIC ACIDS RES, V19, P4775, DOI 10.1093/nar/19.17.4775; Schirch L. V., 1984, FOLATES PTERINS CHEM, V1, P399; SCHIRCH LV, 1967, BIOCHEMISTRY-US, V6, P253, DOI 10.1021/bi00853a039; Schirch V, 1997, METHOD ENZYMOL, V281, P146; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SHERMAN F, 1986, METHODS YEAST GENETI, P125; SIDI Y, 1985, J CLIN INVEST, V76, P2416, DOI 10.1172/JCI112255; Stefanelli C, 1998, BIOCHEM BIOPH RES CO, V243, P821, DOI 10.1006/bbrc.1998.8154; STOVER P, 1993, TRENDS BIOCHEM SCI, V18, P102, DOI 10.1016/0968-0004(93)90162-G; STOVER P, 1992, ANAL BIOCHEM, V202, P82, DOI 10.1016/0003-2697(92)90210-X; STOVER P, 1993, ADV EXP MED BIOL, V338, P679; STOVER P, 1990, J BIOL CHEM, V265, P14227; STOVER P, 1991, J BIOL CHEM, V266, P1543; SULLIVAN JE, 1994, BIOCHEM BIOPH RES CO, V200, P1551, DOI 10.1006/bbrc.1994.1627; Szebenyi DME, 2000, BIOCHEMISTRY-US, V39, P13313, DOI 10.1021/bi000635a; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tibbetts AS, 1997, ARCH BIOCHEM BIOPHYS, V340, P195, DOI 10.1006/abbi.1997.9919; Tibbetts AS, 2000, J BIOL CHEM, V275, P20920, DOI 10.1074/jbc.M909851199; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; Wach A, 1998, METHOD MICROBIOL, V26, P67; Wilson WA, 1996, CURR BIOL, V6, P1426, DOI 10.1016/S0960-9822(96)00747-6	58	34	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20205	20213		10.1074/jbc.M201242200	http://dx.doi.org/10.1074/jbc.M201242200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11923304	hybrid			2022-12-27	WOS:000176204500016
J	Ishmael, FT; Alley, SC; Benkovic, SJ				Ishmael, FT; Alley, SC; Benkovic, SJ			Assembly of the bacteriophage T4 helicase - Architecture and stoichiometry of the gp41-gp59 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; DNA-REPLICATION; GENE-59 PROTEIN; BINDING-PROTEIN; CROSS-LINKING; PRIMASE; GP32; GP59; FORK; PURIFICATION	The bacteriophage T4 59 protein (gp59) plays an essential role in recombination and replication by mediating the assembly of the gene 41 helicase (gp41) onto DNA. gp59 is required to displace the gp32 single-stranded binding protein on the lagging strand to expose a site for helicase binding. To gain a better understanding of the mechanism of helicase assembly, the architecture and stoichiometry of the gp41-gp59 complex were investigated. Both the N and C termini of gp41 were found to lie close to or in the gp41-gp41 subunit interface and interact with gp59. The site of interaction of gp41 on gp59 is proximal to Cys-215 of gp59. Binding of gp41 to gp59 stimulates a conformational change in the protein resulting in hexamer formation of gp59, and gp59 likewise stimulates oligomer formation of gp41. The gp59 subunits in this complex are arranged in a head to head orientation, such that Cys-42 of one subunit is in close proximity to Cys-42 on an adjacent subunit, and Cys-215 on one subunit is close to Cys-215 on a neighboring subunit. As the helicase is loaded onto DNA, a conformational change in the gp41-gp59 complex occurs, which may serve to displace gp32 from the lagging strand and load the hexameric helicase in its place.	Penn State Univ, Dept Chem, Wartik Lab 414, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Benkovic, SJ (corresponding author), Penn State Univ, Dept Chem, Wartik Lab 414, University Pk, PA 16802 USA.							Alley SC, 2000, J AM CHEM SOC, V122, P6126, DOI 10.1021/ja000591t; BARRY J, 1994, J BIOL CHEM, V269, P33049; Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; CUNNINGHAM RP, 1977, VIROLOGY, V80, P67, DOI 10.1016/0042-6822(77)90381-6; Dong F, 1996, J BIOL CHEM, V271, P19625, DOI 10.1074/jbc.271.32.19625; HINTON DM, 1987, J BIOL CHEM, V262, P10873; Ishmael FT, 2001, J BIOL CHEM, V276, P25236, DOI 10.1074/jbc.M100783200; Jones CE, 2000, J BIOL CHEM, V275, P27145; Kaboord BF, 1996, BIOCHEMISTRY-US, V35, P1084, DOI 10.1021/bi9520747; KARAM JD, 1994, MOL BIOL BACTERIOP T, V4, P38; Lefebvre SD, 1997, J MOL BIOL, V272, P312, DOI 10.1006/jmbi.1997.1264; Lefebvre SD, 1999, J BIOL CHEM, V274, P22830, DOI 10.1074/jbc.274.32.22830; MORRICAL SW, 1994, J BIOL CHEM, V269, P33069; Morrical SW, 1996, J BIOL CHEM, V271, P20198, DOI 10.1074/jbc.271.33.20198; MOSIG G, 1994, MOL BIOL BACTERIOP T, V4; Mueser TC, 2000, J MOL BIOL, V296, P597, DOI 10.1006/jmbi.1999.3438; Raney KD, 1996, J BIOL CHEM, V271, P14074, DOI 10.1074/jbc.271.24.14074; San Martin C, 1998, STRUCTURE, V6, P501; Sexton DJ, 1996, J BIOL CHEM, V271, P28045, DOI 10.1074/jbc.271.45.28045; Sexton DJ, 1998, BIOCHEMISTRY-US, V37, P7749, DOI 10.1021/bi980088h; Valentine AM, 2001, BIOCHEMISTRY-US, V40, P15074, DOI 10.1021/bi0108554; Xu H, 2001, BIOCHEMISTRY-US, V40, P7651, DOI 10.1021/bi010116n; YONESAKI T, 1994, J BIOL CHEM, V269, P1284	23	40	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20555	20562		10.1074/jbc.M111951200	http://dx.doi.org/10.1074/jbc.M111951200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11927580	hybrid			2022-12-27	WOS:000176204500060
J	Lum, AFH; Green, CE; Lee, GR; Staunton, DE; Simon, SI				Lum, AFH; Green, CE; Lee, GR; Staunton, DE; Simon, SI			Dynamic regulation of LFA-1 activation and neutrophil arrest on intercellular adhesion molecule 1 (ICAM-1) in shear flow	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTION-ASSOCIATED ANTIGEN-1; I-DOMAIN; INTEGRIN AFFINITY; MAC-1 CD11B/CD18; CELL-ADHESION; E-SELECTIN; LEUKOCYTE; BINDING; ALPHA; CXC	Neutrophil recruitment during acute inflammation is triggered by G-protein-linked chemotactic receptors that in turn activate beta(2) integrin (CD18), deemed a critical step in facilitating cell capture and arrest under the shear force of blood flow. A conformational switch in the I domain allosteric site (IDAS) and in CD18 regulates LFA-1 affinity for endothelial ligands including intercellular adhesion molecule I (ICAM-1). We examined the dynamics of CD18 activation in terms of the efficiency of neutrophil capture of ICAM-1, and we correlated this with the membrane topography of 327C, an antibody that recognizes the active conformation of CD18 I-like domain. Adhesion increased in direct proportion to chemotactic stimulus rising 7-fold over a log range of interleukin-8 (IL-8). A threshold dose of similar to75 pM IL-8, corresponding to ligation of only similar to10-100 receptors, was sufficient to activate similar to20,000 CD18 and a rapid boost in the capture efficiency on ICAM-1. This was accompanied by a rapid redistribution of active LFA-1, but not Mac-1, into membrane patches, a necessary component for optimum adhesion efficiency. Shear-resistant arrest on a monolayer of ICAM-1 was reversed within minutes of chemotactic stimulation correlating with a shift from high to low affinity CD18 and dispersal of patches of active CD18. Mobility of active CD18 into high avidity patches was dependent on phosphatidylinositol 3-kinase activity and not F-actin polymerization. The data reveal that the number of chemotactic receptors bound and the topography and lifetime of high affinity LFA-1 tightly regulate the efficiency of neutrophil capture on ICAM-1.	Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; ICOS Corp, Bothell, WA 98021 USA	University of California System; University of California Davis; Icos Corporation	Simon, SI (corresponding author), Univ Calif Davis, Dept Biomed Engn, 1 Shields Ave, Davis, CA 95616 USA.	sisimon@ucdavis.edu						ABBASSI O, 1993, J CLIN INVEST, V92, P2719, DOI 10.1172/JCI116889; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bazzoni G, 1998, TRENDS BIOCHEM SCI, V23, P30, DOI 10.1016/S0968-0004(97)01141-9; Beals CR, 2001, J IMMUNOL, V167, P6113, DOI 10.4049/jimmunol.167.11.6113; Bleijs DA, 2000, J CELL SCI, V113, P391; Burns AR, 2000, J CELL SCI, V113, P45; CABANAS C, 1993, P NATL ACAD SCI USA, V90, P5838, DOI 10.1073/pnas.90.12.5838; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; DIAMOND MS, 1993, J CELL BIOL, V120, P1031, DOI 10.1083/jcb.120.4.1031; Ding ZM, 1999, J IMMUNOL, V163, P5029; Dunne JL, 2002, BLOOD, V99, P336, DOI 10.1182/blood.V99.1.336; Gopalan PK, 1997, J IMMUNOL, V158, P367; Greenwood JA, 2000, J CELL BIOL, V150, P627, DOI 10.1083/jcb.150.3.627; Henderson RB, 2001, J EXP MED, V194, P219, DOI 10.1084/jem.194.2.219; Hentzen ER, 2000, BLOOD, V95, P911, DOI 10.1182/blood.V95.3.911.003k36_911_920; Huth JR, 2000, P NATL ACAD SCI USA, V97, P5231, DOI 10.1073/pnas.97.10.5231; Issekutz AC, 1999, J LEUKOCYTE BIOL, V65, P117, DOI 10.1002/jlb.65.1.117; Jung U, 1998, J CLIN INVEST, V102, P1526, DOI 10.1172/JCI119893; Kallen J, 1999, J MOL BIOL, V292, P1, DOI 10.1006/jmbi.1999.3047; Kucik DF, 1996, J CLIN INVEST, V97, P2139, DOI 10.1172/JCI118651; Kuijpers TW, 1997, J CLIN INVEST, V100, P1725, DOI 10.1172/JCI119697; Kunkel EJ, 2000, J IMMUNOL, V164, P3301, DOI 10.4049/jimmunol.164.6.3301; LAWRENCE MB, 1994, IMMUNITY, V1, P137, DOI 10.1016/1074-7613(94)90107-4; LAWRENCE MB, 1990, BLOOD, V75, P227; Lu HF, 2000, J LEUKOCYTE BIOL, V68, P73; Lu HF, 1997, J CLIN INVEST, V99, P1340, DOI 10.1172/JCI119293; Lupher ML, 2001, J IMMUNOL, V167, P1431, DOI 10.4049/jimmunol.167.3.1431; McDowall A, 1998, J BIOL CHEM, V273, P27396, DOI 10.1074/jbc.273.42.27396; Murphy PM, 1997, SEMIN HEMATOL, V34, P311; Neelamegham S, 1998, BLOOD, V92, P1626, DOI 10.1182/blood.V92.5.1626.417a02_1626_1638; Pellegatta F, 2001, J CARDIOVASC PHARM, V37, P751, DOI 10.1097/00005344-200106000-00013; PETER K, 1995, J EXP MED, V181, P315, DOI 10.1084/jem.181.1.315; Sampath R, 1998, J BIOL CHEM, V273, P33588, DOI 10.1074/jbc.273.50.33588; Seo SM, 2001, AM J PHYSIOL-CELL PH, V281, pC1568, DOI 10.1152/ajpcell.2001.281.5.C1568; Sigal A, 2000, J IMMUNOL, V165, P442, DOI 10.4049/jimmunol.165.1.442; SIMON SI, 1995, J IMMUNOL, V155, P1502; SIMON SI, 1992, J IMMUNOL, V149, P2765; Skelton NJ, 1999, STRUCTURE, V7, P157, DOI 10.1016/S0969-2126(99)80022-7; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; STACKER SA, 1991, J IMMUNOL, V146, P648; Stewart M, 1996, J CELL BIOCHEM, V61, P554, DOI 10.1002/(SICI)1097-4644(19960616)61:4<554::AID-JCB8>3.0.CO;2-N; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; Tsang YTM, 1997, J IMMUNOL, V159, P4566; Van Damme J, 1990, Cytokine, V2, P106, DOI 10.1016/1043-4666(90)90004-D; van Kooyk Y, 2000, CURR OPIN CELL BIOL, V12, P542, DOI 10.1016/S0955-0674(00)00129-0; VONANDRIAN UH, 1993, J CLIN INVEST, V91, P2893, DOI 10.1172/JCI116535; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058; ZIMMERMAN GA, 1990, J CELL BIOL, V110, P529, DOI 10.1083/jcb.110.2.529	49	91	97	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20660	20670		10.1074/jbc.M202223200	http://dx.doi.org/10.1074/jbc.M202223200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11929876	hybrid			2022-12-27	WOS:000176204500073
J	Lewicki, DN; Gallagher, TM				Lewicki, DN; Gallagher, TM			Quaternary structure of coronavirus spikes in complex with carcinoembryonic antigen-related cell adhesion molecule cellular receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRAL MEMBRANE-FUSION; INFLUENZA-VIRUS HEMAGGLUTININ; MURINE CORONAVIRUS; ENVELOPE GLYCOPROTEIN; HIV-1 GP41; ESCHERICHIA-COLI; HEPATITIS-VIRUS; MONOCLONAL-ANTIBODIES; PROTEOLYTIC CLEAVAGE; OLIGOMERIC STRUCTURE	Oligomeric spike (S) glycoproteins extend from coronavirus membranes. These integral membrane proteins assemble within the endoplasmic reticulum of infected cells and are subsequently endoproteolyzed in the Golgis, generating noncovalently associated S1 and S2 fragments. Once on the surface of infected cells and virions, peripheral S1 fragments bind carcinoembryonic antigen-related cell adhesion molecule (CEACAM) receptors, and this triggers membrane fusion reactions mediated by integral membrane S2 fragments. We focused on the quaternary structure of S and its interaction with CEACAMs. We discovered that soluble S1 fragments were dimers and that CEACAM binding was entirely dependent on this quaternary structure. However, two differentially tagged CEACAMs could not co-precipitate with the S dimers, suggesting that binding sites were closely juxtaposed in the dimer (steric hindrance) or that a single CEACAM generated global conformational changes that precluded additional interactions (negative cooperativity). CEACAM binding did indeed alter S1 conformations, generating alternative disulfide linkages that were revealed on SDS golgis. CEACAM binding also induced separation of S1 and S2. Differentially tagged S2 fragments that were free of S1 dimers were not co-precipitated, suggesting that S1 harbored the primary oligomerization determinants. We discuss the distinctions between the S-CEACAM interaction and other virus-receptor complexes involved in receptor-triggered entry.	Loyola Univ, Med Ctr, Dept Microbiol & Immunol, Maywood, IL 60153 USA	Loyola University Chicago	Gallagher, TM (corresponding author), Loyola Univ, Med Ctr, Dept Microbiol & Immunol, 2160 S 1st Ave, Maywood, IL 60153 USA.	tgallag@lumc.edu			NIAID NIH HHS [5T32 AI07508-05] Funding Source: Medline; NINDS NIH HHS [R01 NS 31616] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031616] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beauchemin N, 1999, EXP CELL RES, V252, P243; BERNSTEIN HB, 1995, J VIROL, V69, P2745, DOI 10.1128/JVI.69.5.2745-2750.1995; Billker O, 2002, EMBO J, V21, P560, DOI 10.1093/emboj/21.4.560; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Cavanagh D, 1995, CORONAVIRIDAE, P73; Center RJ, 2001, P NATL ACAD SCI USA, V98, P14877, DOI 10.1073/pnas.261573898; Center RJ, 2000, J VIROL, V74, P4448, DOI 10.1128/JVI.74.10.4448-4455.2000; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chen J, 1995, P NATL ACAD SCI USA, V92, P12205, DOI 10.1073/pnas.92.26.12205; DELMAS B, 1990, J VIROL, V64, P5367, DOI 10.1128/JVI.64.11.5367-5375.1990; DOMS RW, 1991, ADV EXP MED BIOL, V300, P203; DOMS RW, 1993, VIROLOGY, V193, P545, DOI 10.1006/viro.1993.1164; Doranz BJ, 1999, J VIROL, V73, P10346, DOI 10.1128/JVI.73.12.10346-10358.1999; Dutch RE, 1999, VIROLOGY, V254, P147; DVEKSLER GS, 1993, P NATL ACAD SCI USA, V90, P1716, DOI 10.1073/pnas.90.5.1716; DVEKSLER GS, 1991, J VIROL, V65, P6881, DOI 10.1128/JVI.65.12.6881-6891.1991; EARL PL, 1992, J VIROL, V66, P5610, DOI 10.1128/JVI.66.9.5610-5614.1992; EARL PL, 1990, P NATL ACAD SCI USA, V87, P648, DOI 10.1073/pnas.87.2.648; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Fass D, 1997, SCIENCE, V277, P1662, DOI 10.1126/science.277.5332.1662; FELDMANN H, 1991, VIROLOGY, V182, P353, DOI 10.1016/0042-6822(91)90680-A; FLEMING JO, 1983, VIROLOGY, V131, P296, DOI 10.1016/0042-6822(83)90498-1; FRANA MF, 1985, J VIROL, V56, P912, DOI 10.1128/JVI.56.3.912-920.1985; FUERST TR, 1987, MOL CELL BIOL, V7, P2538, DOI 10.1128/MCB.7.7.2538; Gallagher TM, 1997, J VIROL, V71, P3129, DOI 10.1128/JVI.71.4.3129-3137.1997; Gallagher TM, 1996, J VIROL, V70, P4683, DOI 10.1128/JVI.70.7.4683-4690.1996; GALLAGHER TM, 1990, J VIROL, V64, P731, DOI 10.1128/JVI.64.2.731-741.1990; Gallaher WR, 1996, CELL, V85, P477, DOI 10.1016/S0092-8674(00)81248-9; Hernandez LD, 1996, ANNU REV CELL DEV BI, V12, P627, DOI 10.1146/annurev.cellbio.12.1.627; HOLMES KV, 1994, COLD SPRING HARBOR M, P403; Joshi SB, 1998, VIROLOGY, V248, P20, DOI 10.1006/viro.1998.9242; Kim M, 2001, J BIOL CHEM, V276, P42667, DOI 10.1074/jbc.M104166200; Krueger DK, 2001, J VIROL, V75, P2792, DOI 10.1128/JVI.75.6.2792-2802.2001; KUBO H, 1994, J VIROL, V68, P5403, DOI 10.1128/JVI.68.9.5403-5410.1994; Kuo LL, 2000, J VIROL, V74, P1393, DOI 10.1128/JVI.74.3.1393-1406.2000; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8; LEUSCH HG, 1991, INFECT IMMUN, V59, P2051, DOI 10.1128/IAI.59.6.2051-2057.1991; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Luo ZL, 1998, VIROLOGY, V244, P483, DOI 10.1006/viro.1998.9121; MACKETT M, 1984, J VIROL, V49, P857, DOI 10.1128/JVI.49.3.857-864.1984; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; PARKER SE, 1989, VIROLOGY, V173, P664, DOI 10.1016/0042-6822(89)90579-5; Perlman S, 2000, EFFECTS OF MICROBES ON THE IMMUNE SYSTEM, P331; Phillips JJ, 1999, J VIROL, V73, P7752, DOI 10.1128/JVI.73.9.7752-7760.1999; Pletnev SV, 2001, CELL, V105, P127, DOI 10.1016/S0092-8674(01)00302-6; ROUTLEDGE E, 1991, J VIROL, V65, P254, DOI 10.1128/JVI.65.1.254-262.1991; Russell CJ, 2001, EMBO J, V20, P4024, DOI 10.1093/emboj/20.15.4024; Salzwedel K, 2000, P NATL ACAD SCI USA, V97, P12794, DOI 10.1073/pnas.230438497; Sanchez CM, 1999, J VIROL, V73, P7607; SATTENTAU QJ, 1991, J EXP MED, V174, P407, DOI 10.1084/jem.174.2.407; SATTENTAU QJ, 1993, J VIROL, V67, P7383, DOI 10.1128/JVI.67.12.7383-7393.1993; SCHMIDT I, 1987, J GEN VIROL, V68, P47, DOI 10.1099/0022-1317-68-1-47; Singh M, 1999, J MOL BIOL, V290, P1031, DOI 10.1006/jmbi.1999.2796; Skehel JJ, 1998, CELL, V95, P871, DOI 10.1016/S0092-8674(00)81710-9; STEGMANN T, 1990, EMBO J, V9, P4231, DOI 10.1002/j.1460-2075.1990.tb07871.x; STURMAN LS, 1985, J VIROL, V56, P904, DOI 10.1128/JVI.56.3.904-911.1985; STURMAN LS, 1990, J VIROL, V64, P3042, DOI 10.1128/JVI.64.6.3042-3050.1990; Suzuki H, 1996, J VIROL, V70, P2632, DOI 10.1128/JVI.70.4.2632-2636.1996; Taguchi F, 2002, J VIROL, V76, P950, DOI 10.1128/JVI.76.3.950-958.2002; TATU U, 1995, EMBO J, V14, P1340, DOI 10.1002/j.1460-2075.1995.tb07120.x; VENNEMA H, 1990, ADV EXP MED BIOL, V276, P9; Weissenhorn W, 1998, P NATL ACAD SCI USA, V95, P6032, DOI 10.1073/pnas.95.11.6032; Weissenhorn W, 1999, MOL MEMBR BIOL, V16, P3, DOI 10.1080/096876899294706; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weissenhorn W, 1996, EMBO J, V15, P1507, DOI 10.1002/j.1460-2075.1996.tb00494.x; Weissenhorn W, 1997, P NATL ACAD SCI USA, V94, P6065, DOI 10.1073/pnas.94.12.6065; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; YOO D, 1991, VIROLOGY, V180, P395, DOI 10.1016/0042-6822(91)90045-D; Young BD, 1984, CENTRIFUGATION PRACT, P127	73	53	56	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19727	19734		10.1074/jbc.M201837200	http://dx.doi.org/10.1074/jbc.M201837200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11912215	Green Published, hybrid			2022-12-27	WOS:000175894800065
J	Yin, LY; Zhang, YQ; Hillgartner, FB				Yin, LY; Zhang, YQ; Hillgartner, FB			Sterol regulatory element-binding protein-1 interacts with the nuclear thyroid hormone receptor to enhance acetyl-CoA carboxylase-alpha transcription in hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHICK-EMBRYO HEPATOCYTES; MALIC ENZYME GENE; FATTY-ACID SYNTHESIS; LEUCINE ZIPPER PROTEIN; COENZYME-A CARBOXYLASE; STIMULATES TRANSCRIPTION; ADIPOCYTE DETERMINATION; INHIBITS TRANSCRIPTION; RESPONSE ELEMENT; SYNTHASE GENE	In previous work, we characterized a 3,5,3'-triiodothyronine response element (T3RE) in acetyl-CoA carboxylase-alpha (ACCalpha) promoter 2 that mediated 3,5,3'-triiodothyronine (T3) regulation of ACCalpha transcription in chick embryo hepatocytes. Sequence comparison analysis revealed the presence of sterol regulatory element-1 (SRE-1) located 5 by downstream of the ACCalpha T3RE. Here, we investigated the role of this SRE-1 in modulating T3 regulation of ACCalpha transcription. Transfection analyses demonstrated that the SRE-1 enhanced T3-induced ACCalpha transcription by more than 2-fold in hepatocytes. The effect of the SRE-1 on T3 responsiveness required the presence of the T3RE in its native orientation. In pull-down experiments, the mature form of sterol regulatory element-binding protein-1 (SREBP-1) specifically bound the alpha-isoform of the nuclear T3 receptor (TR), and the presence of T3 enhanced this interaction. A region of TRalpha containing the DNA-binding domain plus flanking sequences (amino acids 21-157) was required for interaction with SREBP-1, and a region of SREBP-1 containing the basic helix-loop-helix-leucine zipper domain (amino acids 300-389) was required for interaction with TRa. In gel mobility shift experiments, TRa, retinoid X receptor-alpha, and mature SREBP-1 formed a tetrameric complex on a DNA probe containing the ACCalpha T3RE and SRE-1, and the presence of T3 enhanced the formation of this complex. Formation of the tetrameric complex stabilized the binding of SREBP-1 to the SRE-1. These results indicate that SREBP-1 directly interacts with TR-retinoid X receptor in an orientation-specific manner to enhance T3-induced ACCalpha transcription in hepatocytes. T3 regulation of ACCalpha transcription in nonhepatic cell cultures such as chick embryo fibroblasts is markedly reduced compared with that of chick embryo hepatocytes. Here, we also show that alterations in SREBP expression play a role in mediating cell type-dependent differences in T3 regulation of ACCalpha transcription.	W Virginia Univ, Dept Biochem & Mol Pharmacol, Morgantown, WV 26506 USA	West Virginia University	Hillgartner, FB (corresponding author), W Virginia Univ, Dept Biochem & Mol Pharmacol, POB 9142, Morgantown, WV 26506 USA.							BAILLIE RA, 1993, J NUTR BIOCHEM, V4, P431, DOI 10.1016/0955-2863(93)90074-7; Bennett MK, 1999, J BIOL CHEM, V274, P13025, DOI 10.1074/jbc.274.19.13025; BLENNEMANN B, 1995, MOL CELL ENDOCRINOL, V110, P1, DOI 10.1016/0303-7207(95)03509-6; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; BURMAN KD, 1977, ENDOCRINOLOGY, V101, P1331, DOI 10.1210/endo-101-4-1331; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dooley KA, 1998, J BIOL CHEM, V273, P1349, DOI 10.1074/jbc.273.3.1349; Ericsson J, 1997, J BIOL CHEM, V272, P7298, DOI 10.1074/jbc.272.11.7298; Ericsson J, 1996, J BIOL CHEM, V271, P24359, DOI 10.1074/jbc.271.40.24359; Fang XX, 1998, ARCH BIOCHEM BIOPHYS, V349, P138, DOI 10.1006/abbi.1997.0406; Foretz M, 1999, MOL CELL BIOL, V19, P3760; GAVIN LA, 1980, J BIOL CHEM, V255, P49; GAVIN LA, 1988, ENDOCRINOLOGY, V123, P1075, DOI 10.1210/endo-123-2-1075; Gondret F, 2001, J LIPID RES, V42, P106; GOODRIDG.AG, 1973, J BIOL CHEM, V248, P1924; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; HILLGARTNER F, 1995, PHYSIOL REV, V75, P47, DOI 10.1152/physrev.1995.75.1.47; HILLGARTNER FB, 1992, J BIOL CHEM, V267, P12299; Hillgartner FB, 1997, J LIPID RES, V38, P2548; Hillgartner FB, 1996, BIOCHEM J, V319, P263, DOI 10.1042/bj3190263; Hillgartner FB, 1997, ARCH BIOCHEM BIOPHYS, V337, P159, DOI 10.1006/abbi.1996.9776; Hodnett DW, 1996, ARCH BIOCHEM BIOPHYS, V334, P309, DOI 10.1006/abbi.1996.0460; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Huang CL, 1998, BIOCHEM BIOPH RES CO, V249, P704, DOI 10.1006/bbrc.1998.9217; Ito M, 2001, TRENDS ENDOCRIN MET, V12, P127, DOI 10.1016/S1043-2760(00)00355-6; Jump DB, 2001, J BIOL CHEM, V276, P34419, DOI 10.1074/jbc.M105471200; JUMP DB, 1989, J BIOL CHEM, V264, P4698; Kim KH, 1997, ANNU REV NUTR, V17, P77, DOI 10.1146/annurev.nutr.17.1.77; Koo SH, 2001, J BIOL CHEM, V276, P9437, DOI 10.1074/jbc.M010029200; KUSHNER PJ, 1994, MOL ENDOCRINOL, V8, P405, DOI 10.1210/me.8.4.405; Lee Y, 1997, MOL CELL BIOL, V17, P2745, DOI 10.1128/MCB.17.5.2745; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; Magana MM, 1997, J LIPID RES, V38, P1630; Magana MM, 2000, J BIOL CHEM, V275, P4726, DOI 10.1074/jbc.275.7.4726; MARIASH CN, 1986, J BIOL CHEM, V261, P9583; MARIASH CN, 1980, J CLIN INVEST, V65, P1126, DOI 10.1172/JCI109766; Mater MK, 1999, J BIOL CHEM, V274, P32725, DOI 10.1074/jbc.274.46.32725; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Oliner JD, 1996, GENE DEV, V10, P2903, DOI 10.1101/gad.10.22.2903; Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200; Osborne TF, 1995, CRIT REV EUKAR GENE, V5, P317, DOI 10.1615/CritRevEukarGeneExpr.v5.i3-4.50; Park EA, 1999, J BIOL CHEM, V274, P211, DOI 10.1074/jbc.274.1.211; PERLMANN T, 1993, GENE DEV, V7, P1411, DOI 10.1101/gad.7.7b.1411; Ruderman NB, 1999, AM J PHYSIOL-ENDOC M, V276, pE1, DOI 10.1152/ajpendo.1999.276.1.E1; SALATI LM, 1991, J BIOL CHEM, V266, P4010; SANCHEZ HB, 1995, J BIOL CHEM, V270, P1161, DOI 10.1074/jbc.270.3.1161; Sato R, 2000, J BIOL CHEM, V275, P12497, DOI 10.1074/jbc.275.17.12497; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STAPLETON SR, 1990, J BIOL CHEM, V265, P18442; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; Wang YT, 2002, BIOCHEM J, V361, P391, DOI 10.1042/bj3610391; Wang YT, 2001, J BIOL CHEM, V276, P23838, DOI 10.1074/jbc.M102166200; Xu J, 2001, J BIOL CHEM, V276, P9800, DOI 10.1074/jbc.M008973200; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yin LY, 2000, BBA-GENE STRUCT EXPR, V1517, P91, DOI 10.1016/S0167-4781(00)00267-0; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Zhang YQ, 2001, J BIOL CHEM, V276, P974, DOI 10.1074/jbc.M005894200	66	63	66	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19554	19565		10.1074/jbc.M111771200	http://dx.doi.org/10.1074/jbc.M111771200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11907029	hybrid			2022-12-27	WOS:000175894800043
J	Mezentsev, A; Seta, F; Dunn, MW; Ono, N; Falck, JR; Laniado-Schwartzman, M				Mezentsev, A; Seta, F; Dunn, MW; Ono, N; Falck, JR; Laniado-Schwartzman, M			Eicosanoid regulation of vascular endothelial growth factor expression and angiogenesis in microvessel endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT CORNEAL EPITHELIUM; P42/P44 MAP KINASE; CONTACT-LENS MODEL; ARACHIDONIC-ACID; 12(R)-HYDROXYEICOSATRIENOIC ACID; 12-HYDROXYEICOSATRIENOIC ACID; INFLAMMATORY EICOSANOIDS; SIGNALING ANGIOGENESIS; KAPPA-B; HYPOXIA	12(R)-Hydroxy-5,8,14-eicosatrienoic acid (HETrE) is a potent inflammatory and angiogenic eicosanoid in ocular and dermal tissues. Previous studies suggested that 12(R)-HETrE activates microvessel endothelial cells via a high affinity binding site; however, the cellular mechanisms underlying 12(R)-HETrE angiogenic activity are unexplored. Because the synthesis of 12(R)-HETrE is induced in response to hypoxic injury, we examined its interactions with vascular endothelial growth factor (VEGF) in rabbit limbal microvessel endothelial cells. Addition of 12(R)-HETrE (0.1 mm) to the cells increased VEGF mRNA levels with maximum 5-fold increase at 45 min. The increase in VEGF mRNA was followed by an increase in immunoreactive VEGF protein. 12(R)-HETrE (0.1 mm) rapidly activated the extracellular signal-regulated kinases (ERKs) ERK1 and ERK2. Moreover, preincubation of cells with PD98059, a selective inhibitor of MEK-1, inhibited 12(R)-HETrE-induced VEGF mRNA. Addition of VEGF antibody to cells grown in Matrigel-coated culture plates inhibited 12(R)-HETrE-induced capillary tube-like formation, suggesting that VEGF mediates, at least in part, the angiogenic response to 12(R)HETrE. The results indicate that in microvessel endothelial cells, 12(R)-HETrE induces VEGF expression via activation of ERK1/2 and that VEGF mediates, at least in part, the angiogenic activity of 12(R)-HETrE. Given the fact that both VEGF and 12(R)-HETrE are produced in the cornea after hypoxic injury, their interaction may be an important determinant in the development of neovascularized tissues.	New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75235 USA	New York Medical College; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Laniado-Schwartzman, M (corresponding author), New York Med Coll, Dept Pharmacol, Basic Sci Bldg 530, Valhalla, NY 10595 USA.		Mezentsev, Alexandre/B-2559-2008; Seta, Francesca/ABB-1566-2020	Mezentsev, Alexandre/0000-0001-7100-1068; Mezentsev, Alexandre/0000-0002-4972-9922; Seta, Francesca/0000-0001-7985-5615; Falck, John/0000-0002-9219-7845	NEI NIH HHS [EY06513] Funding Source: Medline; NIGMS NIH HHS [GM31278] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031278] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bamba H, 2000, BIOCHEM BIOPH RES CO, V273, P485, DOI 10.1006/bbrc.2000.2969; BENAV P, 1995, FEBS LETT, V372, P83, DOI 10.1016/0014-5793(95)00956-A; Berra E, 2000, BIOCHEM PHARMACOL, V60, P1171, DOI 10.1016/S0006-2952(00)00423-8; CAMP RDR, 1988, BRIT J PHARMACOL, V94, P1043, DOI 10.1111/j.1476-5381.1988.tb11620.x; Cheng T, 1998, INVEST OPHTH VIS SCI, V39, P581; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Conners MS, 1997, INVEST OPHTH VIS SCI, V38, P1963; CONNERS MS, 1995, INVEST OPHTH VIS SCI, V36, P828; CONNERS MS, 1995, INVEST OPHTH VIS SCI, V36, P841; CONNERS MS, 1994, J INVEST DERMATOL, V104, P1; Fleming I, 2001, PFLUG ARCH EUR J PHY, V442, P511, DOI 10.1007/s004240100565; Folkman J., 1992, INFLAMMATION BASIC P, P821; FORM DM, 1983, P SOC EXP BIOL MED, V172, P214; HARADA S, 1994, J CLIN INVEST, V93, P2490, DOI 10.1172/JCI117258; HOLTZMAN MJ, 1989, J CLIN INVEST, V84, P1446, DOI 10.1172/JCI114319; KLINTWORTH GK, 1990, CORNEAL ANGIOGENESIS; LANIADOSCHWARTZMAN M, 1994, J BIOL CHEM, V269, P24321; Leahy KM, 2000, CURR MED CHEM, V7, P1163, DOI 10.2174/0929867003374336; MASFERRER JL, 1991, EXP EYE RES, V52, P417, DOI 10.1016/0014-4835(91)90037-F; Mastyugin V, 1999, J PHARMACOL EXP THER, V289, P1611; Mastyugin V, 2001, CURR EYE RES, V23, P1, DOI 10.1076/ceyr.23.1.1.5422; Mieyal PA, 2000, INVEST OPHTH VIS SCI, V41, P2170; Mieyal PA, 2001, INVEST OPHTH VIS SCI, V42, P328; Munzenmaier DH, 2000, AM J PHYSIOL-HEART C, V278, pH1163, DOI 10.1152/ajpheart.2000.278.4.H1163; Nie DT, 2000, BLOOD, V95, P2304, DOI 10.1182/blood.V95.7.2304.007k23_2304_2311; Nie DT, 2000, BIOCHEM BIOPH RES CO, V267, P245, DOI 10.1006/bbrc.1999.1840; Pages G, 2000, ANN NY ACAD SCI, V902, P187; Pai R, 2001, BIOCHEM BIOPH RES CO, V286, P923, DOI 10.1006/bbrc.2001.5494; Schwartzman ML, 1997, ADVANCES IN OCULAR TOXICOLOGY, P3; SHIN DS, 1989, TETRAHEDRON LETT, V30, P3923, DOI 10.1016/S0040-4039(00)99285-2; Stoltz RA, 1996, AM J PATHOL, V148, P129; Stoltz RA, 1997, J OCUL PHARMACOL TH, V13, P191, DOI 10.1089/jop.1997.13.191; Stoltz RA, 1996, P NATL ACAD SCI USA, V93, P2832, DOI 10.1073/pnas.93.7.2832; Vafeas C, 1998, J PHARMACOL EXP THER, V287, P903; VANWAUWE J, 1991, EICOSANOIDS, V4, P155; WAINWRIGHT S, 1990, BIOCHEMISTRY-US, V29, P10126, DOI 10.1021/bi00495a017	36	36	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					18670	18676		10.1074/jbc.M201143200	http://dx.doi.org/10.1074/jbc.M201143200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11901160	hybrid			2022-12-27	WOS:000175975800058
J	Waditee, R; Hibino, T; Tanaka, Y; Nakamura, T; Incharoensakdi, A; Hayakawa, S; Suzuki, S; Futsuhara, Y; Kawamitsu, Y; Takabe, T; Takabe, T				Waditee, R; Hibino, T; Tanaka, Y; Nakamura, T; Incharoensakdi, A; Hayakawa, S; Suzuki, S; Futsuhara, Y; Kawamitsu, Y; Takabe, T; Takabe, T			Functional characterization of betaine/proline transporters in betaine-accumulating mangrove	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID PERMEASE; GLYCINE BETAINE; ESCHERICHIA-COLI; CORYNEBACTERIUM-GLUTAMICUM; PROLINE BETAINE; SYSTEM; CLONING; STRESS; YEAST; GENE	Betaine is an important osmoprotectant in many plants, but its transport activity has only been demonstrated using a proline transporter from tomato, a betaine-nonaccumulating plant. In this study, two full-length and one partial transporter genes were isolated from betaine-accumulating mangrove Avicennia marina. Their homologies to betaine transporters from bacteria and betaine/4-aminobutyrate transporters from mammalian cells were low but were high to proline transporters from Arabidopsis and tomato. Two full-length transporters could complement the Na+-sensitive phenotype of the Escherichia coli mutant deficient in betT, putPA, proP, and proU. Both transporters could efficiently take up betaine and proline with similar affinities (K-m, 0.32-0.43 mm) and maximum velocities (1.9-3.6 nmol/min/mg of protein). The uptakes of betaine and proline were significantly inhibited by mono- and dimethylglycine but only partially inhibited by betaine aldehyde, choline, and 4-aminobutyrate. Sodium and potassium chloride markedly enhanced betaine uptake rates with optimum concentrations at 0.5 m, whereas sucrose showed only modest activation. The change of amino acids Thr(290)-Thr-Ser(292) in a putative periplasmic loop to Arg(290)-Gly-Arg(292) yielded the active transporter independent of salts, suggesting the positive charge induced a conformational change to the active form. These data clearly indicate that the betaine-accumulating mangrove contains betaine/proline transporters whose properties are distinct from betaine transporters of bacteria and mammalian cells.	Meijo Univ, Res Inst, Tenpaku Ku, Nagoya, Aichi 4688502, Japan; Meijo Univ, Fac Sci & Technol, Tenpaku Ku, Nagoya, Aichi 4688502, Japan; Meijo Univ, Sch Agr, Tenpaku Ku, Nagoya, Aichi 4688502, Japan; Chulalongkorn Univ, Fac Sci, Dept Biochem, Bangkok 10330, Thailand; Chiba Univ, Fac Pharmaceut Sci, Chiba 2638522, Japan; Univ Ryukyus, Fac Agr, Okinawa 9030213, Japan; Nagoya Univ, Grad Sch Agr Sci, Chikusa Ku, Aichi 4648601, Japan	Meijo University; Meijo University; Meijo University; Chulalongkorn University; Chiba University; University of the Ryukyus; Nagoya University	Takabe, T (corresponding author), Meijo Univ, Res Inst, Tenpaku Ku, Nagoya, Aichi 4688502, Japan.	takabe@ccmfs.meijo-u.ac.jp						Breitkreuz KE, 1999, FEBS LETT, V450, P280, DOI 10.1016/S0014-5793(99)00516-5; Bremer E, 2000, BACTERIAL STRESS RESPONSES, P79; CULHAM DE, 1993, J MOL BIOL, V229, P268, DOI 10.1006/jmbi.1993.1030; Fischer WN, 1998, TRENDS PLANT SCI, V3, P188, DOI 10.1016/S1360-1385(98)01231-X; FROMMER WB, 1993, P NATL ACAD SCI USA, V90, P5944, DOI 10.1073/pnas.90.13.5944; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; HAARDT M, 1995, MOL GEN GENET, V246, P783, DOI 10.1007/BF00290728; Hamada A, 2001, PLANT PHYSIOL, V125, P437, DOI 10.1104/pp.125.1.437; Hibino T, 2001, PLANT MOL BIOL, V45, P353, DOI 10.1023/A:1006497113323; HOFMANN K, 1992, COMPUT APPL BIOSCI, V8, P331; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; HSU LC, 1993, P NATL ACAD SCI USA, V90, P7441, DOI 10.1073/pnas.90.16.7441; Igarashi Y, 2000, PLANT CELL PHYSIOL, V41, P750, DOI 10.1093/pcp/41.6.750; Kappes RM, 1996, J BACTERIOL, V178, P5071, DOI 10.1128/jb.178.17.5071-5079.1996; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAMARK T, 1991, MOL MICROBIOL, V5, P1049, DOI 10.1111/j.1365-2958.1991.tb01877.x; Makela P, 1996, PLANT SCI, V121, P221, DOI 10.1016/S0168-9452(96)04527-X; NELSON K, 1992, J BACTERIOL, V174, P6886, DOI 10.1128/JB.174.21.6886-6895.1992; Ortiz-Lopez A, 2000, BBA-BIOMEMBRANES, V1465, P275, DOI 10.1016/S0005-2736(00)00144-9; Peter H, 1998, J BIOL CHEM, V273, P2567, DOI 10.1074/jbc.273.5.2567; Peter H, 1996, J BACTERIOL, V178, P5229, DOI 10.1128/jb.178.17.5229-5234.1996; Racher KI, 1999, BIOCHEMISTRY-US, V38, P1676, DOI 10.1021/bi981279n; Rathinasabapathi B, 1997, P NATL ACAD SCI USA, V94, P3454, DOI 10.1073/pnas.94.7.3454; Rentsch D, 1996, PLANT CELL, V8, P1437, DOI 10.1105/tpc.8.8.1437; RHODES D, 1993, ANNU REV PLANT PHYS, V44, P357, DOI 10.1146/annurev.pp.44.060193.002041; Rubenhagen R, 2001, EMBO J, V20, P5412, DOI 10.1093/emboj/20.19.5412; Schwacke R, 1999, PLANT CELL, V11, P377, DOI 10.1105/tpc.11.3.377; Sleator RD, 1999, APPL ENVIRON MICROB, V65, P2078; Takabe T, 1998, STRESS RESPONSES OF PHOTOSYNTHETIC ORGANISMS, P115; van der Heide T, 2000, P NATL ACAD SCI USA, V97, P7102, DOI 10.1073/pnas.97.13.7102; Waditee R, 2001, J BIOL CHEM, V276, P36931, DOI 10.1074/jbc.M103650200; Williams KA, 1999, EMBO J, V18, P3558, DOI 10.1093/emboj/18.13.3558; YAMAUCHI A, 1992, J BIOL CHEM, V267, P649	34	60	63	1	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					18373	18382		10.1074/jbc.M112012200	http://dx.doi.org/10.1074/jbc.M112012200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11907031	hybrid			2022-12-27	WOS:000175975800017
J	Griffith, JD; Lindsey-Boltz, LA; Sancar, A				Griffith, JD; Lindsey-Boltz, LA; Sancar, A			Structures of the human Rad17-replication factor C and checkpoint Rad 9-1-1 complexes visualized by glycerol spray/low voltage microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION-FACTOR-C; LOADER SMALL-SUBUNIT; DNA-POLYMERASE-III; SCHIZOSACCHAROMYCES-POMBE; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; ELECTRON-MICROSCOPY; PYROCOCCUS-FURIOSUS; DAMAGE CHECKPOINTS; PROTEIN COMPLEX	Human checkpoint Rad proteins are thought to function as damage sensors in the DNA damage checkpoint response pathway. The checkpoint proteins hRad9, hHus1, and hRad1 have limited homology to the replication processivity factor proliferating cell nuclear antigen (PCNA), and hRad17 has homology to replication factor C (RFC). Such observations have led to the proposal that these checkpoint Rad proteins may function similarly to their replication counterparts during checkpoint control. We purified two complexes formed by the checkpoint Rad proteins and investigated their structures using an electron microscopic preparative method in which the complexes are sprayed from a glycerol solution onto very thin carbon foils, decorated in vacuo with tungsten, and imaged at low voltage. We found that the hRad9, hHus1, and hRad1 proteins make a trimeric ring structure (checkpoint 9-1-1 complex) reminiscent of the PCNA ring. Similarly we found that hRad17 makes a heteropentameric complex with the four RFC small subunits (hRad17-RFC) with a deep groove or cleft and is similar to the RFC clamp loader. Therefore, our results demonstrate structural similarity between the checkpoint Rad complexes and the PCNA and RFC replication factors and thus provide further support for models proposing analogous functions for these complexes.	Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sancar, A (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.		Lindsey-Boltz, Laura/A-3121-2010	Lindsey-Boltz, Laura/0000-0001-6493-8194	NCI NIH HHS [T32-CA09156] Funding Source: Medline; NIGMS NIH HHS [GM31809, F32-GM20830] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM020830] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Burtelow MA, 2000, J BIOL CHEM, V275, P26343, DOI 10.1074/jbc.M001244200; Burtelow MA, 2001, J BIOL CHEM, V276, P25903, DOI 10.1074/jbc.M102946200; Cai JS, 1996, P NATL ACAD SCI USA, V93, P12896, DOI 10.1073/pnas.93.23.12896; Caspari T, 2000, MOL CELL BIOL, V20, P1254, DOI 10.1128/MCB.20.4.1254-1262.2000; FOWLER WE, 1979, J MOL BIOL, V134, P241, DOI 10.1016/0022-2836(79)90034-2; Green CM, 2000, CURR BIOL, V10, P39, DOI 10.1016/S0960-9822(99)00263-8; GRIFFITHS DJF, 1995, EMBO J, V14, P5812, DOI 10.1002/j.1460-2075.1995.tb00269.x; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Hang HY, 2000, GENOMICS, V65, P24, DOI 10.1006/geno.2000.6142; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Kaur R, 2001, MOL BIOL CELL, V12, P3744, DOI 10.1091/mbc.12.12.3744; Kondo T, 2001, SCIENCE, V294, P867, DOI 10.1126/science.1063827; Kondo T, 1999, MOL CELL BIOL, V19, P1136; KORNBERG A, 1992, DNA REPLICATION, P116; KRISHNA TSR, 1994, J MOL BIOL, V241, P265, DOI 10.1006/jmbi.1994.1495; Lindsey-Boltz LA, 2001, P NATL ACAD SCI USA, V98, P11236, DOI 10.1073/pnas.201373498; Mayanagi K, 2001, J STRUCT BIOL, V134, P35, DOI 10.1006/jsbi.2001.4357; Melo JA, 2001, GENE DEV, V15, P2809; Naiki T, 2000, MOL CELL BIOL, V20, P5888, DOI 10.1128/MCB.20.16.5888-5896.2000; O'Donnell M, 2001, CURR BIOL, V11, pR935, DOI 10.1016/S0960-9822(01)00559-0; Oyama T, 2001, MOL CELL, V8, P455, DOI 10.1016/S1097-2765(01)00328-8; Shimada M, 1999, MOL BIOL CELL, V10, P3991, DOI 10.1091/mbc.10.12.3991; Shimomura T, 1998, MOL CELL BIOL, V18, P5485, DOI 10.1128/MCB.18.9.5485; Shiomi Y, 2000, P NATL ACAD SCI USA, V97, P14127, DOI 10.1073/pnas.97.26.14127; SHOTTON DM, 1979, J MOL BIOL, V131, P303, DOI 10.1016/0022-2836(79)90078-0; St Onge RP, 1999, MOL BIOL CELL, V10, P1985; Thelen MP, 1999, CELL, V96, P769, DOI 10.1016/S0092-8674(00)80587-5; Venclovas C, 2000, NUCLEIC ACIDS RES, V28, P2481, DOI 10.1093/nar/28.13.2481; Volkmer E, 1999, J BIOL CHEM, V274, P567, DOI 10.1074/jbc.274.2.567; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302	30	102	106	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 3	2002	277	18					15233	15236		10.1074/jbc.C200129200	http://dx.doi.org/10.1074/jbc.C200129200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	550PA	11907025	hybrid			2022-12-27	WOS:000175510400004
J	Beers, J; Glerum, DM; Tzagoloff, A				Beers, J; Glerum, DM; Tzagoloff, A			Purification and characterization of yeast Sco1p, a mitochondrial copper protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C1; METABOLISM; REQUIRES; GENE	The present studies were undertaken to further characterize the properties of Sco1p, a constituent of the mitochondrial inner membrane implicated in copper transfer to cytochrome oxidase. We report a procedure capable of yielding Sco1p of >95% purity. Sco1p has been purified from strains of Saccharomyces cerevisiae that overexpress the protein. The amino-terminal sequence of purified Sco1p indicates that the first 40 amino acids of the primary translation product constitute a mitochondrial targeting sequence that is proteolytically cleaved during import. We estimate that Sco1p constitutes 0.08% total mitochondrial proteins in wild type yeast and 5% in the transformant used for the purification. Sco1p contains similar to1 mol of copper/mol protein. The copper is not removed by the treatment of Sco1p with EDTA, indicating that it is bound with high affinity. Purified Sco1p sediments identical to Sco1p in crude extracts of mitochondria from wild type yeast or from a strain transformed with SCO1 on a high copy plasmid. Native Sco1p has an estimated mass of 88 kDa, suggesting that it is a homotrimer. Sco1p expressed as a soluble protein lacking the internal 17 amino acids of the membrane-anchoring domain has been localized in the matrix. The protein has also been targeted to the intermembrane space. Neither soluble matrix nor intermembrane-localized Sco1p is able to complement a sco1 mutant, suggesting that only the membrane form with the carboxyl-terminal domain facing the intermembrane space is able to exert its normal function.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Tzagoloff, A (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	spud@cubpet2.bio.columbia.edu	Glerum, Moira/AHD-3271-2022		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050187] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM50187, R01 GM050187] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnold I, 1998, J BIOL CHEM, V273, P1469, DOI 10.1074/jbc.273.3.1469; Beers J, 1997, J BIOL CHEM, V272, P33191, DOI 10.1074/jbc.272.52.33191; BUCHWALD P, 1991, MOL GEN GENET, V229, P413, DOI 10.1007/BF00267464; GASSER SM, 1982, P NATL ACAD SCI-BIOL, V79, P267, DOI 10.1073/pnas.79.2.267; Glerum DM, 1996, J BIOL CHEM, V271, P20531, DOI 10.1074/jbc.271.34.20531; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Heaton DN, 2001, BIOCHEMISTRY-US, V40, P743, DOI 10.1021/bi002315x; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Hiser L, 2000, J BIOL CHEM, V275, P619, DOI 10.1074/jbc.275.1.619; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lode A, 2000, FEBS LETT, V485, P19, DOI 10.1016/S0014-5793(00)02176-1; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maniatis T., 1982, MOL CLONING; MARTIN RG, 1961, J BIOL CHEM, V236, P1372; Nittis T, 2001, J BIOL CHEM, V276, P42520, DOI 10.1074/jbc.M107077200; NUNNARI J, 1993, SCIENCE, V262, P1997, DOI 10.1126/science.8266095; SADLER I, 1984, EMBO J, V3, P2137, DOI 10.1002/j.1460-2075.1984.tb02103.x; SCHMIDT RJ, 1984, MOL BIOL EVOL, V1, P317; SCHULZE M, 1989, MOL GEN GENET, V216, P37, DOI 10.1007/BF00332228; TZAGOLOFF A, 1990, EMBO J, V9, P2759, DOI 10.1002/j.1460-2075.1990.tb07463.x; Valentine JS, 1997, SCIENCE, V278, P817, DOI 10.1126/science.278.5339.817	22	52	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22185	22190		10.1074/jbc.M202545200	http://dx.doi.org/10.1074/jbc.M202545200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11948192	hybrid			2022-12-27	WOS:000176313600012
J	Koeduka, T; Matsui, K; Akakabe, Y; Kajiwara, T				Koeduka, T; Matsui, K; Akakabe, Y; Kajiwara, T			Catalytic properties of rice alpha-oxygenase - A comparison with mammalian prostaglandin H synthases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGHER OXIDATION-STATES; CHAIN FATTY-ACIDS; ENDOPEROXIDE SYNTHASE; CHIRAL LACTOLS; HIGHER-PLANTS; HEME; IDENTIFICATION; DIOXYGENASE; PEROXIDASE; MECHANISM	Long-chain fatty acids can be metabolized to Cn-1 aldehydes by alpha-oxidation in plants. The reaction mechanism of the enzyme has not been elucidated. In this study, a complete nucleotide sequence of fatty acid alpha-oxygenase gene in rice plants (Oryza sativa) was isolated. The deduced amino acid sequence showed some similarity with those of mammalian prostaglandin H synthases (PGHSs). The gene was expressed in Escherichia coli and purified to apparently homogenous state. It showed the highest activity with linoleic acid and predominantly formed 2-hydroperoxide of the fatty acid (C-n), which is then spontaneously decarboxylated to form corresponding Cn-1 aldehyde. With linoleic or linoleic acids as a substrate, rice alpha-oxygenase formed no product having a lambda(max) at approximately 234 rim, which indicated that the enzyme could not oxygenize the pentadiene system in the substrate. The spectroscopic feature of the purified enzyme in its ferrous state is similar to that of mammalian PGHS, whereas that of dithionite-reduced state showed significant difference. Site-directed mutagenesis revealed that His-158, Tyr-380, and Ser-558 were essential for the alpha-oxygenase activity. These residues are conserved in PGHS and known as a heme ligand, a source of a radical species to initiate oxygenation reaction and a residue involved in substrate binding, respectively. This finding suggested that the initial step of the oxygenation reaction in alpha-oxygenase has a high similarity with that of PGHS. The rice alpha-oxygenase activity was inhibited by imidazole but hardly inhibited by nonsteroidal anti-inflammatory drugs, such as aspirin, ibuprofen, and flurbiprofen, which are known as typical PGHS inhibitors. In addition, peroxidase activity could not be detected with alpha-oxygenase when palmitic acid 2-hydroperoxide was used as a substrate. From these findings, the catalytic resemblance between alpha-oxygenase and PGHS seems to be evident, although there still are differences in their substrate recognitions and peroxidation activities.	Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi 7538515, Japan	Yamaguchi University	Matsui, K (corresponding author), Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi 7538515, Japan.	matsui@agr.yamaguchi-u.ac.jp						Akakabe Y, 1999, TETRAHEDRON LETT, V40, P1137, DOI 10.1016/S0040-4039(98)02547-7; Benveniste I, 1998, BIOCHEM BIOPH RES CO, V243, P688, DOI 10.1006/bbrc.1998.8156; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREMER J, 1984, FATTY ACID METABOLIS, P113; DEWITT DL, 1988, P NATL ACAD SCI USA, V85, P1412, DOI 10.1073/pnas.85.5.1412; DEWITT DL, 1990, J BIOL CHEM, V265, P5192; DIETZ R, 1988, EUR J BIOCHEM, V171, P321, DOI 10.1111/j.1432-1033.1988.tb13793.x; GALLIARD T, 1976, BIOCHIM BIOPHYS ACTA, V424, P26, DOI 10.1016/0005-2760(76)90046-1; Goodwin DC, 2000, BIOCHEMISTRY-US, V39, P5422, DOI 10.1021/bi992752f; Hamberg M, 1999, J BIOL CHEM, V274, P24503, DOI 10.1074/jbc.274.35.24503; HITCHCOC.C, 1966, BIOCHIM BIOPHYS ACTA, V116, P413, DOI 10.1016/0005-2760(66)90112-3; Hornsten L, 1999, J BIOL CHEM, V274, P28219, DOI 10.1074/jbc.274.40.28219; Jansen GA, 1997, NAT GENET, V17, P190, DOI 10.1038/ng1097-190; KAJIWARA T, 1991, PHYTOCHEMISTRY, V30, P193, DOI 10.1016/0031-9422(91)84122-9; Kalgutkar AS, 2000, P NATL ACAD SCI USA, V97, P925, DOI 10.1073/pnas.97.2.925; KANG MY, 1986, J BIOCHEM-TOKYO, V99, P549, DOI 10.1093/oxfordjournals.jbchem.a135511; KNOLLMULLER M, 1986, MONATSH CHEM, V117, P407, DOI 10.1007/BF00816535; LAMBEIR AM, 1985, J BIOL CHEM, V260, P4894; LATIES GG, 1967, PHYTOCHEMISTRY, V6, P49, DOI 10.1016/0031-9422(67)85007-6; Matsunaga I, 1996, FEBS LETT, V386, P252, DOI 10.1016/0014-5793(96)00451-6; NOE CR, 1982, CHEM BER-RECL, V115, P1591, DOI 10.1002/cber.19821150434; NOE CR, 1986, CHEM BER-RECL, V119, P729, DOI 10.1002/cber.19861190230; OBANION MK, 1992, P NATL ACAD SCI USA, V89, P4888, DOI 10.1073/pnas.89.11.4888; Psylinakis E, 2001, BBA-MOL CELL BIOL L, V1533, P119, DOI 10.1016/S1388-1981(01)00150-0; Saffert A, 2000, PLANT PHYSIOL, V123, P1545, DOI 10.1104/pp.123.4.1545; Sanz A, 1998, PLANT CELL, V10, P1523, DOI 10.1105/tpc.10.9.1523; SHIMOKAWA T, 1991, J BIOL CHEM, V266, P6168; SHINE WE, 1974, ARCH BIOCHEM BIOPHYS, V162, P147, DOI 10.1016/0003-9861(74)90113-1; SMITH WL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P1, DOI 10.1016/0005-2760(91)90119-3; TSAI AL, 1993, J BIOL CHEM, V268, P8554; TSAI AL, 1995, J BIOL CHEM, V270, P10503, DOI 10.1074/jbc.270.18.10503; vanderBiezen EA, 1996, MOL GEN GENET, V251, P267, DOI 10.1007/BF02172517; VANDEROUDERAA FJ, 1979, BIOCHIM BIOPHYS ACTA, V572, P29, DOI 10.1016/0005-2760(79)90197-8	33	45	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22648	22655		10.1074/jbc.M110420200	http://dx.doi.org/10.1074/jbc.M110420200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11909851	hybrid			2022-12-27	WOS:000176313600071
J	Suhara, W; Yoneyama, A; Kitabayashi, I; Fujita, T				Suhara, W; Yoneyama, A; Kitabayashi, I; Fujita, T			Direct involvement of CREB-binding protein/p300 in sequence-specific DNA binding of virus-activated interferon regulatory factor-3 holocomplex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; TRANSCRIPTION FACTOR; GENE-EXPRESSION; BETA GENE; COACTIVATOR P300; IN-VIVO; ACETYLATION; INDUCTION; IRF-3	Infections of bacteria and viruses induce host defense reactions known as innate responses including the activation of interferon regulatory factor-3 (IRF-3), critical for the activation of type I interferon system. Upon immediate early signals triggered by the infection, IRF-3 is phosphorylated and a homodimer results. The homodimer complexes with the coactivator CREB-binding protein (CBP)/p300 in the nucleus; thus, holocomplex of IRF-3 competent in DNA binding is generated. We showed CBP/p300 to be indispensable for the DNA binding activity of the holocomplex and to aid the binding through direct interaction with the DNA. We demonstrated that p300 binds with the IRF-3 homodimer via a Q-rich domain and that an intact histone acetyltransferase (HAT) domain is indispensable for the DNA binding of the holocomplex along with a CH3 domain, which connects the HAT and Q-rich domains. These results highlight a novel function of CBP/p300: direct involvement in sequence-specific DNA binding. Furthermore, the critical function of these domains in virus-induced gene activation was demonstrated in vivo by using p300 mutants.	Tokyo Metropolitan Inst Med Sci, Dept Tumor Cell Biol, Bunkyo Ku, Tokyo 1138613, Japan	Tokyo Metropolitan Institute of Medical Science	Fujita, T (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Tumor Cell Biol, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138613, Japan.		Kitabayashi, Issay/G-2204-2017; Yoneyama, Mitsutoshi/D-8244-2017	Yoneyama, Mitsutoshi/0000-0001-9512-0408; Kitabayashi, Issay/0000-0002-8409-0407				ACKRILL AM, 1991, NUCLEIC ACIDS RES, V19, P4387, DOI 10.1093/nar/19.16.4387; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; BAEUERLE PA, 1989, GENE DEV, V3, P1689, DOI 10.1101/gad.3.11.1689; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; De Guzman RN, 2000, J MOL BIOL, V303, P243, DOI 10.1006/jmbi.2000.4141; DEMAEYER E, 1988, INTERFERONS OTHER RE, P1; DU W, 1992, P NATL ACAD SCI USA, V89, P2150, DOI 10.1073/pnas.89.6.2150; DU W, 1993, CELL, V74, P887, DOI 10.1016/0092-8674(93)90468-6; FUJITA T, 1989, NUCLEIC ACIDS RES, V17, P3335, DOI 10.1093/nar/17.9.3335; FUJITA T, 1989, P NATL ACAD SCI USA, V86, P9936, DOI 10.1073/pnas.86.24.9936; FUJITA T, 1989, NATURE, V337, P270, DOI 10.1038/337270a0; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kitabayashi I, 2001, EMBO J, V20, P7184, DOI 10.1093/emboj/20.24.7184; Kraus WL, 1999, MOL CELL BIOL, V19, P8123; Kumar KP, 2000, MOL CELL BIOL, V20, P4159, DOI 10.1128/MCB.20.11.4159-4168.2000; Lin CH, 2001, MOL CELL, V8, P581, DOI 10.1016/S1097-2765(01)00333-1; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Liu L, 1999, MOL CELL BIOL, V19, P1202; Masumi A, 2001, J BIOL CHEM, V276, P20973, DOI 10.1074/jbc.M101707200; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P11, DOI 10.1016/0968-0004(96)80878-4; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V425, P112, DOI 10.1016/S0014-5793(98)00210-5; Schafer SL, 1998, J BIOL CHEM, V273, P2714, DOI 10.1074/jbc.273.5.2714; SEN GC, 1992, J BIOL CHEM, V267, P5017; Shinobu N, 2002, FEBS LETT, V517, P251, DOI 10.1016/S0014-5793(02)02636-4; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suhara W, 2000, J BIOCHEM-TOKYO, V128, P301, DOI 10.1093/oxfordjournals.jbchem.a022753; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tomita A, 2000, ONCOGENE, V19, P444, DOI 10.1038/sj.onc.1203329; WATANABE N, 1991, NUCLEIC ACIDS RES, V19, P4421, DOI 10.1093/nar/19.16.4421; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Weaver BK, 1998, MOL CELL BIOL, V18, P1359, DOI 10.1128/MCB.18.3.1359; Yeow WS, 2001, J VIROL, V75, P3021, DOI 10.1128/JVI.75.6.3021-3027.2001; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 1996, J BIOCHEM-TOKYO, V120, P160	40	85	87	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22304	22313		10.1074/jbc.M200192200	http://dx.doi.org/10.1074/jbc.M200192200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11940575	hybrid			2022-12-27	WOS:000176313600026
J	Warren, CE; Krizus, A; Roy, PJ; Culotti, JG; Dennis, JW				Warren, CE; Krizus, A; Roy, PJ; Culotti, JG; Dennis, JW			The Caenorhabditis elegans gene, gly-2, can rescue the N-acetylglucosaminyltransferase V mutation of Lec4 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-ELEGANS; EPITHELIAL INVAGINATION; FUCOSYL-TRANSFERASE; CDNA CLONING; PROTEIN; GLYCOSYLATION; GOLGI; EXPRESSION; OLIGOSACCHARIDES; RECOGNITION	UDP-N-acetylglucosamine:alpha-6-D-mannoside beta-1,6-N-acetylglucosaminyltransferase V (GlcNAc-TV) is a regulator of polylactosamine-containing N-glycans and is causally involved in T cell regulation and tumor metastasis. The Caenorhabditis elegans genome contains a single orthologous gene, gly-2, that is transcribed and encodes a 669-residue type II membrane protein that is 36.7% identical to mammalian GlcNAc-TV (Mgat-5). Recombinant GLY-2 possessed GlcNAc-TV activity when assayed in vitro, and protein truncations demonstrated that the N-terminal boundary of the catalytic domain is Ile-138. gly-2 complemented the Phaseolus vulgaris leucoagglutinin binding defect of Chinese hamster ovary Lec4 cells, whereas GLY-2(L116R), an equivalent mutation to that which causes the Lec4A phenotype, could not. We conclude that the worm gene is functionally interchangeable with the mammalian form. GlcNAc-TV activity was detected in wild-type animals but not those homozygous for a deletion allele of gly-2. Activity was restored in mutant animals by an extrachromosomal array that encompassed the gly-2 gene. Green fluorescent protein reporter transgenes driven by the gly-2 promoter were expressed by developing embryos from the late comma stage onward, present in a complex subset of neurons in larvae and, in addition, the spermathecal and pharyngeal-intestinal valves and certain vulval cells of adults. However, no overt phenotypes were observed in animals homozygous for deletion alleles of gly-2.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Dennis, JW (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	dennis@mshri.on.ca	Culotti, Joseph/G-6467-2013; Dennis, James/E-7268-2013; Roy, Peter/G-5357-2014	Roy, Peter/0000-0003-2959-2276; Culotti, Joseph/0000-0001-6325-4612				Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; BARANSKI TJ, 1992, J BIOL CHEM, V267, P23342; Berninsone P, 2001, P NATL ACAD SCI USA, V98, P3738, DOI 10.1073/pnas.061593098; BLUMENTHAL T, 1997, C ELEGANS, V2, P117; BRENNER S, 1974, GENETICS, V77, P71; Bulik DA, 2000, P NATL ACAD SCI USA, V97, P10838, DOI 10.1073/pnas.97.20.10838; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Chalfie M., 1988, NEMATODE CAENORHABDI, P337; Chen SH, 1999, J BIOL CHEM, V274, P288, DOI 10.1074/jbc.274.1.288; De Souza SJ, 1998, P NATL ACAD SCI USA, V95, P5094, DOI 10.1073/pnas.95.9.5094; DeBose-Boyd RA, 1998, GLYCOBIOLOGY, V8, P905, DOI 10.1093/glycob/8.9.905; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; Dennis JW, 1999, BIOESSAYS, V21, P412, DOI 10.1002/(SICI)1521-1878(199905)21:5<412::AID-BIES8>3.0.CO;2-5; Epstein HF, 1995, METHODS CELL BIOL, V48; FITCH DHA, 1997, C ELEGANS, V2, P815; Fullekrug J, 1999, J CELL SCI, V112, P2813; Granovsky M, 2000, NAT MED, V6, P306; Granovsky M, 1995, GLYCOBIOLOGY, V5, P797, DOI 10.1093/glycob/5.8.797; Greenwald I, 1998, GENE DEV, V12, P1751, DOI 10.1101/gad.12.12.1751; Guerardel Y, 2001, BIOCHEM J, V357, P167, DOI 10.1042/0264-6021:3570167; Hagen FK, 1998, J BIOL CHEM, V273, P8268, DOI 10.1074/jbc.273.14.8268; Harfe BD, 1998, DEVELOPMENT, V125, P421; Herman T, 1999, P NATL ACAD SCI USA, V96, P968, DOI 10.1073/pnas.96.3.968; Herman T, 1999, P NATL ACAD SCI USA, V96, P974, DOI 10.1073/pnas.96.3.974; Jungmann J, 1998, EMBO J, V17, P423, DOI 10.1093/emboj/17.2.423; Korczak B, 2000, GLYCOBIOLOGY, V10, P595, DOI 10.1093/glycob/10.6.595; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAND M, 1994, J BIOL CHEM, V269, P14820; Liu LX, 1999, GENOME RES, V9, P859, DOI 10.1101/gr.9.9.859; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Lo NW, 1998, GLYCOBIOLOGY, V8, P517, DOI 10.1093/glycob/8.5.517; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; Oriol R, 1999, GLYCOBIOLOGY, V9, P323, DOI 10.1093/glycob/9.4.323; Padgett RW, 1998, BIOESSAYS, V20, P382, DOI 10.1002/(SICI)1521-1878(199805)20:5&lt;382::AID-BIES5&gt;3.0.CO;2-Q; Riddle DL, 1997, C ELEGANS; Sacchetti A, 2001, FEBS LETT, V492, P151, DOI 10.1016/S0014-5793(01)02246-3; SAITO H, 1994, BIOCHEM BIOPH RES CO, V198, P318, DOI 10.1006/bbrc.1994.1045; SAITO H, 1995, EUR J BIOCHEM, V233, P18, DOI 10.1111/j.1432-1033.1995.018_1.x; SHOREIBAH MG, 1992, J BIOL CHEM, V267, P2920; SRIVASTAVA OP, 1988, CARBOHYD RES, V179, P137, DOI 10.1016/0008-6215(88)84115-6; Sternberg PW, 1998, TRENDS GENET, V14, P466, DOI 10.1016/S0168-9525(98)01592-3; Warren CE, 2002, GLYCOBIOLOGY, V12, p8G; Warren CE, 2001, GLYCOBIOLOGY, V11, P979, DOI 10.1093/glycob/11.11.979; WATERSTON R, 1992, NAT GENET, V1, P114, DOI 10.1038/ng0592-114; Weinstein J, 1996, J BIOL CHEM, V271, P27462, DOI 10.1074/jbc.271.44.27462; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wood WB, 1988, NEMATODE CAENORHABDI; ZHU L, 1993, GENE DEV, V7, P1111, DOI 10.1101/gad.7.7a.1111; ZWAAL RR, 1993, P NATL ACAD SCI USA, V90, P7431, DOI 10.1073/pnas.90.16.7431	54	26	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22829	22838		10.1074/jbc.M201390200	http://dx.doi.org/10.1074/jbc.M201390200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11937505	hybrid			2022-12-27	WOS:000176313600093
J	Filippova, M; Song, H; Connolly, JL; Dermody, TS; Duerksen-Hughes, PJ				Filippova, M; Song, H; Connolly, JL; Dermody, TS; Duerksen-Hughes, PJ			The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; NF-KAPPA-B; FACTOR RECEPTOR; FACTOR-ALPHA; E6-ENHANCED SUSCEPTIBILITY; MEDIATED APOPTOSIS; UBIQUITIN LIGASE; HPV E6; ONCOPROTEIN; DEATH	High risk strains of human papillomavirus (HPV), such as HPV 16, cause human cervical carcinoma. The E6 protein of HPV 16 mediates the rapid degradation of p53, although this is not the only function of E6 and cannot completely explain its transforming potential. Previous work in our laboratory has demonstrated that transfection of HPV 16 E6 into the tumor necrosis factor (TNF)-sensitive LM cell line protects expressing cells from TNF-induced apoptosis in a p53-independent manner, and the purpose of this study was to determine the molecular mechanism underlying this protection. Caspase 3 and caspase 8 activation were significantly reduced in E6-expressing cells, indicating that E6 acts early in the TNF apoptotic pathway. In fact, E6 binds directly to TNF R1, as shown both by co-immunoprecipitation and mammalian two-hybrid approaches. E6 requires the same C-terminal portion of TNF R1 for binding as does TNF R1-associated death domain, and TNF R1/TNF R1-associated death domain interactions are decreased in the presence of E6. HA-E6 also blocked cell death triggered by transfection of the death domain of TNF R1. Together, these results provide strong support for a model in which HPV E6 binding to TNF R1 interferes with formation of the death-inducing signaling complex and thus with transduction of proapoptotic signals. They also demonstrate that HPV, like several other viruses, has developed a method for evading the TNF-mediated host immune response.	Loma Linda Univ, Sch Med, Ctr Mol Biol & Gene Therapy, Dept Biochem & Microbiol, Loma Linda, CA 92354 USA; Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Elizabeth B Lamb Ctr Pediat Res, Nashville, TN 37232 USA	Loma Linda University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Duerksen-Hughes, PJ (corresponding author), Loma Linda Univ, Sch Med, Ctr Mol Biol & Gene Therapy, Dept Biochem & Microbiol, 11085 Campus St,105 Mortensen Hall, Loma Linda, CA 92354 USA.	pdhughes@som.llu.edu	Duerksen-Hughes, Penelope/A-3488-2008	Duerksen-Hughes, Penelope/0000-0002-0998-2157	NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593] Funding Source: NIH RePORTER; NCI NIH HHS [CA68485] Funding Source: Medline; NIAID NIH HHS [AI50080] Funding Source: Medline; NIDDK NIH HHS [DK20593] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amarante-Mendes GP, 1998, CELL DEATH DIFFER, V5, P298, DOI 10.1038/sj.cdd.4400354; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Benedict CA, 2001, J BIOL CHEM, V276, P3270, DOI 10.1074/jbc.M008218200; CHEN JJ, 1995, SCIENCE, V269, P529, DOI 10.1126/science.7624774; Connolly JL, 2000, J VIROL, V74, P2981, DOI 10.1128/JVI.74.7.2981-2989.2000; Connolly JL, 2001, J VIROL, V75, P4029, DOI 10.1128/JVI.75.9.4029-4039.2001; Dbaibo GS, 2001, FEBS LETT, V503, P7, DOI 10.1016/S0014-5793(01)02625-4; Duerksen-Hughes PJ, 1999, VIROLOGY, V264, P55, DOI 10.1006/viro.1999.9977; Elston RC, 1998, J GEN VIROL, V79, P371, DOI 10.1099/0022-1317-79-2-371; Fogel S, 1998, VIROLOGY, V244, P97, DOI 10.1006/viro.1998.9086; Gao QS, 1999, MOL CELL BIOL, V19, P733; GLAUSINGER BA, 2001, ONCOGENE, V19, P5270; GOODING LR, 1991, J VIROL, V65, P3083, DOI 10.1128/JVI.65.6.3083-3094.1991; GOODING LR, 1994, INFECT AGENT DIS, V3, P106; GOODING LR, 1990, J IMMUNOL, V145, P3080; GOODING LR, 1990, CRIT REV IMMUNOL, V10, P53; HOWARD ST, 1991, VIROLOGY, V180, P633, DOI 10.1016/0042-6822(91)90077-O; HOWLEY PM, 1992, PRINCESS TAKAMATSU S, V22, P239; Inoue T, 1998, MOL CARCINOGEN, V21, P215; Kiyono T, 1997, P NATL ACAD SCI USA, V94, P11612, DOI 10.1073/pnas.94.21.11612; Klingelhutz AJ, 1996, NATURE, V380, P79, DOI 10.1038/380079a0; Kuhne C, 1998, J BIOL CHEM, V273, P34302, DOI 10.1074/jbc.273.51.34302; Kukimoto I, 1998, BIOCHEM BIOPH RES CO, V249, P258, DOI 10.1006/bbrc.1998.9066; Le SS, 1997, P NATL ACAD SCI USA, V94, P6670, DOI 10.1073/pnas.94.13.6670; Lee SS, 2000, J VIROL, V74, P9680, DOI 10.1128/JVI.74.20.9680-9693.2000; Liu Y, 1999, J BIOL CHEM, V274, P24819, DOI 10.1074/jbc.274.35.24819; Lopez-Ocejo O, 2000, ONCOGENE, V19, P4611, DOI 10.1038/sj.onc.1203817; Mantovani F, 2001, ONCOGENE, V20, P7874, DOI 10.1038/sj.onc.1204869; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; Neznanov N, 2001, J VIROL, V75, P10409, DOI 10.1128/JVI.75.21.10409-10420.2001; PAN HC, 1995, GENE DEV, V9, P2157, DOI 10.1101/gad.9.17.2157; Patel D, 1999, EMBO J, V18, P5061, DOI 10.1093/emboj/18.18.5061; Pim D, 2000, ONCOGENE, V19, P719, DOI 10.1038/sj.onc.1203374; Rapp L, 1999, ONCOGENE, V18, P607, DOI 10.1038/sj.onc.1202373; Ronco LV, 1998, GENE DEV, V12, P2061, DOI 10.1101/gad.12.13.2061; Scaffidi C, 1999, J BIOL CHEM, V274, P22532, DOI 10.1074/jbc.274.32.22532; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SHEPARD HM, 1988, J CLIN IMMUNOL, V8, P333, DOI 10.1007/BF00917148; SMITH CA, 1991, BIOCHEM BIOPH RES CO, V176, P335, DOI 10.1016/0006-291X(91)90929-2; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; Song SY, 1998, P NATL ACAD SCI USA, V95, P2290, DOI 10.1073/pnas.95.5.2290; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; Spitkovsky D, 1996, ONCOGENE, V13, P1027; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; Thomas M, 2001, ONCOGENE, V20, P5431, DOI 10.1038/sj.onc.1204719; Thomas M, 1998, ONCOGENE, V17, P2943, DOI 10.1038/sj.onc.1202223; Tong XA, 1997, P NATL ACAD SCI USA, V94, P4412, DOI 10.1073/pnas.94.9.4412; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; TROSSMESILATY S, 1998, P NATL ACAD SCI USA, V95, P8058; UPTON C, 1991, VIROLOGY, V184, P370, DOI 10.1016/0042-6822(91)90853-4; VAN AD, 1996, SCIENCE, V274, P787; Veldman T, 2001, J VIROL, V75, P4467, DOI 10.1128/JVI.75.9.4467-4472.2001; Vikhanskaya F, 2002, INT J CANCER, V97, P732, DOI 10.1002/ijc.10114; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; WHITE E, 1992, MOL CELL BIOL, V12, P2570, DOI 10.1128/MCB.12.6.2570; WONG GHW, 1992, ANTIVIRAL PROPERTIES; Yang J, 1998, CARCINOGENESIS, V19, P1117, DOI 10.1093/carcin/19.6.1117; Zhu NL, 2001, VIROLOGY, V283, P178, DOI 10.1006/viro.2001.0896; Zimmermann H, 1999, J VIROL, V73, P6209, DOI 10.1128/JVI.73.8.6209-6219.1999	59	142	148	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21730	21739		10.1074/jbc.M200113200	http://dx.doi.org/10.1074/jbc.M200113200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11934887	hybrid			2022-12-27	WOS:000176286000081
J	Kopriva, S; Buchert, T; Fritz, G; Suter, M; Benda, RD; Schunemann, V; Koprivova, A; Schurmann, P; Trautwein, AX; Kroneck, PMH; Brunold, C				Kopriva, S; Buchert, T; Fritz, G; Suter, M; Benda, RD; Schunemann, V; Koprivova, A; Schurmann, P; Trautwein, AX; Kroneck, PMH; Brunold, C			The presence of an iron-sulfur cluster in adenosine 5 '-phosphosulfate reductase separates organisms utilizing adenosine 5 '-phosphosulfate and phosphoadenosine 5 '-phosphosulfate for sulfate assimilation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							5'-ADENYLYLSULFATE REDUCTASE; ESCHERICHIA-COLI; ADENYLYLSULPHATE REDUCTASE; ALLOCHROMATIUM-VINOSUM; CYSTEINE BIOSYNTHESIS; APS REDUCTASES; HIGHER-PLANTS; GENE; ADENOSINE-5'-PHOSPHOSULFATE; ENZYME	It was generally accepted that plants, algae, and phototrophic bacteria use adenosine 5'-phosphosulfate (APS) for assimilatory sulfate reduction, whereas bacteria and fungi use phosphoadenosine 5'-phosphosulfate (PAPS). The corresponding enzymes, APS and PAPS reductase, share 25-30% identical amino acids. Phylogenetic analysis of APS and PAPS reductase amino acid sequences from different organisms, which were retrieved from the GenBank(TM), revealed two clusters. The first cluster comprised known PAPS reductases from enteric bacteria, cyanobacteria, and yeast. On the other hand, plant APS reductase sequences were clustered together with many bacterial ones, including those from Pseudomonas and Rhizobium. The gene for APS reductase cloned from the APS-reducing cyanobacterium Plectonema also clustered together with the plant sequences, confirming that the two classes of sequences represent PAPS and APS reductases, respectively. Compared with the PAPS reductase, all sequences of the APS reductase cluster contained two additional cysteine pairs homologous to the cysteine residues involved in binding an iron-sulfur cluster in plants. Mossbauer analysis revealed that the recombinant APS reductase from Pseudomonas aeruginosa contains a [4Fe-4S] cluster with the same characteristics as the plant enzyme. We conclude, therefore, that the presence of an iron-sulfur cluster determines the APS specificity of the sulfate-reducing enzymes and thus separates the APS- and PAPS-dependent assimilatory sulfate reduction pathways.	Univ Freiburg, Inst Forest Bot & Tree Physiol, D-79085 Freiburg, Germany; Univ Konstanz, Fachbereich Biol, D-78457 Constance, Germany; Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland; Univ Bern, Inst Plant Sci, CH-3013 Bern, Switzerland; Med Univ Lubeck, Inst Phys, D-23538 Lubeck, Germany; Univ Freiburg, D-79104 Freiburg, Germany; Univ Neuchatel, Biochim Lab, CH-2000 Neuchatel, Switzerland	University of Freiburg; University of Konstanz; University of Zurich; University of Bern; University of Lubeck; University of Freiburg; University of Neuchatel	Kopriva, S (corresponding author), Univ Freiburg, Inst Forest Bot & Tree Physiol, Georges Kohler Allee Geb 053-054, D-79085 Freiburg, Germany.		Schünemann, Volker/C-6603-2016; Kopriva, Stanislav/C-7401-2013; Fritz, Guenter/E-2933-2013	Kopriva, Stanislav/0000-0002-7416-6551; Fritz, Guenter/0000-0002-4571-8812				Abola AP, 1999, J BACTERIOL, V181, P5280, DOI 10.1128/JB.181.17.5280-5287.1999; BERENDT U, 1995, EUR J BIOCHEM, V233, P347, DOI 10.1111/j.1432-1033.1995.347_1.x; Bick JA, 2000, J BACTERIOL, V182, P135, DOI 10.1128/JB.182.1.135-142.2000; Bick JA, 1998, P NATL ACAD SCI USA, V95, P8404, DOI 10.1073/pnas.95.14.8404; BRUNOLD C, 1990, SULFUR NUTRITION AND SULFUR ASSIMILATION IN HIGHER PLANTS, P13; Brunold C., 1990, METHODS PLANT BIOCH, P339; DelicAttree I, 1997, MOL MICROBIOL, V24, P1275, DOI 10.1046/j.1365-2958.1997.4121799.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FISCHER DS, 1964, CLIN CHEM, V10, P21, DOI 10.1016/0009-8981(64)90210-4; Friedrich MW, 2002, J BACTERIOL, V184, P278, DOI 10.1128/JB.184.1.278-289.2002; Fritz G, 2000, FEBS LETT, V473, P63, DOI 10.1016/S0014-5793(00)01500-3; Gao Y, 2000, PLANT PHYSIOL, V123, P1087, DOI 10.1104/pp.123.3.1087; Gupta RS, 1998, MICROBIOL MOL BIOL R, V62, P1435, DOI 10.1128/MMBR.62.4.1435-1491.1998; Gupta RS, 2000, FEMS MICROBIOL REV, V24, P367, DOI 10.1111/j.1574-6976.2000.tb00547.x; GutierrezMarcos JF, 1996, P NATL ACAD SCI USA, V93, P13377, DOI 10.1073/pnas.93.23.13377; Hipp WM, 1997, MICROBIOL-UK, V143, P2891, DOI 10.1099/00221287-143-9-2891; JONESMORTIMER MC, 1973, HEREDITY, V31, P213, DOI 10.1038/hdy.1973.76; Kappler U, 2001, FEMS MICROBIOL LETT, V203, P1, DOI 10.1016/S0378-1097(01)00304-4; Kopriva S, 2001, J BIOL CHEM, V276, P42881, DOI 10.1074/jbc.M107424200; KREDICH NM, 1993, SULFUR NUTRITION AND ASSIMILATION IN HIGHER PLANTS, P37; KRONE FA, 1991, MOL GEN GENET, V225, P314, DOI 10.1007/BF00269864; LAMPREIA J, 1990, EUR J BIOCHEM, V188, P653, DOI 10.1111/j.1432-1033.1990.tb15447.x; Leustek T, 2000, ANNU REV PLANT PHYS, V51, P141, DOI 10.1146/annurev.arplant.51.1.141; LEUSTEK T, 2000, SULFUR NUTR SULFUR A, P1; LI JY, 1991, BIOCHEM J, V274, P355, DOI 10.1042/bj2740355; Martin W, 1997, CURR GENET, V32, P1, DOI 10.1007/s002940050241; Martin W, 1999, BIOESSAYS, V21, P99, DOI 10.1002/(SICI)1521-1878(199902)21:2<99::AID-BIES3>3.3.CO;2-2; Marzluf GA, 1997, ANNU REV MICROBIOL, V51, P73, DOI 10.1146/annurev.micro.51.1.73; Neumann S, 2000, MOL BIOL REP, V27, P27, DOI 10.1023/A:1007058421714; Postgate JR, 1984, SULPHATE REDUCING BA, V2nd; RIESTER J, 1989, EUR J BIOCHEM, V178, P751, DOI 10.1111/j.1432-1033.1989.tb14506.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 2002, MOL CLONING LAB MANU; Sanchez O, 2001, ARCH MICROBIOL, V176, P301, DOI 10.1007/s002030100327; SCHIFF JA, 1987, METHOD ENZYMOL, V143, P329; SCHMIDT A, 1977, FEMS MICROBIOL LETT, V1, P137, DOI 10.1016/0378-1097(77)90143-4; SCHMIDT A, 1977, EXPERIENTIA, V33, P1008, DOI 10.1007/BF01945936; Setya A, 1996, P NATL ACAD SCI USA, V93, P13383, DOI 10.1073/pnas.93.23.13383; SPEICH N, 1994, MICROBIOL-UK, V140, P1273, DOI 10.1099/00221287-140-6-1273; Suter M, 2000, J BIOL CHEM, V275, P930, DOI 10.1074/jbc.275.2.930; TRAUTWEIN AX, 1991, STRUCT BOND, V78, P1; TRUPER HG, 1982, PHILOS T ROY SOC B, V298, P529, DOI 10.1098/rstb.1982.0095; TSANG MLS, 1975, PLANT SCI LETT, V4, P301, DOI 10.1016/0304-4211(75)90102-9; TUOVINEN OH, 1975, ARCH MICROBIOL, V105, P123, DOI 10.1007/BF00447125; VANDEPEER Y, 1993, COMPUT APPL BIOSCI, V9, P177; Weber M, 2000, EUR J BIOCHEM, V267, P3647, DOI 10.1046/j.1432-1327.2000.01394.x	46	79	84	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21786	21791		10.1074/jbc.M202152200	http://dx.doi.org/10.1074/jbc.M202152200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11940598	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000176286000087
J	Montero-Lomeli, M; Morais, BLB; Figueiredo, DL; Neto, DCS; Martins, JRP; Masuda, CA				Montero-Lomeli, M; Morais, BLB; Figueiredo, DL; Neto, DCS; Martins, JRP; Masuda, CA			The initiation factor eIF4A is involved in the response to lithium stress in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLATION INITIATION; PROTEIN-SYNTHESIS; TRANSCRIPTIONAL RESPONSE; HELICASE ACTIVITY; TOR PROTEINS; GENES TIF1; YEAST; DEPLETION; ACTIVATOR; TAP42	A gene, TIF2, was identified as corresponding to the translation initiation factor eIF4A and when overexpressed it confers lithium tolerance in galactose medium to Saccharomyces cerevisiae. Incubation of yeast with 6 mm LiCl in galactose medium leads to inhibition of [S-35]methionine incorporation. By polysome analysis we show that translation is inhibited by lithium at the initiation step, accumulating 80 S monosomes. We further show by immunoblot analysis that when cells are incubated with lithium eIF4A does not sediment with ribosomal subunits. Overexpression of TIF2 overcomes inhibition of protein synthesis and restores its sedimentation with the initiation complex. In vivo, eIF4A is induced by lithium stress. We have shown previously that lithium is highly toxic to yeast when grown in galactose medium mainly due to inhibition of phosphoglucomutase, an enzyme responsible for the entry of galactose into glycolysis. We show that conditions that revert inhibition of phosphoglucomutase also revert inhibition of protein synthesis. Interestingly, glucose starvation leads to loss of polysomes but not to dissociation of eIF4A from the preinitiation complexes. Overexpression of SIT4, a protein phosphatase related to the TOR kinase pathway, reverts inhibition of protein synthesis by lithium and association of eIF4A with the initiation complex.	Univ Fed Rio de Janeiro, Dept Bioquim Med, ICB CCS, BR-21941590 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Montero-Lomeli, M (corresponding author), Univ Fed Rio de Janeiro, Dept Bioquim Med, ICB CCS, CP 68041, BR-21941590 Rio De Janeiro, Brazil.	montero@server.bioqmed.ufrj.br	Montero-Lomeli, Monica/D-9885-2013; Masuda, Claudio A/F-7214-2014	Masuda, Claudio A/0000-0002-0310-7108; Bozaquel Morais, Bruno Leonardo/0000-0001-5477-4851				Altmann M, 1997, EMBO J, V16, P1114, DOI 10.1093/emboj/16.5.1114; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; BERG WE, 1968, EXP CELL RES, V50, P133, DOI 10.1016/0014-4827(68)90401-1; Berset C, 1998, P NATL ACAD SCI USA, V95, P4264, DOI 10.1073/pnas.95.8.4264; BLUM S, 1989, P NATL ACAD SCI USA, V86, P6043, DOI 10.1073/pnas.86.16.6043; Crespo JL, 2001, J BIOL CHEM, V276, P34441, DOI 10.1074/jbc.M103601200; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Dominguez D, 1999, J BIOL CHEM, V274, P26720, DOI 10.1074/jbc.274.38.26720; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; HINNEBUSCH AG, 1984, P NATL ACAD SCI-BIOL, V81, P6442, DOI 10.1073/pnas.81.20.6442; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; Johnston M, 1999, TRENDS GENET, V15, P29, DOI 10.1016/S0168-9525(98)01637-0; KAO KR, 1986, NATURE, V322, P371, DOI 10.1038/322371a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDER P, 1989, P NATL ACAD SCI USA, V86, P2286, DOI 10.1073/pnas.86.7.2286; LINDER P, 1988, NUCLEIC ACIDS RES, V16, P10359, DOI 10.1093/nar/16.21.10359; LIU HP, 1992, GENETICS, V132, P665; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MartinezPastor MT, 1996, FEBS LETT, V390, P319, DOI 10.1016/0014-5793(96)00683-7; Masuda CA, 2001, J BIOL CHEM, V276, P37794; Masuda CA, 2000, J BIOL CHEM, V275, P30957, DOI 10.1074/jbc.M004869200; Nickels JT, 1996, GENE DEV, V10, P382, DOI 10.1101/gad.10.4.382; NIELSEN PJ, 1988, EMBO J, V7, P2097, DOI 10.1002/j.1460-2075.1988.tb03049.x; Posas F, 2000, J BIOL CHEM, V275, P17249, DOI 10.1074/jbc.M910016199; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; RHOADS RE, 1993, J BIOL CHEM, V268, P3017; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; Rohde J, 2001, J BIOL CHEM, V276, P9583, DOI 10.1074/jbc.R000034200; ROLFES RJ, 1993, MOL CELL BIOL, V13, P5099, DOI 10.1128/MCB.13.8.5099; Rolland F, 2001, TRENDS BIOCHEM SCI, V26, P310, DOI 10.1016/S0968-0004(01)01805-9; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Schou M, 1997, ARCH GEN PSYCHIAT, V54, P9; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Tuite JF, 1988, METHOD MICROBIOL, V26, P351; WOLCOTT DL, 1982, EXP CELL RES, V137, P427, DOI 10.1016/0014-4827(82)90044-1; Yale J, 2001, J BIOL CHEM, V276, P15996, DOI 10.1074/jbc.M008209200; YODERHILL J, 1993, J BIOL CHEM, V268, P5566	39	36	37	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21542	21548		10.1074/jbc.M201977200	http://dx.doi.org/10.1074/jbc.M201977200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11940596	hybrid			2022-12-27	WOS:000176286000056
J	Rodriguez, PC; Zea, AH; Culotta, KS; Zabaleta, J; Ochoa, JB; Ochoa, AC				Rodriguez, PC; Zea, AH; Culotta, KS; Zabaleta, J; Ochoa, JB; Ochoa, AC			Regulation of T cell receptor CD3 chain expression by L-arginine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE-SYNTHASE; SYNTHETASE GENE-EXPRESSION; MESSENGER-RNA STABILITY; AMINO-ACID REGULATION; ZETA-CHAIN; SIGNAL-TRANSDUCTION; ANTIGEN RECEPTOR; LIVER-TRANSPLANTATION; CLINICAL-SIGNIFICANCE; MACROPHAGE FUNCTIONS	L-Arg plays a central role in the normal function of several organ systems including the immune system. L-Arg can be depleted by arginase I produced by macrophages and hepatocytes in several disease states such as trauma and sepsis and following liver transplantation. The decrease in L-Arg levels induces a profound decrease in T cell function through mechanisms that have remained unclear. The data presented here demonstrate that Jurkat T cells cultured in medium without L-Arg (L-Arg-free RPMI) have a rapid decrease in the expression of the T cell antigen receptor zeta chain (CD3zeta), the principal signal transduction element in this receptor, and a decrease in T cell proliferation. This phenomenon is completely reversed by the replenishment Of L-Arg but not other amino acids. These changes are not caused by cell apoptosis; instead, the diminished expression of CD3zeta protein is paralleled by a decrease in CD3zeta mRNA, This change in CD3zeta mRNA expression is not caused by a decrease in the transcription rate but rather by a significantly shorter CD3zeta mRNA half-life. This mechanism is sensitive to cycloheximide. Therefore, the regulation Of L-Arg concentration in the microenvironment could represent an important mechanism to modulate the expression of CD3zeta and the T cell receptor and consequently of T cell function.	Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, Tumor Immunol Program, New Orleans, LA 70112 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA 70112 USA; Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15261 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ochoa, AC (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, Tumor Immunol Program, 533 Bolivar St,Rm 455, New Orleans, LA 70112 USA.	aochoa@lsuhsc.edu	Rodríguez, Paulo/HDM-9539-2022	Rodriguez, Paulo/0000-0001-7480-6566	NCI NIH HHS [CA82689-01, R21 CA831198, CA88885-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA082689, R01CA088885] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBINA JE, 1989, J EXP MED, V169, P1021, DOI 10.1084/jem.169.3.1021; Alcover A, 2000, CRIT REV IMMUNOL, V20, P325; Angele MK, 1999, J TRAUMA, V46, P34, DOI 10.1097/00005373-199901000-00006; Aulak KS, 1999, J BIOL CHEM, V274, P30424, DOI 10.1074/jbc.274.43.30424; Aulak KS, 1996, J BIOL CHEM, V271, P29799, DOI 10.1074/jbc.271.47.29799; Bernard AC, 2001, SHOCK, V15, P215, DOI 10.1097/00024382-200115030-00009; Boussiotis VA, 2000, J CLIN INVEST, V105, P1317, DOI 10.1172/JCI9918; BRITTENDEN J, 1994, SURGERY, V115, P205; Bronstein-Sitton N, 1999, J BIOL CHEM, V274, P23659, DOI 10.1074/jbc.274.33.23659; Bruhat A, 1997, J BIOL CHEM, V272, P17588, DOI 10.1074/jbc.272.28.17588; Bruhat A, 1999, P NUTR SOC, V58, P625, DOI 10.1017/S0029665199000828; Brzozowski T, 1997, J GASTROENTEROL, V32, P442, DOI 10.1007/BF02934081; Carraway MS, 1998, EXP LUNG RES, V24, P253, DOI 10.3109/01902149809041533; Chang CI, 1998, AM J PHYSIOL-HEART C, V274, pH342, DOI 10.1152/ajpheart.1998.274.1.H342; Chang CI, 2001, CANCER RES, V61, P1100; Chen X, 2000, BRIT J HAEMATOL, V111, P817, DOI 10.1046/j.1365-2141.2000.02415.x; Combadiere B, 1996, J EXP MED, V183, P2109, DOI 10.1084/jem.183.5.2109; Correa MR, 1997, J IMMUNOL, V158, P5292; Curiel RE, 1999, BLOOD, V94, P1782, DOI 10.1182/blood.V94.5.1782.417a04_1782_1789; Diah SK, 2001, BBA-GENE STRUCT EXPR, V1518, P267, DOI 10.1016/S0167-4781(01)00202-0; EIGUN S, 1999, INT UROL NEPHROL, V31, P95; Fafournoux P, 2000, BIOCHEM J, V351, P1, DOI 10.1042/0264-6021:3510001; GAZZOLA GC, 1972, BIOCHIM BIOPHYS ACTA, V266, P407, DOI 10.1016/0005-2736(72)90097-1; GONG SS, 1991, MOL CELL BIOL, V11, P6059, DOI 10.1128/MCB.11.12.6059; GUERRINI L, 1993, MOL CELL BIOL, V13, P3202, DOI 10.1128/MCB.13.6.3202; Heys SD, 1997, BRIT J SURG, V84, P238, DOI 10.1002/bjs.1800840229; Hyatt SL, 1997, J BIOL CHEM, V272, P19951, DOI 10.1074/jbc.272.32.19951; Ikemoto M, 1998, CLIN CHIM ACTA, V271, P11, DOI 10.1016/S0009-8981(97)00226-X; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; Jousse C, 2000, J NUTR, V130, P1555, DOI 10.1093/jn/130.6.1555; Jousse C, 1999, FEBS LETT, V448, P211, DOI 10.1016/S0014-5793(99)00373-7; KIRK SJ, 1992, JPEN-PARENTER ENTER, V16, P429, DOI 10.1177/0148607192016005429; Kono K, 1996, CLIN CANCER RES, V2, P1825; Kono K, 1996, EUR J IMMUNOL, V26, P1308, DOI 10.1002/eji.1830260620; Kuss I, 1999, CLIN CANCER RES, V5, P329; LANGLE F, 1995, TRANSPLANT P, V27, P2872; Liossis SNC, 1998, J CLIN INVEST, V101, P1448, DOI 10.1172/JCI1457; Liu YL, 1996, NUCLEIC ACIDS RES, V24, P2718, DOI 10.1093/nar/24.14.2718; MENDEZ JD, 1992, BIOCHEM INT, V28, P569; MINAMI Y, 1987, P NATL ACAD SCI USA, V84, P2688, DOI 10.1073/pnas.84.9.2688; Mori M, 2000, BIOCHEM BIOPH RES CO, V275, P715, DOI 10.1006/bbrc.2000.3169; Morris SM, 1998, AM J PHYSIOL-ENDOC M, V275, pE740, DOI 10.1152/ajpendo.1998.275.5.E740; Munder M, 1998, J IMMUNOL, V160, P5347; MURRAY HW, 1992, J INFECT DIS, V165, P513, DOI 10.1093/infdis/165.3.513; Nambiar MP, 2000, J CELL BIOCHEM, V79, P416, DOI 10.1002/1097-4644(20001201)79:3<416::AID-JCB70>3.0.CO;2-5; NATHAN C, 1991, RES IMMUNOL, V142, P600, DOI 10.1016/0923-2494(91)90117-2; NATHAN C, 1991, Behring Institute Mitteilungen, P200; NATHAN CF, 1991, CURR OPIN IMMUNOL, V3, P65, DOI 10.1016/0952-7915(91)90079-G; Ochoa JB, 2000, SURGERY, V127, P419, DOI 10.1067/msy.2000.104745; Ochoa JB, 2001, JPEN-PARENTER ENTER, V25, P23, DOI 10.1177/014860710102500123; Porembska Z, 2001, CLIN CHIM ACTA, V305, P157, DOI 10.1016/S0009-8981(00)00432-0; Quillard M, 1996, EUR J BIOCHEM, V236, P56, DOI 10.1111/j.1432-1033.1996.00056.x; Rellahan BL, 1998, J IMMUNOL, V160, P2794; Ross J, 1996, TRENDS GENET, V12, P171, DOI 10.1016/0168-9525(96)10016-0; ROTH E, 1994, TRANSPLANTATION, V57, P665, DOI 10.1097/00007890-199403150-00006; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; SAINI KS, 1990, MOL CELL BIOCHEM, V96, P15; Schmielau J, 2001, CLIN CANCER RES, V7, p933S; SUER GS, 1999, CANC BIOCH BIOPHYS, V17, P125; Taheri F, 2001, CLIN CANCER RES, V7, p958S; Taylor DD, 2001, BRIT J CANCER, V84, P1624, DOI 10.1054/bjoc.2001.1847; Valitutti S, 1997, J EXP MED, V185, P1859, DOI 10.1084/jem.185.10.1859; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WEISSMAN AM, 1988, J IMMUNOL, V141, P3532; WU CW, 1994, J CLIN GASTROENTEROL, V18, P84, DOI 10.1097/00004836-199401000-00019; WU CW, 2001, CHINESE J MICROBIOL, V20, P279; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835; Zea AH, 1995, CLIN CANCER RES, V1, P1327; Zea AH, 1998, INFECT IMMUN, V66, P499, DOI 10.1128/IAI.66.2.499-504.1998; ZHANG C, 2001, FASEB J	71	334	359	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21123	21129		10.1074/jbc.M110675200	http://dx.doi.org/10.1074/jbc.M110675200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11950832	hybrid			2022-12-27	WOS:000176286000004
J	Brandt, D; Gimona, M; Hillmann, M; Haller, H; Mischak, H				Brandt, D; Gimona, M; Hillmann, M; Haller, H; Mischak, H			Protein kinase C induces actin reorganization via a Src- and Rho-dependent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-ASSOCIATED PROTEINS; CELL-CYCLE PROGRESSION; FOCAL ADHESION KINASE; NIH 3T3 FIBROBLASTS; TYROSINE PHOSPHORYLATION; PHORBOL ESTER; ENDOTHELIAL-CELLS; STRESS FIBERS; P190 RHOGAP; PKC-DELTA	We have investigated the mechanism of PKC-induced actin reorganization in A7r5 vascular smooth muscle cells. PKC activation by 12-O-tetradecanoylphorbol-13-acetate induces the disassembly of actin stress fibers concomitant with the appearance of membrane ruffles. PKC also induces rapid tyrosine phosphorylation in these cells. As we could show, utilizing the Sre-specific inhibitor PP2 and a kinase-deficient c-Sre mutant, actin reorganization is dependent on PKC-induced Src activation. Subsequently, the activity of the small G-protein RhoA is decreased, whereas Rac and Cdc42 activities remain unchanged. Disassembly of actin stress fibers could also be observed using the Rho kinase-specific inhibitor Y-27632, indicating that the decrease in RhoA activity on its own is responsible for actin reorganization. In addition, we show that tyrosine phosphorylation of p190RhoGAP is increased upon 12-O-tetradecanoylphorbol-13-acetate stimulation, directly linking Src activation to a decrease in RhoA activity. Our data provide substantial evidence for a model elucidating the molecular mechanisms of PKC-induced actin rearrangements.	Hannover Med Sch, Dept Nephrol, D-30625 Hannover, Germany; Austrian Acad Sci, Inst Mol Biol, Dept Cell Biol, A-5020 Salzburg, Austria	Hannover Medical School; Austrian Academy of Sciences	Mischak, H (corresponding author), Hannover Med Sch, Dept Nephrol, Feodor Lynen Str 5, D-30625 Hannover, Germany.		Mischak, Harald/E-8685-2011	Mischak, Harald/0000-0003-0323-0306				Adams JC, 1999, MOL BIOL CELL, V10, P4177, DOI 10.1091/mbc.10.12.4177; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Aspenstrom P, 1999, CURR OPIN CELL BIOL, V11, P95, DOI 10.1016/S0955-0674(99)80011-8; Ballestrem C, 1998, J CELL SCI, V111, P1649; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; BEUG H, 1978, CELL, V14, P834; Borowski P, 1999, BIOL CHEM, V380, P403, DOI 10.1515/BC.1999.054; Brouns MR, 2000, DEVELOPMENT, V127, P4891; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; Bruce-Staskal PJ, 2001, EXP CELL RES, V264, P296, DOI 10.1006/excr.2000.5137; Cabodi S, 2000, MOL CELL, V6, P1121, DOI 10.1016/S1097-2765(00)00110-6; Caloca MJ, 2001, J BIOL CHEM, V276, P18303, DOI 10.1074/jbc.M011368200; Chang BY, 2001, J BIOL CHEM, V276, P20346, DOI 10.1074/jbc.M101375200; CHANG JH, 1993, ONCOGENE, V8, P959; Chen NY, 2001, J BIOL CHEM, V276, P46722, DOI 10.1074/jbc.M107156200; CHENG JC, 1995, CELL GROWTH DIFFER, V6, P139; Coghlan MP, 2000, MOL CELL BIOL, V20, P2880, DOI 10.1128/MCB.20.8.2880-2889.2000; DENHERTOG J, 1995, CELL GROWTH DIFFER, V6, P303; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; Emkey R, 1997, J BIOL CHEM, V272, P31182, DOI 10.1074/jbc.272.49.31182; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Fagerstrom S, 1998, J BIOL CHEM, V273, P2336, DOI 10.1074/jbc.273.4.2336; Fincham VJ, 1999, J CELL SCI, V112, P947; Fukumoto S, 1997, J BIOL CHEM, V272, P13816, DOI 10.1074/jbc.272.21.13816; GILMORE T, 1983, NATURE, V306, P487, DOI 10.1038/306487a0; GOODNIGHT J, 1995, J BIOL CHEM, V270, P9991, DOI 10.1074/jbc.270.17.9991; GOULD KL, 1985, CELL, V42, P849, DOI 10.1016/0092-8674(85)90281-8; Harder KW, 1998, J BIOL CHEM, V273, P31890, DOI 10.1074/jbc.273.48.31890; Harrington EO, 1997, J BIOL CHEM, V272, P7390, DOI 10.1074/jbc.272.11.7390; Haskell MD, 2001, J CELL SCI, V114, P1699; Imamura H, 1998, MOL BIOL CELL, V9, P2561, DOI 10.1091/mbc.9.9.2561; Kam Y, 2001, MOL CELL BIOL, V21, P4055, DOI 10.1128/MCB.21.12.4055-4066.2001; Keenan C, 1998, CELL SIGNAL, V10, P225, DOI 10.1016/S0898-6568(97)00121-6; Lin XY, 1996, J BIOL CHEM, V271, P28430, DOI 10.1074/jbc.271.45.28430; LITCHFIELD DW, 1986, BIOCHEM BIOPH RES CO, V134, P1276, DOI 10.1016/0006-291X(86)90388-8; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; MORAN MF, 1991, MOL CELL BIOL, V11, P1804, DOI 10.1128/MCB.11.4.1804; MOYERS JS, 1993, MOL CELL BIOL, V13, P2391, DOI 10.1128/MCB.13.4.2391; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; NEWTON AC, 1995, J BIOL CHEM, V270, P28496; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Pietromonaco SF, 1998, J BIOL CHEM, V273, P7594, DOI 10.1074/jbc.273.13.7594; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RIDLEY AJ, 1993, EMBO J, V12, P5151, DOI 10.1002/j.1460-2075.1993.tb06210.x; Rojnuckarin P, 2001, BLOOD, V97, P154, DOI 10.1182/blood.V97.1.154; Romanova LY, 1999, J CELL PHYSIOL, V179, P157, DOI 10.1002/(SICI)1097-4652(199905)179:2<157::AID-JCP6>3.0.CO;2-4; Roof RW, 1998, MOL CELL BIOL, V18, P7052, DOI 10.1128/MCB.18.12.7052; Sabe H, 1995, J BIOL CHEM, V270, P31219, DOI 10.1074/jbc.270.52.31219; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; Shanmugam M, 1998, ONCOGENE, V16, P1649, DOI 10.1038/sj.onc.1201684; Sinnett-Smith J, 2001, EXP CELL RES, V266, P292, DOI 10.1006/excr.2001.5219; Tang SQ, 1997, J BIOL CHEM, V272, P28704, DOI 10.1074/jbc.272.45.28704; Timpson P, 2001, CURR BIOL, V11, P1836, DOI 10.1016/S0960-9822(01)00583-8; Toker Alex, 1998, Frontiers in Bioscience, V3, pD1134; TRACY S, 1995, J BIOL CHEM, V270, P10587, DOI 10.1074/jbc.270.18.10587; Uberall F, 1999, J CELL BIOL, V144, P413, DOI 10.1083/jcb.144.3.413; Uberall F, 1997, J BIOL CHEM, V272, P4072, DOI 10.1074/jbc.272.7.4072; VAN AL, 1997, GENE DEV, V11, P2295; Vincent S, 1999, EUR J CELL BIOL, V78, P539, DOI 10.1016/S0171-9335(99)80019-3; WERTH DK, 1983, J BIOL CHEM, V258, P1423; Xian WJ, 1997, ONCOGENE, V14, P1435, DOI 10.1038/sj.onc.1200980; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964	66	116	118	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20903	20910		10.1074/jbc.M200946200	http://dx.doi.org/10.1074/jbc.M200946200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11925438	hybrid			2022-12-27	WOS:000176204500103
J	Smith, RWP; Steffen, C; Grosse, F; Nasheuer, HP				Smith, RWP; Steffen, C; Grosse, F; Nasheuer, HP			Species specificity of simian virus 40 DNA replication in vitro requires multiple functions of human DNA polymerase alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SV40 T-ANTIGEN; PROTEIN-A; COMPLEX-FORMATION; PRIMASE ACTIVITY; P48 CONTROL; INITIATION; SUBUNIT; POLYOMAVIRUS; ORIGIN; BINDING	Human cell extracts support the replication of SV40 DNA, whereas mouse cell extracts do not. Species specificity is determined at the level of initiation of DNA replication, and it was previously found that this requires the large subunit, p180, of DNA polymerase a-primase to be of human origin. Furthermore, a functional interaction between SV40 large T antigen (TAg) and p180 is essential for viral DNA replication. In this study we determined that the N-terminal regions of human p180, which contain the TAg-binding sites, can be replaced with those of murine origin without losing the ability to support SV40 DNA replication in vitro. The same substitutions do not prevent SV40 TAg from stimulating the activity of DNA polymerase a-primase on single-stranded DNA in the presence of replication protein A. Furthermore, biophysical studies show that the interactions of human and murine DNA polymerase a-primase with SV40 TAg are of a similar magnitude. These studies strongly suggest that requirement of SV40 DNA replication for human DNA polymerase a depends neither on the TAg-binding site being of human origin nor on the strength of the binary interaction between SV40 TAg and DNA polymerase a-primase but rather on sequences in the C-terminal region of human p180.	Inst Mol Biotechnol, Biochem Abt, D-07745 Jena, Germany		Nasheuer, HP (corresponding author), Inst Mol Biotechnol, Biochem Abt, Beutenbergstr 11, D-07745 Jena, Germany.	nasheuer@imb-jena.de	Smith, Richard/J-8117-2019; Nasheuer, Heinz P./B-9025-2008	Smith, Richard/0000-0002-6475-6910; Nasheuer, Heinz Peter/0000-0002-9218-9079				BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; BRUCKNER A, 1995, MOL CELL BIOL, V15, P1716; COLLINS KL, 1991, MOL CELL BIOL, V11, P2108, DOI 10.1128/MCB.11.4.2108; COLLINS KL, 1993, EMBO J, V12, P4555, DOI 10.1002/j.1460-2075.1993.tb06144.x; DORNREITER I, 1990, EMBO J, V9, P3329, DOI 10.1002/j.1460-2075.1990.tb07533.x; DORNREITER I, 1992, EMBO J, V11, P769, DOI 10.1002/j.1460-2075.1992.tb05110.x; DORNREITER I, 1993, MOL CELL BIOL, V13, P809, DOI 10.1128/MCB.13.2.809; EKI T, 1991, J VIROL, V65, P4874, DOI 10.1128/JVI.65.9.4874-4881.1991; FANNING E, 1992, ANNU REV BIOCHEM, V61, P55; GANNON J V, 1990, New Biologist, V2, P84; Hassell J, 1996, DNA REPLICATION EUKA, P639; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hubscher U, 2000, TRENDS BIOCHEM SCI, V25, P143, DOI 10.1016/S0968-0004(99)01523-6; KAMAKAKA RT, 1994, MOL CELL BIOL, V14, P5114, DOI 10.1128/MCB.14.8.5114; Kautz AR, 2001, J VIROL, V75, P1751, DOI 10.1128/JVI.75.4.1751-1760.2001; Kautz AR, 2001, J VIROL, V75, P8569, DOI 10.1128/JVI.75.18.8569-8578.2001; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Kuhn C, 1999, ONCOGENE, V18, P769, DOI 10.1038/sj.onc.1202327; KUHN C, 1998, THESIS F SCHILLER U; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUMOTO T, 1990, P NATL ACAD SCI USA, V87, P9712, DOI 10.1073/pnas.87.24.9712; MELENDY T, 1993, J BIOL CHEM, V268, P3389; Mizuno T, 1999, MOL CELL BIOL, V19, P7886; Mizuno T, 1998, MOL CELL BIOL, V18, P3552, DOI 10.1128/MCB.18.6.3552; MURAKAMI Y, 1993, J BIOL CHEM, V268, P11008; MURAKAMI Y, 1993, J BIOL CHEM, V268, P11018; MURAKAMI Y, 1986, P NATL ACAD SCI USA, V83, P2869, DOI 10.1073/pnas.83.9.2869; NASHEUER HP, 1992, CHROMOSOMA, V102, pS52, DOI 10.1007/BF02451786; NASHEUER HP, 1988, J BIOL CHEM, V263, P8981; Nesper J, 1997, J VIROL, V71, P7421, DOI 10.1128/JVI.71.10.7421-7428.1997; PODUST LM, 1995, MOL CELL BIOL, V15, P3072; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schneider A, 1998, J BIOL CHEM, V273, P21608, DOI 10.1074/jbc.273.34.21608; SCHNEIDER C, 1994, MOL CELL BIOL, V14, P3176, DOI 10.1128/MCB.14.5.3176; Schub O, 2001, J BIOL CHEM, V276, P38076; SMALE ST, 1986, MOL CELL BIOL, V6, P4077, DOI 10.1128/MCB.6.11.4077; Smith RWP, 2000, REC RES DEV VIROL, V2, P67; Soe K, 2001, NUCLEIC ACIDS RES, V29, P3195, DOI 10.1093/nar/29.15.3195; STADLBAUER F, 1994, EUR J BIOCHEM, V222, P781, DOI 10.1111/j.1432-1033.1994.tb18925.x; Stadlbauer F, 1996, MOL CELL BIOL, V16, P94; STIGGER E, 1994, P NATL ACAD SCI USA, V91, P579, DOI 10.1073/pnas.91.2.579; TANAKA S, 1982, J BIOL CHEM, V257, P8386; Tooze J, 1981, MOL BIOL TUMOR VIRUS; TSENG BY, 1983, J BIOL CHEM, V258, P9845; TSURIMOTO T, 1990, NATURE, V346, P534, DOI 10.1038/346534a0; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1961; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1950; Voitenleitner C, 1997, ONCOGENE, V14, P1611, DOI 10.1038/sj.onc.1200975; Voitenleitner C, 1999, MOL CELL BIOL, V19, P646; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Wang M, 2000, NUCLEIC ACIDS RES, V28, P4742, DOI 10.1093/nar/28.23.4742; Weisshart K, 2000, J BIOL CHEM, V275, P17328, DOI 10.1074/jbc.M000717200; WOBBE CR, 1987, P NATL ACAD SCI USA, V84, P1834, DOI 10.1073/pnas.84.7.1834; YANG L, 1987, P NATL ACAD SCI USA, V84, P950, DOI 10.1073/pnas.84.4.950; Zlotkin T, 1996, EMBO J, V15, P2298, DOI 10.1002/j.1460-2075.1996.tb00583.x; [No title captured]	59	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20541	20548		10.1074/jbc.M201908200	http://dx.doi.org/10.1074/jbc.M201908200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11927598	hybrid			2022-12-27	WOS:000176204500058
J	Vulin, AI; Stanley, FM				Vulin, AI; Stanley, FM			A Forkhead/winged helix-related transcription factor mediates insulin-increased plasminogen activator inhibitor-1 gene transcription.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; FACTOR-BINDING PROTEIN-1; HUMAN ENDOTHELIAL-CELLS; TYPE-1 PAI-1 GENE; PROLACTIN GENE; FACTOR FKHR; RESPONSE ELEMENT; TGF-BETA; IN-VIVO; ANGIOTENSIN-II	Plasminogen activator inhibitor-1 (PAI-1) is an important regulator of fibrinolysis by its inhibition of both tissue-type and urokinase plasminogen activators. PAI-1 levels are elevated in type II diabetes and this elevation correlates with macro- and microvascular complications of diabetes. Insulin increases PAI-1 production in several experimental systems, but the mechanism of insulin-activated PAI-1 transcription remains to be determined. Deletion analysis of the PAI-1 promoter revealed that the insulin response element is between -117 and -7. Mutation of the AT-rich site at -52/-45 abolished the insulin responsiveness of the PAI-1 promoter. This sequence is similar to the inhibitory sequence found in the phosphoenolpyruvate carboxylkinase/insulin-like growth factor-l-binding protein I promoters. Gel-mobility shift assays demonstrated that the forkhead bound to the PAI-1 promoter insulin response element. Expression of the DNA-binding domain of FKHR acted as a dominant negative to block insulin-increased PAI-1-CAT expression. A LexA-FKHR construct was also insulin responsive. These data suggested that a member of the Forkhead/winged helix family of transcription factors mediated the effect of insulin on PAI-1 transcription. Inhibition of phosphatidylinositol 3-kinase reduced the effect of insulin on PAI-1 gene expression, a result consistent with activation through FKHR. However, it was likely that a different member of the FKHR family (not FKHR) mediated this effect since FKHR was present in both insulin-responsive and non-responsive cell lines.	NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA	New York University	Stanley, FM (corresponding author), NYU, Med Ctr, Dept Med, TCH 450,550 1St Ave, New York, NY 10016 USA.			Stanley, Frederick/0000-0002-3684-2168				ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; AGRENIUS V, 1989, AM REV RESPIR DIS, V140, P1381, DOI 10.1164/ajrccm/140.5.1381; Arts J, 1999, ARTERIOSCL THROM VAS, V19, P39, DOI 10.1161/01.ATV.19.1.39; Banfi C, 2001, DIABETES, V50, P1522, DOI 10.2337/diabetes.50.7.1522; Brown NJ, 2000, J CLIN ENDOCR METAB, V85, P336, DOI 10.1210/jc.85.1.336; BRUZDZINSKI CJ, 1993, MOL ENDOCRINOL, V7, P1169, DOI 10.1210/me.7.9.1169; Busso N, 1997, ANN RHEUM DIS, V56, P550, DOI 10.1136/ard.56.9.550; Cahill CM, 2001, J BIOL CHEM, V276, P13402, DOI 10.1074/jbc.M010042200; Carmassi F, 1999, AM J MED, V107, P344, DOI 10.1016/S0002-9343(99)00240-5; Chen YQ, 1998, J BIOL CHEM, V273, P8225, DOI 10.1074/jbc.273.14.8225; COCKELL KA, 1995, THROMB RES, V77, P119, DOI 10.1016/0049-3848(95)91618-U; Dichtl W, 1999, ARTERIOSCL THROM VAS, V19, P3025, DOI 10.1161/01.ATV.19.12.3025; Dietzmann K, 2000, PATHOL RES PRACT, V196, P15, DOI 10.1016/S0344-0338(00)80017-5; Friess H, 1998, SURGERY, V124, P79, DOI 10.1016/S0039-6060(98)70078-9; FROST SC, 1985, J BIOL CHEM, V260, P2646; Gallicchio M, 1996, J IMMUNOL, V157, P2610; Grenett HE, 1999, THROMB HAEMOSTASIS, V82, P1504; Grenett HE, 1998, ARTERIOSCL THROM VAS, V18, P1803, DOI 10.1161/01.ATV.18.11.1803; Hasenstab D, 1997, CIRC RES, V80, P490, DOI 10.1161/01.RES.80.4.490; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Jacob KK, 1998, J BIOL CHEM, V273, P4800, DOI 10.1074/jbc.273.8.4800; JACOB KK, 1995, J BIOL CHEM, V270, P27773, DOI 10.1074/jbc.270.46.27773; Jacob KK, 2001, J BIOL CHEM, V276, P24931, DOI 10.1074/jbc.M102826200; JACOB KK, 1994, J BIOL CHEM, V269, P25515; Kaestner KH, 2000, GENE DEV, V14, P142; Kietzmann T, 1999, BLOOD, V94, P4177, DOI 10.1182/blood.V94.12.4177.424k14_4177_4185; KNUDSEN H, 1994, EUR J BIOCHEM, V220, P63, DOI 10.1111/j.1432-1033.1994.tb18599.x; LANG IM, 1994, CIRCULATION, V89, P2715, DOI 10.1161/01.CIR.89.6.2715; LANGER SJ, 1992, MOL CELL BIOL, V12, P5355, DOI 10.1128/MCB.12.12.5355; Lau HKF, 1999, CARDIOVASC RES, V43, P1049, DOI 10.1016/S0008-6363(99)00136-4; Marutsuka K, 1998, CORONARY ARTERY DIS, V9, P177, DOI 10.1097/00019501-199809040-00002; Motojima M, 2000, BIOCHEM J, V349, P435, DOI 10.1042/0264-6021:3490435; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; NORDT TK, 1994, CIRCULATION, V89, P321, DOI 10.1161/01.CIR.89.1.321; Nordt TK, 1998, J MOL CELL CARDIOL, V30, P1535, DOI 10.1006/jmcc.1998.0719; NORDT TK, 1995, CIRCULATION, V91, P764, DOI 10.1161/01.CIR.91.3.764; OBRIEN RM, 1991, P NATL ACAD SCI USA, V88, P6580, DOI 10.1073/pnas.88.15.6580; Olman MA, 1999, BLOOD, V94, P2029, DOI 10.1182/blood.V94.6.2029.418k25_2029_2038; PADRO T, 1995, ARTERIOSCL THROM VAS, V15, P893, DOI 10.1161/01.ATV.15.7.893; Rena G, 2001, BIOCHEM J, V354, P605, DOI 10.1042/0264-6021:3540605; Samad F, 1996, J CLIN INVEST, V97, P37, DOI 10.1172/JCI118404; Samad F, 1996, MOL MED, V2, P568, DOI 10.1007/BF03401641; Samad F, 2000, MOL MED, V6, P680, DOI 10.1007/BF03402048; SATO Y, 1990, J CELL BIOL, V111, P757, DOI 10.1083/jcb.111.2.757; SAWA H, 1992, ARTERIOSCLER THROMB, V12, P1507, DOI 10.1161/01.ATV.12.12.1507; SAWA H, 1993, CIRC RES, V73, P671, DOI 10.1161/01.RES.73.4.671; SHARROCKS AD, 1992, NUCLEIC ACIDS RES, V20, P1147, DOI 10.1093/nar/20.5.1147; SIMPSON AJ, 1991, J CLIN PATHOL, V44, P139, DOI 10.1136/jcp.44.2.139; Sobel BE, 1998, CIRCULATION, V97, P2213, DOI 10.1161/01.CIR.97.22.2213; Song CZ, 1998, J BIOL CHEM, V273, P29287, DOI 10.1074/jbc.273.45.29287; STANLEY F, 1989, MOL ENDOCRINOL, V3, P1627, DOI 10.1210/mend-3-10-1627; STANLEY FM, 1992, J BIOL CHEM, V267, P16719; SUWANICHKUL A, 1990, J BIOL CHEM, V265, P21185; Tamaki K, 1996, J AM SOC NEPHROL, V7, P2578; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tomizawa M, 2000, J BIOL CHEM, V275, P7289, DOI 10.1074/jbc.275.10.7289; White LA, 2000, EXP CELL RES, V260, P127, DOI 10.1006/excr.2000.5001; Yamamoto K, 1997, AM J PATHOL, V151, P725	59	23	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20169	20176		10.1074/jbc.M112073200	http://dx.doi.org/10.1074/jbc.M112073200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11919188	hybrid			2022-12-27	WOS:000176204500012
J	Cemerski, S; Cantagrel, A; van Meerwijk, JPM; Romagnoli, P				Cemerski, S; Cantagrel, A; van Meerwijk, JPM; Romagnoli, P			Reactive oxygen species differentially affect T cell receptor-signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEIN-TYROSINE KINASES; HYDROGEN-PEROXIDE; RHEUMATOID-ARTHRITIS; OXIDATIVE STRESS; ZETA-CHAIN; DECREASED EXPRESSION; REDOX REGULATION; SYNOVIAL-FLUID	Oxidative stress plays an important role in the induction of T lymphocyte hyporesponsiveness observed in several human pathologies including cancer, rheumatoid arthritis, leprosy, and AIDS. To investigate the molecular basis of oxidative stress-induced T cell hyporesponsiveness, we have developed an in vitro system in which T lymphocytes are rendered hyporesponsive by co-culture with oxygen radical-producing activated neutrophils. We have observed a direct correlation between the level of T cell hyporesponsiveness induced and the concentration of reactive oxygen species produced. Moreover, induction of T cell hyporesponsiveness is blocked by addition of N-acetyl cysteine, Mn(III)tetrakis(4-benzoic acid)porphyrin chloride, and catalase, confirming the critical role of oxidative stress in this system. The pattern of tyrosine-phosphorylated proteins was profoundly altered in hyporesponsive as compared with normal T cells. In hyporesponsive T cells, T cell receptor (TCR) ligation no longer induced phospholipase C-gamma1 activation and caused reduced Ca2+ flux. In contrast, despite increased levels of ERK1/2 phosphorylation, TCR-dependent activation of mitogen-activated protein kinase ERK1/2 was unaltered in hyporesponsive T lymphocytes. A late TCR-signaling event such as caspase 3 activation was as well unaffected in hyporesponsive T lymphocytes. Our data indicate that TCR-signaling pathways are differentially affected by physiological levels of oxidative stress and would suggest that although "hyporesponsive" T cells have lost certain effector functions, they may have maintained or gained others.	CHU Purpan, Inst Claude Preval IFR 30, INSERM, U563 Tolerance & Autoimmun Sect, F-31024 Toulouse 3, France; Univ Toulouse 3, Fac Life Sci, UFR SVT, F-31062 Toulouse, France; Hop Rangueil, Dept Rheumatol, F-31403 Toulouse 4, France; Inst Univ France, F-75005 Paris, France	CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Institut Universitaire de France	Romagnoli, P (corresponding author), CHU Purpan, Inst Claude Preval IFR 30, INSERM, U563 Tolerance & Autoimmun Sect, BP 3028, F-31024 Toulouse 3, France.		Romagnoli, Paola/K-2237-2014; van Meerwijk, Joost P.M./K-1345-2014	van Meerwijk, Joost P.M./0000-0001-8231-1897				Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; ALLEN ME, 1995, EUR J IMMUNOL, V25, P1547, DOI 10.1002/eji.1830250612; Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7; Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; AOE T, 1995, J EXP MED, V181, P1881, DOI 10.1084/jem.181.5.1881; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; BUTTKE TM, 1995, FREE RADICAL RES, V22, P389, DOI 10.3109/10715769509147548; CAYOTA A, 1994, INT IMMUNOL, V6, P611, DOI 10.1093/intimm/6.4.611; CLERICI M, 1989, J CLIN INVEST, V84, P1892, DOI 10.1172/JCI114376; DAVIS MJ, 1990, INT MED SPECIALIST, V11, P121; Dumont A, 1999, ONCOGENE, V18, P747, DOI 10.1038/sj.onc.1202325; FINKE JH, 1993, CANCER RES, V53, P5613; FLESCHER E, 1994, J IMMUNOL, V153, P4880; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Griffith CE, 1998, J BIOL CHEM, V273, P10771, DOI 10.1074/jbc.273.17.10771; Gringhuis SI, 2000, J IMMUNOL, V164, P2170, DOI 10.4049/jimmunol.164.4.2170; HARDWICK JS, 1995, P NATL ACAD SCI USA, V92, P4527, DOI 10.1073/pnas.92.10.4527; Hehner SP, 2000, J IMMUNOL, V165, P4319, DOI 10.4049/jimmunol.165.8.4319; KANNER SB, 1992, P NATL ACAD SCI USA, V89, P300, DOI 10.1073/pnas.89.1.300; KEISARI Y, 1983, IMMUNOBIOLOGY, V165, P78, DOI 10.1016/S0171-2985(83)80048-5; Kono K, 1996, CLIN CANCER RES, V2, P1825; Kono K, 1996, EUR J IMMUNOL, V26, P1308, DOI 10.1002/eji.1830260620; Lahdenpohja N, 1998, J IMMUNOL, V160, P1354; Lander HM, 1997, FASEB J, V11, P118, DOI 10.1096/fasebj.11.2.9039953; LANDER HM, 1995, J BIOL CHEM, V270, P21195, DOI 10.1074/jbc.270.36.21195; Livolsi A, 2001, EUR J BIOCHEM, V268, P1508, DOI 10.1046/j.1432-1327.2001.02028.x; LO YYC, 1995, J BIOL CHEM, V270, P11727, DOI 10.1074/jbc.270.20.11727; Matsuda M, 1998, SCAND J IMMUNOL, V47, P254; Maurice MM, 1997, J IMMUNOL, V158, P1458; Maurice MM, 1997, J IMMUNOL, V159, P2973; MCCORD JM, 1974, SCIENCE, V185, P529, DOI 10.1126/science.185.4150.529; MIESCHER S, 1988, INT J CANCER, V42, P659, DOI 10.1002/ijc.2910420504; MIZOGUCHI H, 1992, SCIENCE, V258, P1795, DOI 10.1126/science.1465616; NAKAGOMI H, 1993, CANCER RES, V53, P5610; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; NAKAMURA K, 1993, ONCOGENE, V8, P3133; NATHAN CF, 1977, J EXP MED, V146, P1648, DOI 10.1084/jem.146.6.1648; OHBA M, 1994, J CELL BIOL, V126, P1079, DOI 10.1083/jcb.126.4.1079; Otsuji M, 1996, P NATL ACAD SCI USA, V93, P13119, DOI 10.1073/pnas.93.23.13119; OTTENHOFF THM, 1994, INT J LEPROSY, V62, P108; Renner C, 1996, BLOOD, V88, P236; Romagnoli P, 2001, INT IMMUNOL, V13, P305, DOI 10.1093/intimm/13.3.305; SALMON M, 1988, CLIN EXP IMMUNOL, V71, P79; SCHIEVEN GL, 1994, J BIOL CHEM, V269, P20718; SCHIEVEN GL, 1993, BLOOD, V82, P1212, DOI 10.1182/blood.V82.4.1212.bloodjournal8241212; Schmielau J, 2001, CANCER RES, V61, P4756; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Schreck R, 1991, Trends Cell Biol, V1, P39, DOI 10.1016/0962-8924(91)90072-H; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; Stefanova I, 1996, J CLIN INVEST, V98, P1290, DOI 10.1172/JCI118915; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; Suzukawa K, 2000, J BIOL CHEM, V275, P13175, DOI 10.1074/jbc.275.18.13175; TAUBER AI, 1979, BIOCHEMISTRY-US, V18, P5576, DOI 10.1021/bi00592a009; Thannickal VJ, 1998, J BIOL CHEM, V273, P23611, DOI 10.1074/jbc.273.36.23611; Wang XT, 2001, J BIOL CHEM, V276, P28364, DOI 10.1074/jbc.M102693200; WHISLER RL, 1995, ARCH BIOCHEM BIOPHYS, V319, P23, DOI 10.1006/abbi.1995.1263; WHISLER RL, 1994, LYMPHOKINE CYTOK RES, V13, P399; Zea AH, 1995, CLIN CANCER RES, V1, P1327; ZOSCHKE DC, 1987, CLIN IMMUNOL IMMUNOP, V42, P160, DOI 10.1016/0090-1229(87)90003-1	60	92	96	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19585	19593		10.1074/jbc.M111451200	http://dx.doi.org/10.1074/jbc.M111451200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11916964	hybrid			2022-12-27	WOS:000175894800047
J	Govindraj, P; West, L; Koob, TJ; Neame, P; Doege, K; Hassell, JR				Govindraj, P; West, L; Koob, TJ; Neame, P; Doege, K; Hassell, JR			Isolation and identification of the major heparan sulfate proteoglycans in the developing bovine rib growth plate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPILLARY ELECTROPHORESIS; BASEMENT-MEMBRANES; PERLECAN; CARTILAGE; AGGRECAN; CHONDROCYTES; BIOSYNTHESIS; EXPRESSION; PROTEIN; MATRIX	Heparan sulfate proteoglycans are thought to mediate the action of growth factors. The heparan sulfate-containing proteoglycans in extracts of the bovine fetal rib growth plate were detected using the monoclonal antibody 3610, which recognizes a neoepitope generated by heparitinase digestion (David, G., Bai, X. M., Van der Schueren, B., Cassiman, J. J., and Van den Berghe, H. (1992) J. Cell Biol. 119, 961-975). The heparan sulfate proteoglycans that react with this antibody were identified using antisera to known proteoglycans; purified using CsCl density gradient centrifugation, molecular sieve, and ion exchange chromatography; and then characterized. The major heparan sulfate proteoglycans in the growth plate had core proteins of 200 kDa and larger and were identified as perlecan and aggrecan. These two heparan sulfate proteoglycans could be effectively separated from each other by CsCl density gradient centrifugation alone. Perlecan contained 25% heparan sulfate and 75% chondroitin sulfate. The heparan sulfate chains on growth plate perlecan were considerably smaller than the chondroitin sulfate chains, and the heparan sulfate disaccharide content was different than that found for heparan sulfate from either kidney, tumor tissue, or growth plate aggrecan. Aggrecan contained only 0.1% heparan sulfate, which was localized to the CS-1 domain of aggrecan. These results indicate that perlecan and aggrecan would be the principal candidate proteoglycans involved in the action of heparan sulfate-binding proteins in the developing growth plate.	Shriners Hosp Children, Dept Res, Ctr Res Skeletal Dev & Pediat Orthoped, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Biochem & Mol Biol, Tampa, FL 33612 USA	State University System of Florida; University of South Florida	Hassell, JR (corresponding author), Shriners Hosp Children, Dept Res, Ctr Res Skeletal Dev & Pediat Orthoped, 12502 N Pine Dr, Tampa, FL 33612 USA.							ALHAKIM A, 1991, ANAL BIOCHEM, V195, P68, DOI 10.1016/0003-2697(91)90296-6; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354, DOI 10.1038/15537; Arikawa-Hirasawa E, 2001, NAT GENET, V27, P431, DOI 10.1038/86941; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; BUCKWALTER JA, 1987, CALCIFIED TISSUE INT, V41, P228, DOI 10.1007/BF02555243; CHINTALA SK, 1995, ARCH BIOCHEM BIOPHYS, V316, P227, DOI 10.1006/abbi.1995.1032; CHINTALA SK, 1994, ARCH BIOCHEM BIOPHYS, V310, P180, DOI 10.1006/abbi.1994.1155; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; DOEGE K, 1987, J BIOL CHEM, V262, P17757; Doege K, 1997, MATRIX BIOL, V16, P211, DOI 10.1016/S0945-053X(97)90010-X; Doege KJ, 1997, J BIOL CHEM, V272, P13974, DOI 10.1074/jbc.272.21.13974; Dolan M, 1997, J BIOL CHEM, V272, P4316, DOI 10.1074/jbc.272.7.4316; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P246; GROVER J, 1995, BIOCHEM J, V309, P963, DOI 10.1042/bj3090963; Handler M, 1997, DEV DYNAM, V210, P130, DOI 10.1002/(SICI)1097-0177(199710)210:2<130::AID-AJA6>3.0.CO;2-H; HASSELL JR, 1980, P NATL ACAD SCI-BIOL, V77, P4494, DOI 10.1073/pnas.77.8.4494; Hering TM, 1997, ARCH BIOCHEM BIOPHYS, V345, P259, DOI 10.1006/abbi.1997.0261; Horton WE, 1998, OSTEOARTHR CARTILAGE, V6, P245, DOI 10.1053/joca.1998.0117; HUNZIKER EB, 1987, J BONE JOINT SURG AM, V69A, P162, DOI 10.2106/00004623-198769020-00002; Karamanos NK, 1996, ELECTROPHORESIS, V17, P391, DOI 10.1002/elps.1150170217; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Nicole S, 2000, NAT GENET, V26, P480, DOI 10.1038/82638; Noonan KJ, 1998, J ORTHOPAED RES, V16, P500, DOI 10.1002/jor.1100160416; Olsen BR, 1999, J CELL BIOL, V147, P909, DOI 10.1083/jcb.147.5.909; PLAAS AHK, 1993, MATRIX, V13, P135, DOI 10.1016/S0934-8832(11)80072-7; POOLE AR, 1982, J CELL BIOL, V92, P249, DOI 10.1083/jcb.92.2.249; ROBINSON HC, 1978, J BIOL CHEM, V253, P6687; SUNDARRAJ N, 1995, J CELL SCI, V108, P2663; Tapanadechopone P, 1999, BIOCHEM BIOPH RES CO, V265, P680, DOI 10.1006/bbrc.1999.1714; TIAN MY, 1986, ARCH BIOCHEM BIOPHYS, V247, P221, DOI 10.1016/0003-9861(86)90551-5; YANAGISHITA M, 1987, METHOD ENZYMOL, V138, P279; ZHANG LJ, 1994, J BIOL CHEM, V269, P19295; ZHANG LJ, 1995, J BIOL CHEM, V270, P27127, DOI 10.1074/jbc.270.45.27127	34	49	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19461	19469		10.1074/jbc.M200786200	http://dx.doi.org/10.1074/jbc.M200786200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11909863	hybrid			2022-12-27	WOS:000175894800031
J	Iversen, LF; Moller, KB; Pedersen, AK; Peters, GH; Petersen, AS; Andersen, HS; Branner, S; Mortensen, SB; Moller, NPH				Iversen, LF; Moller, KB; Pedersen, AK; Peters, GH; Petersen, AS; Andersen, HS; Branner, S; Mortensen, SB; Moller, NPH			Structure determination of T cell protein-tyrosine phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; STRUCTURE-BASED DESIGN; CRYSTAL-STRUCTURE; INSULIN SENSITIVITY; SPECIFICITY; INHIBITOR; PTP-1B; ALPHA; PTP1B; ACID	Protein-tyrosine phosphatase 1B (PTP1B) has recently received much attention as a potential drug target in type 2 diabetes. This has in particular been spurred by the finding that PTP1B knockout mice show increased insulin sensitivity and resistance to diet-induced obesity. Surprisingly, the highly homologous T cell protein-tyrosine phosphatase (TC-PTP) has received much less attention, and no x-ray structure has been provided. We have previously co-crystallized PTP1B with a number of low molecular weight inhibitors that inhibit TC-PTP with similar efficiency. Unexpectedly, we were not able to co-crystallize TC-PTP with the same set of inhibitors. This seems to be due to a multimerization process where residues 130-132, the DDQ loop, from one molecule is inserted into the active site of the neighboring molecule, resulting in a continuous string of interacting TC-PTP molecules. Importantly, despite the high degree of functional and structural similarity between TC-PTP and PTP1B, we have been able to identify areas close to the active site that might be addressed to develop selective inhibitors of each enzyme.	Novo Nordisk AS, Signal Transduct, DK-2880 Bagsvaerd, Denmark; Med Chem Res 1, DK-2760 Malov, Denmark; Tech Univ Denmark, Chem Dept, MEMPHYS, DK-2800 Lyngby, Denmark; Royal Danish Sch Pharm, Dept Med Chem, DK-2100 Copenhagen, Denmark	Novo Nordisk; Technical University of Denmark; Royal Danish School of Pharmacy	Iversen, LF (corresponding author), Novo Nordisk AS, Signal Transduct, 6A1 086 Novo Alle, DK-2880 Bagsvaerd, Denmark.	lfiv@novonordisk.com; NPHM@novonordisk.com	Peters, Günther H.J./T-7100-2017	Peters, Günther H.J./0000-0001-9754-2663				Andersen HS, 2000, J BIOL CHEM, V275, P7101, DOI 10.1074/jbc.275.10.7101; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; Blanchetot C, 2000, FEBS LETT, V484, P235, DOI 10.1016/S0014-5793(00)02165-7; Blanchetot C, 2000, J BIOL CHEM, V275, P12446, DOI 10.1074/jbc.275.17.12446; Bleasdale JE, 2001, BIOCHEMISTRY-US, V40, P5642, DOI 10.1021/bi002865v; Burke TR, 1996, BIOCHEMISTRY-US, V35, P15989, DOI 10.1021/bi961256d; CHERNOFF J, 1990, P NATL ACAD SCI USA, V87, P2735, DOI 10.1073/pnas.87.7.2735; COOL DE, 1989, P NATL ACAD SCI USA, V86, P5257, DOI 10.1073/pnas.86.14.5257; Dalgarno D C, 2000, Curr Opin Drug Discov Devel, V3, P549; Dunn D, 1996, J BIOL CHEM, V271, P168, DOI 10.1074/jbc.271.1.168; EKMAN P, 1993, ANAL BIOCHEM, V214, P138, DOI 10.1006/abio.1993.1468; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Fauman EB, 1996, J BIOL CHEM, V271, P18780, DOI 10.1074/jbc.271.31.18780; Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x; Fukada T, 2001, J BIOL CHEM, V276, P25512, DOI 10.1074/jbc.M101354200; Groves MR, 1998, BIOCHEMISTRY-US, V37, P17773, DOI 10.1021/bi9816958; Hao LN, 1997, J BIOL CHEM, V272, P29322, DOI 10.1074/jbc.272.46.29322; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Ibarra-Sanchez MD, 2000, SEMIN IMMUNOL, V12, P379, DOI 10.1006/smim.2000.0220; Iversen LF, 2000, J BIOL CHEM, V275, P10300, DOI 10.1074/jbc.275.14.10300; Iversen LF, 2001, BIOCHEMISTRY-US, V40, P14812, DOI 10.1021/bi011389l; Jiang GL, 1999, NATURE, V401, P606, DOI 10.1038/44170; Keng YF, 1999, EUR J BIOCHEM, V259, P809, DOI 10.1046/j.1432-1327.1999.00090.x; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Lam MHC, 2001, J BIOL CHEM, V276, P37700, DOI 10.1074/jbc.M105128200; Lohse DL, 1997, BIOCHEMISTRY-US, V36, P4568, DOI 10.1021/bi963094r; LORENZEN JA, 1995, J CELL BIOL, V131, P631, DOI 10.1083/jcb.131.3.631; Majeti R, 2000, CELL, V103, P1059, DOI 10.1016/S0092-8674(00)00209-9; Moller N P, 2000, Curr Opin Drug Discov Devel, V3, P527; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; O'Reilly AM, 1998, MOL CELL BIOL, V18, P161, DOI 10.1128/MCB.18.1.161; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pannifer ADB, 1998, J BIOL CHEM, V273, P10454, DOI 10.1074/jbc.273.17.10454; Peters GH, 2000, J BIOL CHEM, V275, P18201, DOI 10.1074/jbc.M910273199; Ravichandran LV, 2001, MOL ENDOCRINOL, V15, P1768, DOI 10.1210/me.15.10.1768; SHIFRIN VI, 1993, J BIOL CHEM, V268, P25376; STUCKEY JA, 1994, NATURE, V370, P571, DOI 10.1038/370571a0; Tenev T, 1997, J BIOL CHEM, V272, P5966, DOI 10.1074/jbc.272.9.5966; Tiganis T, 1998, MOL CELL BIOL, V18, P1622, DOI 10.1128/MCB.18.3.1622; TONKS NK, 1988, J BIOL CHEM, V263, P6731; TONKS NK, 1988, J BIOL CHEM, V263, P6722; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; YouTen KE, 1997, J EXP MED, V186, P683, DOI 10.1084/jem.186.5.683; ZANDER NF, 1993, ONCOGENE, V8, P1175; Zhang ZY, 1997, CURR TOP CELL REGUL, V35, P21, DOI 10.1016/S0070-2137(97)80002-7	53	140	146	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19982	19990		10.1074/jbc.M200567200	http://dx.doi.org/10.1074/jbc.M200567200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11907034	hybrid			2022-12-27	WOS:000175894800098
J	Kim, MC; Lee, SH; Kim, JK; Chun, HJ; Choi, MS; Chung, WS; Moon, BC; Kang, CH; Park, CY; Yoo, JH; Kang, YH; Koo, SC; Koo, YD; Jung, JC; Kim, ST; Schulze-Lefert, P; Lee, SY; Cho, MJ				Kim, MC; Lee, SH; Kim, JK; Chun, HJ; Choi, MS; Chung, WS; Moon, BC; Kang, CH; Park, CY; Yoo, JH; Kang, YH; Koo, SC; Koo, YD; Jung, JC; Kim, ST; Schulze-Lefert, P; Lee, SY; Cho, MJ			Mlo, a modulator of plant defense and cell death, is a novel calmodulin-binding protein - Isolation and characterization of a rice Mlo homologue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERSENSITIVE DISEASE RESISTANCE; NITRIC-OXIDE SYNTHASE; LIGHT-CHAIN KINASE; OXIDATIVE BURST; FUNGAL ELICITOR; POWDERY MILDEW; GLUTAMATE-DECARBOXYLASE; CYTOSOLIC CALCIUM; PLASMA-MEMBRANE; PEPTIDE COMPLEX	Transient influx of Ca2+ constitutes an early event in the signaling cascades that trigger plant defense responses. However, the downstream components of defense-associated Ca2+ signaling are largely unknown. Because Ca2+ signals are mediated by Ca2+-binding proteins, including calmodulin (CaM), identification and characterization of CaM-binding proteins elicited by pathogens should provide insights into the mechanism by which Ca2+ regulates defense responses. In this study, we isolated a gene encoding rice Mlo (Oryza sativa Mlo; OsMlo) using a protein-protein interaction-based screening of a cDNA expression library constructed from pathogen-elicited rice suspension cells. OsMlo has a molecular mass of 62 kDa and shares 65% sequence identity and scaffold topology with barley Mlo, a heptahelical transmembrane protein known to function as a negative regulator of broad spectrum disease resistance and leaf cell death. By using gel overlay assays, we showed that OsMlo produced in Escherichia coli binds to soybean CaM isoform-1 (SCaM-1) in a Ca2+-dependent manner. We located a 20-amino acid CaM-binding domain (CaMBD) in the OsMlo C-terminal cytoplasmic tail that is necessary and sufficient for Ca2+-dependent CaM complex formation. Specific binding of the conserved CaMBD to CaM was corroborated by site-directed mutagenesis, a gel mobility shift assay, and a competition assay with a Ca2+/CaM-dependent enzyme. Expression of OsMlo was strongly induced by a fungal pathogen and by plant defense signaling molecules. We propose that binding of Ca2+-loaded CaM to the C-terminal tail may be a common feature of Mlo proteins.	Gyeongsang Natl Univ, Div Appl Life Sci, Program BK21, Plant Mol Biol & Biotechnol Res Ctr, Chinju 660701, South Korea; Max Planck Inst Zuchtungsforsch, D-50829 Cologne, Germany	Gyeongsang National University; Max Planck Society	Cho, MJ (corresponding author), Gyeongsang Natl Univ, Div Appl Life Sci, Program BK21, Plant Mol Biol & Biotechnol Res Ctr, Chinju 660701, South Korea.		Schulze-Lefert, Paul/B-6707-2011; Park, Chan Young/F-5696-2010; Schulze-Lefert, Paul/A-7746-2008; Cho, Moo Je/F-1649-2010	Park, Chan Young/0000-0002-5183-3665; Kim, Sun Tae/0000-0002-3853-1419; gim, seontae/0000-0001-9705-6868; Kang, Chang Ho/0000-0003-4342-5247				ARAZI T, 1995, PLANT PHYSIOL, V108, P551, DOI 10.1104/pp.108.2.551; BACH M, 1993, PLANT PHYSIOL, V103, P407, DOI 10.1104/pp.103.2.407; BAGCHI IC, 1992, J BIOL CHEM, V267, P3024; Blume B, 2000, PLANT CELL, V12, P1425, DOI 10.1105/tpc.12.8.1425; Bofill-Cardona E, 2000, J BIOL CHEM, V275, P32672, DOI 10.1074/jbc.M002780200; BOLWELL GP, 1995, FREE RADICAL RES, V23, P517, DOI 10.3109/10715769509065273; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; BUSH DS, 1995, ANNU REV PLANT PHYS, V46, P95, DOI 10.1146/annurev.pp.46.060195.000523; Cho MJ, 1998, BIOCHEMISTRY-US, V37, P15593, DOI 10.1021/bi981497g; Chung WS, 2000, PLANT CELL, V12, P1393, DOI 10.1105/tpc.12.8.1393; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Devoto A, 1999, J BIOL CHEM, V274, P34993, DOI 10.1074/jbc.274.49.34993; DeWitt ND, 1996, PLANT PHYSIOL, V112, P833, DOI 10.1104/pp.112.2.833; Diggle TA, 1999, FEBS LETT, V457, P189, DOI 10.1016/S0014-5793(99)01034-0; Ebel J, 1998, BIOESSAYS, V20, P569, DOI 10.1002/(SICI)1521-1878(199807)20:7&lt;569::AID-BIES8&gt;3.0.CO;2-F; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; ERICKSONVIITANEN S, 1987, METHOD ENZYMOL, V139, P455; FELIX G, 1994, P NATL ACAD SCI USA, V91, P952, DOI 10.1073/pnas.91.3.952; Freialdenhoven A, 1996, PLANT CELL, V8, P5, DOI 10.1105/tpc.8.1.5; GAWIENOWSKI MC, 1993, PLANT MOL BIOL, V22, P215, DOI 10.1007/BF00014930; Grant M, 2000, PLANT J, V23, P441, DOI 10.1046/j.1365-313x.2000.00804.x; Harmon AC, 2000, TRENDS PLANT SCI, V5, P154, DOI 10.1016/S1360-1385(00)01577-6; Heo WD, 1999, P NATL ACAD SCI USA, V96, P766, DOI 10.1073/pnas.96.2.766; HOFTE H, 1992, PLANT CELL, V4, P995, DOI 10.1105/tpc.4.8.995; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Jabs T, 1997, P NATL ACAD SCI USA, V94, P4800, DOI 10.1073/pnas.94.9.4800; JAMES P, 1995, TRENDS BIOCHEM SCI, V20, P38, DOI 10.1016/S0968-0004(00)88949-5; Kim CY, 2000, MOL PLANT MICROBE IN, V13, P470, DOI 10.1094/MPMI.2000.13.4.470; Kim CY, 1998, PLANT MOL BIOL, V37, P523, DOI 10.1023/A:1005960313459; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Kondo R, 1999, J BIOL CHEM, V274, P36213, DOI 10.1074/jbc.274.51.36213; KUROSAKI F, 1987, PHYTOCHEMISTRY, V26, P1919, DOI 10.1016/S0031-9422(00)81729-X; Lee SH, 1997, J BIOL CHEM, V272, P9252, DOI 10.1074/jbc.272.14.9252; LEE SH, 1995, J BIOL CHEM, V270, P21806, DOI 10.1074/jbc.270.37.21806; Lee SH, 2000, BIOCHEM J, V350, P299, DOI 10.1042/0264-6021:3500299; Lee SH, 1999, BBA-PROTEIN STRUCT M, V1433, P56, DOI 10.1016/S0167-4838(99)00149-1; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Liu Z., 1991, ACTA BOT SIN, V35, P363; LU YT, 1994, PLANT PHYSIOL BIOCH, V32, P413; LU YT, 1995, PLANT PHYSIOL, V108, P1197, DOI 10.1104/pp.108.3.1197; MATSUSHIMA S, 1994, BIOCHEM BIOPH RES CO, V202, P1329, DOI 10.1006/bbrc.1994.2076; Matsushita M, 1998, J BIOL CHEM, V273, P21473, DOI 10.1074/jbc.273.34.21473; McAinsh MR, 1998, TRENDS PLANT SCI, V3, P32, DOI 10.1016/S1360-1385(97)01150-3; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Minakami R, 1997, J BIOL CHEM, V272, P20291, DOI 10.1074/jbc.272.32.20291; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nurnberger T, 2001, TRENDS PLANT SCI, V6, P372, DOI 10.1016/S1360-1385(01)02019-2; ODonnell PJ, 1996, SCIENCE, V274, P1914, DOI 10.1126/science.274.5294.1914; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; PRICE AH, 1994, PLANT CELL, V6, P1301, DOI 10.1105/tpc.6.9.1301; Reddy ASN, 1996, PLANT J, V10, P9, DOI 10.1046/j.1365-313X.1996.10010009.x; REDDY ASN, 1993, PLANT SCI, V94, P109, DOI 10.1016/0168-9452(93)90012-O; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; ROBERTS DM, 1992, ANNU REV PLANT PHYS, V43, P375, DOI 10.1146/annurev.pp.43.060192.002111; Sambrook J., 2002, MOL CLONING LAB MANU; Sanders D, 1999, PLANT CELL, V11, P691, DOI 10.1105/tpc.11.4.691; Snedden WA, 1998, TRENDS PLANT SCI, V3, P299, DOI 10.1016/S1360-1385(98)01284-9; STAB MR, 1987, ARCH BIOCHEM BIOPHYS, V257, P416, DOI 10.1016/0003-9861(87)90585-6; STEPONKUS PL, 1967, PLANT PHYSIOL, V42, P1423, DOI 10.1104/pp.42.10.1423; TAKEZAWA D, 1995, PLANT MOL BIOL, V27, P693, DOI 10.1007/BF00020223; TAVERNIER E, 1995, PLANT PHYSIOL, V109, P1025, DOI 10.1104/pp.109.3.1025; TENHAKEN R, 1995, P NATL ACAD SCI USA, V92, P4158, DOI 10.1073/pnas.92.10.4158; Trewavas AJ, 1998, CURR OPIN PLANT BIOL, V1, P428, DOI 10.1016/S1369-5266(98)80268-9; Wang DX, 1999, J BIOL CHEM, V274, P22081, DOI 10.1074/jbc.274.31.22081; Wang W, 1996, PLANT MOL BIOL, V31, P683, DOI 10.1007/BF00042240; Wasternack C, 1997, TRENDS PLANT SCI, V2, P302, DOI 10.1016/S1360-1385(97)89952-9; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; WOLTER M, 1993, MOL GEN GENET, V239, P122, DOI 10.1007/BF00281610; Xu HX, 1998, PLANT CELL, V10, P585, DOI 10.1105/tpc.10.4.585; Yang TB, 1996, MOL GEN GENET, V252, P684, DOI 10.1007/BF02173974; Yuan T, 1998, J BIOL CHEM, V273, P30328, DOI 10.1074/jbc.273.46.30328; ZHANG ZG, 1995, PLANT J, V8, P139, DOI 10.1046/j.1365-313X.1995.08010139.x; Zielinski RE, 1998, ANNU REV PLANT PHYS, V49, P697, DOI 10.1146/annurev.arplant.49.1.697	75	106	136	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19304	19314		10.1074/jbc.M108478200	http://dx.doi.org/10.1074/jbc.M108478200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11904292	hybrid			2022-12-27	WOS:000175894800010
J	Rabilloud, T; Heller, M; Gasnier, F; Luche, S; Rey, C; Aebersold, R; Benahmed, M; Louisot, P; Lunardi, J				Rabilloud, T; Heller, M; Gasnier, F; Luche, S; Rey, C; Aebersold, R; Benahmed, M; Louisot, P; Lunardi, J			Proteomics analysis of cellular response to oxidative stress - Evidence for in vivo overoxidation of peroxiredoxins at their active site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMOBILIZED PH GRADIENTS; CYSTEINE-SULFENIC ACID; NECROSIS-FACTOR-ALPHA; 2-DIMENSIONAL ELECTROPHORESIS; SACCHAROMYCES-CEREVISIAE; THIOREDOXIN PEROXIDASE; PROTEIN; CLONING; EXPRESSION; FAMILY	The proteomics analysis reported here shows that a major cellular response to oxidative stress is the modification of several peroxiredoxins. An acidic form of the peroxiredoxins appeared to be systematically increased under oxidative stress conditions. Peroxiredoxins are enzymes catalyzing the destruction of peroxides. In doing so, a reactive cysteine in the peroxiredoxin active site is weakly oxidized (disulfide or sulfenic acid) by the destroyed peroxides. Cellular thiols (e.g. thioredoxin) are used to regenerate the peroxiredoxins to their active state. Tandem mass spectrometry was carried out to characterize the modified form of the protein produced in vivo by oxidative stress. The cysteine present in the active site was shown to be oxidized into cysteic acid, leading to an inactivated form of peroxiredoxin. This strongly suggested that peroxiredoxins behave as a dam upon oxidative stress, being both important peroxide-destroying enzymes and peroxide targets. Results obtained in a primary culture of Leydig cells challenged with tumor necrosis factor a suggested that this oxidized/native balance of peroxiredoxin 2 may play an active role in resistance or susceptibility to tumor necrosis factor a-induced apoptosis.	CEA Grenoble, BECP, DRDC, Lab Bioenerget Cellulaire & Pathol,EA UJF 294, F-38054 Grenoble 9, France; Univ Washington, Dept Mol Biotechnol, Seattle, WA 98115 USA; Fac Med Lyon Sud, Unite INSERM, U189, F-69921 Oullins, France; Fac Med Lyon Sud, Unite INSERM, U407, F-69921 Oullins, France	CEA; University of Washington; University of Washington Seattle; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Rabilloud, T (corresponding author), CEA Grenoble, BECP, DRDC, Lab Bioenerget Cellulaire & Pathol,EA UJF 294, 17 Rue Martyrs, F-38054 Grenoble 9, France.			Heller, Manfred/0000-0002-6364-7325				ADAMSON GM, 1992, ARCH BIOCHEM BIOPHYS, V294, P223, DOI 10.1016/0003-9861(92)90161-O; Araki M, 1999, J BIOL CHEM, V274, P2271, DOI 10.1074/jbc.274.4.2271; Baier M, 1997, PLANT J, V12, P179, DOI 10.1046/j.1365-313X.1997.12010179.x; BENAHMED M, 1987, MOL CELL ENDOCRINOL, V50, P69, DOI 10.1016/0303-7207(87)90078-5; Buck M, 1996, EMBO J, V15, P1753, DOI 10.1002/j.1460-2075.1996.tb00524.x; CHAE HZ, 1993, J BIOL CHEM, V268, P16815; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Choi HJ, 1998, NAT STRUCT BIOL, V5, P400, DOI 10.1038/nsb0598-400; FRIDOVICH I, 1986, ANNU REV PHYSIOL, V48, P693; Godon C, 1998, J BIOL CHEM, V273, P22480, DOI 10.1074/jbc.273.35.22480; GORG A, 1987, ELECTROPHORESIS, V8, P122, DOI 10.1002/elps.1150080207; ISHII T, 1993, J BIOL CHEM, V268, P18633; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Knoops B, 1999, J BIOL CHEM, V274, P30451, DOI 10.1074/jbc.274.43.30451; KWON SJ, 1994, BIOCHEM BIOPH RES CO, V201, P8, DOI 10.1006/bbrc.1994.1662; Lee SR, 1999, J BIOL CHEM, V274, P4722, DOI 10.1074/jbc.274.8.4722; LIM YS, 1994, BIOCHEM BIOPH RES CO, V199, P199, DOI 10.1006/bbrc.1994.1214; Matsumoto A, 1999, FEBS LETT, V443, P246, DOI 10.1016/S0014-5793(98)01736-0; Mitsumoto A, 2001, FREE RADICAL BIO MED, V30, P625, DOI 10.1016/S0891-5849(00)00503-7; Peshenko IV, 2001, FREE RADICAL BIO MED, V31, P292, DOI 10.1016/S0891-5849(01)00579-2; Phelan SA, 1998, GENOMICS, V54, P132, DOI 10.1006/geno.1998.5568; POOLE LB, 1989, J BIOL CHEM, V264, P12330; RABILLOUD T, 1994, ELECTROPHORESIS, V15, P1552, DOI 10.1002/elps.11501501223; Rabilloud T, 1995, BIOCHEM J, V312, P699, DOI 10.1042/bj3120699; Rabilloud T, 2001, PROTEOMICS, V1, P699, DOI 10.1002/1615-9861(200104)1:5<699::AID-PROT699>3.3.CO;2-3; Rabilloud T, 1997, ELECTROPHORESIS, V18, P307, DOI 10.1002/elps.1150180303; RABILLOUD T, 1999, PROTEOME RES 2 DIMEN, P107; Rey C, 2000, BIOCHEM PHARMACOL, V60, P1639, DOI 10.1016/S0006-2952(00)00500-1; SHULL S, 1991, J BIOL CHEM, V266, P24398; SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x; Sinha P, 2001, PROTEOMICS, V1, P835, DOI 10.1002/1615-9861(200107)1:7<835::AID-PROT835>3.3.CO;2-U; Spyrou G, 1997, J BIOL CHEM, V272, P2936, DOI 10.1074/jbc.272.5.2936; Verdoucq L, 1999, J BIOL CHEM, V274, P19714, DOI 10.1074/jbc.274.28.19714; WATABE S, 1994, J BIOCHEM, V115, P648, DOI 10.1093/oxfordjournals.jbchem.a124390; Yates JR, 1996, J AM SOC MASS SPECTR, V7, P1089, DOI 10.1016/S1044-0305(96)00079-7; Zhang P, 1997, J BIOL CHEM, V272, P30615, DOI 10.1074/jbc.272.49.30615	37	331	344	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19396	19401		10.1074/jbc.M106585200	http://dx.doi.org/10.1074/jbc.M106585200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11904290	hybrid			2022-12-27	WOS:000175894800022
J	Kjeldsen, T; Ludvigsen, S; Diers, I; Balschmidt, P; Sorensen, AR; Kaarsholm, NC				Kjeldsen, T; Ludvigsen, S; Diers, I; Balschmidt, P; Sorensen, AR; Kaarsholm, NC			Engineering-enhanced protein secretory expression in yeast with application to insulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; QUALITY-CONTROL; BINDING; STABILITY; PRECURSORS; EFFICIENCY; PEPTIDE; HEXAMER; MONOMER; LEADERS	Adaptation to efficient heterologous expression is a prerequisite for recombinant proteins to fulfill their clinical and biotechnological potential. We describe a rational strategy to optimize the secretion efficiency in yeast of an insulin precursor by structure-based engineering of the folding stability. The yield of a fast-acting insulin analogue (Asp(B28)) expressed in yeast was enhanced 5-fold by engineering a specific interaction between an aromatic amino acid in the connecting peptide and a phenol binding site in the hydrophobic core of the molecule. This insulin precursor is characterized by significantly enhanced folding stability. The improved folding properties enhanced the secretion efficiency of the insulin precursor from 10 to 50%. The precursor remains fully in vitro convertible to mature fast-acting insulin.	Novo Nordisk AS, Insulin Res, DK-2880 Bagsvaerd, Denmark	Novo Nordisk	Kjeldsen, T (corresponding author), Novo Nordisk AS, Insulin Res, Novo Alle, DK-2880 Bagsvaerd, Denmark.			Kjeldsen, Thomas/0000-0003-0094-9286; LUDVIGSEN, SVEND/0000-0002-5671-4542				BLOOM CR, 1995, J MOL BIOL, V245, P324, DOI 10.1006/jmbi.1994.0027; BLUNDELL TL, 1971, NATURE, V231, P506, DOI 10.1038/231506a0; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; DEREWENDA U, 1991, J MOL BIOL, V220, P425, DOI 10.1016/0022-2836(91)90022-X; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; KAARSHOLM NC, 1993, BIOCHEMISTRY-US, V32, P10773, DOI 10.1021/bi00091a031; KAARSHOLM NC, 1989, BIOCHEMISTRY-US, V28, P4427, DOI 10.1021/bi00436a046; Kjeldsen T, 1999, J BIOTECHNOL, V75, P195, DOI 10.1016/S0168-1656(99)00159-5; Kjeldsen T, 1996, GENE, V170, P107, DOI 10.1016/0378-1119(95)00822-5; Kjeldsen T, 1997, PROTEIN EXPRES PURIF, V9, P331, DOI 10.1006/prep.1996.0695; Kjeldsen T, 2000, APPL MICROBIOL BIOT, V54, P277, DOI 10.1007/s002530000402; Kjeldsen T, 2001, Biotechnol Genet Eng Rev, V18, P89; Kowalski JM, 1998, BIOCHEMISTRY-US, V37, P1264, DOI 10.1021/bi9722397; Kowalski JM, 1998, J BIOL CHEM, V273, P19453, DOI 10.1074/jbc.273.31.19453; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kurtzhals P, 2000, DIABETES, V49, P999, DOI 10.2337/diabetes.49.6.999; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LUDVIGSEN S, 1994, BIOCHEMISTRY-US, V33, P7998, DOI 10.1021/bi00192a003; Ludvigsen S, 2001, BIOCHEMISTRY-US, V40, P9082, DOI 10.1021/bi010433u; MARKUSSEN J, 1985, INT J PEPT PROT RES, V26, P70; MARKUSSEN J, 1987, PEPTIDES 1986, P189, DOI DOI 10.1002/BIT.260460206; NAKAGAWA SH, 1992, BIOCHEMISTRY-US, V31, P3204, DOI 10.1021/bi00127a023; SNEL L, 1988, HORM METAB RES, V20, P476, DOI 10.1055/s-2007-1010862; Whittingham JL, 1998, BIOCHEMISTRY-US, V37, P11516, DOI 10.1021/bi980807s; Zhang BY, 2001, J CELL BIOL, V153, P1187, DOI 10.1083/jcb.153.6.1187	27	52	62	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					18245	18248		10.1074/jbc.C200137200	http://dx.doi.org/10.1074/jbc.C200137200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11923277	hybrid			2022-12-27	WOS:000175975800001
J	Ma, K; Vattem, KM; Wek, RC				Ma, K; Vattem, KM; Wek, RC			Dimerization and release of molecular chaperone inhibition facilitate activation of eukaryotic initiation factor-2 kinase in response to endoplasmic reticulum stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; UNFOLDED PROTEIN RESPONSE; FACTOR 2-ALPHA KINASE; TRANSLATIONAL REGULATION; TRANSMEMBRANE PROTEIN; MAMMALIAN HOMOLOG; GENE-EXPRESSION; ALPHA-SUBUNIT; IN-VITRO; PKR	Phosphorylation of eukaryotic initiation factor-2 (eIF2) by pancreatic eIF2 kinase (PEK), induces a program of translational expression in response to accumulation of malfolded protein in the endoplasmic reticulum (ER). This study addresses the mechanisms activating PEK, also designated PERK or EIEF2AK3. We describe the characterization of two regions in the ER luminal portion of the transmembrane PEK that carry out distinct functions in the regulation of this eIF2 kinase. The first region mediates oligomerization between PEK polypeptides, and deletion of this portion of PEK blocked induction of eIF2 kinase activity. The second characterized region of PEK facilitates interaction with ER chaperones. In the absence of stress, PEK associates with ER chaperones GRP78 (BiP) and GRP94, and this binding is released in response to ER stress. ER luminal sequences flanking the transmembrane domain are required for GRP78 interaction, and deletion of this portion of PEK led to its activation even in the absence of ER stress. These results suggest that this ER chaperone serves as a repressor of PEK activity, and release of ER chaperones from PEK when misfolded proteins accumulate in the ER induces gene expression required to enhance the protein folding capacity of the ER.	Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Wek, RC (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	rwek@iupui.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049164] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM49164, R01GM643540] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Austin RC, 1998, J BIOL CHEM, V273, P30808, DOI 10.1074/jbc.273.46.30808; Berlanga JJ, 1999, EUR J BIOCHEM, V265, P754, DOI 10.1046/j.1432-1327.1999.00780.x; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Brostrom CO, 1998, PROG NUCLEIC ACID RE, V58, P79; Castelnau P, 2000, EUR J PEDIATR, V159, P631, DOI 10.1007/PL00008394; Chen JJ, 2000, COLD SPRING HARBOR M, V39, P529; Clemens MJ, 1996, TRANSLATIONAL CONTRO, P139; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Donze O, 2001, EMBO J, V20, P3771, DOI 10.1093/emboj/20.14.3771; Donze O, 1999, MOL CELL BIOL, V19, P8422, DOI 10.1128/mcb.19.12.8422; Han AP, 2001, EMBO J, V20, P6909, DOI 10.1093/emboj/20.23.6909; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kaufman RJ, 1999, P NATL ACAD SCI USA, V96, P11693, DOI 10.1073/pnas.96.21.11693; KRAMER MF, 1999, CURRENT PROTOCOLS MO, V3; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; Ma YL, 2001, RAPID COMMUN MASS SP, V15, P1693, DOI 10.1002/rcm.426; MORI K, 1993, CELL, V74, P743; Morris JA, 1997, J BIOL CHEM, V272, P4327, DOI 10.1074/jbc.272.7.4327; Nanduri S, 2000, EMBO J, V19, P5567, DOI 10.1093/emboj/19.20.5567; Okamura K, 2000, BIOCHEM BIOPH RES CO, V279, P445, DOI 10.1006/bbrc.2000.3987; Ortega LG, 1996, VIROLOGY, V215, P31, DOI 10.1006/viro.1996.0004; PATEL RC, 1995, P NATL ACAD SCI USA, V92, P8283, DOI 10.1073/pnas.92.18.8283; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; PROUD CG, 1995, TRENDS BIOCHEM SCI, V20, P241, DOI 10.1016/S0968-0004(00)89025-8; Romano PR, 1998, MOL CELL BIOL, V18, P2282, DOI 10.1128/MCB.18.4.2282; Ron D, 2000, COLD SPRING HARBOR M, V39, P547; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Sidrauski C, 1998, TRENDS CELL BIOL, V8, P245, DOI 10.1016/S0962-8924(98)01267-7; Sood R, 2000, BIOCHEM J, V346, P281, DOI 10.1042/0264-6021:3460281; Sood R, 2000, GENETICS, V154, P787; Thornton CM, 1997, PEDIATR PATHOL LAB M, V17, P487, DOI 10.1080/107710497174778; Thulasiraman V, 1998, EUR J BIOCHEM, V255, P552, DOI 10.1046/j.1432-1327.1998.2550552.x; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Uma S, 1999, MOL CELL BIOL, V19, P5861; Uma S, 1997, J BIOL CHEM, V272, P11648; Vattem KM, 2001, EUR J BIOCHEM, V268, P3674, DOI 10.1046/j.1432-1327.2001.02273.x; Vattem KM, 2001, EUR J BIOCHEM, V268, P1143, DOI 10.1046/j.1432-1327.2001.01979.x; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; WEK RC, 1994, TRENDS BIOCHEM SCI, V19, P491, DOI 10.1016/0968-0004(94)90136-8; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Zhang C, 2001, J BIOL CHEM, V276, P35867, DOI 10.1074/jbc.M100747200; Zhang F, 2001, J BIOL CHEM, V276, P24946, DOI 10.1074/jbc.M102108200; Zhu SH, 1997, J BIOL CHEM, V272, P14434, DOI 10.1074/jbc.272.22.14434; Zhu SH, 1996, J BIOL CHEM, V271, P24989, DOI 10.1074/jbc.271.40.24989	54	188	203	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					18728	18735		10.1074/jbc.M200903200	http://dx.doi.org/10.1074/jbc.M200903200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11907036	hybrid			2022-12-27	WOS:000175975800065
J	Dixon, MP; Pau, RN; Howlett, GJ; Dunstan, DE; Sawyer, WH; Davidson, BE				Dixon, MP; Pau, RN; Howlett, GJ; Dunstan, DE; Sawyer, WH; Davidson, BE			The central domain of Escherichia coli TyrR is responsible for hexamerization associated with tyrosine-mediated repression of gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BINDING PROTEIN; INDUCED SELF-ASSOCIATION; REGULATORY PROTEIN; SECONDARY STRUCTURE; NTRC; DNA; ACTIVATION; ATP; PHENYLALANINE; RECOGNITION	TyrR from Escherichia coli regulates the expression of genes for aromatic amino acid uptake and biosynthesis. Its central ATP-hydrolyzing domain is similar to conserved domains of bacterial regulatory proteins that interact with RNA polymerase holoenzyme associated with the alternative sigma factor, sigma(54). It is also related to the common module of the AAA+ superfamily of proteins that is involved in a wide range of cellular activities. We expressed and purified two TyrR central domain polypeptides. The fragment comprising residues 188-467, called TyrR-(188-467), was soluble and stable, in contrast to that corresponding to the conserved core from residues 193 to 433. TyrR-(188-467) bound ATP and rhodamine-ATP with association constants 2- to 5-fold lower than TyrR and hydrolyzed ATP at five times the rate of TyrR. In contrast to TyrR, which is predominantly dimeric at protein concentrations less than 10 mum in the absence of ligands, or in the presence of ATP or tyrosine alone, TyrR-(188-467) is a monomer, even at high protein concentrations. Tyrosine in the presence of ATP or ATPgammaS promotes the oligomerization of TyrR(188-467) to a hexamer. Tyrosine-dependent repression of gene transcription by TyrR therefore depends on ligand binding and hexamerization determinants located in the central domain polypeptide TyrR-(188-467).	Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; Univ Melbourne, Cooperat Res Ctr Biophys, Parkville, Vic 3010, Australia	University of Melbourne; University of Melbourne	Pau, RN (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia.		Dunstan, Dave/B-8936-2014	Dunstan, Dave/0000-0002-9931-010X				ARGAET VP, 1994, J BIOL CHEM, V269, P5171; Bailey MF, 1996, J MOL BIOL, V263, P671, DOI 10.1006/jmbi.1996.0607; Bantscheff M, 1999, BIOCHEMISTRY-US, V38, P11012, DOI 10.1021/bi990781k; BECERRA SP, 1991, BIOCHEMISTRY-US, V30, P11707, DOI 10.1021/bi00114a015; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; CUI JS, 1993, J BIOL CHEM, V268, P13023; CUI JS, 1993, J BIOL CHEM, V268, P5040; Dunstan DE, 2000, MACROMOLECULES, V33, P193, DOI 10.1021/ma9908503; FarezVidal ME, 1996, MOL MICROBIOL, V22, P779, DOI 10.1046/j.1365-2958.1996.01530.x; FLASHNER Y, 1995, J MOL BIOL, V249, P700, DOI 10.1006/jmbi.1995.0330; Garmendia J, 2000, MICROBIOL-SGM, V146, P2555, DOI 10.1099/00221287-146-10-2555; HAGMAR P, 1995, BBA-GEN SUBJECTS, V1244, P259, DOI 10.1016/0304-4165(95)00015-4; HAYES DB, 1999, SEDNTERP SEDIMENTATI; Hopper S, 1996, J BACTERIOL, V178, P199, DOI 10.1128/jb.178.1.199-203.1996; Howlett GJ, 2000, METHOD ENZYMOL, V323, P231; Hwang JS, 1997, J BACTERIOL, V179, P1051, DOI 10.1128/jb.179.4.1051-1058.1997; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kristl S, 2001, BIOCHEM BIOPH RES CO, V280, P81, DOI 10.1006/bbrc.2000.4076; Kristl S, 2000, FEBS LETT, V467, P87, DOI 10.1016/S0014-5793(00)01118-2; KWOK T, 1995, MOL MICROBIOL, V17, P471, DOI 10.1111/j.1365-2958.1995.mmi_17030471.x; KWOK T, 1998, THESIS U MELBOURNE V; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; MAROUDAS P, 1999, THESIS U MELBOURNE V; MORETT E, 1993, J BACTERIOL, V175, P6067, DOI 10.1128/JB.175.19.6067-6074.1993; Neuwald AF, 1999, GENOME RES, V9, P27; NG LC, 1995, J BACTERIOL, V177, P1485, DOI 10.1128/jb.177.6.1485-1490.1995; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Osuna J, 1997, PROTEIN SCI, V6, P543; Pelton JG, 1999, J MOL BIOL, V292, P1095, DOI 10.1006/jmbi.1999.3140; PITTARD AJ, 1991, MOL MICROBIOL, V5, P1585, DOI 10.1111/j.1365-2958.1991.tb01904.x; Pittard J, 1996, GENES CELLS, V1, P717, DOI 10.1111/j.1365-2443.1996.tb00012.x; Rippe K, 1998, J MOL BIOL, V278, P915, DOI 10.1006/jmbi.1998.1746; Rombel I, 1998, COLD SPRING HARB SYM, V63, P157, DOI 10.1101/sqb.1998.63.157; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Sawyer WH, 2000, BIOCHEMISTRY-US, V39, P5653, DOI 10.1021/bi0000723; Song J, 1996, MOL MICROBIOL, V22, P497, DOI 10.1046/j.1365-2958.1996.00131.x; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Wade JT, 2000, MOL MICROBIOL, V36, P223, DOI 10.1046/j.1365-2958.2000.01850.x; WILSON T, 1995, THESIS U MELBOURNE V; WILSON TJ, 1994, J MOL BIOL, V238, P309, DOI 10.1006/jmbi.1994.1294; WILSON TJ, 1995, MOL MICROBIOL, V17, P483, DOI 10.1111/j.1365-2958.1995.mmi_17030483.x; WNAG Y, 2001, PROTEIN SCI, V10, P592; Womack F C, 1973, Methods Enzymol, V27, P464; WOOTTON JC, 1989, PROTEIN ENG, V2, P535, DOI 10.1093/protein/2.7.535; Wyman C, 1997, SCIENCE, V275, P1658, DOI 10.1126/science.275.5306.1658; YANG J, 1993, J BACTERIOL, V175, P6372, DOI 10.1128/JB.175.19.6372-6375.1993; YANG J, 1993, J BACTERIOL, V175, P1767, DOI 10.1128/JB.175.6.1767-1776.1993	49	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 28	2002	277	26					23186	23192		10.1074/jbc.M112184200	http://dx.doi.org/10.1074/jbc.M112184200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567FX	11923293	hybrid			2022-12-27	WOS:000176475700014
J	Maggio, F; King, GF				Maggio, F; King, GF			Scanning mutagenesis of a Janus-faced atracotoxin reveals a bipartite surface patch that is essential for neurotoxic function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; SODIUM CURRENT INACTIVATION; MU-CONOTOXIN GIIIA; INSECTICIDAL NEUROTOXIN; POTASSIUM CHANNEL; PEPTIDE BLOCKER; TOXINS; RESIDUES; SITE; CYTOPLASM	The Janus-faced atracotoxins (J-ACTXs) are a family of insect-specific excitatory neurotoxins isolated from the venom of Australian funnel web spiders. In addition to a strikingly asymmetric distribution of charged residues, from which their name is derived, these toxins contain an extremely rare vicinal disulfide bond. To shed light on the mechanism of action of these toxins and to enhance their utility as lead compounds for insecticide development, we developed a recombinant expression system for the prototypic family member, J-ACTX-Hv1c, and mapped the key functional residues using site-directed mutagenesis. An alanine scan using a panel of 24 mutants provided the first complete map of the bioactive surface of a spider toxin and revealed that the entire J-ACTX-Hv1c pharmacophore is restricted to seven residues that form a bipartite surface patch on one face of the toxin. However, the primary pharmacophore, or hot spot, is formed by just five residues (Arg(8), Pro(9), Tyr(31), and the Cys(13)-Cys(14) vicinal disulfide). The Arg(8)-Tyr(31) diad in J-ACTX-Hv1c superimposes closely on the Lys-(Tyr/Phe) diad that is spatially conserved across a range of structurally dissimilar K+ channel blockers, which leads us to speculate that the J-ACTXs might target an invertebrate K+ channel.	Univ Connecticut, Ctr Hlth, Dept Biochem, Farmington, CT 06032 USA; Univ Connecticut, Ctr Hlth, Dept Microbiol, Farmington, CT 06032 USA	University of Connecticut; University of Connecticut	King, GF (corresponding author), Univ Connecticut, Ctr Hlth, Dept Biochem, MC3305,263 Farmington Ave, Farmington, CT 06032 USA.	glenn@psel.uchc.edu	King, Glenn F/J-5059-2012	King, Glenn F/0000-0002-2308-2200				Bernard C, 2001, BIOCHEMISTRY-US, V40, P12795, DOI 10.1021/bi015537j; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; BLAKE CCF, 1994, NAT STRUCT BIOL, V1, P102, DOI 10.1038/nsb0294-102; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Brogdon WG, 1998, EMERG INFECT DIS, V4, P605, DOI 10.3201/eid0404.980410; Chang NS, 1998, BIOCHEMISTRY-US, V37, P4407, DOI 10.1021/bi9724927; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Dauplais M, 1997, J BIOL CHEM, V272, P4302, DOI 10.1074/jbc.272.7.4302; Debarbieux L, 1999, CELL, V99, P117, DOI 10.1016/S0092-8674(00)81642-6; DERMAN AI, 1993, SCIENCE, V262, P1744, DOI 10.1126/science.8259521; DiasKadambi BL, 1996, J BIOL CHEM, V271, P23828, DOI 10.1074/jbc.271.39.23828; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; EITAN M, 1990, BIOCHEMISTRY-US, V29, P5941, DOI 10.1021/bi00477a009; Feyereisen R, 1995, TOXICOL LETT, V82-3, P83, DOI 10.1016/0378-4274(95)03470-6; Fletcher JI, 1997, NAT STRUCT BIOL, V4, P559, DOI 10.1038/nsb0797-559; Fletcher JI, 1999, EUR J BIOCHEM, V264, P525, DOI 10.1046/j.1432-1327.1999.00659.x; Ganetzky B, 2000, KIDNEY INT, V57, P766, DOI 10.1046/j.1523-1755.2000.00913.x; Gordon D, 1996, J BIOL CHEM, V271, P8034, DOI 10.1074/jbc.271.14.8034; Gorell JM, 1998, NEUROLOGY, V50, P1346, DOI 10.1212/WNL.50.5.1346; Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326; Jacobsen RB, 2000, J BIOL CHEM, V275, P24639, DOI 10.1074/jbc.C900990199; KAO PN, 1986, J BIOL CHEM, V261, P8085; Khera PK, 1996, BIOCHEMISTRY-US, V35, P3503, DOI 10.1021/bi9528457; KING GF, 2002, IN PRESS J TOXICOL T; Kobayashi K, 2000, BIOCHEMISTRY-US, V39, P14761, DOI 10.1021/bi001506x; Krittanai C, 1997, ANAL BIOCHEM, V253, P57, DOI 10.1006/abio.1997.2366; Lew MJ, 1997, J BIOL CHEM, V272, P12014, DOI 10.1074/jbc.272.18.12014; Li RA, 2001, J BIOL CHEM, V276, P11072, DOI 10.1074/jbc.M010862200; Miller MK, 2000, TOXICON, V38, P409, DOI 10.1016/S0041-0101(99)00171-3; NADASDI L, 1995, BIOCHEMISTRY-US, V34, P8076, DOI 10.1021/bi00025a013; Norton RS, 1998, TOXICON, V36, P1573, DOI 10.1016/S0041-0101(98)00149-4; OERKE EC, 1994, CROP PRODUCTION CROP, P72; OLIVERA BM, 1995, TRENDS BIOTECHNOL, V13, P422, DOI 10.1016/S0167-7799(00)88996-9; Olivera BM, 2001, TOXICON, V39, P7, DOI 10.1016/S0041-0101(00)00157-4; PRIBIC R, 1993, ANAL BIOCHEM, V214, P366, DOI 10.1006/abio.1993.1511; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; RILEY LG, 1994, EUR J BIOCHEM, V219, P877, DOI 10.1111/j.1432-1033.1994.tb18569.x; SATO K, 1991, J BIOL CHEM, V266, P16989; STAMPE P, 1994, BIOCHEMISTRY-US, V33, P443, DOI 10.1021/bi00168a008; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; Tedford HW, 2001, J BIOL CHEM, V276, P26568, DOI 10.1074/jbc.M102199200; Wang XH, 2000, NAT STRUCT BIOL, V7, P505, DOI 10.1038/75921; Wang XH, 1999, EUR J BIOCHEM, V264, P488, DOI 10.1046/j.1432-1327.1999.00646.x; Wang XH, 2001, J BIOL CHEM, V276, P40306, DOI 10.1074/jbc.M105206200; Woody R.W., 1996, CIRCULAR DICHROISM C, P25, DOI DOI 10.1007/978-1-4757-2508-7_2; Zilberberg N, 1997, J BIOL CHEM, V272, P14810, DOI 10.1074/jbc.272.23.14810	46	54	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22806	22813		10.1074/jbc.M202297200	http://dx.doi.org/10.1074/jbc.M202297200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11937509	hybrid			2022-12-27	WOS:000176313600090
J	Lemercier, C; Brocard, MP; Puvion-Dutilleul, F; Kao, HY; Albagli, O; Khochbin, S				Lemercier, C; Brocard, MP; Puvion-Dutilleul, F; Kao, HY; Albagli, O; Khochbin, S			Class II histone deacetylases are directly recruited by BCL6 transcriptional repressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLZF-RAR-ALPHA; GERMINAL-CENTER FORMATION; TUMOR-SUPPRESSOR GENE; FINGER ENCODING GENE; FUSION PARTNERS; POZ DOMAIN; LAZ3 BCL6; PROTEIN; EXPRESSION; BINDING	BCL6 is a member of the POZ/zinc finger (POK) family involved in survival and/or differentiation of a number of cell types and in B cell lymphoma upon chromosomal alteration. Transcriptional repression by BCL6 is thought to be achieved in part by recruiting a repressor complex containing two class I histone deacetylases (HDACs). In this study we investigated whether BCL6 could also target members of class II HDACs. Our results indicate that three related class II deacetylases, HDAC4, HDAC5, and HDAC7 can associate with BCL6 in vivo and in vitro. Using electron microscopy, we found that endogenous BCL6 and class II HDACs partially co-localize in the nucleus. Overexpression experiments showed that BCL6 and HDAC4, -5, or -7 are intermingled onto common nuclear substructures and form stable complexes. A highly conserved domain in the N-terminal region of HDAC5 and HDAC7 as well as the zinc finger region of BCL6 were found necessary for the complex formation in vivo and in vitro. Moreover, our data point to the zinc finger region of BCL6 as a multifunctional domain which, beside its known capacity to bind DNA, is involved in the nuclear targeting of the protein and in the recruitment of the class II HDACs, and hence constitutes an autonomous repressor domain. Since PLZF, a BCL6 relative, could also interact with HDAC4, -5, and 7, we suggest that class Il HDACs are largely involved in the control of the POK transcription factors activity.	CNRS, UPR 1983, F-94801 Villejuif, France; Inst Albert Bonniot, Equipe Chromatine & Express Genes, INSERM, U309, F-38706 La Tronche, France; Case Western Reserve Univ, Univ Hosp Cleveland, Sch Med, Dept Biochem,Res Inst, Cleveland, OH 44106 USA; Case Western Reserve Univ, Ctr Comprehens Canc, Cleveland, OH 44106 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University	Khochbin, S (corresponding author), CNRS, UPR 1983, 7 Rue Guy Moquet,BP 8, F-94801 Villejuif, France.	khochbin@ujf-grenoble.fr	Lemercier, Claudie/F-6759-2015; Khochbin, Saadi/M-8090-2013	Khochbin, Saadi/0000-0002-0455-0857				Albagli O, 1999, ONCOGENE, V18, P5063, DOI 10.1038/sj.onc.1202892; Albagli O, 2000, MOL CELL BIOL, V20, P8560, DOI 10.1128/MCB.20.22.8560-8570.2000; Albagli-Curiel O, 1998, DIFFERENTIATION, V64, P33, DOI 10.1046/j.1432-0436.1998.6410033.x; Bereshchenko OR, 2000, BLOOD, V96, p702A; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; David G, 1998, ONCOGENE, V16, P2549, DOI 10.1038/sj.onc.1202043; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Dhordain P, 1998, NUCLEIC ACIDS RES, V26, P4645, DOI 10.1093/nar/26.20.4645; Dhordain P, 2000, ONCOGENE, V19, P6240, DOI 10.1038/sj.onc.1203976; Fischer DD, 2002, J BIOL CHEM, V277, P6656, DOI 10.1074/jbc.M108055200; Fujii H, 1998, ONCOGENE, V16, P2159, DOI 10.1038/sj.onc.1201976; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200; Guidez F, 1998, BLOOD, V91, P2634, DOI 10.1182/blood.V91.8.2634.2634_2634_2642; Hong SH, 1997, P NATL ACAD SCI USA, V94, P9028, DOI 10.1073/pnas.94.17.9028; Huang EY, 2000, GENE DEV, V14, P45; Huynh KD, 1998, ONCOGENE, V17, P2473, DOI 10.1038/sj.onc.1202197; Huynh KD, 2000, GENE DEV, V14, P1810; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Kao HY, 2002, J BIOL CHEM, V277, P187, DOI 10.1074/jbc.M108931200; Kao HY, 2000, GENE DEV, V14, P55; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; Khochbin S, 2001, CURR OPIN GENET DEV, V11, P162, DOI 10.1016/S0959-437X(00)00174-X; Kojima S, 2001, DEVELOPMENT, V128, P57; Koken MHM, 1997, P NATL ACAD SCI USA, V94, P10255, DOI 10.1073/pnas.94.19.10255; KRUDE T, 1995, EXP CELL RES, V220, P304, DOI 10.1006/excr.1995.1320; Kumagai T, 1999, ONCOGENE, V18, P467, DOI 10.1038/sj.onc.1202306; Lemercier C, 2000, J BIOL CHEM, V275, P15594, DOI 10.1074/jbc.M908437199; Lemercier C, 1998, EMBO J, V17, P1412, DOI 10.1093/emboj/17.5.1412; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Lutz M, 2000, NUCLEIC ACIDS RES, V28, P1707, DOI 10.1093/nar/28.8.1707; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; Miska EA, 2001, NUCLEIC ACIDS RES, V29, P3439, DOI 10.1093/nar/29.16.3439; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Numoto M, 1999, BIOCHEM BIOPH RES CO, V256, P573, DOI 10.1006/bbrc.1999.0375; Reuter S, 1998, EMBO J, V17, P215, DOI 10.1093/emboj/17.1.215; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Sparrow DB, 1999, EMBO J, V18, P5085, DOI 10.1093/emboj/18.18.5085; Tyler JK, 1996, MOL CELL BIOL, V16, P6149; Verdel A, 1999, J BIOL CHEM, V274, P2440, DOI 10.1074/jbc.274.4.2440; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570; Wang AH, 1999, MOL CELL BIOL, V19, P7816; Wang AH, 2000, MOL CELL BIOL, V20, P6904, DOI 10.1128/MCB.20.18.6904-6912.2000; Wen Y, 2000, GENETICS, V156, P195; Wong CW, 1998, J BIOL CHEM, V273, P27695, DOI 10.1074/jbc.273.42.27695; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; Yoshida T, 1996, BIOCHEM BIOPH RES CO, V228, P216, DOI 10.1006/bbrc.1996.1642; Zhang CL, 2001, J BIOL CHEM, V276, P35, DOI 10.1074/jbc.M007364200; Zhao X, 2001, J BIOL CHEM, V276, P35042, DOI 10.1074/jbc.M105086200; Zhou XB, 2000, P NATL ACAD SCI USA, V97, P1056, DOI 10.1073/pnas.97.3.1056; Zhou XB, 2001, P NATL ACAD SCI USA, V98, P10572, DOI 10.1073/pnas.191375098	58	135	138	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					22045	22052		10.1074/jbc.M201736200	http://dx.doi.org/10.1074/jbc.M201736200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11929873	Green Submitted, hybrid			2022-12-27	WOS:000176286000117
J	Leung, JY; Kolligs, FT; Wu, R; Zhai, YL; Kuick, R; Hanash, S; Cho, KR; Fearon, ER				Leung, JY; Kolligs, FT; Wu, R; Zhai, YL; Kuick, R; Hanash, S; Cho, KR; Fearon, ER			Activation of AXIN2 expression by beta-catenin-T cell factor - A feedback repressor pathway regulating Wnt signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATION; NEGATIVE REGULATOR; OVARIAN CARCINOMAS; COLORECTAL-CANCER; TUMOR-SUPPRESSOR; UP-REGULATION; CYCLIN D1; C-MYC; TARGET; APC	The Wnt pathway regulates cell fate, proliferation, and apoptosis, and defects in the pathway play a key role in many cancers. Although Wnts act to stabilize beta-catenin levels in the cytosol and nucleus, a multiprotein complex containing adenomatous polyposis coli, glycogen synthase kinase 3beta, and Axin1 or its homolog Axin2/Axil/conductin promotes beta-catenin phosphorylation and subsequent proteasomal degradation. We found that the rat Axil gene was strongly induced upon neoplastic transformation of RK3E cells by mutant beta-catenin or gamma-catenin or after ligand-induced activation of a beta-catenin-estrogen receptor fusion protein. Expression of Wnt1 in murine breast epithelial cells activated the conductin gene, and human cancers with defective beta-catenin regulation had elevated AXIN2 gene and protein expression. Expression of AXIN2/Axil was strongly repressed in cancer cells by restoration of wild type adenomatous polyposis coli function or expression of a dominant negative form of T cell factor (TCF)-4. TCF binding sites in the AXIN2 promoter played a key role in the ability of beta-catenin to activate AXIN2 transcription. In contrast to AXIN2/Axil, expression of human or rat Axin1 homologs was nominally affected by beta-catenin-TCF. Because Axin2 can inhibit beta-catenin abundance and function, the data implicate AXIN2 in a negative feedback pathway regulating Wnt signaling. Additionally, although Axin1 and Axin2 have been thought to have comparable functions, the observation that Wnt pathway activation elevates AXIN2 but not AXIN1 expression suggests that there may be potentially significant functional differences between the two proteins.	Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Pediat, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Fearon, ER (corresponding author), Univ Michigan, Med Ctr, Div Med Genet, 1500 E Med Ctr Dr,4301 MSRB 3,Box 0638, Ann Arbor, MI 48109 USA.	fearon@umich.edu		Cho, Kathleen/0000-0003-0500-9998	NATIONAL CANCER INSTITUTE [R01CA085463, U19CA084953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK058771] Funding Source: NIH RePORTER; NCI NIH HHS [CA84953, CA85463] Funding Source: Medline; NIDDK NIH HHS [DK58771] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; Crawford HC, 2001, MOL CELL BIOL, V21, P1370, DOI 10.1128/MCB.21.4.1370-1383.2001; Dahmen RP, 2001, CANCER RES, V61, P7039; Farr GH, 2000, J CELL BIOL, V148, P691, DOI 10.1083/jcb.148.4.691; Fujita M, 2001, CANCER RES, V61, P7722; Furuhashi M, 2001, MOL CELL BIOL, V21, P5132, DOI 10.1128/MCB.21.15.5132-5141.2001; Gamallo C, 1999, AM J PATHOL, V155, P527, DOI 10.1016/S0002-9440(10)65148-6; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Howe LR, 1999, CANCER RES, V59, P1572; Howe LR, 2001, J BIOL CHEM, V276, P20108, DOI 10.1074/jbc.M010692200; Hsu W, 1999, J BIOL CHEM, V274, P3439, DOI 10.1074/jbc.274.6.3439; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Kadoya T, 2000, J BIOL CHEM, V275, P37030, DOI 10.1074/jbc.M005984200; Kikuchi A, 1999, CYTOKINE GROWTH F R, V10, P255, DOI 10.1016/S1359-6101(99)00017-9; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Kolligs FT, 2000, GENE DEV, V14, P1319; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Louro ID, 1999, CELL GROWTH DIFFER, V10, P503; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Polakis P, 2000, GENE DEV, V14, P1837; Polakis P, 2001, CELL, V105, P563, DOI 10.1016/S0092-8674(01)00379-8; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Saegusa M, 2001, J PATHOL, V194, P59, DOI 10.1002/path.856; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wu R, 2001, CANCER RES, V61, P8247; Yamamoto H, 2001, J BIOL CHEM, V276, P26875, DOI 10.1074/jbc.M100443200; Yamamoto H, 1998, MOL CELL BIOL, V18, P2867, DOI 10.1128/MCB.18.5.2867; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zhang Y, 1999, J BIOL CHEM, V274, P35247, DOI 10.1074/jbc.274.49.35247; Zhang Y, 2000, J BIOL CHEM, V275, P25008, DOI 10.1074/jbc.M002491200	50	304	315	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21657	21665		10.1074/jbc.M200139200	http://dx.doi.org/10.1074/jbc.M200139200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11940574	hybrid			2022-12-27	WOS:000176286000073
J	Liu, DM; Dillon, JS				Liu, DM; Dillon, JS			Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to G alpha(i2,3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; NUCLEOTIDE-BINDING-PROTEINS; SRC TYROSINE KINASE; ESTROGEN-RECEPTOR; MYOCARDIAL-INFARCTION; RAT-LIVER; CALCIUM-CONCENTRATION; BRADYKININ RECEPTOR; INTRACELLULAR CA2+; PEPTIDE RECEPTOR	The adrenal steroid dehydroepiandrosterone (DHEA) has no known cellular receptor or unifying mechanism of action, despite evidence suggesting beneficial vascular effects in humans. Based on previous data from our laboratory, we hypothesized that DHEA binds to specific cell-surface receptors to activate intracellular G-proteins and endothelial nitric-oxide synthase (eNOS). We now pharmacologically characterize a putative plasma membrane DHEA receptor and define its associated G-proteins. The [H-3]DHEA binding to isolated plasma membranes from bovine aortic endothelial cells was of high affinity (K-d = 48.7 pM) and saturable (B-max = 500 fmol/mg protein). Structurally related steroids failed to compete with DHEA for binding. The putative DHEA receptor was functionally coupled to G-proteins, because guanosine 5'-O-(3-thio)triphosphate (GTPgammaS) inhibited [H-3]DHEA binding to plasma membranes by 69%, and DHEA increased [S-35]GTPgammaS binding by 157%. DHEA stimulated [S-35]GTPgammaS binding to Galpha(i2) and Galpha(13), but not to Galpha(i1) or Galpha(o). Pretreatment of plasma membranes with antibody to Galpha(i2) or Galpha(i3), but not to Galpha(i1), inhibited the DREA activation of eNOS. Thus, DHEA receptors are expressed on endothelial cell plasma membranes and are coupled to eNOS activity through Galpha(12) and Galpha(i3). These novel findings should allow us to isolate the putative receptor and reevaluate the physiological role of DHEA activity.	Vet Adm Med Ctr, Iowa City, IA 52246 USA; Univ Iowa, Coll Med, Dept Internal Med, Div Endocrinol, Iowa City, IA 52246 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Iowa	Dillon, JS (corresponding author), Vet Adm Med Ctr, 3E10, Iowa City, IA 52246 USA.		Liu, Dongmin/A-8069-2011	Dillon, Joseph/0000-0002-4002-1418	NIA NIH HHS [AG55741, R01 AG018928] Funding Source: Medline; NIDDK NIH HHS [DK25295] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018928] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alexandersen P, 1996, ATHEROSCLEROSIS, V125, P1, DOI 10.1016/0021-9150(96)05864-9; Anstead GM, 1997, STEROIDS, V62, P268, DOI 10.1016/S0039-128X(96)00242-5; ARAD Y, 1989, ARTERIOSCLEROSIS, V9, P159, DOI 10.1161/01.ATV.9.2.159; BARRETTCONNOR E, 1986, NEW ENGL J MED, V315, P1519, DOI 10.1056/NEJM198612113152405; BATH PMW, 1991, ARTERIOSCLER THROMB, V11, P254, DOI 10.1161/01.ATV.11.2.254; Benten WPM, 1999, FASEB J, V13, P123, DOI 10.1096/fasebj.13.1.123; BROWN PJ, 1993, J BIOL CHEM, V268, P6668; Chambliss KL, 2000, CIRC RES, V87, pE44, DOI 10.1161/01.RES.87.11.e44; CHAN TM, 1993, CLIN EXP IMMUNOL, V91, P110; CHATTERJEE TK, 1993, MOL PHARMACOL, V43, P167; Christ M, 1999, STEROIDS, V64, P35, DOI 10.1016/S0039-128X(98)00103-2; COOPER CL, 1989, J BIOL CHEM, V264, P6202; Cuevas BD, 2001, J BIOL CHEM, V276, P27455, DOI 10.1074/jbc.M100556200; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; DWORKIN CR, 1986, LIFE SCI, V38, P1451, DOI 10.1016/0024-3205(86)90557-6; Eisen C, 1997, CELL MOL BIOL, V43, P165; Fiorelli G, 1996, J STEROID BIOCHEM, V59, P233, DOI 10.1016/S0960-0760(96)00092-1; Furutama D, 1998, BBA-MOL BASIS DIS, V1406, P107, DOI 10.1016/S0925-4439(97)00085-9; GILLONGO J, 1993, EUR J PHARM-MOLEC PH, V247, P119, DOI 10.1016/0922-4106(93)90068-K; GORCZYNSKA E, 1995, ENDOCRINOLOGY, V136, P2052, DOI 10.1210/en.136.5.2052; GORDON GB, 1988, J CLIN INVEST, V82, P712, DOI 10.1172/JCI113652; Haynes MP, 2000, CIRC RES, V87, P677, DOI 10.1161/01.RES.87.8.677; Herrington DM, 1995, ANN NY ACAD SCI, V774, P271; HOKLAND B, 1992, J LIPID RES, V33, P1335; HUBBARD AL, 1983, J CELL BIOL, V96, P217, DOI 10.1083/jcb.96.1.217; Jesse RL, 1995, ANN NY ACAD SCI, V774, P281; KALIMI M, 1988, BIOCHEM BIOPH RES CO, V156, P22, DOI 10.1016/S0006-291X(88)80800-3; KAWAI S, 1995, ANTICANCER RES, V15, P427; LACROIX AZ, 1992, CIRCULATION, V86, P1529, DOI 10.1161/01.CIR.86.5.1529; LANTINHERMOSO RL, 1997, AM J PHYSIOL, V273, P119; Laubinger W, 1999, LIFE SCI, V65, pPL183, DOI 10.1016/S0024-3205(99)00394-X; LESZCZYNSKI D E, 1989, Steroids, V54, P37, DOI 10.1016/0039-128X(89)90074-3; LIAO JK, 1993, J CLIN INVEST, V92, P2168, DOI 10.1172/JCI116818; LIEBERHERR M, 1994, J BIOL CHEM, V269, P7217; Lorenzen A, 2001, MOL PHARMACOL, V59, P349, DOI 10.1124/mol.59.2.349; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; MCEWEN BS, 1991, TRENDS PHARMACOL SCI, V12, P141, DOI 10.1016/0165-6147(91)90531-V; MEIKLE AW, 1992, J STEROID BIOCHEM, V42, P293, DOI 10.1016/0960-0760(92)90132-3; MITCHELL LE, 1994, CIRCULATION, V89, P89, DOI 10.1161/01.CIR.89.1.89; Miyamoto A, 1997, J BIOL CHEM, V272, P19601, DOI 10.1074/jbc.272.31.19601; MOHAN PF, 1992, STEROIDS, V57, P244, DOI 10.1016/0039-128X(92)90109-M; MUNSHI R, 1991, J BIOL CHEM, V266, P22285; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; NEGISHI M, 1993, J BIOL CHEM, V268, P26067; Nemere I, 1998, BIOCHEM BIOPH RES CO, V248, P443, DOI 10.1006/bbrc.1998.8492; Nephew KP, 1998, MOL CELL ENDOCRINOL, V143, P133, DOI 10.1016/S0303-7207(98)00128-2; OKABE T, 1995, J CLIN ENDOCR METAB, V80, P2993, DOI 10.1210/jc.80.10.2993; Picotto G, 1999, BIOCHEM J, V339, P71, DOI 10.1042/0264-6021:3390071; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; REUTER S, 1995, J STEROID BIOCHEM, V54, P227, DOI 10.1016/0960-0760(95)00132-J; Rossato M, 1999, STEROIDS, V64, P168, DOI 10.1016/S0039-128X(98)00104-4; SAKAI T, 1992, CHEM PHARM BULL, V40, P2864, DOI 10.1248/cpb.40.2864; Santos-Alvarez J, 1999, J CELL BIOCHEM, V73, P469, DOI 10.1002/(SICI)1097-4644(19990615)73:4<469::AID-JCB5>3.0.CO;2-U; Sarkar R, 1998, J VASC RES, V35, P135, DOI 10.1159/000025576; Schmidt BMW, 2000, FRONT NEUROENDOCRIN, V21, P57, DOI 10.1006/frne.1999.0189; SCHWARTZ AG, 1988, CANCER RES, V48, P4817; SENOGLES SE, 1990, J BIOL CHEM, V265, P4507; Shin WS, 1996, ANN NY ACAD SCI, V786, P233, DOI 10.1111/j.1749-6632.1996.tb39066.x; SHIVAJI S, 1992, BIOCHIM BIOPHYS ACTA, V1108, P99, DOI 10.1016/0005-2736(92)90119-7; SLOWINSKASRZEDNICKA J, 1989, ATHEROSCLEROSIS, V79, P197; SPIEGEL AM, 1987, MOL CELL ENDOCRINOL, V49, P1, DOI 10.1016/0303-7207(87)90058-X; TRUEBA M, 1991, J MEMBRANE BIOL, V120, P115, DOI 10.1007/BF01872394; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; VANBOMMEL T, 1987, ANTICANCER RES, V7, P1217; Vazquez G, 1997, BIOCHEM BIOPH RES CO, V239, P562, DOI 10.1006/bbrc.1997.7501; Watson CS, 1999, P SOC EXP BIOL MED, V220, P9, DOI 10.1046/j.1525-1373.1999.d01-2.x; WEHLING M, 1994, STEROIDS, V59, P160, DOI 10.1016/0039-128X(94)90095-7; WEHLING M, 1995, CIRC RES, V76, P973, DOI 10.1161/01.RES.76.6.973; Wehling M, 1997, ANNU REV PHYSIOL, V59, P365, DOI 10.1146/annurev.physiol.59.1.365; Wenzel-Seifert K, 1999, J BIOL CHEM, V274, P33259, DOI 10.1074/jbc.274.47.33259; Whiting KP, 2000, LIFE SCI, V67, P743, DOI 10.1016/S0024-3205(00)00669-X; WILLIAMS M, 2001, P 83 ANN M END SOC D; Wyckoff MH, 2001, J BIOL CHEM, V276, P27071, DOI 10.1074/jbc.M100312200; Yoneyama A, 1997, LIFE SCI, V60, P833, DOI 10.1016/S0024-3205(97)00011-8; Yoshimata T, 1999, LIFE SCI, V65, P431, DOI 10.1016/S0024-3205(99)00264-7	77	231	235	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21379	21388		10.1074/jbc.M200491200	http://dx.doi.org/10.1074/jbc.M200491200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11934890	hybrid			2022-12-27	WOS:000176286000035
J	Yadava, N; Potluri, P; Smith, EN; Bisevac, A; Scheffler, IE				Yadava, N; Potluri, P; Smith, EN; Bisevac, A; Scheffler, IE			Species-specific and mutant MWFE proteins - Their effect on the assembly of a functional mammalian mitochondrial complex I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; HAMSTER CELL MUTANTS; QUINONE OXIDOREDUCTASE; PARACOCCUS-DENITRIFICANS; STRUCTURAL-ANALYSIS; DEFICIENT; SUBUNITS; DEFECTS; NDH-1; GENE	The MWFE protein (70 amino acids) is highly conserved in evolution, but the human protein (80% identical to hamster) does not complement a null mutation in Chinese hamster cells. We have identified a small protein segment where significant differences exist between rodents and primates, illustrating very specifically the need for compatibility of the nuclear and mitochondrial genomes in the assembly of complex I. The segment between amino acids 39 and 46 appears to be critical for species-specific compatibility. Amino acid substitutions in this region were tested that caused a reduction of activity of the hamster protein or converted the inactive human protein into a partially active one. Such mutations could be useful in making mice with partial complex I activity as models for mitochondrial diseases. Their potential as dominant negative mutants was explored. More deleterious mutations in the NDUFA1 gene were also characterized. A conservative substitution, R50K, or a short C-terminal deletion makes the protein completely inactive. In the absence of MWFE, no high molecular weight complex was detectable by Blue Native-gel electrophoresis. The MWFE protein itself is unstable in the absence of assembled mitochondrially encoded integral membrane proteins of complex I.	Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Scheffler, IE (corresponding author), Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA.	ischeffler@ucsd.edu	Smith, Erin/E-5933-2011		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059909] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM59909] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Au HC, 1999, P NATL ACAD SCI USA, V96, P4354, DOI 10.1073/pnas.96.8.4354; Au HC, 1997, SOMAT CELL MOLEC GEN, V23, P27, DOI 10.1007/BF02679953; Barrientos A, 1998, J BIOL CHEM, V273, P14210, DOI 10.1074/jbc.273.23.14210; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; BREEN GAM, 1979, SOMAT CELL GENET, V5, P441, DOI 10.1007/BF01538879; Chomyn A, 2001, J BIOENERG BIOMEMBR, V33, P251, DOI 10.1023/A:1010791204961; Dabbeni-Sala F, 2001, FASEB J, V15, P164, DOI 10.1096/fj.00-0129com; DITTA G, 1976, SOMAT CELL GENET, V2, P331, DOI 10.1007/BF01538838; Dupuis A, 2001, J BIOENERG BIOMEMBR, V33, P159, DOI 10.1023/A:1010770600418; Finel M, 1998, BBA-BIOENERGETICS, V1364, P112, DOI 10.1016/S0005-2728(98)00022-X; FINEL M, 1994, EUR J BIOCHEM, V226, P237, DOI 10.1111/j.1432-1033.1994.tb20046.x; Friedrich T, 2001, J BIOENERG BIOMEMBR, V33, P169, DOI 10.1023/A:1010722717257; Grigorieff N, 1999, CURR OPIN STRUC BIOL, V9, P476, DOI 10.1016/S0959-440X(99)80067-0; Guenebaut V, 1998, J MOL BIOL, V276, P105, DOI 10.1006/jmbi.1997.1518; Kenyon L, 1997, P NATL ACAD SCI USA, V94, P9131, DOI 10.1073/pnas.94.17.9131; Loeffen J, 1998, AM J HUM GENET, V63, P1598, DOI 10.1086/302154; Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G; Loeffen JLCM, 1998, BIOCHEM BIOPH RES CO, V253, P415, DOI 10.1006/bbrc.1998.9786; Matsuno-Yagi A, 2001, J BIOENERG BIOMEMBR, V33, P155, DOI 10.1023/A:1010702116348; Moser S, 2000, BIOTECHNOL PROGR, V16, P724, DOI 10.1021/bp000077r; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Rasmusson AG, 1998, BBA-BIOENERGETICS, V1364, P101, DOI 10.1016/S0005-2728(98)00021-8; Robinson BH, 1998, BBA-BIOENERGETICS, V1364, P271, DOI 10.1016/S0005-2728(98)00033-4; SARKAR G, 1989, SCIENCE, V244, P331, DOI 10.1126/science.2565599; Sazanov LA, 2000, BIOCHEMISTRY-US, V39, P7229, DOI 10.1021/bi000335t; Schagger H, 2001, METHOD CELL BIOL, V65, P231, DOI 10.1016/S0091-679X(01)65014-3; Schapira AHV, 1998, BBA-BIOENERGETICS, V1364, P261, DOI 10.1016/S0005-2728(98)00032-2; SCHEFFLER IE, 1986, CARBOHYD METABOL, P77; Schulte U, 1995, METHOD ENZYMOL, V260, P3, DOI 10.1016/0076-6879(95)60126-0; Schulte U, 2001, J BIOENERG BIOMEMBR, V33, P205, DOI 10.1023/A:1010730919074; Seo BB, 1998, P NATL ACAD SCI USA, V95, P9167, DOI 10.1073/pnas.95.16.9167; Smeitink J, 2001, J BIOENERG BIOMEMBR, V33, P259, DOI 10.1023/A:1010743321800; Smeitink JAM, 1998, HUM MOL GENET, V7, P1573, DOI 10.1093/hmg/7.10.1573; SODERBERG K, 1979, SOMAT CELL GENET, V5, P225, DOI 10.1007/BF01539163; Takano S, 1996, BIOCHEMISTRY-US, V35, P9120, DOI 10.1021/bi9605853; Triepels RH, 2001, J BIOL CHEM, V276, P8892, DOI 10.1074/jbc.M009903200; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Videira A, 2001, J BIOENERG BIOMEMBR, V33, P197, DOI 10.1023/A:1010778802236; WALKER JE, 1995, BBA-MOL BASIS DIS, V1271, P221, DOI 10.1016/0925-4439(95)00031-X; Walker JE, 1995, METHOD ENZYMOL, V260, P14, DOI 10.1016/0076-6879(95)60127-9; WALKER JE, 1992, J MOL BIOL, V226, P1051, DOI 10.1016/0022-2836(92)91052-Q; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Walker JE, 1995, METHOD ENZYMOL, V260, P163, DOI 10.1016/0076-6879(95)60136-8; WALLACE DC, 1979, SOMAT CELL GENET, V5, P373, DOI 10.1007/BF01538849; YAGI T, 1993, J BIOENERG BIOMEMBR, V25, P339, DOI 10.1007/BF00762459; YAGI T, 1993, BIOCHIM BIOPHYS ACTA, V1141, P1, DOI 10.1016/0005-2728(93)90182-F; Yagi T, 1998, BBA-BIOENERGETICS, V1364, P125, DOI 10.1016/S0005-2728(98)00023-1; YAMAGUCHI M, 1993, BIOCHEMISTRY-US, V32, P1935, DOI 10.1021/bi00059a008; Yamaguchi M, 1998, J BIOL CHEM, V273, P8094, DOI 10.1074/jbc.273.14.8094; Yano T, 1999, J BIOL CHEM, V274, P28606, DOI 10.1074/jbc.274.40.28606; Zhuchenko O, 1996, GENOMICS, V37, P281, DOI 10.1006/geno.1996.0561	51	58	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21221	21230		10.1074/jbc.M202016200	http://dx.doi.org/10.1074/jbc.M202016200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11937507	hybrid			2022-12-27	WOS:000176286000015
J	Alami, M; Trescher, D; Wu, LF; Muller, M				Alami, M; Trescher, D; Wu, LF; Muller, M			Separate analysis of twin-arginine translocation (Tat)-specific membrane binding and translocation in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN TRANSLOCATION; GREEN FLUORESCENT PROTEIN; PLASMA-MEMBRANE; BACTERIAL PROTEIN; EXPORT SYSTEM; TAT PATHWAY; COMPONENTS; COMPLEX; REQUIREMENTS; PROMOTERS	The twin-arginine translocation (Tat) pathway exports those precursor proteins to the periplasmic space of bacteria that harbor a twin-arginine (RR) consensus motif in their signal sequences. We have reproduced translocation of several Tat substrates into inside-out plasma membrane vesicles from Escherichia coli. Translocation proceeding at an efficiency of up to 20% occurs specifically via the Tat pathway as indicated by M its requirement for elevated levels of the TatABC proteins in the membrane vesicles, (ii) competition by an intact twin-arginine signal peptide, and (iii) susceptibility toward dissipation of the transmembrane H+ gradient. The latter treatment, while blocking translocation, still allows for functional membrane association of Tat precursors. This is shown by the finding that translocation of isolated membrane-bound Tat precursor is restored upon re-energization of the vesicles.	Univ Freiburg, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; CNRS, Inst Biol Struct & Microbiol, UPR9043, Chim Bacterienne Lab, F-13402 Marseille 20, France	University of Freiburg; Centre National de la Recherche Scientifique (CNRS)	Muller, M (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, Hermann Herderstr 7, D-79104 Freiburg, Germany.							Behrmann M, 1998, J BIOL CHEM, V273, P13898, DOI 10.1074/jbc.273.22.13898; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Bolhuis A, 2000, FEBS LETT, V472, P88, DOI 10.1016/S0014-5793(00)01428-9; CASADABAN MJ, 1979, P NATL ACAD SCI USA, V76, P4530, DOI 10.1073/pnas.76.9.4530; Chanal A, 1998, MOL MICROBIOL, V30, P674, DOI 10.1046/j.1365-2958.1998.01095.x; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cristobal S, 1999, EMBO J, V18, P2982, DOI 10.1093/emboj/18.11.2982; De Leeuw E, 2001, FEBS LETT, V506, P143, DOI 10.1016/S0014-5793(01)02904-0; ERNST F, 1994, J BIOL CHEM, V269, P12840; MANEEWANNAKUL S, 1994, PLASMID, V31, P300, DOI 10.1006/plas.1994.1032; Muller M, 2001, PROG NUCLEIC ACID RE, V66, P107; MULLER M, 1984, P NATL ACAD SCI-BIOL, V81, P7421, DOI 10.1073/pnas.81.23.7421; MULLER M, 1987, EMBO J, V6, P3855, DOI 10.1002/j.1460-2075.1987.tb02723.x; Neumann-Haefelin C, 2000, EMBO J, V19, P6419, DOI 10.1093/emboj/19.23.6419; Oresnik IJ, 2001, MOL MICROBIOL, V40, P323, DOI 10.1046/j.1365-2958.2001.02391.x; Robinson C, 2001, NAT REV MOL CELL BIO, V2, P350, DOI 10.1038/35073038; Rodrigue A, 1999, J BIOL CHEM, V274, P13223, DOI 10.1074/jbc.274.19.13223; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Santini CL, 2001, J BIOL CHEM, V276, P8159, DOI 10.1074/jbc.C000833200; Sargent F, 2001, EUR J BIOCHEM, V268, P3361, DOI 10.1046/j.1432-1327.2001.02263.x; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Thomas JD, 2001, MOL MICROBIOL, V39, P47, DOI 10.1046/j.1365-2958.2001.02253.x; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Wexler M, 1998, FEBS LETT, V431, P339, DOI 10.1016/S0014-5793(98)00790-X; WIESELER B, 1993, MOL MICROBIOL, V7, P167, DOI 10.1111/j.1365-2958.1993.tb01108.x; Wu LF, 2000, J MOL MICROB BIOTECH, V2, P179; Yahr TL, 2001, EMBO J, V20, P2472, DOI 10.1093/emboj/20.10.2472	30	76	82	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20499	20503		10.1074/jbc.M201711200	http://dx.doi.org/10.1074/jbc.M201711200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11923313	hybrid			2022-12-27	WOS:000176204500052
J	Carreno, S; Caron, E; Cougoule, C; Emorine, LJ; Maridonneau-Parini, I				Carreno, S; Caron, E; Cougoule, C; Emorine, LJ; Maridonneau-Parini, I			p59Hck isoform induces F-actin reorganization to form protrusions of the plasma membrane in a Cdc42- and Rac-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; SRC-FAMILY KINASES; PROTEIN-TYROSINE KINASES; GAMMA RECEPTOR; SIGNAL-TRANSDUCTION; FUNCTIONAL ASSOCIATION; UROKINASE RECEPTOR; HUMAN NEUTROPHILS; CELL MOTILITY; RHO GTPASES	Hck is a protein kinase of the Src family specifically expressed in phagocytes as two isoforms, p59Hck and p61Hck, localized at the plasma membrane and lysosomes, respectively. Their individual involvement in functions ascribed to Hck, phagoeytosis, cell migration, and lysosome mobilization, is still unclarified. To investigate the specific role of p59Hck, a constitutively active variant in fusion with green fluorescent protein (p59Hck(ca)) was expressed in HeLa cells. p59Hck(ca) was found at focal adhesion sites and triggered reorganization of the actin cytoskeleton, leading to plasma membrane protrusions where it co-localized with F-actin. Similarly, microinjection of p59Hck(ca) cDNA in J774.A1 macrophages induced membrane protrusions. Whereas kinase activity and membrane association of p59Hck were dispensable for location at focal adhesions, p59Hck-induced membrane protrusions were dependent on kinase activity, plasma membrane association, and Src homology 2 but not Src homology 3 domain and were inhibited by dominant-negative forms of Cdc42 or Rac but not by blocking Rho activity. A dominant negative form of p59Hck inhibited the Cdc42- and Rac-dependent FcgammaRIIa-mediated phagocytosis. Expression of the Cdc42/Rac-interacting domain of p21-activated kinase in macrophages abolished the p59Hck(ca)-induced morphological changes. Therefore, p59Hck-triggered remodeling of the actin cytoskeleton depends upon the activity of Cdc42 and Rac to promote formation of membrane protrusions necessary for phagocytosis and cell migration.	CNRS, Inst Pharmacol & Biol Struct, UMR 5089, F-31077 Toulouse, France; UCL, MRC, Mol Cell Biol Lab, CRC Oncogene & Signal Transduct Grp, London WC1E 6BT, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of London; University College London	Maridonneau-Parini, I (corresponding author), CNRS, Inst Pharmacol & Biol Struct, UMR 5089, 205 Route Narbonne, F-31077 Toulouse, France.	maridono@ipbs.fr	Maridonneau-Parini, Isabelle/F-1985-2011; COUGOULE, Céline/ABB-4180-2021	Maridonneau-Parini, Isabelle/0000-0003-0189-0976; Carreno, Sebastien/0000-0002-5839-2102				Allen WE, 1997, J CELL SCI, V110, P707; Anderson SM, 1997, J BIOL CHEM, V272, P739, DOI 10.1074/jbc.272.2.739; Astarie-Dequeker C, 1999, INFECT IMMUN, V67, P469, DOI 10.1128/IAI.67.2.469-477.1999; BOHUSLAV J, 1995, J EXP MED, V181, P1381, DOI 10.1084/jem.181.4.1381; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Carreno S, 2000, J BIOL CHEM, V275, P36223, DOI 10.1074/jbc.M003901200; Cassard L, 2000, IMMUNOL LETT, V75, P1, DOI 10.1016/S0165-2478(00)00286-8; Chiaradonna F, 1999, EMBO J, V18, P3013, DOI 10.1093/emboj/18.11.3013; Chimini G, 2000, NAT CELL BIOL, V2, pE191, DOI 10.1038/35036454; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; DEHIO C, 1995, EMBO J, V14, P2471, DOI 10.1002/j.1460-2075.1995.tb07244.x; Doussau F, 2000, J BIOL CHEM, V275, P7764, DOI 10.1074/jbc.275.11.7764; Downey GP, 1999, J BIOL CHEM, V274, P28436, DOI 10.1074/jbc.274.40.28436; English BK, 1997, J LEUKOCYTE BIOL, V62, P859, DOI 10.1002/jlb.62.6.859; Fan GF, 2001, J BIOL CHEM, V276, P13240, DOI 10.1074/jbc.M011578200; Fazioli F, 1997, EMBO J, V16, P7279, DOI 10.1093/emboj/16.24.7279; Fincham VJ, 1998, EMBO J, V17, P81, DOI 10.1093/emboj/17.1.81; Fitzer-Attas CJ, 2000, J EXP MED, V191, P669, DOI 10.1084/jem.191.4.669; GEIGER B, 1985, J CELL BIOL, V101, P1523, DOI 10.1083/jcb.101.4.1523; GHAZIZADEH S, 1994, J BIOL CHEM, V269, P8878; Gresham HD, 2000, J EXP MED, V191, P515, DOI 10.1084/jem.191.3.515; Han JW, 1997, MOL CELL BIOL, V17, P1346, DOI 10.1128/MCB.17.3.1346; Hauck CR, 1998, EMBO J, V17, P443, DOI 10.1093/emboj/17.2.443; Hoffmann I, 2001, J CELL BIOL, V155, P133, DOI 10.1083/jcb.200106148; Ibarrola I, 1997, BBA-MOL CELL RES, V1357, P348, DOI 10.1016/S0167-4889(97)00034-7; Izadi KD, 1998, EXP CELL RES, V245, P330, DOI 10.1006/excr.1998.4259; KAPLAN G, 1977, SCAND J IMMUNOL, V6, P797, DOI 10.1111/j.1365-3083.1977.tb02153.x; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Lionberger JM, 2000, J BIOL CHEM, V275, P18581, DOI 10.1074/jbc.C000126200; LOCK P, 1991, MOL CELL BIOL, V11, P4363, DOI 10.1128/MCB.11.9.4363; Lowell CA, 1998, P NATL ACAD SCI USA, V95, P7580, DOI 10.1073/pnas.95.13.7580; Majeed M, 2001, J LEUKOCYTE BIOL, V70, P801; MARIDONNEAUPARINI I, 1986, J IMMUNOL, V137, P2925; Massol P, 1998, EMBO J, V17, P6219, DOI 10.1093/emboj/17.21.6219; MOHN H, 1995, BIOCHEM J, V309, P657; MORAN MF, 1990, P NATL ACAD SCI USA, V87, P8622, DOI 10.1073/pnas.87.21.8622; N'Diaye EN, 1998, J IMMUNOL, V161, P4983; Nair KS, 2001, CELL IMMUNOL, V208, P96, DOI 10.1006/cimm.2001.1772; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Olson MF, 1996, CURR BIOL, V6, P1628, DOI 10.1016/S0960-9822(02)70786-0; Patel JC, 2002, MOL BIOL CELL, V13, P1215, DOI 10.1091/mbc.02-01-0002; Pereira S, 2001, J IMMUNOL, V166, P4115, DOI 10.4049/jimmunol.166.6.4115; QUINTRELL N, 1987, MOL CELL BIOL, V7, P2267, DOI 10.1128/MCB.7.6.2267; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; ROBBINS SM, 1995, MOL CELL BIOL, V15, P3507; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Sato N, 1999, J IMMUNOL, V163, P6123; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Suen PW, 1999, J CELL SCI, V112, P4067; Suzuki T, 2000, J IMMUNOL, V165, P473, DOI 10.4049/jimmunol.165.1.473; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Vely F, 1997, HYBRIDOMA, V16, P519, DOI 10.1089/hyb.1997.16.519; WANG AVT, 1994, J EXP MED, V180, P1165, DOI 10.1084/jem.180.3.1165; Welch H, 1997, J BIOL CHEM, V272, P102; Wilde C, 2001, TOXICON, V39, P1647, DOI 10.1016/S0041-0101(01)00152-0; YU HT, 1992, SCIENCE, V258, P1665, DOI 10.1126/science.1280858	58	43	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					21007	21016		10.1074/jbc.M201212200	http://dx.doi.org/10.1074/jbc.M201212200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11904303	hybrid			2022-12-27	WOS:000176204500116
J	Ji, JZ; Tsuk, S; Salapatek, AMF; Huang, XH; Chikvashvili, D; Pasyk, EA; Kang, YH; Sheu, L; Tsushima, R; Diamant, N; Trimble, WS; Lotan, I; Gaisano, HY				Ji, JZ; Tsuk, S; Salapatek, AMF; Huang, XH; Chikvashvili, D; Pasyk, EA; Kang, YH; Sheu, L; Tsushima, R; Diamant, N; Trimble, WS; Lotan, I; Gaisano, HY			The 25-kDa synaptosome-associated protein (SNAP-25) binds and inhibits delayed rectifier potassium channels in secretory cells.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CFTR CHLORIDE CHANNELS; GATED K+ CHANNELS; BOTULINUM NEUROTOXIN; SYNTAXIN 1A; CLOSTRIDIAL NEUROTOXINS; INSULIN-SECRETION; CA2+ CHANNELS; BETA-CELL; KINASE-A; SUBUNIT	Delayed-rectilrier K+ channels (K-DR) are important regulators of membrane excitability in neurons and neuroendocrine cells. Opening of these voltage-dependent K+ channels results in membrane repolarization, leading to the closure of the Ca2+ channels and cessation of insulin secretion in neuroendocrine islet 13 cells. Using patch clamp techniques, we have demonstrated that the activity of the K-DR channel subtype, K(v)1.1, identified by its specific blocker dendrodotoxin-K, is inhibited by SNAP-25 in insulinoma HIT-T15 beta cells. A coprecipitation study of rat brain confirmed that SNAP-25 interacts with the K(v)1.1 protein. Cleavage of SNAP-25 by expression of botulinum neurotoxin A in HIT-T15 cells relieved this SNAP-25-mediated inhibition of KDR. This inhibitory effect of SNAP-25 is mediated by the N terminus of K(v)1.1, likely by direct interactions with K(v)1.1 and/or K(v)beta subunits, as revealed by co-immunoprecipitation performed in the Xenopus oocyte expression system and in vitro binding. Taken together we have concluded that SNAP-25 mediates secretion not only through its participation in the exocytotic SNARE complex but also by regulating membrane potential and calcium entry through its interaction with K-DR channels.	Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; State Ocean Adm, Inst Oceanog 1, Qingdao 266061, Peoples R China; Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); State Oceanic Administration; Tel Aviv University; Sackler Faculty of Medicine	Gaisano, HY (corresponding author), Univ Toronto, Dept Med, Rm 7226,Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	herbert.gaisano@utoronto.ca			Canadian Institutes of Health Research [42394] Funding Source: Medline; NIDDK NIH HHS [DK55160] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK055160] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BETSHOLTZ C, 1990, FEBS LETT, V263, P121, DOI 10.1016/0014-5793(90)80719-Y; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Biggin PC, 2000, CURR OPIN STRUC BIOL, V10, P456, DOI 10.1016/S0959-440X(00)00114-7; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BOKVIST K, 1990, J PHYSIOL-LONDON, V423, P311, DOI 10.1113/jphysiol.1990.sp018024; Bressler R, 1997, ARCH INTERN MED, V157, P836, DOI 10.1001/archinte.157.8.836; CHOW RH, 1994, P NATL ACAD SCI USA, V91, P12765, DOI 10.1073/pnas.91.26.12765; Dascal N., 1992, METHODS MOL BIOL VOL, VVolume 13, P205; Dukes ID, 1996, DIABETES, V45, P845, DOI 10.2337/diabetes.45.7.845; Fili O, 2001, J NEUROSCI, V21, P1964, DOI 10.1523/JNEUROSCI.21-06-01964.2001; Gaisano HY, 1996, MOL BIOL CELL, V7, P2019, DOI 10.1091/mbc.7.12.2019; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Huang XH, 1998, MOL ENDOCRINOL, V12, P1060, DOI 10.1210/me.12.7.1060; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Igarashi M, 1996, J CELL BIOL, V134, P205, DOI 10.1083/jcb.134.1.205; IVANINA T, 1994, BIOCHEMISTRY-US, V33, P8786, DOI 10.1021/bi00195a021; Jing J, 1999, EMBO J, V18, P1245, DOI 10.1093/emboj/18.5.1245; LEVIN G, 1995, J BIOL CHEM, V270, P14611, DOI 10.1074/jbc.270.24.14611; Levin G, 1996, J BIOL CHEM, V271, P29321, DOI 10.1074/jbc.271.46.29321; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; MacDonald PE, 2001, MOL ENDOCRINOL, V15, P1423, DOI 10.1210/me.15.8.1423; Miller C., 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-4-reviews0004.REVIEWS0004, DOI 10.1186/GB-2000-1-4-REVIEWS0004.REVIEWS0004, 10.1186/gb-2000-1-4-reviews0004, DOI 10.1186/GB-2000-1-4-REVIEWS0004]; Naren AP, 1998, P NATL ACAD SCI USA, V95, P10972, DOI 10.1073/pnas.95.18.10972; Naren AP, 1997, NATURE, V390, P302, DOI 10.1038/36882; PELLEGRINI LL, 1995, EMBO J, V14, P4705, DOI 10.1002/j.1460-2075.1995.tb00152.x; Peters KW, 1999, AM J PHYSIOL-CELL PH, V277, pC174, DOI 10.1152/ajpcell.1999.277.1.C174; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; Qi JJ, 1999, J BIOL CHEM, V274, P30345, DOI 10.1074/jbc.274.43.30345; Renstrom E, 1997, J PHYSIOL-LONDON, V502, P105, DOI 10.1111/j.1469-7793.1997.105bl.x; Rorsman P, 1997, DIABETOLOGIA, V40, P487, DOI 10.1007/s001250050706; SADOUL K, 1995, J CELL BIOL, V128, P1019, DOI 10.1083/jcb.128.6.1019; Salapatek AMF, 1999, MOL ENDOCRINOL, V13, P1305, DOI 10.1210/me.13.8.1305; Saxena S, 1999, J BIOL CHEM, V274, P20812, DOI 10.1074/jbc.274.30.20812; Sewing S, 1996, NEURON, V16, P455, DOI 10.1016/S0896-6273(00)80063-X; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; SHEN NV, 1993, NEURON, V11, P67; Sheng ZH, 1996, NATURE, V379, P451, DOI 10.1038/379451a0; SMITH PA, 1990, J GEN PHYSIOL, V95, P1041, DOI 10.1085/jgp.95.6.1041; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0; WAIGNER BJ, 2001, NATURE, V411, P805; WEBER T, 1998, NATURE, V395, P328; Wei SH, 2000, EMBO J, V19, P1279, DOI 10.1093/emboj/19.6.1279; Wheeler MB, 1996, ENDOCRINOLOGY, V137, P1340, DOI 10.1210/en.137.4.1340; Wiser O, 1996, EMBO J, V15, P4100, DOI 10.1002/j.1460-2075.1996.tb00785.x; Wiser O, 1999, P NATL ACAD SCI USA, V96, P248, DOI 10.1073/pnas.96.1.248; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; Yang SN, 1999, P NATL ACAD SCI USA, V96, P10164, DOI 10.1073/pnas.96.18.10164; Yi BA, 2000, NEURON, V27, P423, DOI 10.1016/S0896-6273(00)00052-0; Yu WF, 1996, NEURON, V16, P441, DOI 10.1016/S0896-6273(00)80062-8; Zhong HJ, 1999, NAT NEUROSCI, V2, P939, DOI 10.1038/14721	53	40	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20195	20204		10.1074/jbc.M201034200	http://dx.doi.org/10.1074/jbc.M201034200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11925439	hybrid			2022-12-27	WOS:000176204500015
J	Sandhoff, R; Hepbildikler, ST; Jennemann, R; Geyer, R; Gieselmann, V; Proia, RL; Wiegandt, H; Grone, HJ				Sandhoff, R; Hepbildikler, ST; Jennemann, R; Geyer, R; Gieselmann, V; Proia, RL; Wiegandt, H; Grone, HJ			Kidney sulfatides in mouse models of inherited glycosphingolipid disorders - Determination by nano-electrospray ionization tandem mass spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED GLYCOPROTEIN OLIGOSACCHARIDES; CAPILLARY GAS-CHROMATOGRAPHY; NORMAL HUMAN-LEUKOCYTES; LEUKEMIA HL60 CELLS; LOW PICOMOLE LEVEL; COMPLEX GANGLIOSIDES; EMBRYONIC ANTIGEN-1; NERVOUS-SYSTEM; E-SELECTIN; TAY-SACHS	Sulfatides show structural, and possibly physiological similarities to gangliosides. Kidney dysfunction might be correlated with changes in sulfatides, the major acidic glycosphingolipids in this organ. To elucidate their in vivo metabolic pathway these compounds were analyzed in mice afflicted with inherited glycosphingolipid disorders. The mice under study lacked the genes encoding either beta-hexosaminidase alpha-subunit (Hexa-/-), the beta-hexosaminidase beta-subunit (Hexb-/-), both beta-hexosaminidase a and beta-subunits (Hexa-/- and Hexb-/-), GD3 synthase (GD3S-/-), GD3 synthase and Ga1NAc transferase (GD3S-/- and GaINAcT-/-), GNU activator protein (Gm2a-/-), or arylsulfatase A (ASA-/-). Quantification of the sulfatides, (ISO3)-S-3--GalCer (SM4s), (IISO3-)-S-3. LacCer (SM3), (IISO3-)-S-3-Gg(3)Cer (SM2a), and IV3, II3-(SO3-)(2)-Gg(4)Cer (SB1a), was performed by nano-electrospray tandem mass spectrometry. We conclude for the in vivo situation in mouse kidneys that: 1) a single enzyme (GalNAc transferase) is responsible for the synthesis of SM2a and GNU from SM3 and GM3, respectively. 2) In analogy to GD1a, SB1a is degraded via SM2a. 3) SM2a is hydrolyzed to SM3 by beta-hexosaminidase S (Hex S) and Hex A, but not Hex B. Both enzymes are supported by GNU-activator protein. 4) Arylsulfatase A is required to degrade SB1a. It is probably the sole sphingolipid-sulfatase cleaving the galactosyl-3-sulfate bond. In addition, a human Tay-Sachs patient's liver was investigated, which showed accumulation of SM2a along with GNU storage. The different ceramide compositions of both compounds indicated they were probably derived from different cell types. These data demonstrate that in vivo the sulfatides of the ganglio-series follow the same metabolic pathways as the gangliosides with the replacement of sulfotransferases and sulfatases by sialyltransferases and sialidases. Furthermore, a novel neutral GSL, IV(6)GlcNAcbeta-Gb(4)Cer, was found to accumulate only in Hexa-/- and Hexb-/- mouse kidneys. From this we conclude that Hex S also efficiently cleaves terminal beta1-6-linked HexNAc residues from neutral GSLs in vivo.	Deutsch Krebsforschungszentrum, Abt Zellulare & Mol Pathol, D-69120 Heidelberg, Germany; Univ Bonn, Kekule Inst Organ Chem & Biochem, D-53121 Bonn, Germany; Univ Giessen Klinikum, Inst Biochem, D-35392 Giessen, Germany; Univ Bonn, Inst Physiol Chem, D-53115 Bonn, Germany; NIDDKD, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA	Helmholtz Association; German Cancer Research Center (DKFZ); University of Bonn; University Hospital of Giessen & Marburg; University of Bonn; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Sandhoff, R (corresponding author), Deutsch Krebsforschungszentrum, Abt Zellulare & Mol Pathol, INF 280, D-69120 Heidelberg, Germany.	r.sandhoff@dkfz-heidelberg.de	Proia, Richard L/A-7908-2012	Proia, Richard/0000-0003-0456-1270	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK056000] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BEZOUSKA K, 1994, NATURE, V372, P150, DOI 10.1038/372150a0; Bosio A, 1996, P NATL ACAD SCI USA, V93, P13280, DOI 10.1073/pnas.93.23.13280; Brugger B, 2000, J CELL BIOL, V151, P507, DOI 10.1083/jcb.151.3.507; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; GEYER R, 1982, ANAL BIOCHEM, V121, P263, DOI 10.1016/0003-2697(82)90478-X; GEYER R, 1994, METHOD ENZYMOL, V230, P86; GEYER R, 1983, ANAL BIOCHEM, V133, P197, DOI 10.1016/0003-2697(83)90243-9; Gravel R. A., 2001, METABOLIC MOL BASES, V3, P3827; Gu M, 1997, ANAL BIOCHEM, V244, P347, DOI 10.1006/abio.1996.9915; HARZER K, 1974, H-S Z PHYSIOL CHEM, V355, P744; Hepbildikler ST, 2002, J BIOL CHEM, V277, P2562, DOI 10.1074/jbc.M105457200; Hess B, 1996, P NATL ACAD SCI USA, V93, P14821, DOI 10.1073/pnas.93.25.14821; HIRAIWA N, 1990, CANCER RES, V50, P2917; Hsu FF, 1998, BBA-LIPID LIPID MET, V1392, P202, DOI 10.1016/S0005-2760(98)00034-4; Ishizuka I, 1997, PROG LIPID RES, V36, P245, DOI 10.1016/S0163-7827(97)00011-8; ISHIZUKA I, 1985, J BIOL CHEM, V260, P1256; JENNEMANN R, 1994, J BIOCHEM-TOKYO, V116, P450, DOI 10.1093/oxfordjournals.jbchem.a124545; Kabayama K, 2001, J BIOL CHEM, V276, P26777, DOI 10.1074/jbc.M100428200; Kawai H, 2001, J BIOL CHEM, V276, P6885, DOI 10.1074/jbc.C000847200; KOBAYASHI T, 1993, BRIT J CANCER, V67, P76, DOI 10.1038/bjc.1993.12; KOBAYASHI T, 1994, INT J CANCER, V56, P281, DOI 10.1002/ijc.2910560223; Kolter T, 1999, ANGEW CHEM INT EDIT, V38, P1532, DOI 10.1002/(SICI)1521-3773(19990601)38:11<1532::AID-ANIE1532>3.0.CO;2-U; Kurita T, 2000, J LIPID RES, V41, P846; Liebisch G, 1999, J LIPID RES, V40, P1539; Liu YJ, 1997, P NATL ACAD SCI USA, V94, P8138, DOI 10.1073/pnas.94.15.8138; Marbois BN, 2000, BBA-MOL CELL BIOL L, V1484, P59, DOI 10.1016/S1388-1981(99)00201-2; Metelmann W, 2000, RAPID COMMUN MASS SP, V14, P543, DOI 10.1002/(SICI)1097-0231(20000415)14:7<543::AID-RCM908>3.0.CO;2-J; Metelmann W, 2001, J MASS SPECTROM, V36, P21, DOI 10.1002/jms.100; METZGER K, 1995, ANAL CHEM, V67, P4178, DOI 10.1021/ac00118a022; NAGAI K, 1987, J BIOCHEM-TOKYO, V101, P1115, DOI 10.1093/oxfordjournals.jbchem.a121976; NAGAI K, 1984, J BIOCHEM-TOKYO, V95, P1501, DOI 10.1093/oxfordjournals.jbchem.a134758; NILSSON O, 1982, J LIPID RES, V23, P327; Oya Y, 1998, ACTA NEUROPATHOL, V96, P29, DOI 10.1007/s004010050857; PARENTE JP, 1985, CARBOHYD RES, V141, P41, DOI 10.1016/S0008-6215(00)90753-5; Reinhold VN, 1996, METHOD ENZYMOL, V271, P377; Segrest J P, 1971, Biochem Biophys Res Commun, V44, P390; Sandhoff R, 1999, J LIPID RES, V40, P126; Sango K, 1996, NAT GENET, V14, P348, DOI 10.1038/ng1196-348; SANGO K, 1995, NAT GENET, V11, P170, DOI 10.1038/ng1095-170; Sekine M, 1997, J BIOL CHEM, V272, P27246, DOI 10.1074/jbc.272.43.27246; SEKINE M, 1987, J BIOCHEM-TOKYO, V101, P563, DOI 10.1093/jb/101.3.563; Sekine M, 2001, EUR J BIOCHEM, V268, P1129, DOI 10.1046/j.1432-1327.2001.01980.x; SEKINE M, 1987, J BIOCHEM-TOKYO, V101, P553, DOI 10.1093/jb/101.3.553; Stroud MR, 1996, BIOCHEMISTRY-US, V35, P770, DOI 10.1021/bi952461g; Stroud MR, 1996, BIOCHEMISTRY-US, V35, P758, DOI 10.1021/bi951600r; Sullards MC, 2000, METHOD ENZYMOL, V312, P32; Suzuki K, 1997, J NEUROPATH EXP NEUR, V56, P693; Tadano-Aritomi K, 2000, J LIPID RES, V41, P1237; Takamiya K, 1996, P NATL ACAD SCI USA, V93, P10662, DOI 10.1073/pnas.93.20.10662; Takamiya K, 1998, P NATL ACAD SCI USA, V95, P12147, DOI 10.1073/pnas.95.21.12147; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; VONFIGURA K, 2001, METABOLIC MOL BASES, P3695; Whitfield PD, 2001, MOL GENET METAB, V73, P30, DOI 10.1006/mgme.2001.3165; YAMANAKA S, 1994, P NATL ACAD SCI USA, V91, P9975, DOI 10.1073/pnas.91.21.9975; Yamashita T, 1999, P NATL ACAD SCI USA, V96, P9142, DOI 10.1073/pnas.96.16.9142	55	49	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20386	20398		10.1074/jbc.M110641200	http://dx.doi.org/10.1074/jbc.M110641200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11919180	hybrid			2022-12-27	WOS:000176204500038
J	Tate, JJ; Cox, KH; Rai, R; Cooper, TG				Tate, JJ; Cox, KH; Rai, R; Cooper, TG			Mks1p is required for negative regulation of retrograde gene expression in Saccharomyces cerevisiae but does not affect nitrogen catabolite repression-sensitive gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOR; RAPAMYCIN; PROTEIN; LOCALIZATION; PATHWAY; TARGET; GLN3P; YEAST; URE2P	The Tor1/2p signal transduction pathway regulates nitrogen catabolite repression (NCR)-sensitive (GAP1, GAT1, DAL5) and retrograde (CIT2, DLD3, IDH112) gene expression by controlling intracellular localization of the transcription activators, Gln3p and Gat1p, and Rtg1p and Rtg3p, respectively. The accepted pathway for this regulation is NH3 or excess nitrogen + Mks1p + Ure2p + Gln3p --> DAL5, and rapamycin or limiting nitrogen Torp --> Tap42 + Mks1p --> Rtg1/3p --> CIT2, respectively. In current models, Mks1p positively regulates both Gln3p (and DAL5 expression) and Rtg113p (and CIT2 expression). Here, in contrast, we show the following. W Mks1p is a strong negative regulator of CIT2 expression and does not effect NCR-sensitive expression of DAL5 or GAP1. (ii) Retrograde carbon and NCR-sensitive nitrogen metabolism are not linked by the quality of the nitrogen source, i.e. its ability to elicit NCR, but by the product of its catabolism, i.e. glutamate or ammonia. (iii) In some instances, we can dissociate rapamycin-induced CIT2 expression from Mks1p function, i.e. rapamycin does not suppress Mks1p-mediated down-regulation of CIT2 expression. These findings suggest that currently accepted models of Tor1/2p signal transduction pathway regulation require revision.	Univ Tennessee, Dept Mol Sci, Memphis, TN 38120 USA	University of Tennessee System; University of Tennessee Health Science Center	Cooper, TG (corresponding author), Univ Tennessee, Dept Mol Sci, Memphis, TN 38120 USA.	tcooper@utmem.edu		Cooper, Terrance G./0000-0002-7651-9963	NIGMS NIH HHS [GM-35642, R01 GM035642] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035642] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Cooper T., 1982, MOL BIOL YEAST SACCH, P39, DOI DOI 10.1101/087969180.11B.39; Cooper T. G., 1996, P139; COOPER TG, 2002, FEMS MICROBIOL REV, V737, P1; Cox KH, 1999, YEAST, V15, P703, DOI 10.1002/(SICI)1097-0061(19990615)15:8<703::AID-YEA413>3.0.CO;2-Z; Cox KH, 2000, J BIOL CHEM, V275, P17611, DOI 10.1074/jbc.M001648200; Dennis PB, 1999, CURR OPIN GENET DEV, V9, P49, DOI 10.1016/S0959-437X(99)80007-0; DRILLIEN R, 1972, J BACTERIOL, V109, P203, DOI 10.1128/JB.109.1.203-208.1972; DRILLIEN R, 1973, BIOCHEM BIOPH RES CO, V53, P367, DOI 10.1016/0006-291X(73)90671-2; Edskes HK, 2000, P NATL ACAD SCI USA, V97, P6625, DOI 10.1073/pnas.120168697; Edskes HK, 1999, GENETICS, V153, P585; Feller A, 1997, YEAST, V13, P1337, DOI 10.1002/(SICI)1097-0061(199711)13:14<1337::AID-YEA186>3.0.CO;2-O; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Hofman-Bang J, 1999, MOL BIOTECHNOL, V12, P35, DOI 10.1385/MB:12:1:35; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; Komeili A, 2000, J CELL BIOL, V151, P863, DOI 10.1083/jcb.151.4.863; MAGASANIK B, 1992, MOL CELLULAR BIOL YE, V2, P283; MATSUURA A, 1993, MOL GEN GENET, V238, P6, DOI 10.1007/BF00279524; Pierce MM, 2001, P NATL ACAD SCI USA, V98, P13213, DOI 10.1073/pnas.181486098; RAI R, 1989, MOL CELL BIOL, V9, P602, DOI 10.1128/MCB.9.2.602; RAMOS F, 1985, MOL GEN GENET, V200, P291, DOI 10.1007/BF00425438; Rohde J, 2001, J BIOL CHEM, V276, P9583, DOI 10.1074/jbc.R000034200; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Sekito T, 2000, MOL BIOL CELL, V11, P2103, DOI 10.1091/mbc.11.6.2103; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; ter Schure EG, 2000, FEMS MICROBIOL REV, V24, P67, DOI 10.1016/S0168-6445(99)00030-3; TUROSCY V, 1987, J BACTERIOL, V169, P2598, DOI 10.1128/jb.169.6.2598-2600.1987; WICKERHAM LJ, 1946, J BACTERIOL, V52, P293, DOI 10.1128/JB.52.3.293-301.1946; ZHEGCHANG L, 1999, MOL CELL BIOL, V19, P6720	32	54	54	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20477	20482		10.1074/jbc.M200962200	http://dx.doi.org/10.1074/jbc.M200962200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11923302	hybrid, Green Accepted			2022-12-27	WOS:000176204500049
J	Parnell, SC; Magenheimer, BS; Maser, RL; Zien, CA; Frischauf, AM; Calvet, JP				Parnell, SC; Magenheimer, BS; Maser, RL; Zien, CA; Frischauf, AM; Calvet, JP			Polycystin-1 activation of c-jun N-terminal kinase and AP-1 is mediated by heterotrimeric G proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; MUSCARINIC ACETYLCHOLINE-RECEPTORS; KIDNEY-DISEASE GENE; BETA-GAMMA; IN-VITRO; COUPLED RECEPTORS; CATION CHANNEL; NH2-TERMINAL KINASE; TYROSINE KINASE; ALPHA-SUBUNIT	Functional analysis of polycystin-1, the product of the gene most frequently mutated in autosomal dominant polycystic kidney disease, has revealed that this protein is involved in the regulation of diverse signaling pathways such as the activation of the transcription factor AP-1 and modulation of Wnt signaling. However, the initial steps involved in the activation of such cascades have remained unclear. We demonstrated previously that the C-terminal cytosolic tail of polycystin-1 binds and activates heterotrimeric G proteins in vitro. To test if polycystin-1 can activate cellular signaling cascades via heterotrimeric G protein subunits, polycystin-1 C-terminal tail-mediated c-Jun N-terminal kinase (JNK) and AP-1 activities were assayed in transiently transfected 293T cells in the presence of dominant-negative, G protein inhibiting constructs, and in the presence of cotransfected Galpha subunits. The results showed that polycystin-l-mediated JNK/AP-1 activation is mediated by Galpha and Gbetagamma subunits. Polycystin-1-mediated AP-1 activity could be significantly augmented by cotransfected Galpha(i), Galpha(q), and Galpha(12/13) subunits, suggesting that polycystin-1 can couple with and activate several heterotrimeric G protein families.	Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66160 USA; Salzburg Univ, Inst Genet & Allgemeine Biol, A-5020 Salzburg, Austria	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Salzburg University	Calvet, JP (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK057301, P01DK053763] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK53763, DK57301] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arnould T, 1999, MOL CELL BIOL, V19, P3423; Arnould T, 1998, J BIOL CHEM, V273, P6013, DOI 10.1074/jbc.273.11.6013; Boletta A, 2000, MOL CELL, V6, P1267, DOI 10.1016/S1097-2765(00)00123-4; BURN TC, 1995, HUM MOL GENET, V4, P575, DOI 10.1093/hmg/4.4.575; CALVET JP, 1993, KIDNEY INT, V43, P101, DOI 10.1038/ki.1993.17; Calvet JP, 1998, J NEPHROL, V11, P24; Calvet JP, 2001, SEMIN NEPHROL, V21, P107, DOI 10.1053/snep.2001.20929; CAMPBELL V, 1995, FEBS LETT, V370, P135, DOI 10.1016/0014-5793(95)00813-O; Collins LR, 1996, J BIOL CHEM, V271, P17349, DOI 10.1074/jbc.271.29.17349; COSO OA, 1995, J BIOL CHEM, V270, P5620, DOI 10.1074/jbc.270.10.5620; Coso OA, 1996, J BIOL CHEM, V271, P3963; Delmas P, 2002, J BIOL CHEM, V277, P11276, DOI 10.1074/jbc.M110483200; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; Dolphin AC, 1998, J PHYSIOL-LONDON, V506, P3, DOI 10.1111/j.1469-7793.1998.003bx.x; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; GRANTHAM JJ, 1997, KIDNEY INT S, V63, P93; Guay-Woodford LM, 2000, J AM SOC NEPHROL, V11, P1253, DOI 10.1681/ASN.V1171253; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Hanaoka K, 2000, J AM SOC NEPHROL, V11, P1179, DOI 10.1681/ASN.V1171179; HARRIS PC, 1995, J AM SOC NEPHROL, V6, P1125; HERMOUET S, 1991, P NATL ACAD SCI USA, V88, P10455, DOI 10.1073/pnas.88.23.10455; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Ibraghimov-Beskrovnaya O, 2000, HUM MOL GENET, V9, P1641, DOI 10.1093/hmg/9.11.1641; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Kim E, 1999, J BIOL CHEM, V274, P4947, DOI 10.1074/jbc.274.8.4947; Kim E, 1999, P NATL ACAD SCI USA, V96, P6371, DOI 10.1073/pnas.96.11.6371; Kim K, 2000, P NATL ACAD SCI USA, V97, P1731, DOI 10.1073/pnas.040550097; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Levi NL, 1998, MOL ENDOCRINOL, V12, P815, DOI 10.1210/me.12.6.815; Lohning C, 1997, MAMM GENOME, V8, P307, DOI 10.1007/s003359900429; Mao JH, 1998, P NATL ACAD SCI USA, V95, P12973, DOI 10.1073/pnas.95.22.12973; Marinissen MJ, 1999, MOL CELL BIOL, V19, P4289; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; Martin-Blanco E, 2000, P NATL ACAD SCI USA, V97, P7888, DOI 10.1073/pnas.97.14.7888; McEwen DG, 2000, DEVELOPMENT, V127, P3607; Mechta-Grigoriou F, 2001, ONCOGENE, V20, P2378, DOI 10.1038/sj.onc.1204381; Meir A, 2000, BIOPHYS J, V79, P731, DOI 10.1016/S0006-3495(00)76331-4; MITCHELL FM, 1995, BIOCHEM J, V309, P381, DOI 10.1042/bj3090381; Morisset S, 2000, NATURE, V408, P860, DOI 10.1038/35048583; Parnell SC, 1998, BIOCHEM BIOPH RES CO, V251, P625, DOI 10.1006/bbrc.1998.9514; Parnell SC, 1999, BIOCHEM BIOPH RES CO, V259, P539, DOI 10.1006/bbrc.1999.0810; Ponting CP, 1999, CURR BIOL, V9, pR585, DOI 10.1016/S0960-9822(99)80379-0; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Ramirez MT, 1997, J BIOL CHEM, V272, P14057, DOI 10.1074/jbc.272.22.14057; Rogers JA, 1996, J BIOL CHEM, V271, P17519, DOI 10.1074/jbc.271.29.17519; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Rumenapp U, 2001, J BIOL CHEM, V276, P2474, DOI 10.1074/jbc.M004957200; SLEPAK VZ, 1995, J BIOL CHEM, V270, P4037, DOI 10.1074/jbc.270.8.4037; Stronach BE, 1999, ONCOGENE, V18, P6172, DOI 10.1038/sj.onc.1203125; Sugita S, 1998, J BIOL CHEM, V273, P32715, DOI 10.1074/jbc.273.49.32715; Sutters M, 2001, KIDNEY INT, V60, P484, DOI 10.1046/j.1523-1755.2001.060002484.x; Torres VE, 1998, CURR OPIN NEPHROL HY, V7, P159, DOI 10.1097/00041552-199803000-00004; Vandorpe DH, 2001, J BIOL CHEM, V276, P4093, DOI 10.1074/jbc.M006252200; Vassilev PM, 2001, BIOCHEM BIOPH RES CO, V282, P341, DOI 10.1006/bbrc.2001.4554; VoynoYasenetskaya TA, 1996, J BIOL CHEM, V271, P21081, DOI 10.1074/jbc.271.35.21081; WARD CJ, 1994, CELL, V77, P881; WATSON S, 1996, TRENDS PHARMACOL SCI, V7, P1; Weber U, 2000, DEVELOPMENT, V127, P3619; Wilson PD, 2001, J AM SOC NEPHROL, V12, P834, DOI 10.1681/ASN.V124834; Wisdom R, 1999, EXP CELL RES, V253, P180, DOI 10.1006/excr.1999.4685; Wylie PG, 1999, BIOCHEM J, V338, P619, DOI 10.1042/0264-6021:3380619; Yamaguchi T, 2000, KIDNEY INT, V57, P1460, DOI 10.1046/j.1523-1755.2000.00991.x; Yamauchi J, 2000, J BIOL CHEM, V275, P7633, DOI 10.1074/jbc.275.11.7633; Yamauchi J, 1999, J BIOL CHEM, V274, P1957, DOI 10.1074/jbc.274.4.1957; Yassin M, 1996, BIOCHEM BIOPH RES CO, V220, P453, DOI 10.1006/bbrc.1996.0426	68	129	134	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19566	19572		10.1074/jbc.M201875200	http://dx.doi.org/10.1074/jbc.M201875200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11912216	hybrid			2022-12-27	WOS:000175894800044
J	Leem, JY; Vijayan, S; Han, P; Cai, DM; Machura, M; Lopes, KO; Veselits, ML; Xu, HX; Thinakaran, G				Leem, JY; Vijayan, S; Han, P; Cai, DM; Machura, M; Lopes, KO; Veselits, ML; Xu, HX; Thinakaran, G			Presenilin 1 is required for maturation and cell surface accumulation of nicastrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; SUBCELLULAR-LOCALIZATION; BETA-PROTEIN; CLEAVAGE; APP; INHIBITORS; SITE; A-BETA-40/42; ASSOCIATION	Proteolytic processing of amyloid precursor protein generates beta-amyloid (Abeta) peptides that are deposited in senile plaques in brains of aged individuals and patients with Alzheimer's disease. Presenilins (PS1 and PS2) facilitate the final step in Abeta production, the intramembranous gamma-secretase cleavage of amyloid precursor protein. Biochemical and pharmacological evidence support a catalytic or accessory role for PSI in gamma-secretase cleavage, as well as a regulatory role in select membrane protein trafficking. In this report, we demonstrate that PS1 is required for maturation and cell surface accumulation of nicastrin, an integral component of the multimeric gamma-secretase complex. Using kinetic labeling studies we show that in PS1(-/-)/PS2(-/-) cells nicastrin fails to reach the medial Golgi compartment, and as a consequence, is incompletely glycosylated. Stable expression of human PS1 restores these deficiencies in PS1(-/-) fibroblasts. Moreover, membrane fractionation studies show co-localization of PS1 fragments with mature nicastrin. These results indicate a novel chaperone-type role for PS1 and PS2 in facilitating nicastrin maturation and transport in the early biosynthetic compartments. Our findings are consistent with PS1 influencing gamma-secretase processing at multiple steps, including maturation and intracellular trafficking of substrates and component(s) of the gamma-secretase complex.	Univ Chicago, Ctr Mol Neurobiol, Dept Neurol Pharmacol & Physiol, Chicago, IL 60637 USA; Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA; Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA	University of Chicago; University of Chicago; Rockefeller University	Thinakaran, G (corresponding author), Univ Chicago, Ctr Mol Neurobiol, Dept Neurol Pharmacol & Physiol, Knapp R212,924 E 57th St, Chicago, IL 60637 USA.		Xu, Huaxi/AAV-7177-2021	Radomski, Kryslaine/0000-0001-9624-623X	NATIONAL INSTITUTE ON AGING [P01AG009464, R01AG019070] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG009464, AG09464, AG19070] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; BOURDON MA, 1987, P NATL ACAD SCI USA, V84, P3194, DOI 10.1073/pnas.84.10.3194; Chung HM, 2001, NAT CELL BIOL, V3, P1129, DOI 10.1038/ncb1201-1129; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; Cupers P, 2001, J CELL BIOL, V154, P731, DOI 10.1083/jcb.200104045; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Hu Y, 2002, DEV CELL, V2, P69, DOI 10.1016/S1534-5807(01)00105-8; Kim SH, 2000, NEUROBIOL DIS, V7, P99, DOI 10.1006/nbdi.1999.0280; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Lopez-Schier H, 2002, DEV CELL, V2, P79, DOI 10.1016/S1534-5807(01)00109-5; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; Petit A, 2001, NAT CELL BIOL, V3, P507, DOI 10.1038/35074581; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Sato N, 2000, NAT CELL BIOL, V2, P863, DOI 10.1038/35046500; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295; St George-Hyslop PH, 2000, BIOL PSYCHIAT, V47, P183, DOI 10.1016/S0006-3223(99)00301-7; Taniguchi Y, 2002, P NATL ACAD SCI USA, V99, P4014, DOI 10.1073/pnas.052017699; THINAKARAN G, 1994, J BIOL CHEM, V269, P22099; Thinakaran G, 2001, J MOL NEUROSCI, V17, P183, DOI 10.1385/JMN:17:2:183; Thinakaran G, 1998, NEUROBIOL DIS, V4, P438, DOI 10.1006/nbdi.1998.0171; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; Yan RQ, 2001, J BIOL CHEM, V276, P36788, DOI 10.1074/jbc.M104350200; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	30	173	175	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					19236	19240		10.1074/jbc.C200148200	http://dx.doi.org/10.1074/jbc.C200148200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11943765	hybrid			2022-12-27	WOS:000175975800128
J	Rose, T; Di Cera, E				Rose, T; Di Cera, E			Three-dimensional modeling of thrombin-fibrinogen interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; A-ALPHA; BOVINE THROMBIN; BINDING; DYSFIBRINOGENEMIA; SPECIFICITY; RESOLUTION; RECEPTOR; RESIDUES; PEPTIDES	Three-dimensional models of thrombin complexed with large fragments of the fibrinogen Aalpha and Bbeta chains are presented. The models are consistent with the results of recent mutagenesis studies of thrombin and with the information available on naturally occurring fibrinogen mutants. Thrombin recognizes fibrinogen with an extended binding surface, key elements of which are Tyr(76) in exosite I, located about 20 Angstrom away from the active site, and the aryl binding site located in close proximity to the catalytic triad. A highly conserved aromatic-Pro-aromatic triplet motif is identified in the primed site region of fibrinogen and other natural substrates of thrombin. The role of this triplet, based on the three-dimensional models, is to correctly orient the substrate for optimal bridge binding to exosite I and the active site. The three-dimensional models suggest a possible pattern of recognition by thrombin that applies generally to other natural substrates.	Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Di Cera, E (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, Box 8231, St Louis, MO 63110 USA.			ROSE, Thierry/0000-0001-8863-0207	NHLBI NIH HHS [HL49413, HL58141] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049413, R01HL058141, R29HL049413] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arosio D, 2000, BIOCHEMISTRY-US, V39, P8095, DOI 10.1021/bi0006215; Ayala YM, 2001, PROTEINS, V45, P107, DOI 10.1002/prot.1130; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; BLOMBACK M, 1968, NATURE, V218, P134, DOI 10.1038/218134a0; BODE W, 1992, PROTEIN SCI, V1, P426; Brown JH, 2000, P NATL ACAD SCI USA, V97, P85, DOI 10.1073/pnas.97.1.85; Cantwell AM, 2000, J BIOL CHEM, V275, P39827, DOI 10.1074/jbc.C000751200; DENNINGER MH, 1978, THROMB RES, V13, P453, DOI 10.1016/0049-3848(78)90131-7; Everse SJ, 1998, BIOCHEMISTRY-US, V37, P8637, DOI 10.1021/bi9804129; Fenton J W 2nd, 1981, Ann N Y Acad Sci, V370, P468, DOI 10.1111/j.1749-6632.1981.tb29757.x; GIBBS CS, 1995, NATURE, V378, P413, DOI 10.1038/378413a0; Guinto ER, 1997, BIOPHYS CHEM, V64, P103, DOI 10.1016/S0301-4622(96)02211-9; HAGEMAN TC, 1974, ARCH BIOCHEM BIOPHYS, V164, P707, DOI 10.1016/0003-9861(74)90083-6; HANNA LS, 1984, BIOCHEMISTRY-US, V23, P4681, DOI 10.1021/bi00315a025; HENSCHEN A, 1983, ANN NY ACAD SCI, V408, P28, DOI 10.1111/j.1749-6632.1983.tb23232.x; HESSEL B, 1986, THROMB RES, V42, P21, DOI 10.1016/0049-3848(86)90193-3; HIGGINS DL, 1981, J BIOL CHEM, V256, P2013; HOGG DH, 1974, THROMB RES, V5, P685, DOI 10.1016/0049-3848(74)90057-7; KOOPMAN J, 1992, P NATL ACAD SCI USA, V89, P3478, DOI 10.1073/pnas.89.8.3478; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lord S T, 1990, Blood Coagul Fibrinolysis, V1, P461, DOI 10.1097/00001721-199010000-00017; Madrazo J, 2001, P NATL ACAD SCI USA, V98, P11967, DOI 10.1073/pnas.211439798; MARTIN PD, 1992, J BIOL CHEM, V267, P7911; Martin PD, 1996, BIOCHEMISTRY-US, V35, P13030, DOI 10.1021/bi960656y; MATHEWS II, 1994, BIOCHEMISTRY-US, V33, P3266, DOI 10.1021/bi00177a018; Maurer MC, 1999, PROTEINS, V34, P29, DOI 10.1002/(SICI)1097-0134(19990101)34:1<29::AID-PROT4>3.0.CO;2-U; Maurer MC, 1998, BIOCHEMISTRY-US, V37, P5888, DOI 10.1021/bi972538w; MENACHE D, 1983, ANN NY ACAD SCI, V408, P121, DOI 10.1111/j.1749-6632.1983.tb23240.x; Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11; MUSACCHIO A, 1994, NAT STRUCT BIOL, V1, P546, DOI 10.1038/nsb0894-546; NIWA K, 1993, BLOOD, V82, P3658; RYDEL TJ, 1991, J MOL BIOL, V221, P583, DOI 10.1016/0022-2836(91)80074-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SORIA J, 1972, THROMB DIATH HAEMOST, V27, P619, DOI 10.1055/s-0038-1649401; STUBBS MT, 1992, EUR J BIOCHEM, V206, P187, DOI 10.1111/j.1432-1033.1992.tb16916.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TSIANG M, 1995, J BIOL CHEM, V270, P16854, DOI 10.1074/jbc.270.28.16854; VANNISPEN JW, 1977, ARCH BIOCHEM BIOPHYS, V182, P227, DOI 10.1016/0003-9861(77)90303-4; VIJAYALAKSHMI J, 1994, PROTEIN SCI, V3, P2254, DOI 10.1002/pro.5560031211; Yang Z, 2000, P NATL ACAD SCI USA, V97, P14156, DOI 10.1073/pnas.97.26.14156; YOSHIDA N, 1991, BLOOD, V78, P149	42	52	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					18875	18880		10.1074/jbc.M110977200	http://dx.doi.org/10.1074/jbc.M110977200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11901150	hybrid			2022-12-27	WOS:000175975800082
J	Levert, KL; Waldrop, GL; Stephens, JM				Levert, KL; Waldrop, GL; Stephens, JM			A biotin analog inhibits acetyl-CoA carboxylase activity and adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISM-BASED INHIBITION; FATTY-ACID OXIDATION; ADIPOCYTE; STORAGE; ENZYME	Acetyl-CoA carboxylase catalyzes the first committed step in the synthesis of long chain fatty acids. In this study, we observed that treatment of 3T3-L1 cells with biotin chloroacetylated at the V nitrogen reduced the enzymatic activity of cytosolic acetyl-CoA carboxylase and concomitantly inhibited the differentiation of 3T3-L1 cells in a dose-dependent manner. Treatment with chloroacetylated biotin blocked the induction of PPARgamma, STAT1, and STAT5A expression that normally occurs with adipogenesis. Moreover, addition of chloroacetylated biotin inhibited lipid accumulation, as judged by Oil Red 0 staining. Our results support recent studies that indicate that acetyl-CoA carboxylase may be a suitable target for an anti-obesity therapeutic.	Louisiana State Univ, Dept Biol Sci, Div Biochem & Mol Biol, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Stephens, JM (corresponding author), Louisiana State Univ, Dept Biol Sci, Div Biochem & Mol Biol, Rm 202 Life Sci Bldg, Baton Rouge, LA 70803 USA.		Stephens, Jacqueline M/R-5217-2018		NIDDK NIH HHS [R01DK5268-02] Funding Source: Medline; NIGMS NIH HHS [GM51261] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051261] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Amspacher DR, 1999, ORG LETT, V1, P99, DOI 10.1021/ol990026z; Bull HG, 1996, J AM CHEM SOC, V118, P2359, DOI 10.1021/ja953069t; FLIER JS, 1995, CELL, V80, P15, DOI 10.1016/0092-8674(95)90445-X; Khalil EM, 1999, P NATL ACAD SCI USA, V96, P12418, DOI 10.1073/pnas.96.22.12418; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levert KL, 2002, BIOCHEM BIOPH RES CO, V291, P1213, DOI 10.1006/bbrc.2002.6576; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; MACKALL JC, 1976, J BIOL CHEM, V251, P6462; Rosen ED, 2000, GENE DEV, V14, P1293; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; TANABE T, 1975, EUR J BIOCHEM, V57, P15, DOI 10.1111/j.1432-1033.1975.tb02272.x; Thupari JN, 2001, BIOCHEM BIOPH RES CO, V285, P217, DOI 10.1006/bbrc.2001.5146; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168	14	58	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 10	2002	277	19					16347	16350		10.1074/jbc.C200113200	http://dx.doi.org/10.1074/jbc.C200113200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	551MB	11907024	hybrid			2022-12-27	WOS:000175564500001
J	Shimizu, H; Burch, LR; Smith, AJ; Dornan, D; Wallace, M; Ball, KL; Hupp, TR				Shimizu, H; Burch, LR; Smith, AJ; Dornan, D; Wallace, M; Ball, KL; Hupp, TR			The conformationally flexible S9-S10 linker region in the core domain of p53 contains a novel MDM2 binding site whose mutation increases ubiquitination of p53 in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR P53; TERMINAL REGULATORY DOMAIN; WILD-TYPE P53; DNA-BINDING; P53-DEPENDENT TRANSCRIPTION; MUTANT P53; T-ANTIGEN; SV40-TRANSFORMED CELLS; ONCOPROTEIN MDM2; CYCLIN-A	Although the N-terminal BOX-I domain of the tumor suppressor protein p53 contains the primary docking site for MDM2, previous studies demonstrated that RNA stabilizes the MDM2(.)p53 complex using a p53 mutant lacking the BOX-I motif. In vitro assays measuring the specific activity of MDM2 in the ligand-free and RNA-bound state identified a novel MDM2 interaction site in the core domain of p53. As defined using phage-peptide display, the RNA(.)MDM2 isoform exhibited a notable switch in peptide binding specificity, with enhanced affinity for novel peptide sequences in either p53 or small nuclear ribonucleoprotein-U (snRNP-U) and substantially reduced affinity for the primary p53 binding site in the BOX-I domain. The consensus binding site for the RNA(.)MDM2 complex within p53 is SGXLLGESXF, which links the S9-S10 beta-sheets flanking the BOX-IV and BOX-V motifs in the core domain and which is a site of reversible conformational flexibility in p53. Mutation of conserved amino acids in the linker at Ser(261) and Leu(264), which bridges the S9-S10 beta-sheets, stimulated p53 activity from reporter templates and increased MDM2-dependent ubiquitination of p53. Furthermore, mutation of the conserved Phe(270) within the S10 beta-sheet resulted in a mutant p53, which binds more stably to RNA(.)MDM2 complexes in vitro and which is strikingly hyper-ubiquitinated in vivo. Introducing an Ala(19) mutation into the p53(F270A) protein abolished both RNA(.)MDM2 complex binding and hyper-ubiquitination in vivo, thus indicating that p53(F270A) protein hyper-ubiquitination depends upon MDM2 binding to its primary site in the BOX-I domain. Together, these data identify a novel MDM2 binding interface within the S9-S10 beta-sheet region of p53 that plays a regulatory role in modulating the rate of MDM2-dependent ubiquitination of p53 in cells.	Univ Dundee, Dept Mol & Cellular Pathol, Dundee DD1 9SY, Scotland; Univ Dundee, Canc Res UK Labs, Dept Surg & Mol Oncol, Dundee DD1 9SY, Scotland	University of Dundee; University of Dundee	Hupp, TR (corresponding author), Univ Dundee, Dept Mol & Cellular Pathol, Dundee DD1 9SY, Scotland.							Ball KL, 1997, CURR BIOL, V7, P71, DOI 10.1016/S0960-9822(06)00029-7; Berger M, 2001, J BIOL CHEM, V276, P3785, DOI 10.1074/jbc.M008879200; Blaydes JP, 2000, ONCOGENE, V19, P3829, DOI 10.1038/sj.onc.1203773; Blaydes JP, 1997, ONCOGENE, V14, P1859, DOI 10.1038/sj.onc.1201018; Blaydes JP, 1998, ONCOGENE, V16, P3317, DOI 10.1038/sj.onc.1201880; Blaydes JP, 2001, J BIOL CHEM, V276, P4699, DOI 10.1074/jbc.M003485200; Bottger A, 1997, CURR BIOL, V7, P860, DOI 10.1016/S0960-9822(06)00374-5; Bottger V, 1996, ONCOGENE, V13, P2141; Burch LR, 2000, FEBS LETT, V472, P93, DOI 10.1016/S0014-5793(00)01427-7; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Craig AL, 1999, BIOCHEM J, V342, P133, DOI 10.1042/0264-6021:3420133; Dornan D, 2001, EMBO REP, V2, P139, DOI 10.1093/embo-reports/kve025; Elenbaas B, 1996, MOL MED, V2, P439, DOI 10.1007/BF03401903; Foster BA, 1999, SCIENCE, V286, P2507, DOI 10.1126/science.286.5449.2507; Freedman DA, 1997, MOL MED, V3, P248, DOI 10.1007/BF03401678; Friedlander P, 1996, J BIOL CHEM, V271, P25468, DOI 10.1074/jbc.271.41.25468; Fuchs SY, 1998, ONCOGENE, V17, P2543, DOI 10.1038/sj.onc.1202200; GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x; HALAZONETIS TD, 1993, EMBO J, V12, P1021, DOI 10.1002/j.1460-2075.1993.tb05743.x; Hansen S, 1996, J BIOL CHEM, V271, P3917; Hansen S, 1996, J BIOL CHEM, V271, P30922, DOI 10.1074/jbc.271.48.30922; Hansen S, 1998, J MOL BIOL, V275, P575, DOI 10.1006/jmbi.1997.1507; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hollstein M, 1999, MUTAT RES-FUND MOL M, V431, P199, DOI 10.1016/S0027-5107(99)00162-1; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; HUPP TR, 1994, CURR BIOL, V4, P865, DOI 10.1016/S0960-9822(00)00195-0; Hupp TR, 2000, BIOCHEM J, V352, P1, DOI 10.1042/0264-6021:3520001; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Jayaraman L, 1999, CELL MOL LIFE SCI, V55, P76, DOI 10.1007/s000180050271; Kernohan NM, 1996, J BIOL CHEM, V271, P4954; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Leveillard T, 1997, J BIOL CHEM, V272, P30651, DOI 10.1074/jbc.272.49.30651; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; Loughran O, 2000, MOL CELL BIOL, V20, P2186, DOI 10.1128/MCB.20.6.2186-2197.2000; Luciani MG, 2000, J MOL BIOL, V300, P503, DOI 10.1006/jmbi.2000.3830; Maki CG, 1999, J BIOL CHEM, V274, P16531, DOI 10.1074/jbc.274.23.16531; Maki CG, 1997, MOL CELL BIOL, V17, P355, DOI 10.1128/MCB.17.1.355; Marechal V, 1997, ONCOGENE, V14, P1427, DOI 10.1038/sj.onc.1200967; MARSTON NJ, 1995, ONCOGENE, V10, P1709; Mateu MG, 1999, NAT STRUCT BIOL, V6, P191; Mateu MG, 1998, EMBO J, V17, P2748, DOI 10.1093/emboj/17.10.2748; Midgley CA, 2000, ONCOGENE, V19, P2312, DOI 10.1038/sj.onc.1203593; Nadano D, 2000, J BIOL CHEM, V275, P13967, DOI 10.1074/jbc.275.18.13967; Nikolova PV, 1998, P NATL ACAD SCI USA, V95, P14675, DOI 10.1073/pnas.95.25.14675; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; PICKSLEY SM, 1994, ONCOGENE, V9, P2523; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; SCHEER U, 1994, CURR OPIN CELL BIOL, V6, P354, DOI 10.1016/0955-0674(94)90026-4; Shieh SY, 2000, GENE DEV, V14, P289; THUKRAL SK, 1994, MOL CELL BIOL, V14, P8315, DOI 10.1128/MCB.14.12.8315; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; THUT CJ, 1995, SCIENCE, V267, P100, DOI 10.1126/science.7809597; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; VOJTESEK B, 1995, ONCOGENE, V10, P389; Wasylyk C, 2000, MOL CELL BIOL, V20, P5554, DOI 10.1128/MCB.20.15.5554-5570.2000; Woods DB, 2001, EXP CELL RES, V264, P56, DOI 10.1006/excr.2000.5141; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0; Xirodimas DP, 1999, J BIOL CHEM, V274, P28042, DOI 10.1074/jbc.274.39.28042	64	98	101	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 9	2002	277	32					28446	28458		10.1074/jbc.M202296200	http://dx.doi.org/10.1074/jbc.M202296200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	582GX	11925449	hybrid			2022-12-27	WOS:000177342600015
J	Walters, RW; Pilewski, JM; Chiorini, JA; Zabner, J				Walters, RW; Pilewski, JM; Chiorini, JA; Zabner, J			Secreted and transmembrane mucins inhibit gene transfer with AAV4 more efficiently than AAV5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT ADENOASSOCIATED VIRUS; NONTYPABLE HAEMOPHILUS-INFLUENZAE; AIRWAY EPITHELIA; SIALIC-ACID; FACTOR-IX; GLYCOPROTEINS; TRANSDUCTION; EXPRESSION; BINDING; CLONING	Adeno-associated virus (AAV) is a promising vector for gene transfer in cystic fibrosis. AAV4 and AAV5 both bind to the apical surface of differentiated human airway epithelia, but only AAV5 infects. Both AAV4 and AAV5 require 2,3-linked sialic acid for binding. However, AAV5 interacts with sialic acid on N-linked carbohydrates, whereas AAV4 interacts with sialic acid on O-linked carbohydrates. Because mucin is decorated with O-linked carbohydrates, we hypothesized that mucin binds AAV4 and inhibits gene transfer. To evaluate the effect of secreted mucin, we studied mucin binding and gene transfer to COS cells and the basolateral membrane of well differentiated human airway epithelia. AAV4 bound mucin more efficiently than AAV5, and mucin inhibited gene transfer with AAV4. Moreover, O-glycosidase-pretreated mucin did not block gene transfer with AAV4. Similar to secreted mucin, the transmembrane mucin MUC1 inhibited gene transfer with AAV4 but not AAV5. MUC1 inhibited AAV4 by blocking internalization of the virus. Thus, O-linked carbohydrates of mucin are potent inhibitors of AAV4. Furthermore, whereas mucin plays an important role in innate host defense, its activity is specific; some vectors or pathogens are more resistant to its effects.	NIDCR, Gene Therapeut Branch, NIH, Bethesda, MD 20902 USA; Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Pittsburgh, Dept Med, Pittsburgh, PA 15261 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Iowa; University of Iowa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zabner, J (corresponding author), NIDCR, Gene Therapeut Branch, NIH, 10-1N113,10 Ctr Dr,MSC 1190, Bethesda, MD 20902 USA.	joseph-zabner@uiowa.edu	Pilewski, Joseph/AAF-5149-2021	Zabner, Joseph/0000-0002-9606-1339	NIDDK NIH HHS [T30DK54759] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alisky JM, 2000, NEUROREPORT, V11, P2669, DOI 10.1097/00001756-200008210-00013; Arcasoy SM, 1997, AM J RESP CELL MOL, V17, P422, DOI 10.1165/ajrcmb.17.4.2714; Auricchio A, 2001, MOL THER, V4, P372, DOI 10.1006/mthe.2001.0462; BAUM GL, 1998, MUCUS MUCOCILIARY IN, P253; Beck SE, 1999, J VIROL, V73, P9446, DOI 10.1128/JVI.73.11.9446-9455.1999; Bernstein JM, 2000, OTOLARYNG HEAD NECK, V122, P514, DOI 10.1016/S0194-5998(00)70093-3; Bisaillon M, 1999, J MOL BIOL, V286, P759, DOI 10.1006/jmbi.1998.2495; CHEN CC, 1993, GASTROENTEROLOGY, V105, P84, DOI 10.1016/0016-5085(93)90013-3; Chiorini JA, 1997, J VIROL, V71, P6823, DOI 10.1128/JVI.71.9.6823-6833.1997; Chiorini JA, 1999, J VIROL, V73, P1309, DOI 10.1128/JVI.73.2.1309-1319.1999; CORFIELD AP, 1991, GLYCOCONJUGATE J, V8, P330, DOI 10.1007/BF00731345; DAVIES J, 1995, INFECT IMMUN, V63, P2485, DOI 10.1128/IAI.63.7.2485-2492.1995; Duan DS, 1998, HUM GENE THER, V9, P2761, DOI 10.1089/hum.1998.9.18-2761; Fisher KJ, 1997, NAT MED, V3, P306, DOI 10.1038/nm0397-306; FLOTTE TR, 1993, J BIOL CHEM, V268, P3781; FLOTTE TR, 1995, GENE THER, V2, P357; GENTSCH JR, 1985, J VIROL, V56, P356, DOI 10.1128/JVI.56.2.356-364.1985; Hildinger M, 2001, J VIROL, V75, P6199, DOI 10.1128/JVI.75.13.6199-6203.2001; HIRST GK, 1950, J EXP MED, V91, P161, DOI 10.1084/jem.91.2.161; Hofling K, 1997, J GEN VIROL, V78, P567; Kaludov N, 2001, J VIROL, V75, P6884, DOI 10.1128/JVI.75.15.6884-6893.2001; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Kay MA, 2000, NAT GENET, V24, P257, DOI 10.1038/73464; KONDO M, 1991, AM J PHYSIOL, V261, pL106, DOI 10.1152/ajplung.1991.261.2.L106; KUBIET M, 1995, INFECT IMMUN, V63, P899, DOI 10.1128/IAI.63.3.899-902.1995; Kurpad C, 1999, J HEMATOTH STEM CELL, V8, P585, DOI 10.1089/152581699319740; MUZYCZKA N, 1992, CURR TOP MICROBIOL, V158, P97; Reddy MS, 1997, OTOLARYNG HEAD NECK, V116, P175, DOI 10.1016/S0194-5998(97)70321-8; ROGERS GN, 1986, J BIOL CHEM, V261, P5947; SAMULSKI RJ, 1982, P NATL ACAD SCI-BIOL, V79, P2077, DOI 10.1073/pnas.79.6.2077; SIMS DE, 1991, BIOTECH HISTOCHEM, V66, P173, DOI 10.3109/10520299109109965; Snyder RO, 1997, NAT GENET, V16, P270, DOI 10.1038/ng0797-270; Teramoto S, 1998, J VIROL, V72, P8904, DOI 10.1128/JVI.72.11.8904-8912.1998; THURSTON RJ, 1976, J ULTRA MOL STRUCT R, V56, P39, DOI 10.1016/S0022-5320(76)80139-6; Wagner JA, 1998, LANCET, V351, P1702, DOI 10.1016/S0140-6736(05)77740-0; Walters RW, 2000, J VIROL, V74, P535, DOI 10.1128/JVI.74.1.535-540.2000; Walters RW, 2001, J BIOL CHEM, V276, P20610, DOI 10.1074/jbc.M101559200; WILLOUGHBY RE, 1993, GLYCOBIOLOGY, V3, P437, DOI 10.1093/glycob/3.5.437; YAMAYA M, 1992, AM J PHYSIOL, V262, pL713, DOI 10.1152/ajplung.1992.262.6.L713; YOLKEN RH, 1987, J CLIN INVEST, V79, P148, DOI 10.1172/JCI112775; YOLKEN RH, 1992, J CLIN INVEST, V90, P1984, DOI 10.1172/JCI116078; Zabner J, 2000, J VIROL, V74, P3852, DOI 10.1128/JVI.74.8.3852-3858.2000; Zabner J, 1996, J VIROL, V70, P6994, DOI 10.1128/JVI.70.10.6994-7003.1996	43	55	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2002	277	26					23709	23713		10.1074/jbc.M200292200	http://dx.doi.org/10.1074/jbc.M200292200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567FX	11925433	hybrid			2022-12-27	WOS:000176475700080
J	Boukhvalova, MS; Dahlquist, FW; Stewart, RC				Boukhvalova, MS; Dahlquist, FW; Stewart, RC			CheW binding interactions with CheA and Tar - Importance for chemotaxis signaling in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; BACTERIAL CHEMOTAXIS; CHEMORECEPTOR COMPLEX; TRANSDUCTION PATHWAY; KINASE ACTIVATION; RECEPTOR; PHOSPHORYLATION; METHYLESTERASE; SYSTEM; ADAPTATION	The initial signaling events underlying the chemotactic response of Escherichia coli to aspartic acid occur within a ternary complex that includes Tar (an aspartate receptor), CheA (a protein kinase), and CheW. Because CheW can bind to CheA and to Tar, it is thought to serve as an adapter protein in this complex. The functional importance of CheW binding interactions, however, has not been investigated. To better define the role of CheW and its binding interactions, we performed biochemical characterization of six mutant variants of CheW. We examined the ability of the purified mutant CheW proteins to bind to CheA and Tar, to promote formation of active ternary complexes, and to support chemotaxis in vivo. Our results indicate that mutations which eliminate CheW binding to Tar (V36M) or to CheA (G57D) result in a complete inability to form active ternary complexes in vitro and render the CheW protein incapable of mediating chemotaxis in vivo. The in vivo signaling pathway can, however, tolerate moderate changes in CheW-Tar and CheW-CheA affinities observed with several of the mutants (G133E, G41D, and 154ocr). One mutant (R62H) provided surprising results that may indicate a role for CheW in addition to binding CheA/receptors and promoting ternary complex formation.	Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; Univ Oregon, Dept Chem, Eugene, OR 97403 USA; Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	University System of Maryland; University of Maryland College Park; University of Oregon; University of Oregon	Stewart, RC (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.				NIGMS NIH HHS [GM59544, GM52853] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052853, R01GM059544, R56GM059544] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADLER J, 1966, SCIENCE, V153, P708, DOI 10.1126/science.153.3737.708; AMES P, 1994, J BACTERIOL, V176, P6340, DOI 10.1128/jb.176.20.6340-6348.1994; ARMSTRONG JB, 1967, J BACTERIOL, V93, P390, DOI 10.1128/JB.93.1.390-398.1967; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; BORKOVICH KA, 1989, P NATL ACAD SCI USA, V86, P1208, DOI 10.1073/pnas.86.4.1208; BORKOVICH KA, 1990, CELL, V63, P1339, DOI 10.1016/0092-8674(90)90429-I; BOURRET RB, 1993, J BACTERIOL, V175, P2097, DOI 10.1128/JB.175.7.2097-2101.1993; Bren A, 2000, J BACTERIOL, V182, P6865, DOI 10.1128/JB.182.24.6865-6873.2000; CANTOR CR, 1980, BIOPHYSICAL CHEM 2, P454; Cochran AG, 1996, SCIENCE, V271, P1113, DOI 10.1126/science.271.5252.1113; GEGNER JA, 1992, CELL, V70, P975, DOI 10.1016/0092-8674(92)90247-A; GEGNER JA, 1991, P NATL ACAD SCI USA, V88, P750, DOI 10.1073/pnas.88.3.750; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Griswold IJ, 2002, NAT STRUCT BIOL, V9, P121, DOI 10.1038/nsb753; HESS JF, 1988, CELL, V53, P79, DOI 10.1016/0092-8674(88)90489-8; HESS JF, 1987, P NATL ACAD SCI USA, V84, P7609, DOI 10.1073/pnas.84.21.7609; JARVIS TC, 1990, J BIOL CHEM, V265, P15160; Levit MN, 1998, MOL MICROBIOL, V30, P459, DOI 10.1046/j.1365-2958.1998.01066.x; Levit MN, 1999, BIOCHEMISTRY-US, V38, P6651, DOI 10.1021/bi982839l; Li GY, 2000, CELL, V100, P357, DOI 10.1016/S0092-8674(00)80671-6; LIU JD, 1991, J BACTERIOL, V173, P4941, DOI 10.1128/jb.173.16.4941-4951.1991; LIU JD, 1989, P NATL ACAD SCI USA, V86, P8703, DOI 10.1073/pnas.86.22.8703; Liu Y, 1997, EMBO J, V16, P7231, DOI 10.1093/emboj/16.24.7231; LUPAS A, 1989, J BIOL CHEM, V264, P17337; Lybarger SR, 1999, J BACTERIOL, V181, P5527, DOI 10.1128/JB.181.17.5527-5529.1999; MADDOCK JR, 1993, SCIENCE, V259, P1717; Manson MD, 1998, J BACTERIOL, V180, P1009, DOI 10.1128/JB.180.5.1009-1022.1998; MCNALLY DF, 1991, P NATL ACAD SCI USA, V88, P6269, DOI 10.1073/pnas.88.14.6269; MINTON AP, 1981, BIOPOLYMERS, V20, P2093, DOI 10.1002/bip.1981.360201006; MINTON AP, 1983, MOL CELL BIOCHEM, V55, P119, DOI 10.1007/BF00673707; MUTOH N, 1986, J BACTERIOL, V167, P992, DOI 10.1128/jb.167.3.992-998.1986; NINFA EG, 1991, J BIOL CHEM, V266, P9764; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Osborn M J, 1974, Methods Enzymol, V31, P642; PARKINSON JS, 1978, J BACTERIOL, V135, P45, DOI 10.1128/JB.135.1.45-53.1978; RUSSELL CB, 1987, THESIS U OREGON EUGE; SANDERS DA, 1989, J BACTERIOL, V171, P6271, DOI 10.1128/jb.171.11.6271-6278.1989; SANDERS DA, 1989, J BIOL CHEM, V264, P21770; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHUSTER SC, 1993, NATURE, V365, P343, DOI 10.1038/365343a0; SMITH RA, 1980, P NATL ACAD SCI-BIOL, V77, P5370, DOI 10.1073/pnas.77.9.5370; SPRINGER MS, 1979, NATURE, V280, P279, DOI 10.1038/280279a0; Stewart RC, 1997, BIOCHEMISTRY-US, V36, P2030, DOI 10.1021/bi962261k; STEWART RC, 1990, J BACTERIOL, V172, P3388, DOI 10.1128/jb.172.6.3388-3399.1990; STOCK AM, 1988, COLD SPRING HARB SYM, V53, P49, DOI 10.1101/SQB.1988.053.01.009; STOCK JB, 1978, P NATL ACAD SCI USA, V75, P3659, DOI 10.1073/pnas.75.8.3659; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Surette MG, 1996, J BIOL CHEM, V271, P17966, DOI 10.1074/jbc.271.30.17966; WEBER G, 1953, ADV PROTEIN CHEM, V8, P415, DOI 10.1016/S0065-3233(08)60096-0; WELCH M, 1993, P NATL ACAD SCI USA, V90, P8787, DOI 10.1073/pnas.90.19.8787; WOLFE AJ, 1993, P NATL ACAD SCI USA, V90, P1518, DOI 10.1073/pnas.90.4.1518; WOLFE AJ, 1989, P NATL ACAD SCI USA, V86, P6973, DOI 10.1073/pnas.86.18.6973; WYLIE D, 1988, BIOCHEM BIOPH RES CO, V151, P891, DOI 10.1016/S0006-291X(88)80365-6; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649	55	73	75	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22251	22259		10.1074/jbc.M110908200	http://dx.doi.org/10.1074/jbc.M110908200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11923283	hybrid			2022-12-27	WOS:000176313600020
J	Lee, S; Fan, CY; Younger, JM; Ren, HY; Cyr, DM				Lee, S; Fan, CY; Younger, JM; Ren, HY; Cyr, DM			Identification of essential residues in the Type II Hsp40 Sis1 that function in polypeptide binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNAJ MOLECULAR CHAPERONE; ESCHERICHIA-COLI DNAJ; FINGER-LIKE DOMAIN; SACCHAROMYCES-CEREVISIAE; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; SECONDARY STRUCTURE; ALPHA-LACTALBUMIN; ATP HYDROLYSIS; PROTEIN	Sis1 is an essential yeast Type II Hsp40 protein that assists cytosolic Hsp70 Ssa1 in the facilitation of processes that include translation initiation, the prevention of protein aggregation, and proteasomal protein degradation. An essential function of Sis1 and other Hsp40 proteins is the binding and delivery of non-native polypeptides to Hsp70. How Hsp40s function as molecular chaperones is unknown. The crystal structure of a Sis1 fragment that retains peptide-binding activity suggests that Type II Hsp40s utilize hydrophobic residues located in a solvent-exposed patch on carboxyl-terminal domain I to bind non-native polypeptides. To test this model, amino acid residues Val-184, Leu-186, Lys-199, Phe-201, Ile-203, and Phe-251, which form a depression in carboxyl-terminal domain 1, were mutated, and the ability of Sis1 mutants to support cell viability and function as molecular chaperones was examined. We report that Lys-199, Phe-201, and Phe-251 are essential for cell viability and required for Sis1 polypeptide binding activity. Sis1 I203T could support normal cell growth, but when purified it exhibited severe defects in chaperone function. These data identify essential residues in Sis1 that function in polypeptide binding and help define the nature of the polypeptide-binding site in Type II Hsp40 proteins.	Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Cyr, DM (corresponding author), Univ N Carolina, Dept Cell & Dev Biol, Rm 524 Taylor Hall, Chapel Hill, NC 27599 USA.				NIDDK NIH HHS [R01 DK56203] Funding Source: Medline; NIGMS NIH HHS [R01GM56981] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056981] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Banecki B, 1996, J BIOL CHEM, V271, P14840, DOI 10.1074/jbc.271.25.14840; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; CAPLAN AJ, 1991, J CELL BIOL, V114, P609, DOI 10.1083/jcb.114.4.609; CAPLAN AJ, 1992, CELL, V71, P1143, DOI 10.1016/S0092-8674(05)80063-7; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; CREIGHTON TE, 1994, BIOCHEMISTRY-US, V33, P1534, DOI 10.1021/bi00172a033; CYR DM, 1995, FEBS LETT, V359, P129, DOI 10.1016/0014-5793(95)00024-4; CYR DM, 1992, J BIOL CHEM, V267, P20927; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; CYR DM, 1997, GUIDEBOOK MOL CHAPER, P89; EWBANK JJ, 1993, BIOCHEMISTRY-US, V32, P3694, DOI 10.1021/bi00065a023; Gall WE, 2000, CURR BIOL, V10, P1349, DOI 10.1016/S0960-9822(00)00771-5; Gassler CS, 1998, P NATL ACAD SCI USA, V95, P15229, DOI 10.1073/pnas.95.26.15229; GEORGOPOULOS CP, 1980, MOL GEN GENET, V178, P583, DOI 10.1007/BF00337864; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HILL RB, 1995, BIOCHEMISTRY-US, V34, P5587, DOI 10.1021/bi00016a033; Horton LE, 2001, J BIOL CHEM, V276, P14426, DOI 10.1074/jbc.M100266200; Johnson JL, 2001, J CELL BIOL, V152, P851, DOI 10.1083/jcb.152.4.851; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Lu Z, 1998, J BIOL CHEM, V273, P5970, DOI 10.1074/jbc.273.10.5970; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; LUKE MM, 1991, J CELL BIOL, V114, P623, DOI 10.1083/jcb.114.4.623; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; PALLEROS DR, 1993, NATURE, V365, P664, DOI 10.1038/365664a0; Qian YQ, 1996, J MOL BIOL, V260, P224, DOI 10.1006/jmbi.1996.0394; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Saibil H, 2000, CURR OPIN STRUC BIOL, V10, P251, DOI 10.1016/S0959-440X(00)00074-9; Sha BD, 2000, STRUCTURE, V8, P799, DOI 10.1016/S0969-2126(00)00170-2; Siegert R, 2000, CELL, V103, P621, DOI 10.1016/S0092-8674(00)00165-3; SIKORSKI RS, 1989, GENETICS, V122, P19; Sondheimer N, 2001, EMBO J, V20, P2435, DOI 10.1093/emboj/20.10.2435; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; Szabo A, 1996, EMBO J, V15, P408, DOI 10.1002/j.1460-2075.1996.tb00371.x; SZYPERSKI T, 1994, P NATL ACAD SCI USA, V91, P11343, DOI 10.1073/pnas.91.24.11343; Terada K, 1997, J CELL BIOL, V139, P1089, DOI 10.1083/jcb.139.5.1089; WAWRZYNOW A, 1995, J BIOL CHEM, V270, P19307, DOI 10.1074/jbc.270.33.19307; WERNERWASHBURNE M, 1987, MOL CELL BIOL, V7, P2568, DOI 10.1128/MCB.7.7.2568; WICKNER S, 1991, P NATL ACAD SCI USA, V88, P7903, DOI 10.1073/pnas.88.18.7903; Yan W, 1999, MOL CELL BIOL, V19, P7751; Zhong T, 1996, J BIOL CHEM, V271, P1349, DOI 10.1074/jbc.271.3.1349; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; ZYLICZ M, 1985, J BIOL CHEM, V260, P7591	49	62	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21675	21682		10.1074/jbc.M111075200	http://dx.doi.org/10.1074/jbc.M111075200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11919183	hybrid, Green Published			2022-12-27	WOS:000176286000075
J	Billecke, SS; Bender, AT; Kanelakis, KC; Murphy, PJM; Lowe, ER; Kamada, Y; Pratt, WB; Osawa, Y				Billecke, SS; Bender, AT; Kanelakis, KC; Murphy, PJM; Lowe, ER; Kamada, Y; Pratt, WB; Osawa, Y			hsp90 is required for heme binding and activation of apo-neuronal nitric-oxide synthase - Geldanamycin-mediated oxidant generation is unrelated to any action of hsp90	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; HSP90-BASED CHAPERONE SYSTEM; GLUCOCORTICOID RECEPTOR; IN-VITRO; PROSTHETIC GROUP; STEROID-BINDING; INHIBITION; COMPLEX; TETRAHYDROBIOPTERIN; EXPRESSION	It is established that neuronal NO synthase (nNOS) is associated with the chaperone hsp90, although the functional role for this interaction has not been defined. We have discovered that inhibition of hsp90 by radicicol or geldanamycin nearly prevents the heme-mediated activation and assembly of heme-deficient apo-nNOS in insect cells. This effect is concentration-dependent with over 75% inhibition achieved at 20 pm radicicol. The ferrous carbonyl complex of nNOS is not formed when hsp90 is inhibited, indicating that functional heme insertion is prevented. We propose that the hsp90-based chaperone machinery facilitates functional heme entry into apo-nNOS by the opening of the hydrophobic heme-binding cleft in the protein. Previously, it has been reported that the hsp90 inhibitor geldanamycin uncouples endothelial NOS activity and increases endothelial NOS-dependent O-2(.-) production. Geldanamycin is an ansamycin benzoquinone, and we show here that it causes oxidant production from nNOS in insect cells as well as with the purified protein. At a concentration of 20 mum, geldanamycin causes a 3-fold increase in NADPH oxidation and hydrogen peroxide formation from purified nNOS, whereas the non-quinone hsp90 inhibitor radicicol had no effect. Thus, consistent with the known propensity of other quinones, geldanamycin directly redox cycles with nNOS by a process independent of any action on hsp90, cautioning against the use of geldanamycin as a specific inhibitor of hsp90 in redox-active systems.	Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Osawa, Y (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, Med Sci Res Bldg 3, Ann Arbor, MI 48109 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031573, R37DK031573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007767] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK31573] Funding Source: Medline; NIEHS NIH HHS [ES08365] Funding Source: Medline; NIGMS NIH HHS [GM07767] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABUSOUD HM, 1995, BIOCHEMISTRY-US, V34, P11167, DOI 10.1021/bi00035a023; ASSEFFA A, 1989, ARCH BIOCHEM BIOPHYS, V274, P481, DOI 10.1016/0003-9861(89)90461-X; Bender AT, 2000, J BIOL CHEM, V275, P17407, DOI 10.1074/jbc.M000155200; Bender AT, 2000, J BIOL CHEM, V275, P26018, DOI 10.1074/jbc.275.34.26018; Bender AT, 1999, J BIOL CHEM, V274, P1472, DOI 10.1074/jbc.274.3.1472; BRESNICK EH, 1989, J BIOL CHEM, V264, P4992; Brouet A, 2001, J BIOL CHEM, V276, P32663, DOI 10.1074/jbc.M101371200; CATALANO CE, 1989, J BIOL CHEM, V264, P10534; Feelisch M., 1996, METHODS NITRIC OXIDE, P455; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Giannoukos G, 1999, J BIOL CHEM, V274, P36527, DOI 10.1074/jbc.274.51.36527; Gratton JP, 2000, J BIOL CHEM, V275, P22268, DOI 10.1074/jbc.M001644200; HUTCHISON KA, 1992, J BIOL CHEM, V267, P14047; KLATT P, 1995, EMBO J, V14, P3687, DOI 10.1002/j.1460-2075.1995.tb00038.x; Kumagai Y, 1998, CHEM RES TOXICOL, V11, P608, DOI 10.1021/tx970119u; MANNO M, 1989, XENOBIOTICA, V19, P1023, DOI 10.3109/00498258909043159; MCMILLAN K, 1992, P NATL ACAD SCI USA, V89, P11141, DOI 10.1073/pnas.89.23.11141; Morishima Y, 2000, J BIOL CHEM, V275, P6894, DOI 10.1074/jbc.275.10.6894; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Pritchard KA, 2001, J BIOL CHEM, V276, P17621, DOI 10.1074/jbc.C100084200; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; ROMAN LJ, 1995, P NATL ACAD SCI USA, V92, P8428, DOI 10.1073/pnas.92.18.8428; Schulte TW, 1999, MOL ENDOCRINOL, V13, P1435, DOI 10.1210/me.13.9.1435; Song Y, 2001, BIOCHEM J, V355, P357, DOI 10.1042/0264-6021:3550357; Song Y, 2001, AM J PHYSIOL-CELL PH, V281, pC1819, DOI 10.1152/ajpcell.2001.281.6.C1819; Srinivasan G, 1997, J STEROID BIOCHEM, V60, P1, DOI 10.1016/S0960-0760(96)00182-3; Stancato LF, 1996, J BIOL CHEM, V271, P8831, DOI 10.1074/jbc.271.15.8831; Sugiyama K, 1997, P NATL ACAD SCI USA, V94, P796, DOI 10.1073/pnas.94.3.796; Vasquez-Vivar J, 1999, J BIOL CHEM, V274, P26736, DOI 10.1074/jbc.274.38.26736; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Xu M, 1998, J BIOL CHEM, V273, P13918, DOI 10.1074/jbc.273.22.13918	31	61	63	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20504	20509		10.1074/jbc.M201940200	http://dx.doi.org/10.1074/jbc.M201940200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11923316	hybrid			2022-12-27	WOS:000176204500053
J	Ahrens, T; Pertz, O; Haussinger, D; Fauser, C; Schulthess, T; Engel, J				Ahrens, T; Pertz, O; Haussinger, D; Fauser, C; Schulthess, T; Engel, J			Analysis of heterophilic and homophilic interactions of cadherins using the c-jun/c-fos dimerization domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULES; CRYSTAL-STRUCTURE; CLASSIC CADHERINS; CALCIUM-BINDING; LEUCINE ZIPPERS; STREP-TAG; PROTEINS; PURIFICATION; ULTRASTRUCTURE; SPECIFICITIES	Cadherin-mediated cell-cell adhesion is initiated by cis dimerization of cadherin ectodomains at the cell surface followed by an antiparallel trans interaction of dimers on opposing cells. To resolve open questions concerning the molecular details and specificity of cis and trans interactions, ectodomains of E- and P-cadherin were analyzed by chemical cross-linking and by electron microscopy. At the high intrinsic concentration created by artificial oligomerization the N-terminal cadherin (CAD)-domain of P-cadherin are forming ring-like cis dimers. At 2 mm Ca2+-associated rings involving two cis dimers indicate trans contacts in electron micrographs. cis and trans interactions were further analyzed by heterodimerization of the ectodomains of E-cadherin (ECAD) and P-cadherin (PCAD) through the leucine zipper domains of c-Jun and c-Fos. ECADJun/ECADFos dimers predominantly form ring-like cis dimers at 1 mm Ca2+ and double-ringed trans contacts above 2 mm Ca2+. The Ca2+-dependent tetrameric trans contacts of ECADJun/ECADFos dimers are also detectable after chemical cross-linking. Only cis contacts but no trans interactions are observed for heterodimers of ECADFos and the Trp-2 to Ala mutant ECADW2AJun arguing for a decisive role of Trp-2 in trans but not cis interaction. Neither cis nor trans interaction was found for heterodimers of ECADJun and PCADFos suggesting that specificity for homophilic interactions already exists at the level of cis dimerization.	Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland; Univ Basel, Biozentrum, Dept Biol Struct, CH-4056 Basel, Switzerland; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	University of Basel; University of Basel; Scripps Research Institute	Engel, J (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.		Häussinger, Daniel/C-6617-2016	Häussinger, Daniel/0000-0002-4798-0072; pertz, olivier/0000-0001-8579-4919				Angst BD, 2001, J CELL SCI, V114, P629; Baumgartner W, 2000, P NATL ACAD SCI USA, V97, P4005, DOI 10.1073/pnas.070052697; BECKER JW, 1989, P NATL ACAD SCI USA, V86, P1088, DOI 10.1073/pnas.86.3.1088; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; Bork P, 1996, Q REV BIOPHYS, V29, P119, DOI 10.1017/S0033583500005783; CHANG HC, 1994, P NATL ACAD SCI USA, V91, P11408, DOI 10.1073/pnas.91.24.11408; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; Eble JA, 1998, BIOCHEMISTRY-US, V37, P10945, DOI 10.1021/bi980175+; ENGEL J, 1994, METHOD ENZYMOL, V245, P469; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; INUZUKA H, 1991, NEURON, V7, P69, DOI 10.1016/0896-6273(91)90075-B; Jun CD, 2001, J BIOL CHEM, V276, P29019, DOI 10.1074/jbc.M103394200; Kalandadze A, 1996, J BIOL CHEM, V271, P20156, DOI 10.1074/jbc.271.33.20156; Klingelhofer J, 2000, J CELL SCI, V113, P2829; Koch AW, 1999, CURR OPIN STRUC BIOL, V9, P275, DOI 10.1016/S0959-440X(99)80038-4; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; KOSTELNY SA, 1992, J IMMUNOL, V148, P1547; Leckband D, 2000, CURR OPIN CELL BIOL, V12, P587, DOI 10.1016/S0955-0674(00)00136-8; Malashkevich VN, 1996, SCIENCE, V274, P761, DOI 10.1126/science.274.5288.761; Miyaguchi K, 2000, J STRUCT BIOL, V132, P169, DOI 10.1006/jsbi.2000.4244; MURPHYERDOSH C, 1995, J CELL BIOL, V129, P1379, DOI 10.1083/jcb.129.5.1379; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; NOSE A, 1987, EMBO J, V6, P3655, DOI 10.1002/j.1460-2075.1987.tb02698.x; NOSE A, 1988, CELL, V54, P993, DOI 10.1016/0092-8674(88)90114-6; OLDBERG A, 1992, J BIOL CHEM, V267, P22346; OSHEA EK, 1989, SCIENCE, V245, P646, DOI 10.1126/science.2503872; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; POKUTTA S, 1994, EUR J BIOCHEM, V223, P1019, DOI 10.1111/j.1432-1033.1994.tb19080.x; SCHMIDT TGM, 1994, J CHROMATOGR A, V676, P337, DOI 10.1016/0021-9673(94)80434-6; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Schurmann G, 2001, MOL BIOL CELL, V12, P1765, DOI 10.1091/mbc.12.6.1765; Shan WS, 2000, J CELL BIOL, V148, P579, DOI 10.1083/jcb.148.3.579; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Shapiro L, 1998, CURR OPIN NEUROBIOL, V8, P593, DOI 10.1016/S0959-4388(98)80086-X; Sivasankar S, 1999, P NATL ACAD SCI USA, V96, P11820, DOI 10.1073/pnas.96.21.11820; Skerra A, 2000, METHOD ENZYMOL, V326, P271; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; Tomschy A, 1996, EMBO J, V15, P3507, DOI 10.1002/j.1460-2075.1996.tb00719.x; VANSTRAATEN F, 1983, P NATL ACAD SCI-BIOL, V80, P3183; VOLK T, 1987, CELL, V50, P987, DOI 10.1016/0092-8674(87)90525-3	44	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19455	19460		10.1074/jbc.M200606200	http://dx.doi.org/10.1074/jbc.M200606200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11909859	hybrid			2022-12-27	WOS:000175894800030
J	Balla, A; Tuymetova, G; Barshishat, M; Geiszt, M; Balla, T				Balla, A; Tuymetova, G; Barshishat, M; Geiszt, M; Balla, T			Characterization of type II phosphatidylinositol 4-kinase isoforms reveals association of the enzymes with endosomal vesicular compartments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE KINASES; SACCHAROMYCES-CEREVISIAE; MEMBRANE TRAFFICKING; PROTEIN-KINASE; LIPID KINASE; YEAST; WORTMANNIN; CLATHRIN; GENE; REQUIREMENT	Phosphorylation of phosphatidylinositol (PI) to PI 4-phosphate is one of the key reactions in the production of phosphoinositides, lipid regulators of several cellular functions. This reaction is catalyzed by multiple enzymes that belong either to the type II or the type III family of PI 4-kinases. Type III enzymes are structurally similar to PI 3-kinases and are sensitive to PI 3-kinase inhibitors. In contrast, the recent cloning of the first type II PI 4-kinase enzyme defined a novel enzyme family. Here we characterize a new member of this family, the type IIbeta enzyme that has been identified in the NCBI data base based on its homology to the first-cloned type IIalpha enzyme. The type IIbeta enzyme has a primary transcript size of similar to3.8 kb and shows wide tissue distribution. It contains an open reading frame of 1.4 kb, encoding a protein of similar to54 kDa. Sequence comparison reveals a high degree of similarity to the type IIalpha enzyme within the C-terminal catalytic domain but significantly lower homology within the N-terminal region. Expression of both enzyme yields increased PI 4-kinase activity that is associated with the microsomal membrane fractions and is significantly lower for the type IIbeta than the type IIalpha form. Both enzymes use PI as their primary substrate and have no detectable activity on PI monophosphates. Epitope-tagged as well as green fluorescent protein-tagged forms of both enzymes localize primarily to intracellular membranes and show prominent co-localization with early endosomes and recycling endosomes but not with the Golgi. These compartments participate in the processing of both the transferrin receptor and the G protein-coupled AT(1A) angiotensin receptor. Our data indicate the existence of multiple forms of type II PI 4-kinase in mammalian cells and suggest that their functions are related to the endocytic pathway.	Natl Inst Hlth, NIAID, Lab Host Def, Bethesda, MD 20892 USA; NICHHD, Endocrinol & Reprod Res Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Balla, T (corresponding author), Natl Inst Hlth, NIAID, Lab Host Def, Bldg 49 Rm 6A35 49 Convent Dr, Bethesda, MD 20892 USA.			Balla, Tamas/0000-0002-9077-3335; Balla, Andras/0000-0002-6450-2793	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000196] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000196] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Balla T, 1998, BBA-MOL CELL BIOL L, V1436, P69, DOI 10.1016/S0005-2760(98)00134-9; BALLA T, 1988, J BIOL CHEM, V263, P4083; Barylko B, 2001, J BIOL CHEM, V276, P7705, DOI 10.1074/jbc.C000861200; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; CARPENTER CL, 1990, BIOCHEMISTRY-US, V29, P11147, DOI 10.1021/bi00503a001; COCHET C, 1991, J BIOL CHEM, V266, P637; Cremona O, 2001, J CELL SCI, V114, P1041; Cutler NS, 1997, J BIOL CHEM, V272, P27671, DOI 10.1074/jbc.272.44.27671; Downing GJ, 1996, BIOCHEMISTRY-US, V35, P3587, DOI 10.1021/bi9517493; FLANAGAN CA, 1993, SCIENCE, V262, P1444, DOI 10.1126/science.8248783; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Foti M, 2001, MOL BIOL CELL, V12, P2396, DOI 10.1091/mbc.12.8.2396; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Gaidarov I, 2001, MOL CELL, V7, P443, DOI 10.1016/S1097-2765(01)00191-5; Gehrmann T, 1998, EUR J BIOCHEM, V253, P357, DOI 10.1046/j.1432-1327.1998.2530357.x; HUNTER T, 1995, CELL, V83, P1, DOI 10.1016/0092-8674(95)90225-2; Hurley JH, 2001, CURR OPIN CELL BIOL, V13, P146, DOI 10.1016/S0955-0674(00)00191-5; KAUFFMANNZEH A, 1995, SCIENCE, V268, P1188, DOI 10.1126/science.7761838; Majerus PW, 1999, J BIOL CHEM, V274, P10669, DOI 10.1074/jbc.274.16.10669; Martin N, 1997, J MATER CHEM, V7, P25, DOI 10.1039/a601628f; Minogue S, 2001, J BIOL CHEM, V276, P16635, DOI 10.1074/jbc.M100982200; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; NISHIZUKA Y, 1984, SCIENCE, V225, P1365, DOI 10.1126/science.6147898; Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7; PIKE LJ, 1992, ENDOCR REV, V13, P692, DOI 10.1210/er.13.4.692; Pramanik A, 1997, CELL MOL BIOL, V43, P1007; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6; Walch-Solimena C, 1999, NAT CELL BIOL, V1, P523, DOI 10.1038/70319; Waugh MG, 1998, J BIOL CHEM, V273, P17115, DOI 10.1074/jbc.273.27.17115; Wong K, 1997, J BIOL CHEM, V272, P13236, DOI 10.1074/jbc.272.20.13236; YOSHIDA S, 1994, J BIOL CHEM, V269, P1166	34	151	155	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					20041	20050		10.1074/jbc.M111807200	http://dx.doi.org/10.1074/jbc.M111807200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11923287	hybrid			2022-12-27	WOS:000175894800105
J	Chen, H; Gu, DN; Burton-Wurster, N; MacLeod, JN				Chen, H; Gu, DN; Burton-Wurster, N; MacLeod, JN			Absence of the I-10 protein segment mediates restricted dimerization of the cartilage-specific fibronectin isoform	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; PANCREATIC TRYPSIN-INHIBITOR; EXTRACELLULAR-MATRIX; PLASMA FIBRONECTIN; ARTICULAR-CARTILAGE; OVERLAP EXTENSION; BINDING DOMAIN; CELL-SURFACE; I MODULES; ISOMERASE	The cartilage-specific (V + C)(-) fibronectin isoform does not efficiently heterodimerize with other V-region splice variants of fibronectin. To understand better the structural elements that determine this restricted dimerization profile, a series of truncated fibronectin expression constructs with various internal deletions in the V, III-15, or I-10 segments were constructed and co-transfected into COS-7 cells with either the V+C+ or the (V + C)(-) isoform. SDS-PAGE and immunoblot analyses of the resulting conditioned media suggest that the I-10 segment must either be present in both monomeric subunits of fibronectin or absent from both subunits for efficient dimerization to occur. Further studies suggest that the I-10 segment specifically, not simply a balanced number of type I repeats at the carboxyl terminus of each monomeric subunit, plays an important role in determining different fibronectin dimerization patterns. Neither I-11 nor I-12 could be substituted for segment I-10 without significantly reducing the formation of heterodimers. Therefore, absence of segment I-10 explains why (V + C)- fibronectin is not found in heterodimeric configurations with other native V-region splice variants in cartilage. The unique dimerization pattern of (V + C)(-) fibronectin does not prevent matrix formation yet is consistent with this isoform having specialized properties in situ that are important for either the structural organization and biomechanical properties of cartilage or the regulation of a chondrocytic phenotype.	Cornell Univ, Coll Vet Med, James A Baker Inst Anim Hlth, Dept Biomed Sci, Ithaca, NY 14853 USA; Cornell Univ, Coll Vet Med, James A Baker Inst Anim Hlth, Dept Microbiol & Immunol, Ithaca, NY 14853 USA	Cornell University; Cornell University	MacLeod, JN (corresponding author), Cornell Univ, Coll Vet Med, James A Baker Inst Anim Hlth, Dept Biomed Sci, Ithaca, NY 14853 USA.				NIAMS NIH HHS [AR44340] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044340] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863; ALEXANDER SS, 1979, J BIOL CHEM, V254, P1501; AN SSA, 1992, BIOCHEMISTRY-US, V31, P9927, DOI 10.1021/bi00156a010; Bultmann H, 1998, J BIOL CHEM, V273, P2601, DOI 10.1074/jbc.273.5.2601; Burton-Wurster N, 1999, BIOCHEM J, V341, P555, DOI 10.1042/0264-6021:3410555; BUSHUEV VN, 1985, FEBS LETT, V189, P276, DOI 10.1016/0014-5793(85)81039-5; CASTLE AM, 1995, J CELL SCI, V108, P3827; CHOI MG, 1979, J BIOL CHEM, V254, P2050; CREIGHTON TE, 1995, TRENDS BIOTECHNOL, V13, P18, DOI 10.1016/S0167-7799(00)88896-4; CREIGHTON TE, 1993, J MOL BIOL, V232, P1176, DOI 10.1006/jmbi.1993.1470; Darby NJ, 1998, J MOL BIOL, V276, P239, DOI 10.1006/jmbi.1997.1504; DARBY NJ, 1994, BIOCHEMISTRY-US, V33, P7937, DOI 10.1021/bi00191a022; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P3576, DOI 10.1021/bi00011a012; ENGAVALL E, 1977, INT J CANCER, V20, P1; ERICKSON HP, 1983, J BIOL CHEM, V258, P4539; FOGERTY FJ, 1990, J CELL BIOL, V111, P699, DOI 10.1083/jcb.111.2.699; FREEDMAN RB, 1989, CELL, V57, P1069, DOI 10.1016/0092-8674(89)90043-3; GENDELMAN R, 2001, P 47 ANN M SAN FRANC, V26, P385; GIANCOTTI FG, 1990, CELL, V60, P849, DOI 10.1016/0092-8674(90)90098-Y; GUAN JL, 1990, J CELL BIOL, V110, P833, DOI 10.1083/jcb.110.3.833; HALLIDAY NL, 1995, EXP CELL RES, V217, P109, DOI 10.1006/excr.1995.1069; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOMANDBERG GA, 1987, BIOPOLYMERS, V26, P2087, DOI 10.1002/bip.360261208; HOMANDBERG GA, 1986, BIOCHEMISTRY-US, V25, P6917, DOI 10.1021/bi00370a027; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hynes RO, 1999, P NATL ACAD SCI USA, V96, P2588, DOI 10.1073/pnas.96.6.2588; HYNES RO, 1990, FIBRONECTINS, P200; ICHIHARATANAKA K, 1995, J CELL SCI, V108, P907; KAR L, 1993, J BIOL CHEM, V268, P8580; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langenbach KJ, 1999, J BIOL CHEM, V274, P7032, DOI 10.1074/jbc.274.11.7032; MacLeod JN, 1996, J BIOL CHEM, V271, P18954, DOI 10.1074/jbc.271.31.18954; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; MCKEOWNLONGO PJ, 1989, FIBRONECTIN, P163; Mosher Deane F., 1992, Current Opinion in Cell Biology, V4, P810, DOI 10.1016/0955-0674(92)90104-K; O'Reilly D., 1994, BACULOVIRUS EXPRESSI, P124; Poulouin L, 1999, PROTEIN EXPRES PURIF, V17, P146, DOI 10.1006/prep.1999.1103; QUADE BJ, 1988, J BIOL CHEM, V263, P19602; ROCCO M, 1987, EMBO J, V6, P2343, DOI 10.1002/j.1460-2075.1987.tb02510.x; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; SCHWARZBAUER JE, 1991, BIOESSAYS, V13, P527, DOI 10.1002/bies.950131006; SCHWARZBAUER JE, 1989, J CELL BIOL, V109, P3445, DOI 10.1083/jcb.109.6.3445; SCHWARZBAUER JE, 1987, P NATL ACAD SCI USA, V84, P754, DOI 10.1073/pnas.84.3.754; Schwarzbauer JE, 1999, CURR OPIN CELL BIOL, V11, P622, DOI 10.1016/S0955-0674(99)00017-4; Sechler JL, 1998, ANN NY ACAD SCI, V857, P143, DOI 10.1111/j.1749-6632.1998.tb10114.x; Sechler JL, 1996, J CELL BIOL, V134, P573, DOI 10.1083/jcb.134.2.573; SKORSTENGAARD K, 1986, EUR J BIOCHEM, V161, P441, DOI 10.1111/j.1432-1033.1986.tb10464.x; SOTTILE J, 1993, BIOCHEMISTRY-US, V32, P1641, DOI 10.1021/bi00057a031; SOTTILE J, 1991, J BIOL CHEM, V266, P12840; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UGAROVA TP, 1995, BIOCHEMISTRY-US, V34, P4457, DOI 10.1021/bi00013a039; WILLIAMS MJ, 1994, J MOL BIOL, V235, P1302, DOI 10.1006/jmbi.1994.1083; WOODS A, 1988, EXP CELL RES, V177, P272, DOI 10.1016/0014-4827(88)90461-2; WU CY, 1993, J BIOL CHEM, V268, P21883; WU CY, 1995, CELL, V83, P715, DOI 10.1016/0092-8674(95)90184-1; WURSTER NB, 1982, BIOCHEM BIOPH RES CO, V109, P1094, DOI 10.1016/0006-291X(82)91889-7; YAMADA KM, 1977, BIOCHEMISTRY-US, V16, P5552, DOI 10.1021/bi00644a025; ZAPUN A, 1994, BIOCHEMISTRY-US, V33, P5202, DOI 10.1021/bi00183a025; ZAPUN A, 1995, BIOCHEMISTRY-US, V34, P5075, DOI 10.1021/bi00015a019; Zheng MZ, 2000, ARCH BIOCHEM BIOPHYS, V374, P93, DOI 10.1006/abbi.1999.1613; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	61	5	5	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					20095	20103		10.1074/jbc.M201238200	http://dx.doi.org/10.1074/jbc.M201238200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11914376	hybrid			2022-12-27	WOS:000175894800111
J	Loeb, DM; Korz, D; Katsnelson, M; Burwell, EA; Friedman, AD; Sukumar, S				Loeb, DM; Korz, D; Katsnelson, M; Burwell, EA; Friedman, AD; Sukumar, S			Cyclin E is a target of WT1 transcriptional repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR SUPPRESSOR GENE; DNA-BINDING SPECIFICITY; WILMS; LEUKEMIA; DIFFERENTIATION; EXPRESSION; ACTIVATION; PROTEINS; CELLS; P21	WT1 was originally identified as a Wilms' tumor suppressor gene, but it may have oncogenic potential in leukemia and in some solid tumors. WT1 is a transcription factor that has been implicated in the regulation of target genes related to apoptosis, genitourinary differentiation, and cell cycle progression. Because induction of WT1 leads indirectly to increased p21 expression in osteosarcoma cells, we investigated the possibility that other genes involved in the G(1)/S phase transition might also be WT1 targets. Cyclin E plays a crucial role in the cell cycle by activating cyclin-dependent kinase 2, which phosphorylates Rb, leading to progression from G(1) into S phase. We identified several WT1 binding sites in the cyclin E promoter. We demonstrate that WT1 binds to these sites and that in transient transfection assays WT1 represses the cyclin E promoter. This activity is dependent on the presence of a binding site located downstream of the transcription start site. In intact cells, induction of WT1 expression down-regulates cyclin E protein levels. These results provide the first demonstration that WT1 can directly modulate the expression of a gene involved in cell cycle progression.	Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine	Loeb, DM (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA.				NCI NIH HHS [R01-CA48943] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA048943] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ball K L, 1997, Prog Cell Cycle Res, V3, P125; BICKMORE WA, 1992, SCIENCE, V257, P235, DOI 10.1126/science.1321494; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Davies RC, 1998, GENE DEV, V12, P3217, DOI 10.1101/gad.12.20.3217; Englert C, 1997, CANCER RES, V57, P1429; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; HABER DA, 1991, P NATL ACAD SCI USA, V88, P9618, DOI 10.1073/pnas.88.21.9618; Hossain A, 2001, J BIOL CHEM, V276, P16817, DOI 10.1074/jbc.M009056200; Iida H, 1997, BLOOD, V90, P3707, DOI 10.1182/blood.V90.9.3707; Inoue K, 1998, BLOOD, V91, P2969, DOI 10.1182/blood.V91.8.2969.2969_2969_2976; INOUE K, 1994, BLOOD, V84, P3071, DOI 10.1182/blood.V84.9.3071.3071; Kim J, 1999, MOL CELL BIOL, V19, P2289; King-Underwood L, 1998, BLOOD, V91, P2961, DOI 10.1182/blood.V91.8.2961.2961_2961_2968; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; KUDOH T, 1995, P NATL ACAD SCI USA, V92, P4517, DOI 10.1073/pnas.92.10.4517; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; Loeb DM, 2001, CANCER RES, V61, P921; Mayo MW, 1999, EMBO J, V18, P3990, DOI 10.1093/emboj/18.14.3990; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Nachtigal MW, 1998, CELL, V93, P445, DOI 10.1016/S0092-8674(00)81172-1; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; REDDY JC, 1995, J BIOL CHEM, V270, P10878, DOI 10.1074/jbc.270.18.10878; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; WANG ZY, 1995, ONCOGENE, V10, P415	26	37	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19627	19632		10.1074/jbc.M201336200	http://dx.doi.org/10.1074/jbc.M201336200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11919196	hybrid			2022-12-27	WOS:000175894800052
J	Yin, XY; Grove, L; Rogulski, K; Prochownik, EV				Yin, XY; Grove, L; Rogulski, K; Prochownik, EV			Myc target in myeloid cells-1, a novel c-Myc target, recapitulates multiple c-Myc phenotypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; ORNITHINE-DECARBOXYLASE; DNA-BINDING; PROTEIN; GENE; GROWTH; EXPRESSION; MAX; IDENTIFICATION; APOPTOSIS	Using cDNA microarrays, we recently identified a large number of transcripts that are regulated differentially by the c-Myc oncoprotein in myeloid cells. Here, we characterize one of these, termed MT-MC1 (Myc Target in Myeloid Cells-1). MT-MC1 is a widely expressed nuclear protein whose overexpression, unlike that of c-Myc targets reported previously, recapitulates multiple c-Myc phenotypes. These include promotion of apoptosis, alteration of morphology, enhancement of anchorage-independent growth, tumorigenic conversion, promotion of genomic instability, and inhibition of hematopoietic differentiation. The MT-MC1 promoter is a direct c-Myc target; it contains two consensus E-box elements, both of which bind c-Myc(.)Max heterodimers. Mutation of either site abrogates DNA binding by c-Myc-Max and renders the promoter c-Myc unresponsive. Finally, MT-MC1 regulates the expression of several other c-Myc target genes. MT-MC1 represents a proximal and direct c-Myc target that recapitulates many of the properties typically associated with Myc oneoprotein overexpression.	Childrens Hosp Pittsburgh, Sect Hematol Oncol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Mol Genet & Biochem, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Canc Inst, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Prochownik, EV (corresponding author), Childrens Hosp Pittsburgh, Sect Hematol Oncol, 3705 5th Ave, Pittsburgh, PA 15213 USA.	edward_prochownik@poplar.chp.edu			NCI NIH HHS [CA78257] Funding Source: Medline; NHLBI NIH HHS [HL33741] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078257] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033741] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ASKEW DS, 1991, ONCOGENE, V6, P1915; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; Ben-Porath I, 1999, MOL CELL BIOL, V19, P3529; BOUCHEIX C, 1991, J BIOL CHEM, V266, P117; Brandvold KA, 2000, ONCOGENE, V19, P2780, DOI 10.1038/sj.onc.1203589; Carrier F, 1999, MOL CELL BIOL, V19, P1673; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; Dang CV, 1999, MOL CELL BIOL, V19, P1; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Facchini LM, 1998, FASEB J, V12, P633, DOI 10.1096/fasebj.12.9.633; Falvo JV, 1995, CELL, V83, P1101, DOI 10.1016/0092-8674(95)90137-X; Felsher DW, 2000, P NATL ACAD SCI USA, V97, P10544, DOI 10.1073/pnas.190327097; Felsher DW, 1999, P NATL ACAD SCI USA, V96, P3940, DOI 10.1073/pnas.96.7.3940; GARCIABUSTOS J, 1991, BIOCHIM BIOPHYS ACTA, V1071, P83, DOI 10.1016/0304-4157(91)90013-M; Guo QM, 2000, CANCER RES, V60, P5922; Henriksson M, 1996, ADV CANCER RES, V68, P109, DOI 10.1016/S0065-230X(08)60353-X; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; HURLIN PJ, 1995, EMBO J, V14, P5646, DOI 10.1002/j.1460-2075.1995.tb00252.x; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; Kamita SG, 1997, GENE, V190, P173, DOI 10.1016/S0378-1119(96)00671-3; KOZAK M, 1981, NUCLEIC ACIDS RES, V9, P5233, DOI 10.1093/nar/9.20.5233; Landay M, 2000, CELL DEATH DIFFER, V7, P697, DOI 10.1038/sj.cdd.4400701; Lewis BC, 1997, MOL CELL BIOL, V17, P4967, DOI 10.1128/MCB.17.9.4967; Lewis BC, 2000, CANCER RES, V60, P6178; Li Q, 1999, MOL CELL BIOL, V19, P5339; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; MAEDA S, 1991, VIROLOGY, V180, P807, DOI 10.1016/0042-6822(91)90096-T; Nagamura-Inoue T, 2001, Int Rev Immunol, V20, P83, DOI 10.3109/08830180109056724; Nakayama H, 2000, EXP HEMATOL, V28, P1232, DOI 10.1016/S0301-472X(00)00530-0; Neiman PE, 2001, P NATL ACAD SCI USA, V98, P6378, DOI 10.1073/pnas.111144898; Nesbit CE, 1998, CELL GROWTH DIFFER, V9, P731; Nesbit CE, 1998, BLOOD, V92, P1003; Nesbit CE, 2000, ONCOGENE, V19, P3200, DOI 10.1038/sj.onc.1203636; O'Hagan RC, 2000, NAT GENET, V24, P113, DOI 10.1038/72761; Obaya AJ, 1999, ONCOGENE, V18, P2934, DOI 10.1038/sj.onc.1202749; PACKHAM G, 1994, MOL CELL BIOL, V14, P5741, DOI 10.1128/MCB.14.9.5741; PONCZ M, 1987, BLOOD, V69, P219; Prendergast GC, 1999, ONCOGENE, V18, P2967, DOI 10.1038/sj.onc.1202727; PROCHOWNIK EV, 1986, NATURE, V322, P848, DOI 10.1038/322848a0; PROCHOWNIK EV, 1993, P NATL ACAD SCI USA, V90, P960, DOI 10.1073/pnas.90.3.960; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Shivdasani RA, 1997, HEMATOL ONCOL CLIN N, V11, P1199, DOI 10.1016/S0889-8588(05)70489-5; SMITH MJ, 1990, MOL CELL BIOL, V10, P5333, DOI 10.1128/MCB.10.10.5333; WAX SD, 1994, J BIOL CHEM, V269, P13041; Wood LJ, 2000, MOL CELL BIOL, V20, P5490, DOI 10.1128/MCB.20.15.5490-5502.2000; Yin XY, 1999, ONCOGENE, V18, P1177, DOI 10.1038/sj.onc.1202410; Yin XY, 2001, CANCER RES, V61, P6487; Yin XY, 1999, ONCOGENE, V18, P6621, DOI 10.1038/sj.onc.1203097; Yin XY, 2001, ONCOGENE, V20, P2908, DOI 10.1038/sj.onc.1204417; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A; ZHAN QM, 1994, MOL CELL BIOL, V14, P2361, DOI 10.1128/MCB.14.4.2361; Zhang H, 1997, J BIOL CHEM, V272, P17416, DOI 10.1074/jbc.272.28.17416	57	28	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19998	20010		10.1074/jbc.M200860200	http://dx.doi.org/10.1074/jbc.M200860200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11909865	hybrid			2022-12-27	WOS:000175894800100
J	Chiarini, A; Whitfield, JF; Armato, U; Dal Pra, I				Chiarini, A; Whitfield, JF; Armato, U; Dal Pra, I			Protein kinase C-beta(II) is an apoptotic lamin kinase in polyomavirus-transformed, etoposide-treated pyF111 rat fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOISOMERASE-II INHIBITORS; LEUKEMIA HL60 CELLS; C-DELTA HOLOENZYME; NUCLEAR LAMINS; SUBCELLULAR-LOCALIZATION; CASPASE ACTIVATION; B PHOSPHORYLATION; CALPHOSTIN-C; CDC2 KINASE; IN-VITRO	The role of protein kinase C-beta(II) (PKC-beta(II)) in etoposide (VP-16)-induced apoptosis was studied using polyomavirus-transformed pyF111 rat fibroblasts in which PKC-beta(II), specific activity in the nuclear membrane (NM) doubled and the enzyme was cleaved into catalytic fragments. No PKC-beta(II) complexes with lamin B1 and/or active caspases were immunoprecipitable from the NM of proliferating untreated cells, but large complexes of PKC-beta(II) holoprotein and its catalytic fragments with lamin B1, active caspase-3 and -6, and inactive phospho-CDK-1, but not PKC-beta(I), or PKC-delta, could be immunoprecipitated from the NM of VP-16-treated cells, suggesting that PKC-beta(II) is an apoptotic lamin kinase. By 30 min after normal nuclei were mixed with cytoplasms from VP-16-treated, but not untreated, cells, PKC-beta(II),1 holoprotein had moved from the apoptotic cytoplasm to the normal NM, and lamin B1 was phosphorylated before cleavage by caspase-6. Lamin B1 phosphorylation was partly reduced, but its cleavage was completely prevented, despite the presence of active caspase-6, by adding a selective PKC-betas inhibitor, hispidin, to the apoptotic cytoplasms. Thus, a PKC-beta(II), response to VP-16 seems necessary for lamin B1 cleavage by caspase-6 and nuclear lamina dissolution in apoptosing pyF111 fibroblasts. The possibility of PKC-beta(II) being an apoptotic lamin kinase in these cells was further suggested by lamin B1-bound PKC-delta being inactive or only slightly active and by PKC-alpha not combining with the lamin.	Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; Univ Verona, Sch Med, Dept Biomed & Surg Sci, Histol & Embryol Unit, I-37134 Verona, Italy	National Research Council Canada; University of Verona	Whitfield, JF (corresponding author), Natl Res Council Canada, Inst Biol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.		Chiarini, Anna/F-4097-2011; Dal Prà, Ilaria Pierpaola/R-3534-2017; DAL PRÀ, Ilaria Pierpaola/AAR-4216-2021; Armato, Ubaldo/N-2255-2019	Chiarini, Anna/0000-0002-6974-7685; Dal Prà, Ilaria Pierpaola/0000-0001-5523-4910; DAL PRÀ, Ilaria Pierpaola/0000-0001-5523-4910; Armato, Ubaldo/0000-0002-7804-6143				Blomgren K, 2001, J BIOL CHEM, V276, P10191, DOI 10.1074/jbc.M007807200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chua BT, 2000, J BIOL CHEM, V275, P5131, DOI 10.1074/jbc.275.7.5131; Collas P, 1997, J BIOL CHEM, V272, P21274, DOI 10.1074/jbc.272.34.21274; Cross T, 2000, ONCOGENE, V19, P2331, DOI 10.1038/sj.onc.1203555; Dal Pra I, 2000, EXP CELL RES, V255, P171, DOI 10.1006/excr.1999.4789; Dal Pra I, 1999, EXP CELL RES, V249, P147, DOI 10.1006/excr.1999.4441; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Duan HJ, 1996, J BIOL CHEM, V271, P16720, DOI 10.1074/jbc.271.28.16720; Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7; Emoto Y, 1996, BLOOD, V87, P1990; FIELDS AP, 1988, J BIOL CHEM, V263, P8253; Finkel E, 2001, SCIENCE, V292, P624, DOI 10.1126/science.292.5517.624; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; GJERTSEN BT, 1995, BBA-MOL CELL RES, V1269, P187, DOI 10.1016/0167-4889(95)00117-B; Gokmen-Polar Y, 1998, J BIOL CHEM, V273, P20261, DOI 10.1074/jbc.273.32.20261; Goldberg M, 1999, CRIT REV EUKAR GENE, V9, P285, DOI 10.1615/CritRevEukarGeneExpr.v9.i3-4.130; Goldfine H, 2000, INFECT IMMUN, V68, P5735, DOI 10.1128/IAI.68.10.5735-5741.2000; Gonindard C, 1997, CELL BIOL TOXICOL, V13, P141, DOI 10.1023/A:1007321227010; GOSS VL, 1994, J BIOL CHEM, V269, P19074; Gruenbaum Y, 2000, J STRUCT BIOL, V129, P313, DOI 10.1006/jsbi.2000.4216; Hacker G, 2000, CELL TISSUE RES, V301, P5, DOI 10.1007/s004410000193; Harada K, 1999, J NEUROCHEM, V72, P2556, DOI 10.1046/j.1471-4159.1999.0722556.x; HOCEVAR BA, 1991, J BIOL CHEM, V266, P28; IWATA M, 1994, INT IMMUNOL, V6, P431, DOI 10.1093/intimm/6.3.431; Kajstura J, 1997, J MOL CELL CARDIOL, V29, P859, DOI 10.1006/jmcc.1996.0333; KAUFMANN SH, 1989, CANCER RES, V49, P5870; Kaufmann SH, 1998, BBA-GENE STRUCT EXPR, V1400, P195, DOI 10.1016/S0167-4781(98)00136-5; Kawahara A, 1998, GENES CELLS, V3, P297, DOI 10.1046/j.1365-2443.1998.00189.x; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; KNOX KA, 1993, EXP CELL RES, V207, P68, DOI 10.1006/excr.1993.1164; LOCK RB, 1992, CANCER RES, V52, P1817; Majumder PK, 2000, J BIOL CHEM, V275, P21793, DOI 10.1074/jbc.C000048200; Mandal M, 1996, J BIOL CHEM, V271, P30354, DOI 10.1074/jbc.271.48.30354; Martins LM, 1997, BLOOD, V90, P4283, DOI 10.1182/blood.V90.11.4283.4283_4283_4296; Mayne GC, 1998, J BIOL CHEM, V273, P24115, DOI 10.1074/jbc.273.37.24115; MCINTOSH CHS, 1976, J NEUROCHEM, V27, P449; Mizuno K, 1997, EUR J BIOCHEM, V250, P7, DOI 10.1111/j.1432-1033.1997.00007.x; Moir RD, 1995, INT REV CYTOL, V162B, P141; MOIR RD, 1994, J CELL BIOL, V125, P1201, DOI 10.1083/jcb.125.6.1201; Moir RD, 2001, CELL MOL LIFE SCI, V58, P1748, DOI 10.1007/PL00000814; MURRAY A, 1993, CELL CYCLE; MURRAY NR, 1994, J BIOL CHEM, V269, P21385; MURRAY NR, 1993, J BIOL CHEM, V268, P15847; Murray NR, 1998, J BIOL CHEM, V273, P11514, DOI 10.1074/jbc.273.19.11514; Musashi M, 2000, INT J HEMATOL, V72, P12; NORBURY C, 1994, BIOCHEM BIOPH RES CO, V202, P1400, DOI 10.1006/bbrc.1994.2086; OBERHAMMER FA, 1994, J CELL BIOL, V126, P827, DOI 10.1083/jcb.126.4.827; OCONNOR PM, 1994, P NATL ACAD SCI USA, V91, P9480, DOI 10.1073/pnas.91.20.9480; Ohmori T, 1998, CELL GROWTH DIFFER, V9, P345; Orth K, 1996, J BIOL CHEM, V271, P16443, DOI 10.1074/jbc.271.28.16443; PELLICCIARI C, 1993, EUR J HISTOCHEM, V37, P381; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; Rao L, 1996, J CELL BIOL, V135, P1441, DOI 10.1083/jcb.135.6.1441; ROGUE P, 1990, J BIOL CHEM, V265, P4161; ROSENBERGER U, 1995, BIOCHEM J, V305, P269, DOI 10.1042/bj3050269; SHI L, 1994, SCIENCE, V263, P1143, DOI 10.1126/science.8108732; Shimizu T, 1998, J BIOL CHEM, V273, P8669, DOI 10.1074/jbc.273.15.8669; SHIMIZU T, 1995, CANCER RES, V55, P228; Shimizu T, 1997, LEUKEMIA, V11, P1238, DOI 10.1038/sj.leu.2400734; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; SNAPPER CM, 1988, P NATL ACAD SCI USA, V85, P6107, DOI 10.1073/pnas.85.16.6107; Solomon MJ, 1993, CURR OPIN CELL BIOL, V5, P180, DOI 10.1016/0955-0674(93)90100-5; Sonnenburg ED, 2001, J BIOL CHEM, V276, P45289, DOI 10.1074/jbc.M107416200; Spector D.I., 1998, CELL LAB MANUAL, V1; Stuurman N, 1997, FEBS LETT, V401, P171, DOI 10.1016/S0014-5793(96)01464-0; Takahashi A, 1996, P NATL ACAD SCI USA, V93, P8395, DOI 10.1073/pnas.93.16.8395; Tanabe F, 1998, BIOCHEM BIOPH RES CO, V242, P129, DOI 10.1006/bbrc.1997.7934; Thompson LJ, 1996, J BIOL CHEM, V271, P15045, DOI 10.1074/jbc.271.25.15045; Toker Alex, 1998, Frontiers in Bioscience, V3, pD1134; Varghese J, 2001, EUR J IMMUNOL, V31, P2035, DOI 10.1002/1521-4141(200107)31:7<2035::AID-IMMU2035>3.0.CO;2-Y; Ventura C, 2001, CRIT REV EUKAR GENE, V11, P243; Vlcek S, 2001, CELL MOL LIFE SCI, V58, P1758, DOI 10.1007/PL00000815; WALKER SD, 1995, P NATL ACAD SCI USA, V92, P9156, DOI 10.1073/pnas.92.20.9156; WARD GE, 1990, CELL, V61, P561, DOI 10.1016/0092-8674(90)90469-U; WHITFIELD JF, 2002, CALCIUM GRAND MASTER; WHITFIELD JF, 1997, CALCIUM CELL CYCLE D; Yuan SY, 2000, CIRC RES, V87, P412; Zhao Y, 2001, CELL MOL LIFE SCI, V58, P298, DOI 10.1007/PL00000857	80	33	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					18827	18839		10.1074/jbc.M111921200	http://dx.doi.org/10.1074/jbc.M111921200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11901153	hybrid			2022-12-27	WOS:000175975800077
J	Petroulakis, E; Wang, E				Petroulakis, E; Wang, E			Nerve growth factor specifically stimulates translation of eukaryotic elongation factor 1A-1 (eEF1A-1) mRNA by recruitment to polyribosomes in PC12 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE S6 KINASE; NEUROTROPHIC FACTOR; NEURITE REGENERATION; BINDING-PROTEIN; FACTOR 1-ALPHA; GEL SYSTEM; RAPAMYCIN; EXPRESSION; FACTOR-1-ALPHA; BRAIN	During postnatal brain development the level of peptide elongation factor-1A (eEF1A-1) expression declines and that of the highly homologous isoform, eEF1A-2, increases in neurons. eEF1A-1 is implicated in cytoskeletal interactions, tumorigenesis, differentiation, and the absence of eEF1A-2 is implicated in neurodegeneration in the mouse mutant, wasted. The translation of eEF1A-1 mRNA is up-regulated via mitogenic stimulation. However, it is not known if eEF1A-1 mRNA translation is regulated by neurotrophins or if its synthesis is differentially regulated than that of the neuronal isoform, eEF1A-2. Regulated translation of these factors by neurotrophin, particularly by the Trk class of neurotrophin receptors, would implicate them in differentiation, survival, and neuronal plasticity. In this study, we investigated the effect of nerve growth factor (NGF) stimulation on the synthesis of eEF1A-1 and eEF1A-2. We found that NGF stimulation causes a preferential synthesis of eEF1A-1 over eEF1A-2 in PC12 cells. We analyzed the co-sedimentation of eEF1A-1 mRNA with polyribosome fractions in sucrose gradients, and found that NGF stimulation enriched the presence of eEF1A-1 mRNA in polyribosomes, indicating that the translation of eEF1A-1 mRNA is regulated by NGF. Inhibitors of phosphatidylinositol 3-kinase (LY 294002), mammalian target of rapamycin (rapamycin), and the NGF receptor, TrkA (K-252a), but not of mitogen-activated protein kinase (PD 98059), prevented the recruitment of eEF1A-1 mRNA to polyribosomes. The mobilization of eEF1A-1 mRNA to polyribosomes was rapamycin-sensitive in both proliferating and differentiated PC12 cells, indicating the importance of this pathway during differentiation. Our data shows that after growth factor withdrawal, an NGF-signaling pathway Stimulates eEF1A-1 mRNA translation in proliferating and differentiated PC12 cells. Therefore, eEF1A-1 mRNA is a specific translational target of TrkA signaling.	Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40292 USA; McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3T 1E2, Canada; McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, Montreal, PQ H3T 1E2, Canada	University of Louisville; McGill University; Lady Davis Institute; McGill University	Wang, E (corresponding author), Univ Louisville, Sch Med, Dept Biochem & Mol Biol, 570 S Preston St,Rm 304, Louisville, KY 40292 USA.	eugenia.wang@louisville.edu			NIA NIH HHS [AG10461] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANN DK, 1991, J BIOL CHEM, V266, P10429; Barker PA, 1998, CELL DEATH DIFFER, V5, P346, DOI 10.1038/sj.cdd.4400375; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Bischoff C, 2000, GENOMICS, V68, P63, DOI 10.1006/geno.2000.6271; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P8351, DOI 10.1073/pnas.95.14.8351; Chambers DM, 1998, P NATL ACAD SCI USA, V95, P4463, DOI 10.1073/pnas.95.8.4463; Crosio C, 2000, NUCLEIC ACIDS RES, V28, P2927, DOI 10.1093/nar/28.15.2927; DOUCET JP, 1990, ANAL BIOCHEM, V190, P209, DOI 10.1016/0003-2697(90)90182-9; DOUCET JP, 1988, ANAL BIOCHEM, V168, P265, DOI 10.1016/0003-2697(88)90317-X; Edmonds BT, 1996, J CELL SCI, V109, P2705; FREDERICKSON RM, 1992, MOL CELL BIOL, V12, P1239, DOI 10.1128/MCB.12.3.1239; Gangwani L, 1998, J CELL BIOL, V143, P1471, DOI 10.1083/jcb.143.6.1471; Hidalgo M, 2000, ONCOGENE, V19, P6680, DOI 10.1038/sj.onc.1204091; JEFFERIES HBJ, 1994, J BIOL CHEM, V269, P4367; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; Kahns S, 1998, NUCLEIC ACIDS RES, V26, P1884, DOI 10.1093/nar/26.8.1884; Khalyfa A, 1999, DEV DYNAM, V216, P267, DOI 10.1002/(SICI)1097-0177(199911)216:3<267::AID-DVDY5>3.0.CO;2-V; Khalyfa A, 2001, J BIOL CHEM, V276, P22915, DOI 10.1074/jbc.M101011200; Kleijn M, 1998, J BIOL CHEM, V273, P5536, DOI 10.1074/jbc.273.10.5536; Kleijn M, 2000, BIOCHEM J, V347, P399, DOI 10.1042/0264-6021:3470399; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE S, 1995, EXP CELL RES, V219, P589, DOI 10.1006/excr.1995.1268; LEE S, 1993, J HISTOCHEM CYTOCHEM, V41, P1093, DOI 10.1177/41.7.8515051; LEE S, 1993, J BIOL CHEM, V268, P24453; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; MATSUDA Y, 1986, J NEUROCHEM, V47, P1728, DOI 10.1111/j.1471-4159.1986.tb13081.x; MATSUDA Y, 1987, J BIOL CHEM, V262, P2832; Meyuhas O, 2000, COLD SPRING HARBOR M, V39, P671; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Miller FD, 1998, CELL DEATH DIFFER, V5, P343, DOI 10.1038/sj.cdd.4400385; Moore DD, 1995, GLOB MOB SURV; MUTOH T, 1988, J BIOL CHEM, V263, P15853; Negrutskii BS, 1998, PROG NUCLEIC ACID RE, V60, P47, DOI 10.1016/S0079-6603(08)60889-2; NIELSEN FC, 1995, NATURE, V377, P358, DOI 10.1038/377358a0; Pedersen S, 1997, EUR J BIOCHEM, V247, P449, DOI 10.1111/j.1432-1033.1997.00449.x; Pellizzoni L, 1997, J MOL BIOL, V267, P264, DOI 10.1006/jmbi.1996.0888; Proud Christopher, 2000, V39, P719; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; Runnicki M.A., 1987, TERATOCARCINOMAS EMB, P19; Sabatini DM, 1999, SCIENCE, V284, P1161, DOI 10.1126/science.284.5417.1161; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Snyder SH, 1998, NEURON, V21, P283, DOI 10.1016/S0896-6273(00)80538-3; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Sonenberg N, 2000, TRANSLATIONAL CONTRO; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; Takei N, 2001, J BIOL CHEM, V276, P42818, DOI 10.1074/jbc.M103237200; Tang H, 2001, MOL CELL BIOL, V21, P8671, DOI 10.1128/MCB.21.24.8671-8683.2001; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; TAPLEY P, 1992, ONCOGENE, V7, P371; TWISS JL, 1995, J NEUROCHEM, V64, P550; Twiss JL, 2000, NEUROBIOL DIS, V7, P416, DOI 10.1006/nbdi.2000.0293; Zhu JF, 2001, BBA-GENE STRUCT EXPR, V1521, P19, DOI 10.1016/S0167-4781(01)00277-9	54	18	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					18718	18727		10.1074/jbc.M111782200	http://dx.doi.org/10.1074/jbc.M111782200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11907030	hybrid			2022-12-27	WOS:000175975800064
J	Guttridge, KL; Luft, JC; Dawson, TL; Kozlowska, E; Mahajan, NP; Varnum, B; Earp, HS				Guttridge, KL; Luft, JC; Dawson, TL; Kozlowska, E; Mahajan, NP; Varnum, B; Earp, HS			Mer receptor tyrosine kinase signaling. Prevention of apoptosis and alteration of cytoskeletal architecture without stimulation or proliferation.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; ARREST-SPECIFIC GENE-6; EXPRESSION ANALYSIS; C-MER; TRANSFORMING SIGNALS; HEMATOPOIETIC-CELLS; MOLECULAR-CLONING; PROTEIN-S; RCS RAT; V-RYK	Mer is a member of the Axl/Mer/Tyro3 receptor tyrosine kinase family, a family whose physiological function is not well defined. We constructed a Mer chimera using the epidermal growth factor receptor (EGFR) extracellular and transmembrane domains and the Mer cytoplasmic domain. Stable transfection of the Mer chimera into interleukin 3 (IL-3)-dependent murine 32D cells resulted in ligand-activable surface receptor that tyrosine autophosphorylated, stimulated intracellular signaling, and dramatically reduced apoptosis initiated by IL-3 withdrawal. However, unlike multiple other ectopically expressed receptor tyrosine kinases including full-length EGFR or an EGFR/Axl chimera, the Mer chimera did not stimulate proliferation. Moreover, and in contrast to EGFR, Mer chimera activation induced adherence and cell flattening in the normally suspension-growing 32D cells. The Mer chimera signal also blocked IL-3-dependent proliferation leading to G(1)/S arrest, dephosphorylation of retinoblastoma protein, and elongation of cellular processes. Unlike other agonists that lead to a slow (4-8 days) ligand-dependent differentiation of 32D cells, the combined Mer and IL-3 signal resulted in differentiated morphology and growth cessation in the first 24 h. Thus the Mer chimera blocks apoptosis without stimulating growth and produces cytoskeletal alterations; this outcome is clearly separable from the proliferative signal produced by most receptor tyrosine kinases.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Med & Pharmacol, Sch Med, Chapel Hill, NC 27599 USA; Procter & Gamble Corp, Cincinnati, OH 45202 USA; Amgen Corp, Thousand Oaks, CA 91320 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Procter & Gamble; Amgen	Earp, HS (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Med & Pharmacol, Sch Med, Chapel Hill, NC 27599 USA.		Kozlowska, Ewa/ABB-8371-2020	Kozlowska, Ewa/0000-0002-8655-851X; Dawson, Thomas/0000-0003-3878-1722	NATIONAL CANCER INSTITUTE [R01CA068346, R01CA049240] Funding Source: NIH RePORTER; NCI NIH HHS [CA-49240, CA-68346] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bellosta P, 1997, ONCOGENE, V15, P2387, DOI 10.1038/sj.onc.1201419; Biscardi JS, 1996, J BIOL CHEM, V271, P29049, DOI 10.1074/jbc.271.46.29049; Camenisch TD, 1999, J IMMUNOL, V162, P3498; Chen J, 1997, ONCOGENE, V14, P2033, DOI 10.1038/sj.onc.1201039; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CROSIER PS, 1994, GROWTH FACTORS, V11, P125, DOI 10.3109/08977199409001054; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; DAI W, 1994, ONCOGENE, V9, P975; DIFIORE PP, 1990, SCIENCE, V248, P79, DOI 10.1126/science.2181668; Evans CO, 2001, J CLIN ENDOCR METAB, V86, P3097, DOI 10.1210/jc.86.7.3097; FAUST M, 1992, ONCOGENE, V7, P1287; Fridell YWC, 1998, J BIOL CHEM, V273, P7123, DOI 10.1074/jbc.273.12.7123; Fridell YWC, 1996, MOL CELL BIOL, V16, P135; FUJIMOTO J, 1994, ONCOGENE, V9, P693; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Georgescu MM, 1999, MOL CELL BIOL, V19, P1171; Goruppi S, 1996, ONCOGENE, V12, P471; GRAHAM DK, 1994, CELL GROWTH DIFFER, V5, P647; GRAHAM DK, 1995, ONCOGENE, V10, P2349; JIA R, 1992, J VIROL, V66, P5975, DOI 10.1128/JVI.66.10.5975-5987.1992; JIA R, 1994, J BIOL CHEM, V269, P1839; KATO JY, 1990, BLOOD, V75, P1780; LEE J, 1989, EMBO J, V8, P167, DOI 10.1002/j.1460-2075.1989.tb03361.x; LEHVASLAIHO H, 1989, EMBO J, V8, P159, DOI 10.1002/j.1460-2075.1989.tb03360.x; LING L, 1995, MOL CELL BIOL, V15, P6582; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; Mark MR, 1996, J BIOL CHEM, V271, P9785, DOI 10.1074/jbc.271.16.9785; MARK MR, 1994, J BIOL CHEM, V269, P10720; MCCLOSKEY P, 1994, CELL GROWTH DIFFER, V5, P1105; MCCUNE BK, 1989, J BIOL CHEM, V264, P15501; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; NEUBAUER A, 1994, BLOOD, V84, P1931; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; OHASHI K, 1994, ONCOGENE, V9, P699; PALASZYNSKI EW, 1984, J IMMUNOL, V132, P1872; PELES E, 1993, BIOESSAYS, V15, P815, DOI 10.1002/bies.950151207; RESCIGNO J, 1991, ONCOGENE, V6, P1909; SANTORO M, 1994, MOL CELL BIOL, V14, P663, DOI 10.1128/MCB.14.1.663; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; TAYLOR ICA, 1995, J BIOL CHEM, V270, P6872, DOI 10.1074/jbc.270.12.6872; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Valentinis B, 1999, J BIOL CHEM, V274, P12423, DOI 10.1074/jbc.274.18.12423; VALTIERI M, 1987, J IMMUNOL, V138, P3829; VARNUM BC, 1995, NATURE, V373, P623, DOI 10.1038/373623a0; Wooten DK, 2000, J BIOL CHEM, V275, P26566, DOI 10.1074/jbc.M003495200	50	62	66	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 5	2002	277	27					24057	24066		10.1074/jbc.M112086200	http://dx.doi.org/10.1074/jbc.M112086200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	569PV	11929866	hybrid			2022-12-27	WOS:000176611800013
J	Herbst, R; Ott, C; Jacobs, T; Marti, T; Marciano-Cabral, F; Leippe, M				Herbst, R; Ott, C; Jacobs, T; Marti, T; Marciano-Cabral, F; Leippe, M			Pore-forming polypeptides of the pathogenic protozoon Naegleria fowleri	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY AMEBIC MENINGOENCEPHALITIS; ENTAMOEBA-HISTOLYTICA; NK-LYSIN; MOLECULAR CHARACTERIZATION; SECONDARY STRUCTURE; CYTOLYTIC ACTIVITY; CDNA SEQUENCE; PROTEIN; MEMBRANE; PEPTIDES	The free-living amoeboflagellate and potential human pathogen Naegleria fowleri causes the often fatal disease primary amoebic meningoencephalitis. The molecular repertoire responsible for the cytolytic and tissue-destructive activity of this amoeboid protozoon is largely unknown. We isolated two pore-forming polypeptides from extracts of highly virulent trophozoites of N. fowleri by measuring their membrane-permeabilizing activity. N-terminal sequencing and subsequent molecular cloning yielded the complete primary structures and revealed that the two polypeptides are isoforms. Both polypeptides share similar structural properties with antimicrobial and cytolytic polypeptides of the protozoon Entamoeba histolytica (amoebapores) and of cytotoxic natural killer (NK) and T cells of human (granulysin) and pig (NK-lysin), all characterized by a structure of amphipathic alpha-helices and an invariant framework of cysteine residues involved in disulfide bonds. In contrast to the aforementioned proteins, the Naegleria polypeptides both are processed from large precursor molecules containing additional isoforms of substantial sequence divergence. Moreover, biochemical characterization of the isolated polypeptides in combination with mass determination showed that they are N-glycosylated and variably processed at the C terminus. The biological activity of the purified polypeptides of Naegleria was examined toward human cells and bacteria, and it was found that these factors, named naegleriapores, are active against both types of target cells, which is in good agreement with their proposed biological role as a broad-spectrum effector molecule.	Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; Res Ctr Infect Dis, Mol Parasitol Grp, D-97070 Wurzburg, Germany; Virginia Commonwealth Univ, Med Coll Virginia, Dept Microbiol & Immunol, Richmond, VA 23298 USA	Bernhard Nocht Institut fur Tropenmedizin; University of Wurzburg; Virginia Commonwealth University	Leippe, M (corresponding author), Bernhard Nocht Inst Trop Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	matthias.leippe@mail.uni-wuerzburg.de	Leippe, Matthias/AAP-1677-2020	Herbst, Rosa/0000-0002-2379-7433				AKITA EM, 1993, J IMMUNOL METHODS, V160, P207, DOI 10.1016/0022-1759(93)90179-B; ALDAPE K, 1994, EXP PARASITOL, V78, P230, DOI 10.1006/expr.1994.1023; ANDERSSON M, 1995, EMBO J, V14, P1615, DOI 10.1002/j.1460-2075.1995.tb07150.x; Andersson M, 1999, INFECT IMMUN, V67, P201, DOI 10.1128/IAI.67.1.201-205.1999; ANDREWS NW, 1990, CELL, V61, P1277, DOI 10.1016/0092-8674(90)90692-8; BOMAN HG, 1974, INFECT IMMUN, V10, P136, DOI 10.1128/IAI.10.1.136-145.1974; Bracha R, 1999, MOL MICROBIOL, V34, P463, DOI 10.1046/j.1365-2958.1999.01607.x; Bruhn H, 1999, BIOL CHEM, V380, P1001, DOI 10.1515/BC.1999.124; BUCK MA, 1989, ANAL BIOCHEM, V182, P295, DOI 10.1016/0003-2697(89)90597-6; CARTER RF, 1970, J PATHOL, V100, P217, DOI 10.1002/path.1711000402; CASTEELSJOSSON K, 1993, EMBO J, V12, P1569, DOI 10.1002/j.1460-2075.1993.tb05801.x; CHANG SL, 1979, FOLIA PARASIT, V26, P195; Faull KF, 1999, J MASS SPECTROM, V34, P1040, DOI 10.1002/(SICI)1096-9888(199910)34:10<1040::AID-JMS863>3.0.CO;2-X; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; FULFORD DE, 1985, J PROTOZOOL, V32, P176, DOI 10.1111/j.1550-7408.1985.tb03034.x; FULFORD DE, 1986, J PROTOZOOL, V33, P498, DOI 10.1111/j.1550-7408.1986.tb05649.x; HIRAIWA M, 1993, ARCH BIOCHEM BIOPHYS, V304, P110, DOI 10.1006/abbi.1993.1328; HIRAIWA M, 1993, ARCH BIOCHEM BIOPHYS, V303, P326, DOI 10.1006/abbi.1993.1291; Horta MF, 1997, TRENDS MICROBIOL, V5, P363, DOI 10.1016/S0966-842X(97)01109-8; Jacobs T, 1998, MOL MICROBIOL, V27, P269, DOI 10.1046/j.1365-2958.1998.00662.x; JOHN DT, 1982, ANNU REV MICROBIOL, V36, P101, DOI 10.1146/annurev.mi.36.100182.000533; Kervinen J, 1999, EMBO J, V18, P3947, DOI 10.1093/emboj/18.14.3947; Leippe M, 1997, PARASITOL TODAY, V13, P178, DOI 10.1016/S0169-4758(97)01038-7; LEIPPE M, 1992, EMBO J, V11, P3501, DOI 10.1002/j.1460-2075.1992.tb05432.x; LEIPPE M, 1991, P NATL ACAD SCI USA, V88, P7659, DOI 10.1073/pnas.88.17.7659; LEIPPE M, 1994, MOL MICROBIOL, V14, P895, DOI 10.1111/j.1365-2958.1994.tb01325.x; LEIPPE M, 1995, CELL, V83, P17, DOI 10.1016/0092-8674(95)90229-5; Leonova T, 1996, J BIOL CHEM, V271, P17312, DOI 10.1074/jbc.271.29.17312; Liepinsh E, 1997, NAT STRUCT BIOL, V4, P793, DOI 10.1038/nsb1097-793; LOWREY DM, 1985, INFECT IMMUN, V50, P478, DOI 10.1128/IAI.50.2.478-482.1985; MA P, 1990, REV INFECT DIS, V12, P490; MARCIANOCABRAL F, 1990, J PROTOZOOL, V37, P138, DOI 10.1111/j.1550-7408.1990.tb05884.x; MARCIANOCABRAL F, 1988, MICROBIOL REV, V52, P114, DOI 10.1128/MMBR.52.1.114-133.1988; MARCIANOCABRAL FM, 1986, APPL ENVIRON MICROB, V51, P1133, DOI 10.1128/AEM.51.5.1133-1137.1986; MUNFORD RS, 1995, J LIPID RES, V36, P1653; Nickel R, 1998, FEBS LETT, V437, P153, DOI 10.1016/S0014-5793(98)01220-4; NORONHA FSM, 1994, BRAZ J MED BIOL RES, V27, P477; Noronha FSM, 1996, INFECT IMMUN, V64, P3975, DOI 10.1128/IAI.64.10.3975-3982.1996; Pena SV, 1997, J IMMUNOL, V158, P2680; RODRIGUEZZARAGOZA S, 1994, CRIT REV MICROBIOL, V20, P225, DOI 10.3109/10408419409114556; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; TANNICH E, 1991, J BIOL CHEM, V266, P4798; Tatti M, 1999, EUR J BIOCHEM, V263, P486, DOI 10.1046/j.1432-1327.1999.00521.x; TERRY AS, 1988, J BIOL CHEM, V263, P5745; YOUNG JDE, 1989, J BIOL CHEM, V264, P1077; Zaltash S, 1998, FEBS LETT, V423, P1, DOI 10.1016/S0014-5793(97)01582-2; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; ZASLOFF M, 1992, CURR OPIN IMMUNOL, V4, P3, DOI 10.1016/0952-7915(92)90115-U	50	67	70	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22353	22360		10.1074/jbc.M201475200	http://dx.doi.org/10.1074/jbc.M201475200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11948186	hybrid			2022-12-27	WOS:000176313600032
J	Hsu, CH; Wu, SH; Chang, DK; Chen, CP				Hsu, CH; Wu, SH; Chang, DK; Chen, CP			Structural characterizations of fusion peptide analogs of influenza virus hemagglutinin - Implication of the necessity of a helix-hinge-helix motif in fusion activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED MEMBRANE-FUSION; LIPID BILAYERS; PHOSPHOLIPID-VESICLES; PH; SPECTROSCOPY; PROTEINS; CONFORMATION; RESOLUTION; LIPOSOMES; TERMINUS	Infection by enveloped viruses initially involves membrane fusion between viral and host cell membranes. The fusion peptide plays a crucial role in triggering this reaction. To clarify how the fusion peptide exerts this specific function, we carried out biophysical studies of three fusion peptide analogs of influenza virus hemagglutinin HA2, namely E5, G13L, and L17A. E5 exhibits an activity similar to the native fusion peptide, whereas G13L and L17A, which are two point mutants of the E5 analog, possess much less fusion activity. Our CD data showed that the conformations of these three analogs in SDS micelles are pH-dependent, with higher a-helical contents at acidic pH. Tryptophan fluorescence emission experiments indicated that these three analogs insert deeper into lipid bilayers at acidic pH. The three-dimensional structure of the E5 analog in SDS micelles at pH 4.0 revealed that two segments, Leu(2)-Glu(11) and Trp(14)-Ile(18), form amphipathic helical conformations' with Gly(12)-Gly(13) forming a hinge. The hydrophobic residues in the N- and C-terminal helices form a hydrophobic cluster. At neutral pH, however, the C-terminal helix of Trp(14)-Ile(18) reduces dramatically, and the hydrophobic core observed at acidic pH is severely disrupted. We suggest that the disruption of the C-terminal helix renders the E5 analog fusion-inactive at neutral pH. Furthermore, the decrease of the hinge and the reduction of fusion activity in G13L reveal the importance of the hinge in fusion activity. Also, the decrease in the C-terminal helix and the reduction of fusion activity in L17A demonstrates the importance of the C-terminal helix in fusion activity. Based on these biophysical studies, we propose a model that illustrates the structural change of the HA2 fusion peptide analog and explains how the analog interacts with the lipid bilayer at different pH values.	Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; Natl Taiwan Univ, Inst Biochem Sci, Taipei 106, Taiwan; Acad Sinica, Inst Chem, Taipei 115, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; Academia Sinica - Taiwan	Chen, CP (corresponding author), Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan.		Chen, Chinpan/O-4202-2018; HSU, CHUN-HUA/W-4554-2019; Chang, Ding-Kwo/E-7079-2015	HSU, CHUN-HUA/0000-0002-0008-7383; 				Barker WC, 1998, NUCLEIC ACIDS RES, V26, P27, DOI 10.1093/nar/26.1.27; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BRASSEUR R, 1990, BIOCHIM BIOPHYS ACTA, V1029, P267, DOI 10.1016/0005-2736(90)90163-I; BRUNGER AT, 1998, X PLOR; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; CREIGHTON TE, 1993, PROTEINS, P190; Dubovskii PV, 2000, PROTEIN SCI, V9, P786; GETHING MJ, 1986, J CELL BIOL, V102, P11, DOI 10.1083/jcb.102.1.11; Han X, 1999, BIOCHEMISTRY-US, V38, P15052, DOI 10.1021/bi991232h; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; HAYWOOD AM, 1985, P NATL ACAD SCI USA, V82, P4611, DOI 10.1073/pnas.82.14.4611; Koradi R, 1996, J MOL GRAPHICS, V14, P29; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LEAR JD, 1987, J BIOL CHEM, V262, P6500; LUNEBERG J, 1995, J BIOL CHEM, V270, P27606; Macosko JC, 1997, J MOL BIOL, V267, P1139, DOI 10.1006/jmbi.1997.0931; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; Matsumoto T, 1999, BIOPHYS CHEM, V79, P153, DOI 10.1016/S0301-4622(99)00051-4; MIDOUX P, 1995, BBA-BIOMEMBRANES, V1239, P249, DOI 10.1016/0005-2736(95)00163-W; MURATA M, 1993, BIOPHYS J, V64, P724, DOI 10.1016/S0006-3495(93)81432-2; MURATA M, 1992, BIOCHEMISTRY-US, V31, P1986, DOI 10.1021/bi00122a013; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Pichon C, 1997, ANTISENSE NUCLEIC A, V7, P335, DOI 10.1089/oli.1.1997.7.335; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; RAFALSKI M, 1991, BIOCHEMISTRY-US, V30, P10211, DOI 10.1021/bi00106a020; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; SKEHEL JJ, 1982, P NATL ACAD SCI-BIOL, V79, P968, DOI 10.1073/pnas.79.4.968; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; STEINHAUER DA, 1995, J VIROL, V69, P6643, DOI 10.1128/JVI.69.11.6643-6651.1995; TAKAHASHI S, 1990, BIOCHEMISTRY-US, V29, P6257, DOI 10.1021/bi00478a021; VAN MEER G, 1985, BIOCHEMISTRY-US, V24, P3593, DOI 10.1021/bi00335a030; WHARTON SA, 1986, VIROLOGY, V149, P27, DOI 10.1016/0042-6822(86)90083-8; WHITE J, 1982, EMBO J, V1, P217, DOI 10.1002/j.1460-2075.1982.tb01150.x; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0	36	45	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22725	22733		10.1074/jbc.M200089200	http://dx.doi.org/10.1074/jbc.M200089200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11937502	hybrid, Green Published			2022-12-27	WOS:000176313600081
J	Baskakov, IV; Legname, G; Baldwin, MA; Prusiner, SB; Cohen, FE				Baskakov, IV; Legname, G; Baldwin, MA; Prusiner, SB; Cohen, FE			Pathway complexity of prion protein assembly into amyloid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMISSIBLE MINK ENCEPHALOPATHY; TRANSGENIC MICE; 106 RESIDUES; IN-VITRO; SCRAPIE; CONFORMATIONS; PRP; STABILITY; STRAINS; DISEASE	In vivo under pathological conditions, the normal cellular form of the prion protein, PrPC (residues 23-231), misfolds to the pathogenic isoform PrPSc, a beta-rich aggregated pathogenic multimer. Proteinase K digestion of PrPSc leads to a proteolytically resistant core, PrP 27-30 (residues 90-231), that can form amyloid fibrils. To study the kinetic pathways of amyloid formation in vitro, we used unglycosylated recombinant PrP corresponding to the proteinase K-resistant core of PrPSc and found that it can adopt two non-native abnormal isoforms, a beta-oligomer and an amyloid fibril. Several lines of kinetic data suggest that the beta-oligomer is not on the pathway to amyloid formation. The preferences for forming either a beta-oligomer or amyloid can be dictated by experimental conditions, with acidic pH similar to that seen in endocytic vesicles favoring the beta-oligomer and neutral pH favoring amyloid. Although both abnormal isoforms have high beta-sheet content and bind 1-anilinonaphthalene-8-sulfonate, they are dissimilar structurally. Multiple pathways of misfolding and the formation of distinct beta-sheet-rich abnormal isoforms may explain the difficulties in refolding PrPSc in vitro, the need for a PrPSc template, and the significant variation in disease presentation and neuropathology.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cohen, FE (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, Box 0450, San Francisco, CA 94143 USA.		Legname, Giuseppe/C-1723-2012	Legname, Giuseppe/0000-0003-0716-4393				Baskakov IV, 1998, BIOCHEMISTRY-US, V37, P18010, DOI 10.1021/bi981849j; Baskakov IV, 2000, BIOCHEMISTRY-US, V39, P2792, DOI 10.1021/bi9923353; Baskakov IV, 2001, J BIOL CHEM, V276, P19687, DOI 10.1074/jbc.C100180200; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; HECKER R, 1992, GENE DEV, V6, P1213, DOI 10.1101/gad.6.7.1213; Hornemann S, 1998, P NATL ACAD SCI USA, V95, P6010, DOI 10.1073/pnas.95.11.6010; Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935; Kayed R, 1999, J MOL BIOL, V287, P781, DOI 10.1006/jmbi.1999.2646; Klunk WE, 1999, METHOD ENZYMOL, V309, P285; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Konno T, 1999, FEBS LETT, V454, P122, DOI 10.1016/S0014-5793(99)00789-9; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Litvinovich SV, 1998, J MOL BIOL, V280, P245, DOI 10.1006/jmbi.1998.1863; Lu BY, 2001, EUR J BIOCHEM, V268, P3767, DOI 10.1046/j.1432-1327.2001.02283.x; Lu BY, 2001, BIOCHEMISTRY-US, V40, P13390, DOI 10.1021/bi011111t; Maiti NR, 2001, J BIOL CHEM, V276, P2427, DOI 10.1074/jbc.M007862200; Mehlhorn I, 1996, BIOCHEMISTRY-US, V35, P5528, DOI 10.1021/bi952965e; Morillas M, 2001, BIOCHEMISTRY-US, V40, P6982, DOI 10.1021/bi010232q; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Rochet JC, 2000, BIOCHEMISTRY-US, V39, P10619, DOI 10.1021/bi001315u; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; SAFAR J, 1994, BIOCHEMISTRY-US, V33, P8375, DOI 10.1021/bi00193a027; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Scott MR, 1997, J VIROL, V71, P9032, DOI 10.1128/JVI.71.12.9032-9044.1997; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Somerville RA, 1999, J GEN VIROL, V80, P1865, DOI 10.1099/0022-1317-80-7-1865; Supattapone S, 1999, CELL, V96, P869, DOI 10.1016/S0092-8674(00)80596-6; Swietnicki W, 2000, BIOCHEMISTRY-US, V39, P424, DOI 10.1021/bi991967m; Swietnicki W, 1997, J BIOL CHEM, V272, P27517, DOI 10.1074/jbc.272.44.27517; Telling GC, 1996, GENE DEV, V10, P1736, DOI 10.1101/gad.10.14.1736; TURK E, 1988, EUR J BIOCHEM, V176, P21, DOI 10.1111/j.1432-1033.1988.tb14246.x; Wille H, 1996, J MOL BIOL, V259, P608, DOI 10.1006/jmbi.1996.0343	46	367	376	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21140	21148		10.1074/jbc.M111402200	http://dx.doi.org/10.1074/jbc.M111402200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11912192	hybrid			2022-12-27	WOS:000176286000006
J	Borovsky, Z; Mishan-Eisenberg, G; Yaniv, E; Rachmilewitz, J				Borovsky, Z; Mishan-Eisenberg, G; Yaniv, E; Rachmilewitz, J			Serial triggering of T cell receptors results in incremental accumulation of signaling intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; KINASE ACTIVATION; TYROSINE KINASE; TCR ENGAGEMENT; MAP KINASE; ANTIGEN; COMPLEXES; AFFINITY; TRANSDUCTION; MODULATION	Triggering of the T cell receptor (TCR) leads to the production of intracellular intermediates with half-life of a few minutes. Signaling kinetics of events originating from serial TCR triggering and its relation to antigen dose was investigated. In this study we documented incremental accumulation of short-lived intermediates of the extracellular signal-regulated kinase (ERK) family, produced during successive TCR triggering. The rate and extent of the intermediate accumulation are essentially determined by the level of TCR engagement and are augmented by costimulation. ERK-1 and ERK-2 exhibit different rates of accumulation following serial receptor triggering. The data indicate that the quantitative kinetic differences in downstream signaling pathways induce qualitatively distinct biological outcomes. Although CD69, interleukin-2, and interferon-gamma (IFN-gamma) were primarily produced by high antigen doses that supported high MAPK phosphorylation, maximal interleukin-5 expression is induced by low and intermediate stimulus doses that do not support significant accumulation of activated ERK. We further demonstrated that the rate of phosphorylated ERK accumulation correlates with the duration of delay between T cell stimulation and the onset of IFN-gamma response, with stronger stimuli giving a more rapid IFN-gamma response. This delay might reflect the time required for the accumulation of signaling intermediates up to a threshold level that is necessary for activation. Thus, the data suggest that signaling events originating from serially triggered TCR are not simply sustained but are gradually accumulated and are integrated in a corresponding response.	Hadassah Univ Hosp, Goldyne Savad Inst Gene Therapy, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Rachmilewitz, J (corresponding author), Hadassah Univ Hosp, Goldyne Savad Inst Gene Therapy, POB 12000, IL-91120 Jerusalem, Israel.	rjacob@hadassah.org.il						Alcover A, 2000, CRIT REV IMMUNOL, V20, P325; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Bachmann MF, 1997, EUR J IMMUNOL, V27, P2195, DOI 10.1002/eji.1830270912; Beeson C, 1996, J EXP MED, V184, P777, DOI 10.1084/jem.184.2.777; Ben-Sasson SZ, 2001, J IMMUNOL, V166, P112, DOI 10.4049/jimmunol.166.1.112; Berg NN, 1998, J IMMUNOL, V161, P2919; DING L, 1993, J IMMUNOL, V151, P1224; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Dumont FJ, 1998, J IMMUNOL, V160, P2579; Gong K, 2001, NAT IMMUNOL, V2, P29, DOI 10.1038/83134; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; Hardy K, 1997, IMMUNOL CELL BIOL, V75, P528, DOI 10.1038/icb.1997.84; Hashemi BB, 1996, J IMMUNOL, V156, P3660; Hemmer B, 1998, J IMMUNOL, V160, P5807; Hudrisier D, 1998, J IMMUNOL, V161, P553; Itoh Y, 1999, J IMMUNOL, V162, P2073; Lee JE, 1997, J IMMUNOL, V159, P61; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; MOLLICK JA, 1991, J IMMUNOL, V146, P463; Muller S, 1999, IMMUNOLOGY, V97, P287; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Rachmilewitz J, 1999, CELL IMMUNOL, V191, P26, DOI 10.1006/cimm.1998.1408; Redpath S, 1999, J IMMUNOL, V163, P6; Rogers PR, 2000, J IMMUNOL, V164, P2955, DOI 10.4049/jimmunol.164.6.2955; Rogers PR, 1999, J IMMUNOL, V163, P1205; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Wei XB, 1999, P NATL ACAD SCI USA, V96, P8471, DOI 10.1073/pnas.96.15.8471; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WEISS A, 1987, J IMMUNOL, V138, P2169; Wulfing C, 1997, J EXP MED, V185, P1815, DOI 10.1084/jem.185.10.1815	36	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21529	21536		10.1074/jbc.M201613200	http://dx.doi.org/10.1074/jbc.M201613200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11940589	hybrid			2022-12-27	WOS:000176286000054
J	Chen, J; Kaul, S; Simons, SS				Chen, J; Kaul, S; Simons, SS			Structure/activity elements of the multifunctional protein, GMEB-1 - Characterization of domains relevant for the modulation of glucocorticoid receptor transactivation properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE AMINOTRANSFERASE GENE; ESTROGEN-REGULATED RNAS; TRANSCRIPTION FACTOR; AGONIST ACTIVITY; BINDING PROTEIN; KDWK FAMILY; INDUCTION PROPERTIES; BIOLOGICAL-ACTIVITY; HORMONE RECEPTORS; NUCLEAR RECEPTORS	GMEB-1 was initially described as a component of a 550-kDa heteromeric DNA binding complex that is involved in the modulation of two properties of glucocorticoid receptor (GR) transactivation, the dose-response curve of agonists and the partial agonist activity of antagonists. Subsequently, GMEB-1 was also found to bind to hsp27, to associate with the coactivator TIF2 in yeast cells, and to participate in Parvovirus replication. To understand these multiple activities of GMEB-1 at a molecular level, we have now determined which regions are associated with the various activities associated with the modulation of GR transactivation properties. These activities include, homooligomerization, heterooligomerization, DNA binding, binding to GR and the transcriptional cofactor CBP, and GR modulation. Complex activities such as DNA binding and GR modulation, are found to require the physical combination of those domains that would be predicted from the involved biochemical processes. We have previously documented that GMEB-1 possesses both GR modulatory and intrinsic transactivation activity. However, the domains for these two activities of GMEB-1 are found not to overlap. This separation of activities provides a structural basis for our prior biological observations that the modulation of the dose-response curve and partial agonist activity of GR complexes is independent of the total levels of gene activation by the same GR complexes.	NIDDK, Steroid Hormones Sect, Mol & Cellular Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Simons, SS (corresponding author), NIDDK, Steroid Hormones Sect, Mol & Cellular Biol Lab, NIH, Bldg 8,Rm B2A-07, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK057800, ZIADK057800] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMARA JF, 1987, ENDOCRINOLOGY, V120, P264, DOI 10.1210/endo-120-1-264; BAULIEU EE, 1989, SCIENCE, V245, P1351, DOI 10.1126/science.2781282; BAXTER JD, 1971, P NATL ACAD SCI USA, V68, P932, DOI 10.1073/pnas.68.5.932; Beato M, 1996, STEROIDS, V61, P240, DOI 10.1016/0039-128X(96)00030-X; BENOR S, 1993, MOL CELL BIOL, V13, P331, DOI 10.1128/MCB.13.1.331; BERRY M, 1990, EMBO J, V9, P2811, DOI 10.1002/j.1460-2075.1990.tb07469.x; Bottomley MJ, 2001, NAT STRUCT BIOL, V8, P626, DOI 10.1038/89675; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Chen SY, 2000, J BIOL CHEM, V275, P30106, DOI 10.1074/jbc.M005418200; Christensen J, 1997, J VIROL, V71, P5733, DOI 10.1128/JVI.71.8.5733-5741.1997; Christensen J, 1999, MOL CELL BIOL, V19, P7741; Christensen J, 2001, J VIROL, V75, P7009, DOI 10.1128/JVI.75.15.7009-7017.2001; Collier CD, 1996, MOL ENDOCRINOL, V10, P463, DOI 10.1210/me.10.5.463; CRAWFORD ED, 1989, NEW ENGL J MED, V321, P419, DOI 10.1056/NEJM198908173210702; EVANS MI, 1987, P NATL ACAD SCI USA, V84, P8493, DOI 10.1073/pnas.84.23.8493; Garrido C, 1998, CANCER RES, V58, P5495; Giannoukos G, 2001, MOL ENDOCRINOL, V15, P255, DOI 10.1210/me.15.2.255; GILMORE TD, 1993, TRENDS GENET, V9, P427, DOI 10.1016/0168-9525(93)90106-R; Glass CK, 2000, GENE DEV, V14, P121; GOROVITS R, 1994, P NATL ACAD SCI USA, V91, P4786, DOI 10.1073/pnas.91.11.4786; Gross CT, 1996, EMBO J, V15, P1961, DOI 10.1002/j.1460-2075.1996.tb00547.x; Guido EC, 1996, MOL ENDOCRINOL, V10, P1178, DOI 10.1210/me.10.10.1178; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Jackson DA, 1998, J STEROID BIOCHEM, V66, P79, DOI 10.1016/S0960-0760(98)00048-X; Jimenez-Lara AM, 2000, FEBS LETT, V468, P203, DOI 10.1016/S0014-5793(00)01209-6; JORDAN VC, 1990, ENDOCR REV, V11, P578, DOI 10.1210/edrv-11-4-578; Kaul S, 2000, MOL ENDOCRINOL, V14, P1010, DOI 10.1210/me.14.7.1010; Kaul S, 2002, J BIOL CHEM, V277, P12541, DOI 10.1074/jbc.M112330200; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; MAY FEB, 1988, J BIOL CHEM, V263, P12901; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; MERCIER L, 1983, ENDOCRINOLOGY, V112, P601, DOI 10.1210/endo-112-2-601; MERCIER L, 1986, J STEROID BIOCHEM, V25, P11, DOI 10.1016/0022-4731(86)90275-X; MUNCK A, 1984, J BIOL CHEM, V259, P820; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; OSHIMA H, 1995, J BIOL CHEM, V270, P21893, DOI 10.1074/jbc.270.37.21893; OSHIMA H, 1993, J BIOL CHEM, V268, P26858; OSHIMA H, 1992, MOL ENDOCRINOL, V6, P416, DOI 10.1210/me.6.3.416; OSHIMA H, 1992, ENDOCRINOLOGY, V130, P2106, DOI 10.1210/en.130.4.2106; Paul C, 2002, MOL CELL BIOL, V22, P816, DOI 10.1128/MCB.22.3.816-834.2002; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; REICHMAN ME, 1984, BIOCHEMISTRY-US, V23, P5376, DOI 10.1021/bi00317a042; Robyr D, 2000, MOL ENDOCRINOL, V14, P329, DOI 10.1210/me.14.3.329; ROUSSEAU GG, 1977, J STEROID BIOCHEM, V8, P911, DOI 10.1016/0022-4731(77)90187-X; Sheppard KA, 1998, J BIOL CHEM, V273, P29291, DOI 10.1074/jbc.273.45.29291; SIMONS SS, 1992, MOL ENDOCRINOL, V6, P995, DOI 10.1210/me.6.7.995; Song LN, 2001, J BIOL CHEM, V276, P24806, DOI 10.1074/jbc.M102610200; Szapary D, 1996, J BIOL CHEM, V271, P30576, DOI 10.1074/jbc.271.48.30576; Szapary D, 1999, MOL ENDOCRINOL, V13, P2108, DOI 10.1210/me.13.12.2108; SZAPARY D, 1992, ENDOCRINOLOGY, V130, P3492, DOI 10.1210/en.130.6.3492; Theriault JR, 1999, FEBS LETT, V452, P170, DOI 10.1016/S0014-5793(99)00634-1; TURCOTTE B, 1990, MOL CELL BIOL, V10, P5002, DOI 10.1128/MCB.10.9.5002; TZUKERMAN MT, 1994, MOL ENDOCRINOL, V8, P21, DOI 10.1210/me.8.1.21; Vayssiere BM, 1997, MOL ENDOCRINOL, V11, P1245, DOI 10.1210/me.11.9.1245; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; WASNER G, 1988, MOL ENDOCRINOL, V2, P1009, DOI 10.1210/mend-2-11-1009; WESTLEY BR, 1989, J STEROID BIOCHEM, V32, P365, DOI 10.1016/0022-4731(89)90208-2; Zeng HW, 2000, NUCLEIC ACIDS RES, V28, P1819, DOI 10.1093/nar/28.8.1819; Zeng HW, 2000, MOL CELL ENDOCRINOL, V162, P221, DOI 10.1016/S0303-7207(99)00208-7; Zeng HW, 1998, J BIOL CHEM, V273, P17756, DOI 10.1074/jbc.273.28.17756; ZHANG HY, 1993, P NATL ACAD SCI USA, V90, P3880, DOI 10.1073/pnas.90.9.3880	65	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					22053	22062		10.1074/jbc.M202311200	http://dx.doi.org/10.1074/jbc.M202311200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11934901	hybrid			2022-12-27	WOS:000176286000118
J	Choi, JY; Lee, SH; Park, CY; Heo, WD; Kim, JC; Kim, MC; Chung, WS; Moon, BC; Cheong, YH; Kim, CY; Yoo, JH; Koo, JC; Ok, HM; Chi, SW; Ryu, SE; Lee, SY; Lim, CO; Cho, MJ				Choi, JY; Lee, SH; Park, CY; Heo, WD; Kim, JC; Kim, MC; Chung, WS; Moon, BC; Cheong, YH; Kim, CY; Yoo, JH; Koo, JC; Ok, HM; Chi, SW; Ryu, SE; Lee, SY; Lim, CO; Cho, MJ			Identification of calmodulin isoform-specific binding peptides from a phage-displayed random 22-mer peptide library	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; PLANT CALMODULIN; DEPENDENT ENZYMES; CALCIUM CHANNELS; PROTEINS; RECOGNITION; DOMAIN; ACTIVATION; EXPRESSION; RESPONSES	Plants express numerous calmodulin (CaM) isoforms that exhibit differential activation or inhibition of CaM-dependent enzymes in vitro; however, their specificities toward target enzyme/protein binding are uncertain. A random peptide library displaying a 22-mer peptide on a bacteriophage surface was constructed to screen peptides that specifically bind to plant CaM isoforms (soybean calmodulin (ScaM)-1 and SCaM-4 were used in this study) in a Ca2+-dependent manner. The deduced amino acid sequence analyses of the respective 80 phage clones that were independently isolated via affinity panning revealed that SCaM isoforms require distinct amino acid sequences for optimal binding. SCaM-1-binding peptides conform to a 1-5-10 ((FILVW)XXX(FILV) XXXX(FILVW)) motif (where X denotes any amino acid), whereas SCaM-4-binding peptide sequences conform to a 1-8-14 ((FILVW)XXXXXX(FAILVW)XXXXX(FILVW)) motif. These motifs are classified based on the positions of conserved hydrophobic residues. To examine their binding properties further, two representative peptides from each of the SCaM isoform-binding sequences were synthesized and analyzed via gel mobility shift assays, Trp fluorescent spectra analyses, and phosphodiesterase competitive inhibition experiments. The results of these studies suggest that SCaM isoforms possess different binding sequences for optimal target interaction, which therefore may provide a molecular basis for CaM isoform-specific function in plants. Furthermore, the isolated peptide sequences may serve not only as useful CaM-binding sequence references but also as potential reagents for studying CaM isoform-specific function in vivo.	Gyeongsang Nalt Univ, Plant Mol Biool & Biotechnol Res Ctr, Div Appl Life Sci, BK21 Program, Chinju 660701, South Korea; Korea Res Inst Biosci & Biotechnol, Ctr Cellular Switch Prot Struct, Taejon 305333, South Korea	Gyeongsang National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Cho, MJ (corresponding author), Gyeongsang Nalt Univ, Plant Mol Biool & Biotechnol Res Ctr, Div Appl Life Sci, BK21 Program, Chinju 660701, South Korea.		Cho, Moo Je/F-1649-2010; Heo, Won-Do/C-1696-2011; Park, Chan Young/F-5696-2010	Park, Chan Young/0000-0002-5183-3665				AFSHAR M, 1994, J MOL BIOL, V244, P554, DOI 10.1006/jmbi.1994.1752; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; BUSH DS, 1995, ANNU REV PLANT PHYS, V46, P95, DOI 10.1146/annurev.pp.46.060195.000523; Cho MJ, 1998, BIOCHEMISTRY-US, V37, P15593, DOI 10.1021/bi981497g; Chung WS, 2000, PLANT CELL, V12, P1393, DOI 10.1105/tpc.12.8.1393; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; DEDMAN JR, 1993, J BIOL CHEM, V268, P23025; ERICKSONVIITANEN S, 1987, METHOD ENZYMOL, V139, P455; FALKE JJ, 1994, Q REV BIOPHYS, V27, P219, DOI 10.1017/S0033583500003012; GAWIENOWSKI MC, 1993, PLANT MOL BIOL, V22, P215, DOI 10.1007/BF00014930; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Heo WD, 1999, P NATL ACAD SCI USA, V96, P766, DOI 10.1073/pnas.96.2.766; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Ishida H, 2000, BIOCHEMISTRY-US, V39, P13660, DOI 10.1021/bi000582x; Keller D, 2001, BIOCHEMISTRY-US, V40, P10732, DOI 10.1021/bi0108150; Kondo R, 1999, J BIOL CHEM, V274, P36213, DOI 10.1074/jbc.274.51.36213; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Lee SH, 1997, J BIOL CHEM, V272, P9252, DOI 10.1074/jbc.272.14.9252; LEE SH, 1995, J BIOL CHEM, V270, P21806, DOI 10.1074/jbc.270.37.21806; Lee SH, 2000, BIOCHEM J, V350, P299, DOI 10.1042/0264-6021:3500299; Lee SH, 1999, BBA-PROTEIN STRUCT M, V1433, P56, DOI 10.1016/S0167-4838(99)00149-1; Liao BR, 1999, P NATL ACAD SCI USA, V96, P6217, DOI 10.1073/pnas.96.11.6217; LU KP, 1993, ENDOCR REV, V14, P40, DOI 10.1210/er.14.1.40; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Nevalainen LT, 1997, BIOCHEM J, V321, P107, DOI 10.1042/bj3210107; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Pierce HH, 1998, J BIOL CHEM, V273, P23448, DOI 10.1074/jbc.273.36.23448; Poovaiah BW, 1996, J PLANT PHYSIOL, V149, P553, DOI 10.1016/S0176-1617(96)80333-6; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Sambrook J., 2002, MOL CLONING LAB MANU; Snedden WA, 1998, TRENDS PLANT SCI, V3, P299, DOI 10.1016/S1360-1385(98)01284-9; VOGEL HJ, 1994, BIOCHEM CELL BIOL, V72, P357, DOI 10.1139/o94-049; Wang JH, 1995, J BIOL CHEM, V270, P30245, DOI 10.1074/jbc.270.51.30245; Yang TB, 1996, MOL GEN GENET, V252, P684, DOI 10.1007/BF02173974; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Yuan T, 1998, BIOCHEMISTRY-US, V37, P3187, DOI 10.1021/bi9716579; Yuan T, 1998, FEBS LETT, V431, P210, DOI 10.1016/S0014-5793(98)00750-9; Zielinski RE, 1998, ANNU REV PLANT PHYS, V49, P697, DOI 10.1146/annurev.arplant.49.1.697; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	41	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21630	21638		10.1074/jbc.M110803200	http://dx.doi.org/10.1074/jbc.M110803200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11901148	hybrid			2022-12-27	WOS:000176286000069
J	Lim, IA; Hall, DD; Hell, JW				Lim, IA; Hall, DD; Hell, JW			Selectivity and promiscuity of the first and second PDZ domains of PSD-95 and synapse-associated protein 102	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; POSTSYNAPTIC DENSITY PROTEIN; D-ASPARTATE RECEPTORS; TUMOR-SUPPRESSOR PROTEIN; ER RETENTION SIGNAL; SINGLE-AMINO-ACID; GUANYLATE KINASE; SODIUM-CHANNELS; INTERACTING PROTEIN; NEURONAL SYNAPSES	PDZ domains typically interact with the very carboxyl terminus of their binding partners. Type I PDZ domains usually require valine, leucine, or isoleucine at the very COOH-terminal (PO) position, and serine or threonine 2 residues upstream at P-2. We quantitatively defined the contributions of carboxyl-terminal residues to binding selectivity of the prototypic interactions of the PDZ domains of postsynaptic density protein 95 (PSD-95) and its homolog synapse-associated protein 90 (SAP102) with the NR2b subunit of the N-methyl-D-aspartate-type glutamate receptor. Our studies indicate that all of the last five residues of NR2b contribute to the binding selectivity. Prominent were a requirement for glutamate or glutamine at P-3 and for valine at P-o for high affinity binding and a preference for threonine over serine at P-2, in the context of the last 11 residues of the NR2b COOH terminus. This analysis predicts a COOH-terminal (E/Q)(S/T)XV consensus sequence for the strongest binding to the first two PDZ domains of PSD-95 and SAP102. A search of the human genome sequences for proteins with a COOH-terminal (E/Q)(S/T)XV motif yielded 50 proteins, many of which have not been previously identified as PSD-95 or SAP102 binding partners. Two of these proteins, brain-specific angiogenesis inhibitor 1 and protein kinase Calpha, co-immunoprecipitated with PSD-95 and SA-P102 from rat brain extracts.	Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA; Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA	University of Iowa; University of Wisconsin System; University of Wisconsin Madison	Hell, JW (corresponding author), Univ Iowa, Dept Pharmacol, 2-512 BSB,51 Newton Rd, Iowa City, IA 52242 USA.		Hell, Johannes W./P-5085-2019; Hall, Duane/ACD-6815-2022	Hall, Duane/0000-0003-2228-0966	NIA NIH HHS [AG00213] Funding Source: Medline; NIDDK NIH HHS [DK07759] Funding Source: Medline; NINDS NIH HHS [R01-NS35563] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035563] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abe Y, 2000, J BIOL CHEM, V275, P21525, DOI 10.1074/jbc.M909629199; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Brenman JE, 1996, J NEUROSCI, V16, P7407; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Daniels DL, 1998, NAT STRUCT BIOL, V5, P317, DOI 10.1038/nsb0498-317; Davare MA, 1999, J BIOL CHEM, V274, P30280, DOI 10.1074/jbc.274.42.30280; DeMarco SJ, 2001, J BIOL CHEM, V276, P21594, DOI 10.1074/jbc.M101448200; Dobrosotskaya I, 1997, J BIOL CHEM, V272, P31589, DOI 10.1074/jbc.272.50.31589; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; El-Hussein AE, 2000, SCIENCE, V290, P1364; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Furuyashiki T, 1999, J NEUROSCI, V19, P109, DOI 10.1523/JNEUROSCI.19-01-00109.1999; Garcia RAG, 2000, P NATL ACAD SCI USA, V97, P3596, DOI 10.1073/pnas.070042497; Gaudet S, 2000, P NATL ACAD SCI USA, V97, P5167, DOI 10.1073/pnas.090102397; Gee SH, 2000, BIOCHEMISTRY-US, V39, P14638, DOI 10.1021/bi001633t; Gee SH, 1998, J NEUROSCI, V18, P128; GEYSEN HM, 1984, P NATL ACAD SCI-BIOL, V81, P3998, DOI 10.1073/pnas.81.13.3998; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Harris BZ, 2001, BIOCHEMISTRY-US, V40, P5921, DOI 10.1021/bi010142l; Hartmann HA, 1999, NAT NEUROSCI, V2, P593, DOI 10.1038/10147; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Hogan A, 2001, J BIOL CHEM, V276, P26526, DOI 10.1074/jbc.M104156200; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Hu LYA, 2000, J BIOL CHEM, V275, P38659, DOI 10.1074/jbc.M005938200; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Hunt CA, 1996, J NEUROSCI, V16, P1380; Inagaki S, 2001, J BIOL CHEM, V276, P9174, DOI 10.1074/jbc.M009051200; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jaffrey SR, 1998, NEURON, V20, P115, DOI 10.1016/S0896-6273(00)80439-0; Jo K, 1999, J NEUROSCI, V19, P4189, DOI 10.1523/jneurosci.19-11-04189.1999; Katsanis N, 2001, NAT GENET, V29, P88, DOI 10.1038/ng0901-88; Kim E, 1998, J BIOL CHEM, V273, P1591, DOI 10.1074/jbc.273.3.1591; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kim TJ, 1996, MICROPOROUS MATER, V7, P35, DOI 10.1016/0927-6513(96)00024-7; KISTNER U, 1993, J BIOL CHEM, V268, P4580; Koh JT, 2001, MOL BRAIN RES, V87, P223, DOI 10.1016/S0169-328X(01)00004-3; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Kuwahara H, 1999, J BIOL CHEM, V274, P32204, DOI 10.1074/jbc.274.45.32204; LADBURY JE, 1995, P NATL ACAD SCI USA, V92, P3199, DOI 10.1073/pnas.92.8.3199; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Leonard AS, 1997, J BIOL CHEM, V272, P12107, DOI 10.1074/jbc.272.18.12107; Liu TF, 2001, J BIOL CHEM, V276, P35768, DOI 10.1074/jbc.M103585200; Liu XX, 1999, P NATL ACAD SCI USA, V96, P14383, DOI 10.1073/pnas.96.25.14383; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; Lynch BA, 1997, ANAL BIOCHEM, V247, P77, DOI 10.1006/abio.1997.2042; Marfatia SM, 1996, J CELL BIOL, V135, P753, DOI 10.1083/jcb.135.3.753; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Nehring RB, 2000, J NEUROSCI, V20, P156, DOI 10.1523/JNEUROSCI.20-01-00156.2000; Nieba L, 1996, ANAL BIOCHEM, V234, P155, DOI 10.1006/abio.1996.0067; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Niethammer M, 1996, J NEUROSCI, V16, P2157; Passafaro M, 1999, NAT NEUROSCI, V2, P1063, DOI 10.1038/15990; Schultz J, 1998, NAT STRUCT BIOL, V5, P19, DOI 10.1038/nsb0198-19; Schultze W, 2001, J NEUROCHEM, V78, P482, DOI 10.1046/j.1471-4159.2001.00447.x; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Stathakis DG, 1997, GENOMICS, V44, P71, DOI 10.1006/geno.1997.4848; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Stricker NL, 1997, NAT BIOTECHNOL, V15, P336, DOI 10.1038/nbt0497-336; Tochio H, 1999, NAT STRUCT BIOL, V6, P417; Tochio H, 2000, J MOL BIOL, V295, P225, DOI 10.1006/jmbi.1999.3350; Vaccaro P, 2001, J BIOL CHEM, V276, P42122, DOI 10.1074/jbc.M104208200; Valtschanoff JG, 2000, EUR J NEUROSCI, V12, P3605, DOI 10.1046/j.1460-9568.2000.00256.x; Yao I, 1999, J BIOL CHEM, V274, P11889, DOI 10.1074/jbc.274.17.11889; Zhang WD, 1999, J NEUROSCI, V19, P96, DOI 10.1523/JNEUROSCI.19-01-00096.1999	81	115	122	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21697	21711		10.1074/jbc.M112339200	http://dx.doi.org/10.1074/jbc.M112339200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11937501	hybrid			2022-12-27	WOS:000176286000078
J	Raschle, M; Dufner, P; Marra, G; Jiricny, J				Raschle, M; Dufner, P; Marra, G; Jiricny, J			Mutations within the hMLH1 and hPMS2 subunits of the human MutL alpha mismatch repair factor affect its ATPase activity, but not its ability to interact with hMutS alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONPOLYPOSIS COLON-CANCER; HSP90 MOLECULAR CHAPERONE; DNA HELICASE-II; ESCHERICHIA-COLI; BINDING-SITE; TUMOR-CELLS; GENETIC INSTABILITY; MUTATOR MUTATIONS; CRYSTAL-STRUCTURE; TOPOISOMERASE-II	The MutL family of mismatch repair proteins belongs to the GHKL class of ATPases, which contains also type II topoisomerases, HSP90, and histidine kinases. The nucleotide binding domains of these polypeptides are highly conserved, but this similarity has failed to help us understand the biological role of the ATPase activity of the MutL proteins in mismatch repair. hMutLalpha is a heterodimer of the human MutL homologues hMLH1 and hPMS2, and we decided to exploit its asymmetry to study this function. We now show that although the two subunits contribute differently to the ATPase activity of the heterodimer, hMutLalpha variants in which one subunit was able to bind but not hydrolyze ATP displayed similarly reduced mismatch repair activities in vitro. In contrast, variants in which either subunit was unable to bind the nucleotide were inactive. Mutation of the catalytic sites of both subunits abolished repair without altering the ability of these peptides to interact with one another. Since the binding of the nucleotide in hMutLalpha was not required for the formation of ternary complexes with the mismatch recognition factor hMutSalpha bound to a heteroduplex substrate, we propose that the ATPase activity of hMutLalpha is required downstream from this process.	Inst Med Radiobiol, CH-8008 Zurich, Switzerland		Jiricny, J (corresponding author), Inst Med Radiobiol, August Forel Str 7, CH-8008 Zurich, Switzerland.							Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Amin NS, 2001, MOL CELL BIOL, V21, P5142, DOI 10.1128/MCB.21.15.5142-5155.2001; Aronshtam A, 1996, NUCLEIC ACIDS RES, V24, P2498, DOI 10.1093/nar/24.13.2498; AU KG, 1992, J BIOL CHEM, V267, P12142; Baird CL, 1999, P NATL ACAD SCI USA, V96, P13685, DOI 10.1073/pnas.96.24.13685; Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Blackwell LJ, 2001, J BIOL CHEM, V276, P33233, DOI 10.1074/jbc.M105076200; Bowers J, 2000, J MOL BIOL, V302, P327, DOI 10.1006/jmbi.2000.4081; Bowers J, 2001, J MOL BIOL, V306, P957, DOI 10.1006/jmbi.2001.4467; Chadli A, 2000, P NATL ACAD SCI USA, V97, P12524, DOI 10.1073/pnas.220430297; Dao V, 1998, J BIOL CHEM, V273, P9202, DOI 10.1074/jbc.273.15.9202; De Rosa M, 2000, ONCOGENE, V19, P1719, DOI 10.1038/sj.onc.1203447; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Grenert JP, 1999, J BIOL CHEM, V274, P17525, DOI 10.1074/jbc.274.25.17525; GRILLEY M, 1989, J BIOL CHEM, V264, P1000; Gu LY, 1998, NUCLEIC ACIDS RES, V26, P1173, DOI 10.1093/nar/26.5.1173; Guarne A, 2001, EMBO J, V20, P5521, DOI 10.1093/emboj/20.19.5521; Guerrette S, 1999, J BIOL CHEM, V274, P6336, DOI 10.1074/jbc.274.10.6336; Habraken Y, 1998, J BIOL CHEM, V273, P9837, DOI 10.1074/jbc.273.16.9837; Hall MC, 1999, J BIOL CHEM, V274, P1306, DOI 10.1074/jbc.274.3.1306; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Hsieh P, 2001, MUTAT RES-DNA REPAIR, V486, P71, DOI 10.1016/S0921-8777(01)00088-X; Iaccarino I, 2000, J BIOL CHEM, V275, P2080, DOI 10.1074/jbc.275.3.2080; Iaccarino I, 1998, EMBO J, V17, P2677, DOI 10.1093/emboj/17.9.2677; JACKSON AP, 1993, P NATL ACAD SCI USA, V90, P11232, DOI 10.1073/pnas.90.23.11232; Jiricny J, 2000, CURR OPIN GENET DEV, V10, P157, DOI 10.1016/S0959-437X(00)00066-6; Jiricny J, 1998, EMBO J, V17, P6427, DOI 10.1093/emboj/17.22.6427; Jiricny J, 2000, NAT GENET, V24, P6, DOI 10.1038/71698; Junop MS, 2001, MOL CELL, V7, P1, DOI 10.1016/S1097-2765(01)00149-6; Kampranis SC, 1998, J BIOL CHEM, V273, P26305, DOI 10.1074/jbc.273.41.26305; Kondo E, 2001, NUCLEIC ACIDS RES, V29, P1695, DOI 10.1093/nar/29.8.1695; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; Lipkin SM, 2000, NAT GENET, V24, P27, DOI 10.1038/71643; Mechanic LE, 2000, J BIOL CHEM, V275, P38337, DOI 10.1074/jbc.M006268200; Miyaki M, 1997, ONCOGENE, V15, P2877, DOI 10.1038/sj.onc.1201668; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Mushegian AR, 1997, P NATL ACAD SCI USA, V94, P5831, DOI 10.1073/pnas.94.11.5831; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; Nystrom-Lahti M, 2002, GENE CHROMOSOME CANC, V33, P160, DOI 10.1002/gcc.1225; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; ODea MH, 1996, J BIOL CHEM, V271, P9723, DOI 10.1074/jbc.271.16.9723; PALOMBO F, 1995, SCIENCE, V268, P1912, DOI 10.1126/science.7604265; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Prolla TA, 1998, NAT GENET, V18, P276, DOI 10.1038/ng0398-276; Raschle M, 1999, J BIOL CHEM, V274, P32368, DOI 10.1074/jbc.274.45.32368; RISINGER JI, 1995, J BIOL CHEM, V270, P18183, DOI 10.1074/jbc.270.31.18183; Schofield MJ, 2001, J BIOL CHEM, V276, P28291, DOI 10.1074/jbc.M103148200; Shimodaira H, 1998, NAT GENET, V19, P384, DOI 10.1038/1277; Spampinato C, 2000, J BIOL CHEM, V275, P9863, DOI 10.1074/jbc.275.13.9863; TAMURA JK, 1990, J BIOL CHEM, V265, P21342; THOMAS DC, 1991, J BIOL CHEM, V266, P3744; Tran PT, 2000, MOL CELL BIOL, V20, P6390, DOI 10.1128/MCB.20.17.6390-6398.2000; Trojan J, 2002, GASTROENTEROLOGY, V122, P211, DOI 10.1053/gast.2002.30296; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; Yamaguchi M, 1998, J BIOL CHEM, V273, P9197, DOI 10.1074/jbc.273.15.9197; Young JC, 2000, EMBO J, V19, P5930, DOI 10.1093/emboj/19.21.5930	64	91	93	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21810	21820		10.1074/jbc.M108787200	http://dx.doi.org/10.1074/jbc.M108787200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11948175	hybrid, Green Accepted			2022-12-27	WOS:000176286000090
J	Widlak, P; Palyvoda, O; Kumala, S; Garrard, WT				Widlak, P; Palyvoda, O; Kumala, S; Garrard, WT			Modeling apoptotic chromatin condensation in normal cell nuclei - Requirement for intranuclear mobility and actin involvement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA TOPOISOMERASE-II; NUCLEOSOME CORE PARTICLE; CASPASE-ACTIVATED DNASE; CHROMOSOME CONDENSATION; ATTACHMENT SITES; LAEVIS OOCYTES; BINDING-SITES; CLEAVAGE; FRAGMENTATION; ORGANIZATION	Hallmarks of the terminal stages of apoptosis are genomic DNA fragmentation and chromatin condensation. Here, we have studied the mechanism of condensation both in vitro and in vivo. We found that DNA fragmentation per se of isolated nuclei from non-apoptotic cells induced chromatin condensation that closely resembles the morphology seen in apoptotic cells, independent of ATP utilization, at physiological ionic strengths. Interestingly, chromatin condensation was accompanied by release of nuclear actin, and both condensation and actin release could be blocked by reversibly pretreating nuclei with Ca2+, Cu2+, diamide, or low pH, procedures shown to stabilize internal nuclear components. Moreover, specific inhibition of nuclear F-actin depolymerization or promotion of its formation also reduced chromatin condensation. Chromatin condensation could also be inhibited by exposing nuclei to reagents that bind to the DNA minor groove, disrupting native nucleosomal DNA wrapping. In addition, in cultured cells undergoing apoptosis, drugs that inhibit depolymerization of actin or bind to the minor groove also reduced chromatin condensation, but not DNA fragmentation. Therefore, the ability of chromatin fragments with intact nucleosomes to form large clumps of condensed chromatin during apoptosis requires the apparent disassembly of internal nuclear structures that may normally constrain chromosome subdomains in nonapoptotic cells.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Ctr Oncol, Dept Expt & Clin Radiobiol, PL-44100 Gliwice, Poland	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Garrard, WT (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	william.garrard@utsouthwestern.edu	Widlak, Piotr/AAL-8075-2021	Widlak, Piotr/0000-0001-5099-4726	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059809] Funding Source: NIH RePORTER; NIGMS NIH HHS [GMR01-59809] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADACHI Y, 1989, EMBO J, V8, P3997, DOI 10.1002/j.1460-2075.1989.tb08582.x; ADACHI Y, 1991, CELL, V64, P137, DOI 10.1016/0092-8674(91)90215-K; ARENDS MJ, 1990, AM J PATHOL, V136, P593; Barinaga M, 1998, SCIENCE, V280, P32, DOI 10.1126/science.280.5360.32; Belmont HM, 1999, BIODRUGS, V11, P7, DOI 10.2165/00063030-199911010-00002; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Carruthers LM, 1998, BIOCHEMISTRY-US, V37, P14776, DOI 10.1021/bi981684e; Cimbora DM, 2001, CELL, V104, P643, DOI 10.1016/S0092-8674(01)00260-4; CLARK TG, 1977, CELL, V12, P883, DOI 10.1016/0092-8674(77)90152-0; CLARK TG, 1979, CELL, V18, P1101, DOI 10.1016/0092-8674(79)90223-X; COMPTON MM, 1992, CANCER METAST REV, V11, P105, DOI 10.1007/BF00048058; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Durrieu F, 2000, CURR BIOL, V10, P923, DOI 10.1016/S0960-9822(00)00620-5; EARNSHAW WC, 1985, J CELL BIOL, V100, P1706, DOI 10.1083/jcb.100.5.1706; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; ESTES JE, 1981, BIOCHEMISTRY-US, V20, P708, DOI 10.1021/bi00507a006; FOX KR, 1984, NUCLEIC ACIDS RES, V12, P9271, DOI 10.1093/nar/12.24.9271; GAO XL, 1989, BIOCHEMISTRY-US, V28, P751, DOI 10.1021/bi00428a051; Gasser SM, 2001, CELL, V104, P639, DOI 10.1016/S0092-8674(01)00259-8; Halenbeck R, 1998, CURR BIOL, V8, P537, DOI 10.1016/S0960-9822(98)79298-X; Hancock R, 2000, CHROMOSOMA, V109, P219, DOI 10.1007/s004120000077; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Hendzel MJ, 1998, J BIOL CHEM, V273, P24470, DOI 10.1074/jbc.273.38.24470; Hughes FM, 2000, METHOD ENZYMOL, V322, P47; JAIN SC, 1977, J MOL BIOL, V114, P317, DOI 10.1016/0022-2836(77)90253-4; KAS E, 1989, J MOL BIOL, V210, P587, DOI 10.1016/0022-2836(89)90134-4; KAS E, 1993, EMBO J, V12, P115, DOI 10.1002/j.1460-2075.1993.tb05637.x; Kass GEN, 1996, BIOCHEM J, V318, P749, DOI 10.1042/bj3180749; Kaufmann S H, 1986, Methods Achiev Exp Pathol, V12, P141; KAUFMANN SH, 1989, CANCER RES, V49, P5870; Khochbin S, 2001, CURR OPIN GENET DEV, V11, P162, DOI 10.1016/S0959-437X(00)00174-X; KIM SK, 1993, FEBS LETT, V315, P61, DOI 10.1016/0014-5793(93)81133-K; Kimura K, 1999, CELL, V98, P239, DOI 10.1016/S0092-8674(00)81018-1; Lamond AI, 1998, SCIENCE, V280, P547, DOI 10.1126/science.280.5363.547; LAWSON GM, 1982, J BIOL CHEM, V257, P6576; LAZARIDES E, 1974, P NATL ACAD SCI USA, V71, P4742, DOI 10.1073/pnas.71.12.4742; LEBKOWSKI JS, 1982, J MOL BIOL, V156, P309, DOI 10.1016/0022-2836(82)90331-X; Leforestier A, 2001, BIOPHYS J, V81, P2414, DOI 10.1016/S0006-3495(01)75888-2; LEWIS CD, 1982, CELL, V29, P171, DOI 10.1016/0092-8674(82)90101-5; Li TK, 1999, GENE DEV, V13, P1553, DOI 10.1101/gad.13.12.1553; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lupo R, 2001, MOL CELL, V7, P127, DOI 10.1016/S1097-2765(01)00161-7; LUTTER LC, 1979, NUCLEIC ACIDS RES, V6, P41, DOI 10.1093/nar/6.1.41; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Mashima T, 1997, ONCOGENE, V14, P1007, DOI 10.1038/sj.onc.1200919; MCMURRAY CT, 1986, P NATL ACAD SCI USA, V83, P8472, DOI 10.1073/pnas.83.22.8472; Miralles F, 2000, J CELL BIOL, V148, P271, DOI 10.1083/jcb.148.2.271; MIRKOVITCH J, 1984, CELL, V39, P223, DOI 10.1016/0092-8674(84)90208-3; OLINS AL, 1976, NUCLEIC ACIDS RES, V3, P3271, DOI 10.1093/nar/3.12.3271; Pederson T, 1998, J MOL BIOL, V277, P147, DOI 10.1006/jmbi.1997.1618; Percipalle P, 2001, J CELL BIOL, V153, P229, DOI 10.1083/jcb.153.1.229; PFEIFER GP, 1991, GENE DEV, V5, P1102, DOI 10.1101/gad.5.6.1102; Posey SC, 1999, J BIOL CHEM, V274, P4259, DOI 10.1074/jbc.274.7.4259; Povirk LF, 1996, MUTAT RES-FUND MOL M, V355, P71, DOI 10.1016/0027-5107(96)00023-1; RADIC MZ, 1987, CELL, V50, P1101, DOI 10.1016/0092-8674(87)90176-0; Rando OJ, 2000, TRENDS CELL BIOL, V10, P92, DOI 10.1016/S0962-8924(99)01713-4; ROSE SM, 1984, J BIOL CHEM, V259, P8534; Sahara S, 1999, NATURE, V401, P168, DOI 10.1038/43678; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Sakahira H, 1999, CURR BIOL, V9, P543, DOI 10.1016/S0960-9822(99)80240-1; Samejima K, 2001, J BIOL CHEM, V276, P45427, DOI 10.1074/jbc.M108844200; Samejima K, 1998, J CELL BIOL, V143, P225, DOI 10.1083/jcb.143.1.225; SIMPSON RT, 1978, BIOCHEMISTRY-US, V17, P5524, DOI 10.1021/bi00618a030; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; SPERRY AO, 1989, P NATL ACAD SCI USA, V86, P5497, DOI 10.1073/pnas.86.14.5497; Strick R, 2001, J CELL BIOL, V155, P899, DOI 10.1083/jcb.200105026; SUN DY, 1994, J EXP MED, V179, P559, DOI 10.1084/jem.179.2.559; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Thomas JO, 1999, CURR OPIN CELL BIOL, V11, P312, DOI 10.1016/S0955-0674(99)80042-8; Travers A, 1999, TRENDS BIOCHEM SCI, V24, P4, DOI 10.1016/S0968-0004(98)01339-5; Turner PR, 1996, MUTAT RES-FUND MOL M, V355, P141, DOI 10.1016/0027-5107(96)00027-9; UEMURA T, 1987, CELL, V50, P917, DOI 10.1016/0092-8674(87)90518-6; Uhlmann F, 2001, CURR BIOL, V11, pR384, DOI 10.1016/S0960-9822(01)00214-7; VANDYKE MW, 1982, P NATL ACAD SCI-BIOL, V79, P5470; VANDYKE MW, 1983, BIOCHEMISTRY-US, V22, P2373, DOI 10.1021/bi00279a011; VANHOLDE KE, 1988, CHROMATIN, P27; Widlak P, 2000, J BIOL CHEM, V275, P8226, DOI 10.1074/jbc.275.11.8226; Widlak P, 2001, J BIOL CHEM, V276, P48404, DOI 10.1074/jbc.M108461200; Wolffe AP, 2001, CELL, V104, P631, DOI 10.1016/S0092-8674(02)01453-8; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Wright WE, 1999, EXP CELL RES, V251, P492, DOI 10.1006/excr.1999.4602	85	36	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21683	21690		10.1074/jbc.M201027200	http://dx.doi.org/10.1074/jbc.M201027200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11927586	hybrid			2022-12-27	WOS:000176286000076
J	Xu, Y; Mellgren, RL				Xu, Y; Mellgren, RL			Calpain inhibition decreases the growth rate of mammalian cell colonies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEASE; FAMILY; ACTIVATION; ADHESION; GENE; DIFFERENTIATION; PROLIFERATION; CALPASTATIN; MIGRATION; DISTINCT	The calpains, a family of calcium-requiring intracellular proteases, are proposed regulators of cell proliferation. However, ablation of the calpain small subunit gene necessary for function of the conventional calpains did not result in decreased rate of proliferative growth of mouse stem cells under routine culture conditions. To address the reasons for this discrepancy, Chinese hamster ovary cell lines were established that overexpress the calpain inhibitor protein, calpastatin, under control of the ecdysone congener, ponasterone A. Overexpression of calpastatin in these cell lines resulted in a decreased growth of isolated colonies adhering to tissue culture plates. However, when cells were plated at higher density, calpastatin overexpression had no influence on proliferative growth rate. Growth of colonies in soft agar was not inhibited by calpastatin overexpression. Cell adhesion, cell de-adhesion, and cell motility all appeared to be normal after calpastatin overexpression. Differential display analysis was initiated to detect possible alteration of gene expression upon calpastatin overexpression. Analysis of similar to3000 differential display PCR signals resulted in identification of one band that was underexpressed. Northern blot analysis confirmed a decreased amount of similar to1 kb mRNA in cells overexpressing calpastatin. Sequence analysis identified a putative protein, Csr, containing a region homologous to two ubiquitin transferases and a putative cation channel protein.	Med Coll Ohio, Dept Pharmacol & Therapeut, Toledo, OH 43614 USA		Mellgren, RL (corresponding author), Med Coll Ohio, Dept Pharmacol & Therapeut, Toledo, OH 43614 USA.							Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; Barnes TM, 1996, EMBO J, V15, P4477, DOI 10.1002/j.1460-2075.1996.tb00825.x; Bialkowska K, 2000, J CELL BIOL, V151, P685, DOI 10.1083/jcb.151.3.685; Carragher NO, 2001, J BIOL CHEM, V276, P4270, DOI 10.1074/jbc.M008972200; DELANEY SJ, 1991, P NATL ACAD SCI USA, V88, P7214, DOI 10.1073/pnas.88.16.7214; DENISON SH, 1995, J BIOL CHEM, V270, P28519, DOI 10.1074/jbc.270.48.28519; FUKAI F, 1993, BIOCHEM MOL BIOL INT, V30, P225; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Glading A, 2000, J BIOL CHEM, V275, P2390, DOI 10.1074/jbc.275.4.2390; Harder KW, 1998, J BIOL CHEM, V273, P31890, DOI 10.1074/jbc.273.48.31890; Hasselgren PO, 2001, ANN SURG, V233, P9, DOI 10.1097/00000658-200101000-00003; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; Huttenlocher A, 1997, J BIOL CHEM, V272, P32719, DOI 10.1074/jbc.272.52.32719; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; MARCH KL, 1993, CIRC RES, V72, P413, DOI 10.1161/01.RES.72.2.413; MELLGREN RL, 1982, J BIOL CHEM, V257, P7203; MELLGREN RL, 1988, BIOCHEM BIOPH RES CO, V150, P170, DOI 10.1016/0006-291X(88)90501-3; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakamura Y, 1999, EXP EYE RES, V69, P155, DOI 10.1006/exer.1998.0686; Patel YM, 2000, J BIOL CHEM, V275, P17653, DOI 10.1074/jbc.M910445199; Patel YM, 1999, P NATL ACAD SCI USA, V96, P1279, DOI 10.1073/pnas.96.4.1279; Potter DA, 1998, J CELL BIOL, V141, P647, DOI 10.1083/jcb.141.3.647; Rock MT, 2000, EXP CELL RES, V261, P260, DOI 10.1006/excr.2000.5048; Shiraha H, 1999, J CELL BIOL, V146, P243; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SUZUKI K, 1995, BIOL CHEM H-S, V376, P523; Suzuki M, 1998, BIOCHEM BIOPH RES CO, V242, P191, DOI 10.1006/bbrc.1997.7931; Zhang WL, 1996, J BIOL CHEM, V271, P18825, DOI 10.1074/jbc.271.31.18825; Zhang WL, 1997, ONCOGENE, V14, P255, DOI 10.1038/sj.onc.1200841	29	43	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21474	21479		10.1074/jbc.M111689200	http://dx.doi.org/10.1074/jbc.M111689200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11937499	hybrid			2022-12-27	WOS:000176286000047
J	Huang, CF; Handlogten, ME; Miller, RT				Huang, CF; Handlogten, ME; Miller, RT			Parallel activation of phosphatidylinositol 4-kinase and phospholipase C by the extracellular calcium-sensing receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANINE KIDNEY-CELLS; CA2+-SENSING RECEPTOR; POTASSIUM CHANNELS; RAT-KIDNEY; KINASE; IDENTIFICATION; PROTEIN; PHOSPHOINOSITIDES; DIFFERENTIATION; EXPRESSION	The calcium-sensing receptor (Call) is a G protein-coupled receptor that regulates physiological processes including Ca2+ metabolism, Na+, Cl-, K+, and H2O balance, and the growth of some epithelial cells through diverse signaling pathways. Although many effects of CaR are mediated by the heterotrimeric G proteins Galpha(q) and Galpha(i), not all signaling pathways regulated by CaR have been identified. We used human embryonic kidney (HEK)-293 cells that stably express human CaR to study the regulation of inositol lipid metabolism by CaR. The nonfunctional mutant CaRR796W was used as a negative control. We found that CaR regulates phosphatidylinositol (PI) 4-kinase, the first step in inositol lipid biosynthesis. In cells pretreated with U73122 to inhibit phospholipase C activation and to block the degradation of PI 4,5-bisphosphate to form [H-3]inositol trisphosphate (IP3), CaR stimulated the accumulation of [3H]PI monophosphate (PIP). Additionally, wortmannin, an inhibitor of both PI 3-kinase and type III PI 4-kinase, blocked Call-stimulated accumulation of [H-3]PIP and inhibited [H-3]IP3 production. CaR-stimulated inositol lipid synthesis was attributable to PI 4-kinase and not PI 3-kinase because CaR did not activate Akt, a downstream target of PI 3-kinase. CaR associates with PI 4-kinase based on the findings that CaR and the 110-kDa PI 4-kinase 13 can be co-immunoprecipitated with antibodies against either CaR or PI 4-kinase. The PI-4 kinase in co-immunoprecipitates with anti-Call antibody was activated in Ca2+-stimulated HEK-293 cells, which stably express the wild type CaR. Pertussis toxin did not affect the formation of [H-3]IP3 or the rise in intracellular Ca2+ (Handlogten, M. E., Huang, C. F., Shiraishi, N., Awata, H., and Miller, R. T. (2001) J. Biol. Chem. 276, 1394113948). RGS4, an accelerator of GTPase activity of members of the Gai and Gaq families, attenuated the CaR-stimulated PLC activation and IP3 accumulation, which is mediated by Gaq, but did not inhibit CaR-stimulated [H-3]PIP formation. In HEK-293 cells, which express wild type Call, Rho was enriched in immune complexes co-immunoprecipitated with the anti-Call antibody. C-3 toxin, an inhibitor of Rho, also inhibited the CaR-stimulated [H-3]IP3 production but did not lead to CaR-stimulated [H-3]PIP formation, reflecting inhibition of PI 4-kinase. Taken together, our data demonstrate that CaR stimulates PI 4-kinase, the first step in inositol lipid biosynthesis conversion of PI to PI 4-P by Rho-dependent and Galpha(q)- and Galpha(i)-independent pathways.	Case Western Reserve Univ, Louis Stokes Vet Affairs Med Ctr, Dept Med, Div Nephrol, Cleveland, OH 44106 USA; Univ Florida, Coll Med, Dept Med, Gainesville, FL 32106 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; State University System of Florida; University of Florida	Huang, CF (corresponding author), Case Western Reserve Univ, Louis Stokes Vet Affairs Med Ctr, Dept Med, Div Nephrol, 10701 E Blvd,151W, Cleveland, OH 44106 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041726, R29DK041726] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-41726] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		August A, 1997, P NATL ACAD SCI USA, V94, P11227, DOI 10.1073/pnas.94.21.11227; Bai M, 1996, J BIOL CHEM, V271, P19537, DOI 10.1074/jbc.271.32.19537; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; BROWN EM, 1995, CELL, V83, P679, DOI 10.1016/0092-8674(95)90180-9; Bruce JIE, 1999, J BIOL CHEM, V274, P20561, DOI 10.1074/jbc.274.29.20561; BURAS RR, 1995, CELL PROLIFERAT, V28, P245, DOI 10.1111/j.1365-2184.1995.tb00067.x; Chattopadhyay N, 1997, DEV BRAIN RES, V100, P13, DOI 10.1016/S0165-3806(97)00009-6; Chattopadhyay N, 1998, AM J PHYSIOL-GASTR L, V274, pG122, DOI 10.1152/ajpgi.1998.274.1.G122; Cheng I, 1998, J CLIN ENDOCR METAB, V83, P703, DOI 10.1210/jc.83.2.703; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Ferreira MCD, 1998, J BIOL CHEM, V273, P15192, DOI 10.1074/jbc.273.24.15192; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Gasman S, 1998, J BIOL CHEM, V273, P16913, DOI 10.1074/jbc.273.27.16913; Gehrmann T, 1998, EUR J BIOCHEM, V253, P357, DOI 10.1046/j.1432-1327.1998.2530357.x; Godwin SL, 1997, J BIOL CHEM, V272, P11307; Handlogten ME, 2001, J BIOL CHEM, V276, P13941, DOI 10.1074/jbc.M007306200; Handlogten ME, 2000, AM J PHYSIOL-RENAL, V279, pF1083, DOI 10.1152/ajprenal.2000.279.6.F1083; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Hofer AM, 2000, NAT CELL BIOL, V2, P392, DOI 10.1038/35017020; HUANG CF, 1992, J BIOL CHEM, V267, P16859; Huang CF, 1997, P NATL ACAD SCI USA, V94, P6159, DOI 10.1073/pnas.94.12.6159; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; KAUFFMANNZEH A, 1994, J BIOL CHEM, V269, P31243; Kifor O, 1997, J BONE MINER RES, V12, P715, DOI 10.1359/jbmr.1997.12.5.715; Kifor O, 2001, AM J PHYSIOL-RENAL, V280, pF291, DOI 10.1152/ajprenal.2001.280.2.F291; Kifor O, 1998, J BIOL CHEM, V273, P21708, DOI 10.1074/jbc.273.34.21708; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Li M, 2000, MOL PHARMACOL, V57, P446, DOI 10.1124/mol.57.3.446; Li ZM, 1997, P NATL ACAD SCI USA, V94, P13820, DOI 10.1073/pnas.94.25.13820; Lin KI, 1998, BIOCHEM BIOPH RES CO, V249, P325, DOI 10.1006/bbrc.1998.9124; Mayer A, 2000, MOL BIOL CELL, V11, P807, DOI 10.1091/mbc.11.3.807; McNeil SE, 1998, J BIOL CHEM, V273, P1114, DOI 10.1074/jbc.273.2.1114; Mejillano M, 2001, J BIOL CHEM, V276, P1865, DOI 10.1074/jbc.M007271200; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; Oda Y, 1998, J BIOL CHEM, V273, P23344, DOI 10.1074/jbc.273.36.23344; Osborne SL, 2001, NEURON, V32, P9, DOI 10.1016/S0896-6273(01)00455-X; POLLAK MR, 1994, NAT GENET, V8, P303, DOI 10.1038/ng1194-303; POLLAK MR, 1993, CELL, V75, P1297, DOI 10.1016/0092-8674(93)90617-Y; RICCARDI D, 1995, P NATL ACAD SCI USA, V92, P131, DOI 10.1073/pnas.92.1.131; Rosado JA, 2000, J BIOL CHEM, V275, P9110, DOI 10.1074/jbc.275.13.9110; RUAT M, 1995, P NATL ACAD SCI USA, V92, P3161, DOI 10.1073/pnas.92.8.3161; SERUNIAN LA, 1989, J BIOL CHEM, V264, P17809; Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475; Sorensen SD, 1998, MOL PHARMACOL, V53, P827; TANG W, 1988, J INVEST DERMATOL, V90, P37, DOI 10.1111/1523-1747.ep12462536; Wang WH, 1996, AM J PHYSIOL-CELL PH, V271, pC103, DOI 10.1152/ajpcell.1996.271.1.C103; Weernink PAO, 2000, EUR J BIOCHEM, V267, P5237, DOI 10.1046/j.1432-1327.2000.01599.x; Weernink PAO, 2000, J BIOL CHEM, V275, P10168, DOI 10.1074/jbc.275.14.10168; Weisz OA, 2000, J BIOL CHEM, V275, P24341, DOI 10.1074/jbc.M000671200; Yang TX, 1997, AM J PHYSIOL-RENAL, V272, pF751, DOI 10.1152/ajprenal.1997.272.6.F751; Zhao XH, 2000, J BIOL CHEM, V275, P14642, DOI 10.1074/jbc.275.19.14642; Zubenko GS, 1999, BIOL PSYCHIAT, V45, P731, DOI 10.1016/S0006-3223(98)00073-0	55	59	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20293	20300		10.1074/jbc.M200831200	http://dx.doi.org/10.1074/jbc.M200831200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11907035	hybrid			2022-12-27	WOS:000176204500027
J	Kimura, T; Tabuchi, Y; Takeguchi, N; Asano, S				Kimura, T; Tabuchi, Y; Takeguchi, N; Asano, S			Mutational study on the roles of disulfide bonds in the beta-subunit of gastric H+,K+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; FUNCTIONAL EXPRESSION; ALPHA-SUBUNIT; CDNA CLONING; BINDING-SITES; PROTON PUMP; H,K-ATPASE; ATPASE; IDENTIFICATION; NA,K-ATPASE	The gastric proton pump, H+,K+-1ATPase, consists of the catalytic a-subunit and the non-catalytic beta-subunit. Correct assembly between the alpha- and beta-subunits is essential for the functional expression of H+,K+-ATPase. The beta-subunit contains nine conserved cysteine residues; two are in the cytoplasmic domain, one in the transmembrane domain, and six in the ectodomain. The six cysteine residues in the ectodomain form three disulfide bonds. In this study, we replaced each of the cysteine residues of the beta-subunit with serine individually and in several combinations. The mutant beta-subunits were co-expressed with the alpha-subunit in human embryonic kidney 293 cells, and the role of each cysteine residue or disulfide bond in the alpha/beta assembly, stability, and cell surface delivery of the alpha- and beta-subunits and H+K+-ATPase activity was studied. Mutant beta-subunits with a replacement of the cytoplasmic and transmembrane cysteines preserved H+,K+-ATPase activity. All the mutant beta-subunits with replacement(s) of the extracellular cysteines did not assemble with the a-subunit, resulting in loss of H+,K+-ATPase activity. These mutants did not permit delivery of the alpha-subunit to the cell surface. Therefore, each of these disulfide bonds of the beta-subunit is essential for assembly with the a-subunit and expression of H+,K+-ATPase activity as well as for cell surface delivery of the alpha-subunit.	Toyama Med & Pharmaceut Univ, Mol Genet Res Ctr, Toyama 9300194, Japan; Toyama Med & Pharmaceut Univ, Fac Pharmaceut Sci, Toyama 9300194, Japan	University of Toyama; University of Toyama	Asano, S (corresponding author), Toyama Med & Pharmaceut Univ, Mol Genet Res Ctr, 2630 Sugitani, Toyama 9300194, Japan.			Tabuchi, Yoshiaki/0000-0002-6007-6176; Asano, Shinji/0000-0003-1443-8970				Asano S, 2000, J BIOCHEM, V127, P993, DOI 10.1093/oxfordjournals.jbchem.a022716; ASANO S, 1994, BIOCHEM J, V299, P59, DOI 10.1042/bj2990059; Asano S, 2000, J BIOL CHEM, V275, P8324, DOI 10.1074/jbc.275.12.8324; Asano S, 1999, J BIOL CHEM, V274, P22257, DOI 10.1074/jbc.274.32.22257; Asano S, 1997, J BIOL CHEM, V272, P17668, DOI 10.1074/jbc.272.28.17668; Asano S, 1996, J BIOL CHEM, V271, P2740, DOI 10.1074/jbc.271.5.2740; ASANO S, 1989, J BIOCHEM-TOKYO, V106, P1074, DOI 10.1093/oxfordjournals.jbchem.a122967; BAMBERG K, 1992, BIOCHIM BIOPHYS ACTA, V1131, P69, DOI 10.1016/0167-4781(92)90100-E; Beggah AT, 1997, J BIOL CHEM, V272, P10318; Besancon M, 1997, J BIOL CHEM, V272, P22438, DOI 10.1074/jbc.272.36.22438; Bonifacino JS, 1996, NATURE, V384, P405, DOI 10.1038/384405a0; CANFIELD VA, 1990, J BIOL CHEM, V265, P19878; CHOW DC, 1992, AM J PHYSIOL, V263, pC39, DOI 10.1152/ajpcell.1992.263.1.C39; FARLEY RA, 1985, J BIOL CHEM, V260, P3899; GOTTARDI CJ, 1993, J BIOL CHEM, V268, P14342; Hermsen HPH, 2000, BIOCHEMISTRY-US, V39, P1330, DOI 10.1021/bi991396y; Hermsen HPH, 1998, BIOCHEM J, V331, P465, DOI 10.1042/bj3310465; KAWAMURA M, 1984, BIOCHIM BIOPHYS ACTA, V774, P188, DOI 10.1016/0005-2736(84)90290-6; KIRLEY TL, 1990, J BIOL CHEM, V265, P4227; KLAASSEN CHW, 1993, FEBS LETT, V329, P277, DOI 10.1016/0014-5793(93)80237-O; Kowalski JM, 1998, BIOCHEMISTRY-US, V37, P1264, DOI 10.1021/bi9722397; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambrecht N, 1998, J BIOL CHEM, V273, P13719, DOI 10.1074/jbc.273.22.13719; Lambrecht N, 2000, J BIOL CHEM, V275, P4041, DOI 10.1074/jbc.275.6.4041; MA JY, 1991, BIOCHEM BIOPH RES CO, V180, P39; MATHEWS PM, 1995, AM J PHYSIOL-CELL PH, V268, pC1207, DOI 10.1152/ajpcell.1995.268.5.C1207; MORII M, 1995, BIOCHEM PHARMACOL, V49, P1729, DOI 10.1016/0006-2952(95)00090-M; Morii M, 1996, J BIOL CHEM, V271, P4068; NOGUCHI S, 1994, FEBS LETT, V341, P233, DOI 10.1016/0014-5793(94)80463-X; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; REUBEN MA, 1990, P NATL ACAD SCI USA, V87, P6767, DOI 10.1073/pnas.87.17.6767; SEGAL MS, 1992, J CELL BIOL, V118, P227, DOI 10.1083/jcb.118.2.227; SHULL GE, 1990, J BIOL CHEM, V265, P12123; SHULL GE, 1986, J BIOL CHEM, V261, P6788; Sone M, 1997, J BIOL CHEM, V272, P6174, DOI 10.1074/jbc.272.10.6174; Swarts HGP, 1996, J BIOL CHEM, V271, P29764, DOI 10.1074/jbc.271.47.29764; TOH BH, 1990, P NATL ACAD SCI USA, V87, P6418, DOI 10.1073/pnas.87.16.6418; Tyagarajan K, 1997, BIOCHEMISTRY-US, V36, P10200, DOI 10.1021/bi9706125; TYAGARAJAN K, 1995, BBA-BIOMEMBRANES, V1236, P105, DOI 10.1016/0005-2736(95)00044-4; WALDERHAUG MO, 1985, J BIOL CHEM, V260, P3852	40	22	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20671	20677		10.1074/jbc.M200523200	http://dx.doi.org/10.1074/jbc.M200523200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11909858	hybrid			2022-12-27	WOS:000176204500074
J	Lambot, M; Fretier, S; De Beeck, AO; Quatannens, B; Lestavel, S; Clavey, W; Dubuisson, J				Lambot, M; Fretier, S; De Beeck, AO; Quatannens, B; Lestavel, S; Clavey, W; Dubuisson, J			Reconstitution of hepatitis C virus envelope glycoproteins into liposomes as a surrogate model to study virus attachment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; VESICULAR STOMATITIS-VIRUS; ENDOPLASMIC-RETICULUM; RECOMBINANT VACCINIA; E2 GLYCOPROTEINS; HUMAN SERA; VERY-LOW; BINDING; PROTEIN; CD81	The envelope glycoproteins, E1 and E2, of hepatitis C virus (HCV) assemble intracellularly to form a noncovalent heterodimer that is expected to be essential for viral assembly and entry. However, due to the lack of a cell culture system supporting efficient HCV replication, it is very difficult to obtain relevant information on the functions of this glycoprotein oligomer. To get better insights into its biological and biochemical properties, HCV envelope glycoprotein heterodimer expressed by a vaccinia virus recombinant was purified by immunoaffinity. Purified E1E2 heterodimer was recognized by conformation-dependent monoclonal antibodies, showing that the proteins were properly folded. In addition, it interacted with human CD81, a putative HCV receptor, as well as with human low and very low density lipoproteins, which have been shown to be associated with infectious HCV particles isolated from patients. Purified E1E2 heterodimer was also reconstituted into liposomes. E1E2-liposomes were recognized by a conformation-dependent monoclonal antibody as well as by human CD81. Together, these data indicate that E1E2-liposomes are a valuable tool to study the molecular requirements for HCV binding to target cells.	Inst Biol Lille, CNRS, UPR2511, Unite Hepatite C, F-59021 Lille, France; Univ Lille 2, Fac Pharm, Inst Pasteur, INSERM,U545, F-59019 Lille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Dubuisson, J (corresponding author), Inst Biol Lille, CNRS, UPR2511, Unite Hepatite C, 1 Rue Calmette,BP447, F-59021 Lille, France.	jean.dubuisson@ibl.fr	Lestavel, Sophie/B-4658-2017; Dubuisson, Jean/E-6813-2016	Lestavel, Sophie/0000-0001-7839-4757; Dubuisson, Jean/0000-0003-1626-7693				Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Allander T, 2000, VIROLOGY, V277, P358, DOI 10.1006/viro.2000.0617; Baumert TF, 1998, J VIROL, V72, P3827, DOI 10.1128/JVI.72.5.3827-3836.1998; Cocquerel L, 1998, J VIROL, V72, P2183, DOI 10.1128/JVI.72.3.2183-2191.1998; Cocquerel L, 2001, J GEN VIROL, V82, P1629, DOI 10.1099/0022-1317-82-7-1629; CORNET B, 1992, AIDS RES HUM RETROV, V8, P1823, DOI 10.1089/aid.1992.8.1823; CURMAN B, 1980, J BIOL CHEM, V255, P7820; De Beeck AO, 2000, J BIOL CHEM, V275, P31428, DOI 10.1074/jbc.M003003200; Deleersnyder V, 1997, J VIROL, V71, P697, DOI 10.1128/JVI.71.1.697-704.1997; DUBJISSON J, 1996, J VIROL, V70, P778; Dubuisson J, 2000, CURR TOP MICROBIOL, V242, P135; DUBUISSON J, 1994, J VIROL, V68, P6147, DOI 10.1128/JVI.68.10.6147-6160.1994; Duvet S, 1998, J BIOL CHEM, V273, P32088, DOI 10.1074/jbc.273.48.32088; EIDELMAN O, 1984, J BIOL CHEM, V259, P4622; Flint M, 2000, REV MED VIROL, V10, P101, DOI 10.1002/(SICI)1099-1654(200003/04)10:2&lt;101::AID-RMV268&gt;3.0.CO;2-W; Flint M, 2001, Clin Liver Dis, V5, P873, DOI 10.1016/S1089-3261(05)70199-9; Flint M, 2000, J VIROL, V74, P702, DOI 10.1128/JVI.74.2.702-709.2000; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Francki RIB, 1991, ARCH VIROL         S, V2, P223; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Hamaia S, 2001, BLOOD, V98, P2293, DOI 10.1182/blood.V98.8.2293; Harlow E., 1988, ANTIBODIES LAB MANUA; HARMSEN MC, 1985, EUR J BIOCHEM, V149, P591, DOI 10.1111/j.1432-1033.1985.tb08966.x; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Heile JM, 2000, J VIROL, V74, P6885, DOI 10.1128/JVI.74.15.6885-6892.2000; HELENIUS A, 1981, EUR J BIOCHEM, V116, P27, DOI 10.1111/j.1432-1033.1981.tb05296.x; HELENIUS A, 1977, J CELL BIOL, V75, P866, DOI 10.1083/jcb.75.3.866; Higginbottom A, 2000, J VIROL, V74, P3642, DOI 10.1128/JVI.74.8.3642-3649.2000; HOUGHTON M, 1996, FIELDS VIROLOGY, P1035; HUANG RTC, 1980, VIROLOGY, V104, P294, DOI 10.1016/0042-6822(80)90334-7; Lagging LM, 1998, J VIROL, V72, P3539, DOI 10.1128/JVI.72.5.3539-3546.1998; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; MADDEN TD, 1988, INT J BIOCHEM, V20, P889, DOI 10.1016/0020-711X(88)90172-3; MADDEN TD, 1986, CHEM PHYS LIPIDS, V40, P207, DOI 10.1016/0009-3084(86)90071-X; Matsuura Y, 2001, VIROLOGY, V286, P263, DOI 10.1006/viro.2001.0971; METSIKKO K, 1986, EMBO J, V5, P3429, DOI 10.1002/j.1460-2075.1986.tb04665.x; Monazahian M, 1999, J MED VIROL, V57, P223, DOI 10.1002/(SICI)1096-9071(199903)57:3<223::AID-JMV2>3.0.CO;2-4; Monazahian M, 2000, MED MICROBIOL IMMUN, V188, P177, DOI 10.1007/s004300000032; NUSSBAUM O, 1987, J VIROL, V61, P2245, DOI 10.1128/JVI.61.7.2245-2252.1987; Owsianka A, 2001, J GEN VIROL, V82, P1877, DOI 10.1099/0022-1317-82-8-1877; Patel AH, 2000, J GEN VIROL, V81, P2873, DOI 10.1099/0022-1317-81-12-2873; Petracca R, 2000, J VIROL, V74, P4824, DOI 10.1128/JVI.74.10.4824-4830.2000; PETRI WA, 1979, J BIOL CHEM, V254, P4313; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Prince AM, 1996, J VIRAL HEPATITIS, V3, P11, DOI 10.1111/j.1365-2893.1996.tb00075.x; RALSTON R, 1993, J VIROL, V67, P6753, DOI 10.1128/JVI.67.11.6753-6761.1993; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; SCHEULE RK, 1986, BIOCHEMISTRY-US, V25, P4223, DOI 10.1021/bi00363a009; Shelness GS, 2001, CURR OPIN LIPIDOL, V12, P151, DOI 10.1097/00041433-200104000-00008; STEGMANN T, 1987, EMBO J, V6, P2651, DOI 10.1002/j.1460-2075.1987.tb02556.x; THOMSSEN R, 1993, MED MICROBIOL IMMUN, V182, P329; THOMSSEN R, 1992, MED MICROBIOL IMMUN, V181, P293, DOI 10.1007/BF00198849; Wunschmann S, 2000, J VIROL, V74, P10055, DOI 10.1128/JVI.74.21.10055-10062.2000; Xu ZM, 2001, EMBO J, V20, P3840, DOI 10.1093/emboj/20.14.3840	55	35	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20625	20630		10.1074/jbc.M111020200	http://dx.doi.org/10.1074/jbc.M111020200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11937498	hybrid			2022-12-27	WOS:000176204500069
J	Allen-Jennings, AE; Hartman, MG; Kociba, GJ; Hai, TW				Allen-Jennings, AE; Hartman, MG; Kociba, GJ; Hai, TW			The roles of ATF3 in liver dysfunction and the regulation of phosphoenolpyruvate carboxykinase gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING TRANSCRIPTION FACTOR-3; TRANSGENIC MICE; MOLECULAR-BIOLOGY; CHOROID-PLEXUS; C/EBP-ALPHA; IDENTIFICATION; HEPATOCYTE; PROTEIN; REGENERATION; HOMEOSTASIS	Activating transcription factor 3 (ATF3), a member of the ATF/cAMP-responsive element-binding protein family of transcription factors, is a transcriptional repressor, and the expression of its corresponding gene, ATF3, is induced by many stress signals. In this report, we demonstrate that transgenic mice expressing ATF3 in the liver had symptoms of liver dysfunction such as high levels of serum bilirubin, alkaline phosphatase, alanine transaminase, aspartate transaminase, and bile acids. In addition, these mice had physiological responses consistent with hypoglycemia including a low insulin:glucagon ratio in the serum and reduced adipose tissue mass. Electrophoretic mobility shift assays indicated that ATF3 bound to the ATF/cAMP-responsvie element site derived from the promoter of the gene encoding the gluconeogenic enzyme phosphoenolpyruvate carboxykinase (PEPCK). Furthermore, transient transfection assays indicated that ATF3 repressed the activity of the PEPCK promoter. Taken together, our results are consistent with the model that the expression of ATF3 in the liver results in defects in glucose homeostasis by repressing gluconeogenesis. Because ATF3 is a stress-inducible gene, these mice may provide a model to investigate the molecular mechanisms of some stress-associated liver diseases.	Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; Ohio State Univ, Neurobiotechnol Ctr, Columbus, OH 43210 USA; Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Hai, TW (corresponding author), Rm 148 Rightmire Hall 1060 Carmack Rd, Columbus, OH 43210 USA.	hai.2@osu.edu	Hai, Tsonwin/H-4480-2011; Hai, Tsonwin/E-3185-2011	Hai, Tsonwin/0000-0003-4510-0315; Hai, Tsonwin/0000-0003-4510-0315	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064938] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK064938] Funding Source: Medline; PHS HHS [08690] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Allen-Jennings AE, 2001, J BIOL CHEM, V276, P29507, DOI 10.1074/jbc.M100986200; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; BALLARD FJ, 1967, BIOCHEM J, V104, P866, DOI 10.1042/bj1040866; Brindle PK, 1992, CURR OPIN GENET DEV, V2, P199, DOI 10.1016/S0959-437X(05)80274-6; CHEN BPC, 1994, J BIOL CHEM, V269, P15819; Chen BPC, 1996, MOL CELL BIOL, V16, P1157, DOI 10.1128/mcb.16.3.1157; Croniger C, 1998, J BIOL CHEM, V273, P31629, DOI 10.1074/jbc.273.48.31629; Croniger CM, 2001, J BIOL CHEM, V276, P629, DOI 10.1074/jbc.M007576200; DARLINGTON GJ, 1995, CURR OPIN GENET DEV, V5, P565, DOI 10.1016/0959-437X(95)80024-7; Drysdale BE, 1996, MOL IMMUNOL, V33, P989, DOI 10.1016/S0161-5890(96)00043-0; FARBER JM, 1992, MOL CELL BIOL, V12, P1535, DOI 10.1128/MCB.12.4.1535; Fausto N., 1994, LIVER BIOL PATHOBIOL; GIRARD J, 1992, PHYSIOL REV, V72, P507, DOI 10.1152/physrev.1992.72.2.507; GIRARD JR, 1973, J CLIN INVEST, V52, P3190, DOI 10.1172/JCI107519; GRANNER D, 1991, RECENT PROG HORM RES, V47, P319; HABER BA, 1993, J CLIN INVEST, V91, P1319, DOI 10.1172/JCI116332; Hai T, 1999, GENE EXPRESSION, V7, P321; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; HSU JC, 1991, P NATL ACAD SCI USA, V88, P3511, DOI 10.1073/pnas.88.9.3511; Ishiguro T, 1996, CANCER RES, V56, P875; JACOBSSON B, 1989, J HISTOCHEM CYTOCHEM, V37, P31, DOI 10.1177/37.1.2642294; Liang GS, 1997, J BIOL CHEM, V272, P24088, DOI 10.1074/jbc.272.38.24088; MCGRANE MM, 1992, TRENDS BIOCHEM SCI, V17, P40, DOI 10.1016/0968-0004(92)90426-A; MEYER TE, 1993, ENDOCR REV, V14, P269, DOI 10.1210/er.14.3.269; Nizielski SE, 1996, J NUTR, V126, P2697; Okamoto Y, 2001, AM J PATHOL, V159, P639, DOI 10.1016/S0002-9440(10)61735-X; QUINN PG, 1988, MOL CELL BIOL, V8, P3467, DOI 10.1128/MCB.8.8.3467; ROESLER WJ, 1989, J BIOL CHEM, V264, P9657; SASSONECORSI P, 1994, EMBO J, V13, P4717, DOI 10.1002/j.1460-2075.1994.tb06797.x; She P, 2000, MOL CELL BIOL, V20, P6508, DOI 10.1128/MCB.20.17.6508-6517.2000; SHORT JM, 1986, J BIOL CHEM, V261, P9721; STRYER L, 1995, BIOCHEMISTRY-US, P569; Sutherland C, 1997, DIABETES, V46, P17, DOI 10.2337/diabetes.46.1.17; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; WEIR E, 1994, HEPATOLOGY, V20, P955, DOI 10.1002/hep.1840200426; Wolfgang CD, 1997, MOL CELL BIOL, V17, P6700, DOI 10.1128/MCB.17.11.6700; Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245; YAN C, 1990, EMBO J, V9, P869, DOI 10.1002/j.1460-2075.1990.tb08184.x; Ye HG, 1999, MOL CELL BIOL, V19, P8570	41	56	58	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					20020	20025		10.1074/jbc.M200727200	http://dx.doi.org/10.1074/jbc.M200727200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11916968	hybrid			2022-12-27	WOS:000175894800102
J	Fiermonte, G; Palmieri, L; Todisco, S; Agrimi, G; Palmieri, F; Walker, JE				Fiermonte, G; Palmieri, L; Todisco, S; Agrimi, G; Palmieri, F; Walker, JE			Identification of the mitochondrial glutamate transporter - Bacterial expression, reconstitution, functional characterization, and tissue distribution of two human isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; BOVINE MITOCHONDRIA; CARRIER PROTEINS; YEAST; GENES; CDNA; SEQUENCE; SUBUNIT; TRANSLOCASE; CLONING	The mitochondrial carriers are a family of transport proteins in the inner membranes of mitochondria. They shuttle substrates, metabolites, and cofactors through this membrane and connect cytoplasm functions with others in the matrix. Glutamate is co-transported with H+ (or exchanged for OH-), but no protein has ever been associated with this activity. Two human expressed sequence tags encode proteins of 323 and 315 amino acids with 63% identity that are related to the aspartate-glutamate carrier, a member of the carrier family. They have been overexpressed in Escherichia coli and reconstituted into phospholipid vesicles. Their transport properties demonstrate that the two proteins are isoforms of the glutamate/H+ symporter described in the past in whole mitochondria. Isoform 1 is expressed at higher levels than isoform 2 in all the tissues except in brain, where the two isoforms are expressed at comparable levels. The differences in expression levels and kinetic parameters of the two isoforms suggest that isoform 2 matches the basic requirement of all tissues especially with respect to amino acid degradation, and isoform 1 becomes operative to accommodate higher demands associated with specific metabolic functions such as ureogenesis.	Univ Bari, Dept Pharmaco Biol, Biochem & Mol Biol Lab, I-70125 Bari, Italy; MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England	Universita degli Studi di Bari Aldo Moro; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	Palmieri, F (corresponding author), Univ Bari, Dept Pharmaco Biol, Biochem & Mol Biol Lab, Via E Orabona 4, I-70125 Bari, Italy.		Todisco, Simona/AAU-2091-2021; Agrimi, Gennaro/D-4001-2018; agrimi, gennaro/C-6020-2009; Fiermonte, Giuseppe/D-3680-2018	Agrimi, Gennaro/0000-0002-5219-4412; Fiermonte, Giuseppe/0000-0002-6764-9395; Walker, John/0000-0001-7929-2162				AZZI A, 1967, BIOCHEM BIOPH RES CO, V29, P148, DOI 10.1016/0006-291X(67)90556-6; BATTINI R, 1987, J BIOL CHEM, V262, P4355; BRADFORD NM, 1973, BIOCHEM J, V134, P1023, DOI 10.1042/bj1341023; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Dolce V, 2001, P NATL ACAD SCI USA, V98, P2284, DOI 10.1073/pnas.031430998; Fiermonte G, 1998, J BIOL CHEM, V273, P22782, DOI 10.1074/jbc.273.35.22782; Fiermonte G, 2001, J BIOL CHEM, V276, P8225, DOI 10.1074/jbc.M009607200; Fiermonte G, 1998, J BIOL CHEM, V273, P24754, DOI 10.1074/jbc.273.38.24754; FIERMONTE G, 1993, BIOCHEM J, V294, P293, DOI 10.1042/bj2940293; GAY NJ, 1985, EMBO J, V4, P3519, DOI 10.1002/j.1460-2075.1985.tb04111.x; HOEK JB, 1983, J BIOL CHEM, V258, P54; HOULDSWORTH J, 1988, P NATL ACAD SCI USA, V85, P377, DOI 10.1073/pnas.85.2.377; Indiveri C, 1997, BIOCHEM J, V321, P713, DOI 10.1042/bj3210713; KING MJ, 1972, ARCH BIOCHEM BIOPHYS, V152, P670, DOI 10.1016/0003-9861(72)90263-9; Krumer R., 1992, MOL MECHANISMS BIOEN, P359, DOI DOI 10.1016/50167-7306(08)60184-2; LANOUE KF, 1979, ANNU REV BIOCHEM, V48, P871, DOI 10.1146/annurev.bi.48.070179.004255; LANOUE KF, 1984, BIOENERGETICS, P221; LONG C, 1961, BIOCH HDB, P682; MATSUDA C, 1993, J BIOL CHEM, V268, P24950; MCGIVAN JD, 1992, MAMMALIAN AMINO ACID TRANSPORT, P101; MCGIVAN JD, 1973, BIOCHEM J, V134, P209, DOI 10.1042/bj1340209; MEIJER AJ, 1972, BIOCHIM BIOPHYS ACTA, V283, P421, DOI 10.1016/0005-2728(72)90259-9; MEIJER AJ, 1981, MITOCHONDRIA MUSCULA, P97; MEYER J, 1973, BIOCHIM BIOPHYS ACTA, V325, P375, DOI 10.1016/0005-2728(73)90198-9; NECKELMANN N, 1987, P NATL ACAD SCI USA, V84, P7580, DOI 10.1073/pnas.84.21.7580; Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3; PALMIERI F, 1994, FEBS LETT, V346, P48, DOI 10.1016/0014-5793(94)00329-7; Palmieri Ferdinando, 1999, P489; Palmieri L, 1999, J BIOL CHEM, V274, P22184, DOI 10.1074/jbc.274.32.22184; Palmieri L, 1997, FEBS LETT, V417, P114, DOI 10.1016/S0014-5793(97)01269-6; Palmieri L, 1996, FEBS LETT, V399, P299, DOI 10.1016/S0014-5793(96)01350-6; Palmieri L, 1997, FEBS LETT, V410, P447, DOI 10.1016/S0014-5793(97)00630-3; Palmieri L, 2001, EMBO J, V20, P5049, DOI 10.1093/emboj/20.18.5049; Palmieri L, 2001, J BIOL CHEM, V276, P1916, DOI 10.1074/jbc.M004332200; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; POWELL SJ, 1989, BIOCHEMISTRY-US, V28, P866, DOI 10.1021/bi00428a069; SCHLERF A, 1988, EMBO J, V7, P2387, DOI 10.1002/j.1460-2075.1988.tb03083.x; SCHOOLWERTH AC, 1983, J BIOL CHEM, V258, P1735; SEELAN RS, 1991, J BIOL CHEM, V266, P19752; TARVER H, 1963, LIVER, V1, P474; Walker J.E., 1992, CURR OPIN STRUC BIOL, V2, P519, DOI DOI 10.1016/0959-440X(92)90081-H	41	156	162	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19289	19294		10.1074/jbc.M201572200	http://dx.doi.org/10.1074/jbc.M201572200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11897791	hybrid			2022-12-27	WOS:000175894800008
J	Gilboa, R; Zharkov, DO; Golan, G; Fernandes, AS; Gerchman, SE; Matz, E; Kycia, JH; Grollman, AP; Shoham, G				Gilboa, R; Zharkov, DO; Golan, G; Fernandes, AS; Gerchman, SE; Matz, E; Kycia, JH; Grollman, AP; Shoham, G			Structure of formamidopyrimidine-DNA glycosylase covalently complexed to DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-EXCISION-REPAIR; OXIDATIVELY DAMAGED DNA; ALDEHYDIC ABASIC SITES; COLI FPG PROTEIN; ESCHERICHIA-COLI; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; BETA-ELIMINATION; MOLECULAR-REPLACEMENT; ENDONUCLEASE-VIII	Formamidopyrimidine-DNA glycosylase (Fpg) is a DNA repair enzyme that excises oxidized purines from damaged DNA. The Schiff base intermediate formed during this reaction between Escherichia coli Fpg and DNA was trapped by reduction with sodium borohydride, and the structure of the resulting covalently cross-linked complex was determined at a 2.1-Angstrom resolution. Fpg is a bilobal protein with a wide, positively charged DNA-binding groove. It possesses a conserved zinc finger and a helix-two turn-helix motif that participate in DNA binding. The absolutely conserved residues Lys-56, His-70, Asn-168, and Arg-258 form hydrogen bonds to the phosphodiester backbone of DNA, which is sharply kinked at the lesion site. Residues Met-73, Arg-109, and Phe-110 are inserted into the DNA helix, filling the void created by nucleotide eversion. A deep hydrophobic pocket in the active site is positioned to accommodate an everted base. Structural analysis of the Fpg-DNA complex reveals essential features of damage recognition and the catalytic mechanism of Fpg.	SUNY Stony Brook, Dept Pharmacol Sci, Biol Chem Lab, Stony Brook, NY 11794 USA; Hebrew Univ Jerusalem, Dept Inorgan Chem, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Lab Struct Chem & Biol, IL-91904 Jerusalem, Israel; Russian Acad Sci, Siberian Div, Novosibirsk Inst Bioorgan Chem, Novosibirsk 630090, Russia; Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; United States Department of Energy (DOE); Brookhaven National Laboratory	Grollman, AP (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, Biol Chem Lab, Stony Brook, NY 11794 USA.		Zharkov, Dmitry/K-2158-2012	Zharkov, Dmitry/0000-0001-5013-0194	NATIONAL CANCER INSTITUTE [R01CA017395, P01CA047995, R37CA017395] Funding Source: NIH RePORTER; NCI NIH HHS [CA47995, CA17395] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Bhagwat M, 1996, BIOCHEMISTRY-US, V35, P659, DOI 10.1021/bi9522662; BODEPUDI V, 1992, CHEM RES TOXICOL, V5, P608, DOI 10.1021/tx00029a004; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P46, DOI 10.1107/S0108767389009633; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Burrows CJ, 1998, CHEM REV, V98, P1109, DOI 10.1021/cr960421s; David SS, 1998, CHEM REV, V98, P1221, DOI 10.1021/cr980321h; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FERRIN TE, 1988, J MOL GRAPHICS, V6, P13, DOI 10.1016/0263-7855(88)80054-7; GERCHMAN SE, 1994, PROTEIN EXPRES PURIF, V5, P242, DOI 10.1006/prep.1994.1037; Hollis T, 2000, EMBO J, V19, P758, DOI 10.1093/emboj/19.4.758; Jiang DY, 1997, J BACTERIOL, V179, P3773, DOI 10.1128/jb.179.11.3773-3782.1997; Jiang DY, 1997, J BIOL CHEM, V272, P32230, DOI 10.1074/jbc.272.51.32230; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KOUCHAKDJIAN M, 1991, BIOCHEMISTRY-US, V30, P1403, DOI 10.1021/bi00219a034; KRAULIS P, 1991, J APPL CRYSTALLOGR, V4, P946; Kuznetsov SV, 1998, EUR J BIOCHEM, V253, P413, DOI 10.1046/j.1432-1327.1998.2530413.x; Lau AY, 1998, CELL, V95, P249, DOI 10.1016/S0092-8674(00)81755-9; Lavrukhin OV, 2000, BIOCHEMISTRY-US, V39, P15266, DOI 10.1021/bi001587x; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; LU XJ, 1997, J MOL BIOL, V300, P505; MAZUMDER A, 1991, BIOCHEMISTRY-US, V30, P1119, DOI 10.1021/bi00218a033; MAZUMDER A, 1989, J AM CHEM SOC, V111, P8029, DOI 10.1021/ja00202a062; McCullough AK, 1999, ANNU REV BIOCHEM, V68, P255, DOI 10.1146/annurev.biochem.68.1.255; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MICHAELS ML, 1992, BIOCHEMISTRY-US, V31, P10964, DOI 10.1021/bi00160a004; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; MORIYA M, 1993, P NATL ACAD SCI USA, V90, P1122, DOI 10.1073/pnas.90.3.1122; MORIYA M, 1991, MUTAT RES, V254, P281, DOI 10.1016/0921-8777(91)90067-Y; Nash HM, 1996, CURR BIOL, V6, P968, DOI 10.1016/S0960-9822(02)00641-3; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Norman DPG, 2001, J AM CHEM SOC, V123, P359, DOI 10.1021/ja003144m; OCONNOR TR, 1993, J BIOL CHEM, V268, P9063; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Rabow LE, 1997, BIOCHEMISTRY-US, V36, P5084, DOI 10.1021/bi963005a; Rieger RA, 2000, J AM SOC MASS SPECTR, V11, P505, DOI 10.1016/S1044-0305(00)00117-3; Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Sidorkina OM, 1998, NUCLEIC ACIDS RES, V26, P5351, DOI 10.1093/nar/26.23.5351; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; Sugahara M, 2000, EMBO J, V19, P3857, DOI 10.1093/emboj/19.15.3857; TAJIRI T, 1995, MUTAT RES-DNA REPAIR, V336, P257, DOI 10.1016/0921-8777(94)00062-B; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; TCHOU J, 1995, J BIOL CHEM, V270, P11671, DOI 10.1074/jbc.270.19.11671; TCHOU J, 1994, J BIOL CHEM, V269, P15318; TCHOU J, 1991, P NATL ACAD SCI USA, V88, P4690, DOI 10.1073/pnas.88.11.4690; TCHOU J, 1993, J BIOL CHEM, V268, P26738; THAYER MM, 1995, EMBO J, V14, P4108, DOI 10.1002/j.1460-2075.1995.tb00083.x; TONG L, 1993, J APPL CRYSTALLOGR, V26, P748, DOI 10.1107/S0021889893005631; TONG L, 1990, ACTA CRYSTALLOGR A, V46, P783, DOI 10.1107/S0108767390005530; van Aalten DMF, 1999, P NATL ACAD SCI USA, V96, P11809, DOI 10.1073/pnas.96.21.11809; Von Sonntag C, 1987, CHEM BASIS RAD BIOL; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Werner RM, 2000, BIOCHEMISTRY-US, V39, P12585, DOI 10.1021/bi001532v; Zharkov DO, 2000, J BIOL CHEM, V275, P28607, DOI 10.1074/jbc.M002441200; Zharkov DO, 1997, J BIOL CHEM, V272, P5335, DOI 10.1074/jbc.272.8.5335; Zharkov DO, 2002, EMBO J, V21, P789, DOI 10.1093/emboj/21.4.789; Zharkov DO, 2002, FREE RADICAL BIO MED, V32, P1254, DOI 10.1016/S0891-5849(02)00828-6	62	210	221	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19811	19816		10.1074/jbc.M202058200	http://dx.doi.org/10.1074/jbc.M202058200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11912217	hybrid			2022-12-27	WOS:000175894800075
J	Szweras, M; Liu, DM; Partridge, EA; Pawling, J; Sukhu, B; Clokie, C; Jahnen-Dechent, W; Tenenbaum, HC; Swallow, CJ; Grynpas, MD; Dennis, JW				Szweras, M; Liu, DM; Partridge, EA; Pawling, J; Sukhu, B; Clokie, C; Jahnen-Dechent, W; Tenenbaum, HC; Swallow, CJ; Grynpas, MD; Dennis, JW			alpha 2-HS glycoprotein/fetuin, a transforming growth factor-beta/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOPOROSIS-LIKE PHENOTYPE; FACTOR-BETA; TGF-BETA; TARGETED DISRUPTION; GROWTH-FACTOR-BETA-1 GENE; MATRIX PROTEINS; MICE LACKING; MOUSE; OSTEOGENESIS; TGF-BETA-1	Soluble transforming growth factor-beta (TGF-beta)/bone morphogenetic protein (BMP)-binding proteins are widely distributed in mammalian tissues and control cytokine access to membrane signaling receptors. The serum and bone-resident glycoprotein alpha2-HS-glycoprotein/fetuin (ASHG) binds to TGF-beta/BMP cytokines and blocks TGF-beta1 binding to cell surface receptors. Therefore, we examined bone growth and remodeling phenotypes in ASHG-deficient mice. The skeletal structure of Ahsg(-/-) mice appeared normal at birth, but abnormalities were observed in adult Ahsg(-/-) mice. Maturation of growth plate chondrocytes was impaired, and femurs lengthened more slowly between 3 and 18 months of age in Ahsg(-/-) mice. However, bone formation was increased in Ahsg(-/-) mice as indicated by greater cortical thickness, accelerated trabecular bone remodeling, and increased osteoblast numbers on bone surfaces. The normal age-related increase in cortical thickness and bone mineral density was accelerated in Ahsg(-/-) mice and was associated with increased energy required to fracture. Bone formation in response to implanted BMP cytokine extended further from the implant in Ahsg(-/-) compared with Ahsg(+/+) mice, confirming the interaction between ASHG and TGF-beta/BMP cytokines in vivo. Our results demonstrate that ASHG blocks TGF-beta-dependent signaling in osteoblastic cells, and mice lacking ASHG display growth plate defects, increased bone formation with age, and enhanced cytokine-dependent osteogenesis.	Mt Sinai Hosp, Samuel Lauenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Lab Med & Pathol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Dent, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Klinkum RWTH Aachen, IZKF, BIOMAT, D-52057 Aachen, Germany	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University of Toronto; University of Toronto; RWTH Aachen University; RWTH Aachen University Hospital	Dennis, JW (corresponding author), Mt Sinai Hosp, Samuel Lauenfeld Res Inst, Toronto, ON M5G 1X5, Canada.		Grynpas, Marc/ABG-7096-2020; Grynpas, Marc/E-4576-2013; Dennis, James/E-7268-2013; Jahnen-Dechent, Willi/A-7608-2011	Jahnen-Dechent, Willi/0000-0003-1315-4407				AKHOUNDI C, 1994, J BIOL CHEM, V269, P15925; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; ASHTON BA, 1980, CLIN SCI, V58, P435, DOI 10.1042/cs0580435; Bailon-Plaza A, 1999, BONE, V24, P211, DOI 10.1016/S8756-3282(98)00171-9; BALLOCK RT, 1993, DEV BIOL, V158, P414, DOI 10.1006/dbio.1993.1200; Barkai N, 1998, NATURE, V396, P422, DOI 10.1038/24760; Binkert C, 1999, J BIOL CHEM, V274, P28514, DOI 10.1074/jbc.274.40.28514; BORDER WA, 1992, J CLIN INVEST, V90, P1, DOI 10.1172/JCI115821; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; CENTRELLA M, 1991, J BONE JOINT SURG AM, V73A, P1418, DOI 10.2106/00004623-199173090-00022; Cui W, 1996, CELL, V86, P531, DOI 10.1016/S0092-8674(00)80127-0; Daluiski A, 2001, NAT GENET, V27, P84, DOI 10.1038/83810; Demetriou M, 1996, J BIOL CHEM, V271, P12755, DOI 10.1074/jbc.271.22.12755; DICKSON IR, 1975, NATURE, V256, P430, DOI 10.1038/256430a0; DICKSON IR, 1983, CALCIFIED TISSUE INT, V35, P16, DOI 10.1007/BF02405000; Erlebacher A, 1998, MOL BIOL CELL, V9, P1903, DOI 10.1091/mbc.9.7.1903; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Filvaroff E, 1999, DEVELOPMENT, V126, P4267; Gazit D, 1998, J CELL BIOCHEM, V70, P478, DOI 10.1002/(SICI)1097-4644(19980915)70:4<478::AID-JCB5>3.0.CO;2-G; Geiser AG, 1998, BONE, V23, P87, DOI 10.1016/S8756-3282(98)00078-7; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Huiskes R, 2000, NATURE, V405, P704, DOI 10.1038/35015116; JahnenDechent W, 1997, J BIOL CHEM, V272, P31496, DOI 10.1074/jbc.272.50.31496; Ji XH, 2000, J BONE MINER METAB, V18, P132, DOI 10.1007/s007740050103; JILKA RL, 1992, SCIENCE, V257, P88, DOI 10.1126/science.1621100; Jones CM, 1998, DEV BIOL, V194, P12, DOI 10.1006/dbio.1997.8752; JOYCE ME, 1990, J CELL BIOL, V110, P2195, DOI 10.1083/jcb.110.6.2195; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; KELLERMANN J, 1989, J BIOL CHEM, V264, P14121; LEBRETON JP, 1979, J CLIN INVEST, V64, P118; LOPEZCASILLAS F, 1994, J CELL BIOL, V124, P557, DOI 10.1083/jcb.124.4.557; Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486; MIZUTANI H, 1982, CLIN ORTHOP RELAT R, P213; Neumann C, 1997, BIOESSAYS, V19, P721, DOI 10.1002/bies.950190813; OCONNORMCCOURT MD, 1987, J BIOL CHEM, V262, P14090; PARFITT AM, 2000, J BONE MINER RES, V2, P597; Pedersen KO, 1944, NATURE, V154, P575, DOI 10.1038/154575a0; PELTON RW, 1991, J CELL BIOL, V115, P1091, DOI 10.1083/jcb.115.4.1091; Pfeilschifter J, 1998, J BONE MINER RES, V13, P716, DOI 10.1359/jbmr.1998.13.4.716; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; PINERO GJ, 1995, ARCH ORAL BIOL, V40, P145, DOI 10.1016/0003-9969(94)00144-Z; Saito T, 2001, J BIOL CHEM, V276, P11469, DOI 10.1074/jbc.C000859200; Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789; SCHNEYER AL, 1994, ENDOCRINOLOGY, V135, P667, DOI 10.1210/en.135.2.667; SEBETAN IM, 1988, Z RECHTSMED, V101, P205; SHAH M, 1995, J CELL SCI, V108, P985; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; VILLANUEVA AR, 1988, J HISTOTECHNOL, V11, P249, DOI 10.1179/his.1988.11.4.249; Webb DJ, 1996, J BIOL CHEM, V271, P24982, DOI 10.1074/jbc.271.40.24982; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746; Yamada Y, 1998, J BONE MINER RES, V13, P1569, DOI 10.1359/jbmr.1998.13.10.1569; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Zmuda JM, 1998, CALCIFIED TISSUE INT, V63, P5, DOI 10.1007/s002239900481	55	181	186	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19991	19997		10.1074/jbc.M112234200	http://dx.doi.org/10.1074/jbc.M112234200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11901155	hybrid			2022-12-27	WOS:000175894800099
J	Wang, WJ; Russo, SJ; Mulugeta, S; Beers, MF				Wang, WJ; Russo, SJ; Mulugeta, S; Beers, MF			Biosynthesis of surfactant protein C (SP-C) - Sorting of SP-C proprotein involves homomeric association via a signal anchor domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID FIBRIL FORMATION; DISULFIDE-BONDED LOOP; TRANS-GOLGI NETWORK; PULMONARY SURFACTANT; CHROMOGRANIN-B; MEMBRANE-PROTEIN; II CELLS; RAT; EXPRESSION; CONTAINS	Rat surfactant protein C (SP-C) is synthesized as a 194-amino acid propeptide (SP-C-(1-194)) that is directed to the distal secretory pathway and proteolytically processed as an integral membrane protein to yield its mature form. We had shown previously that trafficking of proSP-C is mediated both by a signal anchor domain contained within the mature SP-C sequence and by a targeting domain in the NH2-flanking propeptide. Based on evidence from other integral membrane proteins, we hypothesized that proSP-C targeting is effected by oligomerization of proSP-C monomers. To evaluate this in vitro, cDNA constructs encoding for either wild type proSP-C (peDNA3/SP-C(1-194)) or heterologous fusion proteins containing green fluorescent protein (EGFP) linked to SP-C-(1-194) (EGFP/SP-C-(1-194)), to mutant proSP-C lacking the NH2 targeting domain (EGFP/SP-C-(24-194)), or to mature SP-C alone (EGFP/SP-C-(24-58)) were produced. In transfected A549 cells, fluorescence microscopy revealed that peDNA3/SP-C-(1-194) and EGFP/SP-C-(1-194) were each expressed in CD63 (+), EEA1 (-) cytoplasmic vesicles. Expression of EGFP/SP-C-(24194) or EGFP/SP-C-(24-58) resulted in translocation but retention in early compartments. When cotransfected with pcDNA3/SP-C-(1-194), both EGFP/SPC-(24-194) and EGFP/SP-C-(24-58) were directed to CD63 (+) vesicles that also contained SP-C-(1-194). In contrast, trafficking of a folding mutant that forms juxtanuclear aggregates, EGFP/SP-C-C122/186G, was not corrected by cotransfection with pcDNA3/SP-C-(1-194). Chemical cross-linking studies of transfected cell lysates with bismaleimidohexane produced multimeric forms of both EGFP/SP-C-(1-194) and EGFP/SP-C-(24-58). These results indicate that sorting involves oligomeric association of proSP-C monomers mediated by the mature SP-C domain. Heteromeric assembly allows wild type proSP-C to facilitate trafficking of SP-C mutants with intact transmembrane domains but lacking targeting signals. We speculate that heterotypic oligomerization of wild type with SP-C folding mutants produces a dominant negative thus contributing to the pathology of chronic lung disease associated with patients heterozygous for mutant SP-C alleles.	Univ Penn, Sch Med, Div Pulm & Crit Care, Lung Epithelial Cell Biol Labs,Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Beers, MF (corresponding author), Univ Penn, Sch Med, Div Pulm & Crit Care, Lung Epithelial Cell Biol Labs,Dept Med, 807 BRB 2-3 Bldg,421 Curie Blvd, Philadelphia, PA 19104 USA.	mfbeers@mail.med.upenn.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL019737, P50HL056401] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL19737, P50-HL56401] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aridor M, 2000, TRAFFIC, V1, P836, DOI 10.1034/j.1600-0854.2000.011104.x; Ausbel F.M., 1995, CURRENT PROTOCOLS MO; Beers M. F., 1998, MED INTELL UNIT, P93; Beers MF, 1998, J BIOL CHEM, V273, P15287, DOI 10.1074/jbc.273.24.15287; BEERS MF, 1994, J BIOL CHEM, V269, P20318; Carrell RW, 2002, NEW ENGL J MED, V346, P45, DOI 10.1056/NEJMra010772; CHANAT E, 1993, EMBO J, V12, P2159, DOI 10.1002/j.1460-2075.1993.tb05864.x; Conkright JJ, 2002, AM J RESP CELL MOL, V26, P85, DOI 10.1165/ajrcmb.26.1.4686; Conkright JJ, 2001, J BIOL CHEM, V276, P14658, DOI 10.1074/jbc.M011770200; Cowley DJ, 2000, J BIOL CHEM, V275, P7743, DOI 10.1074/jbc.275.11.7743; CREUWELS LAJM, 1995, BBA-LIPID LIPID MET, V1254, P326, DOI 10.1016/0005-2760(94)00195-5; FISHER JH, 1989, BIOCHIM BIOPHYS ACTA, V995, P225, DOI 10.1016/0167-4838(89)90040-X; Glasser SW, 2001, P NATL ACAD SCI USA, V98, P6366, DOI 10.1073/pnas.101500298; Glombik MM, 1999, EMBO J, V18, P1059, DOI 10.1093/emboj/18.4.1059; Gobran LI, 2001, AM J PHYSIOL-LUNG C, V281, pL1413, DOI 10.1152/ajplung.2001.281.6.L1413; Gow A, 1996, NAT GENET, V13, P422, DOI 10.1038/ng0896-422; Gustafsson M, 1999, FEBS LETT, V464, P138, DOI 10.1016/S0014-5793(99)01692-0; Johansson J, 1997, EUR J BIOCHEM, V244, P675, DOI 10.1111/j.1432-1033.1997.00675.x; Johansson J, 2001, BIOCHEM SOC T, V29, P601, DOI 10.1042/BST0290601; JOHANSSON J, 1994, BIOCHEMISTRY-US, V33, P6015, DOI 10.1021/bi00185a042; Johnson AL, 2001, AM J RESP CELL MOL, V24, P253, DOI 10.1165/ajrcmb.24.3.4312; Kabore AF, 2001, J CELL SCI, V114, P293; KELLER A, 1992, AM J RESP CELL MOL, V6, P601, DOI 10.1165/ajrcmb/6.6.601; KELLER A, 1991, BIOCHEM J, V277, P493, DOI 10.1042/bj2770493; Kim PS, 1998, ENDOCR REV, V19, P173, DOI 10.1210/er.19.2.173; Kromer A, 1998, J CELL BIOL, V140, P1331, DOI 10.1083/jcb.140.6.1331; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATHIALAGAN N, 1990, BIOCHIM BIOPHYS ACTA, V1045, P121, DOI 10.1016/0005-2760(90)90140-S; Millar DG, 1996, J BIOL CHEM, V271, P25823, DOI 10.1074/jbc.271.42.25823; MILLAR DG, 1994, J BIOL CHEM, V269, P12229; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Nogee LM, 2001, NEW ENGL J MED, V344, P573, DOI 10.1056/NEJM200102223440805; Notterpek L, 1999, NEUROBIOL DIS, V6, P450, DOI 10.1006/nbdi.1999.0274; Russo SJ, 1999, AM J PHYSIOL-LUNG C, V277, pL1034, DOI 10.1152/ajplung.1999.277.5.L1034; Solarin KO, 2001, PEDIATR PATHOL MOL M, V20, P471; Solarin KO, 1997, PEDIATR RES, V42, P356, DOI 10.1203/00006450-199709000-00017; Tobler AR, 1999, J NEUROSCI, V19, P2027; VANDENBUSSCHE G, 1992, EUR J BIOCHEM, V203, P201, DOI 10.1111/j.1432-1033.1992.tb19848.x; VOORHOUT WF, 1992, AM J PHYSIOL, V263, pL479, DOI 10.1152/ajplung.1992.263.4.L479; VOORHOUT WF, 1993, MICROSC RES TECHNIQ, V26, P366, DOI 10.1002/jemt.1070260504; Vorbroker DK, 1995, AM J PHYSIOL-LUNG C, V269, pL727, DOI 10.1152/ajplung.1995.269.6.L727; Weaver TE, 2001, ANNU REV PHYSIOL, V63, P555, DOI 10.1146/annurev.physiol.63.1.555; YOO SH, 1993, BIOCHEMISTRY-US, V32, P8816, DOI 10.1021/bi00085a012	43	47	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19929	19937		10.1074/jbc.M201537200	http://dx.doi.org/10.1074/jbc.M201537200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11907042	hybrid			2022-12-27	WOS:000175894800091
J	Yahagi, N; Shimano, H; Hasty, AH; Matsuzaka, T; Ide, T; Yoshikawa, T; Amemiya-Kudo, M; Tomita, S; Okazaki, H; Tamura, Y; Iizuka, Y; Ohashi, K; Osuga, J; Harada, K; Gotoda, T; Nagai, R; Ishibashi, S; Yamada, N				Yahagi, N; Shimano, H; Hasty, AH; Matsuzaka, T; Ide, T; Yoshikawa, T; Amemiya-Kudo, M; Tomita, S; Okazaki, H; Tamura, Y; Iizuka, Y; Ohashi, K; Osuga, J; Harada, K; Gotoda, T; Nagai, R; Ishibashi, S; Yamada, N			Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; ADIPOSE-TISSUE; TRANSCRIPTION FACTOR; TRANSGENIC MICE; CHOLESTEROL-SYNTHESIS; TARGETED DISRUPTION; DIABETES-MELLITUS; ACID SYNTHESIS; MOUSE; DIFFERENTIATION	Obesity is a common nutritional problem often associated with diabetes, insulin resistance, and fatty liver (excess fat deposition in liver). Leptin-deficient Lep(ob)/Lep(ob) mice develop obesity and those obesity-related syndromes. Increased lipogenesis in both liver and adipose tissue of these mice has been suggested. We have previously shown that the transcription factor sterol regulatory element-binding protein-1 (SREBP-1) plays a crucial role in the regulation of lipogenesis in vivo. To explore the possible involvement of SREBP-1 in the pathogenesis of obesity and its related syndromes, we generated mice deficient in both leptin and SREBP-1. In doubly mutant Lep(ob/ob) x Srebp-1(-/-) mice, fatty livers were markedly attenuated, but obesity and insulin resistance remained persistent. The mRNA levels of lipogenic enzymes such as fatty acid synthase were proportional to triglyceride accumulation in liver. In contrast, the mRNA abundance of SREBP-1 and lipogenic enzymes in the adipose tissue of Lep(ob)/Lep(ob) mice was profoundly decreased despite sustained fat, which could explain why the SREBP-1 disruption had little effect on obesity. In conclusion, SREBP-1 regulation of lipogenesis is highly involved in the development of fatty livers but does not seem to be a determinant of obesity in Lep(ob)/Lep(ob) mice.	Univ Tsukuba, Inst Clin Med, Dept Internal Med, Tsukuba, Ibaraki 3058575, Japan; Univ Tokyo, Grad Sch Med, Dept Internal Med, Tokyo 1138655, Japan	University of Tsukuba; University of Tokyo	Shimano, H (corresponding author), Univ Tsukuba, Inst Clin Med, Dept Internal Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.		Shimano, Hitoshi/AAI-5648-2020; Yahagi, Naoya/D-2360-2014; Shimano, Hitoshi/V-1761-2019; Hasty, Alyssa/AAA-2757-2020	Yahagi, Naoya/0000-0002-1823-1865; Shimano, Hitoshi/0000-0002-5562-5572; Hasty, Alyssa/0000-0001-7302-8045				BRAY GA, 1979, PHYSIOL REV, V59, P719, DOI 10.1152/physrev.1979.59.3.719; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; CLANDININ MT, 1996, LIPIDS, V31, P13, DOI DOI 10.1007/BF02637045; Flier JS, 1999, P NATL ACAD SCI USA, V96, P14191, DOI 10.1073/pnas.96.25.14191; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; HEMS DA, 1975, BIOCHEM J, V150, P167, DOI 10.1042/bj1500167; HERBERG L, 1977, METABOLISM, V26, P59, DOI 10.1016/0026-0495(77)90128-7; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; INGALLS AM, 1950, J HERED, V41, P317, DOI 10.1093/oxfordjournals.jhered.a106073; KAPLAN ML, 1981, AM J PHYSIOL, V240, pE101, DOI 10.1152/ajpendo.1981.240.2.E101; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205; Lee J H, 1998, Korean J Intern Med, V13, P12; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; MAYER J, 1951, SCIENCE, V113, P746, DOI 10.1126/science.113.2948.746; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Schoonjans K, 2000, J MOL BIOL, V304, P323, DOI 10.1006/jmbi.2000.4218; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Shimomura I, 1998, J BIOL CHEM, V273, P35299, DOI 10.1074/jbc.273.52.35299; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Soukas A, 2000, GENE DEV, V14, P963; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; Weinstock PH, 1997, P NATL ACAD SCI USA, V94, P10261, DOI 10.1073/pnas.94.19.10261; YOKODE M, 1990, SCIENCE, V250, P1273, DOI 10.1126/science.2244210; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	38	281	289	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19353	19357		10.1074/jbc.M201584200	http://dx.doi.org/10.1074/jbc.M201584200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11923308	hybrid			2022-12-27	WOS:000175894800016
J	Rigourd, M; Ehresmann, C; Parniak, MA; Ehresmann, B; Marquet, R				Rigourd, M; Ehresmann, C; Parniak, MA; Ehresmann, B; Marquet, R			Primer unblocking and rescue of DNA synthesis by azidothymidine (AZT)-resistant HIV-1 reverse transcriptase - Comparison between initiation and elongation of reverse transcription and between (-) and (+) strand DNA synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-LEVEL RESISTANCE; 3'-AZIDO-3'-DEOXYTHYMIDINE AZT; ZIDOVUDINE AZT; MECHANISM; MUTATION; SENSITIVITY; RNA; POLYMERIZATION; REPLICATION; INHIBITION	Azidothymidine (AZT) is a widely used inhibitor of type 1 human immunodeficiency virus reverse transcriptase (RT) that acts as chain terminator. Upon treatment, mutations conferring AZT resistance to RT are gradually selected. It has been shown that resistant RT is able to unblock the AZT-terminated primer by an ATP-dependent mechanism. However, this resistance mechanism has only been demonstrated for DNA-dependent DNA elongation. Here, we compared the AZT resistance of mutant RT during DNA elongation on DNA and RNA templates. We showed that, during DNA elongation, primer unblocking and rescue of DNA synthesis take place with similar rate constants on DNA and RNA templates. However, the fraction of a primer eventually repaired during RNA-dependent DNA synthesis is 2x lower compared with that of DNA-dependent synthesis, leading to reduced resistance. We also compared the initiation of reverse transcription, which uses tRNA(Lys) as a primer and displays characteristic kinetic features, and the subsequent RNA-dependent elongation. Unlike during elongation, resistant RT was unable to unblock the AZT-terminated primer during initiation of (-) DNA strand synthesis. Our results demonstrate that the efficiency of primer unblocking conferred by the AZT resistance mutations greatly vary during the different steps of the provirus synthesis. These results also suggest that inhibitors specifically targeting the initiation of reverse transcription might prove to be advantageous, as compared with elongation inhibitors.	Inst Biol Mol & Cellulaire, CNRS, Unite Propre Rech 9002, F-67084 Strasbourg, France; Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Lady Davis Institute; McGill University	Marquet, R (corresponding author), Inst Biol Mol & Cellulaire, CNRS, Unite Propre Rech 9002, 15 Rue Rene Descartes, F-67084 Strasbourg, France.			Marquet, Roland/0000-0002-4209-3976				Arion D, 1998, BIOCHEMISTRY-US, V37, P15908, DOI 10.1021/bi981200e; Arts EJ, 1996, J VIROL, V70, P712, DOI 10.1128/JVI.70.2.712-720.1996; Balzarini J, 1996, METHOD ENZYMOL, V275, P472; Benas P, 2000, RNA, V6, P1347, DOI 10.1017/S1355838200000911; Canard B, 1998, J BIOL CHEM, V273, P14596, DOI 10.1074/jbc.273.23.14596; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; CARROLL SS, 1994, BIOCHEMISTRY-US, V33, P2113, DOI 10.1021/bi00174a018; *CDCP, 1999, HIV AIDS SURVEILLANC, V11, P1; FRICK LW, 1988, BIOCHEM BIOPH RES CO, V154, P124, DOI 10.1016/0006-291X(88)90659-6; FURMAN PA, 1986, P NATL ACAD SCI USA, V83, P8333, DOI 10.1073/pnas.83.21.8333; GAO Q, 1993, ANTIMICROB AGENTS CH, V37, P1390, DOI 10.1128/AAC.37.6.1390; GAO WY, 1993, P NATL ACAD SCI USA, V90, P8925, DOI 10.1073/pnas.90.19.8925; Gotte M, 2000, J VIROL, V74, P3579, DOI 10.1128/JVI.74.8.3579-3585.2000; GU ZX, 1994, ANTIMICROB AGENTS CH, V38, P275, DOI 10.1128/AAC.38.2.275; ISEL C, 1993, J BIOL CHEM, V268, P25269; Isel C, 1999, EMBO J, V18, P1038, DOI 10.1093/emboj/18.4.1038; ISEL C, 1995, J MOL BIOL, V247, P236, DOI 10.1006/jmbi.1994.0136; Isel C, 1996, EMBO J, V15, P917, DOI 10.1002/j.1460-2075.1996.tb00426.x; Isel C, 2001, J BIOL CHEM, V276, P48725, DOI 10.1074/jbc.M108352200; KATI WM, 1992, J BIOL CHEM, V267, P25988; KELLAM P, 1992, P NATL ACAD SCI USA, V89, P1934, DOI 10.1073/pnas.89.5.1934; Kerr SG, 1997, BIOCHEMISTRY-US, V36, P14056, DOI 10.1021/bi971385+; Kerr SG, 1997, BIOCHEMISTRY-US, V36, P14064, DOI 10.1021/bi9713862; Krebs R, 1997, BIOCHEMISTRY-US, V36, P10292, DOI 10.1021/bi970512z; LACEY SF, 1992, J BIOL CHEM, V267, P15789; Lanchy JM, 1998, J BIOL CHEM, V273, P24425, DOI 10.1074/jbc.273.38.24425; Lanchy JM, 1996, EMBO J, V15, P7178, DOI 10.1002/j.1460-2075.1996.tb01109.x; LARDER BA, 1991, J VIROL, V65, P5232, DOI 10.1128/JVI.65.10.5232-5236.1991; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; LARDER BA, 1989, SCIENCE, V246, P1155, DOI 10.1126/science.2479983; MARQUET R, 1991, NUCLEIC ACIDS RES, V19, P2349, DOI 10.1093/nar/19.9.2349; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 2000, ANTIMICROB AGENTS CH, V44, P3465, DOI 10.1128/AAC.44.12.3465-3472.2000; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; MUNIS JR, 1992, J GEN VIROL, V73, P1899, DOI 10.1099/0022-1317-73-8-1899; REARDON JE, 1993, J BIOL CHEM, V268, P8743; Rigourd M, 2000, J BIOL CHEM, V275, P26944; SCHINAZI RF, 1993, ANTIMICROB AGENTS CH, V37, P875, DOI 10.1128/AAC.37.4.875; SRIVASTAVA KK, 1991, J VIROL, V65, P3900, DOI 10.1128/JVI.65.7.3900-3902.1991; STCLAIR MH, 1991, SCIENCE, V253, P1557, DOI 10.1126/science.1716788; TISDALE M, 1993, P NATL ACAD SCI USA, V90, P5653, DOI 10.1073/pnas.90.12.5653; Victorova L, 1999, FEBS LETT, V453, P6, DOI 10.1016/S0014-5793(99)00615-8; ZHANG D, 1994, ANTIMICROB AGENTS CH, V38, P282, DOI 10.1128/AAC.38.2.282	43	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					18611	18618		10.1074/jbc.M110836200	http://dx.doi.org/10.1074/jbc.M110836200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11901149	hybrid			2022-12-27	WOS:000175975800050
J	Grolleau, A; Bowman, J; Pradet-Balade, B; Puravs, E; Hanash, S; Garcia-Sanz, JA; Beretta, L				Grolleau, A; Bowman, J; Pradet-Balade, B; Puravs, E; Hanash, S; Garcia-Sanz, JA; Beretta, L			Global and specific translational control by rapamycin in T cells uncovered by microarrays and proteomics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; MESSENGER-RNA; INTERNAL INITIATION; PROTEASOME ACTIVITY; PROTHYMOSIN-ALPHA; INTERLEUKIN-2 STIMULATION; SACCHAROMYCES-CEREVISIAE; PROTEIN-SYNTHESIS; EXPRESSION; ACTIVATION	Rapamycin has been shown to affect translation. We have utilized two complementary approaches to identify genes that are predominantly affected by rapamycin in Jurkat T cells. One was to compare levels of polysome-bound and total RNA using oligonucleotide microarrays complementary to 6,300 human genes. Another was to determine protein synthesis levels using two-dimensional PAGE. Analysis of expression changes at the polysome-bound RNA levels showed that translation of most of the expressed genes was partially reduced following rapamycin treatment. However, translation of 136 genes (6% of the expressed genes) was totally inhibited. This group included genes encoding RNA-binding proteins and several proteasome subunit members. Translation of a set of 159 genes (7%) was largely unaffected by rapamycin treatment. These genes included transcription factors, kinases, phosphatases, and members of the RAS superfamily. Analysis of [S-35]methionine-labeled proteins from the same cell populations using two-dimensional PAGE showed that the integrated intensity of 111 of 830 protein spots changed in rapamycin-treated cells by at least 3-fold (70 increased, 41 decreased). We identified 22 affected protein spots representing protein products of 16 genes. The combined microarray and proteomic approach has uncovered novel genes affected by rapamycin that may be involved in its immunosuppressive effect and other genes that are not affected at the level of translation in a context of general inhibition of cap-dependent translation.	Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, E-28049 Madrid, Spain	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Beretta, L (corresponding author), Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.		Garcia-Sanz, Jose A/E-7684-2011; Garcia-Sanz, Jose A./AAA-2956-2019; Julius, Annabelle/A-7276-2010	Garcia-Sanz, Jose A/0000-0002-1153-6025; Garcia-Sanz, Jose A./0000-0002-1153-6025; Laura, Beretta/0000-0002-2054-684X	NIAID NIH HHS [1R01-AI50896] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050896] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abrieu A, 2000, CELL, V102, P817, DOI 10.1016/S0092-8674(00)00070-2; AJCHENBAUM F, 1993, J BIOL CHEM, V268, P4113; BAXEVANIS CN, 1988, IMMUNOPHARMACOLOGY, V15, P73, DOI 10.1016/0162-3109(88)90054-9; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Beretta L, 1996, J VIROL, V70, P8993, DOI 10.1128/JVI.70.12.8993-8996.1996; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; BUSTELO XR, 1991, J BIOL CHEM, V266, P1443; CALVO V, 1992, P NATL ACAD SCI USA, V89, P7571, DOI 10.1073/pnas.89.16.7571; CARLSON RP, 1993, ANN NY ACAD SCI, V685, P86, DOI 10.1111/j.1749-6632.1993.tb35855.x; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Coopman PJP, 2000, NATURE, V406, P742, DOI 10.1038/35021086; CORDERO OJ, 1992, LYMPHOKINE CYTOK RES, V11, P277; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; DUMONT FJ, 1990, J IMMUNOL, V144, P251; Forre O, 2000, SCAND J RHEUMATOL, V29, P73; FRUMAN DA, 1995, EUR J IMMUNOL, V25, P563, DOI 10.1002/eji.1830250239; GRUNBERG E, 1997, INT J THYMOL, V5, P415; HANASH SM, 1993, P NATL ACAD SCI USA, V90, P3314, DOI 10.1073/pnas.90.8.3314; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Horne MC, 1997, J BIOL CHEM, V272, P12650, DOI 10.1074/jbc.272.19.12650; IIZUKA N, 1994, MOL CELL BIOL, V14, P7322, DOI 10.1128/MCB.14.11.7322; Ingle GR, 2000, ANN PHARMACOTHER, V34, P1044, DOI 10.1345/aph.19380; Jackson RJ, 1995, RNA, V1, P985; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; JIANG W, 1997, P NATL ACAD SCI USA, V94, P133; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Kanaan N, 2001, J CELL BIOCHEM, V81, P347, DOI 10.1002/1097-4644(20010501)81:2<347::AID-JCB1049>3.0.CO;2-3; Kim TK, 1996, SCIENCE, V273, P1717, DOI 10.1126/science.273.5282.1717; KOLTIN Y, 1991, MOL CELL BIOL, V11, P1718, DOI 10.1128/MCB.11.3.1718; KUICK RD, 1991, ELECTROPHORESIS, V12, P736, DOI 10.1002/elps.1150121007; Le Naour F, 2001, J BIOL CHEM, V276, P17920, DOI 10.1074/jbc.M100156200; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; MACEJAK DG, 1991, NATURE, V353, P90, DOI 10.1038/353090a0; Marshansky V, 2001, J IMMUNOL, V166, P3130, DOI 10.4049/jimmunol.166.5.3130; Meyer S, 1997, FEBS LETT, V413, P354, DOI 10.1016/S0014-5793(97)00930-7; Mikulits W, 2000, FASEB J, V14, P1641, DOI 10.1096/fj.14.11.1641; MORRIS RE, 1991, IMMUNOL TODAY, V12, P137; MULLNER EW, 1997, MANUAL IMMUNOLOGICAL, P457; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Ponticelli C, 1999, Drugs R D, V1, P55, DOI 10.2165/00126839-199901010-00020; Pradet-Balade B, 2001, BIOTECHNIQUES, V30, P1352, DOI 10.2144/01306rr03; ROUAULT JP, 1992, EMBO J, V11, P1663, DOI 10.1002/j.1460-2075.1992.tb05213.x; Sakamuro D, 1996, NAT GENET, V14, P69, DOI 10.1038/ng0996-69; Sasaki T, 2000, NATURE, V406, P897, DOI 10.1038/35022585; Saunders RN, 2001, KIDNEY INT, V59, P3, DOI 10.1046/j.1523-1755.2001.00460.x; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; SEHGAL SN, 1975, J ANTIBIOT, V28, P727, DOI 10.7164/antibiotics.28.727; Sonenberg N, 1996, TRANSLATIONAL CONTRO, P245; STRAHLER JR, 1989, PROTEIN STRUCTURE PR, P65; Takagaki Y, 1998, MOL CELL, V2, P761, DOI 10.1016/S1097-2765(00)80291-9; Vuckovic-Dekic Ljiljana, 1997, International Journal of Thymology, V5, P399; Wang X, 1998, J IMMUNOL, V160, P788; Wang X, 1997, EUR J IMMUNOL, V27, P2781, DOI 10.1002/eji.1830271106; Yu AX, 2001, J BIOL CHEM, V276, P381, DOI 10.1074/jbc.M007991200; Yu CL, 1997, J BIOL CHEM, V272, P14017, DOI 10.1074/jbc.272.22.14017; Zong Q, 1999, P NATL ACAD SCI USA, V96, P10632, DOI 10.1073/pnas.96.19.10632	58	160	166	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22175	22184		10.1074/jbc.M202014200	http://dx.doi.org/10.1074/jbc.M202014200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11943782	hybrid			2022-12-27	WOS:000176313600011
J	Abeyrathne, PD; Lalev, AI; Nazar, RN				Abeyrathne, PD; Lalev, AI; Nazar, RN			A RAC protein-binding site in the internal transcribed spacer 2 of pre-rRNA transcripts from Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; STRUCTURAL FEATURES; FUNCTIONAL-ANALYSIS; DNA; SEQUENCE; COMPLEX; MUTAGENESIS; MATURATION; MRP	The interdependence of steps in the processing of the eukaryotic preribosomal rRNA transcripts indicate that rRNA processing, at least in part, acts as a quality control mechanism to help ensure that only functional rRNA is incorporated into mature ribosomes. In search of structural components that underlie this interdependence, we have isolated a large protein complex or RAC that contains an independent binding site for all four of the transcribed spacers in the nascent pre-rRNA. In this study the RAC-binding site in the internal transcribed spacer 2 sequence of Schizosaccharomyces pombe rRNA transcripts was identified, and the influence of this site on rRNA maturation was assessed. Modification exclusion analyses indicate that the protein complex interacts with a helical domain previously shown to contain features common to both the internal transcribed spacer 1 and the 3'-external transcribed spacer. Mutagenic analyses in vitro confirm an interaction with this sequence, and parallel analyses in vivo indicated a critical role in both the maturation of the rRNA components of the large subunit as well as the 18 S rRNA component of the small subunit. Hybridization analyses also indicated greatly elevated levels of unprocessed nascent RNA. These effects are contrasted with mutations in other regions of the secondary structure that resulted in some reduction of plasmid-derived mature rRNA but no elevated levels of the precursor molecules. The significance with respect to rRNA maturation and the interdependences in rRNA processing are discussed.	Univ Guelph, Dept Mol Biol & Genet, Guelph, ON N1G 2W1, Canada	University of Guelph	Nazar, RN (corresponding author), Univ Guelph, Dept Mol Biol & Genet, Guelph, ON N1G 2W1, Canada.	rnnazar@UoGuelph.CA						Abeyrathne PD, 2000, BIOTECHNIQUES, V29, P1172, DOI 10.2144/00296bm03; ABOUELELA S, 1995, BBA-GENE STRUCT EXPR, V1262, P164, DOI 10.1016/0167-4781(95)00074-Q; Allmang C, 2000, NUCLEIC ACIDS RES, V28, P1684, DOI 10.1093/nar/28.8.1684; BACHELLERIE JP, 1983, MOL BIOL REP, V9, P79, DOI 10.1007/BF00777477; Chaconas G, 1980, Methods Enzymol, V65, P75; Chamberlain JR, 1998, GENE DEV, V12, P1678, DOI 10.1101/gad.12.11.1678; CHOI YC, 1974, CELL NUCLEUS, V3, P109; ELELA SA, 1994, NUCLEIC ACIDS RES, V22, P686, DOI 10.1093/nar/22.4.686; GOOD L, 1992, NUCLEIC ACIDS RES, V20, P4934, DOI 10.1093/nar/20.18.4934; Good L, 1997, J MOL BIOL, V273, P782, DOI 10.1006/jmbi.1997.1351; Hitchen J, 1997, J MOL BIOL, V274, P481, DOI 10.1006/jmbi.1997.1376; Intine RVA, 1999, J MOL BIOL, V286, P695, DOI 10.1006/jmbi.1998.2502; Lalev AI, 1999, NUCLEIC ACIDS RES, V27, P3071, DOI 10.1093/nar/27.15.3071; Lalev AI, 2001, J BIOL CHEM, V276, P16655, DOI 10.1074/jbc.M101157200; Lalev AI, 1998, J MOL BIOL, V284, P1341, DOI 10.1006/jmbi.1998.2222; Lalev AI, 2000, J MOL BIOL, V302, P65, DOI 10.1006/jmbi.2000.4015; LEE Y, 1995, J BIOL CHEM, V270, P28003; Leupold U., 1970, METHODS CELL PHYSL, V4, P169; MELEKHOVETS YF, 1994, J MOL BIOL, V239, P170, DOI 10.1006/jmbi.1994.1361; MILLER OL, 1969, SCIENCE, V164, P955, DOI 10.1126/science.164.3882.955; MUSTERS W, 1990, RIBOSOME, P435; MUSTERS W, 1990, EMBO J, V9, P3989, DOI 10.1002/j.1460-2075.1990.tb07620.x; NAZAR RN, 1987, J BIOL CHEM, V262, P7523; NAZAR RN, 1982, CELL NUCLEUS, V11, P1; NAZAR RN, 1983, NUCLEIC ACIDS RES, V11, P3155, DOI 10.1093/nar/11.10.3155; PEATTIE DA, 1979, P NATL ACAD SCI USA, V76, P1760, DOI 10.1073/pnas.76.4.1760; PEATTIE DA, 1981, P NATL ACAD SCI-BIOL, V78, P2273, DOI 10.1073/pnas.78.4.2273; PRENTICE HL, 1992, NUCLEIC ACIDS RES, V20, P621, DOI 10.1093/nar/20.3.621; RAUE HA, 1995, GENE EXPRESSION, V5, P71; RAUE HA, 1991, PROG NUCLEIC ACID RE, V41, P89; SAMBROOK J, 1982, MOL CLONING LAB MANU, P133; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Spasov K, 2002, MOL CELL, V9, P433, DOI 10.1016/S1097-2765(02)00461-6; STOHL LL, 1992, MOL CELL BIOL, V12, P2561, DOI 10.1128/MCB.12.6.2561; SUBRAHMANYAM CS, 1982, NUCLEIC ACIDS RES, V10, P3667, DOI 10.1093/nar/10.12.3667; VANDERSANDE CAFM, 1992, J MOL BIOL, V223, P899, DOI 10.1016/0022-2836(92)90251-E; VANNUES RW, 1995, J MOL BIOL, V250, P24, DOI 10.1006/jmbi.1995.0355; VANRYK DI, 1992, J MOL BIOL, V226, P1027, DOI 10.1016/0022-2836(92)91050-Y; Woolford Jr JL, 1991, MOL CELLULAR BIOL YE, P587; YEH LCC, 1990, J MOL BIOL, V211, P699, DOI 10.1016/0022-2836(90)90071-S	40	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21291	21299		10.1074/jbc.M201751200	http://dx.doi.org/10.1074/jbc.M201751200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11923314	hybrid			2022-12-27	WOS:000176286000024
J	Hausmann, S; Shuman, S				Hausmann, S; Shuman, S			Characterization of the CTD phosphatase Fcp1 from fission yeast - Preferential dephosphorylation of serine 2 versus serine 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TERMINAL DOMAIN PHOSPHATASE; SACCHAROMYCES-CEREVISIAE; PROTEIN PHOSPHATASE; PHOSPHOSERINE PHOSPHATASE; ELONGATION COMPLEXES; CAPPING ENZYMES; TRANSCRIPTION; PHOSPHORYLATION; PURIFICATION	The C-terminal domain (CTD) of RNA polymerase II undergoes extensive phosphorylation and dephosphorylation at positions Ser(2) and Ser(5) during the transcription cycle. A single CTD phosphatase, Fcp1, has been identified in yeast and metazoans. Here we conducted a biochemical characterization of Fcp1 from the fission yeast Schizosaccharomyces pombe. The 723-amino acid Fcp1 protein was expressed at high levels in bacteria. Recombinant Fcp1 catalyzed the metal-dependent hydrolysis of para-nitrophenyl phosphate with a pH optimum of 5.5 (k(cat) = 2 s(-1); K-m = 19 mm). Deletion analysis showed that 139- and 143-amino acid segments could be deleted from the N and C termini of Fcp1, respectively, without affecting phosphatase activity. A segment containing amino acids 487-580, deletion of which abolished activity, embraces a BRCT domain present in all known Fcp1 orthologs. Mutations of residues Asp(170) and ASp(172) abrogated Fcp1 phosphatase activity; the essential aspartates are located within a (DXDXT172)-D-170 motif that defines a superfamily of metal-dependent phosphotransferases. We exploited defined synthetic CTD phosphopeptide substrates to show for the first time that: (i) Fcp1 CTD phosphatase activity is not confined to native polymerase II and (ii) Fcp1 displays an inherent preference for a particular CTD phosphorylation array. Using equivalent concentrations (25 gm) of CTD peptides of identical amino acid sequence and phosphoserine content, which differed only in the positions of phosphoserine within the heptad, we found that Fcp1 was 10-fold more active in dephosphorylating Ser(2)-PO4 than Ser(5)-PO4.	Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA.				NIGMS NIH HHS [GM52470] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052470] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Archambault J, 1998, J BIOL CHEM, V273, P27593, DOI 10.1074/jbc.273.42.27593; Archambault J, 1997, P NATL ACAD SCI USA, V94, P14300, DOI 10.1073/pnas.94.26.14300; Chambers RS, 1996, J BIOL CHEM, V271, P24498, DOI 10.1074/jbc.271.40.24498; CHAMBERS RS, 1995, J BIOL CHEM, V270, P14962, DOI 10.1074/jbc.270.25.14962; CHAMBERS RS, 1994, J BIOL CHEM, V269, P26243; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Cho H, 2001, P NATL ACAD SCI USA, V98, P8525, DOI 10.1073/pnas.131213698; Cho H, 1999, GENE DEV, V13, P1540, DOI 10.1101/gad.13.12.1540; Collet JF, 1999, J BIOL CHEM, V274, P33985, DOI 10.1074/jbc.274.48.33985; Collet JF, 1998, J BIOL CHEM, V273, P14107, DOI 10.1074/jbc.273.23.14107; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; Gebara MM, 1997, J CELL BIOCHEM, V64, P390; Hirose Y, 2000, GENE DEV, V14, P1415; Ho CK, 1999, MOL CELL, V3, P405, DOI 10.1016/S1097-2765(00)80468-2; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Kimura M, 2002, MOL CELL BIOL, V22, P1577, DOI 10.1128/MCB.22.5.1577-1588.2002; Kobor MS, 2000, MOL CELL BIOL, V20, P7438, DOI 10.1128/MCB.20.20.7438-7449.2000; Kobor MS, 1999, MOL CELL, V4, P55, DOI 10.1016/S1097-2765(00)80187-2; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Lehman AL, 2000, J BIOL CHEM, V275, P14923, DOI 10.1074/jbc.275.20.14923; Marshall NF, 2000, J BIOL CHEM, V275, P32430, DOI 10.1074/jbc.M005898200; Murray S, 2001, MOL CELL BIOL, V21, P4089, DOI 10.1128/MCB.21.13.4089-4096.2001; Palancade B, 2001, MOL CELL BIOL, V21, P6359, DOI 10.1128/MCB.21.19.6359-6368.2001; Patturajan M, 1998, J BIOL CHEM, V273, P4689, DOI 10.1074/jbc.273.8.4689; Pei Y, 2001, J BIOL CHEM, V276, P28075, DOI 10.1074/jbc.M102170200; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Schwer B, 2001, J BIOL CHEM, V276, P1857, DOI 10.1074/jbc.M006072200; Thaller MC, 1998, PROTEIN SCI, V7, P1647, DOI 10.1002/pro.5560070722; Wang LK, 2002, NUCLEIC ACIDS RES, V30, P1073, DOI 10.1093/nar/30.4.1073; Zhou MS, 2000, MOL CELL BIOL, V20, P5077, DOI 10.1128/MCB.20.14.5077-5086.2000	30	82	83	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21213	21220		10.1074/jbc.M202056200	http://dx.doi.org/10.1074/jbc.M202056200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11934898	hybrid			2022-12-27	WOS:000176286000014
J	Khan, H; Harris, RJ; Barna, T; Craig, DH; Bruce, NC; Munro, AW; Moody, PCE; Scrutton, NS				Khan, H; Harris, RJ; Barna, T; Craig, DH; Bruce, NC; Munro, AW; Moody, PCE; Scrutton, NS			Kinetic and structural basis of reactivity of pentaerythritol tetranitrate reductase with NADPH, 2-cyclohexenone, nitroesters, and nitroaromatic explosives	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLD YELLOW ENZYME; ESTROGEN-BINDING PROTEIN; MORPHINONE REDUCTASE; 2,4,6-TRINITROTOLUENE; SEQUENCE; DEGRADATION; TRINITRATE; CLONING; FLAVIN	The reaction of pentaerythritol tetranitrate reductase with reducing and oxidizing substrates has been studied by stopped-flow spectrophotometry, redox potentiometry, and X-ray crystallography. We show in the reductive half-reaction of pentaerythritol tetranitrate (PETN) reductase that NADPH binds to form an enzyme-NADPH charge transfer intermediate prior to hydride transfer from the nicotinamide coenzyme to FMN. In the oxidative half-reaction, the two-electron-reduced enzyme reacts with several substrates including nitroester explosives (glycerol trinitrate and PETN), nitroaromatic explosives (trinitrotoluene (TNT) and picric acid), and alpha,beta-unsaturated carbonyl compounds (2-cyclohexenone). Oxidation of the flavin by the nitroaromatic substrate TNT is kinetically indistinguishable from formation of its hydride-Meisenheimer complex, consistent with a mechanism involving direct nucleophilic attack by hydride from the flavin N5 atom at the electron-deficient aromatic nucleus of the substrate. The crystal structures of complexes of the oxidized enzyme bound to picric acid and TNT are consistent with direct hydride transfer from the reduced flavin to nitroaromatic substrates. The mode of binding the inhibitor 2,4-dinitrophenol (2,4-DNP) is similar to that observed with picric acid and TNT. In this position, however, the aromatic nucleus is not activated for hydride transfer from the flavin N5 atom, thus accounting for the lack of reactivity with 2,4-DNP. Our work with PETN reductase establishes further a close relationship to the Old Yellow Enzyme family of proteins but at the same time highlights important differences compared with the reactivity of Old Yellow Enzyme. Our studies provide a structural and mechanistic rationale for the ability of PETN reductase to react with the nitroaromatic explosive compounds TNT and picric acid and for the inhibition of enzyme activity with 2,4-DNP.	Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; Univ Leicester, Ctr Chem Biol, Leicester LE1 7RH, Leics, England; Univ Cambridge, Inst Biotechnol, Cambridge CB2 1QT, England	University of Leicester; University of Leicester; University of Cambridge	Scrutton, NS (corresponding author), Univ Leicester, Dept Biochem, Univ Rd, Leicester LE1 7RH, Leics, England.	nss4@le.ac.uk	Munro, Andrew/G-5639-2019; Moody, Peter/A-6832-2008; barna, terez/R-1357-2018	Munro, Andrew/0000-0002-4642-180X; Moody, Peter/0000-0003-1762-9238; 				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barna TM, 2001, J MOL BIOL, V310, P433, DOI 10.1006/jmbi.2001.4779; Binks PR, 1996, APPL ENVIRON MICROB, V62, P1214, DOI 10.1128/AEM.62.4.1214-1219.1996; Blehert DS, 1997, J BACTERIOL, V179, P6912, DOI 10.1128/jb.179.22.6912-6920.1997; Blehert DS, 1999, J BACTERIOL, V181, P6254, DOI 10.1128/JB.181.20.6254-6263.1999; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buckman J, 1998, BIOCHEMISTRY-US, V37, P14326, DOI 10.1021/bi981106y; Buckman J, 2000, BIOCHEMISTRY-US, V39, P10521, DOI 10.1021/bi0006520; Craig DH, 1998, BIOCHEMISTRY-US, V37, P7598, DOI 10.1021/bi980345i; Craig DH, 2001, BIOCHEM J, V359, P315, DOI 10.1042/0264-6021:3590315; Dutton P L, 1978, Methods Enzymol, V54, P411; FOX KM, 1994, STRUCTURE, V2, P1089, DOI 10.1016/S0969-2126(94)00111-1; French CE, 1999, NAT BIOTECHNOL, V17, P491, DOI 10.1038/8673; French CE, 1995, BIOCHEM J, V312, P671, DOI 10.1042/bj3120671; French CE, 1998, APPL ENVIRON MICROB, V64, P2864; French CE, 1996, J BACTERIOL, V178, P6623, DOI 10.1128/jb.178.22.6623-6627.1996; Gutierrez A, 2001, BIOCHEMISTRY-US, V40, P1964, DOI 10.1021/bi001719m; Hooker BS, 1999, NAT BIOTECHNOL, V17, P428, DOI 10.1038/8596; Kohli RM, 1998, J BIOL CHEM, V273, P32763, DOI 10.1074/jbc.273.49.32763; MADANI ND, 1994, P NATL ACAD SCI USA, V91, P922, DOI 10.1073/pnas.91.3.922; MASSEY V, 1978, BIOCHEMISTRY-US, V17, P9, DOI 10.1021/bi00594a002; MASSEY V, 1986, J BIOL CHEM, V261, P1215; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; Meah Y, 2001, P NATL ACAD SCI USA, V98, P8560, DOI 10.1073/pnas.151249098; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pak JW, 2000, APPL ENVIRON MICROB, V66, P4742, DOI 10.1128/AEM.66.11.4742-4750.2000; SAITO K, 1991, J BIOL CHEM, V266, P20720; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Snape JR, 1997, J BACTERIOL, V179, P7796, DOI 10.1128/jb.179.24.7796-7802.1997; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; VAZ ADN, 1995, BIOCHEMISTRY-US, V34, P4246, DOI 10.1021/bi00013a014; VORBECK C, 1994, J BACTERIOL, V176, P932, DOI 10.1128/jb.176.3.932-934.1994; Williams RE, 2001, BIOCHEM SOC SYMP, V68, P143; WILLIAMS RE, 1999, FLAVINS FLAVOPROTEIN, P663	34	70	73	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21906	21912		10.1074/jbc.M200637200	http://dx.doi.org/10.1074/jbc.M200637200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11923299	hybrid			2022-12-27	WOS:000176286000102
J	Lin, F; Kolluri, SK; Chen, GQ; Zhang, XK				Lin, F; Kolluri, SK; Chen, GQ; Zhang, XK			Regulation of retinoic acid-induced inhibition of AP-1 activity by orphan receptor chicken ovalbumin upstream promoter-transcription factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; THYROID-HORMONE RECEPTOR; ACTIVATOR PROTEIN-1 ACTIVITY; HUMAN LUNG-CANCER; FACTOR COUP-TF; A-I GENE; X-RECEPTOR; GLUCOCORTICOID RECEPTOR; NUCLEAR RECEPTORS; ESTROGEN-RECEPTOR	Retinoids are therapeutically effective in the treatment of various cancers, and some of the therapeutic action of retinoids can be ascribed to their potent inhibition of AP-1 activity that regulates transcription of genes associated with cell growth. We recently reported that the expression of orphan receptor chicken ovalbumin upstream promoter-transcription factor (COUP-TF) plays a role in mediating the growth inhibitory effect of trans-retinoic acid (trans-RA) in cancer cells. To gain insight into the molecular mechanism by which COUP-TF regulates trans-RA activity, we evaluated the effect of COUP-TF on antagonism of AP-1 activity by trans-RA. Our results demonstrated a positive correlation between COUP-TF expression and the ability of trans-RA to inhibit AP-1 activity in various cancer cell lines. In transient transfection assay, expression of COUP-TF strongly inhibited tumor promoter 12-O-tetradecanoylphorbol-13-acetate-induced AP-1 transactivation activity and transactivation of c-Jun/c-Fos in both a trans-RA-dependent and -independent manner. In vitro studies demonstrated that the addition of COUP-TF inhibited c-Jun DNA binding through a direct protein-protein interaction that is mediated by the DNA binding domain of COUP-TF and the leucine zipper of c-Jun. Stable expression of COUP-TF in COUP-TF-negative MDA-MB231 breast cancer cells restored the ability of trans-RA to inhibit 12-O-tetradecanoylphorbol-13-acetate-induced c-Jun expression. The effect of COUP-TF in enhancing the trans-RA-induced antagonism of AP-1 activity required expression of retinoic acid receptors (RARs), since stable expression of COUP-TF in COUP-TF-negative HT-1376 bladder cancer cells, which do not express RARalpha and RARbeta, failed to restore trans-RA-induced AP-1 repression. Thus, COUP-TF, through its physical interaction with AP-1, promotes anticancer effects of retinoids by potentiating their anti-AP-1 activity.	Burnham Inst, Ctr Canc, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Zhang, XK (corresponding author), Burnham Inst, Ctr Canc, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.							Agadir A, 1997, CANCER RES, V57, P3444; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; BERRODIN TJ, 1992, MOL ENDOCRINOL, V6, P1468, DOI 10.1210/me.6.9.1468; BUTLER AJ, 1995, NUCLEIC ACIDS RES, V23, P4143, DOI 10.1093/nar/23.20.4143; Caelles C, 1997, GENE DEV, V11, P3351, DOI 10.1101/gad.11.24.3351; CHEN JY, 1995, EMBO J, V14, P1187, DOI 10.1002/j.1460-2075.1995.tb07102.x; COONEY AJ, 1992, MOL CELL BIOL, V12, P4153, DOI 10.1128/MCB.12.9.4153; Crawford HC, 1996, ENZYME PROTEIN, V49, P20, DOI 10.1159/000468614; DiSepio D, 1999, Mol Cell Biol Res Commun, V1, P7, DOI 10.1006/mcbr.1999.0101; FANJUL A, 1994, NATURE, V372, P107, DOI 10.1038/372107a0; Gudas Lorraine J., 1994, P443; Huang CS, 1997, P NATL ACAD SCI USA, V94, P5826, DOI 10.1073/pnas.94.11.5826; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; KLIEWER SA, 1992, P NATL ACAD SCI USA, V89, P1448, DOI 10.1073/pnas.89.4.1448; Klinge CM, 1999, J STEROID BIOCHEM, V71, P1, DOI 10.1016/S0960-0760(99)00124-7; Klinge CM, 1997, J BIOL CHEM, V272, P31465, DOI 10.1074/jbc.272.50.31465; KONIG H, 1992, EMBO J, V11, P2241, DOI 10.1002/j.1460-2075.1992.tb05283.x; LADIAS JAA, 1991, SCIENCE, V251, P561, DOI 10.1126/science.1899293; Lee HY, 1996, CELL GROWTH DIFFER, V7, P997; Li JJ, 1996, CANCER RES, V56, P483; Li Y, 1998, MOL CELL BIOL, V18, P4719, DOI 10.1128/MCB.18.8.4719; Lin BZ, 2000, MOL CELL BIOL, V20, P957, DOI 10.1128/MCB.20.3.957-970.2000; Lin F, 2000, CANCER RES, V60, P3271; Liu Y, 1996, MOL CELL BIOL, V16, P1138; LOTAN R, 1980, BIOCHIM BIOPHYS ACTA, V605, P33, DOI 10.1016/0304-419X(80)90021-9; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MIYAJIMA N, 1988, NUCLEIC ACIDS RES, V16, P11057, DOI 10.1093/nar/16.23.11057; NICHOLSON RC, 1990, EMBO J, V9, P4443, DOI 10.1002/j.1460-2075.1990.tb07895.x; PFAHL M, 1993, ENDOCR REV, V14, P651, DOI 10.1210/er.14.5.651; Qiu Y, 1996, J STEROID BIOCHEM, V56, P81, DOI 10.1016/0960-0760(95)00225-1; Robinson CE, 1999, ENDOCRINOLOGY, V140, P1586, DOI 10.1210/en.140.4.1586; SCHULE R, 1991, P NATL ACAD SCI USA, V88, P6092, DOI 10.1073/pnas.88.14.6092; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; SHEMSHEDINI L, 1991, EMBO J, V10, P3839, DOI 10.1002/j.1460-2075.1991.tb04953.x; Shibata H, 1997, MOL ENDOCRINOL, V11, P714, DOI 10.1210/me.11.6.714; Soprano DR, 1996, ONCOGENE, V12, P577; Teyssier C, 2001, J BIOL CHEM, V276, P36361, DOI 10.1074/jbc.M101806200; TRAN P, 1992, MOL CELL BIOL, V12, P4666, DOI 10.1128/MCB.12.10.4666; VANDERBURG B, 1995, MOL CELL ENDOCRINOL, V112, P143, DOI 10.1016/0303-7207(95)03600-C; WANG LH, 1989, NATURE, V340, P163, DOI 10.1038/340163a0; WIDOM RL, 1992, MOL CELL BIOL, V12, P3380, DOI 10.1128/MCB.12.8.3380; Wu Q, 1997, EMBO J, V16, P1656, DOI 10.1093/emboj/16.7.1656; Wu Q, 1997, MOL CELL BIOL, V17, P6598, DOI 10.1128/MCB.17.11.6598; Yang L, 1999, BREAST CANCER RES TR, V56, P277, DOI 10.1023/A:1006219411078; Yang LM, 1997, CANCER RES, V57, P4652; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; YANGYEN HF, 1991, NEW BIOL, V3, P1206; ZHANG XK, 1991, MOL CELL BIOL, V11, P6016, DOI 10.1128/MCB.11.12.6016; ZHANG XK, 1991, J BIOL CHEM, V266, P8248; Zhang XK, 1996, MUTAT RES-FUND MOL M, V350, P267, DOI 10.1016/0027-5107(95)00102-6; ZHANG XK, 1993, RECEPTOR, V3, P183; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0; Zhou XF, 1999, MOL ENDOCRINOL, V13, P276, DOI 10.1210/me.13.2.276	55	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21414	21422		10.1074/jbc.M201885200	http://dx.doi.org/10.1074/jbc.M201885200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11934895	hybrid			2022-12-27	WOS:000176286000039
J	Solovyan, VT; Bezvenyuk, ZA; Salminen, A; Austin, CA; Courtney, MJ				Solovyan, VT; Bezvenyuk, ZA; Salminen, A; Austin, CA; Courtney, MJ			The role of topoisomerase II in the excision of DNA loop domains during apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASPASE-ACTIVATED DNASE; CELL-DEATH; INTERNUCLEOSOMAL FRAGMENTATION; NEUROBLASTOMA-CELLS; CLEAVAGE; INHIBITOR; ORGANIZATION; INVOLVEMENT; MECHANISMS; ETOPOSIDE	Disintegration of nuclear DNA into high molecular weight (HMW) and oligonucleosomal DNA fragments represents two major periodicities of DNA fragmentation during apoptosis. These are thought to originate from the excision of DNA loop domains and from the cleavage of nuclear DNA at the internucleosomal positions, respectively. In this report, we demonstrate that different apoptotic insults induced apoptosis in NB-2a neuroblastoma cells that was invariably accompanied by the formation of HMW DNA fragments of about 50-100 kb but proceeded either with or without oligonucleosomal DNA cleavage, depending on the type of apoptotic inducer. We demonstrate that differences in the pattern of DNA fragmentation were reproducible in a cell-free apoptotic system and develop conditions that allow in vitro separation of the RAW and oligonucleosomal DNA fragmentation activities. In contrast to apoptosis associated with oligonucleosomal DNA fragmentation, the HMW DNA cleavage in apoptotic cells was accompanied by down-regulation of caspase-activated DNase (CAD) and was not affected by z-VAD-fmk, suggesting that the caspase/CAD pathway is not involved in the excision of DNA loop domains. We further demonstrate that nonapoptotic NB-2a cells contain a constitutively present nuclease activity located in the nuclear matrix fraction that possessed the properties of topoisomerase (topo) II and was capable of reproducing the pattern of HMW DNA cleavage that occurred in apoptotic cells. We demonstrate that the early stages of apoptosis induced by different stimuli were accompanied by activation of topo II-mediated HMW DNA cleavage that was reversible after removal of apoptotic inducers, and we present evidence of the involvement of topo II in the formation of HMW DNA fragments at the advanced stages of apoptosis. The results suggest that topo II is involved in caspase-independent excision of DNA loop domains during apoptosis, and this represents an alternative pathway of apoptotic DNA disintegration from CAD-driven caspase-dependent oligonucleosomal DNA cleavage.	Univ Kuopio, AI Virtanen Inst Mol Sci, FIN-70211 Kuopio, Finland; Ukrainian Acad Sci, Inst Mol Biol & Genet, UA-252627 Kiev, Ukraine; Univ Kuopio, Kuopio Univ Hosp, FIN-70211 Kuopio, Finland; Univ Newcastle Upon Tyne, Sch Med, Sch Biochem & Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	University of Eastern Finland; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; Kuopio University Hospital; University of Eastern Finland; Newcastle University - UK	Solovyan, VT (corresponding author), Univ Kuopio, AI Virtanen Inst Mol Sci, POB 1627, FIN-70211 Kuopio, Finland.		Courtney, Michael J/D-6648-2016	Courtney, Michael J/0000-0001-8693-3933; Austin, Caroline/0000-0002-1921-5947				Bezvenyuk Z, 2000, MOL BRAIN RES, V81, P191, DOI 10.1016/S0169-328X(00)00174-1; BROWN DG, 1993, J BIOL CHEM, V268, P3037; Burden DA, 1998, BBA-GENE STRUCT EXPR, V1400, P139, DOI 10.1016/S0167-4781(98)00132-8; Cao GD, 2001, J NEUROSCI, V21, P4678, DOI 10.1523/JNEUROSCI.21-13-04678.2001; Chen DX, 2000, J BIOL CHEM, V275, P38508, DOI 10.1074/jbc.M003906200; COHEN GM, 1992, BIOCHEM J, V286, P331, DOI 10.1042/bj2860331; COOK PR, 1976, J CELL SCI, V22, P287; Counis MF, 2000, BIOCHEM CELL BIOL, V78, P405, DOI 10.1139/bcb-78-4-405; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Halenbeck R, 1998, CURR BIOL, V8, P537, DOI 10.1016/S0960-9822(98)79298-X; Hinck L, 2001, BIOL REPROD, V64, P555, DOI 10.1095/biolreprod64.2.555; JACKSON DA, 1992, CELL BIOL INT REP, V16, P687, DOI 10.1016/S0309-1651(05)80013-X; Jackson DA, 1995, INT REV CYTOL, V162A, P125; Laemmli UK, 1992, CURR OPIN GENET DEV, V2, P275, DOI 10.1016/S0959-437X(05)80285-0; LAGARKOVA MA, 1995, J BIOL CHEM, V270, P20239, DOI 10.1074/jbc.270.35.20239; Li TK, 1999, GENE DEV, V13, P1553, DOI 10.1101/gad.13.12.1553; LIU LF, 1983, CRC CR REV BIOCH MOL, V15, P1, DOI 10.3109/10409238309102799; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Lorenzo HK, 1999, CELL DEATH DIFFER, V6, P516, DOI 10.1038/sj.cdd.4400527; McIlroy D, 1999, ONCOGENE, V18, P4401, DOI 10.1038/sj.onc.1202868; MIRKOVITCH J, 1984, CELL, V39, P223, DOI 10.1016/0092-8674(84)90208-3; NELSON WG, 1986, ANNU REV BIOPHYS BIO, V15, P457, DOI 10.1146/annurev.bb.15.060186.002325; OBERHAMMER F, 1993, EMBO J, V12, P3679, DOI 10.1002/j.1460-2075.1993.tb06042.x; PAULSON JR, 1977, CELL, V12, P817, DOI 10.1016/0092-8674(77)90280-X; Perry DK, 1997, J BIOL CHEM, V272, P18530, DOI 10.1074/jbc.272.30.18530; Sakahira H, 1999, CURR BIOL, V9, P543, DOI 10.1016/S0960-9822(99)80240-1; Samejima K, 1998, J CELL BIOL, V143, P225, DOI 10.1083/jcb.143.1.225; Solovyan V, 1999, NEUROCHEM INT, V34, P465, DOI 10.1016/S0197-0186(99)00017-0; Solovyan V, 1998, MOL BRAIN RES, V62, P43, DOI 10.1016/S0169-328X(98)00234-4; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Tsutsui K, 2001, J BIOL CHEM, V276, P5769, DOI 10.1074/jbc.M008517200; WALKER PR, 1994, EXP CELL RES, V213, P100, DOI 10.1006/excr.1994.1178; Widlak P, 2000, J BIOL CHEM, V275, P8226, DOI 10.1074/jbc.275.11.8226; Willmore E, 1998, MOL PHARMACOL, V54, P78, DOI 10.1124/mol.54.1.78; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Zhang JH, 1998, P NATL ACAD SCI USA, V95, P12480, DOI 10.1073/pnas.95.21.12480	37	59	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21458	21467		10.1074/jbc.M110621200	http://dx.doi.org/10.1074/jbc.M110621200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11940566	hybrid			2022-12-27	WOS:000176286000045
J	Suzuki-Inoue, K; Tulasne, D; Shen, Y; Bori-Sanz, T; Inoue, O; Jung, SM; Moroi, M; Andrews, RK; Berndt, MC; Watson, SP				Suzuki-Inoue, K; Tulasne, D; Shen, Y; Bori-Sanz, T; Inoue, O; Jung, SM; Moroi, M; Andrews, RK; Berndt, MC; Watson, SP			Association of Fyn and Lyn with the proline-rich domain of glycoprotein VI regulates intracellular signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-GAMMA-CHAIN; COLLAGEN RECEPTOR; TYROSINE PHOSPHORYLATION; PLATELET ACTIVATION; SH3 DOMAIN; PHOSPHOLIPASE C-GAMMA-2; ZETA-CHAIN; SRC; EXPRESSION; BINDING	The glycoprotein VI (GPVI)-Fc receptor (FcR) gamma-chain complex, a key activatory receptor for collagen on platelet surface membranes, is constitutively associated with the Src family kinases Fyn and Lyn. Molecular cloning of GPVI has revealed the presence of a proline-rich domain in the sequence of GPVI cytoplasmic tail which has the consensus for interaction with the Src homology 3 (SH3) domains of Fyn and Lyn. A series of in vitro experiments demonstrated the ability of the SH3 domains of both Src kinases to bind the proline-rich domain of GPVI. Furthermore, depletion of the proline-rich domain in GPVI (Pro(-)-GPVI) prevented binding of Fyn and Lyn and markedly reduced phosphorylation of FcR gamma-chain in transiently transfected COS-7 cells, but did not affect the association of the gamma-chain with GPVI. Jurkat cells stably transfected with wild type GPVI show robust increases in tyrosine phosphorylation and intracellular Ca2+ in response to the snake venom convulxin that targets GPVI. Importantly, convulxin is not able to activate cells transfected with Pro(-)-GPVI, even though the association with the immunoreceptor tyrosine-based activation motif-containing chains is maintained. These findings demonstrate that the proline-rich domain of GPVI mediates the association with Fyn/Lyn via their SH3 domain and that this interaction initiates activation signals through GPVI.	Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; Baker Med Res Inst, Hazel & Pip Appel Vasc Biol Lab, Melbourne, Vic 8008, Australia; Med Sch Edgbaston, Div Med Sci, Birmingham B15 2TT, W Midlands, England; Kurume Univ, Inst Life Sci, Fukuoka 8390861, Japan; Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3168, Australia	University of Oxford; Baker Heart and Diabetes Institute; Kurume University; Monash University	Suzuki-Inoue, K (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.	katsue.inoue@pharm.ox.ac.uk	Watson, Stephen P/Q-6292-2016; Tulasne, David/AAR-5287-2020; Berndt, Michael C/D-5580-2012; Tulasne, David/A-8705-2008	Watson, Stephen P/0000-0002-7846-7423; Tulasne, David/0000-0002-6764-7242; Andrews, Robert Keith/0000-0001-9577-8082				Andrews RK, 2001, J BIOL CHEM, V276, P28092, DOI 10.1074/jbc.M011352200; Asazuma N, 2000, J BIOL CHEM, V275, P33427, DOI 10.1074/jbc.M001439200; Asselin J, 1997, BLOOD, V89, P1235, DOI 10.1182/blood.V89.4.1235; Berlanga O, 2000, BLOOD, V96, P2740; BERLANGA O, 2002, IN PRESS EUR J BIOCH; Briddon SJ, 1999, BIOCHEM J, V338, P203, DOI 10.1042/0264-6021:3380203; CAMBIER JC, 1995, J IMMUNOL, V155, P3281; CLARK MR, 1994, EMBO J, V13, P1911, DOI 10.1002/j.1460-2075.1994.tb06460.x; Clemetson JM, 1999, J BIOL CHEM, V274, P29019, DOI 10.1074/jbc.274.41.29019; Denny MF, 1999, J BIOL CHEM, V274, P5146, DOI 10.1074/jbc.274.8.5146; Du XP, 1996, J BIOL CHEM, V271, P7362, DOI 10.1074/jbc.271.13.7362; ERPEL T, 1995, EMBO J, V14, P963, DOI 10.1002/j.1460-2075.1995.tb07077.x; Ezumi Y, 1998, J EXP MED, V188, P267, DOI 10.1084/jem.188.2.267; Ezumi Y, 2000, BIOCHEM BIOPH RES CO, V277, P27, DOI 10.1006/bbrc.2000.3624; Gauen LKT, 1996, J CELL BIOL, V133, P1007, DOI 10.1083/jcb.133.5.1007; Gibbins J, 1996, J BIOL CHEM, V271, P18095, DOI 10.1074/jbc.271.30.18095; Gibbins JM, 1997, FEBS LETT, V413, P255, DOI 10.1016/S0014-5793(97)00926-5; Gross BS, 1999, EUR J BIOCHEM, V263, P612, DOI 10.1046/j.1432-1327.1999.00560.x; Gu MY, 1999, J CELL BIOL, V147, P1085, DOI 10.1083/jcb.147.5.1085; Jandrot-Perrus M, 2000, BLOOD, V96, P1798, DOI 10.1182/blood.V96.5.1798.h8001798_1798_1807; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kehrel B, 1998, BLOOD, V91, P491; LEDBETTER JA, 1993, CURR OPIN IMMUNOL, V5, P334, DOI 10.1016/0952-7915(93)90050-3; Miura Y, 2000, THROMB RES, V98, P301, DOI 10.1016/S0049-3848(00)00182-1; MOROI M, 1989, J CLIN INVEST, V84, P1440, DOI 10.1172/JCI114318; OSMAN N, 1995, EUR J IMMUNOL, V25, P2863, DOI 10.1002/eji.1830251023; Pasquet JM, 1999, MOL CELL BIOL, V19, P8326; Polgar J, 1997, J BIOL CHEM, V272, P13576, DOI 10.1074/jbc.272.21.13576; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; Quek LS, 2000, BLOOD, V96, P4246; RICKLES RJ, 1994, EMBO J, V13, P5598, DOI 10.1002/j.1460-2075.1994.tb06897.x; RYO R, 1992, AM J HEMATOL, V39, P25, DOI 10.1002/ajh.2830390107; Shen Y, 2000, BLOOD, V95, P903, DOI 10.1182/blood.V95.3.903.003k37_903_910; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; van't Hof W, 1999, J CELL BIOL, V145, P377, DOI 10.1083/jcb.145.2.377; Watson SP, 1999, THROMB HAEMOSTASIS, V82, P365; Wilde JI, 2001, CELL SIGNAL, V13, P691, DOI 10.1016/S0898-6568(01)00191-7; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Zheng YM, 2001, J BIOL CHEM, V276, P12999, DOI 10.1074/jbc.M009344200; zurHausen JD, 1997, EUR J IMMUNOL, V27, P2643, DOI 10.1002/eji.1830271025	40	137	139	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21561	21566		10.1074/jbc.M201012200	http://dx.doi.org/10.1074/jbc.M201012200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11943772	hybrid			2022-12-27	WOS:000176286000059
J	Celie, PHN; van Stempvoort, G; Fribourg, C; Schurgers, LJ; Lenting, PJ; Mertens, K				Celie, PHN; van Stempvoort, G; Fribourg, C; Schurgers, LJ; Lenting, PJ; Mertens, K			The connecting segment between both epidermal growth factor-like domains in blood coagulation factor IX contributes to stimulation by factor VIIIa and its isolated A2 Domain.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA THROMBOPLASTIN ANTECEDENT; X-RAY STRUCTURE; ACTIVE-SITE; HEMOPHILIA-B; LIGHT-CHAIN; INTERACTIVE SITES; CHRISTMAS FACTOR; ENZYME-ACTIVITY; BINDING-SITE; SUBUNIT	The light chain of activated factor IX comprises multiple interactions between both epidermal growth factor-like domains that contribute to enzymatic activity and binding of factor IXa to its cofactor factor VIIIa. To investigate the association between factor IXa-specific properties and surface-exposed structure elements, chimeras were constructed in which the interconnection between the modules Leu(84)-Thr(87) and the factor IX-specific loop Asn(89)-Lys(91) were exchanged for corresponding regions of factor X and factor VII. In absence of factor VIIIa, all chimeras displayed normal enzymatic activity. In the presence of factor VIIIa, replacement of loop Asn(89)-Lys(91) resulted in a minor reduction in factor IXa activity. However, chimeras with substitutions or insertions in the spacer between the epidermal growth factor-like domains showed a major defect in response to factor VIIIa. Of these chimeras, some displayed a normal response to isolated factor VIII A2 domain as a cofactor in factor X activation. Surprisingly, chimeras containing elongated inter-domain spacers from factor X or VII displayed reduced response to both complete factor VIIIa and the isolated A2 domain. Moreover, these chimeras still displayed effective association with immobilized A2 domain as assessed by surface plasmon resonance. We conclude that both sequence and length of the junction Leu(84)-Thr(87) between both epidermal growth factor-like domains contribute to the enhancement of factor IXa enzymatic activity that occurs upon assembly with factor VIIIa.	Sanquin Blood Supply Fdn, Sanquin Res CLB, Dept Plasma Prot, NL-1066 CX Amsterdam, Netherlands; Maastricht Univ, Dept Biochem, NL-6200 MD Maastricht, Netherlands; Univ Utrecht, UIPS, Dept Pharmaceut, NL-3584 CA Utrecht, Netherlands	Maastricht University; Utrecht University	Mertens, K (corresponding author), Sanquin Blood Supply Fdn, Sanquin Res CLB, Dept Plasma Prot, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.		Schurgers, Leon/AAT-7100-2021; Celie, Patrick/AAY-9559-2021; Lenting, Peter/AAH-5663-2019; Lenting, Peter/F-8269-2013	Lenting, Peter/0000-0002-7937-3429; Lenting, Peter/0000-0002-7937-3429; Schurgers, Leon/0000-0001-7867-6957				Bajaj SP, 2001, J BIOL CHEM, V276, P16302, DOI 10.1074/jbc.M011680200; Banner DW, 1997, THROMB HAEMOSTASIS, V78, P512; Bode W, 1997, THROMB HAEMOSTASIS, V78, P501; BOTTEMA CDK, 1991, AM J HUM GENET, V49, P820; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANDSTETTER H, 1995, P NATL ACAD SCI USA, V92, P9796, DOI 10.1073/pnas.92.21.9796; Brandstetter H, 1996, J BIOL CHEM, V271, P29988, DOI 10.1074/jbc.271.47.29988; Celie PHN, 2000, J BIOL CHEM, V275, P229, DOI 10.1074/jbc.275.1.229; Chang JY, 1997, J CLIN INVEST, V100, P886, DOI 10.1172/JCI119604; Christophe OD, 1998, J BIOL CHEM, V273, P222, DOI 10.1074/jbc.273.1.222; Fay PJ, 1998, J BIOL CHEM, V273, P19049, DOI 10.1074/jbc.273.30.19049; FUJIKAWA K, 1974, BIOCHEMISTRY-US, V13, P4508, DOI 10.1021/bi00719a006; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; Johnson DJD, 1999, J STRUCT BIOL, V125, P90, DOI 10.1006/jsbi.1998.4078; Kolkman JA, 1999, BIOCHEM J, V339, P217, DOI 10.1042/0264-6021:3390217; KUWADA M, 1983, ANAL BIOCHEM, V131, P173, DOI 10.1016/0003-2697(83)90150-1; Lapan KA, 1997, J BIOL CHEM, V272, P2082; Lenting PJ, 1996, J BIOL CHEM, V271, P25332, DOI 10.1074/jbc.271.41.25332; LENTING PJ, 1995, J BIOL CHEM, V270, P14884, DOI 10.1074/jbc.270.25.14884; Lenting PJ, 1996, J BIOL CHEM, V271, P1935, DOI 10.1074/jbc.271.4.1935; LENTING PJ, 1994, J BIOL CHEM, V269, P7150; LINDQUIST PA, 1978, J BIOL CHEM, V253, P1902; MANN KG, 1990, BLOOD, V76, P1; Mathus A, 1999, J BIOL CHEM, V274, P18477, DOI 10.1074/jbc.274.26.18477; MERTENS K, 1984, BIOCHEM J, V223, P599, DOI 10.1042/bj2230599; Mertens K, 1999, THROMB HAEMOSTASIS, V82, P209; OBRIEN LM, 1995, J BIOL CHEM, V270, P27087, DOI 10.1074/jbc.270.45.27087; OLSEN ENH, 2001, THROMB HAEMOSTASIS S, V86; PADMANABHAN K, 1993, J MOL BIOL, V232, P947, DOI 10.1006/jmbi.1993.1441; Pike ACW, 1999, P NATL ACAD SCI USA, V96, P8925, DOI 10.1073/pnas.96.16.8925; REES DJG, 1988, EMBO J, V7, P2053, DOI 10.1002/j.1460-2075.1988.tb03045.x; ROBERTS HR, 1993, THROMB HAEMOSTASIS, V70, P1; Stenflo J, 1999, CRIT REV EUKAR GENE, V9, P59, DOI 10.1615/CritRevEukaryotGeneExpr.v9.i1.50; TAO BY, 1994, PCR TECHNOLOGY CURRE, P71; Wilkinson FH, 2002, J BIOL CHEM, V277, P5734, DOI 10.1074/jbc.M107753200	35	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20214	20220		10.1074/jbc.M108446200	http://dx.doi.org/10.1074/jbc.M108446200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11925427	hybrid			2022-12-27	WOS:000176204500017
J	Filipek, A; Jastrzebska, B; Nowotny, M; Kwiatkowska, K; Hetman, M; Surmacz, L; Wyroba, E; Kuznicki, J				Filipek, A; Jastrzebska, B; Nowotny, M; Kwiatkowska, K; Hetman, M; Surmacz, L; Wyroba, E; Kuznicki, J			Ca2+-dependent translocation of the calcyclin-binding protein in neurons and neuroblastoma NB-2a cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING; KINASE-C; SUBCELLULAR-LOCALIZATION; HIPPOCAMPAL-NEURONS; IN-VITRO; S100; FAMILY; TARGET; ASSOCIATION; EXPRESSION	The calcyclin-binding protein (CacyBP) binds calcyclin (S100A6) at physiological levels of [Ca2+] and is highly expressed in brain neurons. Subcellular localization of CacyBP was examined in neurons and neuroblastoma NB-2a cells at different [Ca2+](i). Immunostaining indicates that CacyBP is present in the cytoplasm of unstimulated cultured neurons in which resting [Ca2+](i) is known to be similar to50 nm. When [Ca2+]i was increased to above 300 nm by KCl treatment, the immunostaining was mainly apparent as a ring around the nucleus. Such perinuclear localization of CacyBP was observed in untreated neuroblastoma NB-2a cells in which [Ca2+]. is similar to120 nm. An additional increase in [Ca2+](i) to above 300 nm by thapsigargin treatment did not change CacyBP localization. However, when [Ca2+](i) in NB-2a cells dropped to 70 nm, because of BAPTA/AM treatment, perinuclear localization was diminished. Ca2+-induced translocation of CacyBP was confirmed by immunogold electron microscopy and by fluorescence of NB-2a cells transfected with an EGFP-CacyBP vector. Recombinant CacyBP can be phosphorylated by protein kinase C in vitro. In untreated neuroblastoma NB-2a cells, CacyBP is phosphorylated on a serine residue(s), but exists in the dephosphorylated form in BAPTA/AM-treated cells. Thus, phosphorylation of CacyBP occurs in the same [Ca2+](i) range that leads to its perinuclear translocation.	M Nencki Inst Expt Biol, PL-02093 Warsaw, Poland; Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej	Filipek, A (corresponding author), M Nencki Inst Expt Biol, 3 Pasteur St, PL-02093 Warsaw, Poland.	anfil@nencki.gov.pl	Kwiatkowska, Katarzyna/ABE-9713-2021; Wyroba, Elzbieta/R-7525-2016; Kuznicki, Jacek/AAW-9239-2020; Surmacz, Liliana/I-3458-2016; Wyroba, Elzbieta/P-4434-2019	Kwiatkowska, Katarzyna/0000-0002-0550-8394; Kuznicki, Jacek/0000-0001-6486-0657; Filipek, Anna/0000-0001-9484-9555; Surmacz, Liliana/0000-0002-9517-1608				Ausubel F.M., 1992, SHORT PROTOCOLS MOL; BARANSKA J, 1995, CELL CALCIUM, V17, P207, DOI 10.1016/0143-4160(95)90035-7; BAUDIER J, 1992, P NATL ACAD SCI USA, V89, P11627, DOI 10.1073/pnas.89.23.11627; Brooks P, 2000, BIOCHEM J, V346, P155, DOI 10.1042/0264-6021:3460155; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Filipek A, 1998, J NEUROCHEM, V70, P1793, DOI 10.1046/j.1471-4159.1998.70051793.x; Filipek A, 1996, BIOCHEM J, V320, P585, DOI 10.1042/bj3200585; Gentil BJ, 2001, J BIOL CHEM, V276, P23253, DOI 10.1074/jbc.M010655200; GIBBS FEM, 1994, J BIOL CHEM, V269, P18992; GRYNKIEWICZ G, 1982, J BIOL CHEM, V60, P3440; Hayashi T, 1997, J NEURAL TRANSM, V104, P811, DOI 10.1007/BF01285550; Heierhorst J, 1996, NATURE, V380, P636, DOI 10.1038/380636a0; Heizmann CW, 1998, BIOMETALS, V11, P383, DOI 10.1023/A:1009212521172; Ilg EC, 1996, INT J CANCER, V68, P325, DOI 10.1002/(SICI)1097-0215(19961104)68:3<325::AID-IJC10>3.0.CO;2-7; Ishibashi Y, 2001, FEBS LETT, V506, P33, DOI 10.1016/S0014-5793(01)02881-2; Jastrzebska B, 2000, J HISTOCHEM CYTOCHEM, V48, P1195, DOI 10.1177/002215540004800903; Kaminska B, 2001, BRIT J PHARMACOL, V133, P997, DOI 10.1038/sj.bjp.0704177; KAWAHARA H, 1994, DEV BIOL, V166, P623, DOI 10.1006/dbio.1994.1342; KLIGMAN D, 1988, TRENDS BIOCHEM SCI, V13, P437, DOI 10.1016/0968-0004(88)90218-6; KUZNICKI J, 1996, GUIDEBOOK CALCIUM BI, P143; Lin J, 2001, J BIOL CHEM, V276, P35037, DOI 10.1074/jbc.M104379200; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Millward TA, 1998, EMBO J, V17, P5913, DOI 10.1093/emboj/17.20.5913; Narita K, 1998, J GEN PHYSIOL, V112, P593, DOI 10.1085/jgp.112.5.593; Nowotny M, 2000, J BIOL CHEM, V275, P31178, DOI 10.1074/jbc.M001622200; Pircher TJ, 2001, J BIOL CHEM, V276, P8995, DOI 10.1074/jbc.M007473200; RANDALL RD, 1992, J NEUROSCI, V12, P1882; REGGIO H, 1983, METHOD ENZYMOL, V98, P379; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Scotto C, 1998, MOL CELL BIOL, V18, P4272, DOI 10.1128/MCB.18.7.4272; Scotto C, 1999, MOL CELL BIOL, V19, P7168; Stradal TB, 1999, J BIOL CHEM, V274, P31593, DOI 10.1074/jbc.274.44.31593; Sussman J, 2001, J CELL BIOL, V154, P1019, DOI 10.1083/jcb.200105121; VEIGL ML, 1983, BIOCHIM BIOPHYS ACTA, V738, P21, DOI 10.1016/0304-419X(84)90018-0; Wang LJ, 1998, DEV BRAIN RES, V105, P227, DOI 10.1016/S0165-3806(97)00180-6; Xia ZB, 2000, J HEMATOTH STEM CELL, V9, P651, DOI 10.1089/15258160050196696; Zhao XQ, 2000, BIOCHEM BIOPH RES CO, V267, P77, DOI 10.1006/bbrc.1999.1918; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	38	47	54	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					21103	21109		10.1074/jbc.M111010200	http://dx.doi.org/10.1074/jbc.M111010200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11927578	hybrid			2022-12-27	WOS:000176204500126
J	Hernandez-Acosta, P; Schmid, DG; Jung, G; Culianez-Macia, FA; Kupke, T				Hernandez-Acosta, P; Schmid, DG; Jung, G; Culianez-Macia, FA; Kupke, T			Molecular characterization of the Arabidopsis thaliana flavoprotein AtHAL3a reveals the general reaction mechanism of 4 '-phosphopantothenoylcysteine decarboxylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A BIOSYNTHESIS; OXIDATIVE DECARBOXYLATION; MASS-SPECTROMETRY; ESCHERICHIA-COLI; SUBSTRATE; PEPTIDES; EPIDERMIN; PROTEINS; BACTERIA; ENZYME	The Arabidopsis thaliana flavoprotein AtHAL3a, which is linked to plant growth and salt and osmotic tolerance, catalyzes the decarboxylation of 4'-phosphopantothenoyleysteine to 4'-phosphopantetheine, a key step in coenzyme A biosynthesis. AtHAL3a is similar in sequence and structure to the LanD enzymes EpiD and MrsD, which catalyze the oxidative decarboxylation of peptidylcysteines. Therefore, we hypothesized that the decarboxylation of 4'-phosphopantothenoylcysteine also occurs via an oxidatively decarboxylated intermediate containing an aminoenethiol group. A set of AtHAL3a mutants were analyzed to detect such an intermediate. By exchanging Lys(34), we found that AtHAL3a is not only able to decarboxylate 4'-phosphopantothenoylcysteine but also pantothenoyleysteine to pantothenoylcysteamine. Exchanging residues within the substrate binding clamp of AtHAL3a (for example of Gly(179)) enabled the detection of the proposed aminoenethiol intermediate when pantothenoylcysteine was used as substrate. This intermediate was characterized by its high absorbance at 260 and 280 nm, and the removal of two hydrogen atoms and one molecule of CO2 was confirmed by ultrahigh resolution mass spectrometry. Using the mutant AtHAL3a C175S enzyme, the product pantothenoyleysteamine was not detectable; however, oxidatively decarboxylated pantothenoylcysteine could be identified. This result indicates that reduction of the aminoenethiol intermediate depends on a redox-active cysteine residue in AtHAL3a.	Univ Tubingen, Lehrstuhl Mikrobiol Genet, D-72076 Tubingen, Germany; Univ Tubingen, Inst Organ Chem, D-72076 Tubingen, Germany; Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia 46022, Spain	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Kupke, T (corresponding author), Univ Tubingen, Lehrstuhl Mikrobiol Genet, Morgenstelle 15,Verfugungsgebaude, D-72076 Tubingen, Germany.		Zhang, Ning/F-1387-2014	Kupke, Thomas/0000-0003-2341-1710				Albert A, 2000, STRUCTURE, V8, P961, DOI 10.1016/S0969-2126(00)00187-8; Audi G, 1995, NUCL PHYS A, V595, P409, DOI 10.1016/0375-9474(95)00445-9; Blaesse M, 2000, EMBO J, V19, P6299, DOI 10.1093/emboj/19.23.6299; Cormack B., 1991, CURRENT PROTOCOLS MO, V1, P851; Espinosa-Ruiz A, 1999, PLANT J, V20, P529, DOI 10.1046/j.1365-313X.1999.00626.x; Kempter C, 1996, ANGEW CHEM INT EDIT, V35, P2104, DOI 10.1002/anie.199621041; Kupke T, 1997, J BIOL CHEM, V272, P4759, DOI 10.1074/jbc.272.8.4759; Kupke T, 2000, J BIOL CHEM, V275, P31838, DOI 10.1074/jbc.M004273200; KUPKE T, 1992, J BACTERIOL, V174, P5354, DOI 10.1128/JB.174.16.5354-5361.1992; KUPKE T, 1994, J BIOL CHEM, V269, P5653; Kupke T, 2001, J BIOL CHEM, V276, P19190, DOI 10.1074/jbc.M100776200; Kupke T, 2001, J BIOL CHEM, V276, P27597, DOI 10.1074/jbc.M103342200; KUPKE T, 1995, J BIOL CHEM, V270, P11282, DOI 10.1074/jbc.270.19.11282; Majer F, 2002, J BACTERIOL, V184, P1234, DOI 10.1128/JB.184.5.1234-1243.2002; Marshall AG, 1998, MASS SPECTROM REV, V17, P1, DOI 10.1002/(SICI)1098-2787(1998)17:1<1::AID-MAS1>3.0.CO;2-K; Sahl HG, 1998, ANNU REV MICROBIOL, V52, P41, DOI 10.1146/annurev.micro.52.1.41; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHNELL N, 1988, NATURE, V333, P276, DOI 10.1038/333276a0; SPITZER ED, 1985, J BACTERIOL, V164, P994, DOI 10.1128/JB.164.3.994-1003.1985; Strauss E, 2001, J AM CHEM SOC, V123, P6449, DOI 10.1021/ja016020y; Strauss E, 2001, J BIOL CHEM, V276, P13513, DOI 10.1074/jbc.C100033200	21	36	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20490	20498		10.1074/jbc.M201557200	http://dx.doi.org/10.1074/jbc.M201557200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11923307	hybrid			2022-12-27	WOS:000176204500051
J	Kang, SG; Ortega, J; Singh, SK; Wang, N; Huang, NN; Steven, AC; Maurizi, MR				Kang, SG; Ortega, J; Singh, SK; Wang, N; Huang, NN; Steven, AC; Maurizi, MR			Functional proteolytic complexes of the human mitochondrial ATP-dependent protease, hClpXP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI CLPP; SACCHAROMYCES-CEREVISIAE; SPASTIC PARAPLEGIA; BACTERIAL CLPX; PIM1 PROTEASE; HUMAN HOMOLOG; PROTEINS; DEGRADATION; CHAPERONE; SEQUENCE	Human mitochondrial ClpP (hClpP) and ClpX (hClpX) were separately cloned, and the expressed proteins were purified. Electron microscopy confirmed that hClpP forms heptameric rings and that hClpX forms a hexameric ring. Complexes of a double heptameric ring of hClpP with hexameric hClpX rings bound on each side are stable in the presence of ATP or adenosine 5'-(3-thiotriphosphate) (ATPgammaS), indicating that a symmetry mismatch is a universal feature of Clp proteases. hClpXP displays both ATP-dependent proteolytic activity and ATP- or ATPgammaS-dependent peptidase activity. hClpXP cannot degrade lambdaO protein or GFP-SsrA, specific protein substrates recognized by Escherichia coli (e) ClpXP. However, eClpX interacts with hClpP, and, when examined by electron microscopy, the resulting heterologous complexes are indistinguishable from homologous eClpXP complexes. The hybrid eClpX-hClpP complexes degrade eClpX-specific protein substrates. In contrast, eClpA can neither associate with nor activate hClpP. hClpP has an extra C-terminal extension of 28 amino acids. A mutant lacking this C-terminal extension interacts more tightly with both hClpX and eClpX and shows enhanced enzymatic activities but still does not interact with eCIpA. Our results establish that human ClpX and ClpP constitute a bone fide ATP-dependent protease and confirm that substrate selection, which differs between human and E. coli ClpX, is dependent solely on the Clp ATPase. Our data also indicate that human ClpP has conserved sites required for interaction with eClpX but not eCIpA, implying that the modes of interaction with ClpP may not be identical for ClpA and ClpX.	NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; NIAMS, Struct Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Maurizi, MR (corresponding author), NCI, Cell Biol Lab, NIH, Bldg 37 Room 1B09,37 Convent Dr,MSC 4255, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR027015, Z01AR027015] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Adam Z, 2001, PLANT PHYSIOL, V125, P1912, DOI 10.1104/pp.125.4.1912; ADAMS MD, 1993, NAT GENET, V4, P256, DOI 10.1038/ng0793-256; Arlt H, 1996, CELL, V85, P875, DOI 10.1016/S0092-8674(00)81271-4; Bross P, 1995, FEBS LETT, V377, P249, DOI 10.1016/0014-5793(95)01353-9; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Corydon TJ, 2000, MAMM GENOME, V11, P899, DOI 10.1007/s003350010173; Corydon TJ, 1998, BIOCHEM J, V331, P309, DOI 10.1042/bj3310309; de Sagarra MR, 1999, J MOL BIOL, V292, P819, DOI 10.1006/jmbi.1999.3121; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; Gottesman S, 1995, COLD SPRING HARB SYM, V60, P533, DOI 10.1101/SQB.1995.060.01.057; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; GOTTESMAN S, 1993, J BIOL CHEM, V268, P22618; GOTTESMAN S, 1992, MICROBIOL REV, V56, P592, DOI 10.1128/MMBR.56.4.592-621.1992; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Kocsis E, 1995, ULTRAMICROSCOPY, V60, P219, DOI 10.1016/0304-3991(95)00070-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langer T, 1996, EXPERIENTIA, V52, P1069, DOI 10.1007/BF01952104; LEVCHENKO I, 1995, GENE DEV, V9, P2399, DOI 10.1101/gad.9.19.2399; Majeran W, 2000, PLANT CELL, V12, P137; MAURIZI MR, 1994, METHOD ENZYMOL, V244, P314; Ortega J, 2000, MOL CELL, V6, P1515, DOI 10.1016/S1097-2765(00)00148-9; Pearce DA, 1999, HUM GENET, V104, P443, DOI 10.1007/s004390050985; Santagata S, 1999, J BIOL CHEM, V274, P16311, DOI 10.1074/jbc.274.23.16311; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Singh SK, 2001, J BIOL CHEM, V276, P29420, DOI 10.1074/jbc.M103489200; STUART RA, 1994, EXPERIENTIA, V50, P1002, DOI 10.1007/BF01923454; Suzuki CK, 1997, TRENDS BIOCHEM SCI, V22, P118, DOI 10.1016/S0968-0004(97)01020-7; SUZUKI CK, 1994, SCIENCE, V264, P273, DOI 10.1126/science.8146662; THOMPSON MW, 1994, J BIOL CHEM, V269, P18201; THOMPSON MW, 1994, J BIOL CHEM, V269, P18209; Trus BL, 1996, J STRUCT BIOL, V116, P61, DOI 10.1006/jsbi.1996.0011; van Dyck L, 1998, GENE DEV, V12, P1515, DOI 10.1101/gad.12.10.1515; van Dyck L, 1998, FEBS LETT, V438, P250, DOI 10.1016/S0014-5793(98)01310-6; Van Dyck L, 1999, CELL MOL LIFE SCI, V56, P825, DOI 10.1007/s000180050029; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; WAGNER I, 1994, EMBO J, V13, P5135, DOI 10.1002/j.1460-2075.1994.tb06843.x; Young L, 2001, SCIENCE, V291, P2135, DOI 10.1126/science.1056957	41	100	105	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					21095	21102		10.1074/jbc.M201642200	http://dx.doi.org/10.1074/jbc.M201642200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11923310	hybrid			2022-12-27	WOS:000176204500125
J	Martino, S; Emiliani, C; Tancini, B; Severini, GM; Chigorno, V; Bordignon, C; Sonnino, S; Orlacchio, A				Martino, S; Emiliani, C; Tancini, B; Severini, GM; Chigorno, V; Bordignon, C; Sonnino, S; Orlacchio, A			Absence of metabolic cross-correction in Tay-Sachs cells. Implications for gene therapy.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-N-ACETYLHEXOSAMINIDASE; LYSOSOMAL STORAGE DISEASES; ALPHA-SUBUNIT; HEXOSAMINIDASE-A; CHAIN; DIMETHYLSULFOXIDE; OLIGOSACCHARIDE; FIBROBLASTS; EXPRESSION; TRANSPORT	We have investigated the ability of a receptor-mediated gene transfer strategy (cross-correction) to restore ganglioside metabolism in fibroblasts from Tay-Sachs (TS) patients in vitro. TS disease is a GM2 gangliosidosis attributed to the deficiency of the lysosomal enzyme beta-hexosaminidase A (HexA) (beta-N-acetylhexosaminidase, EC 3.2.1.52). The hypothesis is that transduced cells overexpressing and secreting large amounts of the enzyme would lead to a measurable activity in defective cells via a secretion-recapture mechanism. We transduced NIH3T3 murine fibroblasts with the LalphaHexTN retroviral vector carrying the cDNA encoding for the human Hex a-subunit. The Hex activity in the medium from transduced cells was approximately 10-fold higher (up to 75 milliunits) than observed in non-transduced cells. TS cells were cultured for 72 h in the presence of the cell medium derived from the transduced NIH3T3 cells, and they were analyzed for the presence and catalytic activity of the enzyme. Although TS cells were able to efficiently uptake a large amount of the soluble enzyme, the enzyme failed to reach the lysosomes in a sufficient quantity to hydrolyze the GM2 ganglioside to GM3 ganglioside. Thus, our results showed that delivery of the therapeutic HexA was not sufficient to correct the phenotype of TS cells.	Univ Perugia, Dipartimento Sci Biochim & Biotecnol Mol, I-06126 Perugia, Italy; Hosp San Raffaele, San Raffaele Telethon Inst Gene Therapy, I-20132 Milan, Italy; Childrens Hosp Burlo Garofolo, I-34100 Trieste, Italy; Univ Milan, Study Ctr Biochem & Biotechnol Glycolipids, Ctr Excellence Neurodegenerat Dis, Dept Med Chem & Biochem, I-20090 Segrate, Italy	University of Perugia; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Burlo Garofolo; University of Milan	Orlacchio, A (corresponding author), Univ Perugia, Dipartimento Sci Biochim & Biotecnol Mol, Via Giochetto, I-06126 Perugia, Italy.	martino.sabata@hsr.it	Emiliani, Carla/G-3738-2010; Tancini, Brunella/F-6467-2014; Sonnino, Sandro/R-4154-2017; Martino, Sabata/F-2309-2014	Emiliani, Carla/0000-0002-6368-1515; Tancini, Brunella/0000-0001-9070-5765; Sonnino, Sandro/0000-0001-8180-5908; Martino, Sabata/0000-0002-3942-237X	Telethon [TGT00B02, TGT06S01] Funding Source: Medline	Telethon(Fondazione Telethon)		ACQUOTTI D, 1990, J AM CHEM SOC, V112, P7772, DOI 10.1021/ja00177a043; Akli S, 1996, GENE THER, V3, P769; BANERJEE P, 1994, J BIOL CHEM, V269, P4819; Barranger JA, 1999, NEUROCHEM RES, V24, P601, DOI 10.1023/A:1022548232735; BECCARI T, 1987, BIOCHEM J, V244, P801, DOI 10.1042/bj2440801; BEUTLER E, 1997, CURR OPIN HEMATOL, V1, P19; Bonini C, 1997, SCIENCE, V276, P1719, DOI 10.1126/science.276.5319.1719; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brady RO, 2000, JAMA-J AM MED ASSOC, V284, P2771, DOI 10.1001/jama.284.21.2771; BROCCA P, 1993, GLYCOCONJUGATE J, V10, P441, DOI 10.1007/BF00737964; Chen CS, 1999, LANCET, V354, P901, DOI 10.1016/S0140-6736(98)10034-X; Chen CS, 1998, P NATL ACAD SCI USA, V95, P6373, DOI 10.1073/pnas.95.11.6373; Chigorno V, 1985, GLYCOCONJUGATE J, VV2, P279; Consiglio A, 2001, NAT MED, V7, P310, DOI 10.1038/85454; EMILIANI C, 1990, BIOCHEM J, V267, P111, DOI 10.1042/bj2670111; EMILIANI C, 1992, INT J BIOCHEM, V24, P539, DOI 10.1016/0020-711X(92)90324-T; EMILIANI C, 1990, BIOCHEM J, V272, P211, DOI 10.1042/bj2720211; Eto Y, 2000, J INHERIT METAB DIS, V23, P293, DOI 10.1023/A:1005692215317; GRAVEL RA, 2001, METABOLIC MOL BASES, V3, P30827; Guidotti JE, 1999, HUM MOL GENET, V8, P831, DOI 10.1093/hmg/8.5.831; Guidotti JE, 1998, HUM MOL GENET, V7, P831, DOI 10.1093/hmg/7.5.831; HASILIK A, 1982, EUR J BIOCHEM, V125, P317, DOI 10.1111/j.1432-1033.1982.tb06685.x; Hepbildikler ST, 2002, J BIOL CHEM, V277, P2562, DOI 10.1074/jbc.M105457200; Hou YM, 1996, BIOCHEMISTRY-US, V35, P3963, DOI 10.1021/bi9524575; IKONNE JU, 1975, AM J HUM GENET, V27, P639; Ioannou YA, 2000, J AM SOC NEPHROL, V11, P1542, DOI 10.1681/ASN.V1181542; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kolter T, 1999, BIOCHEM SOC T, V27, P409, DOI 10.1042/bst0270409; KORNELUK RG, 1986, J BIOL CHEM, V261, P8407; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; Lacorazza HD, 1996, NAT MED, V2, P424, DOI 10.1038/nm0496-424; Le Borgne R, 1998, BBA-MOL CELL RES, V1404, P195, DOI 10.1016/S0167-4889(98)00057-3; MAHURAN D, 1985, ISOZYMES-CURR T BIOL, V12, P229; Mahuran DJ, 1999, BBA-MOL BASIS DIS, V1455, P105, DOI 10.1016/S0925-4439(99)00074-5; MARTINO S, 1995, BBA-GEN SUBJECTS, V1243, P489, DOI 10.1016/0304-4165(94)00179-2; Martino S, 1997, BBA-GEN SUBJECTS, V1335, P5, DOI 10.1016/S0304-4165(96)00116-X; MEIER EM, 1991, J BIOL CHEM, V266, P1879; MunierLehmann H, 1996, BIOCHEM SOC T, V24, P133, DOI 10.1042/bst0240133; MYEROWITZ R, 1985, P NATL ACAD SCI USA, V82, P7830, DOI 10.1073/pnas.82.23.7830; NEUFELD EF, 1991, ANNU REV BIOCHEM, V60, P257, DOI 10.1146/annurev.biochem.60.1.257; Pagano RE, 2000, TRAFFIC, V1, P807, DOI 10.1034/j.1600-0854.2000.011101.x; Poenaru L, 1996, GENE THER, V3, P1039; PROIA RL, 1984, J BIOL CHEM, V259, P3350; Schmid JA, 1999, J BIOL CHEM, V274, P19063, DOI 10.1074/jbc.274.27.19063; Sena-Esteves M, 2000, HUM GENE THER, V11, P715, DOI 10.1089/10430340050015617; Sonnino S, 2000, METHOD ENZYMOL, V311, P639; Sonnino S, 1996, GLYCOBIOLOGY, V6, P479, DOI 10.1093/glycob/6.5.479-e; Tancini B, 2000, BBA-GEN SUBJECTS, V1475, P184, DOI 10.1016/S0304-4165(00)00057-X; TETTAMAN.G, 1973, BIOCHIM BIOPHYS ACTA, V296, P160, DOI 10.1016/0005-2760(73)90055-6; Wada R, 2000, P NATL ACAD SCI USA, V97, P10954, DOI 10.1073/pnas.97.20.10954; WEITZ G, 1992, J BIOL CHEM, V267, P10039; Winchester B, 2000, BIOCHEM SOC T, V28, P150, DOI 10.1042/bst0280150	52	31	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20177	20184		10.1074/jbc.M106164200	http://dx.doi.org/10.1074/jbc.M106164200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11923278	hybrid			2022-12-27	WOS:000176204500013
J	Yamagishi, S; Inagaki, Y; Okamoto, T; Amano, S; Koga, K; Takeuchi, M; Makita, Z				Yamagishi, S; Inagaki, Y; Okamoto, T; Amano, S; Koga, K; Takeuchi, M; Makita, Z			Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL SUPEROXIDE-PRODUCTION; PROSTACYCLIN-PRODUCING ABILITY; DIABETIC-NEPHROPATHY; FACTOR-BETA; RECEPTOR; BAX; PROLIFERATION; BIOCHEMISTRY; EXPRESSION; INHIBITOR	Advanced glycation end products (AGE) have been implicated in the pathogenesis of glomerulosclerosis in diabetes. However, their involvement in the development of the early phase of diabetic nephropathy has not been fully elucidated. We investigated the effects of AGE on growth and on vascular endothelial growth factor (VEGF) and monocyte chemoattractant protein-1 (MCP-1) expression in human cultured mesangial cells. We prepared three immunochemically distinct AGE by incubating bovine serum albumin (BSA) with glucose, glyceraldehyde, or glycolaldehyde. When human mesangial cells were cultured with various types of AGE-BSA, viable cell numbers as well as DNA syntheses were significantly decreased. All of the AGE-BSA were found to significantly increase p53 and Bax protein accumulations and subsequently induce apoptotic cell death in mesangial cells. An antioxidant, N-acetylcysteine, significantly prevented the AGE-induced apoptotic cell death in mesangial cells. Human mesangial cells stimulated prostacyclin production by co-cultured glomerular endothelial cells. Furthermore, various types of AGE-BSA were found to up-regulate the levels of mRNAs for VEGF and stimulate the secretion of VEGF and MCP-1 proteins in mesangial cells. The results suggest that AGE disturbed glomerular homeostasis by inducing apoptotic cell death in mesangial cells and elicited hyperfiltration and microalbuminuria by stimulating the secretion of VEGF and MCP-1 proteins, thereby being involved in the pathogenesis of the early phase of diabetic nephropathy.	Kurume Univ, Sch Med, Dept Med, Div Endocrinol & Metab, Kurume, Fukuoka 8300011, Japan; Hokuriku Univ, Fac Pharmaceut Sci, Dept Biochem, Kanazawa, Ishikawa 9201181, Japan	Kurume University; Hokuriku University	Yamagishi, S (corresponding author), Kurume Univ, Sch Med, Dept Med, Div Endocrinol & Metab, Kurume, Fukuoka 8300011, Japan.	shoichi@med.kurume-u.ac.jp						ADAMIS AP, 1994, AM J OPHTHALMOL, V118, P445, DOI 10.1016/S0002-9394(14)75794-0; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Agarwal ML, 1998, J BIOL CHEM, V273, P1, DOI 10.1074/jbc.273.1.1; Banba N, 2000, KIDNEY INT, V58, P684, DOI 10.1046/j.1523-1755.2000.00214.x; BERN MM, 1978, DIABETES, V27, P342, DOI 10.2337/diab.27.3.342; BROWNLEE M, 1981, ANNU REV BIOCHEM, V50, P385, DOI 10.1146/annurev.bi.50.070181.002125; BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315; BUCALA R, 1994, P NATL ACAD SCI USA, V91, P9441, DOI 10.1073/pnas.91.20.9441; Cha DR, 2000, KIDNEY INT, V58, pS104, DOI 10.1046/j.1523-1755.2000.07717.x; Choudhuri T, 2002, FEBS LETT, V512, P334, DOI 10.1016/S0014-5793(02)02292-5; De Vriese A, 2001, J AM SOC NEPHROL, V12, P993, DOI 10.1681/ASN.V125993; DONADIO JV, 1988, MAYO CLIN PROC, V63, P3, DOI 10.1016/S0025-6196(12)62658-5; DWORKIN LD, 1983, AM J PHYSIOL, V244, pF95, DOI 10.1152/ajprenal.1983.244.2.F95; FRIEDMAN EA, 1990, ELLENBERG RIFKINS DI, P684; Giustina A, 1998, DIABETES, V47, P423, DOI 10.2337/diabetes.47.3.423; HABEEB AFS, 1966, ANAL BIOCHEM, V14, P328, DOI 10.1016/0003-2697(66)90275-2; HOUCK KA, 1991, MOL ENDOCRINOL, V5, P1806, DOI 10.1210/mend-5-12-1806; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; KREISBERG J, 1985, AM J PHYSIOL, V249, pF457, DOI 10.1152/ajprenal.1985.249.4.F457; KROLEWSKI AS, 1991, AM J MED S2A, V90, P56; MAKINO H, 1995, KIDNEY INT, V48, P517, DOI 10.1038/ki.1995.322; MAKITA Z, 1991, NEW ENGL J MED, V325, P836, DOI 10.1056/NEJM199109193251202; MAKITA Z, 1992, SCIENCE, V258, P651, DOI 10.1126/science.1411574; MONCADA S, 1978, PHARMACOL REV, V30, P293; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; NOMURA M, 1995, J BIOL CHEM, V270, P28316; Ono Y, 1998, J DIABETES COMPLICAT, V12, P252, DOI 10.1016/S1056-8727(97)00091-3; Podesta F, 2000, AM J PATHOL, V156, P1025, DOI 10.1016/S0002-9440(10)64970-X; Pugliese G, 1997, DIABETES, V46, P1881, DOI 10.2337/diabetes.46.11.1881; Raj DSC, 2000, AM J KIDNEY DIS, V35, P365, DOI 10.1016/S0272-6386(00)70189-2; Sandau K, 1997, KIDNEY INT, V52, P378, DOI 10.1038/ki.1997.344; SCHLONDORFF D, 1987, FASEB J, V1, P272, DOI 10.1096/fasebj.1.4.3308611; SCHWARTZMAN RA, 1993, ENDOCR REV, V14, P133, DOI 10.1210/er.14.2.133; SHARMA K, 1995, DIABETES, V44, P1139, DOI 10.2337/diabetes.44.10.1139; Takeuchi M, 1999, MOL MED, V5, P393, DOI 10.1007/BF03402128; Takeuchi M, 2000, J NEUROPATH EXP NEUR, V59, P1094, DOI 10.1093/jnen/59.12.1094; Tsuchida K, 1999, DIABETOLOGIA, V42, P579, DOI 10.1007/s001250051198; Wenzel UO, 1995, AM J KIDNEY DIS, V26, P982, DOI 10.1016/0272-6386(95)90065-9; Yamagishi S, 1999, LAB INVEST, V79, P501; Yamagishi S, 1997, J BIOL CHEM, V272, P8723, DOI 10.1074/jbc.272.13.8723; Yamagishi S, 1998, DIABETOLOGIA, V41, P1435, DOI 10.1007/s001250051089; Yamagishi S, 1996, FEBS LETT, V384, P103, DOI 10.1016/0014-5793(96)00279-7; Yamagishi S, 1999, MICROVASC RES, V57, P329, DOI 10.1006/mvre.1999.2145; YAMAGISHI S, 1993, BIOCHEM BIOPH RES CO, V191, P840, DOI 10.1006/bbrc.1993.1293; Yamagishi S, 2002, BIOCHEM BIOPH RES CO, V290, P973, DOI 10.1006/bbrc.2001.6312; Yamagishi S, 1999, BIOCHEM BIOPH RES CO, V258, P353, DOI 10.1006/bbrc.1999.0625; Yamagishi S, 2001, DIABETES, V50, P1491, DOI 10.2337/diabetes.50.6.1491; YAMAGISHI S, 1993, BIOCHEM BIOPH RES CO, V190, P418, DOI 10.1006/bbrc.1993.1064; YAMAGISHI SI, 1995, BIOCHEM BIOPH RES CO, V213, P681, DOI 10.1006/bbrc.1995.2185; Yamagishi SI, 2001, J BIOL CHEM, V276, P25096, DOI 10.1074/jbc.M007383200; Yamamoto Y, 2001, J CLIN INVEST, V108, P261, DOI 10.1172/JCI11771; YONISHROUACH E, 1993, MOL CELL BIOL, V13, P1415, DOI 10.1128/MCB.13.3.1415	52	291	311	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20309	20315		10.1074/jbc.M202634200	http://dx.doi.org/10.1074/jbc.M202634200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11912219	hybrid			2022-12-27	WOS:000176204500029
J	Jain, RG; Lenhard, JM				Jain, RG; Lenhard, JM			Select HIV protease inhibitors alter bone and fat metabolism ex vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; MESENCHYMAL STEM-CELLS; MINERAL LOSS; DIFFERENTIATION; OSTEONECROSIS; DENSITY; MEN	Human immunodeficiency virus (HIV) therapies have been associated with alterations in fat metabolism and bone mineral density. This study examined the effects of HIV protease inhibitors (PIs) on bone resorption, bone formation, and adipocyte differentiation using ex vivo cultured osteoclasts, osteoblasts, and adipocytes, respectively. Osteoclast activity, measured using a rat neonatal calvaria assay, increased in the presence of nelfinavir (NFV; 47.2%, p = 0.001), indinavir (34.6%, p = 0.001), saquinavir (24.3%, p = 0.001), or ritonavir (18%, p < 0.01). In contrast, lopinavir (LPV) and amprenavir did not increase osteoclast activity. In human mesenchymal stem cells (hMSCs), the PIs LPV and NFV decreased osteoblast alkaline phosphatase enzyme activity and gene expression significantly (p < 0.05). LPV and NFV diminished calcium deposition and osteoprotegrin expression (p < 0.05), whereas the other PIs investigated did not. Adipogenesis of hMSCs was strongly inhibited by saquinavir and NFV (>50%,p < 0.001) and moderately inhibited by ritonavir and LPV (40%,p < 0.01). Expression of diacylglycerol transferase, a marker of adipocyte differentiation, decreased in hMSCs treated with NFV. Amprenavir and indinavir did not affect adipogenesis or lipolysis. These results suggest that bone and fat formation in hMSCs of bone marrow may be coordinately down-regulated by some but not all PIs.	GlaxoSmithKline Inc, Dept Metab Dis, Res Triangle Pk, NC 27709 USA	GlaxoSmithKline	Lenhard, JM (corresponding author), GlaxoSmithKline Inc, Dept Metab Dis, 5 Moore Dr, Res Triangle Pk, NC 27709 USA.	jml29514@gsk.com						Aukrust P, 1999, J CLIN ENDOCR METAB, V84, P145, DOI 10.1210/jc.84.1.145; Beach JW, 1998, CLIN THER, V20, P2; Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F; Carr A, 2001, AIDS, V15, P703, DOI 10.1097/00002030-200104130-00005; Dowell P, 2000, J BIOL CHEM, V275, P41325, DOI 10.1074/jbc.M006474200; DUBE MP, 2002, IN PRESS CLIN INFECT; Huang JS, 2001, AIDS, V15, P975, DOI 10.1097/00002030-200105250-00005; Jain RG, 2001, ANTIVIR RES, V51, P151, DOI 10.1016/S0166-3542(01)00148-6; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Lenhard JM, 2000, ANTIVIR RES, V47, P121, DOI 10.1016/S0166-3542(00)00102-9; Lenhard JM, 2000, ARTERIOSCL THROM VAS, V20, P2625, DOI 10.1161/01.ATV.20.12.2625; Major NM, 1997, RADIOL CLIN N AM, V35, P1167; Meyer D, 1999, AIDS, V13, P1147, DOI 10.1097/00002030-199906180-00025; Nolan D, 2001, AIDS, V15, P1275, DOI 10.1097/00002030-200107060-00009; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Scribner AN, 2000, J ACQ IMMUN DEF SYND, V25, P19, DOI 10.1097/00126334-200009010-00003; Tebas P, 2000, AIDS, V14, pF63, DOI 10.1097/00002030-200003100-00005; VARGAS SJ, 1990, BONE, V11, P61, DOI 10.1016/8756-3282(90)90073-8; Weiel JE, 2000, AIDS, V14, P2218, DOI 10.1097/00002030-200009290-00028; White AJ, 2001, SEX TRANSM INFECT, V77, P158, DOI 10.1136/sti.77.3.158; Zhang B, 1999, J CLIN ENDOCR METAB, V84, P4274, DOI 10.1210/jc.84.11.4274	22	113	115	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19247	19250		10.1074/jbc.C200069200	http://dx.doi.org/10.1074/jbc.C200069200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11937496	hybrid			2022-12-27	WOS:000175894800002
J	Kunzelmann-Marche, C; Freyssinet, JM; Martinez, MC				Kunzelmann-Marche, C; Freyssinet, JM; Martinez, MC			Loss of plasma membrane phospholipid asymmetry requires raft integrity - Role of transient receptor potential channels and ERK pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED CALCIUM-ENTRY; OPERATED CA2+ ENTRY; HUMAN PLATELETS; T-LYMPHOCYTES; LIPID RAFTS; TRANSBILAYER REDISTRIBUTION; PHOSPHATIDYLSERINE EXPOSURE; SIGNALING PATHWAYS; ACTIN CYTOSKELETON; STIMULATED CELLS	Cholesterol-rich membrane microdomains, also termed lipid rafts, are implicated in the recruitment of essential proteins for intracellular signal transduction. In nonstimulated cells, phosphatidylserine, an anionic aminophospholipid essential for the hemostatic response, is mostly sequestered in the inner leaflet of the plasma membrane. Cell stimulation by Ca2+-mobilizing or apoptogenic agents induces the migration of phosphatidylserine to the exoplasmic leaflet, allowing the assembly and activation of several key enzyme complexes of the coagulation cascade and phagocyte recognition of stimulated or senescent cells. We have recently proposed that store-operated Ca2+ entry regulates externalization of phosphatidylserine at the cell surface (Kunzelmann-Marche, C., Freyssinet, J.-M., and Martinez, M. C. (2001) J. Biol. Chem. 276, 5134-5139). Here, we show that store-operated Ca2+ entry and phosphatidylserine exposure are dramatically reduced after raft disruption by methyl-beta-cyclodextrin. In addition, transient receptor potential channel 1-specific antibody was able to significantly decrease Ca2+-induced redistribution of phosphatidylserine. Furthermore, store-operated Ca2+ entry and phosphatidylserine exposure were dependent in part on the extracellular signal-regulated kinase pathway associated with rafts. Hence, raft integrity and store-operated Ca2+ entry involving transient receptor potential channel 1 channels are essential for completion of the phosphatidylserine transmembrane redistribution process.	Univ Strasbourg 1, Inst Hematol & Immunol, Fac Med, F-67085 Strasbourg, France; Hop Bicetre, INSERM Unite 143, F-94275 Le Kremlin Bicetre, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Martinez, MC (corresponding author), Univ Strasbourg 1, Inst Hematol & Immunol, Fac Med, 4 Rue Kirschleger, F-67085 Strasbourg, France.		Freyssinet, Jean-Marie/G-2719-2013					Aman MJ, 2000, CURR BIOL, V10, P393, DOI 10.1016/S0960-9822(00)00415-2; ANDREE HAM, 1990, J BIOL CHEM, V265, P4923; Atherfold PA, 1999, MOL IMMUNOL, V36, P543, DOI 10.1016/S0161-5890(99)00076-0; Babiychuk EB, 2000, J CELL BIOL, V150, P1113, DOI 10.1083/jcb.150.5.1113; Barabe F, 2002, J BIOL CHEM, V277, P13473, DOI 10.1074/jbc.M112149200; Berg LP, 1997, FEBS LETT, V403, P83, DOI 10.1016/S0014-5793(97)00019-7; Berridge MJ, 2000, SCIENCE, V287, P1604, DOI 10.1126/science.287.5458.1604; Bishara NB, 2002, BRIT J PHARMACOL, V135, P119, DOI 10.1038/sj.bjp.0704465; Catani L, 1998, HAEMATOLOGICA, V83, P385; Christian AE, 1997, J LIPID RES, V38, P2264; CONNOR J, 1989, BIOCHEMISTRY-US, V28, P9680, DOI 10.1021/bi00451a021; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001; deWeerd WFC, 1997, J BIOL CHEM, V272, P17858, DOI 10.1074/jbc.272.28.17858; Dillon SR, 2000, J IMMUNOL, V164, P1322, DOI 10.4049/jimmunol.164.3.1322; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fasolato C, 1998, PFLUG ARCH EUR J PHY, V436, P69, DOI 10.1007/s004240050605; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fielding PE, 2000, BIOCHEMISTRY-US, V39, P14113, DOI 10.1021/bi0004192; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Hart KC, 2000, EXP CELL RES, V257, P89, DOI 10.1006/excr.2000.4874; Henson PM, 2001, NAT REV MOL CELL BIO, V2, P627, DOI 10.1038/35085094; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; Kukkonen JP, 2001, BRIT J PHARMACOL, V132, P1477, DOI 10.1038/sj.bjp.0703964; Kunzelmann-Marche C, 2001, J BIOL CHEM, V276, P5134, DOI 10.1074/jbc.M007924200; Lepage A, 1999, BLOOD, V94, P3366, DOI 10.1182/blood.V94.10.3366.422k35_3366_3380; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Martin S, 2000, BIOCHEM BIOPH RES CO, V279, P639, DOI 10.1006/bbrc.2000.3980; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Martinez MC, 1999, BIOCHEMISTRY-US, V38, P10092, DOI 10.1021/bi990129p; Mendez AJ, 2001, J BIOL CHEM, V276, P3158, DOI 10.1074/jbc.M007717200; Ohvo H, 1996, BIOCHEMISTRY-US, V35, P8018, DOI 10.1021/bi9528816; Parpal S, 2001, J BIOL CHEM, V276, P9670, DOI 10.1074/jbc.M007454200; Parton RG, 2001, SCIENCE, V293, P2404, DOI 10.1126/science.1065677; Pasquet JM, 1996, EUR J BIOCHEM, V239, P647, DOI 10.1111/j.1432-1033.1996.0647u.x; Putney JW, 1999, CELL, V99, P5, DOI 10.1016/S0092-8674(00)80056-2; Rizzo MA, 2001, J BIOL CHEM, V276, P34928, DOI 10.1074/jbc.M105918200; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Rosado JA, 2001, J BIOL CHEM, V276, P15659, DOI 10.1074/jbc.M009218200; Rosado JA, 2000, TRENDS CARDIOVAS MED, V10, P327, DOI 10.1016/S1050-1738(01)00073-1; Rosado JA, 2001, BIOCHEM J, V356, P191, DOI 10.1042/0264-6021:3560191; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Tepper AD, 2000, J CELL BIOL, V150, P155, DOI 10.1083/jcb.150.1.155; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; Wu H, 2002, J PHARMACOL EXP THER, V300, P339, DOI 10.1124/jpet.300.1.339; Yancey PG, 1996, J BIOL CHEM, V271, P16026, DOI 10.1074/jbc.271.27.16026; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	50	72	74	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19876	19881		10.1074/jbc.M200324200	http://dx.doi.org/10.1074/jbc.M200324200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11909856	hybrid			2022-12-27	WOS:000175894800084
J	Rose, T; Di Cera, E				Rose, T; Di Cera, E			Substrate recognition drives the evolution of serine proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINS; GEOMETRY	A method is introduced to identify amino acid residues that dictate the functional diversity acquired during evolution in a protein family. Using over 80 enzymes of the chymotrypsin family, we demonstrate that the general organization of the phylogenetic tree and its functional branch points are fully accounted for by a limited number of residues that cluster around the active site of the protein and define the contact region with the P1-P4 residues of substrate.	Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Di Cera, E (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, Box 8231,660 S Euclid Ave, St Louis, MO 63110 USA.			ROSE, Thierry/0000-0001-8863-0207	NHLBI NIH HHS [HL58141, HL49413] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL049413, R01HL058141, R01HL049413] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BODE W, 1992, PROTEIN SCI, V1, P426; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; FELSENSTEIN J, 1994, PHYLIP PACKAGE VERSI; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Krem MM, 1999, J BIOL CHEM, V274, P28063, DOI 10.1074/jbc.274.40.28063; Landgraf R, 2001, J MOL BIOL, V307, P1487, DOI 10.1006/jmbi.2001.4540; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; MATTEWS II, 1994, BIOCHEMISTRY-US, V33, P3266; RICHARDS FM, 1985, METHOD ENZYMOL, V115, P440; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876	15	27	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19243	19246		10.1074/jbc.C200132200	http://dx.doi.org/10.1074/jbc.C200132200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11925426	hybrid			2022-12-27	WOS:000175894800001
J	Kristensen, C; Andersen, AS; Ostergaard, S; Hansen, PH; Brandt, J				Kristensen, C; Andersen, AS; Ostergaard, S; Hansen, PH; Brandt, J			Functional reconstitution of insulin receptor binding site from non-binding receptor fragments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; ALANINE-SCANNING MUTAGENESIS; ALPHA-SUBUNIT; LIGAND SPECIFICITY; DOMAIN; REGION; IDENTIFICATION; DETERMINANTS; ECTODOMAIN; AFFINITY	We have previously shown that a minimized insulin receptor (IR) consisting of the first 468 amino acids of the insulin receptor fused to 16 amino acids from the C terminus of the a-subunit (CT domain) bound insulin with nanomolar affinity (Kristensen, C., Wiberg, F. C., Schaffer, L., and Andersen, A. S. (1998) J. Biol. Chem 273, 17780-17786). In the present study, we show that a smaller construct that has the first 308 residues fused to the CT domain also binds insulin. Insulin receptor fragments consisting of the first 468 or 308 residues did not bind insulin. However, when these fragments were mixed with a synthetic peptide corresponding to the CT domain, insulin binding was detectable. At concentrations of 10 muM CT peptide, insulin binding was fully reconstituted yielding apparent affinities of 9-11 nM. To further investigate the minimum requirement for the length of the N terminus of IR, we tested smaller receptor fragments for insulin binding in the presence of the CT peptide and found that a fragment consisting of the first 255 amino acids of IR was able to fully reconstitute the insulin binding site, yielding an apparent affinity of 11 +/- 4 nM for insulin.	Novo Nordisk AS, Dept Insulin Res, DK-2880 Bagsvaerd, Denmark; Novo Nordisk AS, Dept Prot Express, DK-2880 Bagsvaerd, Denmark	Novo Nordisk; Novo Nordisk	Brandt, J (corresponding author), Novo Nordisk AS, Dept Insulin Res, Novo Alle 6B1-90, DK-2880 Bagsvaerd, Denmark.		Kristensen, Claus/O-8047-2015; Ostergaard, Soren/B-8123-2019	Ostergaard, Soren/0000-0002-9415-3352; Kristensen, Claus/0000-0002-2594-7722				Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; ANDERSEN AS, 1990, BIOCHEMISTRY-US, V29, P7363, DOI 10.1021/bi00484a002; ANDERSEN AS, 1992, J BIOL CHEM, V267, P13681; BAJAJ M, 1987, BIOCHIM BIOPHYS ACTA, V916, P220, DOI 10.1016/0167-4838(87)90112-9; Brandt J, 2001, J BIOL CHEM, V276, P12378, DOI 10.1074/jbc.M009402200; DEMEYTS P, 1994, DIABETOLOGIA, V37, P135; FABRY M, 1992, BIOL CHEM H-S, V373, P915, DOI 10.1515/bchm3.1992.373.2.915; Garrett TPJ, 1998, NATURE, V394, P395, DOI 10.1038/28668; Hoyne PA, 2000, FEBS LETT, V469, P57, DOI 10.1016/S0014-5793(00)01237-0; Hulme E. C., 1992, RECEPTOR LIGAND INTE, P63; Kristensen C, 1998, J BIOL CHEM, V273, P17780, DOI 10.1074/jbc.273.28.17780; Kristensen C, 1999, J BIOL CHEM, V274, P37351, DOI 10.1074/jbc.274.52.37351; KUROSE T, 1994, J BIOL CHEM, V269, P29190; Luo RZT, 1999, SCIENCE, V285, P1077, DOI 10.1126/science.285.5430.1077; Marino-Buslje C, 1999, BIOCHEM SOC T, V27, P715, DOI 10.1042/bst0270715; Mynarcik DC, 1996, J BIOL CHEM, V271, P2439, DOI 10.1074/jbc.271.5.2439; PASHMFOROUSH M, 1994, J BIOL CHEM, V269, P32639; RICHARDS FM, 1959, J BIOL CHEM, V234, P1459; ROACH P, 1994, DIABETES, V43, P1096, DOI 10.2337/diabetes.43.9.1096; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; SCHAFFER L, 1993, EXP CLIN ENDOCRINOL, V101, P7; SCHUMACHER R, 1993, J BIOL CHEM, V268, P1087; Sparrow LG, 1997, J BIOL CHEM, V272, P29460, DOI 10.1074/jbc.272.47.29460; SURINYA KH, 2002, IN PRESS J BIOL CHEM, V277; Tulloch PA, 1999, J STRUCT BIOL, V125, P11, DOI 10.1006/jsbi.1998.4066; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; WARD CW, 1995, PROTEINS, V22, P141, DOI 10.1002/prot.340220207; WAUGH SM, 1989, BIOCHEMISTRY-US, V28, P2722, DOI 10.1021/bi00432a053; Whittaker J, 2001, J BIOL CHEM, V276, P43980, DOI 10.1074/jbc.M102863200	29	31	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					18340	18345		10.1074/jbc.M112249200	http://dx.doi.org/10.1074/jbc.M112249200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11901156	hybrid			2022-12-27	WOS:000175975800013
J	Zimmermann, K; Ahrens, K; Matthes, S; Buerstedde, JM; Stratling, WH; Loc, PV				Zimmermann, K; Ahrens, K; Matthes, S; Buerstedde, JM; Stratling, WH; Loc, PV			Targeted disruption of the GAS41 gene encoding a putative transcription factor indicates that GAS41 is essential for cell viability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHICKEN LYSOZYME GENE; RNA-POLYMERASE-II; DNA-BINDING PROTEINS; NUCLEAR MATRIX; DISTINCT PHENOTYPES; MAMMALIAN-CELLS; ACUTE-LEUKEMIA; EXPRESSION; FUSION; GLIOMA	The glioma-amplified sequence (GAS) 41 protein has been proposed to be a transcription factor. To investigate its functional role in vivo, we attempted to knock out the GAS41 gene by targeted disruption in the chicken pre-lymphoid cell line DT40. Heterozygous GAS41+/- cell lines generated by the first round of homologous recombination express approximately half the normal level of GAS41 mRNA. However, a homozygous GAS41-/- cell line with both GAS41 alleles disrupted was not obtained following the second round of transfection, indicating that the GAS41 gene is essential for cell viability. Indeed, homozygous GAS41-/- cell lines with two disrupted GAS41 alleles can be generated following substitution of the endogenous gene by stable integration of GAS41 cDNA controlled by a tetracycline-regulated CMV promoter. Inactivation of this promoter by tetracycline withdrawal results in rapid depletion of GAS41, causing a significant decrease in RNA synthesis and subsequently cell death. Thus, our results indicate that GAS41 is required for RNA transcription.	Inst Tierzucht & Tierverhalten, D-20223 Celle, Germany; Heinrich Pette Inst Expt Virol & Immunol, D-20251 Hamburg, Germany; Univ Hamburg, Klinikum Eppendorf, Inst Med Biochem & Mol Biol, D-20246 Hamburg, Germany	Heinrich Pette Institute; University of Hamburg	Zimmermann, K (corresponding author), Inst Tierzucht & Tierverhalten, Dornbergstr 25-27, D-20223 Celle, Germany.							BABA TW, 1985, VIROLOGY, V144, P139, DOI 10.1016/0042-6822(85)90312-5; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; Bezzubova O, 1997, CELL, V89, P185, DOI 10.1016/S0092-8674(00)80198-1; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Cairns BR, 1996, MOL CELL BIOL, V16, P3308; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; Dobson CL, 1999, EMBO J, V18, P3564, DOI 10.1093/emboj/18.13.3564; DUGAICZYK A, 1983, BIOCHEMISTRY-US, V22, P1605, DOI 10.1021/bi00276a013; DWORETZKY SI, 1992, P NATL ACAD SCI USA, V89, P4178, DOI 10.1073/pnas.89.9.4178; Fischer U, 1997, HUM MOL GENET, V6, P1817, DOI 10.1093/hmg/6.11.1817; Fischer U, 1996, HUM GENET, V98, P625, DOI 10.1007/s004390050271; Goethe R, 1997, J LEUKOCYTE BIOL, V61, P367, DOI 10.1002/jlb.61.3.367; Goethe R, 1998, J IMMUNOL, V160, P4970; Harborth J, 2000, J BIOL CHEM, V275, P31979, DOI 10.1074/jbc.M000994200; HENRY NL, 1994, GENE DEV, V8, P2868, DOI 10.1101/gad.8.23.2868; HENRY NL, 1992, J BIOL CHEM, V267, P23388; JACKSON DA, 1985, EMBO J, V4, P919, DOI 10.1002/j.1460-2075.1985.tb03719.x; JACKSON DA, 1993, EMBO J, V12, P1059, DOI 10.1002/j.1460-2075.1993.tb05747.x; LANGLOIS AJ, 1974, CANCER RES, V34, P1457; LUDERUS MEE, 1994, MOL CELL BIOL, V14, P6297, DOI 10.1128/MCB.14.9.6297; LYDERSEN BK, 1980, CELL, V22, P489, DOI 10.1016/0092-8674(80)90359-1; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Mortillaro MJ, 1996, P NATL ACAD SCI USA, V93, P8253, DOI 10.1073/pnas.93.16.8253; Munnia A, 2001, ONCOGENE, V20, P4853, DOI 10.1038/sj.onc.1204650; NAKAMURA T, 1993, P NATL ACAD SCI USA, V90, P4631, DOI 10.1073/pnas.90.10.4631; Nayler O, 1998, NUCLEIC ACIDS RES, V26, P3542, DOI 10.1093/nar/26.15.3542; Phi-van L, 1998, J BIOL CHEM, V273, P18300, DOI 10.1074/jbc.273.29.18300; Phi-Van L, 1999, NUCLEIC ACIDS RES, V27, P3009, DOI 10.1093/nar/27.15.3009; RAHMSDORF HJ, 1987, NUCLEIC ACIDS RES, V15, P1643, DOI 10.1093/nar/15.4.1643; Regenhard P, 2001, J LEUKOCYTE BIOL, V69, P651; RUBNITZ JE, 1994, BLOOD, V84, P1747; Sambrook J., 2002, MOL CLONING LAB MANU; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; VANWIJNEN AJ, 1993, BIOCHEMISTRY-US, V32, P8397, DOI 10.1021/bi00084a003; Wang J, 1996, GENE DEV, V10, P2588, DOI 10.1101/gad.10.20.2588; WANSINK DG, 1993, J CELL BIOL, V122, P283, DOI 10.1083/jcb.122.2.283; Yao F, 1998, HUM GENE THER, V9, P1939, DOI 10.1089/hum.1998.9.13-1939	38	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					18626	18631		10.1074/jbc.M200572200	http://dx.doi.org/10.1074/jbc.M200572200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11901157	hybrid			2022-12-27	WOS:000175975800052
J	Nemergut, ME; Lindsay, ME; Brownawell, AM; Macara, IG				Nemergut, ME; Lindsay, ME; Brownawell, AM; Macara, IG			Ran-binding protein 3 links Crm1 to the Ran guanine nucleotide exchange factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PORE COMPLEX; EXPORT; RCC1; TRANSPORT; REGULATOR; GTPASE; CHROMOSOME; RECEPTOR; COFACTOR; SIGNAL	Ran-binding protein 3 (RanBP3) is an similar to55-kDa protein that functions as a cofactor for Crm1-mediated nuclear export. RanBP3 stimulates export by enhancing the affinity of Crm1 for Ran-GTP and cargo. However, important additional functions for this cofactor may exist. We now report that RanBP3 associates with the Ran-specific guanine nucleotide exchange factor, regulator of chromosome condensation 1 (RCC1). This interaction was stimulated by the addition of Ran; moreover, Ran.GDP, Ran.TP, and Ran without nucleotide could all stimulate complex formation between RanBP3 and RCC1 even though binding of Ran.GDP to RanBP3 alone was undetectable. RanBP3 could also promote binding of Crm1 to RCC1 in the presence of Ran. Binding of RanBP3 to RCC1 increased the catalytic activity of RCC1 toward Ran, and importantly, the ability of RanBP3 to stimulate RCC1 was not affected by the presence of Crm1. These data indicate that RanBP3 acts as a scaffold protein to promote the efficient assembly of export complexes. By tethering Crm1 to catalytically enhanced RCC1, RanBP3 may lower the entropic barrier for the loading of Ran.GTP onto Crm1. We propose that this provides an additional mechanism by which RanBP3 facilitates export.	Univ Virginia, Ctr Cell Signaling, Charlottesville, VA 22908 USA; Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Brownawell, AM (corresponding author), Univ Virginia, Ctr Cell Signaling, HSC Box 800577, Charlottesville, VA 22908 USA.	amb7c@virginia.edu		Nemergut, Michael/0000-0002-6803-1765	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050526] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-50526] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Azuma Y, 1996, J BIOCHEM-TOKYO, V120, P82; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; Black BE, 2001, J CELL BIOL, V152, P141, DOI 10.1083/jcb.152.1.141; Dasso M, 2001, CELL, V104, P321, DOI 10.1016/S0092-8674(01)00218-5; Denning D, 2001, J CELL BIOL, V154, P937, DOI 10.1083/jcb.200101007; Englmeier L, 2001, EMBO REP, V2, P926, DOI 10.1093/embo-reports/kve200; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hofmann W, 2001, J CELL BIOL, V152, P895, DOI 10.1083/jcb.152.5.895; HOPPER AK, 1990, J CELL BIOL, V111, P309, DOI 10.1083/jcb.111.2.309; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; Lindsay ME, 2001, J CELL BIOL, V153, P1391, DOI 10.1083/jcb.153.7.1391; Macara LG, 1999, CURR BIOL, V9, pR436, DOI 10.1016/S0960-9822(99)80275-9; Moore JD, 2001, BIOESSAYS, V23, P77, DOI 10.1002/1521-1878(200101)23:1<77::AID-BIES1010>3.3.CO;2-5; Mueller L, 1998, FEBS LETT, V427, P330, DOI 10.1016/S0014-5793(98)00459-1; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Nemergut ME, 2000, J CELL BIOL, V149, P835, DOI 10.1083/jcb.149.4.835; Nemergut ME, 2001, SCIENCE, V292, P1540, DOI 10.1126/science.292.5521.1540; Noguchi E, 1999, J BIOCHEM-TOKYO, V125, P574, DOI 10.1093/oxfordjournals.jbchem.a022323; OHTSUBO M, 1989, J CELL BIOL, V109, P1389, DOI 10.1083/jcb.109.4.1389; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Plafker SM, 2000, EMBO J, V19, P5502, DOI 10.1093/emboj/19.20.5502; Renault L, 2001, CELL, V105, P245, DOI 10.1016/S0092-8674(01)00315-4; RICHARDS SA, 1995, J BIOL CHEM, V270, P14405, DOI 10.1074/jbc.270.24.14405; Sazer S, 2000, J CELL SCI, V113, P1111; Smith AE, 2002, SCIENCE, V295, P488, DOI 10.1126/science.1064732; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Stoffler D, 1999, CURR OPIN CELL BIOL, V11, P391, DOI 10.1016/S0955-0674(99)80055-6; Taura T, 1997, J BIOL CHEM, V272, P31877, DOI 10.1074/jbc.272.50.31877	32	39	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2002	277	20					17385	17388		10.1074/jbc.c100620200	http://dx.doi.org/10.1074/jbc.c100620200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	553PR	11932251	hybrid			2022-12-27	WOS:000175685100003
J	Swart-Mataraza, JM; Li, ZG; Sacks, DB				Swart-Mataraza, JM; Li, ZG; Sacks, DB			IQGAP1 is a component of Cdc42 signaling to the cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO GTPASES; ACTIN POLYMERIZATION; ACTIVATING PROTEINS; BINDING PROTEIN; GTP-HYDROLYSIS; CELL-POLARITY; TARGET; RAC; IDENTIFICATION; ARGININE	The Ras-GAP related protein IQGAP1 binds several proteins, including actin, calmodulin, E-cadherin and the Rho family GTPase Cdc42. To gain insight into its in vivo function, IQGAP1 was overexpressed in mammalian cells. Transfection of IQGAP1 significantly increased the levels of active, GTP-bound Cdc42, resulting in the formation of peripheral actin microspikes. By contrast, transfection of an IQGAP1 mutant lacking part of the (G) under bar AP-(r) under bar elated (d) under bar omain (IQGAP1DeltaGRD) substantially decreased the amount of GTP-bound Cdc42 in cell lysates. Consistent with these findings, IQGAP1DeltaGRD blocked Cdc42 function in cells that stably overexpress constitutively active Cdc42 and abrogated the effect of bradykinin on Cdc42. In cells transfected with IQGAP1DeltaGRD, bradykinin was unable to activate Cdc42, translocate Cdc42 to the membrane fraction, or induce filopodia production. IQGAP1DeltaGRD transfection altered cellular morphology, producing small, round cells that closely resemble Cdc42(-/-) cells. Some insight into the mechanism was provided by in vitro analysis, which revealed that IQGAP1DeltaGRD increased the intrinsic GTPase activity of Cdc42, thereby increasing the amount of inactive, GDP-bound Cdc42. These data imply that IQGAP1 has a crucial role in transducing Cdc42 signaling to the cytoskeleton.	Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Sacks, DB (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St,Thorn 530, Boston, MA 02115 USA.	dsacks@rics.bwh.harvard.edu		Sacks, David/0000-0003-3100-0735	NCI NIH HHS [CA75205] Funding Source: Medline; NHLBI NIH HHS [HL07627] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R55CA075205, R01CA075205] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Aspenstrom P, 1996, CURR BIOL, V6, P70, DOI 10.1016/S0960-9822(02)00423-2; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Bashour AM, 1997, J CELL BIOL, V137, P1555, DOI 10.1083/jcb.137.7.1555; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BOKOCH GM, 1994, J BIOL CHEM, V269, P31674; Briggs MW, 2002, J BIOL CHEM, V277, P7453, DOI 10.1074/jbc.M104315200; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Chen F, 2000, CURR BIOL, V10, P758, DOI 10.1016/S0960-9822(00)00571-6; Epp JA, 1997, CURR BIOL, V7, P921, DOI 10.1016/S0960-9822(06)00411-8; Erickson JW, 1997, J BIOL CHEM, V272, P24443, DOI 10.1074/jbc.272.39.24443; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Faix J, 1996, FEBS LETT, V394, P251, DOI 10.1016/0014-5793(96)00963-5; FEUERSTEIN J, 1989, J BIOL CHEM, V264, P6188; Fleming IN, 1996, J BIOL CHEM, V271, P33067, DOI 10.1074/jbc.271.51.33067; Fukata M, 1997, J BIOL CHEM, V272, P29579, DOI 10.1074/jbc.272.47.29579; Graham DL, 1999, BIOCHEMISTRY-US, V38, P985, DOI 10.1021/bi9821770; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Joyal JL, 1997, J BIOL CHEM, V272, P15419, DOI 10.1074/jbc.272.24.15419; Kaibuchi K, 1999, CURR OPIN CELL BIOL, V11, P591, DOI 10.1016/S0955-0674(99)00014-9; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Kim SH, 2000, J BIOL CHEM, V275, P36999, DOI 10.1074/jbc.M003430200; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Li ZG, 1999, J BIOL CHEM, V274, P37885, DOI 10.1074/jbc.274.53.37885; Lommel S, 2001, EMBO REP, V2, P850, DOI 10.1093/embo-reports/kve197; Machesky LM, 1998, CURR BIOL, V8, pR202, DOI 10.1016/S0960-9822(98)70125-3; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Martinez-Quiles N, 2001, NAT CELL BIOL, V3, P484, DOI 10.1038/35074551; McCallum SJ, 1998, J BIOL CHEM, V273, P22537, DOI 10.1074/jbc.273.35.22537; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Mittal R, 1996, SCIENCE, V273, P115, DOI 10.1126/science.273.5271.115; Nassar N, 1998, NAT STRUCT BIOL, V5, P1047, DOI 10.1038/4156; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Seewald MJ, 2002, NATURE, V415, P662, DOI 10.1038/415662a; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Sokol SY, 2001, J BIOL CHEM, V276, P48425, DOI 10.1074/jbc.M107975200; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Thompson G, 1998, BIOCHEMISTRY-US, V37, P7885, DOI 10.1021/bi980140+; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517; Yarar D, 1999, CURR BIOL, V9, P555, DOI 10.1016/S0960-9822(99)80243-7; Zhang BL, 1997, J BIOL CHEM, V272, P21999, DOI 10.1074/jbc.272.35.21999	49	119	120	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2002	277	27					24753	24763		10.1074/jbc.M111165200	http://dx.doi.org/10.1074/jbc.M111165200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	569PV	11948177	hybrid			2022-12-27	WOS:000176611800102
J	Chen, A; Kleiman, FE; Manley, JL; Ouchi, T; Pan, ZQ				Chen, A; Kleiman, FE; Manley, JL; Ouchi, T; Pan, ZQ			Autoubiquitination of the BRCA1-BARD1 RING ubiquitin ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN LIGASE; HISTONE H2AX; IN-VIVO; BRCA1; DOMAIN; FINGER; GENE; RECRUITMENT; MUTATIONS; RADIATION	The RING finger of BRCA1 confers ubiquitin ligase activity that is markedly enhanced when complexed with another RING-containing protein, BARD1, and is required for the function of this tumor suppressor protein in protecting genomic integrity. Here, we report that co-expression of BRCA1-(1-639) and BARD1 in bacteria can assemble a potent ubiquitin ligase activity. Purified BRCA1-(1-639).BARD1 stimulated the Ubc5c-mediated monoubiquitination of histone H2A/H2AX in vitro, suggesting a possible role for BRCA1.BARD1 in modifying chromatin structure. Moreover, the truncated BRCA1.BARD1 complex exhibited efficient autoubiquitination activity in vitro capable of assembling non-lysine 48-linked polyubiquitin chains on both BRCA1-(1-639) and BARD1. When co-expressed in cells by transient transfection, the recombinant BRCA1-(1-300).BARD1 complex was found to be associated with polyubiquitin chains, suggesting that BRCA1-(2-300).BARD1 was ubiquitinated in vivo as well. These results raise the possibility that BRCA1.BARD1 acts to assemble non-lysine 48-linked polyubiquitin chains that may serve as part of a signaling platform required for coordinating DNA repair-related events.	Mt Sinai Sch Med, Derald H Ruttenberg Canc Ctr, New York, NY 10029 USA; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Icahn School of Medicine at Mount Sinai; Columbia University	Pan, ZQ (corresponding author), Mt Sinai Sch Med, Derald H Ruttenberg Canc Ctr, 1 Gustave L Levy Pl, New York, NY 10029 USA.	zhen-qiang.pan@mssm.edu		Manley, James/0000-0002-8341-1459	NATIONAL CANCER INSTITUTE [R01CA079892, T32CA078207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061051, R01GM028983] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA79892, CA78207] Funding Source: Medline; NIGMS NIH HHS [GM28983, GM61051] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Borden KLB, 2000, J MOL BIOL, V295, P1103, DOI 10.1006/jmbi.1999.3429; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; CHAN AML, 1994, ONCOGENE, V9, P1057; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen A, 2000, J BIOL CHEM, V275, P15432, DOI 10.1074/jbc.M907300199; DAVIE JR, 1991, BIOCHEM CELL BIOL, V69, P66, DOI 10.1139/o91-009; DAVIE JR, 1990, BIOCHEMISTRY-US, V29, P4752, DOI 10.1021/bi00472a002; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; DUCKWORTHRYSIECKI G, 1985, CANCER RES, V45, P416; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Joukov V, 2001, P NATL ACAD SCI USA, V98, P12078, DOI 10.1073/pnas.211427098; Kaiser P, 2000, CELL, V102, P303, DOI 10.1016/S0092-8674(00)00036-2; Kleiman FE, 2001, CELL, V104, P743, DOI 10.1016/S0092-8674(02)07059-9; LEVINGER L, 1982, CELL, V28, P375, DOI 10.1016/0092-8674(82)90355-5; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Mastrandrea LD, 1999, J BIOL CHEM, V274, P27299, DOI 10.1074/jbc.274.38.27299; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pickart CM, 2001, MOL CELL, V8, P499, DOI 10.1016/S1097-2765(01)00347-1; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Spencer VA, 1999, GENE, V240, P1, DOI 10.1016/S0378-1119(99)00405-9; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Thai TH, 1998, HUM MOL GENET, V7, P195, DOI 10.1093/hmg/7.2.195; VANNOCKER S, 1993, J BIOL CHEM, V268, P24766; Venkitaraman Ashok R., 2000, Biochimica et Biophysica Acta, V1470, pR41, DOI 10.1016/S0304-419X(00)00007-X; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wu K, 2000, MOL CELL BIOL, V20, P1382, DOI 10.1128/MCB.20.4.1382-1393.2000; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; You JX, 2001, J BIOL CHEM, V276, P19871, DOI 10.1074/jbc.M100034200; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	38	169	173	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					22085	22092		10.1074/jbc.M201252200	http://dx.doi.org/10.1074/jbc.M201252200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11927591	hybrid			2022-12-27	WOS:000176286000121
J	Cheng, ZF; Deutscher, MP				Cheng, ZF; Deutscher, MP			Purification and characterization of the Escherichia coli exoribonuclease RNase R - Comparison with RNase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REACTION-MECHANISM; 3 TERMINUS; RIBONUCLEASE; VIRULENCE; VACB	Escherichia coli RNase R, a 3' --> 5' exoribonuclease homologous to RNase II, was overexpressed and purified to near homogeneity in its native untagged form by a rapid procedure. The purified enzyme was free of nucleic acid. It migrated upon gel filtration chromatography as a monomer with an apparent molecular mass of similar to95 kDa, in close agreement with its expected size based on the sequence of the rnr gene. RNase R was most active at pH 7.5-9.5 in the presence of 0.1-0.5 mm Mg2+ and 50-500 mm KCl. The enzyme shares many catalytic properties with RNase II. Both enzymes are nonspecific processive ribonucleases that release 5'-nucleotide monophosphates and leave a short undigested oligonucleotide core. However, whereas RNase R shortens RNA processively to di- and trinucleotides, RNase II becomes more distributive when the length of the substrate reaches similar to10 nucleotides, and it leaves an undigested core of 3-5 nucleotides. Both enzymes work on substrates with a 3'-phosphate group. RNase R and RNase II are most active on synthetic homopolymers such as poly(A), but their substrate specificities differ. RNase II is more active on poly(A), whereas RNase R is much more active on rRNAs. Neither RNase R nor RNase II can degrade a complete RNA-RNA or DNA-RNA hybrid or one with a 4-nucleotide 3'-RNA overhang. RNase R differs from RNase II in that it cannot digest DNA oligomers and is not inhibited by such molecules, suggesting that it does not bind DNA, Although the in vivo function of RNase R is not known, its ability to digest certain natural RNAs may explain why it is maintained in E. coli together with RNase II.	Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA	University of Miami	Deutscher, MP (corresponding author), Univ Miami, Sch Med, Dept Biochem & Mol Biol, POB 016129, Miami, FL 33101 USA.	mdeutsch@med.miami.edu			NIGMS NIH HHS [GM16317] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASHA PK, 1983, P NATL ACAD SCI-BIOL, V80, P3301, DOI 10.1073/pnas.80.11.3301; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cannistraro VJ, 1999, BBA-PROTEIN STRUCT M, V1433, P170, DOI 10.1016/S0167-4838(99)00136-3; CANNISTRARO VJ, 1994, J MOL BIOL, V243, P930, DOI 10.1006/jmbi.1994.1693; Cheng ZF, 1998, J BIOL CHEM, V273, P14077, DOI 10.1074/jbc.273.23.14077; Coburn GA, 1996, J BIOL CHEM, V271, P1048, DOI 10.1074/jbc.271.2.1048; CUDNY H, 1980, P NATL ACAD SCI-BIOL, V77, P837, DOI 10.1073/pnas.77.2.837; Deutscher MP, 2001, PROG NUCLEIC ACID RE, V66, P67; DEUTSCHER MP, 1984, P NATL ACAD SCI-BIOL, V81, P4290, DOI 10.1073/pnas.81.14.4290; EVANS JA, 1976, J BIOL CHEM, V251, P6646; GAREN A, 1960, BIOCHIM BIOPHYS ACTA, V38, P470, DOI 10.1016/0006-3002(60)91282-8; Ghosh S, 1999, P NATL ACAD SCI USA, V96, P4372, DOI 10.1073/pnas.96.8.4372; GUPTA RS, 1977, J BIOL CHEM, V252, P8945; KASAI T, 1977, J BIOL CHEM, V252, P8950; Kevil CG, 1997, BIOCHEM BIOPH RES CO, V238, P277, DOI 10.1006/bbrc.1997.7284; PIEDADE J, 1995, FEMS MICROBIOL LETT, V127, P187; POWERS T, 1991, EMBO J, V10, P2203, DOI 10.1002/j.1460-2075.1991.tb07756.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; TOBE T, 1992, J BACTERIOL, V174, P6359, DOI 10.1128/JB.174.20.6359-6367.1992; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	20	152	161	10	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21624	21629		10.1074/jbc.M202942200	http://dx.doi.org/10.1074/jbc.M202942200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11948193	hybrid			2022-12-27	WOS:000176286000068
J	Nakanishi, T; Sekimizu, K				Nakanishi, T; Sekimizu, K			SDT1/SSM1, a multicopy suppressor of S-II null mutant, encodes a novel pyrimidine 5 '-nucleotidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION ELONGATION; 6-AZAURACIL SENSITIVITY; YEAST; GENE; RESISTANCE; EXPRESSION; PROTEIN; SUBUNIT	SDT1 (suppressor of disruption of TFIIS 1, YGL224c, also known as SSM1, suppressor of S-II null mutant 1) is Saccharomyces cerevisiae gene identified as a multicopy suppressor of 6-azauracil sensitivity in a null mutant of the transcription elongation factor S-II. We found that overproduction of SDT1 caused hyposensitivity to not only 6-azauracil but also 5-fluorouracil and 5-fluorocytosine. This hyposensitivity was limited to pyrimidine derivatives, and no effect was observed for non-pyrimidine drugs including such clinically used anti-fungal drugs as amphotericin B and fluconazole. Purified recombinant SDT1 protein specifically dephosphorylated 5'-UMP and 5'-CMP. These results suggested that SDT1 conferred pyrimidine-specific hyposensitivity by dephosphorylating active metabolites of 6- or 5-modified pyrimidines, i.e. 6- or 5-modified UMP. This is the first description of a highly specific pyrimidine 5'-nucleotidase in S. cerevisiae.	Daiichi Pharmaceut Co Ltd, Discovery Res Labs, Edogawa Ku, Tokyo 1348630, Japan; Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Daiichi Sankyo Company Limited; University of Tokyo	Nakanishi, T (corresponding author), Daiichi Pharmaceut Co Ltd, Discovery Res Labs, Edogawa Ku, Tokyo 1348630, Japan.							Amici A, 1999, NUCLEOS NUCLEOT, V18, P853, DOI 10.1080/15257779908041580; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brewster NK, 2001, MOL CELL BIOL, V21, P3491, DOI 10.1128/MCB.21.10.3491-3502.2001; Costa PJ, 2000, GENETICS, V156, P535; Denis CL, 2001, GENETICS, V158, P627; EXINGER F, 1992, CURR GENET, V22, P9, DOI 10.1007/BF00351735; HANDSCHUMACHER RE, 1958, BIOCHIM BIOPHYS ACTA, V30, P451, DOI 10.1016/0006-3002(58)90088-X; Hemming SA, 2000, J BIOL CHEM, V275, P35506, DOI 10.1074/jbc.M004721200; Hunsucker SA, 2001, J BIOL CHEM, V276, P10498, DOI 10.1074/jbc.M011218200; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; KERN L, 1990, GENE, V88, P149, DOI 10.1016/0378-1119(90)90026-N; NAKANISHI T, 1995, J BIOL CHEM, V270, P8991, DOI 10.1074/jbc.270.15.8991; NAKANISHI T, 1992, J BIOL CHEM, V267, P13200; OHYA Y, 1991, J BIOL CHEM, V266, P12356; Powell W, 1996, J BIOL CHEM, V271, P6866, DOI 10.1074/jbc.271.12.6866; Shaw RJ, 2000, MOL CELL BIOL, V20, P7427, DOI 10.1128/MCB.20.20.7427-7437.2000; Shimoaraiso M, 2000, J BIOL CHEM, V275, P29623, DOI 10.1074/jbc.M910371199; SIKORSKI RS, 1989, GENETICS, V122, P19; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; Widnell C C, 1974, Methods Enzymol, V32, P368; ZIMMERMANN H, 1992, BIOCHEM J, V285, P345, DOI 10.1042/bj2850345	22	23	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					22103	22106		10.1074/jbc.M200573200	http://dx.doi.org/10.1074/jbc.M200573200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11934891	hybrid			2022-12-27	WOS:000176286000123
J	Pummill, PE; DeAngelis, PL				Pummill, PE; DeAngelis, PL			Evaluation of critical structural elements of UDP-sugar substrates and certain cysteine residues of a vertebrate hyaluronan synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHAGE BETA-GLUCOSYLTRANSFERASE; CRYSTAL-STRUCTURE; CATALYTIC MECHANISM; IN-VITRO; GLYCOSYLTRANSFERASES; PROTEIN; BINDING; XENOPUS; DG42; GENE	The hyaluronan (HA) synthases catalyze the addition of two different monosaccharides from UDP-sugar substrates to the linear heteropolysaccharide chain. To accomplish this task, the HA synthases must be able to bind and to transfer from both UDP-sugar substrates. Until now, it has been impossible to distinguish between these two abilities. We have created a mutant of xlHAS1, a HA synthase from Xenopus laevis, that allows for the examination of the enzyme's ability to bind substrate only. The ability of different compounds to protect the xlHAS1(C337S) mutant enzyme from loss of activity due to treatment with N-ethylmaleimide, a cysteine-modifying reagent, yields information on the relative affinity of a variety of nucleotides and nucleotide-sugars. We have observed that the substrate binding selectivity is more relaxed than the specificity of catalytic transfer. The only attribute that appears to be absolutely required for binding is a nucleotide containing two phosphates complexed with magnesium ion. The role of certain cysteine residues in catalysis was also evaluated. Cys(307) Of xl-HAS1 may play a role in catalysis or in maintaining structure. Mutation of Cys(337). raises the UDP-GlcUA Michaelis constant (K-m), suggesting that this residue participates in UDP-GlcUA substrate binding or in catalytic complex formation.	Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Med Glycobiol, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	DeAngelis, PL (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Med Glycobiol, Dept Biochem & Mol Biol, 940 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.				NIGMS NIH HHS [GM56497] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056497] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breton C, 1999, CURR OPIN STRUC BIOL, V9, P563, DOI 10.1016/S0959-440X(99)00006-8; Campbell RE, 2000, BIOCHEMISTRY-US, V39, P7012, DOI 10.1021/bi000181h; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; DeAngelis PL, 1996, J BIOL CHEM, V271, P23657, DOI 10.1074/jbc.271.39.23657; Gastinel LN, 2001, EMBO J, V20, P638, DOI 10.1093/emboj/20.4.638; Gastinel LN, 1999, EMBO J, V18, P3546, DOI 10.1093/emboj/18.13.3546; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Heldermon CD, 2001, GLYCOBIOLOGY, V11, P1017, DOI 10.1093/glycob/11.12.1017; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Kumari K, 2002, J BIOL CHEM, V277, P13943, DOI 10.1074/jbc.M110638200; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Marks DL, 2001, J BIOL CHEM, V276, P26492, DOI 10.1074/jbc.M102612200; Morera S, 2001, J MOL BIOL, V311, P569, DOI 10.1006/jmbi.2001.4905; Morera S, 1999, J MOL BIOL, V292, P717, DOI 10.1006/jmbi.1999.3094; Pedersen LC, 2000, J BIOL CHEM, V275, P34580, DOI 10.1074/jbc.M007399200; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Pummill PE, 1998, J BIOL CHEM, V273, P4976, DOI 10.1074/jbc.273.9.4976; Ramakrishnan B, 2001, J MOL BIOL, V310, P205, DOI 10.1006/jmbi.2001.4757; ROSA F, 1988, DEV BIOL, V129, P114, DOI 10.1016/0012-1606(88)90166-2; Spicer AP, 1998, J BIOL CHEM, V273, P1923, DOI 10.1074/jbc.273.4.1923; SUGAHARA K, 1979, J BIOL CHEM, V254, P6252; Tarbouriech N, 2001, J MOL BIOL, V314, P655, DOI 10.1006/jmbi.2001.5159; Tlapak-Simmons VL, 1999, J BIOL CHEM, V274, P4246, DOI 10.1074/jbc.274.7.4246; Unligil UM, 2000, EMBO J, V19, P5269, DOI 10.1093/emboj/19.20.5269; Unligil UM, 2000, CURR OPIN STRUC BIOL, V10, P510, DOI 10.1016/S0959-440X(00)00124-X; VRIELINK A, 1994, EMBO J, V13, P3413, DOI 10.1002/j.1460-2075.1994.tb06646.x; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Yoshida M, 2000, J BIOL CHEM, V275, P497, DOI 10.1074/jbc.275.1.497	30	7	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21610	21616		10.1074/jbc.M202456200	http://dx.doi.org/10.1074/jbc.M202456200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11943783	hybrid			2022-12-27	WOS:000176286000066
J	Lim, JH; Bustin, M; Ogryzko, VV; Postnikov, YV				Lim, JH; Bustin, M; Ogryzko, VV; Postnikov, YV			Metastable macromolecular complexes containing high mobility group nucleosome-binding chromosomal proteins in HeLa nuclei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE ACETYLASE COMPLEX; SELF-ORGANIZATION; CHROMATIN; HMG-14; DOMAIN; PHOSPHORYLATION; ARCHITECTURE; COMPONENTS; ACTIVATION; DISTINCT	High mobility group nucleosome-binding (HMGN) proteins belong to a family of nuclear proteins that bind to nucleosomes and enhance transcription from chromatin templates by altering the structure of the chromatin fiber. The intranuclear organization of these proteins is dynamic and related to the metabolic state of the cell. Here we report that similar to50% of the HMGN proteins are organized into macromolecular complexes in a fashion that is similar to that of other nuclear activities that modify the structure of the chromatin fiber. We identify several distinct HMGN-containing complexes that are relatively unstable and find that the inclusion of HMGN in the complexes varies according to the metabolic state of the cell. The nucleosome binding ability of HMGN in the complex is stronger than that of the free HMGN. We suggest that the inclusion of HMGN proteins into metastable multiprotein complexes serves to target the HMGN proteins to specific sites in chromatin and enhances their interaction with nucleosomes.	NCI, CCR, Prot Sect, NIH, Bethesda, MD 20892 USA; CNRS, UPR 9079, Inst Andre Lwoff, Lab Oncogenese, F-94801 Villejuif, France	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centre National de la Recherche Scientifique (CNRS)	Postnikov, YV (corresponding author), NCI, CCR, Prot Sect, NIH, Bldg 37 Rm 3E-24, Bethesda, MD 20892 USA.		Ogryzko, Vasily/M-6665-2015; Bustin, Michael/G-6155-2015	Ogryzko, Vasily/0000-0002-8548-1389; Bustin, Michael/0000-0002-5147-7242				Aalfs JD, 2000, TRENDS BIOCHEM SCI, V25, P548, DOI 10.1016/S0968-0004(00)01689-3; AUSIO J, 1989, J MOL BIOL, V206, P451, DOI 10.1016/0022-2836(89)90493-2; BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.biophys.14.1.131; Bianchi ME, 2000, EMBO REP, V1, P109, DOI 10.1093/embo-reports/kvd030; Bustin M, 2001, TRENDS BIOCHEM SCI, V26, P431, DOI 10.1016/S0968-0004(01)01855-2; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; CRIPPA MP, 1992, J MOL BIOL, V228, P442, DOI 10.1016/0022-2836(92)90833-6; Davie JR, 2000, CRIT REV EUKAR GENE, V10, P303; Ding HF, 1997, MOL CELL BIOL, V17, P5843, DOI 10.1128/MCB.17.10.5843; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; Guschin D, 2000, J BIOL CHEM, V275, P35248, DOI 10.1074/jbc.M006041200; Hassan AH, 2001, FRONT BIOSCI, V6, pD1054, DOI 10.2741/Hassan; HESS B, 1995, J THEOR BIOL, V176, P181, DOI 10.1006/jtbi.1995.0187; Hock R, 1998, EMBO J, V17, P6992, DOI 10.1093/emboj/17.23.6992; Hock R, 1998, J CELL BIOL, V143, P1427, DOI 10.1083/jcb.143.6.1427; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Imbalzano AN, 1998, CRIT REV EUKAR GENE, V8, P225, DOI 10.1615/CritRevEukarGeneExpr.v8.i3-4.10; JOHNS EW, 1982, HMG CHROMOSAL PROTEI; Khochbin S, 2001, FEBS LETT, V494, P141, DOI 10.1016/S0014-5793(01)02327-4; Kornberg RD, 1999, CURR OPIN GENET DEV, V9, P148, DOI 10.1016/S0959-437X(99)80022-7; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Kuzmichev A, 2001, CURR TOP MICROBIOL, V254, P35; Langst G, 2001, J CELL SCI, V114, P2561; LEE KAW, 1990, METHOD ENZYMOL, V181, P20; MARDIAN JKW, 1980, SCIENCE, V209, P1534, DOI 10.1126/science.7433974; Misteli T, 2001, J CELL BIOL, V155, P181, DOI 10.1083/jcb.200108110; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Pederson T, 2001, CELL, V104, P635, DOI 10.1016/S0092-8674(02)01455-1; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; POSTNIKOV YV, 1994, NUCLEIC ACIDS RES, V22, P4520, DOI 10.1093/nar/22.21.4520; Prymakowska-Bosak M, 2001, MOL CELL BIOL, V21, P5169, DOI 10.1128/MCB.21.15.5169-5178.2001; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Rothhut B, 1997, CELL MOL LIFE SCI, V53, P522, DOI 10.1007/s000180050066; SANDEEN G, 1980, NUCLEIC ACIDS RES, V8, P3757, DOI 10.1093/nar/8.17.3757; Shirakawa H, 2000, J BIOL CHEM, V275, P37937, DOI 10.1074/jbc.M000989200; Trieschmann L, 1998, P NATL ACAD SCI USA, V95, P5468, DOI 10.1073/pnas.95.10.5468; TRIESCHMANN L, 1995, MOL CELL BIOL, V15, P6663; Vedeler A, 2000, BIOCHEM J, V348, P565, DOI 10.1042/0264-6021:3480565; Wolffe AP, 1999, NUCLEIC ACIDS RES, V27, P711, DOI 10.1093/nar/27.3.711	43	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20774	20782		10.1074/jbc.M200404200	http://dx.doi.org/10.1074/jbc.M200404200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11909857	hybrid			2022-12-27	WOS:000176204500087
J	Lonergan, PE; Martin, DSD; Horrobin, DF; Lynch, MA				Lonergan, PE; Martin, DSD; Horrobin, DF; Lynch, MA			Neuroprotective effect of eicosapentaenoic acid in hippocampus of rats exposed to gamma-irradiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; ACTIVATED PROTEIN-KINASES; POLYUNSATURATED FATTY-ACIDS; AGE-RELATED-CHANGES; CYTOCHROME-C; DIETARY SUPPLEMENTATION; CELL-DEATH; SIGNAL-TRANSDUCTION; CASPASE ACTIVATION; OXIDATIVE STRESS	Exposure to irradiation leads to detrimental changes in several cell types. In this study we assessed the changes induced in hippocampus by exposure of rats to whole body irradiation; the findings reveal that irradiation leads to apoptotic cell death in hippocampus, and as a consequence, long term potentiation in perforant path-granule cell synapses is markedly impaired. The evidence is consistent with the view that irradiation induced an increase in reactive oxygen species and that this leads to stimulation of the stress-activated protein kinase, JNK, and activation of the transcription factor, c-Jun. Consequent upon activation of JNK, a cascade of cell signaling events was stimulated that ultimately resulted in apoptosis, as suggested by parallel increases in cytochrome c translocation, caspase-3 activation, poly(ADP-ribose) polymerase cleavage, and terminal dUTP nick-end labeling staining. Treatment of rats with eicosapentaenoic acid inhibited the irradiation-induced increase in reactive oxygen species production and the subsequent cellular signaling events, suggesting that oxidative stress triggered apoptotic cell death in the hippocampus of rats exposed to irradiation. Significantly, when the compromise in cell viability induced by irradiation was prevented by eicosapentaenoic acid, long term potentiation was sustained in a manner similar to that in the sham-treated control group.	Trinity Coll Dublin, Dept Phys, Trinity Coll Inst Neurosci, Dublin 2, Ireland; Laxdale Ltd, Stirling, Scotland	Trinity College Dublin	Lynch, MA (corresponding author), Trinity Coll Dublin, Dept Phys, Trinity Coll Inst Neurosci, Dublin 2, Ireland.	lynchma@tcd.ie	Lonergan, Peter E/B-4544-2008	Lonergan, Peter E/0000-0001-7233-8156; Lynch, Marina/0000-0002-4631-0499				Babcock T, 2000, NUTRITION, V16, P1116, DOI 10.1016/S0899-9007(00)00392-0; BENKOVIC SA, 1993, J COMP NEUROL, V338, P97, DOI 10.1002/cne.903380108; Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631; Choi WS, 1999, J NEUROSCI RES, V57, P86, DOI 10.1002/(SICI)1097-4547(19990701)57:1<86::AID-JNR9>3.0.CO;2-E; Cortopassi GA, 1999, BBA-BIOENERGETICS, V1410, P183, DOI 10.1016/S0005-2728(98)00166-2; Czeh B, 1998, HIPPOCAMPUS, V8, P548; Delgado M, 2000, J NEUROIMMUNOL, V110, P97, DOI 10.1016/S0165-5728(00)00359-3; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; ENDRES S, 1989, NEW ENGL J MED, V320, P265, DOI 10.1056/NEJM198902023200501; FINNEN MJ, 1991, BIOCHEM SOC T, V19, pS91, DOI 10.1042/bst019091s; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Gahtan E, 1998, EUR J NEUROSCI, V10, P538, DOI 10.1046/j.1460-9568.1998.00058.x; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hallan E, 1997, SCAND J IMMUNOL, V46, P601, DOI 10.1046/j.1365-3083.1997.d01-173.x; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Harper SJ, 2001, CELL SIGNAL, V13, P299, DOI 10.1016/S0898-6568(01)00148-6; Hayashi H, 1999, CURR MED RES OPIN, V15, P177, DOI 10.1185/03007999909114089; HORROBIN DF, 1991, MED HYPOTHESES, V35, P23, DOI 10.1016/0306-9877(91)90078-D; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Kannan, 2000, Pathophysiology, V7, P153, DOI 10.1016/S0928-4680(00)00053-5; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Korystov YN, 1996, FEBS LETT, V388, P238, DOI 10.1016/0014-5793(96)00538-8; Kumagae Y, 1999, MOL BRAIN RES, V67, P10, DOI 10.1016/S0169-328X(99)00013-3; LEBEL CP, 1990, NEUROCHEM INT, V17, P435, DOI 10.1016/0197-0186(90)90025-O; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lo YYC, 1996, J BIOL CHEM, V271, P15703, DOI 10.1074/jbc.271.26.15703; Lynch MA, 2002, VITAM HORM, V64, P185, DOI 10.1016/S0083-6729(02)64006-3; Lynch MA, 1998, PROG NEUROBIOL, V56, P571, DOI 10.1016/S0301-0082(98)00054-9; MacManus A, 2000, J BIOL CHEM, V275, P4713, DOI 10.1074/jbc.275.7.4713; MARTIN DSD, 2000, SOC NEUROSCI, V26, P889; Martinou JC, 1996, CURR OPIN NEUROBIOL, V6, P609, DOI 10.1016/S0959-4388(96)80092-4; Maundrell K, 1997, J BIOL CHEM, V272, P25238, DOI 10.1074/jbc.272.40.25238; McGahon BM, 1999, NEUROBIOL AGING, V20, P643, DOI 10.1016/S0197-4580(99)00027-5; McGahon BM, 1999, NEUROSCIENCE, V94, P305, DOI 10.1016/S0306-4522(99)00219-5; MICHALOWSKI AS, 1994, ACTA ONCOL, V33, P139, DOI 10.3109/02841869409098397; Mielke K, 2000, PROG NEUROBIOL, V61, P45, DOI 10.1016/S0301-0082(99)00042-8; Murray CA, 1998, J BIOL CHEM, V273, P12161, DOI 10.1074/jbc.273.20.12161; Murray CA, 1998, J NEUROSCI, V18, P2974; Neary JT, 1997, NEWS PHYSIOL SCI, V12, P286; NEEDLEMAN P, 1979, P NATL ACAD SCI USA, V76, P944, DOI 10.1073/pnas.76.2.944; O'Brien MA, 2001, BIOTECHNIQUES, V30, P886, DOI 10.2144/01304pf01; O'Donnell E, 2000, EUR J NEUROSCI, V12, P345, DOI 10.1046/j.1460-9568.2000.00900.x; Obukowicz MG, 1998, J PHARMACOL EXP THER, V287, P157; Palakurthi SS, 2000, CANCER RES, V60, P2919; Park J, 1997, J BIOL CHEM, V272, P16725, DOI 10.1074/jbc.272.27.16725; PELLMAR TC, 1993, RADIAT RES, V136, P255, DOI 10.2307/3578619; PELLMAR TC, 1991, NEUROSCIENCE, V44, P353, DOI 10.1016/0306-4522(91)90060-2; PELLMAR TC, 1990, RADIAT RES, V122, P209, DOI 10.2307/3577608; PETTEL JB, 2000, EUR J NEUROSCI, V12, P621; PURASIRI P, 1994, CLIN SCI, V87, P711, DOI 10.1042/cs0870711; RICEEVANS C, 1993, PROG LIPID RES, V32, P71, DOI 10.1016/0163-7827(93)90006-I; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Rosse T, 1998, NATURE, V391, P496, DOI 10.1038/35160; Slee EA, 1999, CELL DEATH DIFFER, V6, P1067, DOI 10.1038/sj.cdd.4400601; Smith MA, 1998, J HISTOCHEM CYTOCHEM, V46, P731, DOI 10.1177/002215549804600605; Spencer JPE, 1998, J NEUROCHEM, V71, P2112; Steinauer KK, 2000, INT J RADIAT ONCOL, V48, P325, DOI 10.1016/S0360-3016(00)00671-4; Stridh H, 1998, FEBS LETT, V429, P351, DOI 10.1016/S0014-5793(98)00630-9; TOLLIVER JM, 1987, RADIAT RES, V112, P555, DOI 10.2307/3577107; Tournier C, 1997, EUR J BIOCHEM, V244, P587, DOI 10.1111/j.1432-1033.1997.00587.x; Vereker E, 2001, EUR J NEUROSCI, V14, P1809, DOI 10.1046/j.0953-816x.2001.01809.x; Vereker E, 2000, J NEUROSCI, V20, P6811, DOI 10.1523/JNEUROSCI.20-18-06811.2000; Vereker E, 2000, J BIOL CHEM, V275, P26252, DOI 10.1074/jbc.M002226200; Wang XT, 1998, BIOCHEM J, V333, P291, DOI 10.1042/bj3330291; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yuen KS, 1997, PHOTOCHEM PHOTOBIOL, V65, P587, DOI 10.1111/j.1751-1097.1997.tb08610.x; Zanke BW, 1996, CURR BIOL, V6, P606, DOI 10.1016/S0960-9822(02)00547-X; Zhivotovsky B, 1998, CELL DEATH DIFFER, V5, P459, DOI 10.1038/sj.cdd.4400386	73	107	111	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20804	20811		10.1074/jbc.M202387200	http://dx.doi.org/10.1074/jbc.M202387200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11912218	hybrid			2022-12-27	WOS:000176204500090
J	Ramakrishnan, B; Qasba, PK				Ramakrishnan, B; Qasba, PK			Structure-based design of beta 1,4-galactosyltransferase I (beta 4GaI-T1) with equally efficient N-acetylgalactosaminyltransferase activity - Point mutation broadens beta 4GaI-T1 donor specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-LACTALBUMIN; CRYSTAL-STRUCTURE; BOVINE; ACCEPTOR; EXPRESSION	beta1,4-Galactosyltransferase I (Gal-T1) normally transfers Gal from LTDP-Gal to GlcNAc in the presence of Mn2+ ion. In the presence of alpha-lactalbumin (LA), the Gal acceptor specificity is altered from GlcNAc to Glc. Gal-T1 also transfers GaINAc from UDP-Ga1NAc to Glc-NAc, but with only similar to0.1% of Gal-T activity. To understand this low GaINAc-transferase activity, we have carried out the crystal structure analysis of the Gal-T1(.)LA complex with UDP-GalNAc at 2.1-Angstrom resolution. The crystal structure reveals that the LTDP-GalNAc binding to Gal-T1 is similar to the binding of LTDP-Gal to Gal-T1, except for an additional hydrogen bond formed between the N-acetyl group of GaINAc moiety with the Tyr-289 side chain hydroxyl group. Elimination of this additional hydrogen bond by mutating Tyr-289 residue to Leu, Ile, or Asn enhances the GaINAc-transferase activity. Although all three mutants exhibit enhanced GalNAc-transferase activity, the mutant Y289L exhibits GalNAc-transferase activity that is nearly 100% of its Gal-T activity, even while completely retaining its Gal-T activity. The steady state kinetic analyses on the Leu-289 mutant indicate that the K-m for GlcNAc has increased compared to the wild type. On the other hand, the catalytic constant (k(cat)) in the Gal-T reaction is comparable with the wild type, whereas it is 3-5-fold higher in the GaINAc-T reaction. Interestingly, in the presence of LA, these mutants also transfer GaINAc to Glc instead of to GlcNAc. The present study demonstrates that, in the Gal-T family, the Tyr-289/Phe-289 residue largely determines the sugar donor specificity.	NCI, Struct Glycobiol Sect, LECB, CCR,NIH, Frederick, MD 21702 USA; NCI, Intramural Res Support Program SAIC, LECB, CCR,NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Qasba, PK (corresponding author), NCI, Struct Glycobiol Sect, LECB, CCR,NIH, Bldg 469,Rm 221, Frederick, MD 21702 USA.				NCI NIH HHS [N01-CO-12400] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDREE PJ, 1978, BIOCHIM BIOPHYS ACTA, V544, P489; AOKI D, 1990, EMBO J, V9, P3171, DOI 10.1002/j.1460-2075.1990.tb07515.x; BERLINER LJ, 1984, MOL CELL BIOCHEM, V62, P37, DOI 10.1007/BF00230075; BERLINER LJ, 1982, BIOCHEMISTRY-US, V21, P6340, DOI 10.1021/bi00268a003; BOEGGEMAN EE, 1993, PROTEIN ENG, V6, P779, DOI 10.1093/protein/6.7.779; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chung SJ, 1998, BIOORG MED CHEM LETT, V8, P3359, DOI 10.1016/S0960-894X(98)00618-0; DO KY, 1995, J BIOL CHEM, V270, P18447, DOI 10.1074/jbc.270.31.18447; HILL R, 1979, UCLA FORUM MED SCI, V21, P63; HINDSGAUL O, 1991, J BIOL CHEM, V266, P17858; KARULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946; KIM SC, 1988, ARCH BIOCHEM BIOPHYS, V267, P54, DOI 10.1016/0003-9861(88)90007-0; Lo NW, 1998, GLYCOBIOLOGY, V8, P517, DOI 10.1093/glycob/8.5.517; Navaza J, 1994, ACTA CRYSTALLOGR D, V50, P760; Nomura T, 1998, J BIOL CHEM, V273, P13570, DOI 10.1074/jbc.273.22.13570; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALCIC M M, 1991, Glycobiology, V1, P205, DOI 10.1093/glycob/1.2.205; Qasba PK, 1997, CRIT REV BIOCHEM MOL, V32, P255, DOI 10.3109/10409239709082574; Ramakrishnan B, 2002, BIOCHEM BIOPH RES CO, V291, P1113, DOI 10.1006/bbrc.2002.6506; Ramakrishnan B, 2002, J MOL BIOL, V318, P491, DOI 10.1016/S0022-2836(02)00020-7; Ramakrishnan B, 2001, J BIOL CHEM, V276, P37665, DOI 10.1074/jbc.M102458200; Ramakrishnan B, 2001, J MOL BIOL, V310, P205, DOI 10.1006/jmbi.2001.4757; Rao V. S. R., 1998, CONFORMATION CARBOHY; Van den Nieuwenhof IM, 1999, GLYCOBIOLOGY, V9, P115, DOI 10.1093/glycob/9.2.115; Van den Nieuwenhof IM, 1999, FEBS LETT, V459, P377, DOI 10.1016/S0014-5793(99)01284-3; Van den Nieuwenhof IM, 2000, EUR J BIOCHEM, V267, P4753, DOI 10.1046/j.1432-1327.2000.01528.x; Zhang YN, 1999, GLYCOBIOLOGY, V9, P815, DOI 10.1093/glycob/9.8.815	27	176	203	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20833	20839		10.1074/jbc.M111183200	http://dx.doi.org/10.1074/jbc.M111183200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11916963	hybrid			2022-12-27	WOS:000176204500094
J	Ulrich, H; Magdesian, MH; Alves, MJM; Colli, W				Ulrich, H; Magdesian, MH; Alves, MJM; Colli, W			In vitro selection of RNA aptamers that bind to cell adhesion receptors of Trypanosoma cruzi and inhibit cell invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; EXPONENTIAL ENRICHMENT; SYSTEMATIC EVOLUTION; MAMMALIAN-CELLS; TRANS-SIALIDASE; LIGANDS; SURFACE; INFECTION; ACTIVATION; MOLECULES	Trypanosoma cruzi causing Chagas' disease needs to invade host cells to complete its life cycle. Macromolecules on host cell surfaces such as laminin, thrombospondin, heparan sulfate, and fibronectin are believed to be important in mediating parasite-host cell adhesions and in the invasion process of the host cell by the parasite. The SELEX technique (systematic evolution of ligands bygxponential enrichment) was used to evolve nuclease-resistant RNA ligands (aptamer = to fit) that bind with affinities of 40-400 nm to parasite receptors for the host cell matrix molecules laminin, fibronectin, thrombospondin, and heparan sulfate. After eight consecutive rounds of in vitro selection four classes of RNA aptamers based on structural similarities were isolated and sequenced. All members of each class shared a common sequence motif and competed with the respective host cell matrix molecule that was used for displacement during the selection procedure. RNA pools following seven and eight selection rounds as well as individual aptamers sharing consensus motifs were active in inhibiting invasion of LLC-MK2 monkey kidney cells by T. cruzi in vitro.	Univ Fed Sao Paulo, Inst Quim, Dept Bioquim, BR-05513970 Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Colli, W (corresponding author), Univ Fed Sao Paulo, Inst Quim, Dept Bioquim, Caixa Postal 26077, BR-05513970 Sao Paulo, Brazil.	walcolli@usp.br	Colli, Walter/ABA-5440-2021; Alves, Maria Julia/K-8976-2012; Ulrich, Henning/AAX-8586-2021; Colli, Walter/AAW-7649-2021; Ulrich, Henning/C-5245-2013; Colli, Walter/G-1188-2012	Alves, Maria Julia/0000-0001-7211-9631; Ulrich, Henning/0000-0002-2114-3815; Colli, Walter/0000-0001-7305-4673; Ulrich, Henning/0000-0002-2114-3815; 				Almeida-de-Faria M, 1999, EXP PARASITOL, V92, P263, DOI 10.1006/expr.1999.4423; ANDREWS NW, 1982, J PROTOZOOL, V29, P264, DOI 10.1111/j.1550-7408.1982.tb04024.x; ARMSTRONG PB, 2000, BIOCHIM BIOPHYS ACTA, V1470, P9; BRENER Z, 1973, ANNU REV MICROBIOL, V27, P347, DOI 10.1146/annurev.mi.27.100173.002023; Brody E N, 2000, J Biotechnol, V74, P5, DOI 10.1016/S1389-0352(99)00004-5; COLLI W, 1993, FASEB J, V7, P1257, DOI 10.1096/fasebj.7.13.8405811; CROSS GAM, 1993, ANNU REV MICROBIOL, V47, P385, DOI 10.1146/annurev.mi.47.100193.002125; Davis KA, 1998, NUCLEIC ACIDS RES, V26, P3915, DOI 10.1093/nar/26.17.3915; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Floege J, 1999, AM J PATHOL, V154, P169, DOI 10.1016/S0002-9440(10)65263-7; Ghosh AK, 2001, P NATL ACAD SCI USA, V98, P13278, DOI 10.1073/pnas.241491198; Giannelli G, 2001, CLIN EXP METASTAS, V18, P439; GIORDANO R, 1994, MOL BIOCHEM PARASIT, V65, P85, DOI 10.1016/0166-6851(94)90117-1; Giordano R, 1999, J BIOL CHEM, V274, P3461, DOI 10.1074/jbc.274.6.3461; GONCALVES MF, 1991, EXP PARASITOL, V72, P43, DOI 10.1016/0014-4894(91)90119-H; Grellier P, 2001, J BIOL CHEM, V276, P47078, DOI 10.1074/jbc.M106017200; HERRERA EM, 1994, MOL BIOCHEM PARASIT, V65, P73, DOI 10.1016/0166-6851(94)90116-3; Hess GP, 2000, P NATL ACAD SCI USA, V97, P13895, DOI 10.1073/pnas.240459497; Homann M, 1999, NUCLEIC ACIDS RES, V27, P2006, DOI 10.1093/nar/27.9.2006; Ito Y, 1998, J BIOACT COMPAT POL, V13, P114, DOI 10.1177/088391159801300203; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Jenison RD, 1998, ANTISENSE NUCLEIC A, V8, P265, DOI 10.1089/oli.1.1998.8.265; Jeong S, 2001, BIOCHEM BIOPH RES CO, V281, P237, DOI 10.1006/bbrc.2001.4327; Kusser W, 2000, J Biotechnol, V74, P27; Leppanen O, 2000, ARTERIOSCL THROM VAS, V20, pE89, DOI 10.1161/01.ATV.20.11.e89; Lima APCA, 2002, J BIOL CHEM, V277, P5875, DOI 10.1074/jbc.M108518200; Magdesian MH, 2001, J BIOL CHEM, V276, P19382, DOI 10.1074/jbc.M011474200; MING M, 1995, CELL, V82, P287, DOI 10.1016/0092-8674(95)90316-X; Morris KN, 1998, P NATL ACAD SCI USA, V95, P2902, DOI 10.1073/pnas.95.6.2902; OConnell D, 1996, P NATL ACAD SCI USA, V93, P5883, DOI 10.1073/pnas.93.12.5883; Ostendorf T, 1999, J CLIN INVEST, V104, P913, DOI 10.1172/JCI6740; OUAISSI MA, 1986, SCIENCE, V234, P603, DOI 10.1126/science.3094145; PAN WH, 1995, P NATL ACAD SCI USA, V92, P11509, DOI 10.1073/pnas.92.25.11509; Pereira M. E. A., 1990, Modern parasite biology: cellular, immunological, and molecular aspects., P64; Rodriguez-Manzaneque JC, 2001, P NATL ACAD SCI USA, V98, P12485, DOI 10.1073/pnas.171460498; Sargiannidou I, 2001, EXP BIOL MED, V226, P726, DOI 10.1177/153537020222600803; Scharfstein J, 2000, J EXP MED, V192, P1289, DOI 10.1084/jem.192.9.1289; Soeiro MD, 1999, CELL STRUCT FUNCT, V24, P139, DOI 10.1247/csf.24.139; Sultan A A, 1999, Int Microbiol, V2, P155; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Ulrich H, 1998, P NATL ACAD SCI USA, V95, P14051, DOI 10.1073/pnas.95.24.14051; Ulrich H, 2001, BRAZ J MED BIOL RES, V34, P295, DOI 10.1590/S0100-879X2001000300002; Wang J, 2000, RNA, V6, P571, DOI 10.1017/S1355838200992215; Willis MC, 1998, BIOCONJUGATE CHEM, V9, P573, DOI 10.1021/bc980002x; Zuker M, 1999, NATO ASI 3 HIGH TECH, V70, P11	45	124	147	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20756	20762		10.1074/jbc.M111859200	http://dx.doi.org/10.1074/jbc.M111859200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11919187	hybrid			2022-12-27	WOS:000176204500085
J	Vargason, JM; Ho, PS				Vargason, JM; Ho, PS			The effect of cytosine methylation on the structure and geometry of the Holliday junction - The structure of d(CCGGTACm(5)CGG) at 1.5 angstrom resolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4-WAY DNA JUNCTION; CRYSTAL-STRUCTURES; NUCLEIC-ACIDS; MACROMOLECULAR STRUCTURES; B-DNA; SEQUENCE; CRYSTALLOGRAPHY; RECOMBINATION; TRANSITION; REFINEMENT	The single crystal structure of the methylated sequence d(CCGGTACm(5)CGG) has been solved as an antiparallel stacked X Holliday junction to 1.5 Angstrom resolution. When compared with the parent nonmethylated d(CCGGTACCGG) structure, the duplexes are translated by 3.4 A along the helix axis and rotated by 10.8degrees relative to each other, rendering the major grooves more accessible overall. A Ca2+ complex is seen in the minor groove opposite the junction but is related to the B conformation of the stacked arms. At the junction itself, the hydrogen bond from the N4 nitrogen of cytosine C8 to the C7 phosphate at the crossover in the parent structure has been replaced by a water bridge. Thus, this direct interaction is not absolutely required to stabilize the junction at the previously defined ACC trinucleotide core. The more compact methylated junction forces the Na+ of the protected central cavity of the nonmethylated junction into a solvent cluster that spans the space between the junction crossover and the stacked arms. A series of void volumes within the methylated and the nonmethylated structures suggests that small monovalent cations can fill and vacate this central cavity without the need to unfold the four-stranded Holliday junction completely.	Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	Oregon State University	Ho, PS (corresponding author), Oregon State Univ, Dept Biochem & Biophys, ALS 2011, Corvallis, OR 97331 USA.		Ho, Pui/AAF-8838-2020; Ho, Pui S/F-6186-2014	Ho, Pui/0000-0002-8082-4311; Ho, Pui S/0000-0002-8082-4311	NIEHS NIH HHS [ES00210] Funding Source: Medline; NIGMS NIH HHS [R01 GM062957, R01 GM062957-01A2] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062957] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEHE M, 1981, P NATL ACAD SCI-BIOL, V78, P1619, DOI 10.1073/pnas.78.3.1619; BERMAN HM, 1992, BIOPHYS J, V63, P751, DOI 10.1016/S0006-3495(92)81649-1; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CLEGG RM, 1992, BIOCHEMISTRY-US, V31, P4846, DOI 10.1021/bi00135a016; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; COOPER JP, 1987, J MOL BIOL, V198, P711, DOI 10.1016/0022-2836(87)90212-9; Cox MM, 2001, ANNU REV GENET, V35, P53, DOI 10.1146/annurev.genet.35.102401.090016; DICKERSON RE, 1987, J BIOMOL STRUCT DYN, V5, P557, DOI 10.1080/07391102.1987.10506413; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Eichman BF, 2000, P NATL ACAD SCI USA, V97, P3971, DOI 10.1073/pnas.97.8.3971; Eichman BF, 2001, J MOL BIOL, V308, P15, DOI 10.1006/jmbi.2001.4567; ElHassan MA, 1996, J MOL BIOL, V259, P95, DOI 10.1006/jmbi.1996.0304; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; FREDERICK CA, 1987, BIOPOLYMERS, V181, pS145; Hanseh C., 1979, SUBSTITUENT CONSTANT; HARDIN CC, 1993, BIOCHEMISTRY-US, V32, P5870, DOI 10.1021/bi00073a021; HO PS, 1988, J PHYS CHEM-US, V92, P939, DOI 10.1021/j100315a017; Ho PS, 2001, CURR OPIN STRUC BIOL, V11, P302, DOI 10.1016/S0959-440X(00)00219-0; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; Huheey J.E., 1978, INORGANIC CHEM PRINC; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Kielkopf CL, 2000, J MOL BIOL, V296, P787, DOI 10.1006/jmbi.1999.3478; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Leitner D, 2000, BIOCHEMISTRY-US, V39, P5886, DOI 10.1021/bi992630n; Lilley DMJ, 2000, Q REV BIOPHYS, V33, P109, DOI 10.1017/S0033583500003590; Lu XJ, 2000, J MOL BIOL, V300, P819, DOI 10.1006/jmbi.2000.3690; Mao CD, 1999, J AM CHEM SOC, V121, P5437, DOI 10.1021/ja9900398; Mayer-Jung C, 1998, EMBO J, V17, P2709, DOI 10.1093/emboj/17.9.2709; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MURCHIE AIH, 1989, NATURE, V341, P763, DOI 10.1038/341763a0; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nowakowski J, 2000, J MOL BIOL, V300, P93, DOI 10.1006/jmbi.2000.3826; Nowakowski J, 1999, NAT STRUCT BIOL, V6, P151; Ortiz-Lombardia M, 1999, NAT STRUCT BIOL, V6, P913; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sha RJ, 2000, CHEM BIOL, V7, P743, DOI 10.1016/S1074-5521(00)00024-7; Smith GR, 2001, ANNU REV GENET, V35, P243, DOI 10.1146/annurev.genet.35.102401.090509; Tolstorukov MY, 2001, BIOPHYS J, V81, P3409, DOI 10.1016/S0006-3495(01)75973-5; Vargason JM, 2000, NAT STRUCT BIOL, V7, P758; Whitehurst CE, 2000, IMMUNITY, V13, P703, DOI 10.1016/S1074-7613(00)00069-8; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xia F, 2001, P NATL ACAD SCI USA, V98, P8644, DOI 10.1073/pnas.151253498	44	23	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					21041	21049		10.1074/jbc.M201357200	http://dx.doi.org/10.1074/jbc.M201357200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11919197	hybrid			2022-12-27	WOS:000176204500119
J	Palmblad, M; Westlind-Danielsson, A; Bergquist, J				Palmblad, M; Westlind-Danielsson, A; Bergquist, J			Oxidation of methionine 35 attenuates formation of amyloid beta-peptide 1-40 oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; IN-VITRO; PROTEIN FIBRILLOGENESIS; CEREBROSPINAL-FLUID; MASS-SPECTROMETER; FIBRIL FORMATION; AGGREGATION; NEUROTOXICITY; DISSOCIATION; MORPHOLOGY	Amyloid plaques formed by aggregation of the amyloid beta-peptide (Abeta) are an intrinsic component of Alzheimer disease pathogenesis. It has been suggested that oxidation of methionine 35 in Abeta has implications for Alzheimer disease, and it has been shown that oxidation of Met-35 significantly inhibits aggregation in vitro. In this study, the aggregational properties of Abeta-(1-40) before and after Met-35 oxidation were investigated using electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry. The results show that Abeta-(1-40)Met-35(0) trimer and tetramer formation is significantly attenuated as compared with Abeta-(1-40). This suggests that oxidation of Met-35 inhibits a conformational switch in Abeta-(1-40) necessary for trimer but not dimer formation. Random incorporation of Abeta-(1-40) and Abeta-(1-40)Met-35(0) in homo- and heterooligomers could also be observed. This is the first report of an early rate-limiting step in Abeta-(1-40) aggregation. Slowing of the fibrillization process at this early step is likely to support prolonged solubility and clearance of Abeta from brain and may reduce disease progression.	Uppsala Univ, Angstrom Lab, Div Ion Phys, SE-75121 Uppsala, Sweden; Karolinska Inst, NEUROTEC, Novum, KFC, SE-14186 Huddinge, Sweden; Sahlgrens Univ Hosp, Univ Gothenburg, Dept Psychiat & Neurochem, Inst Clin Neurosci, SE-43180 Molndal, Sweden; Uppsala Univ, Inst Chem, Dept Analyt Chem, SE-75121 Uppsala, Sweden	Uppsala University; Karolinska Institutet; Sahlgrenska University Hospital; University of Gothenburg; Uppsala University	Bergquist, J (corresponding author), Uppsala Univ, Angstrom Lab, Div Ion Phys, Box 534, SE-75121 Uppsala, Sweden.		Bergquist, Jonas/C-5894-2015; Palmblad, Magnus/N-8203-2015	Palmblad, Magnus/0000-0002-5865-8994; Bergquist, Jonas/0000-0002-4597-041X				BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Butterfield DA, 1999, ANN NY ACAD SCI, V893, P265, DOI 10.1111/j.1749-6632.1999.tb07833.x; Chaney MO, 1998, PROTEIN ENG, V11, P761, DOI 10.1093/protein/11.9.761; Chen XG, 1997, FASEB J, V11, P817, DOI 10.1096/fasebj.11.10.9271367; Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f; Golde TE, 2000, BBA-MOL BASIS DIS, V1502, P172, DOI 10.1016/S0925-4439(00)00043-0; Hakansson K, 2000, J AM SOC MASS SPECTR, V11, P210, DOI 10.1016/S1044-0305(99)00144-0; Harkany T, 2000, REV NEUROSCIENCE, V11, P329; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hasegawa K, 1999, BIOCHEMISTRY-US, V38, P15514, DOI 10.1021/bi991161m; HAYES RN, 1990, METHOD ENZYMOL, V193, P237, DOI 10.1016/0076-6879(90)93418-K; Huang THJ, 2000, J BIOL CHEM, V275, P36436, DOI 10.1074/jbc.M005698200; IVERSEN LL, 1995, BIOCHEM J, V311, P1; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; Kisilevsky R, 1997, CRIT REV BIOCHEM MOL, V32, P361, DOI 10.3109/10409239709082674; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Kuo YM, 2001, J BIOL CHEM, V276, P12991, DOI 10.1074/jbc.M007859200; LANSBURY PT, 1995, NAT STRUCT BIOL, V2, P990, DOI 10.1038/nsb1195-990; Lomakin A, 1997, P NATL ACAD SCI USA, V94, P7942, DOI 10.1073/pnas.94.15.7942; Mehta PD, 2000, ARCH NEUROL-CHICAGO, V57, P100, DOI 10.1001/archneur.57.1.100; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Nilsson S, 2001, RAPID COMMUN MASS SP, V15, P1997, DOI 10.1002/rcm.466.abs; Palmblad M, 2000, RAPID COMMUN MASS SP, V14, P1029, DOI 10.1002/1097-0231(20000630)14:12<1029::AID-RCM984>3.0.CO;2-#; Palmblad M, 2000, EUR J MASS SPECTROM, V6, P267, DOI 10.1255/ejms.348; PIKE CJ, 1995, J NEUROCHEM, V64, P253, DOI 10.1046/j.1471-4159.1995.64010253.x; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Seilheimer B, 1997, J STRUCT BIOL, V119, P59, DOI 10.1006/jsbi.1997.3859; Sennvik K, 2000, NEUROSCI LETT, V278, P169, DOI 10.1016/S0304-3940(99)00929-5; Shao HY, 1999, J MOL BIOL, V285, P755, DOI 10.1006/jmbi.1998.2348; SHEN CL, 1995, BIOPHYS J, V69, P640, DOI 10.1016/S0006-3495(95)79940-4; SNYDER SW, 1994, BIOPHYS J, V67, P1216, DOI 10.1016/S0006-3495(94)80591-0; SOTO C, 1995, J BIOL CHEM, V270, P3063, DOI 10.1074/jbc.270.7.3063; Teplow DB, 1998, AMYLOID, V5, P121, DOI 10.3109/13506129808995290; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Watson AA, 1998, BIOCHEMISTRY-US, V37, P12700, DOI 10.1021/bi9810757; Westlind-Danielsson A, 2001, BIOCHEMISTRY-US, V40, P14736, DOI 10.1021/bi010375c; Yong W, 2002, P NATL ACAD SCI USA, V99, P150, DOI 10.1073/pnas.012584899	43	106	110	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19506	19510		10.1074/jbc.M112218200	http://dx.doi.org/10.1074/jbc.M112218200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11912198	hybrid			2022-12-27	WOS:000175894800037
J	Vanni, C; Mancini, P; Gao, Y; Ottaviano, C; Guo, F; Salani, B; Torrisi, MR; Zheng, Y; Eva, A				Vanni, C; Mancini, P; Gao, Y; Ottaviano, C; Guo, F; Salani, B; Torrisi, MR; Zheng, Y; Eva, A			Regulation of proto-Dbl by intracellular membrane targeting and protein stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; KAPPA-B; TRANSFORMING ACTIVITY; EXCHANGE FACTOR; ONCOGENIC DBL; RHO-GTPASES; C-JUN; ACTIVATION; BINDING; RAC	The pleckstrin homology (PH) domain of onco-Dbl, a guanine nucleotide exchange factor (GEF) for Cdc42 and RhoA GTPases, interacts with phosphoinositides (PIPs). This interaction modulates both the GEF activity and the targeting to the plasma membrane of onco-Dbl. Conversely, we have previously shown that in proto-Dbl an intramolecular interaction between the N-terminal domain and the PH domain imposes a negative regulation on both the DH and PH functions, suppressing its transforming activity. Here we have further investigated the mode of regulation of proto-Dbl by generating proto-Dbl mutants deleted of the last C-terminal 50 amino acids, which contain a PEST motif, and/or unable to bind to PIPs due to substitutions of the positively charged residues of the PH domain. The PH mutants of proto-Dbl retained a relative weak GEF activity toward Cdc42 and RhoA in vitro, but their RhoA activating potential was impaired in vivo. Further, these mutants lost both the plasma membrane targeting and the transforming activities, contrary to the PH mutants of onco-Dbl that retained the exchange activity both in vitro and in vivo and showed significant, but partially, reduced transforming activity. Deletion of the C-terminal sequences from onco-Dbl did not affect its function, whereas similar deletion of proto-Dbl led to an increase of transforming activity. Analysis of the half-life of the proto-Dbl mutants revealed that deletion of the C-terminal sequences increases the stability of the protein. Overall, the transformation potential of proto-Dbl mutants was associated with an augmented localization of the protein to the plasma membrane and a strong activation of Jun N-terminal kinase activity and transcription of cyclin D1. Together with previous observations, these data suggest that the biological activity of proto-Dbl is tightly regulated by a combination of mechanisms that involve intramolecular interaction, PH binding to PIPs, and the N- and C-terminal domain-dependent turnover of the protein.	Ist Giannina Gaslini, Mol Biol Lab, I-16147 Genoa, Italy; Univ Roma La Sapienza, Dipartimento Med Sperimentale & Patol, I-00161 Rome, Italy; Univ Tennessee, Dept Mol Sci, Memphis, TN 38163 USA	University of Genoa; IRCCS Istituto Giannina Gaslini; Sapienza University Rome; University of Tennessee System; University of Tennessee Health Science Center	Eva, A (corresponding author), Ist Giannina Gaslini, Mol Biol Lab, Largo Gaslini 5, I-16147 Genoa, Italy.		Eva, Alessandra/J-8268-2016; Zheng, Yi/J-7235-2015	Eva, Alessandra/0000-0003-2949-078X; Zheng, Yi/0000-0001-7089-6074; mancini, patrizia/0000-0003-0556-2056	NIGMS NIH HHS [GM53943] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Bi F, 2001, MOL CELL BIOL, V21, P1463, DOI 10.1128/MCB.21.5.1463-1474.2001; Butty AC, 1998, SCIENCE, V282, P1511, DOI 10.1126/science.282.5393.1511; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Das B, 2000, J BIOL CHEM, V275, P15074, DOI 10.1074/jbc.M907269199; EVA A, 1985, NATURE, V316, P273, DOI 10.1038/316273a0; Fenwick C, 2000, SCIENCE, V287, P869, DOI 10.1126/science.287.5454.869; Fleming IN, 1999, J BIOL CHEM, V274, P12753, DOI 10.1074/jbc.274.18.12753; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRAZIANI G, 1989, ONCOGENE, V4, P823; Gulli MP, 2001, GENE DEV, V15, P365, DOI 10.1101/gad.876901; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; HART MJ, 1991, NATURE, V354, P311, DOI 10.1038/354311a0; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; Jefferson AB, 1998, ONCOGENE, V16, P2303, DOI 10.1038/sj.onc.1201891; Jin SH, 2000, BIOCHEM BIOPH RES CO, V277, P718, DOI 10.1006/bbrc.2000.3744; Katan M, 1999, FEBS LETT, V452, P36, DOI 10.1016/S0014-5793(99)00531-1; Kimura K, 2000, J BIOL CHEM, V275, P17233, DOI 10.1074/jbc.C000212200; Ma AD, 1998, MOL CELL BIOL, V18, P4744, DOI 10.1128/MCB.18.8.4744; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Montaner S, 1998, J BIOL CHEM, V273, P12779, DOI 10.1074/jbc.273.21.12779; Nern A, 1999, J CELL BIOL, V144, P1187, DOI 10.1083/jcb.144.6.1187; Nishida K, 1999, FEBS LETT, V459, P186, DOI 10.1016/S0014-5793(99)01244-2; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Razzini G, 2000, J BIOL CHEM, V275, P14873, DOI 10.1074/jbc.275.20.14873; Rechsteiner M, 1990, Semin Cell Biol, V1, P433; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; RON D, 1991, NEW BIOL, V3, P372; RON D, 1989, ONCOGENE, V4, P1067; Russo C, 2001, J BIOL CHEM, V276, P19524, DOI 10.1074/jbc.M009742200; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Westwick JK, 1998, J BIOL CHEM, V273, P16739, DOI 10.1074/jbc.273.27.16739; Whitehead LP, 1999, MOL CELL BIOL, V19, P7759; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9; Zheng Y, 1996, J BIOL CHEM, V271, P19017, DOI 10.1074/jbc.271.32.19017; Zhu KJ, 2001, MOL CELL BIOL, V21, P425, DOI 10.1128/MCB.21.2.425-437.2001	43	29	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19745	19753		10.1074/jbc.M111025200	http://dx.doi.org/10.1074/jbc.M111025200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11907027	hybrid			2022-12-27	WOS:000175894800067
J	Wong, LH; Sim, H; Chatterjee-Kishore, M; Hatzinisiriou, I; Devenish, RJ; Stark, G; Ralph, SJ				Wong, LH; Sim, H; Chatterjee-Kishore, M; Hatzinisiriou, I; Devenish, RJ; Stark, G; Ralph, SJ			Isolation and characterization of a human STAT1 gene regulatory element - Inducibility by interferon (IFN) types I and II and role of IFN regulatory factor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED RESPONSE ELEMENT; TRANSCRIPTIONAL ACTIVATOR; GAMMA-INTERFERONS; PROMOTER ELEMENT; ISGF3 COMPONENTS; MELANOMA-CELLS; KAPPA-B; ALPHA; EXPRESSION; DNA	The transcription factor STAT1 plays a pivotal role in signal transduction of type I and II interferons (IFNs). STAT1 activation leads to changes in expression of key regulatory genes encoding caspases and cell cycle inhibitors. Deficient STAT1 expression in human cancer cells and virally mediated inhibition of STAT1 function have been associated with cellular resistance to IFNs and mycobacterial infection in humans. Thus, given the relative importance of STAT1, we isolated and characterized a human STAT1 intronic enhancer region displaying IFN-regulated activity. Functional analyses by transient expression identified a repressor region and type I and II IFN-inducible elements within the STAT1 enhancer sequence. A candidate IRF-E/GAS/IRF-E (IGI) sequence containing GAAANN nucleotide repeats was shown by gel shift assay to bind to IFN regulatory factor-1 (IRF-1), but not to IFN-stimulated gene factor-3 (ISGF-3) or STAT1-3. An additional larger IGI-binding complex containing IRF-1 was identified. Mutation of the GAAANN repeats within the IGI DNA element eliminated IRF-1 binding and the IFN-regulated activity of the STAT1 intronic enhancer region. Transfection of the IFN-resistant MM96 cell line to express increased levels of IRF-1 protein also elevated STAT1, STAT2, and p48/ IRF-9 expression and enhanced cellular responsiveness to IFN-beta. Reciprocating regulation between IRF-1 and STAT1 genes and encoded proteins indicates that an intracellular amplifier circuit exists controlling cellular responsiveness to the IFNs.	Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3168, Australia; Cleveland Clin Fdn, Dept Mol Biol, Cleveland, OH 44195 USA	Monash University; Cleveland Clinic Foundation	Ralph, SJ (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3168, Australia.		Wong, Lee H/H-9757-2012; Ralph, Stephen J./AAE-4888-2019	Wong, Lee H/0000-0002-4005-7330; Ralph, Stephen J./0000-0002-4335-092X				Abril E, 1998, CANCER IMMUNOL IMMUN, V47, P113, DOI 10.1007/s002620050511; Au WC, 2001, J BIOL CHEM, V276, P41629, DOI 10.1074/jbc.M105121200; Bluyssen HAR, 1997, J BIOL CHEM, V272, P4600, DOI 10.1074/jbc.272.7.4600; Bromberg JF, 1998, CELL GROWTH DIFFER, V9, P505; Bromberg JF, 1996, P NATL ACAD SCI USA, V93, P7673, DOI 10.1073/pnas.93.15.7673; Burysek L, 1999, J VIROL, V73, P7334; Chatterjee-Kishore M, 2000, EMBO J, V19, P4111, DOI 10.1093/emboj/19.15.4111; Chin YE, 1997, MOL CELL BIOL, V17, P5328, DOI 10.1128/MCB.17.9.5328; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; CHUMAKOV IM, 1995, NATURE, V377, P175; de Veer MJ, 1998, GENOMICS, V54, P267, DOI 10.1006/geno.1998.5555; Decker T, 1997, J INTERF CYTOK RES, V17, P121, DOI 10.1089/jir.1997.17.121; Dupuis S, 2001, SCIENCE, V293, P300, DOI 10.1126/science.1061154; Escalante CR, 1998, NATURE, V391, P103, DOI 10.1038/34224; FUJITA T, 1988, EMBO J, V7, P3397, DOI 10.1002/j.1460-2075.1988.tb03213.x; Grotzinger T, 1996, J BIOL CHEM, V271, P25253, DOI 10.1074/jbc.271.41.25253; Haddad B, 1998, CYTOGENET CELL GENET, V83, P58, DOI 10.1159/000015126; Haque SJ, 1998, SEMIN ONCOL, V25, P14; Hatina J, 1996, EXP CLIN IMMUNOGENET, V13, P55; Henderson YC, 1997, BRIT J HAEMATOL, V96, P566, DOI 10.1046/j.1365-2141.1997.d01-2057.x; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Kirchhoff S, 1998, BIOCHIMIE, V80, P659, DOI 10.1016/S0300-9084(99)80019-4; Kolla V, 1996, J BIOL CHEM, V271, P10508, DOI 10.1074/jbc.271.18.10508; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; Kusumoto M, 1998, J STRUCT BIOL, V121, P363, DOI 10.1006/jsbi.1998.3970; LEVY DE, 1989, GENE DEV, V3, P1362, DOI 10.1101/gad.3.9.1362; LEW DJ, 1991, MOL CELL BIOL, V11, P182, DOI 10.1128/MCB.11.1.182; LEWIN AR, 1991, EUR J BIOCHEM, V199, P417, DOI 10.1111/j.1432-1033.1991.tb16139.x; Li XX, 1998, BIOCHIMIE, V80, P703, DOI 10.1016/S0300-9084(99)80023-6; Lin CH, 2001, MOL CELL, V8, P581, DOI 10.1016/S1097-2765(01)00333-1; Look DC, 1998, IMMUNITY, V9, P871, DOI 10.1016/S1074-7613(00)80652-4; MARKIE D, 1996, METHODS MOL BIOL YAC, P65; MARTIN E, 1994, J EXP MED, V180, P977, DOI 10.1084/jem.180.3.977; MUNROE DJ, 1994, GENOMICS, V19, P506, DOI 10.1006/geno.1994.1100; Nguyen H, 1997, ONCOGENE, V15, P1425, DOI 10.1038/sj.onc.1201318; Nguyen Hannah, 1997, Cytokine and Growth Factor Reviews, V8, P293, DOI 10.1016/S1359-6101(97)00019-1; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; PINE R, 1990, MOL CELL BIOL, V10, P2448, DOI 10.1128/MCB.10.6.2448; Pine R, 1997, NUCLEIC ACIDS RES, V25, P4346, DOI 10.1093/nar/25.21.4346; PINE R, 1994, EMBO J, V13, P158, DOI 10.1002/j.1460-2075.1994.tb06245.x; PORTER ACG, 1988, EMBO J, V7, P85, DOI 10.1002/j.1460-2075.1988.tb02786.x; REID LE, 1989, P NATL ACAD SCI USA, V86, P840, DOI 10.1073/pnas.86.3.840; SCHINDLER C, 1992, P NATL ACAD SCI USA, V89, P7836, DOI 10.1073/pnas.89.16.7836; SICA A, 1992, P NATL ACAD SCI USA, V89, P1740, DOI 10.1073/pnas.89.5.1740; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Sun WH, 1998, BLOOD, V91, P570, DOI 10.1182/blood.V91.2.570.570_570_576; VEALS SA, 1993, MOL CELL BIOL, V13, P196, DOI 10.1128/MCB.13.1.196; VISVADER JE, 1992, EMBO J, V11, P4557, DOI 10.1002/j.1460-2075.1992.tb05557.x; White LC, 1996, IMMUNITY, V5, P365, DOI 10.1016/S1074-7613(00)80262-9; Wong LH, 1998, J IMMUNOL, V160, P5475; Wong LH, 1997, J BIOL CHEM, V272, P28779, DOI 10.1074/jbc.272.45.28779; Xie RL, 2001, J BIOL CHEM, V276, P18624, DOI 10.1074/jbc.M010391200; Yamamoto K, 1997, CYTOGENET CELL GENET, V77, P207, DOI 10.1159/000134578; YAN RQ, 1995, NUCLEIC ACIDS RES, V23, P459, DOI 10.1093/nar/23.3.459	55	82	84	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19408	19417		10.1074/jbc.M111302200	http://dx.doi.org/10.1074/jbc.M111302200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11909852	hybrid			2022-12-27	WOS:000175894800024
J	Laroche-Joubert, N; Marsy, S; Michelet, S; Imbert-Teboul, M; Doucet, A				Laroche-Joubert, N; Marsy, S; Michelet, S; Imbert-Teboul, M; Doucet, A			Protein kinase A-independent activation of ERK and H,K-ATPase by cAMP in native kidney cells - Role of Epac I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-GATED CHANNEL; SIGNAL-REGULATED KINASE; CALCITONIN RECEPTOR; GRANULE EXOCYTOSIS; COLLECTING DUCT; STREPTOLYSIN-O; RAT-KIDNEY; CYCLIC-AMP; EXPRESSION; BINDING	This study aimed at determining the signaling pathways underlying calcitonin- and isoproterenol-induced stimulation of H,K-ATPase in rat renal collecting duct. H,K-ATPase activity was determined in microdissected collecting ducts preincubated with or without either specific inhibitors or antibodies directed against intracellular signaling proteins. Transient cell membrane permeabilization with streptolysin-O allowed intracellular access of antibodies. The stimulation of H,K-ATPase by calcitonin and isoproterenol was mimicked by cAMP analogues and was abolished by adenylyl cyclase inhibition. Protein kinase A inhibition abolished isoproterenol but not calcitonin effect on H,K-ATPase. Calcitonin increased the phosphorylation of extracellular signal-regulated kinase (ERK) in a protein kinase A-independent manner, and the inhibition of the ERK phosphorylation prevented the stimulation of H,K-ATPase by calcitonin. Antibodies directed against either the cAMP-activated guanine-nucleotide exchange factor Epac I, the monomeric G protein Rap-1 or the kinase Raf-B, curtailed the stimulation of H,K-ATPase by calcitonin, whereas antibodies against the related monomeric G protein Ras or kinase Raf-1 had no effect. In conclusion, calcitonin stimulates H,K-ATPase through a cAMP/Epac I/Rap-1/Raf-B/ERK cascade.	CEA Saclay, Serv Biol Cellulaire, Lab Biol Integree Cellules Renales, CNRS,Unite Rech Associee 1859, F-91191 Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Doucet, A (corresponding author), Ctr Etud Saclay, URA 1859, Batiment 520, F-91191 Gif Sur Yvette, France.							AnkorinaStark I, 1997, CELL CALCIUM, V21, P163, DOI 10.1016/S0143-4160(97)90040-3; Bailey MA, 2000, KIDNEY INT, V58, P1893, DOI 10.1111/j.1523-1755.2000.00361.x; BARNIER JV, 1995, J BIOL CHEM, V270, P23381, DOI 10.1074/jbc.270.40.23381; BASTANI B, 1995, J AM SOC NEPHROL, V5, P1476; BIEL M, 1994, P NATL ACAD SCI USA, V91, P3505, DOI 10.1073/pnas.91.9.3505; BuffinMeyer B, 1997, AM J PHYSIOL-RENAL, V272, pF124, DOI 10.1152/ajprenal.1997.272.1.F124; Chen Y, 1998, J BIOL CHEM, V273, P19809, DOI 10.1074/jbc.273.31.19809; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; ELALOUF JM, 1993, J CLIN INVEST, V91, P264, DOI 10.1172/JCI116180; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Ghani EA, 1999, BIOCHEMISTRY-US, V38, P15204, DOI 10.1021/bi991678y; GOULDING EH, 1992, NEURON, V8, P45, DOI 10.1016/0896-6273(92)90107-O; HERSEY SJ, 1995, PHYSIOL REV, V75, P155, DOI 10.1152/physrev.1995.75.1.155; HOHMAN RJ, 1985, P NATL ACAD SCI USA, V82, P4578, DOI 10.1073/pnas.82.14.4578; HORN VJ, 1988, J BIOL CHEM, V263, P12454; Houslay MD, 2000, MOL PHARMACOL, V58, P659, DOI 10.1124/mol.58.4.659; HOUSSAMI S, 1994, ENDOCRINOLOGY, V135, P183, DOI 10.1210/en.135.1.183; IMBERT M, 1975, PFLUG ARCH EUR J PHY, V354, P213, DOI 10.1007/BF00584645; Kampen GT, 2000, BLOOD, V95, P1911, DOI 10.1182/blood.V95.6.1911; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; KLEIN PS, 1988, SCIENCE, V241, P1467, DOI 10.1126/science.3047871; Laroche-Joubert N, 2000, AM J PHYSIOL-RENAL, V279, pF1053, DOI 10.1152/ajprenal.2000.279.6.F1053; Leino L, 1999, BIOCHEM BIOPH RES CO, V265, P29, DOI 10.1006/bbrc.1999.1631; LEROSEY I, 1991, BIOCHEM BIOPH RES CO, V175, P430, DOI 10.1016/0006-291X(91)91582-W; MANDON B, 1995, AM J PHYSIOL-RENAL, V268, pF1070, DOI 10.1152/ajprenal.1995.268.6.F1070; Milella M, 1997, J IMMUNOL, V158, P3148; MOREL F, 1986, PHYSIOL REV, V66, P377, DOI 10.1152/physrev.1986.66.2.377; Pham N, 2000, CURR BIOL, V10, P555, DOI 10.1016/S0960-9822(00)00473-5; ROTHERMEL JD, 1988, BIOCHEM J, V251, P757, DOI 10.1042/bj2510757; SCHWARTZ GJ, 1985, J CLIN INVEST, V75, P1638, DOI 10.1172/JCI111871; SIGA E, 1994, AM J PHYSIOL, V267, pF354, DOI 10.1152/ajprenal.1994.267.3.F354; SIGA E, 1993, AM J PHYSIOL, V264, pF221, DOI 10.1152/ajprenal.1993.264.2.F221; Siga E, 1996, AM J PHYSIOL-RENAL, V271, pF1217, DOI 10.1152/ajprenal.1996.271.6.F1217; SIGNAL IS, 1986, P NATL ACAD SCI USA, V83, P4725; Trotta R, 1998, J IMMUNOL, V161, P6648; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1	38	104	105	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					18598	18604		10.1074/jbc.M201868200	http://dx.doi.org/10.1074/jbc.M201868200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11897793	hybrid			2022-12-27	WOS:000175975800048
J	Chen, Q; Dowhan, DH; Liang, DC; Moore, DD; Overbeek, PA				Chen, Q; Dowhan, DH; Liang, DC; Moore, DD; Overbeek, PA			CREB-binding protein/p300 co-activation of crystallin gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-A-CRYSTALLIN; TRANSCRIPTION FACTORS; NUCLEAR-RECEPTOR; LENS DEVELOPMENT; DIFFERENTIAL LOCALIZATION; INSITU HYBRIDIZATION; REGULATORY ELEMENTS; CBP; ACTIVATION; ACETYLTRANSFERASE	Although some of the transcription factors that are required for expression of crystallins during lens development have been identified, the molecular interactions that contribute to enhanced crystallin expression are not yet well defined. In this study, we designed experiments to test whether the co-activators CREB-binding protein (CBP) and/or p300 interact with c-Maf, Prox-1, or Sox-1 to enhance transcription of crystallin genes. Promoter regions from the mouse alphaA-, betaB2-, and gammaF-crystallin genes were linked to a luciferase reporter. Expression of c-Maf transactivated each of these promoters. Of particular interest, co-expression of CBP or p300 with c-Maf was found to synergistically co-activate each promoter. CBP and p300 were less effective or ineffective at co-activation with Prox-1 or Sox-1. Co-immunoprecipitation and mammalian two-hybrid experiments revealed that CBP and p300 bind to c-Maf and Prox-1 but not to Sox-1. The co-activation of c-Maf by CBP/p300 requires histone acetyltransferase activity. Our results suggest that c-Maf recruits CBP and/or p300 to crystallin promoters leading to up-regulation of crystallin gene expression through localized histone acetylation and consequent chromatin re-modeling. In a promoter-specific fashion, co-activation can be modulated by Prox-1 and/or Sox-1. This modulation may help to specify the endogenous levels of crystallin gene expression.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine	Overbeek, PA (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	overbeek@bcm.tmc.edu		Overbeek, Paul/0000-0001-9784-2084	NEI NIH HHS [EY10448, EY11348, EY10803] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010803, R01EY010448, R01EY011348] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; BARBEAU D, 1994, ONCOGENE, V9, P359; Chambers C, 1995, GENE, V166, P287, DOI 10.1016/0378-1119(95)00615-X; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Chen Q, 2002, ONCOGENE, V21, P1028, DOI 10.1038/sj.onc.1205050; Chen SL, 2000, GENE DEV, V14, P1209; CVEKL A, 1995, MOL CELL BIOL, V15, P653; Cvekl A, 1996, BIOESSAYS, V18, P621, DOI 10.1002/bies.950180805; Dirks RPH, 1996, EUR J BIOCHEM, V239, P23, DOI 10.1111/j.1432-1033.1996.0023u.x; Doerwald L, 2001, EXP EYE RES, V73, P703, DOI 10.1006/exer.2001.1077; Goodman RH, 2000, GENE DEV, V14, P1553; Graw J, 1997, BIOL CHEM, V378, P1331; Gregory PD, 1998, EUR J BIOCHEM, V251, P9, DOI 10.1046/j.1432-1327.1998.2510009.x; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; Kim JI, 1999, P NATL ACAD SCI USA, V96, P3781, DOI 10.1073/pnas.96.7.3781; Kondoh H, 1999, CURR OPIN GENET DEV, V9, P301, DOI 10.1016/S0959-437X(99)80045-8; Lengler J, 2001, NUCLEIC ACIDS RES, V29, P515, DOI 10.1093/nar/29.2.515; LOK S, 1989, NUCLEIC ACIDS RES, V17, P3563, DOI 10.1093/nar/17.9.3563; LOK S, 1985, MOL CELL BIOL, V5, P2221, DOI 10.1128/MCB.5.9.2221; Martinez-Balbas MA, 1998, EMBO J, V17, P2886, DOI 10.1093/emboj/17.10.2886; MCAVOY JW, 1978, J EMBRYOL EXP MORPH, V44, P149; Moore DD, 1995, GLOB MOB SURV; Nishiguchi S, 1998, GENE DEV, V12, P776, DOI 10.1101/gad.12.6.776; Ogino H, 2000, DEV GROWTH DIFFER, V42, P437; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; PIATIGORSKY J, 1981, DIFFERENTIATION, V19, P134, DOI 10.1111/j.1432-0436.1981.tb01141.x; Ring BZ, 2000, DEVELOPMENT, V127, P307; Robinson ML, 1996, INVEST OPHTH VIS SCI, V37, P2276; ROBINSON ML, 1995, DEVELOPMENT, V121, P505; Sakai M, 2001, NUCLEIC ACIDS RES, V29, P1228, DOI 10.1093/nar/29.5.1228; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6417; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; TRETON JA, 1991, DIFFERENTIATION, V47, P143, DOI 10.1111/j.1432-0436.1991.tb00232.x; UEDA Y, 2001, INVESTIG OPHTHALMOL, V43, P205; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; VANLEEN RW, 1987, DEV BIOL, V123, P338, DOI 10.1016/0012-1606(87)90392-7; Wigle JT, 1999, NAT GENET, V21, P318, DOI 10.1038/6844; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; WISTOW G, 1987, SCIENCE, V236, P1554, DOI 10.1126/science.3589669; Yoshida K, 1997, INVEST OPHTH VIS SCI, V38, P2679	41	59	61	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2002	277	27					24081	24089		10.1074/jbc.M201821200	http://dx.doi.org/10.1074/jbc.M201821200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	569PV	11943779	hybrid			2022-12-27	WOS:000176611800016
J	Dominici, P; Caffarri, S; Armenante, F; Ceoldo, S; Crimi, M; Bassi, R				Dominici, P; Caffarri, S; Armenante, F; Ceoldo, S; Crimi, M; Bassi, R			Biochemical properties of the PsbS subunit of photosystem II either purified from chloroplast or recombinant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; PIGMENT-BINDING PROPERTIES; RESOLVED FLUORESCENCE ANALYSIS; SPINACH THYLAKOID MEMBRANES; CHLOROPHYLL-A/B-PROTEINS; IN-VITRO RECONSTITUTION; ANTENNA PROTEINS; DICYCLOHEXYLCARBODIIMIDE-BINDING; ENERGY-DISSIPATION; CHLORINA MUTANTS	The biochemical properties of PsbS protein, a nuclear-encoded Photosystem H subunit involved in the high energy quenching of chlorophyll fluorescence, have been studied using preparations purified from chloroplasts or obtained by overexpression in bacteria. Despite the homology with chlorophyll a/b/xanthophyll-binding proteins of the Lhc family, native PsbS protein does not show any detectable ability to bind chlorophylls or carotenoids in conditions in which Lhc proteins maintain fall pigment binding. The recombinant protein, when refolded in vitro in the presence of purified pigments, neither binds chlorophylls nor xanthophylls, differently from the homologous proteins LHCII, CP26, and CP29 that refold into stable pigment-binding complexes. Thus, it is concluded that if PsbS is a pigment-binding protein in vivo, the binding mechanism must be different from that present in other Lhc proteins. Primary sequence analysis provides evidence for homology of PsbS helices I and III with the central 2-fold symmetric core of chlorophyll a/b-binding proteins. Moreover, a structural homology owed to the presence of acidic residues in each of the two lumen-exposed loops is found with the dicyclohexylearbodiimide/Ca2+ binding domain of CP29. Consistently, both native and recombinant PsbS proteins showed [C-14]dicyclohexylcarbodiimide binding, thus supporting a functional basis for its homology with CP29 on the lumen-exposed loops. This domain is suggested to be involved in sensing low luminal pH.	Univ Verona, Dipartimento Sci & Tecnol, I-37134 Verona, Italy	University of Verona	Bassi, R (corresponding author), Univ Verona, Dipartimento Sci & Tecnol, I-37134 Verona, Italy.		Caffarri, Stefano/AAX-8913-2021	Caffarri, Stefano/0000-0002-4729-7679; bassi, roberto/0000-0002-4140-8446				ALLEN JF, 1992, BIOCHIM BIOPHYS ACTA, V1098, P275, DOI 10.1016/S0005-2728(09)91014-3; BASSI R, 1985, CARLSBERG RES COMMUN, V50, P145, DOI 10.1007/BF02907142; Bassi R, 1999, P NATL ACAD SCI USA, V96, P10056, DOI 10.1073/pnas.96.18.10056; BASSI R, 1988, BIOCHIM BIOPHYS ACTA, V936, P29, DOI 10.1016/0005-2728(88)90248-4; BASSI R, 1993, EUR J BIOCHEM, V212, P297, DOI 10.1111/j.1432-1033.1993.tb17662.x; BASSI R, 1992, EUR J BIOCHEM, V204, P317, DOI 10.1111/j.1432-1033.1992.tb16640.x; BERGANTINO E, 1995, J BIOL CHEM, V270, P8474, DOI 10.1074/jbc.270.15.8474; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Bossmann B, 1997, PHOTOSYNTH RES, V52, P127, DOI 10.1023/A:1005823711838; BRIANTAIS JM, 1979, BIOCHIM BIOPHYS ACTA, V548, P128, DOI 10.1016/0005-2728(79)90193-2; BRIANTAIS JM, 1996, NATO ASI SERIES A, P113; Crimi M, 2001, EUR J BIOCHEM, V268, P260, DOI 10.1046/j.1432-1033.2001.01874.x; DAINESE P, 1990, PHOTOCHEM PHOTOBIOL, V51, P693, DOI 10.1111/php.1990.51.6.693; DAINESE P, 1991, J BIOL CHEM, V266, P8136; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; DIPAOLO ML, 1990, PLANTA, V181, P275, DOI 10.1007/BF00195877; Frank HA, 2001, BIOCHEMISTRY-US, V40, P1220, DOI 10.1021/bi001160q; FUNK C, 1995, J BIOL CHEM, V270, P30141; FUNK C, 1995, BIOCHEMISTRY-US, V34, P11133, DOI 10.1021/bi00035a019; GABELLINI N, 1988, BIOCHIM BIOPHYS ACTA, V934, P227, DOI 10.1016/0005-2728(88)90186-7; GHANOTAKIS DF, 1984, BIOCHIM BIOPHYS ACTA, V765, P388, DOI 10.1016/0005-2728(84)90180-4; Giuffra E, 1996, EUR J BIOCHEM, V238, P112, DOI 10.1111/j.1432-1033.1996.0112q.x; Hankamer B, 1997, EUR J BIOCHEM, V243, P422, DOI 10.1111/j.1432-1033.1997.0422a.x; Harrer R, 1998, EUR J BIOCHEM, V255, P196, DOI 10.1046/j.1432-1327.1998.2550196.x; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; HOPPE J, 1980, EUR J BIOCHEM, V112, P17, DOI 10.1111/j.1432-1033.1980.tb04981.x; JAHNS P, 1990, EUR J BIOCHEM, V193, P731, DOI 10.1111/j.1432-1033.1990.tb19393.x; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Jegerschold C, 2000, J BIOL CHEM, V275, P12781, DOI 10.1074/jbc.275.17.12781; KIM S, 1992, FEBS LETT, V314, P67, DOI 10.1016/0014-5793(92)81463-V; Kuttkat A, 1996, EUR J BIOCHEM, V242, P288, DOI 10.1111/j.1432-1033.1996.0288r.x; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Nield J, 2000, PHILOS T R SOC B, V355, P1337, DOI 10.1098/rstb.2000.0695; Nield J, 2000, NAT STRUCT BIOL, V7, P44; Pagano A, 1998, J BIOL CHEM, V273, P17154, DOI 10.1074/jbc.273.27.17154; PAULSEN H, 1992, EUR J BIOCHEM, V205, P71, DOI 10.1111/j.1432-1033.1992.tb16752.x; Pesaresi P, 1997, FEBS LETT, V402, P151, DOI 10.1016/S0014-5793(96)01518-9; Pichersky E., 1996, OXYGENIC PHOTOSYNTHE, P507; PLUMLEY FG, 1987, P NATL ACAD SCI USA, V84, P146, DOI 10.1073/pnas.84.1.146; Remelli R, 1999, J BIOL CHEM, V274, P33510, DOI 10.1074/jbc.274.47.33510; Rogl H, 1998, FEBS LETT, V432, P21, DOI 10.1016/S0014-5793(98)00825-4; Ros F, 1998, EUR J BIOCHEM, V253, P653, DOI 10.1046/j.1432-1327.1998.2530653.x; RUBAN AV, 1994, PLANT PHYSIOL, V104, P227, DOI 10.1104/pp.104.1.227; Ruban AV, 2002, J BIOL CHEM, V277, P7785, DOI 10.1074/jbc.M110693200; RUBAN AV, 1992, FEBS LETT, V309, P175, DOI 10.1016/0014-5793(92)81089-5; SANTINI C, 1994, EUR J BIOCHEM, V221, P307, DOI 10.1111/j.1432-1033.1994.tb18742.x; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schmid VHR, 1997, P NATL ACAD SCI USA, V94, P7667, DOI 10.1073/pnas.94.14.7667; SIMPSON DJ, 1985, CARLSBERG RES COMMUN, V50, P223, DOI 10.1007/BF02907148; Walters RG, 1996, P NATL ACAD SCI USA, V93, P14204, DOI 10.1073/pnas.93.24.14204; WALTERS RG, 1994, EUR J BIOCHEM, V226, P1063, DOI 10.1111/j.1432-1033.1994.01063.x; WEDEL N, 1992, FEBS LETT, V314, P61, DOI 10.1016/0014-5793(92)81462-U; Wollman FA, 1999, BBA-BIOENERGETICS, V1411, P21, DOI 10.1016/S0005-2728(99)00043-2; YAMAMOTO HY, 1962, ARCH BIOCHEM BIOPHYS, V97, P168, DOI 10.1016/0003-9861(62)90060-7	55	130	134	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22750	22758		10.1074/jbc.M200604200	http://dx.doi.org/10.1074/jbc.M200604200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11934892	hybrid			2022-12-27	WOS:000176313600084
J	Messenger, MM; Saulnier, RB; Gilchrist, AD; Diamond, P; Gorbsky, GJ; Litchfield, DW				Messenger, MM; Saulnier, RB; Gilchrist, AD; Diamond, P; Gorbsky, GJ; Litchfield, DW			Interactions between protein kinase CK2 and Pin1 - Evidence for phosphorylation-dependent interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOISOMERASE-II-ALPHA; PEPTIDYL-PROLYL ISOMERASE; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; DNA TOPOISOMERASE; BETA-SUBUNIT; C-MYC; MITOTIC PHOSPHORYLATION; EXPRESSION; BINDING	The peptidyl-prolyl isomerase Pin1 interacts in a phosphorylation-dependent manner with several proteins involved in cell cycle events. In this study, we demonstrate that Pin1 interacts with protein kinase CK2, an enzyme that generally exists in tetrameric complexes composed of two catalytic CK2alpha and/or CK2alpha' subunits together with two regulatory CK2beta subunits. Our results indicate that Pin1 can interact with CK2 complexes that contain CK2alpha. Furthermore, Pin1 can interact directly with the C-terminal domain of CK2alpha that contains residues that are phosphorylated in vitro by p34(Cdc2) and in mitotic cells. Substitution of the phosphorylation sites of CK2alpha with alanines resulted in decreased interactions between Pin1 and CK2. The other catalytic isoform. of CK2, designated CK2alpha', is not phosphorylated in mitotic cells and does not interact with Pin1, but a chimeric protein consisting of CK2alpha' with the C terminus of CK2alpha was phosphorylated in mitotic cells and interacts with Pin1, further implicating the phosphorylation sites in the interaction. In vitro, Pin1 inhibits the phosphorylation of Thr-1342 on human topoisomerase IIalpha by CK2. Topoisomerase Ha also interacts with Pin1 suggesting that the effect of Pin1 on the phosphorylation of Thr-1342 could result from its interactions with CK2 and/or topoisomerase IIalpha. As compared with wild-type Pin1, isomerase-deficient and WW domain-deficient mutants of Pin1 are impaired in their ability to interact with CK2 and to inhibit the CK2-catalyzed phosphorylation of topoisomerase IIalpha. Collectively, these results indicate that Pin1 and CK2a interact and suggest a possible role for Pin1 in the regulation of topoisomerase IIalpha. Furthermore, these results provide new insights into the functional role of the mitotic phosphorylation of CK2 and provide a new mechanism for selectively regulating the ability of CK2 to phosphorylate one of its mitotic targets.	Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada; Univ Oklahoma, Hlth Sci Ctr, Ctr Biomed Res, Dept Cell Biol, Oklahoma City, OK 73104 USA	Western University (University of Western Ontario); University of Oklahoma System; University of Oklahoma Health Sciences Center	Litchfield, DW (corresponding author), Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada.		Litchfield, David/E-4636-2015	Litchfield, David/0000-0002-2425-6620; Gorbsky, Gary/0000-0003-3076-4725				ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; BOJANOWSKI K, 1993, J BIOL CHEM, V268, P22920; Bosc DG, 1999, MOL CELL BIOCHEM, V191, P213, DOI 10.1023/A:1006840329973; BOSE DG, 1995, J BIOL CHEM, V270, P25872; BOUSSET K, 1994, CELL MOL BIOL RES, V40, P501; BOUSSET K, 1993, ONCOGENE, V8, P3211; BURDEN DA, 1993, BIOCHEM J, V293, P297, DOI 10.1042/bj2930297; Canton DA, 2001, BIOCHEM J, V358, P87, DOI 10.1042/0264-6021:3580087; CARDENAS ME, 1992, EMBO J, V11, P1785, DOI 10.1002/j.1460-2075.1992.tb05230.x; Crenshaw DG, 1998, EMBO J, V17, P1315, DOI 10.1093/emboj/17.5.1315; Daum JR, 1998, J BIOL CHEM, V273, P30622, DOI 10.1074/jbc.273.46.30622; ENGLERT C, 1995, EMBO J, V14, P4662, DOI 10.1002/j.1460-2075.1995.tb00148.x; Escargueil AE, 2000, J BIOL CHEM, V275, P34710, DOI 10.1074/jbc.M005179200; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; Ford HL, 2000, J BIOL CHEM, V275, P22245, DOI 10.1074/jbc.M002446200; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; GIETZ RD, 1995, J BIOL CHEM, V270, P13017, DOI 10.1074/jbc.270.22.13017; Glover CVC, 1998, PROG NUCLEIC ACID RE, V59, P95; Graham KC, 2000, J BIOL CHEM, V275, P5003, DOI 10.1074/jbc.275.7.5003; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HANES SD, 1989, YEAST, V5, P55, DOI 10.1002/yea.320050108; HANI J, 1995, FEBS LETT, V365, P198, DOI 10.1016/0014-5793(95)00471-K; HANNA DE, 1995, J BIOL CHEM, V270, P25905, DOI 10.1074/jbc.270.43.25905; HECK MMS, 1989, J BIOL CHEM, V264, P15161; Ishida R, 1996, J BIOL CHEM, V271, P30077, DOI 10.1074/jbc.271.47.30077; ISSINGER OG, 1993, PHARMACOL THERAPEUT, V59, P1, DOI 10.1016/0163-7258(93)90039-G; Keller DM, 2001, MOL CELL, V7, P283, DOI 10.1016/S1097-2765(01)00176-9; Kelliher MA, 1996, EMBO J, V15, P5160, DOI 10.1002/j.1460-2075.1996.tb00900.x; Kops O, 1998, J BIOL CHEM, V273, P31971, DOI 10.1074/jbc.273.48.31971; KRIEG J, 1995, ONCOGENE, V10, P2221; Landesman-Bollag E, 1998, ONCOGENE, V16, P2965, DOI 10.1038/sj.onc.1201854; Landesman-Bollag E, 2001, ONCOGENE, V20, P3247, DOI 10.1038/sj.onc.1204411; Landrieu I, 2000, J BIOL CHEM, V275, P10577, DOI 10.1074/jbc.275.14.10577; LITCHFIELD DW, 1992, J BIOL CHEM, V267, P13943; LITCHFIELD DW, 1990, J BIOL CHEM, V265, P7638; LITCHFIELD DW, 1993, MOL CELL BIOCHEM, V128, P187, DOI 10.1007/BF01076770; LITCHFIELD DW, 1995, BBA-MOL CELL RES, V1269, P69, DOI 10.1016/0167-4889(95)00100-7; LITCHFIELD DW, 1991, J BIOL CHEM, V266, P20380; LOZEMAN FJ, 1990, BIOCHEMISTRY-US, V29, P8436, DOI 10.1021/bi00488a034; Lu KP, 1996, NATURE, V380, P544; Lu PJ, 1999, NATURE, V399, P784; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Maleszka R, 1996, P NATL ACAD SCI USA, V93, P447, DOI 10.1073/pnas.93.1.447; MARIDOR G, 1991, J BIOL CHEM, V266, P2362; Patra D, 1999, J BIOL CHEM, V274, P36839, DOI 10.1074/jbc.274.52.36839; Penner CG, 1997, J CELL BIOCHEM, V64, P525; Pinna L A, 1997, Prog Cell Cycle Res, V3, P77; Redwood C, 1998, J BIOL CHEM, V273, P3635, DOI 10.1074/jbc.273.6.3635; SAIJO M, 1992, BIOCHEMISTRY-US, V31, P359, DOI 10.1021/bi00117a007; Sambrook J., 2002, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sayed M, 2001, ONCOGENE, V20, P6994, DOI 10.1038/sj.onc.1204894; SELDIN DC, 1995, SCIENCE, V267, P894, DOI 10.1126/science.7846532; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; Stukenberg PT, 2001, MOL CELL, V7, P1071, DOI 10.1016/S1097-2765(01)00245-3; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vilk G, 1999, J BIOL CHEM, V274, P14406, DOI 10.1074/jbc.274.20.14406; WELLS NJ, 1995, EUR J BIOCHEM, V231, P491, DOI 10.1111/j.1432-1033.1995.tb20723.x; WELLS NJ, 1994, J BIOL CHEM, V269, P29746; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; Winkler KE, 2000, SCIENCE, V287, P1644, DOI 10.1126/science.287.5458.1644; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	65	76	80	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					23054	23064		10.1074/jbc.M200111200	http://dx.doi.org/10.1074/jbc.M200111200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11940573	hybrid			2022-12-27	WOS:000176313600121
J	Thabut, G; El-Benna, J; Samb, A; Corda, S; Megret, J; Leseche, G; Vicaut, E; Aubier, M; Boczkowski, J				Thabut, G; El-Benna, J; Samb, A; Corda, S; Megret, J; Leseche, G; Vicaut, E; Aubier, M; Boczkowski, J			Tumor necrosis factor-alpha increases airway smooth muscle oxidants production through a NADPH oxidase-like system to enhance myosin light chain phosphorylation and contractility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE 1B; LUNG EPITHELIAL-CELLS; SIGNAL-TRANSDUCTION; NITRIC-OXIDE; ENDOTHELIAL-CELLS; SUPEROXIDE ANION; GROWTH-FACTOR; NAD(P)H OXIDASE; IN-VITRO; NEUTROPHILS	Tumor necrosis factor plays a critical role in airway smooth muscle hyperresponsiveness observed in asthma. However, the mechanisms underlying this phenomenon are poorly understood. We investigated if tumor necrosis factor-stimulated airway smooth muscle produced reactive oxygen species, leading to muscular hyperresponsiveness. Tumor necrosis factor increased intracellular and extracellular oxidants production in guinea pig airway smooth muscle cells and tissue homogenates. This production was abolished by inhibitors of NADPH oxidase (diphenylene iodinium or apocynin) and was enhanced by NADPH, whereas inhibitors of mitochondrial respiratory chain, nitric-oxide synthase, cyclooxygenase, and xanthine oxidase had no effect. NADPH oxidase subunits p22(phox) and p47(phox) were detected in smooth muscle cells and tissue homogenates by Western blot, immunohistochemistry, and spectral analysis. Furthermore., oxidants production was significantly reduced by transient transfection of smooth muscle cells with p22(phox) antisense oligonucleotides. Intracellular antioxidants and diphenylene iodinium abolished tumor necrosis factor-induced muscular hyperresponsiveness and increased in phosphorylation of the myosin light chain. Finally, NADPH oxidase subunits p22(phox) and p47(phox) were also detected in human airway smooth muscle. Collectively, these results demonstrate that tumor necrosis factor-stimulated airway smooth muscle produces oxidants through a NADPH oxidase-like system, which plays a pivotal role in muscle hyperresponsiveness and myosin light chain phosphorylation.	Fac Xavier Bichat, INSERM, U408, F-75870 Paris 18, France; Fac Xavier Bichat, INSERM, U479, F-75870 Paris, France; Fac Xavier Bichat, Inst Federat Rech Claude Bernard 02, F-75870 Paris 18, France; Hop Fernand Widal, Lab Etud Microcirculat, F-75010 Paris, France; Hop Beaujon, Serv Chirurg Thorac, F-92110 Clichy, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite	Boczkowski, J (corresponding author), Fac Xavier Bichat, INSERM, U408, BP416, F-75870 Paris 18, France.		Boczkowski, Jorge/S-7474-2018	Boczkowski, Jorge/0000-0001-6619-5785				Abid MR, 2000, FEBS LETT, V486, P252, DOI 10.1016/S0014-5793(00)02305-X; ASANO K, 1994, P NATL ACAD SCI USA, V91, P10089, DOI 10.1073/pnas.91.21.10089; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Barnes PJ, 1998, AM J RESP CRIT CARE, V158, pS123, DOI 10.1164/ajrccm.158.supplement_2.13tac800; Barrett WC, 1999, J BIOL CHEM, V274, P34543, DOI 10.1074/jbc.274.49.34543; Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v; BASS DA, 1983, J IMMUNOL, V130, P1910; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Brar SS, 1999, J BIOL CHEM, V274, P20017, DOI 10.1074/jbc.274.28.20017; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Corda S, 2001, AM J RESP CELL MOL, V24, P762, DOI 10.1165/ajrcmb.24.6.4228; CROSS AR, 1982, BIOCHEM J, V204, P479, DOI 10.1042/bj2040479; Davis AR, 1998, J LEUKOCYTE BIOL, V64, P114, DOI 10.1002/jlb.64.1.114; De Boer J, 1998, AM J RESP CRIT CARE, V158, P1784, DOI 10.1164/ajrccm.158.6.9711005; Deshpande SS, 2000, FASEB J, V14, P1705, DOI 10.1096/fj.99-0910com; FAULKNER KM, 1994, J BIOL CHEM, V269, P23471; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; HANCOCK JT, 1991, FREE RADICAL BIO MED, V11, P25, DOI 10.1016/0891-5849(91)90184-5; JOHNSTON RB, 1984, METHOD ENZYMOL, V105, P365; Kashiwagi A, 1999, AM J PHYSIOL-ENDOC M, V277, pE976, DOI 10.1152/ajpendo.1999.277.6.E976; KINNULA VL, 1992, AM J PHYSIOL, V262, pL708, DOI 10.1152/ajplung.1992.262.6.L708; Kitazawa T, 2000, J BIOL CHEM, V275, P9897, DOI 10.1074/jbc.275.14.9897; KITAZAWA T, 1991, P NATL ACAD SCI USA, V88, P9307, DOI 10.1073/pnas.88.20.9307; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Lopez-Ongil S, 1999, FREE RADICAL BIO MED, V26, P501, DOI 10.1016/S0891-5849(98)00223-8; Luo XP, 1999, FREE RADICAL BIO MED, V26, P1357, DOI 10.1016/S0891-5849(98)00334-7; McFarlane SM, 2001, BIOCHEM PHARMACOL, V61, P749, DOI 10.1016/S0006-2952(01)00530-5; MOORE KP, 1991, EICOSANOIDS, V4, P115; Nakatani Y, 2000, EUR J PHARMACOL, V392, P175, DOI 10.1016/S0014-2999(00)00087-X; Namgaladze D, 2002, J BIOL CHEM, V277, P5962, DOI 10.1074/jbc.M111268200; Page K, 1999, J BIOL CHEM, V274, P22065, DOI 10.1074/jbc.274.31.22065; Parris JRM, 1999, J PHYSIOL-LONDON, V518, P561, DOI 10.1111/j.1469-7793.1999.0561p.x; Pavlovic D, 1998, EUR RESPIR J, V11, P575; Pennings HJ, 1998, EUR RESPIR J, V12, P45, DOI 10.1183/09031936.98.12010045; Pfitzer G, 2001, J APPL PHYSIOL, V91, P497, DOI 10.1152/jappl.2001.91.1.497; PYNE S, 1993, BIOCHEM PHARMACOL, V45, P593, DOI 10.1016/0006-2952(93)90132-G; Ratcliffe MJ, 1999, BIOCHEM J, V338, P471, DOI 10.1042/0264-6021:3380471; Sadeghi-Hashjin G, 1998, MEDIAT INFLAMM, V7, P35, DOI 10.1080/09629359891360; Samb A, 2001, AM J RESP CRIT CARE, V164, P149, DOI 10.1164/ajrccm.164.1.2004030; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; SHAH A, 1995, CLIN EXP ALLERGY, V25, P1038; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; STUEHR DJ, 1991, FASEB J, V5, P98, DOI 10.1096/fasebj.5.1.1703974; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Teshima S, 1998, GASTROENTEROLOGY, V115, P1186, DOI 10.1016/S0016-5085(98)70090-3; YAMAGUCHI T, 1989, J BIOL CHEM, V264, P112	47	35	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22814	22821		10.1074/jbc.M200315200	http://dx.doi.org/10.1074/jbc.M200315200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11940577	hybrid			2022-12-27	WOS:000176313600091
J	Accola, MA; Huang, B; Al Masri, A; McNiven, MA				Accola, MA; Huang, B; Al Masri, A; McNiven, MA			The antiviral dynamin family member, MxA, tubulates lipids and localizes to the smooth endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CONFORMATIONAL CHANGE; CLATHRIN-MEDIATED ENDOCYTOSIS; PLECKSTRIN HOMOLOGY DOMAINS; MOTILITY FACTOR-RECEPTOR; COATED VESICLE FORMATION; GTP HYDROLYSIS; THOGOTO-VIRUS; PROTEIN; OLIGOMERIZATION; CAVEOLAE	Mx proteins are induced by type I interferon and inhibit a broad range of viruses by undefined mechanisms. They are included within the dynamin family of large GTPases, which are involved in vesicle trafficking and share common biophysical features. These properties include the propensity to self-assemble, an affinity for lipids, and the ability to tubulate membranes. In this report we establish that human MxA, despite sharing only 30% homology with conventional dynamin, possesses many of these properties. We demonstrate for the first time that MxA self-assembles into rings that tubulate lipids in vitro, and associates with a specific membrane compartment in cells, the smooth endoplasmic reticulum.	Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Mayo Clin, Ctr Basic Res Digest Dis, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	McNiven, MA (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.							BENLIMAME N, 1995, J CELL BIOL, V129, P459, DOI 10.1083/jcb.129.2.459; Benlimame N, 1998, MOL BIOL CELL, V9, P1773, DOI 10.1091/mbc.9.7.1773; Carr JF, 1997, J BIOL CHEM, V272, P28030, DOI 10.1074/jbc.272.44.28030; Cole CN, 2001, FIELDS VIROLOGY, P2141; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Danino D, 2001, CURR OPIN CELL BIOL, V13, P454, DOI 10.1016/S0955-0674(00)00236-2; Di Paolo C, 1999, J BIOL CHEM, V274, P32071, DOI 10.1074/jbc.274.45.32071; Field CM, 1999, TRENDS CELL BIOL, V9, P387, DOI 10.1016/S0962-8924(99)01632-3; FRESE M, 1995, J VIROL, V69, P3904, DOI 10.1128/JVI.69.6.3904-3909.1995; Gordien E, 2001, J VIROL, V75, P2684, DOI 10.1128/JVI.75.6.2684-2691.2001; Haller O, 1998, REV SCI TECH OIE, V17, P220, DOI 10.20506/rst.17.1.1084; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Henley JR, 1996, J CELL BIOL, V133, P761, DOI 10.1083/jcb.133.4.761; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Henley JR, 1998, MOL BIOL CELL, V9, p195A; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; Hinshaw JE, 1999, CURR OPIN STRUC BIOL, V9, P260, DOI 10.1016/S0959-440X(99)80036-0; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; HORISBERGER MA, 1992, J VIROL, V66, P4705, DOI 10.1128/JVI.66.8.4705-4709.1992; Janzen C, 2000, J VIROL, V74, P8202, DOI 10.1128/JVI.74.17.8202-8206.2000; KARTENBECK J, 1989, J CELL BIOL, V109, P2721, DOI 10.1083/jcb.109.6.2721; Klein DE, 1998, J BIOL CHEM, V273, P27725, DOI 10.1074/jbc.273.42.27725; Kochs G, 2002, J BIOL CHEM, V277, P14172, DOI 10.1074/jbc.M200244200; Kochs G, 1999, P NATL ACAD SCI USA, V96, P2082, DOI 10.1073/pnas.96.5.2082; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Maier O, 1996, BIOCHEM BIOPH RES CO, V223, P229, DOI 10.1006/bbrc.1996.0876; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; McNiven MA, 1998, CELL, V94, P151, DOI 10.1016/S0092-8674(00)81414-2; MELEN K, 1992, J BIOL CHEM, V267, P25898; MELEN K, 1994, J BIOL CHEM, V269, P2009; Muhlberg AB, 1997, EMBO J, V16, P6676, DOI 10.1093/emboj/16.22.6676; NAKAYAMA M, 1993, J BIOL CHEM, V268, P15033; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; PAVLOVIC J, 1990, J VIROL, V64, P3370, DOI 10.1128/JVI.64.7.3370-3375.1990; PITOSSI F, 1993, J VIROL, V67, P6726, DOI 10.1128/JVI.67.11.6726-6732.1993; Ponten A, 1997, J VIROL, V71, P2591, DOI 10.1128/JVI.71.4.2591-2599.1997; RICHTER MF, 1995, J BIOL CHEM, V270, P13512, DOI 10.1074/jbc.270.22.13512; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; SANDVIG K, 1994, J CELL BIOL, V126, P53, DOI 10.1083/jcb.126.1.53; Sandvig Kirsten, 1994, Trends in Cell Biology, V4, P275, DOI 10.1016/0962-8924(94)90211-9; SCHNEIDERSCHAULIES S, 1994, J VIROL, V68, P6910, DOI 10.1128/JVI.68.11.6910-6917.1994; Schnitzer JE, 1996, SCIENCE, V274, P239, DOI 10.1126/science.274.5285.239; Schumacher B, 1998, J BIOL CHEM, V273, P28365, DOI 10.1074/jbc.273.43.28365; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; TUMA PL, 1993, J BIOL CHEM, V268, P17240; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Wang HJ, 1997, J CELL SCI, V110, P3043; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; WEITZ G, 1989, J INTERFERON RES, V9, P679, DOI 10.1089/jir.1989.9.679; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894	54	110	117	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21829	21835		10.1074/jbc.M201641200	http://dx.doi.org/10.1074/jbc.M201641200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11916975	hybrid			2022-12-27	WOS:000176286000092
J	Deo, DD; Axelrad, TW; Robert, EG; Marcheselli, V; Bazan, NG; Hunt, JD				Deo, DD; Axelrad, TW; Robert, EG; Marcheselli, V; Bazan, NG; Hunt, JD			Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells - Evidence for a dual kinase mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; INDUCED IN-VIVO; FACTOR RECEPTOR; SIGNAL-TRANSDUCTION; TYROSINE KINASE; PROTEIN-KINASE; EXTRACELLULAR-MATRIX; PHOSPHOLIPASE-C; LIPID MEDIATORS; PERTUSSIS-TOXIN	Platelet-activating factor (PAF) is a potent proinflammatory phospholipid with multiple pathological and physiological effects. We have shown that basic fibroblast growth factor (bFGF) supplementation induces rapid proliferation of human umbilical vein endothelial cells (HUVEC), which is reduced upon removal of bFGF or by bFGF immunoneutralization. The PAF receptor antagonist LAU-8080 inhibited bFGF-stimulated HUVEC proliferation, indicating the involvement of PAF in the bFGF-mediated signaling of HUVEC. Although FGF receptor phosphorylation was not affected by]LAU-8080, the bFGF-mediated prolonged phosphorylation, and activation of Erk-1 and -2 were attenuated. Phosphorylation of STAT-3 was observed in the presence of PAF or bFGF, which was attenuated by PAFR antagonists. PAF-induced STAT-3 phosphorylation observed in HUVEC pretreated with either Src inhibitor PR1 or JAK-2 inhibitor AG-490 indicated M immediate (1 min) phosphorylation of STAT-3 is dependent on Src, (ii) JAK-2-dependent STAT-3 phosphorylation occurs after the delayed (30 min) PAF exposure, and (iii) prolonged (60 min) STAT-3 phosphorylation may be either through Src and/or JAK-2. Attenuation of the STAT-3 phosphorylation by the PAFR antagonists indicated signaling through the PAF receptor. Taken together, these findings suggest the production of PAF is important for bFGF-mediated signaling and that a dual kinase mechanism is involved in the PAF-mediated signal transduction cascade.	Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Hunt, JD (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, Dept Biochem & Mol Biol, 533 Bolivar St,CSB-4-18, New Orleans, LA 70112 USA.		Bazan, Nicolas/AAN-4121-2020	Bazan, Nicolas/0000-0002-9243-5444; Hunt, Jay/0000-0002-8838-201X				Bazan HEP, 1997, CURR EYE RES, V16, P372, DOI 10.1076/ceyr.16.4.372.10699; BOUTHERINFALSON O, 1990, BIOCHEM BIOPH RES CO, V172, P306, DOI 10.1016/S0006-291X(05)80210-4; Brizzi MF, 1999, CIRC RES, V84, P785; Camussi G, 1997, J IMMUNOL, V158, P1302; Cao XM, 1996, MOL CELL BIOL, V16, P1595; Chaturvedi P, 1998, ONCOGENE, V16, P1749, DOI 10.1038/sj.onc.1201972; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DeCoster MA, 1998, J NEUROSCI RES, V53, P297, DOI 10.1002/(SICI)1097-4547(19980801)53:3<297::AID-JNR3>3.0.CO;2-5; DHAR A, 1994, J BIOL CHEM, V269, P9123; FAFEUR V, 1991, J CELL PHYSIOL, V149, P277, DOI 10.1002/jcp.1041490214; Faris M, 1996, AIDS, V10, P369, DOI 10.1097/00002030-199604000-00004; FLAUMENHAFT R, 1989, J CELL PHYSIOL, V140, P75, DOI 10.1002/jcp.1041400110; FRANKLIN RA, 1993, J IMMUNOL, V151, P1802; FRIESEL RE, 1995, FASEB J, V9, P919, DOI 10.1096/fasebj.9.10.7542215; GOMEZCAMBRONERO J, 1991, J BIOL CHEM, V266, P6240; HONDA Z, 1994, J BIOL CHEM, V269, P2307; HONDA Z, 1991, NATURE, V349, P342, DOI 10.1038/349342a0; Ihida K, 1999, J CELL SCI, V112, P285; Jackson JR, 1998, BBA-LIPID LIPID MET, V1392, P145, DOI 10.1016/S0005-2760(98)00012-5; Ju H, 2000, BIOCHEM J, V351, P257, DOI 10.1042/0264-6021:3510257; Kanda S, 1997, J BIOL CHEM, V272, P23347, DOI 10.1074/jbc.272.37.23347; KLEIN S, 1997, REGULATION ANGIOGENE; Klint P, 1999, ONCOGENE, V18, P3354, DOI 10.1038/sj.onc.1202680; KORNECKI E, 1988, SCIENCE, V260, P315; KREMER NE, 1991, J CELL BIOL, V115, P809, DOI 10.1083/jcb.115.3.809; KUNZ D, 1992, J BIOL CHEM, V267, P9101; LALLEMAIN G, 1991, CELL REGUL, V2, P675, DOI 10.1091/mbc.2.8.675; LANDGREN E, 1995, ONCOGENE, V10, P2027; LEPRINCE C, 1991, LIPIDS, V26, P1204, DOI 10.1007/BF02536532; Liu KD, 1998, CURR OPIN IMMUNOL, V10, P271, DOI 10.1016/S0952-7915(98)80165-9; Lukashova V, 2001, J BIOL CHEM, V276, P24113, DOI 10.1074/jbc.M100720200; Miao HQ, 1996, J BIOL CHEM, V271, P4879; MOHAMMADI M, 1991, MOL CELL BIOL, V11, P5068, DOI 10.1128/MCB.11.10.5068; Montrucchio G, 1997, AM J PATHOL, V151, P557; MONTRUCCHIO G, 1994, J EXP MED, V180, P377, DOI 10.1084/jem.180.1.377; Montrucchio G, 1998, AM J PATHOL, V153, P1589, DOI 10.1016/S0002-9440(10)65747-1; MOSCATELLI D, 1986, P NATL ACAD SCI USA, V83, P2091, DOI 10.1073/pnas.83.7.2091; NAKAMURA M, 1991, J BIOL CHEM, V266, P20400; Pellegrini S, 1997, EUR J BIOCHEM, V248, P615, DOI 10.1111/j.1432-1033.1997.00615.x; Predescu D, 1996, EUR J CELL BIOL, V69, P86; Prescott SM, 2000, ANNU REV BIOCHEM, V69, P419, DOI 10.1146/annurev.biochem.69.1.419; Reddy EP, 2000, ONCOGENE, V19, P2532, DOI 10.1038/sj.onc.1203594; RUI H, 1994, J BIOL CHEM, V269, P5364; SA G, 1995, J BIOL CHEM, V270, P2360, DOI 10.1074/jbc.270.5.2360; SA G, 1994, J BIOL CHEM, V269, P3219; SAMIEI M, 1993, BIOCHIM BIOPHYS ACTA, V1176, P287, DOI 10.1016/0167-4889(93)90057-V; Shimizu T, 1996, ADV EXP MED BIOL, V416, P79; SHUKLA SD, 1992, FASEB J, V6, P2296, DOI 10.1096/fasebj.6.6.1312046; Sirois MG, 1997, AM J PHYSIOL-HEART C, V272, pH2746, DOI 10.1152/ajpheart.1997.272.6.H2746; THURSTON AW, 1993, J PHARMACOL EXP THER, V266, P1106; VELAZQUEZ L, 1995, J BIOL CHEM, V270, P3327, DOI 10.1074/jbc.270.7.3327; VENABLE ME, 1993, J LIPID RES, V34, P691; Wang H, 1997, BIOCHEM J, V322, P603, DOI 10.1042/bj3220603; YE RD, 1991, BIOCHEM BIOPH RES CO, V180, P105, DOI 10.1016/S0006-291X(05)81261-6; Yeh TC, 1999, CELL MOL LIFE SCI, V55, P1523, DOI 10.1007/s000180050392	56	100	102	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21237	21245		10.1074/jbc.M110955200	http://dx.doi.org/10.1074/jbc.M110955200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11940567	hybrid			2022-12-27	WOS:000176286000017
J	Sandal, T; Stapnes, C; Kleivdal, H; Hedin, L; Doskeland, SO				Sandal, T; Stapnes, C; Kleivdal, H; Hedin, L; Doskeland, SO			A novel, extraneuronal role for cyclin-dependent protein kinase 5 (CDK5) - Modulation of cAMP-induced apoptosis in rat leukemia cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CDC2-LIKE KINASE; RETINOBLASTOMA PROTEIN; SELECTIVE INHIBITOR; NEURITE OUTGROWTH; DEATH; EXPRESSION; ACTIVATION; P35; CLEAVAGE; DIFFERENTIATION	A number of cyclin-dependent protein kinase (CDK) inhibitors were tested for the ability to protect IPC-81 rat leukemic cells against cAMP-induced apoptosis. A near perfect proportionality was observed between inhibitor potency to protect against cAMP-induced apoptosis and to antagonize CDK5, and to a lesser extent, CDK2 and CDK1. Enforced expression of dominant negative CDK5 (but not CDK1-dn or CDK2-dn) protected against death, indicating that CDK5 activity was necessary for cAMP-induced apoptosis. The CDK inhibitors failed to protect the cells against daunorubicine-, staurosporine-, or okadaic acid-induced apoptosis. The inhibition of CDK5 prevented the cleavage of pro-caspase-3 in cAMP-treated cells. The cells could be saved closer to the moment of their onset of death by inhibitors of caspases than by inhibitors of CDK5. This suggested that the action of CDK5 was upstream of caspase activation. The cAMP treatment resulted in a moderate increase of the level of CDK5 mRNA and protein in IPC-81 wild-type cells. Such cAMP induction of CDK5 was not observed in cells expressing the inducible cAMP early repressor. The cAMP-induced increase of CDK5 contributed to apoptosis since cells overexpressing CDK5-wt were more sensitive for cAMP-induced death. These results demonstrate the first example of a proapoptotic CDK action upstream of caspase activation and of an extra-neuronal effect of CDK5.	Univ Bergen, Dept Anat & Cell Biol, N-5009 Bergen, Norway	University of Bergen	Doskeland, SO (corresponding author), Univ Bergen, Dept Anat & Cell Biol, N-5009 Bergen, Norway.	stein.doskeland@iac.uib.no		Doskeland, Stein Ove/0000-0002-4009-4756				Ahuja HS, 1997, DEV GENET, V21, P258, DOI 10.1002/(SICI)1520-6408(1997)21:4<258::AID-DVG3>3.0.CO;2-6; Alvarez A, 1999, FEBS LETT, V459, P421, DOI 10.1016/S0014-5793(99)01279-X; Arellano M, 1997, INT J BIOCHEM CELL B, V29, P559, DOI 10.1016/S1357-2725(96)00178-1; Bajaj NPS, 2000, AMYOTROPH LATERAL SC, V1, P319, DOI 10.1080/146608200300079563; BRONSTEIN I, 1992, BIOTECHNIQUES, V12, P748; BRUNO S, 1992, CANCER RES, V52, P470; Catania A, 2001, NEURO-ONCOLOGY, V3, P89, DOI 10.1093/neuonc/3.2.89; Chadebech P, 2000, INT J CANCER, V87, P779, DOI 10.1002/1097-0215(20000915)87:6<779::AID-IJC3>3.3.CO;2-W; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Choi KS, 1999, J BIOL CHEM, V274, P31775, DOI 10.1074/jbc.274.45.31775; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DARZYNKIEWICZ Z, 1995, J CELL BIOCHEM, V58, P151, DOI 10.1002/jcb.240580204; Davis ST, 2001, SCIENCE, V291, P134, DOI 10.1126/science.291.5501.134; DUPREZ E, 1993, J BIOL CHEM, V268, P8332; Fladmark KE, 2002, J BIOL CHEM, V277, P2804, DOI 10.1074/jbc.M109049200; Gao C, 2001, J CELL SCI, V114, P1145; Gao CY, 1997, DEV GENET, V20, P267; Gervais JLM, 1998, J BIOL CHEM, V273, P19207, DOI 10.1074/jbc.273.30.19207; GJERTSEN BT, 1995, J BIOL CHEM, V270, P20599, DOI 10.1074/jbc.270.35.20599; GJERTSEN BT, 1994, J CELL SCI, V107, P3363; Gray N, 1999, CURR MED CHEM, V6, P859; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Hakem A, 1999, J EXP MED, V189, P957, DOI 10.1084/jem.189.6.957; Harvey KJ, 2000, J CELL BIOL, V148, P59, DOI 10.1083/jcb.148.1.59; HELLMICH MR, 1992, P NATL ACAD SCI USA, V89, P10867, DOI 10.1073/pnas.89.22.10867; Henchcliffe C, 1997, NEUROSCI LETT, V230, P41, DOI 10.1016/S0304-3940(97)00472-2; Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471; Humbert S, 2000, J CELL SCI, V113, P975; Ishizuka T, 1995, GENE, V166, P267, DOI 10.1016/0378-1119(95)00650-8; Jin YH, 2000, J BIOL CHEM, V275, P30256, DOI 10.1074/jbc.M001902200; Kim SG, 2001, ONCOGENE, V20, P1254, DOI 10.1038/sj.onc.1204203; KITAGAWA M, 1993, ONCOGENE, V8, P2425; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; LANOTTE M, 1991, J CELL PHYSIOL, V146, P73, DOI 10.1002/jcp.1041460110; Leclerc S, 2001, J BIOL CHEM, V276, P251, DOI 10.1074/jbc.M002466200; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Li BS, 2000, J NEUROSCI, V20, P6055, DOI 10.1523/JNEUROSCI.20-16-06055.2000; Li WW, 2001, CANCER RES, V61, P2579; Lorens JB, 2000, MOL THER, V1, P438, DOI 10.1006/mthe.2000.0063; Lu YJ, 2000, MOL CARCINOGEN, V29, P1; Maccioni RB, 2001, EUR J BIOCHEM, V268, P1517, DOI 10.1046/j.1432-1327.2001.02022.x; Maccioni RB, 2001, EUR J BIOCHEM, V268, P1518, DOI 10.1046/j.1432-1327.2001.02024.x; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Meijer L, 1995, Prog Cell Cycle Res, V1, P351; MEIKRANTZ W, 1995, J CELL BIOCHEM, V58, P160, DOI 10.1002/jcb.240580205; Meikrantz W, 1996, J BIOL CHEM, V271, P10205, DOI 10.1074/jbc.271.17.10205; MEIKRANTZ W, 1994, P NATL ACAD SCI USA, V91, P3754, DOI 10.1073/pnas.91.9.3754; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; Motyl T, 1999, REPROD NUTR DEV, V39, P49, DOI 10.1051/rnd:19990103; Munoz JP, 2000, NEUROREPORT, V11, P2733, DOI 10.1097/00001756-200008210-00025; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Ruchaud S, 1997, BIOCHEM SOC T, V25, P410, DOI 10.1042/bst0250410; Ruchaud S, 1997, ONCOGENE, V15, P827, DOI 10.1038/sj.onc.1201248; Sandal T, 2001, CELL DEATH DIFFER, V8, P754, DOI 10.1038/sj.cdd.4400873; Sassone-Corsi P, 1998, INT J BIOCHEM CELL B, V30, P27, DOI 10.1016/S1357-2725(97)00093-9; Schneider P, 2000, Pharm Acta Helv, V74, P281, DOI 10.1016/S0031-6865(99)00038-2; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Tang DM, 1996, BIOCHEM CELL BIOL, V74, P419, DOI 10.1139/o96-046; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; UCKER DS, 1991, NEW BIOL, V3, P103; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Vaux DL, 1996, P NATL ACAD SCI USA, V93, P2239, DOI 10.1073/pnas.93.6.2239; VESELY J, 1994, EUR J BIOCHEM, V224, P771, DOI 10.1111/j.1432-1033.1994.00771.x; VINTERMYR OK, 1993, EXP CELL RES, V206, P157, DOI 10.1006/excr.1993.1132; Walczak H, 2000, EXP CELL RES, V256, P58, DOI 10.1006/excr.2000.4840; Wolf BB, 1999, J BIOL CHEM, V274, P20049, DOI 10.1074/jbc.274.29.20049; Yao SL, 1996, CANCER RES, V56, P4551; Yin MB, 1999, INT J CANCER, V83, P341, DOI 10.1002/(SICI)1097-0215(19991029)83:3<341::AID-IJC9>3.0.CO;2-3; Zhang JW, 2000, J NEUROCHEM, V75, P2346, DOI 10.1046/j.1471-4159.2000.0752346.x; Zhang Q, 1997, DEV BIOL, V183, P222, DOI 10.1006/dbio.1996.8494	73	54	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20783	20793		10.1074/jbc.M112248200	http://dx.doi.org/10.1074/jbc.M112248200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11909854	hybrid			2022-12-27	WOS:000176204500088
J	Shin, HS; Chin, MR; Kim, JS; Chung, JH; Ryu, CK; Jung, SY; Kim, DK				Shin, HS; Chin, MR; Kim, JS; Chung, JH; Ryu, CK; Jung, SY; Kim, DK			Purification and characterization of a cytosolic, 42-kDa and Ca2+-dependent phospholipase A(2) from bovine red blood cells - Its involvement in Ca2+-dependent release of arachidonic acid from mammalian red blood cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-ERYTHROCYTES; EXTRACELLULAR PHOSPHOLIPASE-A2; ERYTHROPOIETIN RECEPTOR; SIGNAL TRANSDUCTION; PLATELET ACTIVATION; MEMBRANES; COLLAGEN; DEFORMABILITY; HEMATOPOIESIS; LIPOXYGENASE	It has become evident that a Ca2+-dependent release of arachidonic acid (AA) and subsequent formation of bioactive lipid mediators such as prostaglandins and leukotrienes in red blood cells (RBCs) can modify physiological functions of neighboring RECs and platelets. Here we identified a novel type of cytosolic PLA(2) in bovine and human RBCs and purified it to apparent homogeneity with a 14,000-fold purification. The purified enzyme, termed rPLA(2), has a molecular mass of 42 kDa and reveals biochemical properties similar to group IV cPLA(2), but shows different profiles from cPLA, in several column chromatographies. Moreover, rPLA2 did not react with any of anti-cPLA(2) and anti-cPLA(2) antibodies and was identified as an unknown protein in matrix-assisted laser desorption/ ionization time-of-flight mass spectrometric analysis. Divalent metal ions tested exhibited similar effects between rPLA(2) and cPLA(2), whereas mercurials inhibited cPLA(2) but had no effect on rPLA(2). Antibody against the 42-kDa protein not only precipitated the rPLA(2) activity, but also reacted with the 42-kDa protein from bovine and human IRBCs in immunoblot analysis. The 42-kDa protein band was selectively detected in murine fetal liver cells known as a type of progenitor cells of IRBCs. It was found that EA4, a derivative of quinone newly developed as an inhibitor for rPLA2, inhibited a Ca2+ ionophore-induced AA release from human and bovine RBCs, indicating that this enzyme is responsible for the Ca-dependent AA release from mammalian RBCs. Finally, erythroid progenitor cell assay utilizing diaminobenzidine staining of hemoglobinized fetal liver cells showed that rPLA2 detectable in erythroid cells was down-regulated when differentiated to non-erythroid cells. Together, our results suggest that the 42-kDa rPLA, identified as a novel form of Ca-dependent PLA(2) may play an important role in hemostasis, thrombosis, and/or erythropoiesis through the Ca2+-dependent release of AA.	Chung Ang Univ, Coll Pharm, Dept Environm & Hlth Chem, Dongjak Ku, Seoul 156756, South Korea; Seoul Natl Univ, Coll Pharm, Kwanak Ku, Seoul 151742, South Korea; Ewha Womans Univ, Coll Pharm, Dept Pharmaceut Anal, Seoul 120750, South Korea	Chung Ang University; Seoul National University (SNU); Ewha Womans University	Kim, DK (corresponding author), Chung Ang Univ, Coll Pharm, Dept Environm & Hlth Chem, Dongjak Ku, 221 Huksuk Dong, Seoul 156756, South Korea.			Jung, Sung Yun/0000-0003-1521-7977				ADACHI I, 1983, ARCH BIOCHEM BIOPHYS, V226, P118, DOI 10.1016/0003-9861(83)90276-X; ALLEN JE, 1971, SCIENCE, V174, P512, DOI 10.1126/science.174.4008.512; Andrews D A, 1999, Curr Opin Hematol, V6, P76, DOI 10.1097/00062752-199903000-00004; BECKMAN BS, 1991, ADV PROSTAG THROMB L, V21, P831; BECKMAN BS, 1989, EXP HEMATOL, V17, P309; CHANG HW, 1987, J BIOCHEM, V102, P147, DOI 10.1093/oxfordjournals.jbchem.a122026; HARA S, 1989, J BIOCHEM-TOKYO, V105, P395, DOI 10.1093/oxfordjournals.jbchem.a122675; HAZEN SL, 1990, J BIOL CHEM, V265, P10622; Jensen ON, 1997, ANAL CHEM, V69, P4741, DOI 10.1021/ac970896z; JOHNSON GR, 1985, EXP HEMATOL, V13, P200; Jung KM, 2000, PLANT PHYSIOL, V123, P1057, DOI 10.1104/pp.123.3.1057; Kennedy M, 1997, NATURE, V386, P488, DOI 10.1038/386488a0; KIM DK, 1993, BIOCHEM J, V294, P261, DOI 10.1042/bj2940261; KIM DK, 1991, BIOCHEM BIOPH RES CO, V174, P189, DOI 10.1016/0006-291X(91)90504-Z; KIM DK, 1991, BIOCHIM BIOPHYS ACTA, V1083, P80; KOBAYASHI T, 1983, J BIOL CHEM, V258, P9116; KRAMER RM, 1978, BIOCHIM BIOPHYS ACTA, V507, P381, DOI 10.1016/0005-2736(78)90348-6; KRAMER RM, 1991, J BIOL CHEM, V266, P5268; KUDO I, 1993, BIOCHIM BIOPHYS ACTA, V1170, P217, DOI 10.1016/0005-2760(93)90003-R; KUHN H, 1990, J BIOL CHEM, V265, P1454; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSEN FL, 1981, NATURE, V294, P667, DOI 10.1038/294667a0; LEVINE L, 1981, P NATL ACAD SCI-BIOL, V78, P7692, DOI 10.1073/pnas.78.12.7692; Li Q, 1996, J BIOL CHEM, V271, P18651, DOI 10.1074/jbc.271.31.18651; Light DB, 1997, J MEMBRANE BIOL, V158, P229, DOI 10.1007/s002329900260; MASONGARCIA M, 1992, AM J PHYSIOL, V262, pC1197; MASONGARCIA M, 1991, FASEB J, V5, P2958, DOI 10.1096/fasebj.5.14.1752362; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OGAWA M, 1976, BLOOD, V48, P407; Oonishi T, 1998, PROSTAG OTH LIPID M, V56, P89, DOI 10.1016/S0090-6980(98)00045-8; Oonishi T, 1997, AM J PHYSIOL-CELL PH, V273, pC1828, DOI 10.1152/ajpcell.1997.273.6.C1828; Park JB, 2000, J BIOL CHEM, V275, P21295, DOI 10.1074/jbc.M002463200; PAYSANT M, 1967, B SOC CHIM BIOL, V49, P169; PAYSANT M, 1970, B SOC CHIM BIOL, V52, P1257; PRATT YT, 1960, J AM CHEM SOC, V82, P1155, DOI 10.1021/ja01490a035; REIMERS RC, 1984, BLOOD, V64, P1200; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; SANTOS MT, 1986, THROMB HAEMOSTASIS, V56, P376; SANTOS MT, 1991, J CLIN INVEST, V87, P571, DOI 10.1172/JCI115032; SHIGA T, 1985, BIOCHIM BIOPHYS ACTA, V814, P289, DOI 10.1016/0005-2736(85)90447-X; SNYDER DS, 1986, BLOOD, V67, P1675; ULEVITCH RJ, 1988, J BIOL CHEM, V263, P3079; VALLES J, 1991, BLOOD, V78, P154; Valles J, 1997, DIABETES, V46, P1047, DOI 10.2337/diabetes.46.6.1047; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; WURM G, 1991, ARCH PHARM, V324, P491; Yang L, 2000, BLOOD, V95, P2420, DOI 10.1182/blood.V95.7.2420.007k12_2420_2425	47	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					21086	21094		10.1074/jbc.M200203200	http://dx.doi.org/10.1074/jbc.M200203200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11909855	hybrid			2022-12-27	WOS:000176204500124
J	Thoden, JB; Holden, HM				Thoden, JB; Holden, HM			High resolution x-ray structure of galactose mutarotase from Lactococcus lactis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; CLONING; PROGRAM; GENES	Galactose mutarotase plays a key role in normal galactose metabolism by catalyzing the interconversion of Beta-D-galactose and alpha-D-galactose. Here we describe the three-dimensional architecture of galactose mutarotase from Lactococcus lactis determined to 1.9-Angstrom resolution. Each subunit of the dimeric enzyme displays a distinctive beta-sandwich motif. This tertiary structural element was first identified in beta-galactosidase and subsequently observed in copper amine oxidase, hyaluronate lyase, chondroitinase, and maltose phosphorylase. Two cis-peptides are found in each subunit, namely Pro(67) and Lys(136). The active site is positioned in a rather open cleft, and the electron density corresponding to the bound galactose unequivocally demonstrates that both anomers of the substrate are present in the crystalline enzyme. Those residues responsible for anchoring the Arg(71), sugar to the protein include Arg(71), His(96), His(170), As and Glu(304). Both His(96) and His(170) are strictly conserved among mutarotase amino acid sequences determined thus far. The imidazole nitrogens of these residues are located within hydrogen bonding distance to the C-5 oxygen of galactose. Strikingly, the carboxylate group of Glu(304) is situated at similar to2.7 Angstrom from the 1'-hydroxyl group of galactose, thereby suggesting its possible role as a general acid/base group.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Thoden, JB (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK047814, R01DK047814] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK47814] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Beebe JA, 1998, BIOCHEMISTRY-US, V37, P14989, DOI 10.1021/bi9816047; BOUFFARD GG, 1994, J MOL BIOL, V244, P269, DOI 10.1006/jmbi.1994.1728; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Egloff MP, 2001, STRUCTURE, V9, P689, DOI 10.1016/S0969-2126(01)00626-8; Erlandson KA, 2001, APPL ENVIRON MICROB, V67, P1445, DOI 10.1128/AEM.67.4.1445-1452.2001; Fethiere J, 1999, J MOL BIOL, V288, P635, DOI 10.1006/jmbi.1999.2698; GATZ C, 1986, J BACTERIOL, V168, P31, DOI 10.1128/jb.168.1.31-39.1986; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HUCHO F, 1971, EUR J BIOCHEM, V23, P489, DOI 10.1111/j.1432-1033.1971.tb01645.x; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; JONES TA, 1992, MOL REPLACEMENT, P91; Kleywegt GJ, 1994, 1 MAP FINAL MODEL, P59; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; LOUDON GM, 1998, ORGANIC CHEM, P1209; MASKELL DJ, 1992, MOL MICROBIOL, V6, P3051, DOI 10.1111/j.1365-2958.1992.tb01763.x; MOLLET B, 1991, J BACTERIOL, V173, P4464, DOI 10.1128/JB.173.14.4464-4473.1991; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; PARSONS MR, 1995, STRUCTURE, V3, P1171, DOI 10.1016/S0969-2126(01)00253-2; POOLMAN B, 1990, J BACTERIOL, V172, P4037, DOI 10.1128/jb.172.7.4037-4047.1990; Prade RA, 1996, BIOTECHNOL GENET ENG, V13, P101, DOI 10.1080/02648725.1996.10647925; ROUSSEL A, 1991, SILICON GRAPHICS GEO; RYPNIEWSKI WR, 1991, BIOCHEMISTRY-US, V30, P4126, DOI 10.1021/bi00231a003; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; WALLENFELS K, 1965, BIOCHEM Z, V343, P307; ZHANG XJ, 1995, J APPL CRYSTALLOGR, V28, P624, DOI 10.1107/S0021889895001063	27	38	39	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20854	20861		10.1074/jbc.M201415200	http://dx.doi.org/10.1074/jbc.M201415200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11907040	hybrid			2022-12-27	WOS:000176204500097
J	Jaffe, EK; Kervinen, J; Martins, J; Stauffer, F; Neier, R; Wlodawer, A; Zdanov, A				Jaffe, EK; Kervinen, J; Martins, J; Stauffer, F; Neier, R; Wlodawer, A; Zdanov, A			Species-specific inhibition of porphobilinogen synthase by 4-oxosebacic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY STRUCTURE; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; ARTIFICIAL GENE; DEHYDRATASE; RESOLUTION; MECHANISM; MG(II); IONS	Porphobilinogen synthase (PBGS) catalyzes the condensation of two molecules of 5-aminolevulinic acid (ALA), an essential step in tetrapyrrole biosynthesis. 4-Oxosebacic acid (4-OSA) and 4,7-dioxosebacic acid (4,7-DOSA) are bisubstrate reaction intermediate analogs for PBGS. We show that 4-OSA is an active site-directed irreversible inhibitor for Escherichia coli PBGS, whereas human, pea, Pseudomonas aeruginosa, and Bradyrhizobium japonicum PBGS are insensitive to inhibition by 4-OSA. Some variants of human PBGS (engineered to resemble E. coli PBGS) have increased sensitivity to inactivation by 4-OSA, suggesting a structural basis for the specificity. The specificity of 4-OSA as a PBGS inhibitor is significantly narrower than that of 4,7-DOSA. Comparison of the crystal structures for E. coli PBGS inactivated by 4-OSA versus 4,7-DOSA shows significant variation in the half of the inhibitor that mimics the second substrate molecule (A-side ALA). Compensatory changes occur in the structure of the active site lid, which suggests that similar changes normally occur to accommodate numerous hybridization changes that must occur at C3 of A-side ALA during the PBGS-catalyzed reaction. A comparison of these with other PBGS structures identifies highly conserved active site water molecules, which are isolated from bulk solvent and implicated as proton acceptors in the PBGS-catalyzed reaction.	Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA; Univ Neuchatel, Dept Chem, CH-2007 Neuchatel, Switzerland; NCI, Macromol Crystallog Lab, NIH, Frederick, MD 21702 USA	Fox Chase Cancer Center; University of Neuchatel; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Jaffe, EK (corresponding author), Fox Chase Canc Ctr, Inst Canc Res, 7701 Burholme Ave, Philadelphia, PA 19111 USA.				NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003654] Funding Source: NIH RePORTER; NCI NIH HHS [CA06927] Funding Source: Medline; NIEHS NIH HHS [ES03654] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BARNARD GF, 1977, J BIOL CHEM, V252, P8965; Bock CW, 1999, J AM CHEM SOC, V121, P7360, DOI 10.1021/ja9906960; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; COPELAND RA, 1995, BIOORG MED CHEM LETT, V5, P1947, DOI 10.1016/0960-894X(95)00330-V; Erskine PT, 1999, BIOCHEMISTRY-US, V38, P4266, DOI 10.1021/bi982137w; Erskine PT, 2001, FEBS LETT, V503, P196, DOI 10.1016/S0014-5793(01)02721-1; Erskine PT, 2001, J MOL BIOL, V312, P133, DOI 10.1006/jmbi.2001.4947; Frankenberg N, 1999, J MOL BIOL, V289, P591, DOI 10.1006/jmbi.1999.2808; Frankenberg N, 1999, BIOCHEMISTRY-US, V38, P13976, DOI 10.1021/bi9906470; Frankenberg N, 1999, BIOCHEMISTRY-US, V38, P13968, DOI 10.1021/bi9906468; Heine A, 2001, SCIENCE, V294, P369, DOI 10.1126/science.1063601; JAFFE EK, 1990, BIOCHEMISTRY-US, V29, P8345, DOI 10.1021/bi00488a021; JAFFE EK, 1986, J BIOL CHEM, V261, P9348; Jaffe EK, 2000, ACTA CRYSTALLOGR D, V56, P115, DOI 10.1107/S0907444999014894; JAFFE EK, 1995, J BIOENERG BIOMEMBR, V27, P169, DOI 10.1007/BF02110032; Jaffe EK, 2000, J BIOL CHEM, V275, P2619, DOI 10.1074/jbc.275.4.2619; Jaffe EK, 2001, J BIOL CHEM, V276, P1531, DOI 10.1074/jbc.M007663200; Jarret C, 2000, CHEM BIOL, V7, P185, DOI 10.1016/S1074-5521(00)00089-2; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORDAN PM, 1980, J CHEM SOC CHEM COMM, P240, DOI 10.1039/c39800000240; Kervinen J, 2001, BIOCHEMISTRY-US, V40, P8227, DOI 10.1021/bi010656k; Kervinen J, 2000, BIOCHEMISTRY-US, V39, P9018, DOI 10.1021/bi000620c; MITCHELL LW, 1993, ARCH BIOCHEM BIOPHYS, V300, P169, DOI 10.1006/abbi.1993.1024; NANDI DL, 1968, J BIOL CHEM, V243, P1236; NEIER R, 1996, ADV NITROG HETERCYC, V2, P35; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petrovich RM, 1996, J BIOL CHEM, V271, P8692, DOI 10.1074/jbc.271.15.8692; SPENCER P, 1995, BIOCHEM J, V305, P151, DOI 10.1042/bj3050151; Stauffer F, 2001, CHIMIA, V55, P314; Wynn R, 1996, PROTEIN SCI, V5, P1026	30	24	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19792	19799		10.1074/jbc.M201486200	http://dx.doi.org/10.1074/jbc.M201486200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11909869	hybrid			2022-12-27	WOS:000175894800072
J	Karpichev, IV; Cornivelli, L; Small, GM				Karpichev, IV; Cornivelli, L; Small, GM			Multiple regulatory roles of a novel Saccharomyces cerevisiae protein, encoded by YOL002c, in lipid and phosphate metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-COA OXIDASE; TRANSCRIPTION FACTORS; PEROXISOME PROLIFERATION; HISTONE DEACETYLASE; GENE; EXPRESSION; SYSTEM; IDENTIFICATION; CONSTRUCTION; ACCUMULATION	The yeast open reading frame YOL002c encodes a putative membrane protein. This protein is evolutionarily conserved across species, including humans, although the function of each of these proteins remains unknown. YOL002c is highly expressed in yeast cells that are grown in the presence of saturated fatty acids such as myristate. Furthermore, cells in which the YOL002c gene is disrupted grow poorly on this carbon source. These mutant cells are also resistant to the polyene antibiotic, nystatin. Gene chip analysis on yol002cDelta cells revealed that a variety of genes encoding proteins involved in fatty acid metabolism and in the phosphate signaling pathway are induced in this mutant strain. In addition, our studies demonstrated that in the disruption strain acid phosphatase activity is expressed constitutively, and the cells accumulate polyphosphate to much higher levels than wild-type cells. A homologous human protein is able to partially rescue these defects in phosphate metabolism. We propose that YOL002c encodes a Saccharomyces cerevisiae protein that plays a key role in metabolic pathways that regulate lipid and phosphate metabolism.	CUNY City Coll, Dept Biol, New York, NY 10031 USA	City University of New York (CUNY) System; City College of New York (CUNY)	Small, GM (corresponding author), CUNY City Coll, Dept Biol, New York, NY 10031 USA.	gmsbh@cunyvm.cuny.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054976] Funding Source: NIH RePORTER; NCRR NIH HHS [G12 RR03060] Funding Source: Medline; NIDDK NIH HHS [R01DK54976] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADAMS BG, 1972, J BACTERIOL, V111, P308, DOI 10.1128/JB.111.2.308-315.1972; ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; BARD M, 1972, Journal of Bacteriology, V111, P649; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; BOSSIE MA, 1989, J BACTERIOL, V171, P6409, DOI 10.1128/jb.171.12.6409-6413.1989; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; DENIS CL, 1981, J MOL BIOL, V148, P355, DOI 10.1016/0022-2836(81)90181-9; DMOCHOWSKA A, 1990, GENE, V88, P247, DOI 10.1016/0378-1119(90)90038-S; Dorland S, 2000, GENETICS, V154, P573; EINERHAND AWC, 1993, EUR J BIOCHEM, V214, P323, DOI 10.1111/j.1432-1033.1993.tb17927.x; Ferea TL, 1999, P NATL ACAD SCI USA, V96, P9721, DOI 10.1073/pnas.96.17.9721; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Johnston M., 1992, MOL CELLULAR BIOL YE, P193; Kaffman A, 1998, NATURE, V396, P482, DOI 10.1038/24898; KAFFMAN A, 1994, SCIENCE, V263, P1153, DOI 10.1126/science.8108735; KANEKO Y, 1982, MOL CELL BIOL, V2, P127, DOI 10.1128/MCB.2.2.127; Karpichev IV, 1997, MOL CELL BIOL, V17, P69, DOI 10.1128/MCB.17.1.69; Karpichev IV, 1998, MOL CELL BIOL, V18, P6560, DOI 10.1128/MCB.18.11.6560; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/S0968-0004(96)90127-9; Loewith R, 2001, J BIOL CHEM, V276, P24068, DOI 10.1074/jbc.M102176200; Luo Y, 1996, J BIOL CHEM, V271, P12068, DOI 10.1074/jbc.271.20.12068; MARINI F, 1961, J GEN MICROBIOL, V24, P51, DOI 10.1099/00221287-24-1-51; MCDONOUGH VM, 1992, J BIOL CHEM, V267, P5931; Measday V, 1997, MOL CELL BIOL, V17, P1212, DOI 10.1128/MCB.17.3.1212; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; Oshima Y, 1997, GENES GENET SYST, V72, P323, DOI 10.1266/ggs.72.323; Oshima Y, 1982, MOL BIOL YEAST SACCH, P159; Rottensteiner H, 1996, EMBO J, V15, P2924, DOI 10.1002/j.1460-2075.1996.tb00655.x; SIKORSKI RS, 1989, GENETICS, V122, P19; SPRAGUE GF, 1977, J BACTERIOL, V129, P1335, DOI 10.1128/JB.129.3.1335-1342.1977; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; VEENHUIS M, 1987, YEAST, V3, P77, DOI 10.1002/yea.320030204; WANG TW, 1994, J BIOL CHEM, V269, P24480; WANG TW, 1992, NUCLEIC ACIDS RES, V20, P3495, DOI 10.1093/nar/20.13.3495; WURST H, 1995, J BACTERIOL, V177, P898, DOI 10.1128/jb.177.4.898-906.1995; Zhang SR, 1999, GENETICS, V151, P473	39	59	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19609	19617		10.1074/jbc.M202045200	http://dx.doi.org/10.1074/jbc.M202045200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11916977	hybrid			2022-12-27	WOS:000175894800050
J	Mattjus, P; Malewicz, B; Valiyaveettil, JT; Baumann, WJ; Bittman, R; Brown, RE				Mattjus, P; Malewicz, B; Valiyaveettil, JT; Baumann, WJ; Bittman, R; Brown, RE			Sphingomyelin modulates the transbilayer distribution of galactosylceramide in phospholipid membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; PHOSPHATIDYLCHOLINE VESICLES; UNILAMELLAR VESICLES; CHOLESTEROL EFFLUX; BILAYER-MEMBRANES; MODEL MEMBRANES; ASYMMETRY; SPHINGOLIPIDS; DOMAINS; RAFTS	The interrelationships among sphingolipid structure, membrane curvature, and glycosphingolipid transmembrane distribution remain poorly defined despite the emerging importance of sphingolipids in curved regions and vesicle buds of biomembranes. Here, we describe a novel approach to investigate the transmembrane distribution of galactosylceramide in phospholipid small unilamellar vesicles by C-13 NMR spectroscopy. Quantitation of the transbilayer distribution of [6-C-13]galactosylceramide (99.8% isotopic enrichment) was achieved by exposure of vesicles to the paramagnetic ion, Mn2+. The data show that [6-13C]galactosylceramide prefers (70%) the inner leaflet of phosphatidylcholine vesicles. Increasing the sphingomyelin content of the 1-palmitoyl-2-oleoyl-phosphatidylcholine vesicles shifted galactosylceramide from the inner to the outer leaflet. The amount of galactosylceramide localized in the inner leaflet decreased from 70% in pure 1-palmitoyl-2-oleoyl-phosphatidylcholine vesicles to only 40% in 1-palmitoyl-2-oleoyl-phosphatidylcholine/sphingomyelin (1:2) vesicles. The present study demonstrates that sphingomyelin can dramatically alter the transbilayer distribution of a monohexosylceramide, such as galactosylceramide, in 1-palmitoyl-2-oleoyl-phosphatidylcholine/sphingomyelin vesicles. The results suggest that sphingolipid-sphingolipid interactions that occur even in the absence of cholesterol play a role in controlling the transmembrane distributions of cerebrosides.	Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; CUNY Queens Coll, Dept Chem & Biochem, Flushing, NY 11367 USA	University of Minnesota System; City University of New York (CUNY) System; Queens College NY (CUNY)	Brown, RE (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	rebrown@hi.umn.edu	Mattjus, Peter/ABE-3596-2021; Mattjus, Peter/AAQ-7531-2021	Mattjus, Peter/0000-0001-8991-5933; Brown, Rhoderick/0000-0002-7337-3604	NIGMS NIH HHS [R01 GM045928, R01 GM045928-09, R01 GM045928-07, R01 GM045928-08, R01 GM045928-10] Funding Source: Medline; PHS HHS [16660] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045928] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BERDEN JA, 1975, BIOCHIM BIOPHYS ACTA, V375, P186, DOI 10.1016/0005-2736(75)90188-1; Bevers EM, 1999, BBA-MOL CELL BIOL L, V1439, P317, DOI 10.1016/S1388-1981(99)00110-9; BITTMAN R, 1984, BIOCHIM BIOPHYS ACTA, V772, P117, DOI 10.1016/0005-2736(84)90034-8; Bratton DL, 1997, J BIOL CHEM, V272, P26159, DOI 10.1074/jbc.272.42.26159; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brown RE, 1998, J CELL SCI, V111, P1; BRUZIK KS, 1988, BIOCHIM BIOPHYS ACTA, V939, P315, DOI 10.1016/0005-2736(88)90076-4; Bruzik KS, 1997, BIOCHEMISTRY-US, V36, P566, DOI 10.1021/bi962204r; BRUZIK KS, 1990, BIOCHEMISTRY-US, V29, P4017, DOI 10.1021/bi00468a032; CASTELLINO FJ, 1978, ARCH BIOCHEM BIOPHYS, V189, P465, DOI 10.1016/0003-9861(78)90235-7; Closse C, 1999, BRIT J HAEMATOL, V107, P300, DOI 10.1046/j.1365-2141.1999.01718.x; Denzer K, 2000, J CELL SCI, V113, P3365; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; EVANS E, 1994, CHEM PHYS LIPIDS, V73, P39, DOI 10.1016/0009-3084(94)90173-2; EVANS E, 1987, J PHYS CHEM-US, V91, P4219, DOI 10.1021/j100300a003; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; FIANDOR J, 1985, SYNTHESIS-STUTTGART, P1121; GOLOLOBOV YG, 1981, TETRAHEDRON, V37, P437, DOI 10.1016/S0040-4020(01)92417-2; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Holopainen JM, 2000, BIOPHYS J, V78, P830, DOI 10.1016/S0006-3495(00)76640-9; HUANG C, 1978, P NATL ACAD SCI USA, V75, P308, DOI 10.1073/pnas.75.1.308; Huang C, 1974, Methods Enzymol, V32, P485; Hug P, 2000, J VIROL, V74, P6377, DOI 10.1128/JVI.74.14.6377-6385.2000; Huttner WB, 2001, CURR OPIN CELL BIOL, V13, P478, DOI 10.1016/S0955-0674(00)00239-8; ISRAELACHVILI JN, 1977, BIOCHIM BIOPHYS ACTA, V470, P185, DOI 10.1016/0005-2736(77)90099-2; KUMAR VV, 1986, BIOCHEM BIOPH RES CO, V139, P25, DOI 10.1016/S0006-291X(86)80074-2; KUMAR VV, 1989, BIOPHYS J, V55, P789, DOI 10.1016/S0006-3495(89)82877-2; KUMAR VV, 1988, BIOCHEMISTRY-US, V27, P393, DOI 10.1021/bi00401a059; LENTZ BR, 1978, BIOCHEMISTRY-US, V17, P5537, DOI 10.1021/bi00618a032; LENTZ BR, 1980, BIOCHEMISTRY-US, V19, P2555, DOI 10.1021/bi00553a003; Li XM, 2001, BIOCHEMISTRY-US, V40, P5954, DOI 10.1021/bi002791n; Lingwood CA, 2000, METHOD ENZYMOL, V312, P459; LITMAN BJ, 1974, BIOCHEMISTRY-US, V13, P2844, DOI 10.1021/bi00711a010; MAGGIO B, 1994, PROG BIOPHYS MOL BIO, V62, P55, DOI 10.1016/0079-6107(94)90006-X; Masserini M, 2001, BBA-MOL CELL BIOL L, V1532, P149, DOI 10.1016/S1388-1981(01)00128-7; Maulik PR, 1996, BIOPHYS J, V70, P2256, DOI 10.1016/S0006-3495(96)79791-6; Maulik PR, 1996, BIOCHEMISTRY-US, V35, P8025, DOI 10.1021/bi9528356; MURARI R, 1982, J ORG CHEM, V47, P2158, DOI 10.1021/jo00132a034; Ohvo H, 1997, BBA-LIPID LIPID MET, V1349, P131, DOI 10.1016/S0005-2760(97)00126-4; Raphael RM, 1996, BIOPHYS J, V71, P1374, DOI 10.1016/S0006-3495(96)79340-2; Rothblat GH, 1999, J LIPID RES, V40, P781; RUI YJ, 1994, J ORG CHEM, V59, P5758, DOI 10.1021/jo00098a040; RUOCCO MJ, 1983, BIOCHIM BIOPHYS ACTA, V735, P305, DOI 10.1016/0005-2736(83)90307-3; SACKMANN E, 1995, STRUCTURE DYNAMICS M, V1, P213; SCHMIDT CF, 1977, BIOCHEMISTRY-US, V16, P2649, DOI 10.1021/bi00631a011; Sillence DJ, 2000, METHOD ENZYMOL, V312, P562; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Svetina S, 1998, EUR BIOPHYS J BIOPHY, V27, P197, DOI 10.1007/s002490050126; Talbott CM, 2000, BBA-BIOMEMBRANES, V1467, P326, DOI 10.1016/S0005-2736(00)00229-7; Tepper AD, 2000, J CELL BIOL, V150, P155, DOI 10.1083/jcb.150.1.155; TKACZUK P, 1979, BIOCHEM BIOPH RES CO, V91, P1415, DOI 10.1016/0006-291X(79)91224-5; van der Goot FG, 2001, SEMIN IMMUNOL, V13, P89, DOI 10.1006/smim.2000.0300; VASELLA A, 1991, HELV CHIM ACTA, V74, P2073, DOI 10.1002/hlca.19910740842; WEGMANN B, 1987, J CARBOHYD CHEM, V6, P357, DOI 10.1080/07328308708057926; YEAGLE PL, 1976, J BIOL CHEM, V251, P2110; Zha XH, 1998, J CELL BIOL, V140, P39, DOI 10.1083/jcb.140.1.39; [No title captured]	60	29	29	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19476	19481		10.1074/jbc.M201305200	http://dx.doi.org/10.1074/jbc.M201305200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11909867	hybrid, Green Accepted			2022-12-27	WOS:000175894800033
J	Misra, P; Qi, C; Yu, ST; Shah, SH; Cao, WQ; Rao, MS; Thimmapaya, B; Zhu, YJ; Reddy, JK				Misra, P; Qi, C; Yu, ST; Shah, SH; Cao, WQ; Rao, MS; Thimmapaya, B; Zhu, YJ; Reddy, JK			Interaction of PIMT with transcriptional coactivators CBP, p300, and PBP differential role in transcriptional regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; CREB-BINDING-PROTEIN; NUCLEAR-RECEPTOR; HISTONE ACETYLTRANSFERASE; EMBRYONIC-DEVELOPMENT; TRAP220 COMPONENT; GENE; CLONING; COMPLEX; CBP/P300	PIMT (PRIP-interacting protein with methyltransferase domain), an RNA-binding protein with a methyltransferase domain capable of binding S-adenosylmethionine, has been shown previously to interact with nuclear receptor coactivator PRIP (peroxisome proliferator-activated receptor (PPAR)-interacting protein) and enhance its coactivator function. We now report that PIMT strongly interacts with transcriptional coactivators, CBP, p300, and P BP but not with SRC-1 and PGC-1alpha under in vitro and in vivo conditions. The PIMT binding sites on CBP and p300 are located in the cysteine-histidine-rich C/H1 and C/H3 domains, and the PIMT binding site on PBP is in the region encompassing amino acids 1101-1560. The N-terminal of PIMT (residues 1-369) containing the RNA binding domain interacts with both C/H1 and C/H3 domains of CBP and p300 and with the C-terminal portion of PBP that encompasses amino acids 1371-1560. The C-terminal of PIMT (residues 611-852), which binds S-adenosyl-L-methionine, interacts respectively with the C/H3 domain of CBP/p300 and with a region encompassing amino acids 1101-1370 of PBP. Immunoprecipitation data showed that PIMT forms a complex in vivo with CBP, p300, PBP, and PRIP. PIMT appeared to be co-localized in the nucleus with CBP, p300, and PBP. PIMT enhanced PBP-mediated transcriptional activity of the PPARgamma, as it did for PRIP, indicating synergism between PIMT and PBP. In contrast, PIMT functioned as a repressor of CBP/p300-mediated transactivation of PPARgamma. Based on these observations, we suggest that PIMT bridges the CBP/p300-anchored coactivator complex with the PBP-anchored coactivator complex but differentially modulates coactivator function such that inhibition of the CBP/p300 effect may be designed to enhance the activity of PBP and PRIP.	Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Reddy, JK (corresponding author), Northwestern Univ, Dept Pathol, Feinberg Sch Med, 303 E Chicago Ave, Chicago, IL 60611 USA.				NATIONAL CANCER INSTITUTE [R01CA088898, R01CA074403, R01CA084472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K08ES000356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023750, R37GM023750] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA74403, CA88898, CA84472] Funding Source: Medline; NIEHS NIH HHS [K08 ES00356] Funding Source: Medline; NIGMS NIH HHS [GM23750] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Blanco JCG, 1998, GENE DEV, V12, P1638, DOI 10.1101/gad.12.11.1638; BOSSIE MA, 1992, MOL BIOL CELL, V3, P875, DOI 10.1091/mbc.3.8.875; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Caira F, 2000, J BIOL CHEM, V275, P5308, DOI 10.1074/jbc.275.8.5308; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Crawford SE, 2002, J BIOL CHEM, V277, P3585, DOI 10.1074/jbc.M107995200; Dowell P, 1997, J BIOL CHEM, V272, P33435, DOI 10.1074/jbc.272.52.33435; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Goodman RH, 2000, GENE DEV, V14, P1553; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Ito M, 2000, MOL CELL, V5, P683, DOI 10.1016/S1097-2765(00)80247-6; Jung DJ, 2002, J BIOL CHEM, V277, P1229, DOI 10.1074/jbc.M110417200; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; KAMIE Y, 1996, CELL, V85, P403; Ko L, 2000, P NATL ACAD SCI USA, V97, P6212, DOI 10.1073/pnas.97.11.6212; Koh SS, 2001, J BIOL CHEM, V276, P1089, DOI 10.1074/jbc.M004228200; Kung AL, 2000, GENE DEV, V14, P272; Kurokawa R, 1998, SCIENCE, V279, P700, DOI 10.1126/science.279.5351.700; Lee SK, 1999, J BIOL CHEM, V274, P34283, DOI 10.1074/jbc.274.48.34283; Lei EP, 2001, GENE DEV, V15, P1771, DOI 10.1101/gad.892401; Lin CH, 2001, MOL CELL, V8, P581, DOI 10.1016/S1097-2765(01)00333-1; LIN J, 1998, CELL, V92, P829; Mahajan MA, 2000, MOL CELL BIOL, V20, P5048, DOI 10.1128/MCB.20.14.5048-5063.2000; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McCulloch V, 2002, MOL CELL BIOL, V22, P1116, DOI 10.1128/MCB.22.4.1116-1125.2002; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Mitchell KO, 1999, CELL GROWTH DIFFER, V10, P223; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Oike Y, 1999, BLOOD, V93, P2771; ONATE SA, 1995, SCIENCE, V270, P1354; Qi C, 1999, P NATL ACAD SCI USA, V96, P1585, DOI 10.1073/pnas.96.4.1585; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922; Xu W, 2001, SCIENCE, V294, P2507, DOI 10.1126/science.1065961; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Yu ST, 2001, J BIOL CHEM, V276, P42485, DOI 10.1074/jbc.M106480200; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939; Zhu YJ, 2000, J BIOL CHEM, V275, P13510, DOI 10.1074/jbc.275.18.13510; Zhu YJ, 2000, J BIOL CHEM, V275, P14779, DOI 10.1074/jbc.C000121200; Zhu YJ, 1996, GENE EXPRESSION, V6, P185; Zhu YJ, 1997, J BIOL CHEM, V272, P25500, DOI 10.1074/jbc.272.41.25500; Zhu YJ, 2001, P NATL ACAD SCI USA, V98, P10380, DOI 10.1073/pnas.181347498	53	62	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					20011	20019		10.1074/jbc.M201739200	http://dx.doi.org/10.1074/jbc.M201739200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11912212	hybrid			2022-12-27	WOS:000175894800101
J	Wang, ZQ; Wang, MF; Lazo, JS; Carr, BI				Wang, ZQ; Wang, MF; Lazo, JS; Carr, BI			Identification of epidermal growth factor receptor as a target of Cdc25A protein phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; VITAMIN-K ANALOGS; TYROSINE PHOSPHATASES; G(1)/S TRANSITION; MITOTIC INDUCER; FISSION YEAST; S-PHASE; INHIBITION; ACTIVATION; PHOSPHORYLATION	Cdc25A, a dual-specificity protein phosphatase, plays a critical role in cell cycle progression. Although cyclin-dependent kinases are established substrates, Cdc25A may also affect other proteins. We have shown here that Cdc25A interacts with epidermal growth factor receptor (EGFR) both physically and functionally in Hep3B human hepatoma cells. Cdc25A inhibitor Cpd 5, a vitamin K analog, inhibited Cdc25A activity in the Cdc25A-EGFR immunocomplex and consequently caused prolonged EGFR tyrosine phosphorylation. Both purified GST-Cdc25A protein and endogenous Hep3B cellular Cdc25A dephosphorylated tyrosine-phosphorylated EGFR, and Cpd 5 antagonized the phosphatase activity of Cdc25A. A functional Cdc25A-EGFR interaction was seen in NR-6 fibroblasts expressing ectopic EGFR but not with a receptor lacking the C terminus or a mutated kinase domain. These data link the cell cycle control Cdc25A phosphatase to an EGFR-linked mitogenic signaling pathway specifically involving EGFR dephosphorylation.	Univ Pittsburgh, Sch Med, Dept Surg, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Thomas E Starzl Transplantat Inst, Dept Pharmacol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Carr, BI (corresponding author), Univ Pittsburgh, Sch Med, Dept Surg, Thomas E Starzl Transplantat Inst, E1552 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15213 USA.			Carr, Brian/0000-0002-6111-5077	NCI NIH HHS [CA52995, CA82723, CA8039] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U19CA052995, U01CA052995, R01CA082723] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Blomberg I, 1999, MOL CELL BIOL, V19, P6183; BOHMER FD, 1993, FEBS LETT, V331, P276, DOI 10.1016/0014-5793(93)80352-U; CHEN P, 1994, J CELL BIOL, V124, P547, DOI 10.1083/jcb.124.4.547; Coqueret O, 1998, EMBO J, V17, P4680, DOI 10.1093/emboj/17.16.4680; Eckstein J., 1997, BIOCHIM BIOPHYS ACTA, V1332, P53; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; GALAKTIONOV K, 1991, CELL, V67, P1181, DOI 10.1016/0092-8674(91)90294-9; Galaktionov K, 1996, NATURE, V382, P511, DOI 10.1038/382511a0; GALAKTIONOV K, 1995, GENE DEV, V9, P1046, DOI 10.1101/gad.9.9.1046; Giebler HA, 2000, MOL CELL BIOL, V20, P4849, DOI 10.1128/MCB.20.13.4849-4858.2000; GU Y, 1992, EMBO J, V11, P3995, DOI 10.1002/j.1460-2075.1992.tb05493.x; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; HOFFMANN I, 1994, EMBO J, V13, P4302, DOI 10.1002/j.1460-2075.1994.tb06750.x; Hubbard SR, 1998, J BIOL CHEM, V273, P11987, DOI 10.1074/jbc.273.20.11987; Iavarone A, 1997, NATURE, V387, P417; JINNO S, 1994, EMBO J, V13, P1549, DOI 10.1002/j.1460-2075.1994.tb06417.x; Karlsson C, 1999, J CELL BIOL, V146, P573, DOI 10.1083/jcb.146.3.573; Kulas DT, 1996, J BIOL CHEM, V271, P748, DOI 10.1074/jbc.271.2.748; KUMAGAI A, 1992, CELL, V70, P139, DOI 10.1016/0092-8674(92)90540-S; LAMMERS R, 1993, J BIOL CHEM, V268, P22456; Lohse DL, 1997, BIOCHEMISTRY-US, V36, P4568, DOI 10.1021/bi963094r; MILLAR JBA, 1991, EMBO J, V10, P4301, DOI 10.1002/j.1460-2075.1991.tb05008.x; MILLAR JBA, 1991, P NATL ACAD SCI USA, V88, P10500, DOI 10.1073/pnas.88.23.10500; Molinari M, 2000, EMBO REP, V1, P71, DOI 10.1093/embo-reports/kvd018; Ni RZ, 1998, J BIOL CHEM, V273, P9906, DOI 10.1074/jbc.273.16.9906; Nishikawa Y, 1999, J BIOL CHEM, V274, P34803, DOI 10.1074/jbc.274.49.34803; Rice RL, 1997, BIOCHEMISTRY-US, V36, P15965, DOI 10.1021/bi971338h; SADHU K, 1990, P NATL ACAD SCI USA, V87, P5139, DOI 10.1073/pnas.87.13.5139; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SWARUP G, 1982, BIOCHEM BIOPH RES CO, V107, P1104, DOI 10.1016/0006-291X(82)90635-0; Tamura K, 2000, CANCER RES, V60, P1317; Tonks NK, 1996, CELL, V87, P365, DOI 10.1016/S0092-8674(00)81357-4; VANOBBERGHEN E, 1994, DIABETOLOGIA, V37, pS125, DOI 10.1007/BF00400836; Vogt A, 2001, J BIOL CHEM, V276, P20544, DOI 10.1074/jbc.M100078200; Wang ZQ, 2000, J CELL PHYSIOL, V183, P338, DOI 10.1002/(SICI)1097-4652(200006)183:3<338::AID-JCP6>3.0.CO;2-X; Wang ZQ, 2001, CANCER RES, V61, P7211; Wu FYH, 1999, EUR J CANCER, V35, P1388, DOI 10.1016/S0959-8049(99)00156-2; Xia K, 1999, MOL CELL BIOL, V19, P4819; Xu X, 1996, J BIOL CHEM, V271, P5118; ZHOU GC, 1994, J BIOL CHEM, V269, P28084; Zou XH, 2001, MOL CELL BIOL, V21, P4818, DOI 10.1128/MCB.21.14.4818-4828.2001	41	45	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19470	19475		10.1074/jbc.M201097200	http://dx.doi.org/10.1074/jbc.M201097200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11912208	hybrid			2022-12-27	WOS:000175894800032
J	Archer, DA; Graham, ME; Burgoyne, RD				Archer, DA; Graham, ME; Burgoyne, RD			Complexin regulates the closure of the fusion pore during regulated vesicle exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SNARE COMPLEX; MEMBRANE-FUSION; NEUROTRANSMITTER RELEASE; PROTEIN; SNAP-25; BINDING; ROLES	Membrane fusion during exocytosis and throughout the cell is believed to involve members of the SNARE (soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptors) family of proteins. The assembly of these proteins into a four-helix bundle may be part of the driving force for bilayer fusion. Regulated exocytosis in neurons and related cell types is specialized to be fast and Ca2+-dependent suggesting the involvement of other regulatory proteins specific for regulated exocytosis. Among these are the complexins, two closely related proteins that bind only to the assembled SNARE complex. We have investigated the function of complexin by analysis of single vesicle release events in adrenal chromaffin cells using carbon fiber amperometry. These cells express complexin II, and overexpression of this protein modified the kinetics of vesicle release events so that their time course was shortened. This effect depended on complexin interaction with the SNARE complex as introduction of a mutation of Arg-59, a residue that interacts with synaptobrevin in the SNARE complex, abolished its effects. The data are consistent with a function for complexin in stabilizing an intermediate of the SNARE complex to allow kiss-andrun recycling of the exocytosed vesicle.	Univ Liverpool, Physiol Lab, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Burgoyne, RD (corresponding author), Univ Liverpool, Physiol Lab, Crown St, Liverpool L69 3BX, Merseyside, England.	burgoyne@liverpool.ac.uk	Burgoyne, Robert/C-6706-2008; Burgoyne, Robert D/P-6641-2019	Burgoyne, Robert/0000-0002-9219-0387; Burgoyne, Robert D/0000-0002-9219-0387				Burgoyne RD, 2002, TRENDS NEUROSCI, V25, P176, DOI 10.1016/S0166-2236(00)02126-3; BURGOYNE RD, 1995, TRENDS NEUROSCI, V18, P191, DOI 10.1016/0166-2236(95)93900-I; BURGOYNE RD, 1992, NEUROMETHODS, V20, P433; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Criado M, 1999, P NATL ACAD SCI USA, V96, P7256, DOI 10.1073/pnas.96.13.7256; Elhamdani A, 1999, J NEUROSCI, V19, P7375, DOI 10.1523/JNEUROSCI.19-17-07375.1999; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Finley MFA, 2002, J NEUROSCI, V22, P1266, DOI 10.1523/JNEUROSCI.22-04-01266.2002; Fisher RJ, 2001, SCIENCE, V291, P875, DOI 10.1126/science.291.5505.875; Graham ME, 2000, J NEUROSCI, V20, P1281; Graham ME, 2000, BIOCHIMIE, V82, P469, DOI 10.1016/S0300-9084(00)00196-6; Graham ME, 2001, J CELL SCI, V114, P4397; GRAHAM ME, 2002, IN PRESS P NATL ACAD; Harata N, 2001, TRENDS NEUROSCI, V24, P637, DOI 10.1016/S0166-2236(00)02030-0; Hua SY, 1999, NAT NEUROSCI, V2, P1078, DOI 10.1038/16005; ISHIZUKA T, 1995, BIOCHEM BIOPH RES CO, V213, P1107, DOI 10.1006/bbrc.1995.2241; Itakura M, 1999, BIOCHEM BIOPH RES CO, V265, P691, DOI 10.1006/bbrc.1999.1756; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; LINDAU M, 1995, CURR OPIN CELL BIOL, V7, P509, DOI 10.1016/0955-0674(95)80007-7; Machado JD, 2001, MOL PHARMACOL, V60, P514; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Ono S, 1998, EUR J NEUROSCI, V10, P2143, DOI 10.1046/j.1460-9568.1998.00225.x; Pabst S, 2002, J BIOL CHEM, V277, P7838, DOI 10.1074/jbc.M109507200; Pabst S, 2000, J BIOL CHEM, V275, P19808, DOI 10.1074/jbc.M002571200; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; Schroeder TJ, 1996, BIOPHYS J, V70, P1061, DOI 10.1016/S0006-3495(96)79652-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takahashi S, 1999, EUR J NEUROSCI, V11, P2359, DOI 10.1046/j.1460-9568.1999.00652.x; Tokumaru H, 2001, CELL, V104, P421, DOI 10.1016/S0092-8674(01)00229-X; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4	36	100	104	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					18249	18252		10.1074/jbc.C200166200	http://dx.doi.org/10.1074/jbc.C200166200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11929859	hybrid			2022-12-27	WOS:000175975800002
J	Ren, ZY; Schaefer, TS				Ren, ZY; Schaefer, TS			ErbB-2 activates Stat3 alpha in a Src- and JAK2-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; BREAST-CANCER CELLS; TYROSINE KINASE-ACTIVITY; CONSTITUTIVE ACTIVATION; C-ERBB-2 GENE; NEU ONCOGENE; LUNG-CANCER; TRANSCRIPTION FACTOR; SIGNALING PATHWAYS; STAT ACTIVATION	Stats (signal transducer and activator of transcription) are latent transcription factors that translocate from the cytoplasm to the nucleus. Constitutive activation of Stat3alpha by upstream oncoproteins and receptor tyrosine kinases has been found in many human tumors and tumor-derived cell lines. Constitutively activated Stat3alpha is often correlated with the activation of ErbB-2, a member of the EGFR family. To explore the involvement of ErbB-2 in the activation of Stat3 and the mechanism underlying this event, an ErbB-2 point mutant was used as a model of constitutively activated receptor. Phenylalanine mutations (Y-->F) were made in the autophosphorylation sites of the receptor, and their ability to activate Stat3alpha was evaluated. Our results suggest that Stat3alpha and JAK2 associates with ErbB-2 prior to phosphorylation of the receptor and that full activation of Stat3alpha by ErbB-2 requires the participation of other non-receptor tyrosine kinases. Both Src and Jak2 kinases contribute to the activation of Stat3alpha but Src binds to ErbB-2 only when the receptor is phosphorylated. Our results also suggest that tyrosine 1139 may be important for Src homology 2 domain association because a mutant lacking this tyrosine reduces the ability of the Src homology 2 domain to bind to ErbB-2 and significantly decreases its ability to activate Stat3alpha.	Univ Texas, MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Schaefer, TS (corresponding author), Meso Scale Discovery, 9238 Gaither Rd, Gaithersburg, MD 20877 USA.	tschaefer@meso-scale.com						AKIYAMA T, 1986, SCIENCE, V232, P1644, DOI 10.1126/science.3012781; AKIYAMA T, 1991, MOL CELL BIOL, V11, P833, DOI 10.1128/MCB.11.2.833; Ali MS, 2000, J BIOL CHEM, V275, P15586, DOI 10.1074/jbc.M908931199; BARGMANN CI, 1988, P NATL ACAD SCI USA, V85, P5394, DOI 10.1073/pnas.85.15.5394; BARGMANN CI, 1988, EMBO J, V7, P2043, DOI 10.1002/j.1460-2075.1988.tb03044.x; BECHHARDT RN, 1995, ARCH OTOLARYNGOL, V121, P1265; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Cao XM, 1996, MOL CELL BIOL, V16, P1595; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chakraborty A, 1999, BLOOD, V93, P15, DOI 10.1182/blood.V93.1.15.401a46_15_24; Cirri P, 1997, BIOCHEM BIOPH RES CO, V239, P493, DOI 10.1006/bbrc.1997.7493; COFFER PJ, 1995, BIOCHEM BIOPH RES CO, V210, P74, DOI 10.1006/bbrc.1995.1629; Coqueret O, 2000, J BIOL CHEM, V275, P18794, DOI 10.1074/jbc.M001601200; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DIMARCO E, 1990, MOL CELL BIOL, V10, P3247, DOI 10.1128/MCB.10.6.3247; Fernandes A, 1999, INT J CANCER, V83, P564, DOI 10.1002/(SICI)1097-0215(19991112)83:4<564::AID-IJC20>3.0.CO;2-Q; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; GAZIT A, 1991, J MED CHEM, V34, P1896, DOI 10.1021/jm00110a022; Giani C, 1998, ONCOGENE, V17, P425, DOI 10.1038/sj.onc.1201954; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; HUNG MC, 1992, CANCER LETT, V61, P95, DOI 10.1016/0304-3835(92)90166-S; Karni R, 1999, ONCOGENE, V18, P4654, DOI 10.1038/sj.onc.1202835; Kiuchi N, 1999, J EXP MED, V189, P63, DOI 10.1084/jem.189.1.63; Korpelainen EI, 1999, ONCOGENE, V18, P1, DOI 10.1038/sj.onc.1202288; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lenferink AEG, 2001, CANCER RES, V61, P6583; LUTTRELL DK, 1994, P NATL ACAD SCI USA, V91, P83, DOI 10.1073/pnas.91.1.83; MORIYAMA M, 1991, J UROLOGY, V145, P423, DOI 10.1016/S0022-5347(17)38356-8; NATALI PG, 1994, INT J CANCER, V56, P341, DOI 10.1002/ijc.2910560308; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Olayioye MA, 1999, J BIOL CHEM, V274, P17209, DOI 10.1074/jbc.274.24.17209; Park OK, 1996, P NATL ACAD SCI USA, V93, P13704, DOI 10.1073/pnas.93.24.13704; Park SK, 2001, J CELL BIOL, V154, P1245, DOI 10.1083/jcb.200104025; Sachsenmaier C, 1999, ONCOGENE, V18, P3583, DOI 10.1038/sj.onc.1202694; Schaefer TS, 1997, MOL CELL BIOL, V17, P5307, DOI 10.1128/MCB.17.9.5307; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; SCHLEGEL J, 1993, ACTA NEUROPATHOL, V86, P473; SEGATTO O, 1990, New Biologist, V2, P187; SEGATTO O, 1992, ONCOGENE, V7, P1339; SHI DR, 1992, MOL CARCINOGEN, V5, P213, DOI 10.1002/mc.2940050308; Sinibaldi D, 2000, ONCOGENE, V19, P5419, DOI 10.1038/sj.onc.1203947; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; STOVER DR, 1995, J BIOL CHEM, V270, P15591, DOI 10.1074/jbc.270.26.15591; Tan M, 1997, CANCER RES, V57, P1199; TSAI CM, 1995, J NATL CANCER I, V87, P682, DOI 10.1093/jnci/87.9.682; Vignais ML, 1996, MOL CELL BIOL, V16, P1759; Vignais ML, 1999, MOL CELL BIOL, V19, P3727; Wang YZ, 2000, ONCOGENE, V19, P2075, DOI 10.1038/sj.onc.1203548; WeberNordt RM, 1996, J BIOL CHEM, V271, P27954, DOI 10.1074/jbc.271.44.27954; YU DH, 1991, ONCOGENE, V6, P1991; YU DH, 1994, CANCER RES, V54, P3260; Yu DH, 1998, MOL CELL, V2, P581, DOI 10.1016/S1097-2765(00)80157-4; Yu DH, 1996, ONCOGENE, V13, P1359	56	93	98	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2002	277	41					38486	38493		10.1074/jbc.M112438200	http://dx.doi.org/10.1074/jbc.M112438200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602XK	11940572	hybrid			2022-12-27	WOS:000178529600064
J	Nybakken, KE; Turck, CW; Robbins, DJ; Bishop, JM				Nybakken, KE; Turck, CW; Robbins, DJ; Bishop, JM			Hedgehog-stimulated phosphorylation of the kinesin-related protein Costal2 is mediated by the serine/threonine kinase fused	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEGMENT POLARITY GENE; CUBITUS-INTERRUPTUS PROTEIN; BASAL-CELL CARCINOMAS; DROSOPHILA PATCHED GENE; HUMAN SONIC HEDGEHOG; HUMAN HOMOLOG; IN-VIVO; MOLECULAR-ORGANIZATION; SIGNAL-TRANSDUCTION; MEMBRANE-PROTEIN	The Hedgehog (Hh) signaling molecule is required for the development of numerous tissues in Drosophila. Within the cell, Hh signal transduction utilizes a large protein complex consisting of the Fused (Fu), Costal2 (Cos2), and Cubitis interruptus (Ci) proteins, but the functional interactions between these proteins are still largely uncharacterized. Using a baculovirus system, we demonstrate that the serine/threonine kinase Fu phosphorylates the kinesin-like protein Cos2 when coexpressed with Cos2. Coexpression of Cos2 and a kinase-inactive version of Fu eliminates the majority of Cos2 phosphorylation. We then show that the primary Fu-induced phosphorylation site of Cos2 is serine 572, whereas serine 931 is phosphorylated to a lesser extent. Mutation of serine 572 to alanine eliminates most, but not all, specific phosphopeptides of Cos2 when coexpressed with Fu. We also demonstrate that the phosphorylation pattern of Cos2 produced by baculovirus coexpression with kinase-dead Fu is almost identical to the phosphorylation pattern of Cos2 isolated from unstimulated S2 cells. Finally, the phosphorylation pattern of Cos2 produced by baculovirus coinfection with wildtype Fu is almost identical to that of Cos2 isolated from S2 cells stimulated by Hh, indicating that phosphorylation of serines 572 and 931 is a genuine Hh signaling event. This study clarifies the unique functions of Fu and Cos2 in Hh signal transduction and identifies only the second known phosphorylation site of a kinesin-like molecule.	Univ Calif San Francisco, Hooper Fdn, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Nybakken, KE (corresponding author), Harvard Univ, Sch Med, Dept Genet, Warren Alpert Bldg 412,200 Longwood Ave, Boston, MA 02115 USA.	knybakke@genetics.med.harvard.edu			NATIONAL CANCER INSTITUTE [R35CA044338] Funding Source: NIH RePORTER; NCI NIH HHS [CA44338] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Alexandre C, 1996, GENE DEV, V10, P2003, DOI 10.1101/gad.10.16.2003; Alves G, 1998, MECH DEVELOP, V78, P17, DOI 10.1016/S0925-4773(98)00130-0; Ascano M, 2002, MOL CELL BIOL, V22, P1555, DOI 10.1128/MCB.22.5.1555-1566.2002; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Bakker H, 1997, GLYCOBIOLOGY, V7, P539, DOI 10.1093/glycob/7.4.539; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Blangy A, 1997, J BIOL CHEM, V272, P19418, DOI 10.1074/jbc.272.31.19418; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Case RB, 2000, CURR BIOL, V10, P157, DOI 10.1016/S0960-9822(00)00316-X; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chen Y, 1998, P NATL ACAD SCI USA, V95, P2349, DOI 10.1073/pnas.95.5.2349; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Dominguez M, 1996, SCIENCE, V272, P1621, DOI 10.1126/science.272.5268.1621; Dorner C, 1998, J BIOL CHEM, V273, P20267, DOI 10.1074/jbc.273.32.20267; EATON S, 1990, GENE DEV, V4, P1068, DOI 10.1101/gad.4.6.1068; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; FIETZ MJ, 1994, DEV S, V5, P43; FORBES AJ, 1993, DEV S, V4, P115; Frolova LY, 1998, EUR J BIOCHEM, V256, P36, DOI 10.1046/j.1432-1327.1998.2560036.x; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; Gatti A, 1999, J BIOL CHEM, V274, P8022, DOI 10.1074/jbc.274.12.8022; Giet R, 1999, J BIOL CHEM, V274, P15005, DOI 10.1074/jbc.274.21.15005; Glickman JF, 1997, BIOCHEM BIOPH RES CO, V230, P280, DOI 10.1006/bbrc.1996.5943; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Hepker J, 1997, DEVELOPMENT, V124, P549; HIDALGO A, 1991, MECH DEVELOP, V35, P77, DOI 10.1016/0925-4773(91)90059-F; HOOPER JE, 1989, CELL, V59, P751, DOI 10.1016/0092-8674(89)90021-4; INGHAM PW, 1991, NATURE, V353, P184, DOI 10.1038/353184a0; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kaplan KB, 1997, CELL, V91, P491, DOI 10.1016/S0092-8674(00)80435-3; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; LEE KD, 1995, J BIOL CHEM, V270, P5600, DOI 10.1074/jbc.270.10.5600; Lin RT, 1999, MOL CELL BIOCHEM, V191, P169, DOI 10.1023/A:1006850009017; Lindesmith L, 1997, J BIOL CHEM, V272, P22929, DOI 10.1074/jbc.272.36.22929; Marlowe KJ, 1998, EUR J CELL BIOL, V75, P140, DOI 10.1016/S0171-9335(98)80056-3; MOHLER J, 1992, DEVELOPMENT, V115, P957; MOTZNY CK, 1995, MECH DEVELOP, V52, P137, DOI 10.1016/0925-4773(95)00397-J; NAKANO Y, 1989, NATURE, V341, P508, DOI 10.1038/341508a0; Ohlmeyer JT, 1998, NATURE, V396, P749, DOI 10.1038/25533; OKADA Y, 1995, J NEUROSCI, V15, P3053; ORENIC TV, 1990, GENE DEV, V4, P1053, DOI 10.1101/gad.4.6.1053; Oro AE, 1997, SCIENCE, V276, P817, DOI 10.1126/science.276.5313.817; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; PHAM A, 1995, GENETICS, V140, P587; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; PREAT T, 1992, GENETICS, V132, P725; PREAT T, 1990, NATURE, V347, P87, DOI 10.1038/347087a0; Price MA, 1999, DEVELOPMENT, V126, P4331; Raffel C, 1997, CANCER RES, V57, P842; Reifenberger J, 1998, CANCER RES, V58, P1798; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Rosenberg SJ, 1998, CELL SIGNAL, V10, P131, DOI 10.1016/S0898-6568(97)00117-4; Sisson JC, 1997, CELL, V90, P235, DOI 10.1016/S0092-8674(00)80332-3; Stegman MA, 2000, J BIOL CHEM, V275, P21809, DOI 10.1074/jbc.C000043200; Stempka L, 1999, J BIOL CHEM, V274, P8886, DOI 10.1074/jbc.274.13.8886; TABATA T, 1992, GENE DEV, V6, P2635, DOI 10.1101/gad.6.12b.2635; THEROND P, 1993, MECH DEVELOP, V44, P65, DOI 10.1016/0925-4773(93)90017-R; Therond PP, 1996, P NATL ACAD SCI USA, V93, P4224, DOI 10.1073/pnas.93.9.4224; Vale RD, 1997, ANNU REV CELL DEV BI, V13, P745, DOI 10.1146/annurev.cellbio.13.1.745; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; Wang GL, 1999, GENE DEV, V13, P2828, DOI 10.1101/gad.13.21.2828; Wicking C, 1998, ONCOGENE, V16, P1091, DOI 10.1038/sj.onc.1201644; Witthuhn BA, 1999, LEUKEMIA LYMPHOMA, V32, P289, DOI 10.3109/10428199909167389; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201	74	55	57	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2002	277	27					24638	24647		10.1074/jbc.M110730200	http://dx.doi.org/10.1074/jbc.M110730200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	569PV	11934882	hybrid			2022-12-27	WOS:000176611800088
J	Swinney, DC; Xu, YZ; Scarafia, LE; Lee, I; Mak, AY; Gan, QF; Ramesha, CS; Mulkins, MA; Dunn, J; So, OY; Biegel, T; Dinh, M; Volkel, P; Barnett, J; Dalrymple, SA; Lee, S; Huber, M				Swinney, DC; Xu, YZ; Scarafia, LE; Lee, I; Mak, AY; Gan, QF; Ramesha, CS; Mulkins, MA; Dunn, J; So, OY; Biegel, T; Dinh, M; Volkel, P; Barnett, J; Dalrymple, SA; Lee, S; Huber, M			A small molecule ubiquitination inhibitor blocks NF-kappa B-dependent cytokine expression in cells and rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; SIGNAL-INDUCED UBIQUITINATION; SCF-BETA-TRCP; RHEUMATOID-ARTHRITIS; PROTEASOME PATHWAY; CARRIER PROTEIN; IN-VITRO; PHOSPHORYLATION; DEGRADATION; IDENTIFICATION	A small molecule inhibitor of NF-kappaB-dependent cytokine expression was discovered that blocked tumor necrosis factor (TNF) alpha-induced IkappaBalpha degradation in MM6 cells but not the degradation of beta-catenin in Jurkat cells. Ro106-9920 blocked lipopolysaccharide (LPS)-dependent expression of TNFalpha, interieukin-1beta, and interleukin-6 in fresh human peripheral blood mononuclear cells with IC50 values below 1 muM. Ro106-9920 also blocked TNFalpha production in a dose-dependent manner following oral administration in two acute models of inflammation (air pouch and LPS challenge). Ro106-9920 was observed to inhibit an ubiquitination activity that does not require betaTRCP but associates with IkappaBalpha and will ubiquitinate IkappaBalpha S32E,S36E (IkappaBalphaee) specifically at lysine 21 or 22. Ro106-9920 was identified in a cell-free system as a time-dependent inhibitor of IkappaBalphaee ubiquitination with an IC50 value of 2.3 +/- 0.09 muM. The ubiquitin E3 ligase activity is inhibited by cysteine-alkylating reagents, supported by E2UBCH7, and requires cLAP2 or a cLAP2-associated protein for activity. These activities are inconsistent with what has been reported for SCFbetaTRCP, the putative E3 for IkappaBalpha ubiquitination. Ro106-9920 was observed to be selective for IkappaBalphaee ubiquitination over the ubiquitin-activating enzyme (El), E2UBCH7, nonspecific ubiquitination of cellular proteins, and 97 other molecular targets. We propose that Ro106-9920 selectively inhibits an uncharacterized but essential ubiquitination activity associated with LPS-and TNFalpha-induced IkappaBalpha degradation and NF-kappaB activation.	Roche Biosci, Inflamatory & Viral Dis Unit, Palo Alto, CA 94304 USA	Roche Holding	Swinney, DC (corresponding author), Roche Biosci, Inflamatory & Viral Dis Unit, M-S S3-1, Palo Alto, CA 94304 USA.			VOLKEL, Pamela/0000-0001-8582-1550				ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Baert FJ, 1999, GASTROENTEROLOGY, V116, P22, DOI 10.1016/S0016-5085(99)70224-6; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baldi L, 1996, J BIOL CHEM, V271, P376, DOI 10.1074/jbc.271.1.376; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bannwarth W, 1996, BIOORG MED CHEM LETT, V6, P2141, DOI 10.1016/0960-894X(96)00387-3; Bondeson J, 1999, P NATL ACAD SCI USA, V96, P5668, DOI 10.1073/pnas.96.10.5668; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; EDWARDS JCW, 1981, J PATHOL, V134, P147, DOI 10.1002/path.1711340205; ELLIOTT MJ, 1994, LANCET, V344, P1105, DOI 10.1016/S0140-6736(94)90628-9; Epinat JC, 1999, ONCOGENE, V18, P6896, DOI 10.1038/sj.onc.1203218; EUGUI EM, 1994, INT IMMUNOL, V6, P409, DOI 10.1093/intimm/6.3.409; Gonen H, 1999, J BIOL CHEM, V274, P14823, DOI 10.1074/jbc.274.21.14823; Haas AL, 1997, FASEB J, V11, P1257; HAAS AL, 1988, J BIOL CHEM, V263, P13258; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang HK, 2000, J BIOL CHEM, V275, P26661; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; KIAS EA, 1991, HELV CHIM ACTA, V74, P1314; Kroll M, 1999, J BIOL CHEM, V274, P7941, DOI 10.1074/jbc.274.12.7941; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; LUI P, 2000, SHOCK, V13, P217; Miagkov AV, 1998, P NATL ACAD SCI USA, V95, P13859, DOI 10.1073/pnas.95.23.13859; Moreland LW, 1999, ANN INTERN MED, V130, P478, DOI 10.7326/0003-4819-130-6-199903160-00004; Neurath MF, 1996, NAT MED, V2, P998, DOI 10.1038/nm0996-998; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Rodriguez MS, 1996, ONCOGENE, V12, P2425; SCHERER DC, 1995, P NATL ACAD SCI USA, V92, P11259, DOI 10.1073/pnas.92.24.11259; SEGEL IH, 1975, ENZYME KINETICS, P127; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Strack P, 2000, ONCOGENE, V19, P3529, DOI 10.1038/sj.onc.1203647; SULLIVAN ML, 1991, J BIOL CHEM, V266, P23878; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wilkinson KD, 2000, SEMIN CELL DEV BIOL, V11, P141, DOI 10.1006/scdb.2000.0164; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Yaron A, 1997, EMBO J, V16, P6486, DOI 10.1093/emboj/16.21.6486; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159	48	75	83	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 28	2002	277	26					23573	23581		10.1074/jbc.M200842200	http://dx.doi.org/10.1074/jbc.M200842200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567FX	11950839	hybrid			2022-12-27	WOS:000176475700062
J	Cragg, RA; Christie, GR; Phillips, SR; Russi, RM; Kury, S; Mathers, JC; Taylor, PM; Ford, D				Cragg, RA; Christie, GR; Phillips, SR; Russi, RM; Kury, S; Mathers, JC; Taylor, PM; Ford, D			A novel zinc-regulated human zinc transporter, hZTL1, is localized to the enterocyte apical membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR MTF-1; BRUSH-BORDER MEMBRANE; CELL-LINE CACO-2; SACCHAROMYCES-CEREVISIAE; ACRODERMATITIS-ENTEROPATHICA; FUNCTIONAL EXPRESSION; NATURAL-RESISTANCE; CONFERS RESISTANCE; METAL TRANSPORTER; DIETARY ZINC	Zinc is essential to a wide range of cellular processes; therefore, it is important to elucidate the molecular mechanisms of zinc homeostasis. To date, no zinc transporters expressed at the enterocyte apical membrane, and so essential to mammalian zinc homeostasis, have been discovered. We identified hZTL1 as a human expressed sequence tag with homology to the basolateral enterocyte zinc transporter ZnT1 and deduced the full-length cDNA sequence by PCR. The protein of 523 amino acids belongs to the cation diffusion facilitator family of membrane transporters. Unusually, the predicted topology comprises 12 rather than 6 transmembrane domains. ZTL1 mRNA was detected by reverse transcription-PCR in a range of mouse tissues. A Myc-tagged hZTL1 clone was expressed in transiently transfected polarized human intestinal Caco-2 cells at the apical membrane. Expression of hZTL1 mRNA in Caco-2 cells increased with zinc supplementation of the nutrient medium; however, in the placental cell line JAR hZTL1 appeared not to be regulated by zinc. Heterologous expression of hZTL1 in Xenopus laevis oocytes increased zinc uptake across the plasma membrane. The localization, regulatory properties, and function of hZTL1 indicate a role in regulating the absorption of dietary zinc across the apical enterocyte membrane.	Univ Newcastle, Dept Biol & Nutr Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Newcastle, Human Nutr Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Dundee, Sch Life Sci, Div Mol Physiol, Dundee DD1 5EH, Scotland; Fac Med, ADN, Lab Etud Polymorphisme, F-44035 Nantes, France	Newcastle University - UK; Newcastle University - UK; University of Dundee	Ford, D (corresponding author), Univ Newcastle, Dept Biol & Nutr Sci, Kings Rd, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.		KÜRY, Sébastien/G-5971-2015; Taylor, Peter M/A-4667-2010	KÜRY, Sébastien/0000-0001-5497-0465; Mathers, John/0000-0003-3406-3002	Biotechnology and Biological Sciences Research Council [D18271] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andrews GK, 2001, EMBO J, V20, P1114, DOI 10.1093/emboj/20.5.1114; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; BARNES PM, 1973, P ROY SOC MED, V66, P327, DOI 10.1177/003591577306600411; CONKLIN DS, 1992, MOL CELL BIOL, V12, P3678, DOI 10.1128/MCB.12.9.3678; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; FEI YJ, 1994, NATURE, V368, P563, DOI 10.1038/368563a0; Gaither LA, 2000, J BIOL CHEM, V275, P5560, DOI 10.1074/jbc.275.8.5560; Gaither LA, 2001, J BIOL CHEM, V276, P22258, DOI 10.1074/jbc.M101772200; Goswami T, 2001, BIOCHEM J, V354, P511, DOI 10.1042/0264-6021:3540511; Grotz N, 1998, P NATL ACAD SCI USA, V95, P7220, DOI 10.1073/pnas.95.12.7220; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Huang LP, 1997, NAT GENET, V17, P292, DOI 10.1038/ng1197-292; KAMIZONO A, 1989, MOL GEN GENET, V219, P161, DOI 10.1007/BF00261172; Langmade SJ, 2000, J BIOL CHEM, V275, P34803, DOI 10.1074/jbc.M007339200; Li LT, 2001, J BIOL CHEM, V276, P5036, DOI 10.1074/jbc.M008969200; Liuzzi JP, 2001, J NUTR, V131, P46, DOI 10.1093/jn/131.1.46; LUCAS M, 1983, GUT, V24, P734, DOI 10.1136/gut.24.8.734; McMahon RJ, 1998, P NATL ACAD SCI USA, V95, P4841, DOI 10.1073/pnas.95.9.4841; Milon B, 2001, FEBS LETT, V507, P241, DOI 10.1016/S0014-5793(01)02950-7; Murgia C, 1999, AM J PHYSIOL-GASTR L, V277, pG1231, DOI 10.1152/ajpgi.1999.277.6.G1231; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Palmiter RD, 1996, EMBO J, V15, P1784, DOI 10.1002/j.1460-2075.1996.tb00527.x; PASSMORE R, 1955, BRIT J NUTR, V9, P20, DOI 10.1079/BJN19550006; Paulsen IT, 1997, J MEMBRANE BIOL, V156, P99, DOI 10.1007/s002329900192; Persson B, 1996, PROTEIN SCI, V5, P363; Peter GJ, 1999, BIOCHEM J, V343, P169, DOI 10.1042/0264-6021:3430169; PINTO M, 1983, BIOL CELL, V47, P323; Rogers EE, 2000, P NATL ACAD SCI USA, V97, P12356, DOI 10.1073/pnas.210214197; SOLOVYEV VV, 1994, NUCLEIC ACIDS RES, V22, P5156, DOI 10.1093/nar/22.24.5156; SOLOVYEV VV, 1995, P 3 INT C INT SYST M, P367; TACNET F, 1993, J PHYSIOL-LONDON, V465, P57, DOI 10.1113/jphysiol.1993.sp019666; Tandy S, 2000, J BIOL CHEM, V275, P1023, DOI 10.1074/jbc.275.2.1023; Thwaites DT, 1999, EXP PHYSIOL, V84, P275, DOI 10.1017/S0958067099018436; Van Dokkum W., 1995, Nutrition Research Reviews, V8, P271, DOI 10.1079/NRR19950016; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; Walker D, 1998, J PHYSIOL-LONDON, V507, P697, DOI 10.1111/j.1469-7793.1998.697bs.x; Wang K, 2001, AM J HUM GENET, V68, P1055, DOI 10.1086/319514; Zhao H, 1996, J BIOL CHEM, V271, P23203, DOI 10.1074/jbc.271.38.23203; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454; [No title captured]	47	113	120	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22789	22797		10.1074/jbc.M200577200	http://dx.doi.org/10.1074/jbc.M200577200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11937503	hybrid, Green Accepted			2022-12-27	WOS:000176313600088
J	Mulugeta, S; Gray, JM; Notarfrancesco, KL; Gonzales, LW; Koval, M; Feinstein, SI; Ballard, PL; Fisher, AB; Shuman, H				Mulugeta, S; Gray, JM; Notarfrancesco, KL; Gonzales, LW; Koval, M; Feinstein, SI; Ballard, PL; Fisher, AB; Shuman, H			Identification of LBM180, a lamellar body limiting membrane protein of alveolar type II cells, as the ABC transporter protein ABCA3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-FETAL LUNG; RAT GRANULAR PNEUMOCYTES; FATTY-ACID SYNTHESIS; PULMONARY SURFACTANT; EPITHELIAL-CELLS; HORMONAL-REGULATION; SP-A; MESSENGER-RNA; B DEFICIENCY; BINDING	Lamellar bodies are the specialized secretory organelles of alveolar type II (ATII) epithelial cells through which the cell packages pulmonary surfactant and regulates its secretion. Surfactant within lamellar bodies is densely packed as circular arrays of lipid membranes and appears to be the product of several trafficking and biosynthetic processes. To elucidate these processes, we reported previously on the generation of a monoclonal antibody (3C9) that recognizes a unique protein of the lamellar body membrane of 180 kDa, which we named LBM180. We report that mass spectrometry of the protein precipitated by this antibody generated a partial sequence that is identical to the ATP-binding cassette protein, ABCA3. Homology analysis of partial sequences suggests that this protein is highly conserved among species. The ABCA3 gene transcript was found in cell lines of human lung origin, in ATII cells of human, rat, and mouse, as well as different tissues of rat, but the highest expression of ABCA3 was observed in ATII cells. Expression of this transcript was at its maximum prior to birth, and hormonal induction of ABCA3 transcript was observed in human fetal lung at the same time as other surfactant protein transcripts were induced, suggesting that ABCA3 is developmentally regulated. Molecular and biochemical studies show that ABCA3 is targeted to vesicle membranes and is found in the limiting membrane of lamellar bodies. Because ABCA3 is a member of a subfamily of ABC transporters that are predominantly known to be involved in the regulation of lipid transport and membrane trafficking, we speculate that this protein may play a key role in lipid organization during the formation of lamellar bodies.	Univ Penn, Sch Med, Dept Physiol, Inst Environm Med, Philadelphia, PA 19104 USA; Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Div Neonatol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Shuman, H (corresponding author), Univ Penn, Sch Med, Dept Physiol, Inst Environm Med, 3700 hamilton Walk,Richards Bldg, Philadelphia, PA 19104 USA.		Koval, Michael/C-6366-2015	Koval, Michael/0000-0002-5422-5614	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053566, P01HL019737, T32HL007748] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL019737-270018, P01 HL019737, T32HL-07748, HL-19737, HL-53566] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahn J, 2000, J BIOL CHEM, V275, P20399, DOI 10.1074/jbc.M000555200; Alcorn JL, 1997, AM J RESP CELL MOL, V17, P672, DOI 10.1165/ajrcmb.17.6.2858; BALLARD PL, 1989, ENDOCR REV, V10, P165, DOI 10.1210/edrv-10-2-165; Batenburg JJ, 1998, PROG LIPID RES, V37, P235, DOI 10.1016/S0163-7827(98)00011-3; Batenburg JJ, 1990, PULMONARY PHYSL FETU, P106; Beers MF, 1998, J BIOL CHEM, V273, P15287, DOI 10.1074/jbc.273.24.15287; BEERS MF, 1995, PEDIATR RES, V38, P668, DOI 10.1203/00006450-199511000-00007; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Borst P, 2000, BBA-MOL CELL BIOL L, V1486, P128, DOI 10.1016/S1388-1981(00)00053-6; CHANDER A, 1987, J CLIN INVEST, V79, P1133, DOI 10.1172/JCI112929; CHANDER A, 1983, BIOCHIM BIOPHYS ACTA, V753, P119, DOI 10.1016/0005-2760(83)90105-4; CHEVALIER G, 1972, ANAT RECORD, V174, P289, DOI 10.1002/ar.1091740303; Childs S, 1994, Important Adv Oncol, P21; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; Cockshutt AM, 1992, PULMONARY SURFACTANT, P339; Connors TD, 1997, GENOMICS, V39, P231, DOI 10.1006/geno.1996.4500; CRYSTAL RG, 1999, LUNG, P564; Cutz E, 2000, AM J RESP CRIT CARE, V161, P608, DOI 10.1164/ajrccm.161.2.9905062; DAS DK, 1980, BIOCHEM BIOPH RES CO, V92, P867, DOI 10.1016/0006-291X(80)90783-4; De Vree JML, 1998, P NATL ACAD SCI USA, V95, P282, DOI 10.1073/pnas.95.1.282; Dean M, 2001, J LIPID RES, V42, P1007; DEAN M, 1995, CURR OPIN GENET DEV, V5, P779, DOI 10.1016/0959-437X(95)80011-S; DEMELLO DE, 1994, J PEDIATR-US, V125, P43, DOI 10.1016/S0022-3476(94)70119-9; DEMELLO DE, 1994, AM J RESP CELL MOL, V11, P230, DOI 10.1165/ajrcmb.11.2.8049084; DOBBS LG, 1994, AM J RESP CRIT CARE, V150, pS31, DOI 10.1164/ajrccm/150.5_Pt_2.S31; DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141; Elferink RPJO, 1997, FASEB J, V11, P19, DOI 10.1096/fasebj.11.1.9034162; FISHER AB, 1985, ANNU REV PHYSIOL, V47, P789; Gonzales Linda W., 2001, Pediatric Research, V49, p262A; GONZALES LW, 1990, BIOCHIM BIOPHYS ACTA, V1042, P1, DOI 10.1016/0005-2760(90)90049-4; GONZALES LW, 1994, BBA-LIPID LIPID MET, V1215, P49, DOI 10.1016/0005-2760(94)90090-6; Gonzales LW, 2001, PEDIATR PATHOL MOL M, V20, P387, DOI 10.1080/15513810109168622; HALLMAN M, 1981, J CLIN INVEST, V68, P742, DOI 10.1172/JCI110310; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; HENNING SJ, 1978, AM J PHYSIOL, V235, P451; Hettema EH, 2000, BBA-MOL CELL BIOL L, V1486, P18, DOI 10.1016/S1388-1981(00)00045-7; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; JOBE A, 1981, BIOCHIM BIOPHYS ACTA, V666, P47, DOI 10.1016/0005-2760(81)90089-8; Kaminski WE, 2000, BIOCHEM BIOPH RES CO, V273, P532, DOI 10.1006/bbrc.2000.2954; Klein I, 1999, BBA-BIOMEMBRANES, V1461, P237, DOI 10.1016/S0005-2736(99)00161-3; Klugbauer N, 1996, FEBS LETT, V391, P61, DOI 10.1016/0014-5793(96)00700-4; KRESCH MJ, 1987, CLIN PERINATOL, V14, P481, DOI 10.1016/S0095-5108(18)30747-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; LILEY HG, 1989, J CLIN INVEST, V83, P1191, DOI 10.1172/JCI114000; Luciani MF, 1996, EMBO J, V15, P226, DOI 10.1002/j.1460-2075.1996.tb00353.x; MAGOON MW, 1983, BIOCHIM BIOPHYS ACTA, V750, P18, DOI 10.1016/0005-2760(83)90200-X; MENDELSON CR, 1991, J DEV PHYSIOL, V15, P61; MULLER WJ, 1995, AM J PHYSIOL-LUNG C, V269, pL11, DOI 10.1152/ajplung.1995.269.1.L11; Mulugeta S, 2001, FASEB J, V15, pA496; MULUGETA S, 2000, AM J RESP CRIT CARE, V161, P43; OGASAWARA Y, 1991, BIOCHIM BIOPHYS ACTA, V1083, P252, DOI 10.1016/0005-2760(91)90079-W; POST M, 1988, BIOCHIM BIOPHYS ACTA, V947, P249, DOI 10.1016/0304-4157(88)90011-1; Robinson JM, 2001, HISTOCHEM CELL BIOL, V116, P119; ROONEY SA, 1986, PEDIATR RES, V20, P545, DOI 10.1203/00006450-198606000-00013; ROONEY SA, 1994, FASEB J, V8, P957, DOI 10.1096/fasebj.8.12.8088461; ROONEY SA, 1985, AM REV RESPIR DIS, V131, P439; RYAN RM, 1989, J HISTOCHEM CYTOCHEM, V37, P429, DOI 10.1177/37.4.2926121; RYAN US, 1975, TISSUE CELL, V7, P587, DOI 10.1016/0040-8166(75)90028-2; SA G, 1990, INDIAN J BIOCHEM BIO, V27, P43; Schaller-Bals S, 2000, AM J PHYSIOL-LUNG C, V279, pL631, DOI 10.1152/ajplung.2000.279.4.L631; Schmitz G, 2001, CURR OPIN LIPIDOL, V12, P129, DOI 10.1097/00041433-200104000-00006; Schriml LM, 2000, GENOMICS, V64, P24, DOI 10.1006/geno.1999.6102; SHAPIRO DL, 1978, BIOCHIM BIOPHYS ACTA, V530, P197, DOI 10.1016/0005-2760(78)90005-X; Tryka AF, 2000, PEDIATR DEVEL PATHOL, V3, P335, DOI 10.1007/s100249910048; VANGOLDE LMG, 1995, BIOL NEONATE, V67, P2; VOORHOUT WF, 1992, AM J PHYSIOL, V263, pL479, DOI 10.1152/ajplung.1992.263.4.L479; Wagle S, 1999, AM J PHYSIOL-LUNG C, V277, pL381, DOI 10.1152/ajplung.1999.277.2.L381; WEAVER TE, 1991, BIOCHEM J, V273, P249, DOI 10.1042/bj2730249; WRIGHT JR, 1991, ANNU REV PHYSIOL, V53, P395, DOI 10.1146/annurev.physiol.53.1.395; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5; XIE JX, 1995, J BIOL CHEM, V270, P28084; Yamano G, 2001, FEBS LETT, V508, P221, DOI 10.1016/S0014-5793(01)03056-3; YOUNG SL, 1989, J APPL PHYSIOL, V66, P1336, DOI 10.1152/jappl.1989.66.3.1336; YOUNG SL, 1981, J APPL PHYSIOL, V51, P248, DOI 10.1152/jappl.1981.51.2.248; YOUNG SL, 1993, AM J PHYSIOL, V265, pL19, DOI 10.1152/ajplung.1993.265.1.L19; Zen K, 1998, AM J PHYSIOL-LUNG C, V275, pL172, DOI 10.1152/ajplung.1998.275.1.L172	77	158	162	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22147	22155		10.1074/jbc.M201812200	http://dx.doi.org/10.1074/jbc.M201812200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11940594	hybrid			2022-12-27	WOS:000176313600008
J	Ventura, A; Luzi, L; Pacini, S; Baldari, CT; Pelicci, PG				Ventura, A; Luzi, L; Pacini, S; Baldari, CT; Pelicci, PG			The p66Shc longevity gene is silenced through epigenetic modifications of an alternative promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER CELL-LINES; SIGNALING PATHWAY; DNA METHYLATION; MAMMALIAN BRAIN; MESSENGER-RNA; EGF RECEPTOR; SHC ADAPTER; PROTEIN; EXPRESSION; ACTIVATION	The mammal Shc locus encodes three overlapping isoforms (46, 52, and 66 kDa) that differ in the length of their N-terminal regions. p46/p52Shc and p66Shc have been implicated, respectively, in the cytoplasmic propagation of growth and apoptogenic signals. Levels of p66Shc expression correlate with life span duration in mice. p46Shc and p52Shc are ubiquitously expressed, whereas p66Shc is expressed in a cell lineage-specific fashion. However, the mechanisms underlying the regulation of Shc protein expression are unknown. Here we report the identification of two alternative promoters, driving the transcription of two mRNAs coding for p46/p52Shc and p66Shc. We show that treatment with an inhibitor of histone deacetylases or with a demethylating agent results in induction of p66Shc expression in cells that normally do not express this isoform but leaves the levels of the two other isoforms unchanged. Moreover, analysis of the methylation pattern of the p66Shc promoter in a panel of primary and immortalized human cells showed inverse correlation between p66Shc expression and methylation density of its promoter. These results identify histone deacetylation and cytosine methylation as the mechanisms underlying p66Shc silencing in nonexpressing cells.	European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy; Fdn Italiana Ric Canc, Inst Mol Oncol, I-20139 Milan, Italy; Univ Siena, Dept Evolutionary Biol, I-53100 Siena, Italy	IRCCS European Institute of Oncology (IEO); IFOM - FIRC Institute of Molecular Oncology; University of Siena	Pelicci, PG (corresponding author), European Inst Oncol, Dept Expt Oncol, Via Ripamonti 435, I-20141 Milan, Italy.		Pelicci, Pier Giuseppe/AAL-6572-2020; Luzi, Lucilla/K-4350-2018; Ventura, Andrea/F-1789-2011	Luzi, Lucilla/0000-0002-8746-4179; Ventura, Andrea/0000-0003-4320-9907; Baldari, Cosima/0000-0002-4414-6744				Ahuja N, 1998, CANCER RES, V58, P5489; Ahuja N, 2000, HISTOL HISTOPATHOL, V15, P835, DOI 10.14670/HH-15.835; ANTEQUERA F, 1990, CELL, V62, P503, DOI 10.1016/0092-8674(90)90015-7; Archey WB, 1999, CANCER RES, V59, P2292; Ayoubi TAY, 1996, FASEB J, V10, P453, DOI 10.1096/fasebj.10.4.8647344; Baylin SB, 1998, ADV CANCER RES, V72, P141; Cattaneo E, 1998, TRENDS NEUROSCI, V21, P476, DOI 10.1016/S0166-2236(98)01282-X; CHRETIEN S, 1988, P NATL ACAD SCI USA, V85, P6, DOI 10.1073/pnas.85.1.6; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; COLBERT MC, 1988, DEV BIOL, V130, P392, DOI 10.1016/0012-1606(88)90444-7; Conti L, 1997, P NATL ACAD SCI USA, V94, P8185, DOI 10.1073/pnas.94.15.8185; Conti L, 2001, NAT NEUROSCI, V4, P579, DOI 10.1038/88395; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Dhulipala PDK, 1998, ONCOGENE, V17, P1149, DOI 10.1038/sj.onc.1202030; Flouriot G, 1998, MOL ENDOCRINOL, V12, P1939, DOI 10.1210/me.12.12.1939; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; George CX, 1999, P NATL ACAD SCI USA, V96, P4621, DOI 10.1073/pnas.96.8.4621; ISHIKAWA Y, 1990, J BIOL CHEM, V265, P8458; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; Jackson JG, 2000, CLIN CANCER RES, V6, P1135; Kao AW, 1997, ENDOCRINOLOGY, V138, P2474, DOI 10.1210/en.138.6.2474; Kraus J, 1998, FEBS LETT, V428, P165, DOI 10.1016/S0014-5793(98)00520-1; Lai KMV, 2000, GENE DEV, V14, P1132; Luzi L, 2000, CURR OPIN GENET DEV, V10, P668, DOI 10.1016/S0959-437X(00)00146-5; Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng HH, 1999, CURR OPIN GENET DEV, V9, P158, DOI 10.1016/S0959-437X(99)80024-0; Nolan K, 1999, MOL CELL BIOL, V19, P6120; Okada S, 1997, J BIOL CHEM, V272, P28042, DOI 10.1074/jbc.272.44.28042; Pacini S, 1998, J BIOL CHEM, V273, P20487, DOI 10.1074/jbc.273.32.20487; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Stevenson LE, 1998, BREAST CANCER RES TR, V49, P119, DOI 10.1023/A:1006007227747; Suzuki Y, 2001, GENOME RES, V11, P677, DOI 10.1101/gr.GR-1640R; Xie YM, 1996, BIOCHEM BIOPH RES CO, V221, P140, DOI 10.1006/bbrc.1996.0559	37	140	152	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22370	22376		10.1074/jbc.M200280200	http://dx.doi.org/10.1074/jbc.M200280200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11948181	hybrid			2022-12-27	WOS:000176313600034
J	Yik, JHN; Saxena, A; Weigel, PH				Yik, JHN; Saxena, A; Weigel, PH			The minor subunit splice variants, H2b and H2c, of the human asialoglycoprotein receptor are present with the major subunit H1 in different hetero-oligomeric receptor complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOLATED RAT HEPATOCYTES; GALACTOSYL RECEPTORS; MEMBRANE-PROTEIN; SUBPOPULATION; INACTIVATION; DEGRADATION; MONENSIN; GENES; FORMS; CONSERVATION	The hepatic asialoglycoprotein receptor (ASGP-R) is an endocytic receptor that mediates the internalization of desialylated glycoproteins and their delivery to lysosomes. The human ASGP-R is a hetero-oligomeric complex composed of H1 and H2 subunits. There are three naturally occurring H2 splice variants, designated H2a, H2b, and H2c, although the expression of the H2c protein had not been reported. Following deglycosylation of purified ASGP-R, we detected the H2b and H2c proteins in HepG2 and HuH-7 hepatoma cells, using an antibody directed against a COOH-terminal peptide common to all H2 isoforms (anti-H2-COOH) and another antibody against a 19-amino acid cytoplasmic insert found only in H2b (anti-H2-Cyto19). H1 and both H2b and H2-c were co-purified by affinity chromatography, using asialoorosomucoid (ASOR)-, anti-H1-, or anti-H2-COOH-Sepharose, whereas only H1 and H2b were immunoprecipitated with anti-H2-Cyto19. These results indicate that H2b and Me are not present in the same ASGP-R complexes with H1. Similar to the H2b isoform, H2c was also palmitoylated, indicating that the 19-residue cytoplasmic insert does not regulate palmitoylation. Stably transfected SK-Hep-1 cell lines expressing ASGP-R complexes containing H1 and either H2b or H2c had similar binding affinities for ASOR and endocytosed and degraded ASOR at similar rates. The pH dissociation profiles of ASOR-ASGP-R complexes were also identical for complexes containing either H2b or H2c. We conclude that the H2b and H2c isoforms are both functional but are not present with H1 in the same hetero-oligomeric ASGP-R complexes. This structural difference between two functional subpopulations of ASGP-Rs may provide a molecular basis for the existence of two different pathways, designated State 1 and State 2, by which several types of recycling receptors mediate endocytosis.	Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA; Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Weigel, PH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA.	paul-weigel@ouhsc.edu	Yik, Jasper/C-7343-2009	Yik, Jasper/0000-0001-7532-629X	NIGMS NIH HHS [GM49695] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSEN TT, 1982, J BIOL CHEM, V257, P8036; ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; BAENZIGER JU, 1980, J BIOL CHEM, V255, P4607; Bider MD, 1996, J BIOL CHEM, V271, P31996, DOI 10.1074/jbc.271.50.31996; BISCHOFF J, 1987, J BIOL CHEM, V262, P11825; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREITBART RE, 1987, ANNU REV BIOCHEM, V56, P467, DOI 10.1146/annurev.bi.56.070187.002343; CLARKE BL, 1989, BIOCHEM J, V262, P277, DOI 10.1042/bj2620277; GEFFEN I, 1992, INT REV CYTOL, V137B, P181; HALBERG DF, 1987, J BIOL CHEM, V262, P9828; HAYNES PA, 1994, J BIOL CHEM, V269, P33152; HENIS YI, 1990, J CELL BIOL, V111, P1409, DOI 10.1083/jcb.111.4.1409; HOLLAND EC, 1984, P NATL ACAD SCI-BIOL, V81, P7338, DOI 10.1073/pnas.81.23.7338; Huang TM, 2001, MOL BIOL CELL, V12, p330A; KAWASAKI T, 1976, J BIOL CHEM, V251, P1296; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEDERKREMER GZ, 1991, J BIOL CHEM, V266, P1237; LEE RT, 1987, BIOCHEMISTRY-US, V26, P6320, DOI 10.1021/bi00394a005; LEE RT, 1984, BIOCHEMISTRY-US, V23, P4255, DOI 10.1021/bi00313a037; LEE YC, 1989, CIBA FDN S, V145, P80; LODISH HF, 1991, TRENDS BIOCHEM SCI, V16, P374, DOI 10.1016/0968-0004(91)90154-N; MCABEE DD, 1991, J CELL BIOCHEM, V45, P59, DOI 10.1002/jcb.240450113; MCABEE DD, 1988, BIOCHEMISTRY-US, V27, P2061, DOI 10.1021/bi00406a037; MCABEE DD, 1990, J BIOL CHEM, V265, P629; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; OKA JA, 1983, J BIOL CHEM, V258, P253; OKA JA, 1991, ARCH BIOCHEM BIOPHYS, V289, P362, DOI 10.1016/0003-9861(91)90424-H; PAIETTA E, 1992, HEPATOLOGY, V15, P395, DOI 10.1002/hep.1840150307; PAIETTA E, 1992, J BIOL CHEM, V267, P11078; Pinna LA, 1997, INT J BIOCHEM CELL B, V29, P551, DOI 10.1016/S1357-2725(96)00142-2; SANFORD JP, 1990, BIOCHIM BIOPHYS ACTA, V1087, P259, DOI 10.1016/0167-4781(90)90216-O; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHWARTZ AL, 1984, CRC CR REV BIOCH MOL, V16, P207, DOI 10.3109/10409238409108716; SCHWARTZ AL, 1991, TARGETED DIAGN THER, V1, P3; SHARP PA, 1994, CELL, V77, P805, DOI 10.1016/0092-8674(94)90130-9; Shi XY, 2001, J BIOL CHEM, V276, P2075, DOI 10.1074/jbc.M008583200; SHIA MA, 1989, P NATL ACAD SCI USA, V86, P1158, DOI 10.1073/pnas.86.4.1158; SPIESS M, 1985, P NATL ACAD SCI USA, V82, P6465, DOI 10.1073/pnas.82.19.6465; STOCKERT RJ, 1995, PHYSIOL REV, V75, P591, DOI 10.1152/physrev.1995.75.3.591; STOCKERT RJ, 1995, J BIOL CHEM, V270, P16107, DOI 10.1074/jbc.270.27.16107; STOCKERT RJ, 1990, J BIOL CHEM, V265, P1841; TAKEZAWA R, 1993, BIOCHIM BIOPHYS ACTA, V1172, P220, DOI 10.1016/0167-4781(93)90300-3; Tolchinsky S, 1996, J BIOL CHEM, V271, P14496, DOI 10.1074/jbc.271.24.14496; Weigel P H, 1993, Subcell Biochem, V19, P125; WEIGEL PH, 1982, J BIOL CHEM, V257, P1201; WEIGEL PH, 1994, MOL BIOL CELL, V5, P227, DOI 10.1091/mbc.5.2.227; Weigel PH, 1998, BIOCHEM BIOPH RES CO, V246, P563, DOI 10.1006/bbrc.1998.8491; WEIGEL PH, 1993, J BIOL CHEM, V268, P27186; WEIGEL PH, 1992, GLYCOCONJUGATES COMP, P421; Yik JHN, 2001, GLYCOBIOLOGY, V11, P919; ZENG FY, 1995, J BIOL CHEM, V270, P21388, DOI 10.1074/jbc.270.36.21388; Zeng FY, 1996, BIOCHEM BIOPH RES CO, V218, P325, DOI 10.1006/bbrc.1996.0057; Zeng FY, 1996, J BIOL CHEM, V271, P32454, DOI 10.1074/jbc.271.50.32454	53	24	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					23076	23083		10.1074/jbc.M202748200	http://dx.doi.org/10.1074/jbc.M202748200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11943787	hybrid			2022-12-27	WOS:000176313600123
J	Cappellen, D; Luong-Nguyen, NH; Bongiovanni, S; Grenet, O; Wanke, C; Susa, M				Cappellen, D; Luong-Nguyen, NH; Bongiovanni, S; Grenet, O; Wanke, C; Susa, M			Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of NF kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT BONE-MARROW; FACTOR-I; TYROSINE PHOSPHORYLATION; OSTEOPROTEGERIN LIGAND; HUMAN OSTEOBLASTS; GROWTH-FACTOR; MICE LACKING; C-FOS; RANK; FAMILY	Cytokines macrophage colony stimulating factor (M-CSF) and the receptor activator of NFkappaB ligand (RANKL) induce differentiation of bone marrow hematopoietic precursor cells into bone-resorbing osteoclasts without the requirement for stromal cells of mesenchymal origin. We used this recently described mouse cell system and oligonucleotide microarrays representing about 9,400 different genes to analyze gene expression in hematopoietic cells undergoing differentiation to osteoclasts. The ability of microarrays to detect the genes of interest was validated by showing expression and expected regulation of several osteoclast marker genes. In total 750 known transcripts were up-regulated by greater than or equal to2-fold, and 91% of them at an early time in culture, suggesting that almost the whole differentiation program is defined already in pre-osteoclasts. As expected, M-CSF alone induced the receptor for RANKL (RANK), but also, unexpectedly, other RANK/NFkappaB pathway components (TRAF2A, PI3-kinase, MEKK3, RIPK1), providing a molecular explanation for the synergy of M-CSF and RANKL. Furthermore, interleukins, interferons, and their receptors (IL-1alpha, IL-18, IFN-16, IL-11Ralpha2, IL-6/ 11R gp130, IFNgammaR) were induced by M-CSF. Although interleukins are thought to regulate osteoclasts via modulation of M-CSF and RANKL expression in stromal cells, we showed that a mix of IL-1, IL-6, and IL-11 directly increased the activity of osteoclasts by 8.5-fold. RANKL induced about 70 novel target genes, including chemokines and growth factors (RANTES (regulated on activation, normal T cell expressed and secreted), PDGFalpha, IGF1), histamine, and alpha1A-adrenergic receptors, and three waves of distinct receptors, transcription factors, and signaling molecules. In conclusion, M-CSF induced genes necessary for a direct response to RANKL and interleukins, while RANKL directed a three-stage differentiation program and induced genes for interaction with osteoblasts and immune and nerve cells. Thus, global gene expression suggests a more dynamic role of osteoclasts in bone physiology than previously anticipated.	Novartis Pharma Res, Arthrit & Bone Metab Therapeut Area, CH-4002 Basel, Switzerland; Novartis Pharma Dev, Pharmacogen Area, CH-4002 Basel, Switzerland	Novartis; Novartis	Susa, M (corresponding author), Novartis Pharma Res, Arthrit & Bone Metab Therapeut Area, WKL-125-9-12, CH-4002 Basel, Switzerland.	mira.susa_spring@pharma.novartis.com						Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; ARBER S, 1994, CELL, V79, P221, DOI 10.1016/0092-8674(94)90192-9; Arron JR, 2001, J BIOL CHEM, V276, P30011, DOI 10.1074/jbc.M100414200; Atkins GJ, 2000, BONE, V26, P653, DOI 10.1016/S8756-3282(00)00280-5; BARON R, 1999, PRIMER METABOLIC BON, P3; Battaglino R, 2001, J BONE MINER RES, V16, pS153; Cannons JL, 2001, J IMMUNOL, V167, P1313, DOI 10.4049/jimmunol.167.3.1313; CENTRELLA M, 1990, ENDOCRINOLOGY, V126, P39, DOI 10.1210/endo-126-1-39; Csar XF, 2001, J BIOL CHEM, V276, P26211, DOI 10.1074/jbc.M100213200; Darnay BG, 1998, J BIOL CHEM, V273, P20551, DOI 10.1074/jbc.273.32.20551; David JP, 1998, J BONE MINER RES, V13, P1730, DOI 10.1359/jbmr.1998.13.11.1730; Dobigny C, 1997, J CELL PHYSIOL, V173, P10, DOI 10.1002/(SICI)1097-4652(199710)173:1<10::AID-JCP2>3.3.CO;2-A; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; FELIX R, 1994, J CELL BIOCHEM, V55, P340, DOI 10.1002/jcb.240550311; Fenwick C, 2000, SCIENCE, V287, P869, DOI 10.1126/science.287.5454.869; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; FULLER K, 1995, J IMMUNOL, V154, P6065; HaraIrie F, 1996, BONE, V18, P29, DOI 10.1016/8756-3282(95)00425-4; Hiraoka A, 1997, P NATL ACAD SCI USA, V94, P7577, DOI 10.1073/pnas.94.14.7577; Hofbauer LC, 2000, J BONE MINER RES, V15, P2, DOI 10.1359/jbmr.2000.15.1.2; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Hughes AE, 2000, NAT GENET, V24, P45, DOI 10.1038/71667; Insogna KL, 1997, J CLIN INVEST, V100, P2476, DOI 10.1172/JCI119790; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Jimi E, 1999, J IMMUNOL, V163, P434; Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050; Kim JE, 2000, J CELL BIOCHEM, V77, P169, DOI 10.1002/(SICI)1097-4644(20000501)77:2<169::AID-JCB1>3.0.CO;2-L; Kozawa O, 1997, AM J PHYSIOL-ENDOC M, V272, pE208, DOI 10.1152/ajpendo.1997.272.2.E208; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee SY, 1997, J EXP MED, V185, P1275, DOI 10.1084/jem.185.7.1275; Lesclous P, 1999, CELLS TISSUES ORGANS, V164, P23, DOI 10.1159/000016639; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Li XD, 2000, ENDOCRINOLOGY, V141, P2054, DOI 10.1210/en.141.6.2054; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Luchin A, 2001, J BIOL CHEM, V276, P36703, DOI 10.1074/jbc.M106418200; Matsuo K, 2000, NAT GENET, V24, P184, DOI 10.1038/72855; Miyamoto T, 2000, BLOOD, V96, P4335, DOI 10.1182/blood.V96.13.4335.h8004335_4335_4343; Molkentin JD, 1996, MOL CELL BIOL, V16, P3814; Nomura F, 2000, GENES CELLS, V5, P191; RYSECK RP, 1992, MOL CELL BIOL, V12, P674, DOI 10.1128/MCB.12.2.674; Sato M, 1999, BIOCHEM BIOPH RES CO, V254, P384, DOI 10.1006/bbrc.1998.9918; Schoor M, 1999, MECH DEVELOP, V85, P73, DOI 10.1016/S0925-4773(99)00090-8; Shevde NK, 2000, P NATL ACAD SCI USA, V97, P7829, DOI 10.1073/pnas.130200197; Sobacchi C, 2001, HUM MOL GENET, V10, P1767, DOI 10.1093/hmg/10.17.1767; Steingrimsson E, 1998, MAMM GENOME, V9, P250, DOI 10.1007/s003359900736; Suda T, 1997, METHOD ENZYMOL, V282, P223; SUDA T, 1995, BONE, V17, pS87, DOI 10.1016/8756-3282(95)00185-G; Takahashi N, 1999, BIOCHEM BIOPH RES CO, V256, P449, DOI 10.1006/bbrc.1999.0252; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; TANAKA S, 1993, J CLIN INVEST, V91, P257, DOI 10.1172/JCI116179; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; Togari A, 2000, BRAIN RES, V878, P204, DOI 10.1016/S0006-8993(00)02700-1; Udagawa N, 1997, J EXP MED, V185, P1005, DOI 10.1084/jem.185.6.1005; UTANS U, 1995, J CLIN INVEST, V95, P2954, DOI 10.1172/JCI118003; Wegner M, 2001, TRENDS GENET, V17, P286, DOI 10.1016/S0168-9525(01)02275-2; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; XU LX, 1995, J CELL PHYSIOL, V165, P624, DOI 10.1002/jcp.1041650321; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; ZHANG L, 1991, AM J PHYSIOL, V261, pC348, DOI 10.1152/ajpcell.1991.261.2.C348; Zhang YH, 2001, J BIOL CHEM, V276, P563, DOI 10.1074/jbc.M008198200	61	150	162	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21971	21982		10.1074/jbc.M200434200	http://dx.doi.org/10.1074/jbc.M200434200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11923298	hybrid			2022-12-27	WOS:000176286000110
J	Kainulainen, T; Pender, A; D'Addario, M; Feng, YY; Lekic, P; McCulloch, CA				Kainulainen, T; Pender, A; D'Addario, M; Feng, YY; Lekic, P; McCulloch, CA			Cell death and mechanoprotection by filamin A in connective tissues after challenge by applied tensile forces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING PROTEIN; PERIODONTAL-LIGAMENT; MECHANICAL FORCES; PLASMA-MEMBRANE; STRETCH; EXPRESSION; INTEGRINS; APOPTOSIS; IDENTIFICATION; COMMUNICATION	Cells in mechanically challenged environments must cope with high amplitude forces to maintain cell viability and tissue homeostasis. Currently, force-induced cell death and the identity of mechanoprotective factors are not defined. We examined death in cultured periodontal fibroblasts, connective tissue cells that are exposed to heavy applied forces in vivo. Static tensile forces (0.48 piconewtons/mum(2) cell area) were applied through magnetite beads coated with collagen or bovine serum albumin. There was a time-dependent increase of the percentage of propidium iodide-permeable cells in force-loaded cultures incubated with collagen but not bovine serum albumin beads, indicating a role for integrins. Cells exhibited reduced mitochondrial membrane potential, increased caspase-3 activation, nuclear condensation, terminal deoxy-nucleotidyl transferase nick end labeling staining, and detachment from the culture dish. The caspase-3 inhibitor acetyl-Asp-Glu-Val-Asp-aldehyde reduced detachment 3-fold. There was a rapid (<10-s) decrease in plasma membrane potential after force application, which, in filamin A-deficient melanoma cells, contributed to irreversible cell depolarization. In fibroblast cultures, cells with increased permeability to propidium iodide exhibited similar to 2-fold less filamin A content than impermeable cells. Fibroblasts transfected with antisense filamin A constructs or with filamin A constructs without an actin-binding domain exhibited 2-3-fold increased proportions of dead cells relative to controls. We conclude that high amplitude forces delivered through integrins can promote apoptosis in a proportion of cells and that filamin A confers mechanoprotection by preventing membrane depolarization.	Univ Toronto, Canadian Inst Hlth Res, Grp Matrix Dynam, Toronto, ON M5S 3E2, Canada; Univ Oulu, Dept Prosthet Dent & Stomatognath Physiol, Oulu, Finland; Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA; Univ Manitoba, Fac Dent, Dept Prevent Dent Sci, Winnipeg, MB R3E 0W2, Canada	Institute for Work & Health; University of Toronto; University of Oulu; Harvard University; Beth Israel Deaconess Medical Center; University of Manitoba	McCulloch, CA (corresponding author), Univ Toronto, Canadian Inst Hlth Res, Grp Matrix Dynam, Rm 244,Fitzgerald Bldg,150 Coll St, Toronto, ON M5S 3E2, Canada.	christopher.mcculloch@utoronto.ca		Pender, Alexandra/0000-0001-5912-2457				Affar EB, 2001, J BIOL CHEM, V276, P2935, DOI 10.1074/jbc.M007269200; Berkovitz BKB, 1982, PERIODONTAL LIGAMENT; Bortner CD, 2001, J BIOL CHEM, V276, P4304, DOI 10.1074/jbc.M005171200; Bortner CD, 1997, J BIOL CHEM, V272, P32436, DOI 10.1074/jbc.272.51.32436; Browne KA, 2000, J BIOL CHEM, V275, P39262, DOI 10.1074/jbc.C000622200; CHENG W, 1995, J CLIN INVEST, V96, P2247, DOI 10.1172/JCI118280; Clements KM, 2001, OSTEOARTHR CARTILAGE, V9, P499, DOI 10.1053/joca.2000.0417; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; D'Addario M, 2001, J BIOL CHEM, V276, P31969, DOI 10.1074/jbc.M102715200; Edwards YS, 2000, AM J PHYSIOL-LUNG C, V279, pL1236, DOI 10.1152/ajplung.2000.279.6.L1236; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Glogauer M, 1997, J CELL SCI, V110, P11; Glogauer M, 1998, J BIOL CHEM, V273, P1689, DOI 10.1074/jbc.273.3.1689; Goldspink G, 1999, J ANAT, V194, P323, DOI 10.1046/j.1469-7580.1999.19430323.x; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; HOLEVINSKY KO, 1994, J MEMBRANE BIOL, V137, P59; Hui MZ, 1997, J CELL PHYSIOL, V172, P323, DOI 10.1002/(SICI)1097-4652(199709)172:3<323::AID-JCP6>3.0.CO;2-Q; Jankowski M, 1998, P NATL ACAD SCI USA, V95, P14558, DOI 10.1073/pnas.95.24.14558; Kimoto S, 1999, J PERIODONTAL RES, V34, P235, DOI 10.1111/j.1600-0765.1999.tb02249.x; Ko KS, 2000, J MEMBRANE BIOL, V174, P85, DOI 10.1007/s002320001034; Kobayashi ET, 1999, J DENT RES, V78, P1495, DOI 10.1177/00220345990780090301; Kobayashi Y, 2000, J BONE MINER RES, V15, P1924, DOI 10.1359/jbmr.2000.15.10.1924; Lew AM, 1999, BIOCHEM J, V341, P647, DOI 10.1042/0264-6021:3410647; Loening AM, 2000, ARCH BIOCHEM BIOPHYS, V381, P205, DOI 10.1006/abbi.2000.1988; Matsusaka T, 1999, J CLIN INVEST, V103, P1451, DOI 10.1172/JCI5056; Nguyen L, 1997, J PERIODONTAL RES, V32, P419, DOI 10.1111/j.1600-0765.1997.tb00554.x; PENDER N, 1991, J CELL SCI, V100, P187; ROBERTS WE, 1974, ARCH ORAL BIOL, V19, P17, DOI 10.1016/0003-9969(74)90219-2; RUBIN CT, 1985, CALCIFIED TISSUE INT, V37, P411, DOI 10.1007/BF02553711; Sachs F, 1998, REV PHYSIOL BIOCH P, V132, P1, DOI 10.1007/BFb0004985; SACKIN H, 1995, ANNU REV PHYSIOL, V57, P333, DOI 10.1146/annurev.ph.57.030195.002001; SINGER SJ, 1992, SCIENCE, V255, P1671, DOI 10.1126/science.1313187; Stahlhut M, 2000, MOL BIOL CELL, V11, P325, DOI 10.1091/mbc.11.1.325; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Wang J, 2000, AM J PHYSIOL-HEART C, V279, pH2776, DOI 10.1152/ajpheart.2000.279.6.H2776; Weil M, 1996, J CELL BIOL, V133, P1053, DOI 10.1083/jcb.133.5.1053; Wu Z, 1999, BIOCHEM BIOPH RES CO, V261, P419, DOI 10.1006/bbrc.1999.1057	39	78	79	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21998	22009		10.1074/jbc.M200715200	http://dx.doi.org/10.1074/jbc.M200715200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11909861	hybrid			2022-12-27	WOS:000176286000112
J	McManaman, JL; Bain, DL				McManaman, JL; Bain, DL			Structural and conformational analysis of the oxidase to dehydrogenase conversion of xanthine oxidoreductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIMITED PROTEOLYSIS; O-2-DEPENDENT TYPES; DEPENDENT TYPE; FREE-RADICALS; PURIFICATION; PROTEIN; CLONING; NAD; MECHANISM; CLEAVAGE	Xanthine oxidoreductase (XOR) is a 300-kDa homodimer that can exist as an NAD(+)-dependent dehydrogenase (XD) or as an O-2-dependent oxidase (XO) depending on the oxidation state of its cysteine thiols. Both XD and XO undergo limited cleavage by chymotrypsin and trypsin. Trypsin selectively cleaved both enzyme forms at Lys(184), while chymotrypsin cleaved XD primarily at Met(181) but cleaved XO at Met(181) and at Phe(560). Chymotrypsin, but not trypsin, cleavage also prevented the reductive conversion of XO to XD; thus the region surrounding Phe(560) appears to be important in the interconversion of the two forms. Size exclusion chromatography showed that disulfide bond formation reduced the hydrodynamic volume of the enzyme, and two-dimensional gel electrophoresis of chymotrypsin-digested XO showed significant, disulfide bond-mediated, conformational heterogeneity in the N-terminal third of the enzyme but no evidence of disulfide bonds between the N-terminal and C-terminal regions or between XOR subunits. These results indicate that intrasubunit disulfide bond formation leads to a global conformational change in XOR that results in the exposure of the region surrounding Phe(560). Conformational changes within this region in turn appear to play a critical role in the interconversion between the XD and XO forms of the enzyme.	Univ Colorado, Hlth Sci Ctr, Dept Physiol & Biophys, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmaceut Sci, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	McManaman, JL (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Physiol & Biophys, 4200 E 9th Ave, Denver, CO 80262 USA.	jim.mcmanaman@uchsc.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD038129] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045582] Funding Source: NIH RePORTER; NCI NIH HHS [CA46934] Funding Source: Medline; NHLBI NIH HHS [HL 45582-05AZ] Funding Source: Medline; NICHD NIH HHS [P01CHD38129] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AMAYA Y, 1990, J BIOL CHEM, V265, P14170; APPEL RD, 1996, TRENDS BIOCHEM SCI, V19, P258; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; Berglund L, 1996, J DAIRY SCI, V79, P198, DOI 10.3168/jds.S0022-0302(96)76351-8; Bray RC., 1975, ENZYMES, V12, P299, DOI DOI 10.1016/S1874-6047(08)60229-2; BUCHHEIM W, 1982, NATURWISSENSCHAFTEN, V69, P505, DOI 10.1007/BF00365826; CLARE DA, 1981, ARCH BIOCHEM BIOPHYS, V211, P44, DOI 10.1016/0003-9861(81)90427-6; COUGHLAN MP, 1979, J BIOL CHEM, V254, P694; CROSS CE, 1987, ANN INTERN MED, V107, P526, DOI 10.7326/0003-4819-107-4-526; Enroth C, 2000, P NATL ACAD SCI USA, V97, P10723, DOI 10.1073/pnas.97.20.10723; FONTANA A, 1986, BIOCHEMISTRY-US, V25, P1847, DOI 10.1021/bi00356a001; FREDERIKS WM, 1993, J HISTOCHEM CYTOCHEM, V41, P667, DOI 10.1177/41.5.8468447; Gilbert HF, 1997, J BIOL CHEM, V272, P29399, DOI 10.1074/jbc.272.47.29399; GLATIGNY A, 1995, J BIOL CHEM, V270, P3534, DOI 10.1074/jbc.270.8.3534; HILLE R, 1995, FASEB J, V9, P995, DOI 10.1096/fasebj.9.11.7649415; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; HUNT J, 1992, J BIOL CHEM, V267, P21479; ICHIDA K, 1993, GENE, V133, P279; JARASCH ED, 1981, CELL, V25, P67, DOI 10.1016/0092-8674(81)90232-4; LEE CS, 1987, GENETICS, V116, P55; MASSEY V, 1989, J BIOL CHEM, V264, P10567; Mather IH, 1998, J MAMMARY GLAND BIOL, V3, P259, DOI 10.1023/A:1018711410270; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; McManaman JL, 1996, ARCH BIOCHEM BIOPHYS, V332, P135, DOI 10.1006/abbi.1996.0325; McManaman JL, 1999, ARCH BIOCHEM BIOPHYS, V371, P308, DOI 10.1006/abbi.1999.1432; NAGLER LG, 1976, BIOCHIM BIOPHYS ACTA, V427, P78, DOI 10.1016/0005-2795(76)90287-7; NAKAMURA M, 1982, J BIOCHEM-TOKYO, V92, P1279, DOI 10.1093/oxfordjournals.jbchem.a134046; Nishino T, 1997, J BIOL CHEM, V272, P29859, DOI 10.1074/jbc.272.47.29859; Romao MJ, 1998, STRUCT BOND, V90, P69; SAITO T, 1989, J BIOL CHEM, V264, P10015; SAITO T, 1989, J BIOL CHEM, V264, P15930; SATO A, 1995, J BIOL CHEM, V270, P2818, DOI 10.1074/jbc.270.6.2818; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SOUTHORN PA, 1988, MAYO CLIN PROC, V63, P390, DOI 10.1016/S0025-6196(12)64862-9; STIRPE F, 1969, J BIOL CHEM, V244, P3855; Stryer L., 1988, BIOCHEMISTRY-US; TERAO M, 1992, BIOCHEM J, V283, P863, DOI 10.1042/bj2830863; WAUD WR, 1975, ARCH BIOCHEM BIOPHYS, V169, P695, DOI 10.1016/0003-9861(75)90214-3; WAUD WR, 1976, ARCH BIOCHEM BIOPHYS, V172, P365, DOI 10.1016/0003-9861(76)90088-6; WAUD WR, 1976, ARCH BIOCHEM BIOPHYS, V172, P354, DOI 10.1016/0003-9861(76)90087-4; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2	42	37	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21261	21268		10.1074/jbc.M200828200	http://dx.doi.org/10.1074/jbc.M200828200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11914370	hybrid			2022-12-27	WOS:000176286000020
J	Warnmark, A; Treuter, E; Gustafsson, JA; Hubbard, RE; Brzozowski, AM; Pike, ACW				Warnmark, A; Treuter, E; Gustafsson, JA; Hubbard, RE; Brzozowski, AM; Pike, ACW			Interaction of transcriptional intermediary factor 2 nuclear receptor box peptides with the coactivator binding site of estrogen receptor alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; ER-ALPHA; ACTIVATION; PROTEIN; DOMAIN; BETA; MOTIF; ACETYLTRANSFERASE; COOPERATIVITY; DETERMINANTS	The activation function 2/ligand-dependent interaction between nuclear receptors and their coregulators is mediated by a short consensus motif, the so-called nuclear receptor (NR) box. Nuclear receptors exhibit distinct preferences for such motifs depending both on the bound ligand and on the NR box sequence. To better understand the structural basis of motif recognition, we characterized the interaction between estrogen receptor a and the NR box regions of the p160 coactivator TIF2. We have determined the crystal structures of complexes between the ligand-binding domain of estrogen receptor a and 12-mer peptides from the Box 2 and Box 3 regions of TIF2. Surprisingly, the Box 3 module displays an unexpected binding mode that is distinct from the canonical LXXLL interaction observed in other ligand-binding domain/NR box crystal structures. The peptide is shifted along the coactivator binding site in such a way that the interaction motif becomes LXXLL rather than the classical LXXLL. However, analysis of the binding properties of wild type NR box peptides, as well as mutant peptides designed to probe the Box 3 orientation, suggests that the Box 3 peptide primarily adopts the "classical" LXXLL orientation in solution. These results highlight the potential difficulties in interpretation of protein-protein interactions based on co-crystal structures using short peptide motifs.	Univ York, Dept Chem, Struct Biol Lab, York YO10 5DD, N Yorkshire, England; Karolinska Inst, Novum, Dept Biosci, S-14157 Huddinge, Sweden	University of York - UK; Karolinska Institutet	Pike, ACW (corresponding author), Univ York, Dept Chem, Struct Biol Lab, York YO10 5DD, N Yorkshire, England.			Treuter, Eckardt/0000-0002-4147-8989				Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; ARONICA SM, 1993, MOL ENDOCRINOL, V7, P743, DOI 10.1210/me.7.6.743; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blanco JCG, 1998, GENE DEV, V12, P1638, DOI 10.1101/gad.12.11.1638; Bourguet W, 2000, TRENDS PHARMACOL SCI, V21, P381, DOI 10.1016/S0165-6147(00)01548-0; Bramlett KS, 2001, MOL ENDOCRINOL, V15, P909, DOI 10.1210/me.15.6.909; Brandt ME, 1997, J BIOL CHEM, V272, P4843, DOI 10.1074/jbc.272.8.4843; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Cenni B, 1999, TRENDS ENDOCRIN MET, V10, P41, DOI 10.1016/S1043-2760(98)00121-0; Chang CY, 1999, MOL CELL BIOL, V19, P8226; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Glass CK, 2000, GENE DEV, V14, P121; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hegy GB, 1996, STEROIDS, V61, P367, DOI 10.1016/0039-128X(96)00042-6; Klinge CM, 2000, STEROIDS, V65, P227, DOI 10.1016/S0039-128X(99)00107-5; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li H, 1997, P NATL ACAD SCI USA, V94, P8479, DOI 10.1073/pnas.94.16.8479; Mak HY, 1999, MOL CELL BIOL, V19, P3895; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; NOTIDES AC, 1981, P NATL ACAD SCI-BIOL, V78, P4926, DOI 10.1073/pnas.78.8.4926; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pazin MJ, 1997, CELL, V88, P737, DOI 10.1016/S0092-8674(00)81918-2; Pike ACW, 1999, EMBO J, V18, P4608, DOI 10.1093/emboj/18.17.4608; Sheppard HM, 2001, MOL CELL BIOL, V21, P39, DOI 10.1128/MCB.21.1.39-50.2001; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Takeshita A, 1997, J BIOL CHEM, V272, P27629, DOI 10.1074/jbc.272.44.27629; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Warnmark A, 2001, J BIOL CHEM, V276, P23397, DOI 10.1074/jbc.M011651200; Wong CW, 2001, BIOCHEMISTRY-US, V40, P6756, DOI 10.1021/bi010379h; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922; [No title captured]	42	142	145	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21862	21868		10.1074/jbc.M200764200	http://dx.doi.org/10.1074/jbc.M200764200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11937504	hybrid			2022-12-27	WOS:000176286000096
J	Zhang, MY; Smith, EP; Kuroda, H; Banach, W; Chernausek, SD; Fagin, JA				Zhang, MY; Smith, EP; Kuroda, H; Banach, W; Chernausek, SD; Fagin, JA			Targeted expression of a protease-resistant IGFBP-4 mutant in smooth muscle of transgenic mice results in IGFBP-4 stabilization and smooth muscle hypotrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BINDING PROTEIN-4; GROWTH-FACTOR-I; NEURONAL CELL-LINE; IGF-BINDING; PLASMA-PROTEIN; PROTEOLYTIC ACTIVITY; GENE-EXPRESSION; CLEAVAGE SITE; BONE-CELLS; RAT	The insulin-like growth factor-binding protein 4 (IG-FBP-4), the most abundant IGF-binding protein produced by rodent smooth muscle cells (SMC), is degraded by specific protease(s) potentially releasing IGF-I for local bioactivity. IGFBP-4 protease(s) recognizes basic residues within the midregion of the molecule. We constructed a mutant IGFBP-4 with the cleavage domain substitution 119-KHMAKVRDRSKMK-133 to 119-AAMAAVADASAMA-133. Myc-tagged native and IGFBP-4.7A retained equivalent IGF-I binding affinity. Whereas native IGFBP-4 was cleaved by SMC-conditioned medium, IGFBP-4.7A was completely resistant to proteolysis. To explore the function of the protease-resistant IGFBP-4 in vivo, expression of the mutant and native proteins was targeted to SMC of transgenic mice by means of a smooth muscle a-actin promoter. Transgene expression was confined to SMC-rich tissues in all lines. Bladder and aortic immunoreactive IGFBP-4/transgene mRNA ratios in SMP8-BP4.7A mice were increased by 2- to 4-fold relative to SMP8-BP4 mice, indicating that the IGFBP-4.7A protein was stabilized in vivo. SMP8-BP4.7A mice had lower aortic, bladder, and stomach weight and intestinal length relative to SMP8-BP4 counterparts matched for protein expression by Western blotting. Thus, IGFBP-4.7A results in greater growth inhibition than equivalent levels of native IGFBP-4 in vivo, demonstrating a role for IGFBP-4 proteolysis in the regulation of IGF-I action.	Univ Cincinnati, Coll Med, Vontz Ctr Mol Studies, Div Endocrinol & Metab, Cincinnati, OH 45267 USA; Childrens Hosp, Med Ctr, Div Endocrinol & Metab, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Fagin, JA (corresponding author), Univ Cincinnati, Coll Med, Vontz Ctr Mol Studies, Div Endocrinol & Metab, 3125 Eden Ave, Cincinnati, OH 45267 USA.			, steven/0000-0003-4538-8793	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054216] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK54216] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anwar A, 2000, ARTERIOSCL THROM VAS, V20, P370, DOI 10.1161/01.ATV.20.2.370; ANWAR A, 1994, HYPERTENSION, V24, P679, DOI 10.1161/01.HYP.24.6.679; Bayes-Genis A, 2001, NEW ENGL J MED, V345, P1022, DOI 10.1056/NEJMoa003147; Bayes-Genis A, 2001, ARTERIOSCL THROM VAS, V21, P335, DOI 10.1161/01.ATV.21.3.335; Bayes-Genis A, 2000, CIRC RES, V86, P125, DOI 10.1161/01.RES.86.2.125; Besnard N, 1997, BIOL REPROD, V56, P1050, DOI 10.1095/biolreprod56.4.1050; BOES M, 1992, ENDOCRINOLOGY, V131, P327, DOI 10.1210/en.131.1.327; Busby WH, 2000, J BIOL CHEM, V275, P37638, DOI 10.1074/jbc.M006107200; Byun D, 2000, J CLIN ENDOCR METAB, V85, P373, DOI 10.1210/jc.85.1.373; Byun D, 2001, J ENDOCRINOL, V169, P135, DOI 10.1677/joe.0.1690135; Byun DW, 2001, J CLIN ENDOCR METAB, V86, P847, DOI 10.1210/jc.86.2.847; Chelius D, 2000, GROWTH HORM IGF RES, V10, P360, DOI 10.1054/ghir.2000.0177; CHEN Y, 1995, GROWTH REGULAT, V5, P45; CHERNAUSEK SD, 1995, J BIOL CHEM, V270, P11377, DOI 10.1074/jbc.270.19.11377; CHERNAUSEK SD, 2000, END SOC 82 ANN M TOR, P240; CHEUNG PT, 1991, ENDOCRINOLOGY, V129, P1006, DOI 10.1210/endo-129-2-1006; Clemmons DR, 1998, MOL CELL ENDOCRINOL, V140, P19, DOI 10.1016/S0303-7207(98)00024-0; Conover CA, 1999, J CLIN ENDOCR METAB, V84, P4742, DOI 10.1210/jc.84.12.4742; CONOVER CA, 1995, J BIOL CHEM, V270, P4395, DOI 10.1074/jbc.270.9.4395; Delafontaine P, 1995, CARDIOVASC RES, V30, P825, DOI 10.1016/0008-6363(95)00163-8; GIANNELLANETO D, 1992, CIRC RES, V71, P646, DOI 10.1161/01.RES.71.3.646; Imai Y, 1997, J CLIN INVEST, V100, P2596, DOI 10.1172/JCI119803; KAMYAR A, 1994, CIRC RES, V74, P576, DOI 10.1161/01.RES.74.4.576; KANZAKI S, 1994, ENDOCRINOLOGY, V134, P383, DOI 10.1210/en.134.1.383; Knudtson KL, 2001, ENDOCRINOLOGY, V142, P3749, DOI 10.1210/en.142.9.3749; Laursen LS, 2001, FEBS LETT, V504, P36, DOI 10.1016/S0014-5793(01)02760-0; Lawrence JB, 1999, P NATL ACAD SCI USA, V96, P3149, DOI 10.1073/pnas.96.6.3149; Miyakoshi N, 2001, ENDOCRINOLOGY, V142, P2641, DOI 10.1210/en.142.6.2641; MOHAN S, 1995, J BIOL CHEM, V270, P20424, DOI 10.1074/jbc.270.35.20424; MYERS SE, 1993, ENDOCRINOLOGY, V133, P1525, DOI 10.1210/en.133.4.1525; ORLOWSKI CC, 1989, J CELL PHYSIOL, V139, P469, DOI 10.1002/jcp.1041390304; Overgaard MT, 2000, J BIOL CHEM, V275, P31128, DOI 10.1074/jbc.M001384200; Overgaard MT, 2001, J BIOL CHEM, V276, P21849, DOI 10.1074/jbc.M102191200; PARKER A, 1995, ENDOCRINOLOGY, V136, P2470, DOI 10.1210/en.136.6.2470; Pintar John E., 1995, Progress in Growth Factor Research, V6, P437, DOI 10.1016/0955-2235(95)00029-1; Qin XZ, 1999, J BONE MINER RES, V14, P2079, DOI 10.1359/jbmr.1999.14.12.2079; Qin XZ, 2000, ARCH BIOCHEM BIOPHYS, V379, P209, DOI 10.1006/abbi.2000.1872; Qin XZ, 1998, J BIOL CHEM, V273, P23509, DOI 10.1074/jbc.273.36.23509; Rajah R, 1996, ENDOCRINOLOGY, V137, P2676, DOI 10.1210/en.137.7.2676; Rajaram S, 1997, ENDOCR REV, V18, P801, DOI 10.1210/er.18.6.801; Rees C, 1998, ENDOCRINOLOGY, V139, P4182, DOI 10.1210/en.139.10.4182; Shi ZD, 2000, J BIOL CHEM, V275, P18574, DOI 10.1074/jbc.M002172200; SHIMASAKI S, 1990, MOL ENDOCRINOL, V4, P1451, DOI 10.1210/mend-4-10-1451; Shirokawa JM, 2000, MOL ENDOCRINOL, V14, P1725, DOI 10.1210/me.14.11.1725; Smith EP, 2001, ENDOCRINOLOGY, V142, P4420, DOI 10.1210/en.142.10.4420; Wang JW, 1998, ENDOCRINOLOGY, V139, P2605, DOI 10.1210/en.139.5.2605; Wang JW, 1997, J CLIN INVEST, V100, P1425, DOI 10.1172/JCI119663; ZESIAWSKI W, 2001, EMBO J, V20, P3638	48	45	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21285	21290		10.1074/jbc.M112082200	http://dx.doi.org/10.1074/jbc.M112082200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11923290	hybrid			2022-12-27	WOS:000176286000023
J	Liu, GZ; Pit, LY; Walker, JC; Ronald, PC; Song, WY				Liu, GZ; Pit, LY; Walker, JC; Ronald, PC; Song, WY			Biochemical characterization of the kinase domain of the rice disease resistance receptor-like kinase XA21	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASES; HYPERSENSITIVE RESPONSE; GENE; PTO; PLANT; TOMATO; AVRPTO; AUTOPHOSPHORYLATION; ENCODES	The rice disease resistance gene, Xa21, encodes a receptor kinase-like protein consisting of leucine-rich repeats in the putative extracellular domain and a serine/threonine kinase in the putative intracellular domain. The putative XA21 kinase domain was expressed as maltose-binding and glutathione S-transferase fusion proteins in Escherichia coli. The fusion proteins are capable of autophosphorylation. Phosphoamino acid analysis of the glutathione S-transferase fusion protein indicates that only serine and threonine residues are phosphorylated. The relative phosphorylation rate of the XA21 kinase against increasing enzyme concentrations follows a first-order rather than second-order kinetics, indicating an intramolecular phosphorylation mechanism. Moreover, the active XA21 kinase cannot phosphorylate a kinase-deficient mutant of XA21 kinase. The enzymatic activity of the XA21 kinase in a buffer containing Mn2+ is at least 15 times higher than that with Mg2+. The K-m and V-max of XA21 kinase for ATP are 0.3 mum and 8.4 nmol/mg/min, respectively. Tryptic phosphopeptide mapping reveals that multiple sites on the XA21 kinase are phosphorylated. Finally, our data suggest that the region of XA21 kinase corresponding to the RD kinase activation domain is not phosphorylated, revealing a distinct mode of action compared with the tomato Pto serine/threonine kinase conferring disease resistance.	Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA; Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	State University System of Florida; University of Florida; University of Missouri System; University of Missouri Columbia; University of California System; University of California Davis	Song, WY (corresponding author), Univ Florida, Dept Plant Pathol, 1453 Fifield Hall, Gainesville, FL 32611 USA.		Ronald, Pamela/AAK-7664-2020	Walker, John/0000-0002-2050-1641				Braun DM, 1997, PLANT J, V12, P83, DOI 10.1046/j.1365-313X.1997.12010083.x; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; HORN MA, 1994, BBA-PROTEIN STRUCT M, V1208, P65, DOI 10.1016/0167-4838(94)90160-0; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; LOH YT, 1995, PLANT PHYSIOL, V108, P1735, DOI 10.1104/pp.108.4.1735; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; Oh MH, 2000, PLANT PHYSIOL, V124, P751, DOI 10.1104/pp.124.2.751; Rathjen JP, 1999, EMBO J, V18, P3232, DOI 10.1093/emboj/18.12.3232; RONALD PC, 1992, J BACTERIOL, V174, P1604, DOI 10.1128/jb.174.5.1604-1611.1992; Ronald PC, 1997, PLANT MOL BIOL, V35, P179, DOI 10.1023/A:1005750811983; SchulzeMuth P, 1996, J BIOL CHEM, V271, P26684, DOI 10.1074/jbc.271.43.26684; Sessa G, 2000, EMBO J, V19, P2257, DOI 10.1093/emboj/19.10.2257; Sessa G, 1998, J BIOL CHEM, V273, P15860, DOI 10.1074/jbc.273.25.15860; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; SONG W, 1995, SCIENCE, V270, P661; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Tang XY, 1996, SCIENCE, V274, P2060, DOI 10.1126/science.274.5295.2060; Wang GL, 1998, PLANT CELL, V10, P765, DOI 10.1105/tpc.10.5.765; Xiao SY, 2001, SCIENCE, V291, P118, DOI 10.1126/science.291.5501.118; ZHOU JM, 1995, CELL, V83, P925, DOI 10.1016/0092-8674(95)90208-2	24	58	74	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20264	20269		10.1074/jbc.M110999200	http://dx.doi.org/10.1074/jbc.M110999200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11927577	Green Published, hybrid			2022-12-27	WOS:000176204500023
J	Maekawa, A; Austen, KF; Kanaoka, Y				Maekawa, A; Austen, KF; Kanaoka, Y			Targeted gene disruption reveals the role of cysteinyl leukotriene 1 receptor in the enhanced vascular permeability of mice undergoing acute inflammatory responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PASSIVE CUTANEOUS ANAPHYLAXIS; HUMAN MAST-CELLS; MOLECULAR-CLONING; MEMBRANE-PROTEIN; C-4 SYNTHASE; IN-VIVO; EXPRESSION; 5-LIPOXYGENASE; IDENTIFICATION; ZYMOSAN	The cysteinyl leukotrienes (cysLTs), leukotriene (LT) C-4, LTD4, and LTE4, are proinflammatory lipid mediators generated in the mouse by hematopoietic cells such as macrophages and mast cells. There are two mouse receptors for the cysLTs, CysLT, receptor (CysLT(1)R) and CysLT(2)R, which are 38% homologous and are located on mouse chromosomes X and 14, respectively. To clarify the different roles of the CysLT1R and CysLT2R in inflammatory responses in vivo, we generated CysLT,R-deficient mice by targeted gene disruption. These mice developed normally and were fertile. In an intracellular calcium mobilization assay with fura-2 acetoxymethyl ester, peritoneal macrophages from wild-type littermates, which express both CysLT(1)R and CysLT(2)R, responded substantially to 1 X 10(-6) M LTD4 and slightly to 1 x 10(-6) M LTC4, whereas the macrophages from CysLT(1)R-deficient mice did not respond to either LTD4 or LTC4. Plasma protein extravasation, but not neutrophil infiltration, was significantly reduced in CysLT(1)R-deficient mice subjected to zymosan A-induced peritoneal inflammation. Plasma protein extravasation was also significantly diminished in CysLT(1)R-deficient mice undergoing IgE-mediated passive cutaneous anaphylaxis as compared with the wild-type mice. Thus, the cysLTs generated in vivo by either monocytes/macrophages or mast cells utilize CysLT(1)R for the response of the microvasculature in acute inflammation.	Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kanaoka, Y (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Smith Bldg,Rm 626C,1 Jimmy Fund Way, Boston, MA 02115 USA.	ykanaoka@rics.bwh.harvard.edu			NIAID NIH HHS [AI-31599, AI-36610] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI036610, U01AI031599, U19AI031599] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON ME, 1982, P NATL ACAD SCI-BIOL, V79, P1088, DOI 10.1073/pnas.79.4.1088; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Byrum RS, 1999, J IMMUNOL, V163, P6810; DAHLEN SE, 1980, NATURE, V288, P484, DOI 10.1038/288484a0; DOHERTY NS, 1985, PROSTAGLANDINS, V30, P769, DOI 10.1016/0090-6980(85)90006-1; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; EVANS JF, 1985, BIOCHIM BIOPHYS ACTA, V840, P43, DOI 10.1016/0304-4165(85)90160-6; FEINBERG JG, 1961, NATURE, V191, P712, DOI 10.1038/191712a0; Figueroa DJ, 2001, AM J RESP CRIT CARE, V163, P226, DOI 10.1164/ajrccm.163.1.2003101; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Hsieh FH, 2001, J EXP MED, V193, P123, DOI 10.1084/jem.193.1.123; Hui YQ, 2001, J BIOL CHEM, V276, P47489, DOI 10.1074/jbc.M107556200; INAGAKI N, 1986, INT ARCH ALLER A IMM, V81, P58, DOI 10.1159/000234108; INAGAKI N, 1984, INT ARCH ALLER A IMM, V74, P91, DOI 10.1159/000233523; ISRAEL E, 1990, NEW ENGL J MED, V323, P1740, DOI 10.1056/NEJM199012203232505; Kanaoka Y, 2001, J BIOL CHEM, V276, P22608, DOI 10.1074/jbc.M103562200; Kempuraj D, 1999, BLOOD, V93, P3338, DOI 10.1182/blood.V93.10.3338.410k05_3338_3346; Kirshenbaum AS, 1999, BLOOD, V94, P2333, DOI 10.1182/blood.V94.7.2333.419k30_2333_2342; LAM BK, 1989, J BIOL CHEM, V264, P12885; LAM BK, 1994, P NATL ACAD SCI USA, V91, P7663, DOI 10.1073/pnas.91.16.7663; LEE CW, 1983, IMMUNOLOGY, V48, P27; LEWIS RA, 1990, NEW ENGL J MED, V323, P645; Lynch KR, 1999, NATURE, V399, P789; Maekawa A, 2001, P NATL ACAD SCI USA, V98, P2256, DOI 10.1073/pnas.041624398; MANNING PJ, 1990, NEW ENGL J MED, V323, P1736, DOI 10.1056/NEJM199012203232504; Martin V, 2001, BIOCHEM PHARMACOL, V62, P1193, DOI 10.1016/S0006-2952(01)00774-2; Mellor EA, 2002, J EXP MED, V195, P583, DOI 10.1084/jem.20020044; Mellor EA, 2001, P NATL ACAD SCI USA, V98, P7964, DOI 10.1073/pnas.141221498; Menard G, 2000, AM J RESP CELL MOL, V23, P572, DOI 10.1165/ajrcmb.23.4.4152; MILLER DK, 1990, NATURE, V343, P278, DOI 10.1038/343278a0; Mollerup J, 2001, BBA-GENE STRUCT EXPR, V1517, P455, DOI 10.1016/S0167-4781(00)00271-2; Ogasawara H, 2002, J BIOL CHEM, V277, P18763, DOI 10.1074/jbc.M109447200; Qiu ZH, 1998, J BIOL CHEM, V273, P8203, DOI 10.1074/jbc.273.14.8203; RAO TS, 1994, J PHARMACOL EXP THER, V269, P917; RAZIN E, 1983, J EXP MED, V157, P189, DOI 10.1084/jem.157.1.189; ROUZER CA, 1985, P NATL ACAD SCI USA, V82, P6040, DOI 10.1073/pnas.82.18.6040; ROUZER CA, 1982, J EXP MED, V155, P720, DOI 10.1084/jem.155.3.720; ROUZER CA, 1980, P NATL ACAD SCI-BIOL, V77, P4928, DOI 10.1073/pnas.77.8.4928; Shi ZZ, 2001, MOL CELL BIOL, V21, P5389, DOI 10.1128/MCB.21.16.5389-5395.2001; Sjostrom M, 2001, EUR J BIOCHEM, V268, P2578, DOI 10.1046/j.1432-1327.2001.02142.x; TATE SS, 1978, P NATL ACAD SCI USA, V75, P4806, DOI 10.1073/pnas.75.10.4806; Thivierge M, 2000, J IMMUNOL, V165, P5221, DOI 10.4049/jimmunol.165.9.5221; Thivierge M, 2001, J IMMUNOL, V167, P2855, DOI 10.4049/jimmunol.167.5.2855; WELSCH DJ, 1994, P NATL ACAD SCI USA, V91, P9745, DOI 10.1073/pnas.91.21.9745; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506	46	105	106	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20820	20824		10.1074/jbc.M203163200	http://dx.doi.org/10.1074/jbc.M203163200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11932261	hybrid			2022-12-27	WOS:000176204500092
J	Orr, AW; Pallero, MA; Murphy-Ullrich, JE				Orr, AW; Pallero, MA; Murphy-Ullrich, JE			Thrombospondin stimulates focal adhesion disassembly through G(i)- and phosphoinositide 3-kinase-dependent ERK activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE CALRETICULIN; RECEPTOR-RELATED PROTEIN; EPIDERMAL GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; ENDOTHELIAL-CELLS; KINASE PATHWAYS; BINDING; TENASCIN; PEPTIDES	The matricellular protein thrombospondin (TSP) stimulates stress fiber and focal adhesion disassembly through a sequence (hep I) in its heparin-binding domain. TSP/hep I signals focal adhesion disassembly by binding cell surface calreticulin (CRT) and activating phosphoinositide 3-kinase (PI3K). However, other components of this signaling pathway have not been identified. We now show that TSP induces focal adhesion disassembly through activation of pertussis toxin (PTX)sensitive G proteins and ERK phosphorylation. PTX pretreatment inhibits TSP/hep I-mediated focal adhesion disassembly as well as PI3K activation. In addition, membrane-permeable Galpha(i2)- and Gbetagamma-blocking peptides inhibit hep I-mediated focal adhesion disassembly. Hep I stimulates a transient increase in ERK activation, which is abrogated by both PTX and PI3K inhibitors. Inhibiting ERK activation with MEK inhibitors blocks hep I-mediated focal adhesion disassembly, indicating that ERR activation is required for cytoskeletal reorganization. G protein signals and ERK phosphorylation are induced by TSP binding to cell surface CRT, because CRT null mouse embryonic fibroblasts (MEF) fail to stimulate ERK phosphorylation in response to TSP/hep I treatment. These data show that G(i) protein and ERK, in concert with PI3K, are stimulated by TSP-CRT interactions at the cell surface to induce de-adhesive changes in the cytoskeleton.	Univ Alabama, Cell Adhes & Matrix Res Ctr, Birmingham, AL 35294 USA; Univ Alabama, Dept Pathol, Div Mol & Cellular Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Murphy-Ullrich, JE (corresponding author), Univ Alabama, Cell Adhes & Matrix Res Ctr, VH G038D,1530 3rd Ave S, Birmingham, AL 35294 USA.		Orr, Anthony/P-8927-2015	Orr, Anthony/0000-0002-2377-213X	NHLBI NIH HHS [T 32 HL07918-04, HL44575] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007918, R01HL044575] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AUKHIL I, 1993, J BIOL CHEM, V268, P2542; Berrou E, 2001, J BIOL CHEM, V276, P39303, DOI 10.1074/jbc.M011751200; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; BORNSTEIN P, 1992, FASEB J, V6, P3290, DOI 10.1096/fasebj.6.14.1426766; Boulay F, 1997, ANN NY ACAD SCI, V832, P69, DOI 10.1111/j.1749-6632.1997.tb46238.x; Chang M, 2000, J BIOL CHEM, V275, P7021, DOI 10.1074/jbc.275.10.7021; CHANG MSS, 2000, SCI STKE; Chaudhary A, 2000, CURR BIOL, V10, P551, DOI 10.1016/S0960-9822(00)00475-9; Chen H, 2000, MATRIX BIOL, V19, P597, DOI 10.1016/S0945-053X(00)00107-4; Cho JH, 1999, EUR J BIOCHEM, V266, P878, DOI 10.1046/j.1432-1327.1999.00920.x; Cho JH, 2001, CELL STRESS CHAPERON, V6, P148, DOI 10.1379/1466-1268(2001)006<0148:AOHMCL>2.0.CO;2; CHUNG CY, 1994, J CELL BIOL, V126, P539, DOI 10.1083/jcb.126.2.539; Damaj BB, 1996, J BIOL CHEM, V271, P12783, DOI 10.1074/jbc.271.22.12783; Degryse B, 1999, BLOOD, V94, P649, DOI 10.1182/blood.V94.2.649.414k34_649_662; DUNLEVY JR, 1993, J CELL SCI, V105, P489; Eliceiri BP, 2001, CIRC RES, V89, P1104, DOI 10.1161/hh2401.101084; Frazier WA, 1999, J BIOL CHEM, V274, P8554, DOI 10.1074/jbc.274.13.8554; Gahtan V, 1999, SURGERY, V126, P203, DOI 10.1067/msy.1999.98781; Glading A, 2000, J BIOL CHEM, V275, P2390, DOI 10.1074/jbc.275.4.2390; Gohla A, 1999, J BIOL CHEM, V274, P17901, DOI 10.1074/jbc.274.25.17901; Goicoechea S, 2000, J BIOL CHEM, V275, P36358, DOI 10.1074/jbc.M005951200; GRAY AJ, 1995, J BIOL CHEM, V270, P25602; Greenwood JA, 1998, J BIOL CHEM, V273, P1755, DOI 10.1074/jbc.273.3.1755; Greenwood JA, 1998, MICROSC RES TECHNIQ, V43, P420, DOI 10.1002/(SICI)1097-0029(19981201)43:5<420::AID-JEMT8>3.0.CO;2-B; Greenwood JA, 2000, J CELL BIOL, V150, P627, DOI 10.1083/jcb.150.3.627; Gutkind J.S, 2000, SCI STKE; Hashimoto Y, 2000, J NEUROSCI, V20, P8401, DOI 10.1523/JNEUROSCI.20-22-08401.2000; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; HUTTENLOCHER A, 1995, CURR OPIN CELL BIOL, V7, P697, DOI 10.1016/0955-0674(95)80112-X; Jo H, 1997, J BIOL CHEM, V272, P1395, DOI 10.1074/jbc.272.2.1395; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; MCKENZIE FR, 1988, BIOCHEM J, V249, P653, DOI 10.1042/bj2490653; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Misra UK, 1999, ARCH BIOCHEM BIOPHYS, V372, P238, DOI 10.1006/abbi.1999.1521; Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609; MurphyUllrich JE, 1996, J CELL SCI, V109, P2499; MURPHYULLRICH JE, 1989, J CELL BIOL, V109, P1309, DOI 10.1083/jcb.109.3.1309; MURPHYULLRICH JE, 1993, J BIOL CHEM, V268, P26784; OFFERMANNS S, 1994, MOL PHARMACOL, V45, P890; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Reuveni H, 2000, J CELL BIOL, V151, P1179, DOI 10.1083/jcb.151.6.1179; SAGE EH, 1991, J BIOL CHEM, V266, P14831; Sah VP, 2000, ANNU REV PHARMACOL, V40, P459, DOI 10.1146/annurev.pharmtox.40.1.459; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; SENOGLES SE, 1990, J BIOL CHEM, V265, P4507; Sotsios Y, 2000, IMMUNOL REV, V177, P217, DOI 10.1034/j.1600-065X.2000.17712.x; Suchard SJ, 1996, J CELL PHYSIOL, V168, P217, DOI 10.1002/(SICI)1097-4652(199607)168:1<217::AID-JCP26>3.0.CO;2-2; Sugiura T, 1996, INT J CANCER, V68, P774; Sun HY, 2000, CURR BIOL, V10, P281, DOI 10.1016/S0960-9822(00)00359-6; TAYLOR JM, 1994, CELL SIGNAL, V6, P841, DOI 10.1016/0898-6568(94)90017-5; TETI A, 1992, J AM SOC NEPHROL, V2, P582; Tibbles LA, 1999, CELL MOL LIFE SCI, V55, P1230, DOI 10.1007/s000180050369; Vanhaesebroeck B, 1996, CANCER SURV, V27, P249; Wang XQ, 1999, J CELL BIOL, V147, P389, DOI 10.1083/jcb.147.2.389; Wennstrom S, 1999, MOL CELL BIOL, V19, P4279; WHITE TK, 1995, J BIOL CHEM, V270, P15926, DOI 10.1074/jbc.270.27.15926; Xie H, 1998, J CELL SCI, V111, P615	60	75	77	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20453	20460		10.1074/jbc.M112091200	http://dx.doi.org/10.1074/jbc.M112091200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11923291	hybrid			2022-12-27	WOS:000176204500046
J	Wong, W; Newell, EW; Jugloff, DGM; Jones, OT; Schlichter, LC				Wong, W; Newell, EW; Jugloff, DGM; Jones, OT; Schlichter, LC			Cell surface targeting and clustering interactions between heterologously expressed PSD-95 and the Shal voltage-gated potassium channel, Kv4.2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTSYNAPTIC DENSITY PROTEIN; NMDA RECEPTOR SUBUNITS; K+ CHANNEL; OUTWARD CURRENTS; LOCALIZATION; MEMBRANE; BINDING; FAMILY; DENDRITES; NEURONS	Kv4.2 is a voltage-gated potassium channel that is critical in controlling the excitability of myocytes and neurons. Processes that influence trafficking and surface distribution patterns of Kv4.2 will affect its ability to contribute to cellular functions. The scaffolding/clustering protein PSD-95 regulates trafficking and distribution of several receptors and Shaker family Kv channels. We therefore investigated whether the C-terminal valine-serine-alanine-leucine (VSAL) of Kv4.2 is a novel binding motif for PSD-95. By using co-immunoprecipitation assays, we determined that full-length Kv4.2 and PSD-95 interact when co-expressed in mammalian cell lines. Mutation analysis in this heterologous expression system showed that the VSAL motif of Kv4.2 is necessary for PSD-95 binding. PSD-95 increased the surface expression of Kv4.2 protein and caused it to cluster, as shown by deconvolution microscopy and biotinylation assays. Deleting the C-terminal VSAL motif of Kv4.2 eliminated these effects, as did substituting a palmitoylation-deficient PSD-95 mutant. In addition to these effects of PSD-95 on Kv4.2 distribution, the channel itself promoted redistribution of PSD-95 to the cell surface in the heterologous expression system. This work represents the first evidence that a member of the Shal subfamily of Kv channels can bind to PSD-95, with functional consequences.	Univ Toronto, Hlth Network, Toronto Western Res Inst, Div Cellular & Mol Biol, Toronto, ON M5T 2S8, Canada; Univ Toronto, Dept Pharmacol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Schlichter, LC (corresponding author), Toronto Western Hosp, MC9-415,399 Bathurst St, Toronto, ON M5T 2S8, Canada.	schlicht@uhnres.utoronto.ca	Newell, Evan W/F-9711-2012	Newell, Evan W/0000-0002-2889-243X				Adams JP, 2000, J NEUROCHEM, V75, P2277, DOI 10.1046/j.1471-4159.2000.0752277.x; Alonso G, 1997, NEUROSCIENCE, V77, P617; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Anderson AE, 2000, J BIOL CHEM, V275, P5337, DOI 10.1074/jbc.275.8.5337; Aoki C, 2001, SYNAPSE, V40, P239, DOI 10.1002/syn.1047; Arnold DB, 1999, NEURON, V23, P149, DOI 10.1016/S0896-6273(00)80761-8; Bahring R, 2001, J PHYSIOL-LONDON, V535, P65, DOI 10.1111/j.1469-7793.2001.00065.x; BALDWIN TJ, 1991, NEURON, V7, P471, DOI 10.1016/0896-6273(91)90299-F; Burke NA, 1999, J GEN PHYSIOL, V113, P71, DOI 10.1085/jgp.113.1.71; CARR DW, 1992, J BIOL CHEM, V267, P16816; CHANDY KG, 1995, LIGAND VOLTAGE GATED, P1; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Cooper EC, 1998, J NEUROSCI, V18, P965; Debanne D, 1997, NATURE, V389, P286, DOI 10.1038/38502; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; Fujita A, 2000, BIOCHEM BIOPH RES CO, V269, P1, DOI 10.1006/bbrc.1999.1893; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Hsueh YP, 1999, J BIOL CHEM, V274, P532, DOI 10.1074/jbc.274.1.532; Hu LYA, 2000, J BIOL CHEM, V275, P38659, DOI 10.1074/jbc.M005938200; Inagaki S, 2001, J BIOL CHEM, V276, P9174, DOI 10.1074/jbc.M009051200; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; JACKSON MB, 1991, P NATL ACAD SCI USA, V88, P380, DOI 10.1073/pnas.88.2.380; Jerng HH, 1997, BIOPHYS J, V72, P163, DOI 10.1016/S0006-3495(97)78655-7; Johns DC, 1997, J BIOL CHEM, V272, P31598, DOI 10.1074/jbc.272.50.31598; Jones OT, 1997, J NEUROSCI, V17, P6152; Jugloff DGM, 2000, J BIOL CHEM, V275, P1357, DOI 10.1074/jbc.275.2.1357; Khanna R, 2001, J BIOL CHEM, V276, P34028, DOI 10.1074/jbc.M105248200; Khanna R, 1999, J BIOL CHEM, V274, P14838, DOI 10.1074/jbc.274.21.14838; Kim E, 1996, NEUROPHARMACOLOGY, V35, P993, DOI 10.1016/0028-3908(96)00093-7; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KINGSTON RE, 2001, CURRENT PROTOCOLS MO, V2; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kuryshev YA, 2001, AM J PHYSIOL-CELL PH, V281, pC290, DOI 10.1152/ajpcell.2001.281.1.C290; Li DQ, 2000, J BIOL CHEM, V275, P11597, DOI 10.1074/jbc.275.16.11597; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; MALETICSAVATIC M, 1995, J NEUROSCI, V15, P3840; Martens JR, 2000, J BIOL CHEM, V275, P7443, DOI 10.1074/jbc.275.11.7443; Moyer BD, 2000, J BIOL CHEM, V275, P27069; Nakamura TY, 2001, P NATL ACAD SCI USA, V98, P12808, DOI 10.1073/pnas.221168498; Nakamura TY, 2001, FEBS LETT, V499, P205, DOI 10.1016/S0014-5793(01)02560-1; Nehring RB, 2000, J NEUROSCI, V20, P156, DOI 10.1523/JNEUROSCI.20-01-00156.2000; Niethammer M, 1996, J NEUROSCI, V16, P2157; Nishiyama A, 2001, AM J PHYSIOL-HEART C, V281, pH1800, DOI 10.1152/ajpheart.2001.281.4.H1800; Petersen KR, 1999, PFLUG ARCH EUR J PHY, V437, P381, DOI 10.1007/s004240050792; Petrecca K, 2000, J NEUROSCI, V20, P8736; Roquemore EP, 1998, MOL BIOL CELL, V9, P2125, DOI 10.1091/mbc.9.8.2125; Serodio P, 1998, J NEUROPHYSIOL, V79, P1081, DOI 10.1152/jn.1998.79.2.1081; SERODIO P, 1994, J NEUROPHYSIOL, V72, P1516, DOI 10.1152/jn.1994.72.4.1516; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Takeuchi S, 2000, J MOL CELL CARDIOL, V32, P1361, DOI 10.1006/jmcc.2000.1172; Tiffany AM, 2000, J CELL BIOL, V148, P147, DOI 10.1083/jcb.148.1.147; VARGA AW, 2000, P 30 ANN M SOC NEUR; Wickenden AD, 1999, AM J PHYSIOL-HEART C, V276, pH1599, DOI 10.1152/ajpheart.1999.276.5.H1599; Wong W, 2000, MOL BIOL CELL, V11, p222A; Wong W, 2002, BIOPHYS J, V82, p253A; Xu HD, 1999, J PHYSIOL-LONDON, V519, P11, DOI 10.1111/j.1469-7793.1999.0011o.x; Yeola SW, 1997, CARDIOVASC RES, V33, P540, DOI 10.1016/S0008-6363(96)00221-0; Zhu GY, 1998, J NEUROSCI METH, V81, P73, DOI 10.1016/S0165-0270(98)00019-3; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1; [No title captured]	62	62	66	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20423	20430		10.1074/jbc.M109412200	http://dx.doi.org/10.1074/jbc.M109412200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11923279	hybrid			2022-12-27	WOS:000176204500042
J	Geum, D; Son, GH; Kim, K				Geum, D; Son, GH; Kim, K			Phosphorylation-dependent cellular localization and thermoprotective role of heat shock protein 25 in hippocampal progenitor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; HUMAN HSP27; ACTIN POLYMERIZATION; MOLECULAR CHAPERONES; OXIDATIVE STRESS; BINDING PROTEINS; MAPKAP KINASE-2; RESISTANCE; EXPRESSION; APOPTOSIS	The present study examined phosphorylation-dependent cellular localization and the thermoprotective role of heat shock protein (HSP) 25 in hippocampal HiB5 cells. HSP25 was induced and phosphorylated by heat shock (at 43 degreesC for 3 h). HSP25, which was located in the cytoplasm in the normal condition, translocated into the nucleus after the heat shock. Transfection experiments with hsp27 mutants in which specific serine phosphorylation residues (Ser(78) and Ser(82)) were substituted with alanines or aspartic acids showed that phosphorylation of HSP27 is accompanied by its nuclear translocation. Phosphorylation of mitogen-activated protein kinases (MAPKs) such as p38 MAPK and ERK was markedly increased by the heat shock, and SB203580 (a p38 MAPK kinase inhibitor) and/or PD098059 (a MEK inhibitor) inhibited the phosphorylation of HSP25, indicating that p38 MAPK and ERK are upstream regulators of HSP25 phosphorylation in the heat shock condition. In the absence of heat shock, actin filament stability was not affected by SB203580 and/or PD098059. Heat shock caused disruption of the actin filament and cell death when phosphorylation of HSP25 was inhibited by SB203580 and/or PD098059. In addition, actin filament was more stable in Asp(78,82)-hsp27 (mimics the phosphorylated form) transfected HiB5 cells than in the normal and Ala(78,82)-hsp27 (nonphosphorylative form) transfected cells. In accordance with actin filament stability, the survival rate against the heat shock increased markedly in Asp(15,78,82)-hsp27 expressing HiB5 cells but decreased in Ala(15,78,82)-hsp27 expressing cells. These results support the idea that phosphorylation of HSP25 is critical for the maintenance of actin filament and enhancement of thermoresistance. Interestingly, HSP25 was dephosphorylated and returned to cytoplasm in a recovery time-dependent manner. This phenomenon was accompanied by an increment of apoptotic cell death as determined by nuclear and DNA fragmentation and fluorescence-activated cell sorter analysis. These results suggest that nuclear-translocated HSP25 might function to protect nuclear structure, thereby preventing apoptotic cell death.	Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea	Seoul National University (SNU)	Kim, K (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.	kyungjin@snu.ac.kr						ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; ARRIGO AP, 1991, FEBS LETT, V282, P152, DOI 10.1016/0014-5793(91)80466-G; ARRIGO AP, 1988, MOL CELL BIOL, V8, P5059, DOI 10.1128/MCB.8.12.5059; ARRIGO AP, 1990, MOL CELL BIOL, V10, P1276, DOI 10.1128/MCB.10.3.1276; BENNDORF R, 1994, J BIOL CHEM, V269, P20780; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Clerk A, 1998, BIOCHEM J, V333, P581, DOI 10.1042/bj3330581; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; FROHLI E, 1993, GENE, V128, P273, DOI 10.1016/0378-1119(93)90574-M; Guay J, 1997, J CELL SCI, V110, P357; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; HUOT J, 1991, CANCER RES, V51, P5245; HUOT J, 1995, EUR J BIOCHEM, V227, P416, DOI 10.1111/j.1432-1033.1995.tb20404.x; Huot J, 1996, CANCER RES, V56, P273; Ishikawa Y, 1999, BRAIN RES, V824, P71, DOI 10.1016/S0006-8993(99)01108-7; JAKOB U, 1993, J BIOL CHEM, V268, P1517; KIM YJ, 1984, MOL CELL BIOL, V4, P468, DOI 10.1128/MCB.4.3.468; KNAUF U, 1994, EMBO J, V13, P54, DOI 10.1002/j.1460-2075.1994.tb06234.x; Korber P, 1999, J BIOL CHEM, V274, P249, DOI 10.1074/jbc.274.1.249; Kwon YK, 1997, MOL CELLS, V7, P320; LANDRY J, 1992, J BIOL CHEM, V267, P794; LANDRY J, 1989, J CELL BIOL, V109, P7, DOI 10.1083/jcb.109.1.7; LAVOIE JN, 1993, J BIOL CHEM, V268, P3420; LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505; Loktionova SA, 1996, FEBS LETT, V392, P100, DOI 10.1016/0014-5793(96)00792-2; McEwen BS, 1999, FRONT NEUROENDOCRIN, V20, P49, DOI 10.1006/frne.1998.0173; Mehlen P, 1996, J BIOL CHEM, V271, P16510, DOI 10.1074/jbc.271.28.16510; MIRON T, 1991, J CELL BIOL, V114, P255, DOI 10.1083/jcb.114.2.255; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; PLESOFSKYVIG N, 1992, J MOL EVOL, V35, P537, DOI 10.1007/BF00160214; RENFRANZ PJ, 1991, CELL, V66, P713, DOI 10.1016/0092-8674(91)90116-G; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; Schwarz E, 1996, BIOL CHEM, V377, P411; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; Tan SL, 1998, J NEUROCHEM, V71, P95; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; van de Klundert FAJM, 1998, EUR J CELL BIOL, V75, P38, DOI 10.1016/S0171-9335(98)80044-7; WELCH WJ, 1985, J BIOL CHEM, V260, P3058; Zigmond SH, 1996, CURR OPIN CELL BIOL, V8, P66, DOI 10.1016/S0955-0674(96)80050-0	42	111	115	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19913	19921		10.1074/jbc.M104396200	http://dx.doi.org/10.1074/jbc.M104396200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11912188	hybrid			2022-12-27	WOS:000175894800089
J	Janssen, U; Stoffel, W				Janssen, U; Stoffel, W			Disruption of mitochondrial beta-oxidation of unsaturated fatty acids in the 3,2-trans-enoyl-CoA isomerase-deficient mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEHYDROGENASE BIFUNCTIONAL ENZYME; RAT-LIVER MITOCHONDRIA; ENOYL-COA; 3-CIS-2-TRANS-ENOYL-COA ISOMERASE; MOLECULAR-CLONING; GENE-EXPRESSION; PURIFICATION; IDENTIFICATION; ORGANIZATION; SEQUENCE	Cellular energy metabolism is largely sustained by mitochondrial beta-oxidation of saturated and unsaturated fatty acids. To study the role of unsaturated fatty acids in cellular lipid and energy metabolism we generated a null allelic mouse, deficient in 3,2-trans-enoyl-CoA isomerase (ECI) (eci(-/-) mouse). ECI is the link in mitochondrial beta-oxidation of unsaturated and saturated fatty acids and essential for the complete degradation and for maximal energy yield. Mitochondrial beta-oxidation of unsaturated fatty acids is interrupted in eci(-/-) mice at the level of their respective 3-cis- or 3-trans-enoyl-CoA intermediates. Fasting eci(-/-) mice accumulate unsaturated fatty acyl groups in ester lipids and deposit large amounts of triglycerides in hepatocytes (steatosis). Gene expression studies revealed the induction of peroxisome proliferator-activated receptor activation in eci(-/-) mice together with peroxisomal beta- and microsomal omega-oxidation enzymes. Combined peroxisomal beta- and microsomal omega-oxidation of the 3-enoyl-CoA intermediates leads to a specific pattern of medium chain unsaturated dicarboxylic acids excreted in the urine in high concentration (dicarboxylic aciduria). The urinary dicarboxylate pattern is a reliable diagnostic marker of the ECI genetic defect. The eci(-/-) mouse might be a model of a yet undefined inborn mitochondrial beta-oxidation disorder lacking the enzyme link that channels the intermediates of unsaturated fatty acids into the beta-oxidation spiral of saturated fatty acids.	Univ Cologne, Fac Med, Inst Biochem, Lab Mol Neurosci, D-59031 Cologne, Germany	University of Cologne	Stoffel, W (corresponding author), Univ Cologne, Fac Med, Inst Biochem, Lab Mol Neurosci, Joseph Stelzmannstr 52, D-59031 Cologne, Germany.							AMENDT BA, 1987, J CLIN INVEST, V79, P1303, DOI 10.1172/JCI112953; BENNETT MJ, 1990, ANN CLIN BIOCHEM, V27, P519, DOI 10.1177/000456329002700602; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADLEY A, 1987, PRODUCTION ANAL CHIM, P113; CHONCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156; DIMAURO S, 1973, SCIENCE, V182, P929, DOI 10.1126/science.182.4115.929; EULERBERTRAM S, 1990, BIOL CHEM H-S, V371, P603, DOI 10.1515/bchm3.1990.371.2.603; HARDWICK JP, 1987, J BIOL CHEM, V262, P801; HOGAN B, 1986, MANIPULATING MOUSE E; ISHII N, 1987, J BIOL CHEM, V262, P8144; JANSSEN U, 1994, GENOMICS, V23, P223, DOI 10.1006/geno.1994.1480; KOIVURANTA KT, 1994, BIOCHEM J, V304, P787, DOI 10.1042/bj3040787; KRAHLING JB, 1978, BIOCHEM BIOPH RES CO, V82, P136, DOI 10.1016/0006-291X(78)90587-9; KUNAU WH, 1978, EUR J BIOCHEM, V91, P533, DOI 10.1111/j.1432-1033.1978.tb12707.x; LAZAROW PB, 1976, P NATL ACAD SCI USA, V73, P2043, DOI 10.1073/pnas.73.6.2043; LUO MJ, 1994, J BIOL CHEM, V269, P2384; MULLERNEWEN G, 1991, BIOL CHEM H-S, V372, P613, DOI 10.1515/bchm3.1991.372.2.613; MULLERNEWEN G, 1995, EUR J BIOCHEM, V228, P68, DOI 10.1111/j.1432-1033.1995.tb20230.x; MULLERNEWEN G, 1993, BIOCHEMISTRY-US, V32, P11405; Novikov DK, 1999, ADV EXP MED BIOL, V466, P301; OSUMI T, 1985, J BIOL CHEM, V260, P8905; RACLOT T, 1995, J LIPID RES, V36, P2164; Sambrook J., 2002, MOL CLONING LAB MANU; STOFFEL W, 1978, H-S Z PHYSIOL CHEM, V359, P1777, DOI 10.1515/bchm2.1978.359.2.1777; Stoffel W, 1964, Hoppe Seylers Z Physiol Chem, V339, P167, DOI 10.1515/bchm2.1964.339.1.167; STOFFEL W, 1993, FEBS LETT, V333, P119, DOI 10.1016/0014-5793(93)80387-A; TONTONOZ P, 1995, CURR OPIN GENET DEV, V5, P571, DOI 10.1016/0959-437X(95)80025-5; TSERNG KY, 1991, J BIOL CHEM, V266, P11614; VAMECQ J, 1985, BIOCHEM J, V230, P683, DOI 10.1042/bj2300683; VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703; WANDERS RJA, 1992, BIOCHEM BIOPH RES CO, V188, P1139, DOI 10.1016/0006-291X(92)91350-Y; WOOD PA, 1989, PEDIATR RES, V25, P38, DOI 10.1203/00006450-198901000-00010	32	36	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19579	19584		10.1074/jbc.M110993200	http://dx.doi.org/10.1074/jbc.M110993200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11916962	hybrid			2022-12-27	WOS:000175894800046
J	Sano, H; Liu, SCH; Lane, WS; Piletz, JE; Lienhard, GE				Sano, H; Liu, SCH; Lane, WS; Piletz, JE; Lienhard, GE			Insulin receptor substrate 4 associates with the protein IRAS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; PHOSPHATIDYLINOSITOL 3-KINASE; TYROSINE PHOSPHORYLATION; BINDING-SITES; KINASE; ADIPOCYTES; INTERACTS; ANTISERA; SUBUNIT; CLONING	The insulin receptor substrates (IRSs) are key components in signaling from the insulin receptor, and consequently any proteins that interact with them are expected to participate in insulin signaling. In this study we have searched for proteins that interact with IRS-4 by identifying the proteins that coimmunoprecipitated with IRS-4 from human embryonic kidney 293 cells by microsequencing through mass spectrometry. A group of proteins was found. These included phosphatidylinositol 3-kinase, a protein previously identified as an IRS-4 interactor, and several proteins for which there was no previous evidence of IRS-4 association. One of these proteins, named IRAS, that had been found earlier in another context was examined in detail. The results from the overexpression of IRAS, where its amount was about the same as that of IRS-4, indicated that IRAS associated directly with IRS-4 and showed that the increased complexation of IRS-4 with IRAS did not alter the insulin-stimulated tyrosine phosphorylation of IRS-4 or the association of IRS-4 with phosphatidylinositol 3-kinase or Grb2. On the other hand, overexpression of IRAS enhanced IRS-4-dependent insulin stimulation of the extracellularly regulated kinase. The domains of IRAS and IRS-4 responsible for the association of these two proteins were identified, and it was shown that IRAS also associates with IRS-1, IRS-2, and IRS-3.	Dartmouth Coll Sch Med, Dept Biochem, Hanover, NH 03755 USA; Harvard Univ, Dept Mol & Cellular Biol, Microchem & proteom Anal Facil, Cambridge, MA 02138 USA; Univ Mississippi, Med Ctr, Dept Psychiat, Jackson, MS 39216 USA; Univ Mississippi, Med Ctr, Dept Pharmacol, Jackson, MS 39216 USA; Univ Mississippi, Med Ctr, Dept Physiol, Jackson, MS 39216 USA	Dartmouth College; Harvard University; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Lienhard, GE (corresponding author), Dartmouth Coll Sch Med, Dept Biochem, Vail Bldg, Hanover, NH 03755 USA.			Piletz, John/0000-0002-0053-1587	NIMH NIH HHS [R01 MH049248, MH49248] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049248] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Akimoto K, 1996, EMBO J, V15, P788, DOI 10.1002/j.1460-2075.1996.tb00414.x; Alahari SK, 2000, J CELL BIOL, V151, P1141, DOI 10.1083/jcb.151.6.1141; Algenstaedt PM, 1997, J BIOL CHEM, V272, P23696, DOI 10.1074/jbc.272.38.23696; Bogdan S, 2001, CURR BIOL, V11, pR292, DOI 10.1016/S0960-9822(01)00167-1; Burks DJ, 1998, J BIOL CHEM, V273, P31061, DOI 10.1074/jbc.273.47.31061; Chittum HS, 1998, BIOCHEMISTRY-US, V37, P10866, DOI 10.1021/bi981042r; Craparo A, 1997, J BIOL CHEM, V272, P11663; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fantin VR, 1998, J BIOL CHEM, V273, P10726, DOI 10.1074/jbc.273.17.10726; Farah S, 1998, J BIOL CHEM, V273, P4740, DOI 10.1074/jbc.273.8.4740; Ivanov TR, 1998, J AUTONOM NERV SYST, V72, P98, DOI 10.1016/S0165-1838(98)00094-0; KELLER SR, 1995, J BIOL CHEM, V270, P23612, DOI 10.1074/jbc.270.40.23612; Kosaki A, 1998, J BIOL CHEM, V273, P940, DOI 10.1074/jbc.273.2.940; LAMPHERE L, 1992, ENDOCRINOLOGY, V131, P2196, DOI 10.1210/en.131.5.2196; Munshi HG, 1996, BIOCHEMISTRY-US, V35, P15883, DOI 10.1021/bi962107y; Numan S, 1999, MOL BRAIN RES, V72, P97, DOI 10.1016/S0169-328X(99)00160-6; Ogihara T, 1997, J BIOL CHEM, V272, P25267, DOI 10.1074/jbc.272.40.25267; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Piletz JE, 2000, DNA CELL BIOL, V19, P319, DOI 10.1089/10445490050043290; PILETZ JE, 1993, J PHARMACOL EXP THER, V267, P1493; Qu BH, 1999, J BIOL CHEM, V274, P31179, DOI 10.1074/jbc.274.44.31179; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; Sun XJ, 1996, J BIOL CHEM, V271, P10583, DOI 10.1074/jbc.271.18.10583; Ueno H, 2000, MOL BIOL CELL, V11, P735, DOI 10.1091/mbc.11.2.735; VanRenterghem B, 1998, J BIOL CHEM, V273, P29942, DOI 10.1074/jbc.273.45.29942; White MF, 1998, RECENT PROG HORM RES, V53, P119; Xu GG, 1999, J BIOL CHEM, V274, P18067, DOI 10.1074/jbc.274.25.18067; Yamauchi T, 1998, J BIOL CHEM, V273, P15719, DOI 10.1074/jbc.273.25.15719	30	44	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19439	19447		10.1074/jbc.M111838200	http://dx.doi.org/10.1074/jbc.M111838200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11912194	hybrid			2022-12-27	WOS:000175894800028
J	Teneberg, S; Leonardsson, I; Karlsson, H; Jovall, PA; Angstrom, J; Danielsson, D; Naslund, I; Ljungh, A; Wadstrom, T; Karlsson, KA				Teneberg, S; Leonardsson, I; Karlsson, H; Jovall, PA; Angstrom, J; Danielsson, D; Naslund, I; Ljungh, A; Wadstrom, T; Karlsson, KA			Lactotetraosylceramide, a novel glycosphingolipid receptor for Helicobacter pylori, present in human gastric epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-GROUP ANTIGENS; CHROMATOGRAPHY-MASS-SPECTROMETRY; STRUCTURAL CHARACTERIZATION; GLYCOLIPID RECEPTORS; BINDING-SPECIFICITY; GAS-CHROMATOGRAPHY; DUODENAL MUCOSA; SMALL-INTESTINE; GROUP-A; EXPRESSION	The binding of Helicobacterpylori to glycosphingolipids was examined by binding of S-35-labeled bacteria to glycosphingolipids on thin-layer chromatograms. In addition to previously reported binding specificities, a selective binding to a non-acid tetraglycosylceramide of human meconium was found. This H. pylori binding glycosphingolipid was isolated and, on the basis of mass spectrometry, proton NMR spectroscopy, and degradation studies, were identified as Galbeta3GlcNAcbeta3Galbeta4Glcbeta1Cer (lactotetraosylceramide). When using non-acid glycosphingolipid preparations from human gastric epithelial cells, an identical binding of H. pylori to the tetraglycosylceramide interval was obtained in one of seven samples. Evidence for the presence of lactotetraosylceramide in the binding-active interval was obtained by proton NAIR spectroscopy of intact glycosphingolipids and by gas chromatography-electron ionization mass spectrometry of permethylated tetrasaccharides obtained by ceramide glycanase hydrolysis. The lactotetraosylceramide binding property was detected in 65 of 74 H. pylori isolates (88%). Binding of H. pylori to lactotetraosylceramide on thin-layer chromatograms was inhibited by preincubation with lactotetraose but not with lactose. Removal of the terminal galactose of lactotetraosylceramide by galactosidase hydrolysis abolished the binding as did hydrazinolysis of the acetamido group of the N-acetylglucosamine. Therefore, Galbeta3GlcNAc is an essential part of the binding epitope.	Univ Gothenburg, Inst Med Biochem, SE-40530 Gothenburg, Sweden; Orebro Med Ctr Hosp, Dept Gen Surg, SE-70185 Orebro, Sweden; Orebro Med Ctr Hosp, Dept Clin Microbiol & Immunol, SE-70185 Orebro, Sweden; Lund Univ, Dept Med Microbiol Dermatol & Infect, SE-22362 Lund, Sweden	University of Gothenburg; Lund University	Teneberg, S (corresponding author), Univ Gothenburg, Inst Med Biochem, POB 440, SE-40530 Gothenburg, Sweden.							Angstrom J, 1998, GLYCOBIOLOGY, V8, P297, DOI 10.1093/glycob/8.4.297; ASCENCIO F, 1993, J MED MICROBIOL, V38, P240, DOI 10.1099/00222615-38-4-240; BEACHEY EH, 1981, J INFECT DIS, V143, P325, DOI 10.1093/infdis/143.3.325; BJORK S, 1987, J BIOL CHEM, V262, P6758; BLASCO E, 1991, EUR J CANCER, V27, P501, DOI 10.1016/0277-5379(91)90396-U; BODE G, 1988, SCAND J GASTROENTERO, V23, P25, DOI 10.3109/00365528809091710; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; BREIMER ME, 1980, FEBS LETT, V118, P209, DOI 10.1016/0014-5793(80)80220-1; BREIMER ME, 1980, ADV MASS SPECTROM, V8, P1097; CLARKE CA, 1956, BRIT MED J, V2, P725, DOI 10.1136/bmj.2.4995.725; CLAUSEN H, 1986, J BIOL CHEM, V261, P1380; Cover T. L., 2001, PRINCIPLES BACTERIAL, P509; DICKEY W, 1993, GUT, V34, P351, DOI 10.1136/gut.34.3.351; DOHI T, 1991, J BIOL CHEM, V266, P24038; DOHI T, 1990, J BIOL CHEM, V265, P7880; FALK P, 1993, P NATL ACAD SCI USA, V90, P2035, DOI 10.1073/pnas.90.5.2035; Feldman RA, 2001, HELICOBACTER PYLORI: MOLECULAR AND CELLULAR BIOLOGY, P29; GASA S, 1983, J LIPID RES, V24, P174; HAKOMORI S, 1983, HDB LIPID RES, V3, P1; HANSSON GC, 1985, ANAL BIOCHEM, V146, P158, DOI 10.1016/0003-2697(85)90410-5; HANSSON GC, 1989, BIOCHEMISTRY-US, V28, P6672, DOI 10.1021/bi00442a021; HATTORI H, 1981, BIOCHIM BIOPHYS ACTA, V666, P361, DOI 10.1016/0005-2760(81)90295-2; HENRY S, 1995, VOX SANG, V69, P166, DOI 10.1111/j.1423-0410.1995.tb02591.x; HENRY SM, 1994, GLYCOCONJUGATE J, V11, P600, DOI 10.1007/BF00731312; HOLGERSSON J, 1991, J BIOCHEM-TOKYO, V110, P120, DOI 10.1093/oxfordjournals.jbchem.a123530; HOLMES EH, 1989, ARCH BIOCHEM BIOPHYS, V274, P14, DOI 10.1016/0003-9861(89)90410-4; Huesca M, 1996, INFECT IMMUN, V64, P2643, DOI 10.1128/IAI.64.7.2643-2648.1996; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Kamisago S, 1996, INFECT IMMUN, V64, P624, DOI 10.1128/IAI.64.2.624-628.1996; Karlsson Hasse, 1994, Molecular Biotechnology, V1, P165, DOI 10.1007/BF02921557; Karlsson K A, 1978, Prog Chem Fats Other Lipids, V16, P207, DOI 10.1016/0079-6832(78)90045-9; KARLSSON KA, 1987, METHOD ENZYMOL, V138, P212; KARLSSON KA, 1979, J BIOL CHEM, V254, P9311; KARLSSON KA, 1976, GLYCOLIPID METHODOLO, P97; KOERNER TAW, 1983, BIOCHEMISTRY-US, V22, P2676, DOI 10.1021/bi00280a014; LARSON G, 1987, CARBOHYD RES, V161, P281, DOI 10.1016/S0008-6215(00)90085-5; LEDEEN RW, 1978, RES METHOD NEUROCHEM, V4, P371; LINGWOOD CA, 1992, INFECT IMMUN, V60, P2470, DOI 10.1128/IAI.60.6.2470-2474.1992; MARCUS DM, 1976, P NATL ACAD SCI USA, V73, P3263, DOI 10.1073/pnas.73.9.3263; MAYO SL, 1990, J PHYS CHEM-US, V94, P8897, DOI 10.1021/j100389a010; MENTIS A, 1991, EPIDEMIOL INFECT, V106, P221, DOI 10.1017/S0950268800048366; MillerPodraza H, 1996, GLYCOCONJUGATE J, V13, P453, DOI 10.1007/BF00731478; NATOMI H, 1993, LIPIDS, V28, P737, DOI 10.1007/BF02535996; QUIGLEY EMM, 1987, GASTROENTEROLOGY, V92, P1876, DOI 10.1016/0016-5085(87)90619-6; RAPPE AK, 1991, J PHYS CHEM-US, V95, P3358, DOI 10.1021/j100161a070; ROTTER JI, 1983, PRINCIPLES PRACTICE, P863; SAITOH T, 1991, FEBS LETT, V282, P385, DOI 10.1016/0014-5793(91)80519-9; SAMUELSSON BE, 1990, METHOD ENZYMOL, V193, P623, DOI 10.1016/0076-6879(90)93442-N; STELLNER K, 1973, ARCH BIOCHEM BIOPHYS, V155, P464, DOI 10.1016/0003-9861(73)90138-0; THOMSEN LL, 1990, GUT, V31, P1230, DOI 10.1136/gut.31.11.1230; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Waldi D., 1962, DUNNSCHICHT CHROMATO, P496; YANG HJ, 1971, J BIOL CHEM, V246, P1192	53	40	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19709	19719		10.1074/jbc.M201113200	http://dx.doi.org/10.1074/jbc.M201113200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11914375	Green Published, hybrid			2022-12-27	WOS:000175894800063
J	Shibata, M; Katoh, H; Sonoda, M; Ohkawa, H; Shimoyama, M; Fukuzawa, H; Kaplan, A; Ogawa, T				Shibata, M; Katoh, H; Sonoda, M; Ohkawa, H; Shimoyama, M; Fukuzawa, H; Kaplan, A; Ogawa, T			Genes essential to sodium-dependent bicarbonate transport in cyanobacteria - Function and phylogenetic analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; SP STRAIN PCC-6803; HCO3(-) TRANSPORT; NA+ UPTAKE; PCC 7942; PCC6803; IDENTIFICATION; COTRANSPORTER; INHIBITION; SYMPORT	The cyanobacterium. Synechocystis sp. strain PCC 6803 possesses two CO2 uptake systems and two HCO3- transporters. We transformed a mutant impaired in CO2 uptake and in cmpA-D encoding a HCO3- transporter with a transposon inactivation library, and we recovered mutants unable to take up HCO3- and grow in low CO2 at pH 9.0. They are all tagged within slr1512 (designated sbtA). We show that SbtA-mediated transport is induced by low CO2, requires Na+, and plays the major role in HCO3- uptake in Synechocystis. Inactivation of slr1509 (homologous to ntpJ encoding a Na+/K+-translocating protein) abolished the ability of cells to grow at [Na+] higher than 100 m-m and severely depressed the activity of the SbtA-mediated HCO3- transport. We propose that the SbtA-mediated HCO3- transport is driven by DeltamuNa(+) across the plasma membrane, which is disrupted by inactivating ntpJ. Phylogenetic analyses indicated that two types of sbtA exist in various cyanobacterial strains, all of which possess ntpJ. The sbtA gene is the first one identified as essential to Na+-dependent HCO3- transport in photosynthetic organisms and may play a crucial role in carbon acquisition when CO2 supply is limited, or in Prochlorococcus strains that do not possess CO2 uptake systems or Cmp-dependent HCO3- transport.	Nagoya Univ, Biosci Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan; Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; Hebrew Univ Jerusalem, Dept Plant Sci, IL-91904 Jerusalem, Israel	Nagoya University; Kyoto University; Hebrew University of Jerusalem	Ogawa, T (corresponding author), Nagoya Univ, Biosci Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	ogawater@agr.nagoya-u.ac.jp	Fukuzawa, Hideya/I-5906-2018; Kaplan, Aaron/GLN-5655-2022	Fukuzawa, Hideya/0000-0003-0963-5662; Kaplan, Aaron/0000-0002-0815-5731				AGUSTIN V, 1992, NUCLEIC ACIDS RES, V20, P6331; ALBA H, 1981, J BIOL CHEM, V256, P1905; BLUMWALD E, 1984, BIOCHEM BIOPH RES CO, V122, P452, DOI 10.1016/0006-291X(84)90497-2; Bonfil DJ, 1998, FEBS LETT, V430, P236, DOI 10.1016/S0014-5793(98)00662-0; BROWN II, 1990, FEBS LETT, V270, P203, DOI 10.1016/0014-5793(90)81268-S; Chelly Jamel, 1994, P97; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; ESPIE GS, 1994, PLANT PHYSIOL, V104, P1419, DOI 10.1104/pp.104.4.1419; Hagemann M, 1997, J BACTERIOL, V179, P1727, DOI 10.1128/jb.179.5.1727-1733.1997; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Kaneko T, 1996, DNA Res, V3, P109; Kaplan A, 1999, ANNU REV PLANT PHYS, V50, P539, DOI 10.1146/annurev.arplant.50.1.539; KAPLAN A, 1989, PLANT PHYSIOL, V89, P1220, DOI 10.1104/pp.89.4.1220; Katoh A, 1996, J BACTERIOL, V178, P5452, DOI 10.1128/jb.178.18.5452-5455.1996; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MILLER AG, 1984, J BACTERIOL, V159, P100, DOI 10.1128/JB.159.1.100-106.1984; Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298; OGAWA T, 1991, P NATL ACAD SCI USA, V88, P4275, DOI 10.1073/pnas.88.10.4275; Ohkawa H, 2000, J BIOL CHEM, V275, P31630, DOI 10.1074/jbc.M003706200; Ohkawa H, 2000, J BACTERIOL, V182, P2591, DOI 10.1128/JB.182.9.2591-2596.2000; Omata T, 1999, P NATL ACAD SCI USA, V96, P13571, DOI 10.1073/pnas.96.23.13571; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; REINHOLD L, 1984, PLANT PHYSIOL, V76, P1090, DOI 10.1104/pp.76.4.1090; Ritchie RJ, 1996, PLANT PHYSIOL, V112, P1573, DOI 10.1104/pp.112.4.1573; Romero MF, 1997, NATURE, V387, P409, DOI 10.1038/387409a0; SCHERER S, 1988, PLANT PHYSIOL, V86, P769, DOI 10.1104/pp.86.3.769; Shibata M, 2001, P NATL ACAD SCI USA, V98, P11789, DOI 10.1073/pnas.191258298; So AKC, 1998, CAN J BOT, V76, P1084, DOI 10.1139/b98-071; Soleimani M, 2000, KIDNEY INT, V57, P371, DOI 10.1046/j.1523-1755.2000.00857.x; SoltesRak E, 1997, J BACTERIOL, V179, P769, DOI 10.1128/jb.179.3.769-774.1997; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Takami H, 2000, NUCLEIC ACIDS RES, V28, P4317, DOI 10.1093/nar/28.21.4317; Uozumi N, 2000, PLANT PHYSIOL, V122, P1249, DOI 10.1104/pp.122.4.1249; von Caemmerer S, 2000, ADV PHOTOSYNTHESIS, V9, P399	35	204	211	2	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					18658	18664		10.1074/jbc.M112468200	http://dx.doi.org/10.1074/jbc.M112468200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11904298	hybrid			2022-12-27	WOS:000175975800056
J	Subbaramaiah, K; Norton, L; Gerald, W; Dannenberg, AJ				Subbaramaiah, K; Norton, L; Gerald, W; Dannenberg, AJ			Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer - Evidence for involvement of AP-1 and PEA3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN COLON-CANCER; MAMMARY EPITHELIAL-CELLS; SYNTHASE-2 GENE-EXPRESSION; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; GROWTH-FACTOR; CHEMOPREVENTIVE ACTIVITY; PROSTAGLANDIN E-2; PROMOTER ACTIVITY; TRANSGENIC MICE	Markedly increased levels of cyclooxygenase-2 (COX-2) mRNA, protein, and prostaglandin E-2 synthesis were detected in HER-2/neu-transformed human mammary epithelial cells (184B5/HER) compared with its nontransformed partner cell line (184B5). HER-2/neu stimulated COX-2 transcription via the Ras --> Raf --> MAPK pathway. The inductive effects of HER-2/neu were mediated, in part, by enhanced binding of AP-1 (c-Jun, c-Fos, and ATF-2) to the cyclic AMP-response element (-59/-53) of the COX-2 promoter. The potential contribution of the transcription factor PEA3 was also investigated. Elevated levels of PEA3 were detected in 184B5/HER cells. A PEA3 site (-75/-72) was identified juxtaposed to the cyclic AMP-response element. HER-2/ neu-mediated activation of the COX-2 promoter was blocked by mutagenizing the PEA3 site or overexpressing antisense to PEA3. To determine whether HER-2/neu status was also a determinant of COX-2 expression in vivo, we compared levels of COX-2 protein in HER-2/neupositive and -negative human breast cancers. Increased amounts of COX-2 were detected in HER-2/neu-positive tumors. Taken together, these results suggest that closely spaced PEA3 and cyclic AMP-response elements are required for HER-2/neu-mediated induction of COX-2 transcription. The clear relationship between HER-2/neu status and COX-2 expression in human breast tumors suggests that this mechanism is likely to be operative in vivo.	Cornell Univ, Weill Med Coll, New York Presbyterian Hosp, Dept Med, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Strang Canc Prevent Ctr, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Breast Canc Med Serv, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Cornell University; NewYork-Presbyterian Hospital; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Dannenberg, AJ (corresponding author), Cornell Univ, Weill Med Coll, New York Presbyterian Hosp, Dept Med, Cornell Campus,525 E 68th St,Rm F-206, New York, NY 10021 USA.			Norton, Larry/0000-0003-3701-9250	NCI NIH HHS [R01CA89578, 2P01 CA68425] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA089578, P50CA068425] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baselga J, 1998, CANCER RES, V58, P2825; BENAV P, 1995, FEBS LETT, V372, P83, DOI 10.1016/0014-5793(95)00956-A; Benz CC, 1997, ONCOGENE, V15, P1513, DOI 10.1038/sj.onc.1201331; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Chan G, 1999, CANCER RES, V59, P991; Dannenberg AJ, 2001, LANCET ONCOL, V2, P544, DOI 10.1016/S1470-2045(01)00488-0; Dohadwala M, 2001, J BIOL CHEM, V276, P20809, DOI 10.1074/jbc.C100140200; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Egan KM, 1996, J NATL CANCER I, V88, P988, DOI 10.1093/jnci/88.14.988; Fischer SM, 1999, MOL CARCINOGEN, V25, P231; Gum R, 1996, J BIOL CHEM, V271, P10672, DOI 10.1074/jbc.271.18.10672; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Guy CT, 1996, J BIOL CHEM, V271, P7673, DOI 10.1074/jbc.271.13.7673; Harris RE, 2000, CANCER RES, V60, P2101; Howe LR, 2001, J BIOL CHEM, V276, P20108, DOI 10.1074/jbc.M010692200; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Hwang D, 1998, J NATL CANCER I, V90, P455, DOI 10.1093/jnci/90.6.455; INOUE H, 1995, J BIOL CHEM, V270, P24965, DOI 10.1074/jbc.270.42.24965; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; KARGMAN SL, 1995, CANCER RES, V55, P2556; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kawamori T, 1998, CANCER RES, V58, P409; Kiguchi K, 2001, CANCER RES, V61, P6971; KRAMER B, 1995, J BIOL CHEM, V270, P6577; Kulkarni S, 2001, CLIN CANCER RES, V7, P429; Kutchera W, 1996, P NATL ACAD SCI USA, V93, P4816, DOI 10.1073/pnas.93.10.4816; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LENGYEL E, 1995, J BIOL CHEM, V270, P23007, DOI 10.1074/jbc.270.39.23007; Liu CH, 2001, J BIOL CHEM, V276, P18563, DOI 10.1074/jbc.M010787200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mestre JR, 1997, CANCER RES, V57, P1081; MOSS M, 2001, GASTROENTEROLOGY, V120, P1713; OHagan RC, 1996, ONCOGENE, V13, P1323; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; PANKOV R, 1994, P NATL ACAD SCI USA, V91, P873, DOI 10.1073/pnas.91.3.873; PARETT ML, 1997, INT J ONCOL, V10, P503; Petit AMV, 1997, AM J PATHOL, V151, P1523; PIERCE JH, 1991, ONCOGENE, V6, P1189; Press MF, 1997, J CLIN ONCOL, V15, P2894, DOI 10.1200/JCO.1997.15.8.2894; Reese DM, 1997, STEM CELLS, V15, P1, DOI 10.1002/stem.150001; Ristimaki A, 1997, CANCER RES, V57, P1276; Sawaoka H, 1998, AM J PHYSIOL-GASTR L, V274, pG1061, DOI 10.1152/ajpgi.1998.274.6.G1061; SCHREINEMACHERS DM, 1994, EPIDEMIOLOGY, V5, P138, DOI 10.1097/00001648-199403000-00003; SESHADRI R, 1993, J CLIN ONCOL, V11, P1936, DOI 10.1200/JCO.1993.11.10.1936; Sheng HM, 1998, CANCER RES, V58, P362; Sheng HM, 2001, J BIOL CHEM, V276, P18075, DOI 10.1074/jbc.M009689200; Sheng HM, 1997, J CLIN INVEST, V99, P2254, DOI 10.1172/JCI119400; Shepherd T, 2001, J MAMMARY GLAND BIOL, V6, P129, DOI 10.1023/A:1009576801226; Shepherd TG, 2001, CURR BIOL, V11, P1739, DOI 10.1016/S0960-9822(01)00536-X; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; STAMPFER MR, 1985, P NATL ACAD SCI USA, V82, P2394, DOI 10.1073/pnas.82.8.2394; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; Subbaramaiah K, 2001, J BIOL CHEM, V276, P12440, DOI 10.1074/jbc.M007237200; Subbaramaiah K, 1996, CANCER RES, V56, P4424; TIANO H, 1997, P AM ASSOC CANC RES, V38, P1727; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TREMBLE P, 1995, J CELL BIOL, V129, P1707, DOI 10.1083/jcb.129.6.1707; Tsujii M, 1997, P NATL ACAD SCI USA, V94, P3336, DOI 10.1073/pnas.94.7.3336; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Vadlamudi R, 1999, ONCOGENE, V18, P305, DOI 10.1038/sj.onc.1202307; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Williams CS, 2000, J CLIN INVEST, V105, P1589, DOI 10.1172/JCI9621; XIE WL, 1995, J BIOL CHEM, V270, P27622, DOI 10.1074/jbc.270.46.27622; Xie WL, 1996, J BIOL CHEM, V271, P31742, DOI 10.1074/jbc.271.49.31742	68	276	294	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					18649	18657		10.1074/jbc.M111415200	http://dx.doi.org/10.1074/jbc.M111415200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11901151	hybrid			2022-12-27	WOS:000175975800055
J	Konstas, AA; Dabrowski, M; Korbmacher, C; Tucker, SJ				Konstas, AA; Dabrowski, M; Korbmacher, C; Tucker, SJ			Intrinsic sensitivity of Kir1.1 (ROMK) to glibenclamide in the absence of SUR2B - Implications for the identity of the renal ATP-regulated secretory K+ channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFONYLUREA RECEPTOR; POTASSIUM-CHANNEL; EXPRESSION; DETERMINES; SUBUNIT; KIDNEY; STOICHIOMETRY; ASSOCIATION; TRANSPORTER; INHIBITION	The precise molecular identity of the renal ATP-regulated secretory K+ channel is still a matter of some controversy. The inwardly rectifying K+ channel, Kir1.1 (ROMK) appears to form the pore of the channel, and mutations in Kir1.1 are responsible for Bartter syndrome. The native channel is sensitive to inhibition by the sulfonylurea glibenclamide, and it has been proposed that an accessory protein is required to confer glibenclamide sensitivity to Kir1.1. Several recent studies have suggested that the native channel is composed of the splice variant Kir1.1b (ROMK2) and the sulfonylurea receptor isoform. SUR2B and that there is a direct physical interaction between these subunits. In this study, we have monitored the interaction between Kir1.1b and SUR2B. We find that SUR2B reaches the plasma membrane when coexpressed with Kir6.1 or Kir6.2 but not when coexpressed with Kir1.1b. Furthermore, we find that Kir1.1b exhibits an intrinsic sensitivity to inhibition by glibenclamide with an affinity similar to the native channel. These results demonstrate that SUR2B does not traffic to the membrane in the presence of Kir1.1b and is not required to confer glibenclamide sensitivity to Kir1.1b. This has important implications for the presumed structure of the renal ATP-regulated secretory K+ channel.	Univ Oxford, Physiol Lab, Oxford OX1 3PT, England	University of Oxford	Tucker, SJ (corresponding author), Univ Oxford, Physiol Lab, Parks Rd, Oxford OX1 3PT, England.		Tucker, Stephen J./ABE-6741-2020; Tucker, Stephen J./ABE-7468-2020	Tucker, Stephen J./0000-0001-8996-2000; Tucker, Stephen J./0000-0001-8996-2000				Anzai N, 1997, Jpn J Physiol, V47 Suppl 1, pS10; Ashcroft FM, 1999, DIABETOLOGIA, V42, P903, DOI 10.1007/s001250051247; Beesley AH, 1999, PFLUG ARCH EUR J PHY, V438, P1, DOI 10.1007/s004240050872; Best L, 1998, BRIT J PHARMACOL, V125, P874, DOI 10.1038/sj.bjp.0702148; Chraibi A, 1999, J PHARMACOL EXP THER, V290, P341; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Devuyst O, 1996, AM J PHYSIOL-RENAL, V271, pF723, DOI 10.1152/ajprenal.1996.271.3.F723; Dong K, 2001, J BIOL CHEM, V276, P44347, DOI 10.1074/jbc.M108072200; Giebisch G, 2001, KIDNEY INT, V60, P436, DOI 10.1046/j.1523-1755.2001.060002436.x; Golstein PE, 1999, PFLUG ARCH EUR J PHY, V437, P652, DOI 10.1007/s004240050829; Gribble FM, 1997, J PHYSIOL-LONDON, V498, P87, DOI 10.1113/jphysiol.1997.sp021843; Gribble FM, 1998, DIABETES, V47, P1412, DOI 10.2337/diabetes.47.9.1412; Gros L, 1999, BIOCHEM BIOPH RES CO, V257, P766, DOI 10.1006/bbrc.1999.0529; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; Isomoto S, 1996, J BIOL CHEM, V271, P24321, DOI 10.1074/jbc.271.40.24321; Konstas AA, 2001, PFLUG ARCH EUR J PHY, V442, P752, DOI 10.1007/s004240100597; KONSTAS AA, 2002, J BIOL CHEM     0506; Leung YM, 2000, J BIOL CHEM, V275, P10182, DOI 10.1074/jbc.275.14.10182; McNicholas CM, 1996, AM J PHYSIOL-RENAL, V271, pF275, DOI 10.1152/ajprenal.1996.271.2.F275; McNicholas CM, 1996, P NATL ACAD SCI USA, V93, P8083, DOI 10.1073/pnas.93.15.8083; Mennitt PA, 1997, J AM SOC NEPHROL, V8, P1823; Morales MM, 1996, AM J PHYSIOL-RENAL, V270, pF1038, DOI 10.1152/ajprenal.1996.270.6.F1038; Palmer LG, 1997, AM J PHYSIOL-RENAL, V273, pF404, DOI 10.1152/ajprenal.1997.273.3.F404; Ruknudin A, 1998, J BIOL CHEM, V273, P14165, DOI 10.1074/jbc.273.23.14165; Russ U, 1999, MOL PHARMACOL, V56, P955, DOI 10.1124/mol.56.5.955; SCHWANSTECHER M, 1994, BRIT J PHARMACOL, V113, P903, DOI 10.1111/j.1476-5381.1994.tb17078.x; Schwappach B, 2000, NEURON, V26, P155, DOI 10.1016/S0896-6273(00)81146-0; SHEPPARD DN, 1993, ANN NY ACAD SCI, V707, P275, DOI 10.1111/j.1749-6632.1993.tb38058.x; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Tanemoto M, 2000, AM J PHYSIOL-RENAL, V278, pF659, DOI 10.1152/ajprenal.2000.278.4.F659; VOLK T, 1995, CELL PHYSIOL BIOCHEM, V5, P222, DOI 10.1159/000154757; WANG T, 1995, RENAL PHYSIOL BIOCH, V18, P169; Wang WH, 1997, ANNU REV PHYSIOL, V59, P413, DOI 10.1146/annurev.physiol.59.1.413; Yao XQ, 1996, J CLIN INVEST, V97, P2525, DOI 10.1172/JCI118700; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; ZHOU H, 1994, AM J PHYSIOL, V266, pC809, DOI 10.1152/ajpcell.1994.266.3.C809	37	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21346	21351		10.1074/jbc.M202005200	http://dx.doi.org/10.1074/jbc.M202005200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11927600	hybrid			2022-12-27	WOS:000176286000031
J	von Kobbe, C; Karmakar, P; Dawut, L; Opresko, P; Zeng, XM; Brosh, RM; Hickson, ID; Bohr, VA				von Kobbe, C; Karmakar, P; Dawut, L; Opresko, P; Zeng, XM; Brosh, RM; Hickson, ID; Bohr, VA			Colocalization, physical, and functional interaction between Werner and Bloom syndrome proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME GENE-PRODUCT; DNA HELICASE; CELL-CYCLE; FLAP ENDONUCLEASE-1; HOLLIDAY JUNCTIONS; WRN HELICASE; TELOMERASE; BINDING; COMPLEX; 3'->5'-EXONUCLEASE	The RecQ helicase family comprises a conserved group of proteins implicated in several aspects of DNA metabolism. Three of the family members are defective in heritable diseases characterized by abnormal growth, premature aging, and predisposition to malignancies. These include the WRN and BLM gene products that are defective in Werner and Bloom syndromes, disorders which share many phenotypic and cellular characteristics including spontaneous genomic instability. Here, we report a physical and functional interaction between BLM and WRN. These proteins were coimmunoprecipitated from a nuclear matrix-solubilized fraction, and the purified recombinant proteins were shown to interact directly. Moreover, BLM and WRN colocalized to nuclear foci in three human cell lines. Two regions of WRN that mediate interaction with BLM were identified, and one of these was localized to the exonuclease domain of WRN. Functionally, BLM inhibited the exonuclease activity of WRN. This is the first demonstration of a physical and functional interaction between RecQ helicases. Our observation that RecQ family members interact provides new insights into the complex phenotypic manifestations resulting from the loss of these proteins.	NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA; Univ Oxford, Inst Mol Med, Imperial Canc Res Fund Labs, Oxford OX3 9DS, England	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Cancer Research UK; University of Oxford	Bohr, VA (corresponding author), NIA, Lab Mol Gerontol, NIH, 5600 Nathan Schock Dr, Baltimore, MD 21224 USA.	vbohr@nih.gov	Hickson, Ian/AAJ-7548-2020; Bohr, Vilhelm/AAP-5931-2020	von Kobbe, Cayetano/0000-0003-3895-3790; Opresko, Patricia/0000-0002-6470-2189; Hickson, Ian/0000-0002-0583-566X	NATIONAL INSTITUTE ON AGING [Z01AG000741, ZIAAG000741, Z01AG000726, ZIAAG000726] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bischof O, 2001, J CELL BIOL, V153, P367, DOI 10.1083/jcb.153.2.367; Bohr VA, 2000, EXP GERONTOL, V35, P695, DOI 10.1016/S0531-5565(00)00145-5; Brosh RM, 2000, NUCLEIC ACIDS RES, V28, P2420, DOI 10.1093/nar/28.12.2420; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Brosh RM, 2001, EMBO J, V20, P5791; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; Brosh RM, 2001, J BIOL CHEM, V276, P35093, DOI 10.1074/jbc.M103332200; Brosh RM, 2001, J BIOL CHEM, V276, P3024, DOI 10.1074/jbc.M006784200; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; Cooper MP, 2000, GENE DEV, V14, P907; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dutertre S, 2000, ONCOGENE, V19, P2731, DOI 10.1038/sj.onc.1203595; Fontoura BMA, 1999, J CELL BIOL, V144, P1097, DOI 10.1083/jcb.144.6.1097; Frei C, 2000, J CELL SCI, V113, P2641; Gharibyan V, 1999, MOL CARCINOGEN, V26, P261, DOI 10.1002/(SICI)1098-2744(199912)26:4<261::AID-MC5>3.0.CO;2-A; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Grobelny JV, 2000, J CELL SCI, V113, P4577; Henricksen LA, 2000, J BIOL CHEM, V275, P16420, DOI 10.1074/jbc.M909635199; Hisama FM, 2000, CANCER RES, V60, P2372; Huang SR, 2000, NUCLEIC ACIDS RES, V28, P2396, DOI 10.1093/nar/28.12.2396; Imamura O, 2002, ONCOGENE, V21, P954, DOI 10.1038/sj.onc.1205143; Johnson FB, 2001, EMBO J, V20, P905, DOI 10.1093/emboj/20.4.905; Kamath-Loeb AS, 2000, P NATL ACAD SCI USA, V97, P4603, DOI 10.1073/pnas.97.9.4603; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Karow JK, 2000, CURR OPIN GENET DEV, V10, P32, DOI 10.1016/S0959-437X(99)00039-8; Karow JK, 1997, J BIOL CHEM, V272, P30611, DOI 10.1074/jbc.272.49.30611; Kusano K, 2001, SCIENCE, V291, P2600, DOI 10.1126/science.291.5513.2600; Lebel M, 1999, J BIOL CHEM, V274, P37795, DOI 10.1074/jbc.274.53.37795; Li BM, 2000, J BIOL CHEM, V275, P39800; Lindor NM, 2000, AM J MED GENET, V90, P223, DOI 10.1002/(SICI)1096-8628(20000131)90:3<223::AID-AJMG7>3.0.CO;2-Z; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Machwe A, 2000, NUCLEIC ACIDS RES, V28, P2762, DOI 10.1093/nar/28.14.2762; Marciniak RA, 1998, P NATL ACAD SCI USA, V95, P6887, DOI 10.1073/pnas.95.12.6887; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Mohaghegh P, 2001, HUM MOL GENET, V10, P741, DOI 10.1093/hmg/10.7.741; Moser MJ, 2000, NUCLEIC ACIDS RES, V28, P648, DOI 10.1093/nar/28.2.648; Orren DK, 1999, NUCLEIC ACIDS RES, V27, P3557, DOI 10.1093/nar/27.17.3557; Oshima J, 2000, BIOESSAYS, V22, P894, DOI 10.1002/1521-1878(200010)22:10<894::AID-BIES4>3.0.CO;2-B; Schmitt C, 1999, EMBO J, V18, P4332, DOI 10.1093/emboj/18.15.4332; Spillare EA, 1999, GENE DEV, V13, P1355, DOI 10.1101/gad.13.11.1355; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; von Kobbe C, 2000, MOL CELL, V6, P1243, DOI 10.1016/S1097-2765(00)00120-9; Wu L, 2000, J BIOL CHEM, V275, P9636, DOI 10.1074/jbc.275.13.9636; Yankiwski V, 2000, P NATL ACAD SCI USA, V97, P5214, DOI 10.1073/pnas.090525897; Yeager TR, 1999, CANCER RES, V59, P4175	45	107	107	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					22035	22044		10.1074/jbc.M200914200	http://dx.doi.org/10.1074/jbc.M200914200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11919194	hybrid			2022-12-27	WOS:000176286000116
J	Fournier, HN; Dupe-Manet, S; Bouvard, D; Lacombe, ML; Marie, C; Block, MR; Albiges-Rizo, C				Fournier, HN; Dupe-Manet, S; Bouvard, D; Lacombe, ML; Marie, C; Block, MR; Albiges-Rizo, C			Integrin cytoplasmic domain-associated protein 1 alpha (ICAP-1 alpha) interacts directly with the metastasis suppressor nm23-H2, and both proteins are targeted to newly formed cell adhesion sites upon integrin engagement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSIDE DIPHOSPHATE KINASE; X-RAY STRUCTURE; TUMOR-METASTASIS; MELANOMA-CELLS; CATALYTIC MECHANISM; BIOLOGICAL FUNCTION; DEPENDENT PROTEIN; BINDING; GTPASE; LINE	Cell adhesion-dependent signaling implicates cytoplasmic proteins interacting with the intracellular tails of integrins. Among those, the integrin cytoplasmic domain-associated protein 1alpha (ICAP-1alpha) has been shown to interact specifically with the beta(1), integrin cytoplasmic domain. Although it is likely that this protein plays an important role in controlling cell adhesion and migration, little is known about its actual function. To search for potential ICAP-1alpha-binding proteins, we used a yeast two-hybrid screen and identified the human metastatic suppressor protein nm23-H2 as a new partner of ICAP-1alpha. This direct interaction was confirmed in vitro, using purified recombinant ICA-P1alpha and nm23-H2, and by coimmunoprecipitation from CHO cell lysates over-expressing ICAP-1alpha. The physiological relevance of this interaction is provided by confocal fluorescence microscopy, which shows that ICAP-1alpha and nm23-H2 are colocalized in lamellipodia during the early stages of cell spreading. These adhesion sites are enriched in occupied 13, integrins and precede the formation of focal adhesions devoid of ICAP-1alpha and nm23-H2, indicating the dynamic segregation of components of matrix adhesions. This peripheral staining of ICAP-1alpha and nm23-1-12 is only observed in cells spreading on fibronectin and collagen and is absent in cells spreading on poly-L-lysine, vitronectin, or laminin. This is consistent with the fact that targeting of both ICAP-1alpha and nm23-H2 to the cell periphery is dependent on 13, integrin engagement rather than being a consequence of cell adhesion. This finding represents the first evidence that the tumor suppressor nm23-H2 could act on beta(1) integrin-mediated cell adhesion by interacting with one of the integrin partners, ICAP-1alpha.	UJF, Fac Med Grenoble,UMR CNRS 5538, Inst Albert Bonniot, Lab Etud Differenciat & Adherence Cellulaires, F-38706 La Tronche, France; Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; Univ Paris 06, INSERM U402, F-75012 Paris, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Max Planck Society; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Block, MR (corresponding author), UJF, Fac Med Grenoble,UMR CNRS 5538, Inst Albert Bonniot, Lab Etud Differenciat & Adherence Cellulaires, Domaine Merci, F-38706 La Tronche, France.		Bouvard, Daniel/M-2727-2013; Block, Marc R/M-2740-2013; Albiges-Rizo, Corinne/M-2568-2013; Bouvard, Daniel/B-1260-2017	Block, Marc R/0000-0003-2214-9706; Bouvard, Daniel/0000-0002-0845-6681; ALBIGES-RIZO, Corinne/0000-0002-6333-4150				BABA H, 1995, CANCER RES, V55, P1977; Bouvard D, 1998, BIOCHEM BIOPH RES CO, V252, P46, DOI 10.1006/bbrc.1998.9592; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Chang DD, 1997, J CELL BIOL, V138, P1149, DOI 10.1083/jcb.138.5.1149; Chang DD, 2002, J BIOL CHEM, V277, P8140, DOI 10.1074/jbc.M109031200; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; DELAROSA A, 1995, BIOESSAYS, V17, P53, DOI 10.1002/bies.950170111; DUMAS C, 1992, EMBO J, V11, P3203, DOI 10.1002/j.1460-2075.1992.tb05397.x; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; Farrelly N, 1999, J CELL BIOL, V144, P1337, DOI 10.1083/jcb.144.6.1337; Gonin P, 1999, BIOCHEMISTRY-US, V38, P7265, DOI 10.1021/bi982990v; Hamby C V, 1995, Biochem Biophys Res Commun, V211, P579; Hamby CV, 2000, INT J CANCER, V88, P547, DOI 10.1002/1097-0215(20001115)88:4<547::AID-IJC5>3.0.CO;2-L; Hartsough MT, 2000, J BIOENERG BIOMEMBR, V32, P301, DOI 10.1023/A:1005597231776; KANTOR JD, 1993, CANCER RES, V53, P1971; Kashiwagi H, 1997, J CELL BIOL, V137, P1433, DOI 10.1083/jcb.137.6.1433; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; Lacombe ML, 2000, J BIOENERG BIOMEMBR, V32, P247, DOI 10.1023/A:1005584929050; Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P237, DOI 10.1023/A:1005532912212; Lee JW, 2000, MOL BIOL CELL, V11, P1973, DOI 10.1091/mbc.11.6.1973; LEONE A, 1991, CELL, V65, P25, DOI 10.1016/0092-8674(91)90404-M; Liu S, 1999, NATURE, V402, P676, DOI 10.1038/45264; Lochter A, 1999, MOL BIOL CELL, V10, P271, DOI 10.1091/mbc.10.2.271; Lombardi D, 2000, J CELL PHYSIOL, V182, P144, DOI 10.1002/(SICI)1097-4652(200002)182:2<144::AID-JCP2>3.3.CO;2-Y; Ma DQ, 2002, J BIOL CHEM, V277, P1560, DOI 10.1074/jbc.M108359200; Miyazaki H, 1999, CLIN CANCER RES, V5, P4301; Morera S, 1995, STRUCTURE, V3, P1307, DOI 10.1016/S0969-2126(01)00268-4; MOULD AP, 1995, FEBS LETT, V363, P118, DOI 10.1016/0014-5793(95)00301-O; Otero AD, 2000, J BIOENERG BIOMEMBR, V32, P269, DOI 10.1023/A:1005589029959; Otsuki Y, 2001, P NATL ACAD SCI USA, V98, P4385, DOI 10.1073/pnas.071411598; Parks R.E., 1973, ENZYMES, V8, P307, DOI [10.1016/S1874-6047(08)60069-4, DOI 10.1016/S1874-6047(08)60069-4]; POSTEL EH, 1993, SCIENCE, V261, P478, DOI 10.1126/science.8392752; Pozzi M, 1998, J CELL BIOL, V142, P587; Reddy KB, 2001, J BIOL CHEM, V276, P28300, DOI 10.1074/jbc.M102794200; Ridley A, 2000, J CELL BIOL, V150, pF107, DOI 10.1083/jcb.150.4.F107; Sastry SK, 1999, J CELL BIOL, V144, P1295, DOI 10.1083/jcb.144.6.1295; Schaertl S, 1999, J BIOL CHEM, V274, P20159, DOI 10.1074/jbc.274.29.20159; SHATTIL SJ, 1995, J CELL BIOL, V131, P807, DOI 10.1083/jcb.131.3.807; Stroeken PJM, 2000, ONCOGENE, V19, P1232, DOI 10.1038/sj.onc.1203423; Tang SQ, 1999, J CELL BIOL, V147, P1073, DOI 10.1083/jcb.147.5.1073; TAWIL N, 1993, J CELL BIOL, V120, P261, DOI 10.1083/jcb.120.1.261; WAGNER PD, 1995, J BIOL CHEM, V270, P21758, DOI 10.1074/jbc.270.37.21758; WEBB PA, 1995, J MOL BIOL, V251, P574, DOI 10.1006/jmbi.1995.0457; Xu J, 1996, DEV BIOL, V177, P544, DOI 10.1006/dbio.1996.0184; Zamir E, 2001, J CELL SCI, V114, P3583; Zhang XA, 1999, J BIOL CHEM, V274, P11, DOI 10.1074/jbc.274.1.11; Zhu JH, 1999, P NATL ACAD SCI USA, V96, P14911, DOI 10.1073/pnas.96.26.14911	47	88	95	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20895	20902		10.1074/jbc.M200200200	http://dx.doi.org/10.1074/jbc.M200200200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11919189	hybrid			2022-12-27	WOS:000176204500102
J	Gowher, H; Jeltsch, A				Gowher, H; Jeltsch, A			Molecular enzymology of the catalytic domains of the Dnmt3a and Dnmt3b DNA methyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ICF SYNDROME; CYTOSINE-5 METHYLTRANSFERASE; MAINTENANCE METHYLATION; CHROMOSOME INSTABILITY; ENZYMATIC-PROPERTIES; CPG ISLANDS; MOUSE; GENE; REPLICATION; COMPLEX	The C-terminal domains of the mammalian DNA methyltransferases Dnmt1, Dnmt3a, and Dnmt3b harbor all the conserved motifs characteristic for cytosine-C5 methyltransferases. Whereas the isolated catalytic domain of Dnmt1 is inactive, we show here that the C-terminal domains of Dnmt3a and Dnmt3b are catalytically active. Neither Dnmt3a nor Dnmt3b shows a significant preference for the satellite 2 sequence, although Dnmt3b is required for methylation of these regions in vivo. However, the catalytic domain of Dnmt3a methylates DNA in a distributive reaction, whereas Dnmt3b is processive, which accelerates methylation of macromolecular DNA in vitro. This property could make Dnmt3b a preferred enzyme for methylation at satellite 2 repeats, since they are highly CG-rich. We have also analyzed the catalytic activities of six different mutations found in ICF (immunodeficiency, centromeric instability, and facial abnormalities) patients in the catalytic domain of Dnmt3b. Five of them display catalytic activities reduced by 10-50-fold; one mutant was inactive in our assay (residual activity <1%). These results confirm that a reduced catalytic activity of Dnm3b causes ICF. However, the mutations in general do not completely abrogate catalytic activity. This finding may explain why ICF patients are viable, whereas nmt3b knock-out mice die during embryogenesis.	Univ Giessen, FB 8, Inst Biochem, D-35392 Giessen, Germany	Justus Liebig University Giessen	Jeltsch, A (corresponding author), Univ Giessen, FB 8, Inst Biochem, Heinrich Buff Ring 58, D-35392 Giessen, Germany.	Albert.Jeltsch@chemie.bio.uni-giessen.de	Jeltsch, Albert/O-7404-2014; Gowher, Humaira/AAG-7112-2019	Jeltsch, Albert/0000-0001-6113-9290; 				ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Aoki A, 2001, NUCLEIC ACIDS RES, V29, P3506, DOI 10.1093/nar/29.17.3506; Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Bacolla A, 2001, J BIOL CHEM, V276, P18605, DOI 10.1074/jbc.M100404200; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; CHAPMAN V, 1984, NATURE, V307, P284, DOI 10.1038/307284a0; Cheng XD, 2001, NUCLEIC ACIDS RES, V29, P3784, DOI 10.1093/nar/29.18.3784; CHENG XD, 1995, ANNU REV BIOPH BIOM, V24, P293, DOI 10.1146/annurev.bb.24.060195.001453; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; DRYDEN DTF, 1998, S ADENOSYLMETHIONINE, P283; Ehrlich M, 2001, HUM MOL GENET, V10, P2917, DOI 10.1093/hmg/10.25.2917; Fatemi M, 2001, J MOL BIOL, V309, P1189, DOI 10.1006/jmbi.2001.4709; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gowher H, 2001, J MOL BIOL, V309, P1201, DOI 10.1006/jmbi.2001.4710; Guex N, 1999, TRENDS BIOCHEM SCI, V24, P364, DOI 10.1016/S0968-0004(99)01427-9; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hansen RS, 2000, HUM MOL GENET, V9, P2575, DOI 10.1093/hmg/9.18.2575; Hansen RS, 1999, P NATL ACAD SCI USA, V96, P14412, DOI 10.1073/pnas.96.25.14412; Hassan KMA, 2001, HUM GENET, V109, P452; Hsieh CL, 1999, MOL CELL BIOL, V19, P8211; Jeltsch Albert, 2002, Methods Mol Biol, V182, P85; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; KUMAR S, 1994, NUCLEIC ACIDS RES, V22, P1, DOI 10.1093/nar/22.1.1; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Liang GG, 2002, MOL CELL BIOL, V22, P480, DOI 10.1128/MCB.22.2.480-491.2002; LIUB Y, 1998, NUCLEIC ACIDS RES, V26, P1038; Lyko F, 1999, NAT GENET, V23, P363, DOI 10.1038/15551; Margot JB, 2000, J MOL BIOL, V297, P293, DOI 10.1006/jmbi.2000.3588; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pfeifer GP, 2000, CURR TOP MICROBIOL, V249, P1; Pradhan S, 2000, EMBO J, V19, P2103, DOI 10.1093/emboj/19.9.2103; Qiu C, 2002, NAT STRUCT BIOL, V9, P217, DOI 10.1038/nsb759; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Roth M, 1998, J BIOL CHEM, V273, P17333, DOI 10.1074/jbc.273.28.17333; Roth M, 2000, BIOL CHEM, V381, P269, DOI 10.1515/BC.2000.035; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; SANFORD J, 1984, NUCLEIC ACIDS RES, V12, P2823, DOI 10.1093/nar/12.6.2823; Tuck-Muller CM, 2000, CYTOGENET CELL GENET, V89, P121, DOI 10.1159/000015590; Warnecke PM, 2000, CURR OPIN ONCOL, V12, P68, DOI 10.1097/00001622-200001000-00012; Wijmenga C, 2000, HUM MUTAT, V16, P509, DOI 10.1002/1098-1004(200012)16:6<509::AID-HUMU8>3.3.CO;2-M; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Zimmermann C, 1997, BIOL CHEM, V378, P393, DOI 10.1515/bchm.1997.378.5.393	53	148	158	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20409	20414		10.1074/jbc.M202148200	http://dx.doi.org/10.1074/jbc.M202148200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11919202	hybrid			2022-12-27	WOS:000176204500040
J	Cai, ZW; Sheppard, DN				Cai, ZW; Sheppard, DN			Phloxine B interacts with the cystic fibrosis transmembrane conductance regulator at multiple sites to modulate channel activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE CELL-LINE; CL CHANNELS; FLUORESCEIN DERIVATIVES; CHLORIDE CHANNEL; BINDING-SITES; CFTR; INHIBITION; GENISTEIN; BLOCK; ACTIVATION	The fluorescein derivative phloxine B is a potent modulator of the cystic fibrosis transmembrane conductance regulator (CFTR). Low micromolar concentrations of phloxine B stimulate CFTR Cl- currents, whereas higher concentrations of the drug inhibit CFTR. In this study, we investigated the mechanism of action of phloxine B. Phloxine B (1 muM) stimulated wild-type CFTR and the most common cystic fibrosis mutation, DeltaF508, by increasing the open probability of phosphorylated CFTR Cl- channels. At each concentration of ATP tested, the drug slowed the rate of channel closure without altering the opening rate. Based on the effects of fluorescein derivatives on transport ATPases, these data suggest that phloxine B might stimulate CFTR by binding to the ATP-binding site of the second nucleotide-binding domain (NBD2) to slow the dissociation of ATP from NBD1. Channel block by phloxine B (40 muM) was voltage-dependent, enhanced when external Cl- concentration was reduced and unaffected by ATP (5 mM), suggesting that phloxine B inhibits CFTR by occluding the pore. We conclude that phloxine B interacts directly with CFTR at multiple sites to modulate channel activity. It or related agents might be of value in the development of new treatments for diseases caused by the malfunction of CFTR.	Univ Bristol, Sch Med Sci, Dept Physiol, Bristol BS8 1TD, Avon, England; Univ Edinburgh, Western Gen Hosp, Med Genet Sect, Mol Med Ctr, Edinburgh EH4 2XU, Midlothian, Scotland	University of Bristol; University of Edinburgh	Sheppard, DN (corresponding author), Univ Bristol, Sch Med Sci, Dept Physiol, Univ Walk, Bristol BS8 1TD, Avon, England.		Sheppard, David N/AAV-4187-2021	Sheppard, David N/0000-0001-5533-9130				Al-Nakkash L, 2001, J PHARMACOL EXP THER, V296, P464; Bachmann A, 2000, BRIT J PHARMACOL, V131, P433, DOI 10.1038/sj.bjp.0703600; Cai Z, 1999, BRIT J PHARMACOL, V128, P108, DOI 10.1038/sj.bjp.0702748; CAI Z, 2000, PEDIAT PULMONAL S, V20, P180; CARSON MR, 1995, J BIOL CHEM, V270, P1711, DOI 10.1074/jbc.270.4.1711; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Csanady L, 1999, J GEN PHYSIOL, V114, P49, DOI 10.1085/jgp.114.1.49; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; DEWEILLE JR, 1992, J BIOL CHEM, V267, P4557; Elferink RPJO, 2000, SEMIN LIVER DIS, V20, P293, DOI 10.1055/s-2000-9385; French PJ, 1997, AM J PHYSIOL-CELL PH, V273, pC747, DOI 10.1152/ajpcell.1997.273.2.C747; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; Gadsby D. C., 1999, PHYSIOL REV, V79, pS77; Guerrant R. L., 1990, REV INFECT DIS, V12, P41; Gupta J, 2002, PFLUG ARCH EUR J PHY, V443, P739, DOI 10.1007/s00424-001-0762-0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hwang TC, 1999, TRENDS PHARMACOL SCI, V20, P448, DOI 10.1016/S0165-6147(99)01386-3; HWANG TC, 1994, P NATL ACAD SCI USA, V91, P4698, DOI 10.1073/pnas.91.11.4698; Hwang TC, 1997, AM J PHYSIOL-CELL PH, V273, pC988, DOI 10.1152/ajpcell.1997.273.3.C988; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Ishihara H, 1997, AM J PHYSIOL-CELL PH, V273, pC1278, DOI 10.1152/ajpcell.1997.273.4.C1278; KARLISH SJD, 1980, J BIOENERG BIOMEMBR, V12, P111, DOI 10.1007/BF00744678; Lansdell KA, 2000, J PHYSIOL-LONDON, V524, P317, DOI 10.1111/j.1469-7793.2000.t01-1-00317.x; Lansdell KA, 1998, J PHYSIOL-LONDON, V508, P379, DOI 10.1111/j.1469-7793.1998.379bq.x; Li CH, 1996, J BIOL CHEM, V271, P28463, DOI 10.1074/jbc.271.45.28463; Linsdell P, 1996, AM J PHYSIOL-CELL PH, V271, pC628, DOI 10.1152/ajpcell.1996.271.2.C628; Linsdell P, 1999, BRIT J PHARMACOL, V126, P1471, DOI 10.1038/sj.bjp.0702458; Linsdell P, 1996, J PHYSIOL-LONDON, V496, P687, DOI 10.1113/jphysiol.1996.sp021719; Luo JX, 2000, AM J PHYSIOL-CELL PH, V279, pC108, DOI 10.1152/ajpcell.2000.279.1.C108; MARSHALL J, 1994, J BIOL CHEM, V269, P2987; MCDONOUGH S, 1994, NEURON, V13, P623, DOI 10.1016/0896-6273(94)90030-2; NESLUND GG, 1984, CURR TOP CELL REGUL, V24, P447; Randak C, 1999, BIOCHEM J, V340, P227, DOI 10.1042/0264-6021:3400227; RIORDAN JR, 1989, SCIENCE, V245, P1066; Schultz B. D., 1999, Physiological Reviews, V79, pS109; SCHWANSTECHER M, 1995, PHARMACOLOGY, V50, P182, DOI 10.1159/000139281; Sheppard DN, 1997, J PHYSIOL-LONDON, V503, P333, DOI 10.1111/j.1469-7793.1997.333bh.x; Sheppard DN, 1999, PHYSIOL REV, V79, P23; Sullivan LP, 1998, PHYSIOL REV, V78, P1165, DOI 10.1152/physrev.1998.78.4.1165; Venglarik CJ, 1996, BIOPHYS J, V70, P2696, DOI 10.1016/S0006-3495(96)79839-9; Walsh KB, 1999, BRIT J PHARMACOL, V127, P369, DOI 10.1038/sj.bjp.0702562; Wang F, 1998, J GEN PHYSIOL, V111, P477, DOI 10.1085/jgp.111.3.477; Weinreich F, 1997, PFLUG ARCH EUR J PHY, V434, P484, DOI 10.1007/s004240050424; Welsh MJ, 1995, METABOLIC MOL BASES, V3, P3799; WINTER MC, 1994, BIOPHYS J, V66, P1398, DOI 10.1016/S0006-3495(94)80930-0; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; Xie JX, 2000, BIOPHYS J, V78, P1293, DOI 10.1016/S0006-3495(00)76685-9; Yang ICH, 1997, AM J PHYSIOL-CELL PH, V272, pC142, DOI 10.1152/ajpcell.1997.272.1.C142; Zeltwanger S, 1999, J GEN PHYSIOL, V113, P541, DOI 10.1085/jgp.113.4.541	50	52	53	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19546	19553		10.1074/jbc.M108023200	http://dx.doi.org/10.1074/jbc.M108023200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11904291	hybrid			2022-12-27	WOS:000175894800042
J	Gravel, A; Gosselin, J; Flamand, L				Gravel, A; Gosselin, J; Flamand, L			Human herpesvirus 6 immediate-early 1 protein is a sumoylated nuclear phosphoprotein colocalizing with promyelocytic leukemia protein-associated nuclear bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMPLEX VIRUS TYPE-1; UBIQUITIN-LIKE MODIFIERS; HUMAN CYTOMEGALOVIRUS; MULTIPLE-SCLEROSIS; VARIANT-B; COVALENT MODIFICATION; SUMO-1 MODIFICATION; DOMAIN-10 ND10; CODING CONTENT; DNA-SEQUENCES	Immediate-early (IE) proteins are the first proteins expressed following viral entry and play a crucial role in the initiation of infection. We report the cloning and characterization of a full-length IE1 transcript and protein (IE1B) from human herpesvirus 6 (HHV-6) variant B. The IE1B transcript consists of five exons (3720 nucleotides), three of which are coding for the IE1 protein. The 1078-amino acid-long IE1B protein is 62% identical and 75% similar to the 941-amino acid IE1 from HHV-6 variant A. IE1B protein can be detected at 4 h post-infection (P.I.), and it is distributed as small intranuclear structures. The maximal number of IE1 bodies (similar to10-12/nucleus) is detected at 12 h P.I. after which the IE1 bodies condense into 1-3 larger entities by 24-48 h P.I. During infection the IE1B protein is phosphorylated on serine and threonine residues. IE1B undergoes further post-translational modification with its conjugation to the small ubiquitin-like modifier (SUMO-1) peptide. IE1B colocalizes with SUMO-1 and promyelocytic leukemia nuclear bodies during infection as well as in transfection experiments. Finally, IE1 from variant B is a weaker transactivator than IE1 from variant A, when assayed using heterologous promoters. Overall, the characterization of the HHV-6 IE1B protein presented highlights the similarity and divergence between IE1 from both variants and provides useful information pertaining to the early phase of infection.	CHU Laval, Res Ctr, Rheumatol & Immunol Res Ctr, Virol Lab, Quebec City, PQ G1V 4G2, Canada; CHU Laval, Res Ctr, Rheumatol & Immunol Res Ctr, Lab Viral Immunol, Quebec City, PQ G1V 4G2, Canada; Univ Laval, Fac Med, Quebec City, PQ G1V 4G2, Canada	Laval University; Laval University; Laval University	Flamand, L (corresponding author), CHU Laval, Res Ctr, Rheumatol & Immunol Res Ctr, Virol Lab, Room T1-49,2705 Blvd Laurier, Quebec City, PQ G1V 4G2, Canada.			Gravel, Annie/0000-0001-5229-5750; Flamand, Louis/0000-0001-5010-4586				ABLASHI D, 1993, ARCH VIROL, V129, P363, DOI 10.1007/BF01316913; Ablashi DV, 1998, MULT SCLER, V4, P490, DOI 10.1177/135245859800400606; Adamson AL, 2001, J VIROL, V75, P2388, DOI 10.1128/JVI.75.5.2388-2399.2001; Ahn JH, 1997, J VIROL, V71, P4599, DOI 10.1128/JVI.71.6.4599-4613.1997; Ahn JH, 1998, MOL CELL BIOL, V18, P4899, DOI 10.1128/MCB.18.8.4899; Ahn JH, 2001, J VIROL, V75, P3859, DOI 10.1128/JVI.75.8.3859-3872.2001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ASANO Y, 1990, LANCET, V335, P862, DOI 10.1016/0140-6736(90)90983-C; BIEGALKE BJ, 1991, VIROLOGY, V183, P381, DOI 10.1016/0042-6822(91)90151-Z; Bonura F, 1999, MICROBIOLOGICA, V22, P161; Burkham J, 2001, J VIROL, V75, P2353, DOI 10.1128/JVI.75.5.2353-2367.2001; CARRIGAN DR, 1990, J INFECT DIS, V162, P844, DOI 10.1093/infdis/162.4.844; CHALLONER PB, 1995, P NATL ACAD SCI USA, V92, P7440, DOI 10.1073/pnas.92.16.7440; Chelbi-Alix MK, 1998, J VIROL, V72, P1043, DOI 10.1128/JVI.72.2.1043-1051.1998; Coates ARM, 1998, NAT MED, V4, P537, DOI 10.1038/nm0598-537b; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; DEWHURST S, 1993, J CLIN MICROBIOL, V31, P416, DOI 10.1128/JCM.31.2.416-418.1993; Dominguez G, 1999, J VIROL, V73, P8040, DOI 10.1128/JVI.73.10.8040-8052.1999; DOWNING RG, 1987, LANCET, V2, P390; ENSOLI B, 1989, EMBO J, V8, P3019, DOI 10.1002/j.1460-2075.1989.tb08452.x; EVERETT RD, 1994, EMBO J, V13, P5062, DOI 10.1002/j.1460-2075.1994.tb06835.x; Fillet AM, 1998, NAT MED, V4, P537, DOI 10.1038/nm0598-537a; Flamand L, 1998, J VIROL, V72, P8797, DOI 10.1128/JVI.72.11.8797-8805.1998; FLAMAND L, 1991, J VIROL, V65, P5105, DOI 10.1128/JVI.65.9.5105-5110.1991; GHAZAL P, 1991, J VIROL, V65, P6735, DOI 10.1128/JVI.65.12.6735-6742.1991; GOMPELS UA, 1995, VIROLOGY, V209, P29, DOI 10.1006/viro.1995.1228; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Grivel JC, 1999, NAT MED, V5, P344, DOI 10.1038/6565; HALL CB, 1994, NEW ENGL J MED, V331, P432, DOI 10.1056/NEJM199408183310703; Hofmann H, 2000, J VIROL, V74, P2510, DOI 10.1128/JVI.74.6.2510-2524.2000; HORVAT RT, 1991, J VIROL, V65, P2895, DOI 10.1128/JVI.65.6.2895-2902.1991; HUANG LM, 1991, ARCH DIS CHILD, V66, P1443, DOI 10.1136/adc.66.12.1443; HUANG LM, 1990, LANCET, V336, P60, DOI 10.1016/0140-6736(90)91580-4; Isegawa Y, 1999, J VIROL, V73, P8053, DOI 10.1128/JVI.73.10.8053-8063.1999; Ishov AM, 1996, J CELL BIOL, V134, P815, DOI 10.1083/jcb.134.4.815; Ishov AM, 1997, J CELL BIOL, V138, P5, DOI 10.1083/jcb.138.1.5; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kamitani T, 1998, J BIOL CHEM, V273, P11349, DOI 10.1074/jbc.273.18.11349; Kasolo FC, 1997, J GEN VIROL, V78, P847, DOI 10.1099/0022-1317-78-4-847; KELLY C, 1995, J GEN VIROL, V76, P2887, DOI 10.1099/0022-1317-76-11-2887; Korioth F, 1996, EXP CELL RES, V229, P155, DOI 10.1006/excr.1996.0353; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Lapenta V, 1997, GENOMICS, V40, P362, DOI 10.1006/geno.1996.4556; LAVAU C, 1995, ONCOGENE, V11, P871; LIU B, 1992, J VIROL, V66, P4434, DOI 10.1128/JVI.66.7.4434-4444.1992; LOPEZ C, 1988, J INFECT DIS, V157, P1271, DOI 10.1093/infdis/157.6.1271; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; MARTIN MED, 1991, J VIROL, V65, P5381, DOI 10.1128/JVI.65.10.5381-5390.1991; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; MAUL GG, 1994, J GEN VIROL, V75, P1223, DOI 10.1099/0022-1317-75-6-1223; MAUL GG, 1993, J GEN VIROL, V74, P2679, DOI 10.1099/0022-1317-74-12-2679; Maul GG, 1996, VIROLOGY, V217, P67, DOI 10.1006/viro.1996.0094; Muller S, 1999, J VIROL, V73, P5137; NICHOLAS J, 1994, VIROLOGY, V204, P738, DOI 10.1006/viro.1994.1589; PREZIOSO PJ, 1992, J PEDIATR-US, V120, P921, DOI 10.1016/S0022-3476(05)81962-6; Regad T, 2001, EMBO J, V20, P3495, DOI 10.1093/emboj/20.13.3495; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Saitoh H, 1997, P NATL ACAD SCI USA, V94, P3736, DOI 10.1073/pnas.94.8.3736; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; SALAHUDDIN SZ, 1986, SCIENCE, V234, P596, DOI 10.1126/science.2876520; Santoro F, 1999, CELL, V99, P817, DOI 10.1016/S0092-8674(00)81678-5; SCHIEWE U, 1994, J VIROL, V68, P2978, DOI 10.1128/JVI.68.5.2978-2985.1994; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Soldan SS, 1997, NAT MED, V3, P1394, DOI 10.1038/nm1297-1394; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Takahashi Y, 2001, J BIOL CHEM, V276, P48973, DOI 10.1074/jbc.M109295200; Takeda K, 1996, VIRUS RES, V41, P193, DOI 10.1016/0168-1702(96)01287-7; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Xu YX, 2001, J VIROL, V75, P10683, DOI 10.1128/JVI.75.22.10683-10695.2001; YAMANISHI K, 1988, LANCET, V1, P1065; YEUNG KC, 1993, VIROLOGY, V195, P786, DOI 10.1006/viro.1993.1431; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752	77	46	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19679	19687		10.1074/jbc.M200836200	http://dx.doi.org/10.1074/jbc.M200836200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11901159	hybrid			2022-12-27	WOS:000175894800059
J	Richard, E; Alam, SM; Arredondo-Vega, FX; Patel, DD; Hershfield, MS				Richard, E; Alam, SM; Arredondo-Vega, FX; Patel, DD; Hershfield, MS			Clustered charged amino acids of human adenosine deaminase comprise a functional epitope for binding the adenosine deaminase complexing protein CD26/dipeptidyl peptidase IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-PLASMON RESONANCE; T-CELL ACTIVATION; HUMAN CD26; COMBINED IMMUNODEFICIENCY; ENZYMATIC-ACTIVITY; IMMUNE-RESPONSE; HOT-SPOTS; DEFICIENCY; INTERFACES; ANTIGEN	Human adenosine deaminase (ADA) occurs as a 41-kDa soluble monomer in all cells. On epithelia and lymphoid cells of humans, but not mice, ADA also occurs bound to the membrane glycoprotein CD26/dipeptidyl peptidase IV. This "ecto-ADA" has been postulated to regulate extracellular Ado levels, and also the function of CD26 as a co-stimulator of activated T cells. The CD26-binding site of human ADA has been localized by homolog scanning to the peripheral alpha2-helix (amino acids 126-143). Among the 5 non-conserved residues within this segment, Arg-142 in human and Gln-142 in mouse ADA largely determined the capacity for stable binding to CD26 (Richard, E., Arredondo-Vega, F. X., Santisteban, I., Kelly, S. J., Patel, D. D., and Hershfield, M. S. (2000) J. Exp. Med. 192, 1223-1235). We have now mutagenized conserved alpha2-helix residues in human and mouse ADA and used surface plasmon resonance to evaluate binding kinetics to immobilized rabbit CD26. In addition to Arg-142, we found that Glu-139 and Asp-143 of human ADA are also important for CD26 binding. Mutating these residues to alanine increased dissociation rates 6-11-fold and the apparent dissociation constant K-D for wild type human ADA from 17 to 112-160 nM, changing binding free energy by 1.1-1.3 kcal/mol. This cluster of 3 charged residues appears to be a "functional epitope" that accounts for about half of the difference between human and mouse ADA in free energy of binding to CD26.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Hershfield, MS (corresponding author), Duke Univ, Med Ctr, Dept Med, Box 3049, Durham, NC 27710 USA.	msh@biochem.duke.edu	Alam, S. Munir/AAC-6711-2019	Richard Rodriguez, Eva Maria/0000-0001-9711-1417	NIAID NIH HHS [R01 AI47604] Funding Source: Medline; NIDDK NIH HHS [R01 DK20902] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK020902] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abbott CA, 1999, EUR J BIOCHEM, V266, P798, DOI 10.1046/j.1432-1327.1999.00902.x; ANDY RJ, 1982, J BIOL CHEM, V257, P7922; Arredondo-Vega FX, 1998, AM J HUM GENET, V63, P1049, DOI 10.1086/302054; ARREDONDOVEGA FX, 1990, J CLIN INVEST, V86, P444, DOI 10.1172/JCI114730; Blanco J, 1996, EXP CELL RES, V225, P102, DOI 10.1006/excr.1996.0161; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; BRIGHAMBURKE M, 1992, ANAL BIOCHEM, V205, P125, DOI 10.1016/0003-2697(92)90588-X; BRISTOL LA, 1992, J IMMUNOL, V149, P367; CHANG Z, 1991, BIOCHEMISTRY-US, V30, P2273, DOI 10.1021/bi00222a033; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; DADDONA PE, 1978, J BIOL CHEM, V253, P4617; DeMeester I, 1996, J IMMUNOL METHODS, V189, P99, DOI 10.1016/0022-1759(95)00239-1; DINJENS WNM, 1989, J BIOL CHEM, V264, P19215; Dong RP, 1997, J IMMUNOL, V159, P6070; Dong RP, 1996, J IMMUNOL, V156, P1349; FERSHT AR, 1985, NATURE, V314, P235, DOI 10.1038/314235a0; Franco R, 1998, IMMUNOL REV, V161, P27, DOI 10.1111/j.1600-065X.1998.tb01569.x; GIBLETT ER, 1972, LANCET, V2, P1067; Hershfield MS., 2001, METABOLIC MOL BASES, V8th, P2585; Hu ZJ, 2000, PROTEINS, V39, P331, DOI 10.1002/(SICI)1097-0134(20000601)39:4<331::AID-PROT60>3.0.CO;2-A; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KAMEOKA J, 1993, SCIENCE, V261, P466, DOI 10.1126/science.8101391; Lackmann M, 1998, GROWTH FACTORS, V16, P39, DOI 10.3109/08977199809017490; LEE KH, 1994, PROTEINS, V20, P68, DOI 10.1002/prot.340200108; Li YL, 2000, BIOCHEMISTRY-US, V39, P6296, DOI 10.1021/bi000054l; Marguet D, 2000, P NATL ACAD SCI USA, V97, P6874, DOI 10.1073/pnas.120069197; MARTIN M, 1995, J IMMUNOL, V155, P4630; Morimoto C, 1998, IMMUNOL REV, V161, P55, DOI 10.1111/j.1600-065X.1998.tb01571.x; MORRISON ME, 1993, J EXP MED, V177, P1135, DOI 10.1084/jem.177.4.1135; NISHIHARA H, 1973, BIOCHIM BIOPHYS ACTA, V302, P429, DOI 10.1016/0005-2744(73)90172-1; Rich RL, 2000, J MOL RECOGNIT, V13, P388, DOI 10.1002/1099-1352(200011/12)13:6<388::AID-JMR516>3.0.CO;2-#; Richard E, 2000, J EXP MED, V192, P1223, DOI 10.1084/jem.192.9.1223; SANTISTEBAN I, 1995, HUM MOL GENET, V4, P2081, DOI 10.1093/hmg/4.11.2081; SANTISTEBAN I, 1993, J CLIN INVEST, V92, P2291, DOI 10.1172/JCI116833; SCHRADER WP, 1990, J BIOL CHEM, V265, P19312; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; Selzer T, 2000, NAT STRUCT BIOL, V7, P537; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; STEEG C, 1995, CELL IMMUNOL, V164, P311, DOI 10.1006/cimm.1995.1175; TANAKA T, 1993, P NATL ACAD SCI USA, V90, P4586, DOI 10.1073/pnas.90.10.4586; TIRUPPATHI C, 1990, J BIOL CHEM, V265, P1476; TIRUPPATHI C, 1993, AM J PHYSIOL, V265, pG81, DOI 10.1152/ajpgi.1993.265.1.G81; TROTTA PP, 1978, MOL PHARMACOL, V14, P199; Tsai CJ, 1997, PROTEIN SCI, V6, P53; VIVIER I, 1991, J IMMUNOL, V147, P447; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; WILSON DK, 1991, SCIENCE, V252, P1278, DOI 10.1126/science.1925539; YOUNG L, 1994, PROTEIN SCI, V3, P717	49	34	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19720	19726		10.1074/jbc.M111901200	http://dx.doi.org/10.1074/jbc.M111901200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11901152	hybrid			2022-12-27	WOS:000175894800064
J	Kaneko, S; Feldman, RI; Yu, L; Wu, ZG; Gritsko, T; Shelley, SA; Nicosia, SV; Nobori, T; Cheng, JQ				Kaneko, S; Feldman, RI; Yu, L; Wu, ZG; Gritsko, T; Shelley, SA; Nicosia, SV; Nobori, T; Cheng, JQ			Positive feedback regulation between Akt2 and MyoD during muscle differentiation - Cloning of Akt2 promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; TRANSCRIPTION FACTOR; SKELETAL MYOBLASTS; EXPRESSION; INSULIN; GROWTH; CELLS; ACTIVATION; INDUCTION; ONCOGENE	Akt2 is a member of the Akt/PKB family, which is involved in a variety of cellular events including cell survival, proliferation, and differentiation. During skeletal muscle differentiation, the Akt2 but not Akt1 expression was significantly increased. Microinjection of anti-Akt2 but not anti-Akt1 antibody efficiently abrogated myogenesis, indicating that Akt2 plays a specific role in muscle differentiation. It has been well documented that ectopic expression of MyoD is sufficient to induce muscle differentiation in myoblasts. However, the mechanism of induction of Akt2 during muscle differentiation and the significance of Akt2 protein in MyoD-induced myogenesis are largely unknown. In this study, we provide direct evidence that Akt2 is transcriptionally regulated by MyoD and activates MyoD-myocyte enhancer binding factor-2 (MEF2) transactivation activity. The Akt2 promoter was isolated and found to contain nine putative E-boxes (CANNTG), which are putative MyoD binding sites. Electrophoretic mobility shift analyses revealed that MyoD bound to eight of the sites. The expression of MyoD significantly enhanced Akt2 promoter activity and up-regulated Akt2 mRNA and protein levels. Moreover, Akt2 but not Akt1 was activated during differentiation. The expression of Akt2 activated MyoD-MEF2 transcriptional activity and induced myogenin expression. These data indicate that there is a positive feedback regulation loop between Akt2 and MyoD-MEF2 during muscle differentiation, which is essential for MyoD-induced myogenesis.	Univ S Florida, Coll Med, Dept Pathol, Tampa, FL 33612 USA; H Lee Moffitt Canc Ctr, Tampa, FL 33612 USA; Univ S Florida, Dept Pathol & Lab Med, Tampa, FL 33612 USA; Univ S Florida, Dept Mol Oncol, Tampa, FL 33612 USA; Univ S Florida, Drug Discovery Program, Tampa, FL 33612 USA; Res Inst, Tampa, FL 33612 USA; Berlex Biosci, Canc Res Dept, Richmond, CA 94804 USA; Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; Mie Univ, Lab Med, Tsu, Mie, Japan	State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Hong Kong University of Science & Technology; Mie University	Cheng, JQ (corresponding author), Univ S Florida, Coll Med, Dept Pathol, 12901 Bruce B Downes Blvd,MDC Box 11, Tampa, FL 33612 USA.		Wu, Zhenguo/B-8144-2013	Wu, Zhenguo/0000-0003-3049-8324	NATIONAL CANCER INSTITUTE [R01CA089242, R29CA077935, R01CA077935] Funding Source: NIH RePORTER; NCI NIH HHS [CA89242, CA77935] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altomare DA, 1998, ONCOGENE, V16, P2407, DOI 10.1038/sj.onc.1201750; ALTOMARE DA, 1995, ONCOGENE, V11, P1055; Arnold HH, 1998, CURR OPIN GENET DEV, V8, P539, DOI 10.1016/S0959-437X(98)80008-7; BELLACOSA A, 1993, ONCOGENE, V8, P745; Calera MR, 1998, BIOCHEM BIOPH RES CO, V251, P835, DOI 10.1006/bbrc.1998.9566; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; CHENG JQ, 1992, P NATL ACAD SCI USA, V89, P9267, DOI 10.1073/pnas.89.19.9267; Cheng JQ, 1997, ONCOGENE, V14, P2793, DOI 10.1038/sj.onc.1201121; Cheng JQ, 2001, ENCY REFERENCE CANC, P35; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; FLORINI JR, 1991, J BIOL CHEM, V266, P15917; Fujio Y, 1999, MOL CELL BIOL, V19, P5073; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Jiang BH, 1999, P NATL ACAD SCI USA, V96, P2077, DOI 10.1073/pnas.96.5.2077; Kitzmann M, 2001, CELL MOL LIFE SCI, V58, P571, DOI 10.1007/PL00000882; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; Tamir Y, 2000, J BIOL CHEM, V275, P34424, DOI 10.1074/jbc.M005815200; Tureckova J, 2001, J BIOL CHEM, V276, P39264, DOI 10.1074/jbc.M104991200; Vandromme M, 2001, J BIOL CHEM, V276, P8173, DOI 10.1074/jbc.M005587200; Xu Q, 2000, J BIOL CHEM, V275, P36750, DOI 10.1074/jbc.M005030200	29	45	47	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 28	2002	277	26					23230	23235		10.1074/jbc.M201733200	http://dx.doi.org/10.1074/jbc.M201733200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567FX	11948187	hybrid			2022-12-27	WOS:000176475700019
J	Lee, V; Chen, LW; Paiwand, F; Cao, L; Wu, YJ; Inman, R; Adamsi, ME; Yang, BB				Lee, V; Chen, LW; Paiwand, F; Cao, L; Wu, YJ; Inman, R; Adamsi, ME; Yang, BB			Cleavage of the carboxyl tail from the G3 domain of aggrecan but not versican and identification of the amino acids involved in the degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-LIKE MOTIFS; ARTICULAR-CARTILAGE; INTERGLOBULAR DOMAIN; G1 DOMAIN; MATRIX METALLOPROTEINASE; CELL-PROLIFERATION; PRODUCT SECRETION; SYNOVIAL-FLUID; LINK PROTEIN; CORE PROTEIN	Aggrecan, a major structural proteoglycan in cartilage, contains three globular domains, G1, G2, and G3, as well as sequences for glycosaminoglycan modification. A large number of proteases are implicated in aggrecan cleavage in normal metabolism, aging, and arthritis. These proteases are known to cleave at the IGD, KS, and CS domains. Here we report for the first time evidence of cleavage at a novel site, the carboxyl tail of aggrecan. Results from deletion mutants of the tail indicated that the likely cleavage sites were two consensus sequences, RRLXK and RSPR, present in the aggrecan analogs of many species. This was confirmed by site-directed mutagenesis. A construct containing two G3 domains (G3G3) was also found to cleave between the G3 duplicates. When G3 tail was linked to a glycosaminoglycan-modifying sequence, it was protected from cleavage. Furin inhibitor also reduced the levels of tail cleavage. The carboxyl tails of chicken and human versican were not cleaved, despite the presence of the consensus sequence. Our studies indicate that the basic amino acids present in the tail play an important role in cleavage, and this mechanism is specific to aggrecan.	Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M4N 3M5, Canada; Toronto Western Hosp, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Med & Immunol, Toronto, ON M4N 3M5, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Yang, BB (corresponding author), Sunnybrook & Womens Coll Hlth Sci Ctr, Res Bldg,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	burton.yang@swchsc.on.ca		Inman, Robert/0000-0002-4750-1422				Bennett BD, 2000, J BIOL CHEM, V275, P37712, DOI 10.1074/jbc.M005339200; BINETTE F, 1994, J BIOL CHEM, V269, P19116; CHANDRASEKARAN L, 1992, BIOCHEM J, V288, P903, DOI 10.1042/bj2880903; Chen LW, 2002, J BIOL CHEM, V277, P2657, DOI 10.1074/jbc.M101153200; Day JM, 1999, J BIOL CHEM, V274, P38107, DOI 10.1074/jbc.274.53.38107; Day R, 1998, J BIOL CHEM, V273, P829, DOI 10.1074/jbc.273.2.829; Domowicz MS, 2000, J BIOL CHEM, V275, P35098, DOI 10.1074/jbc.275.45.35098; Dufour EK, 2001, J BIOL CHEM, V276, P38971, DOI 10.1074/jbc.M102959200; FLANNERY CR, 1992, J BIOL CHEM, V267, P1008; FOSANG AJ, 1991, J BIOL CHEM, V266, P15579; Fosang AJ, 1996, J CLIN INVEST, V98, P2292, DOI 10.1172/JCI119040; ILIC MZ, 1992, ARCH BIOCHEM BIOPHYS, V294, P115, DOI 10.1016/0003-9861(92)90144-L; Kiani C, 2001, BIOCHEM J, V354, P199, DOI 10.1042/0264-6021:3540199; Lark MW, 1997, J CLIN INVEST, V100, P93, DOI 10.1172/JCI119526; LARK MW, 1995, J BIOL CHEM, V270, P2550, DOI 10.1074/jbc.270.6.2550; LI H, 1993, J BIOL CHEM, V268, P23504; LOHMANDER LS, 1995, J RHEUMATOL, V22, P75; LOHMANDER LS, 1993, ARTHRITIS RHEUM, V36, P1214; LOULAKIS P, 1992, BIOCHEM J, V284, P589, DOI 10.1042/bj2840589; Luo W, 1996, J BIOL CHEM, V271, P16447, DOI 10.1074/jbc.271.28.16447; MANICOURT DH, 1999, DYNAMICS BONE CARTIL, P301; MARGOLIS RU, 1994, METHOD ENZYMOL, V245, P105; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; NEAME PJ, 1993, EXPERIENTIA, V49, P393, DOI 10.1007/BF01923584; PERKINS SJ, 1989, J MOL BIOL, V206, P737, DOI 10.1016/0022-2836(89)90580-9; SANDY JD, 1992, J CLIN INVEST, V89, P1512, DOI 10.1172/JCI115742; SAXNE T, 1992, ARTHRITIS RHEUM, V35, P385, DOI 10.1002/art.1780350404; SHINOMURA T, 1993, J BIOL CHEM, V268, P14461; SINGER II, 1995, J CLIN INVEST, V95, P2178, DOI 10.1172/JCI117907; VERTEL BM, 1993, J BIOL CHEM, V268, P11105; WATANABE T, 1992, J BIOL CHEM, V267, P8270; Wu YJ, 2002, J BIOL CHEM, V277, P12294, DOI 10.1074/jbc.M110748200; Wu YJ, 2001, J BIOL CHEM, V276, P14178, DOI 10.1074/jbc.M100618200; Yang BB, 1998, MATRIX BIOL, V16, P541, DOI 10.1016/S0945-053X(98)90066-X; Yang BL, 2000, J BIOL CHEM, V275, P21255, DOI 10.1074/jbc.M001443200; Yang BL, 1999, J CELL BIOCHEM, V72, P210, DOI 10.1002/(SICI)1097-4644(19990201)72:2<210::AID-JCB5>3.0.CO;2-E; Zhang Y, 1999, J CELL BIOCHEM, V73, P445, DOI 10.1002/(SICI)1097-4644(19990615)73:4<445::AID-JCB3>3.0.CO;2-D; Zhang Y, 1998, J BIOL CHEM, V273, P33054, DOI 10.1074/jbc.273.49.33054; Zhang Y, 1998, J BIOL CHEM, V273, P21342, DOI 10.1074/jbc.273.33.21342; Zhang Y, 2001, EXP CELL RES, V263, P33, DOI 10.1006/excr.2000.5095; Zheng J, 1998, J BIOL CHEM, V273, P12999, DOI 10.1074/jbc.273.21.12999; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x	42	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22279	22288		10.1074/jbc.M110227200	http://dx.doi.org/10.1074/jbc.M110227200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11932252	hybrid			2022-12-27	WOS:000176313600023
J	Mans, BJ; Louw, AI; Neitz, AWH				Mans, BJ; Louw, AI; Neitz, AWH			Savignygrin, a platelet aggregation inhibitor from the soft tick Ornithodoros savignyi, presents the RGD integrin recognition motif on the Kunitz-BPTI fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-IIB-IIIA; FACTOR XA INHIBITOR; SALIVARY-GLANDS; FIBRINOGEN RECEPTOR; PROTEIN STRUCTURES; CELL-ADHESION; VIPER VENOMS; ANTAGONIST; MOUBATA; ARGASIDAE	Savignygrin, a platelet aggregation inhibitor that possesses the RGD integrin recognition motif, has been purified from the soft tick Ornithodoros savignyi. Two isoforms with similar biological activities differ because of R52G and N60G in their amino acid sequences, indicating a recent gene duplication event. Platelet aggregation induced by ADP (IC50,130 nM), collagen, the thrombin receptor-activating peptide, and epinephrine was inhibited, although platelets were activated and underwent a shape change. The binding of alpha-CD41 (P2) to platelets, the binding of purified alpha(IIb)beta(3) to fibrinogen, and the adhesion of platelets to fibrinogen was inhibited, indicating a targeting of the fibrinogen receptor. In contrast, the adhesion of osteosarcoma cells that express the integrin alpha(v)beta(3) to vitronectin or fibrinogen was not inhibited, indicating the specificity of savignygrin toward alpha(IIb)beta(3). Savignygrin shows sequence identity to disagregin, a platelet aggregation inhibitor from the tick Ornithodoros moubata that lacks an RGD motif. The cysteine arrangement of savignygrin is similar to that of the bovine pancreatic trypsin inhibitor family of serine protease inhibitors. A homology model based on the structure of the tick anticoagulant peptide indicates that the RGD motif is presented on the substrate-binding loop of the canonical BPTI inhibitors. However, savignygrin did not inhibit the serine proteases fXa, plasmin, thrombin, or trypsin. This is the first report of a platelet aggregation inhibitor that presents the RGD motif using the Kunitz-BPTI protein fold.	Univ Pretoria, Dept Biochem, ZA-0002 Pretoria, South Africa	University of Pretoria	Neitz, AWH (corresponding author), Univ Pretoria, Dept Biochem, ZA-0002 Pretoria, South Africa.	albert.neitz@bioagric.up.ac.za	Louw, Abraham I/A-5726-2008; Mans, Ben J./M-2427-2017	Mans, Ben J./0000-0002-0177-0029; Neitz, Albert/0000-0001-9248-8469; Louw, Abraham/0000-0002-8036-1513				ADLER M, 1991, SCIENCE, V253, P445, DOI 10.1126/science.1862345; ANDRIEUX A, 1989, J BIOL CHEM, V264, P9258; ANTUCH W, 1994, FEBS LETT, V352, P251, DOI 10.1016/0014-5793(94)00941-4; BEDNAR B, 1995, THROMB RES, V77, P453, DOI 10.1016/0049-3848(95)93881-Y; BEER JH, 1992, BLOOD, V79, P117; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; BRANDT WF, 1984, FEBS LETT, V174, P228, DOI 10.1016/0014-5793(84)81163-1; CALVETE JJ, 1995, P SOC EXP BIOL MED, V208, P346; CALVETE JJ, 1994, THROMB HAEMOSTASIS, V72, P1; CATTANEO M, 1987, BLOOD, V70, P221; CHEN CS, 1991, BIOCHIM BIOPHYS ACTA, V1075, P237, DOI 10.1016/0304-4165(91)90272-I; Clemetson KJ, 1998, CELL MOL LIFE SCI, V54, P499, DOI 10.1007/s000180050178; CREIGHTON TE, 1978, PROG BIOPHYS MOL BIO, V33, P231; FAHEY RC, 1977, J MOL EVOL, V10, P155, DOI 10.1007/BF01751808; Gaspar ARMD, 1996, EXP APPL ACAROL, V20, P583, DOI 10.1007/BF00052809; GIERASCH LM, 1989, BIOCHEMISTRY-US, V28, P923, DOI 10.1021/bi00429a001; GOULD RJ, 1990, P SOC EXP BIOL MED, V195, P168, DOI 10.3181/00379727-195-43129B; Grundy WN, 1999, BIOINFORMATICS, V15, P463, DOI 10.1093/bioinformatics/15.6.463; Huang TF, 1998, CELL MOL LIFE SCI, V54, P527, DOI 10.1007/s000180050181; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Joubert AM, 1998, EXP APPL ACAROL, V22, P603, DOI 10.1023/A:1006198713791; KARCZEWSKI J, 1995, BIOCHEM BIOPH RES CO, V208, P532, DOI 10.1006/bbrc.1995.1371; KARCZEWSKI J, 1994, J BIOL CHEM, V269, P6702; Karczewski J, 1997, BIOCHEM BIOPH RES CO, V241, P744, DOI 10.1006/bbrc.1997.7881; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; KREZEL AM, 1994, SCIENCE, V264, P1944, DOI 10.1126/science.8009227; KUNITANI M, 1986, J CHROMATOGR, V371, P313, DOI 10.1016/S0021-9673(01)94716-8; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LAW JH, 1992, ANNU REV BIOCHEM, V61, P87, DOI 10.1146/annurev.bi.61.070192.000511; LIU CZ, 1994, THROMB HAEMOSTASIS, V72, P919; Mans BJ, 1998, COMP BIOCHEM PHYS B, V120, P617, DOI 10.1016/S0305-0491(98)10061-5; Mans BJ, 2001, ELECTROPHORESIS, V22, P1739, DOI 10.1002/1522-2683(200105)22:9&lt;1739::AID-ELPS1739&gt;3.0.CO;2-7; Mans BJ, 1998, EXP APPL ACAROL, V22, P353, DOI 10.1023/A:1024517209621; Mans BJ, 2000, EXP APPL ACAROL, V24, P271, DOI 10.1023/A:1006440714276; MANS BJ, 2002, IN PRESS INSECT BIOC; MCGREGOR JL, 1983, EUR J BIOCHEM, V131, P427, DOI 10.1111/j.1432-1033.1983.tb07281.x; MCLACHLAN AD, 1982, ACTA CRYSTALLOGR A, V38, P871, DOI 10.1107/S0567739482001806; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nienaber J, 1999, EXP PARASITOL, V93, P82, DOI 10.1006/expr.1999.4448; PAN YCE, 1984, J CHROMATOGR, V297, P13, DOI 10.1016/S0021-9673(01)89024-5; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Plow EF, 2001, THROMB HAEMOSTASIS, V86, P34; Pritchard L, 1999, J MOL BIOL, V285, P1589, DOI 10.1006/jmbi.1998.2437; RIBEIRO JMC, 1991, COMP BIOCHEM PHYS A, V100, P109, DOI 10.1016/0300-9629(91)90190-N; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; SAUDEK V, 1991, BIOCHEMISTRY-US, V30, P7369, DOI 10.1021/bi00244a003; SCARBOROUGH RM, 1991, J BIOL CHEM, V266, P9359; SCARBOROUGH RM, 1993, J BIOL CHEM, V268, P1058; SENN H, 1993, J MOL BIOL, V232, P907, DOI 10.1006/jmbi.1993.1439; SEYMOUR JL, 1990, J BIOL CHEM, V265, P10143; Stuiver I, 1996, J CELL PHYSIOL, V168, P521, DOI 10.1002/(SICI)1097-4652(199609)168:3<521::AID-JCP4>3.0.CO;2-R; SUTCLIFFE MJ, 1994, NAT STRUCT BIOL, V1, P802, DOI 10.1038/nsb1194-802; TARR GE, 1986, MICROCHARACTERIZATIO, P155; vandeLocht A, 1996, EMBO J, V15, P6011, DOI 10.1002/j.1460-2075.1996.tb00989.x; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; Wang XN, 1996, J BIOL CHEM, V271, P17785, DOI 10.1074/jbc.271.30.17785; WAXMAN L, 1993, J BIOL CHEM, V268, P5445; WAXMAN L, 1990, SCIENCE, V248, P593, DOI 10.1126/science.2333510; Yuan YP, 1998, BIOINFORMATICS, V14, P285, DOI 10.1093/bioinformatics/14.3.285; ZUCKER MB, 1989, METHOD ENZYMOL, V169, P117	65	100	115	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21371	21378		10.1074/jbc.M112060200	http://dx.doi.org/10.1074/jbc.M112060200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11932256	hybrid			2022-12-27	WOS:000176286000034
J	Berlot, CH				Berlot, CH			A highly effective dominant negative alpha(s) construct containing mutations that affect distinct functions inhibits multiple G(s)-coupled receptor signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CALCITONIN RECEPTOR; G-PROTEINS; PLASMA-MEMBRANE; ADENYLYL-CYCLASE; LIGAND-BINDING; LIVING CELLS; ACTIVATION; SUBUNITS; LOCALIZATION; G(S)	To investigate the subcellular organization of receptor-G protein signaling pathways, a robust dominant negative a. mutant containing substitutions that alter distinct functions was produced and tested for its effects on G.-coupled receptor activity in HEK-293 cells. Mutations in the alpha3beta5 loop region, which increase receptor affinity, decrease receptor-mediated activation, and impair activation of adenylyl cyclase, were combined with G226A, which increases affinity for betagamma, and A366S, which decreases affinity for GDP. This triple a. mutant can inhibit signaling to G. from the luteinizing hormone receptor by 97% and from the calcitonin receptor by 100%. In addition, this alpha(s) mutant blocks all signaling from the calcitonin receptor to G(q). These results lead to two conclusions about receptor-G protein signaling. First, individual receptors have access to multiple types of G proteins in HEK-293 cell membranes. Second, different G protein a subunits can compete with each other for binding to the same receptor. This dominant negative a. construct will be useful for determining interrelationships among distinct receptor-G protein interactions in a wide variety of cells and tissues.	Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University	Berlot, CH (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA.	catherine.berlot@yale.edu			NIGMS NIH HHS [GM50369] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050369, R29GM050369] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BERLOT CH, 1992, CELL, V68, P911, DOI 10.1016/0092-8674(92)90034-A; CHABRE O, 1992, MOL ENDOCRINOL, V6, P551, DOI 10.1210/me.6.4.551; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Dippel E, 1996, P NATL ACAD SCI USA, V93, P1391, DOI 10.1073/pnas.93.4.1391; Gilchrist A, 2001, J BIOL CHEM, V276, P25672, DOI 10.1074/jbc.M100914200; GORN AH, 1995, J CLIN INVEST, V95, P2680, DOI 10.1172/JCI117970; GRAESER D, 1993, MOL PHARMACOL, V43, P434; Grishina G, 2000, MOL PHARMACOL, V57, P1081; GRUSSENMEYER T, 1985, P NATL ACAD SCI USA, V82, P7952, DOI 10.1073/pnas.82.23.7952; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Iiri T, 1997, P NATL ACAD SCI USA, V94, P5656, DOI 10.1073/pnas.94.11.5656; Iiri T, 1999, P NATL ACAD SCI USA, V96, P499, DOI 10.1073/pnas.96.2.499; IIRI T, 1994, NATURE, V371, P164, DOI 10.1038/371164a0; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; JESAITIS AJ, 1989, J CELL BIOL, V109, P2783, DOI 10.1083/jcb.109.6.2783; Jin T, 2000, SCIENCE, V287, P1034, DOI 10.1126/science.287.5455.1034; JONES DT, 1987, J BIOL CHEM, V262, P14241; Kallal L, 2000, TRENDS PHARMACOL SCI, V21, P175, DOI 10.1016/S0165-6147(00)01477-2; KLEUSS C, 1992, NATURE, V358, P424, DOI 10.1038/358424a0; KLEUSS C, 1991, NATURE, V353, P43, DOI 10.1038/353043a0; KLEUSS C, 1993, SCIENCE, V259, P832, DOI 10.1126/science.8094261; Kosugi S, 1996, J BIOL CHEM, V271, P31813, DOI 10.1074/jbc.271.50.31813; LEE E, 1992, J BIOL CHEM, V267, P1212; LEVINE MA, 1983, AM J MED, V74, P545, DOI 10.1016/0002-9343(83)91008-2; LEVIS MJ, 1992, J CELL BIOL, V119, P1297, DOI 10.1083/jcb.119.5.1297; MacrezLepretre N, 1997, J BIOL CHEM, V272, P10095; MCFARLAND KC, 1989, SCIENCE, V245, P494, DOI 10.1126/science.2502842; Medina R, 1996, J BIOL CHEM, V271, P24720, DOI 10.1074/jbc.271.40.24720; MILLER RT, 1988, NATURE, V334, P712, DOI 10.1038/334712a0; Min L, 2000, MOL ENDOCRINOL, V14, P1797, DOI 10.1210/me.14.11.1797; Moffett S, 2000, J BIOL CHEM, V275, P2191, DOI 10.1074/jbc.275.3.2191; MOORE EE, 1995, MOL ENDOCRINOL, V9, P959, DOI 10.1210/me.9.8.959; Neubig RR, 1998, SEMIN NEUROSCI, V9, P189, DOI 10.1006/smns.1997.0117; NEUBIG RR, 1994, FASEB J, V8, P939, DOI 10.1096/fasebj.8.12.8088459; NUSSENZVEIG DR, 1994, J BIOL CHEM, V269, P28123; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Ostrom RS, 2000, J PHARMACOL EXP THER, V294, P407; OTT S, 1989, J NEUROCHEM, V52, P619, DOI 10.1111/j.1471-4159.1989.tb09164.x; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; Saunders C, 1996, J BIOL CHEM, V271, P995, DOI 10.1074/jbc.271.2.995; Shyu JF, 1996, J BIOL CHEM, V271, P31127, DOI 10.1074/jbc.271.49.31127; SIMMONS MA, 1991, J NEUROSCI, V11, P2130; Skoglund G, 2000, DIABETES, V49, P1156, DOI 10.2337/diabetes.49.7.1156; STOW JL, 1991, AM J PHYSIOL, V261, pF831, DOI 10.1152/ajprenal.1991.261.5.F831; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Vezza R, 2001, MOL PHARMACOL, V59, P1506, DOI 10.1124/mol.59.6.1506; Wade SM, 1999, MOL PHARMACOL, V56, P1005, DOI 10.1124/mol.56.5.1005; WANG HY, 1992, NATURE, V358, P334, DOI 10.1038/358334a0; Wang Q, 1999, J BIOL CHEM, V274, P17365, DOI 10.1074/jbc.274.24.17365; Wang Q, 1997, J BIOL CHEM, V272, P26040, DOI 10.1074/jbc.272.41.26040; WATKINS DC, 1992, SCIENCE, V258, P1373, DOI 10.1126/science.1455234; Yu B, 1998, J BIOL CHEM, V273, P30183, DOI 10.1074/jbc.273.46.30183; Yu B, 2000, J BIOL CHEM, V275, P71, DOI 10.1074/jbc.275.1.71	55	38	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					21080	21085		10.1074/jbc.M201330200	http://dx.doi.org/10.1074/jbc.M201330200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11927592	hybrid			2022-12-27	WOS:000176204500123
J	Field, SJ; Prior, L; Roldan, MD; Cheesman, MR; Thomson, AJ; Spiro, S; Butt, JN; Watmought, NJ; Richardson, DJ				Field, SJ; Prior, L; Roldan, MD; Cheesman, MR; Thomson, AJ; Spiro, S; Butt, JN; Watmought, NJ; Richardson, DJ			Spectral properties of bacterial nitric-oxide reductase - Resolution of pH-dependent forms of the active site heme b(3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNETIC CIRCULAR-DICHROISM; PARACOCCUS-DENITRIFICANS; HORSERADISH-PEROXIDASE; SOYBEAN LEGHEMOGLOBIN; DINUCLEAR CENTER; COPPER OXIDASES; LIGATION; PURIFICATION; TEMPERATURE; MYOGLOBIN	Bacterial nitric-oxide reductase catalyzes the two electron reduction of nitric oxide to nitrous oxide. In the oxidized form the active site non-heme Fe-B and high spin heme b(3) are mu-oxo bridged. The heme b(3) has a ligand-to-metal charge transfer band centered at 595 nm, which is insensitive to pH over the range of 6.0-8.5. Partial reduction of nitric-oxide reductase yields a three electron-reduced state where only the heme b(3) remains oxidized. This results in a shift of the heme b(3) charge transfer band lambda(max) to longer wavelengths. At pH 6.0 the charge transfer band lambda(max) is 605 nm, whereas at pH 8.5 it is 635 nm. At pH 6.5 and 7.5 the nitric-oxide reductase ferric heme b(3) population is a mixture of both 605- and 635-nm forms. Magnetic circular dichroism spectroscopy suggests that at all pH values examined the proximal ligand to the ferric heme b(3) in the three electron-reduced form is histidine. At pH 8.5 the distal ligand is hydroxide, whereas at pH 6.0, when the enzyme is most active, it is water.	Univ E Anglia, Sch Biol Sci, Ctr Met Proc Spect, Norwich NR4 7TJ, Norfolk, England; Univ E Anglia, Sch Chem Sci, Ctr Met Proc Spect, Norwich NR4 7TJ, Norfolk, England	University of East Anglia; University of East Anglia	Richardson, DJ (corresponding author), Univ E Anglia, Sch Biol Sci, Ctr Met Proc Spect, Norwich NR4 7TJ, Norfolk, England.	d.richardson@uea.ac.uk	Watmough, Nicholas J/A-6643-2010; Butt, Julea/E-2133-2011; Roldán Ruiz, María Dolores/K-4370-2014; Spiro, Stephen/B-1838-2009; Richardson, David J/E-2275-2011	Watmough, Nicholas J/0000-0001-5901-6750; Butt, Julea/0000-0002-9624-5226; Roldán Ruiz, María Dolores/0000-0001-7173-8641; Spiro, Stephen/0000-0001-5975-9984; 				BRACETE AM, 1991, BIOCHIM BIOPHYS ACTA, V1080, P264, DOI 10.1016/0167-4838(91)90012-O; BRILL AS, 1961, BIOCHEM J, V78, P246, DOI 10.1042/bj0780246; Butland G, 2001, J BACTERIOL, V183, P189, DOI 10.1128/JB.183.1.189-199.2001; Cheesman MR, 1998, BIOCHEMISTRY-US, V37, P3994, DOI 10.1021/bi972437y; CHENG JC, 1973, NATURE, V241, P193, DOI 10.1038/241193a0; Cramm R, 1999, FEBS LETT, V460, P6, DOI 10.1016/S0014-5793(99)01315-0; DAWSON JH, 1976, J AM CHEM SOC, V98, P3707, DOI 10.1021/ja00428a054; DAWSON JH, 1989, PHYSICAL BIOINORGANI; DEGIER JWL, 1994, MOL MICROBIOL, V13, P183, DOI 10.1111/j.1365-2958.1994.tb00414.x; DERMASTIA M, 1991, J BIOL CHEM, V266, P10899; Dutton P L, 1978, Methods Enzymol, V54, P411; EGLINTON DG, 1983, BIOCHIM BIOPHYS ACTA, V742, P648, DOI 10.1016/0167-4838(83)90284-4; Girsch P, 1997, BBA-BIOENERGETICS, V1318, P202, DOI 10.1016/S0005-2728(96)00138-7; Gronberg KLC, 1999, BIOCHEMISTRY-US, V38, P13780, DOI 10.1021/bi9916426; HEISS B, 1989, J BACTERIOL, V171, P3288, DOI 10.1128/jb.171.6.3288-3297.1989; Hendriks J, 1998, J BIOENERG BIOMEMBR, V30, P15, DOI 10.1023/A:1020547225398; Hendriks J, 1998, BIOCHEMISTRY-US, V37, P13102, DOI 10.1021/bi980943x; Hendriks JHM, 2001, BIOCHEMISTRY-US, V40, P13361, DOI 10.1021/bi011428t; Jones DK, 1998, BIOCHEM J, V330, P983; KOBAYASHI N, 1977, BIOCHIM BIOPHYS ACTA, V493, P340, DOI 10.1016/0005-2795(77)90190-8; Moenne-Loccoz P, 2000, J AM CHEM SOC, V122, P9344, DOI 10.1021/ja0016295; MONKARA F, 1992, BIOCHIM BIOPHYS ACTA, V1100, P184; NOZAWA T, 1976, BIOCHIM BIOPHYS ACTA, V427, P652, DOI 10.1016/0005-2795(76)90209-9; Sakurai N, 1997, BIOCHEMISTRY-US, V36, P13809, DOI 10.1021/bi971070u; SEWARD HE, 1999, THESIS U E ANGLIA; SHINIJI K, 2001, J INORG BIOCHEM, V83, P281; SIEVERS G, 1983, BIOCHIM BIOPHYS ACTA, V742, P637, DOI 10.1016/0167-4838(83)90283-2; SPRINGALL J, 1976, BIOCHIM BIOPHYS ACTA, V453, P494, DOI 10.1016/0005-2795(76)90145-8; Suharti, 2001, BIOCHEMISTRY-US, V40, P2632, DOI 10.1021/bi0020067; VICKERY L, 1976, J AM CHEM SOC, V98, P343, DOI 10.1021/ja00418a005; Watmough NJ, 1998, J BIOENERG BIOMEMBR, V30, P55, DOI 10.1023/A:1020507511285; Watmough NJ, 1999, BBA-BIOENERGETICS, V1411, P456, DOI 10.1016/S0005-2728(99)00032-8; YOSHIDA S, 1975, BIOCHIM BIOPHYS ACTA, V405, P122, DOI 10.1016/0005-2795(75)90322-0	33	40	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20146	20150		10.1074/jbc.M112202200	http://dx.doi.org/10.1074/jbc.M112202200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11901154	hybrid			2022-12-27	WOS:000176204500009
J	Ishikawa, S; Core, L; Perego, M				Ishikawa, S; Core, L; Perego, M			Biochemical characterization of aspartyl phosphate phosphatase interaction with a phosphorylated response regulator and its inhibition by a pentapeptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; SIGNAL-TRANSDUCTION; SPORULATION; 2-COMPONENT; PROTEINS; REPEAT; SPO0F; IGG	The RapA and RapB proteins are aspartyl phosphate phosphatases that specifically dephosphorylate the Spo0Fsimilar toP intermediate response regulator of the phosphorelay signal transduction system for sporulation initiation in Bacillus subtilis. The similar to48-kDa His-tag derivative proteins were purified by metal affinity chromatography, and their molecular and biochemical characteristics were studied. RapA and RapB were found to be dimers in solution. Enzymatic activity was strongly dependent upon maintaining reducing conditions during purification and storage. RapA phosphatase activity on Spo0Fsimilar toP is inhibited in vivo by a pentapeptide generated from the phrA gene. Native gel assays demonstrated that the RapA dimer forms a stable complex with two molecules of Spo0Fsimilar toP or with its PhrA pentapeptide inhibitor. The pentapeptide was shown to displace Spo0Fsimilar toP from a preformed complex with RapA. The structural organization of Rap phosphatases in tetratricopeptide repeats provides insights on the mechanisms of RapA interaction with its substrate and its inhibitor.	Scripps Res Inst, Res Inst, Dept Mol & Expt Med, Div Cellular Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Perego, M (corresponding author), Scripps Res Inst, Res Inst, Dept Mol & Expt Med, Div Cellular Biol, MEM-116,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	mperego@scripps.edu	Ishikawa, Shu/K-5383-2017	Ishikawa, Shu/0000-0002-2239-1116	NIGMS NIH HHS [GM55594] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055594] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABERG A, 1989, J BIOL CHEM, V264, P12249; [Anonymous], 1982, MOL CLONING LAB MANU; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; BURBULYS D, 1991, CELL, V64, P545, DOI 10.1016/0092-8674(91)90238-T; Core LJ, 2001, PEPTIDES, V22, P1549, DOI 10.1016/S0196-9781(01)00491-0; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; Hanly W. Carey, 1995, ILAR J, V37, P93; Harlow E., 1988, ANTIBODIES LAB MANUA; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Jiang M, 2000, J BACTERIOL, V182, P303, DOI 10.1128/JB.182.2.303-310.2000; Jiang M, 2000, MOL MICROBIOL, V38, P535, DOI 10.1046/j.1365-2958.2000.02148.x; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; MUELLER JP, 1992, J BACTERIOL, V174, P4361, DOI 10.1128/JB.174.13.4361-4373.1992; Perego M, 1998, TRENDS MICROBIOL, V6, P366, DOI 10.1016/S0966-842X(98)01350-X; Perego M, 1997, P NATL ACAD SCI USA, V94, P8612, DOI 10.1073/pnas.94.16.8612; PEREGO M, 1994, CELL, V79, P1047, DOI 10.1016/0092-8674(94)90035-3; Perego M, 2001, PEPTIDES, V22, P1541, DOI 10.1016/S0196-9781(01)00490-9; Perego Marta, 1993, P615; RUSSO C, 1983, J IMMUNOL METHODS, V65, P269, DOI 10.1016/0022-1759(83)90324-1; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P701; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; STEINBUCH M, 1969, ARCH BIOCHEM BIOPHYS, V134, P279, DOI 10.1016/0003-9861(69)90285-9; TRACH K, 1990, GENETICS BIOTECHNOLO, V3, P357; Tzeng YL, 1997, J MOL BIOL, V272, P200, DOI 10.1006/jmbi.1997.1226; Tzeng YL, 1998, BIOCHEMISTRY-US, V37, P16538, DOI 10.1021/bi981340o; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	30	42	44	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20483	20489		10.1074/jbc.M201086200	http://dx.doi.org/10.1074/jbc.M201086200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11923303	hybrid			2022-12-27	WOS:000176204500050
J	Rief, N; Lobrich, M				Rief, N; Lobrich, M			Efficient rejoining of radiation-induced DNA double-strand breaks in centromeric DNA of human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOLOGY-DIRECTED REPAIR; RIBOSOMAL-RNA GENES; LIGASE-IV; CHROMOSOME-ABERRATIONS; RESTRICTION FRAGMENTS; ALPHA-SATELLITE; END; RECOMBINATION; DAMAGE; HETEROGENEITY	Although major efforts in elucidating different DNA double-strand break (DSB) repair pathways and their contribution to accurate repair or misrepair have been made, little is known about the influence of chromatin structure on the fidelity of DSB repair. Here, the repair of ionizing radiation-induced DSBs was investigated in heterochromatic centromeric regions of human cells in comparison with other genomic locations. A hybridization assay was applied that allows the quantification of correct DSB rejoining events in specific genomic regions by measuring reconstitution of large restriction fragments. We show for two primary fibroblast lines (MRC-5 and 1801311) and an epithelial tumor cell line that restriction fragment reconstitution is considerably more efficient in the centromere than in average genomic locations. Importantly, however, DNA ligase IV-deficient 1801311 cells show, compared with repair-proficient MRC-5 cells, impaired restriction fragment reconstitution both in average DNA and in the centromere. Thus, the efficient repair of DSBs in centromeric DNA is dependent on functional non-homologous end joining. It is proposed that the condensed chromatin state in the centromere limits the mobility of break ends and leads to enhanced restriction fragment reconstitution by increasing the probability for rejoining correct break ends.	Univ Saarland, Fachrichtung Biophys, D-66421 Homburg, Germany	Saarland University	Lobrich, M (corresponding author), Univ Saarland, Fachrichtung Biophys, D-66421 Homburg, Germany.	markus.loebrich@uniklinik-saarland.de						Badie C, 1997, CANCER RES, V57, P4600; BARTHOLDI MF, 1991, J CELL SCI, V99, P255; Chernikova SB, 1999, RADIAT RES, V151, P159, DOI 10.2307/3579766; Choo KHA., 1997, CENTROMERE; CORNFORTH MN, 1993, ADV RADIAT BIOL, V17, P423; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; DARROUDI F, 1987, MUTAT RES, V177, P149, DOI 10.1016/0027-5107(87)90030-3; DARZYNKIEWICZ Z, 1994, METHOD CELL BIOL, V41, P15; DEVILEE P, 1986, CYTOGENET CELL GENET, V41, P193, DOI 10.1159/000132229; DEVILEE P, 1986, NUCLEIC ACIDS RES, V14, P2059, DOI 10.1093/nar/14.5.2059; Dibiase SJ, 2000, CANCER RES, V60, P1245; DIKOMEY E, 1993, INT J RADIAT BIOL, V64, P659, DOI 10.1080/09553009314551901; DIKOMEY E, 1988, INT J RADIAT BIOL, V73, P269; Evans JW, 1996, RADIAT RES, V145, P39, DOI 10.2307/3579193; FISHMANLOBELL J, 1992, MOL CELL BIOL, V12, P1292, DOI 10.1128/MCB.12.3.1292; Fouladi B, 2000, RADIAT RES, V153, P795, DOI 10.1667/0033-7587(2000)153[0795:CORODD]2.0.CO;2; FRANKENBERGSCHWAGER M, 1989, RADIOTHER ONCOL, V14, P307, DOI 10.1016/0167-8140(89)90143-6; Fukushima T, 2001, J BIOL CHEM, V276, P44413, DOI 10.1074/jbc.M106295200; Gilbert N, 2001, P NATL ACAD SCI USA, V98, P11949, DOI 10.1073/pnas.211322798; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; ICHIKAWA H, 1992, P NATL ACAD SCI USA, V89, P23, DOI 10.1073/pnas.89.1.23; ILIAKIS GE, 1990, INT J RADIAT BIOL, V57, P1213, DOI 10.1080/09553009014551301; Jeggo PA, 1998, ADV GENET, V38, P185, DOI 10.1016/S0065-2660(08)60144-3; Johnson RD, 2001, BIOCHEM SOC T, V29, P196, DOI 10.1042/BST0290196; Karran P, 2000, CURR OPIN GENET DEV, V10, P144, DOI 10.1016/S0959-437X(00)00069-1; KEMP LM, 1986, MUTAT RES, V166, P255, DOI 10.1016/0167-8817(86)90025-8; Kuhne M, 2000, INT J RADIAT BIOL, V76, P891, DOI 10.1080/09553000050050909; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Lobrich M, 2000, GENE CHROMOSOME CANC, V27, P59; Lobrich M, 1995, P NATL ACAD SCI USA, V92, P12050, DOI 10.1073/pnas.92.26.12050; MADEN BEH, 1987, BIOCHEM J, V246, P519, DOI 10.1042/bj2460519; MANUELIDIS L, 1976, NUCLEIC ACIDS RES, V3, P3063, DOI 10.1093/nar/3.11.3063; MCGAHON AJ, 1995, METHOD CELL BIOL, V46, P153; MUHLMANNDIAZ MC, 1994, CHROMOSOMAL ALTERATI, P125; Murphy TD, 1998, CELL, V93, P317, DOI 10.1016/S0092-8674(00)81158-7; Overhauser J., 1992, PULSED FIELD GEL ELE, P129; Riballo E, 1999, CURR BIOL, V9, P699, DOI 10.1016/S0960-9822(99)80311-X; Riballo E, 2001, J BIOL CHEM, V276, P31124, DOI 10.1074/jbc.M103866200; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; Rothkamm K, 1999, MUTAT RES-DNA REPAIR, V433, P193, DOI 10.1016/S0921-8777(99)00008-7; Rothkamm K, 2001, CANCER RES, V61, P3886; Sax K, 1938, GENETICS, V23, P494; Schwartz L M, 1995, Methods Cell Biol, V46, pxv; Shelby RD, 1996, J CELL BIOL, V135, P545, DOI 10.1083/jcb.135.3.545; SLIJEPCEVIC P, 1994, INT J RADIAT BIOL, V66, P747; Sonoda E, 2001, P NATL ACAD SCI USA, V98, P8388, DOI 10.1073/pnas.111006398; SRIVASTAVA AK, 1993, MAMM GENOME, V4, P445, DOI 10.1007/BF00296819; Sullivan KF, 1999, METHOD CELL BIOL, V58, P183; Surralles J, 1997, GENE CHROMOSOME CANC, V20, P173, DOI 10.1002/(SICI)1098-2264(199710)20:2<173::AID-GCC8>3.3.CO;2-A; Tabocchini MA, 2000, MUTAT RES-DNA REPAIR, V461, P71, DOI 10.1016/S0921-8777(00)00041-0; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Thompson LH, 1999, BIOCHIMIE, V81, P87, DOI 10.1016/S0300-9084(99)80042-X; Thompson LH, 2001, MUTAT RES-FUND MOL M, V477, P131, DOI 10.1016/S0027-5107(01)00115-4; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Wachsberger PR, 1999, RADIAT RES, V151, P398, DOI 10.2307/3579826; Wang HC, 2001, NUCLEIC ACIDS RES, V29, P1653, DOI 10.1093/nar/29.8.1653; Wang HC, 2001, ONCOGENE, V20, P2212, DOI 10.1038/sj.onc.1204350; Willard HF, 1991, CURR OPIN GENET DEV, V1, P509, DOI 10.1016/S0959-437X(05)80200-X; WORTON RG, 1988, SCIENCE, V239, P64, DOI 10.1126/science.3336775; Xiao Y, 1999, INT J RADIAT BIOL, V75, P419, DOI 10.1080/095530099140339	61	28	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20572	20582		10.1074/jbc.M200265200	http://dx.doi.org/10.1074/jbc.M200265200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11927583	hybrid			2022-12-27	WOS:000176204500062
J	Yang, YK; Chen, M; Lai, YM; Gantz, I; Georgeson, KE; Harmon, CM				Yang, YK; Chen, M; Lai, YM; Gantz, I; Georgeson, KE; Harmon, CM			Molecular determinants of human melanocortin-4 receptor responsible for antagonist SHU9119 selective activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGOUTI-RELATED PROTEIN; ALPHA-MELANOTROPIN; FRAMESHIFT MUTATION; BIOLOGICAL-ACTIVITY; IN-VITRO; OBESITY; ANALOGS; AGONIST; HORMONE; RATS	The hypothalamic melanocortin-4 receptor (MC4R), a seven transmembrane G-protein-coupled receptor, plays an important role in the regulation of body weight. The synthetic melanocortin analog SHU9119 has been widely used to characterize the physiological role of MC4R in feeding behavior and energy homeostasis. Previous studies indicated that SHU9119 is an agonist at the melanocortin-1 receptor (MC1R) but an antagonist at the MC4R. However, the molecular basis of the interaction between hMC4R and SHU9119 has not been clearly defined. To gain insight into the molecular determinants of hMC4R in the selectivity of SHU9119 chimeras and mutants hMC1R and hMC4R were expressed in cell lines and pharmacologically analyzed. A region of receptor containing the third transmembrane of hMC4R was found to be required for selective SHU9119 antagonism. Further mutagenesis studies of this region of hMC4R demonstrated that the amino acid residue leucine 133 in the third transmembrane was critical for the selective antagonist activity of SHU9119. The single substitution of leucine 133 to methionine did not affect SHU9119 binding to hMC4R. However, this substitution did convert SHU9119 from an antagonist to an agonist. Conversely, exchange of Met(128) in hMC1R to Leu, the homologous residue 133 of hMC4R, displayed a reduction in SHU9119 binding affinity and potency. This report provides the details of the molecular recognition of SHU9119 antagonism at hMC4R and shows that amino acid Leu(133) of hMC4R plays a key role in melanocortin receptor subtype specificity.	Univ Alabama, Div Pediat Surg, Dept Surg, Birmingham, AL 35233 USA; Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA	University of Alabama System; University of Alabama Birmingham; University of Michigan System; University of Michigan	Harmon, CM (corresponding author), Univ Alabama, Div Pediat Surg, Dept Surg, 300 ACC,1600 7th Ave S, Birmingham, AL 35233 USA.							Bednarek MA, 2000, BIOCHEM BIOPH RES CO, V272, P23, DOI 10.1006/bbrc.2000.2589; Benoit SC, 2000, J NEUROSCI, V20, P3442, DOI 10.1523/JNEUROSCI.20-09-03442.2000; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Gu W, 1999, DIABETES, V48, P635, DOI 10.2337/diabetes.48.3.635; Haskell-Luevano C, 2000, PEPTIDES, V21, P49, DOI 10.1016/S0196-9781(99)00167-9; Haskell-Luevano C, 2001, BIOCHEMISTRY-US, V40, P6164, DOI 10.1021/bi010025q; HaskellLuevano C, 1997, J MED CHEM, V40, P1738, DOI 10.1021/jm960845e; Hinney A, 1999, J CLIN ENDOCR METAB, V84, P1483, DOI 10.1210/jc.84.4.1483; HRUBY VJ, 1995, J MED CHEM, V38, P3454, DOI 10.1021/jm00018a005; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jonsson L, 2001, NEUROREPORT, V12, P3703, DOI 10.1097/00001756-200112040-00020; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Raposinho PD, 2000, ENDOCRINOLOGY, V141, P4419, DOI 10.1210/en.141.12.4419; SADAFFAROOGI I, 2000, J CLIN INVEST, V106, P271; SAWYER TK, 1982, P NATL ACAD SCI-BIOL, V79, P1751, DOI 10.1073/pnas.79.6.1751; SAWYER TK, 1980, P NATL ACAD SCI-BIOL, V77, P5754, DOI 10.1073/pnas.77.10.5754; Schioth HB, 1996, LIFE SCI, V59, P797, DOI 10.1016/0024-3205(96)00370-0; Schioth HB, 1997, PEPTIDES, V18, P1009, DOI 10.1016/S0196-9781(97)00079-X; Schioth HB, 1999, NEUROPEPTIDES, V33, P191, DOI 10.1054/npep.1999.0760; Thiele TE, 1998, AM J PHYSIOL-REG I, V274, pR248, DOI 10.1152/ajpregu.1998.274.1.R248; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Vrinten DH, 2001, ANESTH ANALG, V93, P1572, DOI 10.1097/00000539-200112000-00052; Yang Y, 2000, BIOCHEMISTRY-US, V39, P14900, DOI 10.1021/bi001684q; Yang YK, 1997, J BIOL CHEM, V272, P23000, DOI 10.1074/jbc.272.37.23000; Yang YK, 1999, J BIOL CHEM, V274, P14100, DOI 10.1074/jbc.274.20.14100; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404	27	65	65	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20328	20335		10.1074/jbc.M201343200	http://dx.doi.org/10.1074/jbc.M201343200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11912210	hybrid			2022-12-27	WOS:000176204500031
J	Hartman, HB; Hu, X; Tyler, KX; Dalal, CK; Lazar, MA				Hartman, HB; Hu, X; Tyler, KX; Dalal, CK; Lazar, MA			Mechanisms regulating adipocyte expression of resistin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-RECEPTOR-GAMMA; BINDING-PROTEIN-ALPHA; OB GENE-EXPRESSION; PPAR-GAMMA; ADIPOSE-TISSUE; TRANSCRIPTIONAL ACTIVATION; HISTONE H3; ANTIDIABETIC THIAZOLIDINEDIONE; INSULIN-RESISTANCE; 3T3-L1 ADIPOCYTES	Resistin, also known as Adipocyte Secreted Factor (ADSF) and Found in Inflammatory Zone 3 (FIZZ3), is a mouse protein with potential roles in insulin resistance and adipocyte differentiation. The resistin gene is expressed almost exclusively in adipocytes. Here we show that a proximal 264-base pair fragment of the mouse resistin promoter is sufficient for expression in adipocytes. Ectopic expression of the adipogenic transcription factor CCAAT/enhancer-binding protein (C/EBPalpha) was sufficient for expression in non-adipogenic cells. C/EBPalpha binds specifically to a site that is essential for expression of the resistin promoter. Chromatin immunoprecipitation studies of the endogenous gene demonstrated adipocyte-specific association of C/EBPalpha with the proximal resistin promoter in adipocytes but not preadipocytes. C/EBPalpha binding was associated with the recruitment of coactivators p300 and CREB-binding protein and a dramatic increase in histone acetylation in the vicinity of the resistin promoter. The antidiabetic thiazolidinedione (TZD) drug rosiglitazone reduced resistin expression with an ED50 similar to its K-d for binding to peroxisome proliferator activated receptor gamma (PPARgamma). Other TZD- and non-TZD PPARgamma ligands also down-regulated resistin expression. However, no functional PPARgamma binding site was found within 6.2 kb of the transcriptional start site, suggesting that if PPARgamma is involved, it is either acting at a long distance from the start site, in an intron, or indirectly. Nevertheless, rosiglitazone treatment selectively decreased histone acetylation at the resistin promoter without a change in occupation by C/EBPalpha, CREB-binding protein, or p300. Thus, adipocyte specificity of resistin gene expression is because of C/EBPalpha binding, leading to the recruitment of transcriptional coactivators and histone acetylation that is characteristic of an active chromatin environment. TZD reduces resistin gene expression at least in part by reducing histone acetylation associated with the binding of C/EBPalpha in mature adipocytes.	Univ Penn, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Penn Diabet Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Lazar, MA (corresponding author), Univ Penn, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, 611 CRB,415 Curie Blvd, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Lazar, Mitchell A/AAF-3738-2019		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049780, P01DK049210] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK49210, DK49780] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Benoit G, 1999, EMBO J, V18, P7011, DOI 10.1093/emboj/18.24.7011; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Berger SL, 2001, SCIENCE, V292, P64; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Brunmair B, 2001, DIABETES, V50, P2309, DOI 10.2337/diabetes.50.10.2309; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Davies GF, 2001, BIOCHEM PHARMACOL, V62, P1071, DOI 10.1016/S0006-2952(01)00764-X; DeVos P, 1996, J CLIN INVEST, V98, P1004, DOI 10.1172/JCI118860; El-Jack AK, 1999, J BIOL CHEM, V274, P7946, DOI 10.1074/jbc.274.12.7946; Erickson RL, 2001, J BIOL CHEM, V276, P16348, DOI 10.1074/jbc.M100128200; Ferreira R, 2001, EMBO REP, V2, P794, DOI 10.1093/embo-reports/kve173; FLIER JS, 1995, CELL, V80, P15, DOI 10.1016/0092-8674(95)90445-X; Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200; Hamm JK, 1999, ANN NY ACAD SCI, V892, P134, DOI 10.1111/j.1749-6632.1999.tb07792.x; Haugen F, 2001, FEBS LETT, V507, P105, DOI 10.1016/S0014-5793(01)02968-4; HE YF, 1995, J BIOL CHEM, V270, P28887, DOI 10.1074/jbc.270.48.28887; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; Hollenberg AN, 1997, J BIOL CHEM, V272, P5283, DOI 10.1074/jbc.272.8.5283; Hwang CS, 1996, P NATL ACAD SCI USA, V93, P873, DOI 10.1073/pnas.93.2.873; Jonke J, 2002, OBES RES, V10, P1; Kallen CB, 1996, P NATL ACAD SCI USA, V93, P5793, DOI 10.1073/pnas.93.12.5793; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kao HY, 2002, J BIOL CHEM, V277, P187, DOI 10.1074/jbc.M108931200; Kim JH, 2001, J BIOL CHEM, V276, P24667, DOI 10.1074/jbc.M010793200; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; LEHMANN JM, 1992, SCIENCE, V258, P1944, DOI 10.1126/science.1335166; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Li M, 2000, MOL CELL BIOL, V20, P4699, DOI 10.1128/MCB.20.13.4699-4707.2000; LI Y, 2002, IN PRESS MOL ENDOCRI, V16; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Mandrup S, 1997, J BIOL CHEM, V272, P5367, DOI 10.1074/jbc.272.9.5367; McTernan CL, 2002, LANCET, V359, P46, DOI 10.1016/S0140-6736(02)07281-1; Mukherjee R, 1997, NATURE, V386, P407, DOI 10.1038/386407a0; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; Nagaev I, 2001, BIOCHEM BIOPH RES CO, V285, P561, DOI 10.1006/bbrc.2001.5173; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Rangwala SM, 2000, ANNU REV NUTR, V20, P535, DOI 10.1146/annurev.nutr.20.1.535; Reitman ML, 2000, TRENDS ENDOCRIN MET, V11, P410, DOI 10.1016/S1043-2760(00)00309-X; Rocchi S, 2001, MOL CELL, V8, P737, DOI 10.1016/S1097-2765(01)00353-7; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; ROY DY, 1995, MOL CELL BIOL, V15, P6481; Savage DB, 2001, DIABETES, V50, P2199, DOI 10.2337/diabetes.50.10.2199; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; Shao DL, 1997, J BIOL CHEM, V272, P21473, DOI 10.1074/jbc.272.34.21473; SPIEGELMAN BM, 1988, TRENDS GENET, V4, P203, DOI 10.1016/0168-9525(88)90077-7; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Steppan CM, 2001, P NATL ACAD SCI USA, V98, P502, DOI 10.1073/pnas.98.2.502; Subbaramaiah K, 2001, J BIOL CHEM, V276, P12440, DOI 10.1074/jbc.M007237200; Takata Y, 2001, J BIOL CHEM, V276, P12893, DOI 10.1074/jbc.M011655200; Taneja R, 1996, P NATL ACAD SCI USA, V93, P6197, DOI 10.1073/pnas.93.12.6197; Umemiya H, 1997, BIOCHEM BIOPH RES CO, V233, P121, DOI 10.1006/bbrc.1997.6414; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; WU ZD, 1995, GENE DEV, V9, P2350, DOI 10.1101/gad.9.19.2350; Zamir I, 1997, GENE DEV, V11, P835, DOI 10.1101/gad.11.7.835; Zhang B, 1996, J BIOL CHEM, V271, P9455, DOI 10.1074/jbc.271.16.9455; Zhang JS, 1997, MOL CELL BIOL, V17, P6887, DOI 10.1128/MCB.17.12.6887	70	125	136	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19754	19761		10.1074/jbc.M201451200	http://dx.doi.org/10.1074/jbc.M201451200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11901161	hybrid			2022-12-27	WOS:000175894800068
J	Kokoska, RJ; Bebenek, K; Boudsocq, F; Woodgate, R; Kunkel, TA				Kokoska, RJ; Bebenek, K; Boudsocq, F; Woodgate, R; Kunkel, TA			Low fidelity DNA synthesis by a Y family DNA polymerase due to misalignment in the active site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN DINB1 GENE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; POL-ETA; SULFOLOBUS-SOLFATARICUS; XERODERMA-PIGMENTOSUM; REVERSE-TRANSCRIPTASE; INDUCED MUTAGENESIS; ADAPTIVE MUTATION; ERROR-PRONE	Sulfolobus solfataricus DNA polymerase IV (Dpo4) is a member of the Y family of DNA polymerases whose crystal structure has recently been solved. As a model for other evolutionarily conserved Y family members that perform translesion DNA synthesis and have low fidelity, we describe here the base substitution and frameshift fidelity of DNA synthesis by Dpo4. Dpo4 generates all 12 base-base mismatches at high rates, 11 of which are similar to those of its human homolog, DNA polymerase kappa This result is consistent with the Dpo4 structure, implying lower geometric selection for correct base pairs. Surprisingly, Dpo4 generates C-dCMP mismatches at an unusually high average rate and preferentially at cytosine Ranked by 5'-template guanine. Dpo4 also has very low frameshift fidelity and frequently generates deletions of even noniterated nucleotides, especially cytosine flanked by a W-template guanine. Both unusual features of error specificity suggest that Dpo4 can incorporate dNTP precursors when two template nucleotides are present in the active site binding pocket. These results have implications for mutagenesis resulting from DNA synthesis by Y family polymerases.	NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA; NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; NICHHD, Sect DNA Replicat Repair & Mutagenesis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Kunkel, TA (corresponding author), NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA.		Kunkel, Thomas A./D-5088-2019	Kunkel, Thomas A./0000-0002-9900-1788; Woodgate, Roger/0000-0001-5581-4616	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001500] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001500] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BEBENEK K, 1990, P NATL ACAD SCI USA, V87, P4946, DOI 10.1073/pnas.87.13.4946; Bebenek K, 1995, METHOD ENZYMOL, V262, P217; Bebenek K, 2000, COLD SPRING HARB SYM, V65, P81, DOI 10.1101/sqb.2000.65.81; Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Chiapperino D, 2002, J BIOL CHEM, V277, P11765, DOI 10.1074/jbc.M112139200; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; ECKERT KA, 1990, NUCLEIC ACIDS RES, V18, P3739, DOI 10.1093/nar/18.13.3739; Efrati E, 1997, J BIOL CHEM, V272, P2559; Foster PL, 2000, COLD SPRING HARB SYM, V65, P21, DOI 10.1101/sqb.2000.65.21; Haracska L, 2000, NAT GENET, V25, P458, DOI 10.1038/78169; Hashim MF, 1997, J BIOL CHEM, V272, P20205, DOI 10.1074/jbc.272.32.20205; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 2000, P NATL ACAD SCI USA, V97, P3838, DOI 10.1073/pnas.97.8.3838; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Kim SR, 1997, P NATL ACAD SCI USA, V94, P13792, DOI 10.1073/pnas.94.25.13792; Kool ET, 1998, BIOPOLYMERS, V48, P3, DOI 10.1002/(SICI)1097-0282(1998)48:1<3::AID-BIP2>3.0.CO;2-7; KUNKEL TA, 1986, J BIOL CHEM, V261, P3581; KUNKEL TA, 1988, J BIOL CHEM, V263, P14784; Kuraoka I, 2001, J BIOL CHEM, V276, P49283, DOI 10.1074/jbc.M107779200; Levine RL, 2001, J BIOL CHEM, V276, P18717, DOI 10.1074/jbc.M102158200; Lewis DA, 1999, J BIOL CHEM, V274, P32924, DOI 10.1074/jbc.274.46.32924; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Matsuda T, 2001, J MOL BIOL, V312, P335, DOI 10.1006/jmbi.2001.4937; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; McKenzie GJ, 2001, MOL CELL, V7, P571, DOI 10.1016/S1097-2765(01)00204-0; MENDELMAN LV, 1990, J BIOL CHEM, V265, P2338; MENDELMAN LV, 1989, J BIOL CHEM, V264, P14415; Napolitano R, 2000, EMBO J, V19, P6259, DOI 10.1093/emboj/19.22.6259; Ogi T, 1999, GENES CELLS, V4, P607, DOI 10.1046/j.1365-2443.1999.00289.x; Ohashi E, 2000, J BIOL CHEM, V275, P39678, DOI 10.1074/jbc.M005309200; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Osheroff WP, 1999, J BIOL CHEM, V274, P3642, DOI 10.1074/jbc.274.6.3642; Roberts J.D., 1996, DNA REPLICATION EUKA, P217; SAWAYA MR, 1994, SCIENCE, V264, P1930, DOI 10.1126/science.7516581; Silvian LF, 2001, NAT STRUCT BIOL, V8, P984, DOI 10.1038/nsb1101-984; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7; Zhou BL, 2001, MOL CELL, V8, P427, DOI 10.1016/S1097-2765(01)00310-0	43	97	102	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19633	19638		10.1074/jbc.M202021200	http://dx.doi.org/10.1074/jbc.M202021200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11919199	hybrid			2022-12-27	WOS:000175894800053
J	Saitoh, M; Pullen, N; Brennan, P; Cantrell, D; Dennis, PB; Thomas, G				Saitoh, M; Pullen, N; Brennan, P; Cantrell, D; Dennis, PB; Thomas, G			Regulation of an activated S6 kinase 1 variant reveals a novel mammalian target of rapamycin phosphorylation site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; IN-VIVO; LATE-PHASE; PROTEIN; P70(S6K); INSULIN; PDK1; AKT; IDENTIFICATION; GROWTH	A critical step in S6 kinase 1 (S6K1) activation is Thr(229) phosphorylation in the activation loop by the phosphoinositide-dependent protein kinase (PDK1). Thr(229) phosphorylation requires prior phosphorylation of the Ser/Thr-Pro sites in the autoinhibitory domain and Thr(389) in the linker domain, consistent with PDK1 more effectively catalyzing Thr(229) phosphorylation in a variant harboring acidic residues in these positions (S6K1-E389D(3)E). S6K1-E389D(3)E has high basal activity and exhibits partial resistance to rapamycin and wortmannin, and its activity can be further augmented by mitogens, effects presumably mediated by Thr(229) phosphorylation. However, PDK1-induced Thr(229) phosphorylation is reported to be constitutive rather than phosphatidylinositide 3,4,5-trisphosphate-dependent, suggesting that S6K1-E389D(3)E activity is mediated through a distinct site. Here we use phosphospecific antibodies to show that Thr(229) is fully phosphorylated in S6K1-E389D(3)E in the absence of mitogens and that regulation of S6K1-E389D(3)E activity by mitogens, rapamycin, or wortmannin parallels Ser(371) phosphorylation. Consistent with this observation, a dominant interfering allele of the mammalian target of rapamycin, mTOR, inhibits mitogen-induced Ser(371) phosphorylation and activation of S6K1-E389D(3)E, whereas wild type mTOR stimulates both responses. Moreover, in vitro mTOR directly phosphorylates Ser(371), and this event modulates Thr(389) phosphorylation by mTOR, compatible with earlier in vivo findings.	Friedrich Miescher Inst, CH-4058 Basel, Switzerland; Imperial Canc Res Fund, London WC2A 3PX, England	Friedrich Miescher Institute for Biomedical Research; Cancer Research UK	Thomas, G (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.	gthomas@fmi.ch	Brennan, Paul/B-9210-2009; Thomas, George/K-9235-2014; Brennan, Paul/ABB-9196-2021	Brennan, Paul/0000-0001-8792-0499; Thomas, George/0000-0003-3518-8149; Brennan, Paul/0000-0001-8792-0499; Cantrell, Doreen/0000-0001-7525-3350; Pullen, Nicholas/0000-0002-4014-9278				Akimoto K, 1998, BIOCHEM J, V335, P417, DOI 10.1042/bj3350417; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Balendran A, 1999, J BIOL CHEM, V274, P37400, DOI 10.1074/jbc.274.52.37400; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; Belham C, 2001, CURR BIOL, V11, P1155, DOI 10.1016/S0960-9822(01)00369-4; Belham C, 1999, CURR BIOL, V9, pR93, DOI 10.1016/S0960-9822(99)80058-X; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; Conus NM, 1998, J BIOL CHEM, V273, P4776, DOI 10.1074/jbc.273.8.4776; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Dennis PB, 1998, J BIOL CHEM, V273, P14845, DOI 10.1074/jbc.273.24.14845; Dennis PB, 1996, MOL CELL BIOL, V16, P6242; Dennis PB, 1999, CURR OPIN GENET DEV, V9, P49, DOI 10.1016/S0959-437X(99)80007-0; Dufner A, 1999, MOL CELL BIOL, V19, P4525; Fadden P, 1997, J BIOL CHEM, V272, P10240; FERRARI S, 1992, P NATL ACAD SCI USA, V89, P7282, DOI 10.1073/pnas.89.15.7282; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; HAN JW, 1995, J BIOL CHEM, V270, P21396, DOI 10.1074/jbc.270.36.21396; HARA K, 1995, BIOCHEM BIOPH RES CO, V208, P735, DOI 10.1006/bbrc.1995.1399; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hentges KE, 2001, P NATL ACAD SCI USA, V98, P13796, DOI 10.1073/pnas.241184198; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Kohn AD, 1998, J BIOL CHEM, V273, P11937, DOI 10.1074/jbc.273.19.11937; LANE HA, 1993, NATURE, V363, P170, DOI 10.1038/363170a0; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; MING XF, 1994, NATURE, V371, P426, DOI 10.1038/371426a0; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Moser BA, 1997, MOL CELL BIOL, V17, P5648, DOI 10.1128/MCB.17.9.5648; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Radimerski T, 2002, NAT CELL BIOL, V4, P251, DOI 10.1038/ncb763; Reif K, 1997, J BIOL CHEM, V272, P14426, DOI 10.1074/jbc.272.22.14426; Romanelli A, 1999, MOL CELL BIOL, V19, P2921; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Somwar R, 1998, AM J PHYSIOL-ENDOC M, V275, pE618, DOI 10.1152/ajpendo.1998.275.4.E618; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; SUSA M, 1992, J BIOL CHEM, V267, P6905; SUSA M, 1989, CELL, V57, P817, DOI 10.1016/0092-8674(89)90796-4; vonManteuffel SR, 1997, MOL CELL BIOL, V17, P5426, DOI 10.1128/MCB.17.9.5426; Welch H, 1998, J BIOL CHEM, V273, P11248, DOI 10.1074/jbc.273.18.11248; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; WENG QP, 1995, P NATL ACAD SCI USA, V92, P5744, DOI 10.1073/pnas.92.12.5744; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3	58	135	143	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					20104	20112		10.1074/jbc.M201745200	http://dx.doi.org/10.1074/jbc.M201745200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11914378	hybrid			2022-12-27	WOS:000175894800112
J	Skurat, AV; Dietrich, AD; Zhai, LM; Roach, PJ				Skurat, AV; Dietrich, AD; Zhai, LM; Roach, PJ			GNIP, a novel protein that binds and activates glycogenin, the self-glucosylating initiator of glycogen biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE GLYCOGENIN; CLASS-I REGION; MOLECULAR-CLONING; MULTIGENIC FAMILIES; STRUCTURAL-ANALYSIS; FINGER; GENE; BIOGENESIS; MECHANISM; LINKAGE	Glycogenin is a self-glucosylating protein involved in the initiation of glycogen biosynthesis. Self-glucosylation leads to the formation of an oligosaccharide chain, which, when long enough, supports the action of glycogen synthase to elongate it and form a mature glycogen molecule. To identify possible regulators of glycogenin, the yeast two-hybrid strategy was employed. By using rabbit skeletal muscle glycogenin as a bait, cDNAs encoding three different proteins were isolated from the human skeletal muscle cDNA library. Two of the cDNAs encoded glycogenin and glycogen synthase, respectively, proteins known to be interactors. The third cDNA encoded a polypeptide of unknown function and was designated GNIP (glycogenin interacting protein). Northern blot analysis revealed that GNIP mRNA is highly expressed in skeletal muscle. The gene for GNIP generates at least four isoforms by alternative splicing. The largest isoform GNIP1 contains, from NH2- to COOH-terminal, a RING finger, a B box, a putative coiled-coil region, and a B30.2-like motif. The previously identified protein TRIM? (tripartite motif containing protein 7) is also derived from the GNIP gene and is composed of the RING finger, B box, and coiled-coil regions. The GNIP2 and GNIP3 isoforms consist of the coiled-coil region and B30.2-like domain. Physical interaction between GNIP2 and glycogenin was confirmed by co-immunoprecipitation, and in addition GNIP2 was shown to stimulate glycogenin self-glucosylation 3-4-fold. GNIPs may represent a novel participant in the initiation of glycogen synthesis.	Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Ctr Diabet Res, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Roach, PJ (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	proach@iupui.edu						Aksentijevich I, 1997, CELL, V90, P797; ALONSO MD, 1995, FASEB J, V9, P1126, DOI 10.1096/fasebj.9.12.7672505; ALONSO MD, 1995, J BIOL CHEM, V270, P15315, DOI 10.1074/jbc.270.25.15315; Baque S, 1997, FEBS LETT, V417, P355, DOI 10.1016/S0014-5793(97)01299-4; Bernot A, 1997, NAT GENET, V17, P25; CAO YJ, 1995, ARCH BIOCHEM BIOPHYS, V319, P293, DOI 10.1006/abbi.1995.1295; CAO YJ, 1993, J BIOL CHEM, V268, P14687; CAO YJ, 1993, J BIOL CHEM, V268, P21717; CHAN EKL, 1991, J CLIN INVEST, V87, P68, DOI 10.1172/JCI115003; CHENG C, 1995, MOL CELL BIOL, V15, P6632; CHU TW, 1995, GENOMICS, V29, P229, DOI 10.1006/geno.1995.1236; Gassama-Diagne A, 2001, J BIOL CHEM, V276, P18352, DOI 10.1074/jbc.M009784200; Henry J, 1997, IMMUNOGENETICS, V46, P383, DOI 10.1007/s002510050292; Henry J, 1998, MOL BIOL EVOL, V15, P1696, DOI 10.1093/oxfordjournals.molbev.a025896; INOUE S, 1993, P NATL ACAD SCI USA, V90, P11117, DOI 10.1073/pnas.90.23.11117; James P, 1996, GENETICS, V144, P1425; Lin A, 1999, ARCH BIOCHEM BIOPHYS, V363, P163, DOI 10.1006/abbi.1998.1073; Miozzo MC, 1996, BIOCHEM MOL BIOL INT, V40, P173; Mu J, 1997, J BIOL CHEM, V272, P27589, DOI 10.1074/jbc.272.44.27589; OGAVA S, 1998, BIOCHEM BIOPH RES CO, V251, P515; Orimo A, 2000, GENOMICS, V69, P143, DOI 10.1006/geno.2000.6318; Orimo A, 2000, BIOCHEM BIOPH RES CO, V276, P45, DOI 10.1006/bbrc.2000.3380; PITCHER J, 1988, EUR J BIOCHEM, V176, P391, DOI 10.1111/j.1432-1033.1988.tb14294.x; PLATT T, 1972, EXPT MOL GENETICS, P352; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; REDDY BA, 1991, NUCLEIC ACIDS RES, V19, P6330, DOI 10.1093/nar/19.22.6330; REDDY BA, 1991, DEV BIOL, V148, P107, DOI 10.1016/0012-1606(91)90321-S; REDDY BA, 1992, TRENDS BIOCHEM SCI, V17, P344, DOI 10.1016/0968-0004(92)90308-V; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Roach PJ, 1997, PROG NUCLEIC ACID RE, V57, P289, DOI 10.1016/S0079-6603(08)60284-6; RODRIGUEZ IR, 1985, BIOCHEM BIOPH RES CO, V132, P829, DOI 10.1016/0006-291X(85)91206-9; RODRIGUEZ IR, 1988, ARCH BIOCHEM BIOPHYS, V260, P628, DOI 10.1016/0003-9861(88)90491-2; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Seto MH, 1999, PROTEINS, V35, P235, DOI 10.1002/(SICI)1097-0134(19990501)35:2<235::AID-PROT9>3.3.CO;2-O; SKURAT AV, 1993, J BIOL CHEM, V268, P14701; Skurat AV, 1997, EUR J BIOCHEM, V245, P147, DOI 10.1111/j.1432-1033.1997.t01-1-00147.x; SMYTHE C, 1991, EUR J BIOCHEM, V200, P625, DOI 10.1111/j.1432-1033.1991.tb16225.x; SMYTHE C, 1990, EUR J BIOCHEM, V189, P199, DOI 10.1111/j.1432-1033.1990.tb15477.x; SMYTHE C, 1988, EMBO J, V7, P2681, DOI 10.1002/j.1460-2075.1988.tb03121.x; TAKAHASHI M, 1988, MOL CELL BIOL, V8, P1853, DOI 10.1128/MCB.8.4.1853; TISSOT C, 1995, J BIOL CHEM, V270, P14891, DOI 10.1074/jbc.270.25.14891; VERNET C, 1993, J MOL EVOL, V37, P600; VISKUPIC E, 1992, J BIOL CHEM, V267, P25759	45	56	58	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19331	19338		10.1074/jbc.M201190200	http://dx.doi.org/10.1074/jbc.M201190200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11916970	hybrid			2022-12-27	WOS:000175894800013
J	Kambe, T; Narita, H; Yamaguchi-Iwai, Y; Hirose, J; Amano, T; Sugiura, N; Sasaki, R; Mori, K; Iwanaga, T; Nagao, M				Kambe, T; Narita, H; Yamaguchi-Iwai, Y; Hirose, J; Amano, T; Sugiura, N; Sasaki, R; Mori, K; Iwanaga, T; Nagao, M			Cloning and characterization of a novel mammalian zinc transporter, zinc transporter 5, abundantly expressed in pancreatic beta cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFERS RESISTANCE; SYNAPTIC VESICLES; ION-TRANSPORT; GENE; FAMILY; PROTEIN; RECEPTOR; BIOLOGY; MOUSE	Intracellular homeostasis for zinc is achieved through the coordinate regulation of specific transporters engaged in zinc influx, efflux, and intracellular compartmentalization. We have identified a novel mammalian zinc transporter, zinc transporter 5 (ZnT-5), by virtue of its similarity to ZRC1, a zinc transporter of Saccharomyces cerevisiae, a member of the cation diffusion facilitator family. Human ZnT-5 (hZnT-5) cDNA encodes a 765-amino acid protein with 15 predicted membrane-spanning domains. hZnT-5 was ubiquitously expressed in all tested human tissues and abundantly expressed in the pancreas. In the human pancreas, hZnT-5 was expressed abundantly in insulin-containing beta cells that contain zinc at the highest level in the body. The hZnT-5 immunoreactivity was found to be associated with secretory granules by electron microscopy. The hZnT-5-derived zinc transport activity was detected using the Golgi-enriched vesicles prepared from hZnT-5-induced HeLa/hZnT-5 cells in which exogenous hZnT-5 expression is inducible by the Tet-on gene regulation system. This activity was dependent on time, temperature, and concentration and was saturable. Moreover, zinc at a high concentration (10 mm) inhibited the growth of yeast expressing hZnT-5. These results suggest that ZnT-5 plays an important role for transporting zinc into secretory granules in pancreatic beta cells.	Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto 6068502, Japan; Kyoto Womens Univ, Dept Food Sci, Kyoto 6058501, Japan; Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto 6068502, Japan; Univ Shiga Prefecture, Sch Human Cultures, Dept Life Style Studies, Shiga 5228533, Japan; Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Sapporo, Hokkaido 0600818, Japan	Kyoto University; Kyoto Womens University; Kyoto University; University Shiga Prefecture; Hokkaido University	Kambe, T (corresponding author), Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto 6068502, Japan.							Arvan P, 1998, BIOCHEM J, V332, P593, DOI 10.1042/bj3320593; ASLAM N, 1992, J CELL PHYSIOL, V151, P533, DOI 10.1002/jcp.1041510312; BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Clifford KS, 2000, DIABETES RES CLIN PR, V49, P77, DOI 10.1016/S0168-8227(00)00141-8; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Costello LC, 1999, J BIOL CHEM, V274, P17499, DOI 10.1074/jbc.274.25.17499; Cousins RJ, 2000, J NUTR, V130, p1384S, DOI 10.1093/jn/130.5.1384S; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Eide D, 1997, CURR OPIN CELL BIOL, V9, P573, DOI 10.1016/S0955-0674(97)80036-1; Gaither LA, 2000, J BIOL CHEM, V275, P5560, DOI 10.1074/jbc.275.8.5560; Gaither LA, 2001, J BIOL CHEM, V276, P22258, DOI 10.1074/jbc.M101772200; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Guerinot ML, 2000, BBA-BIOMEMBRANES, V1465, P190, DOI 10.1016/S0005-2736(00)00138-3; Hershfinkel M, 2001, P NATL ACAD SCI USA, V98, P11749, DOI 10.1073/pnas.201193398; Huang EP, 1997, P NATL ACAD SCI USA, V94, P13386, DOI 10.1073/pnas.94.25.13386; Huang LP, 1997, NAT GENET, V17, P292, DOI 10.1038/ng1197-292; HUANG XF, 1995, J BIOL CHEM, V270, P20417, DOI 10.1074/jbc.270.35.20417; IKURA K, 1988, BIOCHEMISTRY-US, V27, P2898, DOI 10.1021/bi00408a035; KAMIZONO A, 1989, MOL GEN GENET, V219, P161, DOI 10.1007/BF00261172; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li LT, 2001, J BIOL CHEM, V276, P5036, DOI 10.1074/jbc.M008969200; McMahon RJ, 1998, P NATL ACAD SCI USA, V95, P4841, DOI 10.1073/pnas.95.9.4841; Morishita E, 1996, BLOOD, V88, P465, DOI 10.1182/blood.V88.2.465.bloodjournal882465; Murgia C, 1999, AM J PHYSIOL-GASTR L, V277, pG1231, DOI 10.1152/ajpgi.1999.277.6.G1231; Nagao M, 1999, BIOCHEM BIOPH RES CO, V257, P289, DOI 10.1006/bbrc.1999.0446; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Palmiter RD, 1996, EMBO J, V15, P1784, DOI 10.1002/j.1460-2075.1996.tb00527.x; Paulsen IT, 1997, J MEMBRANE BIOL, V156, P99, DOI 10.1007/s002329900192; Persans MW, 2001, P NATL ACAD SCI USA, V98, P9995, DOI 10.1073/pnas.171039798; Reyes JG, 1996, AM J PHYSIOL-CELL PH, V270, pC401, DOI 10.1152/ajpcell.1996.270.2.C401; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; van der Zaal BJ, 1999, PLANT PHYSIOL, V119, P1047, DOI 10.1104/pp.119.3.1047; Williams R. J. P., 1989, ZINC HUMAN BIOL; ZALEWSKI PD, 1994, J HISTOCHEM CYTOCHEM, V42, P877, DOI 10.1177/42.7.8014471	37	219	227	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					19049	19055		10.1074/jbc.M200910200	http://dx.doi.org/10.1074/jbc.M200910200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11904301	hybrid			2022-12-27	WOS:000175975800105
J	May, P; Reddy, YK; Herz, J				May, P; Reddy, YK; Herz, J			Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE; ALZHEIMERS-DISEASE; CYTOSOLIC ADAPTER; BINDING DOMAIN; APOE RECEPTOR; FE65 PROTEIN; GENE FAMILY; IN-VIVO; NOTCH	The low density lipoprotein (LDL) receptor-related protein (LRP) is a multifunctional cell surface receptor that interacts through its cytoplasmic tail with adaptor and scaffold proteins that participate in cellular signaling. Its extracellular domain, like that of the signaling receptor Notch and of amyloid precursor protein (APP), is proteolytically processed at multiple positions. This similarity led us to investigate whether LRP, like APP and Notch, might also be cleaved at a third, intramembranous or cytoplasmic site, resulting in the release of its intracellular domain. Using independent experimental approaches we demonstrate that the cytoplasmic domain is released by a gamma-secretase-like activity and that this event is modulated by protein kinase C. Furthermore, cytoplasmic adaptor proteins that bind to the LRP tail affect the subcellular localization of the free intracellular domain and may regulate putative signaling functions. Finally, we show that the degradation of the free tail fragment is mediated by the proteasome. These findings suggest a novel role for the intracellular domain of LRP that may involve the subcellular translocation of preassembled signaling complexes from the plasma membrane.	Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Herz, J (corresponding author), Univ Texas SW, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063762, P01HL020948, R37HL063762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043408] Funding Source: NIH RePORTER; NHLBI NIH HHS [R37 HL063762, HL20948, HL63762] Funding Source: Medline; NINDS NIH HHS [NS43408] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Bressler SL, 1996, HUM MOL GENET, V5, P1589, DOI 10.1093/hmg/5.10.1589; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; DUILIO A, 1991, NUCLEIC ACIDS RES, V19, P5269, DOI 10.1093/nar/19.19.5269; Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Guenette SY, 1996, P NATL ACAD SCI USA, V93, P10832, DOI 10.1073/pnas.93.20.10832; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; Herz J, 2001, NEURON, V29, P571, DOI 10.1016/S0896-6273(01)00234-3; HERZ J, 1991, J BIOL CHEM, V266, P21232; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Kim SH, 2001, J BIOL CHEM, V276, P43343, DOI 10.1074/jbc.M108245200; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Kinoshita A, 2001, J NEUROSCI, V21, P8354, DOI 10.1523/JNEUROSCI.21-21-08354.2001; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; Lecourtois M, 1998, CURR BIOL, V8, P771, DOI 10.1016/S0960-9822(98)70300-8; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Liu CX, 2001, J BIOL CHEM, V276, P28889, DOI 10.1074/jbc.M102727200; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Minopoli G, 2001, J BIOL CHEM, V276, P6545, DOI 10.1074/jbc.M007340200; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; NI CY, 2001, SCIENCE, V25, P25; Quinn KA, 1997, J BIOL CHEM, V272, P23946, DOI 10.1074/jbc.272.38.23946; Quinn KA, 1999, EXP CELL RES, V251, P433, DOI 10.1006/excr.1999.4590; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Ulery PG, 2000, J BIOL CHEM, V275, P7410, DOI 10.1074/jbc.275.10.7410; Van Uden E, 1999, MOL CELL NEUROSCI, V14, P129, DOI 10.1006/mcne.1999.0772; Willnow TE, 1996, BIOCHEM J, V313, P71, DOI 10.1042/bj3130071; Willnow TE, 1999, NAT CELL BIOL, V1, pE157, DOI 10.1038/14109; WILLNOW TE, 1994, J CELL SCI, V107, P719	47	252	260	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					18736	18743		10.1074/jbc.M201979200	http://dx.doi.org/10.1074/jbc.M201979200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11907044	hybrid			2022-12-27	WOS:000175975800066
J	Lerner, LE; Gribanova, YE; Whitaker, L; Knox, BE; Farber, DB				Lerner, LE; Gribanova, YE; Whitaker, L; Knox, BE; Farber, DB			The rod cGMP-phosphodiesterase beta-subunit promoter is a specific target for Sp4 and is not activated by other Sp proteins or CRX.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINITIS-PIGMENTOSA; HOMEOBOX GENE; TRANSCRIPTIONAL ACTIVATION; NONSENSE MUTATION; RD MOUSE; PHOTORECEPTOR; EXPRESSION; BINDING; NRL; IDENTIFICATION	The beta-subunit of cGMP-phosphodiesterase (beta-PDE) is a key protein in phototransduction expressed exclusively in rod photoreceptors. It is necessary for visual function and for structural integrity of the retina. beta-PDE promoter deletions showed that the -45/-23 region containing a consensus Crx-response element (CRE) was necessary for low level transcriptional activity. Overexpressed Crx modestly transactivated this promoter in 293 human embryonic kidney cells; however, mutation of CRE had no significant effect on transcription either in transfected Y79 retinoblastoma cells or Xenopus embryonic heads. Thus, Crx is unlikely to be a critical beta-PDE transcriptional regulator in vivo. Interestingly, although the beta/GC element (-59/-49) binds multiple Sp transcription factors in vitro, only Sp4, but not Sp1 or Sp3, significantly enhanced beta-PDE promoter activity. Thus, the Sp4-mediated differential activation of the beta-PDE transcription defines the first specific Sp4 target gene reported to date and implies the importance of Sp4 for retinal function. Further extensive mutagenesis of the beta-PDE upstream sequences showed no additional regulatory elements. Although this promoter lacks a canonical TATA box or Inr element, it has the (T/A)-rich beta/TA sequence located within the -45/-23 region. We found that it binds purified TBP and TFIIB in gel mobility shift assays with cooperative enhancement of binding affinity.	Univ Calif Los Angeles, Sch Med, Dept Ophthalmol, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; Inst Mol Biol, Los Angeles, CA 90095 USA; SUNY Syracuse, Upstate Med Univ, Dept Ophthalmol, Syracuse, NY 13210 USA; SUNY Syracuse, Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Farber, DB (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Ophthalmol, Jules Stein Eye Inst, 100 Stein Plaza, Los Angeles, CA 90095 USA.			Farber, Debora/0000-0002-3207-697X	NEI NIH HHS [K08 EY00367, EY02651, EY11256] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002651, R01EY011256, R37EY002651, K08EY000367] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Batni S, 2000, METHOD ENZYMOL, V316, P50; Bessant DAR, 1999, NAT GENET, V21, P355, DOI 10.1038/7678; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; DANCIGER M, 1995, GENOMICS, V30, P1, DOI 10.1006/geno.1995.0001; DiPolo A, 1997, NUCLEIC ACIDS RES, V25, P3863, DOI 10.1093/nar/25.19.3863; DiPolo A, 1996, INVEST OPHTH VIS SCI, V37, P551; FARBER DB, 1992, NEURON, V9, P349, DOI 10.1016/0896-6273(92)90173-B; Freund CL, 1998, NAT GENET, V18, P311, DOI 10.1038/ng0498-311; FUNG BKK, 1990, BIOCHEMISTRY-US, V29, P2657, DOI 10.1021/bi00463a006; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; GAL A, 1994, NAT GENET, V7, P64, DOI 10.1038/ng0594-64; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; Lerner LE, 2001, J BIOL CHEM, V276, P34999, DOI 10.1074/jbc.M103301200; Lerner LE, 2000, METHOD ENZYMOL, V315, P617; Mani SS, 2001, J BIOL CHEM, V276, P36557, DOI 10.1074/jbc.M101685200; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; Patikoglou GA, 1999, GENE DEV, V13, P3217, DOI 10.1101/gad.13.24.3217; PIRIEV NI, 1993, P NATL ACAD SCI USA, V90, P9340, DOI 10.1073/pnas.90.20.9340; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; Plevy SE, 1997, MOL CELL BIOL, V17, P4572, DOI 10.1128/MCB.17.8.4572; Rehemtulla A, 1996, P NATL ACAD SCI USA, V93, P191, DOI 10.1073/pnas.93.1.191; SUBER ML, 1993, P NATL ACAD SCI USA, V90, P3968, DOI 10.1073/pnas.90.9.3968; Swain PK, 1997, NEURON, V19, P1329, DOI 10.1016/S0896-6273(00)80423-7; WEBER B, 1991, NUCLEIC ACIDS RES, V19, P6263, DOI 10.1093/nar/19.22.6263; Wolner BS, 2000, MOL CELL BIOL, V20, P3608, DOI 10.1128/MCB.20.10.3608-3615.2000	30	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 19	2002	277	29					25877	25883		10.1074/jbc.M201407200	http://dx.doi.org/10.1074/jbc.M201407200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	574UV	11943774	hybrid			2022-12-27	WOS:000176908700010
J	Huebert, RC; Splinter, PL; Garcia, F; Marinelli, RA; LaRusso, NF				Huebert, RC; Splinter, PL; Garcia, F; Marinelli, RA; LaRusso, NF			Expression and localization of aquaporin water channels in rat hepatocytes - Evidence for a role in canalicular bile secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APICAL PLASMA-MEMBRANE; TRANSPORT WATER; CYCLIC-AMP; LIVER; COUPLETS; IMMUNOLOCALIZATION; CHOLANGIOCYTES; VESICLE; TESTIS; PERMEABILITY	Although bile formation requires that large volumes of water be rapidly transported across liver epithelia, including hepatocytes, the molecular mechanisms by which water is secreted into bile are obscure. The aquaporins are a family of 10 channel-forming, integral membrane proteins of similar to28 kDa numbered 0-9 that allow water to rapidly traverse epithelial barriers in several organs including kidney, eye, and brain. We found transcripts of three of 10 aquaporins in hepatocytes (aquaporin 8 >> aquaporin 9 > aquaporin 0) by reverse transcription-polymerase chain reaction and quantitative ribonuclease protection assays; immunohistochemistry confirmed the presence of these three proteins in liver. Immunoblots of subcellular fractions of hepatocytes showed enrichment of aquaporins 0 and 8 in microsomes and canalicular plasma membranes, aquaporin 9 was enriched only in basolateral plasma membranes. Immunofluoreseence of hepatocyte couplets confirmed the intracellular/canalicular localization of aquaporins 0 and 8 and the basolateral localization of aquaporin 9. Upon exposure of couplets to a choleretic stimulus (i.e. dibutyryl cAMP), aquaporin 8 redistributed to the canalicular plasma membrane; the subcellular distributions of aquaporins 0 and 9 were unaffected. In addition, exposure of couplets to dibutyryl cAMP caused an increase in canalicular water transport in the presence and absence of an osmotic gradient, an effect that was blocked by aquaporin inhibitors. These results provide evidence that aquaporins are present in hepatocytes and that aquaporins are involved in agonist-stimulated canalicular bile secretion.	Mayo Med Sch Clin & Fdn, Ctr Basic Res Digest Dis, Rochester, MN 55905 USA; Mayo Med Sch Clin & Fdn, Dept Internal Med, Rochester, MN 55905 USA; Mayo Med Sch Clin & Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Consejo Nacl Invest Cient & Tecn, Inst Fisiol Expt, RA-2000 Rosario, Santa Fe, Argentina	Mayo Clinic; Mayo Clinic; Mayo Clinic; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	LaRusso, NF (corresponding author), Mayo Med Sch Clin & Fdn, Ctr Basic Res Digest Dis, 200 1st St SW, Rochester, MN 55905 USA.			Huebert, Robert/0000-0002-9812-7573	NIDDK NIH HHS [DK24031] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK024031, R01DK024031] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BENEDETTI A, 1994, P NATL ACAD SCI USA, V91, P792, DOI 10.1073/pnas.91.2.792; Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425; Boyer James L., 1993, P597; BOYER JL, 1995, GASTROENTEROLOGY, V109, P1600, DOI 10.1016/0016-5085(95)90649-5; BOYER JL, 1979, YALE J BIOL MED, V52, P61; Cefaratti C, 2000, J BIOL CHEM, V275, P3772, DOI 10.1074/jbc.275.6.3772; Cova E, 2001, HEPATOLOGY, V34, P456, DOI 10.1053/jhep.2001.27092; Echevarria M, 1996, J BIOL CHEM, V271, P25079, DOI 10.1074/jbc.271.41.25079; Elkjaer ML, 2000, BIOCHEM BIOPH RES CO, V276, P1118, DOI 10.1006/bbrc.2000.3505; Elkjaer ML, 2001, AM J PHYSIOL-RENAL, V281, pF1047, DOI 10.1152/ajprenal.0158.2001; Ford P, 2000, J MEMBRANE BIOL, V176, P151, DOI 10.1007/s002320001084; Fotiadis D, 2000, J MOL BIOL, V300, P779, DOI 10.1006/jmbi.2000.3920; Garcia F, 2001, J BIOL CHEM, V276, P12147, DOI 10.1074/jbc.M009403200; Gerloff T, 1999, GASTROENTEROLOGY, V117, P1408, DOI 10.1016/S0016-5085(99)70291-X; GRAF J, 1990, J HEPATOL, V10, P387, DOI 10.1016/0168-8278(90)90152-H; GRAF J, 1984, P NATL ACAD SCI-BIOL, V81, P6516, DOI 10.1073/pnas.81.20.6516; HAYAKAWA T, 1990, AM J PHYSIOL, V259, pG727, DOI 10.1152/ajpgi.1990.259.5.G727; Hurley PT, 2001, AM J PHYSIOL-GASTR L, V280, pG701, DOI 10.1152/ajpgi.2001.280.4.G701; Ishibashi K, 1997, BIOCHEM BIOPH RES CO, V237, P714, DOI 10.1006/bbrc.1997.7219; Ishikawa Y, 1999, BIOCHEM BIOPH RES CO, V265, P94, DOI 10.1006/bbrc.1999.1630; King LS, 2000, MOL MED TODAY, V6, P60, DOI 10.1016/S1357-4310(99)01636-6; Koyama Y, 1997, J BIOL CHEM, V272, P30329, DOI 10.1074/jbc.272.48.30329; Lazaridis KN, 2000, P NATL ACAD SCI USA, V97, P11092, DOI 10.1073/pnas.200325297; MARINELLI R, 1999, AM J PHYSIOL, V39, pG280; Marinelli RA, 2000, HEPATOLOGY, V31, P1313, DOI 10.1053/jhep.2000.7986; Marinelli RA, 1997, J BIOL CHEM, V272, P12984, DOI 10.1074/jbc.272.20.12984; Masyuk AI, 2002, GASTROENTEROLOGY, V122, P545, DOI 10.1053/gast.2002.31035; MEIER PJ, 1988, SEMIN LIVER DIS, V8, P293, DOI 10.1055/s-2008-1040551; Meier PJ, 2000, NEWS PHYSIOL SCI, V15, P89; ROBERTS SK, 1994, P NATL ACAD SCI USA, V91, P13009, DOI 10.1073/pnas.91.26.13009; Roelofsen H, 1998, J CELL SCI, V111, P1137; SCHARSCHMIDT BF, 1979, J LAB CLIN MED, V93, P790; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Soroka CJ, 1999, J BIOL CHEM, V274, P26416, DOI 10.1074/jbc.274.37.26416; Tani T, 2001, ARCH HISTOL CYTOL, V64, P159, DOI 10.1679/aohc.64.159; Tuma PL, 1999, J CELL BIOL, V145, P1089, DOI 10.1083/jcb.145.5.1089; VANHOEK AN, 1990, BIOCHIM BIOPHYS ACTA, V1030, P203, DOI 10.1016/0005-2736(90)90296-Z; Verkman AS, 1999, J AM SOC NEPHROL, V10, P1126; Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512; Yano M, 1996, J BIOL CHEM, V271, P6702, DOI 10.1074/jbc.271.12.6702	40	121	133	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22710	22717		10.1074/jbc.M202394200	http://dx.doi.org/10.1074/jbc.M202394200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11932260	hybrid			2022-12-27	WOS:000176313600079
J	Johnson, MD; Wu, XW; Aithmitti, N; Morrison, RS				Johnson, MD; Wu, XW; Aithmitti, N; Morrison, RS			Peg3/Pw1 is a mediator between p53 and Bax in DNA damage-induced neuronal death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; IMPRINTED GENE PEG3; INDUCED CELL-DEATH; HUMAN HOMOLOG; P53-MEDIATED APOPTOSIS; PROXIMAL CHROMOSOME-7; TUMOR SUPPRESSION; ACTIVATION; PROTEIN; TRANSLOCATION	Neuronal cell death after DNA damage requires p53 and Bax, but the mechanism by which p53 activation leads to Bax translocation and cell death in neurons is not known. We report here that Peg3/Pw1 is up-regulated after DNA damage in cortical neurons in a p53-dependent manner. Overexpression of Peg3/Pw1 leads to decreased neuronal viability. The deleterious effect of Peg3/Pw1 on neuronal survival is abrogated by deletion of either p53 or Bax, indicating an essential role for both in Peg3/Pw1-mediated neuronal death. Moreover, overexpression of a Peg3/Pw1 dominant negative protein inhibits Bax translocation and neuronal cell death after DNA damage. These findings implicate Peg3/Pw1 as a mediator between p53 and Bax in a neuronal cell death pathway activated by DNA damage.	Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Huffington Ctr Aging, Houston, TX 77030 USA	University of Washington; University of Washington Seattle; Baylor College of Medicine	Morrison, RS (corresponding author), Univ Washington, Sch Med, Dept Neurol Surg, Box 356470, Seattle, WA 98195 USA.				NATIONAL CANCER INSTITUTE [R01CA073678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035533] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA73678] Funding Source: Medline; NINDS NIH HHS [NS35533] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; Banasiak KJ, 1998, BRAIN RES, V797, P295, DOI 10.1016/S0006-8993(98)00286-8; CHOPP M, 1992, BIOCHEM BIOPH RES CO, V182, P1201, DOI 10.1016/0006-291X(92)91859-O; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Deng YB, 2000, P NATL ACAD SCI USA, V97, P12050, DOI 10.1073/pnas.97.22.12050; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Fortin A, 2001, J CELL BIOL, V155, P207, DOI 10.1083/jcb.200105137; Ghatan S, 2000, J CELL BIOL, V150, P335, DOI 10.1083/jcb.150.2.335; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Johnson MD, 1998, J NEUROSCI RES, V54, P721, DOI 10.1002/(SICI)1097-4547(19981215)54:6<721::AID-JNR1>3.0.CO;2-1; Johnson MD, 1999, J NEUROSCI, V19, P2996; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; Kim J, 1997, GENOME RES, V7, P532, DOI 10.1101/gr.7.5.532; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kohda T, 2001, GENES CELLS, V6, P237, DOI 10.1046/j.1365-2443.2001.00412.x; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Ledgerwood EC, 2000, LAB INVEST, V80, P1509, DOI 10.1038/labinvest.3780160; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Li LL, 2000, GENOMICS, V63, P333, DOI 10.1006/geno.1999.6103; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Matsuzawa S, 1998, EMBO J, V17, P2736, DOI 10.1093/emboj/17.10.2736; MIYASHITA T, 1995, CELL, V80, P293; Morris EJ, 2001, J NEUROSCI, V21, P5017, DOI 10.1523/JNEUROSCI.21-14-05017.2001; Murphy SK, 2001, GENOMICS, V71, P110, DOI 10.1006/geno.2000.6419; Nemani M, 1996, P NATL ACAD SCI USA, V93, P9039, DOI 10.1073/pnas.93.17.9039; Park DS, 1997, J NEUROSCI, V17, P1256, DOI 10.1523/jneurosci.17-04-01256.1997; Polekhina G, 2002, NAT STRUCT BIOL, V9, P68, DOI 10.1038/nsb743; Putcha GV, 1999, J NEUROSCI, V19, P7476, DOI 10.1523/JNEUROSCI.19-17-07476.1999; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Relaix F, 1998, NAT GENET, V18, P287, DOI 10.1038/ng0398-287; Relaix F, 2000, P NATL ACAD SCI USA, V97, P2105, DOI 10.1073/pnas.040378897; Roperch JP, 1999, P NATL ACAD SCI USA, V96, P8070, DOI 10.1073/pnas.96.14.8070; Stefanis L, 1999, J NEUROSCI, V19, P6235; TIMME TL, 1994, BIOTECHNIQUES, V17, P460; Watanabe H, 1999, BRAIN RES, V837, P38, DOI 10.1016/S0006-8993(99)01652-2; Xiang H, 1996, J NEUROSCI, V16, P6753; Xiang H, 1998, J NEUROSCI, V18, P1363; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; Yamaguchi A, 2002, J BIOL CHEM, V277, P623, DOI 10.1074/jbc.M107435200; ZHANG WW, 1993, BIOTECHNIQUES, V15, P869	41	55	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					23000	23007		10.1074/jbc.M201907200	http://dx.doi.org/10.1074/jbc.M201907200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11943780	hybrid			2022-12-27	WOS:000176313600115
J	Tyagi, S; Korkaya, H; Zafrullah, M; Jameel, S; Lal, SK				Tyagi, S; Korkaya, H; Zafrullah, M; Jameel, S; Lal, SK			The phosphorylated form of the ORF3 protein of hepatitis E virus interacts with its non-glycosylated form of the major capsid protein, ORF2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST 2-HYBRID SYSTEM; READING FRAME-2 PROTEIN; STRUCTURAL PROTEINS; MACAQUE HEPATOCYTES; MOLECULAR-CLONING; SELF-ASSOCIATION; INSECT CELLS; EXPRESSION; HEV; RNA	Hepatitis E virus (HEV) is a human RNA virus containing three open reading frames. Of these, ORF1 encodes the viral nonstructural polyprotein; ORF2 encodes the major capsid protein, which exists in a glycosylated and non-glycosylated form; and ORF3 codes for a phosphoprotein of undefined function. Using fluorescence-based colocalization, yeast two-hybrid experiments, transiently transfected COS-1 cell co-immunoprecipitation, and cell-free coupled transcription-translation techniques, we have shown that the ORF3 protein interacts with the ORF2 protein. The domains involved in this ORF2-ORF3 association have been identified and mapped. Our deletion analysis showed that a 25-amino acid region (residues 57-81) of the ORF3 protein is required for this interaction. Using a Mexican REV isolate, site-directed mutagenesis of ORF3, and a phosphatase digestion assay, we showed that the ORF2-ORF3 interaction is dependent upon the phosphorylation at Ser(80) of ORF3. Finally, using COS-1 cell immunoprecipitation experiments, we found that the phosphorylated ORF3 protein preferentially interacts with the non-glycosylated ORF2 protein. These findings were confirmed using tunicamycin inhibition, point mutants, and deletion mutants expressing only non-glycosylated ORF2. ORF3 maps in the structural region of the HEV genome and now interacts with the major capsid protein, ORF2, in a post-translational modification-dependent manner. Such an interaction of ORF2 with ORF3 suggests a possible well regulated role for ORF3 in HEV structural assembly.	Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi 1100067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Lal, SK (corresponding author), Int Ctr Genet Engn & Biotechnol, Virol Grp, Aruna Asaf Ali Rd, New Delhi 1100067, India.		Korkaya, Hasan/ABD-6282-2020; Korkaya, Hasan/GRY-1016-2022; Korkaya, Hasan/C-2201-2009	Korkaya, Hasan/0000-0002-0719-5862; 				Ansari IH, 2000, J MED VIROL, V60, P275, DOI 10.1002/(SICI)1096-9071(200003)60:3<275::AID-JMV5>3.3.CO;2-0; AYE TT, 1992, NUCLEIC ACIDS RES, V20, P3512, DOI 10.1093/nar/20.13.3512; Bai C, 1996, METHOD ENZYMOL, V273, P331; BROWN NG, 1994, MOL CELL BIOL, V14, P1045, DOI 10.1128/MCB.14.2.1045; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; HARPER JW, 1993, CELL, V75, P805; HE JK, 1993, J CLIN MICROBIOL, V31, P2167, DOI 10.1128/JCM.31.8.2167-2173.1993; HUANG CC, 1992, VIROLOGY, V191, P550, DOI 10.1016/0042-6822(92)90230-M; JACKSON AL, 1993, MOL CELL BIOL, V13, P2899, DOI 10.1128/MCB.13.5.2899; Jameel S, 1996, J VIROL, V70, P207, DOI 10.1128/JVI.70.1.207-216.1996; James P, 1996, GENETICS, V144, P1425; KALPANA GV, 1993, P NATL ACAD SCI USA, V90, P10593, DOI 10.1073/pnas.90.22.10593; KHUDYAKOV YE, 1994, VIROLOGY, V198, P390, DOI 10.1006/viro.1994.1048; KHUDYAKOV YE, 1993, VIROLOGY, V194, P89, DOI 10.1006/viro.1993.1238; KOONIN EV, 1992, P NATL ACAD SCI USA, V89, P8259, DOI 10.1073/pnas.89.17.8259; Korkaya H, 2001, J BIOL CHEM, V276, P42389, DOI 10.1074/jbc.M101546200; Lal SK, 1997, GENE, V190, P63, DOI 10.1016/S0378-1119(96)00698-1; LALO D, 1993, P NATL ACAD SCI USA, V90, P5524, DOI 10.1073/pnas.90.12.5524; Li TC, 1997, J VIROL, V71, P7207, DOI 10.1128/JVI.71.10.7207-7213.1997; Panda SK, 2000, J VIROL, V74, P2430, DOI 10.1128/JVI.74.5.2430-2437.2000; Purcell R. H., 1996, FIELDS VIROLOGY, P2831; Reyes G R, 1993, Arch Virol Suppl, V7, P15; Rose MD., 1990, METHODS YEAST GENETI; Sambrook J., 2002, MOL CLONING LAB MANU; TAKACS AM, 1993, P NATL ACAD SCI USA, V90, P10375, DOI 10.1073/pnas.90.21.10375; Tam AW, 1997, VIROLOGY, V238, P94, DOI 10.1006/viro.1997.8817; TAM AW, 1991, VIROLOGY, V185, P120, DOI 10.1016/0042-6822(91)90760-9; Tam AW, 1996, VIROLOGY, V215, P1, DOI 10.1006/viro.1996.0001; Torresi J, 1999, J GEN VIROL, V80, P1185, DOI 10.1099/0022-1317-80-5-1185; TSAREV SA, 1992, P NATL ACAD SCI USA, V89, P559, DOI 10.1073/pnas.89.2.559; TSAREV SA, 1993, J INFECT DIS, V168, P369, DOI 10.1093/infdis/168.2.369; Tyagi S, 2001, BIOCHEM BIOPH RES CO, V284, P614, DOI 10.1006/bbrc.2001.5017; Tyagi S, 2001, J VIROL, V75, P2493, DOI 10.1128/JVI.75.5.2493-2498.2001; Tyagi S, 2000, BIOCHEM BIOPH RES CO, V277, P589, DOI 10.1006/bbrc.2000.3720; Xing L, 1999, VIROLOGY, V265, P35, DOI 10.1006/viro.1999.0005; Zafrullah M, 1997, J VIROL, V71, P9045, DOI 10.1128/JVI.71.12.9045-9053.1997; Zafrullah M, 1999, J VIROL, V73, P4074, DOI 10.1128/JVI.73.5.4074-4082.1999	37	93	108	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22759	22767		10.1074/jbc.M200185200	http://dx.doi.org/10.1074/jbc.M200185200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11934888	hybrid			2022-12-27	WOS:000176313600085
J	Besson, A; Wilson, TL; Yong, VW				Besson, A; Wilson, TL; Yong, VW			The anchoring protein RACK1 links protein kinase C epsilon to integrin beta chains - Requirement for adhesion and motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; MOTIF-CONTAINING PROTEIN; FOCAL ADHESIONS; TYROSINE PHOSPHORYLATION; INTRACELLULAR RECEPTOR; SIGNAL-TRANSDUCTION; ENDOTHELIAL-CELLS; PKC; ALPHA; INVOLVEMENT	Integrin affinity is modulated by intracellular signaling cascades, in a process known as "inside-out" signaling, leading to changes in cell adhesion and motility. Protein kinase C (PKC) plays a critical role in integrin-mediated events; however, the mechanism that links PKC to integrins remains unclear. Here, we report that PKCepsilon positively regulates integrin-dependent adhesion, spreading, and motility of human glioma cells. PKCepsilon activation was associated with increased focal adhesion and lamellipodia formation as well as clustering of select integrins, and it is required for phorbol 12-myristate 13-acetate-induced adhesion and motility. We provide novel evidence that the scaffolding protein RACK1 mediates the interaction between integrin beta chain and activated PKCepsilon. Both depletion of RACK1 by antisense strategy and overexpression of a truncated form of RACK1 which lacks the integrin binding region resulted in decreased PKCepsilon-induced adhesion and migration, suggesting that RACK1 links PKCepsilon to integrin beta chains. Altogether, these results provide a novel mechanistic link between PKC activation and integrin-mediated adhesion and motility.	Univ Calgary, Dept Oncol, Calgary, AB T2N 4N1, Canada; Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Yong, VW (corresponding author), Univ Calgary, Dept Oncol, 3330 Hosp Dr NW,HMRB 191, Calgary, AB T2N 4N1, Canada.	vyong@ucalgary.ca	Besson, Arnaud/J-6254-2014	Besson, Arnaud/0000-0002-9599-3943; Yong, V. Wee/0000-0002-2600-3563				Aplin AE, 1999, CURR OPIN CELL BIOL, V11, P737, DOI 10.1016/S0955-0674(99)00045-9; Berrier AL, 2000, J CELL BIOL, V151, P1549, DOI 10.1083/jcb.151.7.1549; Besson A, 2000, MOL CELL BIOL, V20, P4580, DOI 10.1128/MCB.20.13.4580-4590.2000; Besson A, 2001, ONCOGENE, V20, P7398, DOI 10.1038/sj.onc.1204899; Buensuceso CS, 2001, J CELL SCI, V114, P1691; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; Chang BY, 2001, J BIOL CHEM, V276, P20346, DOI 10.1074/jbc.M101375200; Croze E, 2000, J IMMUNOL, V165, P5127, DOI 10.4049/jimmunol.165.9.5127; Defilippi P, 1997, J BIOL CHEM, V272, P21726, DOI 10.1074/jbc.272.35.21726; DeNichilo MO, 1996, J BIOL CHEM, V271, P11016, DOI 10.1074/jbc.271.18.11016; Disatnik MH, 1999, J BIOL CHEM, V274, P32486, DOI 10.1074/jbc.274.45.32486; DISATNIK MH, 1994, P NATL ACAD SCI USA, V91, P559, DOI 10.1073/pnas.91.2.559; Fahraeus R, 1999, EMBO J, V18, P2106, DOI 10.1093/emboj/18.8.2106; Geijsen N, 1999, ONCOGENE, V18, P5126, DOI 10.1038/sj.onc.1202896; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; GIMOND C, 1995, EXP CELL RES, V216, P232, DOI 10.1006/excr.1995.1029; Haller H, 1998, CIRC RES, V82, P157; Harrington EO, 1997, J BIOL CHEM, V272, P7390, DOI 10.1074/jbc.272.11.7390; Hemler ME, 1998, CURR OPIN CELL BIOL, V10, P578, DOI 10.1016/S0955-0674(98)80032-X; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; Kazanietz MG, 2000, MOL CARCINOGEN, V28, P5, DOI 10.1002/(SICI)1098-2744(200005)28:1<5::AID-MC2>3.0.CO;2-G; KLEMKE RL, 1994, J CELL BIOL, V127, P859, DOI 10.1083/jcb.127.3.859; Kolanus W, 1997, CURR OPIN CELL BIOL, V9, P725, DOI 10.1016/S0955-0674(97)80127-5; Laudanna C, 1998, J BIOL CHEM, V273, P30306, DOI 10.1074/jbc.273.46.30306; Lewis JM, 1996, J CELL BIOL, V134, P1323, DOI 10.1083/jcb.134.5.1323; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; LITCHFIELD DW, 1986, BIOCHEM BIOPH RES CO, V134, P1276, DOI 10.1016/0006-291X(86)90388-8; Litvak V, 2000, J BIOL CHEM, V275, P32736, DOI 10.1074/jbc.M004200200; Mochly-Rosen D, 1998, FASEB J, V12, P35; MOCHLYROSEN D, 1991, P NATL ACAD SCI USA, V88, P3997, DOI 10.1073/pnas.88.9.3997; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Ng T, 1999, EMBO J, V18, P3909, DOI 10.1093/emboj/18.14.3909; Perez-Moreno M, 1998, J CELL SCI, V111, P3563; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Rabinovitz I, 1999, J CELL BIOL, V146, P1147, DOI 10.1083/jcb.146.5.1147; Ron D, 1999, J BIOL CHEM, V274, P27039, DOI 10.1074/jbc.274.38.27039; RON D, 1994, J BIOL CHEM, V269, P21395; RON D, 1995, P NATL ACAD SCI USA, V92, P492, DOI 10.1073/pnas.92.2.492; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Tang SQ, 1997, J BIOL CHEM, V272, P28704, DOI 10.1074/jbc.272.45.28704; Usacheva A, 2001, J BIOL CHEM, V276, P22948, DOI 10.1074/jbc.M100087200; VUORI K, 1993, J BIOL CHEM, V268, P21459; WOODS A, 1992, J CELL SCI, V101, P277; Yarwood SJ, 1999, J BIOL CHEM, V274, P14909, DOI 10.1074/jbc.274.21.14909; YONG VW, 1987, J NEUROSCI METH, V21, P9, DOI 10.1016/0165-0270(87)90098-7	47	155	160	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					22073	22084		10.1074/jbc.M111644200	http://dx.doi.org/10.1074/jbc.M111644200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11934885	hybrid			2022-12-27	WOS:000176286000120
J	Lachance, G; Levasseur, S; Naccache, PH				Lachance, G; Levasseur, S; Naccache, PH			Chemotactic factor-induced recruitment and activation of Tec family kinases in human neutrophils - Implication of phosphatidylinositol 3-kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUTONS TYROSINE KINASE; PLECKSTRIN HOMOLOGY DOMAIN; T-CELL-ACTIVATION; PHOSPHOINOSITIDE 3-KINASE; PROTEIN-KINASES; SIGNAL-TRANSDUCTION; CROSS-LINKING; PHOSPHORYLATION; RECEPTOR; BINDING	The importance of the tyrosine phosphorylation cascades in the initiation and regulation of the functional responsiveness of human neutrophils is well established. On the other hand, the link between the G protein-coupled receptors (to which the receptors for chemotactic factors belong) and the activation of tyrosine kinases is very poorly characterized. Based on previous observations indicating that the stimulation of tyrosine phosphorylation was sensitive to inhibition by the phosphatidylinositol 3-kinase inhibitor wortmannin and the recent description of pleckstrin homology domain-containing tyrosine kinases (the Tee family), we have examined the potential implication of the latter in the responses of human neutrophils to chemotactic factors. The results obtained indicate firstly that several members of the Tee family of tyrosine kinases are expressed in human neutrophils, including Tee, Btk, and Bmx. Stimulation of the cells with fMet-Leu-Phe led to a rapid activation of Tee as indicated by its translocation to a membrane fraction and to increases in its in situ level of tyrosine phosphorylation and its capacity to tyrosine phosphorylate itself or an exogenous substrate (SAM68-GST) in in vitro kinase assays. The activation of Tee was inhibited by pertussis toxin as well as by wortmannin. The results of this study provide direct evidence for the implication of Tee family kinases in the responses of human neutrophils to chemotactic factors. They also suggest that one of the links between G protein-coupled receptors and tyrosine kinases depends on the activation of phosphatidylinositol 3-kinase and the generation of phosphatidylinositol 3,4,5-trisphosphate.	Univ Laval, Ctr Hosp Univ Laval, Ctr Rech,Ctr Rech Rhumatol & Immunol,Dept Med, Canadian Inst Hlth Res Grp Mol Mechanisms Inflamm, Quebec City, PQ G1V 4G2, Canada	Laval University	Naccache, PH (corresponding author), CHUQ, CHUL, Room T 1-49,2705 Blvd Laurier, Quebec City, PQ G1V 4G2, Canada.	paul.naccache@crchul.ulaval.ca						Andreotti AH, 1997, NATURE, V385, P93, DOI 10.1038/385093a0; Baraldi E, 1999, STRUCTURE, V7, P449, DOI 10.1016/S0969-2126(99)80057-4; BERKOW RL, 1991, J LEUKOCYTE BIOL, V49, P599, DOI 10.1002/jlb.49.6.599; BERTON G, 1994, J CELL BIOL, V126, P1111, DOI 10.1083/jcb.126.4.1111; Bunnell SC, 2000, J BIOL CHEM, V275, P2219, DOI 10.1074/jbc.275.3.2219; Ching KA, 2000, J IMMUNOL, V165, P256, DOI 10.4049/jimmunol.165.1.256; FIALKOW L, 1993, J BIOL CHEM, V268, P17131; Fluckiger AC, 1998, EMBO J, V17, P1973, DOI 10.1093/emboj/17.7.1973; Funaki M, 2000, CELL SIGNAL, V12, P135, DOI 10.1016/S0898-6568(99)00086-8; GAUDRY M, 1993, J CLIN INVEST, V91, P1649, DOI 10.1172/JCI116373; GAUDRY M, 1995, BLOOD, V86, P3567, DOI 10.1182/blood.V86.9.3567.bloodjournal8693567; GAUDRY M, 1991, J LEUKOCYTE BIOL, V51, P103; GERARD C, 1994, ANN REV IMMUNOL; GOMEZCAMBRONERO J, 1989, BIOCHEM BIOPH RES CO, V162, P1478, DOI 10.1016/0006-291X(89)90841-3; GOMEZCAMBRONERO J, 1991, J BIOL CHEM, V266, P6240; GRINSTEIN S, 1991, AM J PHYSIOL, V260, pC1019, DOI 10.1152/ajpcell.1991.260.5.C1019; Guinamard R, 1997, SCAND J IMMUNOL, V45, P587, DOI 10.1046/j.1365-3083.1997.d01-447.x; Gupta N, 1999, J BIOL CHEM, V274, P7489, DOI 10.1074/jbc.274.11.7489; Hamazaki Y, 1998, ONCOGENE, V16, P2773, DOI 10.1038/sj.onc.1201799; Haribabu B, 1999, J BIOL CHEM, V274, P37087, DOI 10.1074/jbc.274.52.37087; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Kaukonen J, 1996, BRIT J HAEMATOL, V94, P455; Knall C, 1997, P NATL ACAD SCI USA, V94, P3052, DOI 10.1073/pnas.94.7.3052; Kojima T, 1997, BIOCHEM BIOPH RES CO, V236, P333, DOI 10.1006/bbrc.1997.6947; KRAFT AS, 1987, BLOOD, V70, P356; Laffargue M, 1999, FEBS LETT, V443, P66, DOI 10.1016/S0014-5793(98)01680-9; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Lowell CA, 1999, J LEUKOCYTE BIOL, V65, P313, DOI 10.1002/jlb.65.3.313; LU DJ, 1993, BLOOD CELLS, V19, P343; Lu YL, 1998, J IMMUNOL, V161, P5404; Mano H, 1999, INT J HEMATOL, V69, P6; Mano H, 1999, CYTOKINE GROWTH F R, V10, P267, DOI 10.1016/S1359-6101(99)00019-2; Miura Y, 2000, BLOOD, V96, P1733, DOI 10.1182/blood.V96.5.1733.h8001733_1733_1739; Mocsai A, 2000, J IMMUNOL, V164, P4321, DOI 10.4049/jimmunol.164.8.4321; Mohamed AJ, 1999, SCAND J IMMUNOL, V49, P113; Murphy PM, 1997, SEMIN HEMATOL, V34, P311; Naccache PH, 2000, J BIOL CHEM, V275, P23636, DOI 10.1074/jbc.M001780200; NACCACHE PH, 1993, LAB INVEST, V69, P19; Niggli V, 1997, EUR J PHARMACOL, V335, P43, DOI 10.1016/S0014-2999(97)01169-2; Oda A, 2000, BLOOD, V95, P1663; Okoh MP, 1999, BIOCHEM BIOPH RES CO, V265, P151, DOI 10.1006/bbrc.1999.1407; Prossnitz ER, 1997, PHARMACOL THERAPEUT, V74, P73, DOI 10.1016/S0163-7258(96)00203-3; ROLLET E, 1994, J IMMUNOL, V153, P353; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Shan XC, 1999, J BIOL CHEM, V274, P29323, DOI 10.1074/jbc.274.41.29323; Shirai T, 1998, BBA-MOL CELL RES, V1402, P292, DOI 10.1016/S0167-4889(98)00014-7; Siddiqui RA, 2000, BBA-MOL CELL BIOL L, V1483, P161, DOI 10.1016/S1388-1981(99)00172-9; Sommers CL, 1999, J EXP MED, V190, P1427, DOI 10.1084/jem.190.10.1427; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; STEPHENS LR, 1991, NATURE, V351, P33, DOI 10.1038/351033a0; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; TRAYNORKAPLAN AE, 1989, J BIOL CHEM, V264, P15668; Varnai P, 1999, J BIOL CHEM, V274, P10983, DOI 10.1074/jbc.274.16.10983; Weil D, 1997, BLOOD, V90, P4332, DOI 10.1182/blood.V90.11.4332.4332_4332_4340; Welch H, 1997, ONCOGENE, V15, P2021, DOI 10.1038/sj.onc.1201356; Welch H, 1997, J BIOL CHEM, V272, P102; Welch Heidi, 1996, Methods (Orlando), V9, P607, DOI 10.1006/meth.1996.0067; Xiao YQ, 1998, EUR J PHARMACOL, V360, P195, DOI 10.1016/S0014-2999(98)00681-5; Yan SR, 1999, FEBS LETT, V451, P33, DOI 10.1016/S0014-5793(99)00539-6; Yang WC, 2001, J IMMUNOL, V166, P387, DOI 10.4049/jimmunol.166.1.387; Yang WC, 1999, J BIOL CHEM, V274, P607, DOI 10.1074/jbc.274.2.607; Yang WC, 2000, IMMUNITY, V12, P373, DOI 10.1016/S1074-7613(00)80189-2; Yoshida K, 2000, J BIOL CHEM, V275, P24945, DOI 10.1074/jbc.M909012199	64	49	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21537	21541		10.1074/jbc.M201903200	http://dx.doi.org/10.1074/jbc.M201903200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11940595	hybrid			2022-12-27	WOS:000176286000055
J	Scholze, P; Norregaard, L; Singer, EA; Freissmuth, M; Gether, U; Sitte, HH				Scholze, P; Norregaard, L; Singer, EA; Freissmuth, M; Gether, U; Sitte, HH			The role of zinc ions in reverse transport mediated by monoamine transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SEROTONIN TRANSPORTER; HUMAN DOPAMINE TRANSPORTER; FACILITATED EXCHANGE DIFFUSION; NEUROTRANSMITTER TRANSPORTERS; GABA TRANSPORTER-1; MAMMALIAN-CELLS; MOLECULAR-BASIS; RELEASE; COCAINE; LOCALIZATION	The human dopamine transporter (hDAT) contains an endogenous high affinity Zn2+ binding site with three coordinating residues on its extracellular face (His(193), His(375), and Glu(396)). Upon binding to this site, Zn2+ causes inhibition of [H-3]1-methyl-4-phenylpyridinium ([H-3]MPP+) uptake. We investigated the effect of Zn2+ on outward transport by superfusing hDAT-expressing HEK-293 cells preloaded with [H-3]MPP+. Although Zn2+ inhibited uptake, Zn2+ facilitated [H-3]MPP+ release induced by amphetamine, MPP+, or K+-induced depolarization specifically at hDAT but not at the human serotonin and the norepinephrine transporter (hNET). Mutation of the Zn2+ coordinating residue His(193) to Lys (the corresponding residue in hNET) eliminated the effect of Zn2+ on efflux. Conversely, the reciprocal mutation (K189H) conferred Zn2+ sensitivity to hNET. The intracellular [H-3]MPP+ concentration was varied to generate saturation isotherms; these showed that Zn2+ increased V-max for efflux (rather than KM-Efflux-intracellular). Thus, blockage of inward transport by Zn2+ is not due to a simple inhibition of the transporter turnover rate. The observations provide evidence against the model of facilitated exchange-diffusion and support the concept that inward and outward transport represent discrete operational modes of the transporter. In addition, they indicate a physiological role of Zn2+, because Zn2+ also facilitated transport reversal of DAT in rat striatal slices	Univ Vienna, Inst Pharmacol, A-1090 Vienna, Austria; Univ Copenhagen, Panum Inst, Dept Pharmacol, Mol Neuropharmacol Grp, DK-2200 Copenhagen N, Denmark	University of Vienna; University of Copenhagen	Sitte, HH (corresponding author), Univ Vienna, Inst Pharmacol, Wahringer Str 13A, A-1090 Vienna, Austria.	harald.sitte@univie.ac.at	Sitte, Harald/O-7025-2019; Sitte, Harald/N-2681-2013	Sitte, Harald/0000-0002-1339-7444; Sitte, Harald/0000-0002-1339-7444; Scholze, Petra/0000-0003-4984-6034; Freissmuth, Michael/0000-0001-9398-1765; Gether, Ulrik/0000-0002-0020-3807	NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012408] Funding Source: NIH RePORTER; NIDA NIH HHS [P01-DA-12408] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H; BERNEIS KH, 1969, NATURE, V224, P281, DOI 10.1038/224281a0; BUCK KJ, 1994, P NATL ACAD SCI USA, V91, P12584, DOI 10.1073/pnas.91.26.12584; CESURA AM, 1987, J NEUROCHEM, V49, P138, DOI 10.1111/j.1471-4159.1987.tb03405.x; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Falkenburger BH, 2001, SCIENCE, V293, P2465, DOI 10.1126/science.1060645; FISCHER JF, 1979, J PHARMACOL EXP THER, V208, P203; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; FREDERICKSON CJ, 1984, NEUROLOGY NEUROBIOLO; GIROS B, 1991, FEBS LETT, V295, P149, DOI 10.1016/0014-5793(91)81406-X; Hastrup H, 2001, P NATL ACAD SCI USA, V98, P10055, DOI 10.1073/pnas.181344298; HEXUM TD, 1974, BIOCHEM PHARMACOL, V23, P3441, DOI 10.1016/0006-2952(74)90347-5; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; Iversen L, 2000, MOL PSYCHIATR, V5, P357, DOI 10.1038/sj.mp.4000728; JAVITCH JA, 1984, EUR J PHARMACOL, V106, P455, DOI 10.1016/0014-2999(84)90740-4; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; LAUBE B, 1995, J PHYSIOL-LONDON, V483, P613, DOI 10.1113/jphysiol.1995.sp020610; LEVI G, 1993, TRENDS NEUROSCI, V16, P415, DOI 10.1016/0166-2236(93)90010-J; Loland CJ, 1999, J BIOL CHEM, V274, P36928, DOI 10.1074/jbc.274.52.36928; MacAulay N, 2001, J BIOL CHEM, V276, P40476, DOI 10.1074/jbc.M105578200; Nelson N, 1998, J NEUROCHEM, V71, P1785; Norregaard L, 1998, EMBO J, V17, P4266, DOI 10.1093/emboj/17.15.4266; Norregaard L, 2000, BIOCHEMISTRY-US, V39, P15836, DOI 10.1021/bi0018335; PEREZCLAUSELL J, 1985, BRAIN RES, V337, P91, DOI 10.1016/0006-8993(85)91612-9; Pifl C, 1999, MOL PHARMACOL, V56, P1047, DOI 10.1124/mol.56.5.1047; PIFL C, 1995, MOL PHARMACOL, V47, P368; POVLOCK SL, 1997, NEUROTRANSMITTER TRA, P1; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; RICHFIELD EK, 1993, MOL PHARMACOL, V43, P100; Rudnick G, 1997, NEUROTRANSMITTER TRA, P73; Schetz JA, 1999, J PHARMACOL EXP THER, V289, P956; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Scholze P, 2001, NEUROSCI LETT, V309, P173, DOI 10.1016/S0304-3940(01)02058-4; SEIDEN LS, 1993, ANNU REV PHARMACOL, V33, P639, DOI 10.1146/annurev.pa.33.040193.003231; Sitte HH, 1998, J NEUROCHEM, V71, P1289; Sitte HH, 2001, MOL PHARMACOL, V59, P1129, DOI 10.1124/mol.59.5.1129; Spiridon M, 1998, J PHYSIOL-LONDON, V506, P363, DOI 10.1111/j.1469-7793.1998.363bw.x; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; VALENTA B, 1988, J PHARMACOL EXP THER, V245, P944; Vandenberg RJ, 1998, MOL PHARMACOL, V54, P189, DOI 10.1124/mol.54.1.189; Vogt K, 2000, NEURON, V26, P187, DOI 10.1016/S0896-6273(00)81149-6; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0	44	72	72	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21505	21513		10.1074/jbc.M112265200	http://dx.doi.org/10.1074/jbc.M112265200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11940571	hybrid			2022-12-27	WOS:000176286000051
J	Jezewska, MJ; Galletto, R; Bujalowskii, W				Jezewska, MJ; Galletto, R; Bujalowskii, W			Dynamics of gapped DNA recognition by human polymerase beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; DIFFERENT BINDING MODES; TRANSFER RNA-PHE; KINETIC MECHANISM; TEMPLATE-PRIMER; REPAIR SYNTHESIS; PROTEIN HEXAMER; ANTICODON LOOP; ABASIC SITE; HELICASE	Kinetics of human polymerase 13 binding to gapped DNA substrates having single stranded (ss) DNA gaps with five or two nucleotide residues in the ssDNA gap has been examined, using the fluorescence stopped-flow technique. The mechanism of the recognition does not depend on the length of the ssDNA gap. Formation of the enzyme complex with both DNA substrates occurs by a minimum three-step reaction, with the bimolecular step followed by two isomerization steps. The results indicate that the polymerase initiates the association with gapped DNA substrates through the DNA-binding subsite located on the 8-kDa domain of the enzyme. This first association step is independent of the length of the ssDNA gap and is characterized by similar rate constants for both examined DNA substrates. The subsequent, first-order transition occurs at the rate of -600-1200 s(-1). This is the major docking step accompanied by favorable free energy changes in which the 31-kDa domain engages in interactions with the DNA. The 5'-terminal PO4- group downstream from the primer is not a specific recognition element of the gap. However, the phosphate group affects the enzyme orientation in the complex with the DNA, particularly, for the substrate with a longer gap.	Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77555 USA; Univ Texas, Med Branch, Sealy ctr struct Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Bujalowskii, W (corresponding author), Univ Texas, Med Branch, Dept Human Biol Chem & Genet, 301 Univ BLvd, Galveston, TX 77555 USA.			Galletto, Roberto/0000-0001-6435-122X	NIGMS NIH HHS [GM-58565] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058565] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bandwar RP, 2001, J BIOL CHEM, V276, P14075, DOI 10.1074/jbc.M011289200; Bernasconi C. F., 1976, RELAXATION KINETICS; Budd ME, 1997, MUTAT RES-DNA REPAIR, V384, P157, DOI 10.1016/S0921-8777(97)00024-4; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P6372, DOI 10.1021/bi00369a005; Bujalowski W, 2000, BIOCHEMISTRY-US, V39, P2106, DOI 10.1021/bi992413m; Bujalowski W, 2000, J MOL BIOL, V295, P831, DOI 10.1006/jmbi.1999.3378; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P6365, DOI 10.1021/bi00369a004; BUJALOWSKI W, 1995, BIOCHEMISTRY-US, V34, P8513, DOI 10.1021/bi00027a001; Bujalowski W., 2000, SPECTROPHOTOMETRY SP, P141; BUJALOWSKI W, 1994, J BIOL CHEM, V269, P1; CONNORS KW, 1990, CHEM KINETICS STUDY, P133; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HAMMOND RA, 1990, BIOCHEMISTRY-US, V29, P286, DOI 10.1021/bi00453a039; HOFFMANN JS, 1995, P NATL ACAD SCI USA, V92, P5356, DOI 10.1073/pnas.92.12.5356; Hubscher U, 2000, TRENDS BIOCHEM SCI, V25, P143, DOI 10.1016/S0968-0004(99)01523-6; Jezewska MJ, 1996, J BIOL CHEM, V271, P4261; Jezewska MJ, 1998, J BIOL CHEM, V273, P9058, DOI 10.1074/jbc.273.15.9058; Jezewska MJ, 1998, BIOCHEMISTRY-US, V37, P3116, DOI 10.1021/bi972564u; Jezewska MJ, 1998, J BIOL CHEM, V273, P10515, DOI 10.1074/jbc.273.17.10515; Jezewska MJ, 2001, J BIOL CHEM, V276, P16123, DOI 10.1074/jbc.M010434200; Jezewska MJ, 2001, J MOL BIOL, V313, P977, DOI 10.1006/jmbi.2001.5042; Jezewska MJ, 2001, BIOCHEMISTRY-US, V40, P3295, DOI 10.1021/bi002749s; Jezewska MJ, 1998, J MOL BIOL, V284, P1113, DOI 10.1006/jmbi.1998.2252; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; MATSUMOTO Y, 1991, MOL CELL BIOL, V11, P4441, DOI 10.1128/MCB.11.9.4441; MATSUMOTO Y, 1994, MOL CELL BIOL, V14, P6187, DOI 10.1128/MCB.14.9.6187; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12762, DOI 10.1021/bi9529566; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; PILAR RL, 1968, ELEMENTARY QUANTUM C; PORSCHKE D, 1978, BIOPOLYMERS, V17, P315; PORSCHKE D, 1976, BIOCHEMISTRY-US, V15, P1495; PRASAD R, 1994, J BIOL CHEM, V269, P18096; Rajendran S, 2000, J MOL BIOL, V303, P773, DOI 10.1006/jmbi.2000.4124; Rajendran S, 2001, BIOCHEMISTRY-US, V40, P11794, DOI 10.1021/bi011173j; Rajendran S, 2001, J MOL BIOL, V308, P477, DOI 10.1006/jmbi.2001.4571; Rajendran S, 1998, J BIOL CHEM, V273, P31021, DOI 10.1074/jbc.273.47.31021; SAWAYA MR, 1994, SCIENCE, V264, P1930, DOI 10.1126/science.7516581; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; WIEBAUER K, 1990, P NATL ACAD SCI USA, V87, P5842, DOI 10.1073/pnas.87.15.5842; Zhong XJ, 1997, BIOCHEMISTRY-US, V36, P11891, DOI 10.1021/bi963181j	43	26	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20316	20327		10.1074/jbc.M200918200	http://dx.doi.org/10.1074/jbc.M200918200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11912205	hybrid			2022-12-27	WOS:000176204500030
J	Milanini-Mongiat, J; Pouyssegur, J; Pages, G				Milanini-Mongiat, J; Pouyssegur, J; Pages, G			Identification of two Sp1 phosphorylation sites for p42/p44 mitogen-activated protein kinases - Their implication in vascular endothelial growth factor gene transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR MESSENGER-RNA; INTERNAL RIBOSOME ENTRY; DNA-BINDING ACTIVITY; NIH 3T3 CELLS; MAP KINASE; FACTOR EXPRESSION; SP1-MEDIATED TRANSCRIPTION; SIGNAL-TRANSDUCTION; PROMOTER ACTIVITY; CYCLE REGULATION	Sp1 regulates activation of many genes implicated in tumor growth and cell cycle progression. We have previously demonstrated its implication in the up-regulation of vascular endothelial growth factor (VEGF) gene transcription following growth factor stimulation of quiescent cells, a situation where p42/p44 mitogen-activate protein kinase (MAPK) activity is dramatically increased. Here we show that p42/p44 MAPK directly phosphorylates Sp1 on threonines 453 and 739 both in vitro and in vivo. Mutation of these sites to alanines decreases by half the MAPK-dependent transcriptional activity of Sp1, in the context of the VEGF promoter, in SL2 Drosophila cells devoid of the endogenous Sp1 protein. Moreover, inducible overexpression of the (T453A,T739A) Sp1 double mutant compromises MAPK-driven VEGF mRNA transcription in fibroblasts. These results highlight Sp1 as a key molecular link between elevated activation of the Ras much greater than p42/p44MAPK signaling pathway and increased VEGF expression, two major steps deregulated in tumor cells.	Ctr Antoine Lacassagne, Inst Signalling Dev Biol & Canc Res, F-06189 Nice 2, France	UNICANCER; Centre Antoine Lacassagne	Pages, G (corresponding author), Ctr Antoine Lacassagne, Inst Signalling Dev Biol & Canc Res, 33 Ave Valombrose, F-06189 Nice 2, France.		Pages, Gilles/N-7135-2017	Milanini, Julie/0000-0002-5861-2830				Armstrong SA, 1997, J BIOL CHEM, V272, P13489, DOI 10.1074/jbc.272.21.13489; BERSE B, 1992, MOL BIOL CELL, V3, P211, DOI 10.1091/mbc.3.2.211; Billon N, 1999, ONCOGENE, V18, P2872, DOI 10.1038/sj.onc.1202712; Black AR, 1999, J BIOL CHEM, V274, P1207, DOI 10.1074/jbc.274.3.1207; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; BRUNET A, 1994, FEBS LETT, V346, P299, DOI 10.1016/0014-5793(94)00475-7; Carter AB, 1999, J BIOL CHEM, V274, P30858, DOI 10.1074/jbc.274.43.30858; CHEN LI, 1994, MOL CELL BIOL, V14, P4380, DOI 10.1128/MCB.14.7.4380; Claffey KP, 1998, MOL BIOL CELL, V9, P469, DOI 10.1091/mbc.9.2.469; CorbalanGarcia S, 1996, MOL CELL BIOL, V16, P5674; COUREY AJ, 1989, CELL, V59, P827, DOI 10.1016/0092-8674(89)90606-5; de Borja PF, 2001, EMBO J, V20, P5737; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; ELDEIRY WS, 1995, CANCER RES, V55, P2910; FINKENZELLER G, 1995, BIOCHEM BIOPH RES CO, V208, P432, DOI 10.1006/bbrc.1995.1356; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Gartel AL, 2000, ONCOGENE, V19, P5182, DOI 10.1038/sj.onc.1203900; GILL G, 1994, P NATL ACAD SCI USA, V91, P192, DOI 10.1073/pnas.91.1.192; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; Gille J, 1997, EMBO J, V16, P750, DOI 10.1093/emboj/16.4.750; Gioeli D, 1999, CANCER RES, V59, P279; GONZALEZ FA, 1993, J CELL BIOL, V122, P1089, DOI 10.1083/jcb.122.5.1089; GRUGEL S, 1995, J BIOL CHEM, V270, P25915, DOI 10.1074/jbc.270.43.25915; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HIPSKIND RA, 1994, MOL CELL BIOL, V14, P6219, DOI 10.1128/MCB.14.9.6219; HIPSKIND RA, 1994, GENE DEV, V8, P1803, DOI 10.1101/gad.8.15.1803; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Huez I, 1998, MOL CELL BIOL, V18, P6178, DOI 10.1128/MCB.18.11.6178; IKEDA E, 1995, J BIOL CHEM, V270, P19761, DOI 10.1074/jbc.270.34.19761; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; JANKNECHT R, 1994, ONCOGENE, V9, P1273; Jensen DE, 1997, J CELL BIOCHEM, V67, P24, DOI 10.1002/(SICI)1097-4644(19971001)67:1<24::AID-JCB3>3.0.CO;2-Y; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; Kivinen L, 1999, ONCOGENE, V18, P6252, DOI 10.1038/sj.onc.1203000; LEE JS, 1993, P NATL ACAD SCI USA, V90, P6145, DOI 10.1073/pnas.90.13.6145; LEGGETT RW, 1995, J BIOL CHEM, V270, P25879, DOI 10.1074/jbc.270.43.25879; Lenormand P, 1996, J BIOL CHEM, V271, P15762, DOI 10.1074/jbc.271.26.15762; Levy AP, 1996, J BIOL CHEM, V271, P25492, DOI 10.1074/jbc.271.41.25492; LEVY AP, 1995, J BIOL CHEM, V270, P13333, DOI 10.1074/jbc.270.22.13333; Levy AP, 1996, J BIOL CHEM, V271, P2746, DOI 10.1074/jbc.271.5.2746; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Mandell JW, 1998, AM J PATHOL, V153, P1411, DOI 10.1016/S0002-9440(10)65728-8; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MELOCHE S, 1992, MOL BIOL CELL, V3, P63, DOI 10.1091/mbc.3.1.63; Merchant JL, 1999, BIOCHEM BIOPH RES CO, V254, P454, DOI 10.1006/bbrc.1998.9964; Milanini J, 1998, J BIOL CHEM, V273, P18165, DOI 10.1074/jbc.273.29.18165; Miyata Y, 1999, BBA-MOL CELL RES, V1451, P334, DOI 10.1016/S0167-4889(99)00107-X; Mortensen ER, 1997, J BIOL CHEM, V272, P16540, DOI 10.1074/jbc.272.26.16540; Mukhopadhyay D, 1997, MOL CELL BIOL, V17, P5629, DOI 10.1128/MCB.17.9.5629; MUKHOPADHYAY D, 1995, NATURE, V375, P577, DOI 10.1038/375577a0; MURATA Y, 1994, J BIOL CHEM, V269, P20674; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; NORTHWOOD IC, 1991, J BIOL CHEM, V266, P15266; OKAZAKI K, 1995, EMBO J, V14, P5048, DOI 10.1002/j.1460-2075.1995.tb00187.x; Pages G, 2000, J BIOL CHEM, V275, P26484, DOI 10.1074/jbc.M002104200; Pal S, 1998, J BIOL CHEM, V273, P26277, DOI 10.1074/jbc.273.41.26277; Pal S, 1997, J BIOL CHEM, V272, P27509, DOI 10.1074/jbc.272.44.27509; Pal S, 2001, J BIOL CHEM, V276, P2395, DOI 10.1074/jbc.M007818200; PASCAL E, 1991, GENE DEV, V5, P1646, DOI 10.1101/gad.5.9.1646; Rak J, 2000, CANCER RES, V60, P490; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Rohlff C, 1997, J BIOL CHEM, V272, P21137, DOI 10.1074/jbc.272.34.21137; ROSSOMANDO AJ, 1994, MOL CELL BIOL, V14, P1594, DOI 10.1128/MCB.14.3.1594; Salh B, 1999, ANTICANCER RES, V19, P731; Salimath B, 2000, ONCOGENE, V19, P3470, DOI 10.1038/sj.onc.1203672; SAMUELS ML, 1994, MOL CELL BIOL, V14, P7855, DOI 10.1128/MCB.14.12.7855; SAMUELS ML, 1993, MOL CELL BIOL, V13, P6241, DOI 10.1128/MCB.13.10.6241; Schmidt CM, 1997, BIOCHEM BIOPH RES CO, V236, P54, DOI 10.1006/bbrc.1997.6840; Segil N, 1996, GENE DEV, V10, P2389, DOI 10.1101/gad.10.19.2389; SETH A, 1992, J BIOL CHEM, V267, P24796; Shima DT, 1996, J BIOL CHEM, V271, P3877, DOI 10.1074/jbc.271.7.3877; SIF S, 1994, J VIROL, V68, P7131, DOI 10.1128/JVI.68.11.7131-7138.1994; Song XD, 1999, J BIOL CHEM, V274, P1677, DOI 10.1074/jbc.274.3.1677; STEIN I, 1995, MOL CELL BIOL, V15, P5363; Stein I, 1998, MOL CELL BIOL, V18, P3112, DOI 10.1128/MCB.18.6.3112; Tedford K, 1997, CURR BIOL, V7, P228, DOI 10.1016/S0960-9822(06)00118-7; Zhang LL, 2000, CANCER RES, V60, P3655	83	261	271	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20631	20639		10.1074/jbc.M201753200	http://dx.doi.org/10.1074/jbc.M201753200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11904305	hybrid			2022-12-27	WOS:000176204500070
J	Nutt, LK; Chandra, J; Pataer, A; Fang, BL; Roth, JA; Swisher, SG; O'Neil, RG; McConkey, DJ				Nutt, LK; Chandra, J; Pataer, A; Fang, BL; Roth, JA; Swisher, SG; O'Neil, RG; McConkey, DJ			Bax-mediated Ca2+ mobilization promotes cytochrome c release during apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-2 FAMILY PROTEINS; ENDOPLASMIC-RETICULUM; INTRACELLULAR CALCIUM; MITOCHONDRIAL CONTROL; PROAPOPTOTIC BAX; ION-CHANNEL; DEATH; PHOSPHORYLATION; HOMEOSTASIS; EXPRESSION	Previous studies have demonstrated that Ca2+ is released from the endoplasmic reticulum (ER) in some models of apoptosis, but the mechanisms involved and the functional significance remain obscure. We confirmed that apoptosis induced by some (but not all) proapoptotic stimuli was associated with caspase-independent, BCL-2-sensitive emptying of the ER Ca2+ pool in human PC-3 prostate cancer cells. This mobilization of ER Ca2+ was associated with a concomitant increase in mitochondrial Ca2+ levels, and neither ER Ca2+ mobilization nor mitochondrial Ca2+ uptake occurred in Bax-null DU-145 cells. Importantly, restoration of DU145 Bax expression via adenoviral gene transfer restored ER Ca2+ release and mitochondrial Ca2+ uptake and dramatically accelerated the kinetics of staurosporine-induced cytochrome c release, demonstrating a requirement for Bax expression in this model system. In addition, an inhibitor of the mitochondrial Ca2+ uniporter (RU-360) attenuated mitochondrial Ca2+ uptake, cytochrome c release, and DNA fragmentation, directly implicating the mitochondrial Ca2+ changes in cell death. Together, our data demonstrate that Bax-mediated alterations in ER and mitochondrial Ca2+ levels serve as important upstream signals for cytochrome c release in some examples of apoptosis.	Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol 173, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Pediat, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Sect Thorac & Mol Oncol, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA; Univ Texas, Houston Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	McConkey, DJ (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol 173, 1515 Holcombe Blvd, Houston, TX 77030 USA.	dmcconke@mdanderson.org			NATIONAL CANCER INSTITUTE [R29CA069676, P01CA078778, T32CA009598] Funding Source: NIH RePORTER; NCI NIH HHS [2P50-CA70970-04, CA09598, P01-CA78778-O1A1, CA69676] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; BAFFY G, 1993, J BIOL CHEM, V268, P6511; Chandra J, 1998, BLOOD, V92, P4220, DOI 10.1182/blood.V92.11.4220.423k49_4220_4229; Csordas G, 1999, EMBO J, V18, P96, DOI 10.1093/emboj/18.1.96; Deng XM, 2001, J BIOL CHEM, V276, P23681, DOI 10.1074/jbc.M100279200; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Foyouzi-Youssefi R, 2000, P NATL ACAD SCI USA, V97, P5723, DOI 10.1073/pnas.97.11.5723; FURUYA Y, 1994, CANCER RES, V54, P6167; Gogvadze V, 2001, J BIOL CHEM, V276, P19066, DOI 10.1074/jbc.M100614200; Haldar S, 1996, CANCER RES, V56, P1253; HALDAR S, 1995, P NATL ACAD SCI USA, V342, P195; He HL, 1997, J CELL BIOL, V138, P1219, DOI 10.1083/jcb.138.6.1219; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Ito T, 1997, J BIOL CHEM, V272, P11671, DOI 10.1074/jbc.272.18.11671; JIANG S, 1994, EXP CELL RES, V212, P84, DOI 10.1006/excr.1994.1121; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kroemer G, 1997, IMMUNOL TODAY, V18, P44, DOI 10.1016/S0167-5699(97)80014-X; Kuo TH, 1998, ONCOGENE, V17, P1903, DOI 10.1038/sj.onc.1202110; LAM M, 1993, MOL ENDOCRINOL, V7, P686, DOI 10.1210/me.7.5.686; LAM M, 1994, P NATL ACAD SCI USA, V91, P6569, DOI 10.1073/pnas.91.14.6569; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; McConkey DJ, 1997, BIOCHEM BIOPH RES CO, V239, P357, DOI 10.1006/bbrc.1997.7409; McConkey DJ, 1996, CANCER RES, V56, P5594; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Murphy AN, 1996, P NATL ACAD SCI USA, V93, P9893, DOI 10.1073/pnas.93.18.9893; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Nutt LK, 2002, J BIOL CHEM, V277, P9219, DOI 10.1074/jbc.M106817200; Nutt LK, 2000, J AM SOC NEPHROL, V11, P1225, DOI 10.1681/ASN.V1171225; Pacher P, 2001, EMBO J, V20, P4107, DOI 10.1093/emboj/20.15.4107; Pataer A, 2000, CANCER RES, V60, P788; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Schendel SL, 1997, P NATL ACAD SCI USA, V94, P5113, DOI 10.1073/pnas.94.10.5113; Schendel SL, 1998, CELL DEATH DIFFER, V5, P372, DOI 10.1038/sj.cdd.4400365; Schlesinger PH, 1997, P NATL ACAD SCI USA, V94, P11357, DOI 10.1073/pnas.94.21.11357; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P577, DOI 10.1073/pnas.97.2.577; Shinoura N, 1999, CANCER RES, V59, P4119; Susin SA, 1996, J EXP MED, V184, P1331, DOI 10.1084/jem.184.4.1331; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wang NS, 2001, J BIOL CHEM, V276, P44117, DOI 10.1074/jbc.M101958200; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129	52	165	176	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20301	20308		10.1074/jbc.M201604200	http://dx.doi.org/10.1074/jbc.M201604200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11909872	hybrid			2022-12-27	WOS:000176204500028
J	Chen, YF; Randlett, MD; Findell, JL; Schaller, GE				Chen, YF; Randlett, MD; Findell, JL; Schaller, GE			Localization of the ethylene receptor ETR1 to the endoplasmic reticulum of Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUXIN-BINDING PROTEIN; PLASMA-MEMBRANE; TRANSMEMBRANE PROTEINS; VACUOLAR MEMBRANE; GENE FAMILY; H+-ATPASE; RESPONSES; RETENTION; MUTANT; PLANTS	The ethylene receptor ETR1 of Arabidopsis contains transmembrane domains responsible for ethylene binding and membrane localization. Sequence analysis does not provide information as to which membrane system of the plant cell ETR1 is localized. Examination by aqueous two-phase partitioning, sucrose density-gradient centrifugation, and immunoelectron microscopy indicates that ETR1 is predominantly localized to the endoplasmic reticulum. Localization of ETR1 showed no change following a cycloheximide chase. Ethylene binding by ETR1 did not affect localization to the endoplasmic reticulum, based upon analysis of plants treated with the ethylene precursor 1-aminocyclopropane-1-carboxylic acid and by examination of a mutant receptor that does not bind ethylene. Determinants within the amino-terminal half of ETR1 are sufficient for targeting to and retention at the endoplasmic reticulum. These data support a central role of the plant endoplasmic reticulum. in hormone perception and signal transduction.	Univ New Hampshire, Dept Biochem & Mol Biol, Durham, NH 03824 USA	University System Of New Hampshire; University of New Hampshire	Schaller, GE (corresponding author), Univ New Hampshire, Dept Biochem & Mol Biol, Durham, NH 03824 USA.							Abeles F, 1992, ETHYLENE PLANT BIOL; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; [Anonymous], FUNDAMENTALS MED C A; Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Bauly JM, 2000, PLANT PHYSIOL, V124, P1229, DOI 10.1104/pp.124.3.1229; Benghezal M, 2000, PLANT CELL, V12, P1179, DOI 10.1105/tpc.12.7.1179; Bleecker AB, 1999, TRENDS PLANT SCI, V4, P269, DOI 10.1016/S1360-1385(99)01427-2; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Chen JG, 2001, GENE DEV, V15, P902, DOI 10.1101/gad.866201; DENECKE J, 1992, EMBO J, V11, P2345, DOI 10.1002/j.1460-2075.1992.tb05294.x; DENECKE J, 1991, PLANT CELL, V3, P1025, DOI 10.1105/tpc.3.9.1025; DeWitt ND, 1996, PLANT PHYSIOL, V112, P833, DOI 10.1104/pp.112.2.833; EVANS DE, 1982, PLANT CELL ENVIRON, V5, P101; EVANS DE, 1982, PLANTA, V154, P48, DOI 10.1007/BF00385495; Gamble RL, 1998, P NATL ACAD SCI USA, V95, P7825, DOI 10.1073/pnas.95.13.7825; GARCIA PD, 1987, J BIOL CHEM, V262, P9463; GAUBLE RL, 2002, PLANT PHYSIOL, V128, P1428; Hall AE, 1999, PLANT PHYSIOL, V121, P291, DOI 10.1104/pp.121.1.291; Henderson J, 1997, PLANTA, V202, P313, DOI 10.1007/s004250050133; Hirayama T, 1999, CELL, V97, P383, DOI 10.1016/S0092-8674(00)80747-3; HOFTE H, 1992, PLANT CELL, V4, P995, DOI 10.1105/tpc.4.8.995; Hong BM, 1999, PLANT PHYSIOL, V119, P1165, DOI 10.1104/pp.119.4.1165; Hua J, 1998, PLANT CELL, V10, P1321, DOI 10.1105/tpc.10.8.1321; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Koizumi N, 2001, PLANT PHYSIOL, V127, P949, DOI 10.1104/pp.010636; Kwak SH, 1997, PLANT CELL PHYSIOL, V38, P1142, DOI 10.1093/oxfordjournals.pcp.a029099; Larsen PB, 2001, PLANT PHYSIOL, V125, P1061, DOI 10.1104/pp.125.2.1061; LARSSON C, 1987, METHOD ENZYMOL, V148, P558; LORD JM, 1987, METHOD ENZYMOL, V148, P542; MAESHIMA M, 1992, PLANT PHYSIOL, V98, P1248, DOI 10.1104/pp.98.4.1248; Martin W, 1998, PLANT PHYSIOL, V118, P9, DOI 10.1104/pp.118.1.9; NAPIER RM, 1992, J CELL SCI, V102, P261; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Pedrazzini E, 1996, P NATL ACAD SCI USA, V93, P4207, DOI 10.1073/pnas.93.9.4207; PIMENTEL E, 1994, HDB GROWTH FACTORS, V3; RAZ V, 1992, PLANT CELL, V4, P1123, DOI 10.1105/tpc.4.9.1123; Rodriguez FI, 1999, SCIENCE, V283, P996, DOI 10.1126/science.283.5404.996; Sandhu P, 2000, J NEUROL NEUROSUR PS, V68, P97, DOI 10.1136/jnnp.68.1.97; SCHALLER GE, 1995, J BIOL CHEM, V270, P12526, DOI 10.1074/jbc.270.21.12526; Schaller GE, 1995, METHOD CELL BIOL, V50, P129, DOI 10.1016/S0091-679X(08)61027-4; SCHALLER GE, 1995, SCIENCE, V270, P1809, DOI 10.1126/science.270.5243.1809; Schaller GE, 2000, ADV BOT RES, V32, P109, DOI 10.1016/S0065-2296(00)32023-7; Taylor RS, 1997, MOL BIOL CELL, V8, P1911, DOI 10.1091/mbc.8.10.1911; Timpte C, 2001, TRENDS PLANT SCI, V6, P586, DOI 10.1016/S1360-1385(01)02150-1; VONHEIJNE G, 1986, J MOL BIOL, V189, P239, DOI 10.1016/0022-2836(86)90394-3; Weatherman RV, 1999, ANNU REV BIOCHEM, V68, P559, DOI 10.1146/annurev.biochem.68.1.559; Woeste KE, 2000, PLANT CELL, V12, P443, DOI 10.1105/tpc.12.3.443; Yang TB, 2000, J BIOL CHEM, V275, P38467, DOI 10.1074/jbc.M003566200	50	234	267	5	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19861	19866		10.1074/jbc.M201286200	http://dx.doi.org/10.1074/jbc.M201286200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11916973	hybrid			2022-12-27	WOS:000175894800082
J	French, CA; Masson, JY; Griffin, CS; O'Regan, P; West, SC; Thacker, J				French, CA; Masson, JY; Griffin, CS; O'Regan, P; West, SC; Thacker, J			Role of mammalian RAD51L2 (RAD51C) in recombination and genetic stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; DNA-REPAIR GENE; HOMOLOGOUS RECOMBINATION; VERTEBRATE CELLS; NUCLEAR FOCI; REPLICATION FORKS; SOMATIC-CELLS; RECA HOMOLOGS; HAMSTER-CELLS; MOUSE GENES	The highly conserved RAD51 protein has a central role in homologous recombination. Five novel RAD51-like genes have been identified in mammalian cells, but little is known about their functions. A DNA damage-sensitive hamster cell line, irs3, was found to have a mutation in the RAD51L2 gene and an undetectable level of RAD51L2 protein. Resistance of irs3 to DNA-damaging agents was significantly increased by expression of the human RAD51L2 gene, but not by other RAD51-like genes or RAD51 itself. Consistent with a role for RAD51L2 in homologous recombination, irs3 cells show a reduction in sister chromatid exchange, an increase in isochromatid breaks, and a decrease in damage-dependent RAD51 focus formation compared with wild type cells. As recently demonstrated for human cells, we show that RAD51L2 forms part of two separate complexes of hamster RAD51-like proteins. Strikingly, neither complex of RAD51-like proteins is formed in irs3 cells. Our results demonstrate that RAD51L2 has a key role in mammalian RAD51-dependent processes, contingent on the formation of protein complexes involved in homologous recombination repair.	MRC, Radiat & Genome Stabil Unit, Harwell OX11 0RD, Oxon, England; Canc Res UK, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Thacker, J (corresponding author), MRC, Radiat & Genome Stabil Unit, Harwell OX11 0RD, Oxon, England.	j.thacker@har.mrc.ac.uk		French, Catherine/0000-0003-2072-8413; West, Stephen/0000-0001-8848-9418; Masson, Jean Yves/0000-0002-4403-7169				Albala JS, 1997, GENOMICS, V46, P476, DOI 10.1006/geno.1997.5062; Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Bishop DK, 1998, J BIOL CHEM, V273, P21482, DOI 10.1074/jbc.273.34.21482; Braybrooke JP, 2000, J BIOL CHEM, V275, P29100, DOI 10.1074/jbc.M002075200; Cartwright R, 1998, NUCLEIC ACIDS RES, V26, P1653, DOI 10.1093/nar/26.7.1653; Cartwright R, 1998, NUCLEIC ACIDS RES, V26, P3084, DOI 10.1093/nar/26.13.3084; Dosanjh MK, 1998, NUCLEIC ACIDS RES, V26, P1179, DOI 10.1093/nar/26.5.1179; GAME JC, 1993, SEMIN CANCER BIOL, V4, P73; Griffin CS, 2000, NAT CELL BIOL, V2, P757, DOI 10.1038/35036399; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; HOEIJMAKERS JHJ, 1993, TRENDS GENET, V9, P211, DOI 10.1016/0168-9525(93)90121-W; Jeggo PA, 1998, RADIAT RES, V150, pS80, DOI 10.2307/3579810; Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43935; JOHNSON RD, 1995, MOL CELL BIOL, V15, P4843; JONES NJ, 1993, CARCINOGENESIS, V14, P2487, DOI 10.1093/carcin/14.12.2487; JONES NJ, 1988, MUTAT RES, V193, P139, DOI 10.1016/0167-8817(88)90044-2; JONES NJ, 1987, MUTAT RES, V183, P279, DOI 10.1016/0167-8817(87)90011-3; Justice MJ, 1999, HUM MOL GENET, V8, P1955, DOI 10.1093/hmg/8.10.1955; Kurumizaka H, 2001, P NATL ACAD SCI USA, V98, P5538, DOI 10.1073/pnas.091603098; Leasure CS, 2001, GENE, V271, P59, DOI 10.1016/S0378-1119(01)00498-X; Liu N, 2002, NUCLEIC ACIDS RES, V30, P1009, DOI 10.1093/nar/30.4.1009; Liu N, 1998, MOL CELL, V1, P783, DOI 10.1016/S1097-2765(00)80078-7; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; Masson JY, 2001, P NATL ACAD SCI USA, V98, P8440, DOI 10.1073/pnas.111005698; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8235, DOI 10.1073/pnas.121007798; Miller KA, 2002, J BIOL CHEM, V277, P8406, DOI 10.1074/jbc.M108306200; O'Regan P, 2001, J BIOL CHEM, V276, P22148, DOI 10.1074/jbc.M102396200; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; PETERSON C, 1991, GENE, V107, P279, DOI 10.1016/0378-1119(91)90328-9; Pittman DL, 1998, GENOMICS, V49, P103, DOI 10.1006/geno.1998.5226; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; Rice MC, 1997, P NATL ACAD SCI USA, V94, P7417, DOI 10.1073/pnas.94.14.7417; SAVAGE JRK, 1976, J MED GENET, V13, P103, DOI 10.1136/jmg.13.2.103; Schild D, 2000, J BIOL CHEM, V275, P16443, DOI 10.1074/jbc.M001473200; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHIBUYA T, 1993, MUTAT RES, V297, P3, DOI 10.1016/0165-1110(93)90005-8; Sigurdsson S, 2001, GENE DEV, V15, P3308, DOI 10.1101/gad.935501; SIMINOVITCH L, 1976, CELL, V7, P1, DOI 10.1016/0092-8674(76)90249-X; Slupianek A, 2001, MOL CELL, V8, P795, DOI 10.1016/S1097-2765(01)00357-4; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Sonoda E, 2001, P NATL ACAD SCI USA, V98, P8388, DOI 10.1073/pnas.111006398; STEINGRIMSDOTTIR H, 1992, NUCLEIC ACIDS RES, V20, P1201, DOI 10.1093/nar/20.6.1201; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; Takata M, 2000, MOL CELL BIOL, V20, P6476, DOI 10.1128/MCB.20.17.6476-6482.2000; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Tambini CE, 1997, GENOMICS, V41, P84, DOI 10.1006/geno.1997.4636; Tan TLR, 1999, CURR BIOL, V9, P325, DOI 10.1016/S0960-9822(99)80142-0; Tashiro S, 1996, ONCOGENE, V12, P2165; Thacker J, 1999, BIOCHIMIE, V81, P77, DOI 10.1016/S0300-9084(99)80041-8; Thacker J, 1999, TRENDS GENET, V15, P166, DOI 10.1016/S0168-9525(99)01733-3; THACKER J, 1994, MUTAGENESIS, V9, P163, DOI 10.1093/mutage/9.2.163; Thompson LH, 1999, BIOCHIMIE, V81, P87, DOI 10.1016/S0300-9084(99)80042-X; TUCKER JD, 1991, MUTAT RES, V254, P143, DOI 10.1016/0921-8777(91)90005-A; WARNEFORD SG, 1992, CELL GROWTH DIFFER, V3, P839; Wiese C, 2002, NUCLEIC ACIDS RES, V30, P1001, DOI 10.1093/nar/30.4.1001; Yuan SSF, 1999, CANCER RES, V59, P3547	61	87	89	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19322	19330		10.1074/jbc.M201402200	http://dx.doi.org/10.1074/jbc.M201402200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11912211	hybrid			2022-12-27	WOS:000175894800012
J	Sitailo, LA; Tibudan, SS; Denning, MF				Sitailo, LA; Tibudan, SS; Denning, MF			Activation of caspase-9 is required for UV-induced apoptosis of human keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RADIATION-INDUCED APOPTOSIS; NECROSIS-FACTOR-ALPHA; KINASE-C-DELTA; NF-KAPPA-B; CYTOCHROME-C; SKIN-CANCER; CELL-DEATH; ULTRAVIOLET-IRRADIATION; EXPRESSION; P53	UV radiation from the sun activates both the membrane death receptor and the intrinsic or mitochondrial apoptotic signaling pathways in epidermal keratinocytes, triggering apoptosis and affording protection against skin cancer formation. We have investigated the involvement of caspase-9 in the UV death effector pathway in human keratinocytes, since this is the initiating caspase in the mitochondrial pathway required for UV-induced apoptosis in some, but not all, cell types. UV radiation triggered activation of caspase-3, caspase-9, and caspase-8 with similar kinetics, although the rank order of activation was caspase-3 > caspase-9 > caspase-8. Inhibition of caspase-9 with either the peptide inhibitor benzyloxycarbonyl-Leu-Glu(OCH3)-His-Asp(OCH3)-fluoromethyl ketone, or expression of a catalytically inactive caspase-9 by retroviral transduction, protected normal keratinocytes from UV-induced apoptosis. HaCaT keratinocytes harboring mutant p53 alleles were also protected from UV-induced apoptosis by the dominant negative caspase-9. The dominant negative caspase-9 blocked UV-induced activation of caspase-3, caspase-9, and caspase-8, and also protected cells from the loss of mitochondrial membrane potential. In contrast, the dominant negative caspase-9 did not protect from anti-Fas-induced apoptosis or caspase activation. These results identify caspase-9 as the critical upstream caspase initiating apoptosis by UV radiation in human keratinocytes, the relevant cell type for this important environmental carcinogen.	Loyola Univ, Med Ctr, Cardinal Bernardin Canc Ctr, Skin Canc Res Program, Maywood, IL 60153 USA; Loyola Univ, Med Ctr, Dept Pathol, Maywood, IL 60153 USA	Loyola University Chicago; Loyola University Chicago	Denning, MF (corresponding author), Loyola Univ, Med Ctr, Cardinal Bernardin Canc Ctr, Skin Canc Res Program, 2160 S 1st Ave,Rm 304, Maywood, IL 60153 USA.				NCI NIH HHS [CA83784] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA083784] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adrain C, 2001, EMBO J, V20, P6627, DOI 10.1093/emboj/20.23.6627; Aragane Y, 1998, J CELL BIOL, V140, P171, DOI 10.1083/jcb.140.1.171; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bacon P. E., 2000, Journal of Investigative Dermatology, V114, P763; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Denning MF, 1998, J BIOL CHEM, V273, P29995, DOI 10.1074/jbc.273.45.29995; Denning MF, 2002, CELL DEATH DIFFER, V9, P40, DOI 10.1038/sj.cdd.4400929; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Fearnhead HO, 1998, P NATL ACAD SCI USA, V95, P13664, DOI 10.1073/pnas.95.23.13664; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; Gillardon F, 1999, CELL DEATH DIFFER, V6, P55, DOI 10.1038/sj.cdd.4400455; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Grenet J, 1999, GENE, V226, P225, DOI 10.1016/S0378-1119(98)00565-4; Grossman D, 2001, J CLIN INVEST, V108, P991, DOI 10.1172/JCI200113345; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hill LL, 1999, SCIENCE, V285, P898, DOI 10.1126/science.285.5429.898; Jiang WD, 1999, ONCOGENE, V18, P4247, DOI 10.1038/sj.onc.1202789; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Kraemer KH, 1997, P NATL ACAD SCI USA, V94, P11, DOI 10.1073/pnas.94.1.11; Kuwana T, 1998, J BIOL CHEM, V273, P16589, DOI 10.1074/jbc.273.26.16589; LEHMAN TA, 1993, CARCINOGENESIS, V14, P833, DOI 10.1093/carcin/14.5.833; Leverkus M, 1998, J INVEST DERMATOL, V110, P353, DOI 10.1046/j.1523-1747.1998.00154.x; Leverkus M, 1997, EXP CELL RES, V232, P255, DOI 10.1006/excr.1997.3514; Li G, 1998, J INVEST DERMATOL, V110, P72, DOI 10.1046/j.1523-1747.1998.00090.x; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; MITRA R, 1994, KERATINOCYTE METHODS, P17; Pena JC, 1997, CELL GROWTH DIFFER, V8, P619; Qin JZ, 1999, J BIOL CHEM, V274, P37957, DOI 10.1074/jbc.274.53.37957; Qin JZ, 2001, J INVEST DERMATOL, V117, P898, DOI 10.1046/j.0022-202x.2001.01477.x; Rehemtulla A, 1997, J BIOL CHEM, V272, P25783, DOI 10.1074/jbc.272.41.25783; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Rodriguez-Villanueva J, 1998, ONCOGENE, V16, P853, DOI 10.1038/sj.onc.1201610; Rossiter H, 2001, CANCER RES, V61, P3619; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; SCHWARZ A, 1995, J INVEST DERMATOL, V104, P922, DOI 10.1111/1523-1747.ep12606202; Shapiro HM, 2000, METHODS, V21, P271, DOI 10.1006/meth.2000.1007; Sheikh MS, 1998, ONCOGENE, V17, P2555, DOI 10.1038/sj.onc.1202292; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; Sun XM, 1999, J BIOL CHEM, V274, P5053, DOI 10.1074/jbc.274.8.5053; Taylor JK, 1999, ONCOGENE, V18, P4495, DOI 10.1038/sj.onc.1202836; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; ZIEGLER A, 1993, P NATL ACAD SCI USA, V90, P4216, DOI 10.1073/pnas.90.9.4216; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	47	132	144	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19346	19352		10.1074/jbc.M200401200	http://dx.doi.org/10.1074/jbc.M200401200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11919192	hybrid			2022-12-27	WOS:000175894800015
J	Funakoshi, Y; Ichiki, T; Takeda, H; Tokuno, T; Iino, N; Takeshita, A				Funakoshi, Y; Ichiki, T; Takeda, H; Tokuno, T; Iino, N; Takeshita, A			Critical role of cAMP-response element-binding protein for angiotensin II-induced hypertrophy of vascular smooth muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR FACTOR CREB; C-FOS GENE; TRANSCRIPTION FACTOR; SIGNALING PATHWAYS; KINASE ACTIVATION; ADENYLATE-CYCLASE; CROSS-TALK; PHOSPHORYLATION; RECEPTOR; EXPRESSION	We reported previously an important role of cyclic AMP-response element (CRE) for the induction of interleukin-6 gene expression by angiotensin H (AngII). We examined signaling pathways that are responsible for AngII-induced phosphorylation of CRE-binding protein (CREB) at serine 133 that is a critical marker for the activation in rat vascular smooth muscle cells (VSMC). AngII time dependently induced phosphorylation of CREB with a peak at 5 min. The AngII-induced phosphorylation of CREB was blocked by CV11974, an AngII type I receptor antagonist, suggesting that AngII type I receptor may mediate the phosphorylation of CREB. Inhibition of extracellular signal-regulated protein kinase (ERK) by PD98059 or inhibition of p38 mitogen-activated protein kinase (MAPK) by SB203580 partially inhibited AngII-induced CREB phosphorylation. A protein kinase A inhibitor, HS9, also partially suppressed AngII-induced CREB phosphorylation. Inhibition of epidermal growth factor-receptor by AG1478 suppressed the AngII-induced CREB phosphorylation as well as activation of ERK and p38MAPK. Overexpression of the dominant negative form of CREB by an adenovirus vector suppressed AngII-induced c-fos expression and incorporation of [H-3]leucine to VSMC. These findings suggest that AngII may activate multiple signaling pathways involving two MAPK pathways and protein kinase A, all of which contribute to the activation of CREB. Transactivation of epidermal growth factor-receptor is also critical for AngII-induced CREB phosphorylation. Activation of CREB may be important for the regulation of gene expression and hypertrophy of VSMC induced by AngII.	Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University	Ichiki, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.							Abraham ST, 1997, CIRC RES, V81, P575, DOI 10.1161/01.RES.81.4.575; Barton K, 1996, NATURE, V379, P81, DOI 10.1038/379081a0; Blair AS, 1999, J BIOL CHEM, V274, P36293, DOI 10.1074/jbc.274.51.36293; BRINDLE P, 1995, P NATL ACAD SCI USA, V92, P10521, DOI 10.1073/pnas.92.23.10521; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; De Cesare D, 1998, P NATL ACAD SCI USA, V95, P12202, DOI 10.1073/pnas.95.21.12202; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; DUFF JL, 1992, BIOCHEM BIOPH RES CO, V188, P257, DOI 10.1016/0006-291X(92)92378-B; Eguchi S, 1998, J BIOL CHEM, V273, P8890, DOI 10.1074/jbc.273.15.8890; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; Fentzke RC, 1998, J CLIN INVEST, V101, P2415, DOI 10.1172/JCI2950; Funakoshi Y, 1999, HYPERTENSION, V34, P118, DOI 10.1161/01.HYP.34.1.118; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HABENER JF, 1990, MOL ENDOCRINOL, V4, P1087, DOI 10.1210/mend-4-8-1087; HANISSIAN SH, 1993, J BIOL CHEM, V268, P20055; HARTIG E, 1991, NUCLEIC ACIDS RES, V19, P4153, DOI 10.1093/nar/19.15.4153; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; JARD S, 1981, J BIOL CHEM, V256, P2603; KAMBAYASHI Y, 1993, J BIOL CHEM, V268, P24543; Lin RZ, 1998, J BIOL CHEM, V273, P30033, DOI 10.1074/jbc.273.45.30033; Mayr BM, 2001, P NATL ACAD SCI USA, V98, P10936, DOI 10.1073/pnas.191152098; MISSALE C, 1989, REGUL PEPTIDES, V24, P167, DOI 10.1016/0167-0115(89)90235-8; MOLLOY CJ, 1993, J BIOL CHEM, V268, P7338; POBINER BF, 1985, J BIOL CHEM, V260, P6200; SASAKI K, 1991, NATURE, V351, P230, DOI 10.1038/351230a0; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Somers JP, 1999, MOL ENDOCRINOL, V13, P1364, DOI 10.1210/me.13.8.1364; Takahashi E, 1997, CIRC RES, V81, P268, DOI 10.1161/01.RES.81.2.268; Takahashi T, 1999, AM J PHYSIOL-HEART C, V276, pH1927, DOI 10.1152/ajpheart.1999.276.6.H1927; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; WANG WW, 1994, GENE, V143, P261, DOI 10.1016/0378-1119(94)90107-4; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; ZOHN IE, 1995, MOL CELL BIOL, V15, P6160	40	74	75	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					18710	18717		10.1074/jbc.M110430200	http://dx.doi.org/10.1074/jbc.M110430200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11907026	hybrid			2022-12-27	WOS:000175975800063
J	Ternes, P; Franke, S; Zahringer, U; Sperling, P; Heinz, E				Ternes, P; Franke, S; Zahringer, U; Sperling, P; Heinz, E			Identification and characterization of a sphingolipid Delta 4-desaturase family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; FATTY-ACID DESATURASE; SACCHAROMYCES-CEREVISIAE; DEGENERATIVE SPERMATOCYTE; OLEATE 12-HYDROXYLASE; SIGNAL-TRANSDUCTION; EGF RECEPTOR; GENE; BIOSYNTHESIS; SPHINGOSINE	Sphingolipids desaturated at the Delta4-position are important signaling molecules in many eukaryotic organisms, including mammals. In a bioinformatics approach, we now identified a new family of protein sequences from animals, plants, and fungi and characterized these sequences biochemically by expression in Saccharomyces cerevisiae. This resulted in the identification of the enzyme sphingolipid Delta4-desaturase (dihydroceramide desaturase) from Homo sapiens, Mus musculus, Drosophila melanogaster, and Candida albicans, in addition to a bifunctional sphingolipid Delta4-desaturase/C-4-hydroxylase from M. musculus. Among the sequences investigated are the Homo sapiens membrane lipid desaturase, the M. musculus degenerative spermatocyte, and the Drosophila melanogaster degenerative spermatocyte proteins. During spermatogenesis, but not oogenesis of des mutant flies, both cell cycle and spermatid differentiation are specifically blocked at the entry into the first meiotic division, leading to male sterility. This mutant phenotype can be restored to wild-type by complementation with a functional copy of the des gene (Endo, K., Akiyama, T., Kobayashi S., and Okada, M. (1996) Mol. Gen. Genet. 253, 157-165). These results suggest that Delta4-desaturated sphingolipids provide an early signal necessary to trigger the entry into both meiotic and spermatid differentiation pathways during Drosophila spermatogenesis.	Univ Hamburg, Inst Allgemeine Bot, D-22609 Hamburg, Germany; Univ Hamburg, Inst Organ Chem, D-20146 Hamburg, Germany; Forschungszentrum Borstel, Lab Grp Immunochem, D-23845 Borstel, Germany	University of Hamburg; University of Hamburg; Forschungszentrum Borstel	Heinz, E (corresponding author), Univ Hamburg, Inst Allgemeine Bot, Ohnhorstr 18, D-22609 Hamburg, Germany.			Ternes, Philipp/0000-0003-0886-5474				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAKER SM, 1995, CELL, V82, P309, DOI 10.1016/0092-8674(95)90318-6; BIELAWSKA A, 1993, J BIOL CHEM, V268, P26226; Broadwater JA, 2002, J BIOL CHEM, V277, P15613, DOI 10.1074/jbc.M200231200; Broun P, 1998, PLANT J, V13, P201, DOI 10.1046/j.1365-313X.1998.00023.x; Broun P, 1998, SCIENCE, V282, P1315, DOI 10.1126/science.282.5392.1315; Cadena DL, 1997, BIOCHEMISTRY-US, V36, P6960, DOI 10.1021/bi970091l; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Clancy MJ, 1998, CURR BIOL, V8, pR461, DOI 10.1016/S0960-9822(98)70293-3; CROSSMAN MW, 1984, BIOCHIM BIOPHYS ACTA, V795, P411, DOI 10.1016/0005-2760(84)90092-4; Dickson RC, 1997, J BIOL CHEM, V272, P30196, DOI 10.1074/jbc.272.48.30196; Endo K, 1997, DEV GROWTH DIFFER, V39, P399, DOI 10.1046/j.1440-169X.1997.00015.x; Endo K, 1996, MOL GEN GENET, V253, P157, DOI 10.1007/s004380050308; Grilley MM, 1998, J BIOL CHEM, V273, P11062, DOI 10.1074/jbc.273.18.11062; GUPTA CM, 1977, P NATL ACAD SCI USA, V74, P4315, DOI 10.1073/pnas.74.10.4315; Gurtu VE, 2002, GENETICS, V160, P271; Haak D, 1997, J BIOL CHEM, V272, P29704, DOI 10.1074/jbc.272.47.29704; Holthuis JCM, 2001, PHYSIOL REV, V81, P1689, DOI 10.1152/physrev.2001.81.4.1689; Jenkins GM, 1997, J BIOL CHEM, V272, P32566, DOI 10.1074/jbc.272.51.32566; KARLSSON KA, 1970, CHEM PHYS LIPIDS, V5, P6, DOI 10.1016/0009-3084(70)90008-3; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; KISIC A, 1995, J LIPID RES, V36, P787; Leipelt M, 2001, J BIOL CHEM, V276, P33621, DOI 10.1074/jbc.M104952200; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lin TY, 1996, DEVELOPMENT, V122, P1331; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; MORRISON WR, 1970, BIOCHIM BIOPHYS ACTA, V202, P460, DOI 10.1016/0005-2760(70)90116-5; Napier JA, 1999, TRENDS PLANT SCI, V4, P2, DOI 10.1016/S1360-1385(98)01357-0; Ng CKY, 2001, NATURE, V410, P596, DOI 10.1038/35069092; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OKULEY J, 1994, PLANT CELL, V6, P147, DOI 10.1105/tpc.6.1.147; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Qiu X, 2001, J BIOL CHEM, V276, P31561, DOI 10.1074/jbc.M102971200; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Sperling P, 2001, EUR J LIPID SCI TECH, V103, P158, DOI 10.1002/1438-9312(200103)103:3<158::AID-EJLT158>3.0.CO;2-1; Sperling P, 2001, FEBS LETT, V494, P90, DOI 10.1016/S0014-5793(01)02332-8; Sperling P, 1998, J BIOL CHEM, V273, P28590, DOI 10.1074/jbc.273.44.28590; STOFFEL W, 1971, H-S Z PHYSIOL CHEM, V352, P1531, DOI 10.1515/bchm2.1971.352.2.1531; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TRECO DA, 1993, CURRENT PROTOCOLS MO; VANDELOO FJ, 1995, P NATL ACAD SCI USA, V92, P6743, DOI 10.1073/pnas.92.15.6743	46	202	216	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 12	2002	277	28					25512	25518		10.1074/jbc.M202947200	http://dx.doi.org/10.1074/jbc.M202947200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	571YP	11937514	hybrid			2022-12-27	WOS:000176747000087
J	Zhang, WB; Navenot, JM; Haribabu, B; Tamamura, H; Hiramatu, K; Omagari, A; Pei, G; Manfredi, JP; Fujii, N; Broach, JR; Peiper, SC				Zhang, WB; Navenot, JM; Haribabu, B; Tamamura, H; Hiramatu, K; Omagari, A; Pei, G; Manfredi, JP; Fujii, N; Broach, JR; Peiper, SC			A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C axe weak partial agonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; HUMAN-IMMUNODEFICIENCY-VIRUS; KAPOSIS-SARCOMA; LYMPHOCYTE CHEMOATTRACTANT; CHEMOKINE RECEPTORS; INHIBITOR; LIGAND; SDF-1; PHOSPHORYLATION; IDENTIFICATION	CXCR4 is a G protein-coupled receptor for stromal-derived factor 1 (SDF-1) that plays a critical role in leukocyte trafficking, metastasis of mammary carcinoma, and human immunodeficiency virus type-1 infection. To elucidate the mechanism for CXCR4 activation, a constitutively active mutant (CAM) was derived by coupling the receptor to the pheromone response pathway in yeast. Conversion of Asn-119 to Ser or Ala, but not Asp or Lys, conferred autonomous CXCR4 signaling in yeast and mammalian cells. SDF-1 induced signaling in variants with substitution of Asn-119 to Ser, Ala, or Asp, but not Lys. These variants had similar cell surface expression and binding affinity for SDF-1. CXCR4-CAMs were constitutively phosphorylated and present in cytosolic inclusions. Analysis of antagonists revealed that exposure to AAM3100 or ALX40-4C induced G protein activation by CXCR4 wild type, which was greater in the CAM, whereas T140 decreased autonomous signaling. The affinity of AAM3100 and ALX40-4C binding to CAMs was less than to wild type, providing evidence of a conformational shift. These results illustrate the importance of transmembrane helix 3 in CXCR4 signaling. Insight into the mechanism for CXCR4 antagonists will allow for the development of a new generation of agents that lack partial agonist activity that may induce toxicities, as observed for AMD3100.	Univ Louisville, Henry Vogt Canc Res Inst, Louisville, KY 40202 USA; Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; Myriad Genet, Salt Lake City, UT 84108 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	University of Louisville; Kyoto University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Myriad Genetics, Inc; Princeton University	Peiper, SC (corresponding author), Univ Louisville, Henry Vogt Canc Res Inst, Louisville, KY 40202 USA.	speiper@mail.mcg.edu	Bodduluri, Haribabu/A-2584-2010	Bodduluri, Haribabu/0000-0002-8261-3294; Broach, James/0000-0003-1197-0312	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041346] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI41346] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Arthos J, 2000, J VIROL, V74, P6418, DOI 10.1128/JVI.74.14.6418-6424.2000; Arvanitakis L, 1997, NATURE, V385, P347, DOI 10.1038/385347a0; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Casarosa P, 2001, J BIOL CHEM, V276, P1133, DOI 10.1074/jbc.M008965200; Cesarman E, 1996, J VIROL, V70, P8218, DOI 10.1128/JVI.70.11.8218-8223.1996; Couty JP, 2001, J BIOL CHEM, V276, P33805, DOI 10.1074/jbc.M104631200; Doranz BJ, 1997, J EXP MED, V186, P1395, DOI 10.1084/jem.186.8.1395; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Geras-Raaka E, 1998, J EXP MED, V188, P405, DOI 10.1084/jem.188.2.405; Gerlach LO, 2001, J BIOL CHEM, V276, P14153, DOI 10.1074/jbc.M010429200; Gershengorn MC, 1998, J CLIN INVEST, V102, P1469, DOI 10.1172/JCI4461; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Ho HH, 2001, J BIOL CHEM, V276, P1376, DOI 10.1074/jbc.M007885200; Klein C, 1998, NAT BIOTECHNOL, V16, P1334, DOI 10.1038/4310; Labrosse B, 1998, J VIROL, V72, P6381, DOI 10.1128/JVI.72.8.6381-6388.1998; Leeb-Lundberg LMF, 2001, J BIOL CHEM, V276, P8785, DOI 10.1074/jbc.M007396200; Liles WC, 2001, BLOOD, V98, p737A; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murakami T, 1997, J EXP MED, V186, P1389, DOI 10.1084/jem.186.8.1389; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Navenot JM, 2001, J MOL BIOL, V313, P1181, DOI 10.1006/jmbi.2001.5086; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Parnot C, 2000, P NATL ACAD SCI USA, V97, P7615, DOI 10.1073/pnas.110142297; PEI G, 1994, P NATL ACAD SCI USA, V91, P2699, DOI 10.1073/pnas.91.7.2699; Petit I, 2001, BLOOD, V98, p811A; Quitterer U, 1996, BIOCHEMISTRY-US, V35, P13368, DOI 10.1021/bi961163w; REN Q, 1993, J BIOL CHEM, V268, P16483; RIM J, 1995, BIOCHEMISTRY-US, V34, P11938, DOI 10.1021/bi00037a035; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; Schols D, 1997, J EXP MED, V186, P1383, DOI 10.1084/jem.186.8.1383; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Tamamura H, 1998, BIOCHEM BIOPH RES CO, V253, P877, DOI 10.1006/bbrc.1998.9871; Tao YX, 2000, MOL ENDOCRINOL, V14, P1272, DOI 10.1210/me.14.8.1272; WESTPHAL RS, 1995, MOL PHARMACOL, V48, P200; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	39	208	217	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2002	277	27					24515	24521		10.1074/jbc.M200889200	http://dx.doi.org/10.1074/jbc.M200889200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	569PV	11923301	hybrid			2022-12-27	WOS:000176611800072
J	Hoffmeister, A; Ropolo, A; Vasseur, S; Mallo, GV; Bodeker, H; Ritz-Laser, B; Dressler, GR; Vaccaro, MI; Dagorn, JC; Moreno, S; Iovanna, JL				Hoffmeister, A; Ropolo, A; Vasseur, S; Mallo, GV; Bodeker, H; Ritz-Laser, B; Dressler, GR; Vaccaro, MI; Dagorn, JC; Moreno, S; Iovanna, JL			The HMG-I/Y-related protein p8 binds to p300 and Pax2 trans-activation domain-interacting protein to regulate the trans-activation activity of the Pax2A and Pax2B transcription factors on the glucagon gene promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; EXPRESSION; ACTIVATION; CLONING; PANCREAS	p8 is a nuclear DNA-binding protein, which was identified because its expression is strongly activated in response to several stresses. Biochemical and biophysical studies revealed that despite a weak sequence homology p8 is an HMG-I/Y-like protein, suggesting that p8 may be involved in transcription regulation. Results reported here strongly support this hypothesis. Using a pull-down approach, we found that p8 interacts with the general co-activator p300. We also found that, similar to the HMG proteins, p300 was able to acetylate recombinant p8 in vitro, although the significance of such modification remains to be determined. Then a screening by the two-hybrid system, using p8 as bait, allowed us to identify the Pax2 trans-activation domain-interacting protein (PTIP) as another partner of p8. Transient transfection studies revealed that PTIP is a strong inhibitor of the trans-activation activities of Pax2A and Pax2B on the glucagon gene promoter, which was chosen as a model because it is a target of the Pax2A and Pax2B transcription factors. This effect is completely abolished by co-transfection of p8 in glucagon-producing InRIG9 cells, indicating that p8 binding to PTIP prevents inhibition of the glucagon gene promoter. This was not observed in NIH3T3 fibroblasts that do not express glucagon. Finally, expression of p8 enhances the effect of p300 on Pax2A and Pax2B transactivation of the glucagon gene promoter. These observations suggest that in glucagon-producing cells p8 is a positive cofactor of the activation of the glucagon gene promoter by Pax2A and Pax2B, both by recruiting the p300 cofactor to increase the Pax2A and Pax2B activities and by binding the Pax2,interacting protein PTIP to suppress its inhibition.	INSERM, EMI 0116, Ctr Rech, F-13276 Marseille 9, France; Univ Buenos Aires, Fac Med, Dept Fisiol, RA-1121 Buenos Aires, DF, Argentina; Ctr Med Univ Geneva, Diabet Unit, CH-1211 Geneva 4, Switzerland; Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, RA-1428 Buenos Aires, DF, Argentina	Institut National de la Sante et de la Recherche Medicale (Inserm); University of Buenos Aires; University of Geneva; University of Michigan System; University of Michigan; University of Buenos Aires	Iovanna, JL (corresponding author), INSERM, EMI 116, Ctr Rech, 163 Ave Luminy,Campus Luminy,BP 172, F-13009 Marseille, France.	iovanna@inserm-adr.univ-mrs.fr	Iovanna, Juan/M-9805-2017; Vaccaro, Maria I./L-8348-2017; vasseur, sophie/O-9803-2017	Iovanna, Juan/0000-0003-1822-2237; vasseur, sophie/0000-0002-2339-8854; Vaccaro, Maria/0000-0002-2456-747X				ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Encinar JA, 2001, J BIOL CHEM, V276, P2742, DOI 10.1074/jbc.M008594200; Garcia-Montero A, 2001, EUR J CELL BIOL, V80, P720, DOI 10.1078/0171-9335-00209; Garcia-Montero AC, 2001, BIOCHEM J, V357, P249, DOI 10.1042/0264-6021:3570249; Ghosh AK, 2000, ONCOGENE, V19, P3546, DOI 10.1038/sj.onc.1203693; Hussain MA, 1999, J BIOL CHEM, V274, P28950, DOI 10.1074/jbc.274.41.28950; Jiang YF, 1999, BIOCHEM BIOPH RES CO, V260, P686, DOI 10.1006/bbrc.1999.0953; Lechner MS, 2000, NUCLEIC ACIDS RES, V28, P2741, DOI 10.1093/nar/28.14.2741; Lechner MS, 1996, J BIOL CHEM, V271, P21088, DOI 10.1074/jbc.271.35.21088; Mallo GV, 1997, J BIOL CHEM, V272, P32360, DOI 10.1074/jbc.272.51.32360; Munshi N, 2001, SCIENCE, V293, P1133, DOI 10.1126/science.293.5532.1133; Ree AH, 1999, CANCER RES, V59, P4675; Ritz-Laser B, 2000, J BIOL CHEM, V275, P32708, DOI 10.1074/jbc.M005704200; Vasseur S, 1999, EUR J BIOCHEM, V259, P670, DOI 10.1046/j.1432-1327.1999.00092.x; Vasseur S, 2002, EMBO REP, V3, P165, DOI 10.1093/embo-reports/kvf023; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200	16	57	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22314	22319		10.1074/jbc.M201657200	http://dx.doi.org/10.1074/jbc.M201657200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11940591	hybrid			2022-12-27	WOS:000176313600027
J	Lawrence, AJ; Coote, JG; Kazi, YF; Lawrence, PD; MacDonald-Fyall, J; Orr, BM; Parton, R; Riehle, M; Sinclair, J; Young, J; Price, NC				Lawrence, AJ; Coote, JG; Kazi, YF; Lawrence, PD; MacDonald-Fyall, J; Orr, BM; Parton, R; Riehle, M; Sinclair, J; Young, J; Price, NC			A direct pyrophosphatase-coupled assay provides new insights into the activation of the secreted adenylate cyclase from Bordetella pertussis by calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXIN; PURIFICATION; IDENTIFICATION; BINDING; TRANSFERASE; PROTEINS; CA-2+; SITE	Continuous recording of the activity of recombinant adenylate cyclase (CyaA) of Bordetella pertussis (EC 4.6.1.1) by conductimetric determination of enzyme-coupled pyrophosphate cleavage has enabled us to define a number of novel features of the activation of this enzyme by calmodulin and establish conditions under which valid activation data can be obtained. Activation either in the presence or absence of calcium is characterized by a concentration-dependent lag phase. The rate of formation and breakdown of the activated complex can be determined from an analysis of the lag phase kinetics and is in good agreement with thermodynamic data obtained by measuring the dependence of activation on calmodulin concentration, which show that calcium increases k(on). by about 30-fold. The rate of breakdown of the activated complex, formed either in the presence or absence of calcium, has been determined by dilution experiments and has been shown to be independent of the presence of calcium. The coupled assay is established as a rapid, convenient and safe method which should be readily applicable to the continuous assays of most other enzymes that catalyze reactions in which inorganic pyrophosphate is liberated.	Univ Glasgow, Div Infect & Immun, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; Univ Glasgow, Ctr Cell Engn, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; Univ Glasgow, Div Biochem & Mol Biol, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Glasgow; University of Glasgow	Lawrence, AJ (corresponding author), Univ Glasgow, Div Infect & Immun, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland.		Hu, Ruogu/B-2203-2008; Riehle, Mathis O/A-3427-2011; Riehle, Mathis/Q-4528-2019	Riehle, Mathis O/0000-0001-7988-1514; Riehle, Mathis/0000-0001-7988-1514				BESSON C, 1994, ANAL CHIM ACTA, V294, P305, DOI 10.1016/0003-2670(94)80314-5; COOTE JG, 1992, FEMS MICROBIOL LETT, V88, P137, DOI 10.1016/0378-1097(92)90688-K; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Fersht A., 1999, STRUCTURE MECH PROTE, P143; GLASER P, 1989, EMBO J, V8, P967, DOI 10.1002/j.1460-2075.1989.tb03459.x; GOLDHAMMER AR, 1983, ANAL BIOCHEM, V124, P45; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; GREENLEE DV, 1982, BIOCHEMISTRY-US, V21, P2759, DOI 10.1021/bi00540a028; HEWLETT EL, 1979, J BIOL CHEM, V254, P5602; HEWLETT EL, 1989, J BIOL CHEM, V264, P19379; Hormozi K, 1999, FEMS IMMUNOL MED MIC, V23, P273, DOI 10.1016/S0928-8244(98)00146-1; KILHOFFER MC, 1983, EUR J BIOCHEM, V133, P111; KLEE CB, 1977, BIOCHEMISTRY-US, V16, P1017, DOI 10.1021/bi00624a033; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; LADANT D, 1989, J BIOL CHEM, V264, P4015; LADANT D, 1986, J BIOL CHEM, V261, P6264; Lawrence A, 1998, BIOCHEM EDUC, V26, P56, DOI 10.1016/S0307-4412(97)00129-5; LAWRENCE AJ, 1972, EUR J BIOCHEM, V24, P538, DOI 10.1111/j.1432-1033.1972.tb19716.x; MASURE HR, 1988, J BIOL CHEM, V263, P6933; MEZNA M, 1994, ANAL BIOCHEM, V218, P370, DOI 10.1006/abio.1994.1194; Mock M, 1993, Trends Microbiol, V1, P187, DOI 10.1016/0966-842X(93)90089-A; MONNERON A, 1988, BIOCHEMISTRY-US, V27, P536, DOI 10.1021/bi00402a005; NAGAI M, 1994, FEMS MICROBIOL LETT, V116, P169, DOI 10.1111/j.1574-6968.1994.tb06696.x; SAKAMOTO H, 1992, J BIOL CHEM, V267, P13598; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; Tu XL, 2001, FEMS MICROBIOL LETT, V205, P119, DOI 10.1111/j.1574-6968.2001.tb10934.x; Westrop GD, 1996, GENE, V180, P91, DOI 10.1016/S0378-1119(96)00412-X; WOLFF J, 1980, P NATL ACAD SCI-BIOL, V77, P3841, DOI 10.1073/pnas.77.7.3841	28	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22289	22296		10.1074/jbc.M106701200	http://dx.doi.org/10.1074/jbc.M106701200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11934879	hybrid			2022-12-27	WOS:000176313600024
J	Linden, D; Lindberg, K; Oscarsson, J; Claesson, C; Asp, L; Li, L; Gustafsson, M; Boren, J; Olofsson, SO				Linden, D; Lindberg, K; Oscarsson, J; Claesson, C; Asp, L; Li, L; Gustafsson, M; Boren, J; Olofsson, SO			Influence of peroxisome proliferator-activated receptor alpha agonists on the intracellular turnover and secretion of apolipoprotein (Apo) B-100 and ApoB-48	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-BINDING-PROTEIN; HEP G2 CELLS; TRIGLYCERIDE TRANSFER PROTEIN; B-CONTAINING LIPOPROTEINS; CULTURED RAT HEPATOCYTES; LOW-DENSITY LIPOPROTEINS; CHAIN FATTY-ACIDS; GROWTH-HORMONE; GENE-EXPRESSION; B-100-CONTAINING LIPOPROTEINS	The peroxisome proliferator-activated receptor (PPAR) alpha agonist WY 14,643 increased the secretion of apolipoprotein (apo) B-100, but not that of apoB-48, and decreased triglyceride biosynthesis and secretion from primary rat hepatocytes. These effects resulted in decreased secretion of apoB-100-very low density lipoprotein (VLDL) and an increased secretion of apoB-100 on low density lipoproteins/intermediate density lipoproteins. ApoB-48-VLDL was also replaced by more dense particles. The proteasomal inhibitor lactacystin did not influence the recovery of apoB-100 or apoB-48 in primary rat hepatocytes, indicating that co-translational (proteasomal) degradation is of less importance in these cells. Treatment with WY 14,643 made the recovery of apoB-100 sensitive to lactacystin, most likely reflecting the decreased biosynthesis of triglycerides. The PPARalpha agonist induced a significant increase in the accumulation of pulse-labeled apoB-100 even after a short pulse (2-5 min). There was also an increase in apoB-100 nascent polypeptides, indicating that the co-translational degradation of apoB-100 was inhibited. However, a minor influence on an early posttranslation degradation cannot be excluded. This decreased co-translational degradation of apoB-100 explained the increased secretion of the protein. The levels of apoB-48 remained unchanged during these pulse-chase experiments, and albumin production was not affected, indicating a specific effect of PPARalpha agonists on the co-translational degradation of apoB-100. These findings explain the difference in the rate of secretion of the two apoB proteins seen after PPARalpha activation. PPARalpha agonists increased the expression and biosynthesis of liver fatty acid-binding protein (LFABP). Increased expression of LFABP by transfection of McA-RH7777 cells increased the secretion of apoB-100, decreased triglyceride biosynthesis and secretion, and increased PPARalpha mRNA levels. These findings suggest that PPARalpha and LFABP could interact to amplify the effect of endogenous PPARalpha agonists on the assembly of VLDL.	Univ Gothenburg, Dept Med Biochem, SE-40530 Gothenburg, Sweden; Univ Gothenburg, Dept Physiol, SE-40530 Gothenburg, Sweden; Univ Gothenburg, Wallenberg Lab Cardiovasc Res, SE-40530 Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg	Olofsson, SO (corresponding author), Univ Gothenburg, Dept Med Biochem, Box 440, SE-40530 Gothenburg, Sweden.		Adiels, Martin/C-9278-2011	Andersson, Karin/0000-0002-9475-3040				Adeli K, 1997, J BIOL CHEM, V272, P5031, DOI 10.1074/jbc.272.8.5031; ANDERSSON M, 1994, J LIPID RES, V35, P535; BASS NM, 1988, INT REV CYTOL, V111, P143, DOI 10.1016/S0074-7696(08)61733-7; BOREN J, 1993, ARTERIOSCLER THROMB, V13, P1743, DOI 10.1161/01.ATV.13.12.1743; BOREN J, 1992, J BIOL CHEM, V267, P9858; BOREN J, 1994, J BIOL CHEM, V269, P25879; BOSTROM K, 1988, J BIOL CHEM, V263, P4434; BRANDES R, 1990, BIOCHIM BIOPHYS ACTA, V1034, P53, DOI 10.1016/0304-4165(90)90152-M; BURRIER RE, 1987, BIOCHIM BIOPHYS ACTA, V919, P221, DOI 10.1016/0005-2760(87)90261-X; Carlsson L, 2001, AM J PHYSIOL-ENDOC M, V281, pE772, DOI 10.1152/ajpendo.2001.281.4.E772; Carlsson L, 1998, ENDOCRINOLOGY, V139, P2699, DOI 10.1210/en.139.6.2699; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Davidson NO, 2000, ANNU REV NUTR, V20, P169, DOI 10.1146/annurev.nutr.20.1.169; Fisher EA, 2001, J BIOL CHEM, V276, P27855, DOI 10.1074/jbc.M008885200; Fisher EA, 1997, J BIOL CHEM, V272, P20427, DOI 10.1074/jbc.272.33.20427; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; GEBEL T, 1992, FEBS LETT, V309, P37, DOI 10.1016/0014-5793(92)80734-X; Hertzel AV, 2000, TRENDS ENDOCRIN MET, V11, P175; ISSEMANN I, 1992, BIOCHEM SOC T, V20, P824, DOI 10.1042/bst0200824; Jolly CA, 1997, ARCH BIOCHEM BIOPHYS, V341, P112, DOI 10.1006/abbi.1997.9957; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; LAMB RG, 1993, BIOCHIM BIOPHYS ACTA, V1165, P299, DOI 10.1016/0005-2760(93)90140-5; Lawrence JW, 2000, J LIPID RES, V41, P1390; Leung KC, 1997, J CLIN ENDOCR METAB, V82, P4208, DOI 10.1210/jc.82.12.4208; Linden D, 2000, AM J PHYSIOL-ENDOC M, V279, pE1335, DOI 10.1152/ajpendo.2000.279.6.E1335; Luxon BA, 1999, AM J PHYSIOL-GASTR L, V277, pG361, DOI 10.1152/ajpgi.1999.277.2.G361; Luxon BA, 2000, BBA-MOL CELL BIOL L, V1487, P309, DOI 10.1016/S1388-1981(00)00104-9; Luxon BA, 1996, AM J PHYSIOL-GASTR L, V271, pG113, DOI 10.1152/ajpgi.1996.271.1.G113; LUXON BA, 1993, AM J PHYSIOL, V265, pG831, DOI 10.1152/ajpgi.1993.265.5.G831; McArthur MJ, 1999, J LIPID RES, V40, P1371; MeunierDurmort C, 1996, BIOCHEM J, V319, P483, DOI 10.1042/bj3190483; Mitchell DM, 1998, P NATL ACAD SCI USA, V95, P14733, DOI 10.1073/pnas.95.25.14733; MOON A, 1987, J CLIN INVEST, V79, P59, DOI 10.1172/JCI112808; Murphy EJ, 1998, AM J PHYSIOL-GASTR L, V275, pG244, DOI 10.1152/ajpgi.1998.275.2.G244; Murphy EJ, 1996, BBA-LIPID LIPID MET, V1301, P191, DOI 10.1016/0005-2760(96)00024-0; Niot I, 1997, BIOCHIMIE, V79, P129, DOI 10.1016/S0300-9084(97)81504-0; Okochi E, 1999, BBA-MOL CELL BIOL L, V1437, P393, DOI 10.1016/S1388-1981(99)00024-4; Olofsson SO, 2000, TRENDS CARDIOVAS MED, V10, P338, DOI 10.1016/S1050-1738(01)00071-8; Olofsson SO, 1999, CURR OPIN LIPIDOL, V10, P341, DOI 10.1097/00041433-199908000-00008; Pariyarath R, 2001, J BIOL CHEM, V276, P541, DOI 10.1074/jbc.M007944200; PIND S, 1993, METHOD ENZYMOL, V221, P222, DOI 10.1016/0076-6879(93)21019-5; PROWS DR, 1995, LIPIDS, V30, P907, DOI 10.1007/BF02537481; Rees S, 1996, BIOTECHNIQUES, V20, P102; Rustaeus S, 1998, J BIOL CHEM, V273, P5196, DOI 10.1074/jbc.273.9.5196; Schoonjans K, 1996, J LIPID RES, V37, P907; Sjoberg A, 1996, J LIPID RES, V37, P275; Storch J, 2000, BBA-MOL CELL BIOL L, V1486, P28, DOI 10.1016/S1388-1981(00)00046-9; Taskinen MR, 2001, EXP CLIN ENDOCR DIAB, V109, pS180, DOI 10.1055/s-2001-18580; WETTESTEN M, 1985, EUR J BIOCHEM, V149, P461, DOI 10.1111/j.1432-1033.1985.tb08947.x; WILLIAMS KJ, 1990, J BIOL CHEM, V265, P16741; Wolfrum C, 1999, BBA-MOL CELL BIOL L, V1437, P194, DOI 10.1016/S1388-1981(99)00008-6; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898	52	77	78	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					23044	23053		10.1074/jbc.M110416200	http://dx.doi.org/10.1074/jbc.M110416200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11925428	hybrid			2022-12-27	WOS:000176313600120
J	Daugherty, M; Polanuyer, B; Farrell, M; Scholle, M; Lykidis, A; de Crecy-Lagard, V; Osterman, A				Daugherty, M; Polanuyer, B; Farrell, M; Scholle, M; Lykidis, A; de Crecy-Lagard, V; Osterman, A			Complete reconstitution of the human coenzyme A biosynthetic pathway via comparative genomics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPHOSPHO-COA KINASE; ESCHERICHIA-COLI; A BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; GENE; ADENYLYLTRANSFERASE; IDENTIFICATION; CLONING; ENZYME; PURIFICATION	The biosynthesis of CoA from pantothenic acid (vitamin B-5) is an essential universal pathway in prokaryotes and eukaryotes. The CoA biosynthetic genes in bacteria have all recently been identified, but their counterparts in humans and other eukaryotes remained mostly unknown. Using comparative genomics, we have identified human genes encoding the last four enzymatic steps in CoA biosynthesis: phosphopantothenoylcysteine synthetase (EC 6.3.2.5), phosphopantothenoylcysteine decarboxylase (EC 4.1.1.36), phosphopantetheine adenylyltransferase (EC 2.7.7.3), and dephospho-CoA kinase (EC 2.7.1.24). Biological functions of these human genes were verified using a complementation system in Escherichia coli based on transposon mutagenesis. The individual human enzymes were overexpressed in E. coli and purified, and the corresponding activities were experimentally verified. In addition, the entire pathway from phosphopantothenate to CoA was successfully reconstituted in vitro using a mixture of purified recombinant enzymes. Human recombinant bifunctional phosphopantetheine adenylyltransferase/dephospho-CoA kinase was kinetically characterized. This enzyme was previously suggested as a point of CoA biosynthesis regulation, and we have observed significant differences in mRNA levels of the corresponding human gene in normal and tumor cells by Northern blot analysis.	Integrated Genom Inc, Chicago, IL 60612 USA; The Scripps Res Inst, La Jolla, CA 92037 USA	Scripps Research Institute	Osterman, A (corresponding author), Integrated Genom Inc, Chicago, IL 60612 USA.	andrei@integratedgenomics.com	Zhang, Ning/F-1387-2014; Daugherty, Matthew/AAT-4418-2020; de Crecy-Lagard, Valerie/AAN-8995-2020					ABIKO Y, 1967, J BIOCHEM-TOKYO, V61, P300, DOI 10.1093/oxfordjournals.jbchem.a128548; ABIKO Y, 1967, J BIOCHEM, V61, P290, DOI 10.1093/oxfordjournals.jbchem.a128547; Afshar K, 2001, GENETICS, V157, P1267; Albert A, 2000, STRUCTURE, V8, P961, DOI 10.1016/S0969-2126(00)00187-8; Begley TP, 2001, VITAM HORM, V61, P157; BORK P, 1995, PROTEINS, V22, P259, DOI 10.1002/prot.340220306; BUCOVAZ ET, 1980, MOL CELL BIOCHEM, V30, P7, DOI 10.1007/BF00215301; Calder RB, 1999, J BIOL CHEM, V274, P2014, DOI 10.1074/jbc.274.4.2014; Daugherty M, 2001, J BACTERIOL, V183, P292, DOI 10.1128/JB.183.1.292-300.2001; Espinosa-Ruiz A, 1999, PLANT J, V20, P529, DOI 10.1046/j.1365-313X.1999.00626.x; Geerlof A, 1999, J BIOL CHEM, V274, P27105, DOI 10.1074/jbc.274.38.27105; Izard T, 1999, EMBO J, V18, P2021, DOI 10.1093/emboj/18.8.2021; Kuhajda FP, 2000, P NATL ACAD SCI USA, V97, P3450, DOI 10.1073/pnas.050582897; Kupke T, 2000, J BIOL CHEM, V275, P31838, DOI 10.1074/jbc.M004273200; Kupke T, 2001, J BIOL CHEM, V276, P19190, DOI 10.1074/jbc.M100776200; Mishra PK, 2001, J BACTERIOL, V183, P2774, DOI 10.1128/JB.183.9.2774-2778.2001; OBRIEN WE, 1976, ANAL BIOCHEM, V76, P423, DOI 10.1016/0003-2697(76)90337-7; OLSEN GJ, 1994, J BACTERIOL, V176, P1, DOI 10.1128/JB.176.1.1-6.1994; Rock CO, 2000, J BIOL CHEM, V275, P1377, DOI 10.1074/jbc.275.2.1377; Scandurra R, 1979, Methods Enzymol, V62, P245; SKREDE S, 1983, EUR J BIOCHEM, V131, P57, DOI 10.1111/j.1432-1033.1983.tb07231.x; SONG WJ, 1992, J BACTERIOL, V174, P6411, DOI 10.1128/JB.174.20.6411-6417.1992; Strauss E, 2001, J AM CHEM SOC, V123, P6449, DOI 10.1021/ja016020y; Strauss E, 2001, J BIOL CHEM, V276, P13513, DOI 10.1074/jbc.C100033200; TAHILIANI AG, 1991, VITAM HORM, V46, P165; Venkatachalam KV, 1999, J BIOL CHEM, V274, P2601, DOI 10.1074/jbc.274.5.2601; Wang HP, 1999, J BIOL CHEM, V274, P14875, DOI 10.1074/jbc.274.21.14875; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WORRALL DM, 1983, BIOCHEM J, V215, P153, DOI 10.1042/bj2150153; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	30	167	174	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21431	21439		10.1074/jbc.M201708200	http://dx.doi.org/10.1074/jbc.M201708200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11923312	hybrid			2022-12-27	WOS:000176286000041
J	Abu Dayyeh, BK; Quan, TK; Castro, M; Ruby, SW				Abu Dayyeh, BK; Quan, TK; Castro, M; Ruby, SW			Probing interactions between the U2 small nuclear ribonucleoprotein and the DEAD-box protein, Prp5.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLATION INITIATION FACTOR-4A; RNA-DEPENDENT ATPASE; SACCHAROMYCES-CEREVISIAE; MUTATIONAL ANALYSIS; YEAST HOMOLOG; BRANCHPOINT RECOGNITION; FACTOR 4A; MESSENGER; SPLICEOSOME; SNRNP	Pre-mRNA binding to the yeast U2 small nuclear ribonucleoprotein (snRNP) during prespliceosome formation requires ATP hydrolysis, the highly conserved UACUAAC box of the branch point region of the pre-mRNA, and several factors. Here we analyzed the binding of a radiolabeled 2'-O-methyl oligonucleotide complementary to U2 small nuclear RNA to study interactions between the UACUAAC box, U2 snRNP, and Prp5p, a DEAD box protein necessary for prespliceosome formation. Binding of the 2'-O-methyl oligonucleotide to the U2 snRNP in yeast cell extract was assayed by gel electrophoresis. Binding was rapid, enhanced by ATP, and dependent on the integrity and conformation of the U2 snRNP. It was also stimulated by Prp5p that was found to associate physically with U2 snRNP. In vitro heat inactivation of the temperature-sensitive prp5-1 mutant extract decreased oligonucleotide binding to U2 and the ATP enhancement of binding by 3-fold. Furthermore, the temperature-sensitive prp5-1 mutation maps to the ATP-binding motif I within the helicase-like domain. Thus the catalytic activity of Prp5p likely promotes a conformational change in the U2 snRNP.	Univ New Mexico, Hlth Sci Ctr, Canc Res & Treatment Ctr, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center	Ruby, SW (corresponding author), Univ New Mexico, Hlth Sci Ctr, Canc Res & Treatment Ctr, Dept Mol Genet & Microbiol, 900 Camino Salud NE, Albuquerque, NM 87131 USA.	sruby@unm.edu						ABOVICH N, 1994, GENE DEV, V8, P843, DOI 10.1101/gad.8.7.843; [Anonymous], 1991, Methods Enzymol, V194, P1; ARES M, 1990, GENE DEV, V4, P2132, DOI 10.1101/gad.4.12a.2132; ARES M, 1995, PROG NUCLEIC ACID RE, V50, P131, DOI 10.1016/S0079-6603(08)60813-2; Ast G, 1997, RNA, V3, P371; Ast G, 2001, NUCLEIC ACIDS RES, V29, P1741, DOI 10.1093/nar/29.8.1741; Awasthi S, 2001, J BIOL CHEM, V276, P31004, DOI 10.1074/jbc.M100022200; BARABINO SML, 1992, NUCLEIC ACIDS RES, V20, P4457, DOI 10.1093/nar/20.17.4457; Benz J, 1999, STRUCTURE, V7, P671, DOI 10.1016/S0969-2126(99)80088-4; Berglund JA, 1997, CELL, V89, P781, DOI 10.1016/S0092-8674(00)80261-5; Berglund JA, 1998, GENE DEV, V12, P858, DOI 10.1101/gad.12.6.858; Burge CB, 1999, RNA WORLD, P525; BURGESS S, 1990, CELL, V60, P705, DOI 10.1016/0092-8674(90)90086-T; CHENG SC, 1987, GENE DEV, V1, P1014, DOI 10.1101/gad.1.9.1014; Cody R.P., 1991, APPL STAT SAS PROGRA; DAUGERON MC, 1992, NUCLEIC ACIDS RES, V20, P3625, DOI 10.1093/nar/20.14.3625; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; Farabaugh PJ, 2000, PROG NUCLEIC ACID RE, V64, P131, DOI 10.1016/S0079-6603(00)64004-7; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Fleckner J, 1997, GENE DEV, V11, P1864, DOI 10.1101/gad.11.14.1864; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Gottschalk A, 2001, RNA, V7, P1554; Guth S, 2000, J BIOL CHEM, V275, P38059, DOI 10.1074/jbc.M001483200; Hotz HR, 1998, GENETICS, V149, P807; Igel H, 1998, RNA, V4, P1; Johnson ER, 1999, RNA, V5, P1526, DOI 10.1017/S1355838299991410; JOHNSTON M, 1984, MOL CELL BIOL, V4, P1440, DOI 10.1128/MCB.4.8.1440; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; KIM SH, 1993, P NATL ACAD SCI USA, V90, P888, DOI 10.1073/pnas.90.3.888; Kistler AL, 2001, GENE DEV, V15, P42, DOI 10.1101/gad.851301; KONARSKA MM, 1986, CELL, V46, P845, DOI 10.1016/0092-8674(86)90066-8; Kramer A, 1999, J CELL BIOL, V145, P1355, DOI 10.1083/jcb.145.7.1355; Kramer A, 1996, ANNU REV BIOCHEM, V65, P367, DOI 10.1146/annurev.biochem.65.1.367; LAMOND AI, 1989, CELL, V58, P383, DOI 10.1016/0092-8674(89)90852-0; LESSER CF, 1993, GENETICS, V133, P851; LIAO XLC, 1992, NUCLEIC ACIDS RES, V20, P4237, DOI 10.1093/nar/20.16.4237; Libri D, 2001, GENE DEV, V15, P36, DOI 10.1101/gad.852101; Luking A, 1998, CRIT REV BIOCHEM MOL, V33, P259, DOI 10.1080/10409239891204233; LUSTIG AJ, 1986, CELL, V47, P953, DOI 10.1016/0092-8674(86)90810-X; MADHANI HD, 1994, ANNU REV GENET, V28, P1; MCPHEETERS DS, 1989, GENE DEV, V3, P2124, DOI 10.1101/gad.3.12b.2124; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; Neubauer G, 1997, P NATL ACAD SCI USA, V94, P385, DOI 10.1073/pnas.94.2.385; NEWHAM CM, 2001, RNA NEW YORK, V7, P1298; Nilsen TW, 1998, COLD SPRING HARBOR M, P279; ODay CL, 1996, J BIOL CHEM, V271, P33261, DOI 10.1074/jbc.271.52.33261; ORRWEAVER TL, 1983, METHOD ENZYMOL, V101, P228; PARKER R, 1987, CELL, V49, P229, DOI 10.1016/0092-8674(87)90564-2; Pauling MH, 2000, MOL CELL BIOL, V20, P2176, DOI 10.1128/MCB.20.6.2176-2185.2000; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Perriman R, 2000, GENE DEV, V14, P97; PIKIELNY CW, 1986, NATURE, V324, P341, DOI 10.1038/324341a0; QUERY CC, 1994, GENE DEV, V8, P587, DOI 10.1101/gad.8.5.587; ROSBASH M, 1991, TRENDS BIOCHEM SCI, V16, P187, DOI 10.1016/0968-0004(91)90073-5; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Ruby SW, 1997, J BIOL CHEM, V272, P17333, DOI 10.1074/jbc.272.28.17333; RUBY SW, 1990, METHOD ENZYMOL, V181, P97; RUBY SW, 1993, GENE DEV, V7, P1909, DOI 10.1101/gad.7.10.1909; Ruby SW, 1999, METH MOL B, V118, P365; Ruby SW, 1999, METH MOL B, V118, P323; RUBY SW, 1988, SCIENCE, V242, P1028, DOI 10.1126/science.2973660; Rutz B, 1999, RNA, V5, P819, DOI 10.1017/S1355838299982286; RYMOND BC, 1990, METHOD ENZYMOL, V181, P122; RYMOND BC, 1987, GENE DEV, V1, P238, DOI 10.1101/gad.1.3.238; Sambrook J, 1989, MOL CLONING; SCHMID SR, 1991, MOL CELL BIOL, V11, P3463, DOI 10.1128/MCB.11.7.3463; SCHWER B, 1992, MOL CELL BIOL, V12, P3540, DOI 10.1128/MCB.12.8.3540; Schwer B, 2001, NAT STRUCT BIOL, V8, P113, DOI 10.1038/84091; Spingola M, 1999, RNA, V5, P221, DOI 10.1017/S1355838299981682; SPROAT BS, 1989, NUCLEIC ACIDS RES, V17, P3373, DOI 10.1093/nar/17.9.3373; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; TODA T, 1987, MOL CELL BIOL, V7, P1371, DOI 10.1128/MCB.7.4.1371; VIJAYRAGHAVAN U, 1989, GENE DEV, V3, P1206, DOI 10.1101/gad.3.8.1206; VIJAYRAGHAVAN U, 1986, EMBO J, V5, P1683, DOI 10.1002/j.1460-2075.1986.tb04412.x; WELLS SE, 1994, MOL CELL BIOL, V14, P6337, DOI 10.1128/MCB.14.9.6337; Wells SE, 1996, GENE DEV, V10, P220, DOI 10.1101/gad.10.2.220; Wiest DK, 1996, J BIOL CHEM, V271, P33268, DOI 10.1074/jbc.271.52.33268; Will CL, 2001, SCIENCE, V291, P1916, DOI 10.1126/science.1059682; Winer B.J., 1991, STAT PRINCIPLES EXPT; Yamaguchi M, 1998, J BIOL CHEM, V273, P9197, DOI 10.1074/jbc.273.15.9197; Yan D, 1998, MOL CELL BIOL, V18, P5000, DOI 10.1128/MCB.18.9.5000; Yan D, 1996, MOL CELL BIOL, V16, P818; ZAVANELLI MI, 1994, MOL CELL BIOL, V14, P1689, DOI 10.1128/MCB.14.3.1689; ZAVANELLI MI, 1991, GENE DEV, V5, P2521, DOI 10.1101/gad.5.12b.2521; Zhang M, 2001, GENE DEV, V15, P30, DOI 10.1101/gad.851701; Zhou W, 2001, P NATL ACAD SCI USA, V98, P1531, DOI 10.1073/pnas.98.4.1531	86	19	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20221	20233		10.1074/jbc.M109553200	http://dx.doi.org/10.1074/jbc.M109553200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11927574	hybrid			2022-12-27	WOS:000176204500018
J	Austin, J; First, EA				Austin, J; First, EA			Potassium functionally replaces the second lysine of the KMSKS signature sequence in human tyrosyl-tRNA synthetase.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; SITE-DIRECTED MUTAGENESIS; SP I; INHIBITOR; CATALYSIS; AMINOACYLATION; FERMENTATION; MECHANISM; SB-219383; BACTERIA	Unlike their bacterial homologues, a number of eukaryotic tyrosyl-tRNA synthetases require potassium to catalyze the aminoacylation reaction. In addition, the second lysine in the class I-specific KMSKS signature motif is absent from all known eukaryotic tyrosyl-tRNA synthetase sequences, except those of higher plants. This lysine, which is the most highly conserved residue in the class I aminoacyl-tRNA synthetase family, has been shown to interact with the pyrophosphate moiety of the ATP substrate in the Bacillus stearothermophilus tyrosyl-tRNA synthetase. Equilibrium dialysis and pre-steady-state kinetic analyses were used to determine the role that potassium plays in the tyrosine activation reaction in the human tyrosyl-tRNA synthetase and whether it can be replaced by any of the other alkali metals. Kinetic analyses indicate that potassium interacts with the pyrophosphate moiety of ATP, stabilizing the E.Tyr.ATP and E.[Tyr-ATP](double dagger) complexes by 2.3 and 4.3 kcal/mol, respectively. Potassium also appears to stabilize the asymmetric conformation of the human tyrosyl-tRNA synthetase dimer by 0.7 kcal/mol. Rubidium is the only other alkali metal that can replace potassium in catalyzing tyrosine activation, although the forward rate constant is half of that observed when potassium is present. The above results are consistent with the hypothesis that potassium functionally replaces the second lysine in the KMSKS signature sequence. Possible implications of these results with respect to the design of antibiotics that target bacterial aminoacyl-tRNA synthetases are discussed.	Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	First, EA (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, 1501 Kings Highway,POB 33932, Shreveport, LA 71130 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM053693, F31GM020928] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM53693, GM20928-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Austin J, 2002, J BIOL CHEM, V277, P14812, DOI 10.1074/jbc.M103396200; BEIKIRCH H, 1972, EUR J BIOCHEM, V26, P182, DOI 10.1111/j.1432-1033.1972.tb01755.x; Brown MJB, 2000, BIOCHEMISTRY-US, V39, P6003, DOI 10.1021/bi000148v; Bush K, 1997, CURR OPIN CHEM BIOL, V1, P169, DOI 10.1016/S1367-5931(97)80006-3; CAPOBIANCO JO, 1989, ANTIMICROB AGENTS CH, V33, P156, DOI 10.1128/AAC.33.2.156; Cotton F.A., 1972, ADV INORG CHEM, P52; ENGEL PC, 1996, ENZYMOLOGY LABFAX, P200; FARMER TH, 1992, J ANTIMICROB CHEMOTH, V30, P587, DOI 10.1093/jac/30.5.587; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P5, DOI 10.1021/bi00672a002; FERSHT AR, 1988, BIOCHEMISTRY-US, V27, P1581, DOI 10.1021/bi00405a028; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P13, DOI 10.1021/bi00672a003; FERSHT AR, 1987, BIOCHEMISTRY-US, V26, P8031, DOI 10.1021/bi00399a001; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; FIRST EA, 1993, BIOCHEMISTRY-US, V32, P13651, DOI 10.1021/bi00212a033; FIRST EA, 1998, COMPREHENSIVE BIOL C, V1, P573; FISHER PA, 1976, BIOCHEMISTRY-US, V15, P4065, DOI 10.1021/bi00663a023; Houge-Frydrych CSV, 2000, J ANTIBIOT, V53, P351, DOI 10.7164/antibiotics.53.351; Kirillov S, 1997, RNA, V3, P905; Kleeman TA, 1997, J BIOL CHEM, V272, P14420, DOI 10.1074/jbc.272.22.14420; KOCH GLE, 1974, NATURE, V249, P316, DOI 10.1038/249316a0; KOCH GLE, 1974, BIOCHEMISTRY-US, V13, P2307, DOI 10.1021/bi00708a011; LODISH H, 1995, MOL CELL BIOL, P640; LOWE DM, 1985, BIOCHEMISTRY-US, V24, P5106, DOI 10.1021/bi00340a022; QUIVY JP, 1988, J BIOL CHEM, V263, P15277; Raczniak G, 2001, TOXICOLOGY, V160, P181, DOI 10.1016/S0300-483X(00)00454-6; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Stefanska AL, 2000, J ANTIBIOT, V53, P345, DOI 10.7164/antibiotics.53.345; Stefanska AL, 2000, J ANTIBIOT, V53, P357, DOI 10.7164/antibiotics.53.357; Stefanska AL, 2000, J ANTIBIOT, V53, P1346, DOI 10.7164/antibiotics.53.1346; Wakasugi K, 1998, EMBO J, V17, P297, DOI 10.1093/emboj/17.1.297; WELLS TNC, 1991, BIOCHEMISTRY-US, V30, P5151, DOI 10.1021/bi00235a006; WELLS TNC, 1986, BIOCHEMISTRY-US, V25, P1881, DOI 10.1021/bi00356a007; WELLS TNC, 1985, NATURE, V316, P656, DOI 10.1038/316656a0; WILKINSON AJ, 1983, BIOCHEMISTRY-US, V22, P3581, DOI 10.1021/bi00284a007	34	19	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20243	20248		10.1074/jbc.M201923200	http://dx.doi.org/10.1074/jbc.M201923200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11927599	hybrid			2022-12-27	WOS:000176204500020
J	Clyne, CD; Speed, CJ; Zhou, J; Simpson, ER				Clyne, CD; Speed, CJ; Zhou, J; Simpson, ER			Liver receptor homologue-1 (LRH-1) regulates expression of aromatase in preadipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE STROMAL CELLS; ORPHAN NUCLEAR RECEPTOR; BREAST-CANCER PATIENTS; TISSUE-SPECIFIC EXPRESSION; P450 CYP19 GENE; ESTROGEN BIOSYNTHESIS; TRANSCRIPTION FACTOR; PROXIMAL PROMOTER; HORMONE-RECEPTOR; CYTOCHROME-P450	Estrogen biosynthesis from C-19 steroids is catalyzed by aromatase cytochrome P450. Aromatase is expressed in breast adipose tissue through the use of a distal, cytokine-responsive promoter (promoter 1.4). Breast tumors, however, secrete soluble factors that stimulate aromatase expression through an alternative proximal promoter, promoter II. In other estrogenic tissues such as ovaries, transcription from promoter II requires the presence of the Ftz-F1 homologue steroidogenic factor-1 (SF-1); adipose tissue, however, does not express SF-1. We have explored the hypothesis that in adipose tissue, an alternative Ftz-F1 family member, liver receptor homologue-1 (LRH-1), substitutes for SF-1 in driving transcription from promoter II. In transient transfection assays using 3T3-L1 preadipocytes, promoter II reporter constructs were modestly (2-3-fold) stimulated by either treatment with activators of protein kinases A or C (PKA/C) or by cotransfection with LRH-1. In combination, these treatments synergistically activated promoter II (>30-fold). Induction by LRH-1 (but not PKA/C) required an AGGTCA motif at -130 base pair to which LRH-1 bound in gel shift assays. Activity of GAL4-LRH-1 fusion proteins was not altered by activators of PKA or PKC. Quantitative real-time PCR revealed that LRH-1 (but not SF-1) is expressed in the preadipocyte fraction of human adipose tissue at levels comparable with that of liver. Differentiation of cultured human preadipocytes into mature adipocytes was associated with a time-dependent induction of peroxisome proliferator-activated receptor-gamma (PPARgamma), an rapid loss of LRH-1 and aromatase expression. We conclude that LRH-1 is a preadipocyte-specific nuclear receptor that regulates expression of aromatase in adipose tissue. Alterations in LRH-1 expression and/or activity in adipose tissue could therefore have considerable effects on local estrogen production and breast cancer development.	Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia	Prince Henry's Institute of Medical Research	Clyne, CD (corresponding author), Prince Henrys Inst Med Res, 246 Clayton Rd, Clayton, Vic 3168, Australia.	Colin.Clyne@med.monash.edu.au						ACKERMAN GE, 1981, J CLIN ENDOCR METAB, V53, P412, DOI 10.1210/jcem-53-2-412; Agarwal VR, 1996, J CLIN ENDOCR METAB, V81, P3843, DOI 10.1210/jc.81.11.3843; Auwerx J, 1999, CELL, V97, P161; BULUN SE, 1993, J CLIN ENDOCR METAB, V77, P1622, DOI 10.1210/jc.77.6.1622; BULUN SE, 1994, BREAST CANCER RES TR, V30, P19, DOI 10.1007/BF00682738; Carlone DL, 1997, MOL ENDOCRINOL, V11, P292, DOI 10.1210/me.11.3.292; CASTILLOOLIVARE.A, 2000, J BIOL CHEM, V275, P17793; CHEN SU, 1988, DNA-J MOLEC CELL BIO, V7, P27, DOI 10.1089/dna.1988.7.27; Galarneau L, 1996, MOL CELL BIOL, V16, P3853; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Harada N, 1997, J STEROID BIOCHEM, V61, P175; HARADA N, 1993, P NATL ACAD SCI USA, V90, P11312, DOI 10.1073/pnas.90.23.11312; HARADA N, 1990, BIOCHEM BIOPH RES CO, V166, P365, DOI 10.1016/0006-291X(90)91954-Q; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; LAVORGNA G, 1991, SCIENCE, V252, P848, DOI 10.1126/science.1709303; Li M, 1998, J BIOL CHEM, V273, P29022, DOI 10.1074/jbc.273.44.29022; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Lu TT, 2001, J BIOL CHEM, V276, P37735, DOI 10.1074/jbc.R100035200; Luo Y, 2001, J BIOL CHEM, V276, P24767, DOI 10.1074/jbc.M100912200; MAHENDROO MS, 1991, J BIOL CHEM, V266, P11276; MEANS GD, 1991, MOL ENDOCRINOL, V5, P2005, DOI 10.1210/mend-5-12-2005; MEANS GD, 1989, J BIOL CHEM, V264, P19385; Michael MD, 1997, MOL CELL ENDOCRINOL, V134, P147, DOI 10.1016/S0303-7207(97)00178-0; MICHAEL MD, 1995, J BIOL CHEM, V270, P13561, DOI 10.1074/jbc.270.22.13561; Munster P N, 2001, Cancer Control, V8, P478; Murata Y, 2000, ONCOL REP, V7, P1299; Nishizawa H, 2002, J BIOL CHEM, V277, P1586, DOI 10.1074/jbc.M104301200; Nitta M, 1999, P NATL ACAD SCI USA, V96, P6660, DOI 10.1073/pnas.96.12.6660; Okubo T, 2001, CANCER RES, V61, P1338; Paganini-Hill A, 2000, BREAST CANCER RES TR, V64, P165, DOI 10.1023/A:1006426132338; Pare JF, 2001, J BIOL CHEM, V276, P13136, DOI 10.1074/jbc.M010737200; Parker KL, 1997, ENDOCR REV, V18, P361, DOI 10.1210/er.18.3.361; PINTO HC, 1995, J HEPATOL, V23, P95, DOI 10.1016/0168-8278(95)80316-5; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Sebastian S, 2001, J CLIN ENDOCR METAB, V86, P4600, DOI 10.1210/jc.86.10.4600; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; Shamay M, 2001, ONCOGENE, V20, P6811, DOI 10.1038/sj.onc.1204879; Shozu M, 1998, MOL CELL ENDOCRINOL, V139, P117, DOI 10.1016/S0303-7207(98)00069-0; SIITERI PK, 1973, HDB PHYSL, P619; Simpson ER, 2001, ENDOCRINOLOGY, V142, P4589, DOI 10.1210/endo.142.11.8547; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; Simpson ER, 1997, RECENT PROG HORM RES, V52, P185; Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400; STEINKAMPF MP, 1987, MOL ENDOCRINOL, V1, P465, DOI 10.1210/mend-1-7-465; Sun TJ, 1998, ENDOCRINOLOGY, V139, P1684, DOI 10.1210/en.139.4.1684; THORSEN T, 1982, EUR J CANCER CLIN ON, V18, P333, DOI 10.1016/0277-5379(82)90002-5; TODA K, 1993, EUR J BIOCHEM, V213, P383, DOI 10.1111/j.1432-1033.1993.tb17772.x; TODA K, 1990, EUR J BIOCHEM, V193, P559, DOI 10.1111/j.1432-1033.1990.tb19372.x; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; VANLANDEGHEM AAJ, 1985, CANCER RES, V45, P2900; Wang ZN, 2001, J MOL ENDOCRINOL, V27, P255, DOI 10.1677/jme.0.0270255; Yang C, 1998, CANCER RES, V58, P5695; Zhang CK, 2001, GENE, V273, P239, DOI 10.1016/S0378-1119(01)00586-8; ZHAO Y, 1995, MOL ENDOCRINOL, V9, P340, DOI 10.1210/me.9.3.340; ZHAO Y, 1995, J BIOL CHEM, V270, P16449, DOI 10.1074/jbc.270.27.16449; Zhao Y, 1997, J STEROID BIOCHEM, V61, P203, DOI 10.1016/S0960-0760(97)80013-1; Zhao Y, 1996, MOL ENDOCRINOL, V10, P1350, DOI 10.1210/me.10.11.1350; Zhou DJ, 1997, J STEROID BIOCHEM, V61, P273	59	202	206	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20591	20597		10.1074/jbc.M201117200	http://dx.doi.org/10.1074/jbc.M201117200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11927588	hybrid			2022-12-27	WOS:000176204500064
J	LeClere, S; Tellez, R; Rampey, RA; Matsuda, SPT; Bartel, B				LeClere, S; Tellez, R; Rampey, RA; Matsuda, SPT; Bartel, B			Characterization of a family of IAA-amino acid conjugate hydrolases from Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINE-MAX L; INDOLEACETIC-ACID; QUANTITATIVE-ANALYSIS; PHASEOLUS-VULGARIS; ESCHERICHIA-COLI; PLANT-TISSUES; GENE; IDENTIFICATION; THALIANA; AMIDOHYDROLASE	The mechanisms by which plants regulate levels of the phytohormone indole-3-acetic acid (IAA) are complex and not fully understood. One level of regulation appears to be the synthesis and hydrolysis of IAA conjugates, which function in both the permanent inactivation and temporary storage of auxin. Similar to free LAA certain LAA-amino acid conjugates inhibit root elongation. We have tested the ability of 19 IAA-L-amino acid conjugates to inhibit Arabidopsis seedling root growth. We have also determined the ability of purified glutathione S-transferase (GST) fusions of four Arabidopsis IAA-amino acid hydrolases (ILR1, LAM, ILL1, and ILL2) to release free IAA by cleaving these conjugates. Each hydrolase cleaves a subset of IAA-amino acid conjugates in vitro, and GST-ILR1, GST-IAR3, and GST-ILL2 have K-m values that suggest physiological relevance. In vivo inhibition of root elongation correlates with in vitro hydrolysis rates for each conjugate, suggesting that the identified hydrolases generate the bioactivity of the conjugates.	Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; Rice Univ, Dept Chem, Houston, TX 77005 USA	Rice University; Rice University	Bartel, B (corresponding author), Rice Univ, Dept Biochem & Cell Biol, 6100 S Main St, Houston, TX 77005 USA.	bartel@rice.edu	Bartel, Bonnie/O-8119-2019; Bartel, Bonnie/D-3550-2011	Bartel, Bonnie/0000-0002-6367-346X; Bartel, Bonnie/0000-0002-6367-346X	NIGMS NIH HHS [R29 GM054749-04, R29 GM054749-05, T32 GM08362, R29 GM54749] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM054749, T32GM008362] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barlier I, 2000, P NATL ACAD SCI USA, V97, P14819, DOI 10.1073/pnas.260502697; BARTEL B, 1995, SCIENCE, V268, P1745, DOI 10.1126/science.7792599; Bartel B, 2001, J PLANT GROWTH REGUL, V20, P198, DOI 10.1007/s003440010025; BIALEK K, 1986, PLANT PHYSIOL, V80, P99, DOI 10.1104/pp.80.1.99; BIALEK K, 1983, PLANT PHYSIOL, V73, P130, DOI 10.1104/pp.73.1.130; BIALEK K, 1992, PLANT PHYSIOL, V100, P2002, DOI 10.1104/pp.100.4.2002; Campanella JJ, 1996, PLANT PHYSIOL, V112, P735, DOI 10.1104/pp.112.2.735; Chou JC, 1996, PLANT PHYSIOL, V112, P1281, DOI 10.1104/pp.112.3.1281; Chou JC, 1998, MOL GEN GENET, V259, P172, DOI 10.1007/s004380050802; COHEN JD, 1982, PLANT PHYSIOL, V70, P749, DOI 10.1104/pp.70.3.749; COHEN JD, 1982, ANNU REV PLANT PHYS, V33, P403, DOI 10.1146/annurev.pp.33.060182.002155; COLOMBO S, 1995, J BACTERIOL, V177, P5561, DOI 10.1128/jb.177.19.5561-5566.1995; Davies Peter J., 1995, P1; Davies RT, 1999, PLANT CELL, V11, P365, DOI 10.1105/tpc.11.3.365; DENAPOLI L, 1993, PHYTOCHEMISTRY, V33, P13, DOI 10.1016/0031-9422(93)85388-8; EHMANN A, 1977, J CHROMATOGR, V132, P267, DOI 10.1016/S0021-9673(00)89300-0; EPSTEIN E, 1980, PLANT PHYSIOL, V65, P415, DOI 10.1104/pp.65.3.415; EPSTEIN E, 1986, PLANT PHYSIOL, V80, P256, DOI 10.1104/pp.80.1.256; HANGARTER RP, 1980, PLANT PHYSIOL, V65, P761, DOI 10.1104/pp.65.5.761; HANGARTER RP, 1981, PLANT PHYSIOL, V68, P1424, DOI 10.1104/pp.68.6.1424; HANI EK, 1995, J BACTERIOL, V177, P2396, DOI 10.1128/jb.177.9.2396-2402.1995; HAUGHN GW, 1986, MOL GEN GENET, V204, P430, DOI 10.1007/BF00331020; Hussein MJ, 1998, J BACTERIOL, V180, P6260; Jackson RG, 2001, J BIOL CHEM, V276, P4350, DOI 10.1074/jbc.M006185200; JAKUBOWSKA A, 1993, J PLANT PHYSIOL, V142, P61, DOI 10.1016/S0176-1617(11)80108-2; Kowalczyk M, 2001, PLANT PHYSIOL, V127, P1845, DOI 10.1104/pp.010525; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; Lasswell J, 2000, PLANT CELL, V12, P2395, DOI 10.1105/tpc.12.12.2395; LudwigMuller J, 1996, PHYSIOL PLANTARUM, V97, P627, DOI 10.1111/j.1399-3054.1996.tb00525.x; MAGNUS V, 1992, J PLANT GROWTH REGUL, V11, P67, DOI 10.1007/BF00198017; MICHALCZUK L, 1990, PLANT BIOL, V9, P93; Normanly J, 1997, PHYSIOL PLANTARUM, V100, P431, DOI 10.1034/j.1399-3054.1997.1000304.x; Ostin A, 1998, PLANT PHYSIOL, V118, P285, DOI 10.1104/pp.118.1.285; OSTIN A, 1992, BIOL MASS SPECTROM, V21, P292, DOI 10.1002/bms.1200210605; PERCIVAL FW, 1976, PLANT PHYSIOL, V58, P60, DOI 10.1104/pp.58.1.60; PISKORNIK Z, 1972, PLANT PHYSIOL, V50, P176, DOI 10.1104/pp.50.1.176; SAKANYAN V, 1993, APPL ENVIRON MICROB, V59, P3878, DOI 10.1128/AEM.59.11.3878-3888.1993; Swofford DL., 2001, PAUP PHYLOGENETIC AN; SZERSZEN JB, 1994, SCIENCE, V265, P1699, DOI 10.1126/science.8085154; Tam YY, 2000, PLANT PHYSIOL, V123, P589, DOI 10.1104/pp.123.2.589; Titarenko E, 1997, PLANT PHYSIOL, V115, P817, DOI 10.1104/pp.115.2.817; Walz A, 2002, P NATL ACAD SCI USA, V99, P1718, DOI 10.1073/pnas.032450399	42	200	213	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20446	20452		10.1074/jbc.M111955200	http://dx.doi.org/10.1074/jbc.M111955200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11923288	hybrid			2022-12-27	WOS:000176204500045
J	Nielsen, TH; Baunsgaard, L; Blennow, A				Nielsen, TH; Baunsgaard, L; Blennow, A			Intermediary glucan structures formed during starch granule biosynthesis are enriched in short side chains, a dynamic pulse labeling approach.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT; DEFICIENT; ENZYME; PHOSPHORYLATION; ISOAMYLASE; LACKING	The formation of intermediary glucans, mature starch, and phytoglycogen was studied using leaves of Arabidopsis thaliana wild type and dbe mutant, which lacks plastidic isoamylase (Zeeman, S. C., Umemoto, T., Lue, W. L., Au-Yeung, P., Martin, C., Smith, A. M., and Chen, J. (1998) Plant Cell 10, 1699-1711). A new approach to the study of starch biosynthesis was developed based on "very short pulse" labeling of leaf starch through photosynthetic fixation of (CO2)-C-14. This allowed selective analysis of the structure of starch formed within a 30-s period. This time frame is shorter than the period required for the formation of a single crystalline amylopectin lamella and consequently permits a direct analysis of intermediary structures during granule formation. Analysis of chain length distribution showed that the most recently formed outer layer of the granules has a structure different from the mature starch. The outer layer is enriched in short chains that are 6-11 glucose residues long. Side chains with 6 glucose residues are the shortest abundant chains formed, and they are formed exclusively by transfer from donor chains of 12 glucose residues or longer. The labeling pattern shows that chain transfer resulting in branching is a rapid and efficient process, and the preferential labeling of shorter chains in the intermediary granule bound glucan is suggested to be a direct consequence of efficient branching. Although similar, the short chain intermediary structure is not identical to phytoglycogen, which is an even more highly branched molecule with very few longer chains (more than 40 glucose residues). Pulse and chase labeling profiles for the dbe mutant showed that the final structure is more highly branched than the intermediary structures, which implies that branching of phytoglycogen occurs over a longer time period than branching of starch.	Royal Vet & Agr Univ, Plant Biochem Lab, DK-1871 Frederiksberg C, Denmark; Royal Vet & Agr Univ, Ctr Mol Plant Physiol, Dept Plant Biol, DK-1871 Frederiksberg C, Denmark	University of Copenhagen; University of Copenhagen	Nielsen, TH (corresponding author), Royal Vet & Agr Univ, Plant Biochem Lab, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark.	thni@kvl.dk	Nielsen, Tom Hamborg H/F-7539-2014; Blennow, Andreas/F-7451-2014	Nielsen, Tom Hamborg H/0000-0002-8469-7145; Blennow, Andreas/0000-0001-6476-9546				Blennow A, 1998, CARBOHYD RES, V307, P45, DOI 10.1016/S0008-6215(98)00015-9; Blennow A, 2000, CARBOHYD POLYM, V41, P163, DOI 10.1016/S0144-8617(99)00082-X; BLENNOW A, 1998, EUR J BIOCHEM, V252, P148; Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3; Buleon A, 1997, PLANT PHYSIOL, V115, P949, DOI 10.1104/pp.115.3.949; CASPAR T, 1985, PLANT PHYSIOL, V79, P11, DOI 10.1104/pp.79.1.11; GUAN HP, 1995, P NATL ACAD SCI USA, V92, P964, DOI 10.1073/pnas.92.4.964; GUAN HP, 1993, PLANT PHYSIOL, V102, P1269, DOI 10.1104/pp.102.4.1269; JAMES MG, 1995, PLANT CELL, V7, P417, DOI 10.1105/tpc.7.4.417; JENKINS JPJ, 1993, STARCH-STARKE, V45, P417; Kossmann J, 2000, CRIT REV PLANT SCI, V19, P171, DOI 10.1016/S0735-2689(00)80002-7; Kubo A, 1999, PLANT PHYSIOL, V121, P399, DOI 10.1104/pp.121.2.399; LIN TP, 1988, PLANT PHYSIOL, V86, P1131, DOI 10.1104/pp.86.4.1131; MANNERS DJ, 1989, CARBOHYD POLYM, V11, P87, DOI 10.1016/0144-8617(89)90018-0; Mouille G, 1996, PLANT CELL, V8, P1353; Myers AM, 2000, PLANT PHYSIOL, V122, P989, DOI 10.1104/pp.122.4.989; Nakamura Y, 1997, PLANT J, V12, P143, DOI 10.1046/j.1365-313X.1997.12010143.x; Preiss J., 1988, BIOCH PLANTS, V14., P181; Rydberg U, 2001, EUR J BIOCHEM, V268, P6140, DOI 10.1046/j.0014-2956.2001.02568.x; Smith AM, 1997, ANNU REV PLANT PHYS, V48, P65, DOI 10.1146/annurev.arplant.48.1.67; Smith AM, 2001, BIOMACROMOLECULES, V2, P335, DOI 10.1021/bm000133c; Tomlinson KL, 1997, PLANT J, V11, P31, DOI 10.1046/j.1365-313X.1997.11010031.x; Zeeman SC, 1998, PLANT J, V15, P357, DOI 10.1046/j.1365-313X.1998.00213.x; Zeeman SC, 1998, PLANT CELL, V10, P1699, DOI 10.1105/tpc.10.10.1699	24	38	41	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20249	20255		10.1074/jbc.M201866200	http://dx.doi.org/10.1074/jbc.M201866200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11919198	hybrid			2022-12-27	WOS:000176204500021
J	Strack, S; Ruediger, R; Walter, G; Dagda, RK; Barwacz, CA; Cribbs, JT				Strack, S; Ruediger, R; Walter, G; Dagda, RK; Barwacz, CA; Cribbs, JT			Protein phosphatase 2A holoenzyme assembly - Identification of contacts between B-family regulatory and scaffolding A subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOVIRUS E4ORF4 PROTEIN; CATALYTIC SUBUNIT; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; TUMOR-ANTIGEN; T-ANTIGENS; CARBOXYL METHYLATION; DNA-REPLICATION; A-SUBUNIT; ASSOCIATION	Protein serine/threonine phosphatase (PP) 2A is a ubiquitous enzyme with pleiotropic functions. Trimeric PP2A consists of a structural A subunit, a catalytic C subunit, and a variable regulatory subunit. Variable subunits (B, B', and B" families) dictate PP2A substrate specificity and subcellular localization. B-family subunits contain seven WD repeats predicted to fold into a beta-propeller structure. We carried out mutagenesis of Bgamma to identify domains important for association with A and C subunits in vivo. Several internal deletions in Bgamma abolished coimmunoprecipitation of A and C subunits expressed in COS-M6 cells. In contrast, small N- and C-terminal By deletions had no effect on incorporation into the PP2A heterotrimer. Thus, holoenzyme association of B-family subunits requires multiple, precisely aligned contacts within a core beta-propeller domain. Charge-reversal mutagenesis of By identified a cluster ;of conserved critical residues in Bgamma WD repeats 3 and 4. Acidic substitution of paired basic residues in By (RR165EE) abolished association with wild-type A and C subunits, while fostering incorporation of Bgamma into a PP2A heterotrimer containing an A subunit with an opposite charge-reversal mutation (EE100RR). Thus, binding of A and B subunits requires electrostatic interactions between conserved pairs of glutamates and arginines. By expressing complementary charge-reversal mutants in neuronal PC6-3 cells, we further show that holoenzyme incorporation protects By from rapid degradation by the ubiquitin/proteasome pathway.	Univ Iowa, Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	University of Iowa; University of California System; University of California San Diego	Strack, S (corresponding author), Univ Iowa, Coll Med, Dept Pharmacol, 2-432 BSB 51 Newton Rd, Iowa City, IA 52242 USA.			Strack, Stefan/0000-0002-6175-7280; Dagda, Ruben/0000-0002-9946-9591	NIDDK NIH HHS [DK25295] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Branton PE, 2001, ONCOGENE, V20, P7855, DOI 10.1038/sj.onc.1204862; Csortos C, 1996, J BIOL CHEM, V271, P2578, DOI 10.1074/jbc.271.5.2578; EGLOFF MP, 1995, J MOL BIOL, V254, P942, DOI 10.1006/jmbi.1995.0667; GOLDBERG J, 1995, NATURE, V376, P745, DOI 10.1038/376745a0; Griswold-Prenner I, 1998, MOL CELL BIOL, V18, P6595, DOI 10.1128/MCB.18.11.6595; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HEALY AM, 1991, MOL CELL BIOL, V11, P5767, DOI 10.1128/MCB.11.11.5767; HENDRIX P, 1993, J BIOL CHEM, V268, P15267; HOROWITZ M, 1983, Journal of Molecular and Applied Genetics, V2, P147; Hsu W, 1999, J BIOL CHEM, V274, P3439, DOI 10.1074/jbc.274.6.3439; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; KAMIBAYASHI C, 1994, J BIOL CHEM, V269, P20139; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kleinberger T, 2000, APOPTOSIS, V5, P211, DOI 10.1023/A:1009644210581; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Li XH, 2002, EUR J BIOCHEM, V269, P546, DOI 10.1046/j.0014-2956.2001.02680.x; Lin XH, 1998, P NATL ACAD SCI USA, V95, P14693, DOI 10.1073/pnas.95.25.14693; MAYER RE, 1991, BIOCHEMISTRY-US, V30, P3589, DOI 10.1021/bi00229a001; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; MCCRIGHT B, 1995, J BIOL CHEM, V270, P26123, DOI 10.1074/jbc.270.44.26123; Moreno CS, 2000, J BIOL CHEM, V275, P5257, DOI 10.1074/jbc.275.8.5257; PALLAS DC, 1992, J VIROL, V66, P886, DOI 10.1128/JVI.66.2.886-893.1992; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; PITTMAN RN, 1993, J NEUROSCI, V13, P3669; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; RUEDIGER R, 1994, J VIROL, V68, P123, DOI 10.1128/JVI.68.1.123-129.1994; RUEDIGER R, 1992, MOL CELL BIOL, V12, P4872, DOI 10.1128/MCB.12.11.4872; Ruediger R, 1999, J VIROL, V73, P839, DOI 10.1128/JVI.73.1.839-842.1999; RUEDIGER R, 1991, MOL CELL BIOL, V11, P4282, DOI 10.1128/MCB.11.8.4282; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; SONTAG E, 1995, J CELL BIOL, V128, P1131, DOI 10.1083/jcb.128.6.1131; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; Strack S, 1999, FEBS LETT, V460, P462, DOI 10.1016/S0014-5793(99)01377-0; Strack S, 1998, J COMP NEUROL, V392, P515; Tanabe O, 1996, FEBS LETT, V379, P107, DOI 10.1016/0014-5793(95)01500-0; Tehrani MA, 1996, J BIOL CHEM, V271, P5164; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; Turowski P, 1999, MOL BIOL CELL, V10, P1997, DOI 10.1091/mbc.10.6.1997; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Voorhoeve PM, 1999, ONCOGENE, V18, P515, DOI 10.1038/sj.onc.1202316; WALTER G, 1990, P NATL ACAD SCI USA, V87, P2521, DOI 10.1073/pnas.87.7.2521; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; Yan Z, 2000, MOL CELL BIOL, V20, P1021, DOI 10.1128/MCB.20.3.1021-1029.2000; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185; Zhao Y, 1997, J BIOL CHEM, V272, P8256, DOI 10.1074/jbc.272.13.8256; ZOLNIEROWICZ S, 1994, BIOCHEMISTRY-US, V33, P11858, DOI 10.1021/bi00205a023; Zolnierowicz S, 1996, BIOCHEM J, V317, P187, DOI 10.1042/bj3170187	54	64	64	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20750	20755		10.1074/jbc.M202992200	http://dx.doi.org/10.1074/jbc.M202992200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11929880	hybrid			2022-12-27	WOS:000176204500084
J	He, YC; Crouch, E				He, YC; Crouch, E			Surfactant protein D gene regulation - Interactions among the conserved CCAAT/enhancer-binding protein elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE-PHASE RESPONSE; COLLAGEN-LIKE DOMAIN; C-REACTIVE PROTEIN; ACUTE LUNG INJURY; C/EBP-DELTA; TRANSCRIPTIONAL REGULATION; DIFFERENTIAL EXPRESSION; CELL-PROLIFERATION; MAMMALIAN LECTIN; INNATE IMMUNITY	Surfactant protein D (SP-D) plays roles in pulmonary host defense and surfactant homeostasis and is increased following acute lung injury. Given the importance of CCAAT/enhancer-binding protein (C/EBP)binding elements in the systemic acute-phase response and lung development and the expression of C/EBP isoforms by lung epithelial cells, we hypothesized that conserved C/EBP motifs in the near-distal and proximal promoters contribute to the regulation of SP-D expression by C/EBPs. Five SP-D motifs (-432, -340, -319, -140, and -90) homologous to the C/EBP consensus sequence specifically bound to C/EBPs in gel shift assays, and four of the five sites (-432, -340, -319, and -90) efficiently competed for the binding of C/EBPalpha, C/EBPbeta, or C/EBPdelta to consensus oligomers. Cotransfection of C/EBPalpha, C/EBPbeta, or C/EBPdelta cDNA in H441 lung adenocarcinoma cells significantly increased the luciferase activity of a wild-type SP-D promoter construct containing 698 by of upstream sequence (SS698). Transfection of C/EBP also increased the level of endogenous SP-D mRNA in H441 cells. Transactivation of the reporter construct was abrogated by deletion of sequences upstream of -205. Independent site-directed mutagenesis of the sites at -432, -340, and -319 reduced C/EBP-mediated activation by similar to50%, and mutagenesis of the site at -432 in combination with either of the tandem sites at -340 and -319 blocked activation. The conserved AP-1 element at -109 was required for maximal promoter activity, but not for the transactivation of SS698 by C/EBPs. Thus, interactions among C/EBP elements in the near-distal promoter can modulate the promoter activity of SP-D.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Crouch, E (corresponding author), Barnes Jewish Hosp, Dept Pathol & Immunol, Rm 2457,N Campus,Surg Pathol Mailstop 90-31-649,2, St Louis, MO 63110 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029594, R01HL044015] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL29594, HL44015] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aderibigbe AO, 1999, AM J RESP CELL MOL, V20, P219, DOI 10.1165/ajrcmb.20.2.3348; AKIRA S, 1992, IMMUNOL REV, V127, P25, DOI 10.1111/j.1600-065X.1992.tb01407.x; ALAM T, 1992, J BIOL CHEM, V267, P5021; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Breed DR, 1997, ENDOCRINOLOGY, V138, P5527, DOI 10.1210/en.138.12.5527; Burgess-Beusse BL, 1998, MOL CELL BIOL, V18, P7269, DOI 10.1128/MCB.18.12.7269; Cassel TN, 2000, AM J RESP CELL MOL, V22, P469, DOI 10.1165/ajrcmb.22.4.3916; Charles A, 2001, J CELL BIOCHEM, V83, P414, DOI 10.1002/jcb.1239; Chen PL, 1996, P NATL ACAD SCI USA, V93, P465, DOI 10.1073/pnas.93.1.465; CHOI AMK, 1995, AM J RESP CELL MOL, V13, P74, DOI 10.1165/ajrcmb.13.1.7598940; Crouch EC, 1998, AM J RESP CELL MOL, V19, P177, DOI 10.1165/ajrcmb.19.2.140; DArmiento J, 1997, GENE, V195, P19, DOI 10.1016/S0378-1119(97)00123-6; Dentener MA, 2000, AM J RESP CELL MOL, V23, P146, DOI 10.1165/ajrcmb.23.2.3855; FEY GH, 1987, MOL BIOL MED, V4, P323; Flodby P, 1996, J BIOL CHEM, V271, P24753, DOI 10.1074/jbc.271.40.24753; HANSEN S, 2002, IN PRESS MOL IMMUNOL; He YC, 2000, J BIOL CHEM, V275, P31051, DOI 10.1074/jbc.M003499200; Heuertz RM, 1997, MOL MED TODAY, V3, P539, DOI 10.1016/S1357-4310(97)01145-3; Ikegami M, 2000, AM J PHYSIOL-LUNG C, V279, pL468, DOI 10.1152/ajplung.2000.279.3.L468; Jain-Vora S, 1998, INFECT IMMUN, V66, P4229; KAWASAKI N, 1994, BIOCHEM BIOPH RES CO, V198, P597, DOI 10.1006/bbrc.1994.1087; Kawasaki N, 1998, J BIOCHEM, V124, P1188, DOI 10.1093/oxfordjournals.jbchem.a022237; KLAMPFER L, 1995, J BIOL CHEM, V270, P3677, DOI 10.1074/jbc.270.8.3677; Lag M, 2000, EXP LUNG RES, V26, P383, DOI 10.1080/019021400408326; Lawson PR, 2000, IMMUNOL REV, V173, P66, DOI 10.1034/j.1600-065X.2000.917308.x; Lawson PR, 1999, AM J RESP CELL MOL, V20, P953, DOI 10.1165/ajrcmb.20.5.3343; Lee PT, 2000, AM J RESP CELL MOL, V23, P652, DOI 10.1165/ajrcmb.23.5.4016; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; LeVine AM, 2000, J IMMUNOL, V165, P3934, DOI 10.4049/jimmunol.165.7.3934; LI F, 1995, AM J PHYSIOL-LUNG C, V269, pL241, DOI 10.1152/ajplung.1995.269.2.L241; Madsen J, 2000, J IMMUNOL, V164, P5866, DOI 10.4049/jimmunol.164.11.5866; MAJELLO B, 1990, EMBO J, V9, P457, DOI 10.1002/j.1460-2075.1990.tb08131.x; McIntosh JC, 1996, AM J RESP CELL MOL, V15, P509, DOI 10.1165/ajrcmb.15.4.8879185; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Reading PC, 1997, J VIROL, V71, P8204, DOI 10.1128/JVI.71.11.8204-8212.1997; Rust K, 1996, AM J RESP CELL MOL, V14, P121, DOI 10.1165/ajrcmb.14.2.8630261; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Sugahara K, 1999, CELL TISSUE RES, V297, P261, DOI 10.1007/s004410051354; Toonen RFG, 1996, BIOCHEM J, V316, P467, DOI 10.1042/bj3160467; White MR, 2000, J IMMUNOL, V165, P2108, DOI 10.4049/jimmunol.165.4.2108; Yamada T, 1997, J BIOCHEM-TOKYO, V121, P731; YANG FM, 1995, LAB INVEST, V73, P433	42	36	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19530	19537		10.1074/jbc.M201126200	http://dx.doi.org/10.1074/jbc.M201126200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11912209	hybrid			2022-12-27	WOS:000175894800040
J	Schouten, A; Rossien, J; Bakker, J; Schots, A				Schouten, A; Rossien, J; Bakker, J; Schots, A			Formation of disulfide bridges by a single-chain Fv antibody in the reducing ectopic environment of the plant cytosol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ENDOPLASMIC-RETICULUM; INTRACELLULAR EXPRESSION; SECRETORY PATHWAY; REDOX STATE; REVERSE-TRANSCRIPTASE; VARIABLE FRAGMENTS; TRANSGENIC TOBACCO; ESCHERICHIA-COLI; PROTEIN	Disulfide bridge formation in the reducing environment of the cytosol is considered a rare event and is mostly linked to inactivation of protein activity. In this report the in vivo redox state of a single-chain Fv (scFv) antibody fragment in the plant cytosol was investigated. The scFv antibody fragment consists of the variable light and heavy chain domains from a mouse IgG antibody, which are connected by a flexible linker peptide. In each domain one disulfide bridge is present. The functionality of antibodies, which are normally secreted via the oxidizing environment of the endoplasmic reticulum, depends on the formation of intramolecular disulfide bridges. We demonstrate that a scFv can form intramolecular disulfide bridges and is functionally expressed in the cytosol of stably transformed plants. In addition, the formation of intermolecular disulfide bridges through a cysteine present in the linker peptide was observed. In contrast, transient expression in tobacco protoplasts resulted in a cytosolic scFv lacking disulfide bridges, which had a substantially reduced affinity for the antigen. This indicates that functionality rather than stability is determined by the presence of disulfide bridges in the in planta-expressed scFv antibody. The controversial observation of disulfide bond formation in the cytosol is discussed.	Univ Wageningen & Res Ctr, Nematol Lab, Lab Mol Recognit & Antibody Technol, Dept Plant Sci, NL-6700 ES Wageningen, Netherlands	Wageningen University & Research	Schouten, A (corresponding author), Univ Wageningen & Res Ctr, Phytopathol Lab, Dept Plant Sci, POB 8025, NL-6700 EE Wageningen, Netherlands.	sander.schouten@fyto.dpw.wau.nl	Schots, Arjen/U-1839-2017; Schots, Arjen/ABF-8014-2020	Schots, Arjen/0000-0002-6036-7088; Schots, Arjen/0000-0002-6036-7088				ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; ALBERINI CM, 1990, NATURE, V347, P485, DOI 10.1038/347485a0; ALOSI MC, 1988, PLANT PHYSIOL, V86, P1089, DOI 10.1104/pp.86.4.1089; ALSCHER RG, 1989, PHYSIOL PLANTARUM, V77, P457, DOI 10.1111/j.1399-3054.1989.tb05667.x; ANDERSON LE, 1995, PLANTA, V196, P118, DOI 10.1007/BF00193225; BIOCCA S, 1993, BIOCHEM BIOPH RES CO, V197, P422, DOI 10.1006/bbrc.1993.2496; BIOCCA S, 1995, BIO-TECHNOL, V13, P1110, DOI 10.1038/nbt1095-1110; BIOCCA S, 1994, BIO-TECHNOL, V12, P396, DOI 10.1038/nbt0494-396; BIOCCA S, 1995, TRENDS CELL BIOL, V5, P248, DOI 10.1016/S0962-8924(00)89019-4; BRAAKMAN I, 1992, NATURE, V356, P260, DOI 10.1038/356260a0; CHANAT E, 1993, EMBO J, V12, P2159, DOI 10.1002/j.1460-2075.1993.tb05864.x; CHOUDHARY AD, 1990, PLANT PHYSIOL, V94, P1802, DOI 10.1104/pp.94.4.1802; CSEKE C, 1986, BIOCHIM BIOPHYS ACTA, V853, P43, DOI 10.1016/0304-4173(86)90004-2; De Jaeger G, 1999, EUR J BIOCHEM, V259, P426, DOI 10.1046/j.1432-1327.1999.00060.x; DENECKE J, 1989, Methods in Molecular and Cellular Biology, V1, P19; DEVRIES AAF, 1995, J VIROL, V69, P3441, DOI 10.1128/JVI.69.6.3441-3448.1995; DUAN LX, 1994, P NATL ACAD SCI USA, V91, P5075, DOI 10.1073/pnas.91.11.5075; Fecker LF, 1997, ARCH VIROL, V142, P1857, DOI 10.1007/s007050050203; Freund C, 1996, BIOCHEMISTRY-US, V35, P8457, DOI 10.1021/bi952764a; Garaci E, 1997, J LEUKOCYTE BIOL, V62, P54, DOI 10.1002/jlb.62.1.54; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; GLOCKSHUBER R, 1992, BIOCHEMISTRY-US, V31, P1270, DOI 10.1021/bi00120a002; GOTO Y, 1979, J BIOCHEM-TOKYO, V86, P1433, DOI 10.1093/oxfordjournals.jbchem.a132661; HEROUART D, 1993, P NATL ACAD SCI USA, V90, P3108, DOI 10.1073/pnas.90.7.3108; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; JAMSA E, 1994, YEAST, V10, P355, DOI 10.1002/yea.320100308; JIANG WR, 1995, J VIROL, V69, P1044, DOI 10.1128/JVI.69.2.1044-1049.1995; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LODISH HF, 1993, J BIOL CHEM, V268, P20598; MACIEJEWSKI JP, 1995, NAT MED, V1, P667, DOI 10.1038/nm0795-667; MHASHILKAR AM, 1995, EMBO J, V14, P1542, DOI 10.1002/j.1460-2075.1995.tb07140.x; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; OWEN M, 1992, BIO-TECHNOL, V10, P790, DOI 10.1038/nbt0792-790; Parks D, 1997, NUCLEIC ACIDS RES, V25, P1289, DOI 10.1093/nar/25.6.1289; PELHAM HRB, 1989, EMBO J, V8, P3171, DOI 10.1002/j.1460-2075.1989.tb08475.x; PINEIRO M, 1994, P NATL ACAD SCI USA, V91, P3867, DOI 10.1073/pnas.91.9.3867; RENNENBERG H, 1982, PLANT PHYSIOL, V69, P766, DOI 10.1104/pp.69.4.766; Ruddon RW, 1997, J BIOL CHEM, V272, P3125, DOI 10.1074/jbc.272.6.3125; Ryabova LA, 1997, NAT BIOTECHNOL, V15, P79, DOI 10.1038/nbt0197-79; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schouten A, 1997, FEBS LETT, V415, P235, DOI 10.1016/S0014-5793(97)01129-0; Schouten A, 1996, PLANT MOL BIOL, V30, P781, DOI 10.1007/BF00019011; Sengupta S, 2001, J BIOL CHEM, V276, P30111, DOI 10.1074/jbc.M104324200; Sengupta S, 2001, J BIOL CHEM, V276, P46896, DOI 10.1074/jbc.M108451200; Shaheen F, 1996, J VIROL, V70, P3392, DOI 10.1128/JVI.70.6.3392-3400.1996; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; Szederkenyi J, 1997, PLANTA, V202, P349, DOI 10.1007/s004250050137; TATU U, 1993, EMBO J, V12, P2151, DOI 10.1002/j.1460-2075.1993.tb05863.x; Tavladoraki P, 1999, EUR J BIOCHEM, V262, P617, DOI 10.1046/j.1432-1327.1999.00443.x; TAVLADORAKI P, 1993, NATURE, V366, P469, DOI 10.1038/366469a0; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; VANENGELEN FA, 1995, TRANSGENIC RES, V4, P288, DOI 10.1007/BF01969123; WERGE TM, 1994, FEBS LETT, V351, P393, DOI 10.1016/0014-5793(94)00892-2; WINGATE VPM, 1988, PLANT PHYSIOL, V87, P206, DOI 10.1104/pp.87.1.206; ZIEGLER DM, 1985, ANNU REV BIOCHEM, V54, P305, DOI 10.1146/annurev.bi.54.070185.001513	57	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19339	19345		10.1074/jbc.M201245200	http://dx.doi.org/10.1074/jbc.M201245200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11916972	hybrid			2022-12-27	WOS:000175894800014
J	Kamemura, K; Hayes, BK; Comer, FI; Hart, GW				Kamemura, K; Hayes, BK; Comer, FI; Hart, GW			Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins - Alternative glycosylation/phosphorylation of Thr-58, a known mutational hot spot of c-Myc in lymphomas, is regulated by mitogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED N-ACETYLGLUCOSAMINE; CYTOSOLIC PROTEINS; GLCNAC TRANSFERASE; TERMINAL DOMAIN; IN-VIVO; NUCLEAR; TRANSACTIVATION; PROTEASOME; EXPRESSION; LITHIUM	Previously, we reported that c-Myc is glycosylated by O-linked N-acetylglucosamine at Thr-58, a known phosphorylation site and a mutational hot spot in lymphomas. In this paper, we describe the production and characterization of two Thr-58 site-specific antibodies and use them to examine the modification of Thr-58 in living cells. One antibody specifically reacts with the Thr-58-glycosylated form of c-Myc, and the other reacts only with unmodified Thr-58 in c-Myc. Using these antibodies together with a commercial anti-Thr-58-phosphorylated c-Myc antibody, we simultaneously detected three forms of c-Myc (Thr-58-unmodified, -phosphorylated, and -glycosylated). It has been reported that Thr-58 phosphorylation is dependent on a prior phosphorylation of Ser-62. Mutagenesis of Ser-62 to Ala showed a marked decrease of Thr-58 phosphorylation and a marked increase of Thr-58 glycosylation. Growth inhibition of HL60 cells by serum starvation increases Thr-58 glycosylation and correspondingly decreases its phosphorylation. Serum stimulation has the opposite effect upon the modification status of Thr-58. A candidate kinase responsible for Thr-58 phosphorylation is the glycogen synthase kinase 3 (GSK3). Lithium, a competitive inhibitor of GSK3, decreased Thr-58 phosphorylation and increased its glycosylation. Finally, we show that the Thr-58-phosphorylated form of c-Myc predominantly accumulates in the cytoplasm rather than the nucleus upon inhibition of proteasome activity. These data suggest that hierarchical phosphorylation of Ser-62 and Thr-58 and alternative glycosylation/phosphorylation of Thr-58 together regulate the myriad functions of c-Myc in cells.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Hart, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.	gwhart@jhmi.edu		Hart, Gerald/0000-0001-7812-4351	NCI NIH HHS [CA42486] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA042486] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALEXANDROVA N, 1995, MOL CELL BIOL, V15, P5188; Amati B, 2001, BBA-REV CANCER, V1471, pM135, DOI 10.1016/S0304-419X(01)00020-8; Bahram F, 2000, BLOOD, V95, P2104, DOI 10.1182/blood.V95.6.2104; BEIJERSBERGEN RL, 1994, EMBO J, V13, P4080, DOI 10.1002/j.1460-2075.1994.tb06725.x; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cheng XG, 2000, BIOCHEMISTRY-US, V39, P11609, DOI 10.1021/bi000755i; Cheng XG, 2001, J BIOL CHEM, V276, P10570, DOI 10.1074/jbc.M010411200; CHOU TY, 1995, P NATL ACAD SCI USA, V92, P4417, DOI 10.1073/pnas.92.10.4417; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Comer FI, 2000, J BIOL CHEM, V275, P29179, DOI 10.1074/jbc.R000010200; Dang CV, 1999, MOL CELL BIOL, V19, P1; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Facchini LM, 1998, FASEB J, V12, P633, DOI 10.1096/fasebj.12.9.633; Ferrer I, 2001, NEUROPATH APPL NEURO, V27, P343, DOI 10.1046/j.1365-2990.2001.00348.x; Flinn EM, 1998, MOL CELL BIOL, V18, P5961, DOI 10.1128/MCB.18.10.5961; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000; Griffith LS, 1999, EUR J BIOCHEM, V262, P824, DOI 10.1046/j.1432-1327.1999.00439.x; Gross-Mesilaty S, 1998, P NATL ACAD SCI USA, V95, P8058, DOI 10.1073/pnas.95.14.8058; Guo QB, 1998, P NATL ACAD SCI USA, V95, P9172, DOI 10.1073/pnas.95.16.9172; GUPTA S, 1993, P NATL ACAD SCI USA, V90, P3216, DOI 10.1073/pnas.90.8.3216; Haltiwanger RS, 1998, J BIOL CHEM, V273, P3611, DOI 10.1074/jbc.273.6.3611; Han I, 1997, MOL CELL BIOL, V17, P2550, DOI 10.1128/MCB.17.5.2550; HANN SR, 1984, MOL CELL BIOL, V4, P2486, DOI 10.1128/MCB.4.11.2486; Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315; HENRIKSSON M, 1993, ONCOGENE, V8, P3199; HOANG AT, 1995, MOL CELL BIOL, V15, P4031; Hong M, 1997, J BIOL CHEM, V272, P25326, DOI 10.1074/jbc.272.40.25326; Izumi H, 2001, J CELL SCI, V114, P1533; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lubas WA, 1997, J BIOL CHEM, V272, P9316; LUTTERBACH B, 1994, MOL CELL BIOL, V14, P5510, DOI 10.1128/MCB.14.8.5510; MAHESWARAN S, 1994, MOL CELL BIOL, V14, P1147, DOI 10.1128/MCB.14.2.1147; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Medina L, 1998, GLYCOBIOLOGY, V8, P383, DOI 10.1093/glycob/8.4.383; Mora A, 2001, J NEUROCHEM, V78, P199, DOI 10.1046/j.1471-4159.2001.00410.x; Noguchi K, 1999, J BIOL CHEM, V274, P32580, DOI 10.1074/jbc.274.46.32580; Noguchi K, 2001, BIOCHEM BIOPH RES CO, V281, P1313, DOI 10.1006/bbrc.2001.4498; PULVERER BJ, 1994, ONCOGENE, V9, P59; ROQUEMORE EP, 1994, METHOD ENZYMOL, V230, P443; Ryves WJ, 2001, BIOCHEM BIOPH RES CO, V280, P720, DOI 10.1006/bbrc.2000.4169; Sakamuro D, 1996, NAT GENET, V14, P69, DOI 10.1038/ng0996-69; Sakamuro D, 1999, ONCOGENE, V18, P2942, DOI 10.1038/sj.onc.1202725; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Shim H, 1998, P NATL ACAD SCI USA, V95, P1511, DOI 10.1073/pnas.95.4.1511; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; WESTIN EH, 1982, P NATL ACAD SCI-BIOL, V79, P2490, DOI 10.1073/pnas.79.8.2490	56	165	192	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					19229	19235		10.1074/jbc.M201729200	http://dx.doi.org/10.1074/jbc.M201729200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11904304	hybrid			2022-12-27	WOS:000175975800127
J	Weng, ZG; Xin, M; Pablo, L; Grueneberg, D; Hagel, M; Bain, G; Muller, T; Papkoff, J				Weng, ZG; Xin, M; Pablo, L; Grueneberg, D; Hagel, M; Bain, G; Muller, T; Papkoff, J			Protection against anoikis and down-regulation of cadherin expression by a regulatable beta-catenin protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							WNT SIGNALING PATHWAY; TRANSCRIPTION FACTOR LEF-1; CELL-ADHESION MOLECULES; APC TUMOR-SUPPRESSOR; MAP KINASE; COLORECTAL-CANCER; XENOPUS EMBRYOS; AXIS FORMATION; C-MYC; NEOPLASTIC TRANSFORMATION	beta-Catenin signaling plays a key role in a variety of cellular contexts during embryonic development and tissue differentiation. Aberrant beta-catenin signaling has also been implicated in promoting human colorectal carcinomas as well as a variety of other cancers. To study the molecular and cellular biological functions of beta-catenin in a controlled fashion, we created a regulatable form of activated beta-catenin by fusion to a modified estrogen receptor (ER) ligand binding domain (G525R). Transfection of tissue culture cells with expression vectors encoding this hybrid protein allows the signal transduction function of beta-catenin to be induced by the synthetic estrogen, 4-hydroxytamoxifen, leading to regulated activation of a beta-catenin-lymphocyte enhancer-binding factor-dependent reporter gene as well as induction of endogenous cyclin D1 expression. The activation of ER-beta-catenin signaling rescues RK3E cells from anoikis and correlates with an increased phosphorylation of mitogen-activated protein kinase. The inhibition of anoikis by ER-beta-catenin can be abolished by a mitogen-activated protein kinase pathway inhibitor, PD98059. Evidence is also provided to show that ER-beta-catenin down-regulates cadherin protein levels. These findings support a key role for activated beta-catenin signaling in processes that contribute to tumor formation and progression.	Aventis Pharmaceut, Canbridge Genom Ctr, Cambridge, MA 02139 USA	Sanofi-Aventis	Weng, ZG (corresponding author), Infin Pharmaceut Inc, 650 Albany St, Boston, MA 02118 USA.			Weng, Zhigang/0000-0003-1885-5501				ABERLE H, 1994, J CELL SCI, V107, P3655; Aoki M, 1999, P NATL ACAD SCI USA, V96, P139, DOI 10.1073/pnas.96.1.139; Aziz N, 1999, MOL CELL BIOL, V19, P1101; BAE SN, 1993, BREAST CANCER RES TR, V24, P241, DOI 10.1007/BF01833264; Behrens J, 2000, ANN NY ACAD SCI, V910, P21; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; BEHRENS J, 1989, J CELL BIOL, V108, P2435, DOI 10.1083/jcb.108.6.2435; Behrens J, 1999, CANCER METAST REV, V18, P15, DOI 10.1023/A:1006200102166; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Berx G, 1998, HUM MUTAT, V12, P226, DOI 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bienz M, 1999, CURR OPIN GENET DEV, V9, P595, DOI 10.1016/S0959-437X(99)00016-7; BRADLEY RS, 1993, J CELL BIOL, V123, P1857, DOI 10.1083/jcb.123.6.1857; Brancolini C, 1997, J CELL BIOL, V139, P759, DOI 10.1083/jcb.139.3.759; Briegel K, 1996, DEVELOPMENT, V122, P3839; Brunet A, 1997, ESSAYS BIOCHEM, V32, P1; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; DEBENEDETTI L, 1994, CANCER RES, V54, P3553; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; Fagotto F, 1996, J CELL BIOL, V132, P1105, DOI 10.1083/jcb.132.6.1105; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; Fearon ER, 2000, JNCI-J NATL CANCER I, V92, P515, DOI 10.1093/jnci/92.7.515; Ferkey DM, 2000, DEV BIOL, V225, P471, DOI 10.1006/dbio.2000.9816; Finlay D, 2000, CELL DEATH DIFFER, V7, P302, DOI 10.1038/sj.cdd.4400652; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; FUNAYAMA N, 1995, J CELL BIOL, V128, P959, DOI 10.1083/jcb.128.5.959; Giannini AL, 2000, EXP CELL RES, V255, P207, DOI 10.1006/excr.1999.4785; Gonzalez-Amaro R, 1999, CRIT REV IMMUNOL, V19, P389; Guilford P, 1999, MOL MED TODAY, V5, P172, DOI 10.1016/S1357-4310(99)01461-6; Hakimelahi S, 2000, J BIOL CHEM, V275, P10905, DOI 10.1074/jbc.275.15.10905; Handschuh G, 1999, ONCOGENE, V18, P4301, DOI 10.1038/sj.onc.1202790; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; HERMEKING H, 1994, SCIENCE, V265, P2091, DOI 10.1126/science.8091232; HINCK L, 1994, J CELL BIOL, V125, P1327, DOI 10.1083/jcb.125.6.1327; Hirohashi S, 1998, AM J PATHOL, V153, P333, DOI 10.1016/S0002-9440(10)65575-7; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Huber O, 1996, CURR OPIN CELL BIOL, V8, P685, DOI 10.1016/S0955-0674(96)80110-4; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Ingham PW, 1996, TRENDS GENET, V12, P382, DOI 10.1016/0168-9525(96)30096-6; ISHIBASHI T, 1994, J BIOL CHEM, V269, P7645; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Malik HS, 1997, P NATL ACAD SCI USA, V94, P13738, DOI 10.1073/pnas.94.25.13738; MAREEL M, 1995, CANCER DETECT PREV, V19, P451; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; MATTIONI T, 1994, METHOD CELL BIOL, V43, P335; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Muller T, 1999, J BIOL CHEM, V274, P10173, DOI 10.1074/jbc.274.15.10173; NAGAFUCHI A, 1989, CELL REGUL, V1, P37, DOI 10.1091/mbc.1.1.37; Nakamura T, 1998, GENES CELLS, V3, P395, DOI 10.1046/j.1365-2443.1998.00198.x; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; Novak A, 1998, P NATL ACAD SCI USA, V95, P4374, DOI 10.1073/pnas.95.8.4374; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Orford K, 1999, J CELL BIOL, V146, P855, DOI 10.1083/jcb.146.4.855; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; Papkoff J, 1996, MOL CELL BIOL, V16, P2128; Papkoff J, 1998, BIOCHEM BIOPH RES CO, V247, P851, DOI 10.1006/bbrc.1998.8888; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; PEIFER M, 1994, DEVELOPMENT, V120, P369; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Polakis P, 2000, GENE DEV, V14, P1837; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Provost E, 1999, CURR OPIN CELL BIOL, V11, P567, DOI 10.1016/S0955-0674(99)00015-0; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Rehberger S, 1997, EXP CELL RES, V233, P363, DOI 10.1006/excr.1997.3562; Reichert M, 2000, J BIOL CHEM, V275, P9492, DOI 10.1074/jbc.275.13.9492; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7; Sakanaka C, 1998, P NATL ACAD SCI USA, V95, P3020, DOI 10.1073/pnas.95.6.3020; SAMUELS ML, 1993, MOL CELL BIOL, V13, P6241, DOI 10.1128/MCB.13.10.6241; Schlaepfer DD, 1998, TRENDS CELL BIOL, V8, P151, DOI 10.1016/S0962-8924(97)01172-0; Schwartz MA, 1997, J CELL BIOL, V139, P575, DOI 10.1083/jcb.139.3.575; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shanmugathasan M, 2000, PATHOL INT, V50, P273, DOI 10.1046/j.1440-1827.2000.01047.x; SHIBAMOTO S, 1994, CELL ADHES COMMUN, V1, P295, DOI 10.3109/15419069409097261; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; SMITH DF, 1993, MOL ENDOCRINOL, V7, P4, DOI 10.1210/me.7.1.4; Sokol SY, 1999, CURR OPIN GENET DEV, V9, P405, DOI 10.1016/S0959-437X(99)80061-6; SOMMERS CL, 1991, CELL GROWTH DIFFER, V2, P365; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; TAKEICHI M, 1988, CELL DIFFER DEV, V25, P91, DOI 10.1016/0922-3371(88)90104-9; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tepass U, 1999, CURR OPIN CELL BIOL, V11, P540, DOI 10.1016/S0955-0674(99)00025-3; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tomlinson A, 1997, DEVELOPMENT, V124, P4515; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; WENG ZG, 1994, MOL CELL BIOL, V14, P4509, DOI 10.1128/MCB.14.7.4509; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wu CY, 1998, J BIOL CHEM, V273, P528, DOI 10.1074/jbc.273.1.528; Xu LF, 2000, GENE DEV, V14, P585; Yokoya F, 1999, MOL BIOL CELL, V10, P1119, DOI 10.1091/mbc.10.4.1119; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700	123	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					18677	18686		10.1074/jbc.M105331200	http://dx.doi.org/10.1074/jbc.M105331200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11904289	hybrid			2022-12-27	WOS:000175975800059
J	Montaville, P; Neumann, JM; Russo-Marie, F; Ochsenbein, F; Sanson, A				Montaville, P; Neumann, JM; Russo-Marie, F; Ochsenbein, F; Sanson, A			A new consensus sequence for phosphatidylserine recognition by annexins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; HETERONUCLEAR NMR; MEMBRANE-BINDING; CALCIUM; PROTEIN; AGGREGATION; MECHANISM; DOMAINS; CELLS; IV	Annexins are abundant and ubiquitous proteins that bind, by their four structurally identical domain cores, to phosphatidylserine-containing membranes in the presence of Ca2+. Using molecular simulation and mutagenesis, we have identified a new phosphatidylserine-binding site in annexin V domain 1 and established its structure. The residues involved in this site constitute a consensus sequence highly conserved in all annexins. Remarkably, this consensus sequence is exclusively found in domains 1 or 2, sometimes in both, but never in domains 3 and 4. Such a pattern actually delineates three classes of annexins, shedding new light on the role played by the four-domain core of annexins that could encode specific information discriminating the different annexins that compete within a given cell for membrane binding. Our findings thus provide new strategies for understanding the regulation of the cellular functions of annexins.	CEA Saclay, Dept Biol Joliot Curie, Serv Biophys Fonct Membrainaires, F-91191 Gif Sur Yvette, France; URA CNRS 2096, F-91191 Gif Sur Yvette, France; Inst Cochin Genet Mol, Unite INSERM U332, F-75014 Paris, France; Univ Paris 06, F-75005 Paris, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite	Sanson, A (corresponding author), CEA Saclay, Dept Biol Joliot Curie, Serv Biophys Fonct Membrainaires, F-91191 Gif Sur Yvette, France.			montaville, Pierre/0000-0002-9931-3482				Avila-Sakar AJ, 1998, BBA-PROTEIN STRUCT M, V1387, P103, DOI 10.1016/S0167-4838(98)00111-3; Benz J, 1996, J MOL BIOL, V260, P638, DOI 10.1006/jmbi.1996.0426; Bitto E, 1998, BIOCHEMISTRY-US, V37, P10231, DOI 10.1021/bi980479w; CONCHA NO, 1993, SCIENCE, V261, P1321, DOI 10.1126/science.8362244; CREUTZ CE, 1978, J BIOL CHEM, V253, P2858; Denisov G, 1998, BIOPHYS J, V74, P731, DOI 10.1016/S0006-3495(98)73998-0; Dubois T, 1998, BIOCHEM J, V330, P1277, DOI 10.1042/bj3301277; DUBOIS T, 1995, BIOCHEM J, V310, P243, DOI 10.1042/bj3100243; FADOK VA, 1992, J IMMUNOL, V148, P2207; FavierPerron B, 1996, BIOCHEMISTRY-US, V35, P1740, DOI 10.1021/bi952092o; Gerke V, 1997, BBA-MOL CELL RES, V1357, P129, DOI 10.1016/S0167-4889(97)00038-4; GILMANSHIN R, 1994, BIOCHEMISTRY-US, V33, P8225, DOI 10.1021/bi00193a008; Hajjar KA, 1996, J BIOL CHEM, V271, P21652, DOI 10.1074/jbc.271.35.21652; HAKA AJ, 1985, J MAGN RESON, V64, P547; HUBER R, 1990, EMBO J, V9, P3867, DOI 10.1002/j.1460-2075.1990.tb07605.x; JUNKER M, 1993, BIOCHEMISTRY-US, V32, P9968, DOI 10.1021/bi00089a012; LEWITBENTLEY A, 1992, EUR J BIOCHEM, V210, P73, DOI 10.1111/j.1432-1033.1992.tb17392.x; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066; Mira JP, 1997, J BIOL CHEM, V272, P10474; Morgan RO, 1999, GENE, V227, P33, DOI 10.1016/S0378-1119(98)00597-6; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; MOSER C, 1991, J MOL BIOL, V217, P241; Moss S. E, 1992, ANNEXINS; Murray D, 1999, BIOPHYS J, V77, P3176, DOI 10.1016/S0006-3495(99)77148-1; NELSON MR, 1995, BIOCHEMISTRY-US, V34, P3121, DOI 10.1021/bi00009a044; NEUMANN JM, 1994, EUR J BIOCHEM, V225, P819, DOI 10.1111/j.1432-1033.1994.0819b.x; Oling F, 2000, J MOL BIOL, V304, P561, DOI 10.1006/jmbi.2000.4183; OUDINET JP, 1993, BIOCHEM J, V292, P63, DOI 10.1042/bj2920063; PALMER AG, 1991, J AM CHEM SOC, V113, P4371, DOI 10.1021/ja00012a001; PIGAULT C, 1994, J MOL BIOL, V236, P199, DOI 10.1006/jmbi.1994.1129; Pons JL, 1996, J BIOMOL NMR, V8, P445, DOI 10.1007/BF00228146; Rosengarth A, 2001, J MOL BIOL, V306, P489, DOI 10.1006/jmbi.2000.4423; ROUH A, 1993, J MAGN RESON SER A, V102, P357, DOI 10.1006/jmra.1993.1117; Seaton B. A., 1996, ANNEXINS MOL STRUCTU; SOPKOVA J, 1993, J MOL BIOL, V234, P816, DOI 10.1006/jmbi.1993.1627; SWAIRJO MA, 1995, NAT STRUCT BIOL, V2, P968, DOI 10.1038/nsb1195-968; TAIT JF, 1988, BIOCHEMISTRY-US, V27, P62; VERMES IC, 1995, J IMMUNOL METHODS, V180, P38; Vetterling W.T., 1988, NUMERICAL RECIPES C; WENG XW, 1993, PROTEIN SCI, V2, P448; Zanotti G, 1998, BIOCHEM J, V329, P101, DOI 10.1042/bj3290101; ZWAAL RFA, 1977, NATURE, V268, P358, DOI 10.1038/268358a0	43	56	59	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 5	2002	277	27					24684	24693		10.1074/jbc.M109595200	http://dx.doi.org/10.1074/jbc.M109595200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	569PV	11948176	hybrid			2022-12-27	WOS:000176611800094
J	Kim, HU; Hsieh, K; Ratnayake, C; Huang, AHC				Kim, HU; Hsieh, K; Ratnayake, C; Huang, AHC			A novel group of oleosins is present inside the pollen of Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEED OIL BODIES; GLYCINE-RICH PROTEINS; BRASSICA-NAPUS; LIPID BODIES; NUCLEOTIDE-SEQUENCE; THALIANA; GENES; TAPETUM; EXPRESSION; COAT	In plants, subcellular triacylglycerol granules in seeds (oil bodies) and floral tapetum (tapetosomes) are stabilized by amphipathic structural protein called oleosin. We hereby report a novel group of oleosins that is present inside the pollen of Arabidopsis thaliana. We have used the conserved sequence of oleosins to locate, via the DNA database, all 16 oleosin genes in the Arabidopsis genome. The oleosin genes can be divided into three groups according to their sequences and tissue-specific expressions, as probed by RNA blot hybridization and reverse transcriptase-PCR. The first group includes eight genes specifically expressed in the floret tapetum. The second group includes five genes specifically expressed in maturing seeds. The third, novel group includes three genes expressed in both maturing seeds and floral microspores, which will become pollen. Transgenic study using the promoter of one of these genes attached to a reporter gene has provided corroborative evidence for the specific expression of the gene in the microspores in the florets. One of the pollen oleosins can be identified by microsequencing and specific immunoblotting. Pollen oleosins synthesized by recombinant bacteria can collaborate with phospholipids in stabilizing reconstituted oil bodies. Thus, pollen has oleosins to stabilize the abundant subcellular oil bodies. Seed oil bodies and floret tapetosomes have been isolated from the miniature Arabidopsis plants, and the success indicates that the organelles can be subjected to future biochemical and genetic studies.	Univ Calif Riverside, Dept Bot & Plant Sci, Ctr Plant Cell Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Huang, AHC (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Ctr Plant Cell Biol, Riverside, CA 92521 USA.	Anthony.Huang@ucr.edu	KIM, HYUN UK/AAJ-1055-2021	KIM, HYUN UK/0000-0002-4566-3057				Bowman J., 1994, ARABIDOPSIS ATLAS MO, V102, P117; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Davis R.A., 1996, BIOCH LIPIDS LIPOPRO, P473; DEOLIVEIRA DE, 1990, PLANT CELL, V2, P427, DOI 10.1105/tpc.2.5.427; DEOLIVEIRA DE, 1993, PLANT J, V3, P495, DOI 10.1046/j.1365-313X.1993.03040495.x; DERUERE J, 1994, PLANT CELL, V6, P119, DOI 10.1105/tpc.6.1.119; Hanley SZ, 1999, FEBS LETT, V447, P99, DOI 10.1016/S0014-5793(99)00235-5; Heid HW, 1996, BIOCHEM J, V320, P1025, DOI 10.1042/bj3201025; HUANG AHC, 1992, ANNU REV PLANT PHYS, V43, P177, DOI 10.1146/annurev.pp.43.060192.001141; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kim HU, 2001, PLANT PHYSIOL, V126, P330, DOI 10.1104/pp.126.1.330; Kirik V, 1996, PLANT MOL BIOL, V31, P413, DOI 10.1007/BF00021803; Leber R, 1998, MOL BIOL CELL, V9, P375, DOI 10.1091/mbc.9.2.375; LEE K, 1991, PLANT PHYSIOL, V96, P1395, DOI 10.1104/pp.96.4.1395; LEE KY, 1994, PLANT MOL BIOL, V26, P1981, DOI 10.1007/BF00019508; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Mather IH, 1998, J MAMMARY GLAND BIOL, V3, P259, DOI 10.1023/A:1018711410270; Mayfield JA, 2000, NAT CELL BIOL, V2, P128, DOI 10.1038/35000084; Mayfield JA, 2001, SCIENCE, V292, P2482, DOI 10.1126/science.1060972; McDowell JM, 1996, GENETICS, V142, P587; MURPHY DJ, 1993, PROG LIPID RES, V32, P247, DOI 10.1016/0163-7827(93)90009-L; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Narayanaswami V, 2000, BBA-MOL CELL BIOL L, V1483, P15, DOI 10.1016/S1388-1981(99)00176-6; ROBERT LS, 1994, PLANT J, V6, P927, DOI 10.1046/j.1365-313X.1994.6060927.x; Ross JHE, 1996, PLANT J, V9, P625, DOI 10.1046/j.1365-313X.1996.9050625.x; Ruiter RK, 1997, PLANT CELL, V9, P1621, DOI 10.1105/tpc.9.9.1621; Sambrook J., 2002, MOL CLONING LAB MANU; SCOTT R, 1991, PLANT MOL BIOL, V17, P195, DOI 10.1007/BF00039494; STAIGER D, 1994, PLANTA, V192, P221, DOI 10.1007/BF01089038; STANLEY RG, 1974, POLLEN; Ting JTL, 1997, J BIOL CHEM, V272, P3699, DOI 10.1074/jbc.272.6.3699; Ting JTL, 1998, PLANT J, V16, P541, DOI 10.1046/j.1365-313x.1998.00325.x; TZEN JTC, 1993, PLANT PHYSIOL, V101, P267, DOI 10.1104/pp.101.1.267; TZEN JTC, 1992, J CELL BIOL, V117, P327, DOI 10.1083/jcb.117.2.327; VANCE VB, 1987, J BIOL CHEM, V262, P11275; VANROOIJEN GJH, 1992, PLANT MOL BIOL, V18, P1177, DOI 10.1007/BF00047721; Wang TW, 1997, PLANT J, V11, P475, DOI 10.1046/j.1365-313X.1997.11030475.x; Wu SSH, 1997, P NATL ACAD SCI USA, V94, P12711, DOI 10.1073/pnas.94.23.12711; ZOU JT, 1995, PLANT PHYSIOL, V108, P563, DOI 10.1104/pp.108.2.563	40	125	135	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22677	22684		10.1074/jbc.M109298200	http://dx.doi.org/10.1074/jbc.M109298200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11929861	hybrid			2022-12-27	WOS:000176313600075
J	Tachibana, T; Astumi, S; Shioda, R; Ueno, M; Uritani, M; Ushimaru, T				Tachibana, T; Astumi, S; Shioda, R; Ueno, M; Uritani, M; Ushimaru, T			A novel non-conventional heat shock element regulates expression of MDJ1 encoding a DnaJ homolog in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST METALLOTHIONEIN GENE; TRANSCRIPTION FACTOR CONTAINS; PROTEIN-KINASE-C; STRESS-RESPONSE; IN-VIVO; COOPERATIVE BINDING; OXIDATIVE STRESS; LEUCINE ZIPPER; ACTIVATION; DROSOPHILA	The heat shock factor (HSF) is a pivotal transcriptional factor that regulates the expression of genes encoding heat shock proteins (HSPs) via heat shock elements (HSEs). nGAAnnTTCnnGAAn functions as the minimum consensus HSE (cHSE) in vivo. Here we show that the expression of Saccharomyces cerevisiae MDJ1 encoding a mitochondrial DnaJ homolog is regulated by HSF,via a novel non-consensus HSE (ncHSE(MDJ1)), which consists of three separated pentameric nGAAn motifs, nTTCn-(11 bp)-nGAAn-(5 bp)-nGAAn. This is the first evidence to show that the immediate contact of nGAAn motifs is dispensable for regulation by HSF in vivo. ncH-SEMDJ1 confers different heat shock responses versus cHSE and, unlike cHSE, definitively requires a carboxyl-terminal activation domain of HSF in the expression. ncHSE(MDJ1)-like elements are found in promoter regions of some other DnaJ-related genes. The highly conserved HSF/HSE system suggests that similar ncHSEs may be used for the expression of HSP genes in other eukaryotes including humans.	Shizuoka Univ, Fac Sci, Dept Biol & Geosci, Shizuoka 4228529, Japan; Shizuoka Univ, Fac Sci, Dept Chem, Shizuoka 4228529, Japan	Shizuoka University; Shizuoka University	Ushimaru, T (corresponding author), Shizuoka Univ, Fac Sci, Dept Biol & Geosci, Shizuoka 4228529, Japan.	sbtushi@ipe.shizuoka.ac.jp	Ueno, Masaru/G-3990-2019					AMIN J, 1988, MOL CELL BIOL, V8, P3761, DOI 10.1128/MCB.8.9.3761; ATENCIO DP, 1992, MOL CELL BIOL, V12, P283, DOI 10.1128/MCB.12.1.283; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; BONNER JJ, 1994, MOL CELL BIOL, V14, P501, DOI 10.1128/MCB.14.1.501; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Brachmann CB, 1998, YEAST, V14, P115; CLOS J, 1990, CELL, V63, P1085, DOI 10.1016/0092-8674(90)90511-C; CRAIG EA, 1993, MICROBIOL REV, V57, P402, DOI 10.1128/MMBR.57.2.402-414.1993; CRAIG EA, 1991, TRENDS BIOCHEM SCI, V16, P135, DOI 10.1016/0968-0004(91)90055-Z; Dsouza M, 1997, TRENDS GENET, V13, P497, DOI 10.1016/S0168-9525(97)01347-4; ERKINE AM, 1995, NUCLEIC ACIDS RES, V23, P1822, DOI 10.1093/nar/23.10.1822; Erkine AM, 1999, MOL CELL BIOL, V19, P1627; FERNANDES M, 1994, NUCLEIC ACIDS RES, V22, P167, DOI 10.1093/nar/22.2.167; FIORENZA MT, 1995, NUCLEIC ACIDS RES, V23, P467, DOI 10.1093/nar/23.3.467; FLICK KE, 1994, J BIOL CHEM, V269, P12475; GALLO GJ, 1993, MOL CELL BIOL, V13, P749, DOI 10.1128/MCB.13.2.749; GIARDINA C, 1995, MOL CELL BIOL, V15, P2737; GROSS DS, 1990, J MOL BIOL, V216, P611, DOI 10.1016/0022-2836(90)90387-2; GROSS DS, 1993, EMBO J, V12, P3931, DOI 10.1002/j.1460-2075.1993.tb06071.x; HARRISON CJ, 1994, SCIENCE, V263, P224, DOI 10.1126/science.8284672; HOHFELD J, 1994, J CELL BIOL, V126, P305, DOI 10.1083/jcb.126.2.305; JAKOBSEN BK, 1991, EMBO J, V10, P369, DOI 10.1002/j.1460-2075.1991.tb07958.x; JAKOBSEN BK, 1988, MOL CELL BIOL, V8, P5040, DOI 10.1128/MCB.8.11.5040; Jedlicka P, 1997, EMBO J, V16, P2452, DOI 10.1093/emboj/16.9.2452; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; KAWAKAMI K, 1992, GENETICS, V131, P821; Kim R, 2001, J BIOL CHEM, V276, P17524, DOI 10.1074/jbc.M010695200; KINGSTON RE, 1987, MOL CELL BIOL, V7, P1530, DOI 10.1128/MCB.7.4.1530; KROEGER PE, 1994, MOL CELL BIOL, V14, P7592, DOI 10.1128/MCB.14.11.7592; LALORAYA S, 1994, P NATL ACAD SCI USA, V91, P6481, DOI 10.1073/pnas.91.14.6481; LANGER T, 1995, BIOL HEAT SHOCK PROT, P53; Lin JT, 1999, MOL CELL BIOL, V19, P3237; Liu HD, 1996, GENE DEV, V10, P592; Liu XD, 1997, EMBO J, V16, P6466, DOI 10.1093/emboj/16.21.6466; Lutz T, 2001, J MOL BIOL, V307, P815, DOI 10.1006/jmbi.2001.4527; MAGER WH, 1993, BIOCHEM J, V290, P1; Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445; MORI K, 1993, CELL, V74, P743; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; MORISHIMA N, 1990, J BIOL CHEM, V265, P15189; Moskvina E, 1998, YEAST, V14, P1041, DOI 10.1002/(SICI)1097-0061(199808)14:11<1041::AID-YEA296>3.0.CO;2-4; Nakai A, 1997, MOL CELL BIOL, V17, P469, DOI 10.1128/MCB.17.1.469; NIETOSOTELO J, 1990, CELL, V62, P807, DOI 10.1016/0092-8674(90)90124-W; PERISIC O, 1989, CELL, V59, P797, DOI 10.1016/0092-8674(89)90603-X; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; RABINDRAN SK, 1993, SCIENCE, V259, P230, DOI 10.1126/science.8421783; Raitt DC, 2000, MOL BIOL CELL, V11, P2335, DOI 10.1091/mbc.11.7.2335; Rallu M, 1997, P NATL ACAD SCI USA, V94, P2392, DOI 10.1073/pnas.94.6.2392; ROWLEY N, 1994, CELL, V77, P249, DOI 10.1016/0092-8674(94)90317-4; Santoro N, 1998, MOL CELL BIOL, V18, P6340, DOI 10.1128/MCB.18.11.6340; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; SARGE KD, 1994, BIOL REPROD, V50, P1334, DOI 10.1095/biolreprod50.6.1334; SEWELL AK, 1995, J BIOL CHEM, V270, P25079, DOI 10.1074/jbc.270.42.25079; Siderius M, 1997, MICROBIOL-SGM, V143, P3241, DOI 10.1099/00221287-143-10-3241; SILAR P, 1991, MOL CELL BIOL, V11, P1232, DOI 10.1128/MCB.11.3.1232; SISTONEN L, 1992, MOL CELL BIOL, V12, P4104, DOI 10.1128/MCB.12.9.4104; SLATER MR, 1987, MOL CELL BIOL, V7, P1906, DOI 10.1128/MCB.7.5.1906; SORGER PK, 1990, CELL, V62, P793, DOI 10.1016/0092-8674(90)90123-V; SORGER PK, 1987, NATURE, V329, P81, DOI 10.1038/329081a0; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Strain J, 1998, J BIOL CHEM, V273, P31138, DOI 10.1074/jbc.273.47.31138; STUART JS, 1994, MOL CELL BIOL, V14, P896, DOI 10.1128/MCB.14.2.896; TAMAI KT, 1994, MOL CELL BIOL, V14, P8155, DOI 10.1128/MCB.14.12.8155; Tanabe M, 1997, J BIOL CHEM, V272, P15389, DOI 10.1074/jbc.272.24.15389; Treger JM, 1998, J BIOL CHEM, V273, P26875, DOI 10.1074/jbc.273.41.26875; Voisine C, 2001, P NATL ACAD SCI USA, V98, P1483, DOI 10.1073/pnas.98.4.1483; WATANABE Y, 1995, MOL CELL BIOL, V15, P5740; WESTERMANN B, 1995, EMBO J, V14, P3452, DOI 10.1002/j.1460-2075.1995.tb07351.x; Westermann B, 1996, MOL CELL BIOL, V16, P7063; WIEDERRECHT G, 1988, CELL, V54, P841, DOI 10.1016/S0092-8674(88)91197-X; WU C, 1984, NATURE, V309, P229, DOI 10.1038/309229a0; Xia WL, 1997, J BIOL CHEM, V272, P4094, DOI 10.1074/jbc.272.7.4094; XIAO H, 1991, CELL, V64, P585, DOI 10.1016/0092-8674(91)90242-Q; YASHAR B, 1995, MOL CELL BIOL, V15, P6545; YOUNG MR, 1993, MOL CELL BIOL, V13, P5637, DOI 10.1128/MCB.13.9.5637; Zhao C, 1998, MOL CELL BIOL, V18, P1013, DOI 10.1128/MCB.18.2.1013; Zhong T, 1996, J BIOL CHEM, V271, P1349, DOI 10.1074/jbc.271.3.1349; ZIMARINO V, 1987, NATURE, V327, P727, DOI 10.1038/327727a0	80	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22140	22146		10.1074/jbc.M201267200	http://dx.doi.org/10.1074/jbc.M201267200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11940587	hybrid			2022-12-27	WOS:000176313600007
J	Taoka, S; Banerjee, R				Taoka, S; Banerjee, R			Stopped-flow kinetic analysis of the reaction catalyzed by the full-length yeast cystathionine beta-synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ACETYLSERINE SULFHYDRYLASE; HEME PROTEIN; PYRIDOXAL 5'-PHOSPHATE; HUMAN ENZYME; HOMOCYSTEINE; HOMOCYSTINURIA; MECHANISM; DISEASE	Cystathionine beta-synthase found in yeast catalyzes a pyridoxal phosphate-dependent condensation of homocysteine and serine to form cystathionine. Unlike the homologous mammalian enzymes, yeast cystathionine beta-synthase lacks a second cofactor, heme, which facilitates detailed kinetic studies of the enzyme because the different pyridoxal phosphate-bound intermediates can be followed by their characteristic absorption spectra. We conducted a rapid reaction kinetic analysis of the full-length yeast enzyme in the forward and reverse directions. In the forward direction, we observed formation of the external aldimine of serine (14 mM(-1) s(-1)) and the aminoacrylate intermediate (15 s(-1)). Homocysteine binds to the aminoacrylate with a bimolecular rate constant of 35 mm(-1) s(-1) and rapidly converts to cystathionine (180 s(-1)), leading to the accumulation of a 420 nm absorbing species, which has been assigned as the external aldimine of cystathionine. Release of cystathionine is slow (k = 2.3 s(-1)), which is similar to k(cat) (1.7 s(-1)) at 15 degreesC, consistent with this being a rate-determining step. In the reverse direction, cystathionine binds to the enzyme with a bimolecular rate constant of 1.5 nM(-1) s(-1) and is rapidly converted to the aminoacrylate without accumulation of the external aldimine. The kinetic behavior of the full-length enzyme shows notable differences from that reported for a truncated form of the enzyme lacking the C-terminal third of the protein.	Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Banerjee, R (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL58984] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALEXANDER FW, 1994, EUR J BIOCHEM, V219, P953, DOI 10.1111/j.1432-1033.1994.tb18577.x; BORCSOK E, 1982, ARCH BIOCHEM BIOPHYS, V213, P695, DOI 10.1016/0003-9861(82)90600-2; Burkhard P, 1998, J MOL BIOL, V283, P121, DOI 10.1006/jmbi.1998.2037; Clarke R, 1998, ARCH NEUROL-CHICAGO, V55, P1449, DOI 10.1001/archneur.55.11.1449; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FINKELSTEIN JD, 1975, BIOCHEM BIOPH RES CO, V66, P81, DOI 10.1016/S0006-291X(75)80297-X; Gallagher DT, 1998, STRUCTURE, V6, P465, DOI 10.1016/S0969-2126(98)00048-3; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; Jhee KH, 2001, BIOCHEMISTRY-US, V40, P10873, DOI 10.1021/bi011087j; Jhee KH, 2000, J BIOL CHEM, V275, P11541, DOI 10.1074/jbc.C000056200; Jhee KH, 2000, BIOCHEMISTRY-US, V39, P10548, DOI 10.1021/bi001020g; Kabil O, 2001, J BIOL CHEM, V276, P19350, DOI 10.1074/jbc.M100029200; KERY V, 1994, J BIOL CHEM, V269, P25283; Kraus JP, 1999, HUM MUTAT, V13, P362; Meier M, 2001, EMBO J, V20, P3910, DOI 10.1093/emboj/20.15.3910; MILLS JL, 1995, LANCET, V345, P149, DOI 10.1016/S0140-6736(95)90165-5; MUDD SH, 1985, AM J HUM GENET, V37, P1; Ojha S, 2002, BIOCHEMISTRY-US, V41, P4649, DOI 10.1021/bi011827o; Ojha S, 2000, BIOCHEMISTRY-US, V39, P10542, DOI 10.1021/bi000831h; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Tai CH, 2001, ACCOUNTS CHEM RES, V34, P49, DOI 10.1021/ar990169l; Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179; Taoka S, 2001, J INORG BIOCHEM, V87, P253, DOI 10.1016/S0162-0134(01)00336-1; Taoka S, 1999, BIOCHEMISTRY-US, V38, P13155, DOI 10.1021/bi990865t; Taoka S, 2001, J INORG BIOCHEM, V87, P245, DOI 10.1016/S0162-0134(01)00335-X	25	27	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22421	22425		10.1074/jbc.M202513200	http://dx.doi.org/10.1074/jbc.M202513200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11948191	hybrid			2022-12-27	WOS:000176313600041
J	Woodcock, EA; Wang, BH; Arthur, JF; Lennard, A; Matkovich, SJ; Du, XJ; Brown, JH; Hannan, RD				Woodcock, EA; Wang, BH; Arthur, JF; Lennard, A; Matkovich, SJ; Du, XJ; Brown, JH; Hannan, RD			Inositol polyphosphate 1-phosphatase is a novel antihypertrophic factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL DNA-TRANSCRIPTION; ACTIVE ALPHA(1B)-ADRENERGIC RECEPTORS; RAT NEONATAL CARDIOMYOCYTES; PROTEIN-KINASE-C; CARDIAC-HYPERTROPHY; VENTRICULAR MYOCYTES; PHOSPHATE RELEASE; PHOSPHOLIPASE-C; MYOCARDIAL HYPERTROPHY; RDNA TRANSCRIPTION	Activation of G(q)-coupled alpha(1)-adrenergic receptors leads to hypertrophic growth of neonatal rat ventricular cardiomyoeytes that is associated with increased expression of hypertrophy-related genes, including atrial natriuretic peptide (ANP) and myosin light chain-2 (MLC), as well as increased ribosome synthesis. The role of inositol phosphates in signaling pathways involved in these changes in gene expression was examined by overexpressing inositol phosphate-metabolizing enzymes and determining effects on ANP, MLC, and 45 S ribosomal gene expression following co-transfection of appropriate reporter gene constructs. Overexpression of enzymes that metabolize inositol 1,4,5-trisphosphate did not reduce ANP or MLC responses, but overexpression of the enzyme primarily responsible for metabolism of inositol 4,5-bisphosphate (Ins(1,4)P-2), inositol polyphosphate 1-phosphatase (INPP), reduced ANP and MLC responses associated with alpha(1)-adrenergic receptor-mediated hypertrophy. Similarly overexpressed INPP reduced ANP and MLC responses associated with contraction-induced hypertrophy. In addition, overexpression of MPP reduced the increase in ribosomal DNA transcription associated with both hypertrophic models. Hypertrophied cells from both cell models as well as ventricular tissue from mouse hearts hypertrophied by pressure overload in vivo contained heightened levels of Ins(1,4)P-2, suggesting reduced INPP activity in three different models of hypertrophy. These studies provide evidence for an involvement of Ins(1,4)P-2 in hypertrophic signaling pathways in ventricular myocytes.	Baker Med Res Inst, Gene Transcript Lab, Melbourne, Vic 8008, Australia; Baker Med Res Inst, Cellular Biochem Lab, Melbourne, Vic 8008, Australia; Baker Med Res Inst, Expt Cardiol Lab, Melbourne, Vic 8008, Australia; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92037 USA	Baker Heart and Diabetes Institute; Baker Heart and Diabetes Institute; Baker Heart and Diabetes Institute; University of California System; University of California San Diego	Woodcock, EA (corresponding author), Baker Med Res Inst, Gene Transcript Lab, POB 6492,St Kilda Rd Cent, Melbourne, Vic 8008, Australia.	liz.woodcock@baker.edu.au	Matkovich, Scot J/B-9077-2009; ARTHUR, JANE/AAW-9983-2020; Matkovich, Scot J/AFP-0908-2022	Matkovich, Scot J/0000-0002-7398-6857; Matkovich, Scot J/0000-0002-7398-6857; Hannan, Ross/0000-0002-2166-4493				Adams JW, 1998, CIRC RES, V83, P167, DOI 10.1161/01.RES.83.2.167; Akhter SA, 1998, SCIENCE, V280, P574, DOI 10.1126/science.280.5363.574; ANDERSON KE, 1995, CIRC RES, V76, P261, DOI 10.1161/01.RES.76.2.261; Arthur JF, 2001, J BIOL CHEM, V276, P37341, DOI 10.1074/jbc.M106572200; Autelitano DJ, 1998, J MOL CELL CARDIOL, V30, P1515, DOI 10.1006/jmcc.1998.0717; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BERRIDGE MJ, 1988, COLD SPRING HARB SYM, V53, P927, DOI 10.1101/SQB.1988.053.01.107; Bogoyevitch MA, 1996, INT J BIOCHEM CELL B, V28, P1, DOI 10.1016/1357-2725(95)00142-5; Brandenburger Y, 2001, FASEB J, V15, P2051, DOI 10.1096/fj.00-0853fje; Dorn GW, 1999, TRENDS CARDIOVAS MED, V9, P26, DOI 10.1016/S1050-1738(99)00004-3; DU XJ, 1995, CIRCULATION, V91, P2712, DOI 10.1161/01.CIR.91.11.2712; Hanakahi LA, 2000, CELL, V102, P721, DOI 10.1016/S0092-8674(00)00061-1; Hannan R, 1999, NUCLEIC ACIDS RES, V27, P1205, DOI 10.1093/nar/27.4.1205; HANNAN RD, 1995, J BIOL CHEM, V270, P8290, DOI 10.1074/jbc.270.14.8290; Hannan RD, 1996, J BIOL CHEM, V271, P3213, DOI 10.1074/jbc.271.6.3213; Hannan RD, 1996, P NATL ACAD SCI USA, V93, P8750, DOI 10.1073/pnas.93.16.8750; Harrison SN, 1998, CIRC RES, V83, P1232, DOI 10.1161/01.RES.83.12.1232; Ho MWY, 1997, AM J PHYSIOL-CELL PH, V272, pC1160, DOI 10.1152/ajpcell.1997.272.4.C1160; Homcy CJ, 1998, CIRCULATION, V97, P1890, DOI 10.1161/01.CIR.97.19.1890; INHORN RC, 1987, P NATL ACAD SCI USA, V84, P2170, DOI 10.1073/pnas.84.8.2170; Jacobsen AN, 1996, CIRCULATION, V93, P23, DOI 10.1161/01.CIR.93.1.23; Kent RL, 1996, CIRC RES, V78, P829, DOI 10.1161/01.RES.78.5.829; KENTISH JC, 1990, AM J PHYSIOL, V258, pH610, DOI 10.1152/ajpheart.1990.258.2.H610; LAXMINARAYAN KM, 1994, J BIOL CHEM, V269, P17305; Lin G, 2001, CIRC RES, V89, P343, DOI 10.1161/hh1601.095912; Lipp P, 2000, CURR BIOL, V10, P939, DOI 10.1016/S0960-9822(00)00624-2; Lorell BH, 1997, CIRCULATION, V96, P3824; Matkovich SJ, 2000, J BIOL CHEM, V275, P10845, DOI 10.1074/jbc.275.15.10845; McKinsey TA, 1999, CURR OPIN GENET DEV, V9, P267, DOI 10.1016/S0959-437X(99)80040-9; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Molkentin JD, 2000, CIRC RES, V87, P731, DOI 10.1161/01.RES.87.9.731; Morissette MR, 2000, AM J PHYSIOL-HEART C, V278, pH1769, DOI 10.1152/ajpheart.2000.278.6.H1769; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Shears SB, 2000, BIOESSAYS, V22, P786, DOI 10.1002/1521-1878(200009)22:9<786::AID-BIES3>3.3.CO;2-S; SHUBEITA HE, 1992, P NATL ACAD SCI USA, V89, P1305, DOI 10.1073/pnas.89.4.1305; SHUBEITA HE, 1990, J BIOL CHEM, V265, P20555; SKINNER MP, 1991, J BIOL CHEM, V266, P5371; SYLVIA V, 1988, CELL, V54, P651, DOI 10.1016/S0092-8674(88)80009-6; TREJO J, 1992, MOL CELL BIOL, V12, P4742, DOI 10.1128/MCB.12.10.4742; Venkatakrishnan G, 1996, J BIOL CHEM, V271, P5066; Wang BH, 2000, AM J PHYSIOL-HEART C, V279, pH1079, DOI 10.1152/ajpheart.2000.279.3.H1079; WOODCOCK EA, 1995, J MOL CELL CARDIOL, V27, P867, DOI 10.1016/0022-2828(95)90036-5; Woodcock EA, 1997, J MOL CELL CARDIOL, V29, P449, DOI 10.1006/jmcc.1996.0287; Woodcock EA, 1998, CARDIOVASC RES, V40, P251, DOI 10.1016/S0008-6363(98)00187-4; WOODCOCK EA, 1995, CIRC RES, V76, P252, DOI 10.1161/01.RES.76.2.252; Wu GY, 2000, J BIOL CHEM, V275, P29927, DOI 10.1074/jbc.C000380200; YORK JD, 1994, J BIOL CHEM, V269, P19992; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; YORK JD, 1993, P NATL ACAD SCI USA, V90, P5833, DOI 10.1073/pnas.90.12.5833	50	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22734	22742		10.1074/jbc.M110405200	http://dx.doi.org/10.1074/jbc.M110405200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11932254	hybrid			2022-12-27	WOS:000176313600082
J	Fabbro, M; Rodriguez, JA; Baer, R; Henderson, BR				Fabbro, M; Rodriguez, JA; Baer, R; Henderson, BR			BARD1 induces BRCA1 intranuclear foci formation by increasing RING-dependent BRCA1 nuclear import and inhibiting BRCA1 nuclear export	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; RNA-POLYMERASE-II; INTERACT IN-VIVO; SUBCELLULAR-LOCALIZATION; CELL-CYCLE; TRANSCRIPTIONAL ACTIVATION; BREAST; PROTEIN; GENE; ASSOCIATION	BRCA1 is a tumor suppressor with several important nuclear functions. BRCA1 has no known cytoplasmic functions. We show here that the two previously identified nuclear localization signals (NLSs) are insufficient for nuclear localization of BRCA1 due to the opposing action of an N-H-2-terminal nuclear export signal. In transfected breast cancer cells, BRCA1 nuclear localization requires both the NLSs and NH2-terminal RING domain region; mutating either of these sequences shifts BRCA1 to the cytoplasm. The BRCA1 RING element mediates nuclear import via association with BARDI, and this is not affected by cancer-associated RING mutations. Moreover, BARDI directly masks the BRCA1 nuclear export signal, and the resulting block to nuclear export is requisite for efficient import and nuclear localization of ectopic and endogenous BRCA1. Our results explain why BRCA1 exon 11 splice variants, which lack the NLSs but retain the RING domain, are frequently detected in the nucleus and in nuclear foci in vivo. In fact, co-expression of BARD1 promoted formation of DNA damage-induced nuclear foci comprising ectopic wild-type or NLS-deficient BRCA1, implicating BARD1 in nuclear targeting of BRCA1 for DNA repair. Our identification of BARD1 as a BRCA1 nuclear chaperone has regulatory implications for its reported effects on BRCA1 protein stability, ubiquitin ligase activity, and DNA repair.	Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Westmead Inst Canc Res, Westmead, NSW 2145, Australia; Columbia Univ Coll Phys & Surg, Dept Pathol, Inst Canc Genet, New York, NY 10032 USA	University of Sydney; Westmead Institute for Medical Research; Columbia University	Henderson, BR (corresponding author), Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Westmead Inst Canc Res, Darcy Rd,POB 412, Westmead, NSW 2145, Australia.	beric_henderson@wmi.usyd.edu.au	Rodriguez, Jose Antonio/AAA-1125-2019	Rodriguez, Jose Antonio/0000-0002-2823-3733				Aprelikova ON, 1999, P NATL ACAD SCI USA, V96, P11866, DOI 10.1073/pnas.96.21.11866; Baer R, 2002, CURR OPIN GENET DEV, V12, P86, DOI 10.1016/S0959-437X(01)00269-6; Berthelsen J, 1999, GENE DEV, V13, P946, DOI 10.1101/gad.13.8.946; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Chai YL, 1999, ONCOGENE, V18, P263, DOI 10.1038/sj.onc.1202323; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Chen CF, 1996, J BIOL CHEM, V271, P32863, DOI 10.1074/jbc.271.51.32863; CHEN YM, 1995, SCIENCE, V270, P789, DOI 10.1126/science.270.5237.789; Chiba N, 2001, J BIOL CHEM, V276, P38549, DOI 10.1074/jbc.M105227200; Couch FJ, 1996, HUM MUTAT, V8, P8, DOI 10.1002/humu.1380080102; Fan SJ, 2001, ONCOGENE, V20, P77, DOI 10.1038/sj.onc.1204073; Gowen LC, 1998, SCIENCE, V281, P1009, DOI 10.1126/science.281.5379.1009; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Huber LJ, 2001, MOL CELL BIOL, V21, P4005, DOI 10.1128/MCB.21.12.4005-4015.2001; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Jin Y, 1997, P NATL ACAD SCI USA, V94, P12075, DOI 10.1073/pnas.94.22.12075; Joukov V, 2001, P NATL ACAD SCI USA, V98, P12078, DOI 10.1073/pnas.211427098; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kleiman FE, 1999, SCIENCE, V285, P1576, DOI 10.1126/science.285.5433.1576; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; MacLachlan TK, 2000, J BIOL CHEM, V275, P2777, DOI 10.1074/jbc.275.4.2777; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Meza JE, 1999, J BIOL CHEM, V274, P5659, DOI 10.1074/jbc.274.9.5659; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; Rodriguez JA, 2000, J BIOL CHEM, V275, P38589, DOI 10.1074/jbc.M003851200; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Ruffner H, 1997, P NATL ACAD SCI USA, V94, P7138, DOI 10.1073/pnas.94.14.7138; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Scully R, 1996, SCIENCE, V272, P123, DOI 10.1126/science.272.5258.123; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; Thai TH, 1998, HUM MOL GENET, V7, P195, DOI 10.1093/hmg/7.2.195; Thakur S, 1997, MOL CELL BIOL, V17, P444, DOI 10.1128/MCB.17.1.444; Vaughn JP, 1996, CELL GROWTH DIFFER, V7, P711; Wang Q, 1998, ONCOGENE, V17, P1939, DOI 10.1038/sj.onc.1202403; Welcsh PL, 2000, TRENDS GENET, V16, P69, DOI 10.1016/S0168-9525(99)01930-7; Wilson CA, 1999, NAT GENET, V21, P236, DOI 10.1038/6029; Wilson CA, 1997, ONCOGENE, V14, P1, DOI 10.1038/sj.onc.1200924; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Yarden RI, 1999, P NATL ACAD SCI USA, V96, P4983, DOI 10.1073/pnas.96.9.4983; Yeh SY, 2000, P NATL ACAD SCI USA, V97, P11256, DOI 10.1073/pnas.190353897; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Zhang HB, 1998, ONCOGENE, V16, P1713, DOI 10.1038/sj.onc.1201932; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747; Zhu JY, 1999, NATURE, V398, P256, DOI 10.1038/18473	52	146	153	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21315	21324		10.1074/jbc.M200769200	http://dx.doi.org/10.1074/jbc.M200769200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11925436	hybrid			2022-12-27	WOS:000176286000027
J	Panni, S; Dente, L; Cesareni, G				Panni, S; Dente, L; Cesareni, G			In vitro evolution of recognition specificity mediated by SH3 domains reveals target recognition rules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY; SH3-LIGAND INTERACTIONS; PEPTIDE APTAMERS; ABL-SH3 DOMAIN; PROTEIN; BINDING; SRC; SELECTION; LIBRARIES; DISPLAY	We have designed a repertoire of 10(7) different SH3 domains by grafting the residues that are represented in the binding surfaces of natural SH3 domains onto the scaffold of the human Abl-SH3 domain. This phage-displayed library was screened by affinity selection for SH3 domains that bind to the synthetic peptides, APTYPP-PLPP and LSSRPLPTLPSP, which are peptide ligands for the human Abl or Src SH3 domains, respectively. By characterizing the isolates, we have observed that as few as two or three amino acid substitutions lead to dramatic changes in recognition specificity. We propose that the ability to shift recognition specificity with a small number of amino acid replacements is an important evolutionary characteristic of protein binding modules. Furthermore, we have used the information obtained by these in vitro evolution experiments to generate a scoring matrix that evaluates the probability that any SH3 domain binds to the peptide ligands for the Abl and Src SH3 domains. A table of predictions for the 28 SH3 domains of baker's yeast is presented.	Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy	University of Rome Tor Vergata	Cesareni, G (corresponding author), Univ Roma Tor Vergata, Dept Biol, Via Ric Sci, I-00133 Rome, Italy.	cesareni@uniroma2.it	Cesareni, Gianni/AAW-1382-2020	DENTE, LUCIANA/0000-0002-9617-0922; panni, simona/0000-0002-7500-4028				Altamirano MM, 2000, NATURE, V403, P617, DOI 10.1038/35001001; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Blum JH, 2000, P NATL ACAD SCI USA, V97, P2241, DOI 10.1073/pnas.040573397; Castagnoli L, 2001, COMB CHEM HIGH T SCR, V4, P121; Fanning AS, 1999, CURR OPIN CELL BIOL, V11, P432, DOI 10.1016/S0955-0674(99)80062-3; Fazi B, 2002, J BIOL CHEM, V277, P5290, DOI 10.1074/jbc.M109848200; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Geyer CR, 1999, P NATL ACAD SCI USA, V96, P8567, DOI 10.1073/pnas.96.15.8567; Hoffmuller U, 2000, EMBO J, V19, P4866, DOI 10.1093/emboj/19.18.4866; Kang H, 2000, EMBO J, V19, P2889, DOI 10.1093/emboj/19.12.2889; Kasanov J, 2001, CHEM BIOL, V8, P231, DOI 10.1016/S1074-5521(01)00005-9; Kato M, 2000, J BIOL CHEM, V275, P37481, DOI 10.1074/jbc.M007251200; Kay BK, 2000, FEBS LETT, V480, P55, DOI 10.1016/S0014-5793(00)01778-6; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Keefe AD, 2001, NATURE, V410, P715, DOI 10.1038/35070613; LEE CH, 1995, EMBO J, V14, P5006, DOI 10.1002/j.1460-2075.1995.tb00183.x; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Malabarba MG, 2001, ONCOGENE, V20, P5186, DOI 10.1038/sj.onc.1204654; Mayer BJ, 2001, J CELL SCI, V114, P1253; Mongiovi AM, 1999, EMBO J, V18, P5300, DOI 10.1093/emboj/18.19.5300; MORAN MF, 1990, P NATL ACAD SCI USA, V87, P8622, DOI 10.1073/pnas.87.21.8622; MUSACCHIO A, 1994, NAT STRUCT BIOL, V1, P546, DOI 10.1038/nsb0894-546; MUSACCHIO A, 2002, SH3 DOMAINS RECOGNIZ, P61; Norman TC, 1999, SCIENCE, V285, P591, DOI 10.1126/science.285.5427.591; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pisabarro MT, 1998, J MOL BIOL, V281, P513, DOI 10.1006/jmbi.1998.1932; Pisabarro MT, 1996, BIOCHEMISTRY-US, V35, P10634, DOI 10.1021/bi960203t; Ponting CP, 1999, NUCLEIC ACIDS RES, V27, P229, DOI 10.1093/nar/27.1.229; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; RICKLES RJ, 1994, EMBO J, V13, P5598, DOI 10.1002/j.1460-2075.1994.tb06897.x; Santi E, 2000, J MOL BIOL, V296, P497, DOI 10.1006/jmbi.1999.3471; Schneider S, 1999, NAT BIOTECHNOL, V17, P170, DOI 10.1038/6172; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; SONGYANG Z, 1995, J BIOL CHEM, V270, P26029, DOI 10.1074/jbc.270.44.26029; SPARKS AB, 1995, METHOD ENZYMOL, V255, P498; Stricker NL, 1997, NAT BIOTECHNOL, V15, P336, DOI 10.1038/nbt0497-336; Sudol M, 1998, ONCOGENE, V17, P1469, DOI 10.1038/sj.onc.1202182; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Xu X, 2001, NAT GENET, V27, P23, DOI 10.1038/83717; Zucconi A, 2001, J MOL BIOL, V307, P1329, DOI 10.1006/jmbi.2001.4572	40	34	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21666	21674		10.1074/jbc.M109788200	http://dx.doi.org/10.1074/jbc.M109788200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11929862	hybrid			2022-12-27	WOS:000176286000074
J	Sanchez, MA; Tryon, R; Green, J; Boor, J; Landfear, SM				Sanchez, MA; Tryon, R; Green, J; Boor, J; Landfear, SM			Six related nucleoside/nucleobase transporters from Trypanosoma brucei exhibit distinct biochemical functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-STREAM FORMS; NUCLEOSIDE TRANSPORTER; LEISHMANIA-ENRIETTII; TUBULIN GENES; CLONING; FAMILY; EXPRESSION; ADENOSINE; AFFINITY; PURINE	Purine nucleoside and nucleobase transporters are of fundamental importance for Trypanosoma brucei and related kinetoplastid parasites because these protozoa are not able to synthesize purines de novo and must salvage the compounds from their hosts. In the studies reported here, we have identified a family of six clustered genes in T. brucei that encode nucleoside/nucleobase transporters. These genes, TbNT2/927, TbNT3, TbNT4, TbNT5, TbNT6, and TbNT7, have predicted amino acid sequences that show high identity to each other and to TbNT2, a PI type nucleoside transporter recently identified in our laboratory. Expression in Xenopus laevis oocytes revealed that TbNT2/927, TbNT5, TbNT6, and TbNT7 are high affinity adenosine/inosine transporters with K-m values of <5 &mu;M. In addition, TbNT5, and to a limited degree TbNT6 and TbNT7, also mediate the uptake of the nucleobase hypoxanthine. Ribonuclease protection assays showed that mRNA from all of the six members of this gene family are expressed in the bloodstream stage of the T. brucei life cycle but that TbNT2/927 and TbNT5 mRNAs are also expressed in the insect stage of the life cycle. These results demonstrate that T. brucei expresses multiple purine transporters with distinct substrate specificities and different patterns of expression during the parasite life cycle.	Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA	Oregon Health & Science University	Sanchez, MA (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, 3181 SW Sam Jackson Pk Rd,L220, Portland, OR 97201 USA.				NIAID NIH HHS [R01 AI044138, AI44138] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044138] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ARRIZA JL, 1993, J BIOL CHEM, V268, P15329; Baldwin SA, 1999, MOL MED TODAY, V5, P216, DOI 10.1016/S1357-4310(99)01459-8; Berens Randolph L., 1995, P89, DOI 10.1016/B978-012473345-9/50007-6; BOOTHROYD JC, 1985, ANNU REV MICROBIOL, V39, P475, DOI 10.1146/annurev.mi.39.100185.002355; BRINGAUD F, 1994, MOL BIOL EVOL, V11, P220; Burchmore RJS, 1998, J BIOL CHEM, V273, P29118, DOI 10.1074/jbc.273.44.29118; CARTER NS, 1995, J BIOL CHEM, V270, P28153, DOI 10.1074/jbc.270.47.28153; CARTER NS, 1993, NATURE, V361, P173, DOI 10.1038/361173a0; CUNNINGHAM I, 1977, J PROTOZOOL, V24, P325, DOI 10.1111/j.1550-7408.1977.tb00987.x; De Koning HP, 1999, MOL PHARMACOL, V56, P1162, DOI 10.1124/mol.56.6.1162; de Koning HP, 1998, BIOCHEM CELL BIOL, V76, P853, DOI 10.1139/bcb-76-5-853; de Koning HP, 1998, J BIOL CHEM, V273, P9486, DOI 10.1074/jbc.273.16.9486; DeKoning HP, 1997, EUR J BIOCHEM, V247, P1102, DOI 10.1111/j.1432-1033.1997.01102.x; deKoning HP, 1997, MOL BIOCHEM PARASIT, V89, P245, DOI 10.1016/S0166-6851(97)00129-1; Deves R, 1998, PHYSIOL REV, V78, P487, DOI 10.1152/physrev.1998.78.2.487; Griffiths M, 1997, BIOCHEM J, V328, P739, DOI 10.1042/bj3280739; HAMMOND DJ, 1984, MOL BIOCHEM PARASIT, V13, P243, DOI 10.1016/0166-6851(84)90117-8; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; LANDFEAR SM, 1983, MOL CELL BIOL, V3, P1070, DOI 10.1128/MCB.3.6.1070; LANGFORD CK, 1994, J BIOL CHEM, V269, P17939; LANHAM SM, 1970, EXP PARASITOL, V28, P521, DOI 10.1016/0014-4894(70)90120-7; Lin RY, 1998, J BIOL CHEM, V273, P28959, DOI 10.1074/jbc.273.44.28959; Maser P, 1999, SCIENCE, V285, P242, DOI 10.1126/science.285.5425.242; Mastroberardino L, 1998, NATURE, V395, P288, DOI 10.1038/26246; Parker MD, 2000, BIOCHEM J, V349, P67, DOI 10.1042/0264-6021:3490067; Sambrook J., 2002, MOL CLONING LAB MANU; Sanchez MA, 1999, J BIOL CHEM, V274, P30244, DOI 10.1074/jbc.274.42.30244; SEEBECK T, 1983, P NATL ACAD SCI-BIOL, V80, P4634, DOI 10.1073/pnas.80.15.4634; Sundaram M, 2001, J BIOL CHEM, V276, P45270, DOI 10.1074/jbc.M107169200; van Deursen FJ, 2001, MOL BIOCHEM PARASIT, V112, P163, DOI 10.1016/S0166-6851(00)00359-5; Vasudevan G, 1998, P NATL ACAD SCI USA, V95, P9873, DOI 10.1073/pnas.95.17.9873	32	52	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21499	21504		10.1074/jbc.M202319200	http://dx.doi.org/10.1074/jbc.M202319200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11937511	hybrid			2022-12-27	WOS:000176286000050
J	Pawlowski, JE; Ertel, JR; Allen, MP; Xu, M; Butler, C; Wilson, EM; Wierman, ME				Pawlowski, JE; Ertel, JR; Allen, MP; Xu, M; Butler, C; Wilson, EM; Wierman, ME			Liganded androgen receptor interaction with beta-catenin - Nuclear co-localization and modulation of transcriptional activity in neuronal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; AR SUPPRESSES TRANSCRIPTION; PROSTATE-CANCER CELLS; MAMMARY-TUMOR VIRUS; COLORECTAL CARCINOMAS; OVARIAN CARCINOMAS; GENE ACTIVATION; XENOPUS EMBRYOS; BINDING DOMAIN; FACTOR LEF-1	A yeast two-hybrid assay was employed to identify androgen receptor (AR) protein partners in gonadotropin-releasing hormone neuronal cells. By using an AR deletion construct (AR-(Delta371-485)) as a bait beta-catenin was identified as an AR-interacting protein from a gonadotropin-releasing hormone neuronal cell library. Immunolocalization of co-transfected AR and FLAG-beta-catenin demonstrated that FLAG-beta-catenin was predominantly cytoplasmic in the absence of androgen. In the presence of 5alpha-dihydrotestosterone, FLAG-beta-catenin completely co-localized to the nucleus with AR. This effect was specific to AR because liganded progesterone, glucocorticoid, or estrogen a receptors did not translocate FLAG-beta-catenin to the nucleus. Agonist-bound AR was required because the AR antagonists casodex and hydroxyflutamide failed to translocate beta-catenin. Time course experiments demonstrated that co-translocation occurred with similar kinetics. Nuclear co-localization was independent of the glycogen synthase kinase-3beta, p42/44 ERK mitogen-activated protein kinase, and phosphatidylinositol 3-kinase pathways because inhibitors of these pathways had no effect. Transcription assays demonstrated that liganded AR repressed beta-catenin/T cell factor-responsive reporter gene activity. Conversely, co-expression of beta-catenin/T cell factor repressed AR stimulation of AR-responsive reporter gene activity. Our data suggest that liganded AR shuttles beta-catenin to the nucleus and that nuclear interaction of AR with beta-catenin may modulate transcriptional activity in androgen target tissues.	Vet Affairs Med Ctr, Res Serv, Denver, CO 80220 USA; Univ Colorado, Dept Med, Ctr Hlth Sci, Denver, CO 80220 USA; Univ N Carolina, Lab Reprod Biol, Chapel Hill, NC 27599 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of North Carolina; University of North Carolina Chapel Hill	Wierman, ME (corresponding author), Vet Affairs Med Ctr, Res Serv, 111H,1055 Clermont St, Denver, CO 80220 USA.							Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; ADLER AJ, 1993, MOL CELL BIOL, V13, P6326, DOI 10.1128/MCB.13.10.6326; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Brady ME, 1999, J BIOL CHEM, V274, P17599, DOI 10.1074/jbc.274.25.17599; CHALEPAKIS G, 1988, CELL, V53, P371, DOI 10.1016/0092-8674(88)90157-2; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; Curtin D, 2001, MOL ENDOCRINOL, V15, P1906, DOI 10.1210/me.15.11.1906; Easwaran V, 1999, CURR BIOL, V9, P1415, DOI 10.1016/S0960-9822(00)80088-3; El-Tanani M, 2001, J BIOL CHEM, V276, P41675, DOI 10.1074/jbc.M103966200; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; Fujimoto N, 1999, J BIOL CHEM, V274, P8316, DOI 10.1074/jbc.274.12.8316; Fukuchi T, 1998, CANCER RES, V58, P3526; Gamallo C, 1999, AM J PATHOL, V155, P527, DOI 10.1016/S0002-9440(10)65148-6; Garcia-Rostan G, 1999, CANCER RES, V59, P1811; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Issack PS, 1998, CELL GROWTH DIFFER, V9, P837; Jorgensen JS, 2001, MOL ENDOCRINOL, V15, P1496, DOI 10.1210/me.15.9.1496; Jorgensen JS, 2001, MOL ENDOCRINOL, V15, P1505, DOI 10.1210/me.15.9.1505; Kang HY, 1999, J BIOL CHEM, V274, P8570, DOI 10.1074/jbc.274.13.8570; KEMPPAINEN JA, 1992, J BIOL CHEM, V267, P968; Kemppainen JA, 1999, MOL ENDOCRINOL, V13, P440, DOI 10.1210/me.13.3.440; KEPA JK, 1992, NUCLEIC ACIDS RES, V20, P1393, DOI 10.1093/nar/20.6.1393; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Lamb DJ, 2001, VITAM HORM, V62, P199, DOI 10.1016/S0083-6729(01)62005-3; Langley E, 1998, J BIOL CHEM, V273, P92, DOI 10.1074/jbc.273.1.92; LANGLEY E, 1995, J BIOL CHEM, V270, P29983; LIEBERHERR M, 1994, J BIOL CHEM, V269, P7217; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Mirabelli-Primdahl L, 1999, CANCER RES, V59, P3346; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Mulholland DJ, 2002, J BIOL CHEM, V277, P17933, DOI 10.1074/jbc.M200135200; Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; Palacios J, 1998, CANCER RES, V58, P1344; Peterziel H, 1999, ONCOGENE, V18, P6322, DOI 10.1038/sj.onc.1203032; Prefontaine GG, 1999, J BIOL CHEM, V274, P26713, DOI 10.1074/jbc.274.38.26713; RADOVICK S, 1991, P NATL ACAD SCI USA, V88, P3402, DOI 10.1073/pnas.88.8.3402; ROCHE PJ, 1992, MOL ENDOCRINOL, V6, P2229, DOI 10.1210/me.6.12.2229; Sato N, 1997, J BIOL CHEM, V272, P17485, DOI 10.1074/jbc.272.28.17485; SCARLETT CO, 1995, MOL ENDOCRINOL, V9, P413, DOI 10.1210/me.9.4.413; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Sun W, 2001, J NEUROENDOCRINOL, V13, P249, DOI 10.1046/j.1365-2826.2001.00620.x; Tan JA, 2000, ENDOCRINOLOGY, V141, P3440, DOI 10.1210/en.141.9.3440; TAN JA, 1988, MOL ENDOCRINOL, V2, P1276, DOI 10.1210/mend-2-12-1276; Truica CI, 2000, CANCER RES, V60, P4709; Tyagi RK, 2000, MOL ENDOCRINOL, V14, P1162, DOI 10.1210/me.14.8.1162; VANLEEUWEN F, 1994, NATURE, V368, P342, DOI 10.1038/368342a0; Voeller HJ, 1998, CANCER RES, V58, P2520; Wang X, 2001, J BIOL CHEM, V276, P40417, DOI 10.1074/jbc.M104765200; Wright K, 1999, INT J CANCER, V82, P625, DOI 10.1002/(SICI)1097-0215(19990827)82:5<625::AID-IJC1>3.0.CO;2-2; Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200; Yeh SY, 1996, P NATL ACAD SCI USA, V93, P5517, DOI 10.1073/pnas.93.11.5517; Yokoya F, 1999, MOL BIOL CELL, V10, P1119, DOI 10.1091/mbc.10.4.1119; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Yu X, 2001, MOL CELL BIOL, V21, P4614, DOI 10.1128/MCB.21.14.4614-4625.2001; ZHOU ZX, 1994, J BIOL CHEM, V269, P13115; Zhurinsky J, 2000, J CELL SCI, V113, P3127	66	144	149	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20702	20710		10.1074/jbc.M200545200	http://dx.doi.org/10.1074/jbc.M200545200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11916967	hybrid			2022-12-27	WOS:000176204500078
J	Shen, GZ; Zhao, JD; Reimer, SK; Antonkine, ML; Cai, Q; Weiland, SM; Golbeck, JH; Bryant, DA				Shen, GZ; Zhao, JD; Reimer, SK; Antonkine, ML; Cai, Q; Weiland, SM; Golbeck, JH; Bryant, DA			Assembly of photosystem II. Inactivation of the rubA gene encoding a membrane-associated rubredoxin in the cyanobacterium Synechococcus sp PCC 7002 causes a loss of photosystem I activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS PROTECTION; AMINO-ACID-SEQUENCE; DESULFOVIBRIO-VULGARIS; NUCLEOTIDE-SEQUENCE; ELECTRON-TRANSFER; ESCHERICHIA-COLI; EXPRESSION; PROTEINS; RUBRERYTHRIN; CLONING	A 4.4-kb HindIII fragment, encoding an unusual rubredoxin (denoted RubA), a homolog of the Synechocystis sp. PCC 6803 gene slr2034 and Arabidopsis thaliana HCF136, and the psbEFLJ operon, was cloned from the cyanobacterium Synechococcus sp. PCC 7002. Inactivation of the slr2034 homolog produced a mutant with no detectable phenotype and wild-type photosystem (PS) II levels. Inactivation of the rubA gene of Synechococcus sp. PCC 7002 produced a mutant unable to grow photoautotrophically. RubA and PS I electron transport activity were completely absent in the mutant, although PS 11 activity was similar to80% of the wild-type level. RubA contains a domain of similar to50 amino acids with very high similarity to the rubredoxins of anaerobic bacteria and archaea, but it also contains a region of about 50 amino acids that is predicted to form a flexible hinge and a transmembrane a-helix at its C terminus. Overproduction of the water-soluble rubredoxin domain in Escherichia coli led to a product with the absorption and EPR spectra of typical rubredoxins. RubA was present in thylakoid but not plasma membranes of cyanobacteria and in chloroplast thylakoids isolated from spinach and Chlamydomonas reinhardtii. Fractionation studies suggest that RubA might transiently associate with PS I monomers, but no evidence for an association with PS I trimers or PS II was observed. PS I levels were significantly lower than in the wild type (similar to40%), but trimeric PS I complexes could be isolated from the rubA mutant. These PS I complexes completely lacked the stromal subunits PsaC, PsaD), and PsaE but contained all membrane-intrinsic subunits. The three missing proteins could be detected immunologically in whole cells, but their levels were greatly reduced, and degradation products were also detected. Our results indicate that RubA plays a specific role in the biogenesis of PS I.	Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; Peking Univ, Coll Life Sci, Dept Plant Mol Biol, Beijing 100871, Peoples R China; St Francis Univ, Dept Biol, Loretto, PA 15940 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Peking University	Bryant, DA (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, S-234 Frear Bldg, University Pk, PA 16802 USA.	dab14@psu.edu						Bartsevich VV, 1997, J BIOL CHEM, V272, P6382, DOI 10.1074/jbc.272.10.6382; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Boudreau E, 1997, EMBO J, V16, P6095, DOI 10.1093/emboj/16.20.6095; BROSIUS J, 1989, DNA-J MOLEC CELL BIO, V8, P759, DOI 10.1089/dna.1989.8.759; BUZBY JS, 1985, SCIENCE, V230, P805, DOI 10.1126/science.2997920; CANTRELL A, 1987, PLANT MOL BIOL, V9, P453, DOI 10.1007/BF00015877; Chitnis PR, 2001, ANNU REV PLANT PHYS, V52, P593, DOI 10.1146/annurev.arplant.52.1.593; Coulter ED, 2001, ARCH BIOCHEM BIOPHYS, V394, P76, DOI 10.1006/abbi.2001.2531; da Costa PN, 2001, MOL MICROBIOL, V41, P217, DOI 10.1046/j.1365-2958.2001.02509.x; Das A, 2001, J BACTERIOL, V183, P1560, DOI 10.1128/JB.183.5.1560-1567.2001; DINER BA, 1996, OXYGENIC PHOTOSYNTHE, P213; Douglas S, 2001, NATURE, V410, P1091, DOI 10.1038/35074092; Eidsness MK, 1999, BIOCHEMISTRY-US, V38, P14803, DOI 10.1021/bi991661f; EISEN JA, 2002, IN PRESS P NATL ACAD; Funk C, 1999, BIOCHEMISTRY-US, V38, P9397, DOI 10.1021/bi990545+; GEISSDORFER W, 1995, MICROBIOL-UK, V141, P1425, DOI 10.1099/13500872-141-6-1425; Golbeck J. H., 1995, CRC HDB ORGANIC PHOT, P1407; GOLBECK JH, 1991, CURR TOP BIOENERG, V16, P83; Gomes CM, 1997, J BIOL CHEM, V272, P22502, DOI 10.1074/jbc.272.36.22502; Guedon E, 2001, BIOCHEM BIOPH RES CO, V285, P496, DOI 10.1006/bbrc.2001.5196; Harlow E., 1988, ANTIBODIES LAB MANUA; He QF, 2001, J BIOL CHEM, V276, P306, DOI 10.1074/jbc.M008686200; Jenney FE, 1999, SCIENCE, V286, P306, DOI 10.1126/science.286.5438.306; Johnson TW, 2000, J BIOL CHEM, V275, P8523, DOI 10.1074/jbc.275.12.8523; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Jung YS, 1995, PHOTOSYNTH RES, V46, P249, DOI 10.1007/BF00020437; Kaneko T, 2001, DNA RES, V8, P205, DOI 10.1093/dnares/8.5.205; Kaneko T, 1996, DNA Res, V3, P185, DOI 10.1093/dnares/3.3.185; KOK M, 1989, J BIOL CHEM, V264, P5442; LeGall J, 1998, FEBS LETT, V429, P295, DOI 10.1016/S0014-5793(98)00610-3; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Lojero CG, 1996, PHOTOSYNTH RES, V47, P293, DOI 10.1007/BF02184290; Lumppio HL, 2001, J BACTERIOL, V183, P101, DOI 10.1128/JB.183.1.101-108.2001; MATHIEU I, 1992, BIOCHEM J, V285, P255, DOI 10.1042/bj2850255; Meurer J, 1998, EMBO J, V17, P5286, DOI 10.1093/emboj/17.18.5286; MEYER J, 1990, BIOCHEM J, V271, P839, DOI 10.1042/bj2710839; Naver H, 2001, PLANT CELL, V13, P2731, DOI 10.1105/tpc.010253; Norling B, 1998, FEBS LETT, V436, P189, DOI 10.1016/S0014-5793(98)01123-5; Pakrasi HB, 1995, ANNU REV GENET, V29, P755; REY L, 1992, J MOL BIOL, V228, P998, DOI 10.1016/0022-2836(92)90886-O; Sakamoto T, 1997, PHYSIOLOGY, BIOCHEMISTRY AND MOLECULAR BIOLOGY OF PLANT LIPIDS, P380; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schluchter WM, 1996, PHOTOCHEM PHOTOBIOL, V64, P53, DOI 10.1111/j.1751-1097.1996.tb02421.x; Schweimer K, 2000, PROTEIN SCI, V9, P1474, DOI 10.1110/ps.9.8.1474; SEKI Y, 1989, J BIOCHEM-TOKYO, V106, P336, DOI 10.1093/oxfordjournals.jbchem.a122854; SHEN GZ, 1994, J BIOL CHEM, V269, P13904; SHEN GZ, 1995, PHOTOSYNTH RES, V44, P41, DOI 10.1007/BF00018295; Shen GZ, 2002, J BIOL CHEM, V277, P20355, DOI 10.1074/jbc.M201104200; Shen GZ, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P3147; STEVENS SE, 1980, P NATL ACAD SCI-BIOL, V77, P6052, DOI 10.1073/pnas.77.10.6052; STUDIER FW, 1918, METHOD ENZYMOL, P60; Theologis A, 2000, NATURE, V408, P816, DOI 10.1038/35048500; Togasaki Robert K., 1998, Advances in Photosynthesis, V7, P13; Vassiliev IR, 2001, BBA-BIOENERGETICS, V1507, P139, DOI 10.1016/S0005-2728(01)00197-9; VERMAAS W, 1993, ANNU REV PLANT PHYS, V44, P457, DOI 10.1146/annurev.pp.44.060193.002325; Wastl J, 2000, J BIOL CHEM, V275, P30058, DOI 10.1074/jbc.M004629200; Wastl J, 2000, FEBS LETT, V471, P191, DOI 10.1016/S0014-5793(00)01399-5; Yang F, 1998, J PHYS CHEM B, V102, P8288, DOI 10.1021/jp981952i; Yoon KS, 1999, J BIOL CHEM, V274, P29772, DOI 10.1074/jbc.274.42.29772; Zhao JD, 1998, ANAL BIOCHEM, V264, P263, DOI 10.1006/abio.1998.2845; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	61	99	115	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20343	20354		10.1074/jbc.M201103200	http://dx.doi.org/10.1074/jbc.M201103200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11914373	hybrid			2022-12-27	WOS:000176204500033
J	Spencer, ML; Shao, HP; Andres, DA				Spencer, ML; Shao, HP; Andres, DA			Induction of neurite extension and survival in pheochromocytoma cells by the Rit GTPase.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; ACTIVATED PROTEIN-KINASE; RAS-RELATED GTPASES; PC12 CELLS; NEURONAL SURVIVAL; MAP KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; B-RAF; SYMPATHETIC NEURONS; BINDING PROTEIN	The Rit, Rin, and Ric proteins comprise a distinct and evolutionarily conserved subfamily of the Ras-like small G-proteins. Although these proteins share the majority of core effector domain residues with Ras, recent studies suggest that Rit uses novel effector pathways to regulate NIH3T3 cell proliferation and transformation, while the functions of Rin and Ric remain largely unknown. Since we demonstrate that Rit is expressed in neurons, we investigated the role of Rit signaling in promoting the differentiation and survival of pheochromocytoma cells. In this study, we show that expression of constitutively active Rit (RitL79) in PC6 cells results in neuronal differentiation, characterized by the elaboration of an extensive network of neurite-like processes that are morphologically distinct from those mediated by the expression of oncogenic Ras. Although activated Rit fails to stimulate mitogen-activated protein kinase/extracellular-signal-regulated kinase (MAPK/ERK) signaling pathways in COS cells, RitL79 induced the phosphorylation of ERK1/2 in PC6 cells. We also find that Rit-mediated effects on neurite outgrowth can be blocked by co-expression of dominant-negative mutants of C-Raf1 or mitogen-activated protein kinase kinase I (MEK1). Moreover, expression of dominant-negative Rit is sufficient to inhibit NGF-induced neurite outgrowth. Expression of active Rit inhibits growth factor-withdrawal mediated apoptosis of PC6 cells, but does not induce phosphorylation of Akt/protein kinase B, suggesting that survival does not utilize the phosphatidylinositol 3-kinase (PI3K)/Akt pathway. Instead, pharmacological inhibitors of MEK block Rit-stimulated cell survival. Taken together, these studies suggest that Rit represents a distinct regulatory protein, capable of mediating differentiation and cell survival in PC6 cells using a MEK-dependent signaling pathway to achieve its effects.	Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Kentucky	Andres, DA (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, 800 Rose St, Lexington, KY 40536 USA.	dandres@pop.uky.edu						Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; BOUME HR, 1991, NATURE, V349, P117; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Creedon DJ, 1996, J BIOL CHEM, V271, P20713, DOI 10.1074/jbc.271.34.20713; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Estus S, 1997, J NEUROSCI, V17, P7736; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Finkbeiner S, 1996, NEURON, V16, P233, DOI 10.1016/S0896-6273(00)80040-9; Finlin BS, 1997, J BIOL CHEM, V272, P21982, DOI 10.1074/jbc.272.35.21982; Finlin BS, 2000, BIOCHEM J, V347, P223, DOI 10.1042/0264-6021:3470223; Finlin BS, 2001, J BIOL CHEM, V276, P42259, DOI 10.1074/jbc.M105888200; Graham SM, 1999, ONCOGENE, V18, P2107, DOI 10.1038/sj.onc.1202517; Grammer TC, 1997, ONCOGENE, V14, P1635, DOI 10.1038/sj.onc.1201000; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hetman M, 2000, ACTA NEUROBIOL EXP, V60, P531; JAISWAL RK, 1994, MOL CELL BIOL, V14, P6944, DOI 10.1128/MCB.14.10.6944; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; KIMURA K, 1994, J BIOL CHEM, V269, P18961; Klesse LJ, 1999, ONCOGENE, V18, P2055, DOI 10.1038/sj.onc.1202524; Klesse LJ, 1998, J NEUROSCI, V18, P10420; LANGECARTER CA, 1994, SCIENCE, V265, P1458, DOI 10.1126/science.8073291; Lee CHJ, 1996, J NEUROSCI, V16, P6784; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; Mazzoni IE, 1999, J NEUROSCI, V19, P9716; Morooka T, 1998, J BIOL CHEM, V273, P24285, DOI 10.1074/jbc.273.38.24285; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; Ohtsuka T, 1996, J BIOL CHEM, V271, P1258, DOI 10.1074/jbc.271.3.1258; Owada K, 1999, J NEUROCHEM, V73, P2084; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; PITTMAN RN, 1993, J NEUROSCI, V13, P3669; Reuther GW, 2000, CURR OPIN CELL BIOL, V12, P157, DOI 10.1016/S0955-0674(99)00071-X; Rusyn EV, 2000, ONCOGENE, V19, P4685, DOI 10.1038/sj.onc.1203836; Sarner S, 2000, MOL CELL BIOL, V20, P158, DOI 10.1128/MCB.20.1.158-172.2000; SCHAAP D, 1993, J BIOL CHEM, V268, P20232; Shao HP, 2000, J BIOL CHEM, V275, P26914; Shao HP, 1999, ARCH BIOCHEM BIOPHYS, V371, P207, DOI 10.1006/abbi.1999.1448; Spencer ML, 2002, J BIOL CHEM, V277, P17605, DOI 10.1074/jbc.M111400200; SZEBERENYI J, 1990, MOL CELL BIOL, V10, P5324, DOI 10.1128/MCB.10.10.5324; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; Villalba M, 1997, J NEUROSCI, V17, P83, DOI 10.1523/JNEUROSCI.17-01-00083.1997; Virdee K, 1996, J NEUROCHEM, V67, P1801; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wes PD, 1996, EMBO J, V15, P5839, DOI 10.1002/j.1460-2075.1996.tb00971.x; WOOD KW, 1993, P NATL ACAD SCI USA, V90, P5016, DOI 10.1073/pnas.90.11.5016; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	59	42	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20160	20168		10.1074/jbc.M201092200	http://dx.doi.org/10.1074/jbc.M201092200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11914372	hybrid			2022-12-27	WOS:000176204500011
J	Thuerauf, DJ; Morrison, LE; Hoover, H; Glembotski, CC				Thuerauf, DJ; Morrison, LE; Hoover, H; Glembotski, CC			Coordination of ATF6-mediated transcription and ATF6 degradation by a domain that is shared with the viral transcription factor, VP16	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; GLUCOSE-REGULATED PROTEINS; RNA-POLYMERASE-II; DNA-BINDING; IN-VIVO; ELEMENT; ACTIVATION; GENE; INDUCTION	ATF6 is a 670-amino acid endoplasmic reticulum (ER) transmembrane protein that is cleaved in response to ER stress. The resulting N-terminal fragment of similar to400 amino acids translocates to the nucleus and activates selected ER stress-inducible genes, such as GRP-78 and sarco/endoplasmic reticulum ATPase, which are required for cell survival. In studying the mechanism of ATF6-activated transcription, we found that when HeLa cells were transfected with a plasmid encoding ATF6-(1-373), ER stress-inducible reporter gene activation was high, but ATF6-(1-373) expression was low, unless a proteasome inhibitor was added. In contrast, transfection with a plasmid encoding ATF6494-373) resulted in low reporter activation and high expression of ATF6-(94-373), which was independent of the proteasome inhibitor. Thus, the information responsible for transcriptional activation and proteasomal degradation must lie within the N-terminal 93 amino acids of ATF6. This portion of ATF6 was found to be homologous to the herpes simplex viral protein, VP16. One 8-amino acid domain of particular interest in this region of ATF6 is 75% identical to the VN8 region in VP16. VN8 is required for VP16-mediated transcription, as well as rapid degradation of VP16 by proteasomes. Point mutations in the VNS-Iike region of ATF6 caused a loss of transcription, increased expression levels, and an increase in half-life. Thus, the potent transcriptional activities and rapid degradation of ATF6 and VP16 require the VN8 domains in each protein. Homology searches indicate that ATF6 is the only eukaryotic protein known that possesses an active VN8 domain, raising questions about how this domain evolved and the functional importance underlying its appearance in only these two transcription factors.	San Diego State Univ, Heart Inst, San Diego, CA 92182 USA; San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	California State University System; San Diego State University; California State University System; San Diego State University; California State University System; San Diego State University	Glembotski, CC (corresponding author), San Diego State Univ, Heart Inst, San Diego, CA 92182 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056861] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-56861] Funding Source: Medline; NINDS NIH HHS [NS/HL-25073] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Desterro JMP, 2000, CELL MOL LIFE SCI, V57, P1207, DOI 10.1007/PL00000760; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Haze K, 2001, BIOCHEM J, V355, P19, DOI 10.1042/0264-6021:3550019; Hoppe T, 2001, CURR OPIN CELL BIOL, V13, P344, DOI 10.1016/S0955-0674(00)00218-0; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; LEE A S, 1992, Current Opinion in Cell Biology, V4, P267, DOI 10.1016/0955-0674(92)90042-B; LEE AS, 1987, TRENDS BIOCHEM SCI, V12, P20, DOI 10.1016/0968-0004(87)90011-9; LI WW, 1994, MOL CELL BIOL, V14, P5533, DOI 10.1128/MCB.14.8.5533; MARMORSTEIN R, 1992, NATURE, V356, P408, DOI 10.1038/356408a0; MIN J, 1995, GENOMICS, V30, P149, DOI 10.1006/geno.1995.9891; Mitsui A, 1999, P NATL ACAD SCI USA, V96, P6054, DOI 10.1073/pnas.96.11.6054; Molinari E, 1999, EMBO J, V18, P6439, DOI 10.1093/emboj/18.22.6439; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; REGIER JL, 1993, P NATL ACAD SCI USA, V90, P883, DOI 10.1073/pnas.90.3.883; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; SETH A, 1992, J BIOL CHEM, V267, P24796; Spear E, 2001, TRAFFIC, V2, P515, DOI 10.1034/j.1600-0854.2001.20801.x; Tanaka M, 1996, P NATL ACAD SCI USA, V93, P4311, DOI 10.1073/pnas.93.9.4311; Thomas D, 2000, CURR BIOL, V10, pR341, DOI 10.1016/S0960-9822(00)00462-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thuerauf DJ, 1998, J BIOL CHEM, V273, P20636, DOI 10.1074/jbc.273.32.20636; Thuerauf DJ, 2001, J BIOL CHEM, V276, P48309, DOI 10.1074/jbc.M107146200; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wu M, 2000, GENE DEV, V14, P301; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	31	54	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20734	20739		10.1074/jbc.M201749200	http://dx.doi.org/10.1074/jbc.M201749200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11909875	hybrid			2022-12-27	WOS:000176204500082
J	Hao, JJ; Narayanan, K; Ramachandran, A; He, G; Almushayt, A; Evans, C; George, A				Hao, JJ; Narayanan, K; Ramachandran, A; He, G; Almushayt, A; Evans, C; George, A			Odontoblast cells immortalized by telomerase produce mineralized dentin-like tissue both in vitro and in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR IMMORTALIZATION; MATRIX PROTEIN-1; IN-VITRO; DIFFERENTIATION; EXPRESSION; GENE; PULP; LINE; BIOMINERALIZATION; ESTABLISHMENT	The formation of dentin provides one well accepted paradigm for studying mineralized tissue formation. For the assembly of dentin, several cellular signaling pathways cooperate to provide neural crest-derived mesenchymal cells with positional information. Further, "cross-talk" between signaling pathways from the mesenchymal derived odontoblast cells and the epithelially derived ameloblasts during development is responsible for the formation of functional odontoblasts. These intercellular signals are tightly regulated, both temporally and spatially. When isolated from the developing tooth germ, odontoblasts quickly lose their potential to maintain the odontoblast-specific phenotype. Therefore, generation of an odontoblast cell line would be a valuable reproducible tool for studying the modulatory effects involved in odontoblast differentiation as well as the molecular events involved in mineralized dentin formation. In this study an immortalized odontoblast cell line, which has the required biochemical machinery to produce mineralized tissue in vitro, has been generated. These cells were implanted into animal models to determine their in vivo effects on dentin formation. After implantation, we observed a multistep, programmed cascade of gene expression in the exogenous odontoblasts as the dentin formed de novo. Some of the genes expressed include the dentin matrix proteins 1, 2, and 3, which are extracellular matrix molecules responsible for the ultimate formation of mineralized dentin. The biological response was also examined by histology and radiography and confirmed for mineral deposition by von Kossa staining. Thus, a transformed odontoblast cell line was created with high proliferative capacity that might ultimately be used for the regeneration and repair of dentin in vivo.	Univ Illinois, Dept Oral Biol, Chicago, IL 60612 USA; Univ Illinois, Dept Orthodont, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	George, A (corresponding author), Univ Illinois, Dept Oral Biol, MC 690, Chicago, IL 60612 USA.		Hu, Ruogu/B-2203-2008; Narayanan, Karthikeyan/D-1957-2010; Almushayt, Abdullah/GQH-3275-2022	Narayanan, Karthikeyan/0000-0001-5136-2296; GEORGE, ANNE/0000-0002-9008-7642	NIDCR NIH HHS [DE11657] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE011657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE011657] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; D'Errico JA, 1999, BONE, V25, P39, DOI 10.1016/S8756-3282(99)00096-4; D'Souza RN, 1999, DEVELOPMENT, V126, P2911; Den Besten PK, 1998, CONNECT TISSUE RES, V38, P3; DUCY P, 1997, CELL, V89, P677; GEORGE A, 1993, J BIOL CHEM, V268, P12624; George A, 1996, J BIOL CHEM, V271, P32869, DOI 10.1074/jbc.271.51.32869; GOLDBERG M, 1998, P 6 INT C CHEM BIOL, P297; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Hahn WC, 2001, ANN MED, V33, P123, DOI 10.3109/07853890109002067; KASUGAI S, 1993, ARCH ORAL BIOL, V38, P769, DOI 10.1016/0003-9969(93)90073-U; KASUGAI S, 1988, ARCH ORAL BIOL, V33, P887, DOI 10.1016/0003-9969(88)90018-0; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; MacDougall M, 1989, Connect Tissue Res, V22, P71; MacDougall M, 1997, J BIOL CHEM, V272, P835, DOI 10.1074/jbc.272.2.835; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Migliaccio M, 2000, J IMMUNOL, V165, P4978, DOI 10.4049/jimmunol.165.9.4978; Narayanan K, 2001, P NATL ACAD SCI USA, V98, P4516, DOI 10.1073/pnas.081075198; O'Hare MJ, 2001, P NATL ACAD SCI USA, V98, P646, DOI 10.1073/pnas.98.2.646; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; RUCH JV, 1995, INT J DEV BIOL, V39, P51; SAKAMOTO S, 1985, BIOCHEM BIOPH RES CO, V133, P709, DOI 10.1016/0006-291X(85)90962-3; Sambrook J., 2002, MOL CLONING LAB MANU; Srinivasan R, 1999, CONNECT TISSUE RES, V40, P251, DOI 10.3109/03008209909000703; TAKAGI Y, 1983, CLIN ORTHOP RELAT R, P282; TAKAGI Y, 1981, CHEM BIOL MINERALIZE, P233; THESLEFF I, 1995, INT J DEV BIOL, V39, P35; Thonemann B, 2000, ARCH ORAL BIOL, V45, P857, DOI 10.1016/S0003-9969(00)00056-X; Winn SR, 1999, J BONE MINER RES, V14, P1721, DOI 10.1359/jbmr.1999.14.10.1721; Zhang XH, 2001, NAT GENET, V27, P151, DOI 10.1038/84765	31	44	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19976	19981		10.1074/jbc.M112223200	http://dx.doi.org/10.1074/jbc.M112223200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11904297	hybrid			2022-12-27	WOS:000175894800097
J	Rolny, C; Spillmann, D; Lindahl, U; Claesson-Welsh, L				Rolny, C; Spillmann, D; Lindahl, U; Claesson-Welsh, L			Heparin amplifies platelet-derived growth factor (PDGF)-BB-induced PDGF alpha-receptor but not PDGF beta-receptor tyrosine phosphorylation in heparan sulfate-deficient cells - Effects on signal transduction and biological responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; PROTEASE-ACTIVATED LIGAND; DIFFERENT DIMERIC FORMS; FACTOR-A CHAIN; FIBROBLAST-GROWTH; KINASE ACTIVATION; B-CHAIN; BINDING; FGF; DIMERIZATION	Platelet-derived growth factor (PDGF) induces mitogenic and migratory responses in a wide variety of cells, by activating specific receptor tyrosine kinases denoted the PDGF alpha- and beta-receptors. Different PDGF isoforms bind in a distinct manner to glycosaminoglycans, particularly heparan sulfate. In the present study, we show potentiation by exogenous heparin of PDGF-BB-induced PDGF alpha-receptor tyrosine phosphorylation in heparan sulfate-deficient Chinese hamster ovary (CHO) 677 cells. This effect was not seen for PDGF-AA treatment, and heparin lacked a potentiating effect on PDGF-BB stimulation of the PDGF beta-receptor. Heparin did not affect the affinity of PDGF-BB binding for the PDGF receptors on CHO 677 cells. The PDGF-BB-stimulated PDGF alpha-receptor phosphorylation was enhanced in a dose-dependent fashion by heparin at low concentration. The effect was modulated by 2-O- and 6-O-desulfation of the polysaccharide. Maximal induction of PDGF alpha-receptor tyrosine phosphorylation (6-fold) in CHO 677 cells was achieved by treatment with a heparin decasaccharide, but shorter oligosaccharides consisting of four or more monosaccharide units were also able to augment PDGF alpha-receptor phosphorylation, albeit at higher concentrations. Heparin potentiated PDGF-BB-induced activation of mitogen-activated protein kinase and protein kinase B (Akt) and allowed increased chemotaxis of the CHO 677 cells toward PDGF-BB. In conclusion, heparin modulates PDGF-BB-induced PDGF a-receptor phosphorylation and downstream signaling, with consequences for cellular responsiveness to the growth factor.	Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, S-75185 Uppsala, Sweden; Biomed Ctr, Dept Biochem & Microbiol, S-75123 Uppsala, Sweden	Uppsala University	Claesson-Welsh, L (corresponding author), Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, Dag Hammarskjolds V20, S-75185 Uppsala, Sweden.		Rolny, Charlotte/AET-0493-2022	Rolny, Charlotte/0000-0003-4979-9266				Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; BLUMENKRANTZ N, 1973, ANAL BIOCHEM, V56, P10, DOI 10.1016/0003-2697(73)90163-2; BONTHRON DT, 1988, P NATL ACAD SCI USA, V85, P1492, DOI 10.1073/pnas.85.5.1492; Chon JH, 2001, AM J PHYSIOL-CELL PH, V280, pC1394, DOI 10.1152/ajpcell.2001.280.6.C1394; CLAESSONWELSH L, 1989, P NATL ACAD SCI USA, V86, P4917, DOI 10.1073/pnas.86.13.4917; CLAESSONWELSH L, 1989, ACTA ONCOL, V28, P331, DOI 10.3109/02841868909111202; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Esko JD, 1991, CURR OPIN CELL BIOL, V3, P805, DOI 10.1016/0955-0674(91)90054-3; FAGER G, 1995, J CELL PHYSIOL, V163, P380, DOI 10.1002/jcp.1041630218; Feyzi E, 1997, J BIOL CHEM, V272, P24850, DOI 10.1074/jbc.272.40.24850; Feyzi E, 1997, J BIOL CHEM, V272, P5518, DOI 10.1074/jbc.272.9.5518; GAO GX, 1995, EMBO J, V14, P2183, DOI 10.1002/j.1460-2075.1995.tb07212.x; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; HAMMACHER A, 1988, EUR J BIOCHEM, V176, P179, DOI 10.1111/j.1432-1033.1988.tb14266.x; Heldin Carl-Henrik, 1996, Cytokine and Growth Factor Reviews, V7, P3, DOI 10.1016/1359-6101(96)00002-0; HELDIN CH, 1988, EMBO J, V7, P1387, DOI 10.1002/j.1460-2075.1988.tb02955.x; HELDIN CH, 1989, J BIOL CHEM, V264, P8905; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; JACOBSSON I, 1980, J BIOL CHEM, V255, P5094; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; KELLY JD, 1991, J BIOL CHEM, V266, P8987; KELLY JL, 1993, J CELL BIOL, V121, P1153, DOI 10.1083/jcb.121.5.1153; LaRochelle WJ, 2001, NAT CELL BIOL, V3, P517, DOI 10.1038/35074593; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; LINDAHL U, 1966, J BIOL CHEM, V241, P2113; Loo BM, 2001, J BIOL CHEM, V276, P16868, DOI 10.1074/jbc.M011226200; MACCARANA M, 1993, J BIOL CHEM, V268, P23898; MAHADEVAN D, 1995, J BIOL CHEM, V270, P27595, DOI 10.1074/jbc.270.46.27595; ORNITZ DM, 1995, SCIENCE, V268, P432, DOI 10.1126/science.7536345; OSTMAN A, 1991, CELL REGUL, V2, P503, DOI 10.1091/mbc.2.7.503; Ostrovsky O, 2002, J BIOL CHEM, V277, P2444, DOI 10.1074/jbc.M108540200; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Pukac LA, 1997, J CELL PHYSIOL, V172, P69, DOI 10.1002/(SICI)1097-4652(199707)172:1<69::AID-JCP8>3.0.CO;2-B; RAINES EW, 1993, BRIT HEART J, V69, pS30; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Schilling D, 1998, BIOCHEM J, V333, P637, DOI 10.1042/bj3330637; Spillmann D, 1998, J BIOL CHEM, V273, P15487, DOI 10.1074/jbc.273.25.15487; Sundberg C, 1997, AM J PATHOL, V151, P479; Swertfeger DK, 2001, J BIOL CHEM, V276, P25043, DOI 10.1074/jbc.M102357200	42	48	49	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19315	19321		10.1074/jbc.M111805200	http://dx.doi.org/10.1074/jbc.M111805200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11912193	hybrid			2022-12-27	WOS:000175894800011
J	Wong, I; Lundquist, AJ; Bernards, AS; Mosbaugh, DW				Wong, I; Lundquist, AJ; Bernards, AS; Mosbaugh, DW			Presteady-state analysis of a single catalytic turnover by Escherichia coli uracil-DNA glycosylase reveals a "pinch-pull-push" mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFUSION-DRIVEN MECHANISMS; BASE-EXCISION-REPAIR; INHIBITOR PROTEIN; CRYSTAL-STRUCTURE; NUCLEIC-ACIDS; KINETIC-ANALYSIS; ABASIC SITES; TARGET BASE; COMPLEX; METHYLTRANSFERASE	Uracil-DNA glycosylase catalyzes the excision of uracils from DNA via a mechanism where the uracil is extrahelically flipped out of the DNA helix into the enzyme active site. A conserved leucine is inserted into the DNA duplex space vacated by the uracil leading to the paradigmatic "push-pull" mechanism of nucleotide flipping. However, the order of these two steps during catalysis has not been conclusively established. We report a complete kinetic analysis of a single catalytic turnover using a hydrolyzable duplex oligodeoxyribonucleotide substrate containing a uracil:2-aminopurine base pair. Rapid chemical-quenched-flow methods defined the kinetics of excision at the active site during catalysis. Stopped-flow fluorometry monitoring the 2-aminopurine fluorescence defined the kinetics of uracil flipping. Parallel experiments detecting the protein fluorescence showed a slower Leu(191) insertion step occurring after nucleotide flipping but before excision. The inserted Leu(191) acts as a doorstop to prevent the return of the flipped-out uracil residue, thereby facilitating the capture of the uracil in the active site and does not play a direct role in "pushing" the uracil out of the DNA helix. The results define for the first time the proper sequence of events during a catalytic cycle and establish a "pull-push", as opposed to a "push-pull", mechanism for nucleotide flipping.	Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA; Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA; Oregon State Univ, Environm Hlth Sci Ctr, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University	Wong, I (corresponding author), Oregon State Univ, Dept Biochem & Biophys, 2011 Agr & Life Sci Bldg, Corvallis, OR 97331 USA.		Hu, Ruogu/B-2203-2008		NIEHS NIH HHS [ES00210] Funding Source: Medline; NIGMS NIH HHS [GM32823, GM58771] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058771, R01GM032823] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; BENNETT SE, 1993, J BIOL CHEM, V268, P26879; BENNETT SE, 1992, J BIOL CHEM, V267, P22512; BENNETT SE, 1995, BIOCHEMISTRY-US, V34, P6109, DOI 10.1021/bi00018a014; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Cheng XD, 1996, STRUCTURE, V4, P639, DOI 10.1016/S0969-2126(96)00068-8; Drohat AC, 1999, BIOCHEMISTRY-US, V38, P11876, DOI 10.1021/bi9910880; Drohat AC, 1999, BIOCHEMISTRY-US, V38, P11866, DOI 10.1021/bi9910878; Handa P, 2001, J BIOL CHEM, V276, P17324, DOI 10.1074/jbc.M011166200; HIGLEY M, 1993, MUTAT RES, V294, P109, DOI 10.1016/0921-8777(93)90019-D; Hornby DP, 1998, CURR OPIN BIOTECH, V9, P354, DOI 10.1016/S0958-1669(98)80007-4; Jiang YL, 2001, BIOCHEMISTRY-US, V40, P7710, DOI 10.1021/bi010622c; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; JOHNSON KA, 1995, METHOD ENZYMOL, V249, P38; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Lloyd RS, 1997, BIOPOLYMERS, V44, P139; MOL CD, 1995, CELL, V80, P869, DOI 10.1016/0092-8674(95)90290-2; MOL CD, 1995, CELL, V82, P701, DOI 10.1016/0092-8674(95)90467-0; MOSBAUGH DW, 1994, PROG NUCLEIC ACID RE, V48, P315, DOI 10.1016/S0079-6603(08)60859-4; O'Gara M, 1998, NAT STRUCT BIOL, V5, P872, DOI 10.1038/2312; Parikh SS, 2000, P NATL ACAD SCI USA, V97, P5083, DOI 10.1073/pnas.97.10.5083; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Parikh SS, 2000, MUTAT RES-DNA REPAIR, V460, P183, DOI 10.1016/S0921-8777(00)00026-4; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Putnam CD, 1999, J MOL BIOL, V287, P331, DOI 10.1006/jmbi.1999.2605; Rachofsky EL, 2001, BIOCHEMISTRY-US, V40, P957, DOI 10.1021/bi001665g; RANEY KD, 1994, P NATL ACAD SCI USA, V91, P6644, DOI 10.1073/pnas.91.14.6644; Ravishankar R, 1998, NUCLEIC ACIDS RES, V26, P4880, DOI 10.1093/nar/26.21.4880; ROBERTS RJ, 1995, CELL, V82, P9, DOI 10.1016/0092-8674(95)90046-2; Roberts RJ, 1998, ANNU REV BIOCHEM, V67, P181, DOI 10.1146/annurev.biochem.67.1.181; Sanderson RJ, 1996, J BIOL CHEM, V271, P29170, DOI 10.1074/jbc.271.46.29170; SAVVA R, 1995, NAT STRUCT BIOL, V2, P752, DOI 10.1038/nsb0995-752; SAVVA R, 1995, NATURE, V373, P487, DOI 10.1038/373487a0; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; Stivers JT, 1998, NUCLEIC ACIDS RES, V26, P3837, DOI 10.1093/nar/26.16.3837; Stivers JT, 1999, BIOCHEMISTRY-US, V38, P952, DOI 10.1021/bi9818669; Surby MA, 1996, BIOCHEMISTRY-US, V35, P2209, DOI 10.1021/bi951884f; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Werner RM, 2000, BIOCHEMISTRY-US, V39, P14054, DOI 10.1021/bi0018178; Werner RM, 2000, BIOCHEMISTRY-US, V39, P12585, DOI 10.1021/bi001532v; WHITSON PA, 1986, BIOCHEMISTRY-US, V25, P3845, DOI 10.1021/bi00361a016; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6961, DOI 10.1021/bi00527a030; Wong I, 1997, BIOCHEMISTRY-US, V36, P3115, DOI 10.1021/bi9621977; Xiao GY, 1999, PROTEINS, V35, P13; ZIMMERLE CT, 1989, BIOCHEM J, V258, P381, DOI 10.1042/bj2580381	45	60	62	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19424	19432		10.1074/jbc.M201198200	http://dx.doi.org/10.1074/jbc.M201198200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11907039	hybrid			2022-12-27	WOS:000175894800026
J	Dumermuth, E; Beuret, N; Spiess, M; Crottet, P				Dumermuth, E; Beuret, N; Spiess, M; Crottet, P			Ubiquitous 9-O-acetylation of sialoglycoproteins restricted to the Golgi complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZA-C-VIRUS; N-LINKED OLIGOSACCHARIDES; ACID O-ACETYLTRANSFERASE; HAMSTER OVARY CELLS; SIALIC ACIDS; N-ACETYL-9-O-ACETYLNEURAMINIC ACID; RECEPTOR DETERMINANT; BOVINE CORONAVIRUS; GLYCOSYLATION; MEMBRANE	9-O-Acetylation of sialic acid is known as a cell type-specific modification of secretory and plasma membrane glycoconjugates of higher vertebrates with important functions in modulating cell-cell recognition. Using a recombinant probe derived from influenza C virus hemagglutinin, we discovered 9-O-acetylated protein in the Golgi complex of various cell lines, most of which did not display 9-O-acetylated sialic acid on the cell surface. All cell lines expressed a sulfated glycoprotein of 50 kDa (sgp50) carrying 9-O-acetylated sialic acids, which was used as a model substrate. Like gp40, the major receptor for influenza C virus of Madin-Darby canine kidney I cells, sgp50 is 9-O-acetylated on O-linked glycans. However, gp40 was not 9-O-acetylated when expressed in Madin-Darby canine kidney II or COS-7 cells. The results demonstrate the existence of two 9-O-acetylation machineries for O-glycosylated proteins with distinct substrate specificities. The widespread occurrence of 9-O-acetylated protein in the Golgi furthermore suggests an additional intracellular role for this modification.	Univ Basel, Bioctr, CH-4056 Basel, Switzerland	University of Basel	Spiess, M (corresponding author), Univ Basel, Bioctr, Klingelbergstr 70, CH-4056 Basel, Switzerland.	Martin.Spiess@unibas.ch		Spiess, Martin/0000-0001-7139-0550				BUTOR C, 1993, J BIOL CHEM, V268, P10197; Chammas R, 1996, MOL BIOL CELL, V7, P1691, DOI 10.1091/mbc.7.11.1691; DIAZ S, 1989, J BIOL CHEM, V264, P19416; GILMORE R, 1985, CELL, V42, P497, DOI 10.1016/0092-8674(85)90107-2; Harms G, 1996, GLYCOCONJUGATE J, V13, P621, DOI 10.1007/BF00731450; HERRLER G, 1987, VIROLOGY, V159, P102, DOI 10.1016/0042-6822(87)90352-7; HERRLER G, 1988, J GEN VIROL, V69, P839, DOI 10.1099/0022-1317-69-4-839; Huet G, 1998, J CELL BIOL, V141, P1311, DOI 10.1083/jcb.141.6.1311; Itin C, 1997, J BIOL CHEM, V272, P27737, DOI 10.1074/jbc.272.44.27737; KLEIN A, 1994, P NATL ACAD SCI USA, V91, P7782, DOI 10.1073/pnas.91.16.7782; KONAMI Y, 1994, FEBS LETT, V342, P334, DOI 10.1016/0014-5793(94)80527-X; Krishna M, 1997, J EXP MED, V185, P1997, DOI 10.1084/jem.185.11.1997; LEE EU, 1989, J BIOL CHEM, V264, P13848; LEITINGER B, 1994, J BIOL CHEM, V269, P8115; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; Liu XD, 2000, ANAL BIOCHEM, V280, P20, DOI 10.1006/abio.2000.4478; LOHMANDER LS, 1979, J BIOL CHEM, V254, P551; MUCHMORE EA, 1987, FASEB J, V1, P229, DOI 10.1096/fasebj.1.3.3623000; Puthalakath H, 1996, J BIOL CHEM, V271, P27818, DOI 10.1074/jbc.271.44.27818; ROBERTSON MA, 1978, CELL, V13, P515, DOI 10.1016/0092-8674(78)90325-2; ROGERS GN, 1986, J BIOL CHEM, V261, P5947; SCHAUER R, 1991, Glycobiology, V1, P449, DOI 10.1093/glycob/1.5.449; SCHULTZE B, 1992, J GEN VIROL, V73, P901, DOI 10.1099/0022-1317-73-4-901; SCHULTZE B, 1993, ADV EXP MED BIOL, V342, P299; Schwarz A, 1997, J HISTOCHEM CYTOCHEM, V45, P611, DOI 10.1177/002215549704500413; Shi WX, 1996, J BIOL CHEM, V271, P15130, DOI 10.1074/jbc.271.25.15130; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; SJOBERG ER, 1994, J CELL BIOL, V126, P549, DOI 10.1083/jcb.126.2.549; VARKI A, 1991, CELL, V65, P65, DOI 10.1016/0092-8674(91)90408-Q; VARKI A, 1992, GLYCOBIOLOGY, V2, P25, DOI 10.1093/glycob/2.1.25; Varki A, 1997, FASEB J, V11, P248, DOI 10.1096/fasebj.11.4.9068613; Varki A, 1998, TRENDS CELL BIOL, V8, P34, DOI 10.1016/S0962-8924(97)01198-7; WESSELS HP, 1991, METHOD CELL BIOL, V34, P287; Yim M, 2001, P NATL ACAD SCI USA, V98, P2222, DOI 10.1073/pnas.041621998; ZIMMER G, 1992, EUR J BIOCHEM, V204, P209, DOI 10.1111/j.1432-1033.1992.tb16626.x; ZIMMER G, 1994, GLYCOBIOLOGY, V4, P343, DOI 10.1093/glycob/4.3.343; ZIMMER G, 1995, J BIOL CHEM, V270, P17815, DOI 10.1074/jbc.270.30.17815; Zimmer G, 1997, BIOCHEM J, V326, P99, DOI 10.1042/bj3260099	39	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					18687	18693		10.1074/jbc.M109408200	http://dx.doi.org/10.1074/jbc.M109408200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11904293	hybrid			2022-12-27	WOS:000175975800060
J	Katz, YS; Danon, A				Katz, YS; Danon, A			The 3 '-untranslated region of chloroplast psbA mRNA stabilizes binding of regulatory proteins to the leader of the message	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; CHLAMYDOMONAS-REINHARDTII; 5'-UNTRANSLATED REGION; TRANSLATION INITIATION; TOBACCO CHLOROPLASTS; SECONDARY STRUCTURE; GENE-EXPRESSION; LIGHT; REQUIRES; DETERMINANTS	The 5'-leader and 3'-tail of chloroplast mRNAs have been suggested to play a role in posttranscriptional regulation of expression of the message. The regulation is thought to be mediated, at least in part, by regulatory proteins that are encoded by the nuclear genome and targeted to the chloroplast where they interact with chloroplast mRNAs. Previous studies identified high affinity binding of the 5'-untranslated region (UTR) of the chloroplast psbA mRNA by Chlamydomonas reinhardtit proteins. Here we tested whether the 3'-UTR of psbA mRNA alone or linked in cis with the 5'-UTR of the mRNA affects the high affinity binding of the message in vitro. We did not detect high affinity binding that is unique to the 3'-UTR. However, we show that the cis-linked 3'-UTR increases the stability of the 5'-UTR binding complex. This effect could provide a means for translational discrimination against mRNAs that are incorrectly processed.	Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Danon, A (corresponding author), Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel.							Alexander C, 1998, NUCLEIC ACIDS RES, V26, P2265, DOI 10.1093/nar/26.10.2265; Boudreau E, 2000, EMBO J, V19, P3366, DOI 10.1093/emboj/19.13.3366; Bruick RK, 1999, TRENDS PLANT SCI, V4, P190, DOI 10.1016/S1360-1385(99)01402-8; Bruick RK, 1998, J CELL BIOL, V143, P1145, DOI 10.1083/jcb.143.5.1145; DANON A, 1991, EMBO J, V10, P3993, DOI 10.1002/j.1460-2075.1991.tb04974.x; Drager RG, 1999, PLANT J, V19, P521, DOI 10.1046/j.1365-313X.1999.00546.x; Eibl C, 1999, PLANT J, V19, P333, DOI 10.1046/j.1365-313X.1999.00543.x; Fargo DC, 2001, PLANT CELL, V13, P207, DOI 10.1105/tpc.13.1.207; Franch T, 1996, MOL MICROBIOL, V21, P1049, DOI 10.1046/j.1365-2958.1996.771431.x; Gallie DR, 1998, GENE, V216, P1, DOI 10.1016/S0378-1119(98)00318-7; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; GIRARDBASCOU J, 1992, CURR GENET, V22, P47, DOI 10.1007/BF00351741; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Hayes R, 1996, EMBO J, V15, P1132, DOI 10.1002/j.1460-2075.1996.tb00451.x; Hirose T, 1996, EMBO J, V15, P1687, DOI 10.1002/j.1460-2075.1996.tb00514.x; Kim JM, 1997, SCIENCE, V278, P1954, DOI 10.1126/science.278.5345.1954; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lindahl L, 1992, CURR OPIN GENET DEV, V2, P720, DOI 10.1016/S0959-437X(05)80132-7; Lisitsky I, 1996, P NATL ACAD SCI USA, V93, P13398, DOI 10.1073/pnas.93.23.13398; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Mathews M. B., 1996, TRANSLATIONAL CONTRO, P1; MAYFIELD SP, 1994, J CELL BIOL, V127, P1537, DOI 10.1083/jcb.127.6.1537; MAYFIELD SP, 1995, ANNU REV PLANT PHYS, V46, P147, DOI 10.1146/annurev.pp.46.060195.001051; McCormac DJ, 2001, J BIOL CHEM, V276, P3476, DOI 10.1074/jbc.M009236200; Memon AR, 1996, PLANT MOL BIOL, V30, P1195, DOI 10.1007/BF00019552; Monde RA, 2000, BIOCHIMIE, V82, P573, DOI 10.1016/S0300-9084(00)00606-4; Monde RA, 2000, PLANT MOL BIOL, V44, P529, DOI 10.1023/A:1026540310934; Ossenbuhl F, 2000, MOL CELL BIOL, V20, P8134, DOI 10.1128/MCB.20.21.8134-8142.2000; Rott R, 1998, MOL CELL BIOL, V18, P4605, DOI 10.1128/MCB.18.8.4605; SCHUSTER G, 1991, EMBO J, V10, P1493, DOI 10.1002/j.1460-2075.1991.tb07669.x; STAUB JM, 1994, PLANT J, V6, P547, DOI 10.1046/j.1365-313X.1994.6040547.x; Trebitsh T, 2000, MOL CELL BIOL, V20, P1116, DOI 10.1128/MCB.20.4.1116-1123.2000; Vaistij FE, 2000, PLANT J, V21, P469, DOI 10.1046/j.1365-313x.2000.00700.x; Voorma H. O., 1996, TRANSLATIONAL CONTRO, p[759, 759]; Yohn CB, 1998, J CELL BIOL, V142, P435, DOI 10.1083/jcb.142.2.435; Yohn CB, 1996, MOL CELL BIOL, V16, P3560; Yohn CB, 1998, P NATL ACAD SCI USA, V95, P2238, DOI 10.1073/pnas.95.5.2238	37	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					18665	18669		10.1074/jbc.M201033200	http://dx.doi.org/10.1074/jbc.M201033200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11904302	hybrid			2022-12-27	WOS:000175975800057
J	Giuffre, A; Barone, MC; Brunori, M; D'Itri, E; Ludwig, B; Malatesta, F; Muller, HW; Sarti, P				Giuffre, A; Barone, MC; Brunori, M; D'Itri, E; Ludwig, B; Malatesta, F; Muller, HW; Sarti, P			Nitric oxide reacts with the single-electron reduced active site of cytochrome c oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARACOCCUS-DENITRIFICANS; RHODOBACTER-SPHAEROIDES; PROTON-TRANSFER; BINUCLEAR CENTER; HELIX-VIII; SUBUNIT-I; K-PATHWAY; INHIBITION; MECHANISM; RESPIRATION	The reduction kinetics of the mutants K354M and D124N of the Paracoccus denitrificans cytochrome oxidase (heme aa(3)) by ruthenium hexamine was investigated by stopped-flow spectrophotometry in the absence/presence of NO. Quick heme a reduction precedes the biphasic heme a(3) reduction, which is extremely slow in the K354M mutant (k(1) = 0.09 +/- 0.01 s(-1); k(2) = 0.005 +/- 0.001 s(-1)) but much faster in the D124N aa(3) (k(1) = 21 +/- 6 s(-1); k(2) = 2.2 +/- 0.5 s(-1)). NO causes a very large increase (>100-fold) in the rate constant of heme as reduction in the K354M mutant but only a similar to5-fold increase in the D124N mutant. The K354M enzyme reacts rapidly with O-2 when fully reduced but is essentially inactive in turnover; thus, it was proposed that impaired reduction of the active site is the cause of activity loss. Since at saturating [NO], heme as reduction is similar to100-fold faster than the extremely low turnover rate, we conclude that, contrary to O-2, NO can react not only with the two-electron but also with the single-electron reduced active site. This mechanism would account for the efficient inhibition of cytochrome oxidase activity by NO in the wild-type enzyme, both from P. denitrificans and from beef heart. Results also suggest that the H+-conducting K pathway, but not the D pathway, controls the kinetics of the single-electron reduction of the active site.	Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, CNR, Inst Biol & Patol Mol, I-00185 Rome, Italy; Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy; Univ Frankfurt, Biozentrum, Inst Biochem Mol Genet, D-60439 Frankfurt, Germany; Univ Aquila, Dept Pure & Appl Biol, I-67100 Laquila, Italy	Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome; Sapienza University Rome; Goethe University Frankfurt; University of L'Aquila	Giuffre, A (corresponding author), Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, CNR, Inst Biol & Patol Mol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.		Sarti, Paolo/D-2946-2009; Giuffrè, Alessandro/K-4341-2015; Malatesta, Francesco/AAT-4757-2020	Giuffrè, Alessandro/0000-0001-5301-0681; Brunori, Maurizio/0000-0002-7795-1635; Sarti, Paolo/0000-0002-8219-4827				Adelroth P, 1998, BIOCHEMISTRY-US, V37, P2470, DOI 10.1021/bi971813b; Branden M, 2001, P NATL ACAD SCI USA, V98, P5013, DOI 10.1073/pnas.081088398; BROWN GC, 1994, FEBS LETT, V356, P295, DOI 10.1016/0014-5793(94)01290-3; BROWN GC, 1995, FEBS LETT, V369, P136, DOI 10.1016/0014-5793(95)00763-Y; Brunori M, 1997, J BIOL CHEM, V272, P19870, DOI 10.1074/jbc.272.32.19870; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; Cooper CE, 1997, FEBS LETT, V414, P281, DOI 10.1016/S0014-5793(97)01009-0; GIBSON QH, 1963, BIOCHEM J, V86, P541, DOI 10.1042/bj0860541; Giuffre A, 1998, J BIOL CHEM, V273, P32475, DOI 10.1074/jbc.273.49.32475; Giuffre A, 1996, J BIOL CHEM, V271, P33404, DOI 10.1074/jbc.271.52.33404; HENDLER RW, 1991, BIOPHYS J, V60, P415, DOI 10.1016/S0006-3495(91)82067-7; HENRY ER, 1992, METHOD ENZYMOL, V210, P129; Hosler JP, 1996, BIOCHEMISTRY-US, V35, P10776, DOI 10.1021/bi9606511; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Junemann S, 1997, BIOCHEMISTRY-US, V36, P14456, DOI 10.1021/bi971458p; Konstantinov AA, 1997, P NATL ACAD SCI USA, V94, P9085, DOI 10.1073/pnas.94.17.9085; MALATESTA F, 1990, P NATL ACAD SCI USA, V87, P7410, DOI 10.1073/pnas.87.19.7410; Michel H, 1999, BIOCHEMISTRY-US, V38, P15129, DOI 10.1021/bi9910934; Pfitzner U, 1998, J BIOENERG BIOMEMBR, V30, P89, DOI 10.1023/A:1020515713103; Ruitenberg M, 2000, P NATL ACAD SCI USA, V97, P4632, DOI 10.1073/pnas.080079097; Stubauer G, 1998, BIOCHEM BIOPH RES CO, V245, P459, DOI 10.1006/bbrc.1998.8457; SVENSSON M, 1995, BIOCHEMISTRY-US, V34, P5252, DOI 10.1021/bi00015a040; TORRES J, 1995, BIOCHEM J, V312, P169, DOI 10.1042/bj3120169; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; VERKHOVSKY MI, 1995, BIOCHEMISTRY-US, V34, P7483, DOI 10.1021/bi00022a023; Verkhovsky MI, 2001, BIOCHEMISTRY-US, V40, P7077, DOI 10.1021/bi010030u; Vygodina TV, 1998, BIOCHEMISTRY-US, V37, P3053, DOI 10.1021/bi971876u; Wikstrom M, 2000, BBA-BIOENERGETICS, V1459, P514, DOI 10.1016/S0005-2728(00)00191-2; Zaslavsky D, 1998, BIOCHEMISTRY-US, V37, P3062, DOI 10.1021/bi971877m; Zaslavsky D, 1999, BIOCHEMISTRY-US, V38, P16016, DOI 10.1021/bi9916675; Zaslavsky D, 2000, BBA-BIOENERGETICS, V1458, P164, DOI 10.1016/S0005-2728(00)00066-9	31	33	33	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22402	22406		10.1074/jbc.M201514200	http://dx.doi.org/10.1074/jbc.M201514200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11950842	hybrid			2022-12-27	WOS:000176313600038
J	Henricksen, LA; Veeraraghavan, J; Chafin, DR; Bambara, RA				Henricksen, LA; Veeraraghavan, J; Chafin, DR; Bambara, RA			DNA ligase I competes with FEN1 to expand repetitive DNA sequences in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAG REPEAT TRACTS; HUMAN GENETIC-DISEASE; SACCHAROMYCES-CEREVISIAE; TRINUCLEOTIDE REPEAT; MISMATCH REPAIR; TRIPLET REPEATS; REPLICATION MUTATIONS; SECONDARY STRUCTURE; POLYMERASE-DELTA; TRANSGENIC MICE	Repeat sequences in various genomes undergo expansion by poorly understood mechanisms. By using an oligonucleotide system containing such repeats, we recapitulated the last steps in Okazaki fragment processing, which have been implicated in sequence expansion. A template containing either triplet or tandem repeats was annealed to a downstream primer containing complementary repeats at its 5'-end. Overlapping upstream primers, designed to strand-displace varying numbers of repeats in the downstream primer, were annealed. Human DNA ligase I joined overlapping segments of repeats generating an expansion product from the primer strands. Joining efficiency decreased with repeat length. Flap endonuclease 1 (FEN1) cleaved the displaced downstream strand and together with DNA ligase I produced non-expanded products. However, both expanded and non-expanded products formed irrespective of relative nuclease and ligase concentrations tested or enzyme addition order, suggesting the preexistence and persistence of intermediates leading to both outcomes. FEN1 activity decreased with the length of repeat segment displaced presumably because the flap forms structures that inhibit cleavage. Increased MgCl2 disfavored ligation of substrate intermediates that result in expansion products. Examination of expansion in vitro enables dissection of substrate and replication enzyme dynamics on repeat sequences.	Univ Rochester, Med Ctr, Dept Biochem & Biophys, Sch Med, Rochester, NY 14642 USA; Univ Rochester, Sch Med, Ctr Canc, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Bambara, RA (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, Sch Med, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052426, R01GM024441] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM24441, GM52426] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Balakumaran BS, 2000, HUM MOL GENET, V9, P93, DOI 10.1093/hmg/9.1.93; Bambara RA, 1997, J BIOL CHEM, V272, P4647, DOI 10.1074/jbc.272.8.4647; Bennett P, 2000, J CLIN PATHOL-MOL PA, V53, P177; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; Chastain PD, 1998, J MOL BIOL, V275, P405, DOI 10.1006/jmbi.1997.1502; Fortune MT, 2000, HUM MOL GENET, V9, P439, DOI 10.1093/hmg/9.3.439; Freudenreich CH, 1997, MOL CELL BIOL, V17, P2090, DOI 10.1128/MCB.17.4.2090; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; GACY AM, 1995, CELL, V81, P533; Gordenin DA, 1997, NAT GENET, V16, P116, DOI 10.1038/ng0697-116; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Henricksen LA, 2000, J BIOL CHEM, V275, P16420, DOI 10.1074/jbc.M909635199; Ireland MJ, 2000, GENETICS, V155, P1657; Jakupciak JP, 2000, J BIOL CHEM, V275, P40003, DOI 10.1074/jbc.M007153200; Jankowski C, 2000, P NATL ACAD SCI USA, V97, P2134, DOI 10.1073/pnas.040460297; JAWORSKI A, 1995, P NATL ACAD SCI USA, V92, P11019, DOI 10.1073/pnas.92.24.11019; Jin YH, 2001, P NATL ACAD SCI USA, V98, P5122, DOI 10.1073/pnas.091095198; Kokoska RJ, 1998, MOL CELL BIOL, V18, P2779, DOI 10.1128/MCB.18.5.2779; Kovtun IV, 2001, NAT GENET, V27, P407, DOI 10.1038/86906; Kovtun IV, 2000, HUM MOL GENET, V9, P2767, DOI 10.1093/hmg/9.18.2767; Manley K, 1999, NAT GENET, V23, P471, DOI 10.1038/70598; Miret JJ, 1998, P NATL ACAD SCI USA, V95, P12438, DOI 10.1073/pnas.95.21.12438; Moore H, 1999, P NATL ACAD SCI USA, V96, P1504, DOI 10.1073/pnas.96.4.1504; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Ohshima K, 1997, J BIOL CHEM, V272, P16798, DOI 10.1074/jbc.272.27.16798; Pearson CE, 1998, NUCLEIC ACIDS RES, V26, P816, DOI 10.1093/nar/26.3.816; Pearson CE, 1998, CURR OPIN STRUC BIOL, V8, P321, DOI 10.1016/S0959-440X(98)80065-1; Petruska J, 1996, NUCLEIC ACIDS RES, V24, P1992, DOI 10.1093/nar/24.11.1992; Richard GF, 2000, EMBO J, V19, P2381, DOI 10.1093/emboj/19.10.2381; Rolfsmeier ML, 2000, MOL CELL BIOL, V20, P173, DOI 10.1128/MCB.20.1.173-180.2000; Rolfsmeier ML, 2001, GENETICS, V157, P1569; Rolfsmeier ML, 2000, MOL CELL, V6, P1501, DOI 10.1016/S1097-2765(00)00146-5; Saenger W., 1984, PRINCIPLES NUCL ACID; Schweitzer JK, 1999, GENETICS, V152, P953; Schweitzer JK, 1998, HUM MOL GENET, V7, P69, DOI 10.1093/hmg/7.1.69; Spiro C, 1999, MOL CELL, V4, P1079, DOI 10.1016/S1097-2765(00)80236-1; SUTHERLAND GR, 1995, P NATL ACAD SCI USA, V92, P3636, DOI 10.1073/pnas.92.9.3636; TERAOKA H, 1993, J BIOL CHEM, V268, P24156; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; Usdin K, 2000, CELL MOL LIFE SCI, V57, P914, DOI 10.1007/PL00000734; White PJ, 1999, MOL CELL BIOL, V19, P5675	42	41	43	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22361	22369		10.1074/jbc.M201765200	http://dx.doi.org/10.1074/jbc.M201765200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11948189	hybrid			2022-12-27	WOS:000176313600033
J	Akache, B; Turcotte, B				Akache, B; Turcotte, B			New regulators of drug sensitivity in the family of yeast zinc cluster proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTER; MULTIDRUG-RESISTANCE TRANSPORTER; 4-NITROQUINOLINE N-OXIDE; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATOR; PLEIOTROPIC DRUG; GENE-EXPRESSION; ENCODING GENE; METAL RESISTANCE; ABC PROTEINS	The Gal4p family of yeast zinc cluster proteins comprises over 50 members that are putative transcriptional regulators. For example, Pdr1p and Pdr3p activate multidrug resistance genes by binding to pleiotropic drug response elements (PDREs) found in promoters of target genes such as PDR5, encoding a drug efflux pump involved in resistance to cycloheximide. However, the role of many zinc cluster proteins is unknown. We tested a panel of strains carrying deletions of zinc cluster genes in the presence of various drugs. One deletion strain (Deltardr1) was resistant to cycloheximide, whereas eight strains showed sensitivity to the antifungal ketoconazole or cycloheximide. Unnamed zinc cluster genes identified in our screen were called RDS for regulators of drug sensitivity. RNA levels of multidrug resistance genes such as PDR16, SNQ2, and PDR5 were decreased in many deletion strains. For example, cycloheximide sensitivity of a Deltastb5 strain was correlated with decreased RNA levels and promoter activity of the PDR5 gene. We tested if activation of PDR5 is mediated via a PDRE by inserting this DNA element in front of a minimal promoter linked to the lacZ gene. Strikingly, activity of the reporter was decreased in a Deltastb5 strain. The purified DNA binding domain of Stb5p bound to a PDRE in vitro. Mutations in the PDRE known to affect binding of Pdr1p/Pdr3p showed similar effects when assayed with Stb5p. These results strongly suggest that Stb5p is a transcriptional activator of multidrug resistance genes. Thus, we have identified new regulators of drug sensitivity in the family of zinc cluster proteins.	McGill Univ, Royal Victoria Hosp, Dept Med, Ctr Hlth, Montreal, PQ H3A 1A1, Canada; McGill Univ, Royal Victoria Hosp, Ctr Hlth, Dept Biochem, Montreal, PQ H3A 1A1, Canada; McGill Univ, Royal Victoria Hosp, Ctr Hlth, Dept Microbiol & Immunol, Montreal, PQ H3A 1A1, Canada	McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital	Turcotte, B (corresponding author), McGill Univ, Royal Victoria Hosp, Dept Med, Ctr Hlth, 687 Pine Ave W, Montreal, PQ H3A 1A1, Canada.	turcotte@lan1.molonc.mcgill.ca		Akache, Bassel/0000-0002-5377-7193				Adams A, 1997, METHODS YEAST GENETI; Akache B, 2001, NUCLEIC ACIDS RES, V29, P2181, DOI 10.1093/nar/29.10.2181; Angus-Hill ML, 2001, MOL CELL, V7, P741, DOI 10.1016/S1097-2765(01)00219-2; BALZI E, 1995, J BIOENERG BIOMEMBR, V27, P71, DOI 10.1007/BF02110333; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Bauer BE, 1999, BBA-BIOMEMBRANES, V1461, P217, DOI 10.1016/S0005-2736(99)00160-1; Brachmann CB, 1998, YEAST, V14, P115; CREUSOT F, 1988, J MOL BIOL, V204, P263, DOI 10.1016/0022-2836(88)90574-8; Crowley JH, 1998, J BACTERIOL, V180, P4177, DOI 10.1128/JB.180.16.4177-4183.1998; Cui Z, 1998, MOL MICROBIOL, V29, P1307, DOI 10.1046/j.1365-2958.1998.01027.x; Cui ZF, 1999, BIOSCI BIOTECH BIOCH, V63, P162, DOI 10.1271/bbb.63.162; DEAN M, 1995, CURR OPIN GENET DEV, V5, P779, DOI 10.1016/0959-437X(95)80011-S; Decottignies A, 1997, NAT GENET, V15, P137, DOI 10.1038/ng0297-137; DECOTTIGNIES A, 1995, J BIOL CHEM, V270, P18150, DOI 10.1074/jbc.270.30.18150; DELAHODDE A, 1995, MOL CELL BIOL, V15, P4043; GARDNER KH, 1991, BIOCHEMISTRY-US, V30, P11292, DOI 10.1021/bi00111a015; GOMPELKLEIN P, 1990, CURR GENET, V18, P93, DOI 10.1007/BF00321122; GOUNALAKI N, 1994, EMBO J, V13, P4036, DOI 10.1002/j.1460-2075.1994.tb06720.x; Groom KR, 1998, YEAST, V14, P77, DOI 10.1002/(SICI)1097-0061(19980115)14:1<77::AID-YEA201>3.0.CO;2-P; Hallstrom TC, 2001, J BIOL CHEM, V276, P23674, DOI 10.1074/jbc.M101568200; Hallstrom TC, 1998, J BIOL CHEM, V273, P2098, DOI 10.1074/jbc.273.4.2098; Hampsey M, 1997, YEAST, V13, P1099, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1099::AID-YEA177>3.3.CO;2-Z; Hellauer K, 1996, MOL CELL BIOL, V16, P6096; Hellauer K, 2001, J BIOL CHEM, V276, P13587, DOI 10.1074/jbc.M011196200; HELLAUER K, 2002, IN PRESS J BIOL CHEM, V277; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HIGGINS CF, 1995, CELL, V82, P693, DOI 10.1016/0092-8674(95)90465-4; HIRATA D, 1994, CURR GENET, V26, P285, DOI 10.1007/BF00310491; Iraqui I, 1999, MOL CELL BIOL, V19, P3360; Jackson JC, 1996, NUCLEIC ACIDS RES, V24, P1322, DOI 10.1093/nar/24.7.1322; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Kasten MM, 1997, MOL GEN GENET, V256, P376, DOI 10.1007/s004380050581; KATZMANN DJ, 1995, MOL CELL BIOL, V15, P6875; KATZMANN DJ, 1994, MOL CELL BIOL, V14, P4653, DOI 10.1128/MCB.14.7.4653; Katzmann DJ, 1996, J BIOL CHEM, V271, P23049, DOI 10.1074/jbc.271.38.23049; Kolaczkowska A, 1999, DRUG RESIST UPDATE, V2, P403, DOI 10.1054/drup.1999.0113; KUCHLER K, 1992, ENDOCR REV, V13, P499, DOI 10.1210/er.13.3.499; LEPPERT G, 1990, GENETICS, V125, P13; Lesage P, 1996, MOL CELL BIOL, V16, P1921, DOI 10.1128/mcb.16.5.1921; LOHR D, 1995, FASEB J, V9, P777, DOI 10.1096/fasebj.9.9.7601342; Mahe Y, 1996, MOL MICROBIOL, V20, P109, DOI 10.1111/j.1365-2958.1996.tb02493.x; Mendizabal I, 1998, FEBS LETT, V425, P323, DOI 10.1016/S0014-5793(98)00249-X; MEYERS S, 1992, CURR GENET, V21, P431, DOI 10.1007/BF00351651; Michaelis S, 1995, COLD SPRING HARB SYM, V60, P291, DOI 10.1101/SQB.1995.060.01.034; NEEDLEMAN R, 1991, MOL MICROBIOL, V5, P2079, DOI 10.1111/j.1365-2958.1991.tb02136.x; NISHIMURA H, 1992, FEBS LETT, V297, P155, DOI 10.1016/0014-5793(92)80349-L; Nourani A, 1997, MOL CELL BIOL, V17, P5453, DOI 10.1128/MCB.17.9.5453; Ozcan S, 1996, MOL CELL BIOL, V16, P6419; PFEIFER K, 1989, CELL, V56, P291, DOI 10.1016/0092-8674(89)90903-3; SCHNELL N, 1991, EUR J BIOCHEM, V200, P487, DOI 10.1111/j.1432-1033.1991.tb16209.x; Schwabe JWR, 1997, NAT STRUCT BIOL, V4, P680, DOI 10.1038/nsb0997-680; SIKORSKI RS, 1989, GENETICS, V122, P19; TAO P, 1990, P NATL ACAD SCI USA, V87, P2077, DOI 10.1073/pnas.87.6.2077; Todd RB, 1997, FUNGAL GENET BIOL, V21, P388, DOI 10.1006/fgbi.1997.0993; VIK A, 2000, MOL CELL BIOL, V20, P4381; Vincent O, 1998, EMBO J, V17, P7002, DOI 10.1093/emboj/17.23.7002; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WEMMIE JA, 1994, J BIOL CHEM, V269, P32592; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wolfger H, 1997, FEBS LETT, V418, P269, DOI 10.1016/S0014-5793(97)01382-3; WU AL, 1993, J BIOL CHEM, V268, P18850	61	60	71	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21254	21260		10.1074/jbc.M202566200	http://dx.doi.org/10.1074/jbc.M202566200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11943786	hybrid			2022-12-27	WOS:000176286000019
J	Conway, C; McCulloch, R; Ginger, ML; Robinson, NP; Browitt, A; Barry, JD				Conway, C; McCulloch, R; Ginger, ML; Robinson, NP; Browitt, A; Barry, JD			Ku is important for telomere maintenance, but not for differential expression of telomeric VSG genes, in African trypanosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; BINDING PROTEIN KU; ANTIGENIC VARIATION; SACCHAROMYCES-CEREVISIAE; DNA-REPAIR; HOMOLOGOUS RECOMBINATION; LENGTH MAINTENANCE; FISSION YEAST; BRUCEI; END	Trypanosome antigenic variation, involving differential expression of variant surface glycoprotein (VSG) genes, has a strong association with telomeres and with DNA recombination. All expressed VSGs are telomeric, and differential activation involves recombination into the telomeric environment or silencing/activation of subtelomeric promoters. A number of pathogen contingency gene systems associated with immune evasion involve telomeric loci, which has prompted speculation that chromosome ends provide conditions conducive for the operation of rapid gene switching mechanisms. Ku is a protein associated with eukaryotic telomeres that is directly involved in DNA recombination and in gene silencing. We have tested the hypothesis that Ku in trypanosomes is centrally involved in differential VSG expression. We show, via the generation of null mutants, that trypanosome Ku is closely involved in telomere length maintenance, more so for a transcriptionally active than an inactive telomere, but exhibits no detectable influence on DNA double strand break repair. The absence of Ku and the consequent great shortening of telomeres had no detectable influence either on the rate of VSG switching or on the silencing of the telomeric promoters of the VSG subset that is expressed in the tsetse fly.	Univ Glasgow, Anderson Coll, Wellcome Ctr Mol Parasitol, Glasgow G11 6NU, Lanark, Scotland	University of Glasgow	Barry, JD (corresponding author), Univ Glasgow, Anderson Coll, Wellcome Ctr Mol Parasitol, 56 Dumbarton Rd, Glasgow G11 6NU, Lanark, Scotland.	j.d.barry@biol.gla.ac.uk		Ginger, Michael/0000-0002-9643-8482; Robinson, Nick/0000-0002-6094-1924				Aravind L, 2001, GENOME RES, V11, P1365, DOI 10.1101/gr.181001; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Barry JD, 1998, MOL BIOCHEM PARASIT, V91, P93, DOI 10.1016/S0166-6851(97)00193-X; Barry JD, 2001, ADV PARASIT, V49, P1, DOI 10.1016/S0065-308X(01)49037-3; Baumann P, 2000, MOL BIOL CELL, V11, P3265, DOI 10.1091/mbc.11.10.3265; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Blundell PA, 1996, MOL BIOCHEM PARASIT, V76, P215, DOI 10.1016/0166-6851(95)02560-X; Boulton SJ, 1996, EMBO J, V15, P5093, DOI 10.1002/j.1460-2075.1996.tb00890.x; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; BRUN R, 1979, ACTA TROP, V36, P289; Chaves I, 1999, EMBO J, V18, P4846, DOI 10.1093/emboj/18.17.4846; CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; Cross GAM, 1996, BIOESSAYS, V18, P283, DOI 10.1002/bies.950180406; Deitsch KW, 1997, MICROBIOL MOL BIOL R, V61, P281, DOI 10.1128/.61.3.281-293.1997; del Portillo HA, 2001, NATURE, V410, P839, DOI 10.1038/35071118; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Doherty AJ, 2001, FEBS LETT, V500, P186, DOI 10.1016/S0014-5793(01)02589-3; Donelson JE, 1998, MOL BIOCHEM PARASIT, V91, P51, DOI 10.1016/S0166-6851(97)00209-0; Downs JA, 1999, MOL CELL BIOL, V19, P6260; Dubrana K, 2001, CURR OPIN CELL BIOL, V13, P281, DOI 10.1016/S0955-0674(00)00210-6; Featherstone C, 1999, CURR BIOL, V9, pR759, DOI 10.1016/S0960-9822(00)80005-6; Featherstone C, 1999, MUTAT RES-DNA REPAIR, V434, P3, DOI 10.1016/S0921-8777(99)00006-3; Ferreira MG, 2001, MOL CELL, V7, P55, DOI 10.1016/S1097-2765(01)00154-X; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Gell D, 1999, NUCLEIC ACIDS RES, V27, P3494, DOI 10.1093/nar/27.17.3494; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; GRAHAM SV, 1990, PARASITOLOGY, V101, P361, DOI 10.1017/S0031182000060558; Grandin N, 2000, MOL CELL BIOL, V20, P8397, DOI 10.1128/MCB.20.22.8397-8408.2000; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Horn D, 2000, EMBO J, V19, P2332, DOI 10.1093/emboj/19.10.2332; Horn D, 1997, EMBO J, V16, P7422, DOI 10.1093/emboj/16.24.7422; HORN D, 1995, CELL, V83, P555, DOI 10.1016/0092-8674(95)90095-0; Kass-Eisler A, 2000, TRENDS BIOCHEM SCI, V25, P200, DOI 10.1016/S0968-0004(00)01557-7; KITTEN T, 1990, P NATL ACAD SCI USA, V87, P6077, DOI 10.1073/pnas.87.16.6077; Lieber MR, 1999, GENES CELLS, V4, P77, DOI 10.1046/j.1365-2443.1999.00245.x; Mages GJ, 1996, J BIOL CHEM, V271, P7910, DOI 10.1074/jbc.271.14.7910; Manolis KG, 2001, EMBO J, V20, P210, DOI 10.1093/emboj/20.1.210; McCulloch R, 1997, MOL CELL BIOL, V17, P833, DOI 10.1128/MCB.17.2.833; McCulloch R, 1999, GENE DEV, V13, P2875, DOI 10.1101/gad.13.21.2875; Milne GT, 1996, MOL CELL BIOL, V16, P4189; MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1; Munoz-Jordan JL, 2001, EMBO J, V20, P579, DOI 10.1093/emboj/20.3.579; Murti KG, 1999, P NATL ACAD SCI USA, V96, P14436, DOI 10.1073/pnas.96.25.14436; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; PAYS E, 1983, NUCLEIC ACIDS RES, V11, P8137, DOI 10.1093/nar/11.23.8137; Pays E, 2001, MOL BIOCHEM PARASIT, V114, P1, DOI 10.1016/S0166-6851(01)00242-0; Peterson SE, 2001, NAT GENET, V27, P64, DOI 10.1038/83778; Porter SE, 1996, NUCLEIC ACIDS RES, V24, P582, DOI 10.1093/nar/24.4.582; Robinson NP, 1999, MOL CELL BIOL, V19, P5839; Rudenko G, 1998, TRENDS MICROBIOL, V6, P113, DOI 10.1016/S0966-842X(97)01200-6; RUDENKO G, 1995, CELL, V83, P547, DOI 10.1016/0092-8674(95)90094-2; Scherf A, 2001, CURR OPIN MICROBIOL, V4, P409, DOI 10.1016/S1369-5274(00)00227-7; SCHWARTZ JL, 1989, MUTAT RES, V216, P111, DOI 10.1016/0165-1161(89)90011-3; Shore D, 2001, CURR OPIN GENET DEV, V11, P189, DOI 10.1016/S0959-437X(00)00178-7; Siede W, 1996, GENETICS, V142, P91; Stringer JR, 2001, INFECT IMMUN, V69, P627, DOI 10.1128/IAI.69.2.627-639.2001; Vanhamme L, 2001, TRENDS PARASITOL, V17, P338, DOI 10.1016/S1471-4922(01)01922-5; VegaPalas MA, 1997, NAT GENET, V15, P232, DOI 10.1038/ng0397-232; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Woodard RL, 2001, J BIOL CHEM, V276, P15423, DOI 10.1074/jbc.M010752200	61	63	63	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21269	21277		10.1074/jbc.M200550200	http://dx.doi.org/10.1074/jbc.M200550200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11919193	hybrid			2022-12-27	WOS:000176286000021
J	Ji, ZS; Miranda, RD; Newhouse, YM; Weisgraber, KH; Huang, YD; Mahley, RW				Ji, ZS; Miranda, RD; Newhouse, YM; Weisgraber, KH; Huang, YD; Mahley, RW			Apolipoprotein E4 potentiates amyloid beta peptide-induced lysosomal leakage and apoptosis in neuronal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							LOW-DENSITY-LIPOPROTEIN; RECEPTOR-RELATED PROTEIN; CENTRAL-NERVOUS-SYSTEM; RADICAL OXIDATIVE STRESS; ALZHEIMERS-DISEASE; NEURITE OUTGROWTH; FIBRIL FORMATION; TERMINAL DOMAIN; TRANSGENIC MICE; CYTOCHROME-C	We assessed the isoform-specific effects of apolipoprotein (apo) E on the response of Neuro-2a cells to the amyloid beta peptide (Abeta1-42). As determined by the intracellular staining pattern and the release of beta-hexosaminidase into the cytosol, apoE4-transfected cells treated with aggregated Abeta1-42 showed a greater tendency toward lysosomal leakage than neo- or apoE3-transfected cells. Abeta1-42 caused significantly greater cell death and more than 2-fold greater DNA fragmentation in apoE4-secreting than in apoE3-secreting or control cells. H2O2 or staurosporine enhanced cell death and apoptosis in apoE4-transfected cells but not in apoE3-transfected cells. A caspase-9 inhibitor abolished the potentiation of Abeta1-42-induced apoptosis by apoE4. Similar results were obtained with conditioned medium from cells secreting apoE3 or apoE4. Cells preincubated for 4 h with a source of apoE3 or apoE4, followed by removal of apoE from the medium and from the cell surface, still exhibited the isoform-specific response to Abeta1-42, indicating that the potentiation of apoptosis required intracellular apoE, presumably in the endosomes or lysosomes. Studies of phospholipid (dimyristoylphosphatidylcholine) bilayer vesicles encapsulating 5-(and-6)-carboxyfluoreseein dye showed that apoE4 remodeled and disrupted the phospholipid vesicles to a greater extent than apoE3 or apoE2. In response to Abeta1-42, vesicles containing apoE4 were disrupted to a greater extent than those containing apoE3. These findings are consistent with apoE4 forming a reactive molecular intermediate that avidly binds phospholipid and may insert into the lysosomal membrane, destabilizing it and causing lysosomal leakage and apoptosis in response to Abeta1-42.	Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94141 USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94141 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Mahley, RW (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, POB 419100, San Francisco, CA 94141 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL047660] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL47660] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aleshkov SB, 1999, BIOCHEMISTRY-US, V38, P8918, DOI 10.1021/bi982002q; Bales KR, 1999, P NATL ACAD SCI USA, V96, P15233, DOI 10.1073/pnas.96.26.15233; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; BELLOSTA S, 1995, J BIOL CHEM, V270, P27063, DOI 10.1074/jbc.270.45.27063; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Blacker D, 1998, NAT GENET, V19, P357, DOI 10.1038/1243; Boland K, 1996, J BIOL CHEM, V271, P18032, DOI 10.1074/jbc.271.30.18032; Burdick D, 1997, BRAIN RES, V746, P275, DOI 10.1016/S0006-8993(96)01262-0; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; Butterfield DA, 1997, CHEM RES TOXICOL, V10, P495, DOI 10.1021/tx960130e; Buttini M, 2000, NEUROSCIENCE, V97, P207, DOI 10.1016/S0306-4522(00)00069-5; Carter DB, 2001, ANN NEUROL, V50, P468, DOI 10.1002/ana.1134; CASTANO EM, 1995, BIOCHEM J, V306, P599, DOI 10.1042/bj3060599; Cataldo AM, 1996, J NEUROSCI, V16, P186; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; DONG LM, 1994, J BIOL CHEM, V269, P22358; Drouet B, 2001, J NEUROCHEM, V76, P117, DOI 10.1046/j.1471-4159.2001.00047.x; Du YS, 1997, J NEUROCHEM, V69, P299; Estus S, 1997, J NEUROSCI, V17, P7736; Fagan AM, 1996, J BIOL CHEM, V271, P30121, DOI 10.1074/jbc.271.47.30121; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; HERZ J, 1994, ANN NY ACAD SCI, V737, P14, DOI 10.1111/j.1749-6632.1994.tb44298.x; HOLTZMAN DM, 1995, P NATL ACAD SCI USA, V92, P9480, DOI 10.1073/pnas.92.21.9480; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; HOWLETT DR, 1995, NEURODEGENERATION, V4, P23, DOI 10.1006/neur.1995.0003; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Huang YD, 2001, P NATL ACAD SCI USA, V98, P8838, DOI 10.1073/pnas.151254698; Huang YD, 1998, J BIOL CHEM, V273, P26388, DOI 10.1074/jbc.273.41.26388; Hughes SR, 1998, P NATL ACAD SCI USA, V95, P3275, DOI 10.1073/pnas.95.6.3275; HUSSAIN MM, 1991, J BIOL CHEM, V266, P13936; Isahara K, 1999, NEUROSCIENCE, V91, P233, DOI 10.1016/S0306-4522(98)00566-1; JI ZS, 1993, J BIOL CHEM, V268, P10160; Jolivalt C, 2000, FREE RADICAL BIO MED, V28, P129, DOI 10.1016/S0891-5849(99)00232-4; Jordan J, 1998, J NEUROSCI, V18, P195; Kaback M M, 1977, Prog Clin Biol Res, V18, P267; Kagedal K, 2001, BIOCHEM J, V359, P335, DOI 10.1042/0264-6021:3590335; Kalman J, 2000, NEUROBIOL AGING, V21, P555, DOI 10.1016/S0197-4580(00)00150-0; Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013; KLAUSNER RD, 1985, J BIOL CHEM, V260, P3719; Krajewski S, 1999, P NATL ACAD SCI USA, V96, P5752, DOI 10.1073/pnas.96.10.5752; Kruger R, 1999, ANN NEUROL, V45, P611, DOI 10.1002/1531-8249(199905)45:5<611::AID-ANA9>3.0.CO;2-X; Kuida K, 2000, INT J BIOCHEM CELL B, V32, P121, DOI 10.1016/S1357-2725(99)00024-2; LaDu MJ, 1997, J NEUROSCI RES, V49, P9, DOI 10.1002/(SICI)1097-4547(19970701)49:1<9::AID-JNR2>3.0.CO;2-H; LaFerla FM, 1996, J CLIN INVEST, V98, P1626, DOI 10.1172/JCI118957; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LeBlanc A, 1999, J BIOL CHEM, V274, P23426, DOI 10.1074/jbc.274.33.23426; Lendon CL, 2000, EUR J NEUROSCI, V12, P2235, DOI 10.1046/j.1460-9568.2000.00113.x; Li YP, 1996, BRAIN RES, V738, P196, DOI 10.1016/S0006-8993(96)00733-0; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; LOO DT, 1993, P NATL ACAD SCI USA, V90, P7951, DOI 10.1073/pnas.90.17.7951; Lu B, 2000, J BIOL CHEM, V275, P20775, DOI 10.1074/jbc.M003508200; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mazziotti M, 1998, BIOCHEM J, V332, P517, DOI 10.1042/bj3320517; McLaurin J, 2000, J STRUCT BIOL, V130, P259, DOI 10.1006/jsbi.2000.4289; Michikawa M, 2001, J NEUROSCI, V21, P7226, DOI 10.1523/JNEUROSCI.21-18-07226.2001; Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55; Morishima Y, 2001, J NEUROSCI, V21, P7551, DOI 10.1523/JNEUROSCI.21-19-07551.2001; MORROW J, 2000, PROTEIN SCI S1, V9, P101; Morrow JA, 2000, BIOCHEMISTRY-US, V39, P11657, DOI 10.1021/bi000099m; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Narita M, 1997, J NEUROCHEM, V69, P1904; NATHAN BP, 1995, J BIOL CHEM, V270, P19791, DOI 10.1074/jbc.270.34.19791; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Nicoll JAR, 1996, ANN NY ACAD SCI, V777, P271, DOI 10.1111/j.1749-6632.1996.tb34431.x; Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7; Pedersen WA, 2000, J NEUROCHEM, V74, P1426, DOI 10.1046/j.1471-4159.2000.0741426.x; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Pillot T, 1999, J NEUROCHEM, V72, P230, DOI 10.1046/j.1471-4159.1999.0720230.x; Pillot T, 1999, J NEUROCHEM, V73, P1626, DOI 10.1046/j.1471-4159.1999.0731626.x; Pillot T, 1997, EUR J BIOCHEM, V243, P650, DOI 10.1111/j.1432-1033.1997.00650.x; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Qiu ZH, 1999, J NEUROCHEM, V73, P1393, DOI 10.1046/j.1471-4159.1999.0731393.x; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Ramassamy C, 1999, FREE RADICAL BIO MED, V27, P544, DOI 10.1016/S0891-5849(99)00102-1; Roberg K, 2001, LAB INVEST, V81, P149, DOI 10.1038/labinvest.3780222; Roberg K, 1999, FREE RADICAL BIO MED, V27, P1228, DOI 10.1016/S0891-5849(99)00146-X; Rodrigues CMP, 2000, MOL MED, V6, P936, DOI 10.1007/BF03401828; Roth KA, 2001, J NEUROPATH EXP NEUR, V60, P829, DOI 10.1093/jnen/60.9.829; SANAN DA, 1994, J CLIN INVEST, V94, P860, DOI 10.1172/JCI117407; SAUNDERS AM, 1993, LANCET, V342, P710, DOI 10.1016/0140-6736(93)91709-U; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SELKOE DJ, 1994, J NEUROPATH EXP NEUR, V53, P438, DOI 10.1097/00005072-199409000-00003; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Slooter AJC, 1997, JAMA-J AM MED ASSOC, V277, P818, DOI 10.1001/jama.277.10.818; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; SWANSON J, 1987, J CELL BIOL, V104, P1217, DOI 10.1083/jcb.104.5.1217; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Troy CM, 2001, J NEUROCHEM, V77, P157, DOI 10.1046/j.1471-4159.2001.00218.x; Troy CM, 2000, J NEUROSCI, V20, P1386; UEDA K, 1994, BRAIN RES, V639, P240, DOI 10.1016/0006-8993(94)91736-1; Uetsuki T, 1999, J NEUROSCI, V19, P6955, DOI 10.1523/JNEUROSCI.19-16-06955.1999; Ulery PG, 2000, J CLIN INVEST, V106, P1077, DOI 10.1172/JCI11455; Varadarajan S, 2000, J STRUCT BIOL, V130, P184, DOI 10.1006/jsbi.2000.4274; WEINSTEIN JN, 1981, BIOCHIM BIOPHYS ACTA, V647, P270, DOI 10.1016/0005-2736(81)90255-8; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; WISNIEWSKI T, 1994, AM J PATHOL, V145, P1030; Xu J, 2001, J CEREBR BLOOD F MET, V21, P702, DOI 10.1097/00004647-200106000-00008; Yang AJ, 1998, J NEUROSCI RES, V52, P691, DOI 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3; Yang DS, 1999, NEUROSCIENCE, V90, P1217, DOI 10.1016/S0306-4522(98)00561-2; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739	113	140	146	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21821	21828		10.1074/jbc.M112109200	http://dx.doi.org/10.1074/jbc.M112109200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11912196	hybrid			2022-12-27	WOS:000176286000091
J	Lin, YQ; Hwang, WC; Basavappa, R				Lin, YQ; Hwang, WC; Basavappa, R			Structural and functional analysis of the human mitotic-specific ubiquitin-conjugating enzyme, UbcH10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; PROTEIN; ANAPHASE; E2-C; DESTRUCTION; COMPLEX; IDENTIFICATION; EXPRESSION	Cell cycle progression is controlled at several different junctures by the targeted destruction of cell cycle regulatory proteins. These carefully orchestrated events include the destruction of the securin protein to permit entry into anaphase, and the destruction of cyclin B to permit exit from mitosis. These destruction events are mediated by the ubiquitin/proteasome system. The human ubiquitin-conjugating enzyme, UbcH10, is an essential mediator of the mitotic destruction events. We report here the 1.95-Angstrom crystal structure of a mutant UbcH10, in which the active site cysteine has been replaced with a serine. Functional analysis indicates that the mutant is active in accepting ubiquitin, although not as efficiently as wild-type. Examination of the crystal structure reveals that the NH2-terminal extension in UbcH10 is disordered and that a conserved 3(10)-helix places a lysine residue near the active site. Analysis of relevant mutants demonstrates that for ubiquitin-adduct formation the presence or absence of the NH2-terminal extension has little effect, whereas the lysine residue near the active site has significant effect. The structure provides additional insight into UbcH10 function including possible sites of interaction with the anaphase promoting complex/cyclosome and the disposition of a putative destruction box motif in the structure.	Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Basavappa, R (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA.	Ravi_Basavappa@urmc.rochester.edu	Basavappa, Ravi/AAF-7385-2021		NIGMS NIH HHS [GM 57536] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057536] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amon A, 2001, NAT CELL BIOL, V3, pE12, DOI 10.1038/35050642; Aristarkhov A, 1996, P NATL ACAD SCI USA, V93, P4294, DOI 10.1073/pnas.93.9.4294; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; ARNOLD JE, 1990, BIOCHEM J, V267, P751, DOI 10.1042/bj2670751; Arvand A, 1998, ONCOGENE, V17, P2039, DOI 10.1038/sj.onc.1202129; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BANERJEE A, 1993, J BIOL CHEM, V268, P5668; BANERJEE A, 1995, J BIOL CHEM, V270, P26209, DOI 10.1074/jbc.270.44.26209; BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CIECHANOVER A, 1982, J BIOL CHEM, V257, P2537; COOK WJ, 1992, J BIOL CHEM, V267, P15116; COOK WJ, 1993, BIOCHEMISTRY-US, V32, P13809, DOI 10.1021/bi00213a009; Cook WJ, 1997, BIOCHEMISTRY-US, V36, P1621, DOI 10.1021/bi962639e; Funabiki H, 1997, EMBO J, V16, P5977, DOI 10.1093/emboj/16.19.5977; Giraud MF, 1998, ACTA CRYSTALLOGR D, V54, P891, DOI 10.1107/S0907444998002480; Gmachl M, 2000, P NATL ACAD SCI USA, V97, P8973, DOI 10.1073/pnas.97.16.8973; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; GWOZD CS, 1995, BIOCHEMISTRY-US, V34, P6296, DOI 10.1021/bi00019a006; Haldeman MT, 1997, BIOCHEMISTRY-US, V36, P10526, DOI 10.1021/bi970750u; Hershko A, 1999, PHILOS T R SOC B, V354, P1571, DOI 10.1098/rstb.1999.0500; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Jiang F, 1999, BIOCHEMISTRY-US, V38, P6471, DOI 10.1021/bi9901329; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leverson JD, 2000, MOL BIOL CELL, V11, P2315, DOI 10.1091/mbc.11.7.2315; Mitsui A, 1999, P NATL ACAD SCI USA, V96, P6054, DOI 10.1073/pnas.96.11.6054; Miura T, 1999, J MOL BIOL, V290, P213, DOI 10.1006/jmbi.1999.2859; Moraes TF, 2001, NAT STRUCT BIOL, V8, P669, DOI 10.1038/90373; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Noton E, 2000, MOL CELL, V5, P85, DOI 10.1016/S1097-2765(00)80405-0; Osaka F, 1997, MOL CELL BIOL, V17, P3388, DOI 10.1128/MCB.17.6.3388; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PICKART CM, 1985, J BIOL CHEM, V260, P1573; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; RUSSELL RB, 1999, STAMP VERSION 4 2 MA; SULLIVAN ML, 1993, J BIOL CHEM, V268, P8777; SUNG P, 1991, J MOL BIOL, V221, P745, DOI 10.1016/0022-2836(91)80169-U; Tokumoto M, 1999, FEBS LETT, V458, P375, DOI 10.1016/S0014-5793(99)01189-8; Tong H, 1997, J BIOL CHEM, V272, P21381, DOI 10.1074/jbc.272.34.21381; Townsley FM, 1997, P NATL ACAD SCI USA, V94, P2362, DOI 10.1073/pnas.94.6.2362; Townsley FM, 1998, TRENDS CELL BIOL, V8, P238, DOI 10.1016/S0962-8924(98)01268-9; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Wada H, 2000, J BIOL CHEM, V275, P17008, DOI 10.1074/jbc.275.22.17008; Worthylake DR, 1998, J BIOL CHEM, V273, P6271, DOI 10.1074/jbc.273.11.6271; Yamanaka A, 2000, MOL BIOL CELL, V11, P2821, DOI 10.1091/mbc.11.8.2821; Yu HT, 1996, CURR BIOL, V6, P455, DOI 10.1016/S0960-9822(02)00513-4; Zhang C, 2000, J MOL BIOL, V299, P1075, DOI 10.1006/jmbi.2000.3678; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	56	52	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21913	21921		10.1074/jbc.M109398200	http://dx.doi.org/10.1074/jbc.M109398200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11927573	hybrid			2022-12-27	WOS:000176286000103
J	Sakaguchi, T; Gu, XB; Golden, HM; Suh, ER; Rhoads, DB; Reinecker, HC				Sakaguchi, T; Gu, XB; Golden, HM; Suh, ER; Rhoads, DB; Reinecker, HC			Cloning of the human claudin-2 5 '-flanking region revealed a TATA-less promoter with conserved binding sites in mouse and human for caudal-related homeodomain proteins and hepatocyte nuclear factor-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINE-SPECIFIC TRANSCRIPTION; PHLORHIZIN HYDROLASE GENE; SUCRASE-ISOMALTASE GENE; TIGHT JUNCTION STRANDS; EPITHELIAL-CELL LINE; NF-KAPPA-B; HOMEOBOX GENE; FACTOR-I; EXPRESSION; HNF-1-ALPHA	Claudin-2 is a structural component of tight junctions in the kidneys, liver, and intestine, but the mechanisms regulating its expression have not been defined. The 5'-flanking region of the claudin-2 gene contains binding sites for intestine-specific Cdx homeodomain proteins and hepatocyte nuclear factor (HNF)-1, which are conserved in human and mouse. Both Cdx1 and Cdx2 activated the claudin-2 promoter in the human intestinal epithelial cell line Caco-2. HNF-1alpha augmented the Cdx2-induced but not Cdx1-induced transcriptional activation of the human claudin-2 promoter. In mice, HNF-1alpha was required for claudin-2 expression in the villus epithelium of the ileum and within the liver but not in the kidneys, indicating an organ-specific function of HNF-1alpha in the regulation of claudin-2 gene expression. Tight junction structural components, which determine epithelial polarization and intestinal barrier function, can be regulated by homeodomain proteins that control the differentiation of the intestinal epithelium.	Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Dept Med, Gastrointestinal Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pediat, Pediat Endocrine Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Univ Penn, Sch Med, Dept Internal Med, Philadelphia, PA 19104 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Pennsylvania	Reinecker, HC (corresponding author), Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Dept Med, Gastrointestinal Unit, 32 Fruit St, Boston, MA 02114 USA.				NIDDK NIH HHS [DK51003, DK54399, DK54427, DK33506] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK033506, R01DK054427, R01DK051003, R01DK054399] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akiyama TE, 2000, J BIOL CHEM, V275, P27117; ANDERSON JM, 1995, AM J PHYSIOL-GASTR L, V269, pG467, DOI 10.1152/ajpgi.1995.269.4.G467; Awane M, 1999, J IMMUNOL, V162, P5337; BACH I, 1993, EMBO J, V12, P4229, DOI 10.1002/j.1460-2075.1993.tb06107.x; Boudreau F, 2001, J BIOL CHEM, V276, P32122, DOI 10.1074/jbc.M102002200; Cereghini S, 1996, FASEB J, V10, P267, DOI 10.1096/fasebj.10.2.8641560; Charite J, 1998, DEVELOPMENT, V125, P4349; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Drummond F, 1996, EUR J BIOCHEM, V236, P670, DOI 10.1111/j.1432-1033.1996.t01-1-00670.x; Drummond FJ, 1998, FEBS LETT, V423, P218, DOI 10.1016/S0014-5793(98)00103-3; Dukes ID, 1998, J BIOL CHEM, V273, P24457, DOI 10.1074/jbc.273.38.24457; DUPREY P, 1988, GENE DEV, V2, P1647, DOI 10.1101/gad.2.12a.1647; Fang RX, 2000, GASTROENTEROLOGY, V118, P115, DOI 10.1016/S0016-5085(00)70420-3; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; GILMORE TD, 1990, CELL, V62, P841, DOI 10.1016/0092-8674(90)90257-F; Hu CB, 1999, AM J PHYSIOL-GASTR L, V276, pG1181, DOI 10.1152/ajpgi.1999.276.5.G1181; JAMES R, 1994, J BIOL CHEM, V269, P15229; Kinugasa T, 2000, GASTROENTEROLOGY, V118, P1001, DOI 10.1016/S0016-5085(00)70351-9; Krasinski SD, 2001, AM J PHYSIOL-GASTR L, V281, pG69, DOI 10.1152/ajpgi.2001.281.1.G69; KUO CJ, 1990, P NATL ACAD SCI USA, V87, P9838, DOI 10.1073/pnas.87.24.9838; Lambert M, 1996, EUR J BIOCHEM, V236, P778, DOI 10.1111/j.1432-1033.1996.00778.x; Lee YH, 1998, MOL CELL BIOL, V18, P3059, DOI 10.1128/MCB.18.5.3059; Lorentz O, 1997, J CELL BIOL, V139, P1553, DOI 10.1083/jcb.139.6.1553; Lynch J, 2000, J BIOL CHEM, V275, P4499, DOI 10.1074/jbc.275.6.4499; Madara JL, 1998, ANNU REV PHYSIOL, V60, P143, DOI 10.1146/annurev.physiol.60.1.143; MENDEL DB, 1991, SCIENCE, V254, P1762, DOI 10.1126/science.1763325; MENDEL DB, 1991, GENE DEV, V5, P1042, DOI 10.1101/gad.5.6.1042; Mitchelmore C, 2000, BIOCHEM J, V346, P529, DOI 10.1042/0264-6021:3460529; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; ORKIN SH, 1992, BLOOD, V80, P575; Park J, 2000, GASTROENTEROLOGY, V119, P89, DOI 10.1053/gast.2000.8520; Pontoglio M, 2000, J AM SOC NEPHROL, V11, pS140; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Rahner C, 2001, GASTROENTEROLOGY, V120, P411, DOI 10.1053/gast.2001.21736; Rings EHHM, 2001, GASTROENTEROLOGY, V121, P1437, DOI 10.1053/gast.2001.29618; Schneeberger EE, 1992, AM J PHYSIOL, V262, P647; SERFAS MS, 1993, AM J PHYSIOL, V265, pG506, DOI 10.1152/ajpgi.1993.265.3.G506; Silberg DG, 2000, GASTROENTEROLOGY, V119, P961, DOI 10.1053/gast.2000.18142; Silberg DG, 1997, GASTROENTEROLOGY, V113, P478, DOI 10.1053/gast.1997.v113.pm9247467; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; Soubeyran P, 1999, GASTROENTEROLOGY, V117, P1326, DOI 10.1016/S0016-5085(99)70283-0; Suh E, 1996, MOL CELL BIOL, V16, P619; SUH E, 1994, MOL CELL BIOL, V14, P7340, DOI 10.1128/MCB.14.11.7340; Suh ER, 2001, AM J PHYSIOL-GASTR L, V280, pG149, DOI 10.1152/ajpgi.2001.280.1.G149; Suzuki Y, 2001, GENOME RES, V11, P677, DOI 10.1101/gr.GR-1640R; TRABER PG, 1992, MOL CELL BIOL, V12, P3614, DOI 10.1128/MCB.12.8.3614; Troelsen JT, 1997, BIOCHEM J, V322, P833, DOI 10.1042/bj3220833; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tsukita S, 2000, J CELL BIOL, V149, P13, DOI 10.1083/jcb.149.1.13; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; WASYLYK C, 1989, MOL CELL BIOL, V9, P2247, DOI 10.1128/MCB.9.5.2247; Whyte DA, 1999, AM J PHYSIOL-RENAL, V277, pF587, DOI 10.1152/ajprenal.1999.277.4.F587; WU GD, 1994, J BIOL CHEM, V269, P17080; Xu FH, 1999, J BIOL CHEM, V274, P34310, DOI 10.1074/jbc.274.48.34310	55	143	150	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21361	21370		10.1074/jbc.M110261200	http://dx.doi.org/10.1074/jbc.M110261200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11934881	hybrid			2022-12-27	WOS:000176286000033
J	Duchesne, L; Pellerin, I; Delamarche, C; Deschamps, S; Lagree, V; Froger, A; Bonnec, G; Thomas, D; Hubert, JF				Duchesne, L; Pellerin, I; Delamarche, C; Deschamps, S; Lagree, V; Froger, A; Bonnec, G; Thomas, D; Hubert, JF			Role of C-terminal domain and transmembrane helices 5 and 6 in function and quaternary structure of major intrinsic proteins - Analysis of aquaporin/glycerol facilitator chimeric proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WATER CHANNELS; MIP FAMILY; OLIGOMERIZATION STATE; ESCHERICHIA-COLI; GLYCEROL CHANNEL; XENOPUS OOCYTES; FREEZE-FRACTURE; AQUAPORIN-1; PERMEATION; MEMBRANES	We previously observed that aquaporins and glycerol facilitators exhibit different oligomeric states when studied by sedimentation on density gradients following nondenaturing detergent solubilization. To determine the domains of major intrinsic protein (MIP) family proteins involved in oligomerization, we constructed protein chimeras corresponding to the aquaporin AQPcic substituted in the loop E (including the proximal part of transmembrane domain (TM) 5) and/or the C-terminal part (including the distal part of TM 6) by the equivalent domain of the glycerol channel aquaglyceroporin (GlpF) (chimeras called AGA, AAG, and AGG). The analogous chimeras of GlpF were also constructed (chimeras GAG, GGA, and GAA). cRNA corresponding to all constructs were injected into Xenopus oocytes. AQPcic, GlpF, AAG, AGG, and GAG were targeted to plasma membranes. Water or glycerol membrane permeability measurements demonstrated that only the AAG chimera exhibited a channel function corresponding to water transport. Analysis of all proteins expressed either in oocytes or in yeast by velocity sedimentation on sucrose gradients following solubilization by 2% n-octyl glucoside indicated that only AQPcic and AAG exist in tetrameric forms. GlpF, GAG, and GAA sediment in a monomeric form, whereas GGA and AGG were found mono/dimeric. These data bring new evidence that, within the MIP family, aquaporins and GlpFs behave differently toward nondenaturing detergents. We demonstrate that the C-terminal part of AQPcic, including the distal half of TM 6, can be substituted by the equivalent domain of GlpF (AAG chimera) without modifying the transport specificity. Our results also suggest that interactions of TM 5 of one monomer with TM 1 of the adjacent monomer are crucial for aquaporin tetramer stability.	Univ Rennes 1, UMR 6026, CNRS, F-35042 Rennes, Bretagne, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Hubert, JF (corresponding author), Univ Rennes 1, UMR 6026, CNRS, Campus Beaulieu,Batiment 13, F-35042 Rennes, Bretagne, France.		THOMAS, Danniel/AAJ-5033-2020; DELAMARCHE, Christian/A-2138-2010	THOMAS, Danniel/0000-0002-9650-0434; DELAMARCHE, Christian/0000-0002-8963-0062; Duchesne, Laurence/0000-0003-1985-6266				BEURON F, 1995, J BIOL CHEM, V270, P17414, DOI 10.1074/jbc.270.29.17414; Borgnia MJ, 2001, P NATL ACAD SCI USA, V98, P2888, DOI 10.1073/pnas.051628098; Bron P, 1999, J STRUCT BIOL, V128, P287, DOI 10.1006/jsbi.1999.4196; CENTENO F, 1994, FEBS LETT, V354, P117, DOI 10.1016/0014-5793(94)01104-4; Cheng AC, 1997, NATURE, V387, P627, DOI 10.1038/42517; Delamarche C, 2000, BIOTECHNIQUES, V29, P100, DOI 10.2144/00291bc01; Duchesne L, 2001, KIDNEY INT, V60, P422, DOI 10.1046/j.1523-1755.2001.060002422.x; Froger A, 1998, PROTEIN SCI, V7, P1458, DOI 10.1002/pro.5560070623; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Heymann JB, 2000, J MOL BIOL, V295, P1039, DOI 10.1006/jmbi.1999.3413; Ishibashi K, 1998, NEWS PHYSIOL SCI, V13, P137; Jensen MO, 2001, STRUCTURE, V9, P1083, DOI 10.1016/S0969-2126(01)00668-2; JUNG JS, 1994, J BIOL CHEM, V269, P14648; Kamsteeg EJ, 2000, NEPHROL DIAL TRANSPL, V15, P26, DOI 10.1093/ndt/15.suppl_6.26; Kuwahara M, 1999, BIOCHEMISTRY-US, V38, P16340, DOI 10.1021/bi9916776; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lagree V, 1998, J BIOL CHEM, V273, P12422, DOI 10.1074/jbc.273.20.12422; Lagree V, 1998, J BIOL CHEM, V273, P33949, DOI 10.1074/jbc.273.51.33949; Lagree V, 1999, J BIOL CHEM, V274, P6817, DOI 10.1074/jbc.274.11.6817; LeCaherec F, 1996, EUR J BIOCHEM, V241, P707, DOI 10.1111/j.1432-1033.1996.00707.x; Manley DM, 2000, BIOCHEMISTRY-US, V39, P12303, DOI 10.1021/bi000703t; Mathai JC, 1999, BIOCHEMISTRY-US, V38, P923, DOI 10.1021/bi9823683; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Mulders SM, 1998, PFLUG ARCH EUR J PHY, V436, P599, DOI 10.1007/s004240050677; Mulders SM, 1997, J AM SOC NEPHROL, V8, P242; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nollert P, 2001, FEBS LETT, V504, P112, DOI 10.1016/S0014-5793(01)02710-7; Park JH, 1996, J MEMBRANE BIOL, V153, P171, DOI 10.1007/s002329900120; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; PRESTON GM, 1993, J BIOL CHEM, V268, P17; Ren G, 2000, J STRUCT BIOL, V130, P45, DOI 10.1006/jsbi.2000.4211; SMITH BL, 1991, J BIOL CHEM, V266, P6407; Tsiuriupa G P, 1994, Mol Biol (Mosk), V28, P725; VERBAVATZ JM, 1993, J CELL BIOL, V123, P605, DOI 10.1083/jcb.123.3.605; Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512; Zhu FQ, 2001, FEBS LETT, V504, P212, DOI 10.1016/S0014-5793(01)02749-1	36	27	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20598	20604		10.1074/jbc.M201179200	http://dx.doi.org/10.1074/jbc.M201179200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11927589	hybrid			2022-12-27	WOS:000176204500065
J	Vabulas, RM; Braedel, S; Hilf, N; Singh-Jasuja, H; Herter, S; Ahmad-Nejad, P; Kirschning, CJ; da Costa, C; Rammensee, HG; Wagner, H; Schild, H				Vabulas, RM; Braedel, S; Hilf, N; Singh-Jasuja, H; Herter, S; Ahmad-Nejad, P; Kirschning, CJ; da Costa, C; Rammensee, HG; Wagner, H; Schild, H			The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the toll-like receptor 2/4 pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED ENDOCYTOSIS; CUTTING EDGE; MATURATION; ANTIGEN; CHAPERONE; IMMUNITY; SIGNAL; HSP90; HSP70; CD91	The heat shock protein Gp96 has been shown to induce specific immune responses. On one hand, this phenomenon is based on the specific interaction with CD91 that mediates endocytosis and results in major histocompatibility complex class I-restricted representation of the Gp96-associated peptides. On the other hand, Gp96 induces activation of professional antigen-presenting cells, resulting in the production of pro-inflammatory cytokines and up-regulation of costimulatory molecules by unknown mechanisms. In this study, we have analyzed the consequences of Gp96 interaction with cells expressing different Toll-like receptors (TLRs) and with bone marrow-derived dendritic cells from mice lacking functional TLR2 and/or TLR4 molecules. We find that the Gp96-TLR2/4 interaction results in activation of nuclear factor kappaB-driven reporter genes and mitogen- and stress-activated protein kinases and induces IkappaBalpha degradation. Bone marrow-derived dendritic cells of C3H/HeJ and more pronounced C3H/HeJ/ TLR2(-/-) mice fail to respond to Gp96. Interestingly, activation of bone marrow-derived dendritic cells depends on endocytosis of Gp96 molecules. Our results provide, for the first time, the molecular basis for understanding the Gp96-mediated activation of antigen-presenting cells by describing the simultaneous stimulation of the innate and adaptive immune system. This feature explains the remarkable ability of Gp96 to induce specific immune responses against tumors and pathogens.	Univ Tubingen, Inst Cell Biol, Dept Immunol, D-72076 Tubingen, Germany; Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany	Eberhard Karls University of Tubingen; Technical University of Munich	Schild, H (corresponding author), Univ Tubingen, Inst Cell Biol, Dept Immunol, Morgenstelle 15, D-72076 Tubingen, Germany.	hansjoerg.schild@uni-tuebingen.de	Vabulas, R. Martin/D-3506-2011					Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; ARNOLD D, 1995, J EXP MED, V182, P885, DOI 10.1084/jem.182.3.885; Arnold-Schild D, 1999, J IMMUNOL, V162, P3757; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Berwin B, 2001, J BIOL CHEM, V276, P21083, DOI 10.1074/jbc.M101836200; BEVAN MJ, 1976, J IMMUNOL, V117, P2233; Binder RJ, 2000, NAT IMMUNOL, V1, P151, DOI 10.1038/77835; BLACHERE NE, 1993, J IMMUNOTHER, V14, P352, DOI 10.1097/00002371-199311000-00016; Blachere NE, 1997, J EXP MED, V186, P1315, DOI 10.1084/jem.186.8.1315; Chen W, 1999, J IMMUNOL, V162, P3212; DAVIES PJA, 1980, NATURE, V283, P162, DOI 10.1038/283162a0; Golenbock DT, 2001, NAT IMMUNOL, V2, P286, DOI 10.1038/86289; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Kaisho T, 2001, TRENDS IMMUNOL, V22, P78, DOI 10.1016/S1471-4906(00)01811-1; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; ROCK KL, 1990, SCIENCE, V249, P918, DOI 10.1126/science.2392683; Schild H, 1999, CURR OPIN IMMUNOL, V11, P109, DOI 10.1016/S0952-7915(99)80019-3; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Singh-Jasuja H, 2000, J EXP MED, V191, P1965, DOI 10.1084/jem.191.11.1965; Singh-Jasuja H, 2000, EUR J IMMUNOL, V30, P2211, DOI 10.1002/1521-4141(2000)30:8<2211::AID-IMMU2211>3.0.CO;2-0; Srivastava PK, 1998, IMMUNITY, V8, P657, DOI 10.1016/S1074-7613(00)80570-1; SRIVASTAVA PK, 1991, CURR OPIN IMMUNOL, V3, P654; SUTO R, 1995, SCIENCE, V269, P1585, DOI 10.1126/science.7545313; UDONO H, 1994, J IMMUNOL, V152, P5398; UDONO H, 1994, P NATL ACAD SCI USA, V301, P919; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; Wagner H, 2001, IMMUNITY, V14, P499, DOI 10.1016/S1074-7613(01)00144-3; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; Zheng H, 2001, J IMMUNOL, V167, P6731, DOI 10.4049/jimmunol.167.12.6731	35	377	399	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20847	20853		10.1074/jbc.M200425200	http://dx.doi.org/10.1074/jbc.M200425200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11912201	hybrid			2022-12-27	WOS:000176204500096
J	Feng, JW; Wehbi, H; Roberts, MF				Feng, JW; Wehbi, H; Roberts, MF			Role of tryptophan residues in interfacial binding of phosphatidylinositol-specific phospholipase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTRA; ANGLE NEUTRON-SCATTERING; BACILLUS-CEREUS; CRYSTAL-STRUCTURE; ACTIVE-SITE; ACTIVATION; PROTEINS; DOMAIN; INHIBITION	The phosphatidylinositol-specific phospholipase C (PI-PLC) from Bacillus thuringiensis exhibits several types of interfacial activation. In the crystal structure of the closely related Bacillus cereus PI-PLC, the rim of the active site is flanked by a short helix B and a loop that show an unusual clustering of hydrophobic amino acids. Two of the seven tryptophans in PI-PLC are among the exposed residues. To test the importance of these residues in substrate and activator binding, we prepared several mutants of Trp-47 (in helix B) and Trp-242 (in the loop). Two other tryptophans, Trp-178 and Trp-280, which are not near the rim, were mutated as controls. Kinetic (both phosphotransferase and cyclic phosphodiesterase activities), fluorescence, and vesicle binding analyses showed that both Trp-47 and Trp-242 residues are important for the enzyme to bind to interfaces, both activating zwitterionic and substrate anionic surfaces. Partitioning of the enzyme to vesicles is decreased more than 10-fold for either W47A or W242A, and removal of both tryptophans (W47A/W242A) yields enzyme with virtually no affinity for phospholipid surfaces. Replacement of either tryptophan with phenylalanine or isoleucine has moderate effects on enzyme affinity for surfaces but yields a fully active enzyme. These results are used to describe how the enzyme is activated by interfaces.	Boston Coll, Merkert Chem Ctr, Boston, MA 02167 USA	Boston College	Roberts, MF (corresponding author), Boston Coll, Merkert Chem Ctr, 2609 Beacon St, Boston, MA 02167 USA.	mary.roberts@bc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060418] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM60418] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; BERRIDGE MJ, 1984, BIOCHEM J, V220, P345, DOI 10.1042/bj2200345; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Braman J, 1996, Methods Mol Biol, V57, P31; Ellis MV, 1998, J BIOL CHEM, V273, P11650, DOI 10.1074/jbc.273.19.11650; GARIGAPATI VR, 1995, J COLLOID INTERF SCI, V169, P486, DOI 10.1006/jcis.1995.1059; Gassler CS, 1997, BIOCHEMISTRY-US, V36, P12802, DOI 10.1021/bi971102d; Gelb MH, 1999, CURR OPIN STRUC BIOL, V9, P428, DOI 10.1016/S0959-440X(99)80059-1; Grobler JA, 1996, NAT STRUCT BIOL, V3, P788, DOI 10.1038/nsb0996-788; HEINZ DW, 1995, EMBO J, V14, P3855, DOI 10.1002/j.1460-2075.1995.tb00057.x; HENDRICKSON HS, 1992, BIOCHEMISTRY-US, V31, P12169, DOI 10.1021/bi00163a028; LEWIS KA, 1993, BIOCHEMISTRY-US, V32, P8836, DOI 10.1021/bi00085a014; LIN TL, 1986, J AM CHEM SOC, V108, P3499, DOI 10.1021/ja00272a055; LIN TL, 1987, J PHYS CHEM-US, V91, P406, DOI 10.1021/j100286a031; Lookene A, 1997, J BIOL CHEM, V272, P766, DOI 10.1074/jbc.272.2.766; Malenbaum SE, 1998, BIOCHEMISTRY-US, V37, P17915, DOI 10.1021/bi981230h; MARQUES MB, 1989, J CLIN MICROBIOL, V27, P2451, DOI 10.1128/JCM.27.11.2451-2454.1989; MENGAUD J, 1991, MOL MICROBIOL, V5, P367, DOI 10.1111/j.1365-2958.1991.tb02118.x; Moser J, 1997, J MOL BIOL, V273, P269, DOI 10.1006/jmbi.1997.1290; Nakamura M, 1998, J BIOCHEM, V123, P1145; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; Pigault C, 1999, BIOCHEM BIOPH RES CO, V254, P484, DOI 10.1006/bbrc.1998.9965; Qian XQ, 1998, BIOCHEMISTRY-US, V37, P6513, DOI 10.1021/bi972650u; SHASHIDHAR MS, 1990, BIOCHIM BIOPHYS ACTA, V1042, P410, DOI 10.1016/0005-2760(90)90172-T; Stieglitz K, 1999, J BIOL CHEM, V274, P35367, DOI 10.1074/jbc.274.50.35367; Sumandea M, 1999, BIOCHEMISTRY-US, V38, P16290, DOI 10.1021/bi9921384; Verza G, 2000, BBA-BIOMEMBRANES, V1464, P27, DOI 10.1016/S0005-2736(99)00244-8; VOLWERK JJ, 1994, BIOCHEMISTRY-US, V33, P3464, DOI 10.1021/bi00178a002; Wallace BA, 1999, ADV EXP MED BIOL, V467, P789; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Williams RL, 1999, BBA-MOL CELL BIOL L, V1441, P255, DOI 10.1016/S1388-1981(99)00150-X; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Wu YQ, 1997, BIOCHEMISTRY-US, V36, P8514, DOI 10.1021/bi970560j; ZHONG L, 1994, BIOCHEMISTRY-US, V33, P2121; Zhou C, 1997, BIOCHEMISTRY-US, V36, P347, DOI 10.1021/bi960601w; Zhou C, 1997, BIOCHEMISTRY-US, V36, P10089, DOI 10.1021/bi970846o; Zhou C, 1998, BIOCHEMISTRY-US, V37, P16430, DOI 10.1021/bi980601r	37	50	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19867	19875		10.1074/jbc.M200938200	http://dx.doi.org/10.1074/jbc.M200938200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11912206	hybrid			2022-12-27	WOS:000175894800083
J	Saito, Y; Hojo, Y; Tanimoto, T; Abe, J; Berk, BC				Saito, Y; Hojo, Y; Tanimoto, T; Abe, J; Berk, BC			Protein kinase C-alpha and protein kinase C-epsilon are required for Grb2-associated binder-1 tyrosine phosphorylation in response to platelet-derived growth factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL MORPHOGENESIS DOWNSTREAM; SIGNAL-REGULATED KINASE; GAB1 DOCKING PROTEIN; GRB2 BINDING-SITE; PHOSPHATIDYLINOSITOL 3-KINASE; ANGIOTENSIN-II; PHOSPHOINOSITIDE 3-KINASE; FOCAL ADHESIONS; PH DOMAIN; RECEPTOR	Grb2-associated binder-1 (Gab1) is an adapter protein related to the insulin receptor substrate family. It is a substrate for the insulin receptor as well as the epidermal growth factor (EGF) receptor and other receptor-tyrosine kinases. To investigate the role of Gab1 in signaling pathways downstream of growth factor receptors, we stimulated rat aortic vascular smooth muscle cells (VSMC) with EGF and platelet-derived growth factor (PDGF). Gab1 was tyrosine-phosphorylated by EGF and PDGF within 1 min. AG1478 (an EGF receptor kinase-specific inhibitor) failed to block PDGF-induced Gab1 tyrosine phosphorylation, suggesting that transactivated EGF receptor is not responsible for this signaling event. Because Gab1 associates with phospholipase Cgamma (PLCgamma), we studied the role of the PLCgamma pathway in Gab1 tyrosine phosphorylation. Gab1 tyrosine phosphorylation by PDGF was impaired in Chinese hamster ovary cells expressing mutant PDGFbeta receptor (Y977F/Y989F: lacking the binding site for PLCgamma). Pretreatment of VSMC with U73122 (a specific PLCgamma inhibitor) inhibited Gab1 tyrosine phosphorylation as well, indicating the importance of the PLCgamma pathway. Gab1 was tyrosine-phosphorylated by phorbol ester to the same extent as PDGF stimulation. Studies using antisense protein kinase C (PKC) oligonucleotides and specific inhibitors showed that PKCalpha and PKCepsilon are required for Gab1 tyrosine phosphorylation. Binding of Gab1 to the protein-tyrosine phosphatase SHP2 and phosphatidylinositol 3-kinase was significantly decreased by PLCgamma and/or PKC inhibition, suggesting the importance of the PLCgamma/PKC-dependent Gab1 tyrosine phosphorylation for the interaction with other signaling molecules. Because PDGF-mediated ERK activation is enhanced in Chinese hamster ovary cells that overexpress Gab1, Gab1 serves as an important link between PKC and ERK activation by PDGFbeta receptors in VSMC.	Univ Rochester, Ctr Cardiolvasc Res, Rochester, NY 14642 USA	University of Rochester	Berk, BC (corresponding author), Univ Rochester, Ctr Cardiolvasc Res, 601 Elmwood Ave,Box 679, Rochester, NY 14642 USA.	bradford_berk@urmc.rochester.edu		Berk, Bradford/0000-0002-2767-4115	NHLBI NIH HHS [HL49192, HL63462] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063462, R01HL049192] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Cunnick JM, 2000, J BIOL CHEM, V275, P13842, DOI 10.1074/jbc.275.18.13842; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; ERPEL T, 1995, CURR OPIN CELL BIOL, V7, P176, DOI 10.1016/0955-0674(95)80025-5; Fixman ED, 1997, J BIOL CHEM, V272, P20167, DOI 10.1074/jbc.272.32.20167; Giardina JB, 2001, HYPERTENSION, V37, P561, DOI 10.1161/01.HYP.37.2.561; Gual P, 2000, ONCOGENE, V19, P1509, DOI 10.1038/sj.onc.1203514; Haller H, 1998, CIRC RES, V82, P157; Heeneman S, 2000, J BIOL CHEM, V275, P15926, DOI 10.1074/jbc.M909616199; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; HolgadoMadruga M, 1997, P NATL ACAD SCI USA, V94, P12419, DOI 10.1073/pnas.94.23.12419; Ingham RJ, 2001, J BIOL CHEM, V276, P12257, DOI 10.1074/jbc.M010590200; Ingham RJ, 1998, J BIOL CHEM, V273, P30630, DOI 10.1074/jbc.273.46.30630; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; Ishida T, 1999, J CLIN INVEST, V103, P789, DOI 10.1172/JCI4189; Itoh M, 2000, MOL CELL BIOL, V20, P3695, DOI 10.1128/MCB.20.10.3695-3704.2000; Korhonen JM, 1999, J BIOL CHEM, V274, P37307, DOI 10.1074/jbc.274.52.37307; Laffargue M, 1999, J BIOL CHEM, V274, P32835, DOI 10.1074/jbc.274.46.32835; Lecoq-Lafon C, 1999, BLOOD, V93, P2578, DOI 10.1182/blood.V93.8.2578.408k24_2578_2585; Lehr S, 1999, BIOCHEMISTRY-US, V38, P151, DOI 10.1021/bi9818265; Liao DF, 1997, J BIOL CHEM, V272, P6146, DOI 10.1074/jbc.272.10.6146; Maroun CR, 2000, MOL CELL BIOL, V20, P8513, DOI 10.1128/MCB.20.22.8513-8525.2000; Maroun CR, 1999, J BIOL CHEM, V274, P31719, DOI 10.1074/jbc.274.44.31719; Maroun CR, 1999, MOL CELL BIOL, V19, P1784; MYERS MG, 1994, TRENDS BIOCHEM SCI, V19, P289, DOI 10.1016/0968-0004(94)90007-8; Nguyen L, 1997, J BIOL CHEM, V272, P20811, DOI 10.1074/jbc.272.33.20811; Okuda M, 1999, J BIOL CHEM, V274, P26803, DOI 10.1074/jbc.274.38.26803; Rodrigues GA, 2000, MOL CELL BIOL, V20, P1448, DOI 10.1128/MCB.20.4.1448-1459.2000; Saito Y, 2001, MOL CELL BIOL, V21, P6387, DOI 10.1128/MCB.21.19.6387-6394.2001; Saito Y, 2001, J MOL CELL CARDIOL, V33, P3, DOI 10.1006/jmcc.2000.1272; Schaeper U, 2000, J CELL BIOL, V149, P1419, DOI 10.1083/jcb.149.7.1419; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Takahashi-Tezuka M, 1998, MOL CELL BIOL, V18, P4109, DOI 10.1128/MCB.18.7.4109; von Lindern M, 2000, J BIOL CHEM, V275, P34719, DOI 10.1074/jbc.M007042200; Wickrema A, 1999, J BIOL CHEM, V274, P24469, DOI 10.1074/jbc.274.35.24469; Yart A, 2001, J BIOL CHEM, V276, P8856, DOI 10.1074/jbc.M006966200	35	25	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2002	277	26					23216	23222		10.1074/jbc.M200605200	http://dx.doi.org/10.1074/jbc.M200605200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567FX	11940581	hybrid			2022-12-27	WOS:000176475700017
J	Piccinini, G; Bacchiocchi, R; Serresi, M; Vivani, C; Rossetti, S; Gennaretti, C; Cabonari, D; Fazioli, F				Piccinini, G; Bacchiocchi, R; Serresi, M; Vivani, C; Rossetti, S; Gennaretti, C; Cabonari, D; Fazioli, F			A ligand-inducible epidermal growth factor receptor/anaplastic lymphoma kinase chimera promotes mitogenesis and transforming properties in 3T3 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; ACTIVATED PROTEIN-KINASE; PHOSPHOLIPASE-C-GAMMA; ANAPLASTIC LYMPHOMA; MOLECULAR CHARACTERIZATION; KI-1 LYMPHOMA; ALK; GENE; SPECIFICITY; SHC	Oncogenic rearrangements of the anaplastic lymphoma kinase (ALK) gene, encoding a receptor type tyrosine kinase, are frequently associated with anaplastic large cell lymphomas. Such rearrangements juxtapose the intracellular domain of ALK to 5'-end sequences belonging to different genes and create transforming fusion proteins. To understand how the oncogenic versions of ALK contribute to lymphomagenesis, it is important to analyze the biological effects and the biochemical properties of this receptor under controlled conditions of activation. To this aim, we constructed chimeric receptor molecules in which the extracellular domain of the ALK kinase is replaced by the extracellular, ligand-binding domain of the epidermal growth factor receptor (EGFR). Upon transfection in NIH 3T3 fibroblasts, the EGFR/ALK chimera was correctly synthesized and transported to the cell surface, where it was fully functional in forming high versus low affinity EGF-binding sites and transducing an EGF-dependent signal intracellularly. Overexpression of the EGFR/ALK chimera in NIH 3T3 was sufficient to induce the malignant phenotype; the appearance of the transformed phenotype was, however, conditionally dependent on the administration of EGF. Moreover, the EGFR/ALK chimera was significantly more active in inducing transformation and DNA synthesis than the wild type EGFR when either was expressed at similar levels in NIH 3T3 cells. Comparative analysis of the biochemical pathways implicated in the transduction of mitogenic signals did not show any increased ability of the EGFR/ALK to phosphorylate PLC-gamma and MAPK compared with the EGFR. On the contrary, EGFR/ALK showed to have a consistently greater effect on phosphatidylinositol 3-kinase activity compared with the EGFR, indicating that this enzyme plays a major role in mediating the mitogenic effects of ALK in NIH 3T3 cells.	Univ Ancona, Inst Internal Med, Cellular & Mol Biol Lab, I-60020 Ancona, Italy; Univ Ancona, Inst Urol, I-60020 Ancona, Italy	Marche Polytechnic University; Marche Polytechnic University	Fazioli, F (corresponding author), Univ Ancona, Inst Internal Med, Cellular & Mol Biol Lab, Via Tronto 10-A, I-60020 Ancona, Italy.	fazioli@popcsi.unian.it						AARONSON SA, 1991, SCIENCE, V254, P1146, DOI 10.1126/science.1659742; Bai RY, 1998, MOL CELL BIOL, V18, P6951, DOI 10.1128/MCB.18.12.6951; Bai RY, 2000, BLOOD, V96, P4319, DOI 10.1182/blood.V96.13.4319; BATZER AG, 1994, MOL CELL BIOL, V14, P5192, DOI 10.1128/MCB.14.8.5192; Bischof D, 1997, MOL CELL BIOL, V17, P2312, DOI 10.1128/MCB.17.4.2312; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; CHAN WY, 1989, BIOCHEMISTRY-US, V28, P1033, DOI 10.1021/bi00429a017; DAVIS RJ, 1988, J BIOL CHEM, V263, P9462; DIFIORE PP, 1990, MOL CELL BIOL, V10, P2749, DOI 10.1128/MCB.10.6.2749; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; Falini B, 1998, AM J PATHOL, V153, P875, DOI 10.1016/S0002-9440(10)65629-5; FAZIOLI F, 1991, MOL CELL BIOL, V11, P2040, DOI 10.1128/MCB.11.4.2040; Fujimoto J, 1996, P NATL ACAD SCI USA, V93, P4181, DOI 10.1073/pnas.93.9.4181; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Harlow E., 1988, ANTIBODIES LABORATOR, P341; HERBST R, 1991, J BIOL CHEM, V266, P19908; Hernandez L, 1999, BLOOD, V94, P3265; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; KADIN ME, 1994, J CLIN ONCOL, V12, P884, DOI 10.1200/JCO.1994.12.5.884; KAPLAN DR, 1987, CELL, V50, P1021, DOI 10.1016/0092-8674(87)90168-1; Kuefer MU, 1997, BLOOD, V90, P2901, DOI 10.1182/blood.V90.8.2901; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lamant L, 1999, BLOOD, V93, P3088; LAND H, 1983, SCIENCE, V222, P771, DOI 10.1126/science.6356358; LANFRANCONE L, 1995, ONCOGENE, V10, P907; LEE J, 1989, EMBO J, V8, P167, DOI 10.1002/j.1460-2075.1989.tb03361.x; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; LEHVASLAIHO H, 1989, EMBO J, V8, P159, DOI 10.1002/j.1460-2075.1989.tb03360.x; LONARDO F, 1990, New Biologist, V2, P992; Ma ZG, 2000, BLOOD, V95, P2144, DOI 10.1182/blood.V95.6.2144; MACPHERSON I, 1964, VIROLOGY, V23, P291, DOI 10.1016/0042-6822(64)90301-0; MASON DY, 1990, BRIT J HAEMATOL, V74, P161; MATUOKA K, 1993, EMBO J, V12, P3467, DOI 10.1002/j.1460-2075.1993.tb06021.x; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Morris SW, 1997, ONCOGENE, V14, P2175, DOI 10.1038/sj.onc.1201062; MULLIGAN RC, 1981, P NATL ACAD SCI-BIOL, V78, P2072, DOI 10.1073/pnas.78.4.2072; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; PRUSS RM, 1977, P NATL ACAD SCI USA, V74, P3918, DOI 10.1073/pnas.74.9.3918; RIEDEL H, 1989, EMBO J, V8, P2943, DOI 10.1002/j.1460-2075.1989.tb08444.x; ROSSOMANDO A, 1992, P NATL ACAD SCI USA, V89, P5221, DOI 10.1073/pnas.89.12.5221; SALCINI AE, 1994, ONCOGENE, V9, P2827; SANTORO M, 1994, MOL CELL BIOL, V14, P663, DOI 10.1128/MCB.14.1.663; SEEDORF K, 1992, MOL CELL BIOL, V12, P4347, DOI 10.1128/MCB.12.10.4347; SEGATTO O, 1991, MOL CELL BIOL, V11, P3191, DOI 10.1128/MCB.11.6.3191; SEGER R, 1991, P NATL ACAD SCI USA, V88, P6142, DOI 10.1073/pnas.88.14.6142; SHIOTA M, 1994, ONCOGENE, V9, P1567; Slupianek A, 2001, CANCER RES, V61, P2194; Souttou B, 1997, J BIOL CHEM, V272, P19588, DOI 10.1074/jbc.272.31.19588; Souttou B, 2001, J BIOL CHEM, V276, P9526, DOI 10.1074/jbc.M007333200; STEIN H, 1991, ANN ONCOL, V2, P33, DOI 10.1093/annonc/2.suppl_2.33; Stoica GE, 2001, J BIOL CHEM, V276, P16772, DOI 10.1074/jbc.M010660200; Tort F, 2001, LAB INVEST, V81, P419, DOI 10.1038/labinvest.3780249; Touriol C, 2000, BLOOD, V95, P3204, DOI 10.1182/blood.V95.10.3204.010k04_3204_3207; Trinei M, 2000, CANCER RES, V60, P793; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Weber D, 2000, CANCER RES, V60, P5284; WHITMAN M, 1987, BIOCHEM J, V247, P165, DOI 10.1042/bj2470165; WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6; YAN H, 1991, SCIENCE, V252, P561, DOI 10.1126/science.1850551	61	23	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22231	22239		10.1074/jbc.M111145200	http://dx.doi.org/10.1074/jbc.M111145200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11919185	hybrid			2022-12-27	WOS:000176313600018
J	Budworth, H; Dianova, II; Podust, VN; Dianov, GL				Budworth, H; Dianova, II; Podust, VN; Dianov, GL			Repair of clustered DNA lesions - Sequence-specific inhibition of long-patch base excision repair by 8-oxoguanine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN APURINIC/APYRIMIDINIC ENDONUCLEASE; DOUBLE-STRAND BREAK; POLYMERASE-BETA; IONIZING-RADIATION; ESCHERICHIA-COLI; MAMMALIAN-CELLS; URACIL RESIDUES; OGG1 PROTEIN; GAPPED DNA; DAMAGE	Ionizing radiation induces clustered DNA damage where two or more lesions are located proximal to each other on the same or opposite DNA strands. It has been suggested that individual lesions within a cluster are removed sequentially and that the presence of a vicinal lesion(s) may affect the rate and fidelity of DNA repair. In this study, we addressed the question of how 8-oxoguanine located opposite to normal or reduced abasic sites would affect the repair of these sites by the base excision repair system. We have found that an 8-oxoguanine located opposite to an abasic site does not affect either the efficiency or fidelity of repair synthesis by DNA polymerase beta. In contrast, an 8-oxoguanine located one nucleotide 3'-downstream of the abasic site significantly reduces both strand displacement synthesis supported by DNA polymerase beta or delta and cleavage by flap endonuclease of the generated flap, thus inhibiting the long-patch base excision repair pathway.	MRC, Radiat & Genome Stabil Unit, Harwell OX11 0RD, Oxon, England; Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	Vanderbilt University; University of Oxford	Dianov, GL (corresponding author), MRC, Radiat & Genome Stabil Unit, Harwell OX11 0RD, Oxon, England.		Budworth, Helen/A-1327-2013		NIGMS NIH HHS [GM52948] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052948] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn JW, 1998, BIOCHEM J, V331, P79, DOI 10.1042/bj3310079; Blaisdell JO, 2001, P NATL ACAD SCI USA, V98, P7426, DOI 10.1073/pnas.131077798; Chagovetz AM, 1997, J BIOL CHEM, V272, P27501, DOI 10.1074/jbc.272.44.27501; Chaudhry MA, 1997, J BIOL CHEM, V272, P15650, DOI 10.1074/jbc.272.25.15650; Cunniffe S, 1999, RADIAT RES, V152, P421, DOI 10.2307/3580227; David-Cordonnier MH, 2001, BIOCHEMISTRY-US, V40, P11811, DOI 10.1021/bi0112356; David-Cordonnier MH, 2001, NUCLEIC ACIDS RES, V29, P1107, DOI 10.1093/nar/29.5.1107; DeMott MS, 1996, J BIOL CHEM, V271, P30068, DOI 10.1074/jbc.271.47.30068; Dianov G, 1999, NUCLEIC ACIDS RES, V27, P1365, DOI 10.1093/nar/27.5.1365; DIANOV G, 1992, MOL CELL BIOL, V12, P1605, DOI 10.1128/MCB.12.4.1605; Dianov GL, 2000, J BIOL CHEM, V275, P11809, DOI 10.1074/jbc.275.16.11809; DIANOV GL, 1991, MOL GEN GENET, V225, P448, DOI 10.1007/BF00261686; Dianov GL, 2001, BIOESSAYS, V23, P745, DOI 10.1002/bies.1104; DIANOV GL, 1986, MUTAT RES, V159, P41, DOI 10.1016/0027-5107(86)90110-7; Frosina G, 1996, J BIOL CHEM, V271, P9573, DOI 10.1074/jbc.271.16.9573; GOODHEAD DT, 1993, INT J RADIAT BIOL, V63, P543, DOI 10.1080/09553009314450721; GOODHEAD DT, 1994, INT J RADIAT BIOL, V61, P7; Harrison L, 1999, J MOL BIOL, V290, P667, DOI 10.1006/jmbi.1999.2892; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; KOKONTIS JM, 1993, CARCINOGENESIS, V14, P645, DOI 10.1093/carcin/14.4.645; KUMAR A, 1990, J BIOL CHEM, V265, P2124; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; Miller H, 2000, BIOCHEMISTRY-US, V39, P1029, DOI 10.1021/bi991789x; Milligan JR, 2000, INT J RADIAT BIOL, V76, P1475; Podlutsky AJ, 2001, EMBO J, V20, P1477, DOI 10.1093/emboj/20.6.1477; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; SLUPPHAUG G, 1995, BIOCHEMISTRY-US, V34, P128, DOI 10.1021/bi00001a016; Strauss PR, 1997, J BIOL CHEM, V272, P1302, DOI 10.1074/jbc.272.2.1302; Sutherland BM, 2000, P NATL ACAD SCI USA, V97, P103, DOI 10.1073/pnas.97.1.103; Tomkinson AE, 2001, PROG NUCLEIC ACID RE, V68, P151; WALLACE SS, 1988, ENVIRON MOL MUTAGEN, V12, P431, DOI 10.1002/em.2860120411; WALLACE SS, 1997, OXIDATIVE STRESS MOL, P49; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; WARD JF, 1985, RADIAT RES, V104, P103; Weinfeld M, 2001, RADIAT RES, V156, P584, DOI 10.1667/0033-7587(2001)156[0584:ROBERE]2.0.CO;2	36	43	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21300	21305		10.1074/jbc.M201918200	http://dx.doi.org/10.1074/jbc.M201918200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11923315	hybrid			2022-12-27	WOS:000176286000025
J	Lee, HS; Kim, MS; Cho, HS; Kim, JI; Kim, TJ; Choi, JH; Park, C; Lee, HS; Oh, BH; Park, KH				Lee, HS; Kim, MS; Cho, HS; Kim, JI; Kim, TJ; Choi, JH; Park, C; Lee, HS; Oh, BH; Park, KH			Cyclomaltodextrinase, neopullulanase, and maltogenic amylase are nearly indistinguishable from each other	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-ENCODING CYCLOMALTODEXTRINASE; ALPHA-AMYLASE; CYCLODEXTRIN; ENZYME; PURIFICATION; SPECIFICITY; DOMAIN	Over 20 enzymes denoted as cyclomaltodextrinase, maltogenic amylase, or neopullulanase that share 40-86% sequence identity with each other are found in public data bases. These enzymes are distinguished from typical alpha-amylases by containing a novel N-terminal domain and exhibiting preferential substrate specificities for cyclomaltodextrins (CDs) over starch. In this research field, a great deal of confusion exists regarding the features distinguishing the three groups of enzymes from one another. Although a different enzyme code has been assigned to each of the three different enzyme names, even a single differentiating enzymatic property has not been documented in the literature. On the other hand, an outstanding question related to this issue concerns the structural basis for the preference of these enzymes for CDs. To clarify the confusion and to address this question, we have determined the structures of two enzymes, one from alkalophilic Bacillus sp. 1-5 and named cyclomaltodextrinase and the other from a Thermus species and named maltogenic amylase. The structure of the Bacillus enzyme reveals a dodecameric assembly composed of six copies of the dimer, which is the structural and functional unit of the Thermus enzyme and an enzyme named neopullulanase. The structure of the Thermus enzyme in complex with beta-CD led to the conclusion that Trp(47), a well conserved N-terminal domain residue, contributes greatly to the preference for beta-CD. The common dimer formation through the novel N-terminal domain, which contributes to the preference for CDs by lining the active-site cavity, convincingly indicates that the three groups of enzymes are not different enough to preserve the different names and enzyme codes.	Pohang Univ Sci & Technol, Dept Life Sci, Natl Creat Res Initiat Ctr Biomol Recognit, Pohang 790784, Kyungbuk, South Korea; Pohang Accelerator Lab, Pohang 790784, Kyungbuk, South Korea; Seoul Natl Univ, New Biomat Agr Res Ctr, Suwon 441744, South Korea; Seoul Natl Univ, Dept Food Sci & Technol, Suwon 441744, South Korea; Kyung Hee Univ, Dept Food Sci & Technol, Suwon 449701, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Seoul National University (SNU); Seoul National University (SNU); Kyung Hee University	Oh, BH (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Natl Creat Res Initiat Ctr Biomol Recognit, Pohang 790784, Kyungbuk, South Korea.	bhoh@postech.ac.kr	Oh, Byung-Ha/C-2061-2011					BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BENDER H, 1993, APPL MICROBIOL BIOT, V39, P714, DOI 10.1007/BF00164455; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Fiedler G, 1996, J MOL BIOL, V256, P279, DOI 10.1006/jmbi.1996.0085; FOX JD, 1991, ANAL BIOCHEM, V195, P93, DOI 10.1016/0003-2697(91)90300-I; Fujiwara S, 1996, GENE, V179, P165, DOI 10.1016/S0378-1119(96)00428-3; Hashimoto Y, 2001, J BACTERIOL, V183, P5050, DOI 10.1128/JB.183.17.5050-5057.2001; HONDOH H, 2001, 1 S ALPH AM FAM SEPT, P48; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim JS, 1999, J BIOL CHEM, V274, P26279, DOI 10.1074/jbc.274.37.26279; Kim MJ, 1999, ARCH BIOCHEM BIOPHYS, V371, P277, DOI 10.1006/abbi.1999.1423; Kim TJ, 1998, ARCH BIOCHEM BIOPHYS, V353, P221, DOI 10.1006/abbi.1998.0639; Kim TJ, 2001, BIOCHEMISTRY-US, V40, P14182, DOI 10.1021/bi015531u; KITAHATA S, 1983, AGR BIOL CHEM TOKYO, V47, P1441, DOI 10.1080/00021369.1983.10865801; Kondo S, 2001, J BIOCHEM, V129, P423, DOI 10.1093/oxfordjournals.jbchem.a002873; OGUMA T, 1990, BIOCHIM BIOPHYS ACTA, V1036, P1, DOI 10.1016/0304-4165(90)90205-B; Ohdan K, 2000, APPL MICROBIOL BIOT, V53, P430, DOI 10.1007/s002530051637; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park KH, 2000, BBA-PROTEIN STRUCT M, V1478, P165, DOI 10.1016/S0167-4838(00)00041-8; PODKOVYROV SM, 1992, J BACTERIOL, V174, P5400, DOI 10.1128/JB.174.16.5400-5405.1992; SOGAARD M, 1993, J BIOL CHEM, V268, P22480; Tibbot BK, 2000, J PROTEIN CHEM, V19, P663, DOI 10.1023/A:1007148202270; Yeates TO, 1997, METHOD ENZYMOL, V276, P344, DOI 10.1016/S0076-6879(97)76068-3; Zhang Z, 1998, NUCLEIC ACIDS RES, V26, P3986, DOI 10.1093/nar/26.17.3986	24	122	130	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21891	21897		10.1074/jbc.M201623200	http://dx.doi.org/10.1074/jbc.M201623200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11923309	hybrid			2022-12-27	WOS:000176286000100
J	Maxwell, RA; Welch, WH; Horodyski, FM; Schegg, KM; Schooley, DA				Maxwell, RA; Welch, WH; Horodyski, FM; Schegg, KM; Schooley, DA			Juvenile hormone diol kinase - II. Sequencing, cloning, and molecular modeling of juvenile hormone-selective diol kinase from Manduca sexta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEIN; P-LOOP; CRYSTAL-STRUCTURE; PHOSPHOENOLPYRUVATE CARBOXYKINASE; FAMILY; MOTIF; GTP; MECHANISM; CLEAVAGE; IDENTIFICATION	The gene sequence of Manduca sexta juvenile hormone diol kinase (JHDK) codes for an enzyme that has 59% sequence identity to Drosophila melanogaster sarcoplasmic calcium-binding protein-2 (dSCP2). JHDK and dSCP2 are similar to G-proteins with three conserved sequence elements involved in purine nucleotide binding. Both proteins contain two pairs of EF-hand motifs. Characterization and partial purification of the D. melanogaster homolog of M. sexta JHDK from adult D. melanogaster gave material with JHDK activity. This activity has an experimental pI and molecular mass that are nearly identical to those of dSCP2. Moreover, D. melanogaster phosphotransferase activity has very similar chromatographic retention in three systems compared with M. sexta JHDK. Substrate docking to three-dimensional models of JHDK has shown that the three conserved nucleotide-binding elements surround the putative substrate-binding site and align with conserved sequence elements of p21(Ras) and adenylate kinase. D. melanogaster dSCP2 is a homolog of M. sexta JHDK, and these proteins constitute a novel kinase family that binds nucleotides using the scaffold of an SCP (Protein Data Bank code 2SCP).	Univ Nevada, Dept Biochem, Reno, NV 89557 USA; Ohio Univ, Dept Biomed Sci, Athens, OH 45701 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; University System of Ohio; Ohio University	Schooley, DA (corresponding author), Univ Nevada, Dept Biochem, 1664 N Virginia St, Reno, NV 89557 USA.							ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; CAVENER DR, 1991, NUCLEIC ACIDS RES, V19, P3185, DOI 10.1093/nar/19.12.3185; COX JA, 1981, BIOCHEMISTRY-US, V20, P5430, DOI 10.1021/bi00522a012; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; de Rinaldis M, 1998, J MOL BIOL, V284, P1211, DOI 10.1006/jmbi.1998.2248; deKort CAD, 1996, ARCH INSECT BIOCHEM, V33, P1, DOI 10.1002/(SICI)1520-6327(1996)33:1&lt;1::AID-ARCH1&gt;3.0.CO;2-2; DEVER TE, 1987, P NATL ACAD SCI USA, V84, P1814, DOI 10.1073/pnas.84.7.1814; DURUSSEL I, 1993, BIOCHEMISTRY-US, V32, P2394, DOI 10.1021/bi00060a034; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; Feyereisen R., 1985, P391; Gombos Z, 2001, J BIOL CHEM, V276, P22529, DOI 10.1074/jbc.M010508200; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Holm L, 1997, PROTEINS, V28, P72, DOI 10.1002/(SICI)1097-0134(199705)28:1<72::AID-PROT7>3.0.CO;2-L; INGLIS AS, 1983, METHOD ENZYMOL, V91, P324; Izard T, 2000, EMBO J, V19, P2690, DOI 10.1093/emboj/19.11.2690; Kelly LE, 1997, INSECT BIOCHEM MOLEC, V27, P783, DOI 10.1016/S0965-1748(97)00062-3; Kjeldgaard M, 1996, FASEB J, V10, P1347, DOI 10.1096/fasebj.10.12.8903506; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Llorca O, 1997, J STRUCT BIOL, V118, P31, DOI 10.1006/jsbi.1996.3832; Lo Conte L, 2000, NUCLEIC ACIDS RES, V28, P257, DOI 10.1093/nar/28.1.257; Matte A, 1996, J MOL BIOL, V256, P126, DOI 10.1006/jmbi.1996.0072; Matte A, 1997, J BIOL CHEM, V272, P8105, DOI 10.1074/jbc.272.13.8105; Maxwell RA, 2002, J BIOL CHEM, V277, P21874, DOI 10.1074/jbc.M201510200; Maxwell RA, 2002, ANAL BIOCHEM, V305, P40, DOI 10.1006/abio.2002.5660; MILNERWHITE EJ, 1991, J MOL BIOL, V221, P751; Nelson TJ, 1996, P NATL ACAD SCI USA, V93, P13808, DOI 10.1073/pnas.93.24.13808; Orengo CA, 1999, CURR OPIN STRUC BIOL, V9, P374, DOI 10.1016/S0959-440X(99)80051-7; PISZKIEW.D, 1970, BIOCHEM BIOPH RES CO, V40, P1173, DOI 10.1016/0006-291X(70)90918-6; Rety S, 1999, NAT STRUCT BIOL, V6, P89; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schlauderer GJ, 1996, J MOL BIOL, V256, P223, DOI 10.1006/jmbi.1996.0080; SEGALAS I, 1995, FEBS LETT, V371, P171, DOI 10.1016/0014-5793(95)00844-Y; Smith CA, 1996, BIOPHYS J, V70, P1590, DOI 10.1016/S0006-3495(96)79745-X; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Thompson PR, 1998, J BIOL CHEM, V273, P14788, DOI 10.1074/jbc.273.24.14788; Truman JW, 1999, NATURE, V401, P447, DOI 10.1038/46737; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; Vetter IR, 1999, Q REV BIOPHYS, V32, P1, DOI 10.1017/S0033583599003480; Via A, 2000, J MOL BIOL, V303, P455, DOI 10.1006/jmbi.2000.4151; VIJAYKUMAR S, 1992, J MOL BIOL, V224, P413, DOI 10.1016/0022-2836(92)91004-9; Zarembinski TI, 1998, P NATL ACAD SCI USA, V95, P15189, DOI 10.1073/pnas.95.26.15189; [No title captured]	43	27	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21882	21890		10.1074/jbc.M201509200	http://dx.doi.org/10.1074/jbc.M201509200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11909870	hybrid			2022-12-27	WOS:000176286000099
J	Phillips, RS; Demidkina, TV; Zakomirdina, LN; Bruno, S; Ronda, L; Mozzarelli, A				Phillips, RS; Demidkina, TV; Zakomirdina, LN; Bruno, S; Ronda, L; Mozzarelli, A			Crystals of tryptophan indole-lyase and tyrosine phenol-lyase form stable quinonoid complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; STOPPED-FLOW SPECTROPHOTOMETRY; CARBON CARBON LYASES; ESCHERICHIA-COLI; CITROBACTER-FREUNDII; PYRIDOXAL-PHOSPHATE; MECHANISTIC DEDUCTIONS; SUBSTRATE-SPECIFICITY; PROTEUS-VULGARIS; LINEAR DICHROISM	The binding of substrates and inhibitors to wild-type Proteus vulgaris tryptophan indole-lyase and to wild type and Y71F Citrobacter freundii tyrosine phenol-lyase was investigated in the crystalline state by polarized absorption microspectrophotometry. Oxindolyl-L-alanine binds to tryptophan indole-lyase crystals to accumulate predominantly a stable quinonoid intermediate absorbing at 502 nm with a dissociation constant of 35 mum, approximately 10-fold higher than that in Solution. L-Trp or L-Ser react with tryptophan indole-lyase crystals to give, as in solution, a mixture of external aldimine and quinonoid intermediates and gem-diamine and external aldimine intermediates, respectively. Different from previous solution studies (Phillips, M S., Sundararju, B., & Faleev, N. G. (2000) J. Am Chem Soc. 122, 1008-1114), the reaction of benzimidazole and L-Trp or L-Ser with tryptophan indole-lyase crystals does not result in the formation of an a-aminoacrylate intermediate, suggesting that the crystal lattice might prevent a ligand-induced conformational change associated with this catalytic step. Wildtype tyrosine phenol-lyase crystals bind L-Met and L-Phe to form mixtures of external aldimine and quinonoid intermediates as in solution. A stable quinonoid intermediate with lambda(max) at 502 nm is accumulated in the reaction of crystals of Y71F tyrosine phenol-lyase, an inactive mutant, with 3-F-L-Tyr with a dissociation constant of 1 mM, approximately 10-fold higher than that in solution. The stability exhibited by the quinonoid intermediates formed both by wild-type tryptophan indole-lyase and by wild type and Y71F tyrosine phenol-lyase crystals demonstrates that they are suitable for structural determination by x-ray crystallography, thus allowing the elucidation of a key species of pyridoxal 5'-phosphate-dependent enzyme catalysis.	Univ Georgia, Dept Chem, Athens, GA 30602 USA; Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow 117984, Russia; Univ Parma, Dept Biochem & Mol Biol, I-43100 Parma, Italy; Univ Parma, Natl Inst Phys Matter, I-43100 Parma, Italy	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; University of Parma; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Parma	Phillips, RS (corresponding author), Univ Georgia, Dept Chem, Athens, GA 30602 USA.	rsphillips@chem.uga.edu	Mozzarelli, Andrea/C-3615-2014; Ronda, Luca/E-5214-2012; Bruno, Stefano/A-4582-2011; Demidkina, Tatyana/AAD-9427-2019	Mozzarelli, Andrea/0000-0003-3762-0062; Bruno, Stefano/0000-0002-7890-2472; Ronda, Luca/0000-0002-5389-2669; Phillips, Robert/0000-0001-8710-562X	FIC NIH HHS [TW-00106] Funding Source: Medline; NIGMS NIH HHS [GM-42588] Funding Source: Medline	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANTSON AA, 1993, BIOCHEMISTRY-US, V32, P4195, DOI 10.1021/bi00067a006; Bruno S, 2001, J BIOL CHEM, V276, P16, DOI 10.1074/jbc.C000588200; CHEN HY, 1995, BIOCHEMISTRY-US, V34, P12276, DOI 10.1021/bi00038a023; CHEN HY, 1995, EUR J BIOCHEM, V229, P540, DOI 10.1111/j.1432-1033.1995.tb20496.x; CHEN HY, 1993, BIOCHEMISTRY-US, V32, P11591, DOI 10.1021/bi00094a016; DEMENTIEVA IS, 1994, J MOL BIOL, V235, P783; DEMIDKINA TV, 1989, BIOCHIMIE, V71, P565, DOI 10.1016/0300-9084(89)90188-0; FALEEV NG, 1988, EUR J BIOCHEM, V177, P395, DOI 10.1111/j.1432-1033.1988.tb14388.x; HOFRICHTER J, 1976, ANNU REV BIOPHYS BIO, V5, P511, DOI 10.1146/annurev.bb.05.060176.002455; Isupov MN, 1998, J MOL BIOL, V276, P603, DOI 10.1006/jmbi.1997.1561; KAMATH AV, 1992, J BIOL CHEM, V267, P19978; KIICK DM, 1988, BIOCHEMISTRY-US, V27, P7333, DOI 10.1021/bi00419a023; KIICK DM, 1988, BIOCHEMISTRY-US, V27, P7339, DOI 10.1021/bi00419a024; KUMAGAI H, 1970, J BIOL CHEM, V245, P1767; Mozzarelli A, 1998, J MOL BIOL, V283, P135, DOI 10.1006/jmbi.1998.2038; MOZZARELLI A, 1989, J BIOL CHEM, V264, P15774; Mozzarelli A, 2000, J BIOL CHEM, V275, P6956, DOI 10.1074/jbc.275.10.6956; Mozzarelli A, 1996, ANNU REV BIOPH BIOM, V25, P343; Mozzarelli A, 2001, ADVANCED FUNCTIONAL MOLECULES AND POLYMERS, VOL 4, P55; MURO T, 1978, J BIOCHEM-TOKYO, V84, P633, DOI 10.1093/oxfordjournals.jbchem.a132168; PHILLIPS RS, 1987, ARCH BIOCHEM BIOPHYS, V256, P302, DOI 10.1016/0003-9861(87)90450-4; PHILLIPS RS, 1990, BIOCHEMISTRY-US, V29, P8608, DOI 10.1021/bi00489a016; PHILLIPS RS, 1984, BIOCHEMISTRY-US, V23, P6228, DOI 10.1021/bi00320a052; PHILLIPS RS, 1985, J BIOL CHEM, V260, P4665; PHILLIPS RS, 1991, BIOCHEMISTRY-US, V30, P5927, DOI 10.1021/bi00238a017; Phillips RS, 2000, J AM CHEM SOC, V122, P1008, DOI 10.1021/ja991647q; PHILLIPS RS, 2002, BIOCHEMISTRY-US, V41, P4348; Sloan MJ, 1996, BIOCHEMISTRY-US, V35, P16165, DOI 10.1021/bi961211c; SUELTER CH, 1976, FEBS LETT, V66, P230, DOI 10.1016/0014-5793(76)80510-8; Sundararaju B, 1997, BIOCHEMISTRY-US, V36, P6502, DOI 10.1021/bi962917+; Szebenyi DME, 2000, BIOCHEMISTRY-US, V39, P13313, DOI 10.1021/bi000635a; VINCENT MG, 1984, CHEM BIOL ASPECTS VI, P233; VonTersch RL, 1996, ACS SYM SER, V639, P95; WATANABE T, 1977, J BIOCHEM, V82, P733, DOI 10.1093/oxfordjournals.jbchem.a131750; ZAKOMIRDINA LN, 1990, EUR J BIOCHEM, V193, P243, DOI 10.1111/j.1432-1033.1990.tb19329.x	35	26	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21592	21597		10.1074/jbc.M200216200	http://dx.doi.org/10.1074/jbc.M200216200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11934889	hybrid			2022-12-27	WOS:000176286000063
J	Solbiati, J; Chapman-Smith, A; Cronan, JE				Solbiati, J; Chapman-Smith, A; Cronan, JE			Stabilization of the biotinoyl domain of Escherichia coli Acetyl-CoA carboxylase by interactions between the attached biotin and the protruding "thumb" structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A CARBOXYLASE; POSTTRANSLATIONAL MODIFICATION; MULTIFUNCTIONAL ENZYMES; SWINGING ARMS; MOLECULAR RECOGNITION; CARRIER PROTEIN; TERMINAL DOMAIN; BIOTINYLATION; REPRESSOR; SUBUNIT	We previously reported (Chapman-Smith, A., Forbes, B. E., Wallace, J. C., and Cronan, J. E., Jr. (1997) J. Biol. Chem. 272, 26017-26022) that the biotinylated (holo) species of the biotin carboxyl carrier protein (BCCP) biotinoyl domain is much more resistant to chemical modification and proteolysis than the unbiotinylated (apo) form. We hypothesized that the increased stability was due to a conformational change engendered by interaction of the domain with biotin protein ligase, the enzyme that attaches the biotin moiety. We now report that a BCCP-87 species to which the biotin moiety was attached by chemical acylation rather than by biotin protein ligase showed the characteristically greater stability of the holo biotinoyl domain. This result demonstrates that our hypothesis was incorrect; the attached biotin is solely responsible for the increased stability. The bacteria] and chloroplast multisubunit acetyl-CoA carboxylases are unusual in that the highly symmetrical and conserved structure of the biotinoyl domain of the BCCP subunit is disrupted by a structured loop called the "thumb" that protrudes from body of the domain. Prior structural work showed that the thumb interacts with uriedo ring of the attached biotin moiety. We have tested whether the thumb-biotin interactions are responsible for the greater holo form stability by examination of two BCCP-87 species that lack the thumb. These BCCP species were produced in both the apo and holo forms, and their sensitivities to trypsin digestion were compared. The holo forms of these proteins were found to be only marginally more stable than their apo forms and much more sensitive to trypsin digestion than the wild type holo-BCCP-87. Therefore, removal of the thumb has an effect similar to lack of biotinylation, indicating that thumb-biotin interactions are responsible for most (but not all) of the increased stability of the holo biotinoyl domain. In the course of these experiments we demonstrated that treatment of Escherichia coli with the peptide deformylase inhibitor, actinonin, results in the expected (but previously unreported) accumulation of an N-formylated protein species.	Univ Illinois, Dept Microbiol, Chem & Life Sci Lab B103, Urbana, IL 61801 USA; Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cronan, JE (corresponding author), Univ Illinois, Dept Microbiol, Chem & Life Sci Lab B103, 601 S Goodwin Ave, Urbana, IL 61801 USA.		Cronan, John/V-6626-2019		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015650, R01AI015650] Funding Source: NIH RePORTER; NIAID NIH HHS [AI15650] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALBERTS AW, 1972, ENZYMES, V6, P37; Athappilly FK, 1995, STRUCTURE, V3, P1407, DOI 10.1016/S0969-2126(01)00277-5; BARKER DF, 1981, J MOL BIOL, V146, P469, DOI 10.1016/0022-2836(81)90043-7; BAYER EA, 1990, METHOD ENZYMOL, V184, P138; Beckett D, 1998, METHOD ENZYMOL, V295, P424; Blanchard CZ, 1999, J BIOL CHEM, V274, P31767, DOI 10.1074/jbc.274.45.31767; Chapman-Smith A, 1999, J BIOL CHEM, V274, P1449, DOI 10.1074/jbc.274.3.1449; ChapmanSmith A, 1997, J BIOL CHEM, V272, P26017, DOI 10.1074/jbc.272.41.26017; CHAPMANSMITH A, 1994, BIOCHEM J, V302, P881, DOI 10.1042/bj3020881; Chen DZ, 2000, BIOCHEMISTRY-US, V39, P1256, DOI 10.1021/bi992245y; CRONAN JE, 1995, FEMS MICROBIOL LETT, V130, P221, DOI 10.1016/0378-1097(95)00210-V; Cronan JE, 2001, J BIOL CHEM, V276, P37355, DOI 10.1074/jbc.M106353200; Cronan JE, 2000, METHOD ENZYMOL, V326, P440; FALL RR, 1976, J BIOL CHEM, V251, P2063; FALL RR, 1973, J BIOL CHEM, V248, P2078; Fontana A, 1997, J MOL BIOL, V266, P223, DOI 10.1006/jmbi.1996.0787; KNOWLES JR, 1989, ANNU REV BIOCHEM, V58, P195, DOI 10.1146/annurev.bi.58.070189.001211; LI SJ, 1992, J BIOL CHEM, V267, P855; Means G.E., 1971, CHEM MODIFICATION PR; NERVI AM, 1971, ARCH BIOCHEM BIOPHYS, V143, P401, DOI 10.1016/0003-9861(71)90227-X; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Perham RN, 1998, BIOCHEM SOC T, V26, P299, DOI 10.1042/bst0260299; Reche P, 1999, EMBO J, V18, P2673, DOI 10.1093/emboj/18.10.2673; REED KE, 1991, J BIOL CHEM, V266, P11425; Roberts EL, 1999, BIOCHEMISTRY-US, V38, P5045, DOI 10.1021/bi982466o; Schmitt E, 1996, BIOCHIMIE, V78, P543, DOI 10.1016/S0300-9084(96)80001-0; SINGER M, 1989, MICROBIOL REV, V53, P1; Solbiati J, 1999, J MOL BIOL, V290, P607, DOI 10.1006/jmbi.1999.2913; Xu Y, 1995, BIOCHEMISTRY-US, V34, P16624, DOI 10.1021/bi00051a010; Xu Y, 1996, BIOCHEMISTRY-US, V35, P1783, DOI 10.1021/bi952269e; Yao X, 1997, BIOCHEMISTRY-US, V36, P15089, DOI 10.1021/bi971485f; Yao X, 1999, PROTEIN SCI, V8, P307	32	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21604	21609		10.1074/jbc.M201928200	http://dx.doi.org/10.1074/jbc.M201928200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11943781	hybrid			2022-12-27	WOS:000176286000065
J	Li, HC; Lee, TH; Avraham, H				Li, HC; Lee, TH; Avraham, H			A novel tricomplex of BRCA1, Nmi, and c-Myc inhibits c-Myc-induced human telomerase reverse transcriptase gene (hTERT) promoter activity in breast cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; PROTEIN; ACTIVATION; CTIP; LOCALIZATION; ASSOCIATION; EXPRESSION; COMPLEX	Germ-line mutations in BRCA1 predispose individuals to breast and ovarian cancers. We observed a novel endogenous association of BRCA1 with Nmi (N-Mye-interacting protein) in breast cancer cells. Nmi was found to interact specifically with BRCA1, both in vitro and in vivo, by binding to two major domains in BRCA1, amino acid residues 298-683 and 1301-1863. Homodimerization of Nmi enhanced its association with BRCA1 Nmi functioned as an adaptor molecule to recruit c-Mye to a complex containing Nmi-c-Myc-BRCAL Because c-Myc can activate transcription of the human telomerase reverse transcriptase gene (hTERT), we addressed the role of BRCA1 and Nmi in modulating c-Myc-induced hTERT promoter activity. Although Nmi or BRCA1 alone had no effect on c-Myc induced hTERT promoter activity, BRCA1 together with Nmi significantly inhibited this c-Myc induced hTERT promoter activity (similar to75% inhibition). Two mutated forms of BRCA1, a missense (A1708E) and a nonsense (Y1853X) that have been identified in familial breast cancers, associated with Nmi and c-Myc but failed to suppress c-Myc-induced hTERT promoter activity. These results demonstrate a novel pathogenic mechanism whereby mutations in BRCA1, via a novel transcription factor complex containing BRCA1, c-Myc, and Nmi, impair inhibition of c-Mye-induced hTERT promoter activity, which allows sustained activation of telomerase, a key enzyme in carcinogenesis.	Harvard Univ, Inst Med, Div Expt Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center	Avraham, H (corresponding author), Harvard Univ, Inst Med, Div Expt Med, Beth Israel Deaconess Med Ctr, 4 Blackfan Circle, Boston, MA 02115 USA.	havraham@caregroup.harvard.edu		Avraham, Hava/0000-0002-7545-3640	NATIONAL CANCER INSTITUTE [R21CA087290, R01CA076226] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051456] Funding Source: NIH RePORTER; NCI NIH HHS [CA76226, R21CA87290] Funding Source: Medline; NHLBI NIH HHS [HL51456] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson SE, 1998, NAT GENET, V19, P254, DOI 10.1038/930; BANGE FC, 1994, J BIOL CHEM, V269, P1091; Bao JX, 1996, ONCOGENE, V12, P2171; Baudino TA, 2001, MOL CELL BIOL, V21, P691, DOI 10.1128/MCB.21.3.691-702.2001; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Chen YM, 1999, J CELL PHYSIOL, V181, P385, DOI 10.1002/(SICI)1097-4652(199912)181:3<385::AID-JCP2>3.0.CO;2-4; Claassen GF, 1999, ONCOGENE, V18, P2925, DOI 10.1038/sj.onc.1202747; Deng CX, 2000, ONCOGENE, V19, P1059, DOI 10.1038/sj.onc.1203269; Falchetti ML, 1999, ONCOGENE, V18, P1515, DOI 10.1038/sj.onc.1202438; Fan S, 1999, SCIENCE, V284, P1354, DOI 10.1126/science.284.5418.1354; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; Greider CW, 1998, P NATL ACAD SCI USA, V95, P90, DOI 10.1073/pnas.95.1.90; Holt JT, 1996, NAT GENET, V12, P298, DOI 10.1038/ng0396-298; Kleiman FE, 1999, SCIENCE, V285, P1576, DOI 10.1126/science.285.5433.1576; Kwon T, 2000, J BIOL CHEM, V275, P423, DOI 10.1074/jbc.275.1.423; Kyo S, 2000, NUCLEIC ACIDS RES, V28, P669, DOI 10.1093/nar/28.3.669; Lee ND, 1999, J INTERF CYTOK RES, V19, P1245, DOI 10.1089/107999099312902; Li S, 1999, J BIOL CHEM, V274, P11334, DOI 10.1074/jbc.274.16.11334; MARQUIS ST, 1995, NAT GENET, V11, P17, DOI 10.1038/ng0995-17; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; Oh S, 1999, BIOCHEM BIOPH RES CO, V263, P361, DOI 10.1006/bbrc.1999.1366; Ouchi T, 1998, P NATL ACAD SCI USA, V95, P2302, DOI 10.1073/pnas.95.5.2302; Ruffner H, 1997, P NATL ACAD SCI USA, V94, P7138, DOI 10.1073/pnas.94.14.7138; Sakamuro D, 1999, ONCOGENE, V18, P2942, DOI 10.1038/sj.onc.1202725; Schlegel BP, 2000, P NATL ACAD SCI USA, V97, P3148, DOI 10.1073/pnas.070452397; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Sedivy JM, 1998, P NATL ACAD SCI USA, V95, P9078, DOI 10.1073/pnas.95.16.9078; Shay Jerry W., 1996, Current Opinion in Oncology, V8, P66, DOI 10.1097/00001622-199601000-00012; Takakura M, 1999, CANCER RES, V59, P551; Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769; Wang Q, 1998, ONCOGENE, V17, P1939, DOI 10.1038/sj.onc.1202403; Wang Q, 2000, ONCOGENE, V19, P6152, DOI 10.1038/sj.onc.1203974; Yarden RI, 1999, P NATL ACAD SCI USA, V96, P4983, DOI 10.1073/pnas.96.9.4983; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Yu X, 2000, J BIOL CHEM, V275, P18541, DOI 10.1074/jbc.M909494199; Zhou XJ, 2000, J BIOL CHEM, V275, P21364, DOI 10.1074/jbc.M003177200; Zhu MH, 1999, CELL, V96, P121, DOI 10.1016/S0092-8674(00)80965-4	40	104	109	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20965	20973		10.1074/jbc.M112231200	http://dx.doi.org/10.1074/jbc.M112231200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11916966	hybrid			2022-12-27	WOS:000176204500111
J	Murakami, M; Horowitz, A; Tang, SQ; Ware, JA; Simons, M				Murakami, M; Horowitz, A; Tang, SQ; Ware, JA; Simons, M			Protein kinase C (PKC) delta regulates PKC alpha activity in a syndecan-4-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPILLARY ENDOTHELIAL-CELLS; CYTOPLASMIC DOMAIN; PROLIFERATION; GROWTH; PHOSPHORYLATION; MIGRATION; INHIBITION; EXPRESSION; ACTIVATION; MORPHOLOGY	The phosphorylation state of Ser(183) in the cytoplasmic tail of syndecan-4 determines the binding affinity of the cytoplasmic tail to phosphatidylinositol 4,5-bisphosphate (PIP2), the capacity of the tail to multimerize, and its ability to activate protein kinase C (PKC) alpha. We sought to identify the kinase responsible for this phosphorylation and to determine its downstream effects on PKCalpha activity and on endothelial cell function. Among several PKC isoenzymes tested, only PKCalpha and -delta were able to specifically phosphorylate Ser(183) in vitro. However, studies in cultured endothelial cells showed that the phosphorylation level of syndecan-4 was significantly reduced in endothelial cells expressing a dominant negative (DN) PKCS but not a DN PKCalpha mutant. Syndecan-4/plp(2)-dependent PKCa activity was significantly increased in PKCdelta DN cells, while PKCdelta overexpression was accompanied by decreased PKCa activity. PKCdelta-overexpressing cells exhibited a significantly lower proliferation rate and an impaired tube formation in response to FGF2, which were mirrored by similar observations in PKCa DN endothelial cells. These findings suggest that PKCdelta is the kinase responsible for syndecan-4 phosphorylation, which, in turn, attenuates the cellular response to FGF2 by reducing PKCalpha activity. The reduced PKCa activity then leads to impaired endothelial cell function. We conclude that PKCdelta regulates PKCalpha activity in a syndecan-4-dependent manner.	Dartmouth Hitchcock Med Ctr, Dartmouth Med Sch, Cardiol Sect, Lebanon, NH 03756 USA; Dartmouth Hitchcock Med Ctr, Dartmouth Med Sch, Angiogenesis Res Ctr, Lebanon, NH 03756 USA; Eli Lilly & Co, Indianapolis, IN 46285 USA	Dartmouth College; Dartmouth College; Eli Lilly	Simons, M (corresponding author), Dartmouth Hitchcock Med Ctr, Dartmouth Med Sch, Cardiol Sect, 1 Med Ctr Dr, Lebanon, NH 03756 USA.		Simons, Michael/G-8553-2014; Horowitz, Arie/AAT-9482-2021; Horowitz, Arie/F-4628-2015	Simons, Michael/0000-0003-0348-7734; Horowitz, Arie/0000-0001-6239-1287	NHLBI NIH HHS [HL63609, HL62289, HL51043] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062289, P50HL063609, R01HL051043] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ashton AW, 1999, J BIOL CHEM, V274, P20805, DOI 10.1074/jbc.274.30.20805; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Fukumoto S, 1997, J BIOL CHEM, V272, P13816, DOI 10.1074/jbc.272.21.13816; Garcia-Paramio P, 1998, BIOCHEM J, V333, P631, DOI 10.1042/bj3330631; Harrington EO, 1997, J BIOL CHEM, V272, P7390, DOI 10.1074/jbc.272.11.7390; Horowitz A, 1999, BIOCHEMISTRY-US, V38, P15871, DOI 10.1021/bi991363i; Horowitz A, 1998, J BIOL CHEM, V273, P25548, DOI 10.1074/jbc.273.40.25548; Horowitz A, 1998, J BIOL CHEM, V273, P10914, DOI 10.1074/jbc.273.18.10914; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; KENT KC, 1995, CIRC RES, V77, P231, DOI 10.1161/01.RES.77.2.231; Longley RL, 1999, J CELL SCI, V112, P3421; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Oh ES, 1997, J BIOL CHEM, V272, P11805, DOI 10.1074/jbc.272.18.11805; Oh ES, 1997, J BIOL CHEM, V272, P8133, DOI 10.1074/jbc.272.13.8133; OLAH Z, 1994, ANAL BIOCHEM, V221, P94, DOI 10.1006/abio.1994.1384; Rosson D, 1997, J BIOL CHEM, V272, P14950, DOI 10.1074/jbc.272.23.14950; Shizukuda Y, 1999, CIRC RES, V85, P247, DOI 10.1161/01.RES.85.3.247; Simons M, 2001, CELL SIGNAL, V13, P855, DOI 10.1016/S0898-6568(01)00190-5; Volk R, 1999, J BIOL CHEM, V274, P24417, DOI 10.1074/jbc.274.34.24417; Way KJ, 2000, TRENDS PHARMACOL SCI, V21, P181, DOI 10.1016/S0165-6147(00)01468-1; Woods A, 2001, CURR OPIN CELL BIOL, V13, P578, DOI 10.1016/S0955-0674(00)00254-4	23	70	71	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20367	20371		10.1074/jbc.M202501200	http://dx.doi.org/10.1074/jbc.M202501200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11916978	hybrid			2022-12-27	WOS:000176204500035
J	Siligardi, G; Panaretou, B; Meyer, P; Singh, S; Woolfson, DN; Piper, PW; Pearl, LH; Prodromou, C				Siligardi, G; Panaretou, B; Meyer, P; Singh, S; Woolfson, DN; Piper, PW; Pearl, LH; Prodromou, C			Regulation of Hsp90 ATPase activity by the co-chaperone Cdc37p/p50(cdc97)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASES; BINDING-SITE; DOMAIN; CDC37; P50(CDC37); CYCLE; RAF; HOP; IDENTIFICATION; INVOLVEMENT	In vivo activation of client proteins by Hsp90 depends on its ATPase-coupled conformational cycle and on interaction with a variety of co-chaperone proteins. For some client proteins the co-chaperone Sti1/Hop/p60 acts as a "scaffold," recruiting Hsp70 and the bound client to Hsp90 early in the cycle and suppressing ATP turnover by Hsp90 during the loading phase. Recruitment of protein kinase clients to the Hsp90 complex appears to involve a specialized co-chaperone, Cdc37p/p50(cdc37), whose binding to Hsp90 is mutually exclusive of Sti1/Hop/p60. We now show that Cdc37p/p50(cdc37), like Sti1/Hop/p60, also suppresses ATP turnover by Hsp90 supporting the idea that client protein loading to Hsp90 requires a "relaxed" ADP-bound conformation. Like Sti1/Hop/p60, Cdc37p/p50(cdc37) binds to Hsp90 as a dimer, and the suppressed ATPase activity of Hsp90 is restored when Cde37p/p50(cdc37) is displaced by the immunophilin co-chaperone Cpr6/Cyp40. However, unlike Sti1/Hop/p60, which can displace geldanamycin upon binding to Hsp90, Cdc37p/p50(cdc37) forms a stable complex with geldanamycin-bound Hsp90 and may be sequestered in geldanamycin-inhibited Hsp90 complexes in vivo.	Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England; Kings Coll London, Pharmaceut Opt Spect Ctr, Dept Pharm, London SE1 9NN, England; Kings Coll London, Div Life Sci, London SE1 9NN, England; Univ Sussex, Sch Biol Sci, Ctr Biolmol Design & Drug Dev, Brighton BN1 9QG, E Sussex, England; UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; King's College London; University of London; King's College London; University of Sussex; University of London; University College London	Prodromou, C (corresponding author), Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	prodromu@icr.ac.uk	Woolfson, Dek Neil/ABC-4338-2021; Prodromou, Chrisostomos/ABA-9133-2021; Meyer, Philippe/AAC-6038-2019; Siligardi, Giuliano/AAO-7024-2020	Prodromou, Chrisostomos/0000-0003-4320-1147; Meyer, Philippe/0000-0002-6220-0679; Pearl, Laurence/0000-0002-6910-1809				Abbas-Terki T, 2000, FEBS LETT, V467, P111, DOI 10.1016/S0014-5793(00)01134-0; Chang HCJ, 1997, MOL CELL BIOL, V17, P318, DOI 10.1128/MCB.17.1.318; Chen SY, 1996, MOL ENDOCRINOL, V10, P682, DOI 10.1210/me.10.6.682; Chen SY, 1998, CELL STRESS CHAPERON, V3, P118, DOI 10.1379/1466-1268(1998)003<0118:DIOPAT>2.3.CO;2; Farrell A, 2000, MOL CELL BIOL, V20, P749, DOI 10.1128/MCB.20.3.749-754.2000; Freeman DJ, 1998, J CHEM SOC PERK T 2, P129, DOI 10.1039/a703530f; Fujita N, 2002, J BIOL CHEM, V277, P10346, DOI 10.1074/jbc.M106736200; GERBER MR, 1995, P NATL ACAD SCI USA, V92, P4651, DOI 10.1073/pnas.92.10.4651; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Grenert JP, 1999, J BIOL CHEM, V274, P17525, DOI 10.1074/jbc.274.25.17525; Hunter T, 1997, TRENDS CELL BIOL, V7, P157, DOI 10.1016/S0962-8924(97)01027-1; Johnson BD, 1998, J BIOL CHEM, V273, P3679, DOI 10.1074/jbc.273.6.3679; KURZ LC, 1992, BIOCHEMISTRY-US, V31, P7908, DOI 10.1021/bi00149a023; Morishima Y, 2000, J BIOL CHEM, V275, P6894, DOI 10.1074/jbc.275.10.6894; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; OwensGrillo JK, 1996, J BIOL CHEM, V271, P13468, DOI 10.1074/jbc.271.23.13468; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pearl LH, 2002, ADV PROTEIN CHEM, V59, P157; Perdew GH, 1997, BIOCHEMISTRY-US, V36, P3600, DOI 10.1021/bi9612529; Pratt WB, 1998, P SOC EXP BIOL MED, V217, P420; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Ramsey AJ, 2000, J BIOL CHEM, V275, P17857, DOI 10.1074/jbc.M001625200; Renzoni DA, 1996, BIOCHEMISTRY-US, V35, P15646, DOI 10.1021/bi9620969; Russell LC, 1999, J BIOL CHEM, V274, P20060, DOI 10.1074/jbc.274.29.20060; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Scheibel T, 1998, P NATL ACAD SCI USA, V95, P1495, DOI 10.1073/pnas.95.4.1495; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Setalo G, 2002, J NEUROBIOL, V50, P1, DOI 10.1002/neu.10000; Shao J, 2001, J BIOL CHEM, V276, P206, DOI 10.1074/jbc.M007583200; Siligardi G, 1998, ENANTIOMER, V3, P77; Silverstein AM, 1998, J BIOL CHEM, V273, P20090, DOI 10.1074/jbc.273.32.20090; Smith DF, 2000, SEMIN CELL DEV BIOL, V11, P45, DOI 10.1006/scdb.1999.0350; SMITH DF, 1995, MOL CELL BIOL, V15, P6804; SMITH DF, 1993, MOL CELL BIOL, V13, P869, DOI 10.1128/MCB.13.2.869; STANCATO LF, 1993, J BIOL CHEM, V268, P21711; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Xu Y, 1999, P NATL ACAD SCI USA, V96, P109, DOI 10.1073/pnas.96.1.109; Young JC, 1998, J BIOL CHEM, V273, P18007, DOI 10.1074/jbc.273.29.18007	39	211	220	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20151	20159		10.1074/jbc.M201287200	http://dx.doi.org/10.1074/jbc.M201287200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11916974	hybrid			2022-12-27	WOS:000176204500010
J	Stark, JM; Hu, P; Pierce, AJ; Moynahan, ME; Ellis, N; Jasin, M				Stark, JM; Hu, P; Pierce, AJ; Moynahan, ME; Ellis, N; Jasin, M			ATP hydrolysis by mammalian RAD51 has a key role during homology-directed DNA repair.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; SISTER-CHROMATID EXCHANGES; ESCHERICHIA-COLI RECA; SACCHAROMYCES-CEREVISIAE; CHROMOSOME STABILITY; BRC REPEATS; RECOMBINATION; PROTEIN; MOUSE; EXPRESSION	Disruption of the gene encoding RAD51, the protein that catalyzes strand exchange during homologous recombination, leads to the accumulation of chromosome breaks and lethality in vertebrate cells. As RAD51 is implicated in BRCA1- and BRCA2-mediated tumor suppression as well as cellular viability, we have begun a functional analysis of a defined RAD51 mutation in mammalian cells. By using a dominant negative approach, we generated a mouse embryonic stem cell line that expresses an ATP hydrolysis-defective RAD51 protein, hRAD51-K133R, at comparable levels to the endogenous wild-type RAD51 protein, whose expression is retained in these cells. We found that these cells have increased sensitivity to the DNA-damaging agents mitomycin C and ionizing radiation and also exhibit a decreased rate of spontaneous sister-chromatid exchange. By using a reporter for the repair of a single chromosomal double-strand break, we also found that expression of the hRAD51-K133R protein specifically inhibits homology-directed double-strand break repair. Furthermore, expression of a BRC repeat from BRCA2, a peptide inhibitor of an early step necessary for strand exchange, exacerbates the inhibition of homology-directed repair in the hRAD51-K133R expressing cell line. Thus, ATP hydrolysis by RAD51 has a key role in various types of DNA repair in mammalian cells.	Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; Cornell Univ, Grad Sch Med Sci, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Jasin, M (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave, New York, NY 10021 USA.	m-jasin@ski.mskcc.org		Moynahan, Mary Ellen/0000-0002-0167-1020; Pierce, Andrew/0000-0001-9062-0307	NCI NIH HHS [R01 CA085867-02, R01 CA085867] Funding Source: Medline; NIGMS NIH HHS [GM54688] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085867] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; Bork P, 1996, NAT GENET, V13, P22, DOI 10.1038/ng0596-22; Chanet R, 1996, MOL CELL BIOL, V16, P4782; Chen CF, 1999, J BIOL CHEM, V274, P32931, DOI 10.1074/jbc.274.46.32931; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Cox MM, 2000, PROG NUCLEIC ACID RE, V63, P311, DOI 10.1016/S0079-6603(08)60726-6; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; DONOVAN JW, 1994, GENE DEV, V8, P2552, DOI 10.1101/gad.8.21.2552; Dronkert MLG, 2000, MOL CELL BIOL, V20, P3147, DOI 10.1128/MCB.20.9.3147-3156.2000; Essers J, 1997, CELL, V89, P195, DOI 10.1016/S0092-8674(00)80199-3; Fasullo M, 2001, GENETICS, V158, P959; Fukushima T, 2001, J BIOL CHEM, V276, P44413, DOI 10.1074/jbc.M106295200; Gowen LC, 1998, SCIENCE, V281, P1009, DOI 10.1126/science.281.5379.1009; Jasin M., 2001, CONT CANC RES, VIII, P207; Johnson RD, 2001, BIOCHEM SOC T, V29, P196, DOI 10.1042/BST0290196; Kang LE, 2000, MOL CELL BIOL, V20, P9162, DOI 10.1128/MCB.20.24.9162-9172.2000; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Lambert S, 2000, EMBO J, V19, P3090, DOI 10.1093/emboj/19.12.3090; Lambert S, 2001, ONCOGENE, V20, P6627, DOI 10.1038/sj.onc.1204813; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Lim DS, 1996, MOL CELL BIOL, V16, P7133; Liu N, 1998, MOL CELL, V1, P783, DOI 10.1016/S1097-2765(00)80078-7; Maniatis T., 1982, MOL CLONING; MIYAZAKI J, 1989, GENE, V79, P269; MORITA T, 1993, P NATL ACAD SCI USA, V90, P6577, DOI 10.1073/pnas.90.14.6577; Morrison C, 1999, MOL CELL BIOL, V19, P6891; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Moynahan ME, 2001, CANCER RES, V61, P4842; Namsaraev EA, 1998, J BIOL CHEM, V273, P6177, DOI 10.1074/jbc.273.11.6177; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pierce AJ, 2001, TRENDS CELL BIOL, V11, pS52, DOI 10.1016/S0962-8924(01)02149-3; Rice KP, 2001, J BIOL CHEM, V276, P38570, DOI 10.1074/jbc.M105678200; Richardson C, 1998, GENE DEV, V12, P3831, DOI 10.1101/gad.12.24.3831; RIELE HT, 1990, NATURE, V348, P649, DOI 10.1038/348649a0; Robu ME, 2001, P NATL ACAD SCI USA, V98, P8211, DOI 10.1073/pnas.131022698; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; SHINOHARA A, 1993, NAT GENET, V4, P239, DOI 10.1038/ng0793-239; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Signon L, 2001, MOL CELL BIOL, V21, P2048, DOI 10.1128/MCB.21.6.2048-2056.2001; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Sung P, 1996, J BIOL CHEM, V271, P27983, DOI 10.1074/jbc.271.45.27983; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; TEBBS RS, 1995, P NATL ACAD SCI USA, V92, P6354, DOI 10.1073/pnas.92.14.6354; Thacker J, 1999, TRENDS GENET, V15, P166, DOI 10.1016/S0168-9525(99)01733-3; Thompson LH, 1999, BIOCHIMIE, V81, P87, DOI 10.1016/S0300-9084(99)80042-X; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; Xia F, 2001, P NATL ACAD SCI USA, V98, P8644, DOI 10.1073/pnas.151253498; Yu X, 2001, P NATL ACAD SCI USA, V98, P8419, DOI 10.1073/pnas.111005398	58	100	102	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20185	20194		10.1074/jbc.M112132200	http://dx.doi.org/10.1074/jbc.M112132200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11923292	hybrid			2022-12-27	WOS:000176204500014
J	Kanazawa, H; Ohsawa, K; Sasaki, Y; Kohsaka, S; Imai, Y				Kanazawa, H; Ohsawa, K; Sasaki, Y; Kohsaka, S; Imai, Y			Macrophage/microglia-specific protein Iba1 enhances membrane ruffling and Rac activation via phospholipase C-gamma-dependent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL ANTIGEN RECEPTOR; ACTIN STRESS FIBERS; GROWTH-FACTOR; PHOSPHOINOSITIDE 3-KINASE; HUMAN NEUTROPHILS; BINDING PROTEIN; CHEMOTAXIS; INVOLVEMENT; RHO; KINASE	Iba1 is a macrophage/microglia-specific calcium-binding protein that is involved in RacGTPase-dependent membrane ruffling and phagocytosis. In this study, we introduced Iba1 into Swiss 3T3 fibroblasts and demonstrated the enhancement of platelet-derived growth factor (PDGF)-induced membrane ruffling and chemotaxis. Wortmannin treatment did not completely suppressed this enhanced membrane ruffling in Iba1-expressing cells, whereas it did in Iba1-nonexpressing cells, suggesting that the enhancement is mediated through a phosphatidylinositol 3-kinase (PI3K)-independent signaling pathway. Porcine aorta endothelial cells transfected with expression constructs of Iba1 and PDGF receptor add-back mutants were used to analyze the signaling pathway responsible for the Iba1-induced enhancement of membrane ruffling. In the absence of Iba1 expression, PDGF did not induced membrane ruffling in cells expressing the Tyr-1021 receptor mutant, which is capable of activating phospholipase C-gamma (PLC-gamma) but not PI3K. In contrast, in the presence of Iba1 expression, membrane ruffling was formed in cells expressing the Tyr-1021 mutant. In addition, Rac was shown to be activated during membrane ruffling in cells expressing Iba1 and the Tyr-1021 mutant. Furthermore, dominant negative forms of PLC-gamma completely suppressed PDGF-induced Iba1-dependent membrane ruffling and Rac activation. These results indicate the existence of a novel signaling pathway where PLC-gamma activates Rac in a manner dependent on Iba1.	Natl Inst Neurosci, Dept Neurochem, Kodaira, Tokyo 1878502, Japan	National Center for Neurology & Psychiatry - Japan	Kohsaka, S (corresponding author), Natl Inst Neurosci, Dept Neurochem, 4-1-1 Ogawahigashi, Kodaira, Tokyo 1878502, Japan.							Akasaki T, 1999, J BIOL CHEM, V274, P18055, DOI 10.1074/jbc.274.25.18055; Allen WE, 1997, J CELL SCI, V110, P707; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Arrieumerlou C, 1998, EUR J IMMUNOL, V28, P1877, DOI 10.1002/(SICI)1521-4141(199806)28:06<1877::AID-IMMU1877>3.3.CO;2-9; Bae YS, 1998, J BIOL CHEM, V273, P4465, DOI 10.1074/jbc.273.8.4465; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; DOWNEY GP, 1994, CURR OPIN IMMUNOL, V6, P113, DOI 10.1016/0952-7915(94)90042-6; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Geijsen N, 1999, BLOOD, V94, P1121, DOI 10.1182/blood.V94.3.1121.415k04_1121_1130; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HARTWIG JH, 1988, CELL MOTIL CYTOSKEL, V10, P117, DOI 10.1002/cm.970100116; Hashimoto A, 1998, J EXP MED, V188, P1287, DOI 10.1084/jem.188.7.1287; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; HOMMA Y, 1992, J BIOL CHEM, V267, P21844; HooshmandRad R, 1997, EXP CELL RES, V234, P434, DOI 10.1006/excr.1997.3636; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; KOTANI K, 1994, EMBO J, V13, P2313, DOI 10.1002/j.1460-2075.1994.tb06515.x; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; KUNDRA V, 1994, NATURE, V367, P474, DOI 10.1038/367474a0; MA YH, 1994, J BIOL CHEM, V269, P30734; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; MUSTELIN T, 1990, SCIENCE, V247, P1584, DOI 10.1126/science.2138816; NAKAJIMA K, 1993, NEUROSCI RES, V17, P187, DOI 10.1016/0168-0102(93)90047-T; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; NOBES CD, 1995, J CELL SCI, V108, P225; Ohsawa K, 2000, J CELL SCI, V113, P3073; Ohsawa K, 1997, GLIA, V21, P285; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ronnstrand L, 1999, J BIOL CHEM, V274, P22089, DOI 10.1074/jbc.274.31.22089; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; WENNSTROM S, 1994, ONCOGENE, V9, P651; WESTERMARK B, 1990, P NATL ACAD SCI USA, V87, P128, DOI 10.1073/pnas.87.1.128; Yokote K, 1996, J BIOL CHEM, V271, P5101	41	139	142	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					20026	20032		10.1074/jbc.M109218200	http://dx.doi.org/10.1074/jbc.M109218200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11916959	hybrid			2022-12-27	WOS:000175894800103
J	Ozawa, M				Ozawa, M			Lateral dimerization of the E-cadherin extracellular domain is necessary but not sufficient for adhesive activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROXIMAL REGION; CELL-ADHESION; CYTOPLASMIC DOMAIN; CALCIUM-BINDING; PROTEIN INTERACTIONS; MOLECULE UVOMORULIN; COMPLEX-FORMATION; STRUCTURAL BASIS; N-CADHERIN; P120(CTN)	Cadherins are transmembrane glycoproteins involved in Ca2+-dependent cell-cell adhesion. Using L cells coexpressing E-cadherin constructs with different epitope tags, we examined the lateral dimerization of E-cadherin and its adhesive activity by co-immunoprecipitation and aggregation assays, respectively. Although the transmembrane domain is required for dimerization, tail-less constructs possessing the transmembrane domain of either N-cadherin or CD45 show dimerization and are active in aggregation assays. Two mutant constructs having either of two amino acid substitutions, W2A or substitutions that disrupt the recognition sequence for endoproteolytic enzymes involved in removal of the precursor segment, cannot form dimers and are inactive in aggregation. These monomeric proteins, like their wild-type dimerizing counterparts, retain their Ca2+-dependent resistance to trypsin digestion, suggesting that dimerization per se does not induce a large conformational change. Two other constructs, having either an amino acid substitution, D134A, or a C-terminal deletion of 70 amino acid residues, retain the ability to associate laterally but are inactive in aggregation assays. Staurosporine treatment of cells expressing the latter construct increases aggregation but does not increase the extent of lateral dimerization. Thus, lateral dimerization is necessary, but not sufficient for adhesive activity.	Kagoshima Univ, Fac Med, Dept Biochem, Kagoshima 8908520, Japan	Kagoshima University	Ozawa, M (corresponding author), Kagoshima Univ, Fac Med, Dept Biochem, Kagoshima 8908520, Japan.			Ozawa, Masayuki/0000-0002-7887-8441				Alattia JR, 1997, FEBS LETT, V417, P405, DOI 10.1016/S0014-5793(97)01333-1; Aono S, 1999, J CELL BIOL, V145, P551, DOI 10.1083/jcb.145.3.551; Baumgartner W, 2000, P NATL ACAD SCI USA, V97, P4005, DOI 10.1073/pnas.070052697; Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; Chitaev NA, 1998, J CELL BIOL, V142, P837, DOI 10.1083/jcb.142.3.837; Corps E, 2001, J BIOL CHEM, V276, P30862, DOI 10.1074/jbc.M101712200; GEIGER B, 1992, ANNU REV CELL BIOL, V8, P307, DOI 10.1146/annurev.cb.08.110192.001515; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; HINCK L, 1994, J CELL BIOL, V125, P1327, DOI 10.1083/jcb.125.6.1327; Huber O, 1999, J CELL SCI, V112, P4415; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; Koch AW, 1997, BIOCHEMISTRY-US, V36, P7697, DOI 10.1021/bi9705624; LEMMON MA, 1994, FEBS LETT, V346, P17, DOI 10.1016/0014-5793(94)00467-6; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Nieman MT, 1999, J CELL SCI, V112, P1621; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; Ohkubo T, 1999, J BIOL CHEM, V274, P21409, DOI 10.1074/jbc.274.30.21409; OVERDUIN M, 1995, SCIENCE, V267, P386, DOI 10.1126/science.7824937; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; Ozawa M, 2001, J CELL SCI, V114, P503; OZAWA M, 1990, CELL, V63, P1033, DOI 10.1016/0092-8674(90)90506-A; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Ozawa M, 1998, J CELL BIOL, V142, P1605, DOI 10.1083/jcb.142.6.1605; OZAWA M, 1990, J CELL BIOL, V111, P1645, DOI 10.1083/jcb.111.4.1645; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; POKUTTA S, 1994, EUR J BIOCHEM, V223, P1019, DOI 10.1111/j.1432-1033.1994.tb19080.x; REID RA, 1990, NUCLEIC ACIDS RES, V18, P5896, DOI 10.1093/nar/18.19.5896; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; RINGWALD M, 1987, EMBO J, V6, P3647, DOI 10.1002/j.1460-2075.1987.tb02697.x; Shan WS, 2000, J CELL BIOL, V148, P579, DOI 10.1083/jcb.148.3.579; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sivasankar S, 1999, P NATL ACAD SCI USA, V96, P11820, DOI 10.1073/pnas.96.21.11820; STREULI M, 1987, J EXP MED, V166, P1548, DOI 10.1084/jem.166.5.1548; Takeda H, 1999, NAT STRUCT BIOL, V6, P310, DOI 10.1038/7542; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Tomschy A, 1996, EMBO J, V15, P3507, DOI 10.1002/j.1460-2075.1996.tb00719.x; Troxell ML, 1999, AM J PHYSIOL-CELL PH, V276, pC404, DOI 10.1152/ajpcell.1999.276.2.C404; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0	44	61	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19600	19608		10.1074/jbc.M202029200	http://dx.doi.org/10.1074/jbc.M202029200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11916976	hybrid			2022-12-27	WOS:000175894800049
J	Kryndushkin, DS; Smirnov, VN; Ter-Avanesyan, MD; Kushnirov, VV				Kryndushkin, DS; Smirnov, VN; Ter-Avanesyan, MD; Kushnirov, VV			Increased expression of Hsp40 chaperones, transcriptional factors, and ribosomal protein Rpp0 can cure yeast prions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PHOSPHOPROTEINS P1; ESCHERICHIA-COLI; PSI+ PRION; HSP104; HSP70; PROPAGATION; GENE; PSI(+); SUP35	The SuP35 (eRF3) translation termination factor of Saccharomyces cerevisiae can undergo a prion-like conformational conversion, thus resulting in the [PSI+] nonsense-suppressor determinant. In vivo this process depends critically on the chaperone Hsp104, whose lack or overexpression can cure [PSI+]. The use of artificial prion [PSIPS+] based on a hybrid Sup35PS with prion domain from the yeast Pichia methanolica allowed us to uncover three more chaperones, Ssb1, Ssa1, and Ydj1, whose overexpression can cure prion determinants. Here, we used the [PSIPS+] to search a multicopy yeast genomic library for novel factors able to cure prions. It was found that overexpression of the Hsp40 family chaperones Sis1 and Yn1077w, chaperone Stil, transcriptional factors SfI1 and Ssn8, and acidic ribosomal protein Rpp0 can interfere with propagation and manifestation of [PSIPS+] in a prion strain-specific manner. Some of these factors also affected the manifestation and propagation of conventional [PSI+]. Excess of SfI1, Ssn8, and Rpp0 influenced at least one of the tested chaperone-specific promoters, SSA4, HSP104, and model promoters, with either the heat shock or stress response elements. Thus, the induction of chaperone expression by these proteins could explain their prion-curing effects.	Cardiol Res Ctr, Inst Expt Cardiol, Moscow 121552, Russia	National Medical Research Center of Cardiology	Kushnirov, VV (corresponding author), Cardiol Res Ctr, Inst Expt Cardiol, 3rd Cherepkovskaya St 15A, Moscow 121552, Russia.	vita@cardio.ru	Vitaly, Kushnirov/AAU-6003-2021	Kushnirov, Vitaly/0000-0003-0316-0766				BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARLSON M, 1984, GENETICS, V107, P19; CASADABAN MJ, 1983, METHOD ENZYMOL, V100, P293; Chacinska A, 2001, CURR GENET, V39, P62, DOI 10.1007/s002940000180; Chai YH, 1999, J NEUROSCI, V19, P10338; CHANG HCJ, 1994, J BIOL CHEM, V269, P24983; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Cooper KF, 1997, EMBO J, V16, P4665, DOI 10.1093/emboj/16.15.4665; Cooper KF, 1999, GENE EXPRESSION, V8, P43; Derkatch IL, 1996, GENETICS, V144, P1375; Dul JL, 2001, J CELL BIOL, V152, P705, DOI 10.1083/jcb.152.4.705; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; FUJITA A, 1989, GENE, V85, P321; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; JONES JS, 1990, YEAST, V6, P363, DOI 10.1002/yea.320060502; Jung G, 2000, GENETICS, V156, P559; Kochneva-Pervukhova NV, 2001, YEAST, V18, P489, DOI 10.1002/yea.700; Kushnirov VV, 2000, EMBO J, V19, P324, DOI 10.1093/emboj/19.3.324; Kushnirov VV, 2000, CURR BIOL, V10, P1443, DOI 10.1016/S0960-9822(00)00802-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI Y, 1995, P NATL ACAD SCI USA, V92, P10864, DOI 10.1073/pnas.92.24.10864; Lorenz MC, 1998, GENETICS, V150, P1443; LOWNDES NF, 1991, NATURE, V350, P247, DOI 10.1038/350247a0; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; Moriyama H, 2000, MOL CELL BIOL, V20, P8916, DOI 10.1128/MCB.20.23.8916-8922.2000; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; Newnam GP, 1999, MOL CELL BIOL, V19, P1325; NICOLET CM, 1989, MOL CELL BIOL, V9, P3638, DOI 10.1128/MCB.9.9.3638; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; PIPER P, 1997, YEAST STRESS RESPONS; Raitt DC, 2000, MOL BIOL CELL, V11, P2335, DOI 10.1091/mbc.11.7.2335; REMACHA M, 1995, MOL CELL BIOL, V15, P4754; Robertson LS, 1998, P NATL ACAD SCI USA, V95, P13783, DOI 10.1073/pnas.95.23.13783; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANTOS C, 1994, J BIOL CHEM, V269, P15689; SAROKIN L, 1985, MOL CELL BIOL, V5, P2521, DOI 10.1128/MCB.5.10.2521; Sherman F., 1986, METHODS YEAST GENETI; Sondheimer N, 2001, EMBO J, V20, P2435, DOI 10.1093/emboj/20.10.2435; Song WJ, 1998, EMBO J, V17, P5757, DOI 10.1093/emboj/17.19.5757; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; Trotter EW, 2001, P NATL ACAD SCI USA, V98, P7313, DOI 10.1073/pnas.121172998; Urakov V N, 2001, BMC Mol Biol, V2, P9, DOI 10.1186/1471-2199-2-9; Wickner RB, 2000, J STRUCT BIOL, V130, P310, DOI 10.1006/jsbi.2000.4250; Yan W, 1999, MOL CELL BIOL, V19, P7751	48	70	72	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2002	277	26					23702	23708		10.1074/jbc.M111547200	http://dx.doi.org/10.1074/jbc.M111547200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567FX	11923285	hybrid			2022-12-27	WOS:000176475700079
J	Burchett, SA; Flanary, P; Aston, C; Jiang, LX; Young, KH; Uetz, P; Fields, S; Dohlman, HG				Burchett, SA; Flanary, P; Aston, C; Jiang, LX; Young, KH; Uetz, P; Fields, S; Dohlman, HG			Regulation of stress response signaling by the N-terminal disshevelled/EGL-10/pleckstrin domain of Sst2, a regulator of G protein signaling in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; COUPLED RECEPTOR KINASE; OSMOLARITY GLYCEROL PATHWAY; ALPHA-INTERACTING PROTEIN; PLASMA-MEMBRANE ATPASE; GENE-EXPRESSION; RGS-DOMAIN; SELECTIVE REGULATION; SYNTAXIN HOMOLOG; FINGER PROTEINS	All members of the regulator of G protein signaling (RGS) family contain a conserved core domain that can accelerate G protein GTPase activity. The RGS in yeast, Sst2, can inhibit a G protein signal leading to mating. In addition, some RGS proteins contain an N-terminal domain of unknown function. Here we use complementary whole genome analysis methods to investigate the function of the N-terminal Sst2 domain. To identify, a signaling pathway regulated by N-Sst2, we performed genome-wide transcription profiling of cells expressing this fragment alone and found differences in 53 transcripts. Of these, 40 are induced by N-Sst2, and nearly all contain a stress response element (STRE) in the promoter region. To identify components of a signaling pathway leading from N-Sst2 to STREs, we performed a genome-wide two-hybrid analysis using N-Sst2 as bait and found 17 interacting proteins. To identify the functionally relevant interacting proteins, we analyzed all of the available gene deletion mutants and found three (vps36Delta, pep12Delta, and tlg2Delta) that induce STRE and also repress pheromone-dependent transcription. We selected VPS36 for further characterization. A vps36Delta mutation diminishes signaling by pheromone as well as by downstream components including the G protein, effector kinase (Ste11), and transcription factor (Ste12). Conversely, overexpression of Vps36 enhances the pheromone response in sst2Delta cells but not in wild type. These findings indicate that Vps36 and Sst2 have opposite and opposing effects on the pheromone and stress response pathways, with Vps36 acting downstream of the G protein and independently of Sst2 RGS activity.	Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06536 USA; Wyeth Ayerst Res, Neurosci Res, Princeton, NJ 08543 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Genet, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA	Yale University; Pfizer; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Dohlman, HG (corresponding author), Univ N Carolina, Dept Biochem & Biophys, 405 Mary Ellen Jones Bldg,Campus Box 7260, Chapel Hill, NC 27599 USA.	henrik_dohlman@med.unc.edu	Uetz, Peter/A-7119-2012	Uetz, Peter/0000-0001-6194-4927; Dohlman, Henrik/0000-0003-2443-0729	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055316, R01GM059167] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM055316, R01 GM059167] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abeliovich H, 1998, J BIOL CHEM, V273, P11719, DOI 10.1074/jbc.273.19.11719; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apanovitch DM, 1998, BIOCHEMISTRY-US, V37, P4815, DOI 10.1021/bi9729965; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Becherer KA, 1996, MOL BIOL CELL, V7, P579, DOI 10.1091/mbc.7.4.579; Benzing T, 2000, J BIOL CHEM, V275, P28167; Boulton SJ, 2002, SCIENCE, V295, P127, DOI 10.1126/science.1065986; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Burchett SA, 2000, J NEUROCHEM, V75, P1335, DOI 10.1046/j.1471-4159.2000.0751335.x; Cabrera JL, 1998, BIOCHEM BIOPH RES CO, V249, P898, DOI 10.1006/bbrc.1998.9218; Cagney G, 2000, METHOD ENZYMOL, V328, P3, DOI 10.1016/S0076-6879(00)28386-9; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Chen TS, 1997, MOL CELL BIOL, V17, P3429, DOI 10.1128/MCB.17.6.3429; COLE GM, 1990, MOL CELL BIOL, V10, P510, DOI 10.1128/MCB.10.2.510; De Vries L, 1998, MOL BIOL CELL, V9, P1123, DOI 10.1091/mbc.9.5.1123; De Vries L, 1998, P NATL ACAD SCI USA, V95, P12340, DOI 10.1073/pnas.95.21.12340; DiBello PR, 1998, J BIOL CHEM, V273, P5780, DOI 10.1074/jbc.273.10.5780; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; DOHLMAN HG, 1995, MOL CELL BIOL, V15, P3635; Dohlman HG, 1996, MOL CELL BIOL, V16, P5194; DOLAN JW, 1990, GENE DEV, V4, P492, DOI 10.1101/gad.4.4.492; DULIC V, 1990, J CELL SCI, V97, P517; ESTRUCH F, 1993, MOL CELL BIOL, V13, P3872, DOI 10.1128/MCB.13.7.3872; Garrison TR, 1999, J BIOL CHEM, V274, P36387, DOI 10.1074/jbc.274.51.36387; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gerrard SR, 2000, TRAFFIC, V1, P259, DOI 10.1034/j.1600-0854.2000.010308.x; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hill AA, 2000, SCIENCE, V290, P809, DOI 10.1126/science.290.5492.809; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hoffman GA, 2000, J BIOL CHEM, V275, P37533, DOI 10.1074/jbc.M005751200; Holthuis JCM, 1998, EMBO J, V17, P113, DOI 10.1093/emboj/17.1.113; Inoue Y, 1998, J BIOL CHEM, V273, P2977, DOI 10.1074/jbc.273.5.2977; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kamura T, 2001, J BIOL CHEM, V276, P16528, DOI 10.1074/jbc.M010142200; Kim E, 1999, P NATL ACAD SCI USA, V96, P6371, DOI 10.1073/pnas.96.11.6371; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; LATTERICH M, 1991, MOL MICROBIOL, V5, P2417, DOI 10.1111/j.1365-2958.1991.tb02087.x; LATTERICH M, 1993, BIOCHEM BIOPH RES CO, V191, P1111, DOI 10.1006/bbrc.1993.1331; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Luo WJ, 1997, J CELL BIOL, V138, P731, DOI 10.1083/jcb.138.4.731; Luo WJ, 2000, MOL BIOL CELL, V11, P579, DOI 10.1091/mbc.11.2.579; MAEDA T, 1995, SCIENCE, V269, P554, DOI 10.1126/science.7624781; MARCHLER G, 1993, EMBO J, V12, P1997, DOI 10.1002/j.1460-2075.1993.tb05849.x; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; Melchior F, 1998, TRENDS CELL BIOL, V8, P175, DOI 10.1016/S0962-8924(98)01252-5; Moskvina E, 1998, YEAST, V14, P1041, DOI 10.1002/(SICI)1097-0061(199808)14:11<1041::AID-YEA296>3.0.CO;2-4; Moskvina E, 1999, MOL MICROBIOL, V32, P1263, DOI 10.1046/j.1365-2958.1999.01438.x; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; NOMOTO S, 1990, EMBO J, V9, P691, DOI 10.1002/j.1460-2075.1990.tb08161.x; Nothwehr SF, 1996, MOL CELL BIOL, V16, P2700; Ogier-Denis E, 2000, J BIOL CHEM, V275, P39090, DOI 10.1074/jbc.M006198200; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Petiot A, 1999, BIOCHEM J, V337, P289, DOI 10.1042/0264-6021:3370289; Popov S, 1997, P NATL ACAD SCI USA, V94, P7216, DOI 10.1073/pnas.94.14.7216; Raitt DC, 2000, EMBO J, V19, P4623, DOI 10.1093/emboj/19.17.4623; Reineke U, 2001, CURR OPIN BIOTECH, V12, P59, DOI 10.1016/S0958-1669(00)00178-6; Reiser V, 2000, NAT CELL BIOL, V2, P620, DOI 10.1038/35023568; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; ROTHMAN JH, 1989, EMBO J, V8, P2057, DOI 10.1002/j.1460-2075.1989.tb03614.x; Sallese M, 2000, MOL PHARMACOL, V57, P826, DOI 10.1124/mol.57.4.826; Sato TK, 2001, SCIENCE, V294, P1881, DOI 10.1126/science.1065763; Schiff ML, 2000, NATURE, V408, P723, DOI 10.1038/35047093; Schmidt AE, 1999, J BIOL CHEM, V274, P21981, DOI 10.1074/jbc.274.31.21981; Schmitt AP, 1996, P NATL ACAD SCI USA, V93, P5777, DOI 10.1073/pnas.93.12.5777; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; SIKORSKI RS, 1989, GENETICS, V122, P19; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; Song JP, 1996, J BIOL CHEM, V271, P20273, DOI 10.1074/jbc.271.34.20273; STEVENSON BJ, 1992, GENE DEV, V6, P1293, DOI 10.1101/gad.6.7.1293; Tadi D, 1999, YEAST, V15, P1733, DOI 10.1002/(SICI)1097-0061(199912)15:16<1733::AID-YEA490>3.0.CO;2-L; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Usui K, 2000, INT J MOL MED, V5, P335; VARELA JCS, 1995, MOL CELL BIOL, V15, P6232; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; WHITEWAY M, 1990, MOL CELL BIOL, V10, P217, DOI 10.1128/MCB.10.1.217; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Wylie F, 1999, AM J PHYSIOL-CELL PH, V276, pC497, DOI 10.1152/ajpcell.1999.276.2.C497; Xu BE, 2001, GENETICS, V159, P1559; YEGHIAYAN P, 1995, YEAST, V11, P219, DOI 10.1002/yea.320110304; Zheng B, 2001, SCIENCE, V294, P1939, DOI 10.1126/science.1064757	93	32	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22156	22167		10.1074/jbc.M202254200	http://dx.doi.org/10.1074/jbc.M202254200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11940600				2022-12-27	WOS:000176313600009
J	Yao, XY; Nguyen, V; Wriggers, W; Rubenstein, PA				Yao, XY; Nguyen, V; Wriggers, W; Rubenstein, PA			Regulation of yeast actin behavior by interaction of charged residues across the interdomain cleft	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEVERELY DECREASED HYDROPHOBICITY; IN-VITRO; MUTATION; POLYMERIZATION; DYNAMICS; MECHANISM; FILAMENT; LOOP	His(73) participates in the regulation of the nucleotide binding cleft conformation in yeast actin. Earlier molecular dynamics studies suggested that Asp(184) interacts with His(73) thereby stabilizing a "closed-cleft" G-actin. However, beta-actin in the open-cleft state shows a closer interaction of His(73) with Asp(179) than with Asp(184). We have thus assessed the relative importance of Asp(184) and Asp(179) on yeast actin stability and function. Neutral substitutions at 184 or 179 alone had little adverse effect on the monomer and polymerization behavior of actin. Arg or His at 184 in H73E actin partially rescued the monomeric properties of H73E actin, as demonstrated by near-normal thermostability and wild-type (WT)-like protease digestion patterns. ATP exchange was still considerably faster than with WT-actin although slower than that of H73E alone. However, polymerization of H73E/D184R and H73E/D184H is worse than with H73E alone. Conversely, D179R rescued all monomeric properties of H73E to near WT values and largely restored polymerization rate and filament thermostability. These results and new simulations of G-actin in the "open" state underscore the importance of the His(73)-Asp(179) interaction and suggest that the open and not the closed state of yeast actin may be favored in the absence of the methyl group of His(73).	Univ Iowa, Coll Med, Dept Biochem, Iowa City, IA 52242 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	University of Iowa; Scripps Research Institute	Rubenstein, PA (corresponding author), Univ Iowa, Coll Med, Dept Biochem, Iowa City, IA 52242 USA.			Wriggers, Willy/0000-0001-5326-3152; Rubenstein, Peter/0000-0003-1225-4414	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033689] Funding Source: NIH RePORTER; NCRR NIH HHS [P41RR12255] Funding Source: Medline; NIGMS NIH HHS [GM33689] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASATOOR AM, 1967, BIOCHEM BIOPH RES CO, V26, P168, DOI 10.1016/0006-291X(67)90229-X; BRUNGER AT, 1992, X PLOR SYSTEM XRAY C; Carlier M F, 1990, Adv Biophys, V26, P51, DOI 10.1016/0065-227X(90)90007-G; CHEN X, 1995, J BIOL CHEM, V270, P11415, DOI 10.1074/jbc.270.19.11415; CHEN X, 1993, J CELL BIOL, V123, P1185, DOI 10.1083/jcb.123.5.1185; CHEN X, 1995, J BIOL CHEM, V270, P11406, DOI 10.1074/jbc.270.19.11406; Chik JK, 1996, J MOL BIOL, V263, P607, DOI 10.1006/jmbi.1996.0602; COOK RK, 1992, J BIOL CHEM, V267, P9430; COOK RK, 1991, J BIOL CHEM, V266, P16825; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; JOHNSON P, 1967, BIOCHEM J, V105, P361, DOI 10.1042/bj1050361; Kalhor HR, 1999, ARCH BIOCHEM BIOPHYS, V370, P105, DOI 10.1006/abbi.1999.1370; Kim E, 1996, BIOCHEMISTRY-US, V35, P16566, DOI 10.1021/bi9623892; Kuang B, 1997, J BIOL CHEM, V272, P1237, DOI 10.1074/jbc.272.2.1237; Kuang B, 1997, J BIOL CHEM, V272, P4412, DOI 10.1074/jbc.272.7.4412; MCLAUGHLIN PJ, 1993, NATURE, V364, P685, DOI 10.1038/364685a0; MILLER CJ, 1995, BIOPHYS J S, V68, P50; Orlova A, 1997, J MOL BIOL, V271, P235, DOI 10.1006/jmbi.1997.1163; Page R, 1998, J MOL BIOL, V280, P463, DOI 10.1006/jmbi.1998.1879; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Pollard TD, 2001, J CELL SCI, V114, P3; SUSSMAN DJ, 1984, J BIOL CHEM, V259, P7349; Wriggers W, 1999, PROTEINS, V35, P262, DOI 10.1002/(SICI)1097-0134(19990501)35:2<262::AID-PROT11>3.0.CO;2-N; Yao XY, 2001, J BIOL CHEM, V276, P25598, DOI 10.1074/jbc.M011797200; Yao XY, 1999, J BIOL CHEM, V274, P37443, DOI 10.1074/jbc.274.52.37443	25	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22875	22882		10.1074/jbc.M201685200	http://dx.doi.org/10.1074/jbc.M201685200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11940592	Green Submitted, hybrid			2022-12-27	WOS:000176313600098
J	Suarez, T; Biswas, SB; Biswas, EE				Suarez, T; Biswas, SB; Biswas, EE			Biochemical defects in retina-specific human ATP binding cassette transporter nucleotide binding domain 1 mutants associated with macular degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE GENE ABCR; ARCHAEON THERMOCOCCUS-LITORALIS; STARGARDT-DISEASE; FLUORESCENCE ANISOTROPY; MUTATIONAL ANALYSIS; MOLECULAR-GENETICS; NUMERICAL-ANALYSIS; ESTROGEN-RECEPTOR; CRYSTAL-STRUCTURE; PIGMENTOSA	The retina-specific human ABC transporter (ABCR) functions in the retinal transport system and has been implicated in several inherited visual diseases, including Stargardt disease, fundus flavimaculatus, cone-rod dystrophy, and age-related macular degeneration. We have previously described a general ribonucleotidase activity of the first nucleotide binding domain (NBD1) of human ABCR (Biswas, E. E. (2001) Biochemistry 40, 8181-8187). In this communication, we present a quantitative study analyzing the effects of certain disease-associated mutations, Gly-863 --> Ala, Pro-940 --> Arg, and Arg-943 --> Gln on the nucleotide binding, and general ribonucleotidase activities of this domain. NBD1 proteins, harboring these mutations, were created through in vitro site-specific mutagenesis and expressed in Escherichia coli. Results of the enzyme-kinetic studies indicated that these mutations altered the ATPase and CTPase activities of NBD1. The G863A and P940R mutations were found to have significant attenuation of the rates of nucleotide hydrolysis and binding affinities. On the other hand, the R943Q mutation had small, but detectable reduction in its nucleotidase activity and nucleotide binding affinity. We have measured the nucleotide binding affinities of NB protein and its mutants quantitatively by fluorescence anisotropy changes during protein binding to ethenoadenosine ATP (epsilonATP), a fluorescent ATP analogue. We have correlated the dissociation constant (K-D) and the rates of nucleotide hydrolysis (V-max) of NBD1 and its mutants with the available genetic data for these mutations.	Thomas Jefferson Univ, Dept Lab Sci, Program Biotechnol, Philadelphia, PA 19107 USA; Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Mol Biol, Stratford, NJ 08043 USA; Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Stratford, NJ 08043 USA	Jefferson University; Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Biswas, EE (corresponding author), Thomas Jefferson Univ, Dept Lab Sci, Program Biotechnol, Philadelphia, PA 19107 USA.				NATIONAL EYE INSTITUTE [R15EY013113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036002] Funding Source: NIH RePORTER; NEI NIH HHS [EY13113-01] Funding Source: Medline; NIGMS NIH HHS [GM36002-13] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allikmets R, 1996, HUM MOL GENET, V5, P1649, DOI 10.1093/hmg/5.10.1649; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; BERKOWER C, 1991, EMBO J, V10, P3777, DOI 10.1002/j.1460-2075.1991.tb04947.x; Bessant DAR, 2001, CURR OPIN GENET DEV, V11, P307, DOI 10.1016/S0959-437X(00)00195-7; Biswas EE, 1999, BIOCHEMISTRY-US, V38, P10919, DOI 10.1021/bi990048t; Biswas EE, 1995, PROTEIN EXPRES PURIF, V6, P763, DOI 10.1006/prep.1995.0007; Biswas EE, 2001, BIOCHEMISTRY-US, V40, P8181, DOI 10.1021/bi0106686; Biswas EE, 2000, BIOCHEMISTRY-US, V39, P15879, DOI 10.1021/bi0015966; Booth CL, 2000, BIOCHEMISTRY-US, V39, P5518, DOI 10.1021/bi992931x; Boyer M, 2000, NUCLEIC ACIDS RES, V28, P2494, DOI 10.1093/nar/28.13.2494; BRADFORD M, 1906, ANAL BIOCHEM, V72, P248; Briggs CE, 2001, INVEST OPHTH VIS SCI, V42, P2229; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; Diederichs K, 2000, EMBO J, V19, P5951, DOI 10.1093/emboj/19.22.5951; Drobnik W, 2001, GASTROENTEROLOGY, V120, P1203, DOI 10.1053/gast.2001.23250; ENDICOTT JA, 1989, ANNU REV BIOCHEM, V58, P137, DOI 10.1146/annurev.bi.58.070189.001033; EWART GD, 1994, J BIOL CHEM, V269, P10370; Greller G, 1999, J BIOL CHEM, V274, P20259, DOI 10.1074/jbc.274.29.20259; Hettema EH, 1996, EMBO J, V15, P3813, DOI 10.1002/j.1460-2075.1996.tb00755.x; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; Imasheva ES, 2001, BIOCHEMISTRY-US, V40, P13320, DOI 10.1021/bi0110138; Jacobson SG, 2000, INVEST OPHTH VIS SCI, V41, P1898; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lewis RA, 1999, AM J HUM GENET, V64, P422, DOI 10.1086/302251; Martinez-Mir A, 1998, NAT GENET, V18, P11, DOI 10.1038/ng0198-11; Maugeri A, 1999, AM J HUM GENET, V64, P1024, DOI 10.1086/302323; Molday LL, 2000, NAT GENET, V25, P257, DOI 10.1038/77004; MORBACH S, 1993, J BIOL CHEM, V268, P18617; Nasonkin I, 1998, HUM GENET, V102, P21, DOI 10.1007/s004390050649; Neitz M, 2000, ARCH OPHTHALMOL-CHIC, V118, P691; Ozers MS, 1997, J BIOL CHEM, V272, P30405, DOI 10.1074/jbc.272.48.30405; Papaioannou M, 2000, INVEST OPHTH VIS SCI, V41, P16; PAPERMASTER DS, 1978, J CELL BIOL, V78, P415, DOI 10.1083/jcb.78.2.415; ROYER CA, 1993, ANAL BIOCHEM, V210, P91, DOI 10.1006/abio.1993.1155; ROYER CA, 1992, METHOD ENZYMOL, V210, P481; ROYER CA, 1990, ANAL BIOCHEM, V191, P287, DOI 10.1016/0003-2697(90)90221-T; Rozet JM, 1999, J MED GENET, V36, P447; Shroyer NF, 2001, INVEST OPHTH VIS SCI, V42, P2757; Souied EH, 2000, INVEST OPHTH VIS SCI, V41, P244; Sun H, 2000, NAT GENET, V26, P242, DOI 10.1038/79994; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Webster AR, 2001, INVEST OPHTH VIS SCI, V42, P1179; Zhang K, 1999, AM J OPHTHALMOL, V128, P720, DOI 10.1016/S0002-9394(99)00236-6	47	25	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21759	21767		10.1074/jbc.M202053200	http://dx.doi.org/10.1074/jbc.M202053200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11919200	hybrid			2022-12-27	WOS:000176286000084
J	Szaszak, M; Gaborik, Z; Turu, G; McPherson, PS; Clark, AJL; Catt, KJ; Hunyady, L				Szaszak, M; Gaborik, Z; Turu, G; McPherson, PS; Clark, AJL; Catt, KJ; Hunyady, L			Role of the proline-rich domain of dynamin-2 and its interactions with Src homology 3 domains during endocytosis of the AT(1) angiotensin receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; PROTEIN-COUPLED RECEPTORS; SIGNAL-TRANSDUCTION; BETA-ARRESTIN; SH3 DOMAIN; VESICLE FORMATION; BINDING PARTNERS; COATED PITS; AMPHIPHYSIN; INTERNALIZATION	In nonneural tissues, the dynamin-2 isoform. participates in the formation of clathrin-coated vesicles during receptor endocytosis. In this study, the mechanism of dynamin-2 action was explored during endocytosis of the G protein-coupled AT(1A) angiotensin receptor expressed in Chinese hamster ovary cells. Dynamin-2 molecules with mutant pleckstrin homology domains or deleted proline-rich domains (PRD) exerted dominant negative inhibition on the endocytosis of radiolabeled angiotensin II. However, only the PRD mutation interfered with the localization of the dynamin-2 molecule to clathrin-coated pits and reduced the inhibitory effect of the GTPase-deficient K44A mutant dynamin-2. Green fluorescent protein-tagged Src homology 3 (SH3) domains of endophilin I and amphiphysin II, two major binding partners of dynamins, also inhibited AT(1A) receptor-mediated endocytosis of angiotensin II. These effects were partially or fully, respectively, restored by the overexpression of dynamin-2. Transient overexpression of these SH3 domains also reduced the localization of dynamin-2 to clathrin-coated pits. These data indicate that, similar to the recruitment of dynamin-1 during the recycling of synaptic vesicles, interaction of the dynamin-2 PRD with SH3 domains of proteins such as the amphiphysins and endophilins is essential for AT(1A) receptor endocytosis. This mechanism could be of general importance in dynamin-dependent endocytosis of other G protein-coupled receptors in nonneural tissues.	Semmelweis Univ, Fac Med, Dept Physiol, H-1444 Budapest 8, Hungary; McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; Univ London, Queen Mary, Barts & London, Dept Endocrinol, London EC1A 7BE, England; NICHD, Endocrinol & Reprod Res Branch, NIH, Bethesda, MD 20892 USA	Semmelweis University; McGill University; University of London; Queen Mary University London; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Hunyady, L (corresponding author), Semmelweis Univ, Fac Med, Dept Physiol, PBO 259, H-1444 Budapest 8, Hungary.	Hunyady@puskin.sote.hu	Szaszak, Marta/G-7957-2011	Turu, Gabor/0000-0002-4421-3812	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000193, ZIAHD000193] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Achiriloaie M, 1999, MOL CELL BIOL, V19, P1410; Anborgh PH, 2000, MOL ENDOCRINOL, V14, P2040, DOI 10.1210/me.14.12.2040; Balla T, 2000, TRENDS PHARMACOL SCI, V21, P238, DOI 10.1016/S0165-6147(00)01500-5; Barylko B, 1998, J BIOL CHEM, V273, P3791, DOI 10.1074/jbc.273.6.3791; Bauerfeind R, 1997, J BIOL CHEM, V272, P30984, DOI 10.1074/jbc.272.49.30984; Berk BC, 1999, J AM SOC NEPHROL, V10, pS62; Bunemann M, 1999, ANNU REV PHYSIOL, V61, P169, DOI 10.1146/annurev.physiol.61.1.169; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Celli M, 1999, J PHYS-CONDENS MAT, V11, P10229, DOI 10.1088/0953-8984/11/50/315; Corvera S, 1998, TRENDS CELL BIOL, V8, P442, DOI 10.1016/S0962-8924(98)01366-X; de Gasparo M, 2000, PHARMACOL REV, V52, P415; deHeuvel E, 1997, J BIOL CHEM, V272, P8710, DOI 10.1074/jbc.272.13.8710; Eguchi S, 2000, REGUL PEPTIDES, V91, P13, DOI 10.1016/S0167-0115(00)00126-9; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Fish KN, 2000, J CELL BIOL, V150, P145, DOI 10.1083/jcb.150.1.145; Gaborik Z, 2001, MOL PHARMACOL, V59, P239, DOI 10.1124/mol.59.2.239; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Gold ES, 1999, J EXP MED, V190, P1849, DOI 10.1084/jem.190.12.1849; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; Hill E, 2001, J CELL BIOL, V152, P309, DOI 10.1083/jcb.152.2.309; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; HUNYADY L, 1994, J BIOL CHEM, V269, P31378; Hunyady L, 2001, J RENIN-ANGIO-ALDO S, V2, pS16, DOI 10.1177/14703203010020010301; Hunyady L, 2000, REGUL PEPTIDES, V91, P29, DOI 10.1016/S0167-0115(00)00137-3; Huttner WB, 2001, CURR OPIN CELL BIOL, V13, P478, DOI 10.1016/S0955-0674(00)00239-8; Kasai K, 1999, J BIOCHEM, V125, P780, DOI 10.1093/oxfordjournals.jbchem.a022349; Klein DE, 1998, J BIOL CHEM, V273, P27725, DOI 10.1074/jbc.273.42.27725; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kranenburg O, 1999, J BIOL CHEM, V274, P35301, DOI 10.1074/jbc.274.50.35301; Laporte SA, 2000, J BIOL CHEM, V275, P23120, DOI 10.1074/jbc.M002581200; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lee A, 1999, CURR BIOL, V9, P261, DOI 10.1016/S0960-9822(99)80115-8; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; Micheva KD, 1997, J BIOL CHEM, V272, P27239, DOI 10.1074/jbc.272.43.27239; Muhlberg AB, 1997, EMBO J, V16, P6676, DOI 10.1093/emboj/16.22.6676; Nicoziani P, 2000, MOL BIOL CELL, V11, P481, DOI 10.1091/mbc.11.2.481; Okamoto PM, 1997, J BIOL CHEM, V272, P11629; Owen DJ, 1998, EMBO J, V17, P5273, DOI 10.1093/emboj/17.18.5273; Qian HW, 2001, MOL ENDOCRINOL, V15, P1706, DOI 10.1210/me.15.10.1706; Ramjaun AR, 1998, J NEUROCHEM, V70, P2369; Rebecchi MJ, 1998, ANNU REV BIOPH BIOM, V27, P503, DOI 10.1146/annurev.biophys.27.1.503; Ringstad N, 2001, J BIOL CHEM, V276, P40424, DOI 10.1074/jbc.M106338200; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Shpetner HS, 1996, J BIOL CHEM, V271, P13, DOI 10.1074/jbc.271.1.13; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tang YT, 1999, P NATL ACAD SCI USA, V96, P12559, DOI 10.1073/pnas.96.22.12559; Thomas WG, 1999, REGUL PEPTIDES, V79, P9, DOI 10.1016/S0167-0115(98)00140-2; Tsao PI, 2001, PHARMACOL THERAPEUT, V89, P139, DOI 10.1016/S0163-7258(00)00107-8; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6; Werbonat Y, 2000, J BIOL CHEM, V275, P21969, DOI 10.1074/jbc.M001736200; Whistler JL, 1999, J BIOL CHEM, V274, P24575, DOI 10.1074/jbc.274.35.24575; Wigge P, 1997, CURR BIOL, V7, P554, DOI 10.1016/S0960-9822(06)00254-5; Wunderlich L, 1999, CELL SIGNAL, V11, P25, DOI 10.1016/S0898-6568(98)00027-8; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922	64	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21650	21656		10.1074/jbc.M200778200	http://dx.doi.org/10.1074/jbc.M200778200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11925437	hybrid			2022-12-27	WOS:000176286000072
J	Valerius, O; Brendel, C; Duvel, K; Braus, GH				Valerius, O; Brendel, C; Duvel, K; Braus, GH			Multiple factors prevent transcriptional interference at the yeast ARO4-HIS7 locus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-I; SACCHAROMYCES-CEREVISIAE; GENE; TERMINATION; PROMOTER; REGION; DNA; INITIATION; BINDING; ABF1P	Increased transcriptional activity may cause transcriptional interference in organisms with compact genomes such as the Yeast Saccharomyces cerevisiae. Replacement of the yeast ARO4 promoter by the stronger ACTI promoter increases ARO4 transcription and simultaneously reduces the basal transcription of the downstream HIS7 gene. The open reading frames of ARO4 and HIS7 are tandemly transcribed and are separated by 416 bp. In wild-type cells, a nuclease-resistant site suggests that the two genes are separated by a single positioned nucleosome. Transcriptional interference correlates with Micrococcus nuclease accessibility of this otherwise nuclease-resistant site. Deletion analyses of the region between the two open reading frames revealed that transcriptional interference increases upon removal of either parts of the ARO4 3' end or HIS7 promoter sequences. The abolishment of the Abf1p-binding site within the HIS7 promoter significantly enhances transcriptional interference, resulting in a histidine auxotrophic strain. Our data suggest that the yeast cell prevents transcriptional interference by the combined action of efficient ARO4 transcription termination, the positioning of a fixed nucleosome, and transcription factor binding to the HIS7 promoter.	Univ Gottingen, Inst Microbiol & Genet, D-37077 Gottingen, Germany	University of Gottingen	Braus, GH (corresponding author), Univ Gottingen, Inst Microbiol & Genet, Grisebachstr 8, D-37077 Gottingen, Germany.		Braus, Gerhard H/G-3999-2012; Braus, Gerhard/ABC-6293-2021	Braus, Gerhard H/0000-0002-3117-5626; Braus, Gerhard/0000-0002-3117-5626				CROSS FR, 1991, CELL, V65, P875, DOI 10.1016/0092-8674(91)90394-E; DEWINDE JH, 1993, YEAST, V9, P847, DOI 10.1002/yea.320090805; DORSMAN JC, 1990, NUCLEIC ACIDS RES, V18, P2769, DOI 10.1093/nar/18.9.2769; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Greger IH, 1998, EMBO J, V17, P4771, DOI 10.1093/emboj/17.16.4771; Greger IH, 1998, NUCLEIC ACIDS RES, V26, P1294, DOI 10.1093/nar/26.5.1294; Greger IH, 2000, P NATL ACAD SCI USA, V97, P8415, DOI 10.1073/pnas.140217697; IRNIGER S, 1991, MOL CELL BIOL, V11, P3060, DOI 10.1128/MCB.11.6.3060; Jansa P, 2001, NUCLEIC ACIDS RES, V29, P423, DOI 10.1093/nar/29.2.423; KUNZLER M, 1993, J BACTERIOL, V175, P5548; Langst G, 1997, EMBO J, V16, P760, DOI 10.1093/emboj/16.4.760; Lascaris RF, 2000, NUCLEIC ACIDS RES, V28, P1390, DOI 10.1093/nar/28.6.1390; MIOZZARI G, 1978, J BACTERIOL, V134, P48, DOI 10.1128/JB.134.1.48-59.1978; PARAVICINI G, 1988, MOL GEN GENET, V214, P165, DOI 10.1007/BF00340197; PROUDFOOT NJ, 1986, NATURE, V322, P562, DOI 10.1038/322562a0; PROUDFOOT NJ, 1989, TRENDS BIOCHEM SCI, V14, P105, DOI 10.1016/0968-0004(89)90132-1; Puig S, 1999, CURR MICROBIOL, V39, P369, DOI 10.1007/s002849900474; Rose MD., 1990, METHODS YEAST GENETI; Springer C, 1997, MOL GEN GENET, V256, P136, DOI 10.1007/s004380050555; Springer C, 1997, J BIOL CHEM, V272, P26318, DOI 10.1074/jbc.272.42.26318; THOMA F, 1984, J MOL BIOL, V177, P715, DOI 10.1016/0022-2836(84)90046-9; Thoma F, 1996, METHOD ENZYMOL, V274, P197; ZARET KS, 1982, CELL, V28, P563, DOI 10.1016/0092-8674(82)90211-2	23	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21440	21445		10.1074/jbc.M201841200	http://dx.doi.org/10.1074/jbc.M201841200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11937506	hybrid			2022-12-27	WOS:000176286000042
J	Brett, PJ; Tiwana, H; Feavers, IM; Charalambous, BM				Brett, PJ; Tiwana, H; Feavers, IM; Charalambous, BM			Characterization of oligopeptides that cross-react with carbohydrate-specific antibodies by real time kinetics, in-solution competition enzyme-linked immunosorbent assay, and immunological analyses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEISSERIA-MENINGITIDIS SEROGROUP; CAPSULAR POLYSACCHARIDE; PEPTIDE MIMOTOPES; IMMUNE-RESPONSE; ANTICARBOHYDRATE ANTIBODIES; CLONAL CHARACTERIZATION; MONOCLONAL-ANTIBODIES; B POLYSACCHARIDE; OLIGOSACCHARIDE; EPITOPES	Phage displaying random cyclic 7-mer, and linear 7-mer and 12-mer peptides at the N terminus of the coat protein, pIII, were panned with the murine monoclonal antibody, 9-2-L379 specific for meningoeoccal lipo-oligosaccharide. Five cyclic peptides with two sequence motifs, six linear 7-mers, and five linear 12-mers with different sequence motifs were identified. Only phage displaying cyclic peptides were specifically captured by and were antigenic for 9-2-L379. Monoclonal antibody 9-2-L379 exhibited "apparent" binding affinities to the cyclic peptides between 11 and 184 nm, comparable with lipo-oligosaccharide. All cyclic peptides competed with the binding of 9-2-L379 to lipo-oligosaccharide with EC50 values in the range 10-105 pm, which correlated with their apparent binding affinities. Structural modifications of the cyclic peptides eliminated their ability to bind and compete with monoclonal antibody 9-2-L379. Mice (C3H/HeN) immunized with the cyclic peptide with optimal apparent binding affinity and EC50 of competition elicited cross-reactive antibodies to meningococcal lipo-oligosaccharide with end point dilution serum antibody titers of 3200. Cyclic peptides were converted to T-cell-dependent immunogens without disrupting these properties by C-terminal biotinylation and complexing with NeutrAvidin(R). The data indicate that constrained peptides can cross-react with a carbohydrate-specific antibody with greater specificity than linear peptides, and critical to this specificity is their structural conformation.	UCL, Royal Free & Univ Coll Med Sch, Dept Med Microbiol, London NW3 2PF, England; Natl Inst Biol Stand & Controls, Div Bacteriol, S Mimms EN6 3QG, Herts, England	University of London; University College London; National Institute for Biological Standards & Control	Charalambous, BM (corresponding author), UCL, Royal Free & Univ Coll Med Sch, Dept Med Microbiol, Royal Free Campus,Rowland Hill St, London NW3 2PF, England.	b.charalambous@rfc.ucl.ac.uk						Agadjanyan M, 1997, NAT BIOTECHNOL, V15, P547, DOI 10.1038/nbt0697-547; Charalambous BM, 1999, CLIN DIAGN LAB IMMUN, V6, P838, DOI 10.1128/CDLI.6.6.838-843.1999; Charalambous BM, 2001, J MED MICROBIOL, V50, P937, DOI 10.1099/0022-1317-50-11-937; Charalambous BM, 2000, FEMS MICROBIOL LETT, V191, P45, DOI 10.1016/S0378-1097(00)00368-2; De Berardinis P, 2000, NAT BIOTECHNOL, V18, P873, DOI 10.1038/78490; De Bolle X, 1999, J MOL BIOL, V294, P181, DOI 10.1006/jmbi.1999.3248; ESTABROOK MM, 1993, J INFECT DIS, V167, P966, DOI 10.1093/infdis/167.4.966; Evans JS, 1996, MICROBIOL-UK, V142, P57, DOI 10.1099/13500872-142-1-57; GIEBEL LB, 1995, BIOCHEMISTRY-US, V34, P15430, DOI 10.1021/bi00047a006; GREENWOOD J, 1991, J MOL BIOL, V220, P821, DOI 10.1016/0022-2836(91)90354-9; GRIFFISS JM, 1984, J INFECT DIS, V150, P71, DOI 10.1093/infdis/150.1.71; Grothaus MC, 2000, VACCINE, V18, P1253, DOI 10.1016/S0264-410X(99)00390-4; GU XX, 1993, INFECT IMMUN, V61, P1873, DOI 10.1128/IAI.61.5.1873-1880.1993; Harris SL, 1997, P NATL ACAD SCI USA, V94, P2454, DOI 10.1073/pnas.94.6.2454; HAYRINEN J, 1989, MOL IMMUNOL, V26, P523, DOI 10.1016/0161-5890(89)90003-5; HOESS R, 1993, GENE, V128, P43, DOI 10.1016/0378-1119(93)90151-R; HUSE WD, 1989, SCIENCE, V246, P1275, DOI 10.1126/science.2531466; Hutchins WA, 1999, HYBRIDOMA, V18, P121, DOI 10.1089/hyb.1999.18.121; JENNINGS HJ, 1983, CARBOHYD RES, V121, P233, DOI 10.1016/0008-6215(83)84020-8; JONES D, 1995, MENINGOCOCCAL DIS, P147; Kieber-Emmons T, 1998, IMMUNOL RES, V17, P95, DOI 10.1007/BF02786435; KieberEmmons T, 1997, HYBRIDOMA, V16, P3, DOI 10.1089/hyb.1997.16.3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Luo P, 1998, MOL IMMUNOL, V35, P865, DOI 10.1016/S0161-5890(98)00067-4; MACKINNON FG, 1993, MICROB PATHOGENESIS, V15, P359, DOI 10.1006/mpat.1993.1085; Moe GR, 1999, FEMS IMMUNOL MED MIC, V26, P209; Nieba L, 1996, ANAL BIOCHEM, V234, P155, DOI 10.1006/abio.1996.0067; Phalipon A, 1997, EUR J IMMUNOL, V27, P2620, DOI 10.1002/eji.1830271022; Pincus SH, 1998, J IMMUNOL, V160, P293; Plested JS, 1999, INFECT IMMUN, V67, P5417, DOI 10.1128/IAI.67.10.5417-5426.1999; Preston A, 1996, CRIT REV MICROBIOL, V22, P139, DOI 10.3109/10408419609106458; Qiu JP, 1999, HYBRIDOMA, V18, P103, DOI 10.1089/hyb.1999.18.103; Schuck P, 1996, TRENDS BIOCHEM SCI, V21, P458, DOI 10.1016/S0968-0004(96)20025-8; Schulz-Utermoehl T, 2000, DRUG METAB DISPOS, V28, P544; SCOTT MG, 1989, J IMMUNOL, V143, P293; TARRAND JJ, 1989, J IMMUNOL, V142, P2519; TZITZILONIS C, 2000, 12 INT PATH NEISS C; Valadon P, 1996, J MOL BIOL, V261, P11, DOI 10.1006/jmbi.1996.0438; Venkatesh N, 1999, EUR J BIOCHEM, V265, P1061, DOI 10.1046/j.1432-1327.1999.00828.x; VERHEUL AFM, 1991, INFECT IMMUN, V59, P3566, DOI 10.1128/IAI.59.10.3566-3573.1991; VERHEUL AFM, 1993, MICROBIOL REV, V57, P34, DOI 10.1128/MMBR.57.1.34-49.1993; VERHEUL AFM, 1994, CLIN DIAGN LAB IMMUN, V1, P729, DOI 10.1128/CDLI.1.6.729-736.1994; WESTERINK MAJ, 1995, P NATL ACAD SCI USA, V92, P4021, DOI 10.1073/pnas.92.9.4021; WESTERINK MAJ, 1988, INFECT IMMUN, V56, P1120, DOI 10.1128/IAI.56.5.1120-1127.1988; WESTERINK MAJ, 1992, MICROB PATHOGENESIS, V12, P19, DOI 10.1016/0882-4010(92)90062-S	45	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20468	20476		10.1074/jbc.M200387200	http://dx.doi.org/10.1074/jbc.M200387200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11923297	hybrid			2022-12-27	WOS:000176204500048
J	Kuemmerle, JF; Zhou, HP				Kuemmerle, JF; Zhou, HP			Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates growth and IGF-I secretion in human intestinal smooth muscle by Ras-dependent activation of p38 MAP kinase and Erk1/2 pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASAL PROMOTER ACTIVITY; BREAST-CANCER CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; TRANSGENIC MICE; EXON-2 PROMOTER; GENE; INHIBITION; PROLIFERATION; RECEPTOR; BETA	Insulin-like growth factor-binding protein-5 (IGFBP-5) and insulin-like growth factor-I (IGF-I) are produced by human intestinal smooth muscle cells. Endogenous IGF-I stimulates growth and increases IGFBP-5 secretion. IGFBP-5 augments the effects of IGF-I by facilitating interaction of IGF-I with the IGF-I receptor tyrosine kinase. Andress (Andress, D. L. (1998) Aim J. Physiol. 274, E744-E750) and Berfield et al. (Berfield, A. K., Andress, D. L., and Abrass, C. K. (2000) Kidney Int. 57, 1991-2003) have shown that in osteoblasts and kidney mesangial cells, IGFBP-5 stimulates proliferation and filopodia formation independently of IGF-I, presumably by activating a distinct IGFBP-5 receptor serine kinase. The present study determined whether IGFBP-5 exerts direct effects on growth in human intestinal smooth muscle cells and identified the intracellular signaling pathways involved. IGFBP-5 caused a concentration-dependent increase in [H-3]thymidine incorporation and an increase in IGF-I secretion that occurred independently of IGF-I and the IGF-I receptor tyrosine kinase. IGFBP-5-induced phosphorylation of p38 ALAP kinase, which was abolished by SB203580, or expression of a dominant negative Pas mutant, Ras(S17N), and phosphorylation of Erk1/2, which was abolished by a Raf1 kinase inhibitor, U1026, or expression of Ras(S17N). IGFBP-5-stimulated [H-3]thymidine incorporation and IGF-I secretion were partly inhibited by SB203580 or U1026 and abolished by the combination of the two inhibitors or by expression of Ras(S17N). These data show that IGFBP-5 stimulates growth and IGF-I secretion in human intestinal smooth muscle cells by activation of p38 MAP kinase-dependent and Erk1/2-dependent pathways that are independent of IGF-I. A positive feedback mechanism therefore links IGFBP-5 and IGF-I secretion that reinforces their individual effects on growth.	Virginia Commonwealth Univ, Med Coll Virginia, Div Gastroenterol, Dept Med, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Div Gastroenterol, Dept Physiol, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Kuemmerle, JF (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Div Gastroenterol, Dept Med, POB 980711, Richmond, VA 23298 USA.	jkuemmerle@hsc.vcu.edu	Zhou, Huiping/J-3639-2015; Zhou, Huiping/H-6875-2019	Zhou, Huiping/0000-0002-0050-372X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK049691, R56DK049691, R01DK049691] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK49691] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDRESS DL, 1993, BIOCHEM BIOPH RES CO, V195, P25, DOI 10.1006/bbrc.1993.2004; ANDRESS DL, 1995, J BIOL CHEM, V270, P28289; Andress DL, 1998, AM J PHYSIOL-ENDOC M, V274, pE744, DOI 10.1152/ajpendo.1998.274.4.E744; Berfield AK, 2000, KIDNEY INT, V57, P1991, DOI 10.1046/j.1523-1755.2000.00049.x; Bushman TL, 1998, AM J PHYSIOL-GASTR L, V275, pG1282, DOI 10.1152/ajpgi.1998.275.6.G1282; COHEN P, 1993, MOL ENDOCRINOL, V7, P380, DOI 10.1210/me.7.3.380; DAUGHADAY WH, 1987, J LAB CLIN MED, V109, P355; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Fanayan S, 2000, J BIOL CHEM, V275, P39146, DOI 10.1074/jbc.M006964200; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Hou YT, 2000, BIOCHEM BIOPH RES CO, V275, P422, DOI 10.1006/bbrc.2000.3283; JONES JI, 1993, P NATL ACAD SCI USA, V90, P10553, DOI 10.1073/pnas.90.22.10553; Kelley KM, 1996, INT J BIOCHEM CELL B, V28, P619, DOI 10.1016/1357-2725(96)00005-2; Keummerle JF, 2001, J BIOL CHEM, V276, P7187, DOI 10.1074/jbc.M011145200; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Kuemmerle JF, 2000, AM J PHYSIOL-GASTR L, V279, pG975, DOI 10.1152/ajpgi.2000.279.5.G975; Kuemmerle JF, 2000, AM J PHYSIOL-GASTR L, V278, pG710, DOI 10.1152/ajpgi.2000.278.5.G710; Kuemmerle JF, 1998, AM J PHYSIOL-GASTR L, V275, pG151, DOI 10.1152/ajpgi.1998.275.1.G151; Kuemmerle JF, 1997, GASTROENTEROLOGY, V113, P817, DOI 10.1016/S0016-5085(97)70176-8; Lackey K, 2000, BIOORG MED CHEM LETT, V10, P223, DOI 10.1016/S0960-894X(99)00668-X; Lee SH, 2001, J BIOL CHEM, V276, P25066, DOI 10.1074/jbc.M010892200; Li WQ, 2001, J BIOL CHEM, V276, P34728, DOI 10.1074/jbc.M103496200; Mainiero F, 2000, IMMUNITY, V12, P7, DOI 10.1016/S1074-7613(00)80154-5; Ming XF, 2001, MOL CELL BIOL, V21, P5778, DOI 10.1128/MCB.21.17.5778-5789.2001; Murthy KS, 2001, GASTROENTEROLOGY, V120, pA201, DOI 10.1016/S0016-5085(01)80997-5; OH YM, 1993, J BIOL CHEM, V268, P14964; Ohneda K, 1997, GASTROENTEROLOGY, V112, P444, DOI 10.1053/gast.1997.v112.pm9024298; Parrizas M, 1997, J BIOL CHEM, V272, P154; PIETRZKOWSKI Z, 1992, CANCER RES, V52, P6447; RUBIN R, 1995, LAB INVEST, V73, P311; Schedlich LJ, 1998, J BIOL CHEM, V273, P18347, DOI 10.1074/jbc.273.29.18347; Schedlich LJ, 2000, J BIOL CHEM, V275, P23462, DOI 10.1074/jbc.M002208200; Sun HY, 2000, CURR BIOL, V10, P281, DOI 10.1016/S0960-9822(00)00359-6; Taylor SJ, 2001, METHOD ENZYMOL, V333, P333; Umayahara Y, 1999, J BIOL CHEM, V274, P10609, DOI 10.1074/jbc.274.15.10609; Valentinis B, 2001, J CLIN PATHOL-MOL PA, V54, P133, DOI 10.1136/mp.54.3.133; Wang JW, 1997, J CLIN INVEST, V100, P1425, DOI 10.1172/JCI119663; Wang L, 2000, ENDOCRINOLOGY, V141, P1118, DOI 10.1210/en.141.3.1118; Wang X, 1998, ENDOCRINOLOGY, V139, P1054, DOI 10.1210/en.139.3.1054; Wang X, 1997, ENDOCRINOLOGY, V138, P1528, DOI 10.1210/en.138.4.1528; Zeeh JM, 2001, EUR J GASTROEN HEPAT, V13, P851, DOI 10.1097/00042737-200107000-00014; Zimmermann EM, 1997, AM J PHYSIOL-GASTR L, V273, pG875, DOI 10.1152/ajpgi.1997.273.4.G875; Zimmermann EM, 2001, AM J PHYSIOL-GASTR L, V280, pG1022, DOI 10.1152/ajpgi.2001.280.5.G1022	44	56	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20563	20571		10.1074/jbc.M200885200	http://dx.doi.org/10.1074/jbc.M200885200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11923300	hybrid			2022-12-27	WOS:000176204500061
J	van Tienhoven, M; Atkins, J; Li, Y; Glynn, P				van Tienhoven, M; Atkins, J; Li, Y; Glynn, P			Human neuropathy target esterase catalyzes hydrolysis of membrane lipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-INDEPENDENT PHOSPHOLIPASE A(2); LYSOPHOSPHOLIPASE ACTIVITY; TRIFLUOROMETHYL KETONES; DELAYED NEUROTOXICITY; LYSOPHOSPHATIDIC ACID; CLONING; BRAIN; NEURODEGENERATION; PURIFICATION; INHIBITION	A neuronal membrane protein, neuropathy target esterase (NTE), reacts with those organophosphates that initiate a syndrome of axonal degeneration. NTE has homologues in Drosophila and yeast and is detected in vitro by assays with a non-physiological ester substrate, phenyl valerate. We report that NEST, the recombinant esterase domain of NTE (residues 727-1216) purified from bacterial lysates, can catalyze hydrolysis of several naturally occurring membrane-associated lipids. The active site regions of NEST and calcium-independent phospholipase A(2) (iPlA(2)) share sequence similarity, and the phenyl valerate hydrolase activity of NEST is inhibited by low concentrations of iPLA(2) inhibitors. However, on incubation with NEST, fatty acid was liberated only extremely slowly from the sn-2 position of phospholipids (V-max similar to0.01 mumol/min/mg and K-m similar to0.4 mm for 1-palmitoyl, 2-oleoylphosphatidyleholine). Comparison of the NEST-mediated generation of C-14-labeled products from two differentially labeled C-14-phospholipid substrates suggested that a rate-limiting sn-2 cleavage was followed very rapidly by hydrolysis of the resulting lysophospholipid. Among the various naturally occurring lipids tested with NEST, lysophospholipids were by far the most avidly hydrolyzed substrates (V-max similar to20 mumol/ min/mg and k(m) similar to0.05 mm for 1-palmitoyl-lysophosphatidyleholine). NEST also catalyzed the hydrolysis of monoacylglycerols, preferring the 1-acyl to the 2-acyl isomer (V-max similar to1 mumol/min/mg and K-m similar to0.4 mm for 1-palmitoylglycerol). NEST did not catalyze hydrolysis of di- or triacylglycerols or fatty acid amides. This demonstration that membrane lipids are its putative cellular substrates raises the possibility that NTE and its homologues may be involved in intracellular membrane trafficking.	Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England	University of Leicester	Glynn, P (corresponding author), Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England.	pg8@le.ac.uk		Li, Yong/0000-0001-6266-8717				ACKERMANN EJ, 1995, J BIOL CHEM, V270, P445, DOI 10.1074/jbc.270.1.445; ACKERMANN EJ, 1994, J BIOL CHEM, V269, P9227; Atkins J, 2002, BIOCHEM J, V361, P119, DOI 10.1042/0264-6021:3610119; Atkins J, 2000, J BIOL CHEM, V275, P24477, DOI 10.1074/jbc.M002921200; CHEMOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; de Figueiredo P, 1998, P NATL ACAD SCI USA, V95, P8642, DOI 10.1073/pnas.95.15.8642; DEREWENDA ZS, 1993, TRENDS BIOCHEM SCI, V18, P20, DOI 10.1016/0968-0004(93)90082-X; Dessen A, 2000, BBA-MOL CELL BIOL L, V1488, P40, DOI 10.1016/S1388-1981(00)00108-6; Glynn P, 1998, NEUROSCIENCE, V83, P295, DOI 10.1016/S0306-4522(97)00388-6; Glynn P, 2000, PROG NEUROBIOL, V61, P61, DOI 10.1016/S0301-0082(99)00043-X; JOHNSON MK, 1969, BIOCHEM J, V114, P711, DOI 10.1042/bj1140711; JOHNSON MK, 1977, ARCH TOXICOL, V37, P113, DOI 10.1007/BF00293860; JOHNSON MK, 1982, REV BIOCHEM TOXICOL, V4, P141; JOHNSON MK, 1975, BIOCHEM PHARMACOL, V24, P797, DOI 10.1016/0006-2952(75)90123-9; Kretzschmar D, 1997, J NEUROSCI, V17, P7425; Kuroiwa N, 2001, BIOCHEM BIOPH RES CO, V281, P582, DOI 10.1006/bbrc.2001.4381; LESLIE CC, 1991, J BIOL CHEM, V266, P11366; Lin QS, 2000, BIOCHEMISTRY-US, V39, P9335, DOI 10.1021/bi000017u; Lio YC, 1996, BBA-LIPID LIPID MET, V1302, P55, DOI 10.1016/0005-2760(96)00002-1; Lio YC, 1998, BBA-LIPID LIPID MET, V1392, P320, DOI 10.1016/S0005-2760(98)00049-6; Loo RW, 1997, J BIOL CHEM, V272, P19214, DOI 10.1074/jbc.272.31.19214; Lush MJ, 1998, BIOCHEM J, V332, P1; Moser M, 2000, MECH DEVELOP, V90, P279, DOI 10.1016/S0925-4773(99)00239-7; Pete MJ, 1996, J BIOL CHEM, V271, P18114, DOI 10.1074/jbc.271.30.18114; REYNOLDS LJ, 1991, METHOD ENZYMOL, V197, P3; RICHARDSON RJ, 1979, J NEUROCHEM, V32, P607, DOI 10.1111/j.1471-4159.1979.tb00391.x; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; SHIMIZU S, 1980, ANAL BIOCHEM, V107, P193, DOI 10.1016/0003-2697(80)90511-4; Sugimoto H, 1996, J BIOL CHEM, V271, P7705, DOI 10.1074/jbc.271.13.7705; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; THOMAS TC, 1990, BIOCHEM PHARMACOL, V40, P2587, DOI 10.1016/0006-2952(90)90575-6; Wang AJ, 1999, BBA-MOL CELL BIOL L, V1437, P157, DOI 10.1016/S1388-1981(99)00012-8; Wang AJ, 1997, J BIOL CHEM, V272, P12723, DOI 10.1074/jbc.272.19.12723; Weigert R, 1999, NATURE, V402, P429, DOI 10.1038/46587; WU SY, 1992, CHEM RES TOXICOL, V5, P680, DOI 10.1021/tx00029a014; Yokoyama K, 2000, J LIPID RES, V41, P142; ZAMBRANO F, 1975, BIOCHIM BIOPHYS ACTA, V380, P357, DOI 10.1016/0005-2760(75)90104-6	37	135	139	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20942	20948		10.1074/jbc.M200330200	http://dx.doi.org/10.1074/jbc.M200330200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11927584	hybrid			2022-12-27	WOS:000176204500108
J	Pafumi, Y; Lairon, D; de la Porte, PL; Juhel, C; Storch, J; Hamosh, M; Armand, M				Pafumi, Y; Lairon, D; de la Porte, PL; Juhel, C; Storch, J; Hamosh, M; Armand, M			Mechanisms of inhibition of triacylglycerol hydrolysis by human gastric lipase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-TO-CORE; LINGUAL LIPASE; CYSTIC-FIBROSIS; FAT DIGESTION; SERUM-ALBUMIN; PANCREATIC LIPASE; LIPID-COMPOSITION; ENZYME-ACTIVITY; DROPLET SIZES; HUMAN STOMACH	In the human stomach, gastric lipase hydrolyzes only 10 to 30% of ingested triacylglycerols because of an inhibition process induced by the long chain free fatty acids generated, which are mostly protonated at gastric pH. The aim of this work was to elucidate the mechanisms by which free fatty acids inhibit further hydrolysis. In vitro experiments examined gastric lipolysis of differently sized phospholipid-triolein emulsions by human gastric juice or purified human gastric lipase, under close to physiological conditions. The lipolysis process was further investigated by scanning electron microscopy, and gastric lipase and free fatty acid movement during lipolysis were followed by fluorescence microscopy. The results demonstrate that: 1) free fatty acids generated during lipolysis partition between the surface and core of lipid droplets with a molar phase distribution coefficient of 7.4 at pH 5.40; 2) the long chain free fatty acids have an inhibitory effect only when generated during lipolysis; 3) inhibition of gastric lipolysis can be delayed by the use of lipid emulsions composed of small-size lipid droplets; 4) the release of free fatty acids during lipolysis induces a marked increase in droplet surface area, leading to the formation of novel particles at the lipid droplet surface; and 5) the gastric lipase is trapped in these free fatty acid-rich particles during their formation. In conclusion, we propose a model in which the sequential physicochemical events occurring during gastric lipolysis lead to the inhibition of further triacylglycerol lipolysis.	Univ Mediterranee, U476, INSERM, Natl Inst Hlth & Med Res, F-13009 Marseille, France; Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA; Georgetown Univ, Med Ctr, Dept Pediat, Div Dev Biol & Nutr, Washington, DC 20007 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Rutgers State University New Brunswick; Georgetown University	Armand, M (corresponding author), Univ Mediterranee, U476, INSERM, Natl Inst Hlth & Med Res, 18 Ave Mozart, F-13009 Marseille, France.	armand@marseille.inserm.fr	ARMAND, Martine/O-5780-2016	ARMAND, Martine/0000-0002-8712-6620; Storch, Judith/0000-0001-5482-1777; Lairon, Denis/0000-0001-9941-3742	NIDDK NIH HHS [R01 DK038389] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038389] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABRAMS CK, 1984, J CLIN INVEST, V73, P374, DOI 10.1172/JCI111222; Armand M, 1996, PEDIATR RES, V40, P429, DOI 10.1203/00006450-199609000-00011; ARMAND M, 1992, J NUTR BIOCHEM, V3, P333, DOI 10.1016/0955-2863(92)90024-D; Armand M, 1999, AM J CLIN NUTR, V70, P1096; Armand M, 1996, AM J PHYSIOL-GASTR L, V271, pG172, DOI 10.1152/ajpgi.1996.271.1.G172; ARMAND M, 1994, AM J PHYSIOL, V266, pG372, DOI 10.1152/ajpgi.1994.266.3.G372; BALASUBRAMANIAN K, 1992, PANCREAS, V7, P305, DOI 10.1097/00006676-199205000-00006; BELFRAGE P, 1969, J LIPID RES, V10, P341; BITMAN J, 1981, J LIQ CHROMATOGR, V4, P1023, DOI 10.1080/01483918108059602; BOREL P, 1994, J NUTR BIOCHEM, V5, P124, DOI 10.1016/0955-2863(94)90083-3; Borel P, 1996, J LIPID RES, V37, P250; Boyle E, 1996, J LIPID RES, V37, P764; Brockman H.L., 1984, P3; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CAREY MC, 1983, ANNU REV PHYSIOL, V45, P651, DOI 10.1146/annurev.ph.45.030183.003251; CARRIERE F, 1993, GASTROENTEROLOGY, V105, P876, DOI 10.1016/0016-5085(93)90908-U; Charles M, 2000, J AGR FOOD CHEM, V48, P1810, DOI 10.1021/jf9906533; EKMAN S, 1988, BIOCHIM BIOPHYS ACTA, V959, P343, DOI 10.1016/0005-2760(88)90208-1; FOLCH J, 1957, J BIOL CHEM, V226, P497; GARGOURI Y, 1987, EUR J BIOCHEM, V169, P125, DOI 10.1111/j.1432-1033.1987.tb13588.x; GARGOURI Y, 1986, BIOCHIM BIOPHYS ACTA, V879, P419, DOI 10.1016/0005-2760(86)90234-1; GARGOURI Y, 1986, GASTROENTEROLOGY, V91, P919, DOI 10.1016/0016-5085(86)90695-5; GARGOURI Y, 1986, EUR J BIOCHEM, V156, P305, DOI 10.1111/j.1432-1033.1986.tb09583.x; HAMOSH M, 1979, J BIOL CHEM, V254, P2121; HAMOSH M, 1990, LIGUAL GASTRIC LIPAS; HERNELL O, 1990, BIOCHEMISTRY-US, V29, P2041, DOI 10.1021/bi00460a012; HOLCZINGER L, 1959, Acta Histochem, V8, P167; LAU SJ, 1974, J BIOL CHEM, V249, P5878; MILLER KW, 1983, J BIOL CHEM, V258, P3772; MILLER KW, 1980, CIRCULATION, V62, P45; MILLER KW, 1982, J COLLOID INTERF SCI, V89, P466, DOI 10.1016/0021-9797(82)90197-7; MILLER KW, 1987, PLASMA LIPOPROTEINS, P1; PATTON JS, 1982, BIOCHIM BIOPHYS ACTA, V712, P400, DOI 10.1016/0005-2760(82)90359-9; ROULET M, 1980, PEDIATR RES, V14, P1360, DOI 10.1203/00006450-198012000-00019; Roussel A, 1999, J BIOL CHEM, V274, P16995, DOI 10.1074/jbc.274.24.16995; SMALL DM, 1986, HDB LIPID RES PHYSIC, P589; SPOONER PJR, 1988, J BIOL CHEM, V263, P1444; SPOONER PJR, 1990, J BIOL CHEM, V265, P12650; TIRUPPATHI C, 1985, INDIAN J BIOCHEM BIO, V22, P111; Winer BJ., 1970, STAT PRINCIPLES EXPT, V2nd	40	155	157	2	56	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2002	277	31					28070	28079		10.1074/jbc.M202839200	http://dx.doi.org/10.1074/jbc.M202839200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	579QR	11940604	hybrid			2022-12-27	WOS:000177189800063
J	Bulock, KG; Beardsley, GP; Anderson, KS				Bulock, KG; Beardsley, GP; Anderson, KS			The kinetic mechanism of the human bifunctional enzyme ATIC (5-amino-4-imidazolecarboxamide ribonucleotide transformylase/inosine 5 '-monophosphate cyclohydrolase) - A surprising lack of substrate channeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBOTIDE TRANSFORMYLASE; GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE; IMP CYCLOHYDROLASE; CRYSTAL-STRUCTURE; METHOTREXATE; INHIBITION; SYNTHASE; 5,10-DIDEAZA-5,6,7,8-TETRAHYDROFOLATE; FORMYLTRANSFERASE; POLYGLUTAMATES	5-Amino-4-imidazolecarboxamide ribonucleotide transformylase/IMP cyclohydrolase (ATIC) is a bifunctional protein possessing two enzymatic activities that sequentially catalyze the last two steps in the pathway for de novo synthesis of inosine 5'-monophosphate. This bifunctional enzyme is of particular interest because of its potential as a chemotherapeutic target. Furthermore, these two catalytic activities reside on the same protein throughout all of nature, raising the question of whether there is some kinetic advantage to the bifunctionality. Rapid chemical quench, stopped-flow absorbance, and steady-state kinetic techniques were used to elucidate the complete kinetic mechanism of human ATIC. The kinetic simulation program KINSIM was used to model the kinetic data obtained in this study. The detailed kinetic analysis, in combination with kinetic simulations, provided the following key features of the enzyme reaction pathway. 1) The rate-limiting step in the overall reaction (2.9 +/- 0.4 s(-1)) is likely the release of tetrahydrofolate from the formyltransferase active site or a conformational change associated with tetrahydrofolate release. 2) The rate of the reverse transformylase reaction (6.7 s(-1)) is similar to2-3-fold faster than the forward rate (2.9 s(-1)), whereas the cyclohydrolase reaction is essentially unidirectional in the forward sense. The cyclohydrolase reaction thus draws the overall bifunctional reaction toward the production of inosine monophosphate. 3) There was no kinetic evidence of substrate channeling of the intermediate, the formylaminoimidazole carboxamide ribonucleotide, between the formyltransferase and the cyclohydrolase active sites.	Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA	Yale University; Yale University	Anderson, KS (corresponding author), LMP 4083, 333 Cedar St, New Haven, CT 06520 USA.				NATIONAL CANCER INSTITUTE [R01CA050721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044630] Funding Source: NIH RePORTER; NCI NIH HHS [CA50721] Funding Source: Medline; NIAID NIH HHS [AI44630] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLEGRA CJ, 1985, P NATL ACAD SCI USA, V82, P4881, DOI 10.1073/pnas.82.15.4881; Anderson KS, 1999, METHOD ENZYMOL, V308, P111; ANDERSON KS, 1991, J BIOL CHEM, V266, P8020; BAGGOTT JE, 1986, BIOCHEM J, V236, P193, DOI 10.1042/bj2360193; BALDWIN SW, 1991, BIOCHEMISTRY-US, V30, P1997, DOI 10.1021/bi00221a037; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; BEARDSLEY G P, 1986, P953; Beardsley GP, 1998, ADV EXP MED BIOL, V431, P221; BEARDSLEY GP, 1989, J BIOL CHEM, V264, P328; BEARDSLEY GP, 1990, CHEMISTRY AND BIOLOGY OF PTERIDINES 1989, P1001; BLACK SL, 1978, ANAL BIOCHEM, V90, P397, DOI 10.1016/0003-2697(78)90042-8; CRONSTEIN BN, 1993, J CLIN INVEST, V92, P2675, DOI 10.1172/JCI116884; Greasley SE, 2001, NAT STRUCT BIOL, V8, P402, DOI 10.1038/87555; Holden HM, 1999, CELL MOL LIFE SCI, V56, P507, DOI 10.1007/s000180050448; Krahn JM, 1997, BIOCHEMISTRY-US, V36, P11061, DOI 10.1021/bi9714114; Liang PH, 1998, BIOCHEMISTRY-US, V37, P12195, DOI 10.1021/bi9803168; Muchmore CRA, 1998, PROTEIN SCI, V7, P39, DOI 10.1002/pro.5560070104; MUELLER WT, 1981, BIOCHEMISTRY-US, V20, P337, DOI 10.1021/bi00505a017; RABINOWITZ JC, 1963, METHOD ENZYMOL, V6, P814, DOI 10.1016/0076-6879(63)06256-X; Rayl EA, 1996, J BIOL CHEM, V271, P2225, DOI 10.1074/jbc.271.4.2225; Rowe P.B, 1971, METHODS ENZYMOL B, V18, P733; RUDOLPH J, 1995, BIOCHEMISTRY-US, V34, P2241, DOI 10.1021/bi00007a019; Sugita T, 1997, J BIOCHEM-TOKYO, V122, P309; Szabados E, 1998, INT J BIOCHEM CELL B, V30, P933, DOI 10.1016/S1357-2725(98)00026-0; SZABADOS E, 1994, ANAL BIOCHEM, V221, P401, DOI 10.1006/abio.1994.1433; Vergis JM, 2001, J BIOL CHEM, V276, P7727, DOI 10.1074/jbc.M009940200; Wall M, 2000, BIOCHEMISTRY-US, V39, P11303, DOI 10.1021/bi0007268; Yamauchi M, 1995, DNA Res, V2, P269, DOI 10.1093/dnares/2.6.269	28	30	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22168	22174		10.1074/jbc.M111964200	http://dx.doi.org/10.1074/jbc.M111964200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11948179	hybrid			2022-12-27	WOS:000176313600010
J	Hughes, WE; Larijani, B; Parker, PJ				Hughes, WE; Larijani, B; Parker, PJ			Detecting protein-phospholipid interactions - Epidermal growth factor-induced activation of phospholipase D1b in situ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION-FACTOR; LIFETIME IMAGING MICROSCOPY; KINASE-C-ALPHA; PLASMA-MEMBRANE; SECRETORY GRANULES; CELLS; LOCALIZATION; PHOSPHATIDYLINOSITOL; STIMULATION; DOWNSTREAM	Phospholipase D (PLD) proteins have been identified in secretory and endocytic vesicles, consistent with their proposed role in regulating membrane traffic. However, their sites of catalytic action remain obscure. We have developed here a novel, analytical approach to monitor PLD activation in intact cells employing lifetime imaging microscopy to measure fluorescence resonance energy transfer between protein and membrane phospholipid. Verification and application of this technique demonstrates a dispersed endosomal, epidermal growth factor-induced activation of the PLD1b isoform. Application of this approach will facilitate the spatial resolution of many protein-phospholipid interact-ions that are key events in the regulation of cellular processes.	Canc Res United Kingdom London Res Inst, Prot Phosphorylat Lab, Lincolns Inn Fields Labs, London WC2A 3PX, England; Canc Res United Kingdom London Res Inst, Cell Biophys Lab, Lincolns Inn Fields Labs, London WC2A 3PX, England	Cancer Research UK; Cancer Research UK	Parker, PJ (corresponding author), Canc Res United Kingdom London Res Inst, Prot Phosphorylat Lab, Lincolns Inn Fields Labs, 44 Lincolns Inn Fields, London WC2A 3PX, England.		Larijani, Banafshe/H-3909-2015	Larijani, Banafshe/0000-0003-4735-1169; parker, peter/0000-0002-6218-2933; Hughes, William/0000-0002-7149-3987				BALBOA MA, 1995, J BIOL CHEM, V270, P29843; Brown FD, 1998, CURR BIOL, V8, P835, DOI 10.1016/S0960-9822(98)70326-4; CLEGG RM, 1994, FLUORESCENCE IMAGING, P179; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Czarny M, 1999, J BIOL CHEM, V274, P2717, DOI 10.1074/jbc.274.5.2717; Dittie AS, 1999, J CELL SCI, V112, P3955; Exton JH, 1999, BBA-MOL CELL BIOL L, V1439, P121, DOI 10.1016/S1388-1981(99)00089-X; FRANCO M, 1995, J BIOL CHEM, V270, P1337, DOI 10.1074/jbc.270.3.1337; Freyberg Z, 2001, MOL BIOL CELL, V12, P943, DOI 10.1091/mbc.12.4.943; GADELLA TWJ, 1993, BIOPHYS CHEM, V48, P221, DOI 10.1016/0301-4622(93)85012-7; Hammond SM, 1997, J BIOL CHEM, V272, P3860, DOI 10.1074/jbc.272.6.3860; Horn JM, 2001, BBA-MOL CELL BIOL L, V1530, P97, DOI 10.1016/S1388-1981(00)00172-4; Hughes WE, 2001, BIOCHEM J, V356, P727, DOI 10.1042/0264-6021:3560727; Hughes WE, 2000, J BIOL CHEM, V275, P801, DOI 10.1074/jbc.275.2.801; KTISTAKIS NT, 1995, P NATL ACAD SCI USA, V92, P4952, DOI 10.1073/pnas.92.11.4952; Larijani B, 2001, BIOCHEM J, V356, P495, DOI 10.1042/0264-6021:3560495; Liscovitch M, 1999, BBA-MOL CELL BIOL L, V1439, P245, DOI 10.1016/S1388-1981(99)00098-0; Liscovitch M, 2000, BIOCHEM J, V345, P401, DOI 10.1042/0264-6021:3450401; Lopez I, 1998, J BIOL CHEM, V273, P12846, DOI 10.1074/jbc.273.21.12846; Millar CA, 1999, BIOCHEM BIOPH RES CO, V254, P734, DOI 10.1006/bbrc.1998.0110; Morgan CP, 1997, BIOCHEM J, V325, P581, DOI 10.1042/bj3250581; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Ng T, 1999, SCIENCE, V283, P2085, DOI 10.1126/science.283.5410.2085; SIDDIQI AR, 1995, J BIOL CHEM, V270, P8466, DOI 10.1074/jbc.270.15.8466; Squire A, 1999, J MICROSC-OXFORD, V193, P36, DOI 10.1046/j.1365-2818.1999.00427.x; Sung TC, 1999, J BIOL CHEM, V274, P3659, DOI 10.1074/jbc.274.6.3659; Toda K, 1999, FEBS LETT, V442, P221, DOI 10.1016/S0014-5793(98)01646-9; WANG P, 1991, J BIOL CHEM, V266, P14877; Whatmore J, 1996, BIOCHEM J, V320, P785, DOI 10.1042/bj3200785; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134; Wustner D, 2001, TRAFFIC, V2, P277, DOI 10.1034/j.1600-0854.2001.9o135.x; Xu LZ, 2000, BIOCHEM BIOPH RES CO, V273, P77, DOI 10.1006/bbrc.2000.2907	33	19	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22974	22979		10.1074/jbc.M201391200	http://dx.doi.org/10.1074/jbc.M201391200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11950840	hybrid			2022-12-27	WOS:000176313600111
J	Yurchenko, V; Zybarth, G; O'Connor, M; Dai, WW; Franchin, G; Hao, T; Guo, HM; Hung, HC; Toole, B; Gallay, P; Sherry, B; Bukrinsky, M				Yurchenko, V; Zybarth, G; O'Connor, M; Dai, WW; Franchin, G; Hao, T; Guo, HM; Hung, HC; Toole, B; Gallay, P; Sherry, B; Bukrinsky, M			Active site residues of cyclophilin A are crucial for its signaling activity via CD147	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEINASE INDUCER; COLLAGENASE-STIMULATORY FACTOR; NEUTROPHIL ELASTASE INHIBITOR; CIS-TRANS-ISOMERASES; RHEUMATOID-ARTHRITIS; T-LYMPHOCYTES; EXTRACELLULAR-MATRIX; IMMUNOGLOBULIN SUPERFAMILY; MONOCLONAL-ANTIBODIES; CELL-LINE	Cyclophilin A (CyPA), a ubiquitously distributed intracellular protein, is a peptidylprolyl cis-trans-isomerase and the major target of the potent immunosuppressive drug cyclosporin A. Although expressed predominantly as an intracellular molecule, CyPA is secreted by cells in response to inflammatory stimuli and is a potent neutrophil and eosinophil chemoattractant in vitro and in vivo. The mechanisms underlying CyPA-mediated signaling and chemotaxis are unknown. Here, we identified CD147 as a cell surface receptor for CyPA and demonstrated that CD147 is an essential component in the CyPA-initiated signaling cascade that culminates in ERK activation. Both signaling and chemotactic activities of CyPA depended also on the presence of heparans, which served as primary binding sites for CyPA on target cells. The proline 180 and glycine 181 residues in the extracellular domain of CD147 were critical for signaling and chemotactic activities mediated by CD147. Also crucial were active site residues of CyPA, because rotamase-defective CyPA mutants failed to initiate signaling events. These results establish cyclophilins as natural ligands for CD147 and suggest an unusual, rotamase-dependent mechanism of signaling.	George Washington Univ, Dept Microbiol & Trop Med, Med Ctr, Washington, DC 20037 USA; Picower Inst Med Res, Manhasset, NY 11030 USA; Tufts Univ, Sch Med, Dept Anat & Cellular Biol, Boston, MA 02111 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	George Washington University; Northwell Health; Tufts University; Scripps Research Institute	Bukrinsky, M (corresponding author), George Washington Univ, Dept Microbiol & Trop Med, Med Ctr, Ross Hall,Rm 734,2300 Eye St NW, Washington, DC 20037 USA.		Sherry, Barbara/GSD-7179-2022; Franchin, Giovanni/AAC-2398-2020; Yurchenko, Vyacheslav/E-4532-2013	Sherry, Barbara/0000-0003-3119-1463; Franchin, Giovanni/0000-0003-1988-2739; Yurchenko, Vyacheslav/0000-0003-4765-3263; Franchin, Giovanni/0000-0003-2609-7974	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029110, R01AI038245] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI 29110, R01 AI 38245] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; Allain F, 2002, P NATL ACAD SCI USA, V99, P2714, DOI 10.1073/pnas.052284899; Berditchevski F, 1997, J BIOL CHEM, V272, P2595, DOI 10.1074/jbc.272.5.2595; Berditchevski F, 1997, J BIOL CHEM, V272, P29174, DOI 10.1074/jbc.272.46.29174; Billich A, 1997, J EXP MED, V185, P975, DOI 10.1084/jem.185.5.975; BISWAS C, 1995, CANCER RES, V55, P434; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Braaten D, 1997, J VIROL, V71, P2107, DOI 10.1128/JVI.71.3.2107-2113.1997; Carpentier M, 1999, J BIOL CHEM, V274, P10990, DOI 10.1074/jbc.274.16.10990; DeCastro R, 1996, J INVEST DERMATOL, V106, P1260, DOI 10.1111/1523-1747.ep12348959; Denys A, 1998, BIOCHEM J, V336, P689, DOI 10.1042/bj3360689; Edwards SW, 1997, IMMUNOL TODAY, V18, P320, DOI 10.1016/S0167-5699(97)01087-6; ELLIS SM, 1989, CANCER RES, V49, P3385; Firestein GS, 1996, ARTHRITIS RHEUM, V39, P1781, DOI 10.1002/art.1780391103; FRIEDMAN J, 1993, P NATL ACAD SCI USA, V90, P6815, DOI 10.1073/pnas.90.14.6815; FRUMAN DA, 1994, FASEB J, V8, P391, DOI 10.1096/fasebj.8.6.7513288; GALAT A, 1993, EUR J BIOCHEM, V216, P689, DOI 10.1111/j.1432-1033.1993.tb18189.x; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; GILAT D, 1994, J IMMUNOL, V153, P4899; HARRIS ED, 1990, NEW ENGL J MED, V322, P1277, DOI 10.1056/nejm199005033221805; Igakura T, 1998, DEV BIOL, V194, P152, DOI 10.1006/dbio.1997.8819; Ingalls RR, 1999, INFECT DIS CLIN N AM, V13, P341, DOI 10.1016/S0891-5520(05)70078-7; Inoue H, 1999, GLIA, V28, P265, DOI 10.1002/(SICI)1098-1136(199912)28:3<265::AID-GLIA10>3.0.CO;2-F; Janusz MJ, 1997, INFLAMM RES, V46, P503, DOI 10.1007/s000110050233; Jin ZG, 2000, CIRC RES, V87, P789, DOI 10.1161/01.RES.87.9.789; KAKIMOTO K, 1995, CELL IMMUNOL, V165, P26, DOI 10.1006/cimm.1995.1183; Kasinrerk W, 1999, IMMUNOLOGY, V96, P184; Kirsch AH, 1997, TISSUE ANTIGENS, V50, P147, DOI 10.1111/j.1399-0039.1997.tb02853.x; KOFRON JL, 1991, BIOCHEMISTRY-US, V30, P6127, DOI 10.1021/bi00239a007; Konttinen YT, 2000, ARTHRITIS RHEUM, V43, P275, DOI 10.1002/1529-0131(200002)43:2<275::AID-ANR6>3.0.CO;2-#; LIU J, 1993, IMMUNOL TODAY, V14, P290, DOI 10.1016/0167-5699(93)90048-P; LIU J, 1991, BIOCHEMISTRY-US, V30, P2306, DOI 10.1021/bi00223a003; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; MCCACHREN SS, 1991, ARTHRITIS RHEUM-US, V34, P1085; Mutin M, 1997, TISSUE ANTIGENS, V50, P449, DOI 10.1111/j.1399-0039.1997.tb02899.x; Pushkarsky T, 2001, P NATL ACAD SCI USA, V98, P6360, DOI 10.1073/pnas.111583198; Saphire ACS, 1999, EMBO J, V18, P6771, DOI 10.1093/emboj/18.23.6771; Schonherr E, 2000, Dev Immunol, V7, P89, DOI 10.1155/2000/31748; SEWELL KL, 1993, LANCET, V341, P283, DOI 10.1016/0140-6736(93)92627-6; Sherry B, 1998, P NATL ACAD SCI USA, V95, P1758, DOI 10.1073/pnas.95.4.1758; SHERRY B, 1992, P NATL ACAD SCI USA, V89, P3511, DOI 10.1073/pnas.89.8.3511; STOCKINGER H, 1997, LEUKOCYTE TYPING, V6, P760; TANAKA Y, 1993, NATURE, V361, P79, DOI 10.1038/361079a0; Wimazal F, 1999, TISSUE ANTIGENS, V54, P499, DOI 10.1034/j.1399-0039.1999.540507.x; XU Q, 1992, J BIOL CHEM, V267, P11968; Yoo SH, 1997, J MOL BIOL, V269, P780, DOI 10.1006/jmbi.1997.1051; Yurchenko V, 2001, BIOCHEM BIOPH RES CO, V288, P786, DOI 10.1006/bbrc.2001.5847; Zucker S, 1999, ANN NY ACAD SCI, V878, P212, DOI 10.1111/j.1749-6632.1999.tb07687.x; ZYDOWSKY LD, 1992, PROTEIN SCI, V1, P1092, DOI 10.1002/pro.5560010903	49	260	279	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22959	22965		10.1074/jbc.M201593200	http://dx.doi.org/10.1074/jbc.M201593200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11943775	hybrid			2022-12-27	WOS:000176313600109
J	Zhang, CS; Stratmann, A; Block, O; Bruckner, R; Podeschwa, M; Altenbach, HJ; Wehmeier, UF; Piepersberg, W				Zhang, CS; Stratmann, A; Block, O; Bruckner, R; Podeschwa, M; Altenbach, HJ; Wehmeier, UF; Piepersberg, W			Biosynthesis of the C-7-cyclitol moiety of acarbose in Actinoplanes species SE50/110 - 7-O-phosphorylation of the initial cyclitol precursor leads to proposal of a new biosynthetic pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSIDASE INHIBITOR ACARBOSE; ANTIBIOTIC-PRODUCING ORGANISMS; STREPTOMYCES-GRISEUS; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; VALIDAMYCIN-A; EXPRESSION; CLONING; IDENTIFICATION; PURIFICATION	We have previously demonstrated that the biosynthesis of the C-7-cyclitol, called valienol (or valienamine), of the a-glucosidase inhibitor acarbose starts from the cyclization of sedo-heptulose 7-phosphate to 2-epi-5-epivaliolone (Stratmann, A., Mahmud, T., Lee, S., Distler, J., Floss, H. G., and Piepersberg, W. (1999) J. Biol. Chem. 274, 10889-10896). Synthesis of the intermediate 2-epi-5-epi-valiolone is catalyzed by the cyclase AcbC encoded in the biosynthetic (acb) gene cluster of Actinoplanes sp. SE50/110. The acbC gene lies in a possible transcription unit, acbKLMNOC, cluster encompassing putative biosynthetic genes for cyclitol conversion. All genes were heterologously expressed in strains of Streptomyces lividans 66 strains 1326, TK23, and TK64. The AcbK protein was identified as the acarbose 7-kinase, which had been described earlier (Drepper, A., and Pape, H. (1996) J. Antibiot. (Tokyo) 49, 664-668). The multistep conversion of 2-epi-5-epi-valiolone to the final cyclitol moiety was studied by testing enzymatic mechanisms such as dehydration, reduction, epimerization, and phosphorylation. Thus, a phosphotransferase activity was identified modifying 2-epi-5-epi-valiolone by ATP-dependent phosphorylation. This activity could be attributed to the AcbM protein by verifying this activity in S. lividans strain TK64/pCW4123M, expressing His-tagged AcbM. The His-tagged AcbM protein was purified and subsequently characterized as a 2-epi-5-epi-valiolone 7-kinase, presumably catalyzing the first enzyme reaction in the biosynthetic route, leading to an activated form of the intermediate 1-epi-valienol. The AcbK protein could not catalyze the same reaction nor convert any of the other C-7-cyclitol monomers tested. The 2-epi-5-epi-valiolone 7-phosphate was further converted by the AcbO protein to another isomeric and phosphorylated intermediate, which was likely to be the 2-epimer 5-epi-valiolone 7-phosphate. The products of both enzyme reactions were characterized by mass spectrometric methods. The product of the AcbM-catalyzed reaction, 2-epi-5-epi-valiolone 7-phosphate, was purified on a preparative scale and identified by NAIR spectroscopy. A biosynthetic pathway for the pseudodisaccharidic acarviosyl moiety of acarbose is proposed on the basis of these data.	Berg Univ Wuppertal, Inst Chem Microbiol, D-42097 Wuppertal, Germany; Berg Univ Wuppertal, Inst Organ Chem, D-42097 Wuppertal, Germany; Res Ctr Julich, Inst Biotechnol 1, D-52425 Julich, Germany	University of Wuppertal; University of Wuppertal; Helmholtz Association; Research Center Julich	Piepersberg, W (corresponding author), Berg Univ Wuppertal, Inst Chem Microbiol, Gauss Str 20, D-42097 Wuppertal, Germany.	piepersb@uni-wuppertal.de	Zhang, Changsheng/B-5965-2012	Zhang, Changsheng/0000-0003-2349-3138				BABCOCK MJ, 1988, J BACTERIOL, V170, P2802, DOI 10.1128/jb.170.6.2802-2808.1988; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CUNDLIFFE E, 1989, ANNU REV MICROBIOL, V43, P207, DOI 10.1146/annurev.micro.43.1.207; DISTLER J, 1985, FEMS MICROBIOL LETT, V30, P145; Dong HJ, 2001, J AM CHEM SOC, V123, P2733, DOI 10.1021/ja003643n; Doumith M, 2000, MOL GEN GENET, V264, P477, DOI 10.1007/s004380000329; Drepper A, 1996, FEBS LETT, V388, P177, DOI 10.1016/0014-5793(96)00554-6; Drepper A, 1996, J ANTIBIOT, V49, P664, DOI 10.7164/antibiotics.49.664; GOCKE K, 1996, J ANTIBIOT TOKYO, V49, P661; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hemker M, 2001, J BACTERIOL, V183, P4484, DOI 10.1128/JB.183.15.4484-4492.2001; Hopwood D.A., 1985, GENETIC MANIPULATION; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LIU HW, 1994, ANNU REV MICROBIOL, V48, P223, DOI 10.1146/annurev.micro.48.1.223; Mahmud T, 2001, J ORG CHEM, V66, P5066, DOI 10.1021/jo0101003; Mahmud T, 1999, J AM CHEM SOC, V121, P6973, DOI 10.1021/ja991102w; MANSOURI K, 1991, MOL GEN GENET, V228, P459, DOI 10.1007/BF00260640; Mendez C, 2001, RES MICROBIOL, V152, P341, DOI 10.1016/S0923-2508(01)01205-0; MULLER L, 1989, NOVEL MICROBIAL PROD, P109; Piepersberg W., 1997, BIOTECHNOLOGY ANTIBI, P81; Rehm H. J., 1997, BIOTECHNOLOGY, P397; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; SPRENGER GA, 1995, EUR J BIOCHEM, V230, P525; Stratmann A, 1999, J BIOL CHEM, V274, P10889, DOI 10.1074/jbc.274.16.10889; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TAKANO E, 1995, GENE, V166, P133, DOI 10.1016/0378-1119(95)00545-2; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tercero JA, 1996, J BIOL CHEM, V271, P1579, DOI 10.1074/jbc.271.3.1579; Thompson C J, 1995, Biotechnology, V28, P197; TRUSCHEIT E, 1981, ANGEW CHEM INT EDIT, V20, P744, DOI 10.1002/anie.198107441; Volff JN, 1996, MOL MICROBIOL, V21, P1037, DOI 10.1046/j.1365-2958.1996.761428.x; Walker J B, 1975, Methods Enzymol, V43, P429; Wehmeier UF, 2001, FEMS MICROBIOL LETT, V197, P53, DOI 10.1111/j.1574-6968.2001.tb10582.x; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	36	56	64	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22853	22862		10.1074/jbc.M202375200	http://dx.doi.org/10.1074/jbc.M202375200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11937512	hybrid			2022-12-27	WOS:000176313600096
J	Aubry, L; Mattei, S; Blot, B; Sadoul, R; Satre, M; Klein, G				Aubry, L; Mattei, S; Blot, B; Sadoul, R; Satre, M; Klein, G			Biochemical characterization of two analogues of the apoptosis-linked gene 2 protein in Dictyostelium discoideum and interaction with a physiological partner in mammals, murine alix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEIN; EF-HAND PROTEINS; CA2+-BINDING PROTEINS; CELL-DEATH; ENTAMOEBA-HISTOLYTICA; ESCHERICHIA-COLI; ALG-2 PROTEIN; FAMILY; IDENTIFICATION; EXPRESSION	Two homologues, Dd-ALG-2a and Dd-ALG-2b, of the mammalian calcium-binding protein ALG-2 (apoptosis-linked gene 2) have been characterized in the cellular slime mold Dictyostelium discoideum. Fluorescence titrations showed that both proteins bind calcium ions with affinities (Ca2+)(0.5) of 30 and 450 mum, respectively, at sites specific to calcium. Calcium ion binding resulted in changes of conformation associated with the unmasking of hydrophobic regions of the proteins. Surface plasmon resonance analysis showed that Dd-ALG-2a homodimers formed (K-D of 1 mum) at calcium ion concentrations similar to those necessary for Ca2+-induced conformational changes. Deletion of the hydrophobic N-terminal sequence or EF-hand 5 of Dd-ALG-2a prevented dimerization. The Dd-ALG-2b homodimer was not detected, and the Dd-ALG-2a/2b heterodimer formed only when DdALG-2b was the immobilized partner. Murine Alix formed a heterodimer (K-D = 0.6 mum) with Dd-ALG-2a but not with Dd-ALG-2b, and the interaction strictly depended upon calcium ions. The DeltaNter construct of Dd-ALG-2a lost its interaction capacity with mouse Alix. The genes encoding both proteins, Dd-alg-2a and -2b, were expressed in growing cells. The levels of mRNA were at a maximum during aggregation (4-8 h) and decreased rapidly thereafter. In contrast, the levels of proteins remained fairly stable. Dd-ALG-2a and DdALG-2b were found to be dispensable for growth and development, based on the finding that single Dd-alg2a(-) or Dd-alg-2b(-) and double Dd-alg2a(-)/Dd-alg-2b(-) mutant cell lines showed normal growth in axenic medium or on bacterial lawns and exhibited unaltered development.	Univ Grenoble 1, Dept Reponse & Dynam Cellulaires Biochim & Biophy, Commiss Energie Atom Grenoble, Lab Biochim & Biophys Syst Integres,CNRS,UMR 5092, F-38054 Grenoble 9, France; Univ Grenoble 1, CHU Grenoble, INSERM, Equipe Mixte EMI 0108, F-38043 Grenoble, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Klein, G (corresponding author), Univ Grenoble 1, Dept Reponse & Dynam Cellulaires Biochim & Biophy, Commiss Energie Atom Grenoble, Lab Biochim & Biophys Syst Integres,CNRS,UMR 5092, 17 Rue Martyrs, F-38054 Grenoble 9, France.			Aubry, Laurence/0000-0001-7640-1706; SADOUL, Remy/0000-0002-4763-0320				ABE F, 1995, DEV GROWTH DIFFER, V37, P39; Andre B, 1996, FEBS LETT, V382, P198, DOI 10.1016/0014-5793(96)00176-7; Arnoult D, 2001, MOL BIOL CELL, V12, P3016, DOI 10.1091/mbc.12.10.3016; Baskar R, 2000, INT J DEV BIOL, V44, P491; BERS DM, 1994, METHOD CELL BIOL, V40, P3; Borinstein SC, 2000, CELL SIGNAL, V12, P769, DOI 10.1016/S0898-6568(00)00129-7; Che SL, 1999, J BIOL CHEM, V274, P5522, DOI 10.1074/jbc.274.9.5522; Chen B, 2000, J BIOL CHEM, V275, P19275, DOI 10.1074/jbc.M908994199; CORNILLON S, 1994, J CELL SCI, V107, P2691; COUKELL B, 1995, FEBS LETT, V362, P342, DOI 10.1016/0014-5793(95)00272-B; CUBITT AB, 1995, DEVELOPMENT, V121, P2291; Dorywalska M, 2000, BBA-MOL CELL RES, V1496, P356, DOI 10.1016/S0167-4889(00)00024-0; DYNES JL, 1989, P NATL ACAD SCI USA, V86, P7966, DOI 10.1073/pnas.86.20.7966; Gilchrist CA, 2001, J BIOL CHEM, V276, P11838, DOI 10.1074/jbc.M007375200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HAMADA H, 1988, CANCER RES, V48, P3173; Han YH, 1998, FEBS LETT, V441, P302, DOI 10.1016/S0014-5793(98)01568-3; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Jia J, 2001, STRUCTURE, V9, P267, DOI 10.1016/S0969-2126(01)00585-8; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; KIMMEL AR, 1982, DEV DICTYOSTELIUM DI, P234; Kitaura Y, 1999, BIOCHEM BIOPH RES CO, V263, P68, DOI 10.1006/bbrc.1999.1189; Kitaura Y, 2001, J BIOL CHEM, V276, P14053, DOI 10.1074/jbc.M008649200; Kuspa Adam, 2001, Functional and Integrative Genomics, V1, P279, DOI 10.1007/s101420000033; Levraud JP, 2001, METHOD CELL BIOL, V66, P469; LIU TY, 1992, MOL BIOL CELL, V3, P1403, DOI 10.1091/mbc.3.12.1403; Lo KWH, 1999, BIOCHEMISTRY-US, V38, P7498, DOI 10.1021/bi990034n; Lollike K, 2001, J BIOL CHEM, V276, P17762, DOI 10.1074/jbc.M100965200; Loomis WF., 1975, DICTYOSTELIUM DISCOI; Maki M, 1998, J BIOCHEM, V124, P1170, DOI 10.1093/oxfordjournals.jbchem.a022235; Maki M, 1997, BIOCHEM J, V328, P718; Missotten M, 1999, CELL DEATH DIFFER, V6, P124, DOI 10.1038/sj.cdd.4400456; NELLEN W, 1987, METHOD CELL BIOL, V28, P67; Nickel R, 2000, FEBS LETT, V486, P112, DOI 10.1016/S0014-5793(00)02245-6; Ohkouchi S, 2001, J BIOCHEM-TOKYO, V130, P207, DOI 10.1093/oxfordjournals.jbchem.a002974; Rosel D, 2000, FEBS LETT, V473, P323, DOI 10.1016/S0014-5793(00)01551-9; Schaap P, 1996, EMBO J, V15, P5177, DOI 10.1002/j.1460-2075.1996.tb00902.x; Sussman M., 1966, METHOD CELL PHYSIOL, V2, P397; SUTOH K, 1993, PLASMID, V30, P150, DOI 10.1006/plas.1993.1042; TEAHAN CG, 1992, BIOCHEM J, V286, P549, DOI 10.1042/bj2860549; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Van Driessche N, 2002, DEVELOPMENT, V129, P1543; Vito P, 1999, J BIOL CHEM, V274, P1533, DOI 10.1074/jbc.274.3.1533; Vito P, 1996, SCIENCE, V271, P521, DOI 10.1126/science.271.5248.521; WHITTINGHAM WF, 1960, P NATL ACAD SCI USA, V46, P642, DOI 10.1073/pnas.46.5.642; Wyllie AH, 2001, P NATL ACAD SCI USA, V98, P11, DOI 10.1073/pnas.98.1.11; Zamparelli C, 2000, BIOCHEMISTRY-US, V39, P658, DOI 10.1021/bi991648v	47	22	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21947	21954		10.1074/jbc.M201718200	http://dx.doi.org/10.1074/jbc.M201718200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11927596	hybrid			2022-12-27	WOS:000176286000107
J	Franzoni, L; Lucke, C; Perez, C; Cavazzini, D; Rademacher, M; Ludwig, C; Spisni, A; Rossi, GL; Ruterjans, H				Franzoni, L; Lucke, C; Perez, C; Cavazzini, D; Rademacher, M; Ludwig, C; Spisni, A; Rossi, GL; Ruterjans, H			Structure and backbone dynamics of apo- and holo-cellular retinol-binding protein in solution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID-BINDING; LIGAND-BINDING; X-RAY; CRYSTAL-STRUCTURE; NMR RELAXATION; SPECIFICITY; RESOLUTION; PURIFICATION; MECHANISM; PROGRAM	Retinoid-binding proteins play an important role in regulating transport, storage, and metabolism of vitamin A and its derivatives. The solution structure and backbone dynamics of rat cellular retinol-binding protein type I (CRBP) in the apo- and holo-form have been determined and compared using multidimensional high resolution NMR spectroscopy. The global fold of the protein is consistent with the common motif described for members of the intracellular lipid-binding protein family. The most relevant difference between the NMR structure ensembles of apo- and holoCRBP is the higher backbone disorder, in the ligand-free form, of some segments that frame the putative entrance to the ligand-binding site. These comprise alpha-helix II, the subsequent linker to beta-strand B, the hairpin turn between beta-strands C and D, and the betaE-betaF turn. The internal backbone dynamics, obtained from N-15 relaxation data (T-1, T-2. and heteronuclear nuclear Overhauser effect) at two different fields, indicate several regions with significantly higher backbone mobility in the apoprotein, including the betaC-betaD and betaE-betaF turns. Although apoCRBP contains a binding cavity more shielded than that of any other retinoid carrier, conformational flexibility in the portal region may assist retinol uptake. The stiffening of the backbone in the holoprotein guarantees the stability of the complex during retinol transport and suggests that targeted retinol release requires a transiently open state that is likely to be promoted by the acceptor or the local environment.	Univ Parma, Dept Biochem & Mol Biol, I-43100 Parma, Italy; Univ Parma, Dept Expt Med, Sect Chem & Struct Biochem, I-43100 Parma, Italy; Goethe Univ Frankfurt, Inst Biophys Chem, D-60439 Frankfurt, Germany	University of Parma; University of Parma; Goethe University Frankfurt	Rossi, GL (corresponding author), Univ Parma, Dept Biochem & Mol Biol, Parco Area Sci,23-A, I-43100 Parma, Italy.	rossi@unipr.it	Spisni, Alberto/AAY-7778-2020; Cavazzini, Davide/C-8154-2014	Cavazzini, Davide/0000-0002-1743-2390				Bakowies D, 2002, J MOL BIOL, V315, P713, DOI 10.1006/jmbi.2001.5202; BANASZAK L, 1994, ADV PROTEIN CHEM, V45, P89; BASHOR MM, 1973, P NATL ACAD SCI USA, V70, P3483, DOI 10.1073/pnas.70.12.3483; BYCHKOVA VE, 1992, BIOCHEMISTRY-US, V31, P7566, DOI 10.1021/bi00148a018; Bychkova VE, 1998, FOLD DES, V3, P285, DOI 10.1016/S1359-0278(98)00039-X; Cavanagh John, 1996, P243; Chen X, 1998, J MOL BIOL, V278, P641, DOI 10.1006/jmbi.1998.1734; CHENG L, 1991, J BIOL CHEM, V266, P24404; COWAN SW, 1993, J MOL BIOL, V230, P1225, DOI 10.1006/jmbi.1993.1238; DAUBEROSGUTHORPE P, 1988, PROTEINS, V4, P31, DOI 10.1002/prot.340040106; Elviri L, 2001, RAPID COMMUN MASS SP, V15, P2186, DOI 10.1002/rcm.497; Folli C, 2001, P NATL ACAD SCI USA, V98, P3710, DOI 10.1073/pnas.061455898; Ghyselinck NB, 1999, EMBO J, V18, P4903, DOI 10.1093/emboj/18.18.4903; Gudas Lorraine J., 1994, P443; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; Herr FM, 1999, J BIOL CHEM, V274, P9556, DOI 10.1074/jbc.274.14.9556; HERR FM, 1992, BIOCHEMISTRY-US, V31, P6748, DOI 10.1021/bi00144a014; Hodsdon ME, 1997, BIOCHEMISTRY-US, V36, P2278, DOI 10.1021/bi962018l; Hodsdon ME, 1997, BIOCHEMISTRY-US, V36, P1450, DOI 10.1021/bi961890r; JAKOBY MG, 1993, BIOCHEMISTRY-US, V32, P872, DOI 10.1021/bi00054a019; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KLEYWEGT GJ, 1994, STRUCTURE, V2, P1241, DOI 10.1016/S0969-2126(94)00125-1; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krishnan VV, 2000, BIOCHEMISTRY-US, V39, P9119, DOI 10.1021/bi000296l; Kuser PR, 2001, ACTA CRYSTALLOGR D, V57, P1863, DOI 10.1107/S090744490101825X; LALONDE JM, 1994, BIOCHEMISTRY-US, V33, P4885, DOI 10.1021/bi00182a017; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LASSEN D, 1995, EUR J BIOCHEM, V230, P266, DOI 10.1111/j.1432-1033.1995.tb20560.x; LEVIN MS, 1990, METHOD ENZYMOL, V189, P506; Li E, 1996, ANNU REV NUTR, V16, P205, DOI 10.1146/annurev.nu.16.070196.001225; LI E, 1991, J BIOL CHEM, V266, P3622; LIU RSH, 1984, TETRAHEDRON, V40, P1931, DOI 10.1016/S0040-4020(01)88435-0; Lu JY, 1999, J MOL BIOL, V286, P1179, DOI 10.1006/jmbi.1999.2544; Lu JY, 2000, J MOL BIOL, V300, P619, DOI 10.1006/jmbi.2000.3883; Lucke C, 2001, BIOCHEM J, V354, P259, DOI 10.1042/0264-6021:3540259; Lucke C, 1996, STRUCTURE, V4, P785, DOI 10.1016/S0969-2126(96)00086-X; MACDONALD PN, 1987, J BIOL CHEM, V262, P10550; Malpeli G, 1998, METH MOL B, V89, P111; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Napoli JL, 2000, PROG NUCLEIC ACID RE, V63, P139, DOI 10.1016/S0079-6603(08)60722-9; Ong David E., 1994, P283; ONG DE, 1984, J BIOL CHEM, V259, P1476; ONG DE, 1978, J BIOL CHEM, V253, P828; OTTONELLO S, 1987, J BIOL CHEM, V262, P3975; PALMER AG, 1991, J AM CHEM SOC, V113, P4371, DOI 10.1021/ja00012a001; PENG JW, 1992, BIOCHEMISTRY-US, V31, P8571, DOI 10.1021/bi00151a027; PENG JW, 1992, J MAGN RESON, V98, P308, DOI 10.1016/0022-2364(92)90135-T; Penzes P, 1999, BIOCHEMISTRY-US, V38, P2088, DOI 10.1021/bi982228t; POSCH KC, 1991, BIOCHEMISTRY-US, V30, P6224, DOI 10.1021/bi00239a021; Pristovsek P, 2000, EUR J BIOCHEM, V267, P4205, DOI 10.1046/j.1432-1327.2000.01456.x; RIZO J, 1994, J BIOMOL NMR, V4, P741, DOI 10.1007/BF00398406; ROSS AC, 1993, J NUTR, V123, P346, DOI 10.1093/jn/123.suppl_2.346; SACCHETTINI JC, 1989, J MOL BIOL, V208, P327, DOI 10.1016/0022-2836(89)90392-6; SCAPIN G, 1993, MOL CELL BIOCHEM, V123, P3, DOI 10.1007/BF01076469; SCHLEUCHER J, 1993, ANGEW CHEM INT EDIT, V32, P1489, DOI 10.1002/anie.199314891; SPECHT B, 1994, J BIOTECHNOL, V33, P259, DOI 10.1016/0168-1656(94)90074-4; Steiner T, 2001, J MOL BIOL, V305, P535, DOI 10.1006/jmbi.2000.4301; STUMP DG, 1991, J BIOL CHEM, V266, P4622; Thompson J, 1997, J BIOL CHEM, V272, P7140, DOI 10.1074/jbc.272.11.7140; THOMPSON JR, 1995, J MOL BIOL, V252, P433, DOI 10.1006/jmbi.1995.0509; vanAalten DMF, 1995, PROTEIN ENG, V8, P1129; vanAalten DMF, 1997, PROTEIN ENG, V10, P31, DOI 10.1093/protein/10.1.31; Vogel S, 2001, J BIOL CHEM, V276, P1353, DOI 10.1074/jbc.M005118200; Wang LC, 1997, J BIOL CHEM, V272, P1541, DOI 10.1074/jbc.272.3.1541; Wang LC, 1998, BIOCHEMISTRY-US, V37, P12727, DOI 10.1021/bi9808924; Wang LC, 1998, BIOCHEMISTRY-US, V37, P13021, DOI 10.1021/bi981021x; WINTER NS, 1993, J MOL BIOL, V230, P1247, DOI 10.1006/jmbi.1993.1239; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WUTHRICH K, 1983, J MOL BIOL, V169, P949, DOI 10.1016/S0022-2836(83)80144-2; XU ZH, 1993, J BIOL CHEM, V268, P7874; YOUNG ACM, 1994, STRUCTURE, V2, P523, DOI 10.1016/S0969-2126(00)00052-6	74	48	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21983	21997		10.1074/jbc.M201994200	http://dx.doi.org/10.1074/jbc.M201994200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11934897	hybrid			2022-12-27	WOS:000176286000111
J	Pilch, J; Habermann, R; Felding-Habermann, B				Pilch, J; Habermann, R; Felding-Habermann, B			Unique ability of integrin alpha(v)beta(3) to support tumor cell arrest under dynamic flow conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; BETA-3 INTEGRINS; VITRONECTIN RECEPTOR; PLATELET-AGGREGATION; LIGAND RECOGNITION; P-SELECTIN; IN-VITRO; ALPHA-V; ADHESION; METASTASIS	Shear-resistant arrest of circulating tumor cells is required for metastasis from the blood stream. Arrest during blood flow can be supported by tumor cell interaction with attached, activated platelets. This is mediated by tumor cell integrin alpha(v)beta(3) and cross-linking plasma protein ligands. To analyze the mechanism of tumor cell ligand interactions under dynamic flow conditions, we used real-time video microscopy and tested human melanoma cell binding to fibrinogen, von Willebrand Factor, or fibronectin matrices in a buffer perfusion system. When perfused at venous flow, melanoma cells arrested abruptly and began to spread immediately. This was uniquely mediated by integrin alpha(v)beta(3) on all tested ligands, and required alpha(v)beta(3) activation and actin polymerization. Under static conditions, alpha(v)beta(3) cooperated with alpha(v)beta(1) and alpha(5)beta(1), in supporting melanoma cell adhesion to fibronectin. But even when activated, beta(1), integrins did not contribute to melanoma cell arrest during flow. Soluble ligand served as a cross-linker between attached and circulating tumor cells and enhanced melanoma cell arrest. Cohesion of activated melanoma cells was restricted to the matrix surface and did not occur in suspension. We conclude that the presence of alpha(v)beta(3) in a functionally activated state provides a unique advantage for circulating tumor cells by promoting tumor cell arrest in the presence of flow-dependent shear forces.	Scripps Res Inst, Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute	Felding-Habermann, B (corresponding author), Scripps Res Inst, Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd,Mail Drop MEM 175, La Jolla, CA 92037 USA.		Pilch, Jan/AAM-1976-2020; Pilch, Jan/AAJ-3614-2021	Pilch, Jan/0000-0002-6427-5738; Pilch, Jan/0000-0002-2682-4708	NATIONAL CANCER INSTITUTE [R01CA095458] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA95458] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Al-Mehdi AB, 2000, NAT MED, V6, P100, DOI 10.1038/71429; Borsig L, 2001, P NATL ACAD SCI USA, V98, P3352, DOI 10.1073/pnas.061615598; Chambers AF, 1995, CANCER METAST REV, V14, P279, DOI 10.1007/BF00690599; CHARO IF, 1990, J CELL BIOL, V111, P2795, DOI 10.1083/jcb.111.6.2795; CHERESH DA, 1987, J BIOL CHEM, V262, P17703; Coller BS, 2001, THROMB HAEMOSTASIS, V86, P427; Feigelson S, 2001, J BIOL CHEM, V276, P13891, DOI 10.1074/jbc.M004939200; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; FeldingHabermann B, 1996, J BIOL CHEM, V271, P5892, DOI 10.1074/jbc.271.10.5892; FELDINGHABERMANN B, 1992, J BIOL CHEM, V267, P5070; FELDINGHABERMANN B, 1992, J CLIN INVEST, V89, P2018, DOI 10.1172/JCI115811; Gailit J, 1996, J INVEST DERMATOL, V106, P102, DOI 10.1111/1523-1747.ep12328177; HONN KV, 1992, CANCER METAST REV, V11, P325, DOI 10.1007/BF01307186; Hu DD, 1996, J BIOL CHEM, V271, P21745, DOI 10.1074/jbc.271.36.21745; HU DD, 1995, J BIOL CHEM, V270, P9917, DOI 10.1074/jbc.270.17.9917; Kim YJ, 1998, P NATL ACAD SCI USA, V95, P9325, DOI 10.1073/pnas.95.16.9325; Kiosses WB, 2001, NAT CELL BIOL, V3, P316, DOI 10.1038/35060120; Konstantopoulos K, 1997, J CLIN INVEST, V100, pS19; LAM SCT, 1989, J BIOL CHEM, V264, P3742; MARSHALL JF, 1995, J CELL SCI, V108, P1227; McCarty OJT, 2000, BLOOD, V96, P1789, DOI 10.1182/blood.V96.5.1789.h8001789_1789_1797; Mould AP, 2000, J BIOL CHEM, V275, P20324, DOI 10.1074/jbc.M000572200; NIERODZIK ML, 1995, THROMB HAEMOSTASIS, V74, P282; NIIYA K, 1987, BLOOD, V70, P475; Obergfell A, 2001, J BIOL CHEM, V276, P5916, DOI 10.1074/jbc.M010639200; Orr FW, 2000, J PATHOL, V190, P310, DOI 10.1002/(SICI)1096-9896(200002)190:3<310::AID-PATH525>3.0.CO;2-P; Palumbo JS, 2000, BLOOD, V96, P3302, DOI 10.1182/blood.V96.10.3302; Pampori N, 1999, J BIOL CHEM, V274, P21609, DOI 10.1074/jbc.274.31.21609; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; Savage B, 2001, CURR OPIN HEMATOL, V8, P270, DOI 10.1097/00062752-200109000-00002; Shattil SJ, 1999, THROMB HAEMOSTASIS, V82, P318; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; Suehiro K, 1996, J BIOL CHEM, V271, P10365, DOI 10.1074/jbc.271.17.10365; van Kooyk Y, 2000, CURR OPIN CELL BIOL, V12, P542, DOI 10.1016/S0955-0674(00)00129-0; Wang J, 2001, J BIOL CHEM, V276, P14474, DOI 10.1074/jbc.M007324200; WAYNER EA, 1989, J CELL BIOL, V109, P1321, DOI 10.1083/jcb.109.3.1321; Wong CW, 2001, CANCER RES, V61, P333; Woodside DG, 2001, THROMB HAEMOSTASIS, V86, P316, DOI 10.1055/s-0037-1616229; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200	40	74	81	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21930	21938		10.1074/jbc.M201630200	http://dx.doi.org/10.1074/jbc.M201630200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11934894	hybrid			2022-12-27	WOS:000176286000105
J	Repa, JJ; Berge, KE; Pomajzl, C; Richardson, JA; Hobbs, H; Mangelsdorf, DJ				Repa, JJ; Berge, KE; Pomajzl, C; Richardson, JA; Hobbs, H; Mangelsdorf, DJ			Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORPHAN NUCLEAR RECEPTORS; BILE-ACID SYNTHESIS; RAT HEPATOMA-CELLS; LXR-ALPHA; DIETARY-CHOLESTEROL; MESSENGER-RNA; MICE; IDENTIFICATION; GENE; METABOLISM	Mutations in the ATP-binding cassette (ABC) transporters ABCG5 and ABCG8 have recently been shown to cause the autosomal recessive disorder sitosterolemia. Here we demonstrate that the ABCG5 and ABCG8 genes are direct targets of the oxysterol receptors liver X receptor (LXR) alpha and LXRbeta. Diets containing high cholesterol markedly increased the expression of ABCG5/G8 mRNA in mouse liver and intestine. This increase was also observed using synthetic ligands of LXR and its heterodimeric partner, the retinoid X receptor. In situ hybridization analyses of tissues from LXR agonist-treated mice revealed that ABCG5/G8 mRNA is located in hepatocytes and enterocytes and is increased upon LXR activation. In addition, expression of the LXR target gene ABCA1, previously implicated in the control of cholesterol absorption, was also dramatically up-regulated in jejunal enterocytes upon exposure to LXR agonists. These changes in ABC transporter gene expression were not observed in mice lacking LXRs. Furthermore, in the rat hepatoma cell line FTO2B, LXR-dependent transcription of the ABCG5/G8 genes was cycloheximide-resistant, indicating that these genes are directly regulated by LXRs. The addition of ABCG5 and AECG8 to the growing list of LXR target genes further supports the notion that LXRs serve as sterol sensors to coordinately regulate sterol catabolism, storage, efflux, and elimination.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Mangelsdorf, DJ (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.		Eckhardt, Erik/G-1567-2010	Repa, Joyce/0000-0001-5740-1954; Mangelsdorf, David/0000-0002-4355-0796	NHLBI NIH HHS [HL20948] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alberti S, 2001, J CLIN INVEST, V107, P565, DOI 10.1172/JCI9794; BEHER WT, 1963, J NUTR, V79, P523, DOI 10.1093/jn/79.4.523; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Bjorkhem I., 1995, METABOLIC MOL BASES, P2073; BOEHM MF, 1995, J MED CHEM, V38, P3146, DOI 10.1021/jm00016a018; BROWN MS, 1978, J BIOL CHEM, V253, P1121; Claudel T, 2001, P NATL ACAD SCI USA, V98, P2610, DOI 10.1073/pnas.041609298; Costet P, 2000, J BIOL CHEM, V275, P28240; DeBose-Boyd RA, 2001, P NATL ACAD SCI USA, V98, P1477, DOI 10.1073/pnas.98.4.1477; Drobnik W, 2001, GASTROENTEROLOGY, V120, P1203, DOI 10.1053/gast.2001.23250; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Horton JD, 1999, CURR OPIN LIPIDOL, V10, P143, DOI 10.1097/00041433-199904000-00008; Ikeda S, 2000, BIOCHEM BIOPH RES CO, V273, P1063, DOI 10.1006/bbrc.2000.3071; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Lawn RM, 2001, ARTERIOSCL THROM VAS, V21, P378, DOI 10.1161/01.ATV.21.3.378; Lee MH, 2001, NAT GENET, V27, P79, DOI 10.1038/83799; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Lu TT, 2001, J BIOL CHEM, V276, P37735, DOI 10.1074/jbc.R100035200; Maloney PR, 2000, J MED CHEM, V43, P2971, DOI 10.1021/jm0002127; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; Mukherjee R, 1998, ARTERIOSCL THROM VAS, V18, P272, DOI 10.1161/01.ATV.18.2.272; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Pollner R, 1997, FEBS LETT, V405, P31, DOI 10.1016/S0014-5793(97)00152-X; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; SALEN G, 1989, J LIPID RES, V30, P1319; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Schwarz M, 1998, J LIPID RES, V39, P1833; Shelton JM, 2000, J LIPID RES, V41, P532; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Trappe R, 1999, BBA-GENE STRUCT EXPR, V1446, P341, DOI 10.1016/S0167-4781(99)00107-4; Venkateswaran A, 2000, J BIOL CHEM, V275, P14700, DOI 10.1074/jbc.275.19.14700; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; WIEBEL FJ, 1984, EUR J BIOCHEM, V145, P455, DOI 10.1111/j.1432-1033.1984.tb08577.x; Willy PJ, 1997, GENE DEV, V11, P289, DOI 10.1101/gad.11.3.289; WYNSHAWBORIS A, 1984, J BIOL CHEM, V259, P2161; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001; Zhang Z, 2001, J LIPID RES, V42, P649	42	639	668	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					18793	18800		10.1074/jbc.M109927200	http://dx.doi.org/10.1074/jbc.M109927200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11901146	hybrid			2022-12-27	WOS:000175975800073
J	Kim, EJ; Park, JS; Um, SJ				Kim, EJ; Park, JS; Um, SJ			Identification and characterization of HIPK2 interacting with p73 and modulating functions of the p53 family in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILD-TYPE P53; TUMOR-SUPPRESSOR PROTEIN; TRANSCRIPTIONAL REPRESSION; COVALENT MODIFICATION; HISTONE DEACETYLASES; DOWN-REGULATION; SAM DOMAIN; GENE; P63; EXPRESSION	To study the biological role of p73alpha, a member of the p53 tumor suppressor family, we performed a yeast two-hybrid screen of a human cDNA library. Using a p73alpha fragment consisting of amino acids 49-636 as bait, we found that p73alpha is functionally associated with the human homologue of mouse and hamster homeodomain-interacting protein kinase 2 (HIPK2). The hamster homologue, also known as haHIPK2 or PKM, was used for further characterization of interactions between HIPK2 and members of the p53 protein family. Systematic yeast two-hybrid assays indicated a physical interaction between the oligomerization domains of p73a and p53 (amino acid regions 345-380 and 319-360, respectively) and amino acid region 812-907 of haHIPK2. This region of haHIPK2 includes a PEST sequence, an Ubc9-binding domain, and a partial speckle retention sequence and is identical to amino acid residues 846-941 of human HIPK2 (hHIPK2). The interaction was confirmed by glutathione S-transferase pull-down assays in vitro and immunoprecipitation assays in vivo. HIPK2 colocalized with p73alpha and p53 in nuclear bodies, as shown by confocal microscopy. Overexpression of HIPK2 stabilized the p53 protein and greatly increased the p73- and p53-induced transcriptional repression of multidrug-resistant and collagenase promoters in Saos2 cells but had little effect on the p73- or p53-mediated transcriptional activation of synthetic p53-responsive and p21WAF1 promoters. Stable expression of HIPK2 in U20S cells enhanced the cisplatin response of sub-G(1) and G(2)/M populations, and it also increased the apoptotic response to cisplatin and adriamycin as demonstrated by fluorescence-activated cell sorter and 4',6-diamidino-2-phenylindole-staining analyses. HIPK2 potentiated the inhibition of colony formation by p73 and p53. These results suggest that physical interactions between HIPK2 and members of the p53 family may determine the roles of these proteins in cell cycle regulation and apoptosis.	Sejong Univ, Inst Biosci, Dept Biosci & Biotechnol, Kwangjin Gu, Seoul 143747, South Korea; Catholic Univ, Grad Sch, Dept Med Biosci, Seoul, South Korea; Catholic Univ, Coll Med, Dept Obstet & Gynecol, Seoul 137040, South Korea	Sejong University; Catholic University of Korea; Catholic University of Korea	Um, SJ (corresponding author), Sejong Univ, Inst Biosci, Dept Biosci & Biotechnol, Kwangjin Gu, 98 Kunja Dong, Seoul 143747, South Korea.	umsj@sejong.ac.kr						Ahn J, 1999, ONCOGENE, V18, P5954, DOI 10.1038/sj.onc.1202986; Boisvert FM, 2001, J CELL BIOL, V152, P1099, DOI 10.1083/jcb.152.5.1099; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Chen XB, 1999, MOL MED TODAY, V5, P387, DOI 10.1016/S1357-4310(99)01545-2; CHIN KV, 1992, SCIENCE, V255, P459, DOI 10.1126/science.1346476; Choi CY, 1999, J BIOL CHEM, V274, P33194, DOI 10.1074/jbc.274.47.33194; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; D'Souza S, 2001, J BIOL CHEM, V276, P298, DOI 10.1074/jbc.M007155200; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fogal V, 2000, EMBO J, V19, P6185, DOI 10.1093/emboj/19.22.6185; GINSBERG D, 1991, P NATL ACAD SCI USA, V88, P9979, DOI 10.1073/pnas.88.22.9979; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Hofmann TG, 2000, BIOCHIMIE, V82, P1123, DOI 10.1016/S0300-9084(00)01196-2; Hollstein M, 1996, NUCLEIC ACIDS RES, V24, P141, DOI 10.1093/nar/24.1.141; Hong TM, 2001, J BIOL CHEM, V276, P1510, DOI 10.1074/jbc.M008231200; Ikawa S, 1999, CELL DEATH DIFFER, V6, P1154, DOI 10.1038/sj.cdd.4400631; Irwin MS, 2001, CELL GROWTH DIFFER, V12, P337; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Juan LJ, 2000, J BIOL CHEM, V275, P20436, DOI 10.1074/jbc.M000202200; Kaelin WG, 1999, ONCOGENE, V18, P7701, DOI 10.1038/sj.onc.1202955; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kanaya T, 2000, CLIN CANCER RES, V6, P1239; Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875; Kim YH, 1999, P NATL ACAD SCI USA, V96, P12350, DOI 10.1073/pnas.96.22.12350; Krause K, 2001, BIOCHEM BIOPH RES CO, V284, P743, DOI 10.1006/bbrc.2001.5040; Krause K, 2000, NUCLEIC ACIDS RES, V28, P4410, DOI 10.1093/nar/28.22.4410; Kwek SSS, 2001, ONCOGENE, V20, P2587, DOI 10.1038/sj.onc.1204362; Leach SD, 1998, CANCER RES, V58, P3231; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Levrero M, 2000, J CELL SCI, V113, P1661; Lohrum MAE, 2000, TRENDS CELL BIOL, V10, P197, DOI 10.1016/S0962-8924(00)01736-0; Matsuo R, 2001, J IMMUNOL METHODS, V247, P141, DOI 10.1016/S0022-1759(00)00313-6; McGrath JA, 2001, HUM MOL GENET, V10, P221, DOI 10.1093/hmg/10.3.221; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; MIYASHITA T, 1994, CANCER RES, V54, P3131; Mori N, 1997, BLOOD, V90, P4924, DOI 10.1182/blood.V90.12.4924.4924_4924_4932; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Murphy M, 1996, GENE DEV, V10, P2971, DOI 10.1101/gad.10.23.2971; Ori A, 1998, EMBO J, V17, P544, DOI 10.1093/emboj/17.2.544; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Ozaki T, 1999, CANCER RES, V59, P5902; Park JS, 2000, J BIOL CHEM, V275, P6764, DOI 10.1074/jbc.275.10.6764; Park JS, 2001, INT J CANCER, V91, P822, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0; Pierantoni GM, 2001, ONCOGENE, V20, P6132, DOI 10.1038/sj.onc.1204635; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Roperch JP, 1998, NAT MED, V4, P835, DOI 10.1038/nm0798-835; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANG BC, 1994, ONCOGENE, V9, P853; SHAULIAN E, 1995, ONCOGENE, V10, P671; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; Somasundaram K, 2000, FRONT BIOSCI, V5, pD424, DOI 10.2741/Somasund; Strano S, 2001, FEBS LETT, V490, P163, DOI 10.1016/S0014-5793(01)02119-6; Sun YB, 1999, J BIOL CHEM, V274, P11535, DOI 10.1074/jbc.274.17.11535; Thanos CD, 1999, PROTEIN SCI, V8, P1708, DOI 10.1110/ps.8.8.1708; Trost M, 2000, J BIOL CHEM, V275, P7373, DOI 10.1074/jbc.275.10.7373; Wang Y, 2001, BMC Mol Biol, V2, P8, DOI 10.1186/1471-2199-2-8; Wang Y, 2001, BBA-GENE STRUCT EXPR, V1518, P168, DOI 10.1016/S0167-4781(00)00308-0; Webster NJG, 1996, CANCER RES, V56, P2781; Yang A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yun J, 1999, J BIOL CHEM, V274, P29677, DOI 10.1074/jbc.274.42.29677; Zhang LL, 2000, CANCER RES, V60, P3655; Zhao RB, 2000, GENE DEV, V14, P981	67	73	80	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2002	277	35					32020	32028		10.1074/jbc.M200153200	http://dx.doi.org/10.1074/jbc.M200153200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	588UB	11925430	hybrid			2022-12-27	WOS:000177718700090
J	Alfsen, A; Bomsel, M				Alfsen, A; Bomsel, M			HIV-1 gp41 envelope residues 650-685 exposed on native virus act as a lectin to bind epithelial cell galactosyl ceramide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DENDRITIC CELLS; TYPE-1 GP41; TRANSMEMBRANE GLYCOPROTEIN; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; AQUEOUS-SOLUTION; STRUCTURAL BASIS; AMINO-ACIDS; T-CELLS	The initial step in the interaction between human immunodeficiency virus (HIV-1) and epithelial cells is the binding of HIV-1 envelope glycoproteins to the epithelial cell galactosyl. ceramide (GalCer). Here we show that HIV-1 envelope gp41 residues 650-685 bind GalCer in a galactose-specific manner. The gp41 residues that display this lectin activity are highly conserved among HIV-1 isolates and constitute three regions: residues 650-661, which encompass a charged helix; residues 662-667, referred to as the conserved epitope ELDKWA, the epitope recognized by antibodies that neutralize HIV-1 entry in epithelial and CD4(+)-mononucleated cells; and residues 668-685, a hydrophobic Trp-rich sequence that stabilizes the structure of the galactose binding site. Similar to other galactose-specific lectins, the gp41 lectin site is active only as an oligomer. Finally the orientation of the galactose toward the gp41 lectin site appears to be controlled by the lipid microenvironment of the epithelial membrane. From the experimental data we construct a theoretical model of the interaction between gp41 and GalCer based on thermodynamic considerations. This model integrates the dynamics and the spatial organization of the viral envelope glycoproteins, GalCer organized in raft microdomains in the apical region of the epithelial cell membrane and the interfacial water. Characterization of the minimal sequence and structure of gp41 in direct interaction with GalCer may help unravel the still unknown immunogenic determinant able to elicit antibodies against ELDKWA and target of one of the rare neutralizing antibodies against gp41.	Inst Cochin Genet Mol, Dept Biol Cellulaire, F-75014 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bomsel, M (corresponding author), Inst Cochin Genet Mol, Dept Biol Cellulaire, 22 Rue Mechain, F-75014 Paris, France.		Bomsel, Morgane/GSN-1948-2022	Bomsel, Morgane/0000-0002-9577-7474				Alfsen A, 2001, J IMMUNOL, V166, P6257, DOI 10.4049/jimmunol.166.10.6257; ARMSTRONG FA, 1985, Q REV BIOPHYS, V18, P261, DOI 10.1017/S0033583500000366; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; BHAT S, 1993, AIDS RES HUM RETROV, V9, P175, DOI 10.1089/aid.1993.9.175; BHATTACHARYYA L, 1988, EUR J BIOCHEM, V176, P207, DOI 10.1111/j.1432-1033.1988.tb14270.x; Bomsel M, 1997, NAT MED, V3, P42, DOI 10.1038/nm0197-42; Bomsel M, 1998, IMMUNITY, V9, P277, DOI 10.1016/S1074-7613(00)80610-X; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Cantin R, 1997, BLOOD, V90, P1091, DOI 10.1182/blood.V90.3.1091.1091_1091_1100; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; CHEN RF, 1969, PHYSICAL PRINCIPLE A, P171; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Chermann JC, 1998, AM J REPROD IMMUNOL, V40, P183, DOI 10.1111/j.1600-0897.1998.tb00411.x; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001; Derdeyn CA, 2001, J VIROL, V75, P8605, DOI 10.1128/JVI.75.18.8605-8614.2001; Fantini J, 1997, J BIOL CHEM, V272, P7245, DOI 10.1074/jbc.272.11.7245; FANTINI J, 1993, M S-MED SCI, V9, P891, DOI 10.4267/10608/3009; Fortin JF, 1997, J VIROL, V71, P3588, DOI 10.1128/JVI.71.5.3588-3596.1997; FRANKS F, 1977, PHILOS T ROY SOC B, V278, P33, DOI 10.1098/rstb.1977.0030; FRANKS F, 1968, EQUILIBRIA REACTION, P32; FUNG BKK, 1978, BIOCHEMISTRY-US, V17, P5241, DOI 10.1021/bi00617a025; GALLAY J, 1981, J BIOL CHEM, V256, P1235; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gorny MK, 2000, J VIROL, V74, P6186, DOI 10.1128/JVI.74.13.6186-6192.2000; Granelli-Piperno A, 1998, J VIROL, V72, P2733, DOI 10.1128/JVI.72.4.2733-2737.1998; Hansen GH, 1999, GASTROENTEROLOGY, V116, P610, DOI 10.1016/S0016-5085(99)70183-6; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; HAROUSE JM, 1995, J VIROL, V69, P7383, DOI 10.1128/JVI.69.12.7383-7390.1995; Hinderliter A, 2001, BIOCHEMISTRY-US, V40, P4181, DOI 10.1021/bi0024299; HOEKSTRA D, 1986, BIOCHEMISTRY-US, V25, P1321, DOI 10.1021/bi00354a020; IMBERTY A, 1993, ADV BIOPH C, V0003; Jones PLS, 1998, J BIOL CHEM, V273, P404, DOI 10.1074/jbc.273.1.404; KARLSSON KA, 1995, CURR OPIN STRUC BIOL, V5, P622, DOI 10.1016/0959-440X(95)80054-9; KELLEY RF, 1993, BIOCHEMISTRY-US, V32, P6828, DOI 10.1021/bi00078a005; Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; KLEIN R, 1987, PHOTOCHEM PHOTOBIOL, V45, P55, DOI 10.1111/j.1751-1097.1987.tb08405.x; Kolatkar AR, 1996, J BIOL CHEM, V271, P6679, DOI 10.1074/jbc.271.12.6679; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lawless MK, 1996, BIOCHEMISTRY-US, V35, P13697, DOI 10.1021/bi9606962; Lemieux RU, 1996, ACCOUNTS CHEM RES, V29, P373, DOI 10.1021/ar9600087; Lu M, 1997, J BIOMOL STRUCT DYN, V15, P465, DOI 10.1080/07391102.1997.10508958; LUKU L, 1968, J AM CHEM SOC, V91, P220; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Meng G, 2002, NAT MED, V8, P150, DOI 10.1038/nm0202-150; Mobley PW, 2001, AIDS RES HUM RETROV, V17, P311, DOI 10.1089/08892220150503681; OCHOA JL, 1981, J CHROMATOGR, V215, P351, DOI 10.1016/S0021-9673(00)81414-4; Parker CE, 2001, J VIROL, V75, P10906, DOI 10.1128/JVI.75.22.10906-10911.2001; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Rabenstein MD, 1996, BIOCHEMISTRY-US, V35, P13922, DOI 10.1021/bi961743t; Rietveld A, 1998, BBA-REV BIOMEMBRANES, V1376, P467, DOI 10.1016/S0304-4157(98)00019-7; RINI JM, 1995, ANNU REV BIOPH BIOM, V24, P551, DOI 10.1146/annurev.biophys.24.1.551; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; STILLINGER FH, 1977, PHILOS T R SOC B, V278, P97, DOI 10.1098/rstb.1977.0033; TATISCHEFF L, 1976, EXCITED STAT BIOL ME, P375; THIAUDIERE E, 1991, EUR J BIOCHEM, V195, P203, DOI 10.1111/j.1432-1033.1991.tb15696.x; THOMAS DJ, 1991, J VIROL, V65, P3797, DOI 10.1128/JVI.65.7.3797-3803.1991; van der Goot FG, 2001, SEMIN IMMUNOL, V13, P89, DOI 10.1006/smim.2000.0300; VANMEER G, 1992, TRENDS CELL BIOL, V2, P322; Verkade P, 2000, J CELL BIOL, V148, P727, DOI 10.1083/jcb.148.4.727; Vidalain PO, 2000, EMBO J, V19, P3304, DOI 10.1093/emboj/19.13.3304; VINCENT M, 1982, BIOCHEM BIOPH RES CO, V107, P914, DOI 10.1016/0006-291X(82)90610-6; Wang XQ, 2001, J BIOL CHEM, V276, P8436, DOI 10.1074/jbc.M006097200; WEI S, 1999, BIOCHEMISTRY-US, V38, P5378; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weng YK, 1998, J VIROL, V72, P9676, DOI 10.1128/JVI.72.12.9676-9682.1998; Werling D, 1999, J LEUKOCYTE BIOL, V66, P50, DOI 10.1002/jlb.66.1.50; WILD C, 1994, P NATL ACAD SCI USA, V91, P12676, DOI 10.1073/pnas.91.26.12676; WILD C, 1995, AIDS RES HUM RETROV, V11, P323, DOI 10.1089/aid.1995.11.323; Wyatt R, 1997, J VIROL, V71, P9722, DOI 10.1128/JVI.71.12.9722-9731.1997; YAHI N, 1992, J VIROL, V66, P4848, DOI 10.1128/JVI.66.8.4848-4854.1992; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	75	96	101	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 12	2002	277	28					25649	25659		10.1074/jbc.M200554200	http://dx.doi.org/10.1074/jbc.M200554200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	571YP	11940580	hybrid			2022-12-27	WOS:000176747000104
J	Lu, HS; Forbes, RA; Verma, A				Lu, HS; Forbes, RA; Verma, A			Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME PATHWAY; HIGH LACTATE LEVELS; FACTOR 1-ALPHA; PROLYL HYDROXYLATION; GLUCOSE-METABOLISM; CERVICAL-CANCER; HUMAN GLIOMAS; TUMOR-CELLS; HIF-ALPHA; EXPRESSION	Cancer cells display high rates of aerobic glycolysis, a phenomenon known historically as the Warburg effect. Lactate and pyruvate, the end products of glycolysis, are highly produced by cancer cells even in the presence of oxygen. Hypoxia-induced gene expression in cancer cells has been linked to malignant transformation. Here we provide evidence that lactate and pyruvate regulate hypoxia-inducible gene expression independently of hypoxia by stimulating the accumulation of hypoxia-inducible Factor 1alpha (HIF-1alpha). In human gliomas and other cancer cell lines, the accumulation of HIF-1a protein under aerobic conditions requires the metabolism of glucose to pyruvate that prevents the aerobic degradation of HIF-1a protein, activates HIF-1 DNA binding activity, and enhances the expression of several HIF-1-activated genes including erythropoietin, vascular endothelial growth factor, glucose transporter 3, and aldolase A. Our findings support a novel role for pyruvate in metabolic signaling and suggest a mechanism by which high rates of aerobic glycolysis can promote the malignant transformation and survival of cancer cells.	Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	Verma, A (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Neurol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	averma@usuhs.mil		Verma, Ajay/0000-0001-7715-0443	NINDS NIH HHS [NS-37814] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037814] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acs G, 2001, CANCER RES, V61, P3561; Akakura N, 2001, CANCER RES, V61, P6548; Bergeron M, 2000, ANN NEUROL, V48, P285, DOI 10.1002/1531-8249(200009)48:3<285::AID-ANA2>3.0.CO;2-8; Birner P, 2000, CANCER RES, V60, P4693; Blagosklonny MV, 2001, INT J ONCOL, V19, P257; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Canesi L, 1999, GEN COMP ENDOCR, V116, P241, DOI 10.1006/gcen.1999.7366; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; DOMINGUEZ JE, 1987, METAB BRAIN DIS, V2, P17, DOI 10.1007/BF00999506; Duyndam MCA, 2001, J BIOL CHEM, V276, P48066, DOI 10.1074/jbc.M106282200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Feldser D, 1999, CANCER RES, V59, P3915; FLIER JS, 1987, SCIENCE, V235, P1492, DOI 10.1126/science.3103217; GALARRAGA J, 1986, METAB BRAIN DIS, V1, P279, DOI 10.1007/BF00999357; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; Lee MS, 2001, CANCER RES, V61, P3290; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; NEWSHOLME EA, 1991, ADV ENZYME REGUL, V31, P225, DOI 10.1016/0065-2571(91)90015-E; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; PARADIES G, 1983, CANCER RES, V43, P5068; Richard DE, 2000, J BIOL CHEM, V275, P26765; SCHWICKERT G, 1995, CANCER RES, V55, P4757; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Semenza GL, 2000, CRIT REV BIOCHEM MOL, V35, P71, DOI 10.1080/10409230091169186; Stroka DM, 2001, FASEB J, V15, P2445, DOI 10.1096/fj.01-0125com; Van Veelen C W, 1988, Br J Neurosurg, V2, P257, DOI 10.3109/02688698808992677; Varma SD, 1997, MOL CELL BIOCHEM, V171, P23, DOI 10.1023/A:1006846501081; Walenta S, 1997, AM J PATHOL, V150, P409; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yin L, 2001, J BIOL CHEM, V276, P44641, DOI 10.1074/jbc.M105170200; Zagzag D, 2000, CANCER-AM CANCER SOC, V88, P2606, DOI 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W; Zelzer E, 1998, EMBO J, V17, P5085, DOI 10.1093/emboj/17.17.5085; Zhong H, 1999, CANCER RES, V59, P5830; Zhong H, 2000, CANCER RES, V60, P1541	41	589	623	1	67	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2002	277	26					23111	23115		10.1074/jbc.M202487200	http://dx.doi.org/10.1074/jbc.M202487200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567FX	11943784	hybrid			2022-12-27	WOS:000176475700003
J	Stieglitz, KA; Johnson, KA; Yang, HY; Roberts, MF; Seaton, BA; Head, JF; Stec, B				Stieglitz, KA; Johnson, KA; Yang, HY; Roberts, MF; Seaton, BA; Head, JF; Stec, B			Crystal structure of a dual activity IMPase/FBPase (AF2372) from Archaeoglobus fulgidus - The story of a mobile loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL-POLYPHOSPHATE 1-PHOSPHATASE; MYOINOSITOL MONOPHOSPHATASE; FRUCTOSE 1,6-BISPHOSPHATASE; GENOMIC STRUCTURE; LITHIUM; ENZYME; MECHANISM; CLONING; GENE; FRUCTOSE-1,6-BISPHOSPHATASE	Several hyperthermophilic organisms contain an unusual phosphatase that has dual activity toward inositol monophosphates and fructose 1,6-bisphosphate. The structure of the second member of this family, an FBPase/IMPase from Archaeoglobus fulgidus (AF2372), has been solved. This enzyme shares many kinetic and structural similarities with that of a previously solved enzyme from Methanococcus jannaschii (MJ0109). It also shows some kinetic differences in divalent metal ion binding as well as structural variations at the dimer interface that correlate with decreased thermal stability. The availability of different crystal forms allowed us to investigate the effect of the presence of ligands on the conformation of a mobile catalytic loop independently of the crystal packing. This conformational variability in AF2372 is compared with that observed in other members of this structural family that are sensitive or insensitive to submillimolar concentrations of Li+. This analysis provides support for the previously proposed mechanism of catalysis involving three metal ions. A direct correlation of the loop conformation with strength of Li+ inhibition provides a useful system of classification for this extended family of enzymes.	Rice Univ, WM Keck Ctr Computat Biol, Dept Biochem & Cell Biol, Houston, TX 77005 USA; Boston Coll, Merkert Chem Ctr, Dept Chem, Chestnut Hill, MA 02467 USA; Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA	Rice University; Boston College; Boston University	Stec, B (corresponding author), Rice Univ, WM Keck Ctr Computat Biol, Dept Biochem & Cell Biol, Houston, TX 77005 USA.			Stec, Boguslaw/0000-0002-8696-0349; Stieglitz, Kimberly/0000-0001-6086-3682; Head, James/0000-0002-6226-4146; Seaton, Barbara/0000-0003-4654-7709	NATIONAL LIBRARY OF MEDICINE [T15LM007093] Funding Source: NIH RePORTER; NLM NIH HHS [2T15LM07093] Funding Source: Medline	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Albert A, 2000, J MOL BIOL, V295, P927, DOI 10.1006/jmbi.1999.3408; Atack JR, 1996, BRAIN RES REV, V22, P183; ATACK JR, 1995, FEBS LETT, V361, P1, DOI 10.1016/0014-5793(95)00063-F; BONE R, 1994, BIOCHEMISTRY-US, V33, P9468, DOI 10.1021/bi00198a012; BRUNGER AT, 1992, X PLOR VERSION 3 1; Chen LJ, 2000, BIOCHEMISTRY-US, V39, P12415, DOI 10.1021/bi001517q; Chen LJ, 1999, APPL ENVIRON MICROB, V65, P4559; Chen LJ, 1998, APPL ENVIRON MICROB, V64, P2609; Choe JY, 2000, BIOCHEMISTRY-US, V39, P8565, DOI 10.1021/bi000574g; CHOE YZ, 1998, BIOCHEMISTRY-US, V33, P11441; INHORN RC, 1988, J BIOL CHEM, V263, P14559; ITAYA K, 1966, CLIN CHIM ACTA, V14, P361, DOI 10.1016/0009-8981(66)90114-8; Iwamoto T, 1999, J BIOL CHEM, V274, P23094, DOI 10.1074/jbc.274.33.23094; Johnson KA, 2001, BIOCHEMISTRY-US, V40, P618, DOI 10.1021/bi0016422; Jones TA, 1994, 1 MAP FINAL MODEL, P1; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lopez-Corcuera B, 2001, J BIOL CHEM, V276, P43463, DOI 10.1074/jbc.M107438200; Lopez-Coronado JM, 1999, J BIOL CHEM, V274, P16034, DOI 10.1074/jbc.274.23.16034; Martin DD, 1999, APPL ENVIRON MICROB, V65, P1815; MCALLISTER G, 1992, BIOCHEM J, V284, P749, DOI 10.1042/bj2840749; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; OTWINOWSKI Z, 1993, OSCILLATION DATA RED, P56; Pappenberger G, 2001, NAT STRUCT BIOL, V8, P452, DOI 10.1038/87624; Patel S, 2002, J MOL BIOL, V315, P677, DOI 10.1006/jmbi.2001.5271; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Sjoholt G, 2000, MOL PSYCHIATR, V5, P172, DOI 10.1038/sj.mp.4000681; Spiegelberg BD, 1999, J BIOL CHEM, V274, P13619, DOI 10.1074/jbc.274.19.13619; Stec B, 2000, NAT STRUCT BIOL, V7, P1046, DOI 10.1038/80968; VADNAL R, 1995, NEUROPSYCHOPHARMACOL, V12, P277, DOI 10.1016/0893-133X(94)00088-H; VILLERET V, 1995, P NATL ACAD SCI USA, V92, P8916, DOI 10.1073/pnas.92.19.8916; YANG H, 2002, UNPUB; Yeates TO, 1997, METHOD ENZYMOL, V276, P344, DOI 10.1016/S0076-6879(97)76068-3; YORK JD, 1995, P NATL ACAD SCI USA, V92, P5149, DOI 10.1073/pnas.92.11.5149; YORK JD, 1994, BIOCHEMISTRY-US, V33, P13164, DOI 10.1021/bi00249a002; Yoshikawa T, 2000, MOL PSYCHIATR, V5, P165, DOI 10.1038/sj.mp.4000688; Zhang RL, 1996, BIOCHEMISTRY-US, V35, P3038, DOI 10.1021/bi952188i; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710	38	43	45	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22863	22874		10.1074/jbc.M201042200	http://dx.doi.org/10.1074/jbc.M201042200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11940584	hybrid			2022-12-27	WOS:000176313600097
J	Weiss, KK; Bambara, RA; Kim, B				Weiss, KK; Bambara, RA; Kim, B			Mechanistic role of residue Gln(151) in error prone DNA synthesis by human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) - Pre-steady state kinetic study of the Q151N HIV-1 RT mutant with increased fidelity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-I KLENOW; REPLICATION FIDELITY; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; O-HELIX; MUTAGENESIS; FRAGMENT; ETA; PROCESSIVITY; SELECTION	It has previously been reported that mutations in the Gln(151) residue of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) greatly enhance RT fidelity. In this study, we employed pre-steady state kinetic assays to elucidate the mechanistic role of residue Gln(151) in highly error prone DNA synthesis by HIV-1 RT. Using our Q151N high fidelity mutant, which is structurally altered in its ability to interact with the 3'-OH on the sugar moiety of the incoming deoxynuelcotide triphosphate (dNTP), we examined how this change in RT-dNTP interaction affects HIV-1 RT fidelity. First, we found the binding affinity (K-D) of wild type and Q151N RT proteins to different template/primers to be similar. These results indicate that the Gln(151) residue is not involved in the formation of the binary complex (RT.template/primer) during DNA polymerization. We also found that by changing residue 151 from a Gln-->Asn, the maximum rate of dNTP incorporation (k(pol)) for both correct and incorrect dNTPs was not affected. In contrast, the ability of the Q151N mutant to bind both correct and incorrect dNTPs (K-d) was diminished. The Q151N mutant was 120-fold less efficient at binding correct dNTP than wild type RT, and its decrease in binding was such that we were unable to measure the actual binding affinity of Q151N for incorrect dNTPs. Presumably, the fidelity increase observed during the steady state is explained by this defect in Q151N binding to incorrect dNTP. In wild type RT, residue Gln(151) is important for tight binding of incorrect dNTPs and may contribute to the low fidelity nature of HIV-1 RT. Since the Q151N mutation also alters RT binding to correct dNTPs, the wild type Gln(151) residue may play an important role in efficient binding of RT to correct dNTPs. Our findings suggest that residue Gln(151) is an important element for the execution of both highly error prone and efficient DNA synthesis by HIV-1 RT.	Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Kim, B (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, 601 Elmwood Ave,Box 672, Rochester, NY 14642 USA.				NIGMS NIH HHS [GM29573, GM55500] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM055500] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bebenek K, 2001, J BIOL CHEM, V276, P2317, DOI 10.1074/jbc.C000690200; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; CARROLL SS, 1991, BIOCHEMISTRY-US, V30, P804, DOI 10.1021/bi00217a034; Coffin J. M., 1990, VIROLOGY, P1437; Diamond TL, 2001, J BIOL CHEM, V276, P23624, DOI 10.1074/jbc.M102496200; DONLIN MJ, 1994, BIOCHEMISTRY-US, V33, P14908, DOI 10.1021/bi00253a030; Feng JY, 1999, BIOCHEMISTRY-US, V38, P9440, DOI 10.1021/bi990709m; FITZGIBBON JE, 1993, AIDS RES HUM RETROV, V9, P833, DOI 10.1089/aid.1993.9.833; Friedberg EC, 1999, CELL, V98, P413, DOI 10.1016/S0092-8674(00)81970-4; Gerlach VL, 1999, P NATL ACAD SCI USA, V96, P11922, DOI 10.1073/pnas.96.21.11922; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; JOHNSON KA, 1995, METHOD ENZYMOL, V249, P38; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kaushik N, 2000, BIOCHEMISTRY-US, V39, P2912, DOI 10.1021/bi991376w; Kerr SG, 1997, BIOCHEMISTRY-US, V36, P14056, DOI 10.1021/bi971385+; Kim B, 1997, METHODS, V12, P318, DOI 10.1006/meth.1997.0485; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; Li Y, 1998, PROTEIN SCI, V7, P1116, DOI 10.1002/pro.5560070505; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Ohashi E, 2000, J BIOL CHEM, V275, P39678, DOI 10.1074/jbc.M005309200; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Suo ZC, 1997, BIOCHEMISTRY-US, V36, P12459, DOI 10.1021/bi971217h; Suzuki M, 2000, J BIOL CHEM, V275, P32728, DOI 10.1074/jbc.M000097200; Suzuki M, 1997, J BIOL CHEM, V272, P11228; VARATNIAN JP, 1991, J VIROL, V65, P1779; Weiss KK, 2000, BIOCHEMISTRY-US, V39, P10684, DOI 10.1021/bi000788y; WILLIAMS KJ, 1992, CURR TOP MICROBIOL, V176, P165; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030	34	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22662	22669		10.1074/jbc.M200202200	http://dx.doi.org/10.1074/jbc.M200202200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11927582	hybrid			2022-12-27	WOS:000176313600073
J	Balla, Z; Hoch, B; Karczewski, P; Blasig, IE				Balla, Z; Hoch, B; Karczewski, P; Blasig, IE			Calcium/calmodulin-dependent protein kinase II delta(2) and gamma isoforms regulate potassium currents of rat brain capillary endothelial cells under hypoxic conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K+ CURRENT; VASCULAR ENDOTHELIUM; SMOOTH-MUSCLE; ION CHANNELS; CALCIUM; EXPRESSION; CALMODULIN; MEMBRANE; HEART; ACTIVATION	Endothelial K+ and Ca2+ homeostasis plays an important role in the regulation of tissue supply and metabolism under normal and pathological conditions. However, the exact molecular mechanism of how Ca2+ is involved in the regulation of K+ homeostasis in capillary endothelial cells, especially under oxidative stress, is not clear. To reveal Ca2+-triggered pathways, which modulate K+ homeostasis, Ca2+/calmodulin-dependent protein kinase II and voltage-gated outward K+ currents were studied in rat brain capillary endothelial cells under hypoxia. Whole cell voltage-clamp measurements showed voltage-gated outward K+ current with transient and sustained components. mRNA and protein of Ca2+/calmodulin-dependent protein kinase II delta(2) and two gamma isoenzymes were identified. Activation of the isoforms (autophosphorylation) was typically achieved by the Ca2+ ionophore ionomycin, which was prevented by the Ca2+/calmodulin-dependent protein kinase II-specific inhibitor KN-93. Hypoxia resulted in autophosphorylation of the delta(2) and gamma(B) isoforms, augmented the current amplitude, increased the inactivation time constant, and decreased the extent of inactivation of the transient current. KN-93 prevented both the activation of the isoforms and the alterations in the K+ current characteristics. It is concluded that the activation of Ca2+/calmodulin-dependent protein kinase II decreases inactivation of the voltage-gated outward K+ current, thereby counteracting depolarization of the hypoxic endothelium.	Forschungsinst Mol Pharmakol, D-13125 Berlin, Germany; Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Blasig, IE (corresponding author), Forschungsinst Mol Pharmakol, Robert Rossle Str 10, D-13125 Berlin, Germany.							ARNOULD T, 1992, J CELL PHYSIOL, V152, P215, DOI 10.1002/jcp.1041520127; BKAILY G, 1993, BRIT J PHARMACOL, V110, P519, DOI 10.1111/j.1476-5381.1993.tb13841.x; Blasig IE, 2001, MICROVASC RES, V62, P114, DOI 10.1006/mvre.2001.2318; Borbiev T, 2001, AM J PHYSIOL-LUNG C, V280, pL983, DOI 10.1152/ajplung.2001.280.5.L983; BOSSU JL, 1992, FEBS LETT, V299, P239, DOI 10.1016/0014-5793(92)80123-X; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; BUSSE R, 1993, CIRCULATION, V87, P18; Cai H, 2001, ARTERIOSCL THROM VAS, V21, P1571, DOI 10.1161/hq1001.097028; CANNELL MB, 1989, J PHYSIOL-LONDON, V419, P555, DOI 10.1113/jphysiol.1989.sp017886; DAUT J, 1994, J CARDIOVASC ELECTR, V5, P154, DOI 10.1111/j.1540-8167.1994.tb01156.x; DEJANA E, 1995, FASEB J, V9, P910, DOI 10.1096/fasebj.9.10.7615160; DITTRICH M, 1999, J PHYSL, V277, pH119; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; GIESE H, 1995, NEUROSCI LETT, V191, P169, DOI 10.1016/0304-3940(95)11584-J; Hagemann D, 1999, J CELL BIOCHEM, V74, P202; HE P, 1991, AM J PHYSIOL, V261, pH1246, DOI 10.1152/ajpheart.1991.261.4.H1246; Hoch B, 2000, J CELL BIOCHEM, V79, P293, DOI 10.1002/1097-4644(20001101)79:2<293::AID-JCB120>3.3.CO;2-H; Hoch B, 1998, J CELL BIOCHEM, V68, P259, DOI 10.1002/(SICI)1097-4644(19980201)68:2<259::AID-JCB12>3.0.CO;2-A; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Ikeda M, 1998, CELL CALCIUM, V24, P49, DOI 10.1016/S0143-4160(98)90088-4; Jovanovic S, 2001, INT J MOL MED, V7, P639; Jow F, 1999, J MEMBRANE BIOL, V167, P53, DOI 10.1007/s002329900471; KINGSTON RE, 1994, CURR PROTOCOLS MOL B, V1; Koh SD, 1999, J PHYSIOL-LONDON, V517, P75, DOI 10.1111/j.1469-7793.1999.0075z.x; Kwiatkowski AP, 2000, ARCH BIOCHEM BIOPHYS, V378, P377, DOI 10.1006/abbi.2000.1846; Langheinrich U, 1998, PFLUG ARCH EUR J PHY, V435, P435, DOI 10.1007/s004240050536; LANSMAN JB, 1987, NATURE, V325, P811, DOI 10.1038/325811a0; Ledoux J, 1999, J PHARMACOL EXP THER, V290, P1165; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAYER P, 1995, BASIC RES CARDIOL, V90, P372, DOI 10.1007/BF00788498; Mazzoni MC, 1995, INT J MICROCIRC, V15, P265, DOI 10.1159/000179028; Mertsch K, 1998, BIOCHEM PHARMACOL, V56, P945, DOI 10.1016/S0006-2952(98)00103-8; MERTSCH K, 1995, CELL MOL BIOL, V41, P243; NGHIEM P, 1993, J BIOL CHEM, V268, P5471; NILIUS B, 1994, J GEN PHYSIOL, V103, P787, DOI 10.1085/jgp.103.5.787; Nilius B, 1997, ANNU REV PHYSIOL, V59, P145, DOI 10.1146/annurev.physiol.59.1.145; POPP R, 1992, BIOCHIM BIOPHYS ACTA, V1108, P59, DOI 10.1016/0005-2736(92)90114-2; POPP R, 1992, J PHYSL, DOI UNSP 454435; Roeper J, 1997, J NEUROSCI, V17, P3379; Schroeter ML, 2001, NEUROREPORT, V12, P2513, DOI 10.1097/00001756-200108080-00045; SCHULMAN H, 1995, CURR OPIN NEUROBIOL, V5, P375, DOI 10.1016/0959-4388(95)80051-4; Singer HA, 1997, J BIOL CHEM, V272, P9393; SRINIVASAN M, 1994, J CELL BIOL, V126, P839, DOI 10.1083/jcb.126.4.839; TAKEDA K, 1987, PFLUG ARCH EUR J PHY, V410, P385, DOI 10.1007/BF00586515; Tessier S, 1999, CIRC RES, V85, P810, DOI 10.1161/01.RES.85.9.810; TOBIMATSU T, 1989, J BIOL CHEM, V264, P17907; Uese K, 1999, J MOL CELL CARDIOL, V31, P1975, DOI 10.1006/jmcc.1999.1028; Walsh KB, 1998, AM J PHYSIOL-HEART C, V274, pH506, DOI 10.1152/ajpheart.1998.274.2.H506; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; WARD BJ, 1989, J MOL CELL CARDIOL, V12, P1337; WATSKY MA, 1992, J MEMBRANE BIOL, V128, P123	51	15	15	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21306	21314		10.1074/jbc.M200553200	http://dx.doi.org/10.1074/jbc.M200553200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11925434	hybrid			2022-12-27	WOS:000176286000026
J	Calderwood, DA; Yan, BX; de Pereda, JM; Alvarez, BG; Fujioka, Y; Liddington, RC; Ginsberg, MH				Calderwood, DA; Yan, BX; de Pereda, JM; Alvarez, BG; Fujioka, Y; Liddington, RC; Ginsberg, MH			The phosphotyrosine binding-like domain of talin activates Integrins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CHICKEN-EMBRYO FIBROBLASTS; AMYLOID PRECURSOR PROTEIN; SURFACE-PLASMON RESONANCE; BETA-CYTOPLASMIC DOMAINS; FERM DOMAIN; PTB DOMAIN; TYROSINE PHOSPHORYLATION; STRUCTURAL BASIS; PHORBOL ESTER	Cellular regulation of the ligand binding affinity of integrin adhesion receptors (integrin activation) depends on the integrin beta cytoplasmic domains (tails). The head domain of talin binds to several integrin beta tails and activates integrins. This head domain contains a predicted FERM domain composed of three subdomains (F1, F2, and F3). An integrin-activating talin fragment was predicted to contain the F2 and F3 subdomains. Both isolated subdomains bound specifically to the integrin beta(3) tail. However, talin F3 bound the beta(3) tail with a 4-fold higher affinity than talin F2. Furthermore, expression of talin F3 (but not F2) in cells led to activation of integrin alpha(IIb)beta(3). A molecular model of talin F3 indicated that it resembles a phosphotyrosine-binding (PTB) domain. PTB domains recognize peptide ligands containing beta turns, often formed by NPXY motifs. NPX(Y/F) motifs are highly conserved in integrin beta tails, and mutations that disrupt this motif interfere with both integrin activation and talin binding. Thus, integrin binding to talin resembles the interactions of PTB domains with peptide ligands. These resemblances suggest that the activation of integrins requires the presence of a beta turn at NPX(Y/F) motifs conserved in integrin beta cytoplasmic domains.	Scripps Res Inst, Dept Cell Biol, Div Vasc Biol, La Jolla, CA 92037 USA; Burnham Inst, Program Cell Adhes, La Jolla, CA 92037 USA	Scripps Research Institute; Sanford Burnham Prebys Medical Discovery Institute	Ginsberg, MH (corresponding author), Scripps Res Inst, Dept Cell Biol, Div Vasc Biol, CVN Rm 231,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ginsberg@scripps.edu	de Pereda, Jose M/AAE-5226-2022; Calderwood, David A/AAC-6954-2019; de Pereda, Jose M/F-1733-2010; Garcia-Alvarez, Begoña/K-1409-2016	de Pereda, Jose M/0000-0002-8912-6739; Calderwood, David A/0000-0002-0791-4142; de Pereda, Jose M/0000-0002-8912-6739; Garcia-Alvarez, Begoña/0000-0003-3774-1999	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027214, R37AR027214] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-48728, HL-30915] Funding Source: Medline; NIAMS NIH HHS [AR-27214] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BECKERLE MC, 1990, CELL REGUL, V1, P227, DOI 10.1091/mbc.1.2.227; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cowan KJ, 2000, J BIOL CHEM, V275, P36423, DOI 10.1074/jbc.M004068200; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Dho SE, 1999, J BIOL CHEM, V274, P33097, DOI 10.1074/jbc.274.46.33097; Edwards SD, 2001, BIOCHEMISTRY-US, V40, P7061, DOI 10.1021/bi010419h; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; Forman-Kay JD, 1999, CURR OPIN STRUC BIOL, V9, P690, DOI 10.1016/S0959-440X(99)00031-7; Girault JA, 1999, TRENDS BIOCHEM SCI, V24, P54, DOI 10.1016/S0968-0004(98)01331-0; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Han BG, 2000, NAT STRUCT BIOL, V7, P871; HIBBS ML, 1991, J EXP MED, V174, P1227, DOI 10.1084/jem.174.5.1227; Howell BW, 1999, MOL CELL BIOL, V19, P5179; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JOHANSSON MW, 1994, J CELL BIOL, V126, P1299, DOI 10.1083/jcb.126.5.1299; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; Kaapa A, 1999, EXP CELL RES, V250, P524, DOI 10.1006/excr.1999.4533; KARLSSON R, 1991, J IMMUNOL METHODS, V145, P229, DOI 10.1016/0022-1759(91)90331-9; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAFLAMME SE, 1994, J CELL BIOL, V126, P1287, DOI 10.1083/jcb.126.5.1287; Li SC, 1998, NAT STRUCT BIOL, V5, P1075, DOI 10.1038/4185; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P896; Noguchi T, 1999, EMBO J, V18, P1748, DOI 10.1093/emboj/18.7.1748; OSHANNESSY DJ, 1993, ANAL BIOCHEM, V212, P457, DOI 10.1006/abio.1993.1355; OTOOLE TE, 1995, J BIOL CHEM, V270, P8553, DOI 10.1074/jbc.270.15.8553; Patil S, 1999, J BIOL CHEM, V274, P28575, DOI 10.1074/jbc.274.40.28575; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; Phillips DR, 2001, CURR OPIN CELL BIOL, V13, P546, DOI 10.1016/S0955-0674(00)00250-7; REES DJG, 1990, NATURE, V347, P685, DOI 10.1038/347685a0; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SARASTE M, 1995, CURR OPIN STRUC BIOL, V5, P403, DOI 10.1016/0959-440X(95)80104-9; Schuck P, 1997, ANNU REV BIOPH BIOM, V26, P541, DOI 10.1146/annurev.biophys.26.1.541; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; TAPLEY P, 1989, ONCOGENE, V4, P325; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ulmer TS, 2001, BIOCHEMISTRY-US, V40, P7498, DOI 10.1021/bi010338l; VRIEND G, 1990, J MOL GRAPHICS, V1, P99; Woodside DG, 2001, CURR BIOL, V11, P1799, DOI 10.1016/S0960-9822(01)00565-6; Xing BD, 2001, J BIOL CHEM, V276, P44373, DOI 10.1074/jbc.M108587200; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200; Zhang ZT, 1997, EMBO J, V16, P6141, DOI 10.1093/emboj/16.20.6141; ZHOU MM, 1995, P NATL ACAD SCI USA, V92, P7784, DOI 10.1073/pnas.92.17.7784; Zhou MM, 1996, NAT STRUCT BIOL, V3, P388, DOI 10.1038/nsb0496-388	48	305	312	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21749	21758		10.1074/jbc.M111996200	http://dx.doi.org/10.1074/jbc.M111996200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11932255	hybrid			2022-12-27	WOS:000176286000083
J	Weinberg, RB; Anderson, RA; Cook, VR; Emmanuel, F; Denefle, P; Tall, AR; Steinmetz, A				Weinberg, RB; Anderson, RA; Cook, VR; Emmanuel, F; Denefle, P; Tall, AR; Steinmetz, A			Interfacial exclusion pressure determines the ability of apolipoprotein A-IV truncation mutants to activate cholesterol ester transfer protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEINS; LIPID TRANSFER PROTEIN; HUMAN-PLASMA; TRANSGENIC MICE; ACYLTRANSFERASE; LECITHIN; EFFLUX; POLYMORPHISM; METABOLISM; BINDING	We used a panel of recombinant human apolipoprotein (apo) A-IV truncation mutants, in which pairs of 22-mer alpha-helices were sequentially deleted along the primary sequence, to examine the impact of protein structure and interfacial activity on the ability of apoA-IV to activate cholesterol ester transfer protein. Circular dichroism and fluorescence spectroscopy revealed that the secondary structure, conformation, and molecular stability of recombinant human apoA-lV were identical to the native protein. However, deletion of any of the a-helical domains in apoA-IV disrupted its tertiary structure and impaired its molecular stability. Surprisingly, determination of the water/phospholipid interfacial exclusion pressure of the apoA-lV truncation mutants revealed that, for most, deletion of amphipathic a-helical domains increased their affinity for phospholipid monolayers. All of the truncation mutants activated the transfer of fluorescent-labeled cholesterol esters between high and low density lipoproteins at a rate higher than native apoA-lV. There was a strong positive correlation (r = 0.790, P = 0.002) between the rate constant for cholesterol ester transfer and interfacial exclusion pressure. We conclude that molecular interfacial exclusion pressure, rather than specific helical domains, determines the degree to which apoA-lV, and likely other apolipoproteins, facilitate cholesterol ester transfer protein-mediated lipid exchange.	Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA; Aventis Pharma, Cardiovasc Dept, Gencell Div, F-94403 Vitry Sur Seine, France; Aventis Pharma, Funct Genom Ctr, F-94403 Vitry Sur Seine, France; Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Univ Bonn, St Nikolaus Stiftshosp Teaching Hosp, D-56626 Andernach, Germany	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Sanofi France; Columbia University; University of Bonn	Weinberg, RB (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.		Tall, Alan/AAT-8528-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030897, R23HL030897] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL030897-23, HL30897, R01 HL030897] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGELLON LB, 1991, J BIOL CHEM, V266, P10796; BARTER PJ, 1988, BIOCHEM J, V254, P179, DOI 10.1042/bj2540179; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BIELICKI JK, 1992, J LIPID RES, V33, P1699; BISGAIER CL, 1985, J LIPID RES, V26, P11; BISGAIER CL, 1987, J LIPID RES, V28, P693; Bruce C, 1998, ANNU REV NUTR, V18, P297, DOI 10.1146/annurev.nutr.18.1.297; Campos H, 1997, ARTERIOSCL THROM VAS, V17, P1074, DOI 10.1161/01.ATV.17.6.1074; CHEN CH, 1985, BIOCHIM BIOPHYS ACTA, V836, P279, DOI 10.1016/0005-2760(85)90131-6; EISENBERG D, 1984, ANNU REV BIOCHEM, V53, P595, DOI 10.1146/annurev.bi.53.070184.003115; EMMANUEL F, 1994, J BIOL CHEM, V269, P29883; Fournier N, 2000, ARTERIOSCL THROM VAS, V20, P1283, DOI 10.1161/01.ATV.20.5.1283; Gillotte KL, 1999, J BIOL CHEM, V274, P2021, DOI 10.1074/jbc.274.4.2021; GOLDBERG IJ, 1990, J BIOL CHEM, V265, P4266; GREEN PHR, 1979, J CLIN INVEST, V64, P233, DOI 10.1172/JCI109444; GREEN PHR, 1980, J CLIN INVEST, V65, P911, DOI 10.1172/JCI109745; GUYARDDANGREMONT V, 1994, J LIPID RES, V35, P982; HAYASHI H, 1990, J LIPID RES, V31, P1613; HESLER CB, 1987, J BIOL CHEM, V262, P2275; Kalogeris TJ, 1997, J NUTR, V127, pS537, DOI 10.1093/jn/127.3.537S; KAMBOH MI, 1992, HUM BIOL, V64, P605; KAMBOH MI, 1991, ATHEROSCLEROSIS, V91, P25, DOI 10.1016/0021-9150(91)90184-5; LAGROST L, 1994, BBA-LIPID LIPID MET, V1215, P209, DOI 10.1016/0005-2760(94)90047-7; LAGROST L, 1990, J LIPID RES, V31, P1569; LEFEVRE M, 1984, J LIPID RES, V25, P1603; MAIN LA, 1996, BIOCHIM BIOPHYS ACTA, V29, P17; MILNER TG, 1991, BIOCHIM BIOPHYS ACTA, V1082, P71, DOI 10.1016/0005-2760(91)90301-W; OHNISHI T, 1993, BIOCHEMISTRY-US, V32, P5029, DOI 10.1021/bi00070a009; OHNISHI T, 1994, BIOCHEMISTRY-US, V33, P6093, DOI 10.1021/bi00186a008; Ostos MA, 2000, ATHEROSCLEROSIS, V153, P209, DOI 10.1016/S0021-9150(00)00400-7; PITTMAN RC, 1987, J BIOL CHEM, V262, P2435; Remaley AT, 2001, BIOCHEM BIOPH RES CO, V280, P818, DOI 10.1006/bbrc.2000.4219; RYAN RO, 1990, J LIPID RES, V31, P1725; SEGREST JP, 1992, J LIPID RES, V33, P141; SHORE B, 1969, BIOCHEMISTRY-US, V8, P4510, DOI 10.1021/bi00839a043; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STEINMETZ A, 1990, J BIOL CHEM, V265, P7859; STEINMETZ A, 1985, J BIOL CHEM, V260, P2258; TALL A, 1986, J CLIN INVEST, V77, P1163, DOI 10.1172/JCI112417; TALL AR, 1993, J LIPID RES, V34, P1255; VONECKARDSTEIN A, 1992, AM J HUM GENET, V50, P1115; VONECKARDSTEIN A, 1994, ARTERIOSCLER THROMB, V14, P1114, DOI 10.1161/01.ATV.14.7.1114; WEINBERG RB, 1990, J BIOL CHEM, V265, P18372; WEINBERG RB, 1983, J LIPID RES, V24, P52; WEINBERG RB, 1994, J BIOL CHEM, V269, P29588; WEINBERG RB, 1985, J LIPID RES, V26, P26; WEINBERG RB, 1995, BIOCHEM BIOPH RES CO, V211, P840, DOI 10.1006/bbrc.1995.1888; WEINBERG RB, 1986, BIOCHEM BIOPH RES CO, V135, P756, DOI 10.1016/0006-291X(86)90993-9; Weinberg RB, 2002, CURR OPIN LIPIDOL, V13, P125, DOI 10.1097/00041433-200204000-00003; WEINBERG RB, 1985, J BIOL CHEM, V260, P4914; WEINBERG RB, 1992, J BIOL CHEM, V267, P8977; Weinberg RB, 1996, METHOD ENZYMOL, V263, P282; WEINBERG RB, 1990, J BIOL CHEM, V265, P8081; WEINBERG RB, 1987, BIOCHIM BIOPHYS ACTA, V918, P299, DOI 10.1016/0005-2760(87)90234-7; WEINBERG RB, 1988, BIOCHEMISTRY-US, V27, P1515, DOI 10.1021/bi00405a018; Weinberg RB, 2000, J LIPID RES, V41, P1419; Weinberg RB, 2000, J LIPID RES, V41, P1410; WEINBERG RB, 1992, 3 INT S PLASM HIGH D, P89; WEISGRABER KH, 1978, BIOCHEM BIOPH RES CO, V85, P287, DOI 10.1016/S0006-291X(78)80041-2	59	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21549	21553		10.1074/jbc.M202197200	http://dx.doi.org/10.1074/jbc.M202197200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11940599	hybrid			2022-12-27	WOS:000176286000057
J	Bradshaw, JM; Hudmon, A; Schulman, H				Bradshaw, JM; Hudmon, A; Schulman, H			Chemical quenched flow kinetic studies indicate an intraholoenzyme autophosphorylation mechanism for Ca2+/calmodulin-dependent protein kinase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAM-KINASE; LIGHT-SCATTERING; ELECTRON-MICROSCOPY; SELF-ASSOCIATION; CALMODULIN; CA2+; NEURONS; ALPHA; CA2+-CALMODULIN; PHOSPHORYLATION	Autophosphorylation of alpha-Ca2+/calmodulin-dependent protein kinase II (CaM kinase II) at Thr-286 generates Ca2+-independent activity that outlasts the initial Ca2+ stimulus. Previous studies suggested that this autophosphorylation occurs between subunits within each CaM kinase II holoenzyme. However, electron microscopy studies have questioned this mechanism because a large distance separates a kinase domain from its neighboring subunit. Moreover, the recently discovered ability of CaM kinase II holoenzymes to self-associate has raised questions about data interpretation in previous investigations of autophosphorylation. In this work, we characterize the mechanism of CaM kinase II autophosphorylation. To eliminate ambiguity arising from kinase aggregation, we used dynamic light scattering to establish the monodispersity of all enzyme solutions. We then found using chemical quenched flow kinetics that the autophosphorylation rate was independent of the CaM kinase II concentration, results corroborating intraholoenzyme activation. Experiments with a monomeric CaM kinase II showed that phosphorylation of this construct is intermolecular, supporting intersubunit phosphorylation within a holoenzyme. The autophosphorylation rate at 30 degreesC was similar to12 s(-1), more than 10-fold faster than past estimates. The ability of CaM kinase II to autophosphorylate through an intraholoenzyme, intersubunit mechanism is likely central to its functions of decoding Ca2+ spike frequency and providing a sustained response to Ca2+ signals.	Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Schulman, H (corresponding author), Stanford Univ, Dept Neurobiol, 299 Campus Dr W,Fairchild Bldg, Stanford, CA 94305 USA.				NIGMS NIH HHS [GM30179] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030179, R37GM030179] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berridge MJ, 1997, NATURE, V386, P759, DOI 10.1038/386759a0; COLBRAN RJ, 1993, J BIOL CHEM, V268, P7163; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Dosemeci A, 2000, J NEUROSCI, V20, P3076, DOI 10.1523/JNEUROSCI.20-09-03076.2000; ERONDU NE, 1985, J NEUROSCI, V5, P3270; FERREDAMARE AR, 1994, STRUCTURE, V2, P357, DOI 10.1016/S0969-2126(00)00037-X; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gutfreund H., 1995, KINETICS LIFE SCI RE; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; Hudmon A, 1996, J BIOL CHEM, V271, P8800, DOI 10.1074/jbc.271.15.8800; Hudmon A, 2001, J NEUROCHEM, V76, P1364, DOI 10.1046/j.1471-4159.2001.00119.x; HUDMON A, 2002, IN PRESS ANN REV BIO, V71; IKEDA A, 1991, J BIOL CHEM, V266, P11582; KANASEKI T, 1991, J CELL BIOL, V115, P1049, DOI 10.1083/jcb.115.4.1049; Kolodziej SJ, 2000, J BIOL CHEM, V275, P14354, DOI 10.1074/jbc.275.19.14354; Kubota Y, 1999, NEUROCOMPUTING, V26-7, P29, DOI 10.1016/S0925-2312(99)00085-5; Kubota Y, 2001, J COMPUT NEUROSCI, V11, P263, DOI 10.1023/A:1013727331979; KURET J, 1985, J BIOL CHEM, V260, P6427; LAI Y, 1986, P NATL ACAD SCI USA, V83, P4253, DOI 10.1073/pnas.83.12.4253; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LOU LL, 1989, J NEUROSCI, V9, P2020; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MEYER T, 1991, ANNU REV BIOPHYS BIO, V20, P153, DOI 10.1146/annurev.bb.20.060191.001101; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Morris EP, 2001, J MOL BIOL, V308, P1, DOI 10.1006/jmbi.2001.4584; MUKHERJI S, 1994, J BIOL CHEM, V269, P13744; Okamoto H, 2000, BIOL CYBERN, V82, P35, DOI 10.1007/PL00007960; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; Putkey JA, 1996, J BIOL CHEM, V271, P29619, DOI 10.1074/jbc.271.47.29619; Rich RC, 1998, J BIOL CHEM, V273, P28424, DOI 10.1074/jbc.273.43.28424; SAITOH T, 1985, J CELL BIOL, V100, P835, DOI 10.1083/jcb.100.3.835; Schonfeld HJ, 1998, BIOCHEM SOC T, V26, P753, DOI 10.1042/bst0260753; Schulman H, 1999, CALCIUM AS A CELLULAR REGULATOR, P311; SELBERT MA, 1995, J BIOL CHEM, V270, P17616, DOI 10.1074/jbc.270.29.17616; Singla SI, 2001, J BIOL CHEM, V276, P29353, DOI 10.1074/jbc.M101744200; SOBIESZEK A, 1995, BIOCHEMISTRY-US, V34, P11855, DOI 10.1021/bi00037a025; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Soderling TR, 2001, J BIOL CHEM, V276, P3719, DOI 10.1074/jbc.R000013200; Tao-Cheng JH, 2001, NEUROSCIENCE, V106, P69, DOI 10.1016/S0306-4522(01)00262-7; Teruel MN, 2000, CURR BIOL, V10, P86, DOI 10.1016/S0960-9822(00)00295-5; Waxham MN, 1998, J BIOL CHEM, V273, P17579, DOI 10.1074/jbc.273.28.17579; WOODGETT JR, 1983, EUR J BIOCHEM, V136, P481, DOI 10.1111/j.1432-1033.1983.tb07766.x; Zhabotinsky AM, 2000, BIOPHYS J, V79, P2211, DOI 10.1016/S0006-3495(00)76469-1	46	59	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20991	20998		10.1074/jbc.M202154200	http://dx.doi.org/10.1074/jbc.M202154200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11925447	hybrid			2022-12-27	WOS:000176204500114
J	Ye, LW; Maloney, PC				Ye, LW; Maloney, PC			Structure/function relationships in OxlT, the oxalate/formate antiporter of Oxalobacter formigenes - Assignment of transmembrane helix 2 to the translocation pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MELIBIOSE CARRIER; ESCHERICHIA-COLI; OXALATE; TRANSPORTER; IDENTIFICATION; EXCHANGE; PROTEIN; UHPT	We constructed a single cysteine panel encompassing transmembrane helix two (TM2) of OxlT, the oxalate/formate antiporter of Oxalobacter formigenes. Among the 21 positions targeted, cysteine substitution identified one (phenylalanine 59) as essential to OxlT expression and three (glutamine 56, glutamine 66, and serine 69) as potentially critical to OxlT function. By probing membranes with a bulky hydrophilic probe (Oregon Green maleimide) we also located a central inaccessible core of at least eight residues in length, extending from leucine 61 to glycine 68. Functional assays based on reconstitution of crude detergent extracts showed that of single cysteine mutants within the TAU core only the Q63C variant was substantially (greater than or equal to95%) inhibited by thiol-specific agents (carboxyethyl methanethiosulfonate and ethylsulfonate methanethiosulfonate). Subsequent analytical work using the purified Q63C protein showed that inhibition by ethylsulfonate methanethiosulfonate was blocked by substrate and that the concentration dependence of such substrate protection occurred with a binding constant of 0.16 mm oxalate, comparable with the Michaelis constant observed for oxalate transport (0.23 mm). These findings lead us to conclude that position 63 ties on the OxlT translocation pathway. Our conclusion is strengthened by the finding that position 63, along with most other positions relevant to TM2 function, is found on a helical face that can be cross-linked to the pathway-facing surface of TM11.	Johns Hopkins Med Sch, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Maloney, PC (corresponding author), Johns Hopkins Med Sch, Dept Physiol, Baltimore, MD 21205 USA.	pmaloney@jhmi.edu						Abe K, 1996, J BIOL CHEM, V271, P6789, DOI 10.1074/jbc.271.12.6789; ANANTHARAM V, 1989, J BIOL CHEM, V264, P7244; Fann MC, 1998, J BIOL CHEM, V273, P33735, DOI 10.1074/jbc.273.50.33735; Franco PJ, 2001, BBA-BIOMEMBRANES, V1510, P231, DOI 10.1016/S0005-2736(00)00353-9; Fu DX, 1998, J BIOL CHEM, V273, P17962, DOI 10.1074/jbc.273.28.17962; Fu DX, 2001, J BIOL CHEM, V276, P8753, DOI 10.1074/jbc.M008417200; Fu DX, 1997, J BIOL CHEM, V272, P2129; Hall JA, 1999, J BIOL CHEM, V274, P6148, DOI 10.1074/jbc.274.10.6148; Hall JA, 2001, J BIOL CHEM, V276, P25107, DOI 10.1074/jbc.M102017200; HAMA H, 1994, J BIOL CHEM, V269, P1063; Heymann JAW, 2001, EMBO J, V20, P4408, DOI 10.1093/emboj/20.16.4408; Kaback HR, 2001, NAT REV MOL CELL BIO, V2, P610, DOI 10.1038/35085077; Kim YM, 2001, J BIOL CHEM, V276, P36681, DOI 10.1074/jbc.M106079200; MALONEY PC, 1994, CURR OPIN CELL BIOL, V6, P571, DOI 10.1016/0955-0674(94)90079-5; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Paulsen IT, 2000, J MOL BIOL, V301, P75, DOI 10.1006/jmbi.2000.3961; RUAN ZS, 1992, J BIOL CHEM, V267, P10537; YAN RT, 1993, CELL, V75, P37, DOI 10.1016/S0092-8674(05)80082-0; YAN RT, 1995, P NATL ACAD SCI USA, V92, P5973, DOI 10.1073/pnas.92.13.5973; Ye LW, 2001, J BACTERIOL, V183, P2490, DOI 10.1128/JB.183.8.2490-2496.2001	20	17	19	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20372	20378		10.1074/jbc.M111140200	http://dx.doi.org/10.1074/jbc.M111140200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11919184	hybrid			2022-12-27	WOS:000176204500036
J	Beullens, M; Bollen, M				Beullens, M; Bollen, M			The protein phosphatase-1 regulator NIPP1 is also a splicing factor involved in a late step of spliceosome assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-ORGANIZATION; RNA-BINDING; PHOSPHORYLATION; SUBUNIT; SITE; INHIBITOR; COMPLEX	NIPP1 is a ubiquitous regulator of protein phosphatase-1 (PP1) and is targeted to the splicing factor storage sites (speckles) in the nucleus by its forkhead-associated domain. We show here that NIPP1 is also a component of the spliceosomes in HeLa cell-splicing extracts and that the interaction with the spliceosomes requires a functional forkhead-associated domain. The in vitro splicing of beta-globin pre-mRNA was not affected by exogenous wild type NIPP1 but was blocked by mutants that lacked residues 225-329. The inhibition by these dominant negative mutants resulted from a block in a late phase of spliceosome assembly, i.e. at the transition between the B-complex and the C-complex. Site-directed mutagenesis furthermore showed that this spliceosomal function of NIPP1 was unrelated to its ability to bind PP1 or RNA. Our data suggest that NIPP1 can function independently as a splicing factor and a phosphatase regulator.	Katholieke Univ Leuven, Afdeling Biocheim, Fac Geneeskunde, B-3000 Louvain, Belgium	KU Leuven	Bollen, M (corresponding author), Katholieke Univ Leuven, Afdeling Biocheim, Fac Geneeskunde, Campus Gasthuisberg,Herestr 49, B-3000 Louvain, Belgium.							Beullens M, 2000, BIOCHEM J, V352, P651, DOI 10.1042/0264-6021:3520651; BEULLENS M, 1997, METHOD MOL BIOL, V93, P145; Bollen M, 2002, TRENDS CELL BIOL, V12, P138, DOI 10.1016/S0962-8924(01)02247-4; Boudrez A, 2000, J BIOL CHEM, V275, P25411, DOI 10.1074/jbc.M001676200; CARDINALI B, 1994, FEBS LETT, V352, P276, DOI 10.1016/0014-5793(94)00973-2; Ceulemans H, 2002, BIOESSAYS, V24, P371, DOI 10.1002/bies.10069; CHAMBERS RS, 1994, J BIOL CHEM, V269, P26243; Das R, 2000, MOL CELL, V5, P779, DOI 10.1016/S1097-2765(00)80318-4; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Jagiello I, 2000, J CELL SCI, V113, P3761; JAGIELLO I, 1995, J BIOL CHEM, V270, P17257, DOI 10.1074/jbc.270.29.17257; Jin QM, 1999, BIOCHEM J, V342, P13, DOI 10.1042/0264-6021:3420013; Mayeda A, 1999, METH MOL B, V118, P315; MERMOUD JE, 1992, NUCLEIC ACIDS RES, V20, P5263, DOI 10.1093/nar/20.20.5263; Misteli T, 1997, TRENDS CELL BIOL, V7, P135, DOI 10.1016/S0962-8924(96)20043-1; Murray MV, 1999, GENE DEV, V13, P87, DOI 10.1101/gad.13.1.87; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; PARK IK, 1994, J BIOL CHEM, V269, P944; REED R, 1990, P NATL ACAD SCI USA, V87, P8031, DOI 10.1073/pnas.87.20.8031; Trinkle-Mulcahy L, 1999, J CELL SCI, V112, P157; Vulsteke V, 1997, J BIOL CHEM, V272, P32972, DOI 10.1074/jbc.272.52.32972; Wang CY, 1998, GENE DEV, V12, P1409, DOI 10.1101/gad.12.10.1409; Wang X, 1999, EMBO J, V18, P4549, DOI 10.1093/emboj/18.16.4549; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Xiao SH, 1998, EMBO J, V17, P6359, DOI 10.1093/emboj/17.21.6359	25	37	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19855	19860		10.1074/jbc.M200847200	http://dx.doi.org/10.1074/jbc.M200847200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11909864	hybrid			2022-12-27	WOS:000175894800081
J	Myre, MA; O'Day, DH				Myre, MA; O'Day, DH			Nucleomorphin - A novel, acidic, nuclear calmodulin-binding protein from Dictyostelium that regulates nuclear number	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPMENTAL REGULATION; CHAIN KINASE; CELL; FUSION; DISCOIDEUM; MYOSIN; DOMAIN; PHOSPHORYLATION; NUCLEOPLASMIN; CALCINEURIN	Probing of Dictyostelium discoideum cell extracts after SDS-PAGE using S-35-recombinant calmodulin (CaM) as a probe has revealed approximately three-dozen Ca2+. dependent calmodulin binding proteins. Here, we report the molecular cloning, expression, and subcellular localization of a gene encoding a novel calmodulin-binding protein (CaMBP); we have called nucleomorphin, from D. discoideum. A lambdaZAP cDNA expression library of cells from multicellular development was screened using a recombinant calmodulin probe (S-35-VU1-CaM). The open reading frame of 1119 nucleotides encodes a polypeptide of 340 amino acids with a calculated molecular mass of 38.7 kDa and is constitutively expressed throughout the Dictyostelium life cycle. Nucleomorphin contains a highly acidic glutamic/aspartic acid inverted repeat (DEED) with significant similarity to the conserved nucleoplasmin domain and a putative transmembrane domain in the carboxyl-terminal region. Southern blotting reveals that nucleomorphin exists as a single copy gene. Using gel overlay assays and CaM-agarose we show that bacterially expressed nucleomorphin binds to bovine CaM in a Ca2+-dependent manner. Amino-terminal fusion to the green fluorescence protein (GFP) showed that GFP-NumA localized to the nucleus as distinct arc-like patterns similar to heterochromatin regions. GFP-NumA lacking the acidic DEED repeat still showed are-like accumulations at the nuclear periphery, but the number of nuclei in these cells was increased markedly compared with control cells. Cells expressing GFP-NumA lacking the transmembrane domain localized to the nuclear periphery but did not affect nuclear number or gross morphology. Nucleomorphin is the first nuclear CaMBP to be identified in Dictyostelium. Furthermore, these data present the first identification of a member of the nucleoplasmin family as a calmodulin-binding protein and suggest nucleomorphin has a role in nuclear structure in Dictyostelium.	Univ Toronto, Dept Zool, Mississauga, ON L5L 1C6, Canada	University of Toronto; University Toronto Mississauga	O'Day, DH (corresponding author), Univ Toronto, Dept Zool, 3359 Mississauga Rd,Rm 3030, Mississauga, ON L5L 1C6, Canada.	doday@credit.erin.utoronto.ca		O'Day, Danton/0000-0003-0163-9044				Adachi H, 1997, J CELL BIOL, V137, P891, DOI 10.1083/jcb.137.4.891; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anderson JT, 1996, J BIOL CHEM, V271, P6605, DOI 10.1074/jbc.271.12.6605; Andrade R, 2001, CHROMOSOMA, V109, P545, DOI 10.1007/s004120000121; Arazi T, 1999, PLANT J, V20, P171, DOI 10.1046/j.1365-313x.1999.00588.x; BROCKERHOFF SE, 1994, J CELL BIOL, V124, P315, DOI 10.1083/jcb.124.3.315; CHENEY R E, 1992, Current Opinion in Cell Biology, V4, P27, DOI 10.1016/0955-0674(92)90055-H; Clancy CE, 1997, J BIOL CHEM, V272, P11812, DOI 10.1074/jbc.272.18.11812; COTTEN M, 1986, BIOCHEMISTRY-US, V25, P5063, DOI 10.1021/bi00366a014; Crevel G, 1997, J STRUCT BIOL, V118, P9, DOI 10.1006/jsbi.1996.3836; Dammann H, 1996, EUR J BIOCHEM, V238, P391, DOI 10.1111/j.1432-1033.1996.0391z.x; DASGUPTA M, 1989, J BIOL CHEM, V264, P17156; DILWORTH SM, 1987, CELL, V51, P1009, DOI 10.1016/0092-8674(87)90587-3; DINGERMANN T, 1990, DEV GENET, V11, P410, DOI 10.1002/dvg.1020110514; DINGWALL C, 1989, J CELL SCI, P243; DINGWALL C, 1988, J CELL BIOL, V107, P841, DOI 10.1083/jcb.107.3.841; EARNSHAW WC, 1987, J CELL BIOL, V105, P1479, DOI 10.1083/jcb.105.4.1479; FRIEDBERG F, 1991, PROT SEQ DATA ANAL, V3, P335; Gauthier ML, 2001, CELL SIGNAL, V13, P575, DOI 10.1016/S0898-6568(01)00187-5; HAIECH J, 1981, BIOCHEMISTRY-US, V20, P3890, DOI 10.1021/bi00516a035; Harlow E., 1988, ANTIBODIES LAB MANUA; Hellstern S, 1997, RES MICROBIOL, V148, P335, DOI 10.1016/S0923-2508(97)81589-6; Horn F, 1996, DIFFERENTIATION, V60, P269, DOI 10.1046/j.1432-0436.1996.6050269.x; Howe L, 1998, J BIOL CHEM, V273, P20693, DOI 10.1074/jbc.273.33.20693; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; JAMES P, 1995, TRENDS BIOCHEM SCI, V20, P38, DOI 10.1016/S0968-0004(00)88949-5; KELLER CH, 1982, BIOCHEMISTRY-US, V21, P156, DOI 10.1021/bi00530a027; Kessen U, 1999, J BIOL CHEM, V274, P37821, DOI 10.1074/jbc.274.53.37821; KINCAID R, 1993, ADV SEC MESS PHOSPH, V27, P1; Kolman MF, 1997, J BIOL CHEM, V272, P16904, DOI 10.1074/jbc.272.27.16904; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; LADANT D, 1989, J BIOL CHEM, V264, P4015; LEITING B, 1991, BIOCHEM BIOPH RES CO, V180, P1403, DOI 10.1016/S0006-291X(05)81352-X; Levi S, 2000, PLASMID, V44, P231, DOI 10.1006/plas.2000.1487; Loomis W., 2012, DEV DICTYOSTELIUM DI; Ludbrook SB, 1997, J BIOL CHEM, V272, P15682, DOI 10.1074/jbc.272.25.15682; Lydan M A, 1994, Methods Mol Biol, V31, P389; LYDAN MA, 1988, EXP CELL RES, V178, P51, DOI 10.1016/0014-4827(88)90377-1; LYDAN MA, 1994, FEMS MICROBIOL LETT, V115, P137, DOI 10.1111/j.1574-6968.1994.tb06628.x; LYDAN MA, 1993, EXP CELL RES, V205, P134, DOI 10.1006/excr.1993.1067; LYDAN MA, 1994, BIOCHEM BIOPH RES CO, V201, P430, DOI 10.1006/bbrc.1994.1719; MANLAN A, 1984, ADV CYCLIC NUCLEOTID, V201, P227; MARIDOR G, 1990, NUCLEIC ACIDS RES, V18, P1286, DOI 10.1093/nar/18.5.1286; MARSHAK DR, 1984, BIOCHEMISTRY-US, V23, P2891, DOI 10.1021/bi00308a007; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Neuhaus EM, 1998, J STRUCT BIOL, V121, P326, DOI 10.1006/jsbi.1998.3971; ODAY DH, 1995, MEM MUS NATL HIST NA, V165, P121; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Pang KM, 1998, CURR BIOL, V8, P405, DOI 10.1016/S0960-9822(98)70159-9; PERSECHINI A, 1988, J BIOL CHEM, V263, P12175; PHILPOTT A, 1991, CELL, V65, P569, DOI 10.1016/0092-8674(91)90089-H; PICCIOTTO MR, 1993, J BIOL CHEM, V268, P26512; RATAJCZAK T, 1995, BIOCHEM BIOPH RES CO, V209, P117, DOI 10.1006/bbrc.1995.1478; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Rivero F, 1996, J CELL SCI, V109, P2679; Safadi F, 2000, J BIOL CHEM, V275, P35457, DOI 10.1074/jbc.M002720200; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shackleford Gregory M., 2001, BMC Genomics, V2, P1; SHARP PM, 1989, NUCLEIC ACIDS RES, V17, P5029, DOI 10.1093/nar/17.13.5029; Tsvetkov PO, 1999, J BIOL CHEM, V274, P18161, DOI 10.1074/jbc.274.26.18161; VORHERR T, 1993, BIOCHEMISTRY-US, V32, P6081, DOI 10.1021/bi00074a020; Westphal M, 1997, CURR BIOL, V7, P176, DOI 10.1016/S0960-9822(97)70088-5; WOLENSKI JS, 1995, TRENDS CELL BIOL, V5, P310, DOI 10.1016/S0962-8924(00)89053-4; Ye XJ, 1997, J BIOL CHEM, V272, P3606, DOI 10.1074/jbc.272.6.3606; [No title captured]	65	32	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19735	19744		10.1074/jbc.M109717200	http://dx.doi.org/10.1074/jbc.M109717200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11919178	hybrid			2022-12-27	WOS:000175894800066
J	Wang, Y; Xu, AM; Knight, C; Xu, LY; Cooper, GJS				Wang, Y; Xu, AM; Knight, C; Xu, LY; Cooper, GJS			Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin - Potential role in the modulation of its insulin-sensitizing activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-SPECIFIC PROTEIN; PLASMA-CONCENTRATIONS; ADIPOCYTE; GENE; EXPRESSION; OBESITY; RESISTANCE; ACRP30; PHOSPHORYLATION; IDENTIFICATION	It has recently been shown that the fat-derived hormone adiponectin has the ability to decrease hyperglycemia and to reverse insulin resistance. However, bacterially produced full-length adiponectin is functionally inactive. Here, we show that endogenous adiponectin secreted by adipocytes is post-translationally modified into eight different isoforms, as shown by two-dimensional gel electrophoresis. Carbohydrate detection revealed that six of the adiponectin isoforms are glycosylated. The glycosylation sites were mapped to several lysines (residues 68, 71, 80, and 104) located in the collagenous domain of adiponectin, each having the surrounding motif of GXKGE(D). These four lysines were found to be hydroxylated and subsequently glycosylated. The glycosides attached to each of these four hydroxylated lysines are possibly glucosylgalactosyl groups. Functional analysis revealed that full-length adiponectin produced by mammalian cells is much more potent than bacterially generated adiponectin in enhancing the ability of subphysiological concentrations of insulin to inhibit gluconeogenesis in primary rat hepatocytes, whereas this insulin-sensitizing ability was significantly attenuated when the four glycosylated lysines were substituted with arginines. These results indicate that full-length adiponectin produced by mammalian cells is functionally active as an insulin sensitizer and that hydroxylation and glycosylation of the four lysines in the collagenous domain might contribute to this activity.	Univ Auckland, Sch Biol Sci, Auckland 1001, New Zealand	University of Auckland	Xu, AM (corresponding author), Univ Auckland, Sch Biol Sci, Level 4,Thomas Bldg,Private Bag 92019, Auckland 1001, New Zealand.		Cooper, Garth JS/I-3201-2015; Wang, Yu/B-4534-2009; Xu, Aimin/D-3291-2013	Cooper, Garth JS/0000-0001-5241-3163; Xu, Aimin/0000-0002-0668-033X; wang, yu/0000-0001-8697-2940				Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Bradley RL, 2001, RECENT PROG HORM RES, V56, P329, DOI 10.1210/rp.56.1.329; COLLEY KJ, 1987, J BIOL CHEM, V262, P10290; Combatsiaris TP, 2001, DIABETES, V50, pA271; Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120; Das K, 2001, BIOCHEM BIOPH RES CO, V280, P1120, DOI 10.1006/bbrc.2001.4217; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Fruhbeck G, 2001, AM J PHYSIOL-ENDOC M, V280, pE827, DOI 10.1152/ajpendo.2001.280.6.E827; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; JOHNSON RG, 1980, CLIN ORTHOP RELAT R, P282; Kim S, 2000, J NUTR, V130, p3110S; Leffert H L, 1979, Methods Enzymol, V58, P536; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Nakano Y, 1996, J BIOCHEM-TOKYO, V120, P803; Saito K, 1999, GENE, V229, P67, DOI 10.1016/S0378-1119(99)00041-4; Sato C, 2001, J BIOL CHEM, V276, P28849, DOI 10.1074/jbc.M104148200; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; SHINKAI H, 1979, BIOCHEM J, V177, P847, DOI 10.1042/bj1770847; Statnick M A, 2000, Int J Exp Diabetes Res, V1, P81, DOI 10.1155/EDR.2000.81; Steppan CM, 2002, TRENDS ENDOCRIN MET, V13, P18, DOI 10.1016/S1043-2760(01)00522-7; Takahashi M, 2000, INT J OBESITY, V24, P861, DOI 10.1038/sj.ijo.0801244; Wang Y, 2001, DIABETES, V50, P1821, DOI 10.2337/diabetes.50.8.1821; Wang Y, 1999, FEBS LETT, V462, P25, DOI 10.1016/S0014-5793(99)01496-9; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Wu GC, 2001, J BIOL CHEM, V276, P35450, DOI 10.1074/jbc.M009704200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yang WS, 2001, J CLIN ENDOCR METAB, V86, P3815, DOI 10.1210/jc.86.8.3815	33	283	323	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19521	19529		10.1074/jbc.M200601200	http://dx.doi.org/10.1074/jbc.M200601200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11912203	hybrid			2022-12-27	WOS:000175894800039
J	Cortajarena, AL; Goni, FM; Ostolaza, H				Cortajarena, AL; Goni, FM; Ostolaza, H			His-859 is an essential residue for the activity and pH dependence of Escherichia coli RTX toxin alpha-hemolysin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN TOXIN; SELF-AGGREGATION; BINDING; CALCIUM; CONFORMATION; ERYTHROCYTES; PURIFICATION; MEMBRANES; INSERTION; MECHANISM	Escherichia coli a-hemolysin (HlyA) is a toxin protein that, in common with other members of the RTX family, contains a calcium-binding domain consisting of a number of Gly- and Asp-rich nonapeptides (17 in this case) repeated in tandem. Amino acid number 6 in these nonapeptides is almost invariably Asp, and occasionally Asn, but HlyA contains a His residue (number 859 in the chain) in position 6 of the last-but-one nonapeptide. HlyA mutants have been prepared, by site-directed mutagenesis, in which His-859 has been replaced by an Asn (H859N) or by Asp (H859D). HlyA exists in aqueous media in an aggregate-monomer equilibrium, but only the monomer containing bound Ca2+ (HlyA-Ca) appears to be competent to achieve target membrane insertion and subsequent lysis. In mutant H859N, equilibrium appears to be shifted toward the aggregate, therefore the protein does not exchange Ca2+ with the aqueous environment, no HlyA-Ca monomers are detected, and the protein lacks any membrane lytic activity. Mutant H859D in turn is almost indistinguishable from the wild-type regarding its calcium binding and membrane lytic activity, however, it differs significantly in its pH dependence. Wild-type HlyA activity decreases sigmoidally with pH, following rather closely the protonation curve of a His residue (apparent pK(a) approximate to 6.5). With mutant H859D activity decreases almost linearly with pH and to a smaller extent. It can be concluded that His-859 plays a critical role in several aspects of HlyA activity, namely self-aggregation properties, calcium binding, hemolysis, and pH dependence.	Univ Basque Country, CSIC, UPV EHU, Bilbao 48080, Spain; Univ Basque Country, Dept Bioquim, Bilbao 48080, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; University of Basque Country	Ostolaza, H (corresponding author), Univ Basque Country, CSIC, UPV EHU, Unidad Biofis, Bilbao 48080, Spain.	gbzoseth@lg.ehu.es	Goni, Felix M/M-5425-2015; Cortajarena, Aitziber L/J-6202-2012	Goni, Felix M/0000-0001-6270-9216; Cortajarena, Aitziber L/0000-0002-5331-114X; OSTOLAZA ECHABE, ELENA AMAYA/0000-0003-2933-9975				Bakas L, 1998, BBA-BIOMEMBRANES, V1368, P225, DOI 10.1016/S0005-2736(97)00181-8; Bakas L, 1996, BIOPHYS J, V71, P1869, DOI 10.1016/S0006-3495(96)79386-4; BAUMANN U, 1993, EMBO J, V12, P3357, DOI 10.1002/j.1460-2075.1993.tb06009.x; BOEHM DF, 1990, INFECT IMMUN, V58, P1959, DOI 10.1128/IAI.58.6.1959-1964.1990; COOTE JG, 1996, REV MED MICROBIOL, V7, P53, DOI [10.1097/00013542-199601000-00006, DOI 10.1097/00013542-199601000-00006]; Cortajarena AL, 2001, J BIOL CHEM, V276, P12513, DOI 10.1074/jbc.M006792200; ELLENS H, 1986, BIOCHEMISTRY-US, V25, P285, DOI 10.1021/bi00350a001; Goni FM, 1998, BRAZ J MED BIOL RES, V31, P1019, DOI 10.1590/S0100-879X1998000800002; GONZALEZCARRERO MI, 1985, MOL GEN GENET, V199, P106, DOI 10.1007/BF00327518; LUDWIG A, 1988, MOL GEN GENET, V214, P553, DOI 10.1007/BF00330494; NIEVA JL, 1989, BIOCHEMISTRY-US, V28, P7364, DOI 10.1021/bi00444a032; OSTOLAZA H, 1993, BIOCHIM BIOPHYS ACTA, V1147, P81, DOI 10.1016/0005-2736(93)90318-T; OSTOLAZA H, 1995, FEBS LETT, V371, P303, DOI 10.1016/0014-5793(95)00927-2; OSTOLAZA H, 1995, EUR J BIOCHEM, V228, P39, DOI 10.1111/j.1432-1033.1995.tb20225.x; OSTOLAZA H, 1991, FEBS LETT, V280, P195, DOI 10.1016/0014-5793(91)80291-A; OSTOLAZA H, 1997, J MEMBRANE BIOL, V158, P1; Pereira FB, 1997, BIOPHYS J, V73, P1977, DOI 10.1016/S0006-3495(97)78228-6; SLAVIK J, 1982, BIOCHIM BIOPHYS ACTA, V694, P1, DOI 10.1016/0304-4157(82)90012-0; Soloaga A, 1998, BIOCHEMISTRY-US, V37, P6387, DOI 10.1021/bi9730994; Stanley P, 1998, MICROBIOL MOL BIOL R, V62, P309, DOI 10.1128/MMBR.62.2.309-333.1998; WLECH RA, 2001, CURR OPIN MICROBIOL, V257, P85; Young J, 1999, BBA-BIOMEMBRANES, V1461, P177, DOI 10.1016/S0005-2736(99)00158-3; ZABALA JC, 1984, MOL GEN GENET, V197, P90, DOI 10.1007/BF00327927	23	12	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2002	277	26					23223	23229		10.1074/jbc.M202028200	http://dx.doi.org/10.1074/jbc.M202028200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567FX	11940597	hybrid			2022-12-27	WOS:000176475700018
J	Gevrey, JC; Cordier-Bussat, M; Nemoz-Gaillard, E; Chayvialle, JA; Abello, J				Gevrey, JC; Cordier-Bussat, M; Nemoz-Gaillard, E; Chayvialle, JA; Abello, J			Co-requirement of cyclic AMP- and calcium-dependent protein kinases for transcriptional activation of cholecystokinin gene by protein hydrolysates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; PROGLUCAGON GENE; PEPTONES STIMULATE; STC-1 CELLS; RESPONSIVE ELEMENT; MAP KINASE; CROSS-TALK; EXPRESSION; GLUCOSE; CREB	Little is known about the mechanisms by which protein-derived nutrients regulate hormone gene expression in the intestine. We have previously reported that protein hydrolysates (i.e. peptones), which are representative of the protein fraction in the lumen, increased cholecystokinin (CCK) gene transcription in the STC-1 enteroendocrine cell line. In the present work, we examined the intracellular events evoked by peptones to stimulate CCK gene transcription. In STC-1 cells, peptones stimulated cyclic AMP production and protein kinase A (PKA) activity. This was associated with a nuclear translocation of the PKA catalytic subunit and with a PKA-dependent phosphorylation of the CRE-binding protein (CREB) at Ser(133). Using transient transfection experiments and reporter luciferase assays, we show that peptone-stimulated transcriptional activity of the CCK gene promoter was significantly decreased when the PKA pathway was inhibited. Furthermore, the intracellular calcium chelator 1,2-bis-(O-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid-tetra(acetoxymethyl) ester completely inhibited peptone-induced stimulation of the CCK gene promoter activity, phosphorylation of CREB, and PKA activity. Peptones increased, in a calcium-dependent manner, the phosphorylation of extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) and the MEK inhibitor PD98059 decreased the peptone-induced stimulation of CCK gene promoter activity. This stimulation was also reduced by 30% in the presence of the calcium/calmodulin-dependent protein kinase (CaMK) inhibitor KN-93. Total inhibition was obtained when the PKA, ERK, and CaMK pathways were simultaneously blocked with appropriate inhibitors to these pathways. These results demonstrate the simultaneous involvement of cAMP- and calcium-dependent protein kinases in the stimulation of intestinal CCK gene transcription by protein-derived nutrients.	Hop Edouard Herriot, INSERM, U45, F-69437 Lyon 3, France; Hop Edouard Herriot, IFR 62, F-69437 Lyon, France	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon	Abello, J (corresponding author), Hop Edouard Herriot, INSERM, U45, Pavillon H, F-69437 Lyon 3, France.		Cordier-Bussat, Martine/G-4019-2014					Barsacchi R, 1999, FEBS LETT, V461, P273, DOI 10.1016/S0014-5793(99)01468-4; BENTOUIMOU N, 1995, GASTROEN CLIN BIOL, V19, P659; Bernard C, 2001, ENDOCRINOLOGY, V142, P721, DOI 10.1210/en.142.2.721; Bruhat A, 2000, MOL CELL BIOL, V20, P7192, DOI 10.1128/MCB.20.19.7192-7204.2000; Buchan AMJ, 1999, AM J PHYSIOL-GASTR L, V277, pG1103, DOI 10.1152/ajpgi.1999.277.6.G1103; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Cordier-Bussat M, 1998, DIABETES, V47, P1038, DOI 10.2337/diabetes.47.7.1038; CordierBussat M, 1997, ENDOCRINOLOGY, V138, P1137, DOI 10.1210/en.138.3.1137; CORRELL LA, 1989, J BIOL CHEM, V264, P16672; CUBER JC, 1992, J PHYSIOL-LONDON, V449, P37, DOI 10.1113/jphysiol.1992.sp019073; CUBER JC, 1990, AM J PHYSIOL, V259, pG191, DOI 10.1152/ajpgi.1990.259.2.G191; Deavall DG, 2000, AM J PHYSIOL-GASTR L, V279, pG605, DOI 10.1152/ajpgi.2000.279.3.G605; DRUCKER DJ, 1989, P NATL ACAD SCI USA, V86, P3953, DOI 10.1073/pnas.86.11.3953; DRUCKER DJ, 1994, MOL ENDOCRINOL, V8, P1646, DOI 10.1210/me.8.12.1646; Duplus E, 2000, J BIOL CHEM, V275, P30749, DOI 10.1074/jbc.R000015200; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Garrel G, 1997, ENDOCRINOLOGY, V138, P2259, DOI 10.1210/en.138.6.2259; Gevrey JC, 2001, FEBS LETT, V503, P19, DOI 10.1016/S0014-5793(01)02683-7; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Grewal SS, 2000, J BIOL CHEM, V275, P34433, DOI 10.1074/jbc.M004728200; Groneberg DA, 2001, AM J PHYSIOL-GASTR L, V281, pG697, DOI 10.1152/ajpgi.2001.281.3.G697; HAFNER S, 1994, MOL CELL BIOL, V14, P6696; Hansen TV, 1999, MOL ENDOCRINOL, V13, P466, DOI 10.1210/me.13.3.466; HAUN RS, 1990, J BIOL CHEM, V265, P15455; HEMMINGS BA, 1986, FEBS LETT, V196, P126, DOI 10.1016/0014-5793(86)80226-5; LIDDLE RA, 1988, J CLIN INVEST, V81, P2015, DOI 10.1172/JCI113552; Liu MY, 1996, NATURE, V382, P83, DOI 10.1038/382083a0; Macfarlane WM, 1999, J BIOL CHEM, V274, P1011, DOI 10.1074/jbc.274.2.1011; MEINKOTH JL, 1990, P NATL ACAD SCI USA, V87, P9595, DOI 10.1073/pnas.87.24.9595; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; Murai A, 2000, EUR J PHARMACOL, V394, P27, DOI 10.1016/S0014-2999(00)00076-5; Nemoz-Gaillard E, 1998, ENDOCRINOLOGY, V139, P932, DOI 10.1210/en.139.3.932; Pursiheimo JP, 2000, P NATL ACAD SCI USA, V97, P168, DOI 10.1073/pnas.97.1.168; Reimer RA, 1997, J NUTR, V127, P1923, DOI 10.1093/jn/127.10.1923; RINDI G, 1990, AM J PATHOL, V136, P1349; Roche E, 1999, DIABETES, V48, P2007, DOI 10.2337/diabetes.48.10.2007; Saxena M, 1999, NAT CELL BIOL, V1, P305, DOI 10.1038/13024; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SHIOTANI A, 1995, AM J PHYSIOL-GASTR L, V269, pG458, DOI 10.1152/ajpgi.1995.269.3.G458; Sung JY, 2001, J BIOL CHEM, V276, P13858, DOI 10.1074/jbc.M010610200; TSENG CC, 1994, AM J PHYSIOL, V266, pG887, DOI 10.1152/ajpgi.1994.266.5.G887; Turgeman H, 1998, FEBS LETT, V428, P183, DOI 10.1016/S0014-5793(98)00513-4; Vaulont S, 2000, J BIOL CHEM, V275, P31555, DOI 10.1074/jbc.R000016200; WALSH JH, 1994, PHYSL GASTROINTESTIN, P49; Wayman GA, 1997, J BIOL CHEM, V272, P16073, DOI 10.1074/jbc.272.26.16073; Wayman GA, 1996, MOL CELL BIOL, V16, P6075; Xavier GD, 2000, P NATL ACAD SCI USA, V97, P4023, DOI 10.1073/pnas.97.8.4023	49	24	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22407	22413		10.1074/jbc.M201624200	http://dx.doi.org/10.1074/jbc.M201624200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11950843	hybrid			2022-12-27	WOS:000176313600039
J	Shuttleworth, TL; Wilson, MD; Wicklow, BA; Wilkins, JA; Triggs-Raine, BL				Shuttleworth, TL; Wilson, MD; Wicklow, BA; Wilkins, JA; Triggs-Raine, BL			Characterization of the murine hyaluronidase gene region reveals complex organization and cotranscription of Hyal1 with downstream genes, Fus2 and Hyal3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-CHROMOSOME 3P21.3; TUMOR-SUPPRESSOR GENE; EXPRESSION ANALYSIS; GENOMIC STRUCTURE; PLASMA-MEMBRANE; CANDIDATE; PROTEIN; SPERM; MOUSE; MUTATIONS	Hyaluronidases are required for the breakdown of hyaluronan (HA), an abundant component of the extracellular matrix of vertebrate tissues. Multiple hyaluronidase genes have been identified, but the only clue to the function of their products has come from the identification of hyaluronidase 1 deficiency in a single patient,with a mild clinical phenotype. As a first step in the generation of mice with hyaluronidase deficiency, we have used experimental and bioinformatic approaches to examine the organization of the mouse chromosome 9 region containing, in order, Hyal2, Hyal1, and Hyal3. This region was found to be complex, with Fus2 partially embedded in Hyal3, and Ifrd2 immediately downstream from Hyal3. The Hyal genes were all found to have four exons, and exons 2-4 exhibited the highest sequence conservation. Northern blot analysis demonstrated that the tissue expression profile for Hyal1 was similar in mice and humans, but a greater number of transcripts was detected in mouse tissues. Hyal3 was expressed more broadly in mice compared with humans and again exhibited additional transcripts. Reverse transcription-PCR demonstrated that some of the larger Hyal1 transcripts, seen on the Northern blot, were the result of cotranscription of Hyal1 with downstream genes, Fus2 or Hyal3. In vitro transcription/translation of one of the high abundance bicistronic transcripts produced Hyal1, suggesting that Hyal1 could be produced from all of the bicistronic transcripts. Characterization of the region including mouse Hyal1 and Hyal3 revealed complex organization and transcription that must be considered in the development and interpretation of mouse models involving genes in this region.	Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB R3E 0W3, Canada; Univ Manitoba, Dept Internal Med & Immunol, Winnipeg, MB R3E 0W3, Canada; Univ Victoria, Dept Biol, Ctr Environm Hlth, Victoria, BC V8W 3N5, Canada	University of Manitoba; University of Manitoba; University of Victoria	Triggs-Raine, BL (corresponding author), Univ Manitoba, Dept Biochem & Med Genet, 770 Bannatyne Ave, Winnipeg, MB R3E 0W3, Canada.	traine@ms.umanitoba.ca	Wilson, Michael D/K-6294-2014; Triggs-Raine, Barbara/AAF-6209-2021	Wilson, Michael D/0000-0002-4015-3066; Triggs-Raine, Barbara/0000-0003-4719-6779				BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Csoka AB, 1999, GENOMICS, V60, P356, DOI 10.1006/geno.1999.5876; Csoka TB, 1998, GENOMICS, V48, P63, DOI 10.1006/geno.1997.5158; Deng XN, 1997, MAMM GENOME, V8, P94, DOI 10.1007/s003359900365; FRASER JRE, 1997, J INTERN MED, V242, P23; Frost GI, 1997, BIOCHEM BIOPH RES CO, V236, P10, DOI 10.1006/bbrc.1997.6773; Frost GI, 2000, ONCOGENE, V19, P870, DOI 10.1038/sj.onc.1203317; Frost GL, 1996, TRENDS GLYCOSCI GLYC, V8, P419, DOI 10.4052/tigg.8.419; Gray TA, 1999, P NATL ACAD SCI USA, V96, P5616, DOI 10.1073/pnas.96.10.5616; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; JONES MH, 1995, GENOMICS, V29, P796, DOI 10.1006/geno.1995.9931; LEE SJ, 1991, P NATL ACAD SCI USA, V88, P4250, DOI 10.1073/pnas.88.10.4250; Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466; Lerman MI, 2000, CANCER RES, V60, P6116; Li MW, 1997, MOL REPROD DEV, V48, P356; LIN Y, 1994, J CELL BIOL, V125, P1157, DOI 10.1083/jcb.125.5.1157; MCDONALD JN, 1995, J PHYSIOL-LONDON, V485, P179, DOI 10.1113/jphysiol.1995.sp020722; Natowicz MR, 1996, NEW ENGL J MED, V335, P1029, DOI 10.1056/NEJM199610033351405; Osoegawa K, 2000, GENOME RES, V10, P116; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; Reiss J, 1998, NAT GENET, V20, P51, DOI 10.1038/1706; Ritchie H, 1997, BIOCHEM BIOPH RES CO, V231, P425, DOI 10.1006/bbrc.1997.6126; SAMBROOK J, 1989, MOL CLONING LAB MANU, P779; Schuler GD, 1997, J MOL MED, V75, P694, DOI 10.1007/s001090050155; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Strobl B, 1998, GENOMICS, V53, P214, DOI 10.1006/geno.1998.5472; STUPACK DG, 1991, SCAND J IMMUNOL, V34, P761, DOI 10.1111/j.1365-3083.1991.tb01601.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toole BP, 1997, J INTERN MED, V242, P35, DOI 10.1046/j.1365-2796.1997.00171.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Triggs-Raine B, 1999, P NATL ACAD SCI USA, V96, P6296, DOI 10.1073/pnas.96.11.6296; Wei MH, 1996, CANCER RES, V56, P1487; Zheng Y, 1999, MOL REPROD DEV, V54, P8, DOI 10.1002/(SICI)1098-2795(199909)54:1&lt;8::AID-MRD2&gt;3.0.CO;2-D	33	27	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					23008	23018		10.1074/jbc.M108991200	http://dx.doi.org/10.1074/jbc.M108991200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11929860	hybrid			2022-12-27	WOS:000176313600116
J	Ten Hagen, KG; Tran, DT				Ten Hagen, KG; Tran, DT			A UDP-GalNAc : polypeptide N-acetylgalactosaminyltransferase is essential for viability in Drosophila melanogaster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-D-GALACTOSAMINE; ALPHA-D-GALACTOSAMINE; CDNA CLONING; MOLECULAR-CLONING; EXPRESSION; GLYCOSYLATION; HOMOLOG; FAMILY; GENE; N-ACETYLGALACTOSAMINYLTRANSFERASE-T3	We report the first demonstration that the activity of a member of the LTDP-GalNAc:polypeptide N-acetylgaIactosaminyltransferase gene family is necessary for viability in Drosophila melanogaster. Expression of the wild-type recombinant pgant35A gene in COS7 cells resulted in in vitro activity against peptide and glycopeptide substrates, demonstrating that this gene encodes a biochemically active transferase. Previous mutagenesis studies identified recessive lethal mutations that were rescued by a genomic fragment containing the pgant35A gene; however, the presence of additional open reading frames within this fragment left open the possibility that another gene was responsible for rescue of the observed lethality. Here, we have determined the molecular nature of the mutations in three independent mutant alleles. Two of the mutant alleles contain premature stop codons within the coding region of pgant35A. The third mutant contains an arginine to tryptophan amino acid change, which, when expressed in COS7 cells, resulted in a dramatic reduction of transferase activity in vitro. PCR amplification of this gene from Drosophila cDNA panels and Northern analysis revealed that it is expressed throughout embryonic, larval, and pupal stages as well as in adult males and females. This study provides the first direct evidence for the involvement of a member of this conserved multigene family in eukaryotic development and viability.	NIDDK, Sect Biol Chem, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Ten Hagen, KG (corresponding author), NIDDK, Sect Biol Chem, NIH, 9000 Rockville Pike,Bldg 50,Rm 4120, Bethesda, MD 20892 USA.	Kelly.Tenhagen@nih.gov						ALBONE EF, 1994, J BIOL CHEM, V269, P16845; Ashburner M, 1999, GENETICS, V153, P179; Bennett EP, 1996, J BIOL CHEM, V271, P17006, DOI 10.1074/jbc.271.29.17006; Bennett EP, 1999, J BIOL CHEM, V274, P25362, DOI 10.1074/jbc.274.36.25362; Bennett EP, 1999, FEBS LETT, V460, P226, DOI 10.1016/S0014-5793(99)01268-5; Casso David, 2000, Mechanisms of Development, V91, P451, DOI 10.1016/S0925-4773(00)00248-3; DUPERAT VG, 1995, BIOCHEM J, V305, P211, DOI 10.1042/bj3050211; Flores C, 1999, P NATL ACAD SCI USA, V96, P2964, DOI 10.1073/pnas.96.6.2964; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; Hagen FK, 1999, J BIOL CHEM, V274, P6797, DOI 10.1074/jbc.274.10.6797; Hagen FK, 1998, J BIOL CHEM, V273, P8268, DOI 10.1074/jbc.273.14.8268; Hagen FK, 1997, J BIOL CHEM, V272, P13843, DOI 10.1074/jbc.272.21.13843; HAGEN FK, 1993, J BIOL CHEM, V268, P18960; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; Hiki Y, 2001, KIDNEY INT, V59, P1077, DOI 10.1046/j.1523-1755.2001.00591.x; HOMA FL, 1993, J BIOL CHEM, V268, P12609; KONGSUWAN K, 1985, NATURE, V317, P555, DOI 10.1038/317555a0; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Lin XH, 1999, DEVELOPMENT, V126, P3715; McManus AM, 1999, BIOCHEMISTRY-US, V38, P705, DOI 10.1021/bi981956d; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Nehrke K, 1996, J BIOL CHEM, V271, P7061, DOI 10.1074/jbc.271.12.7061; OHMORI H, 1994, J BIOL CHEM, V269, P17833; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SHEKELS LL, 1995, BIOCHEM J, V311, P775, DOI 10.1042/bj3110775; Ten Hagen BG, 1998, J BIOL CHEM, V273, P27749; Ten Hagen KG, 1999, J BIOL CHEM, V274, P27867; Ten Hagen KG, 2001, J BIOL CHEM, V276, P17395, DOI 10.1074/jbc.M009638200; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; Westerman EL, 1999, GLYCOBIOLOGY, V9, P1121; WHITE T, 1995, J BIOL CHEM, V270, P24156, DOI 10.1074/jbc.270.41.24156; Zara J, 1996, BIOCHEM BIOPH RES CO, V228, P38, DOI 10.1006/bbrc.1996.1613	32	76	78	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22616	22622		10.1074/jbc.M201807200	http://dx.doi.org/10.1074/jbc.M201807200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11925446	hybrid			2022-12-27	WOS:000176313600068
J	Whitsett, JA; Clark, JC; Picard, L; Tichelaar, JW; Wert, SE; Itoh, N; Perl, AKT; Stahlman, MT				Whitsett, JA; Clark, JC; Picard, L; Tichelaar, JW; Wert, SE; Itoh, N; Perl, AKT; Stahlman, MT			Fibroblast growth factor 18 influences proximal programming during lung morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRANCHING MORPHOGENESIS; TRANSGENIC MICE; MOUSE LUNG; MESSENGER-RNA; FACTOR FAMILY; IN-VIVO; EXPRESSION; GENE; LIMB; DIFFERENTIATION	The structure and functions of the airways of the lung change dramatically along their lengths. Large-diameter conducting airways are supported by cartilaginous rings and smooth muscle tissue and are lined by ciliated and secretory epithelial cells that are involved in mucociliary clearance. Smaller peripheral airways formed during branching morphogenesis are lined by cuboidal and squamous cells that facilitate gas exchange to a network of fine capillaries. The factors that mediate formation of these changing cell types and structures along the length of the airways are unknown. We report here that conditional expression of fibroblast growth factor (FGF)-18 in epithelial cells of the developing lung caused the airway to adopt structural features of proximal airways. Peripheral lung tubules were markedly diminished in numbers, whereas the size and extent of conducting airways were increased. Abnormal smooth muscle and cartilage were found in the walls of expanded distal airways, which were accompanied by atypically large pulmonary blood vessels. Expression of proteins normally expressed in peripheral lung tubules, including SP-B and pro-SP-C, was inhibited. FGF-18 mRNA was detected in normal mouse lung in stromal cells surrounding proximal airway cartilage and in peripheral lung mesenchyme. Effects were unique to FGF-18 because expression of other members of the FGF family had different consequences. These data show that FGF-18 is capable of enhancing proximal and inhibiting peripheral programs during lung morphogenesis.	Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA; Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biochem Genet, Kyoto 6068501, Japan; Vanderbilt Univ, Dept Pediat, Nashville, TN 37232 USA	Cincinnati Children's Hospital Medical Center; Kyoto University; Vanderbilt University	Whitsett, JA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Neonatol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	jeff.whitsett@chmcc.org	Perl, Anne-Karina T/M-7174-2013; Tichelaar, Jay/B-9148-2011	Perl, Anne-Karina T/0000-0002-8445-4565; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL041496, P50HL056387, P01HL056387] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL56387, HL41496] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arman E, 1999, P NATL ACAD SCI USA, V96, P11895, DOI 10.1073/pnas.96.21.11895; Bellusci S, 1997, DEVELOPMENT, V124, P4867; Clark JC, 2001, AM J PHYSIOL-LUNG C, V280, pL705, DOI 10.1152/ajplung.2001.280.4.L705; Colvin JS, 2001, DEVELOPMENT, V128, P2095; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; FU YM, 1991, J CELL BIOL, V114, P1261, DOI 10.1083/jcb.114.6.1261; GLASSER SW, 1991, AM J PHYSIOL, V261, pL349, DOI 10.1152/ajplung.1991.261.4.L349; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Guo LF, 1996, GENE DEV, V10, P165, DOI 10.1101/gad.10.2.165; Hogan BLM, 1999, CELL, V96, P225, DOI 10.1016/S0092-8674(00)80562-0; HORLICK RA, 1992, GENE, V120, P291, DOI 10.1016/0378-1119(92)90108-2; Hu MCT, 1998, MOL CELL BIOL, V18, P6063, DOI 10.1128/MCB.18.10.6063; KLINT P, 1999, FRONT BIOSCI, V4, P165; KORHONEN J, 1992, INT J DEV BIOL, V36, P323; Luo YD, 1998, BIOCHEMISTRY-US, V37, P16506, DOI 10.1021/bi9816599; Mailleux AA, 2001, MECH DEVELOP, V102, P81, DOI 10.1016/S0925-4773(01)00286-6; MASON IJ, 1994, MECH DEVELOP, V45, P15, DOI 10.1016/0925-4773(94)90050-7; McKeehan WL, 1998, PROG NUCLEIC ACID RE, V59, P135; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Minowada G, 1999, DEVELOPMENT, V126, P4465; MUENKE M, 2001, CRANIOSYNOSTOSIS SYN, V4, P6117; Ohbayashi N, 1998, J BIOL CHEM, V273, P18161, DOI 10.1074/jbc.273.29.18161; ORRURTREGER A, 1991, DEVELOPMENT, V113, P1419; Park WY, 1998, DEV BIOL, V201, P125, DOI 10.1006/dbio.1998.8994; Perl AKT, 2002, TRANSGENIC RES, V11, P21, DOI 10.1023/A:1013986627504; PETERS K, 1993, DEV BIOL, V155, P423, DOI 10.1006/dbio.1993.1040; PETERS K, 1994, EMBO J, V13, P3296, DOI 10.1002/j.1460-2075.1994.tb06631.x; PETERS KG, 1992, DEVELOPMENT, V114, P233; Powell PP, 1998, AM J RESP CELL MOL, V19, P563, DOI 10.1165/ajrcmb.19.4.2994; SANNES PL, 1992, AM J RESP CELL MOL, V7, P230, DOI 10.1165/ajrcmb/7.2.230; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; SHANNON JM, 1994, DEV BIOL, V166, P600, DOI 10.1006/dbio.1994.1340; Simonet WS, 1995, P NATL ACAD SCI USA, V92, P12461, DOI 10.1073/pnas.92.26.12461; Szebenyi G, 1999, INT REV CYTOL, V185, P45; Tichelaar JW, 1999, J HISTOCHEM CYTOCHEM, V47, P823, DOI 10.1177/002215549904700612; Tichelaar JW, 2000, J BIOL CHEM, V275, P11858, DOI 10.1074/jbc.275.16.11858; ULICH TR, 1994, J CLIN INVEST, V93, P1298, DOI 10.1172/JCI117086; Wang O, 2001, DEVELOPMENT, V128, P3867; Weinstein M, 1998, DEVELOPMENT, V125, P3615; WERT SE, 1993, DEV BIOL, V156, P426, DOI 10.1006/dbio.1993.1090; Xu JS, 2000, DEVELOPMENT, V127, P1833; Zhao BH, 2001, P NATL ACAD SCI USA, V98, P5898, DOI 10.1073/pnas.101116598; Zhou L, 1996, AM J PHYSIOL-LUNG C, V271, pL987, DOI 10.1152/ajplung.1996.271.6.L987	43	65	68	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2002	277	25					22743	22749		10.1074/jbc.M202253200	http://dx.doi.org/10.1074/jbc.M202253200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564KM	11927601	hybrid			2022-12-27	WOS:000176313600083
J	Amano, T; Kaji, N; Ohashi, K; Mizuno, K				Amano, T; Kaji, N; Ohashi, K; Mizuno, K			Mitosis-specific activation of LIM motif-containing protein kinase and roles of cofilin phosphorylation and dephosphorylation in mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED ACTIN REORGANIZATION; CYTOSKELETAL DYNAMICS; DEPOLYMERIZING FACTOR; CLEAVAGE FURROW; CELL-CYCLE; CYTOKINESIS; RHO; IDENTIFICATION; LIM-KINASE-1; REGULATORS	Actin filament dynamics play a critical role in mitosis and cytokinesis. LIM motif-containing protein kinase 1 (LIMK1) regulates actin reorganization by phosphorylating and inactivating cofilin, an actin-depolymerizing and -severing protein. To examine the role of LIMK1 and cofilin during the cell cycle, we measured cell cycle-associated changes in the kinase activity of LIMK1 and in the level of cofilin phosphorylation. Using synchronized HeLa cells, we found that LIMK1 became hyper-phosphorylated. and activated in prometaphase and metaphase, then gradually returned to the basal level as cells entered into telophase and cytokinesis. Although Rho-associated kinase and p21-activated protein kinase phosphorylate and activate LIMK1, they are not likely to be involved in mitosis-specific activation and phosphorylation of LIMK1. Immunoblot and immunofluorescence analyses using an anti-phosphocofilin-specific antibody revealed that the level of cofilin phosphorylation, similar to levels of LIMK1 activity, increased during prometaphase and metaphase then gradually declined in telophase and cytokinesis. Ectopic expression of LIMK1 increased the level of cofilin phosphorylation throughout the cell cycle and induced the formation of multinucleate cells. These results suggest that LIMK1 is involved principally in control of mitosis-specific cofilin phosphorylation and that dephosphorylation and reactivation of cofilin at later stages of mitosis play a critical role in cytokinesis of mammalian cells.	Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan	Tohoku University	Mizuno, K (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Aoba Ku, Aramaki Aza Aoba, Sendai, Miyagi 9808578, Japan.		Mizuno, Kensaku/G-8631-2015; Ohashi, Kazumasa/U-7028-2019	Ohashi, Kazumasa/0000-0001-7617-403X				Abe H, 1996, J CELL BIOL, V132, P871, DOI 10.1083/jcb.132.5.871; AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Amano T, 2001, BIOCHEM J, V354, P149, DOI 10.1042/0264-6021:3540149; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bierne H, 2001, J CELL BIOL, V155, P101, DOI 10.1083/jcb.200104037; Chernoff J, 1999, NAT CELL BIOL, V1, pE115, DOI 10.1038/12942; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Edwards DC, 1999, J BIOL CHEM, V274, P11352, DOI 10.1074/jbc.274.16.11352; FISHKIND DJ, 1995, CURR OPIN CELL BIOL, V7, P23, DOI 10.1016/0955-0674(95)80041-7; GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243; Hirota T, 2000, J CELL BIOL, V149, P1073, DOI 10.1083/jcb.149.5.1073; Kimura K, 2000, J BIOL CHEM, V275, P17233, DOI 10.1074/jbc.C000212200; KISHI K, 1993, J CELL BIOL, V120, P1187, DOI 10.1083/jcb.120.5.1187; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; Mabuchi I, 1993, ZYGOTE, V1, P325, DOI 10.1017/S0967199400001659; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; MIZUNO K, 1994, ONCOGENE, V9, P1605; MOON A, 1995, MOL BIOL CELL, V6, P1423, DOI 10.1091/mbc.6.11.1423; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; NAGAOKA R, 1995, CELL MOTIL CYTOSKEL, V30, P1, DOI 10.1002/cm.970300102; Nagaoka R, 1996, CELL MOTIL CYTOSKEL, V35, P200, DOI 10.1002/(SICI)1097-0169(1996)35:3<200::AID-CM3>3.0.CO;2-C; Nagata K, 1999, BIOCHEM J, V343, P99, DOI 10.1042/0264-6021:3430099; Nishita M, 2002, MOL CELL BIOL, V22, P774, DOI 10.1128/MCB.22.3.774-783.2002; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Okano I, 1995, J BIOL CHEM, V270, P31321, DOI 10.1074/jbc.270.52.31321; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Pines J, 1999, NAT CELL BIOL, V1, pE73, DOI 10.1038/11041; Prokopenko SN, 2000, J CELL BIOL, V148, P843, DOI 10.1083/jcb.148.5.843; Robinson DN, 2000, TRENDS CELL BIOL, V10, P228, DOI 10.1016/S0962-8924(00)01747-5; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Takahashi T, 2001, DEV BIOL, V229, P554, DOI 10.1006/dbio.2000.9999; Takenaka K, 1997, J CELL BIOL, V136, P1091, DOI 10.1083/jcb.136.5.1091; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zebda N, 2000, J CELL BIOL, V151, P1119, DOI 10.1083/jcb.151.5.1119	40	74	76	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					22093	22102		10.1074/jbc.M201444200	http://dx.doi.org/10.1074/jbc.M201444200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11925442	hybrid			2022-12-27	WOS:000176286000122
J	Dwir, O; Steeber, DA; Schwarz, US; Camphausen, RT; Kansas, GS; Tedder, TF; Alon, R				Dwir, O; Steeber, DA; Schwarz, US; Camphausen, RT; Kansas, GS; Tedder, TF; Alon, R			L-selectin dimerization enhances tether formation to properly spaced ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; P-SELECTIN; GLYCOPROTEIN LIGAND-1; LEUKOCYTE ADHESION; CELL-ADHESION; SHEAR THRESHOLD; HIGH-AFFINITY; BINDING-PROPERTIES; HUMAN NEUTROPHILS; FLOW	Selectin counterreceptors are glycoprotein scaffolds bearing multiple carbohydrate ligands with exceptional ability to tether flowing cells under disruptive shear forces. Bond clusters may facilitate formation and stabilization of selectin tethers. L-selectin ligation has been shown to enhance L-selectin rolling on endothelial surfaces. We now report that monoclonal antibodies-induced L-selectin dimerization enhances L-selectin leukocyte tethering to purified physiological L-selectin ligands and glycopeptides. Microkinetic analysis of individual tethers suggests that leukocyte rolling is enhanced through the dimerization-induced increase in tether formation, rather than by tether stabilization. Notably, L-selectin dimerization failed to augment L-selectin-mediated adhesion below a threshold ligand density, suggesting that L-selectin dimerization enhanced adhesiveness only to properly clustered ligand. In contrast, an epidermal growth factor domain substitution of L-selectin enhanced tether formation to L-selectin ligands irrespective of ligand density, suggesting that this domain controls intrinsic ligand binding properties of L-selectin without inducing L-selectin dimerization. Strikingly, at low ligand densities, where L-selectin tethering was not responsive to dimerization, elevated shear stress restored sensitivity of tethering to selectin dimerization. This is the first indication that shear stress augments effective selectin ligand density at local contact sites by promoting L-selectin encounter of immobilized ligand.	Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; Max Planck Inst Colloids & Interfaces, D-14424 Potsdam, Germany; Wyeth Genet Inst, Cambridge, MA 02140 USA; Northwestern Univ, Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA	Weizmann Institute of Science; Duke University; Max Planck Society; Pfizer; Northwestern University	Alon, R (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.		Schwarz, Ulrich/ABB-5642-2020; Schwarz, Ulrich S/K-4111-2014; ALON, RONEN/GRX-6987-2022	Schwarz, Ulrich/0000-0003-1483-640X; Schwarz, Ulrich S/0000-0003-1483-640X; Alon, Ronen/0000-0001-9161-6369	NHLBI NIH HHS [1R24HL64381] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alon R, 1998, P NATL ACAD SCI USA, V95, P11631, DOI 10.1073/pnas.95.20.11631; Alon R, 1997, J CELL BIOL, V138, P1169, DOI 10.1083/jcb.138.5.1169; ALON R, 1995, NATURE, V374, P539, DOI 10.1038/374539a0; Chang KC, 2000, BIOPHYS J, V79, P1891, DOI 10.1016/S0006-3495(00)76439-3; Chang KC, 2000, P NATL ACAD SCI USA, V97, P11262, DOI 10.1073/pnas.200240897; Chang KC, 1999, BIOPHYS J, V76, P1280, DOI 10.1016/S0006-3495(99)77291-7; Chen SQ, 1997, P NATL ACAD SCI USA, V94, P3172, DOI 10.1073/pnas.94.7.3172; Chen SQ, 1999, J CELL BIOL, V144, P185, DOI 10.1083/jcb.144.1.185; Chen SQ, 2001, P NATL ACAD SCI USA, V98, P950, DOI 10.1073/pnas.98.3.950; Dwir O, 1998, CELL ADHES COMMUN, V6, P349, DOI 10.3109/15419069809010793; Dwir O, 2000, J BIOL CHEM, V275, P18682, DOI 10.1074/jbc.M001103200; Dwir O, 2001, J CELL BIOL, V155, P145, DOI 10.1083/jcb.200103042; Evans E, 2001, P NATL ACAD SCI USA, V98, P3784, DOI 10.1073/pnas.061324998; Evans SS, 1999, J IMMUNOL, V162, P3615; Finger EB, 1996, NATURE, V379, P266, DOI 10.1038/379266a0; Goetz DJ, 1997, J CELL BIOL, V137, P509, DOI 10.1083/jcb.137.2.509; Greenberg AW, 2000, BIOPHYS J, V79, P2391, DOI 10.1016/S0006-3495(00)76484-8; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; KANSAS GS, 1994, J CELL BIOL, V124, P609, DOI 10.1083/jcb.124.4.609; KISHIMOTO TK, 1990, P NATL ACAD SCI USA, V87, P2244, DOI 10.1073/pnas.87.6.2244; LASKY LA, 1992, COLD SPRING HARB SYM, V57, P259, DOI 10.1101/SQB.1992.057.01.031; Lawrence MB, 1997, J CELL BIOL, V136, P717, DOI 10.1083/jcb.136.3.717; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; Li FG, 1996, J BIOL CHEM, V271, P3255, DOI 10.1074/jbc.271.6.3255; Li X, 1998, J EXP MED, V188, P1385, DOI 10.1084/jem.188.7.1385; Marttila AT, 2000, FEBS LETT, V467, P31, DOI 10.1016/S0014-5793(00)01119-4; McEver RP, 1997, J CLIN INVEST, V100, P485, DOI 10.1172/JCI119556; MCEVER RP, 1997, J CLIN INVEST, V100, P97; MILLER J, 1995, J EXP MED, V182, P1231, DOI 10.1084/jem.182.5.1231; MOORE KL, 1994, J BIOL CHEM, V269, P23318; MOORE KL, 1995, J CELL BIOL, V128, P661, DOI 10.1083/jcb.128.4.661; Nicholson MW, 1998, J BIOL CHEM, V273, P763, DOI 10.1074/jbc.273.2.763; Puri KD, 1998, NATURE, V392, P930, DOI 10.1038/31954; Ramachandran V, 1999, P NATL ACAD SCI USA, V96, P13771, DOI 10.1073/pnas.96.24.13771; Ramachandran V, 2001, P NATL ACAD SCI USA, V98, P10166, DOI 10.1073/pnas.171248098; ROSEN SD, 1994, CURR OPIN CELL BIOL, V6, P663, DOI 10.1016/0955-0674(94)90092-2; Rosen SD, 1996, CURR BIOL, V6, P261, DOI 10.1016/S0960-9822(02)00473-6; Seppo A, 1996, GLYCOBIOLOGY, V6, P65, DOI 10.1093/glycob/6.1.65; Setiadi H, 1998, J CELL BIOL, V142, P859, DOI 10.1083/jcb.142.3.859; Snapp KR, 1998, J CELL BIOL, V142, P263, DOI 10.1083/jcb.142.1.263; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Spertini O, 1996, J CELL BIOL, V135, P523, DOI 10.1083/jcb.135.2.523; Steeber DA, 1997, J IMMUNOL, V159, P952; Stockton BM, 1998, IMMUNITY, V8, P373, DOI 10.1016/S1074-7613(00)80542-7; Toppila S, 1997, EUR J IMMUNOL, V27, P1360, DOI 10.1002/eji.1830270610; Tu LL, 1996, J IMMUNOL, V157, P3995; VANDERMERWE PA, 1994, BIOCHEMISTRY-US, V33, P10149, DOI 10.1021/bi00199a043; VONANDRIAN UH, 1995, CELL, V82, P989, DOI 10.1016/0092-8674(95)90278-3; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4	49	28	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21130	21139		10.1074/jbc.M201999200	http://dx.doi.org/10.1074/jbc.M201999200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11907045	hybrid			2022-12-27	WOS:000176286000005
J	Gaille, C; Kast, P; Haas, D				Gaille, C; Kast, P; Haas, D			Salicylate biosynthesis in Pseudomonas aeruginosa - Purification and characterization of PchB, a novel bifunctional enzyme displaying isochorismate pyruvate-lyase and chorismate mutase activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MENAQUINONE VITAMIN-K-2 BIOSYNTHESIS; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; MYCOBACTERIUM-SMEGMATIS; PYOCHELIN BIOSYNTHESIS; MOLECULAR-CLONING; ACID; GENES; ENTEROBACTIN; SIDEROPHORE	Isochorismate pyruvate-lyase (IPL), the second enzyme of pyochelin biosynthesis and the product of the pchB gene, was purified to homogeneity from Pseudomonas aeruginosa. In the reaction catalyzed by this enzyme, isochorismate salicylate + pyruvate, no cofactors appear to be required. At the pH optimum (pH 6.8), the enzyme displayed Michaelis-Menten kinetics, with an apparent K-m of 12.5 muM for isochorismate and a k(cat) of 106 min(-1), calculated per monomer. The native enzyme behaved as a homodimer, as judged by molecular sieving chromatography, electrophoresis under nondenaturing conditions, and cross-linking experiments. PchB has approximately 20% amino acid sequence identity with AroQ-class chorismate mutases (CMs). Chorismate was shown to be converted to prephenate by purified PchB in vitro, with an apparent K-m of 150 muM and a k(cat) of 7.8 min(-1). An oxabicyclic diacid transition state analog and well characterized inhibitor of CMs competitively inhibited both IPL and CM activities of PchB. Moreover, a CM-deficient Escherichia coli mutant, which is auxotrophic for phenylalanine and tyrosine, was functionally complemented by the cloned P. aeruginosa pchB gene for growth in minimal medium. A mutant form of PchB, in which isoleucine 88 was changed to threonine, had no detectable IPL activity, but retained wild-type CM activity. In conclusion, the 11.5-kDa subunit of PchB appears to contain a single active site involved in both IPL and CM activity.	Univ Lausanne, Lab Biol Microbienne, CH-1015 Lausanne, Switzerland; Swiss Fed Inst Technol, Organ Chem Lab, CH-8093 Zurich, Switzerland	University of Lausanne; Swiss Federal Institutes of Technology Domain; ETH Zurich	Haas, D (corresponding author), Univ Lausanne, Lab Biol Microbienne, CH-1015 Lausanne, Switzerland.							Adilakshmi T, 2000, J BACTERIOL, V182, P264, DOI 10.1128/JB.182.2.264-271.2000; AHMAD S, 1988, MOL BIOL EVOL, V5, P282; ANKENBAUER RG, 1988, J BACTERIOL, V170, P5364, DOI 10.1128/jb.170.11.5364-5367.1988; ANKENBAUER RG, 1988, J BACTERIOL, V170, P5344, DOI 10.1128/jb.170.11.5344-5351.1988; BARTLETT PA, 1988, J ORG CHEM, V53, P3195, DOI 10.1021/jo00249a013; BARTLETT PA, 1985, J AM CHEM SOC, V107, P7792, DOI 10.1021/ja00311a111; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALHOUN DH, 2001, GENOME BIOL, V2; Chin-A-Woeng TFC, 2001, MOL PLANT MICROBE IN, V14, P1006, DOI 10.1094/MPMI.2001.14.8.1006; COTTON RGH, 1965, BIOCHIM BIOPHYS ACTA, V100, P76, DOI 10.1016/0304-4165(65)90429-0; COX CD, 1981, P NATL ACAD SCI-BIOL, V78, P4256, DOI 10.1073/pnas.78.7.4256; Dahm C, 1998, BBA-GEN SUBJECTS, V1425, P377, DOI 10.1016/S0304-4165(98)00089-0; Daruwala R, 1997, J BACTERIOL, V179, P3133, DOI 10.1128/jb.179.10.3133-3138.1997; DELSAL G, 1988, NUCLEIC ACIDS RES, V16, P9878; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; FARINHA MA, 1990, FEMS MICROBIOL LETT, V70, P221, DOI 10.1016/S0378-1097(05)80043-6; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Gehring AM, 1998, CHEM BIOL, V5, P573, DOI 10.1016/S1074-5521(98)90115-6; GIBSON F, 1964, BIOCHEM J, V90, P256, DOI 10.1042/bj0900256; GORISCH H, 1978, BIOCHEMISTRY-US, V17, P3700, DOI 10.1021/bi00611a004; Grisostomi C, 1997, BIOORG CHEM, V25, P297, DOI 10.1006/bioo.1997.1073; Gu W, 1997, Microb Comp Genomics, V2, P141, DOI 10.1089/omi.1.1997.2.141; HEIDE E, 1978, BIOCHEMISTRY-US, V17, P1573; HUDSON A T, 1970, Tetrahedron Letters, V24, P2077; HUDSON AT, 1970, BIOCHEMISTRY-US, V9, P3984, DOI 10.1021/bi00822a017; Kast P, 1996, TETRAHEDRON LETT, V37, P2691, DOI 10.1016/0040-4039(96)00338-3; Kast P, 1996, P NATL ACAD SCI USA, V93, P5043, DOI 10.1073/pnas.93.10.5043; Kwon O, 1996, J BACTERIOL, V178, P3252, DOI 10.1128/jb.178.11.3252-3259.1996; LAMMELI UK, 1973, J MOL BIOL, V80, P575; LEE AY, 1995, J AM CHEM SOC, V117, P3627, DOI 10.1021/ja00117a038; MacBeath G, 1998, BIOCHEMISTRY-US, V37, P10062, DOI 10.1021/bi980449t; MARSHALL BJ, 1971, BIOCHIM BIOPHYS ACTA, V230, P643, DOI 10.1016/0304-4165(71)90201-7; MARSHALL BJ, 1972, BIOCHIM BIOPHYS ACTA, V264, P106, DOI 10.1016/0304-4165(72)90122-5; Mattei P, 1999, EUR J BIOCHEM, V261, P25, DOI 10.1046/j.1432-1327.1999.00169.x; Mercado-Blanco J, 2001, J BACTERIOL, V183, P1909, DOI 10.1128/JB.183.6.1909-1920.2001; OKUJO N, 1994, BIOMETALS, V7, P109; PATEL N, 1977, J BIOL CHEM, V252, P5839; Quadri LEN, 1999, BIOCHEMISTRY-US, V38, P14941, DOI 10.1021/bi991787c; Reimmann C, 1998, MICROBIOL-UK, V144, P3135, DOI 10.1099/00221287-144-11-3135; Reimmann C, 2001, J BACTERIOL, V183, P813, DOI 10.1128/JB.183.3.813-820.2001; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; Rowland BM, 1996, J BACTERIOL, V178, P854, DOI 10.1128/jb.178.3.854-861.1996; RUSNAK F, 1990, BIOCHEMISTRY-US, V29, P1425, DOI 10.1021/bi00458a013; Sambrook J., 2002, MOL CLONING LAB MANU; SAXENA B, 1986, J GEN MICROBIOL, V132, P2219; SCHMIDT K, 1995, BIOTECHNOL BIOENG, V45, P285, DOI 10.1002/bit.260450402; SERINO L, 1995, MOL GEN GENET, V249, P217, DOI 10.1007/BF00290369; Serino L, 1997, J BACTERIOL, V179, P248, DOI 10.1128/jb.179.1.248-257.1997; SOKOL PA, 1992, J MED MICROBIOL, V36, P184, DOI 10.1099/00222615-36-3-184; TIETZ D, 1987, ANAL BIOCHEM, V161, P395, DOI 10.1016/0003-2697(87)90468-4; van Tegelen LJP, 1999, PLANT PHYSIOL, V119, P705, DOI 10.1104/pp.119.2.705; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; WALSH CT, 1990, CHEM REV, V90, P1105, DOI 10.1021/cr00105a003; XIA TH, 1993, J BACTERIOL, V175, P4729, DOI 10.1128/JB.175.15.4729-4737.1993; YOUNG IG, 1969, BIOCHIM BIOPHYS ACTA, V177, P389, DOI 10.1016/0304-4165(69)90301-8; ZHAO GS, 1992, J BIOL CHEM, V267, P2487	56	96	103	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21768	21775		10.1074/jbc.M202410200	http://dx.doi.org/10.1074/jbc.M202410200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11937513	hybrid			2022-12-27	WOS:000176286000085
J	Hahn, JS; Thiele, DJ				Hahn, JS; Thiele, DJ			Regulation of the Saccharomyces cerevisiae Slt2 kinase pathway by the stress-inducible Sdp1 dual specificity phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; CELL-WALL INTEGRITY; FUS3 MAP KINASE; TYROSINE PHOSPHATASES; DIFFERENTIAL REGULATION; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; OSMOTIC-STRESS; YEAST; HOG1	The Slt2/Mpk1 mitogen-activated protein kinase (MAPK) cell integrity pathway is involved in maintenance of cell shape and integrity during vegetative growth and mating in Saccharomyces cerevisiae. Slt2 is activated by dual phosphorylation of a threonine and tyrosine residue in response to several environmental stresses that perturb cell integrity. Negative regulation of Slt2 is achieved via dephosphorylation by two protein-tyrosine phosphatases, Ptp2 and Ptp3, and a dual specificity phosphatase, Msg5. In this study, we provide genetic and biochemical evidence that the stress-inducible dual specificity phosphatase, Sdp1, negatively regulates Slt2 by direct dephosphorylation. Deletion of SDP1 exacerbated growth defects due to overexpression of Mkk1(p386), a constitutively active mutant of Slt2 MAPK kinase, whereas overexpression of Sdp1 suppressed lethality caused by Mkk1(p386). overexpression. The heat shock-induced phosphorylation level of Slt2 was elevated in an sdp1Delta strain compared with that of the wild type, and heat shock-activated phospho-Slt2 was dephosphorylated by recombinant Sdp1 in vitro. Under normal growth conditions, an Sdp1-GFP fusion protein was localized to both the nucleus and cytoplasm. However, the Sdp1-GFP protein translocated to punctate spots throughout the cell after heat shock. SDP1 transcription was induced by several stress conditions in an Msn2/4-dependent manner but independent of the Rlm1 transcription factor, a downstream target activated by Slt2. Induction of SLT2 by high osmolarity was dependent on Rlm1 transcription factor and Hog1 kinase, suggesting cross-talk between Slt2 and Hog1 MAPK pathways. These studies demonstrate regulation of Slt2 activity and gene expression in coordination with other stress signaling pathways.	Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Thiele, DJ (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 1301 Catherine Rd, Ann Arbor, MI 48109 USA.		Rho, Hyunji/R-6242-2016	Rho, Hyunji/0000-0001-7650-8933	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059911] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM59911] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Davenport KD, 1999, GENETICS, V153, P1091; DAVENPORT KR, 1995, J BIOL CHEM, V270, P30157; DOI K, 1994, EMBO J, V13, P61, DOI 10.1002/j.1460-2075.1994.tb06235.x; ESTRUCH F, 1993, MOL CELL BIOL, V13, P3872, DOI 10.1128/MCB.13.7.3872; Fox D, 1999, MOL MICROBIOL, V34, P451, DOI 10.1046/j.1365-2958.1999.01606.x; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Harrison JC, 2001, NAT CELL BIOL, V3, P417, DOI 10.1038/35070104; Heinisch JJ, 1999, MOL MICROBIOL, V32, P671, DOI 10.1046/j.1365-2958.1999.01375.x; HUANG KN, 1995, GENETICS, V141, P1275; Igual JC, 1996, EMBO J, V15, P5001, DOI 10.1002/j.1460-2075.1996.tb00880.x; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jacoby T, 1997, J BIOL CHEM, V272, P17749, DOI 10.1074/jbc.272.28.17749; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; Ketela T, 1999, J BACTERIOL, V181, P3330, DOI 10.1128/JB.181.11.3330-3340.1999; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; KOCH C, 1994, CURR OPIN CELL BIOL, V6, P451, DOI 10.1016/0955-0674(94)90039-6; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Madden K, 1997, SCIENCE, V275, P1781, DOI 10.1126/science.275.5307.1781; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; MARTIN H, 1993, MOL GEN GENET, V241, P177, DOI 10.1007/BF00280215; Mattison CP, 1999, MOL CELL BIOL, V19, P7651; Mattison CP, 2000, GENE DEV, V14, P1229; Moskvina E, 1998, YEAST, V14, P1041, DOI 10.1002/(SICI)1097-0061(199808)14:11<1041::AID-YEA296>3.0.CO;2-4; Philip B, 2001, MOL CELL BIOL, V21, P271, DOI 10.1128/MCB.21.1.271-280.2001; Rajavel M, 1999, MOL CELL BIOL, V19, P3969; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Verna J, 1997, P NATL ACAD SCI USA, V94, P13804, DOI 10.1073/pnas.94.25.13804; Warmka J, 2001, MOL CELL BIOL, V21, P51, DOI 10.1128/MCB.21.1.51-60.2001; WATANABE Y, 1995, MOL CELL BIOL, V15, P5740; Watanabe Y, 1997, MOL CELL BIOL, V17, P2615, DOI 10.1128/MCB.17.5.2615; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; YASHAR B, 1995, MOL CELL BIOL, V15, P6545; Zarzov P, 1996, EMBO J, V15, P83, DOI 10.1002/j.1460-2075.1996.tb00336.x; Zhan XL, 1997, GENE DEV, V11, P1690, DOI 10.1101/gad.11.13.1690; Zhan XL, 1999, GENE DEV, V13, P2811, DOI 10.1101/gad.13.21.2811	41	95	97	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21278	21284		10.1074/jbc.M202557200	http://dx.doi.org/10.1074/jbc.M202557200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11923319	hybrid			2022-12-27	WOS:000176286000022
J	Zheng, XM; Resnick, RJ; Shalloway, D				Zheng, XM; Resnick, RJ; Shalloway, D			Mitotic activation of protein-tyrosine phosphatase alpha and regulation of its Src-mediated transforming activity by its sites of protein kinase C phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PTP-ALPHA; RPTP-ALPHA; PP60(C-SRC); ASSOCIATION; PP60C-SRC; ADAPTER; GRB2; OVEREXPRESSION; FAMILY; DOMAIN	During mitosis, the catalytic activity of protein-tyrosine phosphatase (PTP) alpha is enhanced, and its inhibitory binding to Grb2, which specifically blocks Src dephosphorylation, is decreased. These effects act synergistically to activate Src in mitosis. We show here that these effects are abrogated by mutation of Ser(180) and/or Ser(204), the sites of protein kinase C-mediated phosphorylation within PTPalpha. Moreover, either a Ser-to-Ala substitution or serine dephosphorylation specifically eliminated the ability of PTPalpha to dephosphorylate and activate Src even during interphase. This explains why the substitutions eliminated PTPalpha transforming activity, even though PTPalpha interphase dephosphorylation of nonspecific substrates was only slightly decreased. This occurred without change in the phosphorylation of PTPalpha at Tyr(789), which is required for "phosphotyrosine displacement" during Src dephosphorylation. Thus, in addition to increasing PTPalpha nonspecific catalytic activity, Ser(180) and Ser(204) phosphorylation (along with Tyr(789) phosphorylation) regulates PTPalpha substrate specificity. This involves serine phosphorylation-dependent differential modulation of the affinity of Tyr(P)(789) for the Src and Grb2 SH2 domains. The results suggest that protein kinase C may participate in the mitotic activation of PTPalpha and Src and that there are intramolecular interactions between the PTPalpha C-terminal and membrane-proximal regions that are regulated, at least in part, by serine phosphorylation.	Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Shalloway, D (corresponding author), Cornell Univ, Dept Mol Biol & Genet, 265 Biotechnol Bldg, Ithaca, NY 14883 USA.	dis2@cornell.edu			NATIONAL CANCER INSTITUTE [R01CA032317] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA032317, CA32317] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arnott CH, 1999, J BIOL CHEM, V274, P26105, DOI 10.1074/jbc.274.37.26105; BAGRODIA S, 1993, MOL CELL BIOL, V13, P1464, DOI 10.1128/MCB.13.3.1464; BAGRODIA S, 1991, NATURE, V349, P172, DOI 10.1038/349172a0; BLACK JD, 2001, FRONT BIOSCI, V5, P406; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; CHACKALAPARAMPIL I, 1988, CELL, V52, P801, DOI 10.1016/0092-8674(88)90422-9; DENHERTOG J, 1994, EMBO J, V13, P3020, DOI 10.1002/j.1460-2075.1994.tb06601.x; DENHERTOG J, 1993, EMBO J, V12, P3789, DOI 10.1002/j.1460-2075.1993.tb06057.x; DENHERTOG J, 1995, CELL GROWTH DIFFER, V6, P303; denHertog J, 1996, EMBO J, V15, P3016, DOI 10.1002/j.1460-2075.1996.tb00665.x; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; GILMER T, 1994, J BIOL CHEM, V269, P31711; HARDIE G, 1995, PROTEIN KINASE FACTS, P240; KAECH S, 1991, NATURE, V350, P431, DOI 10.1038/350431a0; KAPLAN R, 1990, P NATL ACAD SCI USA, V87, P7000, DOI 10.1073/pnas.87.18.7000; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; KRUEGER NX, 1990, EMBO J, V9, P3241, DOI 10.1002/j.1460-2075.1990.tb07523.x; Livneh E, 1997, EUR J BIOCHEM, V248, P1, DOI 10.1111/j.1432-1033.1997.t01-4-00001.x; Ogura K, 1999, J MOL BIOL, V289, P439, DOI 10.1006/jmbi.1999.2792; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Petrone A, 2000, J CELL SCI, V113, P2345; Ponniah S, 1999, CURR BIOL, V9, P535, DOI 10.1016/S0960-9822(99)80238-3; Rahuel J, 1996, NAT STRUCT BIOL, V3, P586, DOI 10.1038/nsb0796-586; Shalloway D, 1997, TRENDS CELL BIOL, V7, P215; SHALLOWAY D, 1984, P NATL ACAD SCI-BIOL, V81, P7071, DOI 10.1073/pnas.81.22.7071; SHENOY S, 1992, P NATL ACAD SCI USA, V89, P7237, DOI 10.1073/pnas.89.15.7237; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; Stetak A, 2001, BIOCHEM BIOPH RES CO, V285, P483, DOI 10.1006/bbrc.2001.5199; Stetak A, 2001, BIOCHEM BIOPH RES CO, V288, P564, DOI 10.1006/bbrc.2001.5811; STOVER DR, 1994, J BIOL CHEM, V269, P26885; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; SU J, 1994, J BIOL CHEM, V269, P18731; Taylor SJ, 1996, BIOESSAYS, V18, P9, DOI 10.1002/bies.950180105; TRACY S, 1995, J BIOL CHEM, V270, P10587, DOI 10.1074/jbc.270.18.10587; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964; Zheng XM, 2001, EMBO J, V20, P6037, DOI 10.1093/emboj/20.21.6037; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	40	57	61	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2002	277	24					21922	21929		10.1074/jbc.M201394200	http://dx.doi.org/10.1074/jbc.M201394200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	563YR	11923305	Green Accepted, hybrid			2022-12-27	WOS:000176286000104
J	Chiba, H; Pattanajitvilai, S; Evans, AJ; Harbeck, RJ; Voelker, DR				Chiba, H; Pattanajitvilai, S; Evans, AJ; Harbeck, RJ; Voelker, DR			Human surfactant protein D (SP-D) binds Mycoplasma pneumoniae by high affinity interactions with lipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPERGILLUS-FUMIGATUS CONIDIA; BRONCHOALVEOLAR LAVAGE; ENHANCES PHAGOCYTOSIS; ALVEOLAR MACROPHAGES; RAT; PHOSPHATIDYLINOSITOL; LIPOPOLYSACCHARIDES; GLUCOSYLCERAMIDE; SPECIFICITY; MECHANISMS	Increasing evidence now identifies surfactant protein D (SP-D) as an important element of the innate immune system of the lung. In this study, we examined the interactions of rat and human SP-D with the human pathogen, Mycoplasma pneumoniae. Rat and human SP-D bound the organism with high affinity in a reaction that required Ca2+ and was inhibited by EGTA. Membranes derived from the organism bound the proteins in a similar manner, except the rat SP-D also exhibited a significant level of Ca2+-independent binding. Pretreatment of membranes with proteases did not alter the Ca2+-dependent SP-D binding of membranes by either protein. Mannose, glucose, maltose, and inositol, at millimolar concentrations, competed for human SP-D binding to the bacterial membrane. Lipids extracted from membranes and separated by two-dimensional thin layer chromatography bound human SP-D with high affinity in a Ca2+-dependent reaction. A tandem mutant of SP-D with E321Q and N323D substitutions, failed to bind M. pneumoniae lipids, directly implicating the carbohydrate recognition domain in the interaction. The interaction of rat and human SP-D with M. pneumoniae was unaffected by the presence of surfactant lipids and the hydrophobic surfactant proteins. These findings demonstrate that M. pneumoniae is likely to be recognized by SP-D in the alveolar environment and that primary determinants recognized on the organism are lipid components of the cell membrane.	Natl Jewish Med & Res Ctr, Dept Med, Cell Biol Program, Denver, CO 80206 USA	National Jewish Health	Voelker, DR (corresponding author), Natl Jewish Med & Res Ctr, Dept Med, Cell Biol Program, 1400 Jackson St, Denver, CO 80206 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045286] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 45286] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allen MJ, 1999, INFECT IMMUN, V67, P4563, DOI 10.1128/IAI.67.9.4563-4569.1999; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CROUCH E, 1994, J BIOL CHEM, V269, P17311; Crouch E, 2001, ANNU REV PHYSIOL, V63, P521, DOI 10.1146/annurev.physiol.63.1.521; DAY AJ, 1994, BIOCHEM SOC T, V22, P83, DOI 10.1042/bst0220083; Eda S, 1997, BIOCHEM J, V323, P393, DOI 10.1042/bj3230393; GIL JC, 1993, ANN ALLERGY, V70, P23; Hartshorn KL, 1998, AM J PHYSIOL-LUNG C, V274, pL958, DOI 10.1152/ajplung.1998.274.6.L958; HARTSHORN KL, 1994, J CLIN INVEST, V94, P311, DOI 10.1172/JCI117323; HAWGOOD S, 1985, BIOCHEMISTRY-US, V24, P184, DOI 10.1021/bi00322a026; Hickman-Davis JM, 1998, AM J PHYSIOL-LUNG C, V274, pL270, DOI 10.1152/ajplung.1998.274.2.L270; HONDA Y, 1995, AM J RESP CRIT CARE, V152, P1860, DOI 10.1164/ajrccm.152.6.8520747; KING RJ, 1973, AM J PHYSIOL, V224, P788, DOI 10.1152/ajplegacy.1973.224.4.788; Kraft M, 1998, AM J RESP CRIT CARE, V158, P998, DOI 10.1164/ajrccm.158.3.9711092; Krause Duncan C., 1992, P417; KUAN SF, 1992, J CLIN INVEST, V90, P97, DOI 10.1172/JCI115861; KUROKI Y, 1988, J BIOL CHEM, V263, P3388; KUROKI Y, 1994, J BIOL CHEM, V269, P25943; KUROKI Y, 1992, BIOCHEM BIOPH RES CO, V187, P963, DOI 10.1016/0006-291X(92)91291-W; LAINE RA, 1974, METHODS MEMBRANE BIO, P205; Madan T, 1997, INFECT IMMUN, V65, P3171, DOI 10.1128/IAI.65.8.3171-3179.1997; McIntosh JC, 1996, AM J PHYSIOL-LUNG C, V271, pL310, DOI 10.1152/ajplung.1996.271.2.L310; MELBYE H, 1994, EUR RESPIR J, V7, P1239, DOI 10.1183/09031936.94.07071239; Ofek I, 2001, INFECT IMMUN, V69, P24, DOI 10.1128/IAI.69.1.24-33.2001; OGASAWARA Y, 1995, J BIOL CHEM, V270, P14725, DOI 10.1074/jbc.270.24.14725; OGASAWARA Y, 1992, J BIOL CHEM, V267, P21244; OGASAWARA Y, 1995, J BIOL CHEM, V270, P19052, DOI 10.1074/jbc.270.32.19052; ORIORDAN DM, 1995, J CLIN INVEST, V95, P2699, DOI 10.1172/JCI117972; PERSSON A, 1990, J BIOL CHEM, V265, P5755; PERSSON AV, 1992, BIOCHEMISTRY-US, V31, P12183, DOI 10.1021/bi00163a030; PLACKETT P, 1969, AUST J EXP BIOL MED, V47, P171, DOI 10.1038/icb.1969.19; POLLACK J D, 1973, Journal of Infectious Diseases, V127, pS32; Restrepo CI, 1999, AM J RESP CELL MOL, V21, P576, DOI 10.1165/ajrcmb.21.5.3334; ROTTEM S, 1980, BIOCHIM BIOPHYS ACTA, V604, P65, DOI 10.1016/0005-2736(80)90585-4; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Sano H, 1999, J IMMUNOL, V163, P387; Sano H, 2000, J BIOL CHEM, V275, P22442, DOI 10.1074/jbc.M001107200; SCHELENZ S, 1995, INFECT IMMUN, V63, P3360, DOI 10.1128/IAI.63.9.3360-3366.1995; SHIMIZU H, 1992, J BIOL CHEM, V267, P1853; van Rozendaal BAWM, 2000, J INFECT DIS, V182, P917, DOI 10.1086/315799	40	39	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20379	20385		10.1074/jbc.M201089200	http://dx.doi.org/10.1074/jbc.M201089200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11916969	hybrid			2022-12-27	WOS:000176204500037
J	Nisole, S; Said, EA; Mische, C; Prevost, MC; Krust, B; Bouvet, P; Bianco, A; Briand, JP; Hovanessian, AG				Nisole, S; Said, EA; Mische, C; Prevost, MC; Krust, B; Bouvet, P; Bianco, A; Briand, JP; Hovanessian, AG			The Anti-HIV pentameric pseudopeptide HB-19 binds the C-terminal end of nucleolin and prevents anchorage of virus particles in the plasma membrane of target cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION-PI INTERACTIONS; SURFACE-EXPRESSED NUCLEOLIN; V3 LOOP; GLYCINE-RICH; PROTEIN; INHIBITION; DOMAIN; ENTRY; GP120; ATTACHMENT	The multivalent pseudopeptide HB-19 that binds the cell-surface-expressed nucleolin is a potent inhibitor of human immunodeficiency virus (HIV) infection by blocking virus particle attachment and thus anchorage in the plasma membrane. We show that cross-linking of surface-bound HB-19A (like HB-19 but with a modified template) results in aggregation of HB-19A with surface nucleolin. Consistent with its specific action, HB-19A binding to different types of cells reaches saturation at concentrations that have been reported to result in inhibition of HrV infection. By using Chinese hamster ovary mutant cell lines, we confirm that the binding of IFM-19A to surface nucleolin is independent of heparan and chondroitin sulfate proteoglyeans. In vitro generated full-length nucleolin was found to bind HB-19A, whereas the N-terminal part containing the acidic amino acid stretches of nucleolin did not. The use of various deletion constructs of the C-terminal part of nucleolin then permitted the identification of the extreme C-terminal end of nucleolin, containing repeats of the amino acid motif, RGG, as the domain that binds HB-19A. Finally, a synthetic peptide corresponding to the last C-terminal 63 amino acids was able to inhibit HIV infection at the stage of HIV attachment to cells, thus suggesting that this domain could be functional in the HIV anchorage process.	Inst Pasteur, URA 1930 CNRS, Unite Virol & Immunol Cellulaire, F-75724 Paris 15, France; Ecole Normale Super Lyon, CNRS UMR 5665, F-69007 Lyon, France; Inst Biol Mol & Cellulaire, UPR 9021 CNRS, F-67084 Strasbourg, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS)	Hovanessian, AG (corresponding author), Inst Pasteur, URA 1930 CNRS, Unite Virol & Immunol Cellulaire, 28 Rue Dr Roux, F-75724 Paris 15, France.	arahovan@pasteur.fr	, Bouvet/AAC-8779-2020; Nisole, Sébastien/ABA-2367-2021; Said, Elias/AAY-5557-2020	Nisole, Sébastien/0000-0001-9793-419X; Said, Elias/0000-0003-4224-6351; Bouvet, Philippe/0000-0003-4524-2233				Bouvet P, 1998, J BIOL CHEM, V273, P19025, DOI 10.1074/jbc.273.30.19025; Callebaut C, 1996, VIROLOGY, V218, P181, DOI 10.1006/viro.1996.0178; Callebaut C, 1998, J BIOL CHEM, V273, P21988, DOI 10.1074/jbc.273.34.21988; Callebaut C, 2001, VIROLOGY, V281, P248, DOI 10.1006/viro.2000.0767; Callebaut C, 1997, J BIOL CHEM, V272, P7159, DOI 10.1074/jbc.272.11.7159; CALLEBAUT C, 2001, J BIOL CHEM, V281, P248; Cartegni L, 1996, J MOL BIOL, V259, P337, DOI 10.1006/jmbi.1996.0324; DEJONG JJ, 1992, J VIROL, V66, P6777, DOI 10.1128/JVI.66.11.6777-6780.1992; Deng JS, 1996, MOL BIOL REP, V23, P191, DOI 10.1007/BF00351168; DEVERDUGO UR, 1995, J VIROL, V69, P6751, DOI 10.1128/JVI.69.11.6751-6757.1995; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Dumler I, 1999, CURR BIOL, V9, P1468, DOI 10.1016/S0960-9822(00)80116-5; ESKO JD, 1987, J BIOL CHEM, V262, P12189; ESKO JD, 1988, SCIENCE, V241, P1092, DOI 10.1126/science.3137658; FANG SH, 1993, EXP CELL RES, V208, P48, DOI 10.1006/excr.1993.1221; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; GHISOLFI L, 1992, J BIOL CHEM, V267, P2955; Ginisty H, 1999, J CELL SCI, V112, P761; Hanakahi LA, 1997, P NATL ACAD SCI USA, V94, P3605, DOI 10.1073/pnas.94.8.3605; Hanakahi LA, 2000, BIOCHEMISTRY-US, V39, P15493, DOI 10.1021/bi001683y; Hanakahi LA, 1999, J BIOL CHEM, V274, P15908, DOI 10.1074/jbc.274.22.15908; Hovanessian AG, 2000, EXP CELL RES, V261, P312, DOI 10.1006/excr.2000.5071; KLEINMAN HK, 1991, ARCH BIOCHEM BIOPHYS, V290, P320, DOI 10.1016/0003-9861(91)90547-V; KRANTZ S, 1995, BBA-MOL CELL RES, V1266, P109, DOI 10.1016/0167-4889(95)00028-Q; Krust B, 2001, P NATL ACAD SCI USA, V98, P14090, DOI 10.1073/pnas.221467298; KRUST B, 1993, AIDS RES HUM RETROV, V9, P1087, DOI 10.1089/aid.1993.9.1087; LAPEYRE B, 1986, J BIOL CHEM, V261, P9167; Larrucea S, 1999, BIOCHEM BIOPH RES CO, V266, P51, DOI 10.1006/bbrc.1999.1766; Limal D, 1998, J PEPT RES, V52, P121; LISCHWE MA, 1985, BIOCHEMISTRY-US, V24, P6025, DOI 10.1021/bi00343a001; Marechal V, 1998, J VIROL, V72, P2208; Mecozzi S, 1996, P NATL ACAD SCI USA, V93, P10566, DOI 10.1073/pnas.93.20.10566; Mondor I, 1998, J VIROL, V72, P3623, DOI 10.1128/JVI.72.5.3623-3634.1998; Moulard M, 2000, J VIROL, V74, P1948, DOI 10.1128/JVI.74.4.1948-1960.2000; Murakami T, 1997, J EXP MED, V186, P1389, DOI 10.1084/jem.186.8.1389; Nisole S, 1999, J BIOL CHEM, V274, P27875, DOI 10.1074/jbc.274.39.27875; Nisole S, 2000, AIDS RES HUM RETROV, V16, P237, DOI 10.1089/088922200309331; NISOLE S, 2002, IN PRESS EXP CELL RE; Pletneva EV, 2001, J AM CHEM SOC, V123, P6232, DOI 10.1021/ja010401u; RODERIQUEZ G, 1995, J VIROL, V69, P2233, DOI 10.1128/JVI.69.4.2233-2239.1995; Saphire ACS, 1999, EMBO J, V18, P6771, DOI 10.1093/emboj/18.23.6771; SCHNEIDER J, 1986, J GEN VIROL, V67, P2533, DOI 10.1099/0022-1317-67-11-2533; Seddiki N, 1999, AIDS RES HUM RETROV, V15, P381, DOI 10.1089/088922299311358; SEMENKOVICH CF, 1990, BIOCHEMISTRY-US, V29, P9708, DOI 10.1021/bi00493a028; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; SRIVASTAVA M, 1989, FEBS LETT, V250, P99, DOI 10.1016/0014-5793(89)80692-1; Stauber RH, 1999, BIOCHEM BIOPH RES CO, V258, P695, DOI 10.1006/bbrc.1999.0511; Tamamura H, 1998, BIOORGAN MED CHEM, V6, P473, DOI 10.1016/S0968-0896(97)10055-4; Ugolini S, 1999, TRENDS MICROBIOL, V7, P144, DOI 10.1016/S0966-842X(99)01474-2; Valenzuela A, 1997, J VIROL, V71, P8289, DOI 10.1128/JVI.71.11.8289-8298.1997; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	53	74	78	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20877	20886		10.1074/jbc.M110024200	http://dx.doi.org/10.1074/jbc.M110024200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11919179	hybrid, Green Published			2022-12-27	WOS:000176204500100
J	Ponimaskin, EG; Profirovic, J; Vaiskunaite, R; Richter, DW; Voyno-Yasenetskaya, TA				Ponimaskin, EG; Profirovic, J; Vaiskunaite, R; Richter, DW; Voyno-Yasenetskaya, TA			5-hydroxytryptamine 4(a) receptor is coupled to the G alpha subunit of heterotrimeric G(13) protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-FAMILY GTPASES; LYSOPHOSPHATIDIC ACID; NEURITE OUTGROWTH; THALAMIC NEURONS; P115 RHOGEF; SF9 CELLS; SEROTONIN; ACTIVATION; GROWTH; BINDING	Serotonin (5-hydroxytryptamine (5-HT)) is an important neurotransmitter that regulates multiple events in the central nervous system. Many of the 5-HT functions are mediated via G protein-coupled receptors that are coupled to multiple heterotrimeric G proteins, including G(s), G(j), and G(q) subfamilies (Martin, G. R., Eglen, R. M., Hamblin, M. W.,Hoyer, D., and Yocca, F. (1998) Trends Pharmacol, Sci 19, 2-4). Here we show for the first time that the 5-hydroxytryptamine 4(a) receptor (5-HT4(a)) is coupled not only to heterotrimeric G(s) but also to G(13) protein, as assessed both by biochemical and functional assays. Using reconstitution of 5-HT4(a) receptor with different G proteins in Spodoptera frugiperda (Sf.9) cells, we have proved that agonist stimulation of receptor-induced guanosine 5'-(3-O-thio)triphosphate binding to Galpha(13) protein. We then determined that expression of 5-HT4(a) receptor in mammalian cells induced constitutive- as well as agonist-promoted activation of a transcription factor, serum response element, through the activation of Gals and RhoA. Finally, we have determined that expression of 5-HT4(a) receptor in neuroblastoma x glioma NIE-115 cells cause RhoA-dependent neurite retraction and cell rounding under basal conditions and after agonist stimulation. These data suggest that by activating 5-HT4(a) receptor-G(13) pathway, serotonin plays a prominent role in regulating neuronal architecture in addition to its classical role in neurotransmission.	Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; Univ Gottingen, Inst Physiol, Abt Neuro & Sinnesphysiol, D-37073 Gottingen, Germany	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Gottingen	Voyno-Yasenetskaya, TA (corresponding author), Univ Illinois, Dept Pharmacol, MC 868,835 S Wolcott Ave, Chicago, IL 60612 USA.	tvy@uic.edu		Ponimaskin, evgeni/0000-0002-4570-5130	NIGMS NIH HHS [GM56159] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM056159, R01GM056159] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aktories K, 2000, BIOL CHEM, V381, P421, DOI 10.1515/BC.2000.054; BAKER MW, 1993, BRAIN RES, V623, P311, DOI 10.1016/0006-8993(93)91444-W; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Barr AJ, 1997, J BIOL CHEM, V272, P2223; BONHOMME N, 1995, BRAIN RES, V675, P215, DOI 10.1016/0006-8993(95)00067-Z; Claeysen S, 1996, FEBS LETT, V398, P19, DOI 10.1016/S0014-5793(96)01132-5; Claeysen S, 1999, MOL PHARMACOL, V55, P910; DIEFENBACH TJ, 1995, DEV BIOL, V167, P282, DOI 10.1006/dbio.1995.1023; EGLEN RM, 1995, TRENDS PHARMACOL SCI, V16, P391, DOI 10.1016/S0165-6147(00)89081-1; Fromm C, 1997, P NATL ACAD SCI USA, V94, P10098, DOI 10.1073/pnas.94.19.10098; GOLDBERG JI, 1991, J NEUROBIOL, V22, P182, DOI 10.1002/neu.480220208; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; HAYDON PG, 1984, SCIENCE, V226, P561, DOI 10.1126/science.6093252; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; IGARASHI M, 1995, J NEUROSCI, V15, P5660; Katoh H, 1998, J BIOL CHEM, V273, P28700, DOI 10.1074/jbc.273.44.28700; Koert CE, 2001, J NEUROSCI, V21, P5597, DOI 10.1523/JNEUROSCI.21-15-05597.2001; Kostner E., 1995, Society for Neuroscience Abstracts, V21, P862; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Kranenburg O, 1997, J CELL SCI, V110, P2417; Kranenburg O, 1999, MOL BIOL CELL, V10, P1851, DOI 10.1091/mbc.10.6.1851; Lieske V, 1999, NEUROSCIENCE, V90, P967, DOI 10.1016/S0306-4522(98)00501-6; LIMA L, 1994, J NEUROSCI RES, V38, P444, DOI 10.1002/jnr.490380410; LIU JP, 1991, DEV BRAIN RES, V62, P297, DOI 10.1016/0165-3806(91)90180-Q; Lotto B, 1999, NEUROSCI LETT, V269, P87, DOI 10.1016/S0304-3940(99)00422-X; Mao JH, 1998, J BIOL CHEM, V273, P27118, DOI 10.1074/jbc.273.42.27118; MarchettiGauthier E, 1997, NEUROPHARMACOLOGY, V36, P697, DOI 10.1016/S0028-3908(97)00058-0; Mercer AR, 1996, J NEUROBIOL, V29, P49, DOI 10.1002/(SICI)1097-4695(199601)29:1<49::AID-NEU4>3.0.CO;2-7; Moolenaar WH, 1997, CURR OPIN CELL BIOL, V9, P168, DOI 10.1016/S0955-0674(97)80059-2; NIU J, 2001, CURR BIOL, V11, P1; Pauwels PJ, 1996, N-S ARCH PHARMACOL, V354, P136; Ponimaskin E, 1998, FEBS LETT, V429, P370, DOI 10.1016/S0014-5793(98)00638-3; Ponimaskin E, 2000, FEBS LETT, V478, P173, DOI 10.1016/S0014-5793(00)01845-7; Ponimaskin EG, 2002, J BIOL CHEM, V277, P2534, DOI 10.1074/jbc.M106529200; Ponimaskin EG, 2001, BIOCHEM J, V353, P627, DOI 10.1042/0264-6021:3530627; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Scott JD, 2000, ADV PHARMACOL, V47, P175; Shepard LW, 2001, J BIOL CHEM, V276, P45979, DOI 10.1074/jbc.M104783200; TAKAGI Y, 1995, J BIOL CHEM, V270, P10072, DOI 10.1074/jbc.270.17.10072; Tigyi G, 1996, J NEUROCHEM, V66, P549; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Vaiskunaite R, 2000, J BIOL CHEM, V275, P26206, DOI 10.1074/jbc.M001863200; VEIT M, 1994, FEBS LETT, V339, P160, DOI 10.1016/0014-5793(94)80406-0; VOGELSANG M, 1994, J CARDIOVASC PHARM, V23, P344, DOI 10.1097/00005344-199402000-00025; VOYNOYASENETSKAYA T, 1994, J BIOL CHEM, V269, P4721; Wong EHF, 1996, BEHAV BRAIN RES, V73, P249; WONG YH, 1991, NATURE, V351, P63, DOI 10.1038/351063a0; Wu-Wong JR, 1998, J CARDIOVASC PHARM, V31, pS185, DOI 10.1097/00005344-199800001-00053; Yan YB, 1997, J BIOL CHEM, V272, P11924, DOI 10.1074/jbc.272.18.11924; Zhong HL, 2001, J PHARMACOL EXP THER, V297, P837	53	67	71	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20812	20819		10.1074/jbc.M112216200	http://dx.doi.org/10.1074/jbc.M112216200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11923294	hybrid			2022-12-27	WOS:000176204500091
J	Zhang, HJ; Zhao, WL; Venkataraman, S; Robbins, MEC; Buettner, GR; Kregel, KC; Oberley, LW				Zhang, HJ; Zhao, WL; Venkataraman, S; Robbins, MEC; Buettner, GR; Kregel, KC; Oberley, LW			Activation of matrix metalloproteinase-2 by overexpression of manganese superoxide dismutase in human breast cancer MCF-7 cells involves reactive oxygen species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSERVED PEPTIDE SEQUENCE; GLUTATHIONE-PEROXIDASE; HYDROGEN-PEROXIDE; CYSTEINE-SWITCH; CU,ZN-SUPEROXIDE DISMUTASE; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; IV COLLAGENASE; GLIOMA-CELLS	Matrix metalloproteinases (MMPs) participate in cell migration and remodeling processes by affecting the extracellular matrix. MMP-2 is thought to be involved in cancer cell invasiveness. It has been proposed that the activity of MMP-2 can be modulated by intracellular reactive oxygen species (ROS)/reactive nitrogen species. We hypothesized that manganese superoxide dismutase (MnSOD) could mediate MMP-2 activity by changing the intracellular ROS level and that nitric oxide (NO) may be involved in this process. Human breast cancer MCF-7 cells were stably transfected with plasmids containing MnSOD cDNA. A 2-30-fold increase of MnSOD protein and activity was observed in four clones. Our data demonstrated that overexpression of MnSOD stimulated the activation of MMP-2 with a corresponding elevation of ROS. A decrease in ROS by ebselen, a glutathione peroxidase mimetic, or by transduction of adenovirus containing human catalase or glutathione peroxidase cDNA abolished the effect of MnSOD on MMP-2 activation. Treatment of MCF-7 cells with antimycin A or rotenone increased intracellular ROS production and MMP-2 activation simultaneously. Our data also showed a suppression of endothelial nitric-oxide synthase expression that was accompanied by decreased (NO)-N-. production in MnSOD-overexpressing cells. However, the changes in endothelial nitric-oxide synthase and (NO)-N-. did not correlate with the MnSOD activity. Corresponding changes of MMP-2 activity after the addition of a NOS inhibitor (N-G--amino-L-arginine) or a (NO)-N-. donor ((Z)-1-[(2-aminoethyl) -N-(2-ammonioethyl) amino]diazen-1-ium-1,2-diolate) to the cells suggested the possibility that (NO)-N-. may be involved in the MnSOD-mediated MMP2 activation pathway. These results indicate that MnSOD induces MMP-2 activity by regulation of intracellular ROS and imply that signaling pathways involving (NO)-N-. may also be involved in the MnSOD mediation of MMP-2 activity.	Univ Iowa, Dept Radiat Oncol, Free Radical & Radiat Biol Program, Iowa City, IA 52242 USA; Univ Iowa, Dept Exercise Sci, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Oberley, LW (corresponding author), Univ Iowa, Dept Radiat Oncol, Free Radical & Radiat Biol Program, B180 ML, Iowa City, IA 52242 USA.			Buettner, Garry/0000-0002-5594-1903	NATIONAL CANCER INSTITUTE [R01CA084462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG012350, R01AG014687, R29AG012350] Funding Source: NIH RePORTER; NCI NIH HHS [CA84462, P01 CA 660841] Funding Source: Medline; NIA NIH HHS [AG 12350, AG 14687] Funding Source: Medline; NIDDK NIH HHS [DK 51612] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMSTAD P, 1991, BIOCHEMISTRY-US, V30, P9305, DOI 10.1021/bi00102a024; AMSTAD P, 1994, J BIOL CHEM, V269, P1606; BASS DA, 1983, J IMMUNOL, V130, P1910; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Bostwick DG, 2000, CANCER, V89, P123, DOI 10.1002/1097-0142(20000701)89:1<123::AID-CNCR17>3.0.CO;2-9; BRAVARD A, 1992, INT J CANCER, V51, P476, DOI 10.1002/ijc.2910510323; Brenneisen P, 1997, FREE RADICAL BIO MED, V22, P515, DOI 10.1016/S0891-5849(96)00404-2; Camhi S L, 1995, New Horiz, V3, P170; CARTER WO, 1994, J LEUKOCYTE BIOL, V55, P253; CRAWFORD HC, 1994, INVAS METAST, V14, P234; Esworthy RS, 1997, ARCH BIOCHEM BIOPHYS, V340, P59, DOI 10.1006/abbi.1997.9901; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lam EWN, 1999, FREE RADICAL BIO MED, V27, P572, DOI 10.1016/S0891-5849(99)00109-4; Li SJ, 2000, CANCER RES, V60, P3927; Liu RG, 1997, HUM GENE THER, V8, P585, DOI 10.1089/hum.1997.8.5-585; LOTTA LA, 1984, AM J PATHOL, V117, P339; MAIORINO M, 1988, BIOCHEM PHARMACOL, V37, P2267, DOI 10.1016/0006-2952(88)90591-6; Malafa M, 2000, J SURG RES, V88, P130, DOI 10.1006/jsre.1999.5773; MELCHIORI A, 1992, CANCER RES, V52, P2353; NOMURA K, 1993, FEBS LETT, V321, P84, DOI 10.1016/0014-5793(93)80626-6; OBERLEY LW, 1979, CANCER RES, V39, P1141; Oberley LW, 1986, FREE RADICALS AGING, P352; OVERALL CM, 1991, J BIOL CHEM, V266, P14064; Paradies G, 2000, FEBS LETT, V466, P323, DOI 10.1016/S0014-5793(00)01082-6; PARHAM MJ, 1987, BIOCHEM PHARMACOL, V36, P3095; PARK AJ, 1991, J BIOL CHEM, V266, P1584; Rodriguez AM, 2000, FREE RADICAL BIO MED, V29, P801, DOI 10.1016/S0891-5849(00)00362-2; ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222; SANCHEZLOPEZ R, 1988, J BIOL CHEM, V263, P11892; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; SEFTOR REB, 1994, ELECTROPHORESIS, V15, P454, DOI 10.1002/elps.1150150162; Siwik DA, 2001, AM J PHYSIOL-CELL PH, V280, pC53, DOI 10.1152/ajpcell.2001.280.1.C53; SPITZ DR, 1989, ANAL BIOCHEM, V179, P8, DOI 10.1016/0003-2697(89)90192-9; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; STETLERSTEVENSON WG, 1991, AM J MED SCI, V302, P163, DOI 10.1097/00000441-199109000-00009; STETLERSTEVENSON WG, 1990, CANCER METAST REV, V9, P289, DOI 10.1007/BF00049520; SUN Y, 1988, FREE RADICAL RES COM, V5, P67, DOI 10.3109/10715768809066913; Thomas Patricia A, 1997, Pathol Oncol Res, V3, P278; Vanden Hoek Terry L., 1997, Journal of Molecular and Cellular Cardiology, V29, P2441, DOI 10.1006/jmcc.1997.0481; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Wenk J, 1999, J BIOL CHEM, V274, P25869, DOI 10.1074/jbc.274.36.25869; Yan T, 1996, CANCER RES, V56, P2864; Zhang HJ, 1999, CANCER RES, V59, P6276; Zhao W, 2000, INT J RADIAT BIOL, V76, P391, DOI 10.1080/095530000138736; Zhong WX, 1996, CELL GROWTH DIFFER, V7, P1175; Zhong WX, 1997, ONCOGENE, V14, P481, DOI 10.1038/sj.onc.1200852	49	164	170	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2002	277	23					20919	20926		10.1074/jbc.M109801200	http://dx.doi.org/10.1074/jbc.M109801200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	562NJ	11929863	hybrid, Green Submitted			2022-12-27	WOS:000176204500105
J	Abrescia, C; De Gregorio, E; Frontini, M; Mantovani, R; Di Nocera, P				Abrescia, C; De Gregorio, E; Frontini, M; Mantovani, R; Di Nocera, P			A novel intragenic sequence enhances initiator-dependent transcription in human embryonic kidney 293 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; CORE PROMOTER ELEMENT; DROSOPHILA-MELANOGASTER; TATA-BOX; DOC-ELEMENTS; DNA-BINDING; F-ELEMENTS; DOWNSTREAM; COMPLEX; ACTIVATION	In a variety of Drosophila TATA-less promoters, transcription is directed by initiator (Inr) sequences, which are faithfully and efficiently recognized only when Ranked 3' by the downstream promoter element (DPE). This motif, which is conserved at similar to30 bp from the RNA start site, is viewed as a downstream counterpart to the TATA box, and is recognized by the general transcription factor (TF) IID. By transient expression assays in human embryonic kidney 293 cells, we show that DE1 (distal element 1), a DNA motif located at residues +23 to +29, sustains faithful Inr-dependent transcription as efficiently as the DPE. Transcription significantly increased when DE1 and DPE sequences were adjacently placed on the same template. Results emerging from in vivo RNA analyses matched electrophoretic mobility shift assay data. In agarose-electrophoretic mobility shift assays, retarded DNA-protein complexes resulting from the interaction of human holo-TFIID with either Inr(+)/DPE+ or Inr(+)/DE1(+) promoters were formed at comparable levels, whereas binding of TFIID to both DE1 and DPE motifs was 2-fold increased. The strict requirement for spacing between the Inr and DPE was not observed for DE1, as locating the motif 4 bp away from the +1 site did not impair transcriptional enhancement. DE1 sequences may be common to many promoters and be overlooked because of their poor sequence homology.	Univ Studi Napoli Federico 2, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy; Univ Modena & Reggio, Dipartimento Biol Anim, I-41100 Modena, Italy	Universita di Modena e Reggio Emilia	Di Nocera, P (corresponding author), Univ Studi Napoli Federico 2, Dipartimento Biol & Patol Cellulare & Mol, Via S Pansini 5, I-80131 Naples, Italy.		De Gregorio, Eliana/AAK-2086-2020	De Gregorio, Eliana/0000-0002-2529-8611				BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burke TW, 1996, GENE DEV, V10, P711, DOI 10.1101/gad.10.6.711; Butler JEF, 2001, GENE DEV, V15, P2515, DOI 10.1101/gad.924301; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLGAN J, 1995, P NATL ACAD SCI USA, V92, P1955, DOI 10.1073/pnas.92.6.1955; CONTURSI C, 1995, J BIOL CHEM, V270, P26570, DOI 10.1074/jbc.270.44.26570; Croager EJ, 2000, AM J PATHOL, V156, P1723, DOI 10.1016/S0002-9440(10)65043-2; EMAMI KH, 1995, MOL CELL BIOL, V15, P5906; Frontini M, 2002, J BIOL CHEM, V277, P5841, DOI 10.1074/jbc.M103651200; GRIMALDI G, 1988, P NATL ACAD SCI USA, V85, P5502, DOI 10.1073/pnas.85.15.5502; JACQ X, 1994, CELL, V79, P107, DOI 10.1016/0092-8674(94)90404-9; KAUFMANN J, 1994, GENE DEV, V8, P821, DOI 10.1101/gad.8.7.821; Knutson A, 2000, J BIOL CHEM, V275, P14190, DOI 10.1074/jbc.275.19.14190; KOLLMAR R, 1994, J BIOL CHEM, V269, P2252; Kraus RJ, 1996, NUCLEIC ACIDS RES, V24, P1531, DOI 10.1093/nar/24.8.1531; Kutach AK, 2000, MOL CELL BIOL, V20, P4754, DOI 10.1128/MCB.20.13.4754-4764.2000; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; Lewis BA, 2000, P NATL ACAD SCI USA, V97, P7172, DOI 10.1073/pnas.120181197; Liberati C, 1999, J MOL BIOL, V285, P1441, DOI 10.1006/jmbi.1998.2384; Minchiotti G, 1997, J MOL BIOL, V267, P37, DOI 10.1006/jmbi.1996.0860; Minchiotti G, 1997, FEBS LETT, V411, P189, DOI 10.1016/S0014-5793(97)00689-3; MINCHIOTTI G, 1991, MOL CELL BIOL, V11, P5171, DOI 10.1128/MCB.11.10.5171; NAKATANI Y, 1990, NATURE, V348, P86, DOI 10.1038/348086a0; Perier RC, 1999, NUCLEIC ACIDS RES, V27, P307, DOI 10.1093/nar/27.1.307; PURNELL BA, 1994, GENE DEV, V8, P830, DOI 10.1101/gad.8.7.830; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; VERRIJZER CP, 1994, SCIENCE, V264, P933, DOI 10.1126/science.8178153; Wieczorek E, 1998, NATURE, V393, P187, DOI 10.1038/30283; Willy PJ, 2000, SCIENCE, V290, P982, DOI 10.1126/science.290.5493.982; Wu CH, 2001, MOL CELL BIOL, V21, P1593, DOI 10.1128/MCB.21.5.1593-1602.2001; ZAWEL L, 1995, ANNU REV BIOCHEM, V64, P533	34	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 31	2002	277	22					19594	19599		10.1074/jbc.M201193200	http://dx.doi.org/10.1074/jbc.M201193200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	557EH	11916971	Green Published, hybrid			2022-12-27	WOS:000175894800048
J	Artz, JD; Schmidt, B; McCracken, JL; Marletta, MA				Artz, JD; Schmidt, B; McCracken, JL; Marletta, MA			Effects of nitroglycerin on soluble guanylate cyclase - Implications for nitrate tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE DONORS; ANGINA-PECTORIS; CARBON-MONOXIDE; BOVINE LUNG; NO DONORS; ACTIVATION; HEME; OXYHEMOGLOBIN; THERAPY; RELAXATION	Soluble guanylate cyclase (sGC) is a heterodimeric hemoprotein that catalyzes the conversion of GTP to cGMP. Upon binding NO to its heme cofactor, purified sGC was activated 300-fold. sGC was only activated 67-fold by nitroglycerin (GTN) and Cys; and in the absence of Cys, GTN did not activate sGC. Electronic absorption spectroscopy studies showed that upon NO binding, the Soret of ferrous sGC shifted from 431 to 399 nm. The data also revealed that activation of sGC by GTN/Cys was not via the expected ferrous heme-NO species as indicated by the absence of the 399 nm heme Soret. Furthermore, EPR studies of the reaction of GTN/Cys with sGC confirmed that no ferrous heme-NO species was formed but that there was heme oxidation. Potassium ferricyanide is known to oxidize ferrous sGC to the ferric oxidation state. Spectroscopic and activity data for the reactions of sGC with GTN alone or with K3Fe(CN)(6) were indistinguishable. These data suggest the following: 1) GTN/Cys do not activate sGC via GTN biotransformation to NO in vitro, and 2) in the absence of added thiol, GTN oxidizes sGC.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Michigan State University	Marletta, MA (corresponding author), Univ Calif Berkeley, Dept Chem, 211 Lewis Hall, Berkeley, CA 94720 USA.		Artz, Jennifer/G-5515-2014	Artz, Jennifer/0000-0003-0500-6156	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054065] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM54065] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrams J, 1998, AM J CARDIOL, V81, p3A, DOI 10.1016/S0002-9149(97)00992-2; Artz JD, 1998, CHEM RES TOXICOL, V11, P1393, DOI 10.1021/tx980205+; Artz JD, 2001, BIOCHEMISTRY-US, V40, P9256, DOI 10.1021/bi002885x; BOHYN M, 1991, CARDIOVASC DRUG THER, V5, P457, DOI 10.1007/BF03029770; Brandish PE, 1998, BIOCHEMISTRY-US, V37, P16898, DOI 10.1021/bi9814989; CHONG S, 1991, BIOCHEM PHARMACOL, V42, P1433; CHUNG SJ, 1993, BIOCHEM PHARMACOL, V45, P157; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; DUNSTAN I, 1965, J CHEM SOC, P1319, DOI 10.1039/jr9650001319; Feelisch M, 1998, N-S ARCH PHARMACOL, V358, P113, DOI 10.1007/PL00005231; GERZER R, 1981, FEBS LETT, V132, P71, DOI 10.1016/0014-5793(81)80429-2; GRUETTER CA, 1986, CAN J PHYSIOL PHARM, V64, P1395, DOI 10.1139/y86-236; IGNARRO LJ, 1982, P NATL ACAD SCI-BIOL, V79, P2870, DOI 10.1073/pnas.79.9.2870; KAMISAKI Y, 1986, J BIOL CHEM, V261, P7236; Keefer LK, 1996, METHOD ENZYMOL, V268, P281; Kelm M, 1997, J BIOL CHEM, V272, P9922; Kharitonov VG, 1999, BIOCHEMISTRY-US, V38, P10699, DOI 10.1021/bi990277f; Kharitonov VG, 1997, BIOCHEM BIOPH RES CO, V239, P284, DOI 10.1006/bbrc.1997.7470; Marsh N, 2000, CLIN EXP PHARMACOL P, V27, P313, DOI 10.1046/j.1440-1681.2000.03240.x; MUNZEL T, 1995, J CLIN INVEST, V95, P187, DOI 10.1172/JCI117637; NEEDLEMAN P, 1972, J PHARMACOL EXP THER, V181, P489; Parker JD, 1998, NEW ENGL J MED, V338, P520, DOI 10.1056/NEJM199802193380807; SCHMIDT K, 1994, BIOCHEM J, V301, P645, DOI 10.1042/bj3010645; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Stone JR, 1996, BIOCHEMISTRY-US, V35, P3258, DOI 10.1021/bi952386+; Stone JR, 1998, CHEM BIOL, V5, P255, DOI 10.1016/S1074-5521(98)90618-4; STONE JR, 1995, BIOCHEM BIOPH RES CO, V207, P572, DOI 10.1006/bbrc.1995.1226; Stone JR, 1996, BIOCHEMISTRY-US, V35, P1093, DOI 10.1021/bi9519718; Thatcher RGJ, 1998, CHEM SOC REV, V27, P331; WALDMAN SA, 1986, BIOCHEM PHARMACOL, V35, P3525, DOI 10.1016/0006-2952(86)90622-2; WEDEL B, 1994, P NATL ACAD SCI USA, V91, P2592, DOI 10.1073/pnas.91.7.2592; Zhao Y, 1999, P NATL ACAD SCI USA, V96, P14753, DOI 10.1073/pnas.96.26.14753; Zhao Y, 1997, BIOCHEMISTRY-US, V36, P15959, DOI 10.1021/bi971825x; Zhao Y, 1998, BIOCHEMISTRY-US, V37, P4502, DOI 10.1021/bi972686m; Zhao YD, 2000, BIOCHEMISTRY-US, V39, P10848, DOI 10.1021/bi9929296	35	38	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 24	2002	277	21					18253	18256		10.1074/jbc.C200170200	http://dx.doi.org/10.1074/jbc.C200170200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	558PM	11937497	hybrid			2022-12-27	WOS:000175975800003
